data_2n0y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n0y _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.5 m80 . . . . . 0 C--O 1.224 -0.254 0 CA-C-O 120.816 0.341 . . . . 2.3900000000000001 110.886 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 8.0 m -161.45 141.62 10.68 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.802 -0.444 . . . . 1.6100000000000001 109.802 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.69 142.95 6.6 Favored Glycine 0 C--O 1.224 -0.491 0 N-CA-C 110.864 -0.894 . . . . 0.17000000000000001 110.864 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.708 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -76.54 117.64 18.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.588 0.694 . . . . 0.97999999999999998 111.847 -175.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.53 162.33 25.91 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.429 0.633 . . . . 1.01 111.92 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.581 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.8 mp -105.07 123.14 59.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.237 -0.892 . . . . 1.0800000000000001 109.082 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -117.15 106.14 13.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.652 -0.249 . . . . 0.66000000000000003 110.516 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 61.0 50.66 4.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.609 0.719 . . . . 1.46 110.366 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt 75.46 -8.67 1.54 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.151 -1.386 . . . . 2.3900000000000001 113.382 170.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.46 HG21 ' HD2' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -93.18 131.62 39.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.393 -0.523 . . . . 1.23 110.172 172.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.581 ' HA ' HG13 ' A' ' 8' ' ' ILE . 40.9 t -79.75 130.39 35.3 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.586 -0.734 . . . . 1.48 110.854 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.631 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -155.87 -156.17 7.69 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.876 -0.678 . . . . 0.16 112.615 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.708 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.7 mm -126.81 153.85 36.17 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-O 120.834 0.349 . . . . 1.05 110.883 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.471 HD12 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -121.5 134.5 64.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.985 -0.552 . . . . 1.01 109.626 178.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.43 109.92 7.45 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.982 0.42 . . . . 0.87 111.924 174.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.555 HD13 HG21 ' A' ' 100' ' ' ILE . 4.0 mp -83.57 118.55 31.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 107.926 -1.139 . . . . 1.05 107.926 171.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.478 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 2.2 t30 -121.41 122.73 40.44 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 110.0 -0.37 . . . . 1.1200000000000001 110.0 -177.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -108.47 83.75 1.82 Allowed 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 117.146 -1.822 . . . . 0.73999999999999999 107.215 163.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.435 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 11.9 t70 -121.99 -11.31 8.52 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.59 -1.633 . . . . 0.58999999999999997 106.59 157.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 23' ' ' SER . 14.9 p -102.31 174.18 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 112.049 -2.342 . . . . 1.0800000000000001 112.198 -154.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.71 ' O ' HG12 ' A' ' 22' ' ' VAL . 6.8 m -54.71 166.56 0.73 Allowed Pre-proline 0 C--O 1.224 -0.281 0 N-CA-C 106.586 -1.635 . . . . 2.0 106.586 164.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 11.9 Cg_endo -42.0 128.09 3.99 Favored 'Trans proline' 0 C--N 1.352 0.732 0 CA-C-N 121.862 1.701 . . . . 0.26000000000000001 111.408 -149.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.501 ' HB1' HG22 ' A' ' 107' ' ' ILE . . . -32.23 133.29 0.11 Allowed 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 125.26 1.6 . . . . 1.02 113.446 -157.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.507 ' HB2' HG11 ' A' ' 22' ' ' VAL . 68.7 mt-10 -124.09 140.8 52.62 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.429 -1.26 . . . . 1.26 111.089 -168.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.567 HD22 ' C ' ' A' ' 27' ' ' LEU . 1.7 tt -101.57 142.6 32.68 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 106.561 -1.644 . . . . 1.0600000000000001 106.561 172.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.443 ' N ' HD22 ' A' ' 27' ' ' LEU . 10.6 m -130.55 108.47 9.95 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.919 -0.712 . . . . 1.05 110.164 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.602 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 88.5 t90 -87.0 112.03 21.43 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.558 0.694 . . . . 0.29999999999999999 109.364 175.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.512 ' HD3' ' O ' ' A' ' 31' ' ' SER . 2.6 tmt_? -118.99 118.19 30.83 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.111 -0.949 . . . . 1.1599999999999999 108.819 -177.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.512 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 35.8 p -56.0 144.28 29.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.292 0.568 . . . . 1.3899999999999999 110.597 -176.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.631 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 21.4 m -53.85 -29.45 41.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.603 -1.18 . . . . 1.1499999999999999 112.008 -175.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -83.56 -25.65 30.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.259 0.552 . . . . 2.3300000000000001 111.065 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.3 16.67 39.61 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.886 -0.673 . . . . 0.55000000000000004 112.337 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.36 -65.27 1.02 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.104 0.478 . . . . 1.1299999999999999 110.99 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.46 ' HD2' HG21 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -106.43 155.06 19.95 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.508 -0.769 . . . . 2.6200000000000001 110.777 -175.364 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 69.0 t -146.81 139.76 19.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.97 -1.014 . . . . 1.3100000000000001 109.636 -175.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -139.34 111.23 7.29 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.234 -0.284 . . . . 0.82999999999999996 110.234 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.3 m -98.31 138.75 35.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.58 0.229 . . . . 1.0600000000000001 111.496 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 41.1 t -113.16 129.44 68.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 122.523 0.329 . . . . 1.3600000000000001 111.521 176.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.546 ' O ' HG12 ' A' ' 45' ' ' ILE . 38.8 t -91.04 108.1 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 109.576 -0.528 . . . . 1.05 109.576 173.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.567 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.8 mm? -53.21 -28.89 29.27 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.091 -0.959 . . . . 1.04 112.597 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.4 m -74.88 -35.76 62.29 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.663 -0.415 . . . . 1.45 111.446 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.3 p -72.28 -14.17 61.7 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 121.376 0.608 . . . . 1.04 109.564 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 41' ' ' VAL . 48.6 mm -82.32 120.93 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.335 -0.848 . . . . 1.02 111.395 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.606 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 15.7 t70 -78.46 -46.09 20.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.73 -0.668 . . . . 0.69999999999999996 110.904 176.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -136.88 150.52 48.3 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.129 -0.487 . . . . 2.4300000000000002 109.975 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.531 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 9.9 tp -113.45 144.23 43.16 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.29 -0.633 . . . . 1.04 109.29 165.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.453 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 14.3 mm100 -120.87 154.57 35.66 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.978 -1.01 . . . . 1.49 109.518 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.463 ' HB1' ' CE ' ' A' ' 97' ' ' MET . . . -162.59 141.44 8.92 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.55 -0.75 . . . . 1.0 108.992 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.591 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 37.1 p -56.53 126.04 68.68 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-O 121.303 0.573 . . . . 1.03 112.055 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 72.9 Cg_endo -74.46 166.37 29.6 Favored 'Trans proline' 0 C--N 1.329 -0.457 0 C-N-CA 123.972 3.114 . . . . 0.73999999999999999 111.314 172.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.6 -27.85 63.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.109 0.481 . . . . 1.54 110.415 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.4 m -69.07 -24.81 64.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.706 -0.679 . . . . 2.0499999999999998 111.282 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.507 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 39.5 t -76.54 148.51 37.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.127 -0.488 . . . . 1.1399999999999999 109.717 177.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -90.68 -2.18 57.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.42 0.629 . . . . 2.8900000000000001 110.116 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -115.39 178.98 4.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.194 -0.912 . . . . 3.1299999999999999 110.858 -174.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.591 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -132.35 107.76 8.74 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.017 -1.105 . . . . 2.0 108.017 168.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 75.1 mtm -154.54 152.0 29.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.982 0.42 . . . . 1.3 111.21 -176.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 97' ' ' MET . 0.8 OUTLIER -112.05 158.33 19.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.242 -0.89 . . . . 1.05 110.229 175.134 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 45.2 ttt180 -153.63 114.32 4.03 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 121.274 0.559 . . . . 3.3999999999999999 111.009 170.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.531 ' CD2' HG21 ' A' ' 45' ' ' ILE . 9.0 mt -92.24 112.91 25.03 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.717 -0.674 . . . . 1.73 110.515 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.493 HD11 ' HD3' ' A' ' 86' ' ' ARG . 5.0 mm -86.7 116.64 29.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.512 0.725 . . . . 1.1599999999999999 110.307 -174.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -85.33 144.97 21.01 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.159 -1.019 . . . . 0.47999999999999998 111.487 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.606 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 8.2 mptt -58.73 134.98 57.3 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.057 0.456 . . . . 1.78 110.734 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--N 1.321 -0.662 0 CA-C-N 115.509 -0.769 . . . . 1.3100000000000001 110.289 -179.326 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 . . . . . 0 N--CA 1.448 -0.527 0 CA-C-O 121.531 0.682 . . . . 1.78 109.264 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.493 ' HD3' HD11 ' A' ' 63' ' ' ILE . 18.7 mtt180 -140.13 153.73 46.78 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.551 -0.749 . . . . 2.8199999999999998 110.33 -168.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -115.88 110.45 19.03 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.08 -0.711 . . . . 0.63 109.08 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.446 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 54.9 ttm -103.25 129.26 50.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.781 0.324 . . . . 1.1200000000000001 110.827 -175.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.471 ' CG ' HD12 ' A' ' 16' ' ' ILE . 80.4 m-85 -123.46 122.54 38.51 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 109.245 -0.65 . . . . 1.6499999999999999 109.245 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.482 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 22.7 m -91.18 128.95 37.21 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.04 -0.527 . . . . 1.1899999999999999 110.838 -174.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.593 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 29.1 m-85 -108.16 174.79 5.72 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.95 -0.568 . . . . 1.6399999999999999 110.816 176.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -119.57 0.22 10.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.706 -0.679 . . . . 1.8300000000000001 109.821 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.504 ' OD1' ' HB ' ' A' ' 95' ' ' THR . 28.7 t-20 -143.38 131.43 21.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.324 -0.853 . . . . 1.22 110.647 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.457 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 0.9 OUTLIER -74.97 -23.28 58.26 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.962 -0.563 . . . . 2.8799999999999999 110.976 -174.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.504 ' HB ' ' OD1' ' A' ' 93' ' ' ASN . 92.8 m -70.99 -54.49 11.07 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.411 -0.516 . . . . 1.1200000000000001 109.783 175.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.0 t -45.7 -57.36 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-N 116.134 -0.485 . . . . 1.1299999999999999 111.103 173.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.463 ' CE ' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -64.12 -29.3 70.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.006 -0.543 . . . . 1.0600000000000001 111.093 -178.134 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.29 -32.18 72.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.407 0.622 . . . . 0.39000000000000001 109.554 175.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.463 ' HA ' ' HE2' ' A' ' 102' ' ' MET . 90.6 m-20 -75.03 -46.82 32.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.887 -1.051 . . . . 1.55 109.844 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.593 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 27.6 mm -61.28 -51.16 76.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.003 -0.999 . . . . 1.0600000000000001 110.276 175.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.52 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 0.0 OUTLIER -55.74 -51.9 65.76 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.614 -0.721 . . . . 1.72 111.197 179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.481 ' N ' ' HE2' ' A' ' 101' ' ' LYS . 11.7 ptp -60.2 -32.15 70.82 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.081 0.467 . . . . 1.76 109.777 -176.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 54.1 m -63.36 -52.04 63.41 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.267 -0.879 . . . . 1.04 110.261 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.567 ' CD2' HD11 ' A' ' 42' ' ' LEU . 11.3 mt -66.95 -55.59 13.87 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.43 -0.805 . . . . 1.05 110.781 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 101' ' ' LYS . 19.2 mm-40 -43.16 -37.54 2.11 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.653 0.596 . . . . 1.45 112.544 178.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -68.1 -35.51 78.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.823 0.82 . . . . 0.66000000000000003 109.555 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.501 HG22 ' HB1' ' A' ' 25' ' ' ALA . 81.3 mt -72.51 -41.66 63.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.017 -1.447 . . . . 1.04 110.319 175.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.41 HG12 HD13 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -65.3 -50.92 70.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.855 -0.611 . . . . 1.04 110.217 -177.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.6 t -58.53 -28.47 65.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.47 0.653 . . . . 1.6100000000000001 109.941 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.461 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 11.0 ttt180 -68.73 -38.81 80.45 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.049 -0.978 . . . . 4.3899999999999997 109.927 177.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 . . . . . 0 N--CA 1.446 -0.65 0 CA-C-N 115.928 -0.578 . . . . 0.71999999999999997 111.698 -175.037 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 261' ' ' PHE . . . . . 0.453 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 6.0 m-85 . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 121.056 0.455 . . . . 0.97999999999999998 110.822 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 12.9 p -135.09 145.22 32.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.669 -0.696 . . . . 1.8999999999999999 109.165 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.607 0 CA-C-O 121.021 0.439 . . . . 2.2400000000000002 110.13 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.614 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 36.0 m80 . . . . . 0 C--O 1.225 -0.191 0 N-CA-C 111.858 0.318 . . . . 2.3900000000000001 111.858 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.4 p -162.37 145.61 11.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.982 0.42 . . . . 1.6100000000000001 110.906 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.48 145.71 6.72 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.71 -0.956 . . . . 0.17000000000000001 110.71 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.696 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -71.68 142.88 49.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.21 0.505 . . . . 0.97999999999999998 111.361 -176.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -152.62 155.09 36.66 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-O 121.209 0.528 . . . . 1.01 111.61 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.518 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.2 mp -92.34 131.18 40.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.606 -0.725 . . . . 1.0800000000000001 109.4 176.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.55 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 89.3 t80 -139.74 112.87 8.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.28 -0.418 . . . . 0.66000000000000003 110.134 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.484 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 51.3 mt-10 68.6 48.83 0.78 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.604 0.716 . . . . 1.46 110.371 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.484 ' HD2' ' C ' ' A' ' 10' ' ' GLU . 4.0 mptt 67.41 4.4 3.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.351 -1.295 . . . . 2.3900000000000001 112.84 173.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.94 134.69 54.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.835 0.35 . . . . 1.23 110.623 175.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.518 ' HA ' HG13 ' A' ' 8' ' ' ILE . 31.8 t -75.02 128.53 35.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.028 -0.533 . . . . 1.48 109.819 176.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.661 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -148.1 -159.88 8.68 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.701 -0.762 . . . . 0.16 112.347 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.696 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.8 mm -126.33 152.66 34.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.066 0.46 . . . . 1.05 110.841 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.417 HG12 HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -122.63 133.04 69.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.647 -0.706 . . . . 1.01 109.842 178.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.14 110.33 7.81 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.92 0.391 . . . . 0.87 111.958 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.614 ' O ' ' HB3' ' A' ' 3' ' ' HIS . 3.6 mp -85.41 119.46 34.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.844 -0.799 . . . . 1.05 108.844 172.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.451 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 2.0 t30 -120.77 123.42 42.62 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.992 -0.373 . . . . 1.1200000000000001 109.992 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.427 ' HG2' ' HB3' ' A' ' 25' ' ' ALA . 15.9 mt-10 -108.85 83.08 1.7 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 117.332 -1.747 . . . . 0.73999999999999999 107.452 164.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -122.04 -10.92 8.55 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 106.522 -1.658 . . . . 0.58999999999999997 106.522 157.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 23' ' ' SER . 14.5 p -102.33 175.5 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 111.919 -2.4 . . . . 1.0800000000000001 112.057 -155.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.688 ' O ' HG12 ' A' ' 22' ' ' VAL . 56.8 p -54.4 165.96 0.78 Allowed Pre-proline 0 C--O 1.225 -0.2 0 N-CA-C 106.714 -1.587 . . . . 2.0 106.714 166.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.571 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 12.0 Cg_endo -42.47 128.97 4.82 Favored 'Trans proline' 0 C--N 1.359 1.095 0 CA-C-N 122.326 1.866 . . . . 0.26000000000000001 111.157 -152.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.528 ' HB1' HG22 ' A' ' 107' ' ' ILE . . . -31.46 136.11 0.06 Allowed 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 125.44 1.712 . . . . 1.02 114.193 -155.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HB2' HG11 ' A' ' 22' ' ' VAL . 64.1 mt-10 -122.64 132.4 54.26 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 114.439 -1.255 . . . . 1.26 110.789 -171.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.596 ' C ' HD23 ' A' ' 27' ' ' LEU . 1.3 tt -100.81 142.18 32.65 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 106.235 -1.765 . . . . 1.0600000000000001 106.235 173.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.415 ' N ' HD23 ' A' ' 27' ' ' LEU . 25.9 m -130.67 109.34 10.56 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 119.537 -0.865 . . . . 1.05 110.551 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.614 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 88.8 t90 -85.83 108.85 18.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.624 0.726 . . . . 0.29999999999999999 109.376 174.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -115.13 115.0 26.05 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.774 -1.103 . . . . 1.1599999999999999 108.467 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.514 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 79.3 p -57.21 150.03 18.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.153 0.501 . . . . 1.3899999999999999 110.751 -173.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.661 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 24.0 m -57.83 -29.05 64.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.176 -0.92 . . . . 1.1499999999999999 110.435 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.474 ' OD2' ' HB3' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -80.65 -27.95 37.02 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.421 -0.809 . . . . 2.3300000000000001 111.548 177.181 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.6 -5.07 56.78 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.818 -0.705 . . . . 0.55000000000000004 113.161 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.474 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 2.4 t70 -67.28 -52.23 43.18 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.3 0.482 . . . . 1.1299999999999999 112.3 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -103.0 143.48 32.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.621 0.724 . . . . 2.6200000000000001 112.426 -174.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 76.9 t -141.86 116.44 5.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.175 -1.375 . . . . 1.3100000000000001 109.802 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -123.75 109.74 14.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.949 -0.569 . . . . 0.82999999999999996 109.904 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 32.8 m -97.35 137.84 35.72 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.944 -0.303 . . . . 1.0600000000000001 111.177 -176.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.51 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 42.0 t -110.91 130.91 63.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 122.815 0.446 . . . . 1.3600000000000001 111.655 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 45' ' ' ILE . 51.0 t -90.91 108.29 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 109.619 -0.512 . . . . 1.05 109.619 172.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.601 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -53.48 -27.96 28.07 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.994 -1.003 . . . . 1.04 112.844 -178.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.0 m -75.47 -34.59 60.91 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.598 -0.441 . . . . 1.45 111.443 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.6 p -75.26 -11.95 60.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.273 0.558 . . . . 1.04 109.71 173.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.639 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 47.5 mm -81.75 117.02 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 115.143 -0.935 . . . . 1.02 111.282 173.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.528 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 21.2 t70 -73.93 -46.24 45.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.429 -0.805 . . . . 0.69999999999999996 111.375 177.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.52 ' HG2' ' OD2' ' A' ' 46' ' ' ASP . 47.9 mmtm -140.75 157.3 45.62 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.473 -0.331 . . . . 2.4300000000000002 110.354 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.636 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 13.2 tp -123.51 140.93 52.5 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.256 0.55 . . . . 1.04 109.941 167.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.544 ' OE1' ' HB3' ' B' ' 263' ' ' GLU . 16.3 mm100 -113.01 157.8 21.07 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.749 -1.114 . . . . 1.49 109.846 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.51 136.32 5.36 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.8 -0.636 . . . . 1.0 109.539 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 40.6 p -51.27 124.74 23.7 Favored Pre-proline 0 N--CA 1.467 0.404 0 CA-C-O 121.259 0.552 . . . . 1.03 111.243 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 48.3 Cg_endo -66.82 166.54 22.15 Favored 'Trans proline' 0 C--N 1.333 -0.287 0 C-N-CA 124.057 3.171 . . . . 0.73999999999999999 111.983 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.11 -25.0 65.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.902 0.382 . . . . 1.54 110.829 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.8 m -78.37 -24.39 46.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.847 -0.615 . . . . 2.0499999999999998 111.521 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.476 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 29.7 t -67.54 149.29 50.33 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.216 -0.661 . . . . 1.1399999999999999 109.216 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.48 -14.36 22.4 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.606 -0.887 . . . . 2.8900000000000001 108.606 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.609 ' HD3' ' N ' ' A' ' 57' ' ' LYS . 2.7 mppt? -94.34 -177.89 4.41 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.821 -1.081 . . . . 3.1299999999999999 110.996 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.486 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -136.49 110.67 8.37 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.388 -0.968 . . . . 2.0 108.388 172.314 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.669 ' HB3' ' CZ ' ' B' ' 261' ' ' PHE . 2.5 mtm -156.54 138.68 14.59 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.694 -0.402 . . . . 1.3 111.854 -173.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.829 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 2.3 mp -109.2 160.05 16.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.843 -0.617 . . . . 1.05 111.078 170.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.526 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 9.8 ttm180 -150.54 114.19 4.97 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.981 -0.554 . . . . 3.3999999999999999 110.356 172.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.517 ' HG ' HD12 ' A' ' 48' ' ' LEU . 6.2 mp -94.19 110.44 22.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.075 0.464 . . . . 1.73 110.502 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.422 HG21 ' HG2' ' A' ' 86' ' ' ARG . 2.2 mm -87.95 124.6 41.21 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 C-N-CA 123.254 0.622 . . . . 1.1599999999999999 109.701 -176.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.639 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -93.58 160.05 24.29 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 119.255 -1.45 . . . . 0.47999999999999998 111.819 174.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.528 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 0.3 OUTLIER -69.29 132.86 47.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.72 0.295 . . . . 1.78 111.088 -178.599 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 C--N 1.316 -0.854 0 N-CA-C 108.807 -0.812 . . . . 1.3100000000000001 108.807 170.674 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.367 0 CA-C-O 121.931 0.872 . . . . 1.78 109.813 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.422 ' HG2' HG21 ' A' ' 63' ' ' ILE . 18.8 mtm180 -115.52 154.47 29.3 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.201 -0.909 . . . . 2.8199999999999998 109.133 -175.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -117.51 109.43 16.73 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.164 -0.471 . . . . 0.63 110.003 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.578 ' HE1' ' CE2' ' B' ' 261' ' ' PHE . 51.1 ttm -108.99 122.38 47.12 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 110.061 -0.348 . . . . 1.1200000000000001 110.061 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.487 ' CD2' ' HB2' ' A' ' 9' ' ' PHE . 57.8 m-85 -112.23 139.79 47.48 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.595 -0.891 . . . . 1.6499999999999999 108.595 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.51 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 31.3 m -97.74 123.11 41.54 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.597 -0.519 . . . . 1.1899999999999999 109.597 177.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.829 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 6.0 m-85 -106.09 165.06 11.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.986 -0.552 . . . . 1.6399999999999999 109.819 -175.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -107.3 -6.46 17.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.882 0.372 . . . . 1.8300000000000001 110.988 -171.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -145.66 128.36 16.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.142 0.496 . . . . 1.22 110.663 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.519 ' NH1' ' HB2' ' A' ' 98' ' ' ASP . 49.1 tpt85 -62.63 -26.24 68.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.06 -0.973 . . . . 2.8799999999999999 111.131 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.2 m -73.46 -60.06 2.42 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.738 0.304 . . . . 1.1200000000000001 110.382 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.405 ' O ' HG12 ' A' ' 100' ' ' ILE . 58.5 t -45.71 -55.57 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 CA-C-N 115.584 -0.734 . . . . 1.1299999999999999 111.441 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.535 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -63.21 -30.63 71.74 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.227 -0.442 . . . . 1.0600000000000001 110.786 -177.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.519 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 36.5 t70 -69.17 -31.3 69.84 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.619 0.723 . . . . 0.39000000000000001 109.557 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.494 ' HA ' ' HE2' ' A' ' 102' ' ' MET . 87.7 m-20 -72.93 -42.36 63.57 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.6 -1.182 . . . . 1.55 109.072 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.529 HG22 HD13 ' A' ' 18' ' ' ILE . 40.4 mm -62.64 -54.09 38.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.783 -1.099 . . . . 1.0600000000000001 111.562 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -60.87 -42.72 98.46 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 120.54 0.21 . . . . 1.72 111.481 -177.221 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.494 ' HE2' ' HA ' ' A' ' 99' ' ' ASN . 13.0 ptp -66.51 -29.56 69.68 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.66 -0.867 . . . . 1.76 108.66 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 32.7 m -66.0 -52.01 53.23 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.751 -1.113 . . . . 1.04 110.025 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.636 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 13.3 mt -69.31 -58.51 3.92 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.444 -0.798 . . . . 1.05 110.945 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.625 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 96.8 mt-30 -49.2 -28.21 4.32 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.757 0.651 . . . . 1.45 112.757 -178.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.4 ' O ' ' HG3' ' A' ' 110' ' ' ARG . 24.3 mt-30 -67.14 -49.02 66.27 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.852 -0.796 . . . . 0.66000000000000003 108.852 176.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.528 HG22 ' HB1' ' A' ' 25' ' ' ALA . 53.0 mt -59.65 -43.89 92.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.669 -1.15 . . . . 1.04 110.494 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -61.18 -58.24 8.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.604 -0.726 . . . . 1.04 110.168 -176.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.9 m -55.37 -29.23 58.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.722 0.296 . . . . 1.6100000000000001 111.467 173.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 92.5 mtt180 -68.93 -18.37 64.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.157 0.503 . . . . 4.3899999999999997 110.481 176.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 . . . . . 0 N--CA 1.442 -0.869 0 CA-C-N 115.687 -0.688 . . . . 0.71999999999999997 109.916 178.16 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 261' ' ' PHE . . . . . 0.669 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 6.2 m-30 . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 120.839 0.352 . . . . 0.97999999999999998 110.414 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.39 148.9 31.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.494 -0.558 . . . . 1.8999999999999999 109.494 174.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 263' ' ' GLU . . . . . 0.544 ' HB3' ' OE1' ' A' ' 49' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.617 0 CA-C-O 121.332 0.587 . . . . 2.2400000000000002 110.523 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.563 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 19.5 m80 . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.722 0.296 . . . . 2.3900000000000001 111.525 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.6 p -163.54 142.44 8.08 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.733 0.301 . . . . 1.6100000000000001 110.375 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.98 147.18 7.92 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.294 -1.122 . . . . 0.17000000000000001 110.294 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.718 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -69.8 144.52 52.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 117.41 0.605 . . . . 0.97999999999999998 111.603 -175.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 89' ' ' PHE . . . -152.64 155.83 38.07 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 121.068 0.461 . . . . 1.01 111.38 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.557 HG13 ' HA ' ' A' ' 13' ' ' SER . 1.9 mp -94.73 133.84 34.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.793 -0.639 . . . . 1.0800000000000001 109.297 177.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.432 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 74.3 t80 -139.69 121.0 14.93 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.285 -0.635 . . . . 0.66000000000000003 109.285 176.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 65.03 41.76 4.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.466 0.651 . . . . 1.46 110.141 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt 74.0 -6.43 1.83 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.519 -1.219 . . . . 2.3900000000000001 112.922 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.97 135.34 36.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.914 0.388 . . . . 1.23 110.539 175.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.557 ' HA ' HG13 ' A' ' 8' ' ' ILE . 9.6 p -73.38 128.93 36.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.79 -0.641 . . . . 1.48 110.691 176.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.646 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -146.8 -159.5 8.31 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 115.645 -0.707 . . . . 0.16 112.192 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.718 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.4 mm -126.39 152.95 34.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 120.905 0.383 . . . . 1.05 111.007 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.408 HG12 HD23 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -124.04 134.34 66.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 116.079 -0.51 . . . . 1.01 109.891 178.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.83 110.78 8.22 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.933 0.397 . . . . 0.87 112.069 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.563 ' O ' ' HB3' ' A' ' 3' ' ' HIS . 3.9 mp -85.13 112.8 22.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.785 -0.82 . . . . 1.05 108.785 171.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.425 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.9 t30 -114.97 125.86 54.1 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.823 -0.351 . . . . 1.1200000000000001 110.139 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -109.76 83.07 1.69 Allowed 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 117.255 -1.778 . . . . 0.73999999999999999 107.37 163.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.425 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 16.9 t70 -122.26 -10.01 8.55 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 106.42 -1.696 . . . . 0.58999999999999997 106.42 157.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 23' ' ' SER . 14.5 p -102.79 174.86 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 112.079 -2.328 . . . . 1.0800000000000001 111.897 -156.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.63 ' O ' HG12 ' A' ' 22' ' ' VAL . 12.0 p -54.52 165.0 0.96 Allowed Pre-proline 0 N--CA 1.453 -0.322 0 N-CA-C 106.661 -1.607 . . . . 2.0 106.661 165.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.577 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 11.8 Cg_endo -41.73 129.01 3.86 Favored 'Trans proline' 0 C--N 1.353 0.792 0 CA-C-N 121.731 1.654 . . . . 0.26000000000000001 111.809 -147.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.504 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -29.41 131.03 0.07 Allowed 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 125.406 1.691 . . . . 1.02 113.137 -159.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.614 ' HB3' HG11 ' A' ' 22' ' ' VAL . 36.7 tt0 -132.49 133.59 43.98 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.412 -1.267 . . . . 1.26 111.532 -160.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.595 ' C ' HD21 ' A' ' 27' ' ' LEU . 1.6 tt -100.38 146.88 26.45 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 107.276 -1.379 . . . . 1.0600000000000001 107.276 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.463 ' N ' HD21 ' A' ' 27' ' ' LEU . 22.6 m -137.57 109.31 7.07 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 120.134 -0.626 . . . . 1.05 110.552 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.585 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 88.3 t90 -85.58 112.38 20.91 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.688 -0.687 . . . . 0.29999999999999999 109.29 175.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -117.93 118.3 31.61 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.442 -0.948 . . . . 1.1599999999999999 108.442 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.536 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 71.6 p -57.21 152.18 14.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.667 0.27 . . . . 1.3899999999999999 111.032 -174.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.646 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 23.7 m -55.53 -35.12 65.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.599 0.714 . . . . 1.1499999999999999 109.889 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.18 -28.05 53.89 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.939 -1.028 . . . . 2.3300000000000001 111.613 178.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.9 1.55 70.27 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.915 -0.66 . . . . 0.55000000000000004 113.246 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -81.35 -25.05 36.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.856 0.328 . . . . 1.1299999999999999 111.688 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -120.82 140.96 51.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.162 0.506 . . . . 2.6200000000000001 111.719 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 73.7 t -142.45 126.11 15.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.298 -0.865 . . . . 1.3100000000000001 110.496 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -128.04 112.22 14.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.913 0.387 . . . . 0.82999999999999996 110.418 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.2 m -96.17 146.81 24.37 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.503 -0.317 . . . . 1.0600000000000001 111.476 -176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 36.9 t -126.28 127.67 70.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 122.476 0.31 . . . . 1.3600000000000001 111.433 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 45' ' ' ILE . 58.4 t -90.39 107.95 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-O 121.392 0.615 . . . . 1.05 109.497 173.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.597 HD13 ' CD2' ' A' ' 104' ' ' LEU . 1.9 mm? -51.15 -29.76 14.66 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.901 -1.045 . . . . 1.04 112.79 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.439 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 60.5 m -73.48 -34.96 65.59 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.565 -0.454 . . . . 1.45 111.528 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.3 p -72.85 -18.1 61.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.362 0.601 . . . . 1.04 109.574 173.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.544 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 50.0 mm -79.72 117.58 25.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.256 -0.884 . . . . 1.02 111.024 175.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.579 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 28.7 t70 -75.81 -43.1 47.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.029 -0.532 . . . . 0.69999999999999996 111.666 177.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.478 ' HG2' ' OD2' ' A' ' 46' ' ' ASP . 48.6 mmtm -141.05 153.93 45.73 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.865 -0.421 . . . . 2.4300000000000002 109.865 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.634 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 9.7 tp -117.31 145.99 43.63 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.203 -0.666 . . . . 1.04 109.203 166.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.614 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 15.9 mm100 -124.12 157.17 35.25 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.661 -1.154 . . . . 1.49 109.974 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.61 146.22 11.42 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.471 -0.786 . . . . 1.0 109.64 177.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.1 p -43.83 125.83 4.12 Favored Pre-proline 0 N--CA 1.468 0.429 0 C-N-CA 123.583 0.753 . . . . 1.03 111.756 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 52.8 Cg_endo -66.82 165.65 25.14 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 C-N-CA 123.803 3.002 . . . . 0.73999999999999999 111.649 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.21 -29.33 67.42 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.092 0.472 . . . . 1.54 110.313 175.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.9 t -70.43 -22.63 62.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.713 -0.676 . . . . 2.0499999999999998 110.611 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.492 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 47.7 t -72.18 145.49 48.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 1.1399999999999999 110.428 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -89.91 -7.98 52.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.354 0.597 . . . . 2.8900000000000001 109.576 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -103.92 179.43 4.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.021 -0.991 . . . . 3.1299999999999999 111.077 -173.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.55 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -137.29 109.88 7.5 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.375 -1.284 . . . . 2.0 108.064 178.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.771 ' HB3' ' CZ ' ' B' ' 261' ' ' PHE . 10.8 ttm -157.98 138.81 13.08 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.343 -0.543 . . . . 1.3 111.375 -169.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.808 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 3.2 mp -111.06 156.35 21.43 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.087 0.47 . . . . 1.05 112.028 174.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 59.9 ttp180 -150.28 113.2 4.81 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.776 -0.647 . . . . 3.3999999999999999 110.593 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.484 ' HG ' HD12 ' A' ' 48' ' ' LEU . 6.4 mp -95.72 110.73 22.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.998 -0.546 . . . . 1.73 110.693 -176.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.517 ' HA ' ' HB3' ' A' ' 86' ' ' ARG . 1.2 mm -87.6 120.98 37.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.163 -0.472 . . . . 1.1599999999999999 110.525 -173.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -83.17 156.24 33.74 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 119.89 -1.148 . . . . 0.47999999999999998 111.747 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.579 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 9.7 mptt -68.48 137.08 54.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.96 0.38 . . . . 1.78 110.29 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 C--N 1.32 -0.68 0 N-CA-C 109.207 -0.664 . . . . 1.3100000000000001 109.207 173.409 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? . . . . . 0 N--CA 1.445 -0.69 0 CA-C-O 121.829 0.823 . . . . 1.78 109.791 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.517 ' HB3' ' HA ' ' A' ' 63' ' ' ILE . 22.3 ptt180 -127.73 141.65 51.54 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.251 -0.886 . . . . 2.8199999999999998 110.444 -174.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -102.32 111.18 23.37 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.043 -0.98 . . . . 0.63 110.207 -170.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.461 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 53.6 ttm -108.27 120.12 41.45 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.598 -0.728 . . . . 1.1200000000000001 110.483 -172.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . 55.8 m-85 -111.5 140.48 46.07 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.394 -0.965 . . . . 1.6499999999999999 108.394 175.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.565 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 49.5 m -97.47 125.08 41.93 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.523 -0.471 . . . . 1.1899999999999999 110.221 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.808 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 5.6 m-85 -107.7 169.0 8.86 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.747 -0.661 . . . . 1.6399999999999999 109.357 -176.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -126.27 -3.4 6.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.851 0.358 . . . . 1.8300000000000001 110.68 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.432 ' OD1' HG22 ' A' ' 96' ' ' VAL . 28.6 t-20 -131.12 125.66 33.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.131 0.491 . . . . 1.22 110.616 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.426 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 12.7 tpt180 -62.29 -33.51 74.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.179 -0.918 . . . . 2.8799999999999999 111.371 -177.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.41 HG22 HD22 ' A' ' 99' ' ' ASN . 87.2 m -73.24 -55.76 6.0 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.951 -0.3 . . . . 1.1200000000000001 110.492 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.432 HG22 ' OD1' ' A' ' 93' ' ' ASN . 95.6 t -45.86 -56.39 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-N 115.824 -0.625 . . . . 1.1299999999999999 111.539 175.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.55 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -65.94 -28.9 69.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.321 -0.399 . . . . 1.0600000000000001 110.7 -177.397 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.95 -37.02 83.51 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.92 -0.77 . . . . 0.39000000000000001 108.92 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.546 ' O ' ' HG3' ' A' ' 102' ' ' MET . 90.4 m-20 -72.79 -48.53 37.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.205 -1.361 . . . . 1.55 109.581 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.498 HG21 HD13 ' A' ' 18' ' ' ILE . 41.0 mm -56.18 -53.05 43.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.985 -1.007 . . . . 1.0600000000000001 110.075 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.462 ' HA ' HD23 ' A' ' 60' ' ' LEU . 6.6 ttpp -55.98 -50.15 71.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.778 -0.646 . . . . 1.72 111.329 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.546 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.1 ppp? -68.56 -24.48 64.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.328 -0.396 . . . . 1.76 110.339 -175.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.7 m -67.62 -51.79 46.02 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.462 0.649 . . . . 1.04 110.071 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.634 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 13.8 mt -69.14 -58.5 3.98 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.132 -0.94 . . . . 1.05 111.364 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.572 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 66.5 mt-30 -51.52 -26.46 8.5 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.758 0.651 . . . . 1.45 112.758 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -66.24 -49.5 67.0 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.411 -0.959 . . . . 0.66000000000000003 108.411 175.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.504 HG21 ' HB3' ' A' ' 25' ' ' ALA . 67.7 mt -58.51 -43.57 87.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.303 -1.317 . . . . 1.04 110.487 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.1 mt -66.79 -49.24 76.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.996 -0.547 . . . . 1.04 110.654 -176.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.2 t -60.27 -26.14 66.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.388 0.613 . . . . 1.6100000000000001 110.095 173.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 83.0 mtt180 -73.87 -30.63 62.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.494 -0.776 . . . . 4.3899999999999997 110.624 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 . . . . . 0 N--CA 1.449 -0.478 0 CA-C-N 116.051 -0.522 . . . . 0.71999999999999997 112.144 -179.364 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 261' ' ' PHE . . . . . 0.771 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 6.7 m-30 . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 121.042 0.449 . . . . 0.97999999999999998 111.701 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.1 p -138.18 148.2 25.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.916 -0.584 . . . . 1.8999999999999999 110.264 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 . . . . . 0 C--N 1.324 -0.501 0 N-CA-C 108.931 -0.766 . . . . 2.2400000000000002 108.931 175.964 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.413 ' CE1' HG23 ' A' ' 103' ' ' THR . 12.4 m80 . . . . . 0 C--O 1.225 -0.224 0 N-CA-C 112.421 0.526 . . . . 2.3900000000000001 112.421 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.9 p -162.8 140.07 7.88 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.318 0.58 . . . . 1.6100000000000001 111.26 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.05 152.79 13.36 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.998 -1.241 . . . . 0.17000000000000001 109.998 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.707 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -73.46 145.88 45.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 117.578 0.689 . . . . 0.97999999999999998 111.5 -175.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.97 152.55 32.62 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.396 0.617 . . . . 1.01 111.525 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.479 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.7 mp -94.15 124.44 46.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.861 -0.792 . . . . 1.0800000000000001 108.861 174.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.559 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 79.9 t80 -128.99 105.62 8.33 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 110.176 -0.305 . . . . 0.66000000000000003 110.176 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 66.98 53.22 0.84 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.573 0.701 . . . . 1.46 110.664 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp 71.28 -8.16 1.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.175 -1.375 . . . . 2.3900000000000001 113.252 171.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.423 HG12 ' HD3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -99.32 132.73 44.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.865 -0.42 . . . . 1.23 109.865 172.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.479 ' HA ' HG13 ' A' ' 8' ' ' ILE . 23.3 t -85.28 123.97 31.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.998 -0.546 . . . . 1.48 109.921 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.633 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -144.48 -155.08 6.32 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 120.906 -0.664 . . . . 0.16 112.276 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.707 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.3 mm -125.11 153.35 32.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 120.977 0.418 . . . . 1.05 110.448 -177.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.489 HG12 HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -123.91 131.69 72.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.826 -0.625 . . . . 1.01 109.904 178.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.22 111.07 8.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.038 -0.528 . . . . 0.87 111.476 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 4.0 mp -84.22 118.98 32.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.053 -1.092 . . . . 1.05 108.053 172.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -121.94 123.23 41.19 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.909 -0.404 . . . . 1.1200000000000001 109.909 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.472 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 15.8 mt-10 -108.51 83.22 1.74 Allowed 'General case' 0 N--CA 1.426 -1.635 0 C-N-CA 117.113 -1.835 . . . . 0.73999999999999999 107.541 164.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -121.49 -10.2 8.88 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 106.38 -1.711 . . . . 0.58999999999999997 106.38 157.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 23' ' ' SER . 14.6 p -102.15 175.98 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 111.933 -2.394 . . . . 1.0800000000000001 111.791 -157.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.698 ' O ' HG12 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -54.51 167.29 0.6 Allowed Pre-proline 0 C--O 1.223 -0.291 0 N-CA-C 106.464 -1.68 . . . . 2.0 106.464 166.354 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 23' ' ' SER . 11.6 Cg_endo -42.05 128.29 4.09 Favored 'Trans proline' 0 C--N 1.357 1.002 0 CA-C-N 122.062 1.772 . . . . 0.26000000000000001 111.309 -153.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.499 ' HB3' HG23 ' A' ' 107' ' ' ILE . . . -30.0 133.73 0.05 Allowed 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 125.384 1.678 . . . . 1.02 114.189 -157.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.515 ' HB2' HG11 ' A' ' 22' ' ' VAL . 28.2 mt-10 -124.27 140.34 53.05 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 114.791 -1.095 . . . . 1.26 111.302 -171.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.568 ' C ' HD23 ' A' ' 27' ' ' LEU . 1.8 tt -100.1 142.9 30.95 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 106.579 -1.638 . . . . 1.0600000000000001 106.579 174.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.532 ' N ' HD23 ' A' ' 27' ' ' LEU . 3.0 m -129.39 107.76 9.76 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.04 -0.664 . . . . 1.05 109.827 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.588 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.4 t90 -91.61 113.27 25.49 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.875 -0.787 . . . . 0.29999999999999999 108.875 176.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -121.01 124.21 44.3 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.527 -0.76 . . . . 1.1599999999999999 109.465 -176.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.408 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 29.8 m -56.01 141.18 40.86 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.801 -0.444 . . . . 1.3899999999999999 109.801 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.633 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 22.8 m -55.29 -34.16 63.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.817 -0.629 . . . . 1.1499999999999999 110.554 -178.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -87.09 -3.28 59.06 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.468 -0.787 . . . . 2.3300000000000001 111.242 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.99 19.66 72.13 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.237 -0.506 . . . . 0.55000000000000004 112.73 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -71.79 -74.58 0.15 Allowed 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 111.973 0.36 . . . . 1.1299999999999999 111.973 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.423 ' HD3' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -116.59 153.39 32.33 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.946 0.403 . . . . 2.6200000000000001 111.036 -177.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 59.7 t -132.36 130.16 59.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.216 -0.447 . . . . 1.3100000000000001 110.641 -176.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -122.62 109.67 14.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.645 0.26 . . . . 0.82999999999999996 110.676 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 7.0 m -94.99 138.64 32.44 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.613 -0.514 . . . . 1.0600000000000001 109.613 175.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.539 ' CG1' ' HB3' ' A' ' 27' ' ' LEU . 8.9 p -128.54 139.12 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 120.569 -0.452 . . . . 1.3600000000000001 111.774 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.56 ' O ' HG12 ' A' ' 45' ' ' ILE . 45.0 t -90.02 110.88 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-O 121.377 0.608 . . . . 1.05 110.389 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.619 HD13 ' CD2' ' A' ' 104' ' ' LEU . 2.4 mm? -54.1 -28.87 42.18 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.872 -1.058 . . . . 1.04 112.633 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.5 m -77.34 -34.28 55.26 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.67 -0.412 . . . . 1.45 111.28 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.482 ' OG1' ' HB ' ' A' ' 41' ' ' VAL . 65.9 p -75.26 -12.14 60.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.525 0.678 . . . . 1.04 109.465 173.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.598 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 40.9 mm -81.58 123.1 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 114.963 -1.017 . . . . 1.02 110.691 170.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.478 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 35.6 t70 -74.71 -48.85 23.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.751 -0.659 . . . . 0.69999999999999996 110.982 176.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HB2' HG13 ' A' ' 63' ' ' ILE . 49.2 mmtm -142.07 165.06 28.48 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.194 -0.457 . . . . 2.4300000000000002 110.172 -177.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.589 ' CD2' ' HG3' ' A' ' 105' ' ' GLN . 10.5 tp -126.09 142.96 51.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.422 0.63 . . . . 1.04 109.386 170.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.409 ' CG ' HD11 ' A' ' 63' ' ' ILE . 12.4 mm100 -117.3 157.46 26.05 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.919 -1.037 . . . . 1.49 109.144 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -161.63 155.38 21.72 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.812 -1.181 . . . . 1.0 107.812 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.6 p -57.87 119.91 37.78 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 121.453 0.644 . . . . 1.03 111.053 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.545 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 63.5 Cg_endo -72.52 169.11 22.59 Favored 'Trans proline' 0 C--N 1.33 -0.439 0 C-N-CA 124.73 3.62 . . . . 0.73999999999999999 111.699 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.4 -26.35 52.95 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.003 0.43 . . . . 1.54 110.287 172.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.0 m -69.26 -25.7 64.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.047 -0.524 . . . . 2.0499999999999998 110.705 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.463 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 22.7 t -87.87 142.91 27.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.942 -0.572 . . . . 1.1399999999999999 109.603 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -94.74 -7.29 41.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.15 0.5 . . . . 2.8900000000000001 110.57 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -102.75 -173.2 2.27 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.717 -0.674 . . . . 3.1299999999999999 111.094 -172.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.498 ' HB3' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -130.35 112.43 13.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.818 -0.628 . . . . 2.0 110.046 175.516 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.539 ' CG ' ' HA ' ' A' ' 90' ' ' SER . 2.2 mtm -157.72 141.83 16.01 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 111.71 0.263 . . . . 1.3 111.71 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.911 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 2.8 mp -109.74 162.63 14.27 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.953 0.406 . . . . 1.05 111.151 171.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.499 ' HG2' ' CB ' ' A' ' 88' ' ' MET . 0.0 OUTLIER -154.16 112.64 3.6 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.818 -0.628 . . . . 3.3999999999999999 109.572 177.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.543 ' CD2' HG21 ' A' ' 45' ' ' ILE . 8.4 mt -95.7 117.28 30.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.3 0.571 . . . . 1.73 110.948 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.44 HG22 ' HG2' ' A' ' 86' ' ' ARG . 7.9 mm -87.67 102.95 13.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.412 -0.813 . . . . 1.1599999999999999 110.704 -174.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -73.74 145.15 34.98 Favored Glycine 0 C--N 1.321 -0.268 0 C-N-CA 119.949 -1.12 . . . . 0.47999999999999998 110.858 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.478 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 1.6 mptm? -54.5 135.28 46.02 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.382 0.611 . . . . 1.78 111.761 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 114.885 -1.052 . . . . 1.3100000000000001 110.156 176.987 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.196 0 CA-C-O 121.296 0.569 . . . . 1.78 110.158 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.44 ' HG2' HG22 ' A' ' 63' ' ' ILE . 25.3 mtt180 -119.31 162.33 18.93 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.89 -0.595 . . . . 2.8199999999999998 111.363 -169.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -124.78 115.24 20.37 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.887 -0.597 . . . . 0.63 110.242 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.499 ' CB ' ' HG2' ' A' ' 61' ' ' ARG . 59.6 ttm -107.07 129.22 54.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.811 -0.177 . . . . 1.1200000000000001 111.111 -173.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.575 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -119.62 140.43 50.61 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.613 -0.884 . . . . 1.6499999999999999 108.613 173.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.539 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 52.6 m -100.31 126.64 46.66 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.115 0.483 . . . . 1.1899999999999999 109.768 177.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.911 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 18.8 m-85 -106.55 160.45 15.42 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.792 -0.64 . . . . 1.6399999999999999 110.649 -173.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -101.99 -6.94 22.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.281 -0.418 . . . . 1.8300000000000001 110.577 -171.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -148.32 131.27 16.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.358 0.599 . . . . 1.22 110.918 -175.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.498 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 9.2 tpt180 -60.88 -31.47 70.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.697 -1.138 . . . . 2.8799999999999999 111.269 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 94.4 m -73.15 -57.88 3.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.806 0.336 . . . . 1.1200000000000001 110.356 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 68.1 t -46.67 -52.67 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.994 -0.548 . . . . 1.1299999999999999 111.716 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.466 ' O ' HD12 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -66.71 -28.33 68.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.198 -0.455 . . . . 1.0600000000000001 110.438 -178.203 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.93 -29.96 69.15 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.181 -0.674 . . . . 0.39000000000000001 109.181 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.616 ' O ' ' HG3' ' A' ' 102' ' ' MET . 55.8 m-80 -77.37 -50.03 13.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.988 -1.005 . . . . 1.55 110.083 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.488 HG22 HD11 ' A' ' 18' ' ' ILE . 40.5 mm -56.71 -50.76 73.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.314 -0.857 . . . . 1.0600000000000001 110.304 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.468 ' HA ' HD21 ' A' ' 60' ' ' LEU . 7.2 ttpp -55.31 -50.78 68.71 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.735 -0.666 . . . . 1.72 111.046 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.616 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.3 ppp? -69.35 -20.95 63.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.118 -0.492 . . . . 1.76 110.646 -174.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.413 HG23 ' CE1' ' A' ' 3' ' ' HIS . 52.7 m -70.98 -56.74 5.55 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.337 0.589 . . . . 1.04 110.093 174.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.619 ' CD2' HD13 ' A' ' 42' ' ' LEU . 13.8 mt -61.2 -55.75 28.6 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.009 -0.996 . . . . 1.05 110.587 -176.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.589 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 75.3 mt-30 -53.61 -26.46 22.0 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.852 0.686 . . . . 1.45 112.852 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -65.93 -30.87 71.52 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 122.057 0.932 . . . . 0.66000000000000003 108.933 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.554 ' O ' ' HB3' ' A' ' 110' ' ' ARG . 30.1 mt -82.7 -43.81 18.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 113.678 -1.601 . . . . 1.04 110.232 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.1 mt -68.81 -47.12 77.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.546 -0.752 . . . . 1.04 111.174 -175.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.8 m -61.03 -27.61 68.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.581 0.705 . . . . 1.6100000000000001 109.42 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.554 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 17.0 ttt180 -67.91 -34.18 76.13 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.598 -1.183 . . . . 4.3899999999999997 109.732 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 . . . . . 0 N--CA 1.446 -0.632 0 CA-C-N 115.992 -0.549 . . . . 0.71999999999999997 111.435 -178.67 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 261' ' ' PHE . . . . . 0.545 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 1.1 m-85 . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 110.055 -0.35 . . . . 0.97999999999999998 110.055 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . 0.479 ' CG1' ' HB3' ' A' ' 52' ' ' PRO . 13.0 p -144.5 165.72 12.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.882 -0.599 . . . . 1.8999999999999999 109.452 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 263' ' ' GLU . . . . . 0.404 ' N ' HG22 ' B' ' 262' ' ' VAL . 14.1 tt0 . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 108.279 -1.008 . . . . 2.2400000000000002 108.279 172.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.474 ' HA ' HG21 ' A' ' 103' ' ' THR . 28.8 m80 . . . . . 0 C--O 1.22 -0.498 0 N-CA-C 112.45 0.537 . . . . 2.3900000000000001 112.45 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 77.1 p -163.86 137.99 5.72 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.736 0.303 . . . . 1.6100000000000001 110.249 177.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.19 151.38 10.57 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.431 -1.067 . . . . 0.17000000000000001 110.431 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.694 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.94 138.16 40.81 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.336 0.568 . . . . 0.97999999999999998 111.598 -175.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.21 157.1 43.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 1.01 110.844 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 2.3 mp -91.27 127.06 43.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.185 -0.672 . . . . 1.0800000000000001 109.185 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.564 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 79.2 t80 -138.51 118.42 13.31 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.845 -0.428 . . . . 0.66000000000000003 109.845 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 70.49 41.56 0.96 Allowed 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 123.851 0.719 . . . . 1.46 110.494 -176.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? 70.27 9.34 6.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.356 -1.293 . . . . 2.3900000000000001 111.956 173.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.29 135.59 58.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.745 0.307 . . . . 1.23 110.524 176.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.491 ' HA ' HG13 ' A' ' 8' ' ' ILE . 48.5 t -76.95 120.57 22.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.089 0.471 . . . . 1.48 110.268 176.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.59 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -141.85 -154.44 6.17 Favored Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 115.766 -0.652 . . . . 0.16 112.004 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.694 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.3 mm -126.89 153.4 35.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 121.052 0.453 . . . . 1.05 110.676 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 4' ' ' SER . 0.1 OUTLIER -122.33 133.68 67.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 115.656 -0.702 . . . . 1.01 109.789 178.243 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.34 108.78 7.37 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.02 0.438 . . . . 0.87 111.607 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 4.0 mp -85.62 113.31 23.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.302 -0.999 . . . . 1.05 108.302 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -116.58 122.66 45.29 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.649 -0.5 . . . . 1.1200000000000001 109.649 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.411 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 8.6 mt-10 -108.17 82.86 1.69 Allowed 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 117.144 -1.823 . . . . 0.73999999999999999 107.38 165.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -122.71 -8.6 8.45 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.6 -1.63 . . . . 0.58999999999999997 106.6 157.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 23' ' ' SER . 14.6 p -101.59 174.2 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 112.182 -2.281 . . . . 1.0800000000000001 111.707 -158.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.686 ' O ' HG13 ' A' ' 22' ' ' VAL . 11.3 p -54.7 165.67 0.89 Allowed Pre-proline 0 N--CA 1.455 -0.176 0 N-CA-C 107.094 -1.447 . . . . 2.0 107.094 166.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.576 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 11.0 Cg_endo -41.85 126.91 3.52 Favored 'Trans proline' 0 C--N 1.358 1.07 0 CA-C-N 122.037 1.763 . . . . 0.26000000000000001 111.57 -147.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.526 ' HB1' HG23 ' A' ' 107' ' ' ILE . . . -30.29 132.41 0.07 Allowed 'General case' 0 CA--C 1.508 -0.637 0 O-C-N 125.391 1.682 . . . . 1.02 113.596 -158.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.507 ' HB2' HG12 ' A' ' 22' ' ' VAL . 36.4 mt-10 -127.47 140.42 52.16 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.697 -1.138 . . . . 1.26 111.525 -167.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.59 ' C ' HD23 ' A' ' 27' ' ' LEU . 1.5 tt -101.36 144.62 29.95 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.101 -1.444 . . . . 1.0600000000000001 107.101 175.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.443 ' N ' HD23 ' A' ' 27' ' ' LEU . 18.5 m -132.23 109.19 9.74 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.954 -0.698 . . . . 1.05 110.223 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.569 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 87.2 t90 -87.04 115.32 24.35 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.723 -0.843 . . . . 0.29999999999999999 108.723 175.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -121.98 123.41 41.59 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.068 -0.969 . . . . 1.1599999999999999 108.984 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.425 ' OG ' ' HB3' ' A' ' 36' ' ' LYS . 22.1 m -54.91 144.09 24.02 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.179 -0.304 . . . . 1.3899999999999999 110.179 -177.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.59 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 19.4 m -55.23 -26.22 38.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.649 -0.705 . . . . 1.1499999999999999 110.735 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -81.62 -27.5 34.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.887 -0.597 . . . . 2.3300000000000001 111.196 175.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.99 22.28 18.19 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.708 -0.758 . . . . 0.55000000000000004 112.849 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -97.51 -72.26 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.082 0.467 . . . . 1.1299999999999999 110.775 -173.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.425 ' HB3' ' OG ' ' A' ' 31' ' ' SER . 18.7 ttmm -82.53 129.97 35.02 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.497 -0.774 . . . . 2.6200000000000001 110.345 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 94.2 t -133.33 125.4 50.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.244 -0.435 . . . . 1.3100000000000001 109.901 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -131.75 121.88 24.93 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.48 -0.327 . . . . 0.82999999999999996 110.602 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.402 HG21 ' HG1' ' A' ' 28' ' ' THR . 31.4 m -104.38 142.07 35.23 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.683 0.278 . . . . 1.0600000000000001 111.276 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 31.0 t -116.27 129.01 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 122.696 0.398 . . . . 1.3600000000000001 111.167 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.523 ' O ' HG12 ' A' ' 45' ' ' ILE . 37.3 t -90.65 108.33 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.244 0.545 . . . . 1.05 109.663 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.584 HD12 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -55.26 -29.0 57.19 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.108 -0.951 . . . . 1.04 112.329 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.2 t -74.52 -30.44 61.79 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.425 -0.51 . . . . 1.45 110.738 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.6 p -80.07 -11.71 59.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.304 0.573 . . . . 1.04 109.532 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.587 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 39.1 mm -85.97 125.82 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.251 -0.886 . . . . 1.02 110.982 173.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.668 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 24.2 t70 -84.27 -38.95 19.82 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.14 -0.482 . . . . 0.69999999999999996 111.217 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -143.89 153.59 42.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.927 -0.578 . . . . 2.4300000000000002 110.053 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.612 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 10.7 tp -120.71 144.23 48.34 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.051 -0.722 . . . . 1.04 109.051 168.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 15.4 mm100 -118.63 157.59 27.1 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.016 -0.993 . . . . 1.49 109.639 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -161.58 141.39 10.35 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.134 -0.939 . . . . 1.0 108.652 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.503 ' HB ' ' CB ' ' A' ' 55' ' ' SER . 38.2 p -47.98 131.83 11.93 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 123.393 0.433 . . . . 1.03 110.877 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 46.7 Cg_endo -66.48 164.94 26.72 Favored 'Trans proline' 0 C--N 1.329 -0.465 0 C-N-CA 123.548 2.832 . . . . 0.73999999999999999 111.536 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.56 -14.21 60.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.953 0.406 . . . . 1.54 111.027 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 56.5 m -84.59 -23.28 29.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.953 -0.567 . . . . 2.0499999999999998 110.789 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.503 ' CB ' ' HB ' ' A' ' 51' ' ' THR . 29.3 t -62.33 137.3 58.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.716 -0.674 . . . . 1.1399999999999999 110.587 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -83.28 -11.94 57.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.384 0.611 . . . . 2.8900000000000001 110.076 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -109.07 171.58 7.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.237 -0.892 . . . . 3.1299999999999999 109.485 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.565 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.2 OUTLIER -129.9 112.36 13.47 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.815 -1.18 . . . . 2.0 107.815 -178.297 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.605 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 2.4 mtm -155.75 140.96 17.52 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 119.936 -0.706 . . . . 1.3 112.237 -171.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.801 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 3.2 mp -109.43 161.08 15.65 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.684 -0.689 . . . . 1.05 110.897 170.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.515 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 7.9 ttm180 -154.57 113.85 3.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.67 -0.695 . . . . 3.3999999999999999 110.273 174.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.557 ' CD2' HG21 ' A' ' 45' ' ' ILE . 10.0 mt -93.67 114.5 26.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.285 0.564 . . . . 1.73 111.249 -177.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.515 HG23 ' HG2' ' A' ' 86' ' ' ARG . 5.9 mm -87.55 108.95 18.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 123.813 0.845 . . . . 1.1599999999999999 110.567 -173.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -80.45 141.4 22.89 Favored Glycine 0 C--O 1.227 -0.308 0 C-N-CA 120.286 -0.959 . . . . 0.47999999999999998 112.048 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.668 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 0.5 OUTLIER -55.69 131.04 45.56 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 117.05 0.425 . . . . 1.78 110.269 179.239 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 C--N 1.319 -0.749 0 CA-C-N 115.899 -0.592 . . . . 1.3100000000000001 109.718 178.577 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.355 0 CA-C-O 121.842 0.83 . . . . 1.78 110.203 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.515 ' HG2' HG23 ' A' ' 63' ' ' ILE . 34.5 mtt180 -112.26 147.43 36.28 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.136 -0.938 . . . . 2.8199999999999998 110.112 -174.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -108.57 112.66 25.13 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.596 -0.52 . . . . 0.63 109.596 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.429 ' HE3' ' NE ' ' A' ' 61' ' ' ARG . 44.7 ttm -107.06 130.71 54.63 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 121.206 -0.198 . . . . 1.1200000000000001 111.449 -174.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.6 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -121.01 141.91 50.3 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.632 -0.877 . . . . 1.6499999999999999 108.632 173.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.57 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 54.8 m -101.35 124.01 46.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.142 0.496 . . . . 1.1899999999999999 110.43 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.801 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 5.7 m-85 -107.96 145.79 33.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.657 -0.702 . . . . 1.6399999999999999 110.244 -175.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -100.17 -2.32 34.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.086 0.47 . . . . 1.8300000000000001 110.639 -174.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -131.93 124.73 30.02 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.943 -0.572 . . . . 1.22 110.479 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.41 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 28.3 tpt180 -57.36 -35.32 69.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.237 -0.892 . . . . 2.8799999999999999 111.015 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.476 HG21 HD22 ' A' ' 99' ' ' ASN . 91.6 m -71.78 -56.66 5.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.815 -0.63 . . . . 1.1200000000000001 110.685 -176.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 85.0 t -45.8 -54.73 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 115.776 -0.647 . . . . 1.1299999999999999 111.392 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.565 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -64.89 -29.22 70.16 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.678 -0.409 . . . . 1.0600000000000001 110.955 -177.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.408 ' O ' ' HE3' ' A' ' 101' ' ' LYS . 29.5 t70 -71.04 -30.88 67.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.679 0.752 . . . . 0.39000000000000001 109.22 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.601 ' O ' ' HG3' ' A' ' 102' ' ' MET . 90.0 m-20 -78.26 -48.68 15.22 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.627 -1.17 . . . . 1.55 109.967 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.515 HG22 HD13 ' A' ' 18' ' ' ILE . 41.3 mm -58.51 -50.37 79.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.232 -0.894 . . . . 1.0600000000000001 110.49 177.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.47 ' HA ' HD23 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -56.36 -48.7 76.28 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.161 -0.472 . . . . 1.72 111.023 178.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.601 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.1 ppp? -69.28 -23.36 63.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.146 0.498 . . . . 1.76 110.159 -175.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.474 HG21 ' HA ' ' A' ' 3' ' ' HIS . 54.9 m -67.64 -52.32 39.56 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.603 -0.726 . . . . 1.04 110.057 175.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.612 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 12.6 mt -70.87 -57.65 4.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.157 -0.929 . . . . 1.05 111.585 -173.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.526 ' HG2' ' HB3' ' A' ' 48' ' ' LEU . 45.2 mt-30 -50.78 -28.22 8.84 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.679 0.622 . . . . 1.45 112.679 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -65.02 -45.84 83.84 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.788 -0.819 . . . . 0.66000000000000003 108.788 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.526 HG23 ' HB1' ' A' ' 25' ' ' ALA . 72.0 mt -63.21 -43.8 98.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.029 -1.441 . . . . 1.04 110.93 176.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.2 mt -62.4 -61.2 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.522 -0.763 . . . . 1.04 111.112 -174.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.7 m -52.99 -28.14 22.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.99 0.424 . . . . 1.6100000000000001 111.261 173.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -71.98 -35.58 69.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.184 0.516 . . . . 4.3899999999999997 110.665 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.467 ' OH ' ' HA ' ' A' ' 24' ' ' PRO . 12.8 m-85 . . . . . 0 C--N 1.323 -0.587 0 CA-C-N 115.752 -0.658 . . . . 0.71999999999999997 112.208 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 261' ' ' PHE . . . . . 0.467 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 5.7 m-30 . . . . . 0 N--CA 1.456 -0.173 0 N-CA-C 109.439 -0.578 . . . . 0.97999999999999998 109.439 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 27.9 m -136.09 169.53 20.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.564 -0.532 . . . . 1.8999999999999999 109.564 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 263' ' ' GLU . . . . . 0.474 ' HA ' HE22 ' A' ' 105' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.648 0 C-N-CA 120.503 -0.479 . . . . 2.2400000000000002 110.715 173.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.574 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.161 0 CA-C-O 120.857 0.36 . . . . 2.3900000000000001 111.392 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.435 ' HG ' ' C ' ' A' ' 3' ' ' HIS . 34.0 m -160.75 149.54 16.64 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.395 -0.594 . . . . 1.6100000000000001 109.395 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.23 150.07 7.67 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.561 -1.016 . . . . 0.17000000000000001 110.561 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.693 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -76.62 139.29 40.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 117.49 0.645 . . . . 0.97999999999999998 111.416 -175.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.79 158.05 43.88 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.216 0.531 . . . . 1.01 111.119 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.541 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.1 mp -99.55 129.7 49.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.284 -0.636 . . . . 1.0800000000000001 109.284 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.571 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 85.3 t80 -138.56 116.0 11.24 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.263 -0.426 . . . . 0.66000000000000003 109.941 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 67.56 42.65 2.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.436 0.636 . . . . 1.46 110.739 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt 68.99 10.51 7.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.327 -1.306 . . . . 2.3900000000000001 112.484 173.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -113.53 132.24 63.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.996 0.427 . . . . 1.23 110.311 173.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.541 ' HA ' HG13 ' A' ' 8' ' ' ILE . 32.6 t -77.75 117.68 19.37 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.833 -0.621 . . . . 1.48 109.952 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.645 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -137.23 -157.33 7.58 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.928 -0.653 . . . . 0.16 112.141 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.693 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 9.3 mm -127.04 153.42 36.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 120.827 0.346 . . . . 1.05 110.795 -176.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.455 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -123.95 132.8 70.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 115.883 -0.599 . . . . 1.01 109.675 179.022 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.93 109.54 7.47 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.109 0.411 . . . . 0.87 112.109 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.574 ' O ' ' HB3' ' A' ' 3' ' ' HIS . 4.0 mp -85.38 103.43 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.001 -0.74 . . . . 1.05 109.001 171.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.419 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -110.44 129.6 55.74 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.724 -0.39 . . . . 1.1200000000000001 110.202 -179.078 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.501 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 39.6 mt-10 -107.78 84.19 1.92 Allowed 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 116.811 -1.956 . . . . 0.73999999999999999 107.345 164.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.419 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 17.2 t70 -121.77 -10.72 8.69 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 106.568 -1.641 . . . . 0.58999999999999997 106.568 156.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 23' ' ' SER . 13.6 p -101.56 179.35 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 111.946 -2.388 . . . . 1.0800000000000001 111.19 -157.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.566 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -52.44 167.2 0.38 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 117.974 -1.012 . . . . 2.0 108.338 168.019 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.549 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 15.8 Cg_endo -44.36 126.17 6.47 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.494 1.463 . . . . 0.26000000000000001 111.525 -156.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.501 ' HB2' ' HG2' ' A' ' 20' ' ' GLU . . . -25.67 132.76 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.99 1.431 . . . . 1.02 114.725 -151.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.513 ' HB2' HG12 ' A' ' 22' ' ' VAL . 39.7 mt-10 -124.99 139.46 53.8 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.201 -0.909 . . . . 1.26 110.929 -172.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.593 HD22 ' C ' ' A' ' 27' ' ' LEU . 1.1 tt -101.31 143.28 31.55 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 106.831 -1.544 . . . . 1.0600000000000001 106.831 175.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.6 m -130.17 108.99 10.46 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.688 -0.805 . . . . 1.05 110.519 -178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.643 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 89.8 t90 -86.63 113.01 22.15 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.471 0.653 . . . . 0.29999999999999999 109.417 174.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -120.47 120.78 36.88 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.173 -0.921 . . . . 1.1599999999999999 109.157 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.44 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 20.1 m -55.9 141.35 39.55 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.771 -0.455 . . . . 1.3899999999999999 109.771 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.645 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 28.8 m -54.15 -31.84 53.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.31 -0.859 . . . . 1.1499999999999999 111.018 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -89.6 -9.21 50.6 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.236 -0.438 . . . . 2.3300000000000001 111.599 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.01 18.8 57.29 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.979 -0.629 . . . . 0.55000000000000004 112.553 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -72.46 -68.38 0.48 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.338 . . . . 1.1299999999999999 111.527 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -110.0 152.29 26.09 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.217 0.532 . . . . 2.6200000000000001 111.626 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 85.2 t -138.06 117.74 15.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.283 -0.871 . . . . 1.3100000000000001 109.877 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -123.74 113.66 18.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.191 -0.459 . . . . 0.82999999999999996 110.148 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.7 m -100.69 143.72 30.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.664 -0.243 . . . . 1.0600000000000001 111.027 -175.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 43.1 t -117.69 128.24 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 111.797 0.295 . . . . 1.3600000000000001 111.797 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 45' ' ' ILE . 33.3 t -90.63 107.93 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.279 0.561 . . . . 1.05 109.61 173.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.57 HD12 ' CD2' ' A' ' 104' ' ' LEU . 1.9 mm? -54.44 -29.83 50.78 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.806 -1.088 . . . . 1.04 112.565 -177.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.549 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 72.5 m -74.4 -34.77 63.38 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.514 -0.475 . . . . 1.45 111.46 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -74.62 -16.51 60.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.483 0.658 . . . . 1.04 109.468 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.549 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 43.3 mm -75.44 118.3 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 115.156 -0.929 . . . . 1.02 111.551 175.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.606 ' CA ' ' HD2' ' A' ' 65' ' ' LYS . 11.1 t70 -74.74 -49.59 20.5 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.423 -0.808 . . . . 0.69999999999999996 111.237 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -134.09 150.92 51.19 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 116.765 -0.198 . . . . 2.4300000000000002 110.58 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.551 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 12.3 tp -115.92 143.18 45.79 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.985 -0.746 . . . . 1.04 108.985 164.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.498 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 7.2 mt-30 -124.24 152.19 43.26 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.09 -0.959 . . . . 1.49 109.603 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.03 143.3 10.8 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.737 -0.838 . . . . 1.0 108.737 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 40.9 p -47.48 127.09 10.2 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-O 121.565 0.698 . . . . 1.03 111.025 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 61.4 Cg_endo -70.17 166.68 27.3 Favored 'Trans proline' 0 C--N 1.33 -0.402 0 C-N-CA 124.152 3.235 . . . . 0.73999999999999999 112.015 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.85 -29.51 59.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.903 0.382 . . . . 1.54 110.896 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.4 m -69.62 -25.59 64.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.96 -0.563 . . . . 2.0499999999999998 111.156 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 37.6 t -74.78 137.31 41.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.974 -0.557 . . . . 1.1399999999999999 110.09 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -91.54 -0.07 57.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.669 0.747 . . . . 2.8900000000000001 109.582 175.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.3 mmmt -107.98 176.55 5.1 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.946 -1.024 . . . . 3.1299999999999999 109.985 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.523 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -137.15 109.48 7.34 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.108 -0.701 . . . . 2.0 109.108 -178.166 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.564 ' HG2' ' HA ' ' A' ' 90' ' ' SER . 68.0 mtm -157.09 140.71 15.89 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.478 0.18 . . . . 1.3 111.102 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.858 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 1.4 mp -110.15 160.05 16.82 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.23 -0.441 . . . . 1.05 111.074 174.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.423 ' CZ ' ' HG3' ' A' ' 86' ' ' ARG . 21.8 ttt180 -153.31 114.88 4.23 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 121.208 0.528 . . . . 3.3999999999999999 111.456 169.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.509 ' HG ' HD13 ' A' ' 48' ' ' LEU . 8.9 mt -92.86 110.19 21.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.864 -0.607 . . . . 1.73 110.813 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.512 ' HA ' ' HB3' ' A' ' 86' ' ' ARG . 3.9 mm -87.55 126.28 41.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 123.111 0.564 . . . . 1.1599999999999999 110.456 -176.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -87.6 152.28 23.98 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.33 -0.938 . . . . 0.47999999999999998 111.019 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.606 ' HD2' ' CA ' ' A' ' 46' ' ' ASP . 10.2 mptt -59.01 136.06 57.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.01 0.405 . . . . 1.78 110.394 178.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 115.774 -0.648 . . . . 1.3100000000000001 109.743 177.913 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 . . . . . 0 N--CA 1.449 -0.515 0 N-CA-C 108.825 -0.805 . . . . 1.78 108.825 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.512 ' HB3' ' HA ' ' A' ' 63' ' ' ILE . 9.6 ptt180 -156.55 160.03 39.1 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.962 -0.563 . . . . 2.8199999999999998 111.669 -166.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -120.29 111.44 17.78 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.594 -0.73 . . . . 0.63 110.058 -172.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.416 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 49.2 ttm -107.51 126.92 53.13 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.501 -0.124 . . . . 1.1200000000000001 110.914 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.424 ' CD2' ' HB2' ' A' ' 9' ' ' PHE . 50.7 m-85 -116.19 143.72 45.13 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.647 -0.872 . . . . 1.6499999999999999 108.647 174.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.564 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 14.9 m -99.11 123.7 43.6 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.974 0.416 . . . . 1.1899999999999999 110.197 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.858 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 7.5 m-85 -108.52 157.17 18.71 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.064 -0.517 . . . . 1.6399999999999999 110.246 -176.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -113.67 -6.34 13.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.904 0.383 . . . . 1.8300000000000001 111.239 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -128.3 124.33 36.25 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.2 0.524 . . . . 1.22 110.145 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.428 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 29.8 tpt180 -57.24 -36.75 71.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.961 -1.018 . . . . 2.8799999999999999 111.175 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 85.2 m -74.04 -55.42 6.14 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.7 -0.682 . . . . 1.1200000000000001 110.83 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 88.4 t -46.05 -55.21 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.125 -0.489 . . . . 1.1299999999999999 111.352 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.523 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -66.88 -28.34 68.24 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.895 -0.322 . . . . 1.0600000000000001 110.808 -177.431 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.15 -31.87 70.83 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.049 -0.723 . . . . 0.39000000000000001 109.049 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.592 ' O ' ' HG3' ' A' ' 102' ' ' MET . 90.7 m-20 -77.78 -46.31 22.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.559 -1.2 . . . . 1.55 109.726 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.494 HG21 HD13 ' A' ' 18' ' ' ILE . 35.4 mm -58.6 -51.54 70.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.104 -0.953 . . . . 1.0600000000000001 110.393 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 4.1 ttpt -57.01 -51.39 69.46 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.886 -0.597 . . . . 1.72 110.429 178.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.592 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.3 ppp? -64.94 -25.18 67.77 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.903 0.383 . . . . 1.76 110.716 -175.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.7 m -66.02 -51.62 56.65 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.452 0.644 . . . . 1.04 110.128 175.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.57 ' CD2' HD12 ' A' ' 42' ' ' LEU . 8.7 mt -70.09 -55.95 8.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.88 -1.055 . . . . 1.05 110.927 -175.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 101' ' ' LYS . 18.7 mm-40 -42.92 -36.15 1.43 Allowed 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.694 0.621 . . . . 1.45 112.664 177.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -65.42 -32.97 74.88 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.919 0.866 . . . . 0.66000000000000003 109.663 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.519 HD11 ' HA ' ' A' ' 104' ' ' LEU . 42.0 mt -79.69 -41.79 22.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.066 -1.424 . . . . 1.04 110.123 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -66.63 -51.34 57.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.248 -0.887 . . . . 1.04 110.87 -176.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.6 t -59.41 -29.03 67.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.411 0.624 . . . . 1.6100000000000001 109.509 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.44 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 10.6 ttt180 -66.3 -34.19 77.44 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.043 -0.98 . . . . 4.3899999999999997 109.949 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 . . . . . 0 N--CA 1.446 -0.653 0 CA-C-N 116.047 -0.524 . . . . 0.71999999999999997 111.472 -177.676 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 261' ' ' PHE . . . . . 0.498 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 1.5 m-85 . . . . . 0 N--CA 1.455 -0.194 0 N-CA-C 109.419 -0.586 . . . . 0.97999999999999998 109.419 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.85 161.74 23.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.864 0.364 . . . . 1.8999999999999999 111.824 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 115.818 -0.628 . . . . 2.2400000000000002 109.478 175.785 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.429 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 13.9 m80 . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 121.34 0.59 . . . . 2.3900000000000001 110.077 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.3 p -162.94 151.31 14.14 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.555 -0.748 . . . . 1.6100000000000001 109.278 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.5 146.98 7.06 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.9 -0.88 . . . . 0.17000000000000001 110.9 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.713 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -79.39 117.26 20.2 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 117.209 0.505 . . . . 0.97999999999999998 111.296 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.49 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -125.23 155.95 39.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.349 0.595 . . . . 1.01 111.513 -177.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.492 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 1.9 mp -96.42 119.59 44.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 108.611 -0.885 . . . . 1.0800000000000001 108.611 176.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.421 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 93.2 t80 -119.47 102.82 8.93 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.518 -0.31 . . . . 0.66000000000000003 110.263 -177.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 65.51 55.33 1.04 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.317 0.58 . . . . 1.46 110.939 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt 72.38 -4.81 1.94 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.641 -1.163 . . . . 2.3900000000000001 113.304 171.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -103.99 130.24 54.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.939 0.399 . . . . 1.23 110.488 172.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.474 ' HA ' HG13 ' A' ' 8' ' ' ILE . 32.4 t -78.43 129.4 34.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.882 -0.599 . . . . 1.48 109.953 177.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.621 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -150.68 -159.84 9.02 Favored Glycine 0 N--CA 1.436 -1.321 0 C-N-CA 120.752 -0.737 . . . . 0.16 112.494 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.713 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 6.4 mm -125.97 153.24 33.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 120.768 0.318 . . . . 1.05 110.583 -177.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.89 135.12 63.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 116.114 -0.494 . . . . 1.01 109.861 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.19 110.57 7.44 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.207 0.447 . . . . 0.87 112.207 176.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.524 HD12 HG22 ' A' ' 100' ' ' ILE . 3.7 mp -86.08 121.44 37.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.667 -0.864 . . . . 1.05 108.667 171.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.72 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.7 OUTLIER -126.7 134.28 50.72 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.699 -0.482 . . . . 1.1200000000000001 109.699 179.001 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.508 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 18.0 mt-10 -114.99 83.15 1.86 Allowed 'General case' 0 N--CA 1.425 -1.723 0 C-N-CA 116.513 -2.075 . . . . 0.73999999999999999 107.663 161.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -121.32 -9.79 9.02 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 106.168 -1.79 . . . . 0.58999999999999997 106.168 159.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.72 ' HB ' HD22 ' A' ' 19' ' ' ASN . 13.2 p -103.52 173.82 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 111.583 -2.553 . . . . 1.0800000000000001 111.821 -159.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.658 ' O ' HG12 ' A' ' 22' ' ' VAL . 16.3 m -55.08 166.28 0.85 Allowed Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 106.692 -1.596 . . . . 2.0 106.692 165.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 10.1 Cg_endo -40.55 128.06 2.44 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 121.601 1.608 . . . . 0.26000000000000001 111.775 -147.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.537 ' HB1' HG21 ' A' ' 107' ' ' ILE . . . -28.2 132.78 0.04 OUTLIER 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 125.466 1.729 . . . . 1.02 113.217 -160.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.647 ' HB3' HG11 ' A' ' 22' ' ' VAL . 35.4 tt0 -130.58 132.04 45.32 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 115.229 -0.896 . . . . 1.26 111.244 -161.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.596 ' C ' HD21 ' A' ' 27' ' ' LEU . 1.5 tt -100.83 144.94 29.18 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 106.94 -1.504 . . . . 1.0600000000000001 106.94 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.497 ' N ' HD21 ' A' ' 27' ' ' LEU . 9.8 m -133.22 108.91 9.07 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.161 -0.616 . . . . 1.05 110.274 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.605 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.3 t90 -89.87 109.8 20.78 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.647 0.737 . . . . 0.29999999999999999 109.056 176.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 30' ' ' ARG . 13.1 ttt-85 -113.35 121.35 44.09 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.132 -0.94 . . . . 1.1599999999999999 109.236 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.455 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 88.9 p -57.33 148.02 24.13 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.078 -0.342 . . . . 1.3899999999999999 110.078 -177.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.621 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 33.4 m -48.42 -38.13 18.85 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.084 0.468 . . . . 1.1499999999999999 110.618 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -68.32 -28.03 66.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.628 -0.715 . . . . 2.3300000000000001 111.642 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.74 21.55 46.68 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.034 -0.603 . . . . 0.55000000000000004 112.068 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -104.91 -37.43 7.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.324 0.583 . . . . 1.1299999999999999 110.816 -172.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -114.61 120.65 40.9 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.587 -0.733 . . . . 2.6200000000000001 109.998 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.5 t -123.52 118.91 55.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.992 0.425 . . . . 1.3100000000000001 110.348 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -119.41 109.96 16.38 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.98 -0.555 . . . . 0.82999999999999996 110.237 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.9 m -95.69 143.32 27.05 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.471 -0.331 . . . . 1.0600000000000001 111.448 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 30.1 t -120.83 124.37 72.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.295 -0.411 . . . . 1.3600000000000001 111.16 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 45' ' ' ILE . 49.1 t -90.54 107.75 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 109.282 -0.636 . . . . 1.05 109.282 174.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.567 HD13 ' CD2' ' A' ' 104' ' ' LEU . 2.4 mm? -51.92 -29.09 18.66 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.957 -1.019 . . . . 1.04 112.67 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.1 t -71.8 -35.59 70.02 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.583 -0.447 . . . . 1.45 110.803 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.2 p -76.36 -13.82 60.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.081 0.467 . . . . 1.04 109.857 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.565 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 46.6 mm -79.84 121.17 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.579 -0.737 . . . . 1.02 111.391 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.62 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 34.0 t70 -81.78 -40.56 22.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.538 0.685 . . . . 0.69999999999999996 110.881 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.551 ' HB2' ' CG1' ' A' ' 63' ' ' ILE . 46.0 mmtm -136.27 142.34 43.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.103 -0.953 . . . . 2.4300000000000002 110.932 -172.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.533 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 12.7 tp -118.0 138.04 52.46 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.457 0.646 . . . . 1.04 109.302 164.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 14.0 mm100 -119.28 157.19 28.57 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.456 -1.247 . . . . 1.49 109.277 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.33 148.92 16.86 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.517 -1.29 . . . . 1.0 107.517 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.447 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 27.4 p -52.77 126.91 42.43 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 121.377 0.608 . . . . 1.03 111.083 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 50.1 Cg_endo -67.46 165.63 26.5 Favored 'Trans proline' 0 C--N 1.329 -0.461 0 C-N-CA 123.584 2.856 . . . . 0.73999999999999999 111.068 176.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.34 -23.04 66.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.125 0.488 . . . . 1.54 110.353 176.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.3 m -73.74 -24.91 59.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.679 -0.691 . . . . 2.0499999999999998 111.346 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 36.3 t -71.41 145.17 49.49 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.882 -0.414 . . . . 1.1399999999999999 109.882 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -90.55 -6.05 55.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.272 0.558 . . . . 2.8900000000000001 109.95 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -111.67 174.44 5.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.201 -0.909 . . . . 3.1299999999999999 109.997 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.632 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 3.5 mmt -131.38 108.76 9.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.174 -0.676 . . . . 2.0 109.174 176.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.516 ' HG3' ' H ' ' A' ' 91' ' ' PHE . 3.9 mpp? -154.42 168.1 27.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.08 0.467 . . . . 1.3 111.666 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 101' ' ' LYS . 1.1 mp -126.52 161.32 28.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.339 -0.846 . . . . 1.05 111.001 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 50.0 ttp180 -153.54 114.38 4.07 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.607 0.241 . . . . 3.3999999999999999 110.986 169.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.536 ' CD2' HG22 ' A' ' 45' ' ' ILE . 12.6 mt -94.43 109.33 21.2 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.702 0.401 . . . . 1.73 110.942 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.551 ' CG1' ' HB2' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -87.4 118.97 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 123.041 0.536 . . . . 1.1599999999999999 110.081 -176.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -80.87 152.56 33.4 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.98 -1.105 . . . . 0.47999999999999998 111.369 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.62 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 6.9 mptt -63.63 139.24 58.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.109 0.454 . . . . 1.78 110.306 176.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 C--N 1.318 -0.766 0 N-CA-C 109.007 -0.738 . . . . 1.3100000000000001 109.007 172.266 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.403 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 122.352 1.072 . . . . 1.78 109.553 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.488 ' HB3' HG22 ' A' ' 63' ' ' ILE . 9.2 ptt180 -113.77 146.02 40.52 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.626 -1.17 . . . . 2.8199999999999998 110.063 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.429 ' CD2' HG22 ' A' ' 40' ' ' VAL . 45.2 m-70 -113.2 111.85 22.78 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.324 -0.853 . . . . 0.63 109.61 -170.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.503 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 53.9 ttm -104.43 126.03 51.15 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.237 -0.585 . . . . 1.1200000000000001 111.395 -176.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.417 ' CE2' HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -115.65 122.36 45.35 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 109.004 -0.739 . . . . 1.6499999999999999 109.004 178.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.492 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 16.1 m -89.56 124.04 34.18 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.835 -0.621 . . . . 1.1899999999999999 110.379 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.592 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 30.5 m-85 -107.29 174.15 6.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.042 -0.526 . . . . 1.6399999999999999 109.753 174.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -122.56 -5.33 8.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.256 -0.429 . . . . 1.8300000000000001 110.126 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -127.82 135.4 50.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.446 0.641 . . . . 1.22 111.135 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.541 ' N ' ' HG3' ' A' ' 58' ' ' MET . 28.0 tpt180 -65.84 -35.18 79.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.531 -1.213 . . . . 2.8799999999999999 111.102 -174.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.403 HG22 HD22 ' A' ' 99' ' ' ASN . 94.7 m -76.27 -52.96 8.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.831 -0.622 . . . . 1.1200000000000001 111.112 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.3 t -45.29 -56.73 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 116.276 -0.42 . . . . 1.1299999999999999 111.437 175.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.632 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -66.56 -29.25 69.27 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.194 -0.457 . . . . 1.0600000000000001 110.718 -178.104 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -66.71 -33.47 75.71 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.121 -0.696 . . . . 0.39000000000000001 109.121 176.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.574 ' O ' ' HG3' ' A' ' 102' ' ' MET . 86.9 m-20 -75.23 -50.9 14.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.651 -1.159 . . . . 1.55 109.808 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.592 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 35.2 mm -56.59 -52.27 55.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.037 -0.983 . . . . 1.0600000000000001 110.685 177.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.438 ' HA ' HD23 ' A' ' 60' ' ' LEU . 4.9 ttpt -55.82 -49.16 74.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.723 -0.672 . . . . 1.72 111.321 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.574 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.2 ppp? -68.88 -24.15 64.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.847 0.356 . . . . 1.76 110.444 -176.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 55.2 m -67.58 -51.81 46.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.436 0.636 . . . . 1.04 110.027 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.567 ' CD2' HD13 ' A' ' 42' ' ' LEU . 10.6 mt -68.02 -56.39 9.09 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.989 -1.005 . . . . 1.05 111.187 -175.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.497 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 70.9 mt-30 -46.44 -31.62 2.79 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.207 0.818 . . . . 1.45 113.207 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -68.78 -27.93 66.33 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.048 0.927 . . . . 0.66000000000000003 109.692 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.537 HG21 ' HB1' ' A' ' 25' ' ' ALA . 64.8 mt -83.58 -43.68 18.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.008 -1.451 . . . . 1.04 110.148 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.436 HD13 HG23 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -62.38 -53.56 45.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.975 -1.011 . . . . 1.04 110.28 -177.156 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.8 t -59.05 -28.07 66.1 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.682 -0.69 . . . . 1.6100000000000001 110.001 176.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 11.3 ttt180 -69.47 -34.35 74.22 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.202 -0.908 . . . . 4.3899999999999997 110.051 178.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 . . . . . 0 N--CA 1.446 -0.647 0 CA-C-N 115.527 -0.76 . . . . 0.71999999999999997 111.319 -178.432 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 261' ' ' PHE . . . . . 0.442 ' CE1' ' HE2' ' A' ' 59' ' ' MET . 5.9 m-30 . . . . . 0 C--O 1.235 0.313 0 N-CA-C 109.323 -0.621 . . . . 0.97999999999999998 109.323 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.3 p -134.99 152.83 33.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.162 -0.31 . . . . 1.8999999999999999 110.162 -177.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 C--N 1.327 -0.408 0 N-CA-C 109.109 -0.7 . . . . 2.2400000000000002 109.109 172.466 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.2 m170 . . . . . 0 CA--C 1.523 -0.063 0 CA-C-O 121.241 0.544 . . . . 2.3900000000000001 110.397 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.5 p -163.98 149.06 10.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.639 -0.71 . . . . 1.6100000000000001 110.034 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.95 143.12 5.66 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 111.119 -0.792 . . . . 0.17000000000000001 111.119 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.711 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.31 121.72 22.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 117.468 0.634 . . . . 0.97999999999999998 111.047 -177.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.497 ' HB3' ' CE1' ' A' ' 91' ' ' PHE . . . -131.59 157.22 44.22 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 121.327 0.584 . . . . 1.01 111.697 -176.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 2.5 mp -95.08 114.58 31.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.477 -0.783 . . . . 1.0800000000000001 109.291 175.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.594 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 74.8 t80 -122.58 111.32 16.65 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.191 -0.459 . . . . 0.66000000000000003 110.031 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.502 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 40.3 mt-10 71.61 47.35 0.35 Allowed 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 124.072 0.857 . . . . 1.46 110.623 -176.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.502 ' HD2' ' C ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER 65.79 8.97 5.65 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.522 -1.217 . . . . 2.3900000000000001 112.658 173.664 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.38 135.2 57.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.869 0.366 . . . . 1.23 110.436 174.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.509 ' HA ' HG13 ' A' ' 8' ' ' ILE . 23.7 t -78.25 124.99 28.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.289 0.566 . . . . 1.48 110.219 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.648 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -146.85 -156.7 7.04 Favored Glycine 0 N--CA 1.437 -1.26 0 CA-C-N 115.654 -0.703 . . . . 0.16 112.341 -178.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.711 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.1 mm -126.95 153.8 36.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.799 0.333 . . . . 1.05 110.582 -177.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.422 HD13 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -126.86 133.34 68.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 116.026 -0.534 . . . . 1.01 109.91 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.35 113.13 9.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.34 -0.391 . . . . 0.87 111.618 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.529 HD11 HG22 ' A' ' 100' ' ' ILE . 4.1 mp -84.43 121.76 37.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.002 -1.11 . . . . 1.05 108.002 171.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.418 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 2.1 t30 -126.26 125.84 43.02 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.99 -0.374 . . . . 1.1200000000000001 109.99 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.469 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 20.8 mt-10 -110.6 83.9 1.84 Allowed 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 116.928 -1.909 . . . . 0.73999999999999999 107.616 163.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.418 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 13.7 t70 -120.87 -8.74 9.37 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.001 -1.851 . . . . 0.58999999999999997 106.001 157.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.699 HG12 ' O ' ' A' ' 23' ' ' SER . 14.9 p -102.46 173.76 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 111.75 -2.477 . . . . 1.0800000000000001 111.982 -158.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.699 ' O ' HG12 ' A' ' 22' ' ' VAL . 4.4 m -54.51 168.1 0.51 Allowed Pre-proline 0 C--O 1.223 -0.319 0 N-CA-C 106.853 -1.536 . . . . 2.0 106.853 165.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 10.2 Cg_endo -40.86 127.81 2.64 Favored 'Trans proline' 0 C--N 1.356 0.938 0 CA-C-N 122.016 1.756 . . . . 0.26000000000000001 111.239 -152.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.532 ' HB3' HG23 ' A' ' 107' ' ' ILE . . . -33.9 136.23 0.12 Allowed 'General case' 0 CA--C 1.504 -0.793 0 O-C-N 125.361 1.663 . . . . 1.02 113.621 -156.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.501 ' HB2' HG11 ' A' ' 22' ' ' VAL . 74.3 mt-10 -124.8 140.29 53.07 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.387 -1.279 . . . . 1.26 111.191 -169.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.592 HD22 ' C ' ' A' ' 27' ' ' LEU . 1.2 tt -101.58 142.41 32.99 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.419 -1.697 . . . . 1.0600000000000001 106.419 172.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.1 m -127.33 109.2 11.55 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.782 -0.767 . . . . 1.05 110.254 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.623 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.9 t90 -88.44 106.14 18.07 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.814 -0.81 . . . . 0.29999999999999999 108.814 175.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -114.17 112.02 22.51 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.759 -1.11 . . . . 1.1599999999999999 108.745 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.55 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 93.7 p -57.69 146.03 32.27 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.406 0.622 . . . . 1.3899999999999999 110.85 -174.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.648 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 7.9 m -57.59 -24.51 56.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.707 -1.133 . . . . 1.1499999999999999 111.236 -175.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -87.92 -27.42 22.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.892 -0.595 . . . . 2.3300000000000001 111.129 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.78 21.96 27.17 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.715 -0.755 . . . . 0.55000000000000004 113.443 176.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -110.2 -9.06 14.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.291 0.545 . . . . 1.1299999999999999 110.833 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -139.92 119.07 12.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.913 -0.585 . . . . 2.6200000000000001 109.96 -174.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 57.8 t -135.09 124.02 41.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.805 0.336 . . . . 1.3100000000000001 110.712 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -130.14 122.17 27.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.309 -0.405 . . . . 0.82999999999999996 110.589 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.5 m -102.43 134.93 44.95 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.664 0.268 . . . . 1.0600000000000001 110.919 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 42.2 t -106.76 128.06 61.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 122.415 0.286 . . . . 1.3600000000000001 111.52 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 45' ' ' ILE . 41.1 t -90.09 108.12 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-O 121.465 0.65 . . . . 1.05 109.595 173.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.554 HD13 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -53.76 -29.96 42.28 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.016 -0.993 . . . . 1.04 112.164 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.4 t -71.75 -35.54 70.15 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.965 -0.294 . . . . 1.45 110.672 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.409 ' OG1' ' HB ' ' A' ' 41' ' ' VAL . 66.8 p -77.1 -14.89 59.74 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 121.104 0.478 . . . . 1.04 110.12 176.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.547 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 41.4 mm -79.46 124.66 37.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.684 -0.689 . . . . 1.02 111.387 175.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.585 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 33.3 t70 -79.36 -48.16 14.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.969 -0.56 . . . . 0.69999999999999996 110.737 176.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -135.31 149.26 49.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.728 -0.669 . . . . 2.4300000000000002 110.543 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.575 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 11.6 tp -112.92 145.24 41.1 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.086 -0.709 . . . . 1.04 109.086 164.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.44 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 13.9 mm100 -122.59 153.34 39.42 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.071 -0.968 . . . . 1.49 109.896 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.69 143.79 10.02 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.451 -0.795 . . . . 1.0 109.491 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.496 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 49.4 p -60.7 125.38 82.66 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-O 121.486 0.66 . . . . 1.03 111.065 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 60.6 Cg_endo -70.96 165.94 30.71 Favored 'Trans proline' 0 C--N 1.329 -0.465 0 C-N-CA 123.727 2.951 . . . . 0.73999999999999999 111.285 175.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.9 -17.61 61.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.215 0.531 . . . . 1.54 110.617 176.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.7 m -77.2 -25.25 51.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.739 -0.664 . . . . 2.0499999999999998 110.558 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.453 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 46.5 t -72.86 150.94 42.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.653 -0.703 . . . . 1.1399999999999999 109.69 177.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -95.44 -2.85 48.02 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.586 0.708 . . . . 2.8900000000000001 109.657 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -107.05 -179.25 3.88 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.824 -1.08 . . . . 3.1299999999999999 110.414 -175.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.496 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -136.97 110.22 7.83 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.278 -1.008 . . . . 2.0 108.278 169.52 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.609 ' HB3' ' CZ ' ' B' ' 261' ' ' PHE . 3.1 ttm -156.24 148.77 23.69 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.384 -0.527 . . . . 1.3 111.825 -173.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.458 HD11 ' O ' ' A' ' 97' ' ' MET . 0.5 OUTLIER -117.7 157.22 26.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.437 -0.801 . . . . 1.05 110.479 173.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 62.8 ttp180 -151.58 114.18 4.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.708 0.29 . . . . 3.3999999999999999 110.756 169.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.516 ' CD2' HG23 ' A' ' 45' ' ' ILE . 10.5 mt -92.3 112.58 24.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.1 0.476 . . . . 1.73 110.61 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.515 HG21 ' HG2' ' A' ' 86' ' ' ARG . 4.4 mm -87.22 113.85 25.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 123.55 0.74 . . . . 1.1599999999999999 110.95 -175.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -79.41 141.0 23.41 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.122 -1.037 . . . . 0.47999999999999998 111.579 176.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.585 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 7.2 mptt -54.46 134.28 45.95 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.964 0.382 . . . . 1.78 110.983 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--N 1.321 -0.665 0 N-CA-C 109.58 -0.526 . . . . 1.3100000000000001 109.58 177.506 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.232 0 CA-C-O 121.442 0.639 . . . . 1.78 110.03 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.515 ' HG2' HG21 ' A' ' 63' ' ' ILE . 13.6 mtm180 -117.1 146.47 43.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.613 -0.721 . . . . 2.8199999999999998 110.217 -172.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -111.13 111.98 23.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.58 -0.736 . . . . 0.63 109.414 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.507 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 50.4 ttm -106.64 129.51 54.54 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.049 0.452 . . . . 1.1200000000000001 111.372 -176.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.422 ' CG ' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -120.03 122.68 41.65 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.719 -0.673 . . . . 1.6499999999999999 109.338 178.028 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.545 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 20.3 m -88.74 128.23 35.62 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.022 -0.536 . . . . 1.1899999999999999 110.45 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.584 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 27.8 m-85 -107.82 173.61 6.24 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.879 -0.6 . . . . 1.6399999999999999 110.629 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -119.05 -0.05 11.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.704 -0.68 . . . . 1.8300000000000001 110.107 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -141.17 128.47 21.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.926 -0.579 . . . . 1.22 109.96 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.468 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 2.5 tmt_? -69.61 -24.4 63.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.546 . . . . 2.8799999999999999 110.371 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.2 m -69.4 -57.19 5.59 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.118 -0.327 . . . . 1.1200000000000001 110.118 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 98.2 t -45.62 -56.38 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 115.955 -0.566 . . . . 1.1299999999999999 111.384 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.458 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -65.02 -28.63 69.63 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 116.021 -0.536 . . . . 1.0600000000000001 110.882 -177.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.42 -32.47 71.46 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.196 -0.668 . . . . 0.39000000000000001 109.196 176.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.435 ' HA ' ' HE1' ' A' ' 102' ' ' MET . 90.7 m-20 -74.09 -49.25 24.8 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.721 -1.127 . . . . 1.55 109.501 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.584 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 34.1 mm -58.49 -53.07 51.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.945 -1.025 . . . . 1.0600000000000001 110.427 175.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.408 ' HE2' ' N ' ' A' ' 102' ' ' MET . 0.1 OUTLIER -55.3 -48.85 73.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.335 -0.848 . . . . 1.72 111.344 179.133 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.435 ' HE1' ' HA ' ' A' ' 99' ' ' ASN . 12.8 ptt? -68.8 -24.99 64.47 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.63 -0.428 . . . . 1.76 110.191 -175.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 41.6 m -66.59 -49.78 65.23 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.427 0.632 . . . . 1.04 109.922 175.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.575 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 12.9 mt -69.94 -57.4 5.07 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.986 -1.006 . . . . 1.05 111.715 -174.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.429 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 38.1 mt-30 -51.51 -27.51 10.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.833 0.679 . . . . 1.45 112.833 -178.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -71.29 -30.13 65.89 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.056 0.931 . . . . 0.66000000000000003 109.472 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.601 ' O ' ' HB3' ' A' ' 110' ' ' ARG . 61.6 mt -75.88 -42.78 39.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 114.141 -1.39 . . . . 1.04 109.775 172.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.4 mt -67.39 -43.1 87.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.731 -0.668 . . . . 1.04 110.624 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.3 m -60.61 -29.1 69.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.366 0.603 . . . . 1.6100000000000001 110.145 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.601 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 12.7 ttt180 -66.76 -30.27 70.44 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.061 -0.972 . . . . 4.3899999999999997 109.588 175.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.487 ' HD2' ' O ' ' A' ' 107' ' ' ILE . 61.6 m-85 . . . . . 0 N--CA 1.447 -0.576 0 CA-C-N 115.78 -0.646 . . . . 0.71999999999999997 111.664 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 261' ' ' PHE . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 2.1 m-85 . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 109.854 -0.424 . . . . 0.97999999999999998 109.854 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 11.8 p -143.37 144.64 23.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.649 -0.251 . . . . 1.8999999999999999 110.639 175.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 C--O 1.235 0.315 0 N-CA-C 109.05 -0.722 . . . . 2.2400000000000002 109.05 173.796 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.59 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 67.4 m80 . . . . . 0 C--O 1.224 -0.252 0 CA-C-O 120.844 0.354 . . . . 2.3900000000000001 110.949 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.421 ' HG ' ' C ' ' A' ' 3' ' ' HIS . 14.3 m -160.44 143.25 13.26 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.867 -0.42 . . . . 1.6100000000000001 109.867 -177.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.29 149.69 8.92 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.414 -1.074 . . . . 0.17000000000000001 110.414 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.671 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -74.84 140.19 43.73 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 117.539 0.669 . . . . 0.97999999999999998 111.19 -176.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.76 153.85 38.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.376 0.608 . . . . 1.01 111.723 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.539 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.0 mp -95.77 117.0 38.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.483 -0.78 . . . . 1.0800000000000001 109.075 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.559 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 74.9 t80 -117.97 109.46 16.52 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.127 -0.323 . . . . 0.66000000000000003 110.127 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 66.84 47.51 1.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.641 0.734 . . . . 1.46 110.758 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp 71.26 6.93 5.96 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.143 -1.389 . . . . 2.3900000000000001 113.024 171.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -114.14 132.93 61.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.782 0.325 . . . . 1.23 110.414 171.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.539 ' HA ' HG13 ' A' ' 8' ' ' ILE . 41.2 t -74.64 134.51 42.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.311 0.577 . . . . 1.48 110.808 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.653 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -155.98 -158.16 8.67 Favored Glycine 0 N--CA 1.434 -1.486 0 CA-C-N 115.431 -0.804 . . . . 0.16 112.237 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.671 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 13.7 mm -124.57 153.56 31.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.053 0.454 . . . . 1.05 110.432 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.406 HG12 HD23 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -123.9 133.29 69.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.759 -0.655 . . . . 1.01 110.111 179.074 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.22 109.54 7.85 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.288 -0.414 . . . . 0.87 111.761 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' A' ' 3' ' ' HIS . 3.7 mp -85.51 121.05 36.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.567 -0.901 . . . . 1.05 108.567 172.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.446 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.3 t30 -126.1 128.93 48.12 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 110.249 -0.278 . . . . 1.1200000000000001 110.249 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.46 ' HG2' ' HB3' ' A' ' 25' ' ' ALA . 33.7 mt-10 -110.0 85.3 2.08 Favored 'General case' 0 N--CA 1.425 -1.715 0 C-N-CA 117.022 -1.871 . . . . 0.73999999999999999 107.632 163.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.446 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 13.1 t70 -120.95 -10.58 9.06 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.287 -1.746 . . . . 0.58999999999999997 106.287 156.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.671 HG13 ' O ' ' A' ' 23' ' ' SER . 14.3 p -102.49 174.76 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 111.66 -2.518 . . . . 1.0800000000000001 112.192 -156.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.671 ' O ' HG13 ' A' ' 22' ' ' VAL . 1.1 t -54.52 167.63 0.56 Allowed Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 106.417 -1.697 . . . . 2.0 106.417 166.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.44 ' HD2' ' OG ' ' A' ' 23' ' ' SER . 13.0 Cg_endo -42.4 128.9 4.72 Favored 'Trans proline' 0 C--N 1.359 1.123 0 CA-C-N 122.266 1.845 . . . . 0.26000000000000001 111.121 -152.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.506 ' HB1' HG21 ' A' ' 107' ' ' ILE . . . -32.43 135.71 0.08 Allowed 'General case' 0 CA--C 1.508 -0.652 0 O-C-N 125.242 1.589 . . . . 1.02 114.01 -155.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.561 ' HB2' HG12 ' A' ' 22' ' ' VAL . 29.2 mt-10 -121.7 136.95 54.93 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.579 -1.191 . . . . 1.26 111.213 -170.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.604 ' C ' HD21 ' A' ' 27' ' ' LEU . 1.2 tt -101.29 143.3 31.52 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 106.222 -1.77 . . . . 1.0600000000000001 106.222 170.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.435 ' N ' HD21 ' A' ' 27' ' ' LEU . 30.0 m -132.51 110.54 10.56 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.868 -0.733 . . . . 1.05 110.134 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.602 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.6 t90 -86.32 106.53 17.45 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.339 -0.846 . . . . 0.29999999999999999 108.957 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -115.04 114.87 25.95 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.62 -1.173 . . . . 1.1599999999999999 108.695 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.545 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 94.6 p -57.07 153.22 11.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.515 0.674 . . . . 1.3899999999999999 111.574 -171.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.653 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 14.8 m -58.62 -28.49 65.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.557 -1.201 . . . . 1.1499999999999999 110.87 -177.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -83.08 -28.6 29.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.085 -0.507 . . . . 2.3300000000000001 110.555 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.22 17.98 32.72 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.112 -0.566 . . . . 0.55000000000000004 113.072 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -103.5 -25.62 13.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.928 0.394 . . . . 1.1299999999999999 111.511 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.1 tttm -117.28 122.07 42.92 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.927 -0.397 . . . . 2.6200000000000001 109.927 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 84.1 t -132.07 123.01 50.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.849 0.357 . . . . 1.3100000000000001 110.695 -177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -131.35 120.98 23.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.197 -0.456 . . . . 0.82999999999999996 110.357 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.488 HG21 ' OE1' ' A' ' 26' ' ' GLU . 35.7 m -101.96 143.52 31.73 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 111.735 0.272 . . . . 1.0600000000000001 111.735 -175.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.522 HG23 ' CD2' ' A' ' 87' ' ' HIS . 38.7 t -116.61 129.44 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 122.83 0.452 . . . . 1.3600000000000001 111.333 176.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.539 ' O ' HG12 ' A' ' 45' ' ' ILE . 53.7 t -91.18 107.98 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 121.5 0.667 . . . . 1.05 109.43 172.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.618 HD12 ' CD2' ' A' ' 104' ' ' LEU . 2.4 mm? -53.19 -32.82 49.88 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.656 -1.156 . . . . 1.04 112.576 -178.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.436 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 52.7 m -75.92 -28.43 58.0 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.933 -0.307 . . . . 1.45 111.456 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.3 p -80.44 -10.89 59.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.187 0.517 . . . . 1.04 109.832 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.539 HG12 ' O ' ' A' ' 41' ' ' VAL . 36.3 mm -82.29 130.09 36.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.483 -0.78 . . . . 1.02 110.861 174.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.612 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 3.7 t70 -86.44 -41.54 14.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.689 -0.687 . . . . 0.69999999999999996 111.456 176.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.52 ' HE3' ' OE1' ' B' ' 263' ' ' GLU . 11.1 tptt -140.47 138.5 34.7 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.795 -0.639 . . . . 2.4300000000000002 110.005 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.61 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 13.9 tp -109.29 141.8 41.09 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.053 -0.721 . . . . 1.04 109.053 164.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 5.8 mt-30 -119.07 154.13 33.66 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.81 -1.086 . . . . 1.49 109.927 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.23 141.61 8.1 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.065 177.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 40.0 p -51.29 127.82 30.44 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-O 121.5 0.667 . . . . 1.03 111.418 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 45.0 Cg_endo -66.89 166.53 22.32 Favored 'Trans proline' 0 C--N 1.334 -0.214 0 C-N-CA 124.107 3.205 . . . . 0.73999999999999999 112.105 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.5 -11.27 59.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.087 0.47 . . . . 1.54 110.569 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.4 t -84.71 -24.64 28.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.999 -0.546 . . . . 2.0499999999999998 109.753 173.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.552 ' OG ' ' HE3' ' A' ' 57' ' ' LYS . 21.2 t -71.59 146.13 48.59 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.067 -0.716 . . . . 1.1399999999999999 109.067 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -95.42 -14.57 23.68 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.223 -1.028 . . . . 2.8900000000000001 108.223 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.552 ' HE3' ' OG ' ' A' ' 55' ' ' SER . 0.0 OUTLIER -88.04 176.02 7.49 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 113.731 -1.577 . . . . 3.1299999999999999 110.313 -177.213 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.502 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -138.32 109.46 6.83 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.454 -0.573 . . . . 2.0 109.454 173.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.558 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 3.2 mpp? -154.61 141.27 18.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.772 0.32 . . . . 1.3 111.448 -176.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.868 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 2.3 mp -109.16 161.83 14.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.722 -0.672 . . . . 1.05 110.719 170.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.468 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 2.8 ttt180 -154.03 114.36 3.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.239 -0.437 . . . . 3.3999999999999999 110.925 172.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.521 ' HG ' HD11 ' A' ' 48' ' ' LEU . 11.7 mt -95.89 110.02 22.28 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 122.659 0.384 . . . . 1.73 110.88 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.5 ' HA ' ' CB ' ' A' ' 86' ' ' ARG . 4.3 mm -86.86 109.68 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.255 -0.43 . . . . 1.1599999999999999 111.062 -174.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -74.97 143.23 30.71 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.136 -1.03 . . . . 0.47999999999999998 110.956 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.612 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 6.2 mttm -64.13 134.65 55.29 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.545 0.688 . . . . 1.78 112.198 -175.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 C--N 1.316 -0.882 0 CA-C-N 114.738 -1.119 . . . . 1.3100000000000001 108.551 174.036 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.284 0 CA-C-O 121.648 0.737 . . . . 1.78 110.192 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.5 ' CB ' ' HA ' ' A' ' 63' ' ' ILE . 26.2 ptt180 -125.12 143.71 50.79 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.535 -0.757 . . . . 2.8199999999999998 111.439 -169.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.522 ' CD2' HG23 ' A' ' 40' ' ' VAL . 97.2 m-70 -104.94 112.8 26.06 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.078 -0.964 . . . . 0.63 110.465 -173.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.437 ' HE3' ' CE2' ' B' ' 261' ' ' PHE . 48.3 ttm -107.56 125.31 51.14 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 110.417 -0.216 . . . . 1.1200000000000001 110.417 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.6 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -117.06 139.33 50.83 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.808 -0.812 . . . . 1.6499999999999999 108.808 176.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.493 ' HB3' ' HB ' ' A' ' 8' ' ' ILE . 31.1 t -97.48 128.16 44.02 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.193 -0.669 . . . . 1.1899999999999999 109.193 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.868 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 6.2 m-85 -108.59 164.35 12.44 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.561 -0.745 . . . . 1.6399999999999999 109.706 -176.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -109.29 -2.9 17.57 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.678 -0.409 . . . . 1.8300000000000001 110.906 -172.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -146.69 127.77 14.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.375 0.607 . . . . 1.22 110.624 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.47 ' NH1' ' HB2' ' A' ' 98' ' ' ASP . 43.3 tpt85 -61.71 -27.28 68.6 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.852 -1.067 . . . . 2.8799999999999999 111.325 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 92.3 m -74.64 -57.88 3.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.429 -0.35 . . . . 1.1200000000000001 110.582 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.3 t -46.04 -54.06 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-N 116.17 -0.468 . . . . 1.1299999999999999 111.289 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.545 ' O ' HD12 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -66.08 -27.76 68.31 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.166 -0.47 . . . . 1.0600000000000001 110.7 -177.566 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.47 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 32.9 t70 -68.93 -34.57 75.58 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 109.18 -0.674 . . . . 0.39000000000000001 109.18 177.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -73.18 -49.26 29.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.34 -1.3 . . . . 1.55 109.53 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.509 HG21 HD11 ' A' ' 18' ' ' ILE . 36.0 mm -55.84 -53.08 41.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.181 -0.918 . . . . 1.0600000000000001 110.409 174.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.473 ' HG3' ' CB ' ' A' ' 50' ' ' ALA . 1.1 tmmm? -53.25 -52.52 58.71 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.781 -0.645 . . . . 1.72 110.937 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 24.3 ptm -67.81 -24.45 65.3 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.95 -0.568 . . . . 1.76 109.768 -173.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.428 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 55.5 m -67.03 -50.52 61.78 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.54 0.686 . . . . 1.04 110.066 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.618 ' CD2' HD12 ' A' ' 42' ' ' LEU . 10.3 mt -70.45 -57.32 4.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.824 -1.08 . . . . 1.05 111.52 -174.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.56 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 63.3 mt-30 -53.85 -25.78 21.42 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.572 0.582 . . . . 1.45 112.572 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -66.42 -30.1 70.39 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.74 0.781 . . . . 0.66000000000000003 109.374 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.552 ' O ' ' HB3' ' A' ' 110' ' ' ARG . 31.7 mt -82.42 -44.28 19.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 114.117 -1.401 . . . . 1.04 110.312 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.4 mt -66.87 -51.38 55.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.574 -0.739 . . . . 1.04 110.804 -175.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.6 t -61.52 -22.38 65.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.544 0.688 . . . . 1.6100000000000001 109.354 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.552 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 14.7 ttt180 -72.99 -38.96 66.46 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.746 -1.115 . . . . 4.3899999999999997 110.184 177.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 . . . . . 0 N--CA 1.449 -0.525 0 CA-C-N 115.857 -0.61 . . . . 0.71999999999999997 111.249 -176.481 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 261' ' ' PHE . . . . . 0.437 ' CE2' ' HE3' ' A' ' 88' ' ' MET . 13.1 m-85 . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 109.419 -0.586 . . . . 0.97999999999999998 109.419 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 7.8 p -140.93 143.99 27.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.818 0.342 . . . . 1.8999999999999999 110.213 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 263' ' ' GLU . . . . . 0.52 ' OE1' ' HE3' ' A' ' 47' ' ' LYS . 44.4 tt0 . . . . . 0 C--N 1.323 -0.552 0 N-CA-C 109.065 -0.717 . . . . 2.2400000000000002 109.065 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.416 ' HA ' HG22 ' A' ' 103' ' ' THR . 45.7 m80 . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 112.701 0.63 . . . . 2.3900000000000001 112.701 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.414 ' HG ' ' C ' ' A' ' 3' ' ' HIS . 20.4 m -158.92 148.8 19.23 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.825 -0.435 . . . . 1.6100000000000001 109.825 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.41 148.05 6.6 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.366 -1.094 . . . . 0.17000000000000001 110.366 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.673 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -73.57 140.0 45.97 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 117.419 0.61 . . . . 0.97999999999999998 111.524 -175.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 89' ' ' PHE . . . -148.65 162.93 38.72 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 121.361 0.6 . . . . 1.01 111.638 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.54 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.1 mp -109.47 126.49 66.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.45 -0.796 . . . . 1.0800000000000001 109.031 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -114.18 99.66 7.79 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 120.879 0.371 . . . . 0.66000000000000003 110.249 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 56.69 59.2 3.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.286 0.565 . . . . 1.46 111.118 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp 76.07 -8.73 1.57 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.858 -1.065 . . . . 2.3900000000000001 113.68 170.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.1 p -96.6 130.38 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 119.892 -0.723 . . . . 1.23 109.987 169.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.54 ' HA ' HG13 ' A' ' 8' ' ' ILE . 18.6 t -85.3 133.55 34.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.024 -0.534 . . . . 1.48 110.804 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.658 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -155.5 -155.95 7.57 Favored Glycine 0 N--CA 1.438 -1.214 0 CA-C-N 115.749 -0.66 . . . . 0.16 112.598 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.673 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.7 mm -126.6 153.44 35.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 120.798 0.333 . . . . 1.05 110.614 -177.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.423 HG12 HD23 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -121.89 132.56 70.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.12 -0.491 . . . . 1.01 110.059 179.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.85 109.46 7.47 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.316 -0.402 . . . . 0.87 111.927 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 3.9 mp -85.95 115.66 27.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.897 -0.779 . . . . 1.05 108.897 173.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.406 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 1.6 t30 -118.38 126.34 51.88 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.982 -0.377 . . . . 1.1200000000000001 109.982 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -110.89 83.35 1.74 Allowed 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 117.362 -1.735 . . . . 0.73999999999999999 107.543 164.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -121.25 -10.5 8.94 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 106.638 -1.615 . . . . 0.58999999999999997 106.638 156.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 23' ' ' SER . 14.8 p -101.43 174.66 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 112.099 -2.319 . . . . 1.0800000000000001 112.031 -156.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.693 ' O ' HG12 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -54.51 165.63 0.86 Allowed Pre-proline 0 C--O 1.225 -0.194 0 N-CA-C 106.04 -1.837 . . . . 2.0 106.04 166.489 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.408 ' HD2' ' OG ' ' A' ' 23' ' ' SER . 10.1 Cg_endo -41.14 128.04 2.93 Favored 'Trans proline' 0 C--N 1.354 0.845 0 CA-C-N 121.899 1.714 . . . . 0.26000000000000001 111.555 -150.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.552 ' HB3' HG23 ' A' ' 107' ' ' ILE . . . -32.15 135.21 0.08 Allowed 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 125.288 1.617 . . . . 1.02 113.719 -156.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.507 ' HB2' HG11 ' A' ' 22' ' ' VAL . 70.7 mt-10 -124.77 137.62 54.31 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 114.792 -1.094 . . . . 1.26 111.366 -168.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.58 ' C ' HD21 ' A' ' 27' ' ' LEU . 1.3 tt -100.65 141.88 32.89 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 106.543 -1.651 . . . . 1.0600000000000001 106.543 173.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.407 ' N ' HD21 ' A' ' 27' ' ' LEU . 6.8 m -130.1 108.77 10.32 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.848 -0.741 . . . . 1.05 110.413 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.631 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 82.8 t90 -88.0 113.68 23.88 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.478 0.656 . . . . 0.29999999999999999 109.755 175.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -120.67 122.97 41.62 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.168 -0.924 . . . . 1.1599999999999999 109.161 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.422 ' OG ' ' HG2' ' A' ' 36' ' ' LYS . 38.1 m -56.59 141.47 43.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.088 0.47 . . . . 1.3899999999999999 110.482 -174.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.658 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 20.2 m -57.54 -35.9 70.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.092 -0.958 . . . . 1.1499999999999999 110.443 -176.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -87.36 -8.04 57.07 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.502 -0.772 . . . . 2.3300000000000001 111.153 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.89 21.02 54.48 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.82 -0.705 . . . . 0.55000000000000004 112.39 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -69.85 -56.36 7.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.337 0.495 . . . . 1.1299999999999999 112.337 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.422 ' HG2' ' OG ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -143.88 161.71 37.99 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.806 0.336 . . . . 2.6200000000000001 110.979 -176.164 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 58.2 t -133.2 138.06 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.337 -0.392 . . . . 1.3100000000000001 110.678 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -135.67 115.77 13.31 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 122.551 0.34 . . . . 0.82999999999999996 110.714 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.5 m -98.89 142.68 30.09 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.783 0.325 . . . . 1.0600000000000001 111.461 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 22.0 t -116.62 128.8 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 122.827 0.451 . . . . 1.3600000000000001 111.209 175.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.532 ' O ' HG12 ' A' ' 45' ' ' ILE . 43.2 t -90.56 109.25 20.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.078 0.466 . . . . 1.05 109.904 175.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.54 HD12 ' CD2' ' A' ' 104' ' ' LEU . 1.9 mm? -54.16 -26.43 27.83 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.372 -0.831 . . . . 1.04 112.762 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.3 m -75.27 -35.1 61.4 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.374 -0.53 . . . . 1.45 111.329 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.8 p -74.0 -14.48 61.03 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.402 -0.592 . . . . 1.04 109.402 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.575 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 48.9 mm -82.92 114.43 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.075 -0.966 . . . . 1.02 110.863 175.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.548 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 31.8 t70 -74.7 -39.46 61.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.109 -0.496 . . . . 0.69999999999999996 111.266 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -147.24 158.13 43.84 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.227 -0.442 . . . . 2.4300000000000002 110.199 -174.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.577 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 10.8 tp -124.53 146.01 49.23 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.303 0.573 . . . . 1.04 109.917 171.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.41 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 15.5 mm100 -123.16 155.98 35.96 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.793 -1.094 . . . . 1.49 109.653 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.18 138.23 6.5 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.55 -0.75 . . . . 1.0 109.649 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.409 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 36.7 p -50.7 126.71 24.31 Favored Pre-proline 0 N--CA 1.466 0.339 0 CA-C-O 121.193 0.52 . . . . 1.03 110.396 176.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 43.0 Cg_endo -65.59 164.76 25.2 Favored 'Trans proline' 0 C--N 1.329 -0.494 0 C-N-CA 123.611 2.874 . . . . 0.73999999999999999 112.017 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.06 66.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.279 0.561 . . . . 1.54 110.064 175.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.5 t -75.03 -24.6 58.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.287 -0.87 . . . . 2.0499999999999998 110.575 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.446 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 46.8 t -68.42 148.37 50.75 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.59 -0.522 . . . . 1.1399999999999999 109.59 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -89.21 -7.68 55.06 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.746 0.784 . . . . 2.8900000000000001 109.389 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -107.89 -175.85 2.9 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.686 -1.143 . . . . 3.1299999999999999 110.9 -172.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.481 ' N ' ' SD ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -141.7 110.39 6.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.257 -0.883 . . . . 2.0 109.171 175.039 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.458 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 2.4 mpp? -156.3 139.94 16.0 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.694 0.283 . . . . 1.3 111.456 -176.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.851 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 1.5 mp -110.66 155.42 22.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.121 -0.49 . . . . 1.05 110.928 171.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.586 ' HD3' ' HD2' ' A' ' 86' ' ' ARG . 25.4 ttm-85 -145.5 113.76 6.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.083 0.468 . . . . 3.3999999999999999 110.043 170.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.508 ' HG ' HD13 ' A' ' 48' ' ' LEU . 6.5 mp -91.9 111.69 23.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.075 -0.512 . . . . 1.73 110.522 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.532 ' HA ' ' CB ' ' A' ' 86' ' ' ARG . 3.0 mm -86.71 125.52 40.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.195 -0.457 . . . . 1.1599999999999999 110.116 -173.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -89.31 156.07 25.66 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.164 -1.017 . . . . 0.47999999999999998 111.474 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.548 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 0.7 OUTLIER -64.12 134.01 54.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.03 0.443 . . . . 1.78 110.025 176.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 C--N 1.317 -0.843 0 CA-C-N 115.615 -0.72 . . . . 1.3100000000000001 109.165 174.679 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? . . . . . 0 CA--C 1.507 -0.709 0 N-CA-C 108.835 -0.802 . . . . 1.78 108.835 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.586 ' HD2' ' HD3' ' A' ' 61' ' ' ARG . 28.7 ptt180 -143.64 140.9 30.34 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.663 -0.699 . . . . 2.8199999999999998 111.303 -171.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -102.88 112.28 25.0 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.795 -1.093 . . . . 0.63 110.734 -170.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.542 ' HE3' ' CZ ' ' B' ' 261' ' ' PHE . 38.6 ttm -104.04 137.54 41.86 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 121.067 -0.253 . . . . 1.1200000000000001 110.806 -177.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.427 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . 56.3 m-85 -124.1 139.18 54.18 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.514 -0.921 . . . . 1.6499999999999999 108.514 169.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.525 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 14.7 m -95.1 124.18 39.0 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.313 -0.625 . . . . 1.1899999999999999 109.313 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.851 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 7.7 m-85 -106.5 168.4 9.19 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 110.044 -0.354 . . . . 1.6399999999999999 110.044 -174.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -114.37 -6.89 12.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.824 0.345 . . . . 1.8300000000000001 111.325 -174.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -138.62 122.93 18.22 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.282 0.563 . . . . 1.22 110.954 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -54.6 -39.6 68.03 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 114.51 -1.223 . . . . 2.8799999999999999 111.327 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.431 HG23 HD22 ' A' ' 99' ' ' ASN . 97.7 m -71.14 -57.25 4.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.564 -0.289 . . . . 1.1200000000000001 110.599 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.451 ' O ' HG12 ' A' ' 100' ' ' ILE . 96.1 t -45.97 -55.6 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 116.126 -0.488 . . . . 1.1299999999999999 111.299 175.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.642 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -65.41 -29.36 70.06 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.254 -0.43 . . . . 1.0600000000000001 110.695 -177.127 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.414 ' HA ' ' CG ' ' A' ' 101' ' ' LYS . 30.2 t70 -71.42 -28.3 63.9 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.853 0.835 . . . . 0.39000000000000001 109.318 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.525 ' O ' ' HG3' ' A' ' 102' ' ' MET . 87.8 m-20 -77.64 -36.84 51.17 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.559 -1.2 . . . . 1.55 109.252 176.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.532 HG23 HD11 ' A' ' 18' ' ' ILE . 33.4 mm -64.42 -53.04 47.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 114.978 -1.01 . . . . 1.0600000000000001 111.144 176.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.642 ' HG2' ' O ' ' A' ' 97' ' ' MET . 2.1 ptmt -59.29 -43.57 92.57 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 121.231 -0.188 . . . . 1.72 110.6 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.525 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.5 ppp? -68.08 -25.83 65.53 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.175 0.512 . . . . 1.76 109.719 -175.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 36.9 m -65.61 -51.95 55.77 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.463 -0.789 . . . . 1.04 109.815 173.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.577 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 12.2 mt -71.15 -56.92 5.09 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 115.183 -0.917 . . . . 1.05 111.141 -175.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 101' ' ' LYS . 21.1 mm-40 -42.85 -35.0 1.05 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.808 0.67 . . . . 1.45 112.808 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -65.59 -48.29 72.82 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.845 -0.798 . . . . 0.66000000000000003 108.845 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.552 HG23 ' HB3' ' A' ' 25' ' ' ALA . 68.2 mt -61.48 -43.12 96.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.39 -1.277 . . . . 1.04 110.6 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -62.37 -54.98 27.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.51 -0.768 . . . . 1.04 109.875 -177.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.8 m -54.4 -32.35 57.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.98 -0.554 . . . . 1.6100000000000001 110.849 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.427 ' HD2' ' HA ' ' A' ' 107' ' ' ILE . 82.9 mtt180 -70.93 -27.99 64.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.593 -0.731 . . . . 4.3899999999999997 110.662 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 N--CA 1.445 -0.709 0 CA-C-N 116.21 -0.45 . . . . 0.71999999999999997 111.277 -178.076 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 261' ' ' PHE . . . . . 0.542 ' CZ ' ' HE3' ' A' ' 88' ' ' MET . 3.9 m-30 . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 109.221 -0.659 . . . . 0.97999999999999998 109.221 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 12.8 p -122.98 139.66 49.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.925 0.393 . . . . 1.8999999999999999 110.322 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 109.156 -0.683 . . . . 2.2400000000000002 109.156 174.691 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.1 m80 . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 121.647 0.737 . . . . 2.3900000000000001 109.478 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.1 p -162.99 154.45 17.55 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.815 -1.084 . . . . 1.6100000000000001 108.626 -176.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.73 145.86 5.48 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.186 -0.765 . . . . 0.17000000000000001 111.186 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.716 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.69 125.78 29.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.324 0.562 . . . . 0.97999999999999998 111.36 -176.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.72 158.39 44.24 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 121.168 0.509 . . . . 1.01 111.36 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 2.0 mp -96.96 127.65 48.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.637 -0.711 . . . . 1.0800000000000001 109.472 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.624 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 80.4 t80 -137.38 117.15 13.11 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.337 -0.616 . . . . 0.66000000000000003 109.337 178.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 66.71 44.18 2.24 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.15 0.58 . . . . 1.46 110.419 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt 74.91 -8.95 1.44 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.777 -1.102 . . . . 2.3900000000000001 112.718 171.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.48 131.92 47.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.903 0.382 . . . . 1.23 110.476 177.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.494 ' HA ' HG13 ' A' ' 8' ' ' ILE . 22.5 t -78.03 123.2 26.55 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.002 -0.544 . . . . 1.48 109.992 176.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.624 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -139.07 -154.73 6.46 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.543 -0.753 . . . . 0.16 112.06 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.716 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.7 mm -127.02 153.76 36.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 120.957 0.408 . . . . 1.05 110.779 -177.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.466 HG12 HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -128.56 132.81 67.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.856 -0.611 . . . . 1.01 110.113 -179.348 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.01 112.09 9.02 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 111.976 0.362 . . . . 0.87 111.976 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.529 HD12 HG23 ' A' ' 100' ' ' ILE . 3.7 mp -86.02 120.86 36.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.836 -0.802 . . . . 1.05 108.836 172.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.428 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.9 t30 -126.22 125.39 42.32 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 110.234 -0.284 . . . . 1.1200000000000001 110.234 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.444 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 22.2 mt-10 -108.47 84.51 1.95 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 117.069 -1.852 . . . . 0.73999999999999999 107.468 163.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.428 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 17.9 t70 -121.54 -9.58 8.94 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 106.341 -1.726 . . . . 0.58999999999999997 106.341 156.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 23' ' ' SER . 14.0 p -102.48 175.98 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 111.732 -2.486 . . . . 1.0800000000000001 111.778 -157.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.699 ' O ' HG13 ' A' ' 22' ' ' VAL . 5.6 m -54.15 167.25 0.56 Allowed Pre-proline 0 C--O 1.225 -0.201 0 N-CA-C 106.997 -1.483 . . . . 2.0 106.997 166.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 10.7 Cg_endo -42.16 128.27 4.22 Favored 'Trans proline' 0 C--N 1.357 1.008 0 CA-C-N 122.018 1.756 . . . . 0.26000000000000001 111.009 -154.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.504 ' HB3' HG22 ' A' ' 107' ' ' ILE . . . -31.58 134.61 0.08 Allowed 'General case' 0 CA--C 1.504 -0.805 0 O-C-N 125.19 1.557 . . . . 1.02 113.93 -155.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.515 ' HB2' HG12 ' A' ' 22' ' ' VAL . 33.6 mt-10 -121.3 134.93 55.16 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.646 -1.161 . . . . 1.26 111.031 -172.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.594 ' C ' HD23 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -100.34 141.26 33.43 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 106.052 -1.833 . . . . 1.0600000000000001 106.052 173.39 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.458 ' N ' HD23 ' A' ' 27' ' ' LEU . 6.2 m -127.92 108.76 10.96 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.677 -0.809 . . . . 1.05 110.434 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.624 ' CE2' ' HB3' ' A' ' 9' ' ' PHE . 88.8 t90 -89.6 107.56 19.16 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.675 0.75 . . . . 0.29999999999999999 109.271 175.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -113.83 120.53 41.06 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.888 -1.051 . . . . 1.1599999999999999 109.088 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.567 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 88.9 p -61.78 144.97 53.93 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.197 -0.668 . . . . 1.3899999999999999 109.197 -176.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.624 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 11.4 m -54.0 -23.25 12.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.013 -0.994 . . . . 1.1499999999999999 111.99 -173.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -87.65 -10.59 50.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 111.982 0.364 . . . . 2.3300000000000001 111.982 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.15 21.43 67.68 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.831 -0.7 . . . . 0.55000000000000004 111.704 -176.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -93.49 -44.72 8.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.065 0.459 . . . . 1.1299999999999999 111.334 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -110.34 146.12 36.32 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.895 -0.593 . . . . 2.6200000000000001 110.794 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 89.0 t -144.12 115.7 2.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.874 -0.603 . . . . 1.3100000000000001 109.69 174.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -125.46 111.22 14.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.926 -0.579 . . . . 0.82999999999999996 110.066 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.473 HG22 ' OE1' ' A' ' 26' ' ' GLU . 14.4 m -98.74 143.17 29.39 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 120.824 -0.351 . . . . 1.0600000000000001 111.326 -175.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 28.7 t -116.43 130.15 71.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 122.416 0.286 . . . . 1.3600000000000001 111.536 176.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 45' ' ' ILE . 60.1 t -91.03 108.28 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-O 121.398 0.618 . . . . 1.05 109.875 173.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.562 HD13 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -53.19 -26.89 18.98 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.808 -1.087 . . . . 1.04 112.927 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.431 ' O ' ' HE3' ' A' ' 65' ' ' LYS . 59.4 m -80.68 -30.25 36.46 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.459 -0.496 . . . . 1.45 111.661 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.2 p -75.66 -16.23 60.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.099 -0.704 . . . . 1.04 109.099 172.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.632 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 46.6 mm -75.09 120.72 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.965 -1.016 . . . . 1.02 111.313 174.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.562 ' OD2' ' HG2' ' A' ' 47' ' ' LYS . 20.2 t70 -74.24 -50.22 19.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.851 -1.068 . . . . 0.69999999999999996 110.99 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.562 ' HG2' ' OD2' ' A' ' 46' ' ' ASP . 48.2 mmtm -142.32 154.46 44.71 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 109.488 -0.56 . . . . 2.4300000000000002 109.488 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.617 ' CD2' ' HG3' ' A' ' 105' ' ' GLN . 9.0 tp -112.59 145.05 41.03 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.391 -0.596 . . . . 1.04 109.391 167.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 15.2 mt-30 -126.73 156.67 40.77 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.686 -1.143 . . . . 1.49 109.876 -177.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -161.76 151.11 16.12 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 22.3 p -50.25 121.22 13.3 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.588 0.709 . . . . 1.03 111.44 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 66.3 Cg_endo -71.95 167.82 25.64 Favored 'Trans proline' 0 C--N 1.331 -0.375 0 C-N-CA 124.205 3.27 . . . . 0.73999999999999999 111.546 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.2 -27.94 37.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.26 0.552 . . . . 1.54 110.52 174.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 t -73.46 -22.78 60.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.838 -0.619 . . . . 2.0499999999999998 110.889 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.474 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 24.6 t -86.6 136.28 33.11 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.9 -0.407 . . . . 1.1399999999999999 109.9 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -88.99 -6.77 56.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.334 0.588 . . . . 2.8900000000000001 111.093 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -99.75 -177.1 3.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.393 -0.821 . . . . 3.1299999999999999 109.977 -176.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.581 ' SD ' ' HB2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -136.29 107.16 6.64 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.032 -0.729 . . . . 2.0 109.032 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.587 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 3.5 mpp? -156.86 146.62 20.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.977 0.418 . . . . 1.3 111.188 -175.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.854 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 1.9 mp -110.77 163.14 14.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.551 -0.75 . . . . 1.05 111.699 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 20.5 ttt180 -155.02 113.44 3.51 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.613 -0.721 . . . . 3.3999999999999999 110.281 173.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.561 HD12 ' CE2' ' A' ' 89' ' ' PHE . 7.3 mp -94.81 113.27 25.0 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.139 0.495 . . . . 1.73 110.427 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.535 HG22 ' HG2' ' A' ' 86' ' ' ARG . 5.1 mm -84.58 124.09 39.59 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 C-N-CA 123.543 0.737 . . . . 1.1599999999999999 109.105 -178.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.632 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -97.65 146.7 18.35 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 119.841 -1.171 . . . . 0.47999999999999998 112.106 177.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.514 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -58.22 131.53 50.86 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.141 0.496 . . . . 1.78 111.452 -175.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 115.387 -0.824 . . . . 1.3100000000000001 109.17 177.364 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 121.647 0.736 . . . . 1.78 110.995 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.535 ' HG2' HG22 ' A' ' 63' ' ' ILE . 25.5 mtm180 -110.33 157.0 19.97 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.495 -0.775 . . . . 2.8199999999999998 111.032 -175.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.403 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 95.2 m-70 -120.39 111.12 17.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.308 -0.86 . . . . 0.63 109.637 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.446 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 55.0 ttm -113.73 125.31 53.97 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.88 -0.145 . . . . 1.1200000000000001 110.633 -174.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.561 ' CE2' HD12 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -118.75 148.43 42.81 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.339 -0.615 . . . . 1.6499999999999999 109.339 174.088 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.587 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 32.2 m -97.79 126.54 43.2 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.659 -0.497 . . . . 1.1899999999999999 109.659 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.854 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 8.8 m-85 -106.53 154.76 20.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.057 0.456 . . . . 1.6399999999999999 111.349 -174.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -100.36 -6.65 25.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.984 -0.553 . . . . 1.8300000000000001 110.955 -171.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -142.76 128.33 19.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.938 0.399 . . . . 1.22 110.581 -175.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.581 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 15.8 tpt180 -59.63 -34.69 73.11 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.109 -0.95 . . . . 2.8799999999999999 110.847 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.477 HG22 HD22 ' A' ' 99' ' ' ASN . 47.6 m -74.03 -58.82 3.05 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.69 -0.687 . . . . 1.1200000000000001 110.618 -177.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.42 ' O ' HG12 ' A' ' 100' ' ' ILE . 94.6 t -45.19 -53.69 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-N 115.792 -0.64 . . . . 1.1299999999999999 111.456 175.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.786 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -66.32 -29.81 70.09 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 120.515 -0.474 . . . . 1.0600000000000001 110.563 -177.206 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 101' ' ' LYS . 35.8 t70 -72.13 -24.26 61.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.62 0.724 . . . . 0.39000000000000001 109.618 178.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.566 ' O ' ' HG3' ' A' ' 102' ' ' MET . 85.7 m-20 -83.78 -42.93 15.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.845 -1.071 . . . . 1.55 109.742 177.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.529 HG23 HD12 ' A' ' 18' ' ' ILE . 33.7 mm -58.54 -51.85 66.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.482 -0.781 . . . . 1.0600000000000001 110.837 176.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.786 ' HG2' ' O ' ' A' ' 97' ' ' MET . 2.6 ptmt -60.23 -39.25 86.01 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 120.851 0.358 . . . . 1.72 111.159 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.566 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.7 ppp? -76.52 -22.93 53.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.079 0.466 . . . . 1.76 109.761 -175.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 52.6 m -68.46 -53.2 25.03 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.649 -0.705 . . . . 1.04 109.679 174.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.611 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 13.1 mt -65.75 -56.59 11.21 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.151 -0.931 . . . . 1.05 110.932 -177.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.617 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 49.1 mt-30 -52.05 -26.38 10.77 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.808 0.67 . . . . 1.45 112.808 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.427 ' O ' ' HG3' ' A' ' 110' ' ' ARG . 19.4 mt-30 -64.59 -43.8 92.66 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.923 -0.769 . . . . 0.66000000000000003 108.923 176.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.525 ' O ' ' HB2' ' A' ' 110' ' ' ARG . 33.4 mt -66.76 -43.89 89.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.293 -1.321 . . . . 1.04 110.876 176.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.2 mt -67.16 -47.84 80.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.05 -0.523 . . . . 1.04 110.445 -176.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.0 t -58.71 -27.34 64.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.366 0.603 . . . . 1.6100000000000001 110.237 172.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.525 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 77.2 mtt180 -70.56 -31.79 68.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 4.3899999999999997 110.25 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 . . . . . 0 N--CA 1.447 -0.617 0 CA-C-N 115.914 -0.584 . . . . 0.71999999999999997 111.934 -178.862 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 261' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.909 -0.404 . . . . 0.97999999999999998 109.909 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.97 166.32 26.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.36 -0.382 . . . . 1.8999999999999999 110.72 -176.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 263' ' ' GLU . . . . . 0.524 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 8.0 pt-20 . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 116.282 -0.417 . . . . 2.2400000000000002 110.089 173.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.556 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 37.9 m80 . . . . . 0 C--O 1.226 -0.164 0 N-CA-C 112.087 0.403 . . . . 2.3900000000000001 112.087 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.422 ' C ' HD12 ' A' ' 100' ' ' ILE . 88.6 p -163.12 149.92 12.61 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.844 0.354 . . . . 1.6100000000000001 110.715 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.72 147.45 6.35 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.496 -1.042 . . . . 0.17000000000000001 110.496 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.709 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.55 136.75 40.55 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 117.653 0.726 . . . . 0.97999999999999998 111.283 -175.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.31 160.11 40.81 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 121.278 0.561 . . . . 1.01 111.323 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.548 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.5 mp -105.58 126.39 60.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.603 -0.726 . . . . 1.0800000000000001 109.163 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -116.82 101.8 8.85 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.711 -0.396 . . . . 0.66000000000000003 110.279 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 60.69 53.0 4.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.19 0.519 . . . . 1.46 110.668 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt 78.99 -8.35 1.65 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.545 -1.207 . . . . 2.3900000000000001 113.298 171.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -97.86 127.58 50.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.203 -0.599 . . . . 1.23 110.712 171.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.548 ' HA ' HG13 ' A' ' 8' ' ' ILE . 10.2 p -78.99 126.13 30.28 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.558 -0.746 . . . . 1.48 111.095 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.655 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -145.24 -155.42 6.46 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.465 -0.789 . . . . 0.16 112.098 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.709 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 6.4 mm -128.71 153.78 38.71 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.741 0 CA-C-O 120.768 0.318 . . . . 1.05 110.768 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.47 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -124.38 131.85 72.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.642 -0.503 . . . . 1.01 109.642 179.126 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.57 112.28 9.44 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.215 -0.448 . . . . 0.87 111.643 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.556 ' O ' ' HB3' ' A' ' 3' ' ' HIS . 4.1 mp -84.8 120.75 35.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.265 -1.013 . . . . 1.05 108.265 171.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -123.64 124.88 43.75 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.967 -0.383 . . . . 1.1200000000000001 109.967 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -108.53 83.11 1.72 Allowed 'General case' 0 N--CA 1.427 -1.62 0 C-N-CA 116.959 -1.896 . . . . 0.73999999999999999 107.342 165.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -121.25 -12.35 8.66 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 106.625 -1.62 . . . . 0.58999999999999997 106.625 158.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 23' ' ' SER . 14.9 p -101.75 177.9 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 111.812 -2.449 . . . . 1.0800000000000001 111.852 -156.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.699 ' O ' HG13 ' A' ' 22' ' ' VAL . 4.4 m -53.61 168.4 0.4 Allowed Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 107.194 -1.41 . . . . 2.0 107.194 165.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 12.2 Cg_endo -42.6 128.21 4.75 Favored 'Trans proline' 0 C--N 1.357 1.016 0 CA-C-N 121.966 1.738 . . . . 0.26000000000000001 110.94 -155.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.502 ' HB2' HG21 ' A' ' 107' ' ' ILE . . . -33.36 135.83 0.11 Allowed 'General case' 0 CA--C 1.507 -0.697 0 O-C-N 125.334 1.646 . . . . 1.02 113.892 -154.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.524 ' HB2' HG12 ' A' ' 22' ' ' VAL . 28.5 mt-10 -123.3 138.61 54.58 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 114.588 -1.187 . . . . 1.26 111.179 -170.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.57 HD22 ' C ' ' A' ' 27' ' ' LEU . 1.4 tt -101.71 143.11 32.06 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 106.567 -1.642 . . . . 1.0600000000000001 106.567 173.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.418 ' N ' HD22 ' A' ' 27' ' ' LEU . 16.5 m -130.99 109.78 10.77 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.846 -0.742 . . . . 1.05 110.67 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.642 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 87.8 t90 -85.92 106.03 16.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.687 0.756 . . . . 0.29999999999999999 109.327 174.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -111.15 115.32 29.2 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.069 -0.969 . . . . 1.1599999999999999 108.759 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.529 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 63.1 p -56.39 144.13 31.98 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.993 0.425 . . . . 1.3899999999999999 110.064 -177.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.655 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 25.9 m -56.44 -25.04 49.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.175 -0.92 . . . . 1.1499999999999999 110.751 -176.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -76.33 -27.96 56.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.899 -0.591 . . . . 2.3300000000000001 111.299 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.83 8.01 60.93 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.702 -0.559 . . . . 0.55000000000000004 111.702 -174.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -84.87 -72.68 0.46 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.056 0.455 . . . . 1.1299999999999999 111.408 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -85.55 141.13 30.08 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.201 0.524 . . . . 2.6200000000000001 111.48 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 93.9 t -137.69 125.86 31.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.741 -1.118 . . . . 1.3100000000000001 109.441 177.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -130.34 111.29 12.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.53 -0.305 . . . . 0.82999999999999996 110.273 -175.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -100.87 141.87 33.15 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 111.863 0.319 . . . . 1.0600000000000001 111.863 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 43.1 t -116.11 129.69 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 122.623 0.369 . . . . 1.3600000000000001 111.688 176.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.564 ' O ' HG12 ' A' ' 45' ' ' ILE . 60.4 t -91.11 108.42 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-O 121.268 0.556 . . . . 1.05 109.579 172.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.571 HD13 ' CD2' ' A' ' 104' ' ' LEU . 1.6 mm? -53.14 -29.52 31.71 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.877 -1.056 . . . . 1.04 112.546 -178.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.406 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 68.4 m -76.89 -33.79 57.78 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.608 -0.437 . . . . 1.45 111.581 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.7 p -74.07 -11.7 60.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.541 0.686 . . . . 1.04 109.371 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 41' ' ' VAL . 47.5 mm -82.62 133.03 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 114.77 -1.105 . . . . 1.02 111.002 173.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.639 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 35.8 t70 -85.91 -50.22 7.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.456 -0.793 . . . . 0.69999999999999996 110.904 174.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HB2' HG13 ' A' ' 63' ' ' ILE . 74.9 mmtt -136.77 156.14 48.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.245 -0.434 . . . . 2.4300000000000002 110.1 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.621 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 11.6 tp -119.18 140.21 50.55 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.213 0.53 . . . . 1.04 109.871 167.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.542 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 11.8 mm100 -115.61 154.82 28.76 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.818 -1.083 . . . . 1.49 109.837 -178.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.583 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.85 141.65 8.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.588 -0.733 . . . . 1.0 109.278 177.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.493 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 33.5 p -51.94 123.52 25.95 Favored Pre-proline 0 N--CA 1.467 0.4 0 CA-C-O 121.484 0.659 . . . . 1.03 111.559 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 71.1 Cg_endo -70.76 167.29 26.16 Favored 'Trans proline' 0 CA--C 1.519 -0.275 0 C-N-CA 124.331 3.354 . . . . 0.73999999999999999 112.126 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.63 -28.13 53.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.236 0.541 . . . . 1.54 110.575 174.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.8 m -68.73 -25.38 64.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.375 -0.83 . . . . 2.0499999999999998 111.324 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.446 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 33.7 t -80.4 143.43 33.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.535 -0.757 . . . . 1.1399999999999999 109.951 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -90.17 -7.66 53.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.484 0.659 . . . . 2.8900000000000001 109.667 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 mmmt -98.89 178.33 4.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.225 -0.898 . . . . 3.1299999999999999 110.403 -175.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.508 ' HB3' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -137.58 110.18 7.52 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.982 -1.008 . . . . 2.0 108.674 176.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.583 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 3.1 ttm -157.3 140.13 15.09 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.744 -0.382 . . . . 1.3 111.422 -173.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.851 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 1.9 mp -109.27 160.82 15.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.06 0.457 . . . . 1.05 111.016 172.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.542 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 20.7 ttm180 -153.56 113.34 3.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.906 -0.588 . . . . 3.3999999999999999 110.263 172.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.55 ' HG ' HD11 ' A' ' 48' ' ' LEU . 7.9 mt -93.61 113.79 25.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.055 0.455 . . . . 1.73 110.293 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.468 HG21 ' HG2' ' A' ' 86' ' ' ARG . 5.4 mm -86.63 109.28 18.78 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 CA-C-N 115.717 -0.674 . . . . 1.1599999999999999 110.461 -173.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -76.43 138.48 22.55 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.731 -1.223 . . . . 0.47999999999999998 111.384 176.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.639 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 1.7 mptp? -53.44 136.68 37.43 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.72 0.295 . . . . 1.78 110.941 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--N 1.32 -0.677 0 N-CA-C 109.923 -0.399 . . . . 1.3100000000000001 109.923 175.267 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.385 0 CA-C-O 121.42 0.628 . . . . 1.78 109.87 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.468 ' HG2' HG21 ' A' ' 63' ' ' ILE . 18.5 mtm180 -110.78 160.42 16.75 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.64 -0.709 . . . . 2.8199999999999998 110.227 -173.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -124.3 111.91 16.38 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.009 -0.542 . . . . 0.63 109.713 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.504 ' HE1' ' HE ' ' A' ' 61' ' ' ARG . 49.7 ttm -111.35 128.53 55.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.716 -0.22 . . . . 1.1200000000000001 110.889 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.416 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 39.8 m-85 -117.24 143.63 45.68 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 108.832 -0.803 . . . . 1.6499999999999999 108.832 173.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.527 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 19.1 m -96.88 125.59 41.43 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.469 -0.567 . . . . 1.1899999999999999 109.469 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.851 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 4.5 m-85 -107.53 162.9 13.52 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.952 -0.388 . . . . 1.6399999999999999 109.952 -177.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -115.91 -7.06 12.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.859 0.361 . . . . 1.8300000000000001 110.911 -176.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -129.09 119.44 24.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.67 -0.493 . . . . 1.22 109.67 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.508 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 8.3 tpt180 -61.44 -29.08 69.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.844 -0.617 . . . . 2.8799999999999999 111.227 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 50.0 m -74.17 -47.05 38.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.245 0.545 . . . . 1.1200000000000001 110.52 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.809 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 66.3 t -60.27 -52.76 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 CA-C-N 115.646 -0.706 . . . . 1.1299999999999999 111.633 177.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.525 ' O ' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -60.41 -26.01 66.37 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.912 -0.715 . . . . 1.0600000000000001 109.735 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 95' ' ' THR . 36.6 t70 -70.29 -41.74 72.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.261 0.553 . . . . 0.39000000000000001 109.9 176.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.809 ' ND2' ' HA ' ' A' ' 96' ' ' VAL . 22.8 p30 -80.21 -29.19 38.54 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.073 -0.967 . . . . 1.55 110.879 -173.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.515 HG23 HD11 ' A' ' 18' ' ' ILE . 31.0 mm -67.41 -54.02 27.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.366 -0.834 . . . . 1.0600000000000001 110.123 169.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -54.79 -48.39 72.78 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.53 -0.759 . . . . 1.72 111.326 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -65.73 -26.09 67.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.9 0.381 . . . . 1.76 110.592 -176.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 22.1 m -68.06 -49.73 59.55 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.204 0.526 . . . . 1.04 110.354 177.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.621 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 9.7 mt -69.38 -57.25 5.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.391 -0.822 . . . . 1.05 111.156 -175.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.614 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 96.0 mt-30 -50.78 -28.35 9.11 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.223 0.453 . . . . 1.45 112.223 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -63.16 -49.81 72.87 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.842 -0.799 . . . . 0.66000000000000003 108.842 176.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.505 HD13 ' HA ' ' A' ' 104' ' ' LEU . 60.1 mt -60.07 -44.75 95.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 113.906 -1.497 . . . . 1.04 110.518 176.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.2 mt -62.53 -55.52 23.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.675 -0.693 . . . . 1.04 110.412 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.6 m -59.01 -26.43 64.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.0 0.429 . . . . 1.6100000000000001 110.966 175.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -69.22 -33.92 74.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.856 -0.611 . . . . 4.3899999999999997 110.21 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 . . . . . 0 C--N 1.321 -0.662 0 CA-C-N 115.585 -0.734 . . . . 0.71999999999999997 111.187 -179.585 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 261' ' ' PHE . . . . . 0.488 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 6.2 m-85 . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 109.434 -0.58 . . . . 0.97999999999999998 109.434 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.72 150.3 19.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.624 -0.51 . . . . 1.8999999999999999 109.624 173.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 263' ' ' GLU . . . . . 0.499 ' HB3' ' OE1' ' A' ' 49' ' ' GLN . 2.5 pp20? . . . . . 0 C--N 1.324 -0.526 0 N-CA-C 109.778 -0.453 . . . . 2.2400000000000002 109.778 176.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.7 m80 . . . . . 0 C--O 1.227 -0.121 0 CA-C-O 121.319 0.581 . . . . 2.3900000000000001 110.005 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.4 m -162.33 150.67 14.66 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.538 -0.755 . . . . 1.6100000000000001 109.195 -177.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.53 140.61 3.97 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.275 -0.73 . . . . 0.17000000000000001 111.275 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.718 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -71.6 121.4 18.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 117.211 0.506 . . . . 0.97999999999999998 111.173 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.528 ' HB1' ' CE1' ' A' ' 91' ' ' PHE . . . -130.83 158.78 39.23 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.256 0.551 . . . . 1.01 112.115 -177.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.494 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.5 mp -97.16 120.56 46.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.349 -0.841 . . . . 1.0800000000000001 109.21 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.551 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 82.8 t80 -122.91 112.53 17.95 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.843 -0.428 . . . . 0.66000000000000003 109.843 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 62.98 48.61 3.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.79 0.805 . . . . 1.46 110.127 -175.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt 72.61 -6.53 1.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.143 -1.389 . . . . 2.3900000000000001 113.373 171.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.92 131.99 46.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.936 0.398 . . . . 1.23 110.236 173.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.494 ' HA ' HG13 ' A' ' 8' ' ' ILE . 23.3 t -78.89 130.55 35.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.059 -0.518 . . . . 1.48 110.522 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.642 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -149.4 -154.61 6.43 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 115.702 -0.681 . . . . 0.16 111.628 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.718 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 9.9 mm -124.44 153.42 31.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.948 0.374 . . . . 1.05 110.619 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.411 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -126.74 133.46 68.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.977 -0.556 . . . . 1.01 109.849 -179.824 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.89 111.44 8.63 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 116.281 -0.418 . . . . 0.87 111.751 175.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.537 HD13 HG21 ' A' ' 100' ' ' ILE . 4.0 mp -84.36 114.06 24.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.139 -1.06 . . . . 1.05 108.139 171.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.403 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.5 t30 -119.25 122.06 41.06 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.952 -0.388 . . . . 1.1200000000000001 109.952 -179.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.474 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 38.0 mt-10 -105.88 84.25 2.04 Favored 'General case' 0 N--CA 1.423 -1.785 0 C-N-CA 116.858 -1.937 . . . . 0.73999999999999999 107.418 163.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.403 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 22.3 t70 -121.4 -11.22 8.78 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.622 -1.621 . . . . 0.58999999999999997 106.622 156.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.651 HG12 ' O ' ' A' ' 23' ' ' SER . 14.2 p -102.58 174.8 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 112.001 -2.363 . . . . 1.0800000000000001 111.653 -157.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.651 ' O ' HG12 ' A' ' 22' ' ' VAL . 17.3 p -54.27 166.3 0.71 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 117.052 -1.452 . . . . 2.0 107.117 166.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.6 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 10.3 Cg_endo -41.49 128.47 3.44 Favored 'Trans proline' 0 C--N 1.362 1.278 0 CA-C-N 122.233 1.833 . . . . 0.26000000000000001 111.374 -151.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.519 ' HB1' HG21 ' A' ' 107' ' ' ILE . . . -29.92 133.81 0.05 Allowed 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 125.251 1.595 . . . . 1.02 114.004 -157.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.524 ' HB2' HG11 ' A' ' 22' ' ' VAL . 23.8 mt-10 -124.9 136.72 54.03 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 114.777 -1.101 . . . . 1.26 111.15 -172.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.598 HD22 ' C ' ' A' ' 27' ' ' LEU . 1.0 OUTLIER -100.3 142.1 32.25 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.469 -1.678 . . . . 1.0600000000000001 106.469 173.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.411 ' N ' HD22 ' A' ' 27' ' ' LEU . 9.7 m -126.94 109.22 11.71 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.796 -0.762 . . . . 1.05 110.241 -178.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.648 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 88.3 t90 -89.23 105.71 17.96 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.684 0.754 . . . . 0.29999999999999999 109.086 175.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.417 ' HD3' ' O ' ' A' ' 31' ' ' SER . 3.6 tmt_? -113.54 115.0 27.28 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.723 -1.126 . . . . 1.1599999999999999 108.523 -177.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.518 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 98.1 p -58.75 144.66 43.06 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.308 0.575 . . . . 1.3899999999999999 110.444 -173.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.642 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 18.5 m -54.82 -25.16 26.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.765 -1.107 . . . . 1.1499999999999999 111.816 -173.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -89.77 -13.95 35.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.97 -0.559 . . . . 2.3300000000000001 111.723 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.69 22.05 60.64 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.319 -0.943 . . . . 0.55000000000000004 111.108 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -84.52 -39.28 19.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.919 -0.64 . . . . 1.1299999999999999 111.913 -174.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -146.74 161.57 40.34 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.207 0.527 . . . . 2.6200000000000001 110.774 -177.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 85.3 t -144.08 131.0 16.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.1 -0.955 . . . . 1.3100000000000001 110.124 -176.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -131.96 109.11 9.82 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.639 -0.709 . . . . 0.82999999999999996 109.813 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.9 m -99.82 137.06 38.81 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.625 -0.262 . . . . 1.0600000000000001 111.294 -175.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 40.7 t -110.01 128.43 66.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 122.653 0.381 . . . . 1.3600000000000001 111.703 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 45' ' ' ILE . 53.2 t -90.53 108.19 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 109.319 -0.623 . . . . 1.05 109.319 172.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.569 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.0 mm? -54.95 -27.26 42.22 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.924 -1.035 . . . . 1.04 112.415 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.504 ' O ' ' HE2' ' A' ' 65' ' ' LYS . 43.1 t -75.75 -34.04 60.26 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.598 -0.441 . . . . 1.45 110.641 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.439 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 58.6 p -77.77 -10.37 59.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.472 0.653 . . . . 1.04 109.661 175.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.596 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 45.2 mm -79.85 123.84 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 114.995 -1.002 . . . . 1.02 111.256 173.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.56 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 5.8 t70 -73.85 -46.26 46.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.29 -0.868 . . . . 0.69999999999999996 111.436 174.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.448 ' O ' HG12 ' A' ' 63' ' ' ILE . 43.6 tptt -151.52 159.48 44.12 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 120.763 0.316 . . . . 2.4300000000000002 110.432 -177.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.6 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 11.8 tp -117.68 148.24 42.16 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.623 -0.51 . . . . 1.04 109.623 170.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.46 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 15.3 mm100 -126.55 156.47 40.78 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.23 -0.895 . . . . 1.49 109.573 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.57 ' HB3' ' HD3' ' A' ' 101' ' ' LYS . . . -163.04 144.06 9.61 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.228 -0.442 . . . . 1.0 109.925 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.508 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 40.8 p -52.41 126.72 38.7 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 121.36 0.6 . . . . 1.03 112.135 -176.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 59.6 Cg_endo -69.31 167.08 24.9 Favored 'Trans proline' 0 C--N 1.334 -0.225 0 C-N-CA 124.323 3.349 . . . . 0.73999999999999999 112.305 177.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.01 -28.65 58.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.842 0.353 . . . . 1.54 111.272 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.3 t -72.43 -23.61 61.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 2.0499999999999998 110.784 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.486 ' CB ' ' HB ' ' A' ' 51' ' ' THR . 31.6 t -71.74 133.46 45.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.923 -0.58 . . . . 1.1399999999999999 110.081 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -80.35 -15.14 57.57 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.758 0.789 . . . . 2.8900000000000001 109.309 177.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -106.49 172.62 6.72 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.054 -0.975 . . . . 3.1299999999999999 109.787 -176.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.524 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.2 OUTLIER -131.34 109.83 10.64 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.526 -0.916 . . . . 2.0 108.526 -177.429 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.529 ' HG2' ' HA ' ' A' ' 90' ' ' SER . 72.9 mtm -154.73 155.5 34.66 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.79 0.329 . . . . 1.3 111.212 -172.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 101' ' ' LYS . 0.7 OUTLIER -120.82 160.13 24.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.553 -0.749 . . . . 1.05 110.956 176.252 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.46 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 48.8 ttp180 -152.43 113.61 4.24 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 120.882 0.372 . . . . 3.3999999999999999 111.198 171.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.498 ' HG ' HD11 ' A' ' 48' ' ' LEU . 10.4 mt -94.46 110.53 22.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.358 -0.383 . . . . 1.73 110.945 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.528 ' HA ' ' HB3' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -87.61 125.7 41.24 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 CA-C-N 116.027 -0.533 . . . . 1.1599999999999999 110.454 -176.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.596 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -99.01 151.94 19.57 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.029 -1.082 . . . . 0.47999999999999998 111.096 174.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.56 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 1.0 OUTLIER -56.5 134.16 53.9 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.858 0.361 . . . . 1.78 111.263 -174.176 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.76 -0.655 . . . . 1.3100000000000001 110.918 -179.844 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.184 0 CA-C-O 121.245 0.545 . . . . 1.78 110.956 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.528 ' HB3' ' HA ' ' A' ' 63' ' ' ILE . 12.9 ptt180 -129.56 145.0 51.51 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.629 0.728 . . . . 2.8199999999999998 111.994 -173.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.413 ' CD2' HG21 ' A' ' 40' ' ' VAL . 91.7 m-70 -107.39 116.63 32.27 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.633 -1.167 . . . . 0.63 110.517 -173.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.401 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 48.6 ttm -104.68 128.73 52.83 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.67 -0.412 . . . . 1.1200000000000001 111.32 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.408 ' CE2' HD13 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -121.84 123.04 40.83 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.054 -0.721 . . . . 1.6499999999999999 109.054 175.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.529 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 64.6 m -93.18 130.69 38.76 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.926 0.393 . . . . 1.1899999999999999 110.264 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.585 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 40.2 m-85 -107.48 169.73 8.4 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.404 0.621 . . . . 1.6399999999999999 110.896 176.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -112.15 -6.07 14.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.413 -0.812 . . . . 1.8300000000000001 109.828 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.47 ' OD1' ' HB ' ' A' ' 95' ' ' THR . 28.6 t-20 -130.65 128.51 41.1 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.284 0.564 . . . . 1.22 111.282 -176.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.418 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 14.6 tpt180 -59.32 -37.06 76.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.76 -1.109 . . . . 2.8799999999999999 111.641 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.47 ' HB ' ' OD1' ' A' ' 93' ' ' ASN . 91.7 m -72.26 -54.94 8.1 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.312 -0.403 . . . . 1.1200000000000001 110.777 -176.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.8 t -44.95 -57.34 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 115.969 -0.559 . . . . 1.1299999999999999 111.434 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.524 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -63.63 -29.92 71.09 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.578 -0.449 . . . . 1.0600000000000001 111.218 -177.656 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.506 ' HA ' ' HE2' ' A' ' 101' ' ' LYS . 26.0 t70 -68.64 -33.06 73.35 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.465 0.65 . . . . 0.39000000000000001 109.251 177.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.6 ' O ' ' HG3' ' A' ' 102' ' ' MET . 91.7 m-20 -77.41 -50.74 12.07 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.634 -1.166 . . . . 1.55 110.055 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.585 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 32.4 mm -56.0 -48.44 78.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.235 -0.893 . . . . 1.0600000000000001 110.14 178.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.57 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 13.3 ttpt -58.61 -50.96 71.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.368 -0.833 . . . . 1.72 111.133 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.6 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.3 ppp? -67.89 -23.06 65.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 1.76 110.335 -175.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 52.1 m -68.13 -51.57 44.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.89 -0.595 . . . . 1.04 110.507 174.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.6 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 13.1 mt -69.04 -56.79 6.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.184 -0.916 . . . . 1.05 111.7 -173.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.51 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 42.2 mt-30 -53.16 -29.19 30.12 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.049 0.388 . . . . 1.45 112.049 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -61.28 -28.16 68.99 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.84 0.828 . . . . 0.66000000000000003 109.265 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.544 ' O ' ' HB3' ' A' ' 110' ' ' ARG . 25.2 mt -85.68 -45.28 17.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 113.803 -1.544 . . . . 1.04 110.791 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.7 mt -67.52 -53.81 28.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.417 -0.811 . . . . 1.04 111.46 -172.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.0 m -65.03 -14.96 61.73 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.567 0.699 . . . . 1.6100000000000001 109.708 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.544 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 14.0 ttt180 -77.65 -42.95 32.94 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.863 -1.062 . . . . 4.3899999999999997 109.752 174.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.759 -0.655 . . . . 0.71999999999999997 111.156 -178.866 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 261' ' ' PHE . . . . . 0.476 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 12.0 m-85 . . . . . 0 N--CA 1.443 -0.802 0 N-CA-C 109.7 -0.481 . . . . 0.97999999999999998 109.7 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.3 p -125.8 156.79 35.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.359 -0.978 . . . . 1.8999999999999999 108.359 172.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 263' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' B' ' 263' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.312 -1.055 0 N-CA-C 109.322 -0.622 . . . . 2.2400000000000002 109.322 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 . . . . . 0 CA--C 1.53 0.201 0 CA-C-O 121.378 0.608 . . . . 2.3900000000000001 111.335 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.7 p -161.89 149.53 14.56 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.757 -0.656 . . . . 1.6100000000000001 109.607 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.23 142.75 4.41 Favored Glycine 0 C--O 1.224 -0.516 0 N-CA-C 111.388 -0.685 . . . . 0.17000000000000001 111.388 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.729 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -73.53 121.25 20.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.175 0.487 . . . . 0.97999999999999998 111.148 -177.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.579 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -128.27 161.01 30.36 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.289 0.566 . . . . 1.01 111.925 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.475 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.7 mp -102.74 113.62 39.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.274 -0.875 . . . . 1.0800000000000001 109.291 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.487 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 84.1 t80 -112.96 101.91 9.93 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.989 -0.375 . . . . 0.66000000000000003 109.989 -178.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 64.8 57.3 1.05 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.516 0.674 . . . . 1.46 110.721 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt 72.54 -8.2 1.26 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.332 -1.304 . . . . 2.3900000000000001 113.369 170.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.433 HG22 ' HD3' ' A' ' 36' ' ' LYS . 0.5 OUTLIER -99.85 127.13 53.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.064 0.459 . . . . 1.23 110.37 173.054 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.475 ' HA ' HG13 ' A' ' 8' ' ' ILE . 14.1 p -78.71 126.55 30.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.817 -0.628 . . . . 1.48 110.552 177.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.639 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -147.3 -157.61 7.48 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.938 -0.649 . . . . 0.16 112.556 -177.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.729 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.0 mm -124.7 154.68 32.51 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.789 0 CA-C-O 120.756 0.312 . . . . 1.05 110.721 -177.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.487 HG12 HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -129.27 133.67 65.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.236 -0.438 . . . . 1.01 110.461 -179.616 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.28 112.62 9.25 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.03 -0.532 . . . . 0.87 111.468 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.506 HD13 HG23 ' A' ' 100' ' ' ILE . 4.8 mp -84.24 105.08 13.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.746 -0.835 . . . . 1.05 108.746 172.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -109.38 120.02 41.25 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 110.242 -0.281 . . . . 1.1200000000000001 110.242 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.483 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 37.3 mt-10 -105.72 83.71 1.97 Allowed 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 117.13 -1.828 . . . . 0.73999999999999999 107.403 165.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -122.04 -13.03 8.26 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 106.756 -1.572 . . . . 0.58999999999999997 106.756 157.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.58 HG21 ' N ' ' A' ' 23' ' ' SER . 13.9 p -102.93 -179.79 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 111.823 -2.444 . . . . 1.0800000000000001 111.58 -157.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.607 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 1.4 p -51.88 165.71 0.45 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 117.706 -1.14 . . . . 2.0 108.416 168.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.607 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 18.7 Cg_endo -45.42 124.38 6.43 Favored 'Trans proline' 0 C--N 1.358 1.071 0 CA-C-N 121.514 1.576 . . . . 0.26000000000000001 111.803 -154.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.486 ' HB1' HG21 ' A' ' 107' ' ' ILE . . . -21.69 133.57 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.721 1.748 . . . . 1.02 115.721 -151.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.554 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -112.93 138.65 49.47 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 114.705 -1.134 . . . . 1.26 110.671 -179.264 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.558 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 2.2 tt -100.78 142.53 32.13 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.519 -1.66 . . . . 1.0600000000000001 106.519 169.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.55 ' N ' HD22 ' A' ' 27' ' ' LEU . 10.5 m -127.47 107.98 10.42 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.973 -0.691 . . . . 1.05 110.122 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.622 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 89.6 t90 -91.34 105.4 17.75 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.664 -0.865 . . . . 0.29999999999999999 108.664 174.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -114.37 117.17 30.29 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.118 -0.946 . . . . 1.1599999999999999 109.053 -177.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.54 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 80.8 p -57.24 148.44 22.49 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.09 0.471 . . . . 1.3899999999999999 110.822 -173.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.639 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 7.5 m -58.4 -27.34 64.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.364 -0.835 . . . . 1.1499999999999999 110.266 -177.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.457 ' OD2' ' HB3' ' A' ' 35' ' ' ASP . 1.4 p-10 -81.37 -27.54 34.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.078 -0.964 . . . . 2.3300000000000001 111.267 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.83 2.69 84.02 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.087 -0.578 . . . . 0.55000000000000004 112.974 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.457 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 12.3 t70 -78.28 -26.1 46.95 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.735 0.272 . . . . 1.1299999999999999 111.735 -177.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.433 ' HD3' HG22 ' A' ' 12' ' ' VAL . 16.7 ptmt -137.73 155.06 49.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.434 0.635 . . . . 2.6200000000000001 110.363 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.3 p -149.64 140.69 16.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.226 -0.897 . . . . 1.3100000000000001 110.392 -175.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -130.72 108.98 10.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.643 0.259 . . . . 0.82999999999999996 110.369 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 27.0 m -97.83 129.3 44.82 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.323 -0.621 . . . . 1.0600000000000001 109.323 175.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.558 ' CG1' ' HB3' ' A' ' 27' ' ' LEU . 9.6 p -119.29 139.98 44.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.76 -0.376 . . . . 1.3600000000000001 111.501 -178.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.615 ' O ' HG12 ' A' ' 45' ' ' ILE . 60.7 t -89.74 109.54 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.288 0.566 . . . . 1.05 110.077 -177.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.627 HD13 ' CD2' ' A' ' 104' ' ' LEU . 2.9 mm? -53.44 -31.84 47.24 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.944 -1.025 . . . . 1.04 112.669 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.437 ' CB ' ' HB2' ' A' ' 24' ' ' PRO . 15.1 t -76.36 -33.76 58.92 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.581 -0.448 . . . . 1.45 111.012 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.541 ' OG1' ' HB ' ' A' ' 41' ' ' VAL . 72.8 p -74.44 -11.26 60.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.073 0.463 . . . . 1.04 109.908 172.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.615 HG12 ' O ' ' A' ' 41' ' ' VAL . 37.4 mm -83.94 121.31 36.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.885 -0.598 . . . . 1.02 110.391 172.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.688 ' HB2' ' CG ' ' A' ' 65' ' ' LYS . 14.6 t70 -85.81 -41.38 15.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.104 0.478 . . . . 0.69999999999999996 111.46 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.591 ' HE2' ' OD2' ' A' ' 46' ' ' ASP . 53.4 mmtt -132.47 143.1 49.54 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.563 -0.532 . . . . 2.4300000000000002 109.563 -177.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' A' ' 104' ' ' LEU . 8.1 tp -114.53 141.22 48.01 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.637 0.732 . . . . 1.04 109.223 165.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.526 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 13.8 mm100 -122.53 151.52 41.28 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.433 -1.258 . . . . 1.49 109.695 -177.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.19 139.94 8.61 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.242 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.44 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 32.3 p -49.95 128.22 21.2 Favored Pre-proline 0 N--CA 1.468 0.472 0 CA-C-O 121.265 0.555 . . . . 1.03 111.705 -178.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 57.3 Cg_endo -69.26 166.94 25.26 Favored 'Trans proline' 0 C--N 1.334 -0.207 0 C-N-CA 124.293 3.329 . . . . 0.73999999999999999 112.153 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.62 -28.49 68.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.255 0.55 . . . . 1.54 110.322 175.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.2 t -68.12 -24.8 65.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.532 -0.758 . . . . 2.0499999999999998 110.333 176.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.46 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 46.6 t -74.06 136.03 43.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.744 -0.662 . . . . 1.1399999999999999 110.413 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -87.14 0.4 55.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.474 0.654 . . . . 2.8900000000000001 110.151 176.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.24 176.83 4.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.094 -0.957 . . . . 3.1299999999999999 109.689 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.459 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -136.53 110.92 8.48 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.801 -1.185 . . . . 2.0 107.801 178.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.576 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 3.9 ttm -156.01 149.43 24.72 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 120.426 -0.509 . . . . 1.3 111.692 -172.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 97' ' ' MET . 0.5 OUTLIER -120.06 151.2 39.37 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.367 -0.833 . . . . 1.05 110.416 174.365 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.543 ' HD3' ' HB2' ' A' ' 88' ' ' MET . 15.9 ttp180 -148.76 114.43 5.66 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 121.149 0.5 . . . . 3.3999999999999999 110.62 171.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.692 HD11 ' CE2' ' A' ' 89' ' ' PHE . 8.9 mp -95.16 113.17 24.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.06 -0.518 . . . . 1.73 110.242 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.487 ' HA ' ' HB3' ' A' ' 86' ' ' ARG . 3.6 mm -87.75 107.54 17.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.881 -0.414 . . . . 1.1599999999999999 109.881 -173.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -78.92 140.82 23.63 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.321 -0.942 . . . . 0.47999999999999998 111.391 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.688 ' CG ' ' HB2' ' A' ' 46' ' ' ASP . 16.1 mttm -59.02 135.2 57.55 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.46 0.648 . . . . 1.78 112.142 -174.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 C--N 1.318 -0.778 0 CA-C-N 114.779 -1.101 . . . . 1.3100000000000001 110.251 -179.202 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 123.334 1.54 . . . . 1.78 109.588 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.487 ' HB3' ' HA ' ' A' ' 63' ' ' ILE . 27.4 ptt180 -110.8 158.5 18.61 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.688 -1.596 . . . . 2.8199999999999998 111.046 -172.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -127.03 112.32 15.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.142 -0.935 . . . . 0.63 110.152 -168.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.543 ' HB2' ' HD3' ' A' ' 61' ' ' ARG . 47.6 ttm -106.21 131.36 53.54 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 111.86 0.318 . . . . 1.1200000000000001 111.86 -173.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.692 ' CE2' HD11 ' A' ' 62' ' ' LEU . 1.5 m-85 -119.04 123.57 44.81 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.071 -0.714 . . . . 1.6499999999999999 109.071 172.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.497 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 23.4 m -87.44 126.76 35.08 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.101 -0.5 . . . . 1.1899999999999999 110.021 178.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 7' ' ' ALA . 33.1 m-85 -107.9 165.17 11.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.584 0.707 . . . . 1.6399999999999999 111.047 176.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -109.9 -12.7 14.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.93 -1.032 . . . . 1.8300000000000001 109.642 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.55 ' OD1' ' HB ' ' A' ' 95' ' ' THR . 28.5 t-20 -126.28 125.18 41.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.595 -0.73 . . . . 1.22 110.752 -174.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -58.48 -35.57 72.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.962 -1.017 . . . . 2.8799999999999999 111.553 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.55 ' HB ' ' OD1' ' A' ' 93' ' ' ASN . 95.4 m -70.74 -55.32 8.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.625 0.25 . . . . 1.1200000000000001 110.59 -176.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.7 t -45.76 -57.86 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 115.904 -0.589 . . . . 1.1299999999999999 111.526 175.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.459 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -62.09 -29.86 70.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 120.616 -0.434 . . . . 1.0600000000000001 111.288 -178.082 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.0 -32.15 70.18 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.412 0.625 . . . . 0.39000000000000001 109.367 177.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.61 ' O ' ' HG3' ' A' ' 102' ' ' MET . 92.0 m-20 -78.16 -48.77 15.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.817 -1.083 . . . . 1.55 110.116 -177.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.553 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 37.8 mm -57.24 -50.97 75.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.314 -0.857 . . . . 1.0600000000000001 110.396 176.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 11.2 ttpt -56.39 -50.48 71.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.634 -0.712 . . . . 1.72 111.101 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.61 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.9 ppp? -66.44 -24.86 66.51 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.881 0.372 . . . . 1.76 110.841 -176.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 49.3 m -69.43 -49.73 52.38 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.48 0.657 . . . . 1.04 110.328 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.627 ' CD2' HD13 ' A' ' 42' ' ' LEU . 13.9 mt -67.74 -56.68 8.32 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.051 -0.977 . . . . 1.05 111.341 -175.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 101' ' ' LYS . 35.6 mt-30 -50.02 -29.89 9.58 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.249 0.463 . . . . 1.45 112.249 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -60.91 -31.3 70.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.979 0.895 . . . . 0.66000000000000003 109.414 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.486 HG21 ' HB1' ' A' ' 25' ' ' ALA . 21.3 mt -84.92 -46.51 17.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 113.594 -1.639 . . . . 1.04 110.503 178.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -64.68 -51.2 70.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.677 -0.692 . . . . 1.04 110.775 -174.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.3 m -57.4 -26.27 60.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.988 0.423 . . . . 1.6100000000000001 110.673 174.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -69.2 -37.35 78.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.453 0.645 . . . . 4.3899999999999997 110.006 177.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.449 ' HD2' ' O ' ' A' ' 107' ' ' ILE . 42.4 m-85 . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 114.982 -1.008 . . . . 0.71999999999999997 111.734 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 261' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 9.8 m-85 . . . . . 0 N--CA 1.444 -0.765 0 N-CA-C 109.747 -0.464 . . . . 0.97999999999999998 109.747 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 10.6 p -135.59 140.17 45.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.272 -0.27 . . . . 1.8999999999999999 110.272 175.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 . . . . . 0 C--N 1.324 -0.526 0 N-CA-C 108.639 -0.874 . . . . 2.2400000000000002 108.639 174.067 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.0 m80 . . . . . 0 C--O 1.228 -0.055 0 CA-C-O 121.23 0.538 . . . . 2.3900000000000001 110.336 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.4 p -162.72 149.53 13.02 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.496 -0.775 . . . . 1.6100000000000001 109.655 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.26 147.0 7.74 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 110.839 -0.905 . . . . 0.17000000000000001 110.839 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.714 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -79.26 117.43 20.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.644 0.722 . . . . 0.97999999999999998 111.619 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.29 158.24 28.59 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.347 0.594 . . . . 1.01 111.587 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.472 HG13 ' HA ' ' A' ' 13' ' ' SER . 3.1 mp -99.01 129.22 49.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.409 -0.814 . . . . 1.0800000000000001 109.263 177.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.56 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 89.1 t80 -139.28 111.96 7.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.913 -0.585 . . . . 0.66000000000000003 109.917 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 69.49 45.21 0.84 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.727 0.775 . . . . 1.46 110.421 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? 70.01 3.14 4.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.276 -1.329 . . . . 2.3900000000000001 112.732 172.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.1 131.68 59.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.784 0.326 . . . . 1.23 110.478 175.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.472 ' HA ' HG13 ' A' ' 8' ' ' ILE . 30.5 t -78.69 117.0 19.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.4 0.619 . . . . 1.48 110.042 177.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.662 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -130.97 -153.91 7.75 Favored Glycine 0 N--CA 1.434 -1.44 0 CA-C-N 115.288 -0.869 . . . . 0.16 111.3 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.714 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 7.8 mm -127.88 153.15 36.86 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 CA-C-O 120.919 0.39 . . . . 1.05 110.687 -177.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.433 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -125.41 131.94 71.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 115.824 -0.625 . . . . 1.01 109.332 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.94 113.97 10.58 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.758 -0.377 . . . . 0.87 111.555 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.501 HD13 HG23 ' A' ' 100' ' ' ILE . 4.4 mp -84.14 113.46 23.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.068 -1.086 . . . . 1.05 108.068 171.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.424 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.1 t30 -121.58 130.33 53.44 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.487 -0.324 . . . . 1.1200000000000001 110.274 -177.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -110.48 84.55 1.95 Allowed 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 116.912 -1.915 . . . . 0.73999999999999999 107.482 164.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.424 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 13.2 t70 -120.85 -10.32 9.14 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 106.122 -1.807 . . . . 0.58999999999999997 106.122 157.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.619 HG11 ' O ' ' A' ' 23' ' ' SER . 14.0 p -102.08 179.15 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 111.743 -2.48 . . . . 1.0800000000000001 111.395 -158.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.619 ' O ' HG11 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -53.33 168.77 0.35 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 117.543 -1.217 . . . . 2.0 108.134 166.522 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 9.2 Cg_endo -41.68 127.2 3.41 Favored 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 121.796 1.664 . . . . 0.26000000000000001 111.088 -157.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.448 ' HB2' HG21 ' A' ' 107' ' ' ILE . . . -30.72 131.51 0.09 Allowed 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 125.279 1.612 . . . . 1.02 113.557 -154.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.512 ' HB2' HG13 ' A' ' 22' ' ' VAL . 47.0 mt-10 -124.09 143.25 50.57 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.676 -1.147 . . . . 1.26 110.864 -169.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.6 HD22 ' C ' ' A' ' 27' ' ' LEU . 1.1 tt -101.26 143.39 31.39 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 106.557 -1.645 . . . . 1.0600000000000001 106.557 175.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.401 ' N ' HD22 ' A' ' 27' ' ' LEU . 14.1 m -129.46 109.65 11.23 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.846 -0.742 . . . . 1.05 110.705 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.654 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 85.1 t90 -86.71 106.59 17.75 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.52 0.676 . . . . 0.29999999999999999 109.544 174.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -114.31 118.87 35.11 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.289 -0.869 . . . . 1.1599999999999999 109.191 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.402 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 49.8 m -56.08 142.04 37.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.871 0.367 . . . . 1.3899999999999999 110.756 -176.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.662 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 18.4 m -59.29 -28.19 66.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.452 -0.795 . . . . 1.1499999999999999 110.166 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.09 -27.19 54.06 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.218 -0.901 . . . . 2.3300000000000001 110.932 175.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.63 -3.98 50.1 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.122 -0.561 . . . . 0.55000000000000004 112.681 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.98 -78.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.458 0.54 . . . . 1.1299999999999999 112.458 -175.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -83.99 142.66 30.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.291 0.567 . . . . 2.6200000000000001 112.057 -175.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 61.1 t -138.29 117.23 14.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.788 -1.096 . . . . 1.3100000000000001 109.618 177.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -124.37 110.01 14.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.31 -0.404 . . . . 0.82999999999999996 110.434 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.7 m -97.72 138.83 34.52 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 121.188 -0.205 . . . . 1.0600000000000001 111.386 -176.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 27.7 t -113.11 129.3 69.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 122.769 0.428 . . . . 1.3600000000000001 111.625 177.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.578 ' O ' HG12 ' A' ' 45' ' ' ILE . 23.0 t -90.81 108.49 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 121.252 0.548 . . . . 1.05 109.942 174.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.587 HD12 ' CD2' ' A' ' 104' ' ' LEU . 1.6 mm? -56.1 -28.1 56.37 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.158 -0.928 . . . . 1.04 112.339 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.1 t -74.88 -31.67 61.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.75 0.309 . . . . 1.45 110.674 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.404 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 82.6 p -80.29 -9.78 59.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.635 0.731 . . . . 1.04 109.738 175.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 41' ' ' VAL . 45.1 mm -85.21 123.75 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 114.872 -1.058 . . . . 1.02 111.143 174.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.644 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 4.9 t70 -74.84 -47.71 28.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.149 -0.932 . . . . 0.69999999999999996 110.718 176.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.506 ' HD2' ' O ' ' A' ' 46' ' ' ASP . 0.5 OUTLIER -147.0 164.75 32.01 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.134 -0.485 . . . . 2.4300000000000002 111.036 -176.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.634 ' CD2' ' HG3' ' A' ' 105' ' ' GLN . 13.0 tp -125.96 146.73 49.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.004 0.431 . . . . 1.04 109.944 172.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 16.7 mm100 -124.08 158.55 31.95 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.182 -0.917 . . . . 1.49 110.176 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -164.66 142.91 6.72 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.496 -0.774 . . . . 1.0 109.928 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.542 ' HB ' ' CB ' ' A' ' 55' ' ' SER . 41.5 p -55.53 129.73 69.99 Favored Pre-proline 0 N--CA 1.471 0.587 0 CA-C-O 121.235 0.54 . . . . 1.03 111.355 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.449 ' O ' ' HB3' ' A' ' 55' ' ' SER . 39.1 Cg_endo -64.59 165.9 19.21 Favored 'Trans proline' 0 N--CA 1.471 0.148 0 C-N-CA 124.017 3.144 . . . . 0.73999999999999999 112.555 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.04 -27.26 65.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.97 0.414 . . . . 1.54 110.726 175.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.7 m -74.62 -24.22 58.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.922 -0.581 . . . . 2.0499999999999998 111.16 177.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.542 ' CB ' ' HB ' ' A' ' 51' ' ' THR . 27.3 t -61.81 138.25 58.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.972 -0.558 . . . . 1.1399999999999999 110.634 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.65 -18.16 42.07 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.793 -0.817 . . . . 2.8900000000000001 108.793 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -103.74 174.1 6.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.718 -1.128 . . . . 3.1299999999999999 109.577 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.51 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -134.24 111.76 10.52 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.151 -0.685 . . . . 2.0 109.151 177.423 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 69.3 mtm -153.77 142.11 20.6 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.932 0.396 . . . . 1.3 111.288 -175.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 97' ' ' MET . 0.3 OUTLIER -110.79 157.26 19.99 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.472 -0.786 . . . . 1.05 110.422 175.556 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 38.0 ttp180 -149.75 114.6 5.35 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-O 121.26 0.552 . . . . 3.3999999999999999 111.629 170.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.55 ' HG ' HD13 ' A' ' 48' ' ' LEU . 8.5 mt -91.97 112.62 24.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.875 -0.602 . . . . 1.73 110.706 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.423 HG23 ' HG2' ' A' ' 86' ' ' ARG . 3.8 mm -86.01 108.88 17.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 C-N-CA 123.72 0.808 . . . . 1.1599999999999999 110.436 -173.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -78.99 155.94 41.34 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 119.969 -1.11 . . . . 0.47999999999999998 111.64 176.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.644 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 0.2 OUTLIER -68.05 135.06 51.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.133 0.467 . . . . 1.78 110.726 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.323 -0.563 0 CA-C-O 120.998 0.428 . . . . 1.3100000000000001 110.018 176.737 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.298 0 CA-C-O 121.864 0.84 . . . . 1.78 110.259 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.423 ' HG2' HG23 ' A' ' 63' ' ' ILE . 6.7 mtm180 -115.2 141.56 47.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.315 -0.857 . . . . 2.8199999999999998 109.816 -175.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -107.69 111.83 24.23 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.852 -0.613 . . . . 0.63 109.781 -173.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.416 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 55.7 ttm -105.02 121.92 44.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.729 0.3 . . . . 1.1200000000000001 111.037 -176.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.412 ' CG ' HD13 ' A' ' 16' ' ' ILE . 91.1 m-85 -119.46 124.41 46.42 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.724 -0.473 . . . . 1.6499999999999999 109.724 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.456 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 42.0 m -90.16 133.28 34.99 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.978 0.418 . . . . 1.1899999999999999 110.874 -176.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.622 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 24.2 m-85 -108.14 173.61 6.24 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.153 0.501 . . . . 1.6399999999999999 111.303 176.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -114.13 1.06 14.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.549 -0.75 . . . . 1.8300000000000001 110.178 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -145.77 126.83 14.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.7 -0.682 . . . . 1.22 109.979 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.463 ' HA ' ' HG2' ' A' ' 97' ' ' MET . 5.9 ttm180 -71.3 -20.79 62.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.785 -0.643 . . . . 2.8799999999999999 110.982 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.7 m -72.73 -55.39 6.84 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.104 -0.332 . . . . 1.1200000000000001 110.104 174.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.9 t -45.81 -56.0 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-N 116.233 -0.439 . . . . 1.1299999999999999 111.289 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.463 ' HG2' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -64.52 -28.56 69.73 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.031 -0.531 . . . . 1.0600000000000001 111.221 -177.533 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.54 -33.31 72.6 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.127 -0.694 . . . . 0.39000000000000001 109.127 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.586 ' O ' ' HG3' ' A' ' 102' ' ' MET . 89.8 m-20 -74.5 -46.3 40.24 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.622 -1.172 . . . . 1.55 109.657 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.622 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 30.0 mm -59.9 -51.4 73.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.917 -1.038 . . . . 1.0600000000000001 110.522 175.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -57.16 -47.79 80.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.515 -0.766 . . . . 1.72 110.85 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.586 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.7 ppp? -67.06 -26.09 66.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.581 -0.281 . . . . 1.76 110.398 -177.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 106' ' ' GLN . 61.0 m -66.64 -54.9 18.29 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.286 0.565 . . . . 1.04 110.143 175.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.595 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 10.6 mt -64.5 -56.22 15.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.264 -0.88 . . . . 1.05 110.925 -175.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.634 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 98.0 mt-30 -52.6 -24.19 7.86 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.889 0.7 . . . . 1.45 112.889 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 102' ' ' MET . 37.6 mt-30 -65.73 -40.97 92.69 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.899 0.857 . . . . 0.66000000000000003 109.013 174.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 104' ' ' LEU . 49.3 mt -72.5 -42.49 63.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 113.765 -1.561 . . . . 1.04 110.727 178.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.1 mt -63.95 -58.21 8.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.454 -0.794 . . . . 1.04 110.595 -176.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.0 t -54.64 -26.24 31.79 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.288 0.566 . . . . 1.6100000000000001 110.802 173.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.456 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 8.3 ttt180 -69.59 -20.5 63.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.675 -0.693 . . . . 4.3899999999999997 110.257 176.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.438 ' HD2' ' O ' ' A' ' 107' ' ' ILE . 18.0 m-85 . . . . . 0 N--CA 1.443 -0.796 0 CA-C-O 121.91 0.862 . . . . 0.71999999999999997 108.694 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 261' ' ' PHE . . . . . 0.445 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 6.6 m-85 . . . . . 0 N--CA 1.447 -0.606 0 N-CA-C 110.045 -0.354 . . . . 0.97999999999999998 110.045 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 10.2 p -143.96 140.81 25.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.75 -0.463 . . . . 1.8999999999999999 109.75 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 . . . . . 0 C--N 1.317 -0.817 0 N-CA-C 108.836 -0.801 . . . . 2.2400000000000002 108.836 175.585 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 52.7 p-80 . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 121.587 0.708 . . . . 2.3900000000000001 110.675 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.4 p -162.7 134.89 5.42 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.205 -0.907 . . . . 1.6100000000000001 109.241 173.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.5 148.22 10.47 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.664 -0.975 . . . . 0.17000000000000001 110.664 -178.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.705 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.39 133.88 41.08 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 117.159 0.48 . . . . 0.97999999999999998 111.44 -175.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.89 156.36 46.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.289 0.566 . . . . 1.01 111.386 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.525 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.2 mp -98.86 110.94 27.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.913 -0.773 . . . . 1.0800000000000001 108.913 177.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.455 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 80.3 t80 -109.96 109.78 20.49 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.366 -0.379 . . . . 0.66000000000000003 110.356 -177.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 63.61 46.53 4.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.883 0.849 . . . . 1.46 110.517 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt 77.18 -5.59 2.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.726 -1.579 . . . . 2.3900000000000001 113.151 170.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.53 133.72 41.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.009 0.433 . . . . 1.23 110.427 173.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.525 ' HA ' HG13 ' A' ' 8' ' ' ILE . 22.6 t -78.16 126.63 31.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.91 -0.586 . . . . 1.48 110.532 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.645 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -150.05 -159.71 8.86 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.597 -0.729 . . . . 0.16 112.476 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.705 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 7.0 mm -126.31 153.43 34.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.821 0.343 . . . . 1.05 110.69 -178.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.406 HG12 HD23 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -124.49 133.69 68.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.977 -0.556 . . . . 1.01 109.762 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.0 108.03 7.18 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.013 0.435 . . . . 0.87 111.898 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 4.3 mp -85.73 110.74 20.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.833 -0.803 . . . . 1.05 108.833 172.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.414 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 1.6 t30 -114.19 127.65 56.0 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.651 -0.42 . . . . 1.1200000000000001 110.268 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -109.8 83.65 1.79 Allowed 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 117.281 -1.768 . . . . 0.73999999999999999 107.464 164.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.404 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 19.5 t70 -122.57 -11.25 8.29 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 106.466 -1.679 . . . . 0.58999999999999997 106.466 156.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.618 HG11 ' HB3' ' A' ' 26' ' ' GLU . 14.5 p -101.44 173.58 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 111.964 -2.38 . . . . 1.0800000000000001 112.072 -155.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.612 ' O ' HG12 ' A' ' 22' ' ' VAL . 7.6 m -54.42 165.81 0.81 Allowed Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 106.673 -1.603 . . . . 2.0 106.673 166.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HA ' ' OH ' ' A' ' 111' ' ' TYR . 9.5 Cg_endo -40.36 127.52 2.24 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.655 1.57 . . . . 0.26000000000000001 111.699 -147.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.502 ' HB2' HG23 ' A' ' 107' ' ' ILE . . . -31.01 131.48 0.1 Allowed 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 125.359 1.662 . . . . 1.02 112.649 -159.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.618 ' HB3' HG11 ' A' ' 22' ' ' VAL . 25.3 tt0 -130.14 133.73 46.83 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.51 -1.223 . . . . 1.26 111.658 -160.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.579 ' C ' HD21 ' A' ' 27' ' ' LEU . 1.6 tt -101.62 147.39 26.47 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 107.006 -1.479 . . . . 1.0600000000000001 107.006 177.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.507 ' N ' HD21 ' A' ' 27' ' ' LEU . 30.3 m -138.44 109.79 6.94 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.204 -0.599 . . . . 1.05 110.729 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.617 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 92.2 t90 -86.65 109.79 19.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.65 -0.705 . . . . 0.29999999999999999 109.219 177.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.72 118.3 35.23 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.344 -0.844 . . . . 1.1599999999999999 109.039 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.475 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 86.7 p -57.28 142.63 42.53 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 110.008 -0.367 . . . . 1.3899999999999999 110.008 -177.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.645 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 38.3 m -46.67 -39.76 11.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.256 0.55 . . . . 1.1499999999999999 110.91 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -72.32 -27.67 62.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.226 -0.897 . . . . 2.3300000000000001 111.646 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.3 21.82 28.73 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.984 -0.627 . . . . 0.55000000000000004 112.471 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -101.78 -30.76 11.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.158 0.504 . . . . 1.1299999999999999 110.781 -173.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.424 ' HZ2' ' HB2' ' A' ' 36' ' ' LYS . 3.3 ttmp? -126.22 130.06 50.2 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.663 -0.698 . . . . 2.6200000000000001 110.154 -176.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 95.9 t -133.59 123.54 46.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.786 0.326 . . . . 1.3100000000000001 110.223 -177.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -125.33 110.99 14.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.193 -0.458 . . . . 0.82999999999999996 110.37 -177.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 40.2 m -92.6 145.05 24.73 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.805 0.336 . . . . 1.0600000000000001 111.663 -177.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 32.0 t -122.02 124.72 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.254 -0.43 . . . . 1.3600000000000001 110.913 174.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.478 ' O ' HG12 ' A' ' 45' ' ' ILE . 59.7 t -91.47 108.32 19.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.014 -0.736 . . . . 1.05 109.014 175.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.578 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.0 mm? -52.72 -27.63 18.46 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.409 -0.814 . . . . 1.04 112.79 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.4 t -75.38 -29.28 59.81 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.599 -0.44 . . . . 1.45 110.822 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.5 p -82.59 -4.64 57.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.46 0.647 . . . . 1.04 109.937 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.591 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 45.5 mm -89.39 126.01 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.134 -0.939 . . . . 1.02 111.448 175.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.554 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 21.7 t70 -77.5 -41.86 37.81 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.732 -0.667 . . . . 0.69999999999999996 110.928 176.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -153.03 160.73 43.02 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 115.856 -0.611 . . . . 2.4300000000000002 110.425 -175.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.565 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 12.9 tp -121.22 149.24 43.13 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.219 0.533 . . . . 1.04 109.566 171.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.535 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 10.6 mm100 -125.39 156.34 38.95 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.229 -0.896 . . . . 1.49 109.5 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.03 145.24 11.89 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.809 -0.812 . . . . 1.0 108.809 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 36.6 p -54.61 124.96 51.82 Favored Pre-proline 0 C--O 1.234 0.286 0 CA-C-O 121.254 0.549 . . . . 1.03 111.419 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 62.0 Cg_endo -70.55 167.28 25.93 Favored 'Trans proline' 0 C--N 1.332 -0.34 0 C-N-CA 124.242 3.295 . . . . 0.73999999999999999 112.061 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.57 -18.57 53.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.425 0.631 . . . . 1.54 110.215 172.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 63.5 m -83.79 -8.67 59.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.293 -0.867 . . . . 2.0499999999999998 111.469 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.52 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 41.2 t -89.05 148.23 23.84 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.081 -0.508 . . . . 1.1399999999999999 110.347 175.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -89.0 -11.2 44.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.798 -0.637 . . . . 2.8900000000000001 110.985 177.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.9 mmmt -108.27 -177.05 3.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.763 -0.653 . . . . 3.1299999999999999 110.324 -173.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.49 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -131.75 109.05 9.88 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.351 -0.981 . . . . 2.0 108.351 170.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.539 ' HG2' ' HA ' ' A' ' 90' ' ' SER . 68.7 mtm -155.39 146.04 22.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.044 0.384 . . . . 1.3 111.733 -175.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.867 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.7 OUTLIER -109.73 164.98 12.05 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.015 -0.539 . . . . 1.05 111.467 174.821 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.535 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 49.4 ttp180 -155.38 113.71 3.46 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.89 -0.595 . . . . 3.3999999999999999 110.68 171.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.541 ' HG ' HD12 ' A' ' 48' ' ' LEU . 7.8 mt -93.37 114.52 26.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.094 0.473 . . . . 1.73 110.762 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.458 HG21 ' HG2' ' A' ' 86' ' ' ARG . 4.0 mm -86.74 106.1 15.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.718 -0.674 . . . . 1.1599999999999999 110.517 -173.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -75.58 149.44 38.46 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 119.664 -1.255 . . . . 0.47999999999999998 111.246 176.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.554 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 0.1 OUTLIER -60.4 134.91 57.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.258 0.529 . . . . 1.78 110.087 178.175 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 C--N 1.323 -0.585 0 CA-C-O 121.126 0.489 . . . . 1.3100000000000001 110.62 176.442 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.447 -0.605 0 CA-C-O 122.483 1.135 . . . . 1.78 108.838 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.458 ' HG2' HG21 ' A' ' 63' ' ' ILE . 27.1 mtt85 -108.61 150.8 27.0 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.285 -1.325 . . . . 2.8199999999999998 109.658 -176.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.467 ' CD2' HG21 ' A' ' 40' ' ' VAL . 68.6 m-70 -109.15 110.41 21.63 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.865 -0.791 . . . . 0.63 108.865 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.458 ' HE3' ' CE2' ' B' ' 261' ' ' PHE . 52.8 ttm -111.44 120.89 43.67 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.698 -0.228 . . . . 1.1200000000000001 110.669 -174.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.621 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -114.62 141.1 48.23 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.77 -0.826 . . . . 1.6499999999999999 108.77 177.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.539 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 65.0 m -95.63 124.76 39.81 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.677 -0.49 . . . . 1.1899999999999999 109.677 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.867 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 3.1 m-85 -107.41 167.29 10.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.302 -0.408 . . . . 1.6399999999999999 109.994 -176.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -115.64 -2.3 12.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.95 0.405 . . . . 1.8300000000000001 110.776 -173.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -145.2 129.29 17.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.18 0.514 . . . . 1.22 110.247 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 98' ' ' ASP . 6.7 tpt180 -65.1 -30.6 71.55 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.202 -0.908 . . . . 2.8799999999999999 110.753 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.512 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 32.4 m -69.34 -47.59 63.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.21 0.529 . . . . 1.1200000000000001 110.332 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.804 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 82.8 t -60.06 -53.18 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 CA-C-N 115.584 -0.735 . . . . 1.1299999999999999 111.404 177.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.494 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -63.56 -24.45 67.81 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.906 -0.718 . . . . 1.0600000000000001 109.582 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.512 ' HB3' ' O ' ' A' ' 95' ' ' THR . 33.0 t70 -69.92 -42.66 73.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.399 0.619 . . . . 0.39000000000000001 109.522 175.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.804 ' ND2' ' HA ' ' A' ' 96' ' ' VAL . 21.5 p30 -80.56 -31.66 36.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.752 -1.113 . . . . 1.55 110.282 -173.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.482 HG23 HD13 ' A' ' 18' ' ' ILE . 27.3 mm -67.1 -52.46 43.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.483 -0.781 . . . . 1.0600000000000001 110.219 171.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.2 ttpp -55.2 -51.18 67.39 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.986 -0.552 . . . . 1.72 110.641 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -63.33 -27.64 69.46 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 120.668 0.271 . . . . 1.76 111.012 -175.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.9 m -65.31 -49.82 68.02 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.279 0.561 . . . . 1.04 109.933 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.578 ' CD2' HD11 ' A' ' 42' ' ' LEU . 9.2 mt -71.17 -57.6 4.35 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 115.193 -0.912 . . . . 1.05 111.19 -176.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.478 ' HG2' ' CD2' ' A' ' 48' ' ' LEU . 23.4 mm-40 -42.22 -35.49 0.97 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.174 0.805 . . . . 1.45 113.174 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -65.92 -44.85 83.97 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.728 0.775 . . . . 0.66000000000000003 108.961 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.502 HG23 ' HB2' ' A' ' 25' ' ' ALA . 72.0 mt -65.68 -43.37 93.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 113.891 -1.504 . . . . 1.04 110.954 177.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.424 HG12 HD13 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -61.6 -57.07 13.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.663 -0.699 . . . . 1.04 110.661 -176.191 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.8 m -54.49 -29.9 51.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.972 -0.558 . . . . 1.6100000000000001 110.829 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -71.65 -29.62 64.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.712 -0.676 . . . . 4.3899999999999997 110.832 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.49 ' OH ' ' HA ' ' A' ' 24' ' ' PRO . 14.5 m-85 . . . . . 0 C--N 1.321 -0.656 0 CA-C-N 115.859 -0.609 . . . . 0.71999999999999997 111.435 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 261' ' ' PHE . . . . . 0.507 ' CE1' ' HB2' ' A' ' 59' ' ' MET . 3.3 m-85 . . . . . 0 N--CA 1.45 -0.468 0 CA-C-O 120.945 0.402 . . . . 0.97999999999999998 110.429 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 4.7 p -133.66 163.65 36.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.962 -0.755 . . . . 1.8999999999999999 108.962 175.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.313 -1.018 0 N-CA-C 109.476 -0.564 . . . . 2.2400000000000002 109.476 173.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.604 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 39.4 m80 . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 120.626 0.25 . . . . 2.3900000000000001 111.352 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 m -161.02 148.22 15.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.684 0.278 . . . . 1.6100000000000001 110.511 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.81 147.6 7.18 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 110.409 -1.077 . . . . 0.17000000000000001 110.409 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.697 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -81.06 119.97 24.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 117.935 0.868 . . . . 0.97999999999999998 111.448 -175.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -127.9 160.35 32.1 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.541 0.686 . . . . 1.01 112.016 -176.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 2.6 mp -100.85 126.9 54.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.179 -0.918 . . . . 1.0800000000000001 109.392 177.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -126.12 112.09 15.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.067 -0.515 . . . . 0.66000000000000003 110.286 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 59.99 47.36 9.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.565 0.698 . . . . 1.46 110.903 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 35.6 mmtt 74.85 0.61 3.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.317 -1.31 . . . . 2.3900000000000001 113.288 171.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -106.04 132.4 53.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.372 -0.531 . . . . 1.23 110.695 171.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.513 ' HA ' HG13 ' A' ' 8' ' ' ILE . 47.5 t -79.85 129.98 34.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.635 -0.711 . . . . 1.48 110.639 178.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.639 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -151.63 -153.26 6.15 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.797 -0.638 . . . . 0.16 112.036 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.697 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 7.5 mm -128.27 153.47 37.72 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 CA-C-O 120.948 0.404 . . . . 1.05 110.76 -177.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.45 HD12 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -122.61 134.6 65.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 115.911 -0.586 . . . . 1.01 109.628 179.672 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.58 109.26 7.04 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.52 -0.309 . . . . 0.87 111.7 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.604 ' O ' ' HB3' ' A' ' 3' ' ' HIS . 3.7 mp -85.69 126.43 40.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.494 -0.928 . . . . 1.05 108.494 171.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.737 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -126.96 129.37 47.99 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.38 -0.528 . . . . 1.1200000000000001 109.752 178.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -113.34 84.26 1.98 Allowed 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 117.353 -1.739 . . . . 0.73999999999999999 107.694 164.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -122.25 -12.01 8.32 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 106.468 -1.678 . . . . 0.58999999999999997 106.468 157.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.75 HG11 ' O ' ' A' ' 23' ' ' SER . 11.1 p -102.18 173.9 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 111.792 -2.458 . . . . 1.0800000000000001 112.745 -154.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.75 ' O ' HG11 ' A' ' 22' ' ' VAL . 5.5 m -54.72 166.7 0.71 Allowed Pre-proline 0 C--O 1.221 -0.415 0 N-CA-C 106.689 -1.597 . . . . 2.0 106.689 165.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.426 ' C ' ' O ' ' A' ' 23' ' ' SER . 11.0 Cg_endo -42.06 127.99 4.03 Favored 'Trans proline' 0 C--N 1.355 0.908 0 CA-C-N 122.036 1.763 . . . . 0.26000000000000001 111.203 -151.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.468 ' HB3' HG23 ' A' ' 107' ' ' ILE . . . -33.47 137.61 0.08 Allowed 'General case' 0 CA--C 1.506 -0.715 0 O-C-N 125.379 1.674 . . . . 1.02 113.833 -155.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.533 ' HB2' HG13 ' A' ' 22' ' ' VAL . 30.6 mt-10 -121.35 131.05 53.97 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 114.933 -1.03 . . . . 1.26 111.055 -169.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.581 ' C ' HD23 ' A' ' 27' ' ' LEU . 1.7 tt -101.02 140.4 35.37 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 106.215 -1.772 . . . . 1.0600000000000001 106.215 171.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.422 ' N ' HD23 ' A' ' 27' ' ' LEU . 19.4 m -131.22 108.83 9.98 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.677 -0.809 . . . . 1.05 110.441 -178.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.615 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 89.6 t90 -85.56 107.78 17.65 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.383 -0.826 . . . . 0.29999999999999999 109.323 176.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -113.46 114.77 27.03 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.788 -1.097 . . . . 1.1599999999999999 108.414 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.559 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 37.3 p -56.48 143.96 33.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.963 0.411 . . . . 1.3899999999999999 110.268 -177.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.639 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 19.8 m -53.0 -33.2 50.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.145 -0.934 . . . . 1.1499999999999999 111.432 -177.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -80.68 -27.84 36.93 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.125 -0.489 . . . . 2.3300000000000001 111.233 177.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.04 0.34 57.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.098 -0.572 . . . . 0.55000000000000004 112.234 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -64.37 -48.18 76.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.104 0.478 . . . . 1.1299999999999999 111.516 -177.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -117.59 148.72 41.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.803 -0.635 . . . . 2.6200000000000001 111.706 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 89.6 t -145.22 125.41 6.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.486 -1.234 . . . . 1.3100000000000001 109.808 178.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -133.08 115.51 15.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.479 -0.328 . . . . 0.82999999999999996 110.717 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.2 m -98.44 139.63 33.9 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.928 -0.309 . . . . 1.0600000000000001 111.403 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.513 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 23.3 t -112.12 129.46 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 122.878 0.471 . . . . 1.3600000000000001 111.127 176.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 45' ' ' ILE . 48.4 t -91.6 108.77 20.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 CA-C-O 121.293 0.568 . . . . 1.05 109.565 173.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.612 HD13 ' CD2' ' A' ' 104' ' ' LEU . 2.1 mm? -53.95 -25.72 22.05 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.127 -0.942 . . . . 1.04 113.03 -178.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 64.6 m -79.78 -31.42 40.85 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.521 -0.471 . . . . 1.45 111.689 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.8 p -76.88 -8.74 57.9 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.178 -0.675 . . . . 1.04 109.178 173.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.563 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 47.3 mm -86.45 121.56 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.044 -0.98 . . . . 1.02 111.552 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.663 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 23.0 t70 -80.08 -43.31 22.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.621 -0.718 . . . . 0.69999999999999996 110.991 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -140.51 157.12 45.98 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.986 -0.376 . . . . 2.4300000000000002 109.986 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.585 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 12.2 tp -118.74 144.73 46.07 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.271 -0.64 . . . . 1.04 109.271 166.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 12.3 mm100 -122.88 151.91 41.27 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.066 -0.97 . . . . 1.49 109.317 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.05 146.3 10.72 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.51 -0.768 . . . . 1.0 109.132 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 54.6 p -60.58 126.12 84.13 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-O 121.548 0.69 . . . . 1.03 111.073 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.467 ' O ' ' HB3' ' A' ' 55' ' ' SER . 57.8 Cg_endo -67.46 166.49 23.55 Favored 'Trans proline' 0 C--N 1.333 -0.276 0 C-N-CA 123.984 3.123 . . . . 0.73999999999999999 111.627 177.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.64 -21.88 66.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.928 0.394 . . . . 1.54 110.67 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 t -78.76 -19.74 51.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 2.0499999999999998 110.545 177.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 52' ' ' PRO . 27.9 t -67.85 145.56 54.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.889 -0.596 . . . . 1.1399999999999999 110.452 176.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -89.82 -13.82 35.75 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.4 0.619 . . . . 2.8900000000000001 110.145 175.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -106.48 173.57 6.26 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.135 -0.939 . . . . 3.1299999999999999 110.053 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.497 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -130.46 112.18 12.98 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.644 -0.707 . . . . 2.0 109.555 175.581 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.608 ' HB3' ' CZ ' ' B' ' 261' ' ' PHE . 2.5 mtm -156.03 148.28 23.49 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.838 0.351 . . . . 1.3 111.691 -176.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.33 154.96 30.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.519 -0.764 . . . . 1.05 110.428 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 21.3 ttm180 -151.11 113.88 4.7 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 120.931 0.396 . . . . 3.3999999999999999 110.823 171.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.525 ' HG ' HD11 ' A' ' 48' ' ' LEU . 9.1 mt -92.56 112.6 24.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.112 0.482 . . . . 1.73 110.509 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.498 HG21 ' HG2' ' A' ' 86' ' ' ARG . 6.3 mm -87.05 111.75 22.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 C-N-CA 123.464 0.705 . . . . 1.1599999999999999 110.513 -172.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.563 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -79.0 150.36 33.92 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 120.254 -0.974 . . . . 0.47999999999999998 111.864 177.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.663 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 1.1 mptm? -63.74 132.19 50.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.012 0.406 . . . . 1.78 110.763 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 C--N 1.318 -0.799 0 N-CA-C 109.19 -0.67 . . . . 1.3100000000000001 109.19 175.874 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.351 0 CA-C-O 121.775 0.798 . . . . 1.78 109.761 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.498 ' HG2' HG21 ' A' ' 63' ' ' ILE . 37.7 mtm180 -116.71 140.32 49.55 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.48 -0.782 . . . . 2.8199999999999998 110.285 -173.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -103.1 111.23 23.48 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.552 -0.749 . . . . 0.63 109.155 -177.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.526 ' HE2' ' CE2' ' B' ' 261' ' ' PHE . 43.4 ttm -102.78 132.41 48.96 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.716 0.293 . . . . 1.1200000000000001 110.754 -176.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.45 ' CG ' HD12 ' A' ' 16' ' ' ILE . 95.4 m-85 -127.16 123.72 37.39 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.526 -0.546 . . . . 1.6499999999999999 109.526 177.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.517 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 50.1 m -91.78 130.85 37.49 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.831 0.348 . . . . 1.1899999999999999 110.556 -177.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.61 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 30.7 m-85 -108.16 173.65 6.23 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.034 -0.53 . . . . 1.6399999999999999 110.156 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -117.43 -3.06 11.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.017 -0.538 . . . . 1.8300000000000001 109.6 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.553 ' OD1' ' HB ' ' A' ' 95' ' ' THR . 28.6 t-20 -137.51 130.62 30.61 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.595 -0.73 . . . . 1.22 110.21 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.499 ' HA ' ' HG2' ' A' ' 97' ' ' MET . 2.2 tmt_? -74.29 -24.05 59.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.866 -0.606 . . . . 2.8799999999999999 110.559 -174.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.553 ' HB ' ' OD1' ' A' ' 93' ' ' ASN . 51.6 m -71.95 -48.33 45.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.96 0.409 . . . . 1.1200000000000001 110.326 177.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.817 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 96.8 t -55.9 -57.12 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-N 115.956 -0.565 . . . . 1.1299999999999999 111.259 174.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.615 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -58.35 -30.9 67.11 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.526 -0.87 . . . . 1.0600000000000001 109.529 -179.14 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.598 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 33.5 t70 -64.8 -43.75 92.15 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.623 0.725 . . . . 0.39000000000000001 110.721 175.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.817 ' ND2' ' HA ' ' A' ' 96' ' ' VAL . 20.6 p30 -76.96 -25.52 52.92 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.071 -0.968 . . . . 1.55 109.899 -173.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.61 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 28.2 mm -72.39 -55.94 11.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.813 -1.085 . . . . 1.0600000000000001 111.196 171.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.615 ' HG2' ' O ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -59.07 -39.29 81.67 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 120.768 0.318 . . . . 1.72 111.259 -177.359 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.431 ' HB3' ' HE2' ' A' ' 101' ' ' LYS . 26.6 ptm -69.85 -27.27 64.7 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.28 -0.637 . . . . 1.76 109.28 -176.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 21.7 m -67.62 -53.37 28.56 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.65 -0.705 . . . . 1.04 110.018 174.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.612 ' CD2' HD13 ' A' ' 42' ' ' LEU . 10.4 mt -65.66 -56.44 12.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.193 -0.912 . . . . 1.05 111.221 -176.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.473 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 42.8 mt-30 -51.68 -30.12 20.69 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.48 0.548 . . . . 1.45 112.48 -178.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -68.6 -26.85 65.58 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.882 0.848 . . . . 0.66000000000000003 109.571 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.511 HD13 ' HA ' ' A' ' 104' ' ' LEU . 47.8 mt -82.56 -41.72 17.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.052 -1.431 . . . . 1.04 110.071 176.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.3 mt -66.98 -49.88 69.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.551 -0.75 . . . . 1.04 110.752 -176.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.7 m -61.34 -22.72 65.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.506 0.669 . . . . 1.6100000000000001 110.063 174.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.485 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 9.7 ttt180 -72.19 -32.15 66.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.106 -0.952 . . . . 4.3899999999999997 109.862 176.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 . . . . . 0 N--CA 1.451 -0.401 0 CA-C-N 116.177 -0.465 . . . . 0.71999999999999997 111.654 -177.288 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 261' ' ' PHE . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 2.8 m-30 . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.956 0.408 . . . . 0.97999999999999998 110.239 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.36 140.6 22.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.927 -0.579 . . . . 1.8999999999999999 110.205 174.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 C--N 1.328 -0.33 0 N-CA-C 108.809 -0.812 . . . . 2.2400000000000002 108.809 171.348 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.3 m80 . . . . . 0 N--CA 1.463 0.188 0 CA-C-O 121.587 0.708 . . . . 2.3900000000000001 109.547 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.1 p -163.27 148.84 11.56 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.929 -1.032 . . . . 1.6100000000000001 108.883 -176.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.22 142.69 5.64 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.188 -0.765 . . . . 0.17000000000000001 111.188 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.716 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -73.4 120.94 19.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 117.361 0.58 . . . . 0.97999999999999998 111.237 -176.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.472 ' HB3' ' CE1' ' A' ' 91' ' ' PHE . . . -130.08 157.7 41.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.394 0.616 . . . . 1.01 111.852 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.508 ' HB ' ' HB3' ' A' ' 90' ' ' SER . 2.6 mp -95.93 124.47 48.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.125 -0.943 . . . . 1.0800000000000001 109.07 176.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.474 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 88.8 t80 -128.69 103.44 7.08 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.164 -0.471 . . . . 0.66000000000000003 109.919 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 67.24 58.41 0.55 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.792 -0.64 . . . . 1.46 110.872 -175.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp 70.13 -8.47 0.84 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.608 -1.178 . . . . 2.3900000000000001 113.374 171.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -104.73 131.83 52.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.969 0.414 . . . . 1.23 111.061 177.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.484 ' HA ' HG13 ' A' ' 8' ' ' ILE . 28.7 p -79.9 125.95 30.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.707 -0.679 . . . . 1.48 110.721 176.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.622 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -144.82 -154.38 6.12 Favored Glycine 0 N--CA 1.436 -1.339 0 CA-C-N 115.711 -0.677 . . . . 0.16 111.637 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.716 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 9.2 mm -126.13 153.84 34.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 120.755 0.312 . . . . 1.05 110.68 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.411 HG12 HD23 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -126.28 133.72 68.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 116.102 -0.499 . . . . 1.01 109.95 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.63 113.98 10.18 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 111.899 0.333 . . . . 0.87 111.899 175.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.502 HD11 HG22 ' A' ' 100' ' ' ILE . 3.8 mp -85.38 124.39 40.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.359 -0.978 . . . . 1.05 108.359 171.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.426 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 2.3 t30 -126.62 124.31 39.61 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.949 -0.389 . . . . 1.1200000000000001 109.949 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.488 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 23.7 mt-10 -109.63 84.05 1.86 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 117.084 -1.847 . . . . 0.73999999999999999 107.519 163.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.426 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 17.7 t70 -121.48 -9.86 8.93 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.476 -1.676 . . . . 0.58999999999999997 106.476 156.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 23' ' ' SER . 14.7 p -101.98 173.1 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 112.045 -2.343 . . . . 1.0800000000000001 111.63 -157.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.676 ' O ' HG12 ' A' ' 22' ' ' VAL . 14.5 m -54.98 166.66 0.75 Allowed Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 106.942 -1.503 . . . . 2.0 106.942 166.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 10.2 Cg_endo -40.67 127.42 2.45 Favored 'Trans proline' 0 C--N 1.357 0.997 0 CA-C-N 121.913 1.719 . . . . 0.26000000000000001 111.34 -150.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.543 ' HB1' HG21 ' A' ' 107' ' ' ILE . . . -33.7 136.34 0.11 Allowed 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 125.379 1.674 . . . . 1.02 113.691 -156.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.523 ' HB2' HG11 ' A' ' 22' ' ' VAL . 80.7 mt-10 -123.5 138.87 54.48 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.422 -1.263 . . . . 1.26 111.099 -169.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.598 ' C ' HD21 ' A' ' 27' ' ' LEU . 1.1 tt -101.41 144.44 30.21 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 106.257 -1.757 . . . . 1.0600000000000001 106.257 171.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.445 ' N ' HD21 ' A' ' 27' ' ' LEU . 18.1 m -129.84 109.18 10.72 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.903 -0.719 . . . . 1.05 110.002 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 89.9 t90 -86.9 105.4 17.04 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.687 -0.857 . . . . 0.29999999999999999 108.687 175.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -113.49 114.84 27.1 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.844 -1.071 . . . . 1.1599999999999999 108.738 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.511 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 37.5 p -56.19 148.33 18.49 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.24 0.543 . . . . 1.3899999999999999 111.282 -174.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.622 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 24.0 m -55.97 -30.09 61.21 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.953 -1.021 . . . . 1.1499999999999999 111.371 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -80.2 -28.54 38.64 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.024 0.44 . . . . 2.3300000000000001 110.756 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.19 6.61 53.43 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.956 -0.64 . . . . 0.55000000000000004 112.631 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.38 -69.72 0.6 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.367 . . . . 1.1299999999999999 111.363 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -82.55 137.6 34.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.472 0.653 . . . . 2.6200000000000001 111.546 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 96.0 t -140.57 120.32 12.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.397 -1.274 . . . . 1.3100000000000001 109.496 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -125.89 114.12 18.11 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.438 -0.347 . . . . 0.82999999999999996 110.438 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.2 m -96.99 138.49 34.45 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 121.205 -0.198 . . . . 1.0600000000000001 111.188 -177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.524 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 37.5 t -113.31 129.79 68.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 122.716 0.407 . . . . 1.3600000000000001 111.722 178.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.536 ' O ' HG12 ' A' ' 45' ' ' ILE . 46.8 t -90.42 108.86 20.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 CA-C-O 121.286 0.565 . . . . 1.05 109.777 172.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.561 HD13 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -55.12 -27.04 42.34 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.312 -0.858 . . . . 1.04 112.633 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.448 ' O ' ' HE2' ' A' ' 65' ' ' LYS . 33.9 t -75.97 -35.11 59.76 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.722 -0.391 . . . . 1.45 110.799 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.2 p -76.99 -16.39 59.35 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.591 0.71 . . . . 1.04 109.249 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.675 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 42.2 mm -73.66 121.47 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 114.977 -1.01 . . . . 1.02 110.964 172.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.626 ' HA ' ' NZ ' ' A' ' 65' ' ' LYS . 23.0 t70 -78.61 -48.23 15.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.21 -0.45 . . . . 0.69999999999999996 111.298 175.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -137.0 151.9 49.51 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 110.165 -0.309 . . . . 2.4300000000000002 110.165 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.591 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 11.9 tp -116.07 144.9 43.5 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.118 -0.697 . . . . 1.04 109.118 166.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.552 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 8.1 mm100 -120.22 159.51 24.8 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.399 -0.819 . . . . 1.49 109.396 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.42 ' CB ' ' HG3' ' A' ' 101' ' ' LYS . . . -161.69 152.43 17.83 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.48 -0.933 . . . . 1.0 108.48 174.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.445 ' CG2' ' HE2' ' A' ' 59' ' ' MET . 33.4 p -55.4 125.49 59.41 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.476 0.655 . . . . 1.03 111.432 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 43.0 Cg_endo -67.39 166.88 22.12 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 124.0 3.133 . . . . 0.73999999999999999 111.581 176.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.01 -22.73 67.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.027 0.441 . . . . 1.54 110.303 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.3 p -74.48 -27.7 60.69 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.558 -0.746 . . . . 2.0499999999999998 110.786 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.455 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 23.0 t -70.29 140.8 52.37 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.214 -0.903 . . . . 1.1399999999999999 109.409 174.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -90.95 -13.63 33.09 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.788 -0.819 . . . . 2.8900000000000001 108.788 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.614 ' HD3' ' N ' ' A' ' 57' ' ' LYS . 2.2 mppt? -99.21 -176.8 3.41 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.745 -1.116 . . . . 3.1299999999999999 111.354 -175.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.44 ' SD ' ' HB2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -139.87 109.22 6.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.483 . . . . 2.0 109.705 -177.082 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.474 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 2.6 mpp? -155.69 167.65 29.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.934 0.397 . . . . 1.3 111.721 -175.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 97' ' ' MET . 0.8 OUTLIER -130.28 161.58 30.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.324 -0.853 . . . . 1.05 111.445 176.38 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.552 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 13.1 ttm180 -154.26 114.3 3.86 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.765 -0.198 . . . . 3.3999999999999999 110.749 173.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.523 ' CD2' HG23 ' A' ' 45' ' ' ILE . 10.7 mt -96.65 110.3 22.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.863 0.364 . . . . 1.73 111.095 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.469 ' CD1' ' HD2' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -89.13 128.73 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.056 0.543 . . . . 1.1599999999999999 110.086 -178.099 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.675 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -95.02 152.28 20.4 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.017 -1.087 . . . . 0.47999999999999998 112.337 176.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.626 ' NZ ' ' HA ' ' A' ' 46' ' ' ASP . 1.2 mptp? -58.33 134.48 56.62 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.755 0.312 . . . . 1.78 110.627 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--N 1.319 -0.719 0 CA-C-O 121.184 0.516 . . . . 1.3100000000000001 110.306 178.078 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.287 0.565 . . . . 1.78 110.385 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.81 160.17 26.57 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.794 -0.639 . . . . 2.8199999999999998 111.017 -174.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.415 ' CD2' HG21 ' A' ' 40' ' ' VAL . 88.5 m-70 -125.08 113.0 17.16 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.282 -0.872 . . . . 0.63 109.406 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.401 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 55.8 ttm -105.15 126.08 51.68 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.835 0.35 . . . . 1.1200000000000001 111.447 -175.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.97 124.59 47.39 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.563 -0.532 . . . . 1.6499999999999999 109.563 178.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.508 ' HB3' ' HB ' ' A' ' 8' ' ' ILE . 33.3 t -93.06 130.72 38.57 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.849 0.357 . . . . 1.1899999999999999 110.226 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.593 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 27.2 m-85 -108.53 172.7 6.69 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.824 -0.625 . . . . 1.6399999999999999 111.417 176.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -119.95 -4.72 10.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.364 -0.834 . . . . 1.8300000000000001 110.465 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -134.63 129.27 34.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.95 0.405 . . . . 1.22 110.338 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.44 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 14.9 tpt180 -59.62 -32.94 70.89 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.398 -0.819 . . . . 2.8799999999999999 111.188 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.477 HG23 HD22 ' A' ' 99' ' ' ASN . 87.3 m -70.42 -58.7 3.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.419 -0.355 . . . . 1.1200000000000001 110.545 -177.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.4 t -45.72 -56.04 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-N 115.695 -0.684 . . . . 1.1299999999999999 111.85 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.503 ' O ' HD12 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -64.7 -28.59 69.7 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.256 -0.429 . . . . 1.0600000000000001 110.966 -176.408 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -73.32 -30.04 63.09 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.037 -0.727 . . . . 0.39000000000000001 109.037 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.61 ' O ' ' HG3' ' A' ' 102' ' ' MET . 91.6 m-20 -77.5 -48.05 18.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.666 -1.152 . . . . 1.55 109.842 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.593 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 36.4 mm -57.9 -49.16 82.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.248 -0.887 . . . . 1.0600000000000001 110.153 176.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.434 ' HG2' HD22 ' A' ' 48' ' ' LEU . 2.3 tmmm? -57.0 -48.53 78.25 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.814 -0.63 . . . . 1.72 110.887 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.61 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 5.0 ppp? -70.08 -24.65 63.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.78 0.324 . . . . 1.76 110.506 -175.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 53.9 m -67.79 -50.79 55.02 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.491 0.662 . . . . 1.04 109.891 176.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.591 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 12.6 mt -69.85 -58.17 4.2 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.963 -1.017 . . . . 1.05 111.326 -175.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.498 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 49.4 mt-30 -53.45 -24.03 11.67 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.804 0.668 . . . . 1.45 112.804 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -65.69 -48.91 70.45 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.637 -0.875 . . . . 0.66000000000000003 108.637 175.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.543 HG21 ' HB1' ' A' ' 25' ' ' ALA . 60.1 mt -58.53 -43.8 87.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.2 -1.364 . . . . 1.04 110.811 175.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.5 mt -65.03 -51.21 69.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.596 -0.729 . . . . 1.04 110.184 -177.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.7 m -55.18 -33.31 62.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.15 0.5 . . . . 1.6100000000000001 110.605 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 91.2 mtt180 -67.19 -30.24 70.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.588 -0.733 . . . . 4.3899999999999997 110.602 178.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 . . . . . 0 N--CA 1.448 -0.533 0 CA-C-N 116.124 -0.489 . . . . 0.71999999999999997 111.357 -179.431 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 261' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 61' ' ' ARG . 7.1 m-30 . . . . . 0 CA--C 1.52 -0.203 0 CA-C-O 120.957 0.408 . . . . 0.97999999999999998 110.856 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.08 160.6 29.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.301 -1.0 . . . . 1.8999999999999999 108.301 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.658 0 C-N-CA 120.082 -0.647 . . . . 2.2400000000000002 109.977 177.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.612 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 19.9 m170 . . . . . 0 C--O 1.225 -0.224 0 CA-C-O 120.618 0.247 . . . . 2.3900000000000001 111.417 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.6 p -164.42 159.31 19.41 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.072 -0.344 . . . . 1.6100000000000001 110.072 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.36 144.71 4.23 Favored Glycine 0 C--O 1.225 -0.456 0 N-CA-C 110.886 -0.886 . . . . 0.17000000000000001 110.886 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.717 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -76.56 120.71 22.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.618 0.709 . . . . 0.97999999999999998 111.124 -177.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.459 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -130.05 159.27 37.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.307 0.575 . . . . 1.01 111.725 -176.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.496 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.3 mp -97.28 118.14 43.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.216 -0.902 . . . . 1.0800000000000001 109.115 175.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.582 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 82.8 t80 -123.35 110.03 14.65 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.379 -0.373 . . . . 0.66000000000000003 109.997 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.575 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 41.1 mt-10 68.74 50.37 0.65 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.488 -0.778 . . . . 1.46 110.702 -175.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.575 ' HD2' ' C ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER 66.49 3.9 3.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.31 -1.314 . . . . 2.3900000000000001 112.791 171.515 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.487 HG21 ' HD2' ' A' ' 36' ' ' LYS . 0.7 OUTLIER -110.81 133.76 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.797 0.332 . . . . 1.23 110.293 172.118 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.496 ' HA ' HG13 ' A' ' 8' ' ' ILE . 31.8 t -78.17 133.25 37.82 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.325 0.583 . . . . 1.48 110.57 178.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.621 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -154.33 -152.95 6.26 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.486 -0.779 . . . . 0.16 111.683 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.717 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.3 mm -126.66 154.02 36.03 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-O 120.795 0.331 . . . . 1.05 110.646 -178.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.463 HD11 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -127.02 135.15 64.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 116.011 -0.541 . . . . 1.01 109.833 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.81 113.28 9.47 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.015 0.436 . . . . 0.87 112.031 174.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.612 ' O ' ' HB3' ' A' ' 3' ' ' HIS . 4.3 mp -84.56 113.18 22.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.74 -0.837 . . . . 1.05 108.74 171.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.8 t30 -118.16 123.98 46.86 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 110.135 -0.321 . . . . 1.1200000000000001 110.135 -178.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 22.3 mt-10 -107.69 83.35 1.79 Allowed 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 117.191 -1.804 . . . . 0.73999999999999999 107.383 165.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.408 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 18.1 t70 -122.21 -11.78 8.37 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.782 -1.562 . . . . 0.58999999999999997 106.782 157.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.66 HG11 ' O ' ' A' ' 23' ' ' SER . 14.8 p -101.68 179.86 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 111.887 -2.415 . . . . 1.0800000000000001 111.737 -155.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.66 ' O ' HG11 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -53.04 165.2 0.62 Allowed Pre-proline 0 C--O 1.224 -0.263 0 N-CA-C 107.699 -1.223 . . . . 2.0 107.699 166.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 15.4 Cg_endo -44.49 126.39 6.83 Favored 'Trans proline' 0 C--N 1.353 0.813 0 CA-C-N 121.366 1.523 . . . . 0.26000000000000001 111.852 -154.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.524 ' HB3' HG23 ' A' ' 107' ' ' ILE . . . -23.69 134.27 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 O-C-N 125.127 1.517 . . . . 1.02 114.882 -153.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.517 ' HB2' HG13 ' A' ' 22' ' ' VAL . 37.9 mt-10 -126.26 137.36 53.51 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.697 -1.138 . . . . 1.26 111.034 -173.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.578 ' C ' HD21 ' A' ' 27' ' ' LEU . 1.2 tt -99.99 145.27 28.07 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 106.47 -1.678 . . . . 1.0600000000000001 106.47 175.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.491 ' N ' HD21 ' A' ' 27' ' ' LEU . 19.2 m -131.96 109.3 9.96 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.891 -0.724 . . . . 1.05 110.392 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.598 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.2 t90 -89.25 108.16 19.46 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.574 -0.739 . . . . 0.29999999999999999 109.143 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -115.89 120.26 38.65 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.252 -0.885 . . . . 1.1599999999999999 109.091 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.475 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 35.5 p -56.01 148.17 18.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.891 0.377 . . . . 1.3899999999999999 110.892 -175.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.621 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 21.7 m -54.26 -32.96 57.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.431 -0.804 . . . . 1.1499999999999999 110.949 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -77.54 -29.66 52.42 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.244 -0.434 . . . . 2.3300000000000001 111.113 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.07 13.66 51.84 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.736 -0.745 . . . . 0.55000000000000004 113.042 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -85.84 -69.04 0.69 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.159 0.504 . . . . 1.1299999999999999 110.336 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.487 ' HD2' HG21 ' A' ' 12' ' ' VAL . 17.0 ptpt -87.49 145.09 26.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.624 0.726 . . . . 2.6200000000000001 110.371 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 65.7 t -147.17 140.51 19.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.487 -1.233 . . . . 1.3100000000000001 109.041 -176.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -141.21 122.67 15.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.571 0.224 . . . . 0.82999999999999996 110.595 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.426 HG21 ' HG1' ' A' ' 28' ' ' THR . 29.0 m -103.85 142.66 34.0 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 121.256 -0.177 . . . . 1.0600000000000001 111.09 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 45.8 t -119.42 130.02 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.187 0.44 . . . . 1.3600000000000001 112.187 178.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 45' ' ' ILE . 49.9 t -91.13 108.88 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-O 121.499 0.666 . . . . 1.05 109.935 172.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.577 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.3 mm? -49.95 -35.46 24.23 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.512 -1.222 . . . . 1.04 112.463 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.489 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 69.4 m -74.9 -29.91 61.13 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.866 -0.333 . . . . 1.45 111.576 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.469 ' OG1' ' HB ' ' A' ' 41' ' ' VAL . 76.1 p -79.97 -8.58 59.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.499 0.666 . . . . 1.04 109.766 175.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.591 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 39.3 mm -82.38 132.58 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.061 -0.972 . . . . 1.02 111.219 174.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.612 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 12.0 t70 -82.82 -41.1 19.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.354 -0.839 . . . . 0.69999999999999996 110.911 175.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.499 ' O ' HG12 ' A' ' 63' ' ' ILE . 45.9 mmtt -145.47 143.02 29.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.374 -0.83 . . . . 2.4300000000000002 110.658 -173.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.652 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 13.6 tp -111.27 139.62 46.51 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.659 -0.817 . . . . 1.04 109.45 163.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.593 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 15.6 mm100 -118.27 155.77 30.01 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.425 -1.262 . . . . 1.49 110.001 -178.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.01 143.73 9.47 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.878 -1.056 . . . . 1.0 108.546 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 47.3 p -54.49 126.18 54.83 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.665 0.745 . . . . 1.03 111.106 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 65.8 Cg_endo -71.7 167.76 25.61 Favored 'Trans proline' 0 C--N 1.332 -0.29 0 C-N-CA 124.349 3.366 . . . . 0.73999999999999999 112.045 176.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.17 -24.23 64.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.993 0.425 . . . . 1.54 110.659 174.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -69.17 -24.04 64.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.53 0.681 . . . . 2.0499999999999998 110.162 174.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.577 ' OG ' ' HE2' ' A' ' 57' ' ' LYS . 28.8 t -84.43 139.34 32.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.471 -0.786 . . . . 1.1399999999999999 109.256 176.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -92.95 -11.9 32.16 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.823 -0.806 . . . . 2.8900000000000001 108.823 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.586 ' HD3' ' N ' ' A' ' 57' ' ' LYS . 2.3 mppt? -90.45 176.48 6.69 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.695 -1.139 . . . . 3.1299999999999999 110.779 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.425 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -135.3 109.58 8.36 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.011 -0.737 . . . . 2.0 109.011 -178.613 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.529 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 63.4 mtm -155.96 150.11 25.51 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.87 0.367 . . . . 1.3 111.23 -173.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.42 156.48 32.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.396 -0.82 . . . . 1.05 110.421 174.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.543 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 33.8 ttt180 -153.67 113.22 3.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.989 0.424 . . . . 3.3999999999999999 110.892 175.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.527 ' HG ' HD12 ' A' ' 48' ' ' LEU . 10.4 mt -93.73 111.66 23.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.105 0.479 . . . . 1.73 110.428 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.515 HG23 ' HG2' ' A' ' 86' ' ' ARG . 3.7 mm -86.17 106.47 15.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 123.534 0.734 . . . . 1.1599999999999999 109.98 -174.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -81.2 139.43 20.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 119.897 -1.144 . . . . 0.47999999999999998 112.1 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.612 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 5.9 mttt -53.3 135.77 38.14 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.227 0.537 . . . . 1.78 111.467 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--N 1.322 -0.622 0 CA-C-O 121.559 0.695 . . . . 1.3100000000000001 111.048 -176.236 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 122.506 1.146 . . . . 1.78 111.038 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.515 ' HG2' HG23 ' A' ' 63' ' ' ILE . 17.8 mtt85 -102.97 144.26 31.48 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.473 -1.24 . . . . 2.8199999999999998 109.813 -174.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -105.82 110.87 23.32 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.802 -0.814 . . . . 0.63 108.802 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.2 ttm -105.1 121.97 44.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.916 0.389 . . . . 1.1200000000000001 110.924 -174.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.463 ' CG ' HD11 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -117.06 123.19 46.24 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.832 -0.803 . . . . 1.6499999999999999 108.832 177.5 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.485 ' HB3' ' HB ' ' A' ' 8' ' ' ILE . 28.2 t -94.64 131.54 40.32 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.149 0.5 . . . . 1.1899999999999999 110.188 -178.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.459 ' CE1' ' HB2' ' A' ' 7' ' ' ALA . 38.2 m-85 -108.59 165.54 11.46 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.527 -0.76 . . . . 1.6399999999999999 110.504 175.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -114.62 -3.3 12.92 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.45 -0.796 . . . . 1.8300000000000001 110.168 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -126.15 121.51 33.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.865 -0.607 . . . . 1.22 109.76 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -54.66 -36.55 64.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.816 -1.084 . . . . 2.8799999999999999 111.483 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.559 HG21 HD22 ' A' ' 99' ' ' ASN . 93.7 m -73.23 -55.59 6.24 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.964 -0.562 . . . . 1.1200000000000001 111.015 -175.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 94.0 t -45.13 -57.24 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-N 116.111 -0.495 . . . . 1.1299999999999999 111.364 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.745 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -60.9 -34.05 74.06 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.579 -0.448 . . . . 1.0600000000000001 110.416 -176.582 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -71.57 -20.35 62.02 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.165 0.507 . . . . 0.39000000000000001 110.427 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.617 ' O ' ' HG3' ' A' ' 102' ' ' MET . 92.1 m-20 -86.93 -37.84 17.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.222 1.01 . . . . 1.55 109.094 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.535 HG21 HD11 ' A' ' 18' ' ' ILE . 1.6 mm -67.65 -50.7 58.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 113.934 -1.485 . . . . 1.0600000000000001 111.675 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.745 ' HG2' ' O ' ' A' ' 97' ' ' MET . 2.6 ptmt -58.63 -39.56 80.86 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 120.689 0.28 . . . . 1.72 110.822 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.617 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.8 ppp? -73.65 -23.62 59.88 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.166 -0.679 . . . . 1.76 109.166 -176.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 21.2 m -68.02 -51.44 46.98 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.405 -0.816 . . . . 1.04 109.92 173.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.652 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 12.6 mt -72.72 -57.17 4.3 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.524 -0.762 . . . . 1.05 111.633 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.606 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 95.1 mt-30 -51.88 -26.56 10.37 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.64 0.607 . . . . 1.45 112.64 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -71.47 -42.8 67.69 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.229 -0.656 . . . . 0.66000000000000003 109.229 177.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.524 HG23 ' HB3' ' A' ' 25' ' ' ALA . 69.8 mt -61.42 -44.43 98.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.545 -1.207 . . . . 1.04 110.145 174.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.2 mt -63.9 -47.8 89.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.635 -0.712 . . . . 1.04 109.906 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.4 t -58.77 -30.68 67.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.354 0.597 . . . . 1.6100000000000001 109.973 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.5 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 12.6 ttt180 -67.36 -37.26 82.91 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.133 -0.939 . . . . 4.3899999999999997 109.778 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 . . . . . 0 N--CA 1.445 -0.699 0 CA-C-N 115.827 -0.624 . . . . 0.71999999999999997 111.479 -175.332 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 261' ' ' PHE . . . . . 0.593 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 8.2 m-30 . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 120.658 0.266 . . . . 0.97999999999999998 110.893 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.71 156.98 12.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.421 -0.354 . . . . 1.8999999999999999 110.233 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 263' ' ' GLU . . . . . 0.445 ' HA ' ' NE2' ' A' ' 105' ' ' GLN . 40.1 tt0 . . . . . 0 C--N 1.327 -0.411 0 N-CA-C 109.279 -0.638 . . . . 2.2400000000000002 109.279 173.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.6 m80 . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 121.117 0.484 . . . . 2.3900000000000001 110.657 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 82.0 p -163.99 148.88 10.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.099 -0.501 . . . . 1.6100000000000001 109.998 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.45 144.85 5.79 Favored Glycine 0 C--O 1.223 -0.579 0 N-CA-C 110.592 -1.003 . . . . 0.17000000000000001 110.592 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.702 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -76.63 119.35 20.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.773 0.786 . . . . 0.97999999999999998 111.448 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.419 ' HB1' ' CE1' ' A' ' 91' ' ' PHE . . . -124.82 158.22 33.93 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.484 0.659 . . . . 1.01 111.7 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.512 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.7 mp -100.48 123.99 53.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.04 -0.982 . . . . 1.0800000000000001 109.028 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.409 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 85.7 t80 -121.9 101.71 7.73 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.29 -0.414 . . . . 0.66000000000000003 110.061 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 65.99 56.98 0.82 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.575 0.702 . . . . 1.46 110.708 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt 73.13 -8.03 1.39 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.407 -1.27 . . . . 2.3900000000000001 113.109 170.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -102.46 130.27 52.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.059 0.457 . . . . 1.23 110.712 174.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.512 ' HA ' HG13 ' A' ' 8' ' ' ILE . 27.0 t -79.86 130.84 35.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.685 -0.689 . . . . 1.48 110.404 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.636 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -148.95 -155.63 6.8 Favored Glycine 0 N--CA 1.435 -1.373 0 CA-C-N 115.588 -0.733 . . . . 0.16 111.906 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.702 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.3 mm -126.74 153.74 35.92 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 CA-C-O 120.801 0.334 . . . . 1.05 110.759 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.434 HD13 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -125.05 133.82 68.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.918 -0.583 . . . . 1.01 109.501 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.3 108.88 6.96 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.002 0.429 . . . . 0.87 111.992 175.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 3.6 mp -85.16 120.21 35.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.559 -0.904 . . . . 1.05 108.559 172.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.409 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 2.0 t30 -124.34 123.84 41.07 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.886 -0.413 . . . . 1.1200000000000001 109.886 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -109.0 83.32 1.73 Allowed 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 117.187 -1.805 . . . . 0.73999999999999999 107.632 165.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -122.48 -10.92 8.37 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 106.774 -1.565 . . . . 0.58999999999999997 106.774 156.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 23' ' ' SER . 14.5 p -101.41 175.1 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 112.181 -2.282 . . . . 1.0800000000000001 111.775 -155.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.693 ' O ' HG12 ' A' ' 22' ' ' VAL . 1.2 t -54.42 165.47 0.86 Allowed Pre-proline 0 C--O 1.225 -0.221 0 N-CA-C 105.972 -1.862 . . . . 2.0 105.972 167.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.565 ' HA ' ' OH ' ' A' ' 111' ' ' TYR . 9.8 Cg_endo -41.22 128.01 3.03 Favored 'Trans proline' 0 C--N 1.357 0.995 0 CA-C-N 122.204 1.823 . . . . 0.26000000000000001 111.744 -151.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.555 ' HB1' HG23 ' A' ' 107' ' ' ILE . . . -29.81 133.81 0.05 Allowed 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 125.348 1.655 . . . . 1.02 113.756 -157.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.51 ' HB2' HG11 ' A' ' 22' ' ' VAL . 31.6 mt-10 -122.56 132.56 54.36 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.768 -1.105 . . . . 1.26 110.98 -171.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.583 ' C ' HD23 ' A' ' 27' ' ' LEU . 1.2 tt -100.92 142.45 32.37 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.398 -1.704 . . . . 1.0600000000000001 106.398 172.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 24.5 m -129.8 110.04 11.42 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.636 -0.826 . . . . 1.05 110.505 -178.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.646 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 86.0 t90 -86.11 105.87 16.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.591 0.71 . . . . 0.29999999999999999 109.27 174.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -113.26 114.14 26.29 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.91 -1.041 . . . . 1.1599999999999999 108.741 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.552 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 93.1 p -57.61 147.53 26.99 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.422 0.63 . . . . 1.3899999999999999 110.424 -174.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.636 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 18.9 m -51.98 -26.44 10.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.447 -1.251 . . . . 1.1499999999999999 112.331 -174.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -88.07 -28.16 21.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.961 0.41 . . . . 2.3300000000000001 111.234 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.91 17.33 28.16 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.996 -0.621 . . . . 0.55000000000000004 112.361 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -90.01 -35.31 15.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.03 0.443 . . . . 1.1299999999999999 111.15 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -118.61 141.71 48.33 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.162 0.506 . . . . 2.6200000000000001 111.114 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 69.3 t -141.79 116.93 5.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.972 -1.013 . . . . 1.3100000000000001 109.853 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -123.36 109.56 14.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.191 -0.459 . . . . 0.82999999999999996 109.934 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.471 HG23 ' OE1' ' A' ' 26' ' ' GLU . 39.0 m -98.07 137.08 37.39 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.985 -0.286 . . . . 1.0600000000000001 111.207 -176.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 40.0 t -110.8 129.69 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 122.705 0.402 . . . . 1.3600000000000001 111.467 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 45' ' ' ILE . 55.3 t -91.21 108.04 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-O 121.282 0.563 . . . . 1.05 109.576 173.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.603 HD12 ' CD2' ' A' ' 104' ' ' LEU . 1.8 mm? -56.09 -28.32 57.24 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.07 -0.968 . . . . 1.04 112.533 -177.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.5 t -74.19 -31.3 62.6 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.297 -0.561 . . . . 1.45 110.504 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.6 p -79.94 -10.01 59.73 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.682 -0.488 . . . . 1.04 109.682 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.555 HG22 ' CD2' ' A' ' 62' ' ' LEU . 44.6 mm -84.44 116.53 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.61 -0.723 . . . . 1.02 111.535 176.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.622 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 2.5 t70 -74.96 -47.54 28.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.242 -0.89 . . . . 0.69999999999999996 111.422 175.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.483 ' O ' HG12 ' A' ' 63' ' ' ILE . 15.5 tptt -136.02 136.66 40.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.047 -0.524 . . . . 2.4300000000000002 109.916 -174.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.652 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 13.2 tp -106.74 142.65 36.04 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 119.661 -0.815 . . . . 1.04 109.081 164.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.501 HE21 ' HB2' ' B' ' 261' ' ' PHE . 4.1 mt-30 -122.96 152.69 40.62 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.687 -1.142 . . . . 1.49 109.675 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -161.47 139.2 9.08 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.473 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 40.4 p -54.95 125.41 56.07 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-O 121.453 0.644 . . . . 1.03 111.715 -178.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 46.1 Cg_endo -67.34 166.74 22.48 Favored 'Trans proline' 0 C--N 1.334 -0.204 0 C-N-CA 124.064 3.176 . . . . 0.73999999999999999 112.238 178.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.419 ' N ' HH21 ' A' ' 94' ' ' ARG . . . -60.43 -28.89 68.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.028 0.442 . . . . 1.54 110.419 175.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 t -71.75 -24.13 61.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.744 -0.662 . . . . 2.0499999999999998 110.466 177.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.471 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 33.4 t -71.51 141.87 50.14 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.549 -0.537 . . . . 1.1399999999999999 109.549 176.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -83.4 -17.64 41.54 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.302 0.572 . . . . 2.8900000000000001 110.149 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -97.09 179.93 4.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.518 -0.764 . . . . 3.1299999999999999 110.662 -173.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.473 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -133.75 110.32 9.73 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.177 -1.046 . . . . 2.0 108.177 171.311 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.491 ' HB3' ' HE1' ' B' ' 261' ' ' PHE . 29.8 ttm -157.11 137.61 13.03 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.592 -0.443 . . . . 1.3 111.247 -171.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.12 155.47 23.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.929 -0.578 . . . . 1.05 110.173 177.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 19.6 ttm180 -151.02 113.59 4.66 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.739 0.304 . . . . 3.3999999999999999 110.794 173.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.555 ' CD2' HG22 ' A' ' 45' ' ' ILE . 10.7 mt -96.94 108.2 20.87 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.056 0.543 . . . . 1.73 111.331 -177.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.488 ' HA ' ' HB3' ' A' ' 86' ' ' ARG . 2.6 mm -88.88 131.46 36.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 C-N-CA 123.21 0.604 . . . . 1.1599999999999999 110.872 -175.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -85.6 166.1 39.33 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.153 -1.022 . . . . 0.47999999999999998 112.056 175.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.622 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 1.1 mptm? -75.07 131.24 40.42 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.622 -0.511 . . . . 1.78 109.622 173.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.2 p . . . . . 0 C--N 1.32 -0.675 0 CA-C-O 121.383 0.611 . . . . 1.3100000000000001 111.416 -178.232 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.216 0 CA-C-O 121.998 0.904 . . . . 1.78 110.817 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.488 ' HB3' ' HA ' ' A' ' 63' ' ' ILE . 21.3 ptt180 -126.62 148.68 49.76 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.546 -0.752 . . . . 2.8199999999999998 111.273 -174.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -117.63 113.07 21.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.227 -0.897 . . . . 0.63 110.523 -169.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.441 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 49.1 ttm -100.59 130.87 46.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.82 0.343 . . . . 1.1200000000000001 111.537 -176.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.434 ' CG ' HD13 ' A' ' 16' ' ' ILE . 79.4 m-85 -126.28 122.66 36.12 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.433 -0.58 . . . . 1.6499999999999999 109.433 174.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.415 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 35.5 m -92.46 132.93 36.38 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.302 -0.408 . . . . 1.1899999999999999 110.161 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.64 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 25.5 m-85 -108.5 171.13 7.59 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.968 0.413 . . . . 1.6399999999999999 110.846 177.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -112.0 -3.27 14.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.823 -0.626 . . . . 1.8300000000000001 110.114 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -141.08 129.13 22.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.346 0.594 . . . . 1.22 110.799 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.42 ' NH1' ' HB2' ' A' ' 98' ' ' ASP . 49.3 tpt85 -61.04 -27.98 68.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.806 -1.088 . . . . 2.8799999999999999 111.405 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.415 HG23 HD22 ' A' ' 99' ' ' ASN . 99.3 m -75.8 -55.63 5.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.629 -0.259 . . . . 1.1200000000000001 111.278 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.3 t -45.52 -56.8 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-O 120.852 0.358 . . . . 1.1299999999999999 111.082 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.68 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -62.24 -32.09 72.74 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.779 -0.646 . . . . 1.0600000000000001 110.602 -177.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.42 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 19.6 t70 -66.55 -34.13 77.22 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.77 0.795 . . . . 0.39000000000000001 109.555 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.592 ' O ' ' HG3' ' A' ' 102' ' ' MET . 89.2 m-20 -76.83 -41.32 44.69 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.421 -1.263 . . . . 1.55 109.878 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.64 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 23.4 mm -63.02 -53.43 46.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.948 -1.024 . . . . 1.0600000000000001 111.15 176.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.68 ' HG2' ' O ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -59.88 -38.14 81.36 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 120.726 0.298 . . . . 1.72 111.065 -177.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.592 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.4 ppp? -71.63 -25.74 62.28 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.365 -0.606 . . . . 1.76 109.365 -175.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 23.1 m -68.13 -52.15 38.11 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.488 -0.778 . . . . 1.04 110.258 174.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.652 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 8.2 mt -69.16 -57.44 5.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.523 -0.762 . . . . 1.05 111.33 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.628 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 95.2 mt-30 -52.7 -25.48 11.13 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.811 0.671 . . . . 1.45 112.811 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -73.41 -35.63 65.86 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.703 0.763 . . . . 0.66000000000000003 109.403 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.555 HG23 ' HB1' ' A' ' 25' ' ' ALA . 69.5 mt -69.53 -41.7 80.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.539 -1.21 . . . . 1.04 110.249 175.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.2 mt -65.6 -50.86 69.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.805 -0.634 . . . . 1.04 110.544 -176.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.6 m -58.69 -28.86 66.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.212 0.53 . . . . 1.6100000000000001 110.141 174.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 8.3 ttt180 -66.09 -39.51 90.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.405 -0.816 . . . . 4.3899999999999997 109.509 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.565 ' OH ' ' HA ' ' A' ' 24' ' ' PRO . 21.3 m-85 . . . . . 0 N--CA 1.446 -0.625 0 CA-C-N 115.503 -0.772 . . . . 0.71999999999999997 111.651 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 261' ' ' PHE . . . . . 0.501 ' HB2' HE21 ' A' ' 49' ' ' GLN . 35.1 m-85 . . . . . 0 N--CA 1.452 -0.371 0 CA-C-O 121.467 0.651 . . . . 0.97999999999999998 112.287 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 11.9 p -144.23 147.64 19.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 114.729 -1.123 . . . . 1.8999999999999999 108.907 171.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 263' ' ' GLU . . . . . 0.472 ' HA ' HE22 ' A' ' 105' ' ' GLN . 17.5 tt0 . . . . . 0 C--N 1.323 -0.547 0 N-CA-C 109.265 -0.643 . . . . 2.2400000000000002 109.265 176.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo . . . . . 0 CA--C 1.527 0.128 0 N-CA-C 111.659 -0.169 . . . . 3.8100000000000001 111.659 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.492 ' O ' HD11 ' A' ' 100' ' ' ILE . 32.5 p -99.14 -59.5 1.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.069 0.461 . . . . 1.8400000000000001 110.912 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -85.85 11.75 10.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.111 -0.495 . . . . 2.3900000000000001 110.886 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 8.0 m -161.45 141.62 10.68 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.802 -0.444 . . . . 1.6100000000000001 109.802 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.69 142.95 6.6 Favored Glycine 0 C--O 1.224 -0.491 0 N-CA-C 110.864 -0.894 . . . . 0.17000000000000001 110.864 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.708 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -76.54 117.64 18.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.588 0.694 . . . . 0.97999999999999998 111.847 -175.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.53 162.33 25.91 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.429 0.633 . . . . 1.01 111.92 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.581 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.8 mp -105.07 123.14 59.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.237 -0.892 . . . . 1.0800000000000001 109.082 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -117.15 106.14 13.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.652 -0.249 . . . . 0.66000000000000003 110.516 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 61.0 50.66 4.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.609 0.719 . . . . 1.46 110.366 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt 75.46 -8.67 1.54 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.151 -1.386 . . . . 2.3900000000000001 113.382 170.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.46 HG21 ' HD2' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -93.18 131.62 39.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.393 -0.523 . . . . 1.23 110.172 172.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.581 ' HA ' HG13 ' A' ' 8' ' ' ILE . 40.9 t -79.75 130.39 35.3 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.586 -0.734 . . . . 1.48 110.854 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.631 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -155.87 -156.17 7.69 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.876 -0.678 . . . . 0.16 112.615 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.708 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.7 mm -126.81 153.85 36.17 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-O 120.834 0.349 . . . . 1.05 110.883 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.471 HD12 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -121.5 134.5 64.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.985 -0.552 . . . . 1.01 109.626 178.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.43 109.92 7.45 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.982 0.42 . . . . 0.87 111.924 174.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.555 HD13 HG21 ' A' ' 100' ' ' ILE . 4.0 mp -83.57 118.55 31.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 107.926 -1.139 . . . . 1.05 107.926 171.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.478 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 2.2 t30 -121.41 122.73 40.44 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 110.0 -0.37 . . . . 1.1200000000000001 110.0 -177.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -108.47 83.75 1.82 Allowed 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 117.146 -1.822 . . . . 0.73999999999999999 107.215 163.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.435 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 11.9 t70 -121.99 -11.31 8.52 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.59 -1.633 . . . . 0.58999999999999997 106.59 157.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 23' ' ' SER . 14.9 p -102.31 174.18 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 112.049 -2.342 . . . . 1.0800000000000001 112.198 -154.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.71 ' O ' HG12 ' A' ' 22' ' ' VAL . 6.8 m -54.71 166.56 0.73 Allowed Pre-proline 0 C--O 1.224 -0.281 0 N-CA-C 106.586 -1.635 . . . . 2.0 106.586 164.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 11.9 Cg_endo -42.0 128.09 3.99 Favored 'Trans proline' 0 C--N 1.352 0.732 0 CA-C-N 121.862 1.701 . . . . 0.26000000000000001 111.408 -149.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.501 ' HB1' HG22 ' A' ' 107' ' ' ILE . . . -32.23 133.29 0.11 Allowed 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 125.26 1.6 . . . . 1.02 113.446 -157.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.507 ' HB2' HG11 ' A' ' 22' ' ' VAL . 68.7 mt-10 -124.09 140.8 52.62 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.429 -1.26 . . . . 1.26 111.089 -168.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.567 HD22 ' C ' ' A' ' 27' ' ' LEU . 1.7 tt -101.57 142.6 32.68 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 106.561 -1.644 . . . . 1.0600000000000001 106.561 172.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.443 ' N ' HD22 ' A' ' 27' ' ' LEU . 10.6 m -130.55 108.47 9.95 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.919 -0.712 . . . . 1.05 110.164 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.602 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 88.5 t90 -87.0 112.03 21.43 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.558 0.694 . . . . 0.29999999999999999 109.364 175.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.512 ' HD3' ' O ' ' A' ' 31' ' ' SER . 2.6 tmt_? -118.99 118.19 30.83 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.111 -0.949 . . . . 1.1599999999999999 108.819 -177.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.512 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 35.8 p -56.0 144.28 29.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.292 0.568 . . . . 1.3899999999999999 110.597 -176.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.631 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 21.4 m -53.85 -29.45 41.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.603 -1.18 . . . . 1.1499999999999999 112.008 -175.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -83.56 -25.65 30.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.259 0.552 . . . . 2.3300000000000001 111.065 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.3 16.67 39.61 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.886 -0.673 . . . . 0.55000000000000004 112.337 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.36 -65.27 1.02 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.104 0.478 . . . . 1.1299999999999999 110.99 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.46 ' HD2' HG21 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -106.43 155.06 19.95 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.508 -0.769 . . . . 2.6200000000000001 110.777 -175.364 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 69.0 t -146.81 139.76 19.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.97 -1.014 . . . . 1.3100000000000001 109.636 -175.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -139.34 111.23 7.29 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.234 -0.284 . . . . 0.82999999999999996 110.234 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.3 m -98.31 138.75 35.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.58 0.229 . . . . 1.0600000000000001 111.496 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 41.1 t -113.16 129.44 68.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 122.523 0.329 . . . . 1.3600000000000001 111.521 176.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.546 ' O ' HG12 ' A' ' 45' ' ' ILE . 38.8 t -91.04 108.1 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 109.576 -0.528 . . . . 1.05 109.576 173.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.567 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.8 mm? -53.21 -28.89 29.27 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.091 -0.959 . . . . 1.04 112.597 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.4 m -74.88 -35.76 62.29 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.663 -0.415 . . . . 1.45 111.446 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.3 p -72.28 -14.17 61.7 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 121.376 0.608 . . . . 1.04 109.564 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 41' ' ' VAL . 48.6 mm -82.32 120.93 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.335 -0.848 . . . . 1.02 111.395 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.606 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 15.7 t70 -78.46 -46.09 20.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.73 -0.668 . . . . 0.69999999999999996 110.904 176.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -136.88 150.52 48.3 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.129 -0.487 . . . . 2.4300000000000002 109.975 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.531 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 9.9 tp -113.45 144.23 43.16 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.29 -0.633 . . . . 1.04 109.29 165.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.453 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 14.3 mm100 -120.87 154.57 35.66 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.978 -1.01 . . . . 1.49 109.518 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.463 ' HB1' ' CE ' ' A' ' 97' ' ' MET . . . -162.59 141.44 8.92 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.55 -0.75 . . . . 1.0 108.992 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.591 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 37.1 p -56.53 126.04 68.68 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-O 121.303 0.573 . . . . 1.03 112.055 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 72.9 Cg_endo -74.46 166.37 29.6 Favored 'Trans proline' 0 C--N 1.329 -0.457 0 C-N-CA 123.972 3.114 . . . . 0.73999999999999999 111.314 172.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.6 -27.85 63.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.109 0.481 . . . . 1.54 110.415 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.4 m -69.07 -24.81 64.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.706 -0.679 . . . . 2.0499999999999998 111.282 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.507 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 39.5 t -76.54 148.51 37.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.127 -0.488 . . . . 1.1399999999999999 109.717 177.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -90.68 -2.18 57.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.42 0.629 . . . . 2.8900000000000001 110.116 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -115.39 178.98 4.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.194 -0.912 . . . . 3.1299999999999999 110.858 -174.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.591 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -132.35 107.76 8.74 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.017 -1.105 . . . . 2.0 108.017 168.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 75.1 mtm -154.54 152.0 29.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.982 0.42 . . . . 1.3 111.21 -176.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 97' ' ' MET . 0.8 OUTLIER -112.05 158.33 19.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.242 -0.89 . . . . 1.05 110.229 175.134 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 45.2 ttt180 -153.63 114.32 4.03 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 121.274 0.559 . . . . 3.3999999999999999 111.009 170.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.531 ' CD2' HG21 ' A' ' 45' ' ' ILE . 9.0 mt -92.24 112.91 25.03 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.717 -0.674 . . . . 1.73 110.515 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.493 HD11 ' HD3' ' A' ' 86' ' ' ARG . 5.0 mm -86.7 116.64 29.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.512 0.725 . . . . 1.1599999999999999 110.307 -174.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -85.33 144.97 21.01 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.159 -1.019 . . . . 0.47999999999999998 111.487 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.606 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 8.2 mptt -58.73 134.98 57.3 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.057 0.456 . . . . 1.78 110.734 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 82' ' ' PRO . 7.7 p -74.43 150.87 7.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.509 -0.769 . . . . 1.3100000000000001 110.289 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.455 ' CG ' ' HZ1' ' A' ' 70' ' ' LYS . 24.3 t70 -80.19 91.98 5.64 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.377 -0.829 . . . . 2.5600000000000001 110.95 -174.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -85.56 -6.35 59.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.333 -0.849 . . . . 3.79 112.001 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.8 p -68.54 -38.72 81.07 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.089 -0.245 . . . . 3.3399999999999999 111.563 -174.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.455 ' HZ1' ' CG ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -137.31 101.94 4.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.018 0.437 . . . . 5.8200000000000003 110.451 174.218 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -54.89 138.61 42.67 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.364 -0.835 . . . . 4.7400000000000002 110.847 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.522 ' HD2' ' HG3' ' A' ' 82' ' ' PRO . 1.7 ptm180 -85.43 170.18 12.94 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.589 -0.732 . . . . 4.7300000000000004 109.735 -176.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -141.96 164.35 30.43 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.409 -0.589 . . . . 5.5300000000000002 109.409 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -90.08 -165.3 1.32 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.187 -0.605 . . . . 4.9800000000000004 110.01 -175.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -54.15 -31.53 52.77 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.729 0.64 . . . . 7.1100000000000003 112.729 -173.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -102.11 8.27 40.8 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.625 0.726 . . . . 7.1299999999999999 110.295 -173.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.09 34.21 42.56 Favored Glycine 0 C--N 1.315 -0.62 0 CA-C-N 114.612 -1.176 . . . . 5.7300000000000004 111.645 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 79' ' ' GLU . 60.5 m-80 -71.37 -92.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.721 -0.239 . . . . 5.6200000000000001 110.7 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 13.6 pt-20 170.52 125.79 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.389 0.675 . . . . 5.0 110.518 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.492 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.0 t -127.94 148.83 32.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.205 -0.665 . . . . 3.5800000000000001 109.205 175.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.4 p -110.19 96.85 27.81 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-O 121.51 0.671 . . . . 3.1499999999999999 110.093 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.522 ' HG3' ' HD2' ' A' ' 72' ' ' ARG . 76.3 Cg_exo -50.31 141.73 31.1 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.656 2.904 . . . . 2.0800000000000001 113.951 -177.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.86 134.61 46.62 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 108.715 -0.846 . . . . 3.5299999999999998 108.715 168.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -54.08 132.34 49.64 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.828 2.352 . . . . 0.75 112.46 -174.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -76.4 155.26 34.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.531 0.682 . . . . 1.78 109.264 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.493 ' HD3' HD11 ' A' ' 63' ' ' ILE . 18.7 mtt180 -140.13 153.73 46.78 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.551 -0.749 . . . . 2.8199999999999998 110.33 -168.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -115.88 110.45 19.03 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.08 -0.711 . . . . 0.63 109.08 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.446 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 54.9 ttm -103.25 129.26 50.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.781 0.324 . . . . 1.1200000000000001 110.827 -175.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.471 ' CG ' HD12 ' A' ' 16' ' ' ILE . 80.4 m-85 -123.46 122.54 38.51 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 109.245 -0.65 . . . . 1.6499999999999999 109.245 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.482 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 22.7 m -91.18 128.95 37.21 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.04 -0.527 . . . . 1.1899999999999999 110.838 -174.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.593 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 29.1 m-85 -108.16 174.79 5.72 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.95 -0.568 . . . . 1.6399999999999999 110.816 176.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -119.57 0.22 10.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.706 -0.679 . . . . 1.8300000000000001 109.821 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.504 ' OD1' ' HB ' ' A' ' 95' ' ' THR . 28.7 t-20 -143.38 131.43 21.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.324 -0.853 . . . . 1.22 110.647 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.457 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 0.9 OUTLIER -74.97 -23.28 58.26 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.962 -0.563 . . . . 2.8799999999999999 110.976 -174.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.504 ' HB ' ' OD1' ' A' ' 93' ' ' ASN . 92.8 m -70.99 -54.49 11.07 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.411 -0.516 . . . . 1.1200000000000001 109.783 175.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.0 t -45.7 -57.36 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-N 116.134 -0.485 . . . . 1.1299999999999999 111.103 173.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.463 ' CE ' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -64.12 -29.3 70.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.006 -0.543 . . . . 1.0600000000000001 111.093 -178.134 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.29 -32.18 72.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.407 0.622 . . . . 0.39000000000000001 109.554 175.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 2' ' ' SER . 90.6 m-20 -75.03 -46.82 32.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.887 -1.051 . . . . 1.55 109.844 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.593 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 27.6 mm -61.28 -51.16 76.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.003 -0.999 . . . . 1.0600000000000001 110.276 175.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.52 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 0.0 OUTLIER -55.74 -51.9 65.76 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.614 -0.721 . . . . 1.72 111.197 179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.481 ' N ' ' HE2' ' A' ' 101' ' ' LYS . 11.7 ptp -60.2 -32.15 70.82 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.081 0.467 . . . . 1.76 109.777 -176.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 54.1 m -63.36 -52.04 63.41 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.267 -0.879 . . . . 1.04 110.261 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.567 ' CD2' HD11 ' A' ' 42' ' ' LEU . 11.3 mt -66.95 -55.59 13.87 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.43 -0.805 . . . . 1.05 110.781 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' A' ' 101' ' ' LYS . 19.2 mm-40 -43.16 -37.54 2.11 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.653 0.596 . . . . 1.45 112.544 178.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -68.1 -35.51 78.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.823 0.82 . . . . 0.66000000000000003 109.555 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.501 HG22 ' HB1' ' A' ' 25' ' ' ALA . 81.3 mt -72.51 -41.66 63.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.017 -1.447 . . . . 1.04 110.319 175.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.594 HG22 ' HD2' ' A' ' 112' ' ' LYS . 0.8 OUTLIER -65.3 -50.92 70.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.855 -0.611 . . . . 1.04 110.217 -177.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.435 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 38.6 t -58.53 -28.47 65.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.47 0.653 . . . . 1.6100000000000001 109.941 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.461 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 11.0 ttt180 -68.73 -38.81 80.45 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.049 -0.978 . . . . 4.3899999999999997 109.927 177.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -88.37 -19.21 26.94 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.928 -0.578 . . . . 0.71999999999999997 111.698 -175.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.594 ' HD2' HG22 ' A' ' 108' ' ' ILE . 12.4 mtpp -76.74 -23.88 53.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.23 0.538 . . . . 2.25 109.734 174.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.26 -25.76 64.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.434 -0.803 . . . . 1.5600000000000001 109.8 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -116.68 27.16 9.35 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.293 -0.867 . . . . 1.3400000000000001 110.707 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.4 t70 . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.488 -0.767 . . . . 2.1600000000000001 110.274 -179.374 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.58 0 N-CA-C 112.001 -0.44 . . . . 25.670000000000002 112.001 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 101.18 170.44 28.34 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.941 -0.647 . . . . 24.66 111.75 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -137.13 162.45 25.31 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.748 -0.739 . . . . 24.199999999999999 111.918 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 110.47 17.25 9.43 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.763 -0.732 . . . . 23.140000000000001 112.226 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' TYR . . . . . 0.633 ' CE2' ' HA ' ' B' ' 249' ' ' GLU . 32.1 p90 -144.98 171.6 14.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.666 0.269 . . . . 24.920000000000002 110.663 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -74.6 143.22 44.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.294 -0.412 . . . . 21.449999999999999 110.396 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 8.5 p 44.85 42.31 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 124.375 1.047 . . . . 20.68 111.072 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . 0.633 ' HA ' ' CE2' ' B' ' 246' ' ' TYR . 10.9 pt-20 -59.78 163.87 4.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.97 -1.013 . . . . 18.16 111.23 175.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 64.6 mtt -125.06 34.49 4.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.555 0.693 . . . . 17.260000000000002 109.604 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . 0.419 ' C ' ' H ' ' B' ' 253' ' ' GLU . 0.0 OUTLIER -63.79 143.44 57.84 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.931 -1.032 . . . . 13.68 109.431 178.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' B' ' 255' ' ' GLU . 52.0 p 67.11 -37.56 0.31 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.907 1.283 . . . . 10.91 111.963 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' B' ' 251' ' ' GLU . 49.6 mt-10 -65.12 -35.71 81.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 11.029999999999999 110.628 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.78 -47.75 84.43 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.823 -0.626 . . . . 10.94 111.48 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' B' ' 252' ' ' SER . 0.0 OUTLIER -71.16 -33.68 70.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.676 0.274 . . . . 9.8200000000000003 111.373 -177.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 21.5 m -72.85 -36.02 67.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.212 0.529 . . . . 5.9100000000000001 111.289 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -89.04 -0.93 57.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.449 0.643 . . . . 6.2000000000000002 110.188 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -68.53 -27.02 65.74 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.547 -0.751 . . . . 6.1399999999999997 111.682 -176.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.88 -55.5 16.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.039 0.447 . . . . 3.3199999999999998 110.647 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 86.59 14.33 65.83 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.746 -0.661 . . . . 1.1200000000000001 111.677 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 261' ' ' PHE . . . . . 0.453 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 6.0 m-85 -116.7 179.05 4.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.056 0.455 . . . . 0.97999999999999998 110.822 -174.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 12.9 p -135.09 145.22 32.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.669 -0.696 . . . . 1.8999999999999999 109.165 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.01 142.25 27.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.021 0.439 . . . . 2.2400000000000002 110.13 176.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.452 ' H ' ' NE2' ' A' ' 105' ' ' GLN . 61.5 t -105.29 103.86 16.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.292 0.568 . . . . 1.8899999999999999 109.945 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . 0.433 ' OD1' ' HE2' ' A' ' 112' ' ' LYS . 23.7 t70 . . . . . 0 C--O 1.248 0.999 0 CA-C-N 115.349 -0.841 . . . . 3.04 109.892 -177.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo . . . . . 0 N--CA 1.481 0.788 0 N-CA-C 110.588 -0.582 . . . . 3.8100000000000001 110.588 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.0 p -71.14 -20.82 62.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.195 0.521 . . . . 1.8400000000000001 110.938 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.614 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 36.0 m80 -85.57 18.07 2.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.739 -0.664 . . . . 2.3900000000000001 111.858 -176.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.4 p -162.37 145.61 11.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.982 0.42 . . . . 1.6100000000000001 110.906 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.48 145.71 6.72 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.71 -0.956 . . . . 0.17000000000000001 110.71 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.696 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -71.68 142.88 49.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.21 0.505 . . . . 0.97999999999999998 111.361 -176.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -152.62 155.09 36.66 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-O 121.209 0.528 . . . . 1.01 111.61 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.518 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.2 mp -92.34 131.18 40.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.606 -0.725 . . . . 1.0800000000000001 109.4 176.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.55 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 89.3 t80 -139.74 112.87 8.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.28 -0.418 . . . . 0.66000000000000003 110.134 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.484 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 51.3 mt-10 68.6 48.83 0.78 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.604 0.716 . . . . 1.46 110.371 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.484 ' HD2' ' C ' ' A' ' 10' ' ' GLU . 4.0 mptt 67.41 4.4 3.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.351 -1.295 . . . . 2.3900000000000001 112.84 173.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.94 134.69 54.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.835 0.35 . . . . 1.23 110.623 175.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.518 ' HA ' HG13 ' A' ' 8' ' ' ILE . 31.8 t -75.02 128.53 35.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.028 -0.533 . . . . 1.48 109.819 176.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.661 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -148.1 -159.88 8.68 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.701 -0.762 . . . . 0.16 112.347 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.696 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.8 mm -126.33 152.66 34.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.066 0.46 . . . . 1.05 110.841 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.417 HG12 HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -122.63 133.04 69.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.647 -0.706 . . . . 1.01 109.842 178.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.14 110.33 7.81 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.92 0.391 . . . . 0.87 111.958 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.614 ' O ' ' HB3' ' A' ' 3' ' ' HIS . 3.6 mp -85.41 119.46 34.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.844 -0.799 . . . . 1.05 108.844 172.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.451 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 2.0 t30 -120.77 123.42 42.62 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.992 -0.373 . . . . 1.1200000000000001 109.992 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.427 ' HG2' ' HB3' ' A' ' 25' ' ' ALA . 15.9 mt-10 -108.85 83.08 1.7 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 117.332 -1.747 . . . . 0.73999999999999999 107.452 164.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -122.04 -10.92 8.55 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 106.522 -1.658 . . . . 0.58999999999999997 106.522 157.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 23' ' ' SER . 14.5 p -102.33 175.5 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 111.919 -2.4 . . . . 1.0800000000000001 112.057 -155.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.688 ' O ' HG12 ' A' ' 22' ' ' VAL . 56.8 p -54.4 165.96 0.78 Allowed Pre-proline 0 C--O 1.225 -0.2 0 N-CA-C 106.714 -1.587 . . . . 2.0 106.714 166.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.571 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 12.0 Cg_endo -42.47 128.97 4.82 Favored 'Trans proline' 0 C--N 1.359 1.095 0 CA-C-N 122.326 1.866 . . . . 0.26000000000000001 111.157 -152.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.528 ' HB1' HG22 ' A' ' 107' ' ' ILE . . . -31.46 136.11 0.06 Allowed 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 125.44 1.712 . . . . 1.02 114.193 -155.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HB2' HG11 ' A' ' 22' ' ' VAL . 64.1 mt-10 -122.64 132.4 54.26 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 114.439 -1.255 . . . . 1.26 110.789 -171.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.596 ' C ' HD23 ' A' ' 27' ' ' LEU . 1.3 tt -100.81 142.18 32.65 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 106.235 -1.765 . . . . 1.0600000000000001 106.235 173.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.415 ' N ' HD23 ' A' ' 27' ' ' LEU . 25.9 m -130.67 109.34 10.56 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 119.537 -0.865 . . . . 1.05 110.551 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.614 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 88.8 t90 -85.83 108.85 18.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.624 0.726 . . . . 0.29999999999999999 109.376 174.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -115.13 115.0 26.05 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.774 -1.103 . . . . 1.1599999999999999 108.467 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.514 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 79.3 p -57.21 150.03 18.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.153 0.501 . . . . 1.3899999999999999 110.751 -173.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.661 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 24.0 m -57.83 -29.05 64.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.176 -0.92 . . . . 1.1499999999999999 110.435 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.474 ' OD2' ' HB3' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -80.65 -27.95 37.02 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.421 -0.809 . . . . 2.3300000000000001 111.548 177.181 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.6 -5.07 56.78 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.818 -0.705 . . . . 0.55000000000000004 113.161 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.474 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 2.4 t70 -67.28 -52.23 43.18 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.3 0.482 . . . . 1.1299999999999999 112.3 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -103.0 143.48 32.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.621 0.724 . . . . 2.6200000000000001 112.426 -174.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 76.9 t -141.86 116.44 5.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.175 -1.375 . . . . 1.3100000000000001 109.802 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -123.75 109.74 14.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.949 -0.569 . . . . 0.82999999999999996 109.904 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 32.8 m -97.35 137.84 35.72 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.944 -0.303 . . . . 1.0600000000000001 111.177 -176.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.51 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 42.0 t -110.91 130.91 63.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 122.815 0.446 . . . . 1.3600000000000001 111.655 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 45' ' ' ILE . 51.0 t -90.91 108.29 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 109.619 -0.512 . . . . 1.05 109.619 172.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.601 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -53.48 -27.96 28.07 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.994 -1.003 . . . . 1.04 112.844 -178.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.0 m -75.47 -34.59 60.91 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.598 -0.441 . . . . 1.45 111.443 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.6 p -75.26 -11.95 60.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.273 0.558 . . . . 1.04 109.71 173.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.639 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 47.5 mm -81.75 117.02 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 115.143 -0.935 . . . . 1.02 111.282 173.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.528 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 21.2 t70 -73.93 -46.24 45.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.429 -0.805 . . . . 0.69999999999999996 111.375 177.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.52 ' HG2' ' OD2' ' A' ' 46' ' ' ASP . 47.9 mmtm -140.75 157.3 45.62 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.473 -0.331 . . . . 2.4300000000000002 110.354 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.636 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 13.2 tp -123.51 140.93 52.5 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.256 0.55 . . . . 1.04 109.941 167.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.544 ' OE1' ' HB3' ' B' ' 263' ' ' GLU . 16.3 mm100 -113.01 157.8 21.07 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.749 -1.114 . . . . 1.49 109.846 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.51 136.32 5.36 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.8 -0.636 . . . . 1.0 109.539 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 40.6 p -51.27 124.74 23.7 Favored Pre-proline 0 N--CA 1.467 0.404 0 CA-C-O 121.259 0.552 . . . . 1.03 111.243 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 48.3 Cg_endo -66.82 166.54 22.15 Favored 'Trans proline' 0 C--N 1.333 -0.287 0 C-N-CA 124.057 3.171 . . . . 0.73999999999999999 111.983 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.11 -25.0 65.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.902 0.382 . . . . 1.54 110.829 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.8 m -78.37 -24.39 46.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.847 -0.615 . . . . 2.0499999999999998 111.521 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.476 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 29.7 t -67.54 149.29 50.33 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.216 -0.661 . . . . 1.1399999999999999 109.216 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.48 -14.36 22.4 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.606 -0.887 . . . . 2.8900000000000001 108.606 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.609 ' HD3' ' N ' ' A' ' 57' ' ' LYS . 2.7 mppt? -94.34 -177.89 4.41 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.821 -1.081 . . . . 3.1299999999999999 110.996 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.486 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -136.49 110.67 8.37 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.388 -0.968 . . . . 2.0 108.388 172.314 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.669 ' HB3' ' CZ ' ' B' ' 261' ' ' PHE . 2.5 mtm -156.54 138.68 14.59 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.694 -0.402 . . . . 1.3 111.854 -173.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.829 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 2.3 mp -109.2 160.05 16.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.843 -0.617 . . . . 1.05 111.078 170.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.61 ' NH1' ' HB3' ' B' ' 259' ' ' ASP . 9.8 ttm180 -150.54 114.19 4.97 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.981 -0.554 . . . . 3.3999999999999999 110.356 172.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.517 ' HG ' HD12 ' A' ' 48' ' ' LEU . 6.2 mp -94.19 110.44 22.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.075 0.464 . . . . 1.73 110.502 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.422 HG21 ' HG2' ' A' ' 86' ' ' ARG . 2.2 mm -87.95 124.6 41.21 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 C-N-CA 123.254 0.622 . . . . 1.1599999999999999 109.701 -176.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.639 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -93.58 160.05 24.29 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 119.255 -1.45 . . . . 0.47999999999999998 111.819 174.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.528 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 0.3 OUTLIER -69.29 132.86 47.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.72 0.295 . . . . 1.78 111.088 -178.599 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 82' ' ' PRO . 12.4 p -89.68 150.32 3.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.807 -0.812 . . . . 1.3100000000000001 108.807 170.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.494 ' CG ' ' HZ3' ' A' ' 70' ' ' LYS . 5.5 p-10 -91.61 130.83 37.36 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.486 0.66 . . . . 2.5600000000000001 112.147 -169.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -85.79 -17.27 36.25 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.082 -0.963 . . . . 3.79 110.465 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -55.88 -39.82 72.08 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.857 -0.611 . . . . 3.3399999999999999 112.205 -173.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.494 ' HZ3' ' CG ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -132.2 52.79 2.05 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.276 0.56 . . . . 5.8200000000000003 110.013 172.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -55.06 141.28 34.97 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.257 -0.883 . . . . 4.7400000000000002 110.237 176.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.568 ' CG ' ' HB ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -88.34 170.32 11.07 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.357 -0.838 . . . . 4.7300000000000004 111.336 -169.195 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.84 167.31 20.43 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.076 -0.713 . . . . 5.5300000000000002 109.076 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.644 ' HB3' HD21 ' A' ' 78' ' ' ASN . 21.1 t70 -79.6 -168.24 1.5 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.408 -0.517 . . . . 4.9800000000000004 110.288 -174.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.477 ' H ' ' CG ' ' A' ' 74' ' ' ASP . 2.0 p-10 -69.46 -15.25 63.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.378 0.535 . . . . 7.1100000000000003 110.22 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.507 ' HB2' ' ND2' ' A' ' 78' ' ' ASN . 32.1 mt-10 -99.49 -3.25 33.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.406 0.622 . . . . 7.1299999999999999 109.868 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.89 35.14 16.59 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.275 -0.875 . . . . 5.7300000000000004 112.145 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.644 HD21 ' HB3' ' A' ' 74' ' ' ASP . 64.0 m-80 -78.22 -96.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.3 0.571 . . . . 5.6200000000000001 111.488 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.3 pt-20 -177.21 120.59 0.12 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.169 -0.923 . . . . 5.0 109.781 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.568 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.2 t -128.59 148.59 33.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.873 -0.788 . . . . 3.5800000000000001 108.873 172.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.35 104.47 44.76 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-O 121.472 0.653 . . . . 3.1499999999999999 110.044 173.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.484 ' HD3' ' HG2' ' A' ' 72' ' ' ARG . 43.2 Cg_exo -42.5 132.09 5.17 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.713 2.942 . . . . 2.0800000000000001 112.459 174.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 60.5 mtpt -65.67 121.45 75.45 Favored Pre-proline 0 N--CA 1.445 -0.681 0 N-CA-C 109.985 -0.376 . . . . 3.5299999999999998 109.985 177.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 83' ' ' LYS . 24.0 Cg_exo -59.47 148.48 86.77 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.007 2.472 . . . . 0.75 111.922 -177.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.77 115.59 15.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.931 0.872 . . . . 1.78 109.813 175.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.422 ' HG2' HG21 ' A' ' 63' ' ' ILE . 18.8 mtm180 -115.52 154.47 29.3 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.201 -0.909 . . . . 2.8199999999999998 109.133 -175.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -117.51 109.43 16.73 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.164 -0.471 . . . . 0.63 110.003 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.578 ' HE1' ' CE2' ' B' ' 261' ' ' PHE . 51.1 ttm -108.99 122.38 47.12 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 110.061 -0.348 . . . . 1.1200000000000001 110.061 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.487 ' CD2' ' HB2' ' A' ' 9' ' ' PHE . 57.8 m-85 -112.23 139.79 47.48 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.595 -0.891 . . . . 1.6499999999999999 108.595 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.51 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 31.3 m -97.74 123.11 41.54 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.597 -0.519 . . . . 1.1899999999999999 109.597 177.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.829 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 6.0 m-85 -106.09 165.06 11.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.986 -0.552 . . . . 1.6399999999999999 109.819 -175.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -107.3 -6.46 17.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.882 0.372 . . . . 1.8300000000000001 110.988 -171.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -145.66 128.36 16.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.142 0.496 . . . . 1.22 110.663 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.519 ' NH1' ' HB2' ' A' ' 98' ' ' ASP . 49.1 tpt85 -62.63 -26.24 68.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.06 -0.973 . . . . 2.8799999999999999 111.131 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.2 m -73.46 -60.06 2.42 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.738 0.304 . . . . 1.1200000000000001 110.382 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.405 ' O ' HG12 ' A' ' 100' ' ' ILE . 58.5 t -45.71 -55.57 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 CA-C-N 115.584 -0.734 . . . . 1.1299999999999999 111.441 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.535 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -63.21 -30.63 71.74 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.227 -0.442 . . . . 1.0600000000000001 110.786 -177.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.519 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 36.5 t70 -69.17 -31.3 69.84 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.619 0.723 . . . . 0.39000000000000001 109.557 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.494 ' HA ' ' HE2' ' A' ' 102' ' ' MET . 87.7 m-20 -72.93 -42.36 63.57 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.6 -1.182 . . . . 1.55 109.072 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.529 HG22 HD13 ' A' ' 18' ' ' ILE . 40.4 mm -62.64 -54.09 38.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.783 -1.099 . . . . 1.0600000000000001 111.562 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -60.87 -42.72 98.46 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 120.54 0.21 . . . . 1.72 111.481 -177.221 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.494 ' HE2' ' HA ' ' A' ' 99' ' ' ASN . 13.0 ptp -66.51 -29.56 69.68 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.66 -0.867 . . . . 1.76 108.66 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 32.7 m -66.0 -52.01 53.23 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.751 -1.113 . . . . 1.04 110.025 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.636 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 13.3 mt -69.31 -58.51 3.92 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.444 -0.798 . . . . 1.05 110.945 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.625 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 96.8 mt-30 -49.2 -28.21 4.32 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.757 0.651 . . . . 1.45 112.757 -178.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.4 ' O ' ' HG3' ' A' ' 110' ' ' ARG . 24.3 mt-30 -67.14 -49.02 66.27 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.852 -0.796 . . . . 0.66000000000000003 108.852 176.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.528 HG22 ' HB1' ' A' ' 25' ' ' ALA . 53.0 mt -59.65 -43.89 92.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.669 -1.15 . . . . 1.04 110.494 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -61.18 -58.24 8.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.604 -0.726 . . . . 1.04 110.168 -176.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.562 ' HA ' ' HD2' ' A' ' 112' ' ' LYS . 13.9 m -55.37 -29.23 58.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.722 0.296 . . . . 1.6100000000000001 111.467 173.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 92.5 mtt180 -68.93 -18.37 64.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.157 0.503 . . . . 4.3899999999999997 110.481 176.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.443 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 23.6 m-85 -107.8 -4.9 17.63 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.687 -0.688 . . . . 0.71999999999999997 109.916 178.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.562 ' HD2' ' HA ' ' A' ' 109' ' ' SER . 1.2 mpmm? -74.77 -36.29 62.55 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.408 -0.815 . . . . 2.25 109.525 172.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.84 -11.84 56.95 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.281 -1.327 . . . . 1.5600000000000001 110.063 174.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.5 29.16 3.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.716 -0.675 . . . . 1.3400000000000001 110.777 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 111' ' ' TYR . 17.0 t70 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.573 -0.727 . . . . 2.1600000000000001 110.505 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.634 0 N-CA-C 111.826 -0.51 . . . . 25.670000000000002 111.826 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -162.51 123.46 1.2 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.692 -0.766 . . . . 24.66 111.906 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 129.36 -105.67 0.7 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.776 -0.726 . . . . 24.199999999999999 111.906 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -83.35 51.92 4.65 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.911 -0.661 . . . . 23.140000000000001 112.457 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -146.52 27.94 1.09 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.629 0.728 . . . . 24.920000000000002 109.525 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -99.13 86.22 3.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.993 -0.549 . . . . 21.449999999999999 109.982 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 39.0 t 55.35 65.0 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.514 -0.766 . . . . 20.68 110.328 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' B' ' 250' ' ' MET . 18.4 tt0 -113.85 167.77 10.36 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.735 -0.666 . . . . 18.16 109.612 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' MET . . . . . 0.515 ' HB2' ' O ' ' B' ' 249' ' ' GLU . 67.5 mtt 82.11 17.9 0.37 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 122.365 1.079 . . . . 17.260000000000002 108.206 -175.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -87.49 139.78 30.19 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.441 -1.709 . . . . 13.68 110.01 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' B' ' 255' ' ' GLU . 70.6 m -82.26 70.17 9.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.05 -0.523 . . . . 10.91 111.417 -175.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -80.27 -60.4 2.34 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.654 -0.703 . . . . 11.029999999999999 110.115 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . 0.507 ' H ' ' CD ' ' B' ' 254' ' ' GLU . 0.6 OUTLIER -79.39 -20.56 47.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.282 -0.872 . . . . 10.94 110.114 179.122 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' GLU . . . . . 0.536 ' HB3' HH21 ' A' ' 61' ' ' ARG . 30.7 mt-10 -71.37 -10.64 60.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.389 -0.823 . . . . 9.8200000000000003 112.044 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 90.3 p 59.97 -164.57 0.22 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.012 0.925 . . . . 5.9100000000000001 110.729 -175.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -73.45 -59.93 2.48 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.206 -0.198 . . . . 6.2000000000000002 111.407 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -86.7 -70.94 0.58 Allowed 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 120.182 -0.607 . . . . 6.1399999999999997 109.803 174.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.61 ' HB3' ' NH1' ' A' ' 61' ' ' ARG . 8.1 p-10 169.54 -39.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.542 -1.208 . . . . 3.3199999999999998 109.528 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 88.43 4.38 77.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.072 -0.585 . . . . 1.1200000000000001 112.95 174.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 261' ' ' PHE . . . . . 0.669 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 6.2 m-30 -100.18 179.68 4.4 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.839 0.352 . . . . 0.97999999999999998 110.414 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.39 148.9 31.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.494 -0.558 . . . . 1.8999999999999999 109.494 174.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 263' ' ' GLU . . . . . 0.544 ' HB3' ' OE1' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -110.92 128.58 55.86 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.332 0.587 . . . . 2.2400000000000002 110.523 179.305 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.492 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 84.5 t -100.98 103.42 14.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.916 -0.584 . . . . 1.8899999999999999 110.592 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.411 -0.804 . . . . 3.04 109.547 177.451 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 N--CA 1.479 0.666 0 N-CA-C 111.445 -0.252 . . . . 3.8100000000000001 111.445 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 p -90.32 -17.02 28.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.154 0.502 . . . . 1.8400000000000001 110.608 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.563 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 19.5 m80 -84.72 17.86 2.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.628 -0.714 . . . . 2.3900000000000001 111.525 -174.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.6 p -163.54 142.44 8.08 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.733 0.301 . . . . 1.6100000000000001 110.375 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.98 147.18 7.92 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.294 -1.122 . . . . 0.17000000000000001 110.294 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.718 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -69.8 144.52 52.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 117.41 0.605 . . . . 0.97999999999999998 111.603 -175.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 89' ' ' PHE . . . -152.64 155.83 38.07 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 121.068 0.461 . . . . 1.01 111.38 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.557 HG13 ' HA ' ' A' ' 13' ' ' SER . 1.9 mp -94.73 133.84 34.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.793 -0.639 . . . . 1.0800000000000001 109.297 177.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.432 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 74.3 t80 -139.69 121.0 14.93 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.285 -0.635 . . . . 0.66000000000000003 109.285 176.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 65.03 41.76 4.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.466 0.651 . . . . 1.46 110.141 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.4 mmtt 74.0 -6.43 1.83 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.519 -1.219 . . . . 2.3900000000000001 112.922 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.97 135.34 36.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.914 0.388 . . . . 1.23 110.539 175.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.557 ' HA ' HG13 ' A' ' 8' ' ' ILE . 9.6 p -73.38 128.93 36.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.79 -0.641 . . . . 1.48 110.691 176.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.646 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -146.8 -159.5 8.31 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 115.645 -0.707 . . . . 0.16 112.192 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.718 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.4 mm -126.39 152.95 34.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 120.905 0.383 . . . . 1.05 111.007 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.408 HG12 HD23 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -124.04 134.34 66.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 116.079 -0.51 . . . . 1.01 109.891 178.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.83 110.78 8.22 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.933 0.397 . . . . 0.87 112.069 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.563 ' O ' ' HB3' ' A' ' 3' ' ' HIS . 3.9 mp -85.13 112.8 22.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.785 -0.82 . . . . 1.05 108.785 171.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.425 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.9 t30 -114.97 125.86 54.1 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.823 -0.351 . . . . 1.1200000000000001 110.139 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -109.76 83.07 1.69 Allowed 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 117.255 -1.778 . . . . 0.73999999999999999 107.37 163.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.425 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 16.9 t70 -122.26 -10.01 8.55 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 106.42 -1.696 . . . . 0.58999999999999997 106.42 157.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 23' ' ' SER . 14.5 p -102.79 174.86 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 112.079 -2.328 . . . . 1.0800000000000001 111.897 -156.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.63 ' O ' HG12 ' A' ' 22' ' ' VAL . 12.0 p -54.52 165.0 0.96 Allowed Pre-proline 0 N--CA 1.453 -0.322 0 N-CA-C 106.661 -1.607 . . . . 2.0 106.661 165.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.577 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 11.8 Cg_endo -41.73 129.01 3.86 Favored 'Trans proline' 0 C--N 1.353 0.792 0 CA-C-N 121.731 1.654 . . . . 0.26000000000000001 111.809 -147.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.504 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -29.41 131.03 0.07 Allowed 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 125.406 1.691 . . . . 1.02 113.137 -159.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.614 ' HB3' HG11 ' A' ' 22' ' ' VAL . 36.7 tt0 -132.49 133.59 43.98 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.412 -1.267 . . . . 1.26 111.532 -160.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.595 ' C ' HD21 ' A' ' 27' ' ' LEU . 1.6 tt -100.38 146.88 26.45 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 107.276 -1.379 . . . . 1.0600000000000001 107.276 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.463 ' N ' HD21 ' A' ' 27' ' ' LEU . 22.6 m -137.57 109.31 7.07 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 120.134 -0.626 . . . . 1.05 110.552 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.585 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 88.3 t90 -85.58 112.38 20.91 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.688 -0.687 . . . . 0.29999999999999999 109.29 175.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -117.93 118.3 31.61 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.442 -0.948 . . . . 1.1599999999999999 108.442 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.536 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 71.6 p -57.21 152.18 14.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.667 0.27 . . . . 1.3899999999999999 111.032 -174.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.646 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 23.7 m -55.53 -35.12 65.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.599 0.714 . . . . 1.1499999999999999 109.889 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.18 -28.05 53.89 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.939 -1.028 . . . . 2.3300000000000001 111.613 178.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.9 1.55 70.27 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.915 -0.66 . . . . 0.55000000000000004 113.246 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -81.35 -25.05 36.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.856 0.328 . . . . 1.1299999999999999 111.688 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -120.82 140.96 51.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.162 0.506 . . . . 2.6200000000000001 111.719 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 73.7 t -142.45 126.11 15.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.298 -0.865 . . . . 1.3100000000000001 110.496 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -128.04 112.22 14.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.913 0.387 . . . . 0.82999999999999996 110.418 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.2 m -96.17 146.81 24.37 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.503 -0.317 . . . . 1.0600000000000001 111.476 -176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 36.9 t -126.28 127.67 70.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 122.476 0.31 . . . . 1.3600000000000001 111.433 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 45' ' ' ILE . 58.4 t -90.39 107.95 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-O 121.392 0.615 . . . . 1.05 109.497 173.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.597 HD13 ' CD2' ' A' ' 104' ' ' LEU . 1.9 mm? -51.15 -29.76 14.66 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.901 -1.045 . . . . 1.04 112.79 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.439 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 60.5 m -73.48 -34.96 65.59 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.565 -0.454 . . . . 1.45 111.528 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.3 p -72.85 -18.1 61.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.362 0.601 . . . . 1.04 109.574 173.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.544 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 50.0 mm -79.72 117.58 25.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.256 -0.884 . . . . 1.02 111.024 175.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.579 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 28.7 t70 -75.81 -43.1 47.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.029 -0.532 . . . . 0.69999999999999996 111.666 177.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.478 ' HG2' ' OD2' ' A' ' 46' ' ' ASP . 48.6 mmtm -141.05 153.93 45.73 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.865 -0.421 . . . . 2.4300000000000002 109.865 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.634 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 9.7 tp -117.31 145.99 43.63 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.203 -0.666 . . . . 1.04 109.203 166.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.614 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 15.9 mm100 -124.12 157.17 35.25 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.661 -1.154 . . . . 1.49 109.974 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.61 146.22 11.42 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.471 -0.786 . . . . 1.0 109.64 177.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.1 p -43.83 125.83 4.12 Favored Pre-proline 0 N--CA 1.468 0.429 0 C-N-CA 123.583 0.753 . . . . 1.03 111.756 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 52.8 Cg_endo -66.82 165.65 25.14 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 C-N-CA 123.803 3.002 . . . . 0.73999999999999999 111.649 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.21 -29.33 67.42 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.092 0.472 . . . . 1.54 110.313 175.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.9 t -70.43 -22.63 62.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.713 -0.676 . . . . 2.0499999999999998 110.611 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.492 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 47.7 t -72.18 145.49 48.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 1.1399999999999999 110.428 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -89.91 -7.98 52.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.354 0.597 . . . . 2.8900000000000001 109.576 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -103.92 179.43 4.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.021 -0.991 . . . . 3.1299999999999999 111.077 -173.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.55 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -137.29 109.88 7.5 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.375 -1.284 . . . . 2.0 108.064 178.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.771 ' HB3' ' CZ ' ' B' ' 261' ' ' PHE . 10.8 ttm -157.98 138.81 13.08 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.343 -0.543 . . . . 1.3 111.375 -169.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.808 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 3.2 mp -111.06 156.35 21.43 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.087 0.47 . . . . 1.05 112.028 174.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 59.9 ttp180 -150.28 113.2 4.81 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.776 -0.647 . . . . 3.3999999999999999 110.593 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.484 ' HG ' HD12 ' A' ' 48' ' ' LEU . 6.4 mp -95.72 110.73 22.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.998 -0.546 . . . . 1.73 110.693 -176.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.517 ' HA ' ' HB3' ' A' ' 86' ' ' ARG . 1.2 mm -87.6 120.98 37.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.163 -0.472 . . . . 1.1599999999999999 110.525 -173.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -83.17 156.24 33.74 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 119.89 -1.148 . . . . 0.47999999999999998 111.747 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.579 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 9.7 mptt -68.48 137.08 54.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.96 0.38 . . . . 1.78 110.29 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 82' ' ' PRO . 9.4 p -104.84 163.18 4.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.207 -0.664 . . . . 1.3100000000000001 109.207 173.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -111.36 109.01 18.8 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.755 -0.461 . . . . 2.5600000000000001 109.755 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.61 -15.79 57.0 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.1 -0.24 . . . . 3.79 111.47 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.6 t -82.67 -39.39 22.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.828 0.346 . . . . 3.3399999999999999 110.712 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -84.92 75.36 10.38 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.219 -0.446 . . . . 5.8200000000000003 110.168 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -64.33 136.85 57.54 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.56 0.695 . . . . 4.7400000000000002 111.062 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.738 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 9.0 ptm180 -84.98 176.22 8.57 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.501 -1.227 . . . . 4.7300000000000004 109.523 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.514 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 12.2 mmtp -120.76 138.79 53.83 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.504 0.192 . . . . 5.5300000000000002 110.543 -172.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.554 ' HB3' HD22 ' A' ' 78' ' ' ASN . 2.7 t70 -93.91 -157.33 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.788 -0.449 . . . . 4.9800000000000004 109.788 -178.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -59.49 -31.05 69.0 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.08 0.4 . . . . 7.1100000000000003 112.08 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -94.75 0.68 55.17 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.797 0.808 . . . . 7.1299999999999999 109.16 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.514 ' HA2' ' HB3' ' A' ' 73' ' ' LYS . . . 68.69 35.22 79.93 Favored Glycine 0 CA--C 1.503 -0.671 0 CA-C-N 114.273 -1.331 . . . . 5.7300000000000004 110.711 -175.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.554 HD22 ' HB3' ' A' ' 74' ' ' ASP . 5.5 p30 -82.46 -86.0 0.11 Allowed 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.297 -0.451 . . . . 5.6200000000000001 110.889 -175.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.738 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 11.4 pt-20 178.91 129.32 0.07 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.196 0.522 . . . . 5.0 110.954 174.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.418 ' HB ' ' HG2' ' A' ' 72' ' ' ARG . 2.1 t -126.5 147.95 31.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.938 -0.764 . . . . 3.5800000000000001 108.938 171.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.3 p -106.61 96.7 14.73 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-O 121.728 0.775 . . . . 3.1499999999999999 109.181 171.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.462 ' O ' HG22 ' A' ' 66' ' ' VAL . 19.1 Cg_endo -61.79 142.02 92.24 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.477 2.785 . . . . 2.0800000000000001 113.557 -173.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.404 ' HG3' ' HD2' ' A' ' 84' ' ' PRO . 15.5 ttpp -71.54 136.33 83.59 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.605 -0.725 . . . . 3.5299999999999998 109.104 171.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.41 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 30.4 Cg_exo -52.19 133.64 47.95 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 123.141 2.561 . . . . 0.75 112.7 -175.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -73.18 130.5 40.39 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.829 0.823 . . . . 1.78 109.791 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.517 ' HB3' ' HA ' ' A' ' 63' ' ' ILE . 22.3 ptt180 -127.73 141.65 51.54 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.251 -0.886 . . . . 2.8199999999999998 110.444 -174.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -102.32 111.18 23.37 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.043 -0.98 . . . . 0.63 110.207 -170.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.461 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 53.6 ttm -108.27 120.12 41.45 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.598 -0.728 . . . . 1.1200000000000001 110.483 -172.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . 55.8 m-85 -111.5 140.48 46.07 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.394 -0.965 . . . . 1.6499999999999999 108.394 175.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.565 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 49.5 m -97.47 125.08 41.93 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.523 -0.471 . . . . 1.1899999999999999 110.221 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.808 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 5.6 m-85 -107.7 169.0 8.86 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.747 -0.661 . . . . 1.6399999999999999 109.357 -176.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -126.27 -3.4 6.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.851 0.358 . . . . 1.8300000000000001 110.68 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.432 ' OD1' HG22 ' A' ' 96' ' ' VAL . 28.6 t-20 -131.12 125.66 33.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.131 0.491 . . . . 1.22 110.616 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.426 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 12.7 tpt180 -62.29 -33.51 74.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.179 -0.918 . . . . 2.8799999999999999 111.371 -177.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.41 HG22 HD22 ' A' ' 99' ' ' ASN . 87.2 m -73.24 -55.76 6.0 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.951 -0.3 . . . . 1.1200000000000001 110.492 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.432 HG22 ' OD1' ' A' ' 93' ' ' ASN . 95.6 t -45.86 -56.39 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-N 115.824 -0.625 . . . . 1.1299999999999999 111.539 175.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.55 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -65.94 -28.9 69.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.321 -0.399 . . . . 1.0600000000000001 110.7 -177.397 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.95 -37.02 83.51 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.92 -0.77 . . . . 0.39000000000000001 108.92 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.546 ' O ' ' HG3' ' A' ' 102' ' ' MET . 90.4 m-20 -72.79 -48.53 37.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.205 -1.361 . . . . 1.55 109.581 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.498 HG21 HD13 ' A' ' 18' ' ' ILE . 41.0 mm -56.18 -53.05 43.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.985 -1.007 . . . . 1.0600000000000001 110.075 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.477 ' HZ1' ' HB ' ' B' ' 264' ' ' VAL . 6.6 ttpp -55.98 -50.15 71.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.778 -0.646 . . . . 1.72 111.329 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.546 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.1 ppp? -68.56 -24.48 64.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.328 -0.396 . . . . 1.76 110.339 -175.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.7 m -67.62 -51.79 46.02 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.462 0.649 . . . . 1.04 110.071 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.634 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 13.8 mt -69.14 -58.5 3.98 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.132 -0.94 . . . . 1.05 111.364 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.572 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 66.5 mt-30 -51.52 -26.46 8.5 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.758 0.651 . . . . 1.45 112.758 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -66.24 -49.5 67.0 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.411 -0.959 . . . . 0.66000000000000003 108.411 175.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.504 HG21 ' HB3' ' A' ' 25' ' ' ALA . 67.7 mt -58.51 -43.57 87.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.303 -1.317 . . . . 1.04 110.487 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.571 HG23 ' HD2' ' A' ' 112' ' ' LYS . 1.1 mt -66.79 -49.24 76.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.996 -0.547 . . . . 1.04 110.654 -176.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.417 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 32.2 t -60.27 -26.14 66.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.388 0.613 . . . . 1.6100000000000001 110.095 173.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 83.0 mtt180 -73.87 -30.63 62.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.494 -0.776 . . . . 4.3899999999999997 110.624 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -94.98 -21.32 18.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.051 -0.522 . . . . 0.71999999999999997 112.144 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.571 ' HD2' HG23 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -75.54 -21.68 57.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.447 0.641 . . . . 2.25 109.488 173.147 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -72.55 -19.12 61.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.957 -1.02 . . . . 1.5600000000000001 110.175 173.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -134.55 36.06 3.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.571 -0.741 . . . . 1.3400000000000001 110.92 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 30.8 t70 . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.608 -0.71 . . . . 2.1600000000000001 110.537 -179.647 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.707 0 N-CA-C 112.197 -0.361 . . . . 25.670000000000002 112.197 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' B' ' 247' ' ' ASP . . . -176.26 60.04 0.1 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.821 -0.704 . . . . 24.66 111.956 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -79.96 151.8 34.08 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.891 -0.671 . . . . 24.199999999999999 112.455 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 124.89 -79.19 0.36 Allowed Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.271 -0.732 . . . . 23.140000000000001 111.271 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -99.47 21.46 12.13 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.695 -0.483 . . . . 24.920000000000002 109.695 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' B' ' 243' ' ' GLY . 9.5 p-10 -62.55 105.75 0.68 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.472 0.653 . . . . 21.449999999999999 110.578 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 4.9 t 52.58 52.56 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 114.879 -1.055 . . . . 20.68 110.328 -175.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -128.13 129.77 47.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.344 -0.844 . . . . 18.16 109.802 176.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 66.0 mtt -138.71 47.78 1.94 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.971 -0.751 . . . . 17.260000000000002 108.971 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.02 151.29 37.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.057 -0.974 . . . . 13.68 110.794 -174.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 56.5 m -143.57 123.47 13.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.734 -0.666 . . . . 10.91 109.595 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -61.47 -31.97 71.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.111 -0.949 . . . . 11.029999999999999 111.188 -175.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -68.18 -21.43 64.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.103 -0.498 . . . . 10.94 111.218 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -84.76 -12.53 53.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.632 -0.258 . . . . 9.8200000000000003 111.352 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 46.5 t -62.96 141.54 58.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.948 0.404 . . . . 5.9100000000000001 110.205 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -78.2 -21.47 50.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.246 0.546 . . . . 6.2000000000000002 109.904 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -86.61 2.29 48.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.617 -0.72 . . . . 6.1399999999999997 110.561 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' B' ' 260' ' ' GLY . 26.9 t0 -140.76 -152.91 0.43 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.222 -1.399 . . . . 3.3199999999999998 107.222 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . 0.405 ' H ' ' CG ' ' B' ' 259' ' ' ASP . . . 90.75 44.26 4.58 Favored Glycine 0 C--N 1.307 -1.044 0 C-N-CA 121.037 -0.601 . . . . 1.1200000000000001 113.071 173.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 261' ' ' PHE . . . . . 0.771 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 6.7 m-30 -66.29 171.81 4.47 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.042 0.449 . . . . 0.97999999999999998 111.701 -177.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.1 p -138.18 148.2 25.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.916 -0.584 . . . . 1.8999999999999999 110.264 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -80.01 121.35 25.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.931 -0.766 . . . . 2.2400000000000002 108.931 175.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.477 ' HB ' ' HZ1' ' A' ' 101' ' ' LYS . 57.7 t -107.33 102.82 14.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.968 0.413 . . . . 1.8899999999999999 110.632 -176.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 35.0 t70 . . . . . 0 C--O 1.248 0.993 0 CA-C-N 115.984 -0.553 . . . . 3.04 109.717 -178.838 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 N--CA 1.475 0.389 0 N-CA-C 110.464 -0.629 . . . . 3.8100000000000001 110.464 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.1 m 69.84 -11.76 0.52 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.982 0.734 . . . . 1.8400000000000001 112.982 175.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.413 ' CE1' HG23 ' A' ' 103' ' ' THR . 12.4 m80 -85.61 13.03 7.53 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.421 0.526 . . . . 2.3900000000000001 112.421 -169.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.9 p -162.8 140.07 7.88 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.318 0.58 . . . . 1.6100000000000001 111.26 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.05 152.79 13.36 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.998 -1.241 . . . . 0.17000000000000001 109.998 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.707 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -73.46 145.88 45.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 117.578 0.689 . . . . 0.97999999999999998 111.5 -175.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.97 152.55 32.62 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.396 0.617 . . . . 1.01 111.525 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.479 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.7 mp -94.15 124.44 46.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.861 -0.792 . . . . 1.0800000000000001 108.861 174.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.559 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 79.9 t80 -128.99 105.62 8.33 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 110.176 -0.305 . . . . 0.66000000000000003 110.176 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 66.98 53.22 0.84 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.573 0.701 . . . . 1.46 110.664 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp 71.28 -8.16 1.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.175 -1.375 . . . . 2.3900000000000001 113.252 171.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.423 HG12 ' HD3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -99.32 132.73 44.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.865 -0.42 . . . . 1.23 109.865 172.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.479 ' HA ' HG13 ' A' ' 8' ' ' ILE . 23.3 t -85.28 123.97 31.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.998 -0.546 . . . . 1.48 109.921 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.633 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -144.48 -155.08 6.32 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 120.906 -0.664 . . . . 0.16 112.276 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.707 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.3 mm -125.11 153.35 32.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 120.977 0.418 . . . . 1.05 110.448 -177.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.489 HG12 HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -123.91 131.69 72.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.826 -0.625 . . . . 1.01 109.904 178.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.22 111.07 8.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.038 -0.528 . . . . 0.87 111.476 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 4.0 mp -84.22 118.98 32.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.053 -1.092 . . . . 1.05 108.053 172.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -121.94 123.23 41.19 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.909 -0.404 . . . . 1.1200000000000001 109.909 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.472 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 15.8 mt-10 -108.51 83.22 1.74 Allowed 'General case' 0 N--CA 1.426 -1.635 0 C-N-CA 117.113 -1.835 . . . . 0.73999999999999999 107.541 164.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -121.49 -10.2 8.88 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 106.38 -1.711 . . . . 0.58999999999999997 106.38 157.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.698 HG12 ' O ' ' A' ' 23' ' ' SER . 14.6 p -102.15 175.98 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 111.933 -2.394 . . . . 1.0800000000000001 111.791 -157.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.698 ' O ' HG12 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -54.51 167.29 0.6 Allowed Pre-proline 0 C--O 1.223 -0.291 0 N-CA-C 106.464 -1.68 . . . . 2.0 106.464 166.354 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 23' ' ' SER . 11.6 Cg_endo -42.05 128.29 4.09 Favored 'Trans proline' 0 C--N 1.357 1.002 0 CA-C-N 122.062 1.772 . . . . 0.26000000000000001 111.309 -153.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.499 ' HB3' HG23 ' A' ' 107' ' ' ILE . . . -30.0 133.73 0.05 Allowed 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 125.384 1.678 . . . . 1.02 114.189 -157.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.515 ' HB2' HG11 ' A' ' 22' ' ' VAL . 28.2 mt-10 -124.27 140.34 53.05 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 114.791 -1.095 . . . . 1.26 111.302 -171.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.568 ' C ' HD23 ' A' ' 27' ' ' LEU . 1.8 tt -100.1 142.9 30.95 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 106.579 -1.638 . . . . 1.0600000000000001 106.579 174.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.532 ' N ' HD23 ' A' ' 27' ' ' LEU . 3.0 m -129.39 107.76 9.76 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.04 -0.664 . . . . 1.05 109.827 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.588 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.4 t90 -91.61 113.27 25.49 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.875 -0.787 . . . . 0.29999999999999999 108.875 176.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -121.01 124.21 44.3 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.527 -0.76 . . . . 1.1599999999999999 109.465 -176.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.408 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 29.8 m -56.01 141.18 40.86 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.801 -0.444 . . . . 1.3899999999999999 109.801 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.633 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 22.8 m -55.29 -34.16 63.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.817 -0.629 . . . . 1.1499999999999999 110.554 -178.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -87.09 -3.28 59.06 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.468 -0.787 . . . . 2.3300000000000001 111.242 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.99 19.66 72.13 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.237 -0.506 . . . . 0.55000000000000004 112.73 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -71.79 -74.58 0.15 Allowed 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 111.973 0.36 . . . . 1.1299999999999999 111.973 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.423 ' HD3' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -116.59 153.39 32.33 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.946 0.403 . . . . 2.6200000000000001 111.036 -177.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 59.7 t -132.36 130.16 59.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.216 -0.447 . . . . 1.3100000000000001 110.641 -176.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -122.62 109.67 14.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.645 0.26 . . . . 0.82999999999999996 110.676 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 7.0 m -94.99 138.64 32.44 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.613 -0.514 . . . . 1.0600000000000001 109.613 175.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.539 ' CG1' ' HB3' ' A' ' 27' ' ' LEU . 8.9 p -128.54 139.12 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 120.569 -0.452 . . . . 1.3600000000000001 111.774 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.56 ' O ' HG12 ' A' ' 45' ' ' ILE . 45.0 t -90.02 110.88 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-O 121.377 0.608 . . . . 1.05 110.389 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.619 HD13 ' CD2' ' A' ' 104' ' ' LEU . 2.4 mm? -54.1 -28.87 42.18 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.872 -1.058 . . . . 1.04 112.633 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.5 m -77.34 -34.28 55.26 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.67 -0.412 . . . . 1.45 111.28 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.482 ' OG1' ' HB ' ' A' ' 41' ' ' VAL . 65.9 p -75.26 -12.14 60.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.525 0.678 . . . . 1.04 109.465 173.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.598 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 40.9 mm -81.58 123.1 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 114.963 -1.017 . . . . 1.02 110.691 170.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.478 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 35.6 t70 -74.71 -48.85 23.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.751 -0.659 . . . . 0.69999999999999996 110.982 176.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HB2' HG13 ' A' ' 63' ' ' ILE . 49.2 mmtm -142.07 165.06 28.48 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.194 -0.457 . . . . 2.4300000000000002 110.172 -177.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.589 ' CD2' ' HG3' ' A' ' 105' ' ' GLN . 10.5 tp -126.09 142.96 51.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.422 0.63 . . . . 1.04 109.386 170.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.409 ' CG ' HD11 ' A' ' 63' ' ' ILE . 12.4 mm100 -117.3 157.46 26.05 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.919 -1.037 . . . . 1.49 109.144 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -161.63 155.38 21.72 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.812 -1.181 . . . . 1.0 107.812 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.6 p -57.87 119.91 37.78 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 121.453 0.644 . . . . 1.03 111.053 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.545 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 63.5 Cg_endo -72.52 169.11 22.59 Favored 'Trans proline' 0 C--N 1.33 -0.439 0 C-N-CA 124.73 3.62 . . . . 0.73999999999999999 111.699 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.4 -26.35 52.95 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.003 0.43 . . . . 1.54 110.287 172.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.0 m -69.26 -25.7 64.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.047 -0.524 . . . . 2.0499999999999998 110.705 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.463 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 22.7 t -87.87 142.91 27.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.942 -0.572 . . . . 1.1399999999999999 109.603 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -94.74 -7.29 41.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.15 0.5 . . . . 2.8900000000000001 110.57 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -102.75 -173.2 2.27 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.717 -0.674 . . . . 3.1299999999999999 111.094 -172.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.498 ' HB3' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -130.35 112.43 13.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.818 -0.628 . . . . 2.0 110.046 175.516 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.539 ' CG ' ' HA ' ' A' ' 90' ' ' SER . 2.2 mtm -157.72 141.83 16.01 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 111.71 0.263 . . . . 1.3 111.71 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.911 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 2.8 mp -109.74 162.63 14.27 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.953 0.406 . . . . 1.05 111.151 171.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.577 ' HG3' ' OD1' ' B' ' 258' ' ' ASP . 0.0 OUTLIER -154.16 112.64 3.6 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.818 -0.628 . . . . 3.3999999999999999 109.572 177.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.543 ' CD2' HG21 ' A' ' 45' ' ' ILE . 8.4 mt -95.7 117.28 30.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.3 0.571 . . . . 1.73 110.948 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.44 HG22 ' HG2' ' A' ' 86' ' ' ARG . 7.9 mm -87.67 102.95 13.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.412 -0.813 . . . . 1.1599999999999999 110.704 -174.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -73.74 145.15 34.98 Favored Glycine 0 C--N 1.321 -0.268 0 C-N-CA 119.949 -1.12 . . . . 0.47999999999999998 110.858 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.478 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 1.6 mptm? -54.5 135.28 46.02 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.382 0.611 . . . . 1.78 111.761 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.487 HG21 ' H ' ' A' ' 67' ' ' ASP . 10.7 p -69.26 171.67 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.885 -1.052 . . . . 1.3100000000000001 110.156 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.487 ' H ' HG21 ' A' ' 66' ' ' VAL . 7.7 t70 -54.1 142.04 26.73 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.242 0.544 . . . . 2.5600000000000001 110.809 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -59.02 -7.59 1.14 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 114.244 1.202 . . . . 3.79 114.244 -171.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.1 t -81.62 -12.94 58.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 118.02 0.373 . . . . 3.3399999999999999 110.308 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? 41.82 -98.41 0.02 OUTLIER 'General case' 0 C--O 1.231 0.102 0 N-CA-C 113.729 1.011 . . . . 5.8200000000000003 113.729 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -72.93 130.38 40.25 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.593 0.711 . . . . 4.7400000000000002 112.111 -172.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.453 ' HG2' ' HB ' ' A' ' 80' ' ' VAL . 8.0 ptm180 -107.25 172.74 6.66 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 106.31 -1.737 . . . . 4.7300000000000004 106.31 169.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.549 ' CB ' ' HA2' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -134.05 162.71 31.34 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.61 -0.681 . . . . 5.5300000000000002 109.963 176.654 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.633 ' HB3' HD21 ' A' ' 78' ' ' ASN . 5.0 t70 -87.56 -166.52 1.6 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.569 -0.9 . . . . 4.9800000000000004 108.569 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -57.42 -28.22 63.09 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.552 0.575 . . . . 7.1100000000000003 112.552 -173.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -101.56 -0.5 34.8 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.24 0.543 . . . . 7.1299999999999999 110.746 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.549 ' HA2' ' CB ' ' A' ' 73' ' ' LYS . . . 81.55 28.83 41.85 Favored Glycine 0 C--N 1.321 -0.299 0 C-N-CA 120.419 -0.896 . . . . 5.7300000000000004 111.2 -176.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.633 HD21 ' HB3' ' A' ' 74' ' ' ASP . 52.6 m-80 -61.33 -37.4 83.14 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.198 0.599 . . . . 5.6200000000000001 112.601 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 46.4 mt-10 98.93 118.18 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 O-C-N 125.201 1.563 . . . . 5.0 111.263 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.453 ' HB ' ' HG2' ' A' ' 72' ' ' ARG . 2.0 t -123.58 147.88 27.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.053 -1.092 . . . . 3.5800000000000001 108.053 172.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.8 p -112.93 103.37 55.64 Favored Pre-proline 0 C--N 1.312 -1.03 0 C-N-CA 119.895 -0.722 . . . . 3.1499999999999999 111.043 177.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.01 139.47 20.3 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.565 2.843 . . . . 2.0800000000000001 111.727 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -80.39 124.78 82.17 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 121.986 0.898 . . . . 3.5299999999999998 111.764 -177.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -59.35 158.47 26.68 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 124.272 3.314 . . . . 0.75 112.962 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.17 119.12 24.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.296 0.569 . . . . 1.78 110.158 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.44 ' HG2' HG22 ' A' ' 63' ' ' ILE . 25.3 mtt180 -119.31 162.33 18.93 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.89 -0.595 . . . . 2.8199999999999998 111.363 -169.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -124.78 115.24 20.37 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.887 -0.597 . . . . 0.63 110.242 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.499 ' CB ' ' HG2' ' A' ' 61' ' ' ARG . 59.6 ttm -107.07 129.22 54.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.811 -0.177 . . . . 1.1200000000000001 111.111 -173.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.575 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -119.62 140.43 50.61 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.613 -0.884 . . . . 1.6499999999999999 108.613 173.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.539 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 52.6 m -100.31 126.64 46.66 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.115 0.483 . . . . 1.1899999999999999 109.768 177.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.911 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 18.8 m-85 -106.55 160.45 15.42 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.792 -0.64 . . . . 1.6399999999999999 110.649 -173.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -101.99 -6.94 22.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.281 -0.418 . . . . 1.8300000000000001 110.577 -171.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -148.32 131.27 16.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.358 0.599 . . . . 1.22 110.918 -175.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.498 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 9.2 tpt180 -60.88 -31.47 70.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.697 -1.138 . . . . 2.8799999999999999 111.269 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 94.4 m -73.15 -57.88 3.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.806 0.336 . . . . 1.1200000000000001 110.356 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 68.1 t -46.67 -52.67 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.994 -0.548 . . . . 1.1299999999999999 111.716 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.466 ' O ' HD12 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -66.71 -28.33 68.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.198 -0.455 . . . . 1.0600000000000001 110.438 -178.203 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.93 -29.96 69.15 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.181 -0.674 . . . . 0.39000000000000001 109.181 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.616 ' O ' ' HG3' ' A' ' 102' ' ' MET . 55.8 m-80 -77.37 -50.03 13.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.988 -1.005 . . . . 1.55 110.083 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.488 HG22 HD11 ' A' ' 18' ' ' ILE . 40.5 mm -56.71 -50.76 73.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.314 -0.857 . . . . 1.0600000000000001 110.304 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.468 ' HA ' HD21 ' A' ' 60' ' ' LEU . 7.2 ttpp -55.31 -50.78 68.71 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.735 -0.666 . . . . 1.72 111.046 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.616 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.3 ppp? -69.35 -20.95 63.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.118 -0.492 . . . . 1.76 110.646 -174.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.413 HG23 ' CE1' ' A' ' 3' ' ' HIS . 52.7 m -70.98 -56.74 5.55 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.337 0.589 . . . . 1.04 110.093 174.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.619 ' CD2' HD13 ' A' ' 42' ' ' LEU . 13.8 mt -61.2 -55.75 28.6 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.009 -0.996 . . . . 1.05 110.587 -176.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.589 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 75.3 mt-30 -53.61 -26.46 22.0 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.852 0.686 . . . . 1.45 112.852 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -65.93 -30.87 71.52 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 122.057 0.932 . . . . 0.66000000000000003 108.933 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.554 ' O ' ' HB3' ' A' ' 110' ' ' ARG . 30.1 mt -82.7 -43.81 18.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 113.678 -1.601 . . . . 1.04 110.232 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.535 HG21 ' HD2' ' A' ' 112' ' ' LYS . 1.1 mt -68.81 -47.12 77.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.546 -0.752 . . . . 1.04 111.174 -175.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.47 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 50.8 m -61.03 -27.61 68.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.581 0.705 . . . . 1.6100000000000001 109.42 175.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.554 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 17.0 ttt180 -67.91 -34.18 76.13 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.598 -1.183 . . . . 4.3899999999999997 109.732 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -95.15 -19.91 19.69 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.992 -0.549 . . . . 0.71999999999999997 111.435 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.535 ' HD2' HG21 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -74.17 -31.44 62.69 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 110.141 -0.318 . . . . 2.25 110.141 174.426 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.39 -1.31 45.08 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.195 0.521 . . . . 1.5600000000000001 110.463 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -114.53 1.58 14.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.668 -0.696 . . . . 1.3400000000000001 110.544 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 30.2 t70 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.439 -0.791 . . . . 2.1600000000000001 110.519 -177.537 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 N-CA-C 111.583 -0.607 . . . . 25.670000000000002 111.583 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -103.98 131.56 10.69 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.902 -0.666 . . . . 24.66 111.83 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -145.75 178.12 23.69 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.61 -0.805 . . . . 24.199999999999999 112.317 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 84.7 170.13 46.65 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.05 -0.595 . . . . 23.140000000000001 112.315 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -105.72 18.35 22.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.976 0.417 . . . . 24.920000000000002 110.832 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -115.18 145.14 42.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.323 -0.398 . . . . 21.449999999999999 110.354 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 10.3 p -83.95 -3.93 8.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 122.04 0.924 . . . . 20.68 109.155 175.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -90.72 121.66 32.8 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.879 -1.055 . . . . 18.16 109.394 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 28.0 ttt -169.06 55.06 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.403 -0.962 . . . . 17.260000000000002 108.403 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.78 117.38 7.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.136 -0.938 . . . . 13.68 110.658 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 24.8 p -146.92 -163.08 1.67 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.282 -0.872 . . . . 10.91 110.423 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -77.77 -12.36 59.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.513 -0.312 . . . . 11.029999999999999 110.904 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . 0.464 ' HA ' ' HB2' ' B' ' 257' ' ' ASP . 33.7 mm-40 -55.6 -26.88 46.24 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.023 -0.535 . . . . 10.94 112.012 -176.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -51.68 -38.3 54.41 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.968 0.413 . . . . 9.8200000000000003 111.261 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 62.4 m -132.25 47.63 2.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.299 0.571 . . . . 5.9100000000000001 110.242 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 257' ' ' ASP . . . . . 0.464 ' HB2' ' HA ' ' B' ' 254' ' ' GLU . 14.6 t70 -82.72 -54.93 4.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.724 -0.671 . . . . 6.2000000000000002 111.268 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.577 ' OD1' ' HG3' ' A' ' 61' ' ' ARG . 14.3 t70 -69.35 -67.94 0.44 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.14 0.495 . . . . 6.1399999999999997 111.123 -177.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -164.01 44.16 0.1 Allowed 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.949 -1.13 . . . . 3.3199999999999998 107.949 174.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 100.33 -4.89 57.13 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 114.685 -1.143 . . . . 1.1200000000000001 112.363 -176.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 261' ' ' PHE . . . . . 0.545 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 1.1 m-85 -111.07 158.84 18.38 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 110.055 -0.35 . . . . 0.97999999999999998 110.055 -177.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . 0.479 ' CG1' ' HB3' ' A' ' 52' ' ' PRO . 13.0 p -144.5 165.72 12.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.882 -0.599 . . . . 1.8999999999999999 109.452 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 263' ' ' GLU . . . . . 0.404 ' N ' HG22 ' B' ' 262' ' ' VAL . 14.1 tt0 -78.99 117.52 20.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.279 -1.008 . . . . 2.2400000000000002 108.279 172.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.532 ' H ' HE22 ' A' ' 105' ' ' GLN . 40.6 t -116.34 103.8 15.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.469 -0.332 . . . . 1.8899999999999999 110.356 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 21.6 t70 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.498 -0.763 . . . . 3.04 110.285 178.175 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.479 0.646 0 N-CA-C 110.734 -0.525 . . . . 3.8100000000000001 110.734 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 4' ' ' SER . 67.0 m -97.55 148.44 23.25 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.77 0.319 . . . . 1.8400000000000001 110.285 174.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.474 ' HA ' HG21 ' A' ' 103' ' ' THR . 28.8 m80 63.65 -4.65 0.32 Allowed 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.45 -0.796 . . . . 2.3900000000000001 112.45 -177.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 2' ' ' SER . 77.1 p -163.86 137.99 5.72 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.736 0.303 . . . . 1.6100000000000001 110.249 177.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.19 151.38 10.57 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.431 -1.067 . . . . 0.17000000000000001 110.431 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.694 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.94 138.16 40.81 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.336 0.568 . . . . 0.97999999999999998 111.598 -175.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.21 157.1 43.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 1.01 110.844 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 2.3 mp -91.27 127.06 43.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.185 -0.672 . . . . 1.0800000000000001 109.185 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.564 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 79.2 t80 -138.51 118.42 13.31 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.845 -0.428 . . . . 0.66000000000000003 109.845 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 70.49 41.56 0.96 Allowed 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 123.851 0.719 . . . . 1.46 110.494 -176.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? 70.27 9.34 6.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.356 -1.293 . . . . 2.3900000000000001 111.956 173.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.29 135.59 58.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.745 0.307 . . . . 1.23 110.524 176.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.491 ' HA ' HG13 ' A' ' 8' ' ' ILE . 48.5 t -76.95 120.57 22.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.089 0.471 . . . . 1.48 110.268 176.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.59 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -141.85 -154.44 6.17 Favored Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 115.766 -0.652 . . . . 0.16 112.004 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.694 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.3 mm -126.89 153.4 35.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 121.052 0.453 . . . . 1.05 110.676 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 4' ' ' SER . 0.1 OUTLIER -122.33 133.68 67.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 115.656 -0.702 . . . . 1.01 109.789 178.243 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.34 108.78 7.37 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.02 0.438 . . . . 0.87 111.607 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 4.0 mp -85.62 113.31 23.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.302 -0.999 . . . . 1.05 108.302 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -116.58 122.66 45.29 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.649 -0.5 . . . . 1.1200000000000001 109.649 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.411 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 8.6 mt-10 -108.17 82.86 1.69 Allowed 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 117.144 -1.823 . . . . 0.73999999999999999 107.38 165.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -122.71 -8.6 8.45 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.6 -1.63 . . . . 0.58999999999999997 106.6 157.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 23' ' ' SER . 14.6 p -101.59 174.2 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 112.182 -2.281 . . . . 1.0800000000000001 111.707 -158.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.686 ' O ' HG13 ' A' ' 22' ' ' VAL . 11.3 p -54.7 165.67 0.89 Allowed Pre-proline 0 N--CA 1.455 -0.176 0 N-CA-C 107.094 -1.447 . . . . 2.0 107.094 166.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.576 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 11.0 Cg_endo -41.85 126.91 3.52 Favored 'Trans proline' 0 C--N 1.358 1.07 0 CA-C-N 122.037 1.763 . . . . 0.26000000000000001 111.57 -147.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.526 ' HB1' HG23 ' A' ' 107' ' ' ILE . . . -30.29 132.41 0.07 Allowed 'General case' 0 CA--C 1.508 -0.637 0 O-C-N 125.391 1.682 . . . . 1.02 113.596 -158.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.507 ' HB2' HG12 ' A' ' 22' ' ' VAL . 36.4 mt-10 -127.47 140.42 52.16 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.697 -1.138 . . . . 1.26 111.525 -167.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.59 ' C ' HD23 ' A' ' 27' ' ' LEU . 1.5 tt -101.36 144.62 29.95 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.101 -1.444 . . . . 1.0600000000000001 107.101 175.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.443 ' N ' HD23 ' A' ' 27' ' ' LEU . 18.5 m -132.23 109.19 9.74 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.954 -0.698 . . . . 1.05 110.223 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.569 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 87.2 t90 -87.04 115.32 24.35 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.723 -0.843 . . . . 0.29999999999999999 108.723 175.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -121.98 123.41 41.59 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.068 -0.969 . . . . 1.1599999999999999 108.984 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.425 ' OG ' ' HB3' ' A' ' 36' ' ' LYS . 22.1 m -54.91 144.09 24.02 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.179 -0.304 . . . . 1.3899999999999999 110.179 -177.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.59 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 19.4 m -55.23 -26.22 38.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.649 -0.705 . . . . 1.1499999999999999 110.735 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -81.62 -27.5 34.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.887 -0.597 . . . . 2.3300000000000001 111.196 175.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.99 22.28 18.19 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.708 -0.758 . . . . 0.55000000000000004 112.849 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -97.51 -72.26 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.082 0.467 . . . . 1.1299999999999999 110.775 -173.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.425 ' HB3' ' OG ' ' A' ' 31' ' ' SER . 18.7 ttmm -82.53 129.97 35.02 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.497 -0.774 . . . . 2.6200000000000001 110.345 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 94.2 t -133.33 125.4 50.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.244 -0.435 . . . . 1.3100000000000001 109.901 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -131.75 121.88 24.93 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.48 -0.327 . . . . 0.82999999999999996 110.602 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.402 HG21 ' HG1' ' A' ' 28' ' ' THR . 31.4 m -104.38 142.07 35.23 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.683 0.278 . . . . 1.0600000000000001 111.276 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 31.0 t -116.27 129.01 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 122.696 0.398 . . . . 1.3600000000000001 111.167 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.523 ' O ' HG12 ' A' ' 45' ' ' ILE . 37.3 t -90.65 108.33 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.244 0.545 . . . . 1.05 109.663 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.584 HD12 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -55.26 -29.0 57.19 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.108 -0.951 . . . . 1.04 112.329 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.2 t -74.52 -30.44 61.79 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.425 -0.51 . . . . 1.45 110.738 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.6 p -80.07 -11.71 59.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.304 0.573 . . . . 1.04 109.532 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.587 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 39.1 mm -85.97 125.82 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.251 -0.886 . . . . 1.02 110.982 173.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.668 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 24.2 t70 -84.27 -38.95 19.82 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.14 -0.482 . . . . 0.69999999999999996 111.217 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -143.89 153.59 42.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.927 -0.578 . . . . 2.4300000000000002 110.053 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.612 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 10.7 tp -120.71 144.23 48.34 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.051 -0.722 . . . . 1.04 109.051 168.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 15.4 mm100 -118.63 157.59 27.1 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.016 -0.993 . . . . 1.49 109.639 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -161.58 141.39 10.35 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.134 -0.939 . . . . 1.0 108.652 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.503 ' HB ' ' CB ' ' A' ' 55' ' ' SER . 38.2 p -47.98 131.83 11.93 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 123.393 0.433 . . . . 1.03 110.877 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 46.7 Cg_endo -66.48 164.94 26.72 Favored 'Trans proline' 0 C--N 1.329 -0.465 0 C-N-CA 123.548 2.832 . . . . 0.73999999999999999 111.536 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.56 -14.21 60.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.953 0.406 . . . . 1.54 111.027 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 56.5 m -84.59 -23.28 29.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.953 -0.567 . . . . 2.0499999999999998 110.789 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.503 ' CB ' ' HB ' ' A' ' 51' ' ' THR . 29.3 t -62.33 137.3 58.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.716 -0.674 . . . . 1.1399999999999999 110.587 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -83.28 -11.94 57.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.384 0.611 . . . . 2.8900000000000001 110.076 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -109.07 171.58 7.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.237 -0.892 . . . . 3.1299999999999999 109.485 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.565 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.2 OUTLIER -129.9 112.36 13.47 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.815 -1.18 . . . . 2.0 107.815 -178.297 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.605 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 2.4 mtm -155.75 140.96 17.52 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 119.936 -0.706 . . . . 1.3 112.237 -171.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.801 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 3.2 mp -109.43 161.08 15.65 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.684 -0.689 . . . . 1.05 110.897 170.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.515 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 7.9 ttm180 -154.57 113.85 3.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.67 -0.695 . . . . 3.3999999999999999 110.273 174.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.557 ' CD2' HG21 ' A' ' 45' ' ' ILE . 10.0 mt -93.67 114.5 26.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.285 0.564 . . . . 1.73 111.249 -177.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.515 HG23 ' HG2' ' A' ' 86' ' ' ARG . 5.9 mm -87.55 108.95 18.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 123.813 0.845 . . . . 1.1599999999999999 110.567 -173.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -80.45 141.4 22.89 Favored Glycine 0 C--O 1.227 -0.308 0 C-N-CA 120.286 -0.959 . . . . 0.47999999999999998 112.048 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.668 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 0.5 OUTLIER -55.69 131.04 45.56 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 117.05 0.425 . . . . 1.78 110.269 179.239 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.4 p -79.43 152.23 4.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.899 -0.592 . . . . 1.3100000000000001 109.718 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -82.19 101.51 10.51 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.799 -0.637 . . . . 2.5600000000000001 110.698 -173.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -68.85 -31.84 71.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.742 -0.663 . . . . 3.79 110.888 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 m -70.3 -38.34 74.98 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 116.118 -0.492 . . . . 3.3399999999999999 110.897 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -98.51 48.45 0.98 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.052 0.453 . . . . 5.8200000000000003 110.145 177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -66.4 126.42 28.75 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-O 121.48 0.657 . . . . 4.7400000000000002 109.533 177.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.59 162.94 25.02 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 115.039 -0.982 . . . . 4.7300000000000004 109.788 -173.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.29 159.78 39.22 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.846 -0.427 . . . . 5.5300000000000002 109.846 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.634 ' HB3' HD22 ' A' ' 78' ' ' ASN . 4.9 t70 -86.67 -157.59 0.37 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.434 -0.348 . . . . 4.9800000000000004 111.017 -173.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -75.29 -16.7 60.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.811 0.338 . . . . 7.1100000000000003 111.15 -172.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 6.2 tp10 -95.0 2.17 55.3 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.064 -1.088 . . . . 7.1299999999999999 108.064 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.99 27.66 71.81 Favored Glycine 0 CA--C 1.505 -0.558 0 CA-C-N 114.487 -1.233 . . . . 5.7300000000000004 111.311 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.634 HD22 ' HB3' ' A' ' 74' ' ' ASP . 3.6 p30 -85.72 -86.67 0.14 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.384 -0.408 . . . . 5.6200000000000001 111.587 -173.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.442 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 9.8 pt-20 -165.74 135.72 3.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 118.596 0.635 . . . . 5.0 112.707 177.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 t -127.44 147.86 32.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.774 -1.195 . . . . 3.5800000000000001 107.774 163.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 p -113.05 99.7 49.42 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-O 121.491 0.662 . . . . 3.1499999999999999 110.377 175.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -52.98 136.03 59.84 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 123.163 2.575 . . . . 2.0800000000000001 112.567 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -75.64 128.05 84.61 Favored Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 109.117 -0.697 . . . . 3.5299999999999998 109.117 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.515 ' HG2' ' OE1' ' B' ' 249' ' ' GLU . 31.7 Cg_exo -49.63 139.56 30.63 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.731 2.954 . . . . 0.75 112.952 -173.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.81 118.73 15.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.842 0.83 . . . . 1.78 110.203 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.515 ' HG2' HG23 ' A' ' 63' ' ' ILE . 34.5 mtt180 -112.26 147.43 36.28 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.136 -0.938 . . . . 2.8199999999999998 110.112 -174.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -108.57 112.66 25.13 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.596 -0.52 . . . . 0.63 109.596 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.429 ' HE3' ' NE ' ' A' ' 61' ' ' ARG . 44.7 ttm -107.06 130.71 54.63 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 121.206 -0.198 . . . . 1.1200000000000001 111.449 -174.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.6 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -121.01 141.91 50.3 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.632 -0.877 . . . . 1.6499999999999999 108.632 173.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.57 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 54.8 m -101.35 124.01 46.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.142 0.496 . . . . 1.1899999999999999 110.43 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.801 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 5.7 m-85 -107.96 145.79 33.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.657 -0.702 . . . . 1.6399999999999999 110.244 -175.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -100.17 -2.32 34.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.086 0.47 . . . . 1.8300000000000001 110.639 -174.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -131.93 124.73 30.02 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.943 -0.572 . . . . 1.22 110.479 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.41 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 28.3 tpt180 -57.36 -35.32 69.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.237 -0.892 . . . . 2.8799999999999999 111.015 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.476 HG21 HD22 ' A' ' 99' ' ' ASN . 91.6 m -71.78 -56.66 5.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.815 -0.63 . . . . 1.1200000000000001 110.685 -176.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 85.0 t -45.8 -54.73 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 115.776 -0.647 . . . . 1.1299999999999999 111.392 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.565 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -64.89 -29.22 70.16 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.678 -0.409 . . . . 1.0600000000000001 110.955 -177.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.408 ' O ' ' HE3' ' A' ' 101' ' ' LYS . 29.5 t70 -71.04 -30.88 67.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.679 0.752 . . . . 0.39000000000000001 109.22 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.601 ' O ' ' HG3' ' A' ' 102' ' ' MET . 90.0 m-20 -78.26 -48.68 15.22 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.627 -1.17 . . . . 1.55 109.967 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.515 HG22 HD13 ' A' ' 18' ' ' ILE . 41.3 mm -58.51 -50.37 79.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.232 -0.894 . . . . 1.0600000000000001 110.49 177.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.47 ' HA ' HD23 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -56.36 -48.7 76.28 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.161 -0.472 . . . . 1.72 111.023 178.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.601 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.1 ppp? -69.28 -23.36 63.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.146 0.498 . . . . 1.76 110.159 -175.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.474 HG21 ' HA ' ' A' ' 3' ' ' HIS . 54.9 m -67.64 -52.32 39.56 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.603 -0.726 . . . . 1.04 110.057 175.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.612 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 12.6 mt -70.87 -57.65 4.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.157 -0.929 . . . . 1.05 111.585 -173.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.526 ' HG2' ' HB3' ' A' ' 48' ' ' LEU . 45.2 mt-30 -50.78 -28.22 8.84 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.679 0.622 . . . . 1.45 112.679 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -65.02 -45.84 83.84 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.788 -0.819 . . . . 0.66000000000000003 108.788 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.526 HG23 ' HB1' ' A' ' 25' ' ' ALA . 72.0 mt -63.21 -43.8 98.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.029 -1.441 . . . . 1.04 110.93 176.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.573 HG22 ' HD2' ' A' ' 112' ' ' LYS . 1.2 mt -62.4 -61.2 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.522 -0.763 . . . . 1.04 111.112 -174.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.7 m -52.99 -28.14 22.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.99 0.424 . . . . 1.6100000000000001 111.261 173.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -71.98 -35.58 69.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.184 0.516 . . . . 4.3899999999999997 110.665 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.467 ' OH ' ' HA ' ' A' ' 24' ' ' PRO . 12.8 m-85 -88.45 -18.85 27.41 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.752 -0.658 . . . . 0.71999999999999997 112.208 -178.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.573 ' HD2' HG22 ' A' ' 108' ' ' ILE . 10.2 mtpp -86.44 -24.58 25.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.004 0.43 . . . . 2.25 110.535 177.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -76.77 -20.87 55.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.709 -0.678 . . . . 1.5600000000000001 109.527 173.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -120.1 32.04 6.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.233 -0.894 . . . . 1.3400000000000001 110.346 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.8 t70 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.539 -0.743 . . . . 2.1600000000000001 110.049 179.258 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.886 0 N-CA-C 112.328 -0.309 . . . . 25.670000000000002 112.328 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -163.98 24.28 0.18 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.918 -0.658 . . . . 24.66 111.601 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -169.77 88.34 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 111.481 -0.648 . . . . 24.199999999999999 111.481 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -114.53 76.56 0.25 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.841 -0.904 . . . . 23.140000000000001 110.841 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 66.96 50.24 1.07 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.473 0.654 . . . . 24.920000000000002 109.392 -173.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -127.49 119.0 25.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.607 -0.724 . . . . 21.449999999999999 110.233 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 18.5 t 57.4 60.21 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.517 0.675 . . . . 20.68 109.942 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . 0.515 ' OE1' ' HG2' ' A' ' 84' ' ' PRO . 36.2 tt0 -63.47 114.78 4.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.454 -0.794 . . . . 18.16 111.245 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 88.6 mmm -130.28 37.5 3.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.386 -0.824 . . . . 17.260000000000002 108.961 175.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -79.46 141.44 36.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.149 -0.932 . . . . 13.68 110.725 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 43.8 m 54.32 60.8 3.35 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.851 0.719 . . . . 10.91 111.288 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.26 -13.66 59.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.558 -0.746 . . . . 11.029999999999999 110.956 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -29.59 68.32 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.832 0.349 . . . . 10.94 110.325 175.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -70.92 -57.61 4.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.091 0.472 . . . . 9.8200000000000003 109.958 170.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 56.2 m -155.97 134.26 11.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.885 -0.598 . . . . 5.9100000000000001 109.965 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -89.14 -64.45 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.108 -0.496 . . . . 6.2000000000000002 110.489 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -85.02 -32.7 22.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.828 -0.623 . . . . 6.1399999999999997 110.88 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 73.76 -15.89 0.54 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.276 -0.874 . . . . 3.3199999999999998 112.346 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 98.35 -7.64 62.01 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.075 -0.583 . . . . 1.1200000000000001 113.356 173.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 261' ' ' PHE . . . . . 0.467 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 5.7 m-30 -128.55 162.94 26.07 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.439 -0.578 . . . . 0.97999999999999998 109.439 -177.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 27.9 m -136.09 169.53 20.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.564 -0.532 . . . . 1.8999999999999999 109.564 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 263' ' ' GLU . . . . . 0.474 ' HA ' HE22 ' A' ' 105' ' ' GLN . 0.0 OUTLIER -102.36 120.33 40.32 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.503 -0.479 . . . . 2.2400000000000002 110.715 173.037 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.09 101.51 12.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.959 -0.756 . . . . 1.8899999999999999 108.959 173.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.607 -0.711 . . . . 3.04 109.975 -176.595 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo . . . . . 0 N--CA 1.479 0.641 0 N-CA-C 110.769 -0.512 . . . . 3.8100000000000001 110.769 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.8 t -174.32 -35.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.219 0.533 . . . . 1.8400000000000001 110.194 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.574 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -82.87 23.73 0.8 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.532 -0.758 . . . . 2.3900000000000001 111.392 -176.246 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.435 ' HG ' ' C ' ' A' ' 3' ' ' HIS . 34.0 m -160.75 149.54 16.64 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.395 -0.594 . . . . 1.6100000000000001 109.395 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.23 150.07 7.67 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.561 -1.016 . . . . 0.17000000000000001 110.561 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.693 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -76.62 139.29 40.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 117.49 0.645 . . . . 0.97999999999999998 111.416 -175.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.79 158.05 43.88 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.216 0.531 . . . . 1.01 111.119 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.541 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.1 mp -99.55 129.7 49.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.284 -0.636 . . . . 1.0800000000000001 109.284 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.571 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 85.3 t80 -138.56 116.0 11.24 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.263 -0.426 . . . . 0.66000000000000003 109.941 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 67.56 42.65 2.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.436 0.636 . . . . 1.46 110.739 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt 68.99 10.51 7.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.327 -1.306 . . . . 2.3900000000000001 112.484 173.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -113.53 132.24 63.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.996 0.427 . . . . 1.23 110.311 173.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.541 ' HA ' HG13 ' A' ' 8' ' ' ILE . 32.6 t -77.75 117.68 19.37 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.833 -0.621 . . . . 1.48 109.952 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.645 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -137.23 -157.33 7.58 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.928 -0.653 . . . . 0.16 112.141 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.693 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 9.3 mm -127.04 153.42 36.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 120.827 0.346 . . . . 1.05 110.795 -176.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.455 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -123.95 132.8 70.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 115.883 -0.599 . . . . 1.01 109.675 179.022 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.93 109.54 7.47 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.109 0.411 . . . . 0.87 112.109 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.574 ' O ' ' HB3' ' A' ' 3' ' ' HIS . 4.0 mp -85.38 103.43 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.001 -0.74 . . . . 1.05 109.001 171.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.419 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -110.44 129.6 55.74 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.724 -0.39 . . . . 1.1200000000000001 110.202 -179.078 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.501 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 39.6 mt-10 -107.78 84.19 1.92 Allowed 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 116.811 -1.956 . . . . 0.73999999999999999 107.345 164.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.419 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 17.2 t70 -121.77 -10.72 8.69 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 106.568 -1.641 . . . . 0.58999999999999997 106.568 156.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 23' ' ' SER . 13.6 p -101.56 179.35 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 111.946 -2.388 . . . . 1.0800000000000001 111.19 -157.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.566 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -52.44 167.2 0.38 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 117.974 -1.012 . . . . 2.0 108.338 168.019 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.549 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 15.8 Cg_endo -44.36 126.17 6.47 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.494 1.463 . . . . 0.26000000000000001 111.525 -156.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.501 ' HB2' ' HG2' ' A' ' 20' ' ' GLU . . . -25.67 132.76 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.99 1.431 . . . . 1.02 114.725 -151.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.513 ' HB2' HG12 ' A' ' 22' ' ' VAL . 39.7 mt-10 -124.99 139.46 53.8 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.201 -0.909 . . . . 1.26 110.929 -172.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.593 HD22 ' C ' ' A' ' 27' ' ' LEU . 1.1 tt -101.31 143.28 31.55 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 106.831 -1.544 . . . . 1.0600000000000001 106.831 175.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.6 m -130.17 108.99 10.46 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.688 -0.805 . . . . 1.05 110.519 -178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.643 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 89.8 t90 -86.63 113.01 22.15 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.471 0.653 . . . . 0.29999999999999999 109.417 174.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -120.47 120.78 36.88 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.173 -0.921 . . . . 1.1599999999999999 109.157 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.44 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 20.1 m -55.9 141.35 39.55 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.771 -0.455 . . . . 1.3899999999999999 109.771 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.645 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 28.8 m -54.15 -31.84 53.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.31 -0.859 . . . . 1.1499999999999999 111.018 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -89.6 -9.21 50.6 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.236 -0.438 . . . . 2.3300000000000001 111.599 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.01 18.8 57.29 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.979 -0.629 . . . . 0.55000000000000004 112.553 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -72.46 -68.38 0.48 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.338 . . . . 1.1299999999999999 111.527 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -110.0 152.29 26.09 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.217 0.532 . . . . 2.6200000000000001 111.626 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 85.2 t -138.06 117.74 15.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.283 -0.871 . . . . 1.3100000000000001 109.877 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -123.74 113.66 18.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.191 -0.459 . . . . 0.82999999999999996 110.148 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.7 m -100.69 143.72 30.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.664 -0.243 . . . . 1.0600000000000001 111.027 -175.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 43.1 t -117.69 128.24 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 111.797 0.295 . . . . 1.3600000000000001 111.797 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 45' ' ' ILE . 33.3 t -90.63 107.93 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.279 0.561 . . . . 1.05 109.61 173.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.57 HD12 ' CD2' ' A' ' 104' ' ' LEU . 1.9 mm? -54.44 -29.83 50.78 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.806 -1.088 . . . . 1.04 112.565 -177.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.549 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 72.5 m -74.4 -34.77 63.38 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.514 -0.475 . . . . 1.45 111.46 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -74.62 -16.51 60.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.483 0.658 . . . . 1.04 109.468 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.549 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 43.3 mm -75.44 118.3 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 115.156 -0.929 . . . . 1.02 111.551 175.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.606 ' CA ' ' HD2' ' A' ' 65' ' ' LYS . 11.1 t70 -74.74 -49.59 20.5 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.423 -0.808 . . . . 0.69999999999999996 111.237 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -134.09 150.92 51.19 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 116.765 -0.198 . . . . 2.4300000000000002 110.58 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.551 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 12.3 tp -115.92 143.18 45.79 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.985 -0.746 . . . . 1.04 108.985 164.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.498 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 7.2 mt-30 -124.24 152.19 43.26 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.09 -0.959 . . . . 1.49 109.603 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.03 143.3 10.8 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.737 -0.838 . . . . 1.0 108.737 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 40.9 p -47.48 127.09 10.2 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-O 121.565 0.698 . . . . 1.03 111.025 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 61.4 Cg_endo -70.17 166.68 27.3 Favored 'Trans proline' 0 C--N 1.33 -0.402 0 C-N-CA 124.152 3.235 . . . . 0.73999999999999999 112.015 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.85 -29.51 59.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.903 0.382 . . . . 1.54 110.896 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.4 m -69.62 -25.59 64.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.96 -0.563 . . . . 2.0499999999999998 111.156 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 37.6 t -74.78 137.31 41.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.974 -0.557 . . . . 1.1399999999999999 110.09 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -91.54 -0.07 57.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.669 0.747 . . . . 2.8900000000000001 109.582 175.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.3 mmmt -107.98 176.55 5.1 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.946 -1.024 . . . . 3.1299999999999999 109.985 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.523 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -137.15 109.48 7.34 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.108 -0.701 . . . . 2.0 109.108 -178.166 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.564 ' HG2' ' HA ' ' A' ' 90' ' ' SER . 68.0 mtm -157.09 140.71 15.89 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.478 0.18 . . . . 1.3 111.102 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.858 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 1.4 mp -110.15 160.05 16.82 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.23 -0.441 . . . . 1.05 111.074 174.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.423 ' CZ ' ' HG3' ' A' ' 86' ' ' ARG . 21.8 ttt180 -153.31 114.88 4.23 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 121.208 0.528 . . . . 3.3999999999999999 111.456 169.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.509 ' HG ' HD13 ' A' ' 48' ' ' LEU . 8.9 mt -92.86 110.19 21.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.864 -0.607 . . . . 1.73 110.813 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.512 ' HA ' ' HB3' ' A' ' 86' ' ' ARG . 3.9 mm -87.55 126.28 41.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 123.111 0.564 . . . . 1.1599999999999999 110.456 -176.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -87.6 152.28 23.98 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.33 -0.938 . . . . 0.47999999999999998 111.019 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.606 ' HD2' ' CA ' ' A' ' 46' ' ' ASP . 10.2 mptt -59.01 136.06 57.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.01 0.405 . . . . 1.78 110.394 178.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.41 ' HB ' ' HG3' ' A' ' 84' ' ' PRO . 9.3 p -72.23 157.66 6.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.774 -0.648 . . . . 1.3100000000000001 109.743 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -59.18 140.1 56.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.902 -0.59 . . . . 2.5600000000000001 110.706 -176.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -56.48 -17.1 7.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.64 -1.164 . . . . 3.79 113.196 -174.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.3 p -87.58 -11.83 47.5 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.892 -0.323 . . . . 3.3399999999999999 111.374 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 45.73 -90.99 0.01 OUTLIER 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.082 0.953 . . . . 5.8200000000000003 113.311 -174.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -61.49 139.62 58.2 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.813 0.816 . . . . 4.7400000000000002 111.689 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.8 ptt85 -128.22 174.0 9.65 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.65 -1.159 . . . . 4.7300000000000004 108.568 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.481 ' HD2' ' O ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -145.58 131.06 18.72 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.27 0.557 . . . . 5.5300000000000002 110.138 177.35 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.57 ' HB3' ' OD1' ' A' ' 78' ' ' ASN . 5.2 t70 -76.21 174.53 10.01 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.326 -0.99 . . . . 4.9800000000000004 108.326 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.428 ' H ' ' CG ' ' A' ' 74' ' ' ASP . 33.6 m-80 -54.74 -15.4 1.85 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.133 1.16 . . . . 7.1100000000000003 114.133 -165.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -87.93 -18.77 28.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.681 0.753 . . . . 7.1299999999999999 109.8 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.6 23.17 47.93 Favored Glycine 0 CA--C 1.506 -0.511 0 N-CA-C 108.972 -1.651 . . . . 5.7300000000000004 108.972 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.57 ' OD1' ' HB3' ' A' ' 74' ' ' ASP . 5.3 p30 -70.8 -31.49 68.25 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 113.04 -1.58 . . . . 5.6200000000000001 112.301 -173.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 53.0 mt-10 85.89 118.74 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.401 1.063 . . . . 5.0 111.483 173.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.92 147.63 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 108.041 -1.096 . . . . 3.5800000000000001 108.041 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 52.0 t -117.6 96.55 49.59 Favored Pre-proline 0 C--N 1.3 -1.585 0 CA-C-O 121.588 0.709 . . . . 3.1499999999999999 110.078 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.82 128.91 9.58 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.52 2.813 . . . . 2.0800000000000001 112.629 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -78.59 152.69 78.25 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.724 -0.671 . . . . 3.5299999999999998 110.076 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.41 ' HG3' ' HB ' ' A' ' 66' ' ' VAL . 31.1 Cg_exo -51.55 140.72 44.35 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.028 2.486 . . . . 0.75 112.732 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -79.35 155.02 28.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.825 -0.805 . . . . 1.78 108.825 177.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.512 ' HB3' ' HA ' ' A' ' 63' ' ' ILE . 9.6 ptt180 -156.55 160.03 39.1 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.962 -0.563 . . . . 2.8199999999999998 111.669 -166.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -120.29 111.44 17.78 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.594 -0.73 . . . . 0.63 110.058 -172.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.416 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 49.2 ttm -107.51 126.92 53.13 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.501 -0.124 . . . . 1.1200000000000001 110.914 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.424 ' CD2' ' HB2' ' A' ' 9' ' ' PHE . 50.7 m-85 -116.19 143.72 45.13 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.647 -0.872 . . . . 1.6499999999999999 108.647 174.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.564 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 14.9 m -99.11 123.7 43.6 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.974 0.416 . . . . 1.1899999999999999 110.197 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.858 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 7.5 m-85 -108.52 157.17 18.71 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.064 -0.517 . . . . 1.6399999999999999 110.246 -176.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -113.67 -6.34 13.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.904 0.383 . . . . 1.8300000000000001 111.239 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -128.3 124.33 36.25 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.2 0.524 . . . . 1.22 110.145 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.428 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 29.8 tpt180 -57.24 -36.75 71.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.961 -1.018 . . . . 2.8799999999999999 111.175 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 85.2 m -74.04 -55.42 6.14 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.7 -0.682 . . . . 1.1200000000000001 110.83 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 88.4 t -46.05 -55.21 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.125 -0.489 . . . . 1.1299999999999999 111.352 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.523 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -66.88 -28.34 68.24 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.895 -0.322 . . . . 1.0600000000000001 110.808 -177.431 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.15 -31.87 70.83 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.049 -0.723 . . . . 0.39000000000000001 109.049 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.592 ' O ' ' HG3' ' A' ' 102' ' ' MET . 90.7 m-20 -77.78 -46.31 22.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.559 -1.2 . . . . 1.55 109.726 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.494 HG21 HD13 ' A' ' 18' ' ' ILE . 35.4 mm -58.6 -51.54 70.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.104 -0.953 . . . . 1.0600000000000001 110.393 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 4.1 ttpt -57.01 -51.39 69.46 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.886 -0.597 . . . . 1.72 110.429 178.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.592 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.3 ppp? -64.94 -25.18 67.77 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.903 0.383 . . . . 1.76 110.716 -175.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.7 m -66.02 -51.62 56.65 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.452 0.644 . . . . 1.04 110.128 175.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.57 ' CD2' HD12 ' A' ' 42' ' ' LEU . 8.7 mt -70.09 -55.95 8.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.88 -1.055 . . . . 1.05 110.927 -175.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 101' ' ' LYS . 18.7 mm-40 -42.92 -36.15 1.43 Allowed 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.694 0.621 . . . . 1.45 112.664 177.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -65.42 -32.97 74.88 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.919 0.866 . . . . 0.66000000000000003 109.663 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.519 HD11 ' HA ' ' A' ' 104' ' ' LEU . 42.0 mt -79.69 -41.79 22.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.066 -1.424 . . . . 1.04 110.123 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.554 HG23 ' HD2' ' A' ' 112' ' ' LYS . 0.6 OUTLIER -66.63 -51.34 57.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.248 -0.887 . . . . 1.04 110.87 -176.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.508 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 13.6 t -59.41 -29.03 67.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.411 0.624 . . . . 1.6100000000000001 109.509 175.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.44 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 10.6 ttt180 -66.3 -34.19 77.44 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.043 -0.98 . . . . 4.3899999999999997 109.949 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -94.74 -14.55 24.66 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 116.047 -0.524 . . . . 0.71999999999999997 111.472 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.554 ' HD2' HG23 ' A' ' 108' ' ' ILE . 10.4 mtpp -80.9 -29.0 35.72 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.708 -0.479 . . . . 2.25 109.708 173.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.08 -17.74 59.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.629 0.728 . . . . 1.5600000000000001 109.149 172.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -108.83 20.51 18.39 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.15 -0.932 . . . . 1.3400000000000001 110.665 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.8 t70 . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.548 -0.739 . . . . 2.1600000000000001 109.593 177.678 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' B' ' 246' ' ' TYR . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 111.454 -0.659 . . . . 25.670000000000002 111.454 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -68.0 -30.43 74.09 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.89 -0.671 . . . . 24.66 112.591 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -80.78 72.73 2.66 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.855 -0.688 . . . . 24.199999999999999 112.356 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 100.61 73.81 1.06 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.705 -0.759 . . . . 23.140000000000001 112.313 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 246' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' B' ' 242' ' ' GLY . 50.5 p90 -117.72 -16.51 10.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.032 0.444 . . . . 24.920000000000002 111.272 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -89.93 104.24 16.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.122 -0.49 . . . . 21.449999999999999 110.522 -172.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 9.4 p 43.04 39.56 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 122.463 1.125 . . . . 20.68 111.202 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -118.55 117.35 28.74 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.977 -1.01 . . . . 18.16 110.846 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 2.3 ppp? -143.95 23.17 1.73 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.764 -1.107 . . . . 17.260000000000002 109.259 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.73 141.23 49.32 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.181 -0.918 . . . . 13.68 111.259 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.3 m -71.83 100.89 2.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.416 -0.811 . . . . 10.91 111.031 -175.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -78.39 -38.36 41.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.032 -0.531 . . . . 11.029999999999999 111.023 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -76.99 -37.72 54.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 10.94 110.731 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -82.44 -15.25 53.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.333 -0.394 . . . . 9.8200000000000003 110.884 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 39.7 t 68.46 104.62 0.05 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.274 -0.875 . . . . 5.9100000000000001 111.093 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -89.91 -40.9 12.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.887 -0.597 . . . . 6.2000000000000002 110.577 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -66.07 -65.14 0.72 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.904 -0.589 . . . . 6.1399999999999997 111.862 -174.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -87.96 -41.8 12.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.237 0.542 . . . . 3.3199999999999998 110.94 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 97.82 0.75 58.85 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.868 -0.893 . . . . 1.1200000000000001 110.868 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 261' ' ' PHE . . . . . 0.498 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 1.5 m-85 -120.87 149.78 42.07 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.419 -0.586 . . . . 0.97999999999999998 109.419 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.85 161.74 23.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.864 0.364 . . . . 1.8999999999999999 111.824 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -90.15 124.48 34.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.818 -0.628 . . . . 2.2400000000000002 109.478 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 59.1 t -115.79 103.11 14.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.803 0.335 . . . . 1.8899999999999999 110.715 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 C--O 1.246 0.902 0 N-CA-C 109.314 -0.624 . . . . 3.04 109.314 177.339 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.415 ' C ' ' H ' ' A' ' 3' ' ' HIS . 11.5 Cg_exo . . . . . 0 N--CA 1.48 0.718 0 N-CA-C 110.169 -0.743 . . . . 3.8100000000000001 110.169 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 99.1 p 63.5 -41.72 0.22 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.299 1.439 . . . . 1.8400000000000001 112.795 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.429 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 13.9 m80 -87.73 22.43 2.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.34 0.59 . . . . 2.3900000000000001 110.077 -178.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.3 p -162.94 151.31 14.14 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.555 -0.748 . . . . 1.6100000000000001 109.278 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.5 146.98 7.06 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.9 -0.88 . . . . 0.17000000000000001 110.9 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.713 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -79.39 117.26 20.2 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 117.209 0.505 . . . . 0.97999999999999998 111.296 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.49 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -125.23 155.95 39.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.349 0.595 . . . . 1.01 111.513 -177.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.492 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 1.9 mp -96.42 119.59 44.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 108.611 -0.885 . . . . 1.0800000000000001 108.611 176.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.421 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 93.2 t80 -119.47 102.82 8.93 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.518 -0.31 . . . . 0.66000000000000003 110.263 -177.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 65.51 55.33 1.04 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.317 0.58 . . . . 1.46 110.939 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt 72.38 -4.81 1.94 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.641 -1.163 . . . . 2.3900000000000001 113.304 171.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -103.99 130.24 54.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.939 0.399 . . . . 1.23 110.488 172.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.474 ' HA ' HG13 ' A' ' 8' ' ' ILE . 32.4 t -78.43 129.4 34.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.882 -0.599 . . . . 1.48 109.953 177.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.621 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -150.68 -159.84 9.02 Favored Glycine 0 N--CA 1.436 -1.321 0 C-N-CA 120.752 -0.737 . . . . 0.16 112.494 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.713 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 6.4 mm -125.97 153.24 33.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 120.768 0.318 . . . . 1.05 110.583 -177.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.89 135.12 63.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 116.114 -0.494 . . . . 1.01 109.861 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.19 110.57 7.44 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.207 0.447 . . . . 0.87 112.207 176.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.524 HD12 HG22 ' A' ' 100' ' ' ILE . 3.7 mp -86.08 121.44 37.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.667 -0.864 . . . . 1.05 108.667 171.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.72 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.7 OUTLIER -126.7 134.28 50.72 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.699 -0.482 . . . . 1.1200000000000001 109.699 179.001 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.508 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 18.0 mt-10 -114.99 83.15 1.86 Allowed 'General case' 0 N--CA 1.425 -1.723 0 C-N-CA 116.513 -2.075 . . . . 0.73999999999999999 107.663 161.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -121.32 -9.79 9.02 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 106.168 -1.79 . . . . 0.58999999999999997 106.168 159.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.72 ' HB ' HD22 ' A' ' 19' ' ' ASN . 13.2 p -103.52 173.82 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 111.583 -2.553 . . . . 1.0800000000000001 111.821 -159.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.658 ' O ' HG12 ' A' ' 22' ' ' VAL . 16.3 m -55.08 166.28 0.85 Allowed Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 106.692 -1.596 . . . . 2.0 106.692 165.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 10.1 Cg_endo -40.55 128.06 2.44 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 121.601 1.608 . . . . 0.26000000000000001 111.775 -147.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.537 ' HB1' HG21 ' A' ' 107' ' ' ILE . . . -28.2 132.78 0.04 OUTLIER 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 125.466 1.729 . . . . 1.02 113.217 -160.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.647 ' HB3' HG11 ' A' ' 22' ' ' VAL . 35.4 tt0 -130.58 132.04 45.32 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 115.229 -0.896 . . . . 1.26 111.244 -161.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.596 ' C ' HD21 ' A' ' 27' ' ' LEU . 1.5 tt -100.83 144.94 29.18 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 106.94 -1.504 . . . . 1.0600000000000001 106.94 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.497 ' N ' HD21 ' A' ' 27' ' ' LEU . 9.8 m -133.22 108.91 9.07 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.161 -0.616 . . . . 1.05 110.274 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.605 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.3 t90 -89.87 109.8 20.78 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.647 0.737 . . . . 0.29999999999999999 109.056 176.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 30' ' ' ARG . 13.1 ttt-85 -113.35 121.35 44.09 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.132 -0.94 . . . . 1.1599999999999999 109.236 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.455 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 88.9 p -57.33 148.02 24.13 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.078 -0.342 . . . . 1.3899999999999999 110.078 -177.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.621 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 33.4 m -48.42 -38.13 18.85 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.084 0.468 . . . . 1.1499999999999999 110.618 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -68.32 -28.03 66.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.628 -0.715 . . . . 2.3300000000000001 111.642 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.74 21.55 46.68 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.034 -0.603 . . . . 0.55000000000000004 112.068 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -104.91 -37.43 7.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.324 0.583 . . . . 1.1299999999999999 110.816 -172.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -114.61 120.65 40.9 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.587 -0.733 . . . . 2.6200000000000001 109.998 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.5 t -123.52 118.91 55.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.992 0.425 . . . . 1.3100000000000001 110.348 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -119.41 109.96 16.38 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.98 -0.555 . . . . 0.82999999999999996 110.237 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.9 m -95.69 143.32 27.05 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.471 -0.331 . . . . 1.0600000000000001 111.448 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 30.1 t -120.83 124.37 72.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.295 -0.411 . . . . 1.3600000000000001 111.16 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 45' ' ' ILE . 49.1 t -90.54 107.75 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 109.282 -0.636 . . . . 1.05 109.282 174.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.567 HD13 ' CD2' ' A' ' 104' ' ' LEU . 2.4 mm? -51.92 -29.09 18.66 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.957 -1.019 . . . . 1.04 112.67 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.1 t -71.8 -35.59 70.02 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.583 -0.447 . . . . 1.45 110.803 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.2 p -76.36 -13.82 60.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.081 0.467 . . . . 1.04 109.857 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.565 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 46.6 mm -79.84 121.17 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.579 -0.737 . . . . 1.02 111.391 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.62 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 34.0 t70 -81.78 -40.56 22.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.538 0.685 . . . . 0.69999999999999996 110.881 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.551 ' HB2' ' CG1' ' A' ' 63' ' ' ILE . 46.0 mmtm -136.27 142.34 43.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.103 -0.953 . . . . 2.4300000000000002 110.932 -172.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.533 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 12.7 tp -118.0 138.04 52.46 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.457 0.646 . . . . 1.04 109.302 164.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 14.0 mm100 -119.28 157.19 28.57 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.456 -1.247 . . . . 1.49 109.277 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.33 148.92 16.86 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.517 -1.29 . . . . 1.0 107.517 177.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.447 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 27.4 p -52.77 126.91 42.43 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 121.377 0.608 . . . . 1.03 111.083 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 50.1 Cg_endo -67.46 165.63 26.5 Favored 'Trans proline' 0 C--N 1.329 -0.461 0 C-N-CA 123.584 2.856 . . . . 0.73999999999999999 111.068 176.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.34 -23.04 66.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.125 0.488 . . . . 1.54 110.353 176.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.3 m -73.74 -24.91 59.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.679 -0.691 . . . . 2.0499999999999998 111.346 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 36.3 t -71.41 145.17 49.49 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.882 -0.414 . . . . 1.1399999999999999 109.882 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -90.55 -6.05 55.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.272 0.558 . . . . 2.8900000000000001 109.95 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -111.67 174.44 5.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.201 -0.909 . . . . 3.1299999999999999 109.997 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.632 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 3.5 mmt -131.38 108.76 9.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.174 -0.676 . . . . 2.0 109.174 176.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.516 ' HG3' ' H ' ' A' ' 91' ' ' PHE . 3.9 mpp? -154.42 168.1 27.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.08 0.467 . . . . 1.3 111.666 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 101' ' ' LYS . 1.1 mp -126.52 161.32 28.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.339 -0.846 . . . . 1.05 111.001 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 50.0 ttp180 -153.54 114.38 4.07 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.607 0.241 . . . . 3.3999999999999999 110.986 169.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.536 ' CD2' HG22 ' A' ' 45' ' ' ILE . 12.6 mt -94.43 109.33 21.2 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.702 0.401 . . . . 1.73 110.942 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.551 ' CG1' ' HB2' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -87.4 118.97 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 123.041 0.536 . . . . 1.1599999999999999 110.081 -176.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -80.87 152.56 33.4 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.98 -1.105 . . . . 0.47999999999999998 111.369 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.62 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 6.9 mptt -63.63 139.24 58.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.109 0.454 . . . . 1.78 110.306 176.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.8 p -91.74 156.88 2.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.007 -0.738 . . . . 1.3100000000000001 109.007 172.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -81.41 90.53 6.19 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.29 0.567 . . . . 2.5600000000000001 110.879 -175.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -84.73 -2.44 57.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.299 -0.864 . . . . 3.79 111.875 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.2 p -57.17 -40.04 76.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.781 0.324 . . . . 3.3399999999999999 111.295 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.83 142.86 24.0 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 110.065 -0.346 . . . . 5.8200000000000003 110.065 174.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -65.92 133.7 51.44 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.113 -0.494 . . . . 4.7400000000000002 110.247 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.503 ' CG ' ' HB ' ' A' ' 80' ' ' VAL . 4.3 ptm180 -76.23 170.51 16.19 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.874 -0.788 . . . . 4.7300000000000004 108.874 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -142.66 147.42 35.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.033 0.444 . . . . 5.5300000000000002 111.563 -174.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -85.01 -157.57 0.31 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.405 -0.816 . . . . 4.9800000000000004 110.915 -174.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -58.03 -30.43 66.11 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.392 0.516 . . . . 7.1100000000000003 112.392 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -89.17 -14.14 36.76 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.675 0.75 . . . . 7.1299999999999999 110.317 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' A' ' 73' ' ' LYS . . . 86.52 32.45 15.95 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 109.477 -1.449 . . . . 5.7300000000000004 109.477 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -85.83 -89.08 0.11 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.881 -1.159 . . . . 5.6200000000000001 111.085 -170.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 10.4 pt-20 -178.74 131.03 0.12 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.202 0.525 . . . . 5.0 110.681 173.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.503 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.4 t -126.88 148.21 31.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.414 -0.958 . . . . 3.5800000000000001 108.414 172.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.4 p -108.39 98.22 26.52 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-O 121.848 0.832 . . . . 3.1499999999999999 109.955 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.409 ' HD3' ' HG2' ' A' ' 72' ' ' ARG . 57.6 Cg_endo -71.19 140.47 37.46 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.877 2.385 . . . . 2.0800000000000001 112.804 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.0 ttpp -79.85 137.52 54.09 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.659 -0.7 . . . . 3.5299999999999998 110.261 175.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -58.56 137.24 79.15 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.917 2.411 . . . . 0.75 111.729 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.403 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 0.2 OUTLIER -74.02 114.19 12.06 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 122.352 1.072 . . . . 1.78 109.553 177.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.488 ' HB3' HG22 ' A' ' 63' ' ' ILE . 9.2 ptt180 -113.77 146.02 40.52 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.626 -1.17 . . . . 2.8199999999999998 110.063 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.429 ' CD2' HG22 ' A' ' 40' ' ' VAL . 45.2 m-70 -113.2 111.85 22.78 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.324 -0.853 . . . . 0.63 109.61 -170.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.503 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 53.9 ttm -104.43 126.03 51.15 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.237 -0.585 . . . . 1.1200000000000001 111.395 -176.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.417 ' CE2' HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -115.65 122.36 45.35 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 109.004 -0.739 . . . . 1.6499999999999999 109.004 178.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.492 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 16.1 m -89.56 124.04 34.18 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.835 -0.621 . . . . 1.1899999999999999 110.379 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.592 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 30.5 m-85 -107.29 174.15 6.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.042 -0.526 . . . . 1.6399999999999999 109.753 174.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -122.56 -5.33 8.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.256 -0.429 . . . . 1.8300000000000001 110.126 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -127.82 135.4 50.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.446 0.641 . . . . 1.22 111.135 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.541 ' N ' ' HG3' ' A' ' 58' ' ' MET . 28.0 tpt180 -65.84 -35.18 79.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.531 -1.213 . . . . 2.8799999999999999 111.102 -174.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.403 HG22 HD22 ' A' ' 99' ' ' ASN . 94.7 m -76.27 -52.96 8.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.831 -0.622 . . . . 1.1200000000000001 111.112 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.3 t -45.29 -56.73 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 116.276 -0.42 . . . . 1.1299999999999999 111.437 175.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.632 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -66.56 -29.25 69.27 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.194 -0.457 . . . . 1.0600000000000001 110.718 -178.104 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -66.71 -33.47 75.71 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.121 -0.696 . . . . 0.39000000000000001 109.121 176.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.574 ' O ' ' HG3' ' A' ' 102' ' ' MET . 86.9 m-20 -75.23 -50.9 14.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.651 -1.159 . . . . 1.55 109.808 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.592 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 35.2 mm -56.59 -52.27 55.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.037 -0.983 . . . . 1.0600000000000001 110.685 177.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.438 ' HA ' HD23 ' A' ' 60' ' ' LEU . 4.9 ttpt -55.82 -49.16 74.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.723 -0.672 . . . . 1.72 111.321 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.574 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.2 ppp? -68.88 -24.15 64.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.847 0.356 . . . . 1.76 110.444 -176.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 55.2 m -67.58 -51.81 46.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.436 0.636 . . . . 1.04 110.027 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.567 ' CD2' HD13 ' A' ' 42' ' ' LEU . 10.6 mt -68.02 -56.39 9.09 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.989 -1.005 . . . . 1.05 111.187 -175.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.497 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 70.9 mt-30 -46.44 -31.62 2.79 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.207 0.818 . . . . 1.45 113.207 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -68.78 -27.93 66.33 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.048 0.927 . . . . 0.66000000000000003 109.692 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.537 HG21 ' HB1' ' A' ' 25' ' ' ALA . 64.8 mt -83.58 -43.68 18.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.008 -1.451 . . . . 1.04 110.148 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.59 HG22 ' HD2' ' A' ' 112' ' ' LYS . 0.8 OUTLIER -62.38 -53.56 45.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.975 -1.011 . . . . 1.04 110.28 -177.156 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.8 t -59.05 -28.07 66.1 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.682 -0.69 . . . . 1.6100000000000001 110.001 176.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 11.3 ttt180 -69.47 -34.35 74.22 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.202 -0.908 . . . . 4.3899999999999997 110.051 178.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -88.08 -28.98 20.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.527 -0.76 . . . . 0.71999999999999997 111.319 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.59 ' HD2' HG22 ' A' ' 108' ' ' ILE . 3.5 mtpp -76.99 -14.13 59.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.429 0.633 . . . . 2.25 109.989 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -76.5 -22.09 54.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.197 -0.91 . . . . 1.5600000000000001 109.624 172.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -104.16 -33.75 8.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.51 -0.768 . . . . 1.3400000000000001 111.516 -177.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.1 t70 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.57 -0.728 . . . . 2.1600000000000001 111.12 -177.602 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.573 0 N-CA-C 111.838 -0.505 . . . . 25.670000000000002 111.838 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 81.11 -163.86 45.62 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.748 -0.739 . . . . 24.66 112.354 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -129.08 -156.9 9.06 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.728 -0.549 . . . . 24.199999999999999 111.728 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.52 -7.37 81.48 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.729 -0.748 . . . . 23.140000000000001 112.665 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -78.55 -34.22 47.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.74 0.781 . . . . 24.920000000000002 109.609 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -125.01 152.92 43.59 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.786 -1.097 . . . . 21.449999999999999 108.868 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.3 76.38 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.312 0.577 . . . . 20.68 110.203 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -107.41 114.96 29.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.865 -0.607 . . . . 18.16 110.304 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 21.6 ptm -139.35 17.01 2.58 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.455 -0.572 . . . . 17.260000000000002 109.455 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.26 148.1 45.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.176 -0.92 . . . . 13.68 110.699 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 252' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' B' ' 256' ' ' SER . 22.3 t 77.5 -18.92 0.46 Allowed 'General case' 0 C--N 1.332 -0.19 0 O-C-N 123.886 0.741 . . . . 10.91 110.985 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -81.36 -54.72 5.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.17 0.51 . . . . 11.029999999999999 109.702 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.75 -46.43 17.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.403 -0.817 . . . . 10.94 111.896 -177.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -65.04 -21.69 66.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.927 0.394 . . . . 9.8200000000000003 111.384 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 256' ' ' SER . . . . . 0.536 ' HB3' ' CG ' ' B' ' 259' ' ' ASP . 69.0 m -96.39 72.23 2.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.417 0.627 . . . . 5.9100000000000001 109.672 173.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -72.7 -43.74 62.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.238 -0.892 . . . . 6.2000000000000002 112.038 -174.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -72.0 -25.48 61.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.19 0.519 . . . . 6.1399999999999997 110.298 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.536 ' CG ' ' HB3' ' B' ' 256' ' ' SER . 2.1 m-20 -67.24 -70.22 0.26 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.211 -0.904 . . . . 3.3199999999999998 109.07 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 78.45 42.69 13.88 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.899 -1.143 . . . . 1.1200000000000001 114.678 171.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 261' ' ' PHE . . . . . 0.442 ' CE1' ' HE2' ' A' ' 59' ' ' MET . 5.9 m-30 -121.36 150.9 40.78 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.323 -0.621 . . . . 0.97999999999999998 109.323 176.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.3 p -134.99 152.83 33.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.162 -0.31 . . . . 1.8999999999999999 110.162 -177.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -78.62 146.45 34.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.109 -0.7 . . . . 2.2400000000000002 109.109 172.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 85.6 t -96.51 103.59 14.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.152 0.501 . . . . 1.8899999999999999 110.259 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 34.4 t70 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.508 -0.758 . . . . 3.04 110.128 -177.118 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo . . . . . 0 N--CA 1.481 0.738 0 N-CA-C 110.584 -0.583 . . . . 3.8100000000000001 110.584 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.6 p -102.04 -26.67 13.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.934 0.397 . . . . 1.8400000000000001 111.328 -177.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.2 m170 -92.26 20.78 5.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.241 0.544 . . . . 2.3900000000000001 110.397 -175.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.5 p -163.98 149.06 10.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.639 -0.71 . . . . 1.6100000000000001 110.034 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.95 143.12 5.66 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 111.119 -0.792 . . . . 0.17000000000000001 111.119 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.711 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.31 121.72 22.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 117.468 0.634 . . . . 0.97999999999999998 111.047 -177.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.497 ' HB3' ' CE1' ' A' ' 91' ' ' PHE . . . -131.59 157.22 44.22 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 121.327 0.584 . . . . 1.01 111.697 -176.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 2.5 mp -95.08 114.58 31.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.477 -0.783 . . . . 1.0800000000000001 109.291 175.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.594 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 74.8 t80 -122.58 111.32 16.65 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.191 -0.459 . . . . 0.66000000000000003 110.031 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.502 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 40.3 mt-10 71.61 47.35 0.35 Allowed 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 124.072 0.857 . . . . 1.46 110.623 -176.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.502 ' HD2' ' C ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER 65.79 8.97 5.65 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.522 -1.217 . . . . 2.3900000000000001 112.658 173.664 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.38 135.2 57.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.869 0.366 . . . . 1.23 110.436 174.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.509 ' HA ' HG13 ' A' ' 8' ' ' ILE . 23.7 t -78.25 124.99 28.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.289 0.566 . . . . 1.48 110.219 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.648 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -146.85 -156.7 7.04 Favored Glycine 0 N--CA 1.437 -1.26 0 CA-C-N 115.654 -0.703 . . . . 0.16 112.341 -178.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.711 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.1 mm -126.95 153.8 36.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.799 0.333 . . . . 1.05 110.582 -177.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.422 HD13 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -126.86 133.34 68.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 116.026 -0.534 . . . . 1.01 109.91 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.35 113.13 9.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.34 -0.391 . . . . 0.87 111.618 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.529 HD11 HG22 ' A' ' 100' ' ' ILE . 4.1 mp -84.43 121.76 37.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.002 -1.11 . . . . 1.05 108.002 171.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.418 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 2.1 t30 -126.26 125.84 43.02 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.99 -0.374 . . . . 1.1200000000000001 109.99 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.469 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 20.8 mt-10 -110.6 83.9 1.84 Allowed 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 116.928 -1.909 . . . . 0.73999999999999999 107.616 163.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.418 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 13.7 t70 -120.87 -8.74 9.37 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.001 -1.851 . . . . 0.58999999999999997 106.001 157.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.699 HG12 ' O ' ' A' ' 23' ' ' SER . 14.9 p -102.46 173.76 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 111.75 -2.477 . . . . 1.0800000000000001 111.982 -158.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.699 ' O ' HG12 ' A' ' 22' ' ' VAL . 4.4 m -54.51 168.1 0.51 Allowed Pre-proline 0 C--O 1.223 -0.319 0 N-CA-C 106.853 -1.536 . . . . 2.0 106.853 165.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 10.2 Cg_endo -40.86 127.81 2.64 Favored 'Trans proline' 0 C--N 1.356 0.938 0 CA-C-N 122.016 1.756 . . . . 0.26000000000000001 111.239 -152.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.532 ' HB3' HG23 ' A' ' 107' ' ' ILE . . . -33.9 136.23 0.12 Allowed 'General case' 0 CA--C 1.504 -0.793 0 O-C-N 125.361 1.663 . . . . 1.02 113.621 -156.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.501 ' HB2' HG11 ' A' ' 22' ' ' VAL . 74.3 mt-10 -124.8 140.29 53.07 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.387 -1.279 . . . . 1.26 111.191 -169.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.592 HD22 ' C ' ' A' ' 27' ' ' LEU . 1.2 tt -101.58 142.41 32.99 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.419 -1.697 . . . . 1.0600000000000001 106.419 172.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.1 m -127.33 109.2 11.55 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.782 -0.767 . . . . 1.05 110.254 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.623 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.9 t90 -88.44 106.14 18.07 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.814 -0.81 . . . . 0.29999999999999999 108.814 175.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -114.17 112.02 22.51 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.759 -1.11 . . . . 1.1599999999999999 108.745 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.55 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 93.7 p -57.69 146.03 32.27 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.406 0.622 . . . . 1.3899999999999999 110.85 -174.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.648 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 7.9 m -57.59 -24.51 56.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.707 -1.133 . . . . 1.1499999999999999 111.236 -175.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -87.92 -27.42 22.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.892 -0.595 . . . . 2.3300000000000001 111.129 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.78 21.96 27.17 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.715 -0.755 . . . . 0.55000000000000004 113.443 176.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -110.2 -9.06 14.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.291 0.545 . . . . 1.1299999999999999 110.833 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -139.92 119.07 12.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.913 -0.585 . . . . 2.6200000000000001 109.96 -174.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 57.8 t -135.09 124.02 41.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.805 0.336 . . . . 1.3100000000000001 110.712 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -130.14 122.17 27.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.309 -0.405 . . . . 0.82999999999999996 110.589 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.5 m -102.43 134.93 44.95 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.664 0.268 . . . . 1.0600000000000001 110.919 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 42.2 t -106.76 128.06 61.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 122.415 0.286 . . . . 1.3600000000000001 111.52 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 45' ' ' ILE . 41.1 t -90.09 108.12 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-O 121.465 0.65 . . . . 1.05 109.595 173.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.554 HD13 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -53.76 -29.96 42.28 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.016 -0.993 . . . . 1.04 112.164 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.4 t -71.75 -35.54 70.15 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.965 -0.294 . . . . 1.45 110.672 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.409 ' OG1' ' HB ' ' A' ' 41' ' ' VAL . 66.8 p -77.1 -14.89 59.74 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 121.104 0.478 . . . . 1.04 110.12 176.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.547 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 41.4 mm -79.46 124.66 37.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.684 -0.689 . . . . 1.02 111.387 175.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.585 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 33.3 t70 -79.36 -48.16 14.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.969 -0.56 . . . . 0.69999999999999996 110.737 176.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -135.31 149.26 49.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.728 -0.669 . . . . 2.4300000000000002 110.543 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.575 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 11.6 tp -112.92 145.24 41.1 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.086 -0.709 . . . . 1.04 109.086 164.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.44 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 13.9 mm100 -122.59 153.34 39.42 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.071 -0.968 . . . . 1.49 109.896 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.69 143.79 10.02 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.451 -0.795 . . . . 1.0 109.491 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.496 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 49.4 p -60.7 125.38 82.66 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-O 121.486 0.66 . . . . 1.03 111.065 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 60.6 Cg_endo -70.96 165.94 30.71 Favored 'Trans proline' 0 C--N 1.329 -0.465 0 C-N-CA 123.727 2.951 . . . . 0.73999999999999999 111.285 175.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.9 -17.61 61.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.215 0.531 . . . . 1.54 110.617 176.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.7 m -77.2 -25.25 51.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.739 -0.664 . . . . 2.0499999999999998 110.558 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.453 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 46.5 t -72.86 150.94 42.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.653 -0.703 . . . . 1.1399999999999999 109.69 177.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -95.44 -2.85 48.02 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.586 0.708 . . . . 2.8900000000000001 109.657 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -107.05 -179.25 3.88 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.824 -1.08 . . . . 3.1299999999999999 110.414 -175.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.496 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -136.97 110.22 7.83 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.278 -1.008 . . . . 2.0 108.278 169.52 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.609 ' HB3' ' CZ ' ' B' ' 261' ' ' PHE . 3.1 ttm -156.24 148.77 23.69 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.384 -0.527 . . . . 1.3 111.825 -173.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.458 HD11 ' O ' ' A' ' 97' ' ' MET . 0.5 OUTLIER -117.7 157.22 26.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.437 -0.801 . . . . 1.05 110.479 173.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 62.8 ttp180 -151.58 114.18 4.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.708 0.29 . . . . 3.3999999999999999 110.756 169.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.516 ' CD2' HG23 ' A' ' 45' ' ' ILE . 10.5 mt -92.3 112.58 24.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.1 0.476 . . . . 1.73 110.61 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.515 HG21 ' HG2' ' A' ' 86' ' ' ARG . 4.4 mm -87.22 113.85 25.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 123.55 0.74 . . . . 1.1599999999999999 110.95 -175.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -79.41 141.0 23.41 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.122 -1.037 . . . . 0.47999999999999998 111.579 176.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.585 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 7.2 mptt -54.46 134.28 45.95 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.964 0.382 . . . . 1.78 110.983 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.1 p -84.15 153.88 3.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.58 -0.526 . . . . 1.3100000000000001 109.58 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -79.09 113.74 17.47 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.8 -0.636 . . . . 2.5600000000000001 110.31 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -82.44 -25.2 33.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.733 -0.667 . . . . 3.79 111.732 -177.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.67 -37.88 73.7 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.869 -0.332 . . . . 3.3399999999999999 110.679 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -90.75 48.37 1.52 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.793 0.33 . . . . 5.8200000000000003 110.692 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -60.75 130.48 46.73 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.079 -0.51 . . . . 4.7400000000000002 110.125 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.469 ' CB ' ' HB ' ' A' ' 80' ' ' VAL . 38.2 mtp180 -76.23 169.59 17.92 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 122.572 1.177 . . . . 4.7300000000000004 113.174 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.461 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -146.59 153.04 39.89 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 112.97 -1.923 . . . . 5.5300000000000002 108.38 177.391 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.478 ' HB3' HD21 ' A' ' 78' ' ' ASN . 4.3 t70 -87.46 -161.13 0.67 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.315 -0.554 . . . . 4.9800000000000004 110.719 -170.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -62.6 -23.43 67.04 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.024 0.379 . . . . 7.1100000000000003 112.024 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.465 ' HB3' ' ND2' ' A' ' 78' ' ' ASN . 28.0 tt0 -95.71 -9.63 31.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.673 0.749 . . . . 7.1299999999999999 109.341 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.461 ' HA2' ' HB2' ' A' ' 73' ' ' LYS . . . 89.09 32.34 10.81 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.971 -1.013 . . . . 5.7300000000000004 110.758 -174.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.478 HD21 ' HB3' ' A' ' 74' ' ' ASP . 63.0 m-80 -74.03 -91.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.671 0.272 . . . . 5.6200000000000001 111.344 -176.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 14.5 pt-20 -176.78 130.6 0.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.526 . . . . 5.0 109.83 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.469 ' HB ' ' CB ' ' A' ' 72' ' ' ARG . 3.0 t -128.96 149.11 33.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.491 -0.929 . . . . 3.5800000000000001 108.491 174.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 p -106.35 99.42 23.94 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-O 121.45 0.643 . . . . 3.1499999999999999 110.63 174.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 80' ' ' VAL . 50.2 Cg_exo -53.38 140.19 63.59 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.199 2.599 . . . . 2.0800000000000001 112.191 175.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -81.8 131.02 58.63 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-O 121.304 0.573 . . . . 3.5299999999999998 110.519 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.421 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 23.6 Cg_exo -58.2 144.98 94.67 Favored 'Trans proline' 0 C--N 1.332 -0.323 0 C-N-CA 123.435 2.757 . . . . 0.75 112.381 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.47 122.05 22.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.442 0.639 . . . . 1.78 110.03 176.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.515 ' HG2' HG21 ' A' ' 63' ' ' ILE . 13.6 mtm180 -117.1 146.47 43.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.613 -0.721 . . . . 2.8199999999999998 110.217 -172.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -111.13 111.98 23.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.58 -0.736 . . . . 0.63 109.414 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.507 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 50.4 ttm -106.64 129.51 54.54 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.049 0.452 . . . . 1.1200000000000001 111.372 -176.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.422 ' CG ' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -120.03 122.68 41.65 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.719 -0.673 . . . . 1.6499999999999999 109.338 178.028 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.545 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 20.3 m -88.74 128.23 35.62 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.022 -0.536 . . . . 1.1899999999999999 110.45 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.584 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 27.8 m-85 -107.82 173.61 6.24 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.879 -0.6 . . . . 1.6399999999999999 110.629 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -119.05 -0.05 11.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.704 -0.68 . . . . 1.8300000000000001 110.107 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -141.17 128.47 21.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.926 -0.579 . . . . 1.22 109.96 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.468 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 2.5 tmt_? -69.61 -24.4 63.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.546 . . . . 2.8799999999999999 110.371 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.2 m -69.4 -57.19 5.59 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.118 -0.327 . . . . 1.1200000000000001 110.118 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 98.2 t -45.62 -56.38 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 115.955 -0.566 . . . . 1.1299999999999999 111.384 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.458 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -65.02 -28.63 69.63 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 116.021 -0.536 . . . . 1.0600000000000001 110.882 -177.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.42 -32.47 71.46 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.196 -0.668 . . . . 0.39000000000000001 109.196 176.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.435 ' HA ' ' HE1' ' A' ' 102' ' ' MET . 90.7 m-20 -74.09 -49.25 24.8 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.721 -1.127 . . . . 1.55 109.501 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.584 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 34.1 mm -58.49 -53.07 51.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.945 -1.025 . . . . 1.0600000000000001 110.427 175.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.408 ' HE2' ' N ' ' A' ' 102' ' ' MET . 0.1 OUTLIER -55.3 -48.85 73.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.335 -0.848 . . . . 1.72 111.344 179.133 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.435 ' HE1' ' HA ' ' A' ' 99' ' ' ASN . 12.8 ptt? -68.8 -24.99 64.47 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.63 -0.428 . . . . 1.76 110.191 -175.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 41.6 m -66.59 -49.78 65.23 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.427 0.632 . . . . 1.04 109.922 175.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.575 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 12.9 mt -69.94 -57.4 5.07 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.986 -1.006 . . . . 1.05 111.715 -174.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.517 HE22 ' HB ' ' B' ' 264' ' ' VAL . 38.1 mt-30 -51.51 -27.51 10.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.833 0.679 . . . . 1.45 112.833 -178.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -71.29 -30.13 65.89 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.056 0.931 . . . . 0.66000000000000003 109.472 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.601 ' O ' ' HB3' ' A' ' 110' ' ' ARG . 61.6 mt -75.88 -42.78 39.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 114.141 -1.39 . . . . 1.04 109.775 172.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.558 ' C ' ' HD2' ' A' ' 112' ' ' LYS . 1.4 mt -67.39 -43.1 87.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.731 -0.668 . . . . 1.04 110.624 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.554 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 45.3 m -60.61 -29.1 69.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.366 0.603 . . . . 1.6100000000000001 110.145 174.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.601 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 12.7 ttt180 -66.76 -30.27 70.44 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.061 -0.972 . . . . 4.3899999999999997 109.588 175.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.487 ' HD2' ' O ' ' A' ' 107' ' ' ILE . 61.6 m-85 -97.75 -18.89 18.55 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.78 -0.646 . . . . 0.71999999999999997 111.664 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.558 ' HD2' ' C ' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -69.56 -35.41 75.37 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.848 -0.797 . . . . 2.25 108.848 170.68 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.84 -15.62 63.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.126 -0.943 . . . . 1.5600000000000001 110.235 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -106.83 8.21 30.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.523 -0.762 . . . . 1.3400000000000001 110.944 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.608 -0.71 . . . . 2.1600000000000001 110.283 -179.471 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 111.827 -0.509 . . . . 25.670000000000002 111.827 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 89.25 113.56 1.35 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.706 -0.759 . . . . 24.66 111.887 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -114.92 23.92 11.27 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.562 -0.827 . . . . 24.199999999999999 112.29 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -132.9 94.22 0.28 Allowed Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.585 -0.817 . . . . 23.140000000000001 112.477 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -157.71 102.14 1.85 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.982 0.42 . . . . 24.920000000000002 110.455 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -101.04 136.19 41.28 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.506 -0.553 . . . . 21.449999999999999 109.506 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.61 71.33 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.428 0.632 . . . . 20.68 109.655 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -69.94 119.54 14.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.314 -0.857 . . . . 18.16 110.858 -177.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 23.6 ttt -142.66 42.93 1.6 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.129 -1.063 . . . . 17.260000000000002 108.129 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -62.51 139.32 58.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.897 -1.047 . . . . 13.68 110.422 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 252' ' ' SER . . . . . 0.466 ' HB3' ' OE2' ' B' ' 254' ' ' GLU . 68.8 m -68.81 109.34 3.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.979 -0.555 . . . . 10.91 110.661 -177.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.89 -34.74 78.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.095 -0.957 . . . . 11.029999999999999 111.376 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . 0.466 ' OE2' ' HB3' ' B' ' 252' ' ' SER . 1.4 pp20? -67.77 -20.88 65.27 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 112.475 0.546 . . . . 10.94 112.475 -176.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -64.62 -24.15 67.49 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.87 0.367 . . . . 9.8200000000000003 110.711 177.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 39.8 m -86.17 83.0 7.84 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.357 -0.608 . . . . 5.9100000000000001 109.357 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -62.08 -23.63 66.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.817 -0.629 . . . . 6.2000000000000002 111.499 -176.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.14 -36.23 72.67 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.351 -0.386 . . . . 6.1399999999999997 110.908 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.494 ' HB2' ' CD2' ' B' ' 261' ' ' PHE . 3.6 p-10 -152.28 -82.34 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.31 -0.404 . . . . 3.3199999999999998 111.843 -177.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . 0.447 ' H ' ' CG ' ' B' ' 259' ' ' ASP . . . 100.51 20.85 13.91 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.746 -0.942 . . . . 1.1200000000000001 110.746 -171.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 261' ' ' PHE . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 2.1 m-85 -113.83 179.94 3.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.031 -0.584 . . . . 0.97999999999999998 109.854 -175.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 11.8 p -143.37 144.64 23.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.649 -0.251 . . . . 1.8999999999999999 110.639 175.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -79.81 122.33 26.49 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.05 -0.722 . . . . 2.2400000000000002 109.05 173.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.517 ' HB ' HE22 ' A' ' 105' ' ' GLN . 15.0 t -103.29 102.68 13.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.853 0.359 . . . . 1.8899999999999999 110.427 -177.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.572 -0.728 . . . . 3.04 110.054 179.239 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo . . . . . 0 N--CA 1.481 0.747 0 N-CA-C 110.648 -0.558 . . . . 3.8100000000000001 110.648 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 t -147.56 -31.14 0.31 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.258 -0.428 . . . . 1.8400000000000001 110.755 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.59 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 67.4 m80 -86.97 15.22 6.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.113 -0.494 . . . . 2.3900000000000001 110.949 -178.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.421 ' HG ' ' C ' ' A' ' 3' ' ' HIS . 14.3 m -160.44 143.25 13.26 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.867 -0.42 . . . . 1.6100000000000001 109.867 -177.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.29 149.69 8.92 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.414 -1.074 . . . . 0.17000000000000001 110.414 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.671 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -74.84 140.19 43.73 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 117.539 0.669 . . . . 0.97999999999999998 111.19 -176.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.76 153.85 38.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.376 0.608 . . . . 1.01 111.723 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.539 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.0 mp -95.77 117.0 38.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.483 -0.78 . . . . 1.0800000000000001 109.075 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.559 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 74.9 t80 -117.97 109.46 16.52 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.127 -0.323 . . . . 0.66000000000000003 110.127 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 66.84 47.51 1.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.641 0.734 . . . . 1.46 110.758 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp 71.26 6.93 5.96 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.143 -1.389 . . . . 2.3900000000000001 113.024 171.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -114.14 132.93 61.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.782 0.325 . . . . 1.23 110.414 171.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.539 ' HA ' HG13 ' A' ' 8' ' ' ILE . 41.2 t -74.64 134.51 42.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.311 0.577 . . . . 1.48 110.808 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.653 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -155.98 -158.16 8.67 Favored Glycine 0 N--CA 1.434 -1.486 0 CA-C-N 115.431 -0.804 . . . . 0.16 112.237 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.671 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 13.7 mm -124.57 153.56 31.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.053 0.454 . . . . 1.05 110.432 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.406 HG12 HD23 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -123.9 133.29 69.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.759 -0.655 . . . . 1.01 110.111 179.074 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.22 109.54 7.85 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.288 -0.414 . . . . 0.87 111.761 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' A' ' 3' ' ' HIS . 3.7 mp -85.51 121.05 36.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.567 -0.901 . . . . 1.05 108.567 172.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.446 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.3 t30 -126.1 128.93 48.12 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 110.249 -0.278 . . . . 1.1200000000000001 110.249 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.46 ' HG2' ' HB3' ' A' ' 25' ' ' ALA . 33.7 mt-10 -110.0 85.3 2.08 Favored 'General case' 0 N--CA 1.425 -1.715 0 C-N-CA 117.022 -1.871 . . . . 0.73999999999999999 107.632 163.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.446 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 13.1 t70 -120.95 -10.58 9.06 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.287 -1.746 . . . . 0.58999999999999997 106.287 156.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.671 HG13 ' O ' ' A' ' 23' ' ' SER . 14.3 p -102.49 174.76 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 111.66 -2.518 . . . . 1.0800000000000001 112.192 -156.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.671 ' O ' HG13 ' A' ' 22' ' ' VAL . 1.1 t -54.52 167.63 0.56 Allowed Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 106.417 -1.697 . . . . 2.0 106.417 166.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.44 ' HD2' ' OG ' ' A' ' 23' ' ' SER . 13.0 Cg_endo -42.4 128.9 4.72 Favored 'Trans proline' 0 C--N 1.359 1.123 0 CA-C-N 122.266 1.845 . . . . 0.26000000000000001 111.121 -152.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.506 ' HB1' HG21 ' A' ' 107' ' ' ILE . . . -32.43 135.71 0.08 Allowed 'General case' 0 CA--C 1.508 -0.652 0 O-C-N 125.242 1.589 . . . . 1.02 114.01 -155.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.561 ' HB2' HG12 ' A' ' 22' ' ' VAL . 29.2 mt-10 -121.7 136.95 54.93 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.579 -1.191 . . . . 1.26 111.213 -170.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.604 ' C ' HD21 ' A' ' 27' ' ' LEU . 1.2 tt -101.29 143.3 31.52 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 106.222 -1.77 . . . . 1.0600000000000001 106.222 170.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.435 ' N ' HD21 ' A' ' 27' ' ' LEU . 30.0 m -132.51 110.54 10.56 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.868 -0.733 . . . . 1.05 110.134 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.602 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.6 t90 -86.32 106.53 17.45 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.339 -0.846 . . . . 0.29999999999999999 108.957 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -115.04 114.87 25.95 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.62 -1.173 . . . . 1.1599999999999999 108.695 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.545 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 94.6 p -57.07 153.22 11.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.515 0.674 . . . . 1.3899999999999999 111.574 -171.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.653 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 14.8 m -58.62 -28.49 65.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.557 -1.201 . . . . 1.1499999999999999 110.87 -177.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -83.08 -28.6 29.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.085 -0.507 . . . . 2.3300000000000001 110.555 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.22 17.98 32.72 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.112 -0.566 . . . . 0.55000000000000004 113.072 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -103.5 -25.62 13.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.928 0.394 . . . . 1.1299999999999999 111.511 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.1 tttm -117.28 122.07 42.92 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.927 -0.397 . . . . 2.6200000000000001 109.927 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 84.1 t -132.07 123.01 50.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.849 0.357 . . . . 1.3100000000000001 110.695 -177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -131.35 120.98 23.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.197 -0.456 . . . . 0.82999999999999996 110.357 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.488 HG21 ' OE1' ' A' ' 26' ' ' GLU . 35.7 m -101.96 143.52 31.73 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 111.735 0.272 . . . . 1.0600000000000001 111.735 -175.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.522 HG23 ' CD2' ' A' ' 87' ' ' HIS . 38.7 t -116.61 129.44 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 122.83 0.452 . . . . 1.3600000000000001 111.333 176.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.539 ' O ' HG12 ' A' ' 45' ' ' ILE . 53.7 t -91.18 107.98 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 121.5 0.667 . . . . 1.05 109.43 172.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.618 HD12 ' CD2' ' A' ' 104' ' ' LEU . 2.4 mm? -53.19 -32.82 49.88 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.656 -1.156 . . . . 1.04 112.576 -178.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.436 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 52.7 m -75.92 -28.43 58.0 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.933 -0.307 . . . . 1.45 111.456 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.3 p -80.44 -10.89 59.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.187 0.517 . . . . 1.04 109.832 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.539 HG12 ' O ' ' A' ' 41' ' ' VAL . 36.3 mm -82.29 130.09 36.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.483 -0.78 . . . . 1.02 110.861 174.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.612 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 3.7 t70 -86.44 -41.54 14.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.689 -0.687 . . . . 0.69999999999999996 111.456 176.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.52 ' HE3' ' OE1' ' B' ' 263' ' ' GLU . 11.1 tptt -140.47 138.5 34.7 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.795 -0.639 . . . . 2.4300000000000002 110.005 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.61 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 13.9 tp -109.29 141.8 41.09 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.053 -0.721 . . . . 1.04 109.053 164.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 5.8 mt-30 -119.07 154.13 33.66 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.81 -1.086 . . . . 1.49 109.927 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.23 141.61 8.1 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.065 177.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 40.0 p -51.29 127.82 30.44 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-O 121.5 0.667 . . . . 1.03 111.418 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 45.0 Cg_endo -66.89 166.53 22.32 Favored 'Trans proline' 0 C--N 1.334 -0.214 0 C-N-CA 124.107 3.205 . . . . 0.73999999999999999 112.105 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.5 -11.27 59.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.087 0.47 . . . . 1.54 110.569 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.4 t -84.71 -24.64 28.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.999 -0.546 . . . . 2.0499999999999998 109.753 173.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.552 ' OG ' ' HE3' ' A' ' 57' ' ' LYS . 21.2 t -71.59 146.13 48.59 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.067 -0.716 . . . . 1.1399999999999999 109.067 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -95.42 -14.57 23.68 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.223 -1.028 . . . . 2.8900000000000001 108.223 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.552 ' HE3' ' OG ' ' A' ' 55' ' ' SER . 0.0 OUTLIER -88.04 176.02 7.49 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 113.731 -1.577 . . . . 3.1299999999999999 110.313 -177.213 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.502 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -138.32 109.46 6.83 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.454 -0.573 . . . . 2.0 109.454 173.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.558 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 3.2 mpp? -154.61 141.27 18.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.772 0.32 . . . . 1.3 111.448 -176.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.868 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 2.3 mp -109.16 161.83 14.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.722 -0.672 . . . . 1.05 110.719 170.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.468 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 2.8 ttt180 -154.03 114.36 3.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.239 -0.437 . . . . 3.3999999999999999 110.925 172.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.521 ' HG ' HD11 ' A' ' 48' ' ' LEU . 11.7 mt -95.89 110.02 22.28 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 122.659 0.384 . . . . 1.73 110.88 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.5 ' HA ' ' CB ' ' A' ' 86' ' ' ARG . 4.3 mm -86.86 109.68 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.255 -0.43 . . . . 1.1599999999999999 111.062 -174.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -74.97 143.23 30.71 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.136 -1.03 . . . . 0.47999999999999998 110.956 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.612 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 6.2 mttm -64.13 134.65 55.29 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.545 0.688 . . . . 1.78 112.198 -175.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 67' ' ' ASP . 11.7 p -83.59 168.58 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.738 -1.119 . . . . 1.3100000000000001 108.551 174.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 66' ' ' VAL . 23.9 t70 -59.89 138.64 57.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.281 0.562 . . . . 2.5600000000000001 110.68 -176.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -54.18 -22.95 12.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.437 -1.256 . . . . 3.79 112.942 -173.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.8 p -75.31 -11.38 60.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.652 0.263 . . . . 3.3399999999999999 111.275 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.431 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 13.8 mmmm 48.84 -95.97 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.107 0.963 . . . . 5.8200000000000003 112.916 -177.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -69.66 125.15 25.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.804 0.812 . . . . 4.7400000000000002 111.765 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 7.1 ptm85 -111.73 173.31 6.41 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.829 -1.078 . . . . 4.7300000000000004 110.427 -173.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -118.66 137.93 52.96 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.14 -0.937 . . . . 5.5300000000000002 108.684 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.636 ' HB3' HD22 ' A' ' 78' ' ' ASN . 2.0 t70 -97.63 -158.04 0.64 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.313 -0.625 . . . . 4.9800000000000004 109.313 177.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -54.1 -31.33 51.73 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.72 0.637 . . . . 7.1100000000000003 112.72 -177.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 36.7 tt0 -111.48 -1.69 15.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.294 0.569 . . . . 7.1299999999999999 111.111 -175.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.07 24.7 73.1 Favored Glycine 0 CA--C 1.508 -0.38 0 N-CA-C 110.469 -1.052 . . . . 5.7300000000000004 110.469 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.636 HD22 ' HB3' ' A' ' 74' ' ' ASP . 2.1 p30 -60.78 -26.21 67.09 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.229 -0.986 . . . . 5.6200000000000001 111.363 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.585 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 52.9 mt-10 88.92 110.1 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.058 -1.428 . . . . 5.0 111.169 174.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.455 ' HB ' ' HG2' ' A' ' 72' ' ' ARG . 2.2 t -109.58 148.38 13.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.449 -0.796 . . . . 3.5800000000000001 108.861 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.0 p -110.36 97.39 31.15 Favored Pre-proline 0 C--N 1.312 -1.038 0 CA-C-O 121.698 0.761 . . . . 3.1499999999999999 110.432 175.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.485 ' HG3' ' HD2' ' A' ' 72' ' ' ARG . 31.1 Cg_exo -57.64 126.68 22.6 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.183 2.589 . . . . 2.0800000000000001 112.073 178.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.524 ' HB3' ' HZ3' ' A' ' 83' ' ' LYS . 1.8 ttpm? -85.37 130.13 52.77 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-O 121.266 0.555 . . . . 3.5299999999999998 110.596 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -58.49 134.22 59.71 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.1 2.533 . . . . 0.75 111.798 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.69 117.96 17.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.648 0.737 . . . . 1.78 110.192 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.5 ' CB ' ' HA ' ' A' ' 63' ' ' ILE . 26.2 ptt180 -125.12 143.71 50.79 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.535 -0.757 . . . . 2.8199999999999998 111.439 -169.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.522 ' CD2' HG23 ' A' ' 40' ' ' VAL . 97.2 m-70 -104.94 112.8 26.06 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.078 -0.964 . . . . 0.63 110.465 -173.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.437 ' HE3' ' CE2' ' B' ' 261' ' ' PHE . 48.3 ttm -107.56 125.31 51.14 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 110.417 -0.216 . . . . 1.1200000000000001 110.417 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.6 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -117.06 139.33 50.83 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.808 -0.812 . . . . 1.6499999999999999 108.808 176.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.493 ' HB3' ' HB ' ' A' ' 8' ' ' ILE . 31.1 t -97.48 128.16 44.02 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.193 -0.669 . . . . 1.1899999999999999 109.193 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.868 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 6.2 m-85 -108.59 164.35 12.44 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.561 -0.745 . . . . 1.6399999999999999 109.706 -176.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -109.29 -2.9 17.57 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.678 -0.409 . . . . 1.8300000000000001 110.906 -172.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -146.69 127.77 14.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.375 0.607 . . . . 1.22 110.624 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.47 ' NH1' ' HB2' ' A' ' 98' ' ' ASP . 43.3 tpt85 -61.71 -27.28 68.6 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.852 -1.067 . . . . 2.8799999999999999 111.325 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 92.3 m -74.64 -57.88 3.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.429 -0.35 . . . . 1.1200000000000001 110.582 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.3 t -46.04 -54.06 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-N 116.17 -0.468 . . . . 1.1299999999999999 111.289 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.545 ' O ' HD12 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -66.08 -27.76 68.31 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.166 -0.47 . . . . 1.0600000000000001 110.7 -177.566 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.47 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 32.9 t70 -68.93 -34.57 75.58 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 109.18 -0.674 . . . . 0.39000000000000001 109.18 177.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -73.18 -49.26 29.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.34 -1.3 . . . . 1.55 109.53 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.509 HG21 HD11 ' A' ' 18' ' ' ILE . 36.0 mm -55.84 -53.08 41.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.181 -0.918 . . . . 1.0600000000000001 110.409 174.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.473 ' HG3' ' CB ' ' A' ' 50' ' ' ALA . 1.1 tmmm? -53.25 -52.52 58.71 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.781 -0.645 . . . . 1.72 110.937 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 24.3 ptm -67.81 -24.45 65.3 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.95 -0.568 . . . . 1.76 109.768 -173.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.428 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 55.5 m -67.03 -50.52 61.78 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.54 0.686 . . . . 1.04 110.066 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.618 ' CD2' HD12 ' A' ' 42' ' ' LEU . 10.3 mt -70.45 -57.32 4.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.824 -1.08 . . . . 1.05 111.52 -174.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.56 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 63.3 mt-30 -53.85 -25.78 21.42 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.572 0.582 . . . . 1.45 112.572 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -66.42 -30.1 70.39 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.74 0.781 . . . . 0.66000000000000003 109.374 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.552 ' O ' ' HB3' ' A' ' 110' ' ' ARG . 31.7 mt -82.42 -44.28 19.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 114.117 -1.401 . . . . 1.04 110.312 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.561 HG21 ' HD2' ' A' ' 112' ' ' LYS . 1.4 mt -66.87 -51.38 55.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.574 -0.739 . . . . 1.04 110.804 -175.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.6 t -61.52 -22.38 65.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.544 0.688 . . . . 1.6100000000000001 109.354 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.552 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 14.7 ttt180 -72.99 -38.96 66.46 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.746 -1.115 . . . . 4.3899999999999997 110.184 177.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -87.0 -27.95 22.93 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.857 -0.61 . . . . 0.71999999999999997 111.249 -176.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.561 ' HD2' HG21 ' A' ' 108' ' ' ILE . 15.0 mtpp -75.62 -18.19 59.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.418 0.628 . . . . 2.25 109.484 176.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.95 -20.36 61.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.076 -0.966 . . . . 1.5600000000000001 109.612 171.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.55 34.17 5.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.363 -0.835 . . . . 1.3400000000000001 110.855 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.6 t70 . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.691 -0.671 . . . . 2.1600000000000001 110.716 -178.101 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 N-CA-C 111.903 -0.479 . . . . 25.670000000000002 111.903 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -166.37 165.13 38.09 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.65 -0.786 . . . . 24.66 112.094 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 80.4 -77.15 1.99 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.155 -0.545 . . . . 24.199999999999999 112.546 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -169.33 -178.29 40.52 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.373 -0.691 . . . . 23.140000000000001 111.373 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 73.4 t80 66.85 114.45 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.346 0.593 . . . . 24.920000000000002 111.045 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -85.25 133.16 34.18 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.278 -0.638 . . . . 21.449999999999999 109.278 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 8.3 p -82.92 14.58 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.605 0.717 . . . . 20.68 110.647 -174.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -116.9 117.3 29.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.096 -0.502 . . . . 18.16 109.789 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 48.4 mtm -120.23 -26.66 5.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.588 0.709 . . . . 17.260000000000002 110.386 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -78.11 126.18 30.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.928 -1.033 . . . . 13.68 110.429 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 40.2 p -170.29 177.01 4.29 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.14 -0.482 . . . . 10.91 110.399 -175.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -73.91 -23.76 59.59 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.27 0.557 . . . . 11.029999999999999 109.84 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.9 -20.22 63.51 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.508 -0.769 . . . . 10.94 111.847 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -56.05 -28.56 57.98 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.293 0.37 . . . . 9.8200000000000003 111.46 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 51.1 m 60.35 87.28 0.09 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.366 0.603 . . . . 5.9100000000000001 112.186 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -63.77 -33.59 76.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.562 -0.745 . . . . 6.2000000000000002 111.072 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.08 -66.25 0.57 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.874 -0.603 . . . . 6.1399999999999997 110.111 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' B' ' 260' ' ' GLY . 4.4 p-10 -168.73 -84.79 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.493 -0.776 . . . . 3.3199999999999998 110.87 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . 0.466 ' H ' ' CG ' ' B' ' 259' ' ' ASP . . . 70.05 22.83 77.33 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.455 -0.878 . . . . 1.1200000000000001 111.812 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 261' ' ' PHE . . . . . 0.437 ' CE2' ' HE3' ' A' ' 88' ' ' MET . 13.1 m-85 -123.21 179.93 4.52 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.419 -0.586 . . . . 0.97999999999999998 109.419 -178.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 7.8 p -140.93 143.99 27.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.818 0.342 . . . . 1.8999999999999999 110.213 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 263' ' ' GLU . . . . . 0.52 ' OE1' ' HE3' ' A' ' 47' ' ' LYS . 44.4 tt0 -89.94 121.36 31.97 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.065 -0.717 . . . . 2.2400000000000002 109.065 174.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 46.8 t -101.02 103.28 14.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.878 0.371 . . . . 1.8899999999999999 110.729 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 30.9 t70 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.405 -0.807 . . . . 3.04 110.089 179.714 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.477 0.509 0 N-CA-C 110.966 -0.436 . . . . 3.8100000000000001 110.966 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.8 p 55.41 -173.33 0.05 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.585 0.754 . . . . 1.8400000000000001 111.188 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.416 ' HA ' HG22 ' A' ' 103' ' ' THR . 45.7 m80 63.55 4.31 1.75 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.701 0.63 . . . . 2.3900000000000001 112.701 175.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.414 ' HG ' ' C ' ' A' ' 3' ' ' HIS . 20.4 m -158.92 148.8 19.23 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.825 -0.435 . . . . 1.6100000000000001 109.825 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.41 148.05 6.6 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.366 -1.094 . . . . 0.17000000000000001 110.366 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.673 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -73.57 140.0 45.97 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 117.419 0.61 . . . . 0.97999999999999998 111.524 -175.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 89' ' ' PHE . . . -148.65 162.93 38.72 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 121.361 0.6 . . . . 1.01 111.638 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.54 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.1 mp -109.47 126.49 66.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.45 -0.796 . . . . 1.0800000000000001 109.031 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -114.18 99.66 7.79 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 120.879 0.371 . . . . 0.66000000000000003 110.249 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 56.69 59.2 3.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.286 0.565 . . . . 1.46 111.118 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp 76.07 -8.73 1.57 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.858 -1.065 . . . . 2.3900000000000001 113.68 170.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.1 p -96.6 130.38 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 119.892 -0.723 . . . . 1.23 109.987 169.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.54 ' HA ' HG13 ' A' ' 8' ' ' ILE . 18.6 t -85.3 133.55 34.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.024 -0.534 . . . . 1.48 110.804 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.658 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -155.5 -155.95 7.57 Favored Glycine 0 N--CA 1.438 -1.214 0 CA-C-N 115.749 -0.66 . . . . 0.16 112.598 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.673 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.7 mm -126.6 153.44 35.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 120.798 0.333 . . . . 1.05 110.614 -177.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.423 HG12 HD23 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -121.89 132.56 70.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.12 -0.491 . . . . 1.01 110.059 179.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.85 109.46 7.47 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.316 -0.402 . . . . 0.87 111.927 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 3.9 mp -85.95 115.66 27.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.897 -0.779 . . . . 1.05 108.897 173.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.406 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 1.6 t30 -118.38 126.34 51.88 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.982 -0.377 . . . . 1.1200000000000001 109.982 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -110.89 83.35 1.74 Allowed 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 117.362 -1.735 . . . . 0.73999999999999999 107.543 164.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -121.25 -10.5 8.94 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 106.638 -1.615 . . . . 0.58999999999999997 106.638 156.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 23' ' ' SER . 14.8 p -101.43 174.66 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 112.099 -2.319 . . . . 1.0800000000000001 112.031 -156.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.693 ' O ' HG12 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -54.51 165.63 0.86 Allowed Pre-proline 0 C--O 1.225 -0.194 0 N-CA-C 106.04 -1.837 . . . . 2.0 106.04 166.489 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.408 ' HD2' ' OG ' ' A' ' 23' ' ' SER . 10.1 Cg_endo -41.14 128.04 2.93 Favored 'Trans proline' 0 C--N 1.354 0.845 0 CA-C-N 121.899 1.714 . . . . 0.26000000000000001 111.555 -150.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.552 ' HB3' HG23 ' A' ' 107' ' ' ILE . . . -32.15 135.21 0.08 Allowed 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 125.288 1.617 . . . . 1.02 113.719 -156.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.507 ' HB2' HG11 ' A' ' 22' ' ' VAL . 70.7 mt-10 -124.77 137.62 54.31 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 114.792 -1.094 . . . . 1.26 111.366 -168.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.58 ' C ' HD21 ' A' ' 27' ' ' LEU . 1.3 tt -100.65 141.88 32.89 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 106.543 -1.651 . . . . 1.0600000000000001 106.543 173.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.407 ' N ' HD21 ' A' ' 27' ' ' LEU . 6.8 m -130.1 108.77 10.32 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.848 -0.741 . . . . 1.05 110.413 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.631 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 82.8 t90 -88.0 113.68 23.88 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.478 0.656 . . . . 0.29999999999999999 109.755 175.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -120.67 122.97 41.62 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.168 -0.924 . . . . 1.1599999999999999 109.161 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.422 ' OG ' ' HG2' ' A' ' 36' ' ' LYS . 38.1 m -56.59 141.47 43.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.088 0.47 . . . . 1.3899999999999999 110.482 -174.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.658 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 20.2 m -57.54 -35.9 70.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.092 -0.958 . . . . 1.1499999999999999 110.443 -176.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -87.36 -8.04 57.07 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.502 -0.772 . . . . 2.3300000000000001 111.153 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.89 21.02 54.48 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.82 -0.705 . . . . 0.55000000000000004 112.39 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -69.85 -56.36 7.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.337 0.495 . . . . 1.1299999999999999 112.337 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.422 ' HG2' ' OG ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -143.88 161.71 37.99 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.806 0.336 . . . . 2.6200000000000001 110.979 -176.164 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 58.2 t -133.2 138.06 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.337 -0.392 . . . . 1.3100000000000001 110.678 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -135.67 115.77 13.31 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 122.551 0.34 . . . . 0.82999999999999996 110.714 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.5 m -98.89 142.68 30.09 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.783 0.325 . . . . 1.0600000000000001 111.461 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 22.0 t -116.62 128.8 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 122.827 0.451 . . . . 1.3600000000000001 111.209 175.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.532 ' O ' HG12 ' A' ' 45' ' ' ILE . 43.2 t -90.56 109.25 20.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.078 0.466 . . . . 1.05 109.904 175.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.54 HD12 ' CD2' ' A' ' 104' ' ' LEU . 1.9 mm? -54.16 -26.43 27.83 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.372 -0.831 . . . . 1.04 112.762 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.3 m -75.27 -35.1 61.4 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.374 -0.53 . . . . 1.45 111.329 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.8 p -74.0 -14.48 61.03 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.402 -0.592 . . . . 1.04 109.402 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.575 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 48.9 mm -82.92 114.43 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.075 -0.966 . . . . 1.02 110.863 175.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.548 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 31.8 t70 -74.7 -39.46 61.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.109 -0.496 . . . . 0.69999999999999996 111.266 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -147.24 158.13 43.84 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.227 -0.442 . . . . 2.4300000000000002 110.199 -174.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.577 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 10.8 tp -124.53 146.01 49.23 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.303 0.573 . . . . 1.04 109.917 171.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.41 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 15.5 mm100 -123.16 155.98 35.96 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.793 -1.094 . . . . 1.49 109.653 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.18 138.23 6.5 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.55 -0.75 . . . . 1.0 109.649 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.409 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 36.7 p -50.7 126.71 24.31 Favored Pre-proline 0 N--CA 1.466 0.339 0 CA-C-O 121.193 0.52 . . . . 1.03 110.396 176.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 43.0 Cg_endo -65.59 164.76 25.2 Favored 'Trans proline' 0 C--N 1.329 -0.494 0 C-N-CA 123.611 2.874 . . . . 0.73999999999999999 112.017 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.06 66.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.279 0.561 . . . . 1.54 110.064 175.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.5 t -75.03 -24.6 58.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.287 -0.87 . . . . 2.0499999999999998 110.575 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.446 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 46.8 t -68.42 148.37 50.75 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.59 -0.522 . . . . 1.1399999999999999 109.59 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -89.21 -7.68 55.06 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.746 0.784 . . . . 2.8900000000000001 109.389 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -107.89 -175.85 2.9 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.686 -1.143 . . . . 3.1299999999999999 110.9 -172.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.481 ' N ' ' SD ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -141.7 110.39 6.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.257 -0.883 . . . . 2.0 109.171 175.039 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.458 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 2.4 mpp? -156.3 139.94 16.0 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.694 0.283 . . . . 1.3 111.456 -176.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.851 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 1.5 mp -110.66 155.42 22.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.121 -0.49 . . . . 1.05 110.928 171.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.586 ' HD3' ' HD2' ' A' ' 86' ' ' ARG . 25.4 ttm-85 -145.5 113.76 6.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.083 0.468 . . . . 3.3999999999999999 110.043 170.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.508 ' HG ' HD13 ' A' ' 48' ' ' LEU . 6.5 mp -91.9 111.69 23.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.075 -0.512 . . . . 1.73 110.522 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.532 ' HA ' ' CB ' ' A' ' 86' ' ' ARG . 3.0 mm -86.71 125.52 40.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.195 -0.457 . . . . 1.1599999999999999 110.116 -173.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -89.31 156.07 25.66 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.164 -1.017 . . . . 0.47999999999999998 111.474 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.548 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 0.7 OUTLIER -64.12 134.01 54.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.03 0.443 . . . . 1.78 110.025 176.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.2 p -80.28 158.08 4.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.615 -0.72 . . . . 1.3100000000000001 109.165 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.577 ' CG ' ' HD3' ' A' ' 70' ' ' LYS . 11.3 t70 -105.2 134.61 48.02 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.224 -0.444 . . . . 2.5600000000000001 109.833 -176.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -84.19 -30.14 26.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.87 -0.604 . . . . 3.79 111.509 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.9 p -82.66 -32.33 28.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.741 0.305 . . . . 3.3399999999999999 111.161 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.577 ' HD3' ' CG ' ' A' ' 67' ' ' ASP . 12.5 mptt -78.14 47.04 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.752 0.278 . . . . 5.8200000000000003 111.752 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -68.83 125.71 27.47 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.67 -0.493 . . . . 4.7400000000000002 109.67 175.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.522 ' HG2' ' HD3' ' A' ' 82' ' ' PRO . 0.4 OUTLIER -89.11 173.83 8.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.624 -0.717 . . . . 4.7300000000000004 111.319 -168.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.534 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 9.9 mmtp -121.46 154.09 37.04 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.398 -0.819 . . . . 5.5300000000000002 109.959 -175.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 75' ' ' ASN . 10.8 t70 -103.41 -157.37 0.61 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.274 -0.639 . . . . 4.9800000000000004 109.274 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.454 ' H ' ' CG ' ' A' ' 74' ' ' ASP . 24.5 t-20 -61.61 -31.87 71.96 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.383 0.512 . . . . 7.1100000000000003 112.383 -172.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -92.39 -0.43 57.37 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.742 0.782 . . . . 7.1299999999999999 109.161 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.534 ' HA2' ' HB3' ' A' ' 73' ' ' LYS . . . 70.96 26.33 74.14 Favored Glycine 0 CA--C 1.501 -0.784 0 CA-C-N 114.384 -1.28 . . . . 5.7300000000000004 110.901 -176.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.512 ' CG ' ' H ' ' A' ' 79' ' ' GLU . 8.4 p30 -73.3 -78.59 0.09 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 119.367 -0.349 . . . . 5.6200000000000001 110.373 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 10.7 pt-20 173.5 138.94 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.165 0.507 . . . . 5.0 111.083 171.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.492 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.3 t -128.55 149.46 33.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.465 -0.939 . . . . 3.5800000000000001 108.465 169.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.43 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 7.3 p -100.97 99.98 11.82 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-O 121.946 0.879 . . . . 3.1499999999999999 109.992 171.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.522 ' HD3' ' HG2' ' A' ' 72' ' ' ARG . 22.4 Cg_endo -62.99 135.33 50.8 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.916 2.411 . . . . 2.0800000000000001 112.57 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.73 142.29 93.65 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.545 -0.752 . . . . 3.5299999999999998 109.354 176.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.38 133.6 37.14 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.855 2.37 . . . . 0.75 113.017 -174.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -67.2 137.19 56.03 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.835 -0.802 . . . . 1.78 108.835 176.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.586 ' HD2' ' HD3' ' A' ' 61' ' ' ARG . 28.7 ptt180 -143.64 140.9 30.34 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.663 -0.699 . . . . 2.8199999999999998 111.303 -171.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -102.88 112.28 25.0 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.795 -1.093 . . . . 0.63 110.734 -170.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.542 ' HE3' ' CZ ' ' B' ' 261' ' ' PHE . 38.6 ttm -104.04 137.54 41.86 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 121.067 -0.253 . . . . 1.1200000000000001 110.806 -177.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.427 ' HB3' ' HB3' ' A' ' 7' ' ' ALA . 56.3 m-85 -124.1 139.18 54.18 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.514 -0.921 . . . . 1.6499999999999999 108.514 169.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.525 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 14.7 m -95.1 124.18 39.0 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.313 -0.625 . . . . 1.1899999999999999 109.313 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.851 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 7.7 m-85 -106.5 168.4 9.19 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 110.044 -0.354 . . . . 1.6399999999999999 110.044 -174.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -114.37 -6.89 12.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.824 0.345 . . . . 1.8300000000000001 111.325 -174.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -138.62 122.93 18.22 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.282 0.563 . . . . 1.22 110.954 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -54.6 -39.6 68.03 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 114.51 -1.223 . . . . 2.8799999999999999 111.327 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.431 HG23 HD22 ' A' ' 99' ' ' ASN . 97.7 m -71.14 -57.25 4.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.564 -0.289 . . . . 1.1200000000000001 110.599 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.451 ' O ' HG12 ' A' ' 100' ' ' ILE . 96.1 t -45.97 -55.6 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 116.126 -0.488 . . . . 1.1299999999999999 111.299 175.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.642 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -65.41 -29.36 70.06 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.254 -0.43 . . . . 1.0600000000000001 110.695 -177.127 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.414 ' HA ' ' CG ' ' A' ' 101' ' ' LYS . 30.2 t70 -71.42 -28.3 63.9 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.853 0.835 . . . . 0.39000000000000001 109.318 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.525 ' O ' ' HG3' ' A' ' 102' ' ' MET . 87.8 m-20 -77.64 -36.84 51.17 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.559 -1.2 . . . . 1.55 109.252 176.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.532 HG23 HD11 ' A' ' 18' ' ' ILE . 33.4 mm -64.42 -53.04 47.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 114.978 -1.01 . . . . 1.0600000000000001 111.144 176.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.642 ' HG2' ' O ' ' A' ' 97' ' ' MET . 2.1 ptmt -59.29 -43.57 92.57 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 121.231 -0.188 . . . . 1.72 110.6 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.525 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.5 ppp? -68.08 -25.83 65.53 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.175 0.512 . . . . 1.76 109.719 -175.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 36.9 m -65.61 -51.95 55.77 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.463 -0.789 . . . . 1.04 109.815 173.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.577 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 12.2 mt -71.15 -56.92 5.09 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 115.183 -0.917 . . . . 1.05 111.141 -175.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 101' ' ' LYS . 21.1 mm-40 -42.85 -35.0 1.05 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.808 0.67 . . . . 1.45 112.808 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -65.59 -48.29 72.82 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.845 -0.798 . . . . 0.66000000000000003 108.845 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.552 HG23 ' HB3' ' A' ' 25' ' ' ALA . 68.2 mt -61.48 -43.12 96.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.39 -1.277 . . . . 1.04 110.6 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.513 HG22 ' HD2' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -62.37 -54.98 27.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.51 -0.768 . . . . 1.04 109.875 -177.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 15.8 m -54.4 -32.35 57.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.98 -0.554 . . . . 1.6100000000000001 110.849 173.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.427 ' HD2' ' HA ' ' A' ' 107' ' ' ILE . 82.9 mtt180 -70.93 -27.99 64.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.593 -0.731 . . . . 4.3899999999999997 110.662 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -95.75 -24.06 16.68 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.21 -0.45 . . . . 0.71999999999999997 111.277 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.513 ' HD2' HG22 ' A' ' 108' ' ' ILE . 12.7 mtpp -71.87 -26.14 62.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.003 0.43 . . . . 2.25 110.081 175.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -72.06 -16.47 62.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.808 -0.633 . . . . 1.5600000000000001 110.054 175.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.87 23.87 9.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.862 -0.608 . . . . 1.3400000000000001 111.079 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.7 t70 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.358 -0.83 . . . . 2.1600000000000001 110.09 179.831 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 112.221 -0.352 . . . . 25.670000000000002 112.221 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.13 -110.92 1.02 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.86 -0.686 . . . . 24.66 111.845 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 70.24 -111.5 3.83 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.973 -0.632 . . . . 24.199999999999999 112.292 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 111.57 -92.78 0.67 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.963 -0.636 . . . . 23.140000000000001 111.647 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -96.71 -11.17 25.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.096 0.474 . . . . 24.920000000000002 110.357 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -104.76 153.97 20.61 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.823 -0.626 . . . . 21.449999999999999 109.773 177.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 6.0 p 47.88 33.43 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.206 1.003 . . . . 20.68 112.071 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -80.36 162.8 24.32 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.547 -0.538 . . . . 18.16 109.547 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 25.8 mmt -139.23 45.0 1.98 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.376 0.608 . . . . 17.260000000000002 109.735 -171.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -63.71 137.2 57.98 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.095 -0.957 . . . . 13.68 110.68 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 252' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' B' ' 255' ' ' GLU . 81.0 p 53.04 42.33 32.22 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.567 -0.742 . . . . 10.91 111.356 -178.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . 0.489 ' HA ' ' HB2' ' B' ' 257' ' ' ASP . 33.2 tt0 -66.66 -53.8 30.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.246 -0.888 . . . . 11.029999999999999 110.978 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.68 -24.31 62.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.885 -0.598 . . . . 10.94 110.208 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 255' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' B' ' 256' ' ' SER . 17.3 mm-40 -69.24 -62.89 1.19 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 9.8200000000000003 110.003 175.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 256' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' B' ' 255' ' ' GLU . 4.8 t 178.16 71.1 0.01 OUTLIER 'General case' 0 C--O 1.231 0.094 0 CA-C-O 121.042 0.449 . . . . 5.9100000000000001 111.405 177.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 257' ' ' ASP . . . . . 0.489 ' HB2' ' HA ' ' B' ' 253' ' ' GLU . 11.0 t70 -78.34 -65.29 1.0 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.134 -0.691 . . . . 6.2000000000000002 109.134 172.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -85.48 -41.04 15.71 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.86 -0.793 . . . . 6.1399999999999997 108.86 169.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -168.18 -24.47 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.948 -1.024 . . . . 3.3199999999999998 111.817 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.58 -1.78 45.89 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.549 -0.834 . . . . 1.1200000000000001 112.457 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 261' ' ' PHE . . . . . 0.542 ' CZ ' ' HE3' ' A' ' 88' ' ' MET . 3.9 m-30 -97.72 175.58 6.13 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.221 -0.659 . . . . 0.97999999999999998 109.221 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 12.8 p -122.98 139.66 49.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.925 0.393 . . . . 1.8999999999999999 110.322 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -76.08 121.73 23.22 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.156 -0.683 . . . . 2.2400000000000002 109.156 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 11.8 t -99.38 102.49 13.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.952 0.406 . . . . 1.8899999999999999 110.226 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 26.7 t70 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.532 -0.747 . . . . 3.04 110.333 -176.001 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 N--CA 1.478 0.596 0 N-CA-C 110.832 -0.488 . . . . 3.8100000000000001 110.832 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.461 ' HA ' ' HB3' ' A' ' 99' ' ' ASN . 10.5 p -121.7 -49.77 2.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.937 0.399 . . . . 1.8400000000000001 110.829 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -91.12 14.34 14.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.647 0.737 . . . . 2.3900000000000001 109.478 176.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.1 p -162.99 154.45 17.55 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.815 -1.084 . . . . 1.6100000000000001 108.626 -176.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.73 145.86 5.48 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.186 -0.765 . . . . 0.17000000000000001 111.186 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.716 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.69 125.78 29.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.324 0.562 . . . . 0.97999999999999998 111.36 -176.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.72 158.39 44.24 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 121.168 0.509 . . . . 1.01 111.36 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 2.0 mp -96.96 127.65 48.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.637 -0.711 . . . . 1.0800000000000001 109.472 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.624 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 80.4 t80 -137.38 117.15 13.11 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.337 -0.616 . . . . 0.66000000000000003 109.337 178.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 66.71 44.18 2.24 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.15 0.58 . . . . 1.46 110.419 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt 74.91 -8.95 1.44 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.777 -1.102 . . . . 2.3900000000000001 112.718 171.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.48 131.92 47.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.903 0.382 . . . . 1.23 110.476 177.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.494 ' HA ' HG13 ' A' ' 8' ' ' ILE . 22.5 t -78.03 123.2 26.55 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.002 -0.544 . . . . 1.48 109.992 176.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.624 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -139.07 -154.73 6.46 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.543 -0.753 . . . . 0.16 112.06 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.716 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.7 mm -127.02 153.76 36.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 120.957 0.408 . . . . 1.05 110.779 -177.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.466 HG12 HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -128.56 132.81 67.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.856 -0.611 . . . . 1.01 110.113 -179.348 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.01 112.09 9.02 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 111.976 0.362 . . . . 0.87 111.976 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.529 HD12 HG23 ' A' ' 100' ' ' ILE . 3.7 mp -86.02 120.86 36.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.836 -0.802 . . . . 1.05 108.836 172.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.428 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.9 t30 -126.22 125.39 42.32 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 110.234 -0.284 . . . . 1.1200000000000001 110.234 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.444 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 22.2 mt-10 -108.47 84.51 1.95 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 117.069 -1.852 . . . . 0.73999999999999999 107.468 163.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.428 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 17.9 t70 -121.54 -9.58 8.94 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 106.341 -1.726 . . . . 0.58999999999999997 106.341 156.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 23' ' ' SER . 14.0 p -102.48 175.98 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 111.732 -2.486 . . . . 1.0800000000000001 111.778 -157.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.699 ' O ' HG13 ' A' ' 22' ' ' VAL . 5.6 m -54.15 167.25 0.56 Allowed Pre-proline 0 C--O 1.225 -0.201 0 N-CA-C 106.997 -1.483 . . . . 2.0 106.997 166.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 10.7 Cg_endo -42.16 128.27 4.22 Favored 'Trans proline' 0 C--N 1.357 1.008 0 CA-C-N 122.018 1.756 . . . . 0.26000000000000001 111.009 -154.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.504 ' HB3' HG22 ' A' ' 107' ' ' ILE . . . -31.58 134.61 0.08 Allowed 'General case' 0 CA--C 1.504 -0.805 0 O-C-N 125.19 1.557 . . . . 1.02 113.93 -155.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.515 ' HB2' HG12 ' A' ' 22' ' ' VAL . 33.6 mt-10 -121.3 134.93 55.16 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.646 -1.161 . . . . 1.26 111.031 -172.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.594 ' C ' HD23 ' A' ' 27' ' ' LEU . 1.0 OUTLIER -100.34 141.26 33.43 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 106.052 -1.833 . . . . 1.0600000000000001 106.052 173.39 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.458 ' N ' HD23 ' A' ' 27' ' ' LEU . 6.2 m -127.92 108.76 10.96 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.677 -0.809 . . . . 1.05 110.434 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.624 ' CE2' ' HB3' ' A' ' 9' ' ' PHE . 88.8 t90 -89.6 107.56 19.16 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.675 0.75 . . . . 0.29999999999999999 109.271 175.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -113.83 120.53 41.06 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.888 -1.051 . . . . 1.1599999999999999 109.088 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.567 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 88.9 p -61.78 144.97 53.93 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.197 -0.668 . . . . 1.3899999999999999 109.197 -176.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.624 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 11.4 m -54.0 -23.25 12.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.013 -0.994 . . . . 1.1499999999999999 111.99 -173.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -87.65 -10.59 50.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 111.982 0.364 . . . . 2.3300000000000001 111.982 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.15 21.43 67.68 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.831 -0.7 . . . . 0.55000000000000004 111.704 -176.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -93.49 -44.72 8.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.065 0.459 . . . . 1.1299999999999999 111.334 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -110.34 146.12 36.32 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.895 -0.593 . . . . 2.6200000000000001 110.794 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 89.0 t -144.12 115.7 2.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.874 -0.603 . . . . 1.3100000000000001 109.69 174.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -125.46 111.22 14.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.926 -0.579 . . . . 0.82999999999999996 110.066 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.473 HG22 ' OE1' ' A' ' 26' ' ' GLU . 14.4 m -98.74 143.17 29.39 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 120.824 -0.351 . . . . 1.0600000000000001 111.326 -175.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 28.7 t -116.43 130.15 71.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 122.416 0.286 . . . . 1.3600000000000001 111.536 176.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 45' ' ' ILE . 60.1 t -91.03 108.28 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-O 121.398 0.618 . . . . 1.05 109.875 173.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.562 HD13 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -53.19 -26.89 18.98 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.808 -1.087 . . . . 1.04 112.927 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.431 ' O ' ' HE3' ' A' ' 65' ' ' LYS . 59.4 m -80.68 -30.25 36.46 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.459 -0.496 . . . . 1.45 111.661 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.2 p -75.66 -16.23 60.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.099 -0.704 . . . . 1.04 109.099 172.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.632 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 46.6 mm -75.09 120.72 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.965 -1.016 . . . . 1.02 111.313 174.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.562 ' OD2' ' HG2' ' A' ' 47' ' ' LYS . 20.2 t70 -74.24 -50.22 19.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.851 -1.068 . . . . 0.69999999999999996 110.99 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.562 ' HG2' ' OD2' ' A' ' 46' ' ' ASP . 48.2 mmtm -142.32 154.46 44.71 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 109.488 -0.56 . . . . 2.4300000000000002 109.488 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.617 ' CD2' ' HG3' ' A' ' 105' ' ' GLN . 9.0 tp -112.59 145.05 41.03 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.391 -0.596 . . . . 1.04 109.391 167.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 15.2 mt-30 -126.73 156.67 40.77 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.686 -1.143 . . . . 1.49 109.876 -177.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -161.76 151.11 16.12 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 22.3 p -50.25 121.22 13.3 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.588 0.709 . . . . 1.03 111.44 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 66.3 Cg_endo -71.95 167.82 25.64 Favored 'Trans proline' 0 C--N 1.331 -0.375 0 C-N-CA 124.205 3.27 . . . . 0.73999999999999999 111.546 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.2 -27.94 37.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.26 0.552 . . . . 1.54 110.52 174.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 t -73.46 -22.78 60.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.838 -0.619 . . . . 2.0499999999999998 110.889 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.474 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 24.6 t -86.6 136.28 33.11 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.9 -0.407 . . . . 1.1399999999999999 109.9 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -88.99 -6.77 56.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.334 0.588 . . . . 2.8900000000000001 111.093 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -99.75 -177.1 3.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.393 -0.821 . . . . 3.1299999999999999 109.977 -176.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.581 ' SD ' ' HB2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -136.29 107.16 6.64 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.032 -0.729 . . . . 2.0 109.032 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.587 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 3.5 mpp? -156.86 146.62 20.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.977 0.418 . . . . 1.3 111.188 -175.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.854 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 1.9 mp -110.77 163.14 14.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.551 -0.75 . . . . 1.05 111.699 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 20.5 ttt180 -155.02 113.44 3.51 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.613 -0.721 . . . . 3.3999999999999999 110.281 173.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.561 HD12 ' CE2' ' A' ' 89' ' ' PHE . 7.3 mp -94.81 113.27 25.0 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.139 0.495 . . . . 1.73 110.427 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.535 HG22 ' HG2' ' A' ' 86' ' ' ARG . 5.1 mm -84.58 124.09 39.59 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 C-N-CA 123.543 0.737 . . . . 1.1599999999999999 109.105 -178.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.632 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -97.65 146.7 18.35 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 119.841 -1.171 . . . . 0.47999999999999998 112.106 177.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.514 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -58.22 131.53 50.86 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.141 0.496 . . . . 1.78 111.452 -175.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.404 ' HB ' ' HA ' ' A' ' 84' ' ' PRO . 7.3 p -88.51 165.04 2.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.387 -0.824 . . . . 1.3100000000000001 109.17 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.532 ' OD1' ' HD3' ' A' ' 70' ' ' LYS . 12.8 t70 -91.69 105.57 17.83 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.036 0.446 . . . . 2.5600000000000001 111.253 -175.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -85.63 -2.46 58.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.614 -0.721 . . . . 3.79 110.665 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.7 t -73.03 -39.94 65.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.401 -0.363 . . . . 3.3399999999999999 111.274 -173.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.532 ' HD3' ' OD1' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -134.63 103.81 5.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.285 0.564 . . . . 5.8200000000000003 110.563 174.342 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.407 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 54.2 mtmt -66.2 146.68 54.35 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.568 -0.742 . . . . 4.7400000000000002 110.56 178.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.676 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 6.1 ptm180 -85.11 174.97 9.29 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.417 -0.81 . . . . 4.7300000000000004 109.135 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.475 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 11.1 mmtp -121.32 146.73 46.54 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.63 0.252 . . . . 5.5300000000000002 110.983 -172.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 75' ' ' ASN . 13.6 t70 -94.98 -163.65 1.07 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.826 -0.805 . . . . 4.9800000000000004 108.826 177.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.472 ' H ' ' CG ' ' A' ' 74' ' ' ASP . 39.4 m-80 -55.78 -31.97 63.07 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.503 0.927 . . . . 7.1100000000000003 113.503 -171.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -90.48 -15.66 30.39 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.672 0.749 . . . . 7.1299999999999999 109.69 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 73' ' ' LYS . . . 94.74 25.72 14.62 Favored Glycine 0 CA--C 1.503 -0.712 0 N-CA-C 110.408 -1.077 . . . . 5.7300000000000004 110.408 -174.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -75.47 -89.8 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.119 -0.541 . . . . 5.6200000000000001 110.62 -177.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.676 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 8.7 pt-20 178.03 132.19 0.07 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.269 0.557 . . . . 5.0 111.606 177.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.448 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.7 t -127.86 148.88 32.44 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 N-CA-C 107.075 -1.454 . . . . 3.5800000000000001 107.075 173.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.7 t -110.06 102.07 49.61 Favored Pre-proline 0 C--N 1.298 -1.657 0 CA-C-O 121.297 0.57 . . . . 3.1499999999999999 109.927 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -43.15 148.91 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 124.465 3.443 . . . . 2.0800000000000001 113.6 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -77.19 128.58 80.44 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.273 -0.64 . . . . 3.5299999999999998 109.273 174.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.569 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 42.6 Cg_exo -52.89 137.31 61.02 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.918 2.412 . . . . 0.75 112.299 -177.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.03 115.67 7.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.647 0.736 . . . . 1.78 110.995 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' A' ' 84' ' ' PRO . 25.5 mtm180 -110.33 157.0 19.97 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.495 -0.775 . . . . 2.8199999999999998 111.032 -175.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.403 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 95.2 m-70 -120.39 111.12 17.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.308 -0.86 . . . . 0.63 109.637 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.446 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 55.0 ttm -113.73 125.31 53.97 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.88 -0.145 . . . . 1.1200000000000001 110.633 -174.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.561 ' CE2' HD12 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -118.75 148.43 42.81 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.339 -0.615 . . . . 1.6499999999999999 109.339 174.088 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.587 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 32.2 m -97.79 126.54 43.2 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.659 -0.497 . . . . 1.1899999999999999 109.659 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.854 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 8.8 m-85 -106.53 154.76 20.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.057 0.456 . . . . 1.6399999999999999 111.349 -174.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -100.36 -6.65 25.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.984 -0.553 . . . . 1.8300000000000001 110.955 -171.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -142.76 128.33 19.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.938 0.399 . . . . 1.22 110.581 -175.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.581 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 15.8 tpt180 -59.63 -34.69 73.11 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.109 -0.95 . . . . 2.8799999999999999 110.847 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.477 HG22 HD22 ' A' ' 99' ' ' ASN . 47.6 m -74.03 -58.82 3.05 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.69 -0.687 . . . . 1.1200000000000001 110.618 -177.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.42 ' O ' HG12 ' A' ' 100' ' ' ILE . 94.6 t -45.19 -53.69 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-N 115.792 -0.64 . . . . 1.1299999999999999 111.456 175.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.786 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -66.32 -29.81 70.09 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 120.515 -0.474 . . . . 1.0600000000000001 110.563 -177.206 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 101' ' ' LYS . 35.8 t70 -72.13 -24.26 61.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.62 0.724 . . . . 0.39000000000000001 109.618 178.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.566 ' O ' ' HG3' ' A' ' 102' ' ' MET . 85.7 m-20 -83.78 -42.93 15.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.845 -1.071 . . . . 1.55 109.742 177.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.529 HG23 HD12 ' A' ' 18' ' ' ILE . 33.7 mm -58.54 -51.85 66.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.482 -0.781 . . . . 1.0600000000000001 110.837 176.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.786 ' HG2' ' O ' ' A' ' 97' ' ' MET . 2.6 ptmt -60.23 -39.25 86.01 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 120.851 0.358 . . . . 1.72 111.159 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.566 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.7 ppp? -76.52 -22.93 53.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.079 0.466 . . . . 1.76 109.761 -175.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 52.6 m -68.46 -53.2 25.03 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.649 -0.705 . . . . 1.04 109.679 174.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.611 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 13.1 mt -65.75 -56.59 11.21 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.151 -0.931 . . . . 1.05 110.932 -177.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.617 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 49.1 mt-30 -52.05 -26.38 10.77 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.808 0.67 . . . . 1.45 112.808 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.427 ' O ' ' HG3' ' A' ' 110' ' ' ARG . 19.4 mt-30 -64.59 -43.8 92.66 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.923 -0.769 . . . . 0.66000000000000003 108.923 176.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.525 ' O ' ' HB2' ' A' ' 110' ' ' ARG . 33.4 mt -66.76 -43.89 89.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.293 -1.321 . . . . 1.04 110.876 176.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.537 HG22 ' HD2' ' A' ' 112' ' ' LYS . 1.2 mt -67.16 -47.84 80.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.05 -0.523 . . . . 1.04 110.445 -176.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.0 t -58.71 -27.34 64.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.366 0.603 . . . . 1.6100000000000001 110.237 172.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.525 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 77.2 mtt180 -70.56 -31.79 68.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 4.3899999999999997 110.25 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -93.94 -23.54 18.03 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.914 -0.584 . . . . 0.71999999999999997 111.934 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.537 ' HD2' HG22 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -73.16 -23.55 60.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.137 0.494 . . . . 2.25 109.979 174.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.55 -22.39 65.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.588 -0.733 . . . . 1.5600000000000001 109.755 172.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -114.0 23.11 13.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.565 -0.743 . . . . 1.3400000000000001 110.711 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.3 t70 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.503 -0.76 . . . . 2.1600000000000001 110.586 -178.006 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.906 0 N-CA-C 112.306 -0.318 . . . . 25.670000000000002 112.306 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 80.18 -121.96 5.61 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.071 -0.585 . . . . 24.66 112.119 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -85.0 57.85 4.99 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.028 -0.606 . . . . 24.199999999999999 111.846 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -110.46 148.38 17.56 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.948 -0.644 . . . . 23.140000000000001 111.864 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -81.05 -21.93 39.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.694 0.759 . . . . 24.920000000000002 109.628 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -133.63 148.37 51.54 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.088 -0.96 . . . . 21.449999999999999 109.33 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 9.3 p -93.31 5.72 6.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.732 0.777 . . . . 20.68 110.035 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -75.13 120.74 21.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.265 -0.88 . . . . 18.16 109.766 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 55.7 ttm -154.35 41.21 0.48 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.749 -0.834 . . . . 17.260000000000002 108.749 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -87.39 114.75 24.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.741 0.782 . . . . 13.68 110.844 -173.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 43.0 m -131.5 18.34 4.8 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.502 -1.226 . . . . 10.91 109.938 176.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -73.67 -36.73 65.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.428 -0.806 . . . . 11.029999999999999 109.833 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -72.46 -25.73 61.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.942 -0.572 . . . . 10.94 110.303 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -79.71 -51.81 8.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.647 -0.706 . . . . 9.8200000000000003 110.45 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 64.7 p -170.48 101.74 0.26 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.028 -0.533 . . . . 5.9100000000000001 110.824 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -76.74 -29.1 56.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.164 0.507 . . . . 6.2000000000000002 110.417 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -73.5 -3.8 29.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.306 -0.861 . . . . 6.1399999999999997 111.158 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -133.47 -145.71 0.25 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.658 -0.867 . . . . 3.3199999999999998 108.658 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 73.86 36.12 53.18 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.153 -0.546 . . . . 1.1200000000000001 113.182 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 261' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -72.35 138.01 46.99 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.909 -0.404 . . . . 0.97999999999999998 109.909 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.97 166.32 26.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.36 -0.382 . . . . 1.8999999999999999 110.72 -176.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 263' ' ' GLU . . . . . 0.524 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 8.0 pt-20 -93.31 142.37 27.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.282 -0.417 . . . . 2.2400000000000002 110.089 173.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.429 HG11 HE22 ' A' ' 105' ' ' GLN . 7.5 p -89.58 106.01 16.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.778 0.799 . . . . 1.8899999999999999 110.506 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.428 -0.796 . . . . 3.04 109.929 179.174 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 N--CA 1.481 0.744 0 N-CA-C 110.783 -0.506 . . . . 3.8100000000000001 110.783 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.0 p 41.51 -93.69 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.528 1.131 . . . . 1.8400000000000001 113.836 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.556 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 37.9 m80 -85.08 18.03 2.71 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.087 0.403 . . . . 2.3900000000000001 112.087 -172.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.422 ' C ' HD12 ' A' ' 100' ' ' ILE . 88.6 p -163.12 149.92 12.61 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.844 0.354 . . . . 1.6100000000000001 110.715 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.72 147.45 6.35 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.496 -1.042 . . . . 0.17000000000000001 110.496 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.709 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.55 136.75 40.55 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 117.653 0.726 . . . . 0.97999999999999998 111.283 -175.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.31 160.11 40.81 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 121.278 0.561 . . . . 1.01 111.323 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.548 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.5 mp -105.58 126.39 60.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.603 -0.726 . . . . 1.0800000000000001 109.163 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -116.82 101.8 8.85 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.711 -0.396 . . . . 0.66000000000000003 110.279 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 60.69 53.0 4.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.19 0.519 . . . . 1.46 110.668 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt 78.99 -8.35 1.65 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.545 -1.207 . . . . 2.3900000000000001 113.298 171.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -97.86 127.58 50.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.203 -0.599 . . . . 1.23 110.712 171.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.548 ' HA ' HG13 ' A' ' 8' ' ' ILE . 10.2 p -78.99 126.13 30.28 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.558 -0.746 . . . . 1.48 111.095 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.655 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -145.24 -155.42 6.46 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.465 -0.789 . . . . 0.16 112.098 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.709 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 6.4 mm -128.71 153.78 38.71 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.741 0 CA-C-O 120.768 0.318 . . . . 1.05 110.768 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.47 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -124.38 131.85 72.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.642 -0.503 . . . . 1.01 109.642 179.126 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.57 112.28 9.44 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.215 -0.448 . . . . 0.87 111.643 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.556 ' O ' ' HB3' ' A' ' 3' ' ' HIS . 4.1 mp -84.8 120.75 35.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.265 -1.013 . . . . 1.05 108.265 171.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -123.64 124.88 43.75 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.967 -0.383 . . . . 1.1200000000000001 109.967 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -108.53 83.11 1.72 Allowed 'General case' 0 N--CA 1.427 -1.62 0 C-N-CA 116.959 -1.896 . . . . 0.73999999999999999 107.342 165.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -121.25 -12.35 8.66 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 106.625 -1.62 . . . . 0.58999999999999997 106.625 158.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 23' ' ' SER . 14.9 p -101.75 177.9 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 111.812 -2.449 . . . . 1.0800000000000001 111.852 -156.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.699 ' O ' HG13 ' A' ' 22' ' ' VAL . 4.4 m -53.61 168.4 0.4 Allowed Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 107.194 -1.41 . . . . 2.0 107.194 165.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 12.2 Cg_endo -42.6 128.21 4.75 Favored 'Trans proline' 0 C--N 1.357 1.016 0 CA-C-N 121.966 1.738 . . . . 0.26000000000000001 110.94 -155.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.502 ' HB2' HG21 ' A' ' 107' ' ' ILE . . . -33.36 135.83 0.11 Allowed 'General case' 0 CA--C 1.507 -0.697 0 O-C-N 125.334 1.646 . . . . 1.02 113.892 -154.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.524 ' HB2' HG12 ' A' ' 22' ' ' VAL . 28.5 mt-10 -123.3 138.61 54.58 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 114.588 -1.187 . . . . 1.26 111.179 -170.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.57 HD22 ' C ' ' A' ' 27' ' ' LEU . 1.4 tt -101.71 143.11 32.06 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 106.567 -1.642 . . . . 1.0600000000000001 106.567 173.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.418 ' N ' HD22 ' A' ' 27' ' ' LEU . 16.5 m -130.99 109.78 10.77 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.846 -0.742 . . . . 1.05 110.67 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.642 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 87.8 t90 -85.92 106.03 16.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.687 0.756 . . . . 0.29999999999999999 109.327 174.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -111.15 115.32 29.2 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.069 -0.969 . . . . 1.1599999999999999 108.759 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.529 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 63.1 p -56.39 144.13 31.98 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.993 0.425 . . . . 1.3899999999999999 110.064 -177.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.655 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 25.9 m -56.44 -25.04 49.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.175 -0.92 . . . . 1.1499999999999999 110.751 -176.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -76.33 -27.96 56.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.899 -0.591 . . . . 2.3300000000000001 111.299 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.83 8.01 60.93 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.702 -0.559 . . . . 0.55000000000000004 111.702 -174.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -84.87 -72.68 0.46 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.056 0.455 . . . . 1.1299999999999999 111.408 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -85.55 141.13 30.08 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.201 0.524 . . . . 2.6200000000000001 111.48 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 93.9 t -137.69 125.86 31.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.741 -1.118 . . . . 1.3100000000000001 109.441 177.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -130.34 111.29 12.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.53 -0.305 . . . . 0.82999999999999996 110.273 -175.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -100.87 141.87 33.15 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 111.863 0.319 . . . . 1.0600000000000001 111.863 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 43.1 t -116.11 129.69 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 122.623 0.369 . . . . 1.3600000000000001 111.688 176.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.564 ' O ' HG12 ' A' ' 45' ' ' ILE . 60.4 t -91.11 108.42 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-O 121.268 0.556 . . . . 1.05 109.579 172.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.571 HD13 ' CD2' ' A' ' 104' ' ' LEU . 1.6 mm? -53.14 -29.52 31.71 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.877 -1.056 . . . . 1.04 112.546 -178.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.406 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 68.4 m -76.89 -33.79 57.78 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.608 -0.437 . . . . 1.45 111.581 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.7 p -74.07 -11.7 60.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.541 0.686 . . . . 1.04 109.371 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 41' ' ' VAL . 47.5 mm -82.62 133.03 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 114.77 -1.105 . . . . 1.02 111.002 173.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.639 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 35.8 t70 -85.91 -50.22 7.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.456 -0.793 . . . . 0.69999999999999996 110.904 174.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.437 ' HB2' HG13 ' A' ' 63' ' ' ILE . 74.9 mmtt -136.77 156.14 48.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.245 -0.434 . . . . 2.4300000000000002 110.1 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.621 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 11.6 tp -119.18 140.21 50.55 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.213 0.53 . . . . 1.04 109.871 167.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.542 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 11.8 mm100 -115.61 154.82 28.76 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.818 -1.083 . . . . 1.49 109.837 -178.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.583 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.85 141.65 8.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.588 -0.733 . . . . 1.0 109.278 177.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.493 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 33.5 p -51.94 123.52 25.95 Favored Pre-proline 0 N--CA 1.467 0.4 0 CA-C-O 121.484 0.659 . . . . 1.03 111.559 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 71.1 Cg_endo -70.76 167.29 26.16 Favored 'Trans proline' 0 CA--C 1.519 -0.275 0 C-N-CA 124.331 3.354 . . . . 0.73999999999999999 112.126 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.63 -28.13 53.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.236 0.541 . . . . 1.54 110.575 174.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.8 m -68.73 -25.38 64.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.375 -0.83 . . . . 2.0499999999999998 111.324 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.446 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 33.7 t -80.4 143.43 33.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.535 -0.757 . . . . 1.1399999999999999 109.951 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -90.17 -7.66 53.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.484 0.659 . . . . 2.8900000000000001 109.667 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 mmmt -98.89 178.33 4.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.225 -0.898 . . . . 3.1299999999999999 110.403 -175.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.508 ' HB3' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -137.58 110.18 7.52 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.982 -1.008 . . . . 2.0 108.674 176.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.583 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 3.1 ttm -157.3 140.13 15.09 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.744 -0.382 . . . . 1.3 111.422 -173.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.851 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 1.9 mp -109.27 160.82 15.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.06 0.457 . . . . 1.05 111.016 172.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.542 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 20.7 ttm180 -153.56 113.34 3.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.906 -0.588 . . . . 3.3999999999999999 110.263 172.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.55 ' HG ' HD11 ' A' ' 48' ' ' LEU . 7.9 mt -93.61 113.79 25.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.055 0.455 . . . . 1.73 110.293 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.468 HG21 ' HG2' ' A' ' 86' ' ' ARG . 5.4 mm -86.63 109.28 18.78 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 CA-C-N 115.717 -0.674 . . . . 1.1599999999999999 110.461 -173.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -76.43 138.48 22.55 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.731 -1.223 . . . . 0.47999999999999998 111.384 176.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.639 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 1.7 mptp? -53.44 136.68 37.43 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.72 0.295 . . . . 1.78 110.941 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 82' ' ' PRO . 10.1 p -79.57 165.86 2.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.923 -0.399 . . . . 1.3100000000000001 109.923 175.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.428 ' H ' HG22 ' A' ' 66' ' ' VAL . 8.5 m-20 -69.72 80.94 0.44 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.84 -0.618 . . . . 2.5600000000000001 112.006 -174.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -80.29 -14.49 58.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.797 -0.638 . . . . 3.79 110.448 174.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.9 p -64.39 -38.48 91.17 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.673 -0.694 . . . . 3.3399999999999999 110.646 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.55 98.69 2.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.901 -0.59 . . . . 5.8200000000000003 110.676 176.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -62.92 143.0 58.08 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.25 0.548 . . . . 4.7400000000000002 110.45 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.449 ' CG ' ' HB ' ' A' ' 80' ' ' VAL . 4.3 ptm180 -80.76 171.05 15.51 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.405 -0.816 . . . . 4.7300000000000004 109.255 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -147.43 152.62 38.41 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.212 0.53 . . . . 5.5300000000000002 110.468 179.036 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.5 ' HB3' HD22 ' A' ' 78' ' ' ASN . 2.6 t70 -92.23 -158.32 0.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.354 -0.839 . . . . 4.9800000000000004 110.545 -172.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -63.81 -31.64 72.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.754 0.312 . . . . 7.1100000000000003 111.375 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -90.1 -3.71 57.75 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.644 0.735 . . . . 7.1299999999999999 109.523 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.512 ' HA2' ' HB2' ' A' ' 73' ' ' LYS . . . 68.66 25.88 74.78 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 114.654 -1.157 . . . . 5.7300000000000004 110.782 -175.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.546 ' O ' ' HB2' ' A' ' 79' ' ' GLU . 8.7 p30 -67.64 -33.3 74.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.267 -0.467 . . . . 5.6200000000000001 111.719 -173.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 38.5 mt-10 100.25 126.56 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 125.367 1.667 . . . . 5.0 111.133 174.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.449 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.3 t -126.58 147.73 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 107.623 -1.251 . . . . 3.5800000000000001 107.623 -176.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.6 t -112.25 100.72 50.41 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 109.528 -0.545 . . . . 3.1499999999999999 109.528 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.562 ' O ' HG23 ' A' ' 66' ' ' VAL . 64.0 Cg_exo -48.53 159.42 0.82 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.86 3.04 . . . . 2.0800000000000001 112.668 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 61.8 tttt -83.08 130.18 58.28 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-O 121.344 0.593 . . . . 3.5299999999999998 110.242 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 83' ' ' LYS . 24.0 Cg_exo -55.44 140.52 82.71 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.547 2.832 . . . . 0.75 112.306 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.99 114.57 19.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.42 0.628 . . . . 1.78 109.87 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.468 ' HG2' HG21 ' A' ' 63' ' ' ILE . 18.5 mtm180 -110.78 160.42 16.75 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.64 -0.709 . . . . 2.8199999999999998 110.227 -173.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -124.3 111.91 16.38 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.009 -0.542 . . . . 0.63 109.713 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.504 ' HE1' ' HE ' ' A' ' 61' ' ' ARG . 49.7 ttm -111.35 128.53 55.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.716 -0.22 . . . . 1.1200000000000001 110.889 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.416 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 39.8 m-85 -117.24 143.63 45.68 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 108.832 -0.803 . . . . 1.6499999999999999 108.832 173.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.527 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 19.1 m -96.88 125.59 41.43 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.469 -0.567 . . . . 1.1899999999999999 109.469 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.851 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 4.5 m-85 -107.53 162.9 13.52 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.952 -0.388 . . . . 1.6399999999999999 109.952 -177.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -115.91 -7.06 12.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.859 0.361 . . . . 1.8300000000000001 110.911 -176.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -129.09 119.44 24.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.67 -0.493 . . . . 1.22 109.67 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.508 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 8.3 tpt180 -61.44 -29.08 69.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.844 -0.617 . . . . 2.8799999999999999 111.227 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 50.0 m -74.17 -47.05 38.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.245 0.545 . . . . 1.1200000000000001 110.52 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.809 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 66.3 t -60.27 -52.76 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 CA-C-N 115.646 -0.706 . . . . 1.1299999999999999 111.633 177.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.525 ' O ' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -60.41 -26.01 66.37 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.912 -0.715 . . . . 1.0600000000000001 109.735 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 95' ' ' THR . 36.6 t70 -70.29 -41.74 72.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.261 0.553 . . . . 0.39000000000000001 109.9 176.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.809 ' ND2' ' HA ' ' A' ' 96' ' ' VAL . 22.8 p30 -80.21 -29.19 38.54 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.073 -0.967 . . . . 1.55 110.879 -173.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.515 HG23 HD11 ' A' ' 18' ' ' ILE . 31.0 mm -67.41 -54.02 27.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.366 -0.834 . . . . 1.0600000000000001 110.123 169.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -54.79 -48.39 72.78 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.53 -0.759 . . . . 1.72 111.326 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -65.73 -26.09 67.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.9 0.381 . . . . 1.76 110.592 -176.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.44 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 22.1 m -68.06 -49.73 59.55 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.204 0.526 . . . . 1.04 110.354 177.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.621 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 9.7 mt -69.38 -57.25 5.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.391 -0.822 . . . . 1.05 111.156 -175.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.614 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 96.0 mt-30 -50.78 -28.35 9.11 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.223 0.453 . . . . 1.45 112.223 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -63.16 -49.81 72.87 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.842 -0.799 . . . . 0.66000000000000003 108.842 176.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.505 HD13 ' HA ' ' A' ' 104' ' ' LEU . 60.1 mt -60.07 -44.75 95.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 113.906 -1.497 . . . . 1.04 110.518 176.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.583 HG21 ' HD2' ' A' ' 112' ' ' LYS . 1.2 mt -62.53 -55.52 23.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.675 -0.693 . . . . 1.04 110.412 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.506 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 59.6 m -59.01 -26.43 64.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.0 0.429 . . . . 1.6100000000000001 110.966 175.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -69.22 -33.92 74.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.856 -0.611 . . . . 4.3899999999999997 110.21 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -86.48 -28.22 23.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.585 -0.734 . . . . 0.71999999999999997 111.187 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.583 ' HD2' HG21 ' A' ' 108' ' ' ILE . 16.0 mtpt -71.54 -27.8 63.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.074 0.464 . . . . 2.25 110.007 174.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.77 -19.93 65.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.491 0.663 . . . . 1.5600000000000001 109.924 175.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -117.22 27.19 9.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.454 -0.793 . . . . 1.3400000000000001 110.805 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 39.0 t70 . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.78 -0.629 . . . . 2.1600000000000001 110.568 178.516 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.873 0 N-CA-C 112.251 -0.34 . . . . 25.670000000000002 112.251 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 137.92 -142.04 12.82 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.976 -0.631 . . . . 24.66 111.785 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 84.85 -62.3 4.57 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.843 -0.694 . . . . 24.199999999999999 112.444 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 70.15 -103.07 1.08 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.199 -0.525 . . . . 23.140000000000001 112.019 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -80.93 -17.65 49.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.337 0.589 . . . . 24.920000000000002 109.842 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -96.95 146.19 25.19 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.252 -0.886 . . . . 21.449999999999999 110.689 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 21.6 m -85.98 41.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.429 0.633 . . . . 20.68 110.792 178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -79.87 126.83 31.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.665 -0.698 . . . . 18.16 109.963 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 20.7 mmt -121.74 28.94 7.38 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.236 -0.653 . . . . 17.260000000000002 109.236 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -71.1 96.35 1.33 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.002 -0.999 . . . . 13.68 110.896 -174.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 49.4 m -165.93 -37.24 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.352 -1.295 . . . . 10.91 110.676 -175.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -52.35 -54.34 32.94 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.974 -0.557 . . . . 11.029999999999999 112.08 -174.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -67.69 -46.51 72.08 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.954 0.353 . . . . 10.94 111.954 -174.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -72.28 -31.83 66.09 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.258 0.466 . . . . 9.8200000000000003 112.258 -174.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 49.0 m -100.91 20.5 15.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.734 0.302 . . . . 5.9100000000000001 111.217 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -84.36 -22.56 30.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.604 -0.271 . . . . 6.2000000000000002 111.013 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -57.43 -44.75 84.92 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 116.225 -0.443 . . . . 6.1399999999999997 110.697 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.5 ' HA ' HH22 ' A' ' 61' ' ' ARG . 20.7 m-20 -100.58 -34.57 9.85 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.058 -0.519 . . . . 3.3199999999999998 110.249 174.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 84.47 -7.31 73.27 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.095 -0.802 . . . . 1.1200000000000001 111.095 -174.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 261' ' ' PHE . . . . . 0.488 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 6.2 m-85 -125.86 179.54 5.15 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.434 -0.58 . . . . 0.97999999999999998 109.434 -176.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.72 150.3 19.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.624 -0.51 . . . . 1.8999999999999999 109.624 173.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 263' ' ' GLU . . . . . 0.499 ' HB3' ' OE1' ' A' ' 49' ' ' GLN . 2.5 pp20? -103.82 134.16 47.59 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.778 -0.453 . . . . 2.2400000000000002 109.778 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.545 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 60.2 t -100.06 108.93 23.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.009 -0.541 . . . . 1.8899999999999999 110.018 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.435 -0.793 . . . . 3.04 110.144 -178.584 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo . . . . . 0 N--CA 1.479 0.649 0 N-CA-C 110.809 -0.496 . . . . 3.8100000000000001 110.809 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.45 ' HA ' ' HB3' ' A' ' 99' ' ' ASN . 31.3 t -100.98 -70.26 0.75 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.212 -0.449 . . . . 1.8400000000000001 110.695 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -92.97 20.28 6.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.319 0.581 . . . . 2.3900000000000001 110.005 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.4 m -162.33 150.67 14.66 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.538 -0.755 . . . . 1.6100000000000001 109.195 -177.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.53 140.61 3.97 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.275 -0.73 . . . . 0.17000000000000001 111.275 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.718 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -71.6 121.4 18.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 117.211 0.506 . . . . 0.97999999999999998 111.173 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.528 ' HB1' ' CE1' ' A' ' 91' ' ' PHE . . . -130.83 158.78 39.23 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.256 0.551 . . . . 1.01 112.115 -177.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.494 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.5 mp -97.16 120.56 46.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.349 -0.841 . . . . 1.0800000000000001 109.21 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.551 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 82.8 t80 -122.91 112.53 17.95 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.843 -0.428 . . . . 0.66000000000000003 109.843 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 62.98 48.61 3.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.79 0.805 . . . . 1.46 110.127 -175.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt 72.61 -6.53 1.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.143 -1.389 . . . . 2.3900000000000001 113.373 171.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.92 131.99 46.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.936 0.398 . . . . 1.23 110.236 173.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.494 ' HA ' HG13 ' A' ' 8' ' ' ILE . 23.3 t -78.89 130.55 35.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.059 -0.518 . . . . 1.48 110.522 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.642 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -149.4 -154.61 6.43 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 115.702 -0.681 . . . . 0.16 111.628 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.718 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 9.9 mm -124.44 153.42 31.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.948 0.374 . . . . 1.05 110.619 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.411 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -126.74 133.46 68.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.977 -0.556 . . . . 1.01 109.849 -179.824 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.89 111.44 8.63 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 116.281 -0.418 . . . . 0.87 111.751 175.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.537 HD13 HG21 ' A' ' 100' ' ' ILE . 4.0 mp -84.36 114.06 24.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.139 -1.06 . . . . 1.05 108.139 171.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.403 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.5 t30 -119.25 122.06 41.06 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.952 -0.388 . . . . 1.1200000000000001 109.952 -179.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.474 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 38.0 mt-10 -105.88 84.25 2.04 Favored 'General case' 0 N--CA 1.423 -1.785 0 C-N-CA 116.858 -1.937 . . . . 0.73999999999999999 107.418 163.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.403 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 22.3 t70 -121.4 -11.22 8.78 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.622 -1.621 . . . . 0.58999999999999997 106.622 156.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.651 HG12 ' O ' ' A' ' 23' ' ' SER . 14.2 p -102.58 174.8 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 112.001 -2.363 . . . . 1.0800000000000001 111.653 -157.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.651 ' O ' HG12 ' A' ' 22' ' ' VAL . 17.3 p -54.27 166.3 0.71 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 117.052 -1.452 . . . . 2.0 107.117 166.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.6 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 10.3 Cg_endo -41.49 128.47 3.44 Favored 'Trans proline' 0 C--N 1.362 1.278 0 CA-C-N 122.233 1.833 . . . . 0.26000000000000001 111.374 -151.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.519 ' HB1' HG21 ' A' ' 107' ' ' ILE . . . -29.92 133.81 0.05 Allowed 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 125.251 1.595 . . . . 1.02 114.004 -157.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.524 ' HB2' HG11 ' A' ' 22' ' ' VAL . 23.8 mt-10 -124.9 136.72 54.03 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 114.777 -1.101 . . . . 1.26 111.15 -172.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.598 HD22 ' C ' ' A' ' 27' ' ' LEU . 1.0 OUTLIER -100.3 142.1 32.25 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.469 -1.678 . . . . 1.0600000000000001 106.469 173.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.411 ' N ' HD22 ' A' ' 27' ' ' LEU . 9.7 m -126.94 109.22 11.71 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.796 -0.762 . . . . 1.05 110.241 -178.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.648 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 88.3 t90 -89.23 105.71 17.96 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.684 0.754 . . . . 0.29999999999999999 109.086 175.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.417 ' HD3' ' O ' ' A' ' 31' ' ' SER . 3.6 tmt_? -113.54 115.0 27.28 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.723 -1.126 . . . . 1.1599999999999999 108.523 -177.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.518 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 98.1 p -58.75 144.66 43.06 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.308 0.575 . . . . 1.3899999999999999 110.444 -173.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.642 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 18.5 m -54.82 -25.16 26.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.765 -1.107 . . . . 1.1499999999999999 111.816 -173.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -89.77 -13.95 35.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.97 -0.559 . . . . 2.3300000000000001 111.723 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.69 22.05 60.64 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.319 -0.943 . . . . 0.55000000000000004 111.108 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -84.52 -39.28 19.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.919 -0.64 . . . . 1.1299999999999999 111.913 -174.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -146.74 161.57 40.34 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.207 0.527 . . . . 2.6200000000000001 110.774 -177.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 85.3 t -144.08 131.0 16.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.1 -0.955 . . . . 1.3100000000000001 110.124 -176.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -131.96 109.11 9.82 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.639 -0.709 . . . . 0.82999999999999996 109.813 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.9 m -99.82 137.06 38.81 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.625 -0.262 . . . . 1.0600000000000001 111.294 -175.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 40.7 t -110.01 128.43 66.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 122.653 0.381 . . . . 1.3600000000000001 111.703 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 45' ' ' ILE . 53.2 t -90.53 108.19 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 109.319 -0.623 . . . . 1.05 109.319 172.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.569 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.0 mm? -54.95 -27.26 42.22 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.924 -1.035 . . . . 1.04 112.415 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.504 ' O ' ' HE2' ' A' ' 65' ' ' LYS . 43.1 t -75.75 -34.04 60.26 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.598 -0.441 . . . . 1.45 110.641 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.439 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 58.6 p -77.77 -10.37 59.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.472 0.653 . . . . 1.04 109.661 175.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.596 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 45.2 mm -79.85 123.84 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 114.995 -1.002 . . . . 1.02 111.256 173.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.56 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 5.8 t70 -73.85 -46.26 46.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.29 -0.868 . . . . 0.69999999999999996 111.436 174.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.448 ' O ' HG12 ' A' ' 63' ' ' ILE . 43.6 tptt -151.52 159.48 44.12 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 120.763 0.316 . . . . 2.4300000000000002 110.432 -177.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.6 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 11.8 tp -117.68 148.24 42.16 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.623 -0.51 . . . . 1.04 109.623 170.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.46 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 15.3 mm100 -126.55 156.47 40.78 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.23 -0.895 . . . . 1.49 109.573 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.57 ' HB3' ' HD3' ' A' ' 101' ' ' LYS . . . -163.04 144.06 9.61 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.228 -0.442 . . . . 1.0 109.925 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.508 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 40.8 p -52.41 126.72 38.7 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 121.36 0.6 . . . . 1.03 112.135 -176.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 59.6 Cg_endo -69.31 167.08 24.9 Favored 'Trans proline' 0 C--N 1.334 -0.225 0 C-N-CA 124.323 3.349 . . . . 0.73999999999999999 112.305 177.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.01 -28.65 58.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.842 0.353 . . . . 1.54 111.272 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.3 t -72.43 -23.61 61.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 2.0499999999999998 110.784 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.486 ' CB ' ' HB ' ' A' ' 51' ' ' THR . 31.6 t -71.74 133.46 45.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.923 -0.58 . . . . 1.1399999999999999 110.081 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -80.35 -15.14 57.57 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.758 0.789 . . . . 2.8900000000000001 109.309 177.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -106.49 172.62 6.72 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.054 -0.975 . . . . 3.1299999999999999 109.787 -176.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.524 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.2 OUTLIER -131.34 109.83 10.64 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.526 -0.916 . . . . 2.0 108.526 -177.429 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.529 ' HG2' ' HA ' ' A' ' 90' ' ' SER . 72.9 mtm -154.73 155.5 34.66 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.79 0.329 . . . . 1.3 111.212 -172.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 101' ' ' LYS . 0.7 OUTLIER -120.82 160.13 24.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.553 -0.749 . . . . 1.05 110.956 176.252 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.46 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 48.8 ttp180 -152.43 113.61 4.24 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 120.882 0.372 . . . . 3.3999999999999999 111.198 171.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.498 ' HG ' HD11 ' A' ' 48' ' ' LEU . 10.4 mt -94.46 110.53 22.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.358 -0.383 . . . . 1.73 110.945 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.528 ' HA ' ' HB3' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -87.61 125.7 41.24 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 CA-C-N 116.027 -0.533 . . . . 1.1599999999999999 110.454 -176.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.596 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -99.01 151.94 19.57 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.029 -1.082 . . . . 0.47999999999999998 111.096 174.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.56 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 1.0 OUTLIER -56.5 134.16 53.9 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.858 0.361 . . . . 1.78 111.263 -174.176 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.445 ' HB ' ' HG3' ' A' ' 84' ' ' PRO . 8.3 p -67.86 168.26 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.76 -0.655 . . . . 1.3100000000000001 110.918 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.444 ' H ' HG21 ' A' ' 66' ' ' VAL . 25.7 t70 -59.01 140.55 55.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.611 0.719 . . . . 2.5600000000000001 111.404 -176.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -54.43 -22.53 12.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.307 -1.315 . . . . 3.79 112.913 -176.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.8 t -74.58 -9.38 58.52 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 121.272 -0.171 . . . . 3.3399999999999999 111.122 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt 50.34 -89.7 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.116 0.966 . . . . 5.8200000000000003 112.647 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -79.32 130.05 35.06 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.136 0.493 . . . . 4.7400000000000002 110.36 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.538 ' CG ' ' HB ' ' A' ' 80' ' ' VAL . 4.1 ptm85 -122.36 170.73 9.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.086 -0.506 . . . . 4.7300000000000004 110.331 -174.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.463 ' HB3' ' C ' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -121.06 165.08 15.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.843 0.354 . . . . 5.5300000000000002 110.657 -177.593 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.629 ' HB3' HD22 ' A' ' 78' ' ' ASN . 6.4 t70 -97.61 -157.61 0.61 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.214 -0.448 . . . . 4.9800000000000004 109.933 -177.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.411 ' H ' ' CG ' ' A' ' 74' ' ' ASP . 28.2 t-20 -64.57 -25.52 68.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.002 0.43 . . . . 7.1100000000000003 111.832 -172.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 34.2 tt0 -99.24 5.35 46.69 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 122.149 0.976 . . . . 7.1299999999999999 109.016 -177.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.463 ' C ' ' HB3' ' A' ' 73' ' ' LYS . . . 70.93 29.41 69.17 Favored Glycine 0 CA--C 1.506 -0.517 0 CA-C-N 115.042 -0.981 . . . . 5.7300000000000004 110.727 -178.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.629 HD22 ' HB3' ' A' ' 74' ' ' ASP . 3.1 p30 -84.47 -87.24 0.12 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.272 -0.464 . . . . 5.6200000000000001 111.61 -177.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.41 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 7.2 pt-20 -167.01 129.43 1.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.538 0.57 . . . . 5.0 112.538 178.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.538 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 3.3 t -128.32 148.65 32.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.321 -0.992 . . . . 3.5800000000000001 108.321 165.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.7 p -111.58 97.47 36.85 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-O 121.711 0.767 . . . . 3.1499999999999999 110.073 174.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.429 ' HD3' ' HG2' ' A' ' 72' ' ' ARG . 60.9 Cg_endo -72.85 136.59 25.51 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.067 2.512 . . . . 2.0800000000000001 112.617 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.536 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 11.1 mptt -89.02 137.98 29.36 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.204 -0.665 . . . . 3.5299999999999998 109.204 177.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.445 ' HG3' ' HB ' ' A' ' 66' ' ' VAL . 34.4 Cg_exo -56.0 133.85 60.54 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.421 2.081 . . . . 0.75 112.114 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.41 115.14 2.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.483 -0.78 . . . . 1.78 110.956 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.528 ' HB3' ' HA ' ' A' ' 63' ' ' ILE . 12.9 ptt180 -129.56 145.0 51.51 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.629 0.728 . . . . 2.8199999999999998 111.994 -173.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.413 ' CD2' HG21 ' A' ' 40' ' ' VAL . 91.7 m-70 -107.39 116.63 32.27 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.633 -1.167 . . . . 0.63 110.517 -173.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.401 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 48.6 ttm -104.68 128.73 52.83 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.67 -0.412 . . . . 1.1200000000000001 111.32 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.408 ' CE2' HD13 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -121.84 123.04 40.83 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.054 -0.721 . . . . 1.6499999999999999 109.054 175.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.529 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 64.6 m -93.18 130.69 38.76 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.926 0.393 . . . . 1.1899999999999999 110.264 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.585 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 40.2 m-85 -107.48 169.73 8.4 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.404 0.621 . . . . 1.6399999999999999 110.896 176.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -112.15 -6.07 14.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.413 -0.812 . . . . 1.8300000000000001 109.828 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.47 ' OD1' ' HB ' ' A' ' 95' ' ' THR . 28.6 t-20 -130.65 128.51 41.1 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.284 0.564 . . . . 1.22 111.282 -176.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.418 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 14.6 tpt180 -59.32 -37.06 76.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.76 -1.109 . . . . 2.8799999999999999 111.641 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.47 ' HB ' ' OD1' ' A' ' 93' ' ' ASN . 91.7 m -72.26 -54.94 8.1 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.312 -0.403 . . . . 1.1200000000000001 110.777 -176.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.8 t -44.95 -57.34 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 115.969 -0.559 . . . . 1.1299999999999999 111.434 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.524 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -63.63 -29.92 71.09 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.578 -0.449 . . . . 1.0600000000000001 111.218 -177.656 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.506 ' HA ' ' HE2' ' A' ' 101' ' ' LYS . 26.0 t70 -68.64 -33.06 73.35 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.465 0.65 . . . . 0.39000000000000001 109.251 177.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.6 ' O ' ' HG3' ' A' ' 102' ' ' MET . 91.7 m-20 -77.41 -50.74 12.07 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.634 -1.166 . . . . 1.55 110.055 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.585 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 32.4 mm -56.0 -48.44 78.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.235 -0.893 . . . . 1.0600000000000001 110.14 178.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.57 ' HD3' ' HB3' ' A' ' 50' ' ' ALA . 13.3 ttpt -58.61 -50.96 71.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.368 -0.833 . . . . 1.72 111.133 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.6 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.3 ppp? -67.89 -23.06 65.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 1.76 110.335 -175.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 52.1 m -68.13 -51.57 44.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.89 -0.595 . . . . 1.04 110.507 174.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.6 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 13.1 mt -69.04 -56.79 6.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.184 -0.916 . . . . 1.05 111.7 -173.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.51 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 42.2 mt-30 -53.16 -29.19 30.12 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.049 0.388 . . . . 1.45 112.049 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -61.28 -28.16 68.99 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.84 0.828 . . . . 0.66000000000000003 109.265 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.544 ' O ' ' HB3' ' A' ' 110' ' ' ARG . 25.2 mt -85.68 -45.28 17.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 113.803 -1.544 . . . . 1.04 110.791 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.546 HG22 ' HD2' ' A' ' 112' ' ' LYS . 1.7 mt -67.52 -53.81 28.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.417 -0.811 . . . . 1.04 111.46 -172.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.482 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 7.0 m -65.03 -14.96 61.73 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.567 0.699 . . . . 1.6100000000000001 109.708 176.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.544 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 14.0 ttt180 -77.65 -42.95 32.94 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.863 -1.062 . . . . 4.3899999999999997 109.752 174.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -74.42 -34.13 63.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.759 -0.655 . . . . 0.71999999999999997 111.156 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.546 ' HD2' HG22 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -74.5 -18.45 60.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.327 0.585 . . . . 2.25 110.105 177.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -79.51 -19.64 49.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.411 -0.813 . . . . 1.5600000000000001 109.683 174.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -114.86 19.76 15.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.437 -0.802 . . . . 1.3400000000000001 110.772 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.3 t70 . . . . . 0 C--O 1.245 0.853 0 CA-C-O 118.479 -0.772 . . . . 2.1600000000000001 110.285 -178.836 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.712 0 N-CA-C 111.87 -0.492 . . . . 25.670000000000002 111.87 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -155.24 59.33 0.38 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.043 -0.599 . . . . 24.66 111.878 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 165.78 -137.22 4.56 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.944 -0.646 . . . . 24.199999999999999 111.832 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.55 -124.66 7.6 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.74 -0.743 . . . . 23.140000000000001 112.299 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 58.8 42.84 19.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.494 0.664 . . . . 24.920000000000002 110.789 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 247' ' ' ASP . . . . . 0.404 ' OD2' ' HB3' ' B' ' 249' ' ' GLU . 3.4 t70 -81.83 126.21 31.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.133 -0.94 . . . . 21.449999999999999 109.68 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 4.1 t -82.43 46.15 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.597 0.713 . . . . 20.68 110.986 -174.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . 0.404 ' HB3' ' OD2' ' B' ' 247' ' ' ASP . 45.3 tt0 -136.55 113.92 10.82 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.663 -0.699 . . . . 18.16 109.244 176.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 10.9 ptt? -172.8 30.16 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.444 0.64 . . . . 17.260000000000002 110.42 -175.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -86.45 91.86 8.66 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.47 -0.787 . . . . 13.68 110.068 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 50.7 p -118.74 22.78 11.82 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.707 0.765 . . . . 10.91 109.434 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -58.12 -55.79 30.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.613 -1.176 . . . . 11.029999999999999 109.955 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -56.8 -22.46 36.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.349 -0.841 . . . . 10.94 111.635 -176.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -76.28 -64.11 1.18 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.626 -0.261 . . . . 9.8200000000000003 110.985 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 52.0 m -160.88 -6.35 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.606 0.241 . . . . 5.9100000000000001 111.238 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -87.56 -4.72 58.96 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.648 0.24 . . . . 6.2000000000000002 111.648 -175.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -60.03 -54.98 39.62 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 120.966 0.412 . . . . 6.1399999999999997 110.221 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' B' ' 260' ' ' GLY . 4.2 p-10 -118.1 -92.65 0.53 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.241 -0.436 . . . . 3.3199999999999998 110.67 173.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . 0.448 ' H ' ' CG ' ' B' ' 259' ' ' ASP . . . 72.24 17.6 77.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.147 -1.025 . . . . 1.1200000000000001 110.858 -174.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 261' ' ' PHE . . . . . 0.476 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 12.0 m-85 -118.3 169.88 9.36 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.227 -0.487 . . . . 0.97999999999999998 109.7 -176.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.3 p -125.8 156.79 35.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.359 -0.978 . . . . 1.8999999999999999 108.359 172.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 263' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' B' ' 263' ' ' GLU . 0.2 OUTLIER -111.04 121.61 45.78 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.322 -0.622 . . . . 2.2400000000000002 109.322 176.67 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.418 ' H ' HE22 ' A' ' 105' ' ' GLN . 46.6 t -101.94 102.82 14.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.734 -0.666 . . . . 1.8899999999999999 111.342 -172.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.382 -0.818 . . . . 3.04 110.012 178.498 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.476 0.456 0 N-CA-C 110.661 -0.554 . . . . 3.8100000000000001 110.661 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.9 p -89.85 -37.76 14.23 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.316 -0.402 . . . . 1.8400000000000001 111.329 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -90.84 31.2 1.09 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.378 0.608 . . . . 2.3900000000000001 111.335 -175.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.7 p -161.89 149.53 14.56 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.757 -0.656 . . . . 1.6100000000000001 109.607 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.23 142.75 4.41 Favored Glycine 0 C--O 1.224 -0.516 0 N-CA-C 111.388 -0.685 . . . . 0.17000000000000001 111.388 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.729 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -73.53 121.25 20.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.175 0.487 . . . . 0.97999999999999998 111.148 -177.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.579 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -128.27 161.01 30.36 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.289 0.566 . . . . 1.01 111.925 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.475 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.7 mp -102.74 113.62 39.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.274 -0.875 . . . . 1.0800000000000001 109.291 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.487 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 84.1 t80 -112.96 101.91 9.93 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.989 -0.375 . . . . 0.66000000000000003 109.989 -178.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 64.8 57.3 1.05 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.516 0.674 . . . . 1.46 110.721 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt 72.54 -8.2 1.26 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.332 -1.304 . . . . 2.3900000000000001 113.369 170.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.433 HG22 ' HD3' ' A' ' 36' ' ' LYS . 0.5 OUTLIER -99.85 127.13 53.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.064 0.459 . . . . 1.23 110.37 173.054 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.475 ' HA ' HG13 ' A' ' 8' ' ' ILE . 14.1 p -78.71 126.55 30.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.817 -0.628 . . . . 1.48 110.552 177.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.639 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -147.3 -157.61 7.48 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.938 -0.649 . . . . 0.16 112.556 -177.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.729 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.0 mm -124.7 154.68 32.51 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.789 0 CA-C-O 120.756 0.312 . . . . 1.05 110.721 -177.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.487 HG12 HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -129.27 133.67 65.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.236 -0.438 . . . . 1.01 110.461 -179.616 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.28 112.62 9.25 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.03 -0.532 . . . . 0.87 111.468 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.506 HD13 HG23 ' A' ' 100' ' ' ILE . 4.8 mp -84.24 105.08 13.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.746 -0.835 . . . . 1.05 108.746 172.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -109.38 120.02 41.25 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 110.242 -0.281 . . . . 1.1200000000000001 110.242 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.483 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 37.3 mt-10 -105.72 83.71 1.97 Allowed 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 117.13 -1.828 . . . . 0.73999999999999999 107.403 165.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -122.04 -13.03 8.26 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 106.756 -1.572 . . . . 0.58999999999999997 106.756 157.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.58 HG21 ' N ' ' A' ' 23' ' ' SER . 13.9 p -102.93 -179.79 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 111.823 -2.444 . . . . 1.0800000000000001 111.58 -157.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.607 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 1.4 p -51.88 165.71 0.45 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 117.706 -1.14 . . . . 2.0 108.416 168.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.607 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 18.7 Cg_endo -45.42 124.38 6.43 Favored 'Trans proline' 0 C--N 1.358 1.071 0 CA-C-N 121.514 1.576 . . . . 0.26000000000000001 111.803 -154.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.486 ' HB1' HG21 ' A' ' 107' ' ' ILE . . . -21.69 133.57 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.721 1.748 . . . . 1.02 115.721 -151.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.554 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 0.5 OUTLIER -112.93 138.65 49.47 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 114.705 -1.134 . . . . 1.26 110.671 -179.264 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.558 ' HB3' ' CG1' ' A' ' 40' ' ' VAL . 2.2 tt -100.78 142.53 32.13 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.519 -1.66 . . . . 1.0600000000000001 106.519 169.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.55 ' N ' HD22 ' A' ' 27' ' ' LEU . 10.5 m -127.47 107.98 10.42 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.973 -0.691 . . . . 1.05 110.122 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.622 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 89.6 t90 -91.34 105.4 17.75 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.664 -0.865 . . . . 0.29999999999999999 108.664 174.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -114.37 117.17 30.29 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.118 -0.946 . . . . 1.1599999999999999 109.053 -177.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.54 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 80.8 p -57.24 148.44 22.49 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.09 0.471 . . . . 1.3899999999999999 110.822 -173.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.639 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 7.5 m -58.4 -27.34 64.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.364 -0.835 . . . . 1.1499999999999999 110.266 -177.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.457 ' OD2' ' HB3' ' A' ' 35' ' ' ASP . 1.4 p-10 -81.37 -27.54 34.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.078 -0.964 . . . . 2.3300000000000001 111.267 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.83 2.69 84.02 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.087 -0.578 . . . . 0.55000000000000004 112.974 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.457 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 12.3 t70 -78.28 -26.1 46.95 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.735 0.272 . . . . 1.1299999999999999 111.735 -177.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.433 ' HD3' HG22 ' A' ' 12' ' ' VAL . 16.7 ptmt -137.73 155.06 49.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.434 0.635 . . . . 2.6200000000000001 110.363 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.3 p -149.64 140.69 16.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.226 -0.897 . . . . 1.3100000000000001 110.392 -175.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -130.72 108.98 10.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.643 0.259 . . . . 0.82999999999999996 110.369 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 27.0 m -97.83 129.3 44.82 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.323 -0.621 . . . . 1.0600000000000001 109.323 175.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.558 ' CG1' ' HB3' ' A' ' 27' ' ' LEU . 9.6 p -119.29 139.98 44.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.76 -0.376 . . . . 1.3600000000000001 111.501 -178.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.615 ' O ' HG12 ' A' ' 45' ' ' ILE . 60.7 t -89.74 109.54 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.288 0.566 . . . . 1.05 110.077 -177.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.627 HD13 ' CD2' ' A' ' 104' ' ' LEU . 2.9 mm? -53.44 -31.84 47.24 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.944 -1.025 . . . . 1.04 112.669 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.437 ' CB ' ' HB2' ' A' ' 24' ' ' PRO . 15.1 t -76.36 -33.76 58.92 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.581 -0.448 . . . . 1.45 111.012 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.541 ' OG1' ' HB ' ' A' ' 41' ' ' VAL . 72.8 p -74.44 -11.26 60.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.073 0.463 . . . . 1.04 109.908 172.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.615 HG12 ' O ' ' A' ' 41' ' ' VAL . 37.4 mm -83.94 121.31 36.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.885 -0.598 . . . . 1.02 110.391 172.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.688 ' HB2' ' CG ' ' A' ' 65' ' ' LYS . 14.6 t70 -85.81 -41.38 15.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.104 0.478 . . . . 0.69999999999999996 111.46 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.591 ' HE2' ' OD2' ' A' ' 46' ' ' ASP . 53.4 mmtt -132.47 143.1 49.54 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.563 -0.532 . . . . 2.4300000000000002 109.563 -177.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' A' ' 104' ' ' LEU . 8.1 tp -114.53 141.22 48.01 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.637 0.732 . . . . 1.04 109.223 165.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.526 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 13.8 mm100 -122.53 151.52 41.28 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.433 -1.258 . . . . 1.49 109.695 -177.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.19 139.94 8.61 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.242 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.44 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 32.3 p -49.95 128.22 21.2 Favored Pre-proline 0 N--CA 1.468 0.472 0 CA-C-O 121.265 0.555 . . . . 1.03 111.705 -178.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 57.3 Cg_endo -69.26 166.94 25.26 Favored 'Trans proline' 0 C--N 1.334 -0.207 0 C-N-CA 124.293 3.329 . . . . 0.73999999999999999 112.153 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.62 -28.49 68.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.255 0.55 . . . . 1.54 110.322 175.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.2 t -68.12 -24.8 65.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.532 -0.758 . . . . 2.0499999999999998 110.333 176.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.46 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 46.6 t -74.06 136.03 43.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.744 -0.662 . . . . 1.1399999999999999 110.413 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -87.14 0.4 55.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.474 0.654 . . . . 2.8900000000000001 110.151 176.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.24 176.83 4.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.094 -0.957 . . . . 3.1299999999999999 109.689 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.459 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -136.53 110.92 8.48 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.801 -1.185 . . . . 2.0 107.801 178.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.576 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 3.9 ttm -156.01 149.43 24.72 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 120.426 -0.509 . . . . 1.3 111.692 -172.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 97' ' ' MET . 0.5 OUTLIER -120.06 151.2 39.37 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.367 -0.833 . . . . 1.05 110.416 174.365 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.543 ' HD3' ' HB2' ' A' ' 88' ' ' MET . 15.9 ttp180 -148.76 114.43 5.66 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 121.149 0.5 . . . . 3.3999999999999999 110.62 171.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.692 HD11 ' CE2' ' A' ' 89' ' ' PHE . 8.9 mp -95.16 113.17 24.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.06 -0.518 . . . . 1.73 110.242 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.487 ' HA ' ' HB3' ' A' ' 86' ' ' ARG . 3.6 mm -87.75 107.54 17.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.881 -0.414 . . . . 1.1599999999999999 109.881 -173.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -78.92 140.82 23.63 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.321 -0.942 . . . . 0.47999999999999998 111.391 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.688 ' CG ' ' HB2' ' A' ' 46' ' ' ASP . 16.1 mttm -59.02 135.2 57.55 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.46 0.648 . . . . 1.78 112.142 -174.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.2 p -83.32 155.89 3.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 114.779 -1.101 . . . . 1.3100000000000001 110.251 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -109.02 95.43 5.64 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.364 -0.835 . . . . 2.5600000000000001 109.739 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -76.79 -4.62 44.45 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.782 -0.645 . . . . 3.79 111.105 -178.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.3 m -63.0 -32.94 74.41 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 120.808 0.337 . . . . 3.3399999999999999 111.423 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.97 80.49 1.49 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.723 0.773 . . . . 5.8200000000000003 111.42 174.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -58.67 136.38 57.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.37 -0.832 . . . . 4.7400000000000002 110.057 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.561 ' CG ' ' HB ' ' A' ' 80' ' ' VAL . 9.0 ptt180 -95.33 169.23 10.22 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.499 -0.556 . . . . 4.7300000000000004 109.499 -175.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.546 ' HB3' ' C ' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -123.97 168.52 12.7 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 110.124 -0.324 . . . . 5.5300000000000002 110.124 -173.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.579 ' HB3' HD21 ' A' ' 78' ' ' ASN . 4.5 t70 -81.14 -165.46 0.93 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.416 -0.513 . . . . 4.9800000000000004 109.66 -176.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -62.81 -20.28 64.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 118.063 0.392 . . . . 7.1100000000000003 111.909 -175.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -98.83 -14.76 19.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.469 0.652 . . . . 7.1299999999999999 110.288 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.546 ' C ' ' HB3' ' A' ' 73' ' ' LYS . . . 98.15 36.61 4.63 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.22 -0.9 . . . . 5.7300000000000004 111.413 -171.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.579 HD21 ' HB3' ' A' ' 74' ' ' ASP . 57.5 m-80 -83.31 -102.94 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.536 0.208 . . . . 5.6200000000000001 110.91 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -155.36 119.48 4.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.361 -0.381 . . . . 5.0 111.035 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.561 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 4.7 t -128.11 149.01 32.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.347 -0.612 . . . . 3.5800000000000001 109.347 168.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 81' ' ' VAL . 7.6 p -111.39 98.49 40.33 Favored Pre-proline 0 C--N 1.308 -1.239 0 CA-C-O 121.872 0.844 . . . . 3.1499999999999999 109.338 171.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.497 ' HD3' ' HG2' ' A' ' 72' ' ' ARG . 23.7 Cg_endo -62.83 141.53 85.16 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.857 2.371 . . . . 2.0800000000000001 112.581 -177.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -72.67 143.22 84.55 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 115.017 -0.992 . . . . 3.5299999999999998 109.832 177.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -55.47 133.2 56.67 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.565 2.177 . . . . 0.75 111.518 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -71.66 113.38 8.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 123.334 1.54 . . . . 1.78 109.588 -174.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.487 ' HB3' ' HA ' ' A' ' 63' ' ' ILE . 27.4 ptt180 -110.8 158.5 18.61 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.688 -1.596 . . . . 2.8199999999999998 111.046 -172.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -127.03 112.32 15.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.142 -0.935 . . . . 0.63 110.152 -168.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.543 ' HB2' ' HD3' ' A' ' 61' ' ' ARG . 47.6 ttm -106.21 131.36 53.54 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 111.86 0.318 . . . . 1.1200000000000001 111.86 -173.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.692 ' CE2' HD11 ' A' ' 62' ' ' LEU . 1.5 m-85 -119.04 123.57 44.81 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.071 -0.714 . . . . 1.6499999999999999 109.071 172.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.497 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 23.4 m -87.44 126.76 35.08 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.101 -0.5 . . . . 1.1899999999999999 110.021 178.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 7' ' ' ALA . 33.1 m-85 -107.9 165.17 11.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.584 0.707 . . . . 1.6399999999999999 111.047 176.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -109.9 -12.7 14.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.93 -1.032 . . . . 1.8300000000000001 109.642 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.55 ' OD1' ' HB ' ' A' ' 95' ' ' THR . 28.5 t-20 -126.28 125.18 41.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.595 -0.73 . . . . 1.22 110.752 -174.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -58.48 -35.57 72.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.962 -1.017 . . . . 2.8799999999999999 111.553 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.55 ' HB ' ' OD1' ' A' ' 93' ' ' ASN . 95.4 m -70.74 -55.32 8.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.625 0.25 . . . . 1.1200000000000001 110.59 -176.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.7 t -45.76 -57.86 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 115.904 -0.589 . . . . 1.1299999999999999 111.526 175.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.459 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -62.09 -29.86 70.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 120.616 -0.434 . . . . 1.0600000000000001 111.288 -178.082 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.0 -32.15 70.18 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.412 0.625 . . . . 0.39000000000000001 109.367 177.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.61 ' O ' ' HG3' ' A' ' 102' ' ' MET . 92.0 m-20 -78.16 -48.77 15.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.817 -1.083 . . . . 1.55 110.116 -177.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.553 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 37.8 mm -57.24 -50.97 75.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.314 -0.857 . . . . 1.0600000000000001 110.396 176.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 105' ' ' GLN . 11.2 ttpt -56.39 -50.48 71.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.634 -0.712 . . . . 1.72 111.101 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.61 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.9 ppp? -66.44 -24.86 66.51 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.881 0.372 . . . . 1.76 110.841 -176.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 49.3 m -69.43 -49.73 52.38 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.48 0.657 . . . . 1.04 110.328 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.627 ' CD2' HD13 ' A' ' 42' ' ' LEU . 13.9 mt -67.74 -56.68 8.32 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.051 -0.977 . . . . 1.05 111.341 -175.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.483 HE22 ' HB ' ' B' ' 264' ' ' VAL . 35.6 mt-30 -50.02 -29.89 9.58 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.249 0.463 . . . . 1.45 112.249 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -60.91 -31.3 70.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.979 0.895 . . . . 0.66000000000000003 109.414 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.486 HG21 ' HB1' ' A' ' 25' ' ' ALA . 21.3 mt -84.92 -46.51 17.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 113.594 -1.639 . . . . 1.04 110.503 178.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.537 HG22 ' HD2' ' A' ' 112' ' ' LYS . 0.9 OUTLIER -64.68 -51.2 70.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.677 -0.692 . . . . 1.04 110.775 -174.436 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.3 m -57.4 -26.27 60.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.988 0.423 . . . . 1.6100000000000001 110.673 174.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -69.2 -37.35 78.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.453 0.645 . . . . 4.3899999999999997 110.006 177.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.449 ' HD2' ' O ' ' A' ' 107' ' ' ILE . 42.4 m-85 -88.79 -24.23 22.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.982 -1.008 . . . . 0.71999999999999997 111.734 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.537 ' HD2' HG22 ' A' ' 108' ' ' ILE . 8.7 mtpp -75.7 -28.3 58.55 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.363 0.601 . . . . 2.25 109.53 172.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -72.1 -16.38 62.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.437 -0.801 . . . . 1.5600000000000001 110.189 174.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -99.92 0.71 41.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.578 -0.737 . . . . 1.3400000000000001 110.514 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.1 t70 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.691 -0.671 . . . . 2.1600000000000001 109.888 -178.175 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 111.986 -0.446 . . . . 25.670000000000002 111.986 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -71.36 121.63 9.08 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.958 -0.639 . . . . 24.66 111.915 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 87.65 -96.87 2.22 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.78 -0.724 . . . . 24.199999999999999 111.693 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 81.26 5.97 89.66 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.88 -0.676 . . . . 23.140000000000001 112.396 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -92.1 39.39 1.02 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.438 0.637 . . . . 24.920000000000002 109.58 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -126.21 133.05 51.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.394 -0.821 . . . . 21.449999999999999 110.671 -173.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 13.3 p -90.58 -0.11 8.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.487 1.137 . . . . 20.68 107.947 169.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -136.0 114.68 11.95 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.023 -1.444 . . . . 18.16 109.155 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 25.3 mmt -108.8 -4.65 16.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.721 0.772 . . . . 17.260000000000002 109.709 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -70.29 134.96 48.48 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.331 -1.304 . . . . 13.68 110.623 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 7.8 p -124.61 -72.36 0.68 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.83 -0.623 . . . . 10.91 110.474 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -80.52 -14.0 58.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.154 0.502 . . . . 11.029999999999999 110.22 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -65.34 -21.77 66.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.459 -0.791 . . . . 10.94 110.746 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.3 -20.6 62.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.256 0.55 . . . . 9.8200000000000003 110.139 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 69.2 m -88.44 122.88 32.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.545 -0.752 . . . . 5.9100000000000001 110.194 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -84.01 -64.35 1.18 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.162 0.505 . . . . 6.2000000000000002 110.033 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -85.45 -61.12 1.84 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.856 -0.611 . . . . 6.1399999999999997 109.944 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -148.28 -38.64 0.18 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.543 -0.753 . . . . 3.3199999999999998 110.534 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 80.5 -6.06 62.26 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.892 -0.671 . . . . 1.1200000000000001 111.436 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 261' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 9.8 m-85 -102.86 -179.33 3.93 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.958 -0.621 . . . . 0.97999999999999998 109.747 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 10.6 p -135.59 140.17 45.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.272 -0.27 . . . . 1.8999999999999999 110.272 175.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -86.69 121.67 29.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.639 -0.874 . . . . 2.2400000000000002 108.639 174.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.483 ' HB ' HE22 ' A' ' 105' ' ' GLN . 52.8 t -103.08 100.53 10.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.792 0.33 . . . . 1.8899999999999999 110.137 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 34.3 t70 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.236 -0.887 . . . . 3.04 110.473 -177.464 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo . . . . . 0 N--CA 1.48 0.681 0 N-CA-C 111.122 -0.376 . . . . 3.8100000000000001 111.122 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.441 ' HA ' ' HB3' ' A' ' 99' ' ' ASN . 92.5 p 51.1 -83.48 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.609 1.164 . . . . 1.8400000000000001 113.211 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -90.31 19.56 5.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.23 0.538 . . . . 2.3900000000000001 110.336 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.4 p -162.72 149.53 13.02 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.496 -0.775 . . . . 1.6100000000000001 109.655 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.26 147.0 7.74 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 110.839 -0.905 . . . . 0.17000000000000001 110.839 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.714 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -79.26 117.43 20.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.644 0.722 . . . . 0.97999999999999998 111.619 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.29 158.24 28.59 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.347 0.594 . . . . 1.01 111.587 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.472 HG13 ' HA ' ' A' ' 13' ' ' SER . 3.1 mp -99.01 129.22 49.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.409 -0.814 . . . . 1.0800000000000001 109.263 177.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.56 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 89.1 t80 -139.28 111.96 7.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.913 -0.585 . . . . 0.66000000000000003 109.917 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 69.49 45.21 0.84 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.727 0.775 . . . . 1.46 110.421 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? 70.01 3.14 4.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.276 -1.329 . . . . 2.3900000000000001 112.732 172.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.1 131.68 59.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.784 0.326 . . . . 1.23 110.478 175.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.472 ' HA ' HG13 ' A' ' 8' ' ' ILE . 30.5 t -78.69 117.0 19.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.4 0.619 . . . . 1.48 110.042 177.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.662 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -130.97 -153.91 7.75 Favored Glycine 0 N--CA 1.434 -1.44 0 CA-C-N 115.288 -0.869 . . . . 0.16 111.3 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.714 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 7.8 mm -127.88 153.15 36.86 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 CA-C-O 120.919 0.39 . . . . 1.05 110.687 -177.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.433 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -125.41 131.94 71.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 115.824 -0.625 . . . . 1.01 109.332 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.94 113.97 10.58 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.758 -0.377 . . . . 0.87 111.555 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.501 HD13 HG23 ' A' ' 100' ' ' ILE . 4.4 mp -84.14 113.46 23.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.068 -1.086 . . . . 1.05 108.068 171.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.424 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.1 t30 -121.58 130.33 53.44 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.487 -0.324 . . . . 1.1200000000000001 110.274 -177.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -110.48 84.55 1.95 Allowed 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 116.912 -1.915 . . . . 0.73999999999999999 107.482 164.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.424 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 13.2 t70 -120.85 -10.32 9.14 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 106.122 -1.807 . . . . 0.58999999999999997 106.122 157.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.619 HG11 ' O ' ' A' ' 23' ' ' SER . 14.0 p -102.08 179.15 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 111.743 -2.48 . . . . 1.0800000000000001 111.395 -158.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.619 ' O ' HG11 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -53.33 168.77 0.35 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 117.543 -1.217 . . . . 2.0 108.134 166.522 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 9.2 Cg_endo -41.68 127.2 3.41 Favored 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 121.796 1.664 . . . . 0.26000000000000001 111.088 -157.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.448 ' HB2' HG21 ' A' ' 107' ' ' ILE . . . -30.72 131.51 0.09 Allowed 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 125.279 1.612 . . . . 1.02 113.557 -154.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.512 ' HB2' HG13 ' A' ' 22' ' ' VAL . 47.0 mt-10 -124.09 143.25 50.57 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.676 -1.147 . . . . 1.26 110.864 -169.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.6 HD22 ' C ' ' A' ' 27' ' ' LEU . 1.1 tt -101.26 143.39 31.39 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 106.557 -1.645 . . . . 1.0600000000000001 106.557 175.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.401 ' N ' HD22 ' A' ' 27' ' ' LEU . 14.1 m -129.46 109.65 11.23 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.846 -0.742 . . . . 1.05 110.705 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.654 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 85.1 t90 -86.71 106.59 17.75 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.52 0.676 . . . . 0.29999999999999999 109.544 174.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -114.31 118.87 35.11 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.289 -0.869 . . . . 1.1599999999999999 109.191 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.402 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 49.8 m -56.08 142.04 37.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.871 0.367 . . . . 1.3899999999999999 110.756 -176.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.662 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 18.4 m -59.29 -28.19 66.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.452 -0.795 . . . . 1.1499999999999999 110.166 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.09 -27.19 54.06 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.218 -0.901 . . . . 2.3300000000000001 110.932 175.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.63 -3.98 50.1 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.122 -0.561 . . . . 0.55000000000000004 112.681 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.98 -78.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.458 0.54 . . . . 1.1299999999999999 112.458 -175.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -83.99 142.66 30.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.291 0.567 . . . . 2.6200000000000001 112.057 -175.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 61.1 t -138.29 117.23 14.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.788 -1.096 . . . . 1.3100000000000001 109.618 177.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -124.37 110.01 14.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.31 -0.404 . . . . 0.82999999999999996 110.434 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.7 m -97.72 138.83 34.52 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 121.188 -0.205 . . . . 1.0600000000000001 111.386 -176.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 27.7 t -113.11 129.3 69.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 122.769 0.428 . . . . 1.3600000000000001 111.625 177.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.578 ' O ' HG12 ' A' ' 45' ' ' ILE . 23.0 t -90.81 108.49 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 121.252 0.548 . . . . 1.05 109.942 174.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.587 HD12 ' CD2' ' A' ' 104' ' ' LEU . 1.6 mm? -56.1 -28.1 56.37 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.158 -0.928 . . . . 1.04 112.339 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.1 t -74.88 -31.67 61.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.75 0.309 . . . . 1.45 110.674 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.404 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 82.6 p -80.29 -9.78 59.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.635 0.731 . . . . 1.04 109.738 175.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 41' ' ' VAL . 45.1 mm -85.21 123.75 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 114.872 -1.058 . . . . 1.02 111.143 174.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.644 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 4.9 t70 -74.84 -47.71 28.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.149 -0.932 . . . . 0.69999999999999996 110.718 176.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.506 ' HD2' ' O ' ' A' ' 46' ' ' ASP . 0.5 OUTLIER -147.0 164.75 32.01 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.134 -0.485 . . . . 2.4300000000000002 111.036 -176.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.634 ' CD2' ' HG3' ' A' ' 105' ' ' GLN . 13.0 tp -125.96 146.73 49.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.004 0.431 . . . . 1.04 109.944 172.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 16.7 mm100 -124.08 158.55 31.95 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.182 -0.917 . . . . 1.49 110.176 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -164.66 142.91 6.72 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.496 -0.774 . . . . 1.0 109.928 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.542 ' HB ' ' CB ' ' A' ' 55' ' ' SER . 41.5 p -55.53 129.73 69.99 Favored Pre-proline 0 N--CA 1.471 0.587 0 CA-C-O 121.235 0.54 . . . . 1.03 111.355 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.449 ' O ' ' HB3' ' A' ' 55' ' ' SER . 39.1 Cg_endo -64.59 165.9 19.21 Favored 'Trans proline' 0 N--CA 1.471 0.148 0 C-N-CA 124.017 3.144 . . . . 0.73999999999999999 112.555 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.04 -27.26 65.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.97 0.414 . . . . 1.54 110.726 175.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.7 m -74.62 -24.22 58.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.922 -0.581 . . . . 2.0499999999999998 111.16 177.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.542 ' CB ' ' HB ' ' A' ' 51' ' ' THR . 27.3 t -61.81 138.25 58.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.972 -0.558 . . . . 1.1399999999999999 110.634 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.65 -18.16 42.07 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.793 -0.817 . . . . 2.8900000000000001 108.793 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -103.74 174.1 6.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.718 -1.128 . . . . 3.1299999999999999 109.577 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.51 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -134.24 111.76 10.52 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.151 -0.685 . . . . 2.0 109.151 177.423 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 69.3 mtm -153.77 142.11 20.6 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.932 0.396 . . . . 1.3 111.288 -175.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 97' ' ' MET . 0.3 OUTLIER -110.79 157.26 19.99 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.472 -0.786 . . . . 1.05 110.422 175.556 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 38.0 ttp180 -149.75 114.6 5.35 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-O 121.26 0.552 . . . . 3.3999999999999999 111.629 170.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.55 ' HG ' HD13 ' A' ' 48' ' ' LEU . 8.5 mt -91.97 112.62 24.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.875 -0.602 . . . . 1.73 110.706 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.423 HG23 ' HG2' ' A' ' 86' ' ' ARG . 3.8 mm -86.01 108.88 17.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 C-N-CA 123.72 0.808 . . . . 1.1599999999999999 110.436 -173.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -78.99 155.94 41.34 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 119.969 -1.11 . . . . 0.47999999999999998 111.64 176.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.644 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 0.2 OUTLIER -68.05 135.06 51.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.133 0.467 . . . . 1.78 110.726 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.67 151.86 4.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.998 0.428 . . . . 1.3100000000000001 110.018 176.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -80.91 81.08 7.26 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.456 -0.793 . . . . 2.5600000000000001 111.198 -175.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -80.73 -2.73 48.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.77 -0.65 . . . . 3.79 111.808 -175.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.8 t -67.53 -36.67 81.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.624 0.249 . . . . 3.3399999999999999 110.763 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 104.27 5.02 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.341 0.591 . . . . 5.8200000000000003 111.408 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.642 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 21.2 ptmt -72.87 139.5 46.95 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.416 0.627 . . . . 4.7400000000000002 110.377 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.597 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.5 mpt_? -68.53 173.65 4.85 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 114.67 1.359 . . . . 4.7300000000000004 114.67 -173.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.642 ' HE2' ' O ' ' A' ' 71' ' ' LYS . 28.2 mmtt -128.01 148.89 50.55 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 114.359 -1.291 . . . . 5.5300000000000002 109.849 -174.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.654 ' HB3' HD21 ' A' ' 78' ' ' ASN . 4.7 t70 -103.28 -168.03 1.46 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.552 -0.907 . . . . 4.9800000000000004 108.552 177.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -54.61 -30.83 55.83 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.501 0.556 . . . . 7.1100000000000003 112.501 -174.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 32.0 tt0 -108.28 -3.33 18.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.141 0.495 . . . . 7.1299999999999999 111.243 -176.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.52 19.05 46.39 Favored Glycine 0 C--N 1.318 -0.42 0 C-N-CA 120.205 -0.998 . . . . 5.7300000000000004 111.678 -175.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.654 HD21 ' HB3' ' A' ' 74' ' ' ASP . 22.8 m-80 -52.39 -39.88 61.4 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.378 0.671 . . . . 5.6200000000000001 111.616 177.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.632 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 46.7 mt-10 91.67 135.65 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 O-C-N 125.323 1.639 . . . . 5.0 110.667 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 t -124.06 148.58 28.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.005 -0.998 . . . . 3.5800000000000001 109.116 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.9 p -109.78 96.22 23.31 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-O 121.994 0.902 . . . . 3.1499999999999999 109.62 171.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.54 158.67 50.58 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.142 2.561 . . . . 2.0800000000000001 112.671 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.446 ' HD3' ' N ' ' A' ' 83' ' ' LYS . 3.8 mppt? -90.6 145.59 32.58 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.496 -0.774 . . . . 3.5299999999999998 110.494 -175.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.434 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 24.4 Cg_exo -57.44 144.12 92.56 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.732 2.288 . . . . 0.75 111.807 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.06 114.04 14.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.864 0.84 . . . . 1.78 110.259 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 84' ' ' PRO . 6.7 mtm180 -115.2 141.56 47.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.315 -0.857 . . . . 2.8199999999999998 109.816 -175.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -107.69 111.83 24.23 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.852 -0.613 . . . . 0.63 109.781 -173.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.416 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 55.7 ttm -105.02 121.92 44.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.729 0.3 . . . . 1.1200000000000001 111.037 -176.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.412 ' CG ' HD13 ' A' ' 16' ' ' ILE . 91.1 m-85 -119.46 124.41 46.42 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.724 -0.473 . . . . 1.6499999999999999 109.724 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.456 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 42.0 m -90.16 133.28 34.99 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.978 0.418 . . . . 1.1899999999999999 110.874 -176.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.622 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 24.2 m-85 -108.14 173.61 6.24 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.153 0.501 . . . . 1.6399999999999999 111.303 176.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -114.13 1.06 14.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.549 -0.75 . . . . 1.8300000000000001 110.178 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -145.77 126.83 14.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.7 -0.682 . . . . 1.22 109.979 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.463 ' HA ' ' HG2' ' A' ' 97' ' ' MET . 5.9 ttm180 -71.3 -20.79 62.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.785 -0.643 . . . . 2.8799999999999999 110.982 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.7 m -72.73 -55.39 6.84 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.104 -0.332 . . . . 1.1200000000000001 110.104 174.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.9 t -45.81 -56.0 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-N 116.233 -0.439 . . . . 1.1299999999999999 111.289 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.463 ' HG2' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -64.52 -28.56 69.73 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.031 -0.531 . . . . 1.0600000000000001 111.221 -177.533 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.54 -33.31 72.6 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.127 -0.694 . . . . 0.39000000000000001 109.127 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.586 ' O ' ' HG3' ' A' ' 102' ' ' MET . 89.8 m-20 -74.5 -46.3 40.24 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.622 -1.172 . . . . 1.55 109.657 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.622 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 30.0 mm -59.9 -51.4 73.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.917 -1.038 . . . . 1.0600000000000001 110.522 175.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -57.16 -47.79 80.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.515 -0.766 . . . . 1.72 110.85 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.586 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.7 ppp? -67.06 -26.09 66.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.581 -0.281 . . . . 1.76 110.398 -177.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 106' ' ' GLN . 61.0 m -66.64 -54.9 18.29 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.286 0.565 . . . . 1.04 110.143 175.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.595 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 10.6 mt -64.5 -56.22 15.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.264 -0.88 . . . . 1.05 110.925 -175.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.634 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 98.0 mt-30 -52.6 -24.19 7.86 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.889 0.7 . . . . 1.45 112.889 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 102' ' ' MET . 37.6 mt-30 -65.73 -40.97 92.69 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.899 0.857 . . . . 0.66000000000000003 109.013 174.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 104' ' ' LEU . 49.3 mt -72.5 -42.49 63.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 113.765 -1.561 . . . . 1.04 110.727 178.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.572 HG22 ' HE3' ' A' ' 112' ' ' LYS . 1.1 mt -63.95 -58.21 8.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.454 -0.794 . . . . 1.04 110.595 -176.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.646 ' HA ' ' HD2' ' A' ' 112' ' ' LYS . 48.0 t -54.64 -26.24 31.79 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.288 0.566 . . . . 1.6100000000000001 110.802 173.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.456 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 8.3 ttt180 -69.59 -20.5 63.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.675 -0.693 . . . . 4.3899999999999997 110.257 176.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.438 ' HD2' ' O ' ' A' ' 107' ' ' ILE . 18.0 m-85 -102.65 -5.06 24.24 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.91 0.862 . . . . 0.71999999999999997 108.694 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.646 ' HD2' ' HA ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -88.14 -23.72 23.57 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.387 -1.279 . . . . 2.25 109.713 171.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -74.07 -17.68 60.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.228 -0.896 . . . . 1.5600000000000001 109.705 171.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -118.7 28.14 8.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.308 -0.86 . . . . 1.3400000000000001 110.397 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.8 t70 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.578 -0.725 . . . . 2.1600000000000001 110.338 -179.49 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.938 -0.465 . . . . 25.670000000000002 111.938 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -162.15 175.01 38.67 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 121.095 -0.574 . . . . 24.66 111.815 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 113.83 -85.54 0.39 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.877 -0.678 . . . . 24.199999999999999 112.027 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -84.29 -32.88 21.71 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.849 -0.691 . . . . 23.140000000000001 111.65 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -131.61 127.6 37.4 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.534 -0.543 . . . . 24.920000000000002 109.534 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -77.71 144.4 37.31 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.952 0.406 . . . . 21.449999999999999 110.303 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.97 -1.53 5.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.929 0.871 . . . . 20.68 109.523 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -117.0 145.44 43.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.869 -1.059 . . . . 18.16 110.186 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 26.0 mmt -120.3 21.35 11.74 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.842 0.829 . . . . 17.260000000000002 108.951 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -69.18 134.87 49.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.317 -1.31 . . . . 13.68 110.241 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 43.6 m -139.17 42.31 2.07 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.004 -0.543 . . . . 10.91 110.43 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -80.78 -29.37 36.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.024 0.44 . . . . 11.029999999999999 110.116 177.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -56.83 -46.38 81.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.306 -0.861 . . . . 10.94 111.635 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -60.73 -55.6 31.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.483 -0.326 . . . . 9.8200000000000003 111.386 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 256' ' ' SER . . . . . 0.424 ' HB3' ' HA2' ' B' ' 260' ' ' GLY . 23.0 t 55.33 101.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.523 0.678 . . . . 5.9100000000000001 112.342 176.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -66.67 -21.43 66.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.895 -0.593 . . . . 6.2000000000000002 110.826 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.3 -40.18 93.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.894 -0.594 . . . . 6.1399999999999997 111.781 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -161.14 -57.53 0.05 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.406 -0.361 . . . . 3.3199999999999998 110.466 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . 0.424 ' HA2' ' HB3' ' B' ' 256' ' ' SER . . . 100.32 -6.5 57.87 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.303 -0.951 . . . . 1.1200000000000001 113.592 171.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 261' ' ' PHE . . . . . 0.445 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 6.6 m-85 -108.02 174.21 5.98 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 110.045 -0.354 . . . . 0.97999999999999998 110.045 -177.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 10.2 p -143.96 140.81 25.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.75 -0.463 . . . . 1.8999999999999999 109.75 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -77.53 119.58 21.3 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.836 -0.801 . . . . 2.2400000000000002 108.836 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 47.1 t -112.52 101.31 12.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.901 0.382 . . . . 1.8899999999999999 110.204 -178.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.498 -0.763 . . . . 3.04 109.994 -178.954 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo . . . . . 0 N--CA 1.477 0.541 0 N-CA-C 109.741 -0.907 . . . . 3.8100000000000001 109.741 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.7 p -125.64 -43.57 1.87 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.037 0.446 . . . . 1.8400000000000001 110.963 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 52.7 p-80 -98.36 26.33 5.53 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.587 0.708 . . . . 2.3900000000000001 110.675 -176.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.4 p -162.7 134.89 5.42 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.205 -0.907 . . . . 1.6100000000000001 109.241 173.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.5 148.22 10.47 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.664 -0.975 . . . . 0.17000000000000001 110.664 -178.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.705 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.39 133.88 41.08 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 117.159 0.48 . . . . 0.97999999999999998 111.44 -175.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.89 156.36 46.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.289 0.566 . . . . 1.01 111.386 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.525 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.2 mp -98.86 110.94 27.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.913 -0.773 . . . . 1.0800000000000001 108.913 177.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.455 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 80.3 t80 -109.96 109.78 20.49 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.366 -0.379 . . . . 0.66000000000000003 110.356 -177.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 63.61 46.53 4.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.883 0.849 . . . . 1.46 110.517 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt 77.18 -5.59 2.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.726 -1.579 . . . . 2.3900000000000001 113.151 170.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.53 133.72 41.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.009 0.433 . . . . 1.23 110.427 173.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.525 ' HA ' HG13 ' A' ' 8' ' ' ILE . 22.6 t -78.16 126.63 31.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.91 -0.586 . . . . 1.48 110.532 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.645 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -150.05 -159.71 8.86 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.597 -0.729 . . . . 0.16 112.476 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.705 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 7.0 mm -126.31 153.43 34.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.821 0.343 . . . . 1.05 110.69 -178.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.406 HG12 HD23 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -124.49 133.69 68.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.977 -0.556 . . . . 1.01 109.762 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.0 108.03 7.18 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.013 0.435 . . . . 0.87 111.898 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 4.3 mp -85.73 110.74 20.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.833 -0.803 . . . . 1.05 108.833 172.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.414 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 1.6 t30 -114.19 127.65 56.0 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.651 -0.42 . . . . 1.1200000000000001 110.268 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -109.8 83.65 1.79 Allowed 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 117.281 -1.768 . . . . 0.73999999999999999 107.464 164.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.404 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 19.5 t70 -122.57 -11.25 8.29 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 106.466 -1.679 . . . . 0.58999999999999997 106.466 156.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.618 HG11 ' HB3' ' A' ' 26' ' ' GLU . 14.5 p -101.44 173.58 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 111.964 -2.38 . . . . 1.0800000000000001 112.072 -155.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.612 ' O ' HG12 ' A' ' 22' ' ' VAL . 7.6 m -54.42 165.81 0.81 Allowed Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 106.673 -1.603 . . . . 2.0 106.673 166.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HA ' ' OH ' ' A' ' 111' ' ' TYR . 9.5 Cg_endo -40.36 127.52 2.24 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.655 1.57 . . . . 0.26000000000000001 111.699 -147.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.502 ' HB2' HG23 ' A' ' 107' ' ' ILE . . . -31.01 131.48 0.1 Allowed 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 125.359 1.662 . . . . 1.02 112.649 -159.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.618 ' HB3' HG11 ' A' ' 22' ' ' VAL . 25.3 tt0 -130.14 133.73 46.83 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.51 -1.223 . . . . 1.26 111.658 -160.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.579 ' C ' HD21 ' A' ' 27' ' ' LEU . 1.6 tt -101.62 147.39 26.47 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 107.006 -1.479 . . . . 1.0600000000000001 107.006 177.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.507 ' N ' HD21 ' A' ' 27' ' ' LEU . 30.3 m -138.44 109.79 6.94 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.204 -0.599 . . . . 1.05 110.729 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.617 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 92.2 t90 -86.65 109.79 19.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.65 -0.705 . . . . 0.29999999999999999 109.219 177.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.72 118.3 35.23 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.344 -0.844 . . . . 1.1599999999999999 109.039 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.475 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 86.7 p -57.28 142.63 42.53 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 110.008 -0.367 . . . . 1.3899999999999999 110.008 -177.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.645 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 38.3 m -46.67 -39.76 11.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.256 0.55 . . . . 1.1499999999999999 110.91 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -72.32 -27.67 62.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.226 -0.897 . . . . 2.3300000000000001 111.646 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.3 21.82 28.73 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.984 -0.627 . . . . 0.55000000000000004 112.471 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -101.78 -30.76 11.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.158 0.504 . . . . 1.1299999999999999 110.781 -173.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.424 ' HZ2' ' HB2' ' A' ' 36' ' ' LYS . 3.3 ttmp? -126.22 130.06 50.2 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.663 -0.698 . . . . 2.6200000000000001 110.154 -176.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 95.9 t -133.59 123.54 46.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.786 0.326 . . . . 1.3100000000000001 110.223 -177.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -125.33 110.99 14.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.193 -0.458 . . . . 0.82999999999999996 110.37 -177.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 40.2 m -92.6 145.05 24.73 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.805 0.336 . . . . 1.0600000000000001 111.663 -177.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 32.0 t -122.02 124.72 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.254 -0.43 . . . . 1.3600000000000001 110.913 174.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.478 ' O ' HG12 ' A' ' 45' ' ' ILE . 59.7 t -91.47 108.32 19.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.014 -0.736 . . . . 1.05 109.014 175.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.578 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.0 mm? -52.72 -27.63 18.46 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.409 -0.814 . . . . 1.04 112.79 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.4 t -75.38 -29.28 59.81 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.599 -0.44 . . . . 1.45 110.822 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.5 p -82.59 -4.64 57.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.46 0.647 . . . . 1.04 109.937 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.591 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 45.5 mm -89.39 126.01 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.134 -0.939 . . . . 1.02 111.448 175.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.554 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 21.7 t70 -77.5 -41.86 37.81 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.732 -0.667 . . . . 0.69999999999999996 110.928 176.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -153.03 160.73 43.02 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 115.856 -0.611 . . . . 2.4300000000000002 110.425 -175.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.565 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 12.9 tp -121.22 149.24 43.13 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.219 0.533 . . . . 1.04 109.566 171.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.535 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 10.6 mm100 -125.39 156.34 38.95 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.229 -0.896 . . . . 1.49 109.5 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.03 145.24 11.89 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.809 -0.812 . . . . 1.0 108.809 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 36.6 p -54.61 124.96 51.82 Favored Pre-proline 0 C--O 1.234 0.286 0 CA-C-O 121.254 0.549 . . . . 1.03 111.419 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 62.0 Cg_endo -70.55 167.28 25.93 Favored 'Trans proline' 0 C--N 1.332 -0.34 0 C-N-CA 124.242 3.295 . . . . 0.73999999999999999 112.061 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.57 -18.57 53.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.425 0.631 . . . . 1.54 110.215 172.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' B' ' 252' ' ' SER . 63.5 m -83.79 -8.67 59.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.293 -0.867 . . . . 2.0499999999999998 111.469 177.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.52 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 41.2 t -89.05 148.23 23.84 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.081 -0.508 . . . . 1.1399999999999999 110.347 175.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -89.0 -11.2 44.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.798 -0.637 . . . . 2.8900000000000001 110.985 177.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.9 mmmt -108.27 -177.05 3.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.763 -0.653 . . . . 3.1299999999999999 110.324 -173.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.49 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -131.75 109.05 9.88 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.351 -0.981 . . . . 2.0 108.351 170.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.539 ' HG2' ' HA ' ' A' ' 90' ' ' SER . 68.7 mtm -155.39 146.04 22.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.044 0.384 . . . . 1.3 111.733 -175.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.867 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.7 OUTLIER -109.73 164.98 12.05 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.015 -0.539 . . . . 1.05 111.467 174.821 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.535 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 49.4 ttp180 -155.38 113.71 3.46 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.89 -0.595 . . . . 3.3999999999999999 110.68 171.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.541 ' HG ' HD12 ' A' ' 48' ' ' LEU . 7.8 mt -93.37 114.52 26.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.094 0.473 . . . . 1.73 110.762 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.458 HG21 ' HG2' ' A' ' 86' ' ' ARG . 4.0 mm -86.74 106.1 15.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.718 -0.674 . . . . 1.1599999999999999 110.517 -173.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -75.58 149.44 38.46 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 119.664 -1.255 . . . . 0.47999999999999998 111.246 176.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.554 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 0.1 OUTLIER -60.4 134.91 57.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.258 0.529 . . . . 1.78 110.087 178.175 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.454 ' HB ' ' CA ' ' A' ' 84' ' ' PRO . 9.4 p -87.72 155.22 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.126 0.489 . . . . 1.3100000000000001 110.62 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.442 ' OD2' ' HB3' ' A' ' 72' ' ' ARG . 2.3 p-10 -92.01 77.46 5.38 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.816 -0.629 . . . . 2.5600000000000001 111.019 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -88.01 -44.27 11.11 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.674 -0.694 . . . . 3.79 111.185 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 p -64.57 -37.45 87.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.597 -0.729 . . . . 3.3399999999999999 110.569 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HD3' ' H ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -107.47 81.89 1.59 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.782 -0.822 . . . . 5.8200000000000003 108.782 174.522 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -51.36 127.56 20.1 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.339 0.59 . . . . 4.7400000000000002 111.349 -174.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.529 ' NE ' ' HG3' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -75.68 171.24 14.68 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.383 -0.969 . . . . 4.7300000000000004 108.383 177.466 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.44 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -136.75 162.5 33.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 117.961 0.346 . . . . 5.5300000000000002 110.608 -175.369 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -91.62 -165.94 1.46 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.63 -0.428 . . . . 4.9800000000000004 109.947 -175.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -61.84 -22.69 65.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.963 0.347 . . . . 7.1100000000000003 111.88 -174.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -99.89 2.18 43.52 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.593 0.711 . . . . 7.1299999999999999 110.101 -178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.44 ' HA2' ' HB2' ' A' ' 73' ' ' LYS . . . 78.69 37.55 26.33 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 114.705 -1.134 . . . . 5.7300000000000004 111.872 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -74.57 -99.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.126 0.488 . . . . 5.6200000000000001 110.818 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 13.6 pt-20 177.01 119.32 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.084 -0.962 . . . . 5.0 109.708 177.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.448 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.9 t -121.52 148.55 24.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.196 -0.668 . . . . 3.5800000000000001 109.196 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.8 p -112.27 96.11 33.76 Favored Pre-proline 0 C--N 1.311 -1.097 0 CA-C-O 122.119 0.961 . . . . 3.1499999999999999 109.401 172.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.529 ' HG3' ' NE ' ' A' ' 72' ' ' ARG . 73.5 Cg_endo -73.77 164.72 34.03 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.368 2.712 . . . . 2.0800000000000001 113.798 -174.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.96 140.94 29.24 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.064 -0.971 . . . . 3.5299999999999998 108.459 169.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.454 ' CA ' ' HB ' ' A' ' 66' ' ' VAL . 36.5 Cg_exo -53.11 129.83 35.25 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.193 1.929 . . . . 0.75 112.134 -178.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.58 112.49 11.98 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 122.483 1.135 . . . . 1.78 108.838 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.458 ' HG2' HG21 ' A' ' 63' ' ' ILE . 27.1 mtt85 -108.61 150.8 27.0 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.285 -1.325 . . . . 2.8199999999999998 109.658 -176.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.467 ' CD2' HG21 ' A' ' 40' ' ' VAL . 68.6 m-70 -109.15 110.41 21.63 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.865 -0.791 . . . . 0.63 108.865 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.458 ' HE3' ' CE2' ' B' ' 261' ' ' PHE . 52.8 ttm -111.44 120.89 43.67 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.698 -0.228 . . . . 1.1200000000000001 110.669 -174.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.621 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -114.62 141.1 48.23 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.77 -0.826 . . . . 1.6499999999999999 108.77 177.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.539 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 65.0 m -95.63 124.76 39.81 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.677 -0.49 . . . . 1.1899999999999999 109.677 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.867 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 3.1 m-85 -107.41 167.29 10.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.302 -0.408 . . . . 1.6399999999999999 109.994 -176.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -115.64 -2.3 12.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.95 0.405 . . . . 1.8300000000000001 110.776 -173.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -145.2 129.29 17.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.18 0.514 . . . . 1.22 110.247 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 98' ' ' ASP . 6.7 tpt180 -65.1 -30.6 71.55 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.202 -0.908 . . . . 2.8799999999999999 110.753 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.512 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 32.4 m -69.34 -47.59 63.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.21 0.529 . . . . 1.1200000000000001 110.332 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.804 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 82.8 t -60.06 -53.18 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 CA-C-N 115.584 -0.735 . . . . 1.1299999999999999 111.404 177.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.494 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -63.56 -24.45 67.81 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.906 -0.718 . . . . 1.0600000000000001 109.582 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.512 ' HB3' ' O ' ' A' ' 95' ' ' THR . 33.0 t70 -69.92 -42.66 73.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.399 0.619 . . . . 0.39000000000000001 109.522 175.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.804 ' ND2' ' HA ' ' A' ' 96' ' ' VAL . 21.5 p30 -80.56 -31.66 36.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.752 -1.113 . . . . 1.55 110.282 -173.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.482 HG23 HD13 ' A' ' 18' ' ' ILE . 27.3 mm -67.1 -52.46 43.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.483 -0.781 . . . . 1.0600000000000001 110.219 171.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.2 ttpp -55.2 -51.18 67.39 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.986 -0.552 . . . . 1.72 110.641 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -63.33 -27.64 69.46 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 120.668 0.271 . . . . 1.76 111.012 -175.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.9 m -65.31 -49.82 68.02 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.279 0.561 . . . . 1.04 109.933 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.578 ' CD2' HD11 ' A' ' 42' ' ' LEU . 9.2 mt -71.17 -57.6 4.35 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 115.193 -0.912 . . . . 1.05 111.19 -176.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.478 ' HG2' ' CD2' ' A' ' 48' ' ' LEU . 23.4 mm-40 -42.22 -35.49 0.97 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.174 0.805 . . . . 1.45 113.174 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -65.92 -44.85 83.97 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.728 0.775 . . . . 0.66000000000000003 108.961 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.502 HG23 ' HB2' ' A' ' 25' ' ' ALA . 72.0 mt -65.68 -43.37 93.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 113.891 -1.504 . . . . 1.04 110.954 177.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.6 HG23 ' HD2' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -61.6 -57.07 13.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.663 -0.699 . . . . 1.04 110.661 -176.191 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 11.8 m -54.49 -29.9 51.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.972 -0.558 . . . . 1.6100000000000001 110.829 174.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -71.65 -29.62 64.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.712 -0.676 . . . . 4.3899999999999997 110.832 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.49 ' OH ' ' HA ' ' A' ' 24' ' ' PRO . 14.5 m-85 -93.29 -23.04 18.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.859 -0.609 . . . . 0.71999999999999997 111.435 -177.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.6 ' HD2' HG23 ' A' ' 108' ' ' ILE . 16.7 mtpp -79.01 -25.02 43.31 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.473 -0.566 . . . . 2.25 109.473 174.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.92 -18.18 64.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.149 -0.932 . . . . 1.5600000000000001 109.883 171.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -115.72 22.19 13.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.318 -0.855 . . . . 1.3400000000000001 110.327 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 111' ' ' TYR . 9.7 t70 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.537 -0.744 . . . . 2.1600000000000001 109.858 -177.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.699 0 N-CA-C 111.854 -0.498 . . . . 25.670000000000002 111.854 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 149.62 -42.68 0.79 Allowed Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 111.465 -0.654 . . . . 24.66 111.465 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -127.12 -39.81 0.36 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.996 -0.621 . . . . 24.199999999999999 111.926 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -118.58 152.11 17.53 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.866 -0.683 . . . . 23.140000000000001 112.14 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -100.04 -13.39 19.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.927 0.394 . . . . 24.920000000000002 110.802 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -80.79 90.0 5.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.997 -0.547 . . . . 21.449999999999999 110.63 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 35.6 m 40.09 45.71 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 O-C-N 124.445 1.091 . . . . 20.68 113.03 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . 0.406 ' HA ' ' OE1' ' B' ' 251' ' ' GLU . 41.4 tt0 -93.14 114.1 26.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.057 0.456 . . . . 18.16 109.884 175.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 47.5 ttm -145.54 5.18 1.05 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.345 -0.843 . . . . 17.260000000000002 109.64 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . 0.406 ' OE1' ' HA ' ' B' ' 249' ' ' GLU . 3.7 pm0 -68.12 134.6 50.83 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.649 -0.705 . . . . 13.68 111.264 -176.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 252' ' ' SER . . . . . 0.534 ' HB3' ' O ' ' A' ' 54' ' ' SER . 24.6 m -75.39 -17.42 60.21 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.269 -0.878 . . . . 10.91 111.846 -173.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -58.13 -33.61 69.36 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.992 0.425 . . . . 11.029999999999999 111.191 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -76.1 -20.52 57.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.03 -0.532 . . . . 10.94 111.631 -175.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -76.75 -10.79 59.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.214 -0.448 . . . . 9.8200000000000003 111.748 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 256' ' ' SER . . . . . 0.436 ' HA ' ' HA3' ' B' ' 260' ' ' GLY . 45.4 m -138.39 92.18 2.62 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.315 -0.402 . . . . 5.9100000000000001 110.69 177.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -79.41 -70.91 0.48 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.566 -0.531 . . . . 6.2000000000000002 109.566 -179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -90.49 -61.17 1.74 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.767 0.794 . . . . 6.1399999999999997 109.36 171.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.61 ' CG ' ' H ' ' B' ' 260' ' ' GLY . 7.0 p-10 -113.47 -89.17 0.54 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.19 -1.368 . . . . 3.3199999999999998 110.452 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . 0.61 ' H ' ' CG ' ' B' ' 259' ' ' ASP . . . 86.79 45.59 5.4 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.096 -0.573 . . . . 1.1200000000000001 114.056 171.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 261' ' ' PHE . . . . . 0.507 ' CE1' ' HB2' ' A' ' 59' ' ' MET . 3.3 m-85 -95.55 169.85 9.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.945 0.402 . . . . 0.97999999999999998 110.429 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 4.7 p -133.66 163.65 36.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.962 -0.755 . . . . 1.8999999999999999 108.962 175.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.73 138.51 40.26 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.476 -0.564 . . . . 2.2400000000000002 109.476 173.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 6.5 p -69.12 103.87 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.756 0.789 . . . . 1.8899999999999999 110.078 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 29.5 t70 . . . . . 0 C--O 1.248 0.974 0 CA-C-N 115.38 -0.827 . . . . 3.04 110.39 -175.928 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 N--CA 1.477 0.536 0 N-CA-C 109.867 -0.859 . . . . 3.8100000000000001 109.867 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.5 p -169.6 -50.72 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.361 0.6 . . . . 1.8400000000000001 110.027 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.604 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 39.4 m80 -92.68 13.54 19.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.901 -0.59 . . . . 2.3900000000000001 111.352 -175.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 m -161.02 148.22 15.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.684 0.278 . . . . 1.6100000000000001 110.511 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.81 147.6 7.18 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 110.409 -1.077 . . . . 0.17000000000000001 110.409 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.697 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -81.06 119.97 24.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 117.935 0.868 . . . . 0.97999999999999998 111.448 -175.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -127.9 160.35 32.1 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.541 0.686 . . . . 1.01 112.016 -176.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 2.6 mp -100.85 126.9 54.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.179 -0.918 . . . . 1.0800000000000001 109.392 177.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -126.12 112.09 15.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.067 -0.515 . . . . 0.66000000000000003 110.286 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 59.99 47.36 9.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.565 0.698 . . . . 1.46 110.903 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 35.6 mmtt 74.85 0.61 3.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.317 -1.31 . . . . 2.3900000000000001 113.288 171.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -106.04 132.4 53.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.372 -0.531 . . . . 1.23 110.695 171.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.513 ' HA ' HG13 ' A' ' 8' ' ' ILE . 47.5 t -79.85 129.98 34.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.635 -0.711 . . . . 1.48 110.639 178.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.639 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -151.63 -153.26 6.15 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.797 -0.638 . . . . 0.16 112.036 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.697 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 7.5 mm -128.27 153.47 37.72 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 CA-C-O 120.948 0.404 . . . . 1.05 110.76 -177.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.45 HD12 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -122.61 134.6 65.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 115.911 -0.586 . . . . 1.01 109.628 179.672 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.58 109.26 7.04 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.52 -0.309 . . . . 0.87 111.7 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.604 ' O ' ' HB3' ' A' ' 3' ' ' HIS . 3.7 mp -85.69 126.43 40.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.494 -0.928 . . . . 1.05 108.494 171.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.737 HD22 ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -126.96 129.37 47.99 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.38 -0.528 . . . . 1.1200000000000001 109.752 178.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -113.34 84.26 1.98 Allowed 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 117.353 -1.739 . . . . 0.73999999999999999 107.694 164.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -122.25 -12.01 8.32 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 106.468 -1.678 . . . . 0.58999999999999997 106.468 157.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.75 HG11 ' O ' ' A' ' 23' ' ' SER . 11.1 p -102.18 173.9 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 111.792 -2.458 . . . . 1.0800000000000001 112.745 -154.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.75 ' O ' HG11 ' A' ' 22' ' ' VAL . 5.5 m -54.72 166.7 0.71 Allowed Pre-proline 0 C--O 1.221 -0.415 0 N-CA-C 106.689 -1.597 . . . . 2.0 106.689 165.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.426 ' C ' ' O ' ' A' ' 23' ' ' SER . 11.0 Cg_endo -42.06 127.99 4.03 Favored 'Trans proline' 0 C--N 1.355 0.908 0 CA-C-N 122.036 1.763 . . . . 0.26000000000000001 111.203 -151.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.468 ' HB3' HG23 ' A' ' 107' ' ' ILE . . . -33.47 137.61 0.08 Allowed 'General case' 0 CA--C 1.506 -0.715 0 O-C-N 125.379 1.674 . . . . 1.02 113.833 -155.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.533 ' HB2' HG13 ' A' ' 22' ' ' VAL . 30.6 mt-10 -121.35 131.05 53.97 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 114.933 -1.03 . . . . 1.26 111.055 -169.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.581 ' C ' HD23 ' A' ' 27' ' ' LEU . 1.7 tt -101.02 140.4 35.37 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 106.215 -1.772 . . . . 1.0600000000000001 106.215 171.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.422 ' N ' HD23 ' A' ' 27' ' ' LEU . 19.4 m -131.22 108.83 9.98 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.677 -0.809 . . . . 1.05 110.441 -178.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.615 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 89.6 t90 -85.56 107.78 17.65 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.383 -0.826 . . . . 0.29999999999999999 109.323 176.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -113.46 114.77 27.03 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.788 -1.097 . . . . 1.1599999999999999 108.414 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.559 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 37.3 p -56.48 143.96 33.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.963 0.411 . . . . 1.3899999999999999 110.268 -177.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.639 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 19.8 m -53.0 -33.2 50.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.145 -0.934 . . . . 1.1499999999999999 111.432 -177.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -80.68 -27.84 36.93 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.125 -0.489 . . . . 2.3300000000000001 111.233 177.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.04 0.34 57.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.098 -0.572 . . . . 0.55000000000000004 112.234 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -64.37 -48.18 76.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.104 0.478 . . . . 1.1299999999999999 111.516 -177.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -117.59 148.72 41.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.803 -0.635 . . . . 2.6200000000000001 111.706 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 89.6 t -145.22 125.41 6.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.486 -1.234 . . . . 1.3100000000000001 109.808 178.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -133.08 115.51 15.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.479 -0.328 . . . . 0.82999999999999996 110.717 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.2 m -98.44 139.63 33.9 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.928 -0.309 . . . . 1.0600000000000001 111.403 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.513 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 23.3 t -112.12 129.46 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 122.878 0.471 . . . . 1.3600000000000001 111.127 176.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 45' ' ' ILE . 48.4 t -91.6 108.77 20.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 CA-C-O 121.293 0.568 . . . . 1.05 109.565 173.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.612 HD13 ' CD2' ' A' ' 104' ' ' LEU . 2.1 mm? -53.95 -25.72 22.05 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.127 -0.942 . . . . 1.04 113.03 -178.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 64.6 m -79.78 -31.42 40.85 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.521 -0.471 . . . . 1.45 111.689 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.8 p -76.88 -8.74 57.9 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.178 -0.675 . . . . 1.04 109.178 173.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.563 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 47.3 mm -86.45 121.56 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.044 -0.98 . . . . 1.02 111.552 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.663 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 23.0 t70 -80.08 -43.31 22.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.621 -0.718 . . . . 0.69999999999999996 110.991 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -140.51 157.12 45.98 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.986 -0.376 . . . . 2.4300000000000002 109.986 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.585 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 12.2 tp -118.74 144.73 46.07 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.271 -0.64 . . . . 1.04 109.271 166.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 12.3 mm100 -122.88 151.91 41.27 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.066 -0.97 . . . . 1.49 109.317 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.05 146.3 10.72 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.51 -0.768 . . . . 1.0 109.132 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 54.6 p -60.58 126.12 84.13 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-O 121.548 0.69 . . . . 1.03 111.073 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.467 ' O ' ' HB3' ' A' ' 55' ' ' SER . 57.8 Cg_endo -67.46 166.49 23.55 Favored 'Trans proline' 0 C--N 1.333 -0.276 0 C-N-CA 123.984 3.123 . . . . 0.73999999999999999 111.627 177.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.64 -21.88 66.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.928 0.394 . . . . 1.54 110.67 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 t -78.76 -19.74 51.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 2.0499999999999998 110.545 177.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 52' ' ' PRO . 27.9 t -67.85 145.56 54.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.889 -0.596 . . . . 1.1399999999999999 110.452 176.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -89.82 -13.82 35.75 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.4 0.619 . . . . 2.8900000000000001 110.145 175.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -106.48 173.57 6.26 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.135 -0.939 . . . . 3.1299999999999999 110.053 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.497 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -130.46 112.18 12.98 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.644 -0.707 . . . . 2.0 109.555 175.581 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.608 ' HB3' ' CZ ' ' B' ' 261' ' ' PHE . 2.5 mtm -156.03 148.28 23.49 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.838 0.351 . . . . 1.3 111.691 -176.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.33 154.96 30.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.519 -0.764 . . . . 1.05 110.428 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 21.3 ttm180 -151.11 113.88 4.7 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 120.931 0.396 . . . . 3.3999999999999999 110.823 171.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.525 ' HG ' HD11 ' A' ' 48' ' ' LEU . 9.1 mt -92.56 112.6 24.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.112 0.482 . . . . 1.73 110.509 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.498 HG21 ' HG2' ' A' ' 86' ' ' ARG . 6.3 mm -87.05 111.75 22.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 C-N-CA 123.464 0.705 . . . . 1.1599999999999999 110.513 -172.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.563 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -79.0 150.36 33.92 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 120.254 -0.974 . . . . 0.47999999999999998 111.864 177.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.663 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 1.1 mptm? -63.74 132.19 50.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.012 0.406 . . . . 1.78 110.763 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.443 ' HB ' ' HA ' ' A' ' 84' ' ' PRO . 15.0 p -90.2 157.84 2.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.19 -0.67 . . . . 1.3100000000000001 109.19 175.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.4 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 5.6 p-10 -81.82 81.47 7.82 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.809 0.814 . . . . 2.5600000000000001 110.816 -177.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -69.57 -18.81 63.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.774 -1.103 . . . . 3.79 111.08 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.8 p -61.08 -34.93 75.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.703 -0.681 . . . . 3.3399999999999999 111.682 -178.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.458 ' HD3' ' N ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -133.12 123.21 25.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.006 0.431 . . . . 5.8200000000000003 110.853 178.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -79.59 136.82 36.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.185 -0.461 . . . . 4.7400000000000002 110.597 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 5.6 ptm180 -73.43 171.24 13.5 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.512 -0.921 . . . . 4.7300000000000004 108.512 175.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.41 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -135.79 155.34 50.51 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.907 -0.405 . . . . 5.5300000000000002 109.907 -177.877 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -88.37 -163.24 0.93 Allowed 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.385 -0.526 . . . . 4.9800000000000004 110.387 -174.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -64.5 -22.43 66.96 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.176 0.435 . . . . 7.1100000000000003 112.176 -174.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HB2' ' ND2' ' A' ' 78' ' ' ASN . 61.5 mm-40 -96.61 -2.16 45.42 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.64 0.733 . . . . 7.1299999999999999 109.998 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 73' ' ' LYS . . . 78.8 43.72 11.16 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.614 -1.175 . . . . 5.7300000000000004 111.183 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.418 ' ND2' ' HB2' ' A' ' 76' ' ' GLU . 66.7 m-80 -81.25 -102.44 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 120.938 0.399 . . . . 5.6200000000000001 110.444 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 10.9 pt-20 177.79 118.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.217 -0.902 . . . . 5.0 110.207 177.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.502 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.4 t -120.54 148.87 23.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.817 -0.809 . . . . 3.5800000000000001 108.817 176.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.8 p -105.07 99.72 21.01 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-O 121.839 0.828 . . . . 3.1499999999999999 109.627 171.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.01 133.96 32.75 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.94 2.427 . . . . 2.0800000000000001 112.442 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.453 ' HD2' ' CZ ' ' A' ' 86' ' ' ARG . 16.5 ttpt -62.72 134.97 95.58 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.656 -0.702 . . . . 3.5299999999999998 110.056 174.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.443 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 52.3 Cg_exo -50.93 150.47 12.99 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.672 2.915 . . . . 0.75 113.06 -178.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.99 115.3 16.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.775 0.798 . . . . 1.78 109.761 176.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.498 ' HG2' HG21 ' A' ' 63' ' ' ILE . 37.7 mtm180 -116.71 140.32 49.55 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.48 -0.782 . . . . 2.8199999999999998 110.285 -173.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -103.1 111.23 23.48 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.552 -0.749 . . . . 0.63 109.155 -177.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.526 ' HE2' ' CE2' ' B' ' 261' ' ' PHE . 43.4 ttm -102.78 132.41 48.96 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.716 0.293 . . . . 1.1200000000000001 110.754 -176.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.45 ' CG ' HD12 ' A' ' 16' ' ' ILE . 95.4 m-85 -127.16 123.72 37.39 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.526 -0.546 . . . . 1.6499999999999999 109.526 177.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.517 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 50.1 m -91.78 130.85 37.49 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.831 0.348 . . . . 1.1899999999999999 110.556 -177.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.61 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 30.7 m-85 -108.16 173.65 6.23 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.034 -0.53 . . . . 1.6399999999999999 110.156 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -117.43 -3.06 11.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.017 -0.538 . . . . 1.8300000000000001 109.6 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.553 ' OD1' ' HB ' ' A' ' 95' ' ' THR . 28.6 t-20 -137.51 130.62 30.61 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.595 -0.73 . . . . 1.22 110.21 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.499 ' HA ' ' HG2' ' A' ' 97' ' ' MET . 2.2 tmt_? -74.29 -24.05 59.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.866 -0.606 . . . . 2.8799999999999999 110.559 -174.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.553 ' HB ' ' OD1' ' A' ' 93' ' ' ASN . 51.6 m -71.95 -48.33 45.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.96 0.409 . . . . 1.1200000000000001 110.326 177.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.817 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 96.8 t -55.9 -57.12 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-N 115.956 -0.565 . . . . 1.1299999999999999 111.259 174.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.615 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -58.35 -30.9 67.11 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.526 -0.87 . . . . 1.0600000000000001 109.529 -179.14 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.598 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 33.5 t70 -64.8 -43.75 92.15 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.623 0.725 . . . . 0.39000000000000001 110.721 175.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.817 ' ND2' ' HA ' ' A' ' 96' ' ' VAL . 20.6 p30 -76.96 -25.52 52.92 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.071 -0.968 . . . . 1.55 109.899 -173.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.61 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 28.2 mm -72.39 -55.94 11.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.813 -1.085 . . . . 1.0600000000000001 111.196 171.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.615 ' HG2' ' O ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -59.07 -39.29 81.67 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 120.768 0.318 . . . . 1.72 111.259 -177.359 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.431 ' HB3' ' HE2' ' A' ' 101' ' ' LYS . 26.6 ptm -69.85 -27.27 64.7 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.28 -0.637 . . . . 1.76 109.28 -176.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 21.7 m -67.62 -53.37 28.56 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.65 -0.705 . . . . 1.04 110.018 174.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.612 ' CD2' HD13 ' A' ' 42' ' ' LEU . 10.4 mt -65.66 -56.44 12.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.193 -0.912 . . . . 1.05 111.221 -176.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.473 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 42.8 mt-30 -51.68 -30.12 20.69 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.48 0.548 . . . . 1.45 112.48 -178.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -68.6 -26.85 65.58 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.882 0.848 . . . . 0.66000000000000003 109.571 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.511 HD13 ' HA ' ' A' ' 104' ' ' LEU . 47.8 mt -82.56 -41.72 17.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.052 -1.431 . . . . 1.04 110.071 176.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.573 HG21 ' HD2' ' A' ' 112' ' ' LYS . 1.3 mt -66.98 -49.88 69.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.551 -0.75 . . . . 1.04 110.752 -176.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.415 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 48.7 m -61.34 -22.72 65.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.506 0.669 . . . . 1.6100000000000001 110.063 174.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.485 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 9.7 ttt180 -72.19 -32.15 66.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.106 -0.952 . . . . 4.3899999999999997 109.862 176.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -95.61 -23.0 17.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.177 -0.465 . . . . 0.71999999999999997 111.654 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.573 ' HD2' HG21 ' A' ' 108' ' ' ILE . 13.0 mtpp -76.43 -21.07 56.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.357 0.599 . . . . 2.25 109.444 174.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -71.16 -19.28 62.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.299 -0.864 . . . . 1.5600000000000001 109.785 173.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -114.47 22.96 13.19 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.463 -0.79 . . . . 1.3400000000000001 110.982 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.2 t70 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.492 -0.766 . . . . 2.1600000000000001 110.028 178.678 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.612 0 N-CA-C 112.019 -0.433 . . . . 25.670000000000002 112.019 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 138.92 -74.5 0.39 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.759 -0.734 . . . . 24.66 112.279 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 99.56 -171.57 24.19 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.803 -0.713 . . . . 24.199999999999999 112.053 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -85.94 -24.36 41.76 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.744 -0.741 . . . . 23.140000000000001 112.451 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 63.55 18.45 11.08 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.899 0.479 . . . . 24.920000000000002 111.465 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -75.32 120.06 20.28 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.075 -0.343 . . . . 21.449999999999999 110.075 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 28.9 m 37.54 51.19 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 124.271 0.982 . . . . 20.68 111.319 -173.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -61.16 114.69 3.28 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.105 -0.952 . . . . 18.16 111.617 -173.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 94.5 mmm -145.98 21.46 1.42 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.584 -1.635 . . . . 17.260000000000002 106.584 177.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -70.28 151.07 45.71 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 113.118 -1.855 . . . . 13.68 110.899 -170.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 22.0 m -139.09 9.1 2.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.209 0.528 . . . . 10.91 110.693 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -74.45 -26.67 60.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.763 -0.653 . . . . 11.029999999999999 110.129 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -67.96 -38.37 82.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.662 -0.699 . . . . 10.94 110.07 176.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -72.9 -25.7 61.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.204 0.526 . . . . 9.8200000000000003 110.388 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 256' ' ' SER . . . . . 0.401 ' HB3' ' NH1' ' A' ' 86' ' ' ARG . 37.7 m -91.79 10.79 27.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.689 -0.687 . . . . 5.9100000000000001 111.198 -176.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -82.52 -59.47 2.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.034 -0.53 . . . . 6.2000000000000002 111.223 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -86.44 -70.13 0.63 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.033 -0.53 . . . . 6.1399999999999997 111.255 -174.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 54.73 28.3 9.98 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.196 0.522 . . . . 3.3199999999999998 111.717 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 94.27 -6.38 71.87 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 120.995 -0.621 . . . . 1.1200000000000001 112.656 177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 261' ' ' PHE . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 2.8 m-30 -117.74 163.13 16.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.956 0.408 . . . . 0.97999999999999998 110.239 -175.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.36 140.6 22.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.927 -0.579 . . . . 1.8999999999999999 110.205 174.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -79.69 121.06 24.85 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.809 -0.812 . . . . 2.2400000000000002 108.809 171.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.91 103.15 14.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.69 -0.686 . . . . 1.8899999999999999 110.927 -171.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--O 1.247 0.946 0 CA-C-N 115.719 -0.673 . . . . 3.04 109.316 176.599 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo . . . . . 0 N--CA 1.48 0.733 0 N-CA-C 111.201 -0.346 . . . . 3.8100000000000001 111.201 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 99' ' ' ASN . 16.9 p -113.24 -65.76 1.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.116 -0.493 . . . . 1.8400000000000001 110.655 178.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -94.33 18.31 11.31 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.587 0.708 . . . . 2.3900000000000001 109.547 177.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.1 p -163.27 148.84 11.56 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.929 -1.032 . . . . 1.6100000000000001 108.883 -176.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.22 142.69 5.64 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.188 -0.765 . . . . 0.17000000000000001 111.188 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.716 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -73.4 120.94 19.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 117.361 0.58 . . . . 0.97999999999999998 111.237 -176.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.472 ' HB3' ' CE1' ' A' ' 91' ' ' PHE . . . -130.08 157.7 41.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.394 0.616 . . . . 1.01 111.852 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.508 ' HB ' ' HB3' ' A' ' 90' ' ' SER . 2.6 mp -95.93 124.47 48.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.125 -0.943 . . . . 1.0800000000000001 109.07 176.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.474 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 88.8 t80 -128.69 103.44 7.08 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.164 -0.471 . . . . 0.66000000000000003 109.919 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 67.24 58.41 0.55 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.792 -0.64 . . . . 1.46 110.872 -175.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp 70.13 -8.47 0.84 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.608 -1.178 . . . . 2.3900000000000001 113.374 171.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -104.73 131.83 52.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.969 0.414 . . . . 1.23 111.061 177.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.484 ' HA ' HG13 ' A' ' 8' ' ' ILE . 28.7 p -79.9 125.95 30.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.707 -0.679 . . . . 1.48 110.721 176.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.622 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -144.82 -154.38 6.12 Favored Glycine 0 N--CA 1.436 -1.339 0 CA-C-N 115.711 -0.677 . . . . 0.16 111.637 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.716 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 9.2 mm -126.13 153.84 34.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 120.755 0.312 . . . . 1.05 110.68 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.411 HG12 HD23 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -126.28 133.72 68.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 116.102 -0.499 . . . . 1.01 109.95 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.63 113.98 10.18 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 111.899 0.333 . . . . 0.87 111.899 175.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.502 HD11 HG22 ' A' ' 100' ' ' ILE . 3.8 mp -85.38 124.39 40.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.359 -0.978 . . . . 1.05 108.359 171.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.426 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 2.3 t30 -126.62 124.31 39.61 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.949 -0.389 . . . . 1.1200000000000001 109.949 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.488 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 23.7 mt-10 -109.63 84.05 1.86 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 117.084 -1.847 . . . . 0.73999999999999999 107.519 163.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.426 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 17.7 t70 -121.48 -9.86 8.93 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.476 -1.676 . . . . 0.58999999999999997 106.476 156.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 23' ' ' SER . 14.7 p -101.98 173.1 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 112.045 -2.343 . . . . 1.0800000000000001 111.63 -157.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.676 ' O ' HG12 ' A' ' 22' ' ' VAL . 14.5 m -54.98 166.66 0.75 Allowed Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 106.942 -1.503 . . . . 2.0 106.942 166.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 10.2 Cg_endo -40.67 127.42 2.45 Favored 'Trans proline' 0 C--N 1.357 0.997 0 CA-C-N 121.913 1.719 . . . . 0.26000000000000001 111.34 -150.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.543 ' HB1' HG21 ' A' ' 107' ' ' ILE . . . -33.7 136.34 0.11 Allowed 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 125.379 1.674 . . . . 1.02 113.691 -156.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.523 ' HB2' HG11 ' A' ' 22' ' ' VAL . 80.7 mt-10 -123.5 138.87 54.48 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.422 -1.263 . . . . 1.26 111.099 -169.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.598 ' C ' HD21 ' A' ' 27' ' ' LEU . 1.1 tt -101.41 144.44 30.21 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 106.257 -1.757 . . . . 1.0600000000000001 106.257 171.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.445 ' N ' HD21 ' A' ' 27' ' ' LEU . 18.1 m -129.84 109.18 10.72 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.903 -0.719 . . . . 1.05 110.002 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 89.9 t90 -86.9 105.4 17.04 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.687 -0.857 . . . . 0.29999999999999999 108.687 175.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -113.49 114.84 27.1 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.844 -1.071 . . . . 1.1599999999999999 108.738 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.511 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 37.5 p -56.19 148.33 18.49 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.24 0.543 . . . . 1.3899999999999999 111.282 -174.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.622 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 24.0 m -55.97 -30.09 61.21 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.953 -1.021 . . . . 1.1499999999999999 111.371 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -80.2 -28.54 38.64 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.024 0.44 . . . . 2.3300000000000001 110.756 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.19 6.61 53.43 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.956 -0.64 . . . . 0.55000000000000004 112.631 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.38 -69.72 0.6 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.367 . . . . 1.1299999999999999 111.363 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -82.55 137.6 34.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.472 0.653 . . . . 2.6200000000000001 111.546 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 96.0 t -140.57 120.32 12.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.397 -1.274 . . . . 1.3100000000000001 109.496 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -125.89 114.12 18.11 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.438 -0.347 . . . . 0.82999999999999996 110.438 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.2 m -96.99 138.49 34.45 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 121.205 -0.198 . . . . 1.0600000000000001 111.188 -177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.524 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 37.5 t -113.31 129.79 68.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 122.716 0.407 . . . . 1.3600000000000001 111.722 178.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.536 ' O ' HG12 ' A' ' 45' ' ' ILE . 46.8 t -90.42 108.86 20.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 CA-C-O 121.286 0.565 . . . . 1.05 109.777 172.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.561 HD13 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -55.12 -27.04 42.34 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.312 -0.858 . . . . 1.04 112.633 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.448 ' O ' ' HE2' ' A' ' 65' ' ' LYS . 33.9 t -75.97 -35.11 59.76 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.722 -0.391 . . . . 1.45 110.799 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.2 p -76.99 -16.39 59.35 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.591 0.71 . . . . 1.04 109.249 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.675 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 42.2 mm -73.66 121.47 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 114.977 -1.01 . . . . 1.02 110.964 172.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.626 ' HA ' ' NZ ' ' A' ' 65' ' ' LYS . 23.0 t70 -78.61 -48.23 15.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.21 -0.45 . . . . 0.69999999999999996 111.298 175.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -137.0 151.9 49.51 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 110.165 -0.309 . . . . 2.4300000000000002 110.165 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.591 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 11.9 tp -116.07 144.9 43.5 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.118 -0.697 . . . . 1.04 109.118 166.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.552 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 8.1 mm100 -120.22 159.51 24.8 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.399 -0.819 . . . . 1.49 109.396 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.42 ' CB ' ' HG3' ' A' ' 101' ' ' LYS . . . -161.69 152.43 17.83 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.48 -0.933 . . . . 1.0 108.48 174.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.445 ' CG2' ' HE2' ' A' ' 59' ' ' MET . 33.4 p -55.4 125.49 59.41 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.476 0.655 . . . . 1.03 111.432 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 43.0 Cg_endo -67.39 166.88 22.12 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 124.0 3.133 . . . . 0.73999999999999999 111.581 176.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.01 -22.73 67.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.027 0.441 . . . . 1.54 110.303 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.3 p -74.48 -27.7 60.69 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.558 -0.746 . . . . 2.0499999999999998 110.786 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.455 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 23.0 t -70.29 140.8 52.37 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.214 -0.903 . . . . 1.1399999999999999 109.409 174.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -90.95 -13.63 33.09 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.788 -0.819 . . . . 2.8900000000000001 108.788 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.614 ' HD3' ' N ' ' A' ' 57' ' ' LYS . 2.2 mppt? -99.21 -176.8 3.41 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.745 -1.116 . . . . 3.1299999999999999 111.354 -175.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.44 ' SD ' ' HB2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -139.87 109.22 6.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.483 . . . . 2.0 109.705 -177.082 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.586 ' HE3' ' O ' ' B' ' 254' ' ' GLU . 2.6 mpp? -155.69 167.65 29.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.934 0.397 . . . . 1.3 111.721 -175.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 97' ' ' MET . 0.8 OUTLIER -130.28 161.58 30.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.324 -0.853 . . . . 1.05 111.445 176.38 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.65 ' NH2' ' HB3' ' B' ' 259' ' ' ASP . 13.1 ttm180 -154.26 114.3 3.86 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.765 -0.198 . . . . 3.3999999999999999 110.749 173.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.523 ' CD2' HG23 ' A' ' 45' ' ' ILE . 10.7 mt -96.65 110.3 22.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.863 0.364 . . . . 1.73 111.095 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.469 ' CD1' ' HD2' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -89.13 128.73 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.056 0.543 . . . . 1.1599999999999999 110.086 -178.099 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.675 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -95.02 152.28 20.4 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.017 -1.087 . . . . 0.47999999999999998 112.337 176.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.626 ' NZ ' ' HA ' ' A' ' 46' ' ' ASP . 1.2 mptp? -58.33 134.48 56.62 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.755 0.312 . . . . 1.78 110.627 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.8 p -90.44 154.83 3.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.184 0.516 . . . . 1.3100000000000001 110.306 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.468 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 4.1 p-10 -86.67 84.41 7.39 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.481 -0.781 . . . . 2.5600000000000001 110.754 -177.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -66.24 -43.78 85.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.149 -0.932 . . . . 3.79 111.972 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.7 p -76.47 -35.11 58.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.507 -0.315 . . . . 3.3399999999999999 111.584 -176.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 67' ' ' ASP . 3.2 mptp? -83.11 55.42 3.11 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.755 -0.461 . . . . 5.8200000000000003 109.755 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -51.28 126.2 16.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.691 -0.686 . . . . 4.7400000000000002 111.336 -174.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 0.5 OUTLIER -74.33 171.12 14.25 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.382 -0.97 . . . . 4.7300000000000004 108.382 177.109 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.494 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -147.13 134.29 20.49 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.241 0.543 . . . . 5.5300000000000002 111.069 -174.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' A' ' 75' ' ' ASN . 17.9 t70 -78.33 -174.28 3.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.282 -0.872 . . . . 4.9800000000000004 109.265 -178.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.44 ' H ' ' CG ' ' A' ' 74' ' ' ASP . 23.7 t-20 -52.14 -28.47 18.07 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.929 1.085 . . . . 7.1100000000000003 113.929 -166.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -106.28 9.11 32.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.56 0.695 . . . . 7.1299999999999999 110.67 -175.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.494 ' HA2' ' HB2' ' A' ' 73' ' ' LYS . . . 77.85 29.4 54.71 Favored Glycine 0 C--N 1.314 -0.65 0 CA-C-N 115.046 -0.979 . . . . 5.7300000000000004 110.959 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 79' ' ' GLU . 23.5 m-80 -53.63 -41.56 66.84 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.702 0.801 . . . . 5.6200000000000001 111.92 -178.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 48.5 mt-10 84.13 106.04 0.05 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.444 -1.253 . . . . 5.0 110.717 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.29 148.57 19.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.84 -1.073 . . . . 3.5800000000000001 109.474 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 81' ' ' VAL . 7.5 p -108.59 99.04 31.5 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-O 121.788 0.804 . . . . 3.1499999999999999 109.519 172.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.429 ' HD3' ' HG2' ' A' ' 72' ' ' ARG . 44.1 Cg_endo -68.62 162.73 39.77 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 123.3 2.667 . . . . 2.0800000000000001 113.201 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.424 ' HG3' ' HD2' ' A' ' 84' ' ' PRO . 20.3 ttmt -79.18 141.24 57.68 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.532 -0.758 . . . . 3.5299999999999998 110.357 176.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.468 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 31.3 Cg_exo -52.83 141.11 56.26 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.185 2.59 . . . . 0.75 112.449 178.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.02 130.04 36.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.287 0.565 . . . . 1.78 110.385 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.81 160.17 26.57 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.794 -0.639 . . . . 2.8199999999999998 111.017 -174.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.415 ' CD2' HG21 ' A' ' 40' ' ' VAL . 88.5 m-70 -125.08 113.0 17.16 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.282 -0.872 . . . . 0.63 109.406 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.401 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 55.8 ttm -105.15 126.08 51.68 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.835 0.35 . . . . 1.1200000000000001 111.447 -175.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.97 124.59 47.39 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.563 -0.532 . . . . 1.6499999999999999 109.563 178.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.508 ' HB3' ' HB ' ' A' ' 8' ' ' ILE . 33.3 t -93.06 130.72 38.57 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.849 0.357 . . . . 1.1899999999999999 110.226 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.593 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 27.2 m-85 -108.53 172.7 6.69 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.824 -0.625 . . . . 1.6399999999999999 111.417 176.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -119.95 -4.72 10.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.364 -0.834 . . . . 1.8300000000000001 110.465 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -134.63 129.27 34.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.95 0.405 . . . . 1.22 110.338 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.44 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 14.9 tpt180 -59.62 -32.94 70.89 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.398 -0.819 . . . . 2.8799999999999999 111.188 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.477 HG23 HD22 ' A' ' 99' ' ' ASN . 87.3 m -70.42 -58.7 3.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.419 -0.355 . . . . 1.1200000000000001 110.545 -177.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.4 t -45.72 -56.04 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-N 115.695 -0.684 . . . . 1.1299999999999999 111.85 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.503 ' O ' HD12 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -64.7 -28.59 69.7 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.256 -0.429 . . . . 1.0600000000000001 110.966 -176.408 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -73.32 -30.04 63.09 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.037 -0.727 . . . . 0.39000000000000001 109.037 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.61 ' O ' ' HG3' ' A' ' 102' ' ' MET . 91.6 m-20 -77.5 -48.05 18.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.666 -1.152 . . . . 1.55 109.842 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.593 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 36.4 mm -57.9 -49.16 82.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.248 -0.887 . . . . 1.0600000000000001 110.153 176.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.434 ' HG2' HD22 ' A' ' 48' ' ' LEU . 2.3 tmmm? -57.0 -48.53 78.25 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.814 -0.63 . . . . 1.72 110.887 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.61 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 5.0 ppp? -70.08 -24.65 63.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.78 0.324 . . . . 1.76 110.506 -175.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 53.9 m -67.79 -50.79 55.02 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.491 0.662 . . . . 1.04 109.891 176.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.591 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 12.6 mt -69.85 -58.17 4.2 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.963 -1.017 . . . . 1.05 111.326 -175.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.498 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 49.4 mt-30 -53.45 -24.03 11.67 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.804 0.668 . . . . 1.45 112.804 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -65.69 -48.91 70.45 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.637 -0.875 . . . . 0.66000000000000003 108.637 175.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.543 HG21 ' HB1' ' A' ' 25' ' ' ALA . 60.1 mt -58.53 -43.8 87.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.2 -1.364 . . . . 1.04 110.811 175.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.5 mt -65.03 -51.21 69.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.596 -0.729 . . . . 1.04 110.184 -177.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.447 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 16.7 m -55.18 -33.31 62.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.15 0.5 . . . . 1.6100000000000001 110.605 172.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 91.2 mtt180 -67.19 -30.24 70.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.588 -0.733 . . . . 4.3899999999999997 110.602 178.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -94.18 -13.45 26.66 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.124 -0.489 . . . . 0.71999999999999997 111.357 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 109' ' ' SER . 9.1 mtpp -84.36 -22.92 30.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.097 0.475 . . . . 2.25 109.947 173.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -70.65 -22.42 62.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.588 0.709 . . . . 1.5600000000000001 109.382 170.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -109.89 26.69 10.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.134 -0.939 . . . . 1.3400000000000001 110.22 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.3 t70 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.516 -0.754 . . . . 2.1600000000000001 110.382 -178.079 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 111.842 -0.503 . . . . 25.670000000000002 111.842 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -135.52 23.9 3.4 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.643 -0.789 . . . . 24.66 112.065 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -80.75 63.48 4.24 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.132 -0.556 . . . . 24.199999999999999 112.405 -178.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -144.17 57.26 0.54 Allowed Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.639 -0.584 . . . . 23.140000000000001 111.639 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -85.57 157.25 20.44 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.797 -0.446 . . . . 24.920000000000002 109.797 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -119.64 120.04 35.5 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.796 -0.446 . . . . 21.449999999999999 109.796 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 7.8 m -75.72 78.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.748 0.785 . . . . 20.68 110.463 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -59.74 121.67 12.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.231 -0.895 . . . . 18.16 110.764 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 19.8 ptp -134.95 28.91 3.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.789 -0.641 . . . . 17.260000000000002 109.903 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -74.57 140.93 44.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.361 -0.836 . . . . 13.68 110.286 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 252' ' ' SER . . . . . 0.435 ' HB3' ' HB2' ' B' ' 255' ' ' GLU . 67.7 m -83.93 52.01 2.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.892 -0.595 . . . . 10.91 111.26 -176.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -71.0 -43.04 68.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.22 0.533 . . . . 11.029999999999999 110.228 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . 0.586 ' O ' ' HE3' ' A' ' 59' ' ' MET . 0.0 OUTLIER -77.2 -35.83 55.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.636 -0.711 . . . . 10.94 110.056 -177.167 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 255' ' ' GLU . . . . . 0.435 ' HB2' ' HB3' ' B' ' 252' ' ' SER . 46.6 mt-10 -60.72 -21.64 63.14 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.115 -0.493 . . . . 9.8200000000000003 111.686 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 35.2 t 73.81 139.3 0.06 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.682 0.753 . . . . 5.9100000000000001 111.779 175.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -89.29 -11.29 43.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.471 -0.786 . . . . 6.2000000000000002 109.452 176.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' B' ' 259' ' ' ASP . 26.2 t70 -85.83 -1.56 57.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.122 -0.945 . . . . 6.1399999999999997 109.874 175.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . 0.65 ' HB3' ' NH2' ' A' ' 61' ' ' ARG . 5.6 m-20 77.83 -41.92 0.35 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.021 -0.991 . . . . 3.3199999999999998 109.907 -175.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 67.37 23.23 73.38 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 116.613 1.405 . . . . 1.1200000000000001 116.613 158.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 261' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 61' ' ' ARG . 7.1 m-30 -124.73 160.13 29.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.879 1.339 . . . . 0.97999999999999998 110.856 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.08 160.6 29.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.301 -1.0 . . . . 1.8999999999999999 108.301 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.71 120.31 39.9 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.082 -0.647 . . . . 2.2400000000000002 109.977 177.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 24.8 t -108.76 109.51 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.816 -0.629 . . . . 1.8899999999999999 111.354 -172.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.574 -0.727 . . . . 3.04 109.283 174.614 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo . . . . . 0 C--O 1.232 0.209 0 N-CA-C 111.565 -0.206 . . . . 3.8100000000000001 111.565 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.2 m 72.72 -35.12 0.32 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.684 0.794 . . . . 1.8400000000000001 113.1 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.612 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 19.9 m170 -85.62 22.35 1.62 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.618 0.247 . . . . 2.3900000000000001 111.417 -175.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.6 p -164.42 159.31 19.41 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.072 -0.344 . . . . 1.6100000000000001 110.072 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.36 144.71 4.23 Favored Glycine 0 C--O 1.225 -0.456 0 N-CA-C 110.886 -0.886 . . . . 0.17000000000000001 110.886 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.717 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -76.56 120.71 22.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.618 0.709 . . . . 0.97999999999999998 111.124 -177.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.459 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -130.05 159.27 37.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.307 0.575 . . . . 1.01 111.725 -176.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.496 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.3 mp -97.28 118.14 43.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.216 -0.902 . . . . 1.0800000000000001 109.115 175.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.582 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 82.8 t80 -123.35 110.03 14.65 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.379 -0.373 . . . . 0.66000000000000003 109.997 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.575 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 41.1 mt-10 68.74 50.37 0.65 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.488 -0.778 . . . . 1.46 110.702 -175.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.575 ' HD2' ' C ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER 66.49 3.9 3.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.31 -1.314 . . . . 2.3900000000000001 112.791 171.515 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.487 HG21 ' HD2' ' A' ' 36' ' ' LYS . 0.7 OUTLIER -110.81 133.76 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.797 0.332 . . . . 1.23 110.293 172.118 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.496 ' HA ' HG13 ' A' ' 8' ' ' ILE . 31.8 t -78.17 133.25 37.82 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.325 0.583 . . . . 1.48 110.57 178.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.621 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -154.33 -152.95 6.26 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.486 -0.779 . . . . 0.16 111.683 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.717 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.3 mm -126.66 154.02 36.03 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-O 120.795 0.331 . . . . 1.05 110.646 -178.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.463 HD11 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -127.02 135.15 64.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 116.011 -0.541 . . . . 1.01 109.833 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.81 113.28 9.47 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.015 0.436 . . . . 0.87 112.031 174.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.612 ' O ' ' HB3' ' A' ' 3' ' ' HIS . 4.3 mp -84.56 113.18 22.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.74 -0.837 . . . . 1.05 108.74 171.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.8 t30 -118.16 123.98 46.86 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 110.135 -0.321 . . . . 1.1200000000000001 110.135 -178.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 22.3 mt-10 -107.69 83.35 1.79 Allowed 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 117.191 -1.804 . . . . 0.73999999999999999 107.383 165.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.408 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 18.1 t70 -122.21 -11.78 8.37 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.782 -1.562 . . . . 0.58999999999999997 106.782 157.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.66 HG11 ' O ' ' A' ' 23' ' ' SER . 14.8 p -101.68 179.86 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 111.887 -2.415 . . . . 1.0800000000000001 111.737 -155.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.66 ' O ' HG11 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -53.04 165.2 0.62 Allowed Pre-proline 0 C--O 1.224 -0.263 0 N-CA-C 107.699 -1.223 . . . . 2.0 107.699 166.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 15.4 Cg_endo -44.49 126.39 6.83 Favored 'Trans proline' 0 C--N 1.353 0.813 0 CA-C-N 121.366 1.523 . . . . 0.26000000000000001 111.852 -154.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.524 ' HB3' HG23 ' A' ' 107' ' ' ILE . . . -23.69 134.27 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 O-C-N 125.127 1.517 . . . . 1.02 114.882 -153.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.517 ' HB2' HG13 ' A' ' 22' ' ' VAL . 37.9 mt-10 -126.26 137.36 53.51 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.697 -1.138 . . . . 1.26 111.034 -173.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.578 ' C ' HD21 ' A' ' 27' ' ' LEU . 1.2 tt -99.99 145.27 28.07 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 106.47 -1.678 . . . . 1.0600000000000001 106.47 175.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.491 ' N ' HD21 ' A' ' 27' ' ' LEU . 19.2 m -131.96 109.3 9.96 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.891 -0.724 . . . . 1.05 110.392 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.598 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.2 t90 -89.25 108.16 19.46 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.574 -0.739 . . . . 0.29999999999999999 109.143 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -115.89 120.26 38.65 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.252 -0.885 . . . . 1.1599999999999999 109.091 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.475 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 35.5 p -56.01 148.17 18.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.891 0.377 . . . . 1.3899999999999999 110.892 -175.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.621 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 21.7 m -54.26 -32.96 57.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.431 -0.804 . . . . 1.1499999999999999 110.949 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -77.54 -29.66 52.42 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.244 -0.434 . . . . 2.3300000000000001 111.113 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.07 13.66 51.84 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.736 -0.745 . . . . 0.55000000000000004 113.042 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -85.84 -69.04 0.69 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.159 0.504 . . . . 1.1299999999999999 110.336 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.487 ' HD2' HG21 ' A' ' 12' ' ' VAL . 17.0 ptpt -87.49 145.09 26.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.624 0.726 . . . . 2.6200000000000001 110.371 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 65.7 t -147.17 140.51 19.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.487 -1.233 . . . . 1.3100000000000001 109.041 -176.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -141.21 122.67 15.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.571 0.224 . . . . 0.82999999999999996 110.595 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.426 HG21 ' HG1' ' A' ' 28' ' ' THR . 29.0 m -103.85 142.66 34.0 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 121.256 -0.177 . . . . 1.0600000000000001 111.09 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 45.8 t -119.42 130.02 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.187 0.44 . . . . 1.3600000000000001 112.187 178.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 45' ' ' ILE . 49.9 t -91.13 108.88 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-O 121.499 0.666 . . . . 1.05 109.935 172.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.577 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.3 mm? -49.95 -35.46 24.23 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.512 -1.222 . . . . 1.04 112.463 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.489 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 69.4 m -74.9 -29.91 61.13 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.866 -0.333 . . . . 1.45 111.576 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.469 ' OG1' ' HB ' ' A' ' 41' ' ' VAL . 76.1 p -79.97 -8.58 59.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.499 0.666 . . . . 1.04 109.766 175.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.591 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 39.3 mm -82.38 132.58 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.061 -0.972 . . . . 1.02 111.219 174.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.612 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 12.0 t70 -82.82 -41.1 19.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.354 -0.839 . . . . 0.69999999999999996 110.911 175.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.499 ' O ' HG12 ' A' ' 63' ' ' ILE . 45.9 mmtt -145.47 143.02 29.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.374 -0.83 . . . . 2.4300000000000002 110.658 -173.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.652 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 13.6 tp -111.27 139.62 46.51 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.659 -0.817 . . . . 1.04 109.45 163.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.593 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 15.6 mm100 -118.27 155.77 30.01 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.425 -1.262 . . . . 1.49 110.001 -178.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.01 143.73 9.47 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.878 -1.056 . . . . 1.0 108.546 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 47.3 p -54.49 126.18 54.83 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.665 0.745 . . . . 1.03 111.106 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 65.8 Cg_endo -71.7 167.76 25.61 Favored 'Trans proline' 0 C--N 1.332 -0.29 0 C-N-CA 124.349 3.366 . . . . 0.73999999999999999 112.045 176.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.17 -24.23 64.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.993 0.425 . . . . 1.54 110.659 174.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -69.17 -24.04 64.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.53 0.681 . . . . 2.0499999999999998 110.162 174.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.577 ' OG ' ' HE2' ' A' ' 57' ' ' LYS . 28.8 t -84.43 139.34 32.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.471 -0.786 . . . . 1.1399999999999999 109.256 176.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -92.95 -11.9 32.16 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.823 -0.806 . . . . 2.8900000000000001 108.823 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.586 ' HD3' ' N ' ' A' ' 57' ' ' LYS . 2.3 mppt? -90.45 176.48 6.69 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.695 -1.139 . . . . 3.1299999999999999 110.779 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.425 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -135.3 109.58 8.36 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.011 -0.737 . . . . 2.0 109.011 -178.613 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.529 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 63.4 mtm -155.96 150.11 25.51 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.87 0.367 . . . . 1.3 111.23 -173.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.42 156.48 32.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.396 -0.82 . . . . 1.05 110.421 174.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.543 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 33.8 ttt180 -153.67 113.22 3.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.989 0.424 . . . . 3.3999999999999999 110.892 175.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.527 ' HG ' HD12 ' A' ' 48' ' ' LEU . 10.4 mt -93.73 111.66 23.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.105 0.479 . . . . 1.73 110.428 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.515 HG23 ' HG2' ' A' ' 86' ' ' ARG . 3.7 mm -86.17 106.47 15.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 123.534 0.734 . . . . 1.1599999999999999 109.98 -174.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -81.2 139.43 20.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 119.897 -1.144 . . . . 0.47999999999999998 112.1 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.612 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 5.9 mttt -53.3 135.77 38.14 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.227 0.537 . . . . 1.78 111.467 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 84' ' ' PRO . 14.6 p -86.95 150.13 3.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.559 0.695 . . . . 1.3100000000000001 111.048 -176.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -93.57 81.23 4.32 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.853 -1.067 . . . . 2.5600000000000001 109.918 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.76 -32.4 27.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.515 -0.766 . . . . 3.79 111.286 -176.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.3 p -63.88 -33.23 75.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.504 0.669 . . . . 3.3399999999999999 109.524 174.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -87.3 63.93 8.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.337 -0.847 . . . . 5.8200000000000003 109.37 174.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -51.51 126.79 18.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.582 0.706 . . . . 4.7400000000000002 111.758 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.487 ' HG2' ' HD3' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -92.5 171.31 9.11 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.162 -0.927 . . . . 4.7300000000000004 109.489 -176.256 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.36 152.09 46.88 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.778 0.323 . . . . 5.5300000000000002 110.389 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.525 ' CG ' ' H ' ' A' ' 75' ' ' ASN . 19.0 t70 -88.98 -163.7 1.03 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.767 -0.651 . . . . 4.9800000000000004 109.473 -177.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.525 ' H ' ' CG ' ' A' ' 74' ' ' ASP . 73.4 m-20 -57.83 -28.17 63.84 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.912 0.708 . . . . 7.1100000000000003 112.912 -169.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -82.42 -17.87 43.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.819 0.818 . . . . 7.1299999999999999 109.549 -175.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.99 30.89 13.09 Favored Glycine 0 CA--C 1.503 -0.683 0 N-CA-C 109.089 -1.604 . . . . 5.7300000000000004 109.089 -175.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -86.22 -86.94 0.14 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.357 -1.421 . . . . 5.6200000000000001 111.904 -169.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 177.81 121.86 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.248 0.547 . . . . 5.0 111.666 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.471 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.6 t -128.54 147.69 33.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.439 -0.578 . . . . 3.5800000000000001 109.439 170.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.9 p -114.51 95.79 41.23 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-O 122.086 0.946 . . . . 3.1499999999999999 108.919 171.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.487 ' HD3' ' HG2' ' A' ' 72' ' ' ARG . 60.7 Cg_endo -72.37 160.59 46.56 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.193 2.595 . . . . 2.0800000000000001 113.784 -172.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.448 ' HD3' ' N ' ' A' ' 83' ' ' LYS . 3.7 mppt? -84.62 146.11 46.1 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 114.935 -1.03 . . . . 3.5299999999999998 108.799 175.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.481 ' HA ' ' HB ' ' A' ' 66' ' ' VAL . 38.3 Cg_exo -53.41 132.36 48.16 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.603 2.202 . . . . 0.75 112.206 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.18 115.18 12.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.506 1.146 . . . . 1.78 111.038 -177.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.515 ' HG2' HG23 ' A' ' 63' ' ' ILE . 17.8 mtt85 -102.97 144.26 31.48 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.473 -1.24 . . . . 2.8199999999999998 109.813 -174.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -105.82 110.87 23.32 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.802 -0.814 . . . . 0.63 108.802 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.2 ttm -105.1 121.97 44.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.916 0.389 . . . . 1.1200000000000001 110.924 -174.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.463 ' CG ' HD11 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -117.06 123.19 46.24 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.832 -0.803 . . . . 1.6499999999999999 108.832 177.5 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.485 ' HB3' ' HB ' ' A' ' 8' ' ' ILE . 28.2 t -94.64 131.54 40.32 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.149 0.5 . . . . 1.1899999999999999 110.188 -178.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.459 ' CE1' ' HB2' ' A' ' 7' ' ' ALA . 38.2 m-85 -108.59 165.54 11.46 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.527 -0.76 . . . . 1.6399999999999999 110.504 175.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -114.62 -3.3 12.92 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.45 -0.796 . . . . 1.8300000000000001 110.168 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -126.15 121.51 33.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.865 -0.607 . . . . 1.22 109.76 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -54.66 -36.55 64.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.816 -1.084 . . . . 2.8799999999999999 111.483 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.559 HG21 HD22 ' A' ' 99' ' ' ASN . 93.7 m -73.23 -55.59 6.24 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.964 -0.562 . . . . 1.1200000000000001 111.015 -175.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 94.0 t -45.13 -57.24 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-N 116.111 -0.495 . . . . 1.1299999999999999 111.364 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.745 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -60.9 -34.05 74.06 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.579 -0.448 . . . . 1.0600000000000001 110.416 -176.582 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -71.57 -20.35 62.02 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.165 0.507 . . . . 0.39000000000000001 110.427 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.617 ' O ' ' HG3' ' A' ' 102' ' ' MET . 92.1 m-20 -86.93 -37.84 17.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.222 1.01 . . . . 1.55 109.094 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.535 HG21 HD11 ' A' ' 18' ' ' ILE . 1.6 mm -67.65 -50.7 58.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 113.934 -1.485 . . . . 1.0600000000000001 111.675 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.745 ' HG2' ' O ' ' A' ' 97' ' ' MET . 2.6 ptmt -58.63 -39.56 80.86 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 120.689 0.28 . . . . 1.72 110.822 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.617 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.8 ppp? -73.65 -23.62 59.88 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.166 -0.679 . . . . 1.76 109.166 -176.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 21.2 m -68.02 -51.44 46.98 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.405 -0.816 . . . . 1.04 109.92 173.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.652 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 12.6 mt -72.72 -57.17 4.3 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.524 -0.762 . . . . 1.05 111.633 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.606 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 95.1 mt-30 -51.88 -26.56 10.37 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.64 0.607 . . . . 1.45 112.64 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -71.47 -42.8 67.69 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.229 -0.656 . . . . 0.66000000000000003 109.229 177.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.524 HG23 ' HB3' ' A' ' 25' ' ' ALA . 69.8 mt -61.42 -44.43 98.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.545 -1.207 . . . . 1.04 110.145 174.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.2 mt -63.9 -47.8 89.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.635 -0.712 . . . . 1.04 109.906 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 44.4 t -58.77 -30.68 67.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.354 0.597 . . . . 1.6100000000000001 109.973 175.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.5 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 12.6 ttt180 -67.36 -37.26 82.91 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.133 -0.939 . . . . 4.3899999999999997 109.778 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -88.5 -19.38 26.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.827 -0.624 . . . . 0.71999999999999997 111.479 -175.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.515 ' HD2' HG21 ' A' ' 108' ' ' ILE . 8.5 mtpp -78.82 -23.73 44.9 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.416 0.627 . . . . 2.25 109.425 172.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -73.44 -14.42 61.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.237 -0.892 . . . . 1.5600000000000001 110.093 175.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -131.97 30.63 4.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.732 -0.667 . . . . 1.3400000000000001 111.073 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.782 -0.628 . . . . 2.1600000000000001 110.825 -178.307 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.777 0 N-CA-C 112.376 -0.29 . . . . 25.670000000000002 112.376 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -123.67 -20.09 2.67 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.798 -0.715 . . . . 24.66 112.334 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -172.37 -143.01 3.96 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.054 -0.593 . . . . 24.199999999999999 111.639 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 84.12 -48.54 4.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.021 -0.609 . . . . 23.140000000000001 112.695 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -74.02 -17.24 61.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.018 0.437 . . . . 24.920000000000002 110.937 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -72.54 138.19 46.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.707 -0.679 . . . . 21.449999999999999 110.495 -177.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 15.5 t -82.48 56.42 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.843 0.83 . . . . 20.68 108.856 174.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -111.45 114.25 27.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.098 -0.956 . . . . 18.16 110.153 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -144.81 14.68 1.54 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.599 -0.273 . . . . 17.260000000000002 111.607 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.87 149.34 24.17 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.359 -0.608 . . . . 13.68 109.359 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 18.9 m -76.88 -12.43 59.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.025 -0.534 . . . . 10.91 110.775 -175.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -64.03 -32.76 74.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.237 -0.438 . . . . 11.029999999999999 111.237 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -75.04 -26.54 59.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.041 0.448 . . . . 10.94 110.584 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -82.15 -42.39 19.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.435 0.636 . . . . 9.8200000000000003 109.554 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 256' ' ' SER . . . . . 0.436 ' HB3' ' HA3' ' B' ' 260' ' ' GLY . 70.2 m -150.55 122.22 8.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.25 -0.886 . . . . 5.9100000000000001 109.174 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -53.93 -67.68 0.24 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.585 0.553 . . . . 6.2000000000000002 112.28 -166.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -88.53 -47.87 8.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.348 0.594 . . . . 6.1399999999999997 109.979 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -167.1 -38.42 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.515 -1.221 . . . . 3.3199999999999998 108.971 -176.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' B' ' 256' ' ' SER . . . 77.95 -7.77 41.21 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 115.366 -0.834 . . . . 1.1200000000000001 114.549 168.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 261' ' ' PHE . . . . . 0.593 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 8.2 m-30 -103.62 177.93 4.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.84 0.32 . . . . 0.97999999999999998 110.893 -176.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.71 156.98 12.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.421 -0.354 . . . . 1.8999999999999999 110.233 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 263' ' ' GLU . . . . . 0.445 ' HA ' ' NE2' ' A' ' 105' ' ' GLN . 40.1 tt0 -106.0 128.65 53.97 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.279 -0.638 . . . . 2.2400000000000002 109.279 173.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 38.6 t -105.44 109.4 27.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.067 0.46 . . . . 1.8899999999999999 110.844 -175.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.491 -0.766 . . . . 3.04 109.621 177.223 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.478 0.608 0 N-CA-C 110.173 -0.741 . . . . 3.8100000000000001 110.173 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.524 ' HA ' ' HB3' ' A' ' 99' ' ' ASN . 55.7 p -108.16 -43.08 4.47 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.944 0.402 . . . . 1.8400000000000001 111.067 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -88.6 12.59 14.22 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.117 0.484 . . . . 2.3900000000000001 110.657 -178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 82.0 p -163.99 148.88 10.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.099 -0.501 . . . . 1.6100000000000001 109.998 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.45 144.85 5.79 Favored Glycine 0 C--O 1.223 -0.579 0 N-CA-C 110.592 -1.003 . . . . 0.17000000000000001 110.592 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.702 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -76.63 119.35 20.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.773 0.786 . . . . 0.97999999999999998 111.448 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.419 ' HB1' ' CE1' ' A' ' 91' ' ' PHE . . . -124.82 158.22 33.93 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.484 0.659 . . . . 1.01 111.7 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.512 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.7 mp -100.48 123.99 53.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.04 -0.982 . . . . 1.0800000000000001 109.028 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.409 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 85.7 t80 -121.9 101.71 7.73 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.29 -0.414 . . . . 0.66000000000000003 110.061 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 65.99 56.98 0.82 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.575 0.702 . . . . 1.46 110.708 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt 73.13 -8.03 1.39 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.407 -1.27 . . . . 2.3900000000000001 113.109 170.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -102.46 130.27 52.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.059 0.457 . . . . 1.23 110.712 174.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.512 ' HA ' HG13 ' A' ' 8' ' ' ILE . 27.0 t -79.86 130.84 35.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.685 -0.689 . . . . 1.48 110.404 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.636 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -148.95 -155.63 6.8 Favored Glycine 0 N--CA 1.435 -1.373 0 CA-C-N 115.588 -0.733 . . . . 0.16 111.906 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.702 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.3 mm -126.74 153.74 35.92 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 CA-C-O 120.801 0.334 . . . . 1.05 110.759 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.434 HD13 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -125.05 133.82 68.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.918 -0.583 . . . . 1.01 109.501 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.3 108.88 6.96 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.002 0.429 . . . . 0.87 111.992 175.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 3.6 mp -85.16 120.21 35.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.559 -0.904 . . . . 1.05 108.559 172.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.409 ' ND2' ' HB ' ' A' ' 22' ' ' VAL . 2.0 t30 -124.34 123.84 41.07 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.886 -0.413 . . . . 1.1200000000000001 109.886 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -109.0 83.32 1.73 Allowed 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 117.187 -1.805 . . . . 0.73999999999999999 107.632 165.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -122.48 -10.92 8.37 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 106.774 -1.565 . . . . 0.58999999999999997 106.774 156.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 23' ' ' SER . 14.5 p -101.41 175.1 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 112.181 -2.282 . . . . 1.0800000000000001 111.775 -155.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.693 ' O ' HG12 ' A' ' 22' ' ' VAL . 1.2 t -54.42 165.47 0.86 Allowed Pre-proline 0 C--O 1.225 -0.221 0 N-CA-C 105.972 -1.862 . . . . 2.0 105.972 167.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.565 ' HA ' ' OH ' ' A' ' 111' ' ' TYR . 9.8 Cg_endo -41.22 128.01 3.03 Favored 'Trans proline' 0 C--N 1.357 0.995 0 CA-C-N 122.204 1.823 . . . . 0.26000000000000001 111.744 -151.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.555 ' HB1' HG23 ' A' ' 107' ' ' ILE . . . -29.81 133.81 0.05 Allowed 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 125.348 1.655 . . . . 1.02 113.756 -157.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.51 ' HB2' HG11 ' A' ' 22' ' ' VAL . 31.6 mt-10 -122.56 132.56 54.36 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.768 -1.105 . . . . 1.26 110.98 -171.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.583 ' C ' HD23 ' A' ' 27' ' ' LEU . 1.2 tt -100.92 142.45 32.37 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.398 -1.704 . . . . 1.0600000000000001 106.398 172.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 39' ' ' THR . 24.5 m -129.8 110.04 11.42 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.636 -0.826 . . . . 1.05 110.505 -178.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.646 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 86.0 t90 -86.11 105.87 16.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.591 0.71 . . . . 0.29999999999999999 109.27 174.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -113.26 114.14 26.29 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.91 -1.041 . . . . 1.1599999999999999 108.741 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.552 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 93.1 p -57.61 147.53 26.99 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.422 0.63 . . . . 1.3899999999999999 110.424 -174.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.636 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 18.9 m -51.98 -26.44 10.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.447 -1.251 . . . . 1.1499999999999999 112.331 -174.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -88.07 -28.16 21.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.961 0.41 . . . . 2.3300000000000001 111.234 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.91 17.33 28.16 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.996 -0.621 . . . . 0.55000000000000004 112.361 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -90.01 -35.31 15.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.03 0.443 . . . . 1.1299999999999999 111.15 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -118.61 141.71 48.33 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.162 0.506 . . . . 2.6200000000000001 111.114 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 69.3 t -141.79 116.93 5.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.972 -1.013 . . . . 1.3100000000000001 109.853 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -123.36 109.56 14.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.191 -0.459 . . . . 0.82999999999999996 109.934 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.471 HG23 ' OE1' ' A' ' 26' ' ' GLU . 39.0 m -98.07 137.08 37.39 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.985 -0.286 . . . . 1.0600000000000001 111.207 -176.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 40.0 t -110.8 129.69 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 122.705 0.402 . . . . 1.3600000000000001 111.467 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 45' ' ' ILE . 55.3 t -91.21 108.04 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-O 121.282 0.563 . . . . 1.05 109.576 173.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.603 HD12 ' CD2' ' A' ' 104' ' ' LEU . 1.8 mm? -56.09 -28.32 57.24 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.07 -0.968 . . . . 1.04 112.533 -177.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.5 t -74.19 -31.3 62.6 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.297 -0.561 . . . . 1.45 110.504 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.6 p -79.94 -10.01 59.73 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.682 -0.488 . . . . 1.04 109.682 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.555 HG22 ' CD2' ' A' ' 62' ' ' LEU . 44.6 mm -84.44 116.53 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.61 -0.723 . . . . 1.02 111.535 176.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.622 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 2.5 t70 -74.96 -47.54 28.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.242 -0.89 . . . . 0.69999999999999996 111.422 175.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.483 ' O ' HG12 ' A' ' 63' ' ' ILE . 15.5 tptt -136.02 136.66 40.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.047 -0.524 . . . . 2.4300000000000002 109.916 -174.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.652 ' CD2' ' HB2' ' A' ' 104' ' ' LEU . 13.2 tp -106.74 142.65 36.04 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 119.661 -0.815 . . . . 1.04 109.081 164.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.501 HE21 ' HB2' ' B' ' 261' ' ' PHE . 4.1 mt-30 -122.96 152.69 40.62 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.687 -1.142 . . . . 1.49 109.675 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -161.47 139.2 9.08 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.473 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 40.4 p -54.95 125.41 56.07 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-O 121.453 0.644 . . . . 1.03 111.715 -178.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 46.1 Cg_endo -67.34 166.74 22.48 Favored 'Trans proline' 0 C--N 1.334 -0.204 0 C-N-CA 124.064 3.176 . . . . 0.73999999999999999 112.238 178.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.419 ' N ' HH21 ' A' ' 94' ' ' ARG . . . -60.43 -28.89 68.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.028 0.442 . . . . 1.54 110.419 175.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 t -71.75 -24.13 61.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.744 -0.662 . . . . 2.0499999999999998 110.466 177.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.471 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 33.4 t -71.51 141.87 50.14 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.549 -0.537 . . . . 1.1399999999999999 109.549 176.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -83.4 -17.64 41.54 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.302 0.572 . . . . 2.8900000000000001 110.149 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -97.09 179.93 4.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.518 -0.764 . . . . 3.1299999999999999 110.662 -173.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.473 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -133.75 110.32 9.73 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.177 -1.046 . . . . 2.0 108.177 171.311 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.491 ' HB3' ' HE1' ' B' ' 261' ' ' PHE . 29.8 ttm -157.11 137.61 13.03 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.592 -0.443 . . . . 1.3 111.247 -171.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.12 155.47 23.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.929 -0.578 . . . . 1.05 110.173 177.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 19.6 ttm180 -151.02 113.59 4.66 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.739 0.304 . . . . 3.3999999999999999 110.794 173.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.555 ' CD2' HG22 ' A' ' 45' ' ' ILE . 10.7 mt -96.94 108.2 20.87 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.056 0.543 . . . . 1.73 111.331 -177.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.488 ' HA ' ' HB3' ' A' ' 86' ' ' ARG . 2.6 mm -88.88 131.46 36.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 C-N-CA 123.21 0.604 . . . . 1.1599999999999999 110.872 -175.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -85.6 166.1 39.33 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.153 -1.022 . . . . 0.47999999999999998 112.056 175.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.622 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 1.1 mptm? -75.07 131.24 40.42 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.622 -0.511 . . . . 1.78 109.622 173.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.545 ' HB ' ' HG3' ' A' ' 84' ' ' PRO . 5.2 p -74.73 152.75 6.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.383 0.611 . . . . 1.3100000000000001 111.416 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.41 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 4.8 p-10 -89.82 82.58 6.22 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.128 -0.942 . . . . 2.5600000000000001 111.457 -177.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 71' ' ' LYS . 0.1 OUTLIER -84.64 -24.44 29.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 3.79 111.059 -178.538 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.2 t -69.06 -20.26 64.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.117 0.484 . . . . 3.3399999999999999 110.814 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.41 ' HE2' ' HB2' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -134.53 62.91 1.64 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.11 -0.496 . . . . 5.8200000000000003 109.963 178.051 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 35.7 mtmm -56.72 146.32 26.15 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.784 0.802 . . . . 4.7400000000000002 112.322 -176.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.443 ' HG2' ' HD3' ' A' ' 82' ' ' PRO . 8.1 ptm180 -82.39 172.91 12.54 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.532 -1.213 . . . . 4.7300000000000004 108.773 175.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.426 ' HB3' ' C ' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -124.7 165.62 17.61 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.836 -0.431 . . . . 5.5300000000000002 109.836 177.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.624 ' HB3' HD22 ' A' ' 78' ' ' ASN . 1.9 t70 -97.49 -157.17 0.57 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.484 -0.561 . . . . 4.9800000000000004 109.484 178.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -57.95 -31.45 66.86 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.238 0.458 . . . . 7.1100000000000003 112.238 -172.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -96.22 1.68 52.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.45 0.643 . . . . 7.1299999999999999 109.843 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.426 ' C ' ' HB3' ' A' ' 73' ' ' LYS . . . 72.42 37.61 58.61 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 114.857 -1.065 . . . . 5.7300000000000004 110.733 -176.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.624 HD22 ' HB3' ' A' ' 74' ' ' ASP . 5.8 p30 -83.88 -91.41 0.08 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.717 -0.241 . . . . 5.6200000000000001 110.588 -177.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.45 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 10.7 pt-20 -175.47 124.57 0.23 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.251 0.548 . . . . 5.0 111.323 175.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.43 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.5 t -127.45 148.3 32.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.04 -0.726 . . . . 3.5800000000000001 109.04 171.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.2 p -111.4 97.19 35.0 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-O 121.812 0.815 . . . . 3.1499999999999999 109.648 172.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.443 ' HD3' ' HG2' ' A' ' 72' ' ' ARG . 18.0 Cg_endo -60.56 137.66 75.13 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.292 2.661 . . . . 2.0800000000000001 112.399 -175.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -54.18 128.17 57.17 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 115.712 -0.677 . . . . 3.5299999999999998 110.275 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.545 ' HG3' ' HB ' ' A' ' 66' ' ' VAL . 25.0 Cg_exo -49.5 135.41 33.1 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.385 2.724 . . . . 0.75 112.896 -173.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.04 117.48 6.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.998 0.904 . . . . 1.78 110.817 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.488 ' HB3' ' HA ' ' A' ' 63' ' ' ILE . 21.3 ptt180 -126.62 148.68 49.76 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.546 -0.752 . . . . 2.8199999999999998 111.273 -174.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -117.63 113.07 21.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.227 -0.897 . . . . 0.63 110.523 -169.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.441 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 49.1 ttm -100.59 130.87 46.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.82 0.343 . . . . 1.1200000000000001 111.537 -176.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.434 ' CG ' HD13 ' A' ' 16' ' ' ILE . 79.4 m-85 -126.28 122.66 36.12 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.433 -0.58 . . . . 1.6499999999999999 109.433 174.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.415 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 35.5 m -92.46 132.93 36.38 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.302 -0.408 . . . . 1.1899999999999999 110.161 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.64 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 25.5 m-85 -108.5 171.13 7.59 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.968 0.413 . . . . 1.6399999999999999 110.846 177.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -112.0 -3.27 14.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.823 -0.626 . . . . 1.8300000000000001 110.114 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -141.08 129.13 22.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.346 0.594 . . . . 1.22 110.799 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.42 ' NH1' ' HB2' ' A' ' 98' ' ' ASP . 49.3 tpt85 -61.04 -27.98 68.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.806 -1.088 . . . . 2.8799999999999999 111.405 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.415 HG23 HD22 ' A' ' 99' ' ' ASN . 99.3 m -75.8 -55.63 5.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.629 -0.259 . . . . 1.1200000000000001 111.278 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.3 t -45.52 -56.8 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-O 120.852 0.358 . . . . 1.1299999999999999 111.082 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.68 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -62.24 -32.09 72.74 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.779 -0.646 . . . . 1.0600000000000001 110.602 -177.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.42 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 19.6 t70 -66.55 -34.13 77.22 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.77 0.795 . . . . 0.39000000000000001 109.555 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.592 ' O ' ' HG3' ' A' ' 102' ' ' MET . 89.2 m-20 -76.83 -41.32 44.69 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.421 -1.263 . . . . 1.55 109.878 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.64 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 23.4 mm -63.02 -53.43 46.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.948 -1.024 . . . . 1.0600000000000001 111.15 176.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.68 ' HG2' ' O ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -59.88 -38.14 81.36 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 120.726 0.298 . . . . 1.72 111.065 -177.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.592 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.4 ppp? -71.63 -25.74 62.28 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.365 -0.606 . . . . 1.76 109.365 -175.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 23.1 m -68.13 -52.15 38.11 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.488 -0.778 . . . . 1.04 110.258 174.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.652 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 8.2 mt -69.16 -57.44 5.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.523 -0.762 . . . . 1.05 111.33 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.628 ' HG3' ' CD2' ' A' ' 48' ' ' LEU . 95.2 mt-30 -52.7 -25.48 11.13 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.811 0.671 . . . . 1.45 112.811 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -73.41 -35.63 65.86 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.703 0.763 . . . . 0.66000000000000003 109.403 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.555 HG23 ' HB1' ' A' ' 25' ' ' ALA . 69.5 mt -69.53 -41.7 80.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.539 -1.21 . . . . 1.04 110.249 175.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.521 HG22 ' HD2' ' A' ' 112' ' ' LYS . 1.2 mt -65.6 -50.86 69.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.805 -0.634 . . . . 1.04 110.544 -176.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.494 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 48.6 m -58.69 -28.86 66.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.212 0.53 . . . . 1.6100000000000001 110.141 174.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 8.3 ttt180 -66.09 -39.51 90.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.405 -0.816 . . . . 4.3899999999999997 109.509 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.565 ' OH ' ' HA ' ' A' ' 24' ' ' PRO . 21.3 m-85 -84.81 -23.19 29.22 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.503 -0.772 . . . . 0.71999999999999997 111.651 -175.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.521 ' HD2' HG22 ' A' ' 108' ' ' ILE . 9.4 mtpp -77.19 -27.92 53.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.407 0.623 . . . . 2.25 109.756 175.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -70.18 -18.27 63.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.159 -0.928 . . . . 1.5600000000000001 110.196 173.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -128.57 32.23 4.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.667 -0.697 . . . . 1.3400000000000001 111.239 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 111' ' ' TYR . 20.4 t70 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.477 -0.773 . . . . 2.1600000000000001 109.844 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 111.839 -0.505 . . . . 25.670000000000002 111.839 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -120.1 25.88 7.3 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.063 -0.589 . . . . 24.66 111.953 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -102.91 60.98 0.49 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.837 -0.697 . . . . 24.199999999999999 111.906 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.05 41.95 5.44 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.798 -0.715 . . . . 23.140000000000001 112.069 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -76.36 -32.13 58.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.238 0.542 . . . . 24.920000000000002 110.686 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -108.63 136.92 47.41 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.787 -0.642 . . . . 21.449999999999999 110.486 -178.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 33.5 m -90.3 9.32 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.915 -0.584 . . . . 20.68 109.996 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -99.53 116.91 32.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.462 -0.79 . . . . 18.16 110.652 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 22.6 ptp -150.61 16.7 0.8 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.971 -0.559 . . . . 17.260000000000002 110.246 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -78.05 139.92 39.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.025 -0.534 . . . . 13.68 111.244 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 14.1 m -72.05 -15.71 62.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.588 -0.733 . . . . 10.91 110.313 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -64.86 -37.11 86.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.732 -0.667 . . . . 11.029999999999999 110.847 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -67.2 -32.33 73.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 10.94 110.622 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 255' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' B' ' 256' ' ' SER . 49.2 mt-10 -84.38 -17.7 38.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.056 -0.52 . . . . 9.8200000000000003 110.657 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 256' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' B' ' 255' ' ' GLU . 41.9 t 73.07 105.76 0.07 Allowed 'General case' 0 C--N 1.332 -0.154 0 O-C-N 124.392 1.057 . . . . 5.9100000000000001 109.487 -171.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -88.19 -35.09 17.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.844 -0.616 . . . . 6.2000000000000002 111.338 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.85 -31.49 71.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 6.1399999999999997 111.806 -175.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -151.54 -38.57 0.12 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.109 0.411 . . . . 3.3199999999999998 112.109 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 100.57 17.54 23.58 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.241 -0.981 . . . . 1.1200000000000001 112.902 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 261' ' ' PHE . . . . . 0.501 ' HB2' HE21 ' A' ' 49' ' ' GLN . 35.1 m-85 -130.38 177.07 7.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.467 0.651 . . . . 0.97999999999999998 112.287 -173.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 11.9 p -144.23 147.64 19.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 114.729 -1.123 . . . . 1.8999999999999999 108.907 171.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 263' ' ' GLU . . . . . 0.472 ' HA ' HE22 ' A' ' 105' ' ' GLN . 17.5 tt0 -100.48 121.22 41.2 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.265 -0.643 . . . . 2.2400000000000002 109.265 176.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 43.5 t -110.18 106.72 21.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.872 0.368 . . . . 1.8899999999999999 110.921 -173.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.522 -0.751 . . . . 3.04 110.616 179.924 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.5 m80 . . . . . 0 C--O 1.224 -0.254 0 CA-C-O 120.816 0.341 . . . . 1.85 110.886 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 8.0 m -161.45 141.62 10.68 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.802 -0.444 . . . . 0.95 109.802 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.69 142.95 6.6 Favored Glycine 0 C--O 1.224 -0.491 0 N-CA-C 110.864 -0.894 . . . . 0.16 110.864 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.734 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -76.54 117.64 18.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.588 0.694 . . . . 0.43 111.847 -175.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.53 162.33 25.91 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.429 0.633 . . . . 0.13 111.92 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.591 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.8 mp -105.07 123.14 59.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.237 -0.892 . . . . 0.29 109.082 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -117.15 106.14 13.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.652 -0.249 . . . . 0.56 110.516 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 61.0 50.66 4.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.609 0.719 . . . . 1.46 110.366 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt 75.46 -8.67 1.54 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.151 -1.386 . . . . 1.91 113.382 170.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.45 HG21 ' HD2' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -93.18 131.62 39.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.393 -0.523 . . . . 0.47 110.172 172.441 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.591 ' HA ' HG13 ' A' ' 8' ' ' ILE . 40.9 t -79.75 130.39 35.3 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.586 -0.734 . . . . 1.02 110.854 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.652 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -155.87 -156.17 7.69 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.876 -0.678 . . . . 0.16 112.615 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.734 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.7 mm -126.81 153.85 36.17 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-O 120.834 0.349 . . . . 0.19 110.883 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.485 HD11 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -121.5 134.5 64.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.985 -0.552 . . . . 0.16 109.626 178.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.43 109.92 7.45 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.982 0.42 . . . . 0.12 111.924 174.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.668 HD11 HG23 ' A' ' 100' ' ' ILE . 4.0 mp -83.57 118.55 31.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 107.926 -1.139 . . . . 0.18 107.926 171.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.531 HD22 ' HB3' ' A' ' 21' ' ' ASP . 4.2 t-20 -121.41 122.73 40.44 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 110.0 -0.37 . . . . 1.12 110.0 -177.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -108.47 83.75 1.82 Allowed 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 117.146 -1.822 . . . . 0.74 107.215 163.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.531 ' HB3' HD22 ' A' ' 19' ' ' ASN . 11.9 t70 -121.99 -11.31 8.52 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.59 -1.633 . . . . 0.59 106.59 157.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.692 HG13 ' O ' ' A' ' 23' ' ' SER . 14.9 p -102.31 174.18 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 112.049 -2.342 . . . . 0.35 112.198 -154.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.692 ' O ' HG13 ' A' ' 22' ' ' VAL . 6.8 m -54.71 166.56 0.73 Allowed Pre-proline 0 C--O 1.224 -0.281 0 N-CA-C 106.586 -1.635 . . . . 1.31 106.586 164.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 11.9 Cg_endo -42.0 128.09 3.99 Favored 'Trans proline' 0 C--N 1.352 0.732 0 CA-C-N 121.862 1.701 . . . . 0.22 111.408 -149.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.668 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -32.23 133.29 0.11 Allowed 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 125.26 1.6 . . . . 0.2 113.446 -157.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.527 ' HB2' HG11 ' A' ' 22' ' ' VAL . 68.7 mt-10 -124.09 140.8 52.62 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.429 -1.26 . . . . 1.26 111.089 -168.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.557 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.7 tt -101.57 142.6 32.68 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 106.561 -1.644 . . . . 0.15 106.561 172.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.458 ' N ' HD23 ' A' ' 27' ' ' LEU . 10.6 m -130.55 108.47 9.95 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.919 -0.712 . . . . 0.21 110.164 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.607 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 88.5 t90 -87.0 112.03 21.43 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.558 0.694 . . . . 0.24 109.364 175.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.518 ' HD3' ' O ' ' A' ' 31' ' ' SER . 2.6 tmt_? -118.99 118.19 30.83 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.111 -0.949 . . . . 0.87 108.819 -177.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.518 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 35.8 p -56.0 144.28 29.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.292 0.568 . . . . 0.75 110.597 -176.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.652 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 21.4 m -53.85 -29.45 41.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.603 -1.18 . . . . 0.39 112.008 -175.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -83.56 -25.65 30.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.259 0.552 . . . . 2.33 111.065 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.3 16.67 39.61 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.886 -0.673 . . . . 0.55 112.337 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.36 -65.27 1.02 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.104 0.478 . . . . 1.13 110.99 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.45 ' HD2' HG21 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -106.43 155.06 19.95 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.508 -0.769 . . . . 2.03 110.777 -175.364 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 69.0 t -146.81 139.76 19.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.97 -1.014 . . . . 0.55 109.636 -175.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -139.34 111.23 7.29 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.234 -0.284 . . . . 0.69 110.234 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.3 m -98.31 138.75 35.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.58 0.229 . . . . 0.3 111.496 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.561 HG11 HD13 ' A' ' 62' ' ' LEU . 41.1 t -113.16 129.44 68.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 122.523 0.329 . . . . 0.66 111.521 176.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.559 ' O ' HG12 ' A' ' 45' ' ' ILE . 38.8 t -91.04 108.1 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 109.576 -0.528 . . . . 0.18 109.576 173.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.58 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.8 mm? -53.21 -28.89 29.27 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.091 -0.959 . . . . 0.12 112.597 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.406 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 68.4 m -74.88 -35.76 62.29 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.663 -0.415 . . . . 1.06 111.446 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.3 p -72.28 -14.17 61.7 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 121.376 0.608 . . . . 0.2 109.564 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.602 HG21 ' CD2' ' A' ' 62' ' ' LEU . 48.6 mm -82.32 120.93 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.335 -0.848 . . . . 0.23 111.395 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.628 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 15.7 t70 -78.46 -46.09 20.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.73 -0.668 . . . . 0.7 110.904 176.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.411 ' HB2' HG13 ' A' ' 63' ' ' ILE . 68.8 mmtt -136.88 150.52 48.3 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.129 -0.487 . . . . 1.95 109.975 -178.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.9 HD22 ' HB2' ' A' ' 104' ' ' LEU . 9.9 tp -113.45 144.23 43.16 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.29 -0.633 . . . . 0.14 109.29 165.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.488 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 82.0 mm-40 -120.87 154.57 35.66 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.978 -1.01 . . . . 1.49 109.518 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.484 ' HB1' ' CE ' ' A' ' 97' ' ' MET . . . -162.59 141.44 8.92 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.55 -0.75 . . . . 0.25 108.992 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.579 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 37.1 p -56.53 126.04 68.68 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-O 121.303 0.573 . . . . 0.37 112.055 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 72.9 Cg_endo -74.46 166.37 29.6 Favored 'Trans proline' 0 C--N 1.329 -0.457 0 C-N-CA 123.972 3.114 . . . . 0.64 111.314 172.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.6 -27.85 63.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.109 0.481 . . . . 1.02 110.415 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.4 m -69.07 -24.81 64.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.706 -0.679 . . . . 1.58 111.282 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.499 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 39.5 t -76.54 148.51 37.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.127 -0.488 . . . . 0.71 109.717 177.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -90.68 -2.18 57.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.42 0.629 . . . . 2.89 110.116 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -115.39 178.98 4.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.194 -0.912 . . . . 2.59 110.858 -174.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.579 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -132.35 107.76 8.74 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.017 -1.105 . . . . 1.78 108.017 168.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 75.1 mtm -154.54 152.0 29.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.982 0.42 . . . . 1.3 111.21 -176.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.471 HD11 ' O ' ' A' ' 97' ' ' MET . 0.8 OUTLIER -112.05 158.33 19.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.242 -0.89 . . . . 0.14 110.229 175.134 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 45.2 ttt180 -153.63 114.32 4.03 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 121.274 0.559 . . . . 2.72 111.009 170.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.713 ' HG ' HD13 ' A' ' 48' ' ' LEU . 9.0 mt -92.24 112.91 25.03 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.717 -0.674 . . . . 0.9 110.515 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.619 HG23 ' HG2' ' A' ' 86' ' ' ARG . 5.0 mm -86.7 116.64 29.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.512 0.725 . . . . 0.4 110.307 -174.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -85.33 144.97 21.01 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.159 -1.019 . . . . 0.48 111.487 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.628 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 8.2 mptt -58.73 134.98 57.3 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.057 0.456 . . . . 1.15 110.734 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--N 1.321 -0.662 0 CA-C-N 115.509 -0.769 . . . . 0.69 110.289 -179.326 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 . . . . . 0 N--CA 1.448 -0.527 0 CA-C-O 121.531 0.682 . . . . 1.78 109.264 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.619 ' HG2' HG23 ' A' ' 63' ' ' ILE . 18.7 mtt180 -140.13 153.73 46.78 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.551 -0.749 . . . . 2.29 110.33 -168.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -115.88 110.45 19.03 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.08 -0.711 . . . . 0.5 109.08 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.483 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 54.9 ttm -103.25 129.26 50.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.781 0.324 . . . . 0.42 110.827 -175.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.485 ' CG ' HD11 ' A' ' 16' ' ' ILE . 80.4 m-85 -123.46 122.54 38.51 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 109.245 -0.65 . . . . 1.33 109.245 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.493 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 22.7 m -91.18 128.95 37.21 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.04 -0.527 . . . . 0.94 110.838 -174.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.603 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 29.1 m-85 -108.16 174.79 5.72 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.95 -0.568 . . . . 1.33 110.816 176.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -119.57 0.22 10.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.706 -0.679 . . . . 1.53 109.821 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.511 ' OD1' ' HB ' ' A' ' 95' ' ' THR . 28.7 t-20 -143.38 131.43 21.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.324 -0.853 . . . . 0.83 110.647 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.491 ' HA ' ' HG2' ' A' ' 97' ' ' MET . 0.9 OUTLIER -74.97 -23.28 58.26 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.962 -0.563 . . . . 2.16 110.976 -174.128 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.511 ' HB ' ' OD1' ' A' ' 93' ' ' ASN . 92.8 m -70.99 -54.49 11.07 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.411 -0.516 . . . . 0.4 109.783 175.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.0 t -45.7 -57.36 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-N 116.134 -0.485 . . . . 0.29 111.103 173.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.491 ' HG2' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -64.12 -29.3 70.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.006 -0.543 . . . . 0.29 111.093 -178.134 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.29 -32.18 72.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.407 0.622 . . . . 0.39 109.554 175.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.495 HD21 HG22 ' A' ' 95' ' ' THR . 90.6 m-20 -75.03 -46.82 32.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.887 -1.051 . . . . 1.55 109.844 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.668 HG23 HD11 ' A' ' 18' ' ' ILE . 27.6 mm -61.28 -51.16 76.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.003 -0.999 . . . . 0.13 110.276 175.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.628 ' HA ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -55.74 -51.9 65.76 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.614 -0.721 . . . . 1.11 111.197 179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.487 ' N ' ' HE2' ' A' ' 101' ' ' LYS . 11.7 ptp -60.2 -32.15 70.82 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.081 0.467 . . . . 1.17 109.777 -176.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 54.1 m -63.36 -52.04 63.41 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.267 -0.879 . . . . 0.15 110.261 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.9 ' HB2' HD22 ' A' ' 48' ' ' LEU . 11.3 mt -66.95 -55.59 13.87 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.43 -0.805 . . . . 0.13 110.781 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.791 ' HG2' HD23 ' A' ' 48' ' ' LEU . 19.2 mm-40 -43.16 -37.54 2.11 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.653 0.596 . . . . 1.45 112.544 178.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -68.1 -35.51 78.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.823 0.82 . . . . 0.65 109.555 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.668 HG21 ' HB3' ' A' ' 25' ' ' ALA . 81.3 mt -72.51 -41.66 63.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.017 -1.447 . . . . 0.17 110.319 175.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.434 HG12 HD12 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -65.3 -50.92 70.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.855 -0.611 . . . . 0.29 110.217 -177.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.6 t -58.53 -28.47 65.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.47 0.653 . . . . 1.22 109.941 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 11.0 ttt180 -68.73 -38.81 80.45 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.049 -0.978 . . . . 3.79 109.927 177.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.401 ' OH ' ' HA ' ' A' ' 24' ' ' PRO . 27.0 m-85 . . . . . 0 N--CA 1.446 -0.65 0 CA-C-N 115.928 -0.578 . . . . 0.6 111.698 -175.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 261' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 6.0 m-85 . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 121.056 0.455 . . . . 0.95 110.822 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 12.9 p -135.09 145.22 32.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.669 -0.696 . . . . 1.37 109.165 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.607 0 CA-C-O 121.021 0.439 . . . . 2.24 110.13 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.612 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 36.0 m80 . . . . . 0 C--O 1.225 -0.191 0 N-CA-C 111.858 0.318 . . . . 1.85 111.858 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.4 p -162.37 145.61 11.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.982 0.42 . . . . 0.95 110.906 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.48 145.71 6.72 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.71 -0.956 . . . . 0.16 110.71 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.736 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -71.68 142.88 49.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.21 0.505 . . . . 0.43 111.361 -176.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.474 ' HB1' ' HB3' ' A' ' 89' ' ' PHE . . . -152.62 155.09 36.66 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-O 121.209 0.528 . . . . 0.13 111.61 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.544 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.2 mp -92.34 131.18 40.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.606 -0.725 . . . . 0.29 109.4 176.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.566 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 89.3 t80 -139.74 112.87 8.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.28 -0.418 . . . . 0.56 110.134 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.495 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 51.3 mt-10 68.6 48.83 0.78 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.604 0.716 . . . . 1.46 110.371 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.495 ' HD2' ' C ' ' A' ' 10' ' ' GLU . 4.0 mptt 67.41 4.4 3.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.351 -1.295 . . . . 1.91 112.84 173.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.94 134.69 54.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.835 0.35 . . . . 0.47 110.623 175.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.544 ' HA ' HG13 ' A' ' 8' ' ' ILE . 31.8 t -75.02 128.53 35.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.028 -0.533 . . . . 1.02 109.819 176.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.691 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -148.1 -159.88 8.68 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.701 -0.762 . . . . 0.16 112.347 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.736 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.8 mm -126.33 152.66 34.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.066 0.46 . . . . 0.19 110.841 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.412 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -122.63 133.04 69.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.647 -0.706 . . . . 0.16 109.842 178.761 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.14 110.33 7.81 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.92 0.391 . . . . 0.12 111.958 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.685 HD11 HG23 ' A' ' 100' ' ' ILE . 3.6 mp -85.41 119.46 34.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.844 -0.799 . . . . 0.18 108.844 172.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.467 HD22 ' HB3' ' A' ' 21' ' ' ASP . 3.2 t-20 -120.77 123.42 42.62 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.992 -0.373 . . . . 1.12 109.992 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.439 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 15.9 mt-10 -108.85 83.08 1.7 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 117.332 -1.747 . . . . 0.74 107.452 164.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.467 ' HB3' HD22 ' A' ' 19' ' ' ASN . 23.0 t70 -122.04 -10.92 8.55 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 106.522 -1.658 . . . . 0.59 106.522 157.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 23' ' ' SER . 14.5 p -102.33 175.5 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 111.919 -2.4 . . . . 0.35 112.057 -155.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.686 ' O ' HG13 ' A' ' 22' ' ' VAL . 56.8 p -54.4 165.96 0.78 Allowed Pre-proline 0 C--O 1.225 -0.2 0 N-CA-C 106.714 -1.587 . . . . 1.31 106.714 166.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 12.0 Cg_endo -42.47 128.97 4.82 Favored 'Trans proline' 0 C--N 1.359 1.095 0 CA-C-N 122.326 1.866 . . . . 0.22 111.157 -152.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.788 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -31.46 136.11 0.06 Allowed 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 125.44 1.712 . . . . 0.2 114.193 -155.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.531 ' HB2' HG11 ' A' ' 22' ' ' VAL . 64.1 mt-10 -122.64 132.4 54.26 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 114.439 -1.255 . . . . 1.26 110.789 -171.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.566 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.3 tt -100.81 142.18 32.65 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 106.235 -1.765 . . . . 0.15 106.235 173.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.432 ' N ' HD23 ' A' ' 27' ' ' LEU . 25.9 m -130.67 109.34 10.56 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 119.537 -0.865 . . . . 0.21 110.551 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.611 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 88.8 t90 -85.83 108.85 18.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.624 0.726 . . . . 0.24 109.376 174.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -115.13 115.0 26.05 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.774 -1.103 . . . . 0.87 108.467 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.542 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 79.3 p -57.21 150.03 18.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.153 0.501 . . . . 0.75 110.751 -173.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.691 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 24.0 m -57.83 -29.05 64.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.176 -0.92 . . . . 0.39 110.435 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.495 ' OD2' ' HB3' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -80.65 -27.95 37.02 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.421 -0.809 . . . . 2.33 111.548 177.181 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.6 -5.07 56.78 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.818 -0.705 . . . . 0.55 113.161 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.495 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 2.4 t70 -67.28 -52.23 43.18 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.3 0.482 . . . . 1.13 112.3 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -103.0 143.48 32.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.621 0.724 . . . . 2.03 112.426 -174.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 76.9 t -141.86 116.44 5.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.175 -1.375 . . . . 0.55 109.802 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -123.75 109.74 14.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.949 -0.569 . . . . 0.69 109.904 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 32.8 m -97.35 137.84 35.72 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.944 -0.303 . . . . 0.3 111.177 -176.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 42.0 t -110.91 130.91 63.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 122.815 0.446 . . . . 0.66 111.655 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.509 ' O ' HG12 ' A' ' 45' ' ' ILE . 51.0 t -90.91 108.29 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 109.619 -0.512 . . . . 0.18 109.619 172.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.616 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -53.48 -27.96 28.07 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.994 -1.003 . . . . 0.12 112.844 -178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.0 m -75.47 -34.59 60.91 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.598 -0.441 . . . . 1.06 111.443 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.6 p -75.26 -11.95 60.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.273 0.558 . . . . 0.2 109.71 173.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.691 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 47.5 mm -81.75 117.02 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 115.143 -0.935 . . . . 0.23 111.282 173.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.537 ' OD2' ' HG2' ' A' ' 47' ' ' LYS . 21.2 t70 -73.93 -46.24 45.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.429 -0.805 . . . . 0.7 111.375 177.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.537 ' HG2' ' OD2' ' A' ' 46' ' ' ASP . 47.9 mmtm -140.75 157.3 45.62 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.473 -0.331 . . . . 1.95 110.354 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.077 HD23 ' HG3' ' A' ' 105' ' ' GLN . 13.2 tp -123.51 140.93 52.5 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.256 0.55 . . . . 0.14 109.941 167.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.558 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 16.3 mm100 -113.01 157.8 21.07 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.749 -1.114 . . . . 1.49 109.846 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.51 136.32 5.36 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.8 -0.636 . . . . 0.25 109.539 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 40.6 p -51.27 124.74 23.7 Favored Pre-proline 0 N--CA 1.467 0.404 0 CA-C-O 121.259 0.552 . . . . 0.37 111.243 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.555 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 48.3 Cg_endo -66.82 166.54 22.15 Favored 'Trans proline' 0 C--N 1.333 -0.287 0 C-N-CA 124.057 3.171 . . . . 0.64 111.983 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.417 ' N ' HH21 ' A' ' 94' ' ' ARG . . . -60.11 -25.0 65.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.902 0.382 . . . . 1.02 110.829 176.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.8 m -78.37 -24.39 46.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.847 -0.615 . . . . 1.58 111.521 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 29.7 t -67.54 149.29 50.33 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.216 -0.661 . . . . 0.71 109.216 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.48 -14.36 22.4 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.606 -0.887 . . . . 2.89 108.606 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.568 ' N ' ' HD3' ' A' ' 57' ' ' LYS . 2.7 mppt? -94.34 -177.89 4.41 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.821 -1.081 . . . . 2.59 110.996 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.511 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -136.49 110.67 8.37 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.388 -0.968 . . . . 1.78 108.388 172.314 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.682 ' HB3' ' CZ ' ' B' ' 261' ' ' PHE . 2.5 mtm -156.54 138.68 14.59 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.694 -0.402 . . . . 1.3 111.854 -173.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.841 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 2.3 mp -109.2 160.05 16.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.843 -0.617 . . . . 0.14 111.078 170.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.558 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 9.8 ttm180 -150.54 114.19 4.97 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.981 -0.554 . . . . 2.72 110.356 172.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.871 ' HG ' HD13 ' A' ' 48' ' ' LEU . 6.2 mp -94.19 110.44 22.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.075 0.464 . . . . 0.9 110.502 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.564 HG23 ' HG2' ' A' ' 86' ' ' ARG . 2.2 mm -87.95 124.6 41.21 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 C-N-CA 123.254 0.622 . . . . 0.4 109.701 -176.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.691 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -93.58 160.05 24.29 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 119.255 -1.45 . . . . 0.48 111.819 174.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 0.3 OUTLIER -69.29 132.86 47.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.72 0.295 . . . . 1.15 111.088 -178.599 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 C--N 1.316 -0.854 0 N-CA-C 108.807 -0.812 . . . . 0.69 108.807 170.674 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? . . . . . 0 CA--C 1.515 -0.367 0 CA-C-O 121.931 0.872 . . . . 1.78 109.813 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.564 ' HG2' HG23 ' A' ' 63' ' ' ILE . 18.8 mtm180 -115.52 154.47 29.3 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.201 -0.909 . . . . 2.29 109.133 -175.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -117.51 109.43 16.73 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.164 -0.471 . . . . 0.5 110.003 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.544 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 51.1 ttm -108.99 122.38 47.12 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 110.061 -0.348 . . . . 0.42 110.061 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.499 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 57.8 m-85 -112.23 139.79 47.48 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.595 -0.891 . . . . 1.33 108.595 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.531 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 31.3 m -97.74 123.11 41.54 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.597 -0.519 . . . . 0.94 109.597 177.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.841 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 6.0 m-85 -106.09 165.06 11.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.986 -0.552 . . . . 1.33 109.819 -175.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -107.3 -6.46 17.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.882 0.372 . . . . 1.53 110.988 -171.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.401 ' HB3' HG23 ' A' ' 96' ' ' VAL . 48.9 t-20 -145.66 128.36 16.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.142 0.496 . . . . 0.83 110.663 -176.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.515 ' NH1' ' HB2' ' A' ' 98' ' ' ASP . 49.1 tpt85 -62.63 -26.24 68.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.06 -0.973 . . . . 2.16 111.131 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.2 m -73.46 -60.06 2.42 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.738 0.304 . . . . 0.4 110.382 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 100' ' ' ILE . 58.5 t -45.71 -55.57 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 CA-C-N 115.584 -0.734 . . . . 0.29 111.441 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.549 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -63.21 -30.63 71.74 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.227 -0.442 . . . . 0.29 110.786 -177.75 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.515 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 36.5 t70 -69.17 -31.3 69.84 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.619 0.723 . . . . 0.39 109.557 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -72.93 -42.36 63.57 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.6 -1.182 . . . . 1.55 109.072 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.685 HG23 HD11 ' A' ' 18' ' ' ILE . 40.4 mm -62.64 -54.09 38.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.783 -1.099 . . . . 0.13 111.562 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.715 ' HA ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -60.87 -42.72 98.46 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 120.54 0.21 . . . . 1.11 111.481 -177.221 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.401 ' HB3' ' HE2' ' A' ' 101' ' ' LYS . 13.0 ptp -66.51 -29.56 69.68 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.66 -0.867 . . . . 1.17 108.66 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 32.7 m -66.0 -52.01 53.23 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.751 -1.113 . . . . 0.15 110.025 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.902 ' HB2' HD22 ' A' ' 48' ' ' LEU . 13.3 mt -69.31 -58.51 3.92 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.444 -0.798 . . . . 0.13 110.945 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 1.077 ' HG3' HD23 ' A' ' 48' ' ' LEU . 96.8 mt-30 -49.2 -28.21 4.32 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.757 0.651 . . . . 1.45 112.757 -178.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -67.14 -49.02 66.27 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.852 -0.796 . . . . 0.65 108.852 176.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.788 HG21 ' HB3' ' A' ' 25' ' ' ALA . 53.0 mt -59.65 -43.89 92.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.669 -1.15 . . . . 0.17 110.494 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -61.18 -58.24 8.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.604 -0.726 . . . . 0.29 110.168 -176.918 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.9 m -55.37 -29.23 58.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.722 0.296 . . . . 1.22 111.467 173.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 92.5 mtt180 -68.93 -18.37 64.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.157 0.503 . . . . 3.79 110.481 176.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 . . . . . 0 N--CA 1.442 -0.869 0 CA-C-N 115.687 -0.688 . . . . 0.6 109.916 178.16 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 261' ' ' PHE . . . . . 0.682 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 6.2 m-30 . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 120.839 0.352 . . . . 0.95 110.414 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.39 148.9 31.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.494 -0.558 . . . . 1.37 109.494 174.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 263' ' ' GLU . . . . . 0.552 ' HB3' ' OE1' ' A' ' 49' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.617 0 CA-C-O 121.332 0.587 . . . . 2.24 110.523 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.561 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 19.5 m80 . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.722 0.296 . . . . 1.85 111.525 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.6 p -163.54 142.44 8.08 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.733 0.301 . . . . 0.95 110.375 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.98 147.18 7.92 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.294 -1.122 . . . . 0.16 110.294 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.762 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -69.8 144.52 52.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 117.41 0.605 . . . . 0.43 111.603 -175.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' A' ' 89' ' ' PHE . . . -152.64 155.83 38.07 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 121.068 0.461 . . . . 0.13 111.38 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.563 HG13 ' HA ' ' A' ' 13' ' ' SER . 1.9 mp -94.73 133.84 34.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.793 -0.639 . . . . 0.29 109.297 177.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.451 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 74.3 t80 -139.69 121.0 14.93 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.285 -0.635 . . . . 0.56 109.285 176.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 65.03 41.76 4.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.466 0.651 . . . . 1.46 110.141 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 11' ' ' LYS . 41.4 mmtt 74.0 -6.43 1.83 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.519 -1.219 . . . . 1.91 112.922 171.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.97 135.34 36.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.914 0.388 . . . . 0.47 110.539 175.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.563 ' HA ' HG13 ' A' ' 8' ' ' ILE . 9.6 p -73.38 128.93 36.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.79 -0.641 . . . . 1.02 110.691 176.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.679 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -146.8 -159.5 8.31 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 115.645 -0.707 . . . . 0.16 112.192 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.762 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.4 mm -126.39 152.95 34.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 120.905 0.383 . . . . 0.19 111.007 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.04 134.34 66.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 116.079 -0.51 . . . . 0.16 109.891 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.83 110.78 8.22 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.933 0.397 . . . . 0.12 112.069 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.678 HD11 HG23 ' A' ' 100' ' ' ILE . 3.9 mp -85.13 112.8 22.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.785 -0.82 . . . . 0.18 108.785 171.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.48 HD22 ' HB3' ' A' ' 21' ' ' ASP . 2.9 t-20 -114.97 125.86 54.1 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.823 -0.351 . . . . 1.12 110.139 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.402 ' HG2' ' HB1' ' A' ' 25' ' ' ALA . 9.8 mt-10 -109.76 83.07 1.69 Allowed 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 117.255 -1.778 . . . . 0.74 107.37 163.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.48 ' HB3' HD22 ' A' ' 19' ' ' ASN . 16.9 t70 -122.26 -10.01 8.55 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 106.42 -1.696 . . . . 0.59 106.42 157.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.93 HG11 ' HB3' ' A' ' 26' ' ' GLU . 14.5 p -102.79 174.86 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 112.079 -2.328 . . . . 0.35 111.897 -156.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.687 ' O ' HG13 ' A' ' 22' ' ' VAL . 12.0 p -54.52 165.0 0.96 Allowed Pre-proline 0 N--CA 1.453 -0.322 0 N-CA-C 106.661 -1.607 . . . . 1.31 106.661 165.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.616 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 11.8 Cg_endo -41.73 129.01 3.86 Favored 'Trans proline' 0 C--N 1.353 0.792 0 CA-C-N 121.731 1.654 . . . . 0.22 111.809 -147.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.646 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -29.41 131.03 0.07 Allowed 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 125.406 1.691 . . . . 0.2 113.137 -159.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.93 ' HB3' HG11 ' A' ' 22' ' ' VAL . 36.7 tt0 -132.49 133.59 43.98 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.412 -1.267 . . . . 1.26 111.532 -160.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 1.6 tt -100.38 146.88 26.45 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 107.276 -1.379 . . . . 0.15 107.276 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.498 ' N ' HD23 ' A' ' 27' ' ' LEU . 22.6 m -137.57 109.31 7.07 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 120.134 -0.626 . . . . 0.21 110.552 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.589 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 88.3 t90 -85.58 112.38 20.91 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.688 -0.687 . . . . 0.24 109.29 175.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -117.93 118.3 31.61 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.442 -0.948 . . . . 0.87 108.442 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.568 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 71.6 p -57.21 152.18 14.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.667 0.27 . . . . 0.75 111.032 -174.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.679 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 23.7 m -55.53 -35.12 65.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.599 0.714 . . . . 0.39 109.889 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.18 -28.05 53.89 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.939 -1.028 . . . . 2.33 111.613 178.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.9 1.55 70.27 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.915 -0.66 . . . . 0.55 113.246 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -81.35 -25.05 36.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.856 0.328 . . . . 1.13 111.688 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -120.82 140.96 51.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.162 0.506 . . . . 2.03 111.719 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 73.7 t -142.45 126.11 15.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.298 -0.865 . . . . 0.55 110.496 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -128.04 112.22 14.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.913 0.387 . . . . 0.69 110.418 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 27' ' ' LEU . 30.2 m -96.17 146.81 24.37 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.503 -0.317 . . . . 0.3 111.476 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 36.9 t -126.28 127.67 70.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 122.476 0.31 . . . . 0.66 111.433 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.469 ' O ' HG12 ' A' ' 45' ' ' ILE . 58.4 t -90.39 107.95 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-O 121.392 0.615 . . . . 0.18 109.497 173.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.611 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.9 mm? -51.15 -29.76 14.66 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.901 -1.045 . . . . 0.12 112.79 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 60.5 m -73.48 -34.96 65.59 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.565 -0.454 . . . . 1.06 111.528 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.3 p -72.85 -18.1 61.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.362 0.601 . . . . 0.2 109.574 173.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.578 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 50.0 mm -79.72 117.58 25.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.256 -0.884 . . . . 0.23 111.024 175.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.592 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 28.7 t70 -75.81 -43.1 47.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.029 -0.532 . . . . 0.7 111.666 177.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.493 ' HG2' ' OD2' ' A' ' 46' ' ' ASP . 48.6 mmtm -141.05 153.93 45.73 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.865 -0.421 . . . . 1.95 109.865 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.036 HD23 ' HG3' ' A' ' 105' ' ' GLN . 9.7 tp -117.31 145.99 43.63 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.203 -0.666 . . . . 0.14 109.203 166.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.667 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 15.9 mm100 -124.12 157.17 35.25 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.661 -1.154 . . . . 1.49 109.974 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.61 146.22 11.42 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.471 -0.786 . . . . 0.25 109.64 177.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.42 ' HA ' ' HD2' ' A' ' 52' ' ' PRO . 20.1 p -43.83 125.83 4.12 Favored Pre-proline 0 N--CA 1.468 0.429 0 C-N-CA 123.583 0.753 . . . . 0.37 111.756 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.567 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 52.8 Cg_endo -66.82 165.65 25.14 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 C-N-CA 123.803 3.002 . . . . 0.64 111.649 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.21 -29.33 67.42 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.092 0.472 . . . . 1.02 110.313 175.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.9 t -70.43 -22.63 62.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.713 -0.676 . . . . 1.58 110.611 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.468 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 47.7 t -72.18 145.49 48.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.71 110.428 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -89.91 -7.98 52.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.354 0.597 . . . . 2.89 109.576 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -103.92 179.43 4.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.021 -0.991 . . . . 2.59 111.077 -173.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.584 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -137.29 109.88 7.5 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.375 -1.284 . . . . 1.78 108.064 178.021 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.773 ' HB3' ' CZ ' ' B' ' 261' ' ' PHE . 10.8 ttm -157.98 138.81 13.08 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.343 -0.543 . . . . 1.3 111.375 -169.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.817 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 3.2 mp -111.06 156.35 21.43 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.087 0.47 . . . . 0.14 112.028 174.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 59.9 ttp180 -150.28 113.2 4.81 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.776 -0.647 . . . . 2.72 110.593 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.787 ' HG ' HD13 ' A' ' 48' ' ' LEU . 6.4 mp -95.72 110.73 22.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.998 -0.546 . . . . 0.9 110.693 -176.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.565 HG23 ' HB3' ' A' ' 86' ' ' ARG . 1.2 mm -87.6 120.98 37.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.163 -0.472 . . . . 0.4 110.525 -173.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -83.17 156.24 33.74 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 119.89 -1.148 . . . . 0.48 111.747 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.592 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 9.7 mptt -68.48 137.08 54.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.96 0.38 . . . . 1.15 110.29 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 C--N 1.32 -0.68 0 N-CA-C 109.207 -0.664 . . . . 0.69 109.207 173.409 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.69 0 CA-C-O 121.829 0.823 . . . . 1.78 109.791 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.565 ' HB3' HG23 ' A' ' 63' ' ' ILE . 22.3 ptt180 -127.73 141.65 51.54 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.251 -0.886 . . . . 2.29 110.444 -174.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -102.32 111.18 23.37 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.043 -0.98 . . . . 0.5 110.207 -170.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.495 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 53.6 ttm -108.27 120.12 41.45 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.598 -0.728 . . . . 0.42 110.483 -172.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.457 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 55.8 m-85 -111.5 140.48 46.07 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.394 -0.965 . . . . 1.33 108.394 175.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.623 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 49.5 m -97.47 125.08 41.93 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.523 -0.471 . . . . 0.94 110.221 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.817 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 5.6 m-85 -107.7 169.0 8.86 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.747 -0.661 . . . . 1.33 109.357 -176.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -126.27 -3.4 6.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.851 0.358 . . . . 1.53 110.68 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.453 ' OD1' HG23 ' A' ' 96' ' ' VAL . 28.6 t-20 -131.12 125.66 33.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.131 0.491 . . . . 0.83 110.616 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.443 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 12.7 tpt180 -62.29 -33.51 74.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.179 -0.918 . . . . 2.16 111.371 -177.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.42 ' HB ' ' OD1' ' A' ' 93' ' ' ASN . 87.2 m -73.24 -55.76 6.0 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.951 -0.3 . . . . 0.4 110.492 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.453 HG23 ' OD1' ' A' ' 93' ' ' ASN . 95.6 t -45.86 -56.39 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-N 115.824 -0.625 . . . . 0.29 111.539 175.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.584 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -65.94 -28.9 69.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.321 -0.399 . . . . 0.29 110.7 -177.397 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.95 -37.02 83.51 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.92 -0.77 . . . . 0.39 108.92 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.558 ' O ' ' HG3' ' A' ' 102' ' ' MET . 18.3 m120 -72.79 -48.53 37.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.205 -1.361 . . . . 1.55 109.581 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.678 HG23 HD11 ' A' ' 18' ' ' ILE . 41.0 mm -56.18 -53.05 43.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.985 -1.007 . . . . 0.13 110.075 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.785 ' HA ' HD21 ' A' ' 48' ' ' LEU . 6.6 ttpp -55.98 -50.15 71.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.778 -0.646 . . . . 1.11 111.329 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.558 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.1 ppp? -68.56 -24.48 64.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.328 -0.396 . . . . 1.17 110.339 -175.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.7 m -67.62 -51.79 46.02 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.462 0.649 . . . . 0.15 110.071 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.982 ' HB2' HD22 ' A' ' 48' ' ' LEU . 13.8 mt -69.14 -58.5 3.98 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.132 -0.94 . . . . 0.13 111.364 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 1.036 ' HG3' HD23 ' A' ' 48' ' ' LEU . 66.5 mt-30 -51.52 -26.46 8.5 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.758 0.651 . . . . 1.45 112.758 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -66.24 -49.5 67.0 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.411 -0.959 . . . . 0.65 108.411 175.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.646 HG21 ' HB3' ' A' ' 25' ' ' ALA . 67.7 mt -58.51 -43.57 87.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.303 -1.317 . . . . 0.17 110.487 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.1 mt -66.79 -49.24 76.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.996 -0.547 . . . . 0.29 110.654 -176.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.2 t -60.27 -26.14 66.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.388 0.613 . . . . 1.22 110.095 173.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 83.0 mtt180 -73.87 -30.63 62.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.494 -0.776 . . . . 3.79 110.624 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 . . . . . 0 N--CA 1.449 -0.478 0 CA-C-N 116.051 -0.522 . . . . 0.6 112.144 -179.364 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 261' ' ' PHE . . . . . 0.773 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 6.7 m-30 . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 121.042 0.449 . . . . 0.95 111.701 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.1 p -138.18 148.2 25.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.916 -0.584 . . . . 1.37 110.264 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 . . . . . 0 C--N 1.324 -0.501 0 N-CA-C 108.931 -0.766 . . . . 2.24 108.931 175.964 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.424 ' CE1' HG23 ' A' ' 103' ' ' THR . 12.4 m80 . . . . . 0 C--O 1.225 -0.224 0 N-CA-C 112.421 0.526 . . . . 1.85 112.421 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.9 p -162.8 140.07 7.88 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.318 0.58 . . . . 0.95 111.26 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.05 152.79 13.36 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.998 -1.241 . . . . 0.16 109.998 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.746 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -73.46 145.88 45.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 117.578 0.689 . . . . 0.43 111.5 -175.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.97 152.55 32.62 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.396 0.617 . . . . 0.13 111.525 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.507 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.7 mp -94.15 124.44 46.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.861 -0.792 . . . . 0.29 108.861 174.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.574 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 79.9 t80 -128.99 105.62 8.33 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 110.176 -0.305 . . . . 0.56 110.176 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 66.98 53.22 0.84 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.573 0.701 . . . . 1.46 110.664 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp 71.28 -8.16 1.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.175 -1.375 . . . . 1.91 113.252 171.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.435 HG11 ' HD3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -99.32 132.73 44.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.865 -0.42 . . . . 0.47 109.865 172.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.507 ' HA ' HG13 ' A' ' 8' ' ' ILE . 23.3 t -85.28 123.97 31.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.998 -0.546 . . . . 1.02 109.921 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.662 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -144.48 -155.08 6.32 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 120.906 -0.664 . . . . 0.16 112.276 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.746 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.3 mm -125.11 153.35 32.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 120.977 0.418 . . . . 0.19 110.448 -177.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.487 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -123.91 131.69 72.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.826 -0.625 . . . . 0.16 109.904 178.616 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.22 111.07 8.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.038 -0.528 . . . . 0.12 111.476 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.651 HD11 HG23 ' A' ' 100' ' ' ILE . 4.0 mp -84.22 118.98 32.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.053 -1.092 . . . . 0.18 108.053 172.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.433 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.8 t30 -121.94 123.23 41.19 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.909 -0.404 . . . . 1.12 109.909 -178.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.481 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 15.8 mt-10 -108.51 83.22 1.74 Allowed 'General case' 0 N--CA 1.426 -1.635 0 C-N-CA 117.113 -1.835 . . . . 0.74 107.541 164.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.433 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 13.3 t70 -121.49 -10.2 8.88 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 106.38 -1.711 . . . . 0.59 106.38 157.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 23' ' ' SER . 14.6 p -102.15 175.98 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 111.933 -2.394 . . . . 0.35 111.791 -157.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.705 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -54.51 167.29 0.6 Allowed Pre-proline 0 C--O 1.223 -0.291 0 N-CA-C 106.464 -1.68 . . . . 1.31 106.464 166.354 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.423 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 11.6 Cg_endo -42.05 128.29 4.09 Favored 'Trans proline' 0 C--N 1.357 1.002 0 CA-C-N 122.062 1.772 . . . . 0.22 111.309 -153.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.655 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -30.0 133.73 0.05 Allowed 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 125.384 1.678 . . . . 0.2 114.189 -157.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.636 ' HB2' HG11 ' A' ' 22' ' ' VAL . 28.2 mt-10 -124.27 140.34 53.05 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 114.791 -1.095 . . . . 1.26 111.302 -171.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.764 ' HB3' HG12 ' A' ' 40' ' ' VAL . 1.8 tt -100.1 142.9 30.95 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 106.579 -1.638 . . . . 0.15 106.579 174.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.546 ' N ' HD23 ' A' ' 27' ' ' LEU . 3.0 m -129.39 107.76 9.76 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.04 -0.664 . . . . 0.21 109.827 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.59 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.4 t90 -91.61 113.27 25.49 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.875 -0.787 . . . . 0.24 108.875 176.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -121.01 124.21 44.3 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.527 -0.76 . . . . 0.87 109.465 -176.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.432 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 29.8 m -56.01 141.18 40.86 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.801 -0.444 . . . . 0.75 109.801 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.662 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 22.8 m -55.29 -34.16 63.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.817 -0.629 . . . . 0.39 110.554 -178.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -87.09 -3.28 59.06 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.468 -0.787 . . . . 2.33 111.242 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.99 19.66 72.13 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.237 -0.506 . . . . 0.55 112.73 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -71.79 -74.58 0.15 Allowed 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 111.973 0.36 . . . . 1.13 111.973 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.435 ' HD3' HG11 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -116.59 153.39 32.33 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.946 0.403 . . . . 2.03 111.036 -177.722 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 59.7 t -132.36 130.16 59.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.216 -0.447 . . . . 0.55 110.641 -176.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -122.62 109.67 14.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.645 0.26 . . . . 0.69 110.676 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 7.0 m -94.99 138.64 32.44 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.613 -0.514 . . . . 0.3 109.613 175.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.764 HG12 ' HB3' ' A' ' 27' ' ' LEU . 8.9 p -128.54 139.12 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 120.569 -0.452 . . . . 0.66 111.774 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.572 ' O ' HG12 ' A' ' 45' ' ' ILE . 45.0 t -90.02 110.88 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-O 121.377 0.608 . . . . 0.18 110.389 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.651 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.4 mm? -54.1 -28.87 42.18 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.872 -1.058 . . . . 0.12 112.633 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.423 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 66.5 m -77.34 -34.28 55.26 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.67 -0.412 . . . . 1.06 111.28 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.492 ' OG1' ' HB ' ' A' ' 41' ' ' VAL . 65.9 p -75.26 -12.14 60.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.525 0.678 . . . . 0.2 109.465 173.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.633 HG21 HD22 ' A' ' 62' ' ' LEU . 40.9 mm -81.58 123.1 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 114.963 -1.017 . . . . 0.23 110.691 170.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.478 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 35.6 t70 -74.71 -48.85 23.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.751 -0.659 . . . . 0.7 110.982 176.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' HG13 ' A' ' 63' ' ' ILE . 49.2 mmtm -142.07 165.06 28.48 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.194 -0.457 . . . . 1.95 110.172 -177.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.054 HD23 ' HG3' ' A' ' 105' ' ' GLN . 10.5 tp -126.09 142.96 51.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.422 0.63 . . . . 0.14 109.386 170.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.421 ' CG ' HD11 ' A' ' 63' ' ' ILE . 30.9 mm-40 -117.3 157.46 26.05 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.919 -1.037 . . . . 1.49 109.144 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -161.63 155.38 21.72 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.812 -1.181 . . . . 0.25 107.812 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 20.6 p -57.87 119.91 37.78 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 121.453 0.644 . . . . 0.37 111.053 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.594 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 63.5 Cg_endo -72.52 169.11 22.59 Favored 'Trans proline' 0 C--N 1.33 -0.439 0 C-N-CA 124.73 3.62 . . . . 0.64 111.699 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.4 -26.35 52.95 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.003 0.43 . . . . 1.02 110.287 172.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.0 m -69.26 -25.7 64.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.047 -0.524 . . . . 1.58 110.705 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 22.7 t -87.87 142.91 27.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.942 -0.572 . . . . 0.71 109.603 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -94.74 -7.29 41.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.15 0.5 . . . . 2.89 110.57 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -102.75 -173.2 2.27 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.717 -0.674 . . . . 2.59 111.094 -172.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.51 ' HB3' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -130.35 112.43 13.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.818 -0.628 . . . . 1.78 110.046 175.516 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.559 ' CG ' ' HA ' ' A' ' 90' ' ' SER . 2.2 mtm -157.72 141.83 16.01 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 111.71 0.263 . . . . 1.3 111.71 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.923 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 2.8 mp -109.74 162.63 14.27 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.953 0.406 . . . . 0.14 111.151 171.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.514 ' HG2' ' CB ' ' A' ' 88' ' ' MET . 0.0 OUTLIER -154.16 112.64 3.6 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.818 -0.628 . . . . 2.72 109.572 177.57 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.71 ' HG ' HD13 ' A' ' 48' ' ' LEU . 8.4 mt -95.7 117.28 30.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.3 0.571 . . . . 0.9 110.948 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.548 HG23 ' HG2' ' A' ' 86' ' ' ARG . 7.9 mm -87.67 102.95 13.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.412 -0.813 . . . . 0.4 110.704 -174.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -73.74 145.15 34.98 Favored Glycine 0 C--N 1.321 -0.268 0 C-N-CA 119.949 -1.12 . . . . 0.48 110.858 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.478 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 1.6 mptm? -54.5 135.28 46.02 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.382 0.611 . . . . 1.15 111.761 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 114.885 -1.052 . . . . 0.69 110.156 176.987 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.196 0 CA-C-O 121.296 0.569 . . . . 1.78 110.158 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.548 ' HG2' HG23 ' A' ' 63' ' ' ILE . 25.3 mtt180 -119.31 162.33 18.93 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.89 -0.595 . . . . 2.29 111.363 -169.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -124.78 115.24 20.37 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.887 -0.597 . . . . 0.5 110.242 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.514 ' CB ' ' HG2' ' A' ' 61' ' ' ARG . 59.6 ttm -107.07 129.22 54.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.811 -0.177 . . . . 0.42 111.111 -173.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.58 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -119.62 140.43 50.61 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.613 -0.884 . . . . 1.33 108.613 173.888 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.559 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 52.6 m -100.31 126.64 46.66 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.115 0.483 . . . . 0.94 109.768 177.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.923 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 18.8 m-85 -106.55 160.45 15.42 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.792 -0.64 . . . . 1.33 110.649 -173.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -101.99 -6.94 22.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.281 -0.418 . . . . 1.53 110.577 -171.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -148.32 131.27 16.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.358 0.599 . . . . 0.83 110.918 -175.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.51 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 9.2 tpt180 -60.88 -31.47 70.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.697 -1.138 . . . . 2.16 111.269 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 94.4 m -73.15 -57.88 3.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.806 0.336 . . . . 0.4 110.356 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 68.1 t -46.67 -52.67 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.994 -0.548 . . . . 0.29 111.716 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.476 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -66.71 -28.33 68.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.198 -0.455 . . . . 0.29 110.438 -178.203 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.93 -29.96 69.15 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.181 -0.674 . . . . 0.39 109.181 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.628 ' O ' ' HG3' ' A' ' 102' ' ' MET . 19.7 m120 -77.37 -50.03 13.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.988 -1.005 . . . . 1.55 110.083 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.651 HG23 HD11 ' A' ' 18' ' ' ILE . 40.5 mm -56.71 -50.76 73.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.314 -0.857 . . . . 0.13 110.304 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.711 ' HA ' HD21 ' A' ' 48' ' ' LEU . 7.2 ttpp -55.31 -50.78 68.71 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.735 -0.666 . . . . 1.11 111.046 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.628 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.3 ppp? -69.35 -20.95 63.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.118 -0.492 . . . . 1.17 110.646 -174.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.424 HG23 ' CE1' ' A' ' 3' ' ' HIS . 52.7 m -70.98 -56.74 5.55 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.337 0.589 . . . . 0.15 110.093 174.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.923 ' HB2' HD22 ' A' ' 48' ' ' LEU . 13.8 mt -61.2 -55.75 28.6 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.009 -0.996 . . . . 0.13 110.587 -176.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 1.054 ' HG3' HD23 ' A' ' 48' ' ' LEU . 75.3 mt-30 -53.61 -26.46 22.0 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.852 0.686 . . . . 1.45 112.852 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -65.93 -30.87 71.52 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 122.057 0.932 . . . . 0.65 108.933 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.655 HG21 ' HB3' ' A' ' 25' ' ' ALA . 30.1 mt -82.7 -43.81 18.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 113.678 -1.601 . . . . 0.17 110.232 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.1 mt -68.81 -47.12 77.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.546 -0.752 . . . . 0.29 111.174 -175.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.8 m -61.03 -27.61 68.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.581 0.705 . . . . 1.22 109.42 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.54 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 17.0 ttt180 -67.91 -34.18 76.13 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.598 -1.183 . . . . 3.79 109.732 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 . . . . . 0 N--CA 1.446 -0.632 0 CA-C-N 115.992 -0.549 . . . . 0.6 111.435 -178.67 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 261' ' ' PHE . . . . . 0.594 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 1.1 m-85 . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 110.055 -0.35 . . . . 0.95 110.055 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 262' ' ' VAL . . . . . 0.49 ' CG1' ' HB3' ' A' ' 52' ' ' PRO . 13.0 p -144.5 165.72 12.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.882 -0.599 . . . . 1.37 109.452 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 263' ' ' GLU . . . . . 0.432 ' N ' HG22 ' B' ' 262' ' ' VAL . 14.1 tt0 . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 108.279 -1.008 . . . . 2.24 108.279 172.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.509 ' HA ' HG21 ' A' ' 103' ' ' THR . 28.8 m80 . . . . . 0 C--O 1.22 -0.498 0 N-CA-C 112.45 0.537 . . . . 1.85 112.45 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 77.1 p -163.86 137.99 5.72 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.736 0.303 . . . . 0.95 110.249 177.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.19 151.38 10.57 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.431 -1.067 . . . . 0.16 110.431 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.717 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.94 138.16 40.81 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.336 0.568 . . . . 0.43 111.598 -175.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.21 157.1 43.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.13 110.844 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 2.3 mp -91.27 127.06 43.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.185 -0.672 . . . . 0.29 109.185 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.579 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 79.2 t80 -138.51 118.42 13.31 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.845 -0.428 . . . . 0.56 109.845 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 70.49 41.56 0.96 Allowed 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 123.851 0.719 . . . . 1.46 110.494 -176.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? 70.27 9.34 6.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.356 -1.293 . . . . 1.91 111.956 173.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.29 135.59 58.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.745 0.307 . . . . 0.47 110.524 176.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.5 ' HA ' HG13 ' A' ' 8' ' ' ILE . 48.5 t -76.95 120.57 22.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.089 0.471 . . . . 1.02 110.268 176.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.626 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -141.85 -154.44 6.17 Favored Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 115.766 -0.652 . . . . 0.16 112.004 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.717 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.3 mm -126.89 153.4 35.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 121.052 0.453 . . . . 0.19 110.676 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 4' ' ' SER . 0.1 OUTLIER -122.33 133.68 67.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 115.656 -0.702 . . . . 0.16 109.789 178.243 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.34 108.78 7.37 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.02 0.438 . . . . 0.12 111.607 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.661 HD11 HG23 ' A' ' 100' ' ' ILE . 4.0 mp -85.62 113.31 23.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.302 -0.999 . . . . 0.18 108.302 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.478 HD22 ' HB3' ' A' ' 21' ' ' ASP . 2.6 t-20 -116.58 122.66 45.29 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.649 -0.5 . . . . 1.12 109.649 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.441 ' HG2' ' HB1' ' A' ' 25' ' ' ALA . 8.6 mt-10 -108.17 82.86 1.69 Allowed 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 117.144 -1.823 . . . . 0.74 107.38 165.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.478 ' HB3' HD22 ' A' ' 19' ' ' ASN . 23.1 t70 -122.71 -8.6 8.45 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.6 -1.63 . . . . 0.59 106.6 157.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 23' ' ' SER . 14.6 p -101.59 174.2 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 112.182 -2.281 . . . . 0.35 111.707 -158.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.672 ' O ' HG13 ' A' ' 22' ' ' VAL . 11.3 p -54.7 165.67 0.89 Allowed Pre-proline 0 N--CA 1.455 -0.176 0 N-CA-C 107.094 -1.447 . . . . 1.31 107.094 166.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.617 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 11.0 Cg_endo -41.85 126.91 3.52 Favored 'Trans proline' 0 C--N 1.358 1.07 0 CA-C-N 122.037 1.763 . . . . 0.22 111.57 -147.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.684 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -30.29 132.41 0.07 Allowed 'General case' 0 CA--C 1.508 -0.637 0 O-C-N 125.391 1.682 . . . . 0.2 113.596 -158.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.607 ' HB2' HG11 ' A' ' 22' ' ' VAL . 36.4 mt-10 -127.47 140.42 52.16 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.697 -1.138 . . . . 1.26 111.525 -167.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.558 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.5 tt -101.36 144.62 29.95 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.101 -1.444 . . . . 0.15 107.101 175.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.462 ' N ' HD23 ' A' ' 27' ' ' LEU . 18.5 m -132.23 109.19 9.74 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.954 -0.698 . . . . 0.21 110.223 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.579 ' CE2' ' HB3' ' A' ' 9' ' ' PHE . 87.2 t90 -87.04 115.32 24.35 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.723 -0.843 . . . . 0.24 108.723 175.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -121.98 123.41 41.59 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.068 -0.969 . . . . 0.87 108.984 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.427 ' OG ' ' HB3' ' A' ' 36' ' ' LYS . 22.1 m -54.91 144.09 24.02 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.179 -0.304 . . . . 0.75 110.179 -177.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.626 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 19.4 m -55.23 -26.22 38.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.649 -0.705 . . . . 0.39 110.735 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -81.62 -27.5 34.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.887 -0.597 . . . . 2.33 111.196 175.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.99 22.28 18.19 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.708 -0.758 . . . . 0.55 112.849 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -97.51 -72.26 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.082 0.467 . . . . 1.13 110.775 -173.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.427 ' HB3' ' OG ' ' A' ' 31' ' ' SER . 18.7 ttmm -82.53 129.97 35.02 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.497 -0.774 . . . . 2.03 110.345 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 94.2 t -133.33 125.4 50.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.244 -0.435 . . . . 0.55 109.901 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -131.75 121.88 24.93 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.48 -0.327 . . . . 0.69 110.602 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 27' ' ' LEU . 31.4 m -104.38 142.07 35.23 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.683 0.278 . . . . 0.3 111.276 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 31.0 t -116.27 129.01 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 122.696 0.398 . . . . 0.66 111.167 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 45' ' ' ILE . 37.3 t -90.65 108.33 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.244 0.545 . . . . 0.18 109.663 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.598 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -55.26 -29.0 57.19 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.108 -0.951 . . . . 0.12 112.329 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 41.2 t -74.52 -30.44 61.79 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.425 -0.51 . . . . 1.06 110.738 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.6 p -80.07 -11.71 59.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.304 0.573 . . . . 0.2 109.532 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.623 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 39.1 mm -85.97 125.82 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.251 -0.886 . . . . 0.23 110.982 173.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.684 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 24.2 t70 -84.27 -38.95 19.82 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.14 -0.482 . . . . 0.7 111.217 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -143.89 153.59 42.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.927 -0.578 . . . . 1.95 110.053 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.025 HD22 ' HB2' ' A' ' 104' ' ' LEU . 10.7 tp -120.71 144.23 48.34 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.051 -0.722 . . . . 0.14 109.051 168.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.556 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 15.4 mm100 -118.63 157.59 27.1 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.016 -0.993 . . . . 1.49 109.639 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -161.58 141.39 10.35 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.134 -0.939 . . . . 0.25 108.652 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.521 ' HB ' ' CB ' ' A' ' 55' ' ' SER . 38.2 p -47.98 131.83 11.93 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 123.393 0.433 . . . . 0.37 110.877 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.433 ' O ' ' HB3' ' A' ' 55' ' ' SER . 46.7 Cg_endo -66.48 164.94 26.72 Favored 'Trans proline' 0 C--N 1.329 -0.465 0 C-N-CA 123.548 2.832 . . . . 0.64 111.536 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.56 -14.21 60.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.953 0.406 . . . . 1.02 111.027 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 56.5 m -84.59 -23.28 29.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.953 -0.567 . . . . 1.58 110.789 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.521 ' CB ' ' HB ' ' A' ' 51' ' ' THR . 29.3 t -62.33 137.3 58.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.716 -0.674 . . . . 0.71 110.587 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -83.28 -11.94 57.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.384 0.611 . . . . 2.89 110.076 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -109.07 171.58 7.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.237 -0.892 . . . . 2.59 109.485 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.603 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.2 OUTLIER -129.9 112.36 13.47 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.815 -1.18 . . . . 1.78 107.815 -178.297 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.617 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 2.4 mtm -155.75 140.96 17.52 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 119.936 -0.706 . . . . 1.3 112.237 -171.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.812 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 3.2 mp -109.43 161.08 15.65 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.684 -0.689 . . . . 0.14 110.897 170.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.556 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 7.9 ttm180 -154.57 113.85 3.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.67 -0.695 . . . . 2.72 110.273 174.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.746 ' HG ' HD13 ' A' ' 48' ' ' LEU . 10.0 mt -93.67 114.5 26.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.285 0.564 . . . . 0.9 111.249 -177.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.751 HG23 ' HG2' ' A' ' 86' ' ' ARG . 5.9 mm -87.55 108.95 18.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 123.813 0.845 . . . . 0.4 110.567 -173.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.623 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -80.45 141.4 22.89 Favored Glycine 0 C--O 1.227 -0.308 0 C-N-CA 120.286 -0.959 . . . . 0.48 112.048 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.684 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 0.5 OUTLIER -55.69 131.04 45.56 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 117.05 0.425 . . . . 1.15 110.269 179.239 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 C--N 1.319 -0.749 0 CA-C-N 115.899 -0.592 . . . . 0.69 109.718 178.577 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.355 0 CA-C-O 121.842 0.83 . . . . 1.78 110.203 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.751 ' HG2' HG23 ' A' ' 63' ' ' ILE . 34.5 mtt180 -112.26 147.43 36.28 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.136 -0.938 . . . . 2.29 110.112 -174.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -108.57 112.66 25.13 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.596 -0.52 . . . . 0.5 109.596 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 44.7 ttm -107.06 130.71 54.63 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 121.206 -0.198 . . . . 0.42 111.449 -174.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.607 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -121.01 141.91 50.3 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.632 -0.877 . . . . 1.33 108.632 173.577 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.589 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 54.8 m -101.35 124.01 46.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.142 0.496 . . . . 0.94 110.43 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.812 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 5.7 m-85 -107.96 145.79 33.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.657 -0.702 . . . . 1.33 110.244 -175.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -100.17 -2.32 34.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.086 0.47 . . . . 1.53 110.639 -174.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -131.93 124.73 30.02 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.943 -0.572 . . . . 0.83 110.479 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.414 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 28.3 tpt180 -57.36 -35.32 69.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.237 -0.892 . . . . 2.16 111.015 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.6 m -71.78 -56.66 5.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.815 -0.63 . . . . 0.4 110.685 -176.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 85.0 t -45.8 -54.73 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 115.776 -0.647 . . . . 0.29 111.392 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.603 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -64.89 -29.22 70.16 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.678 -0.409 . . . . 0.29 110.955 -177.03 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.409 ' O ' ' HE3' ' A' ' 101' ' ' LYS . 29.5 t70 -71.04 -30.88 67.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.679 0.752 . . . . 0.39 109.22 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.614 ' O ' ' HG3' ' A' ' 102' ' ' MET . 19.5 m120 -78.26 -48.68 15.22 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.627 -1.17 . . . . 1.55 109.967 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.661 HG23 HD11 ' A' ' 18' ' ' ILE . 41.3 mm -58.51 -50.37 79.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.232 -0.894 . . . . 0.13 110.49 177.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.797 ' HA ' HD21 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -56.36 -48.7 76.28 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.161 -0.472 . . . . 1.11 111.023 178.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.614 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.1 ppp? -69.28 -23.36 63.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.146 0.498 . . . . 1.17 110.159 -175.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.509 HG21 ' HA ' ' A' ' 3' ' ' HIS . 54.9 m -67.64 -52.32 39.56 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.603 -0.726 . . . . 0.15 110.057 175.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.025 ' HB2' HD22 ' A' ' 48' ' ' LEU . 12.6 mt -70.87 -57.65 4.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.157 -0.929 . . . . 0.13 111.585 -173.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 1.008 ' HG3' HD23 ' A' ' 48' ' ' LEU . 9.5 mt-30 -50.78 -28.22 8.84 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.679 0.622 . . . . 1.45 112.679 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -65.02 -45.84 83.84 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.788 -0.819 . . . . 0.65 108.788 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.684 HG21 ' HB3' ' A' ' 25' ' ' ALA . 72.0 mt -63.21 -43.8 98.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.029 -1.441 . . . . 0.17 110.93 176.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.2 mt -62.4 -61.2 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.522 -0.763 . . . . 0.29 111.112 -174.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.7 m -52.99 -28.14 22.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.99 0.424 . . . . 1.22 111.261 173.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -71.98 -35.58 69.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.184 0.516 . . . . 3.79 110.665 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' A' ' 24' ' ' PRO . 12.8 m-85 . . . . . 0 C--N 1.323 -0.587 0 CA-C-N 115.752 -0.658 . . . . 0.6 112.208 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 261' ' ' PHE . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 5.7 m-30 . . . . . 0 N--CA 1.456 -0.173 0 N-CA-C 109.439 -0.578 . . . . 0.95 109.439 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 27.9 m -136.09 169.53 20.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.564 -0.532 . . . . 1.37 109.564 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.648 0 C-N-CA 120.503 -0.479 . . . . 2.24 110.715 173.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.585 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.161 0 CA-C-O 120.857 0.36 . . . . 1.85 111.392 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.0 m -160.75 149.54 16.64 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.395 -0.594 . . . . 0.95 109.395 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.23 150.07 7.67 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.561 -1.016 . . . . 0.16 110.561 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.735 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -76.62 139.29 40.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 117.49 0.645 . . . . 0.43 111.416 -175.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.79 158.05 43.88 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.216 0.531 . . . . 0.13 111.119 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.567 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.1 mp -99.55 129.7 49.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.284 -0.636 . . . . 0.29 109.284 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.586 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 85.3 t80 -138.56 116.0 11.24 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.263 -0.426 . . . . 0.56 109.941 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 67.56 42.65 2.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.436 0.636 . . . . 1.46 110.739 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt 68.99 10.51 7.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.327 -1.306 . . . . 1.91 112.484 173.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -113.53 132.24 63.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.996 0.427 . . . . 0.47 110.311 173.213 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.567 ' HA ' HG13 ' A' ' 8' ' ' ILE . 32.6 t -77.75 117.68 19.37 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.833 -0.621 . . . . 1.02 109.952 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.661 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -137.23 -157.33 7.58 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.928 -0.653 . . . . 0.16 112.141 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.735 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 9.3 mm -127.04 153.42 36.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 120.827 0.346 . . . . 0.19 110.795 -176.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.466 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -123.95 132.8 70.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 115.883 -0.599 . . . . 0.16 109.675 179.022 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.93 109.54 7.47 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.109 0.411 . . . . 0.12 112.109 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.62 HD11 HG23 ' A' ' 100' ' ' ILE . 4.0 mp -85.38 103.43 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.001 -0.74 . . . . 0.18 109.001 171.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.435 HD22 ' CB ' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -110.44 129.6 55.74 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.724 -0.39 . . . . 1.12 110.202 -179.078 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -107.78 84.19 1.92 Allowed 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 116.811 -1.956 . . . . 0.74 107.345 164.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.435 ' CB ' HD22 ' A' ' 19' ' ' ASN . 17.2 t70 -121.77 -10.72 8.69 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 106.568 -1.641 . . . . 0.59 106.568 156.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.712 HG11 ' HB2' ' A' ' 26' ' ' GLU . 13.6 p -101.56 179.35 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 111.946 -2.388 . . . . 0.35 111.19 -157.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.643 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -52.44 167.2 0.38 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 117.974 -1.012 . . . . 1.31 108.338 168.019 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.582 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 15.8 Cg_endo -44.36 126.17 6.47 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.494 1.463 . . . . 0.22 111.525 -156.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.598 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -25.67 132.76 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.99 1.431 . . . . 0.2 114.725 -151.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.712 ' HB2' HG11 ' A' ' 22' ' ' VAL . 39.7 mt-10 -124.99 139.46 53.8 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.201 -0.909 . . . . 1.26 110.929 -172.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.577 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.1 tt -101.31 143.28 31.55 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 106.831 -1.544 . . . . 0.15 106.831 175.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.402 ' N ' HD23 ' A' ' 27' ' ' LEU . 6.6 m -130.17 108.99 10.46 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.688 -0.805 . . . . 0.21 110.519 -178.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.638 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 89.8 t90 -86.63 113.01 22.15 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.471 0.653 . . . . 0.24 109.417 174.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -120.47 120.78 36.88 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.173 -0.921 . . . . 0.87 109.157 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.46 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 20.1 m -55.9 141.35 39.55 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.771 -0.455 . . . . 0.75 109.771 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.661 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 28.8 m -54.15 -31.84 53.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.31 -0.859 . . . . 0.39 111.018 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -89.6 -9.21 50.6 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.236 -0.438 . . . . 2.33 111.599 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.01 18.8 57.29 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.979 -0.629 . . . . 0.55 112.553 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -72.46 -68.38 0.48 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.338 . . . . 1.13 111.527 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -110.0 152.29 26.09 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.217 0.532 . . . . 2.03 111.626 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 85.2 t -138.06 117.74 15.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.283 -0.871 . . . . 0.55 109.877 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -123.74 113.66 18.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.191 -0.459 . . . . 0.69 110.148 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.7 m -100.69 143.72 30.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.664 -0.243 . . . . 0.3 111.027 -175.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.592 HG11 HD13 ' A' ' 62' ' ' LEU . 43.1 t -117.69 128.24 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 111.797 0.295 . . . . 0.66 111.797 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 45' ' ' ILE . 33.3 t -90.63 107.93 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.279 0.561 . . . . 0.18 109.61 173.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.608 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.9 mm? -54.44 -29.83 50.78 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.806 -1.088 . . . . 0.12 112.565 -177.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.582 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 72.5 m -74.4 -34.77 63.38 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.514 -0.475 . . . . 1.06 111.46 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -74.62 -16.51 60.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.483 0.658 . . . . 0.2 109.468 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.589 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 43.3 mm -75.44 118.3 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 115.156 -0.929 . . . . 0.23 111.551 175.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.618 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 11.1 t70 -74.74 -49.59 20.5 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.423 -0.808 . . . . 0.7 111.237 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -134.09 150.92 51.19 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 116.765 -0.198 . . . . 1.95 110.58 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.92 HD22 ' HB2' ' A' ' 104' ' ' LEU . 12.3 tp -115.92 143.18 45.79 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.985 -0.746 . . . . 0.14 108.985 164.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.55 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 7.2 mt-30 -124.24 152.19 43.26 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.09 -0.959 . . . . 1.49 109.603 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.03 143.3 10.8 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.737 -0.838 . . . . 0.25 108.737 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 40.9 p -47.48 127.09 10.2 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-O 121.565 0.698 . . . . 0.37 111.025 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 61.4 Cg_endo -70.17 166.68 27.3 Favored 'Trans proline' 0 C--N 1.33 -0.402 0 C-N-CA 124.152 3.235 . . . . 0.64 112.015 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.85 -29.51 59.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.903 0.382 . . . . 1.02 110.896 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.4 m -69.62 -25.59 64.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.96 -0.563 . . . . 1.58 111.156 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.483 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 37.6 t -74.78 137.31 41.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.974 -0.557 . . . . 0.71 110.09 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -91.54 -0.07 57.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.669 0.747 . . . . 2.89 109.582 175.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.3 mmmt -107.98 176.55 5.1 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.946 -1.024 . . . . 2.59 109.985 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.555 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -137.15 109.48 7.34 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.108 -0.701 . . . . 1.78 109.108 -178.166 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.603 ' HG2' ' HA ' ' A' ' 90' ' ' SER . 68.0 mtm -157.09 140.71 15.89 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.478 0.18 . . . . 1.3 111.102 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.871 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 1.4 mp -110.15 160.05 16.82 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.23 -0.441 . . . . 0.14 111.074 174.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 21.8 ttt180 -153.31 114.88 4.23 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 121.208 0.528 . . . . 2.72 111.456 169.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.748 ' HG ' HD13 ' A' ' 48' ' ' LEU . 8.9 mt -92.86 110.19 21.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.864 -0.607 . . . . 0.9 110.813 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.579 HG23 ' HB3' ' A' ' 86' ' ' ARG . 3.9 mm -87.55 126.28 41.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 123.111 0.564 . . . . 0.4 110.456 -176.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -87.6 152.28 23.98 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.33 -0.938 . . . . 0.48 111.019 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.618 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 10.2 mptt -59.01 136.06 57.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.01 0.405 . . . . 1.15 110.394 178.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 115.774 -0.648 . . . . 0.69 109.743 177.913 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 . . . . . 0 N--CA 1.449 -0.515 0 N-CA-C 108.825 -0.805 . . . . 1.78 108.825 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.579 ' HB3' HG23 ' A' ' 63' ' ' ILE . 9.6 ptt180 -156.55 160.03 39.1 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.962 -0.563 . . . . 2.29 111.669 -166.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -120.29 111.44 17.78 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.594 -0.73 . . . . 0.5 110.058 -172.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 49.2 ttm -107.51 126.92 53.13 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.501 -0.124 . . . . 0.42 110.914 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.442 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 50.7 m-85 -116.19 143.72 45.13 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.647 -0.872 . . . . 1.33 108.647 174.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.603 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 14.9 m -99.11 123.7 43.6 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.974 0.416 . . . . 0.94 110.197 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.871 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 7.5 m-85 -108.52 157.17 18.71 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.064 -0.517 . . . . 1.33 110.246 -176.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -113.67 -6.34 13.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.904 0.383 . . . . 1.53 111.239 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -128.3 124.33 36.25 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.2 0.524 . . . . 0.83 110.145 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.436 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 29.8 tpt180 -57.24 -36.75 71.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.961 -1.018 . . . . 2.16 111.175 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 85.2 m -74.04 -55.42 6.14 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.7 -0.682 . . . . 0.4 110.83 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 100' ' ' ILE . 88.4 t -46.05 -55.21 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.29 111.352 175.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.555 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -66.88 -28.34 68.24 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.895 -0.322 . . . . 0.29 110.808 -177.431 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.15 -31.87 70.83 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.049 -0.723 . . . . 0.39 109.049 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.602 ' O ' ' HG3' ' A' ' 102' ' ' MET . 20.6 m120 -77.78 -46.31 22.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.559 -1.2 . . . . 1.55 109.726 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.62 HG23 HD11 ' A' ' 18' ' ' ILE . 35.4 mm -58.6 -51.54 70.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.104 -0.953 . . . . 0.13 110.393 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.64 ' HA ' HD21 ' A' ' 48' ' ' LEU . 4.1 ttpt -57.01 -51.39 69.46 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.886 -0.597 . . . . 1.11 110.429 178.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.602 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.3 ppp? -64.94 -25.18 67.77 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.903 0.383 . . . . 1.17 110.716 -175.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.412 HG21 ' HB ' ' A' ' 18' ' ' ILE . 35.7 m -66.02 -51.62 56.65 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.452 0.644 . . . . 0.15 110.128 175.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.92 ' HB2' HD22 ' A' ' 48' ' ' LEU . 8.7 mt -70.09 -55.95 8.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.88 -1.055 . . . . 0.13 110.927 -175.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.763 ' HG2' HD23 ' A' ' 48' ' ' LEU . 18.7 mm-40 -42.92 -36.15 1.43 Allowed 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.694 0.621 . . . . 1.45 112.664 177.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -65.42 -32.97 74.88 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.919 0.866 . . . . 0.65 109.663 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.598 HG21 ' HB3' ' A' ' 25' ' ' ALA . 42.0 mt -79.69 -41.79 22.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.066 -1.424 . . . . 0.17 110.123 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.401 HG13 ' HA ' ' A' ' 105' ' ' GLN . 0.6 OUTLIER -66.63 -51.34 57.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.248 -0.887 . . . . 0.29 110.87 -176.629 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.6 t -59.41 -29.03 67.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.411 0.624 . . . . 1.22 109.509 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 10.6 ttt180 -66.3 -34.19 77.44 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.043 -0.98 . . . . 3.79 109.949 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 . . . . . 0 N--CA 1.446 -0.653 0 CA-C-N 116.047 -0.524 . . . . 0.6 111.472 -177.676 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 261' ' ' PHE . . . . . 0.55 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 1.5 m-85 . . . . . 0 N--CA 1.455 -0.194 0 N-CA-C 109.419 -0.586 . . . . 0.95 109.419 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.85 161.74 23.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.864 0.364 . . . . 1.37 111.824 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 115.818 -0.628 . . . . 2.24 109.478 175.785 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.438 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 13.9 m80 . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 121.34 0.59 . . . . 1.85 110.077 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.3 p -162.94 151.31 14.14 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.555 -0.748 . . . . 0.95 109.278 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.5 146.98 7.06 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.9 -0.88 . . . . 0.16 110.9 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.743 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -79.39 117.26 20.2 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 117.209 0.505 . . . . 0.43 111.296 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.503 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -125.23 155.95 39.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.349 0.595 . . . . 0.13 111.513 -177.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.501 HG13 ' HA ' ' A' ' 13' ' ' SER . 1.9 mp -96.42 119.59 44.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 108.611 -0.885 . . . . 0.29 108.611 176.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.441 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 93.2 t80 -119.47 102.82 8.93 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.518 -0.31 . . . . 0.56 110.263 -177.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 65.51 55.33 1.04 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.317 0.58 . . . . 1.46 110.939 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt 72.38 -4.81 1.94 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.641 -1.163 . . . . 1.91 113.304 171.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -103.99 130.24 54.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.939 0.399 . . . . 0.47 110.488 172.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.501 ' HA ' HG13 ' A' ' 8' ' ' ILE . 32.4 t -78.43 129.4 34.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.882 -0.599 . . . . 1.02 109.953 177.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.618 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -150.68 -159.84 9.02 Favored Glycine 0 N--CA 1.436 -1.321 0 C-N-CA 120.752 -0.737 . . . . 0.16 112.494 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.743 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 6.4 mm -125.97 153.24 33.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 120.768 0.318 . . . . 0.19 110.583 -177.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.89 135.12 63.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 116.114 -0.494 . . . . 0.16 109.861 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.19 110.57 7.44 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.207 0.447 . . . . 0.12 112.207 176.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.619 HD11 HG23 ' A' ' 100' ' ' ILE . 3.7 mp -86.08 121.44 37.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.667 -0.864 . . . . 0.18 108.667 171.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -126.7 134.28 50.72 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.699 -0.482 . . . . 1.12 109.699 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.512 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 18.0 mt-10 -114.99 83.15 1.86 Allowed 'General case' 0 N--CA 1.425 -1.723 0 C-N-CA 116.513 -2.075 . . . . 0.74 107.663 161.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -121.32 -9.79 9.02 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 106.168 -1.79 . . . . 0.59 106.168 159.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.893 HG11 ' HB3' ' A' ' 26' ' ' GLU . 13.2 p -103.52 173.82 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 111.583 -2.553 . . . . 0.35 111.821 -159.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.697 ' O ' HG13 ' A' ' 22' ' ' VAL . 16.3 m -55.08 166.28 0.85 Allowed Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 106.692 -1.596 . . . . 1.31 106.692 165.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 10.1 Cg_endo -40.55 128.06 2.44 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 121.601 1.608 . . . . 0.22 111.775 -147.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.711 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -28.2 132.78 0.04 OUTLIER 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 125.466 1.729 . . . . 0.2 113.217 -160.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.893 ' HB3' HG11 ' A' ' 22' ' ' VAL . 35.4 tt0 -130.58 132.04 45.32 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 115.229 -0.896 . . . . 1.26 111.244 -161.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.558 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.5 tt -100.83 144.94 29.18 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 106.94 -1.504 . . . . 0.15 106.94 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.505 ' N ' HD23 ' A' ' 27' ' ' LEU . 9.8 m -133.22 108.91 9.07 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.161 -0.616 . . . . 0.21 110.274 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.595 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.3 t90 -89.87 109.8 20.78 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.647 0.737 . . . . 0.24 109.056 176.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 30' ' ' ARG . 13.1 ttt-85 -113.35 121.35 44.09 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.132 -0.94 . . . . 0.87 109.236 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.48 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 88.9 p -57.33 148.02 24.13 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.078 -0.342 . . . . 0.75 110.078 -177.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.618 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 33.4 m -48.42 -38.13 18.85 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.084 0.468 . . . . 0.39 110.618 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -68.32 -28.03 66.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.628 -0.715 . . . . 2.33 111.642 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.74 21.55 46.68 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.034 -0.603 . . . . 0.55 112.068 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -104.91 -37.43 7.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.324 0.583 . . . . 1.13 110.816 -172.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -114.61 120.65 40.9 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.587 -0.733 . . . . 2.03 109.998 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.5 t -123.52 118.91 55.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.992 0.425 . . . . 0.55 110.348 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -119.41 109.96 16.38 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.98 -0.555 . . . . 0.69 110.237 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.9 m -95.69 143.32 27.05 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.471 -0.331 . . . . 0.3 111.448 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.586 HG11 HD13 ' A' ' 62' ' ' LEU . 30.1 t -120.83 124.37 72.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.295 -0.411 . . . . 0.66 111.16 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 45' ' ' ILE . 49.1 t -90.54 107.75 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 109.282 -0.636 . . . . 0.18 109.282 174.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.59 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.4 mm? -51.92 -29.09 18.66 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.957 -1.019 . . . . 0.12 112.67 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.455 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 43.1 t -71.8 -35.59 70.02 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.583 -0.447 . . . . 1.06 110.803 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.2 p -76.36 -13.82 60.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.081 0.467 . . . . 0.2 109.857 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.652 HG21 HD22 ' A' ' 62' ' ' LEU . 46.6 mm -79.84 121.17 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.579 -0.737 . . . . 0.23 111.391 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.638 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 34.0 t70 -81.78 -40.56 22.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.538 0.685 . . . . 0.7 110.881 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.597 ' HB2' ' CG1' ' A' ' 63' ' ' ILE . 46.0 mmtm -136.27 142.34 43.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.103 -0.953 . . . . 1.95 110.932 -172.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.027 HD23 ' HG3' ' A' ' 105' ' ' GLN . 12.7 tp -118.0 138.04 52.46 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.457 0.646 . . . . 0.14 109.302 164.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 14.0 mm100 -119.28 157.19 28.57 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.456 -1.247 . . . . 1.49 109.277 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -160.33 148.92 16.86 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.517 -1.29 . . . . 0.25 107.517 177.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 27.4 p -52.77 126.91 42.43 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 121.377 0.608 . . . . 0.37 111.083 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 50.1 Cg_endo -67.46 165.63 26.5 Favored 'Trans proline' 0 C--N 1.329 -0.461 0 C-N-CA 123.584 2.856 . . . . 0.64 111.068 176.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.34 -23.04 66.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.125 0.488 . . . . 1.02 110.353 176.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.3 m -73.74 -24.91 59.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.679 -0.691 . . . . 1.58 111.346 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.479 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 36.3 t -71.41 145.17 49.49 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.882 -0.414 . . . . 0.71 109.882 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -90.55 -6.05 55.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.272 0.558 . . . . 2.89 109.95 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -111.67 174.44 5.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.201 -0.909 . . . . 2.59 109.997 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.672 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 3.5 mmt -131.38 108.76 9.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.174 -0.676 . . . . 1.78 109.174 176.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.52 ' HG3' ' H ' ' A' ' 91' ' ' PHE . 3.9 mpp? -154.42 168.1 27.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.08 0.467 . . . . 1.3 111.666 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.555 HD23 HD11 ' A' ' 48' ' ' LEU . 1.1 mp -126.52 161.32 28.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.339 -0.846 . . . . 0.14 111.001 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 50.0 ttp180 -153.54 114.38 4.07 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.607 0.241 . . . . 2.72 110.986 169.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.652 HD22 HG21 ' A' ' 45' ' ' ILE . 12.6 mt -94.43 109.33 21.2 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.702 0.401 . . . . 0.9 110.942 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.726 HG23 ' HB3' ' A' ' 86' ' ' ARG . 1.0 OUTLIER -87.4 118.97 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 123.041 0.536 . . . . 0.4 110.081 -176.507 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -80.87 152.56 33.4 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.98 -1.105 . . . . 0.48 111.369 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.638 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 6.9 mptt -63.63 139.24 58.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.109 0.454 . . . . 1.15 110.306 176.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 C--N 1.318 -0.766 0 N-CA-C 109.007 -0.738 . . . . 0.69 109.007 172.266 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 122.352 1.072 . . . . 1.78 109.553 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.726 ' HB3' HG23 ' A' ' 63' ' ' ILE . 9.2 ptt180 -113.77 146.02 40.52 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.626 -1.17 . . . . 2.29 110.063 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -113.2 111.85 22.78 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.324 -0.853 . . . . 0.5 109.61 -170.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 53.9 ttm -104.43 126.03 51.15 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.237 -0.585 . . . . 0.42 111.395 -176.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.481 ' CE2' HD12 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -115.65 122.36 45.35 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 109.004 -0.739 . . . . 1.33 109.004 178.114 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.497 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 16.1 m -89.56 124.04 34.18 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.835 -0.621 . . . . 0.94 110.379 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.6 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 30.5 m-85 -107.29 174.15 6.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.042 -0.526 . . . . 1.33 109.753 174.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -122.56 -5.33 8.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.256 -0.429 . . . . 1.53 110.126 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -127.82 135.4 50.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.446 0.641 . . . . 0.83 111.135 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.527 ' N ' ' HG3' ' A' ' 58' ' ' MET . 28.0 tpt180 -65.84 -35.18 79.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.531 -1.213 . . . . 2.16 111.102 -174.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 94.7 m -76.27 -52.96 8.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.831 -0.622 . . . . 0.4 111.112 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.3 t -45.29 -56.73 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 116.276 -0.42 . . . . 0.29 111.437 175.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.672 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -66.56 -29.25 69.27 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.194 -0.457 . . . . 0.29 110.718 -178.104 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -66.71 -33.47 75.71 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.121 -0.696 . . . . 0.39 109.121 176.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.584 ' O ' ' HG3' ' A' ' 102' ' ' MET . 18.0 m120 -75.23 -50.9 14.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.651 -1.159 . . . . 1.55 109.808 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.619 HG23 HD11 ' A' ' 18' ' ' ILE . 35.2 mm -56.59 -52.27 55.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.037 -0.983 . . . . 0.13 110.685 177.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.667 ' HA ' HD21 ' A' ' 48' ' ' LEU . 4.9 ttpt -55.82 -49.16 74.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.723 -0.672 . . . . 1.11 111.321 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.584 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.2 ppp? -68.88 -24.15 64.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.847 0.356 . . . . 1.17 110.444 -176.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 55.2 m -67.58 -51.81 46.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.436 0.636 . . . . 0.15 110.027 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.896 ' HB2' HD22 ' A' ' 48' ' ' LEU . 10.6 mt -68.02 -56.39 9.09 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.989 -1.005 . . . . 0.13 111.187 -175.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 1.027 ' HG3' HD23 ' A' ' 48' ' ' LEU . 70.9 mt-30 -46.44 -31.62 2.79 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.207 0.818 . . . . 1.45 113.207 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -68.78 -27.93 66.33 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.048 0.927 . . . . 0.65 109.692 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.711 HG21 ' HB3' ' A' ' 25' ' ' ALA . 64.8 mt -83.58 -43.68 18.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.008 -1.451 . . . . 0.17 110.148 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.414 HG13 ' HA ' ' A' ' 105' ' ' GLN . 0.8 OUTLIER -62.38 -53.56 45.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.975 -1.011 . . . . 0.29 110.28 -177.156 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.8 t -59.05 -28.07 66.1 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.682 -0.69 . . . . 1.22 110.001 176.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.446 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 11.3 ttt180 -69.47 -34.35 74.22 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.202 -0.908 . . . . 3.79 110.051 178.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 . . . . . 0 N--CA 1.446 -0.647 0 CA-C-N 115.527 -0.76 . . . . 0.6 111.319 -178.432 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 261' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 5.9 m-30 . . . . . 0 C--O 1.235 0.313 0 N-CA-C 109.323 -0.621 . . . . 0.95 109.323 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.3 p -134.99 152.83 33.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.162 -0.31 . . . . 1.37 110.162 -177.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 C--N 1.327 -0.408 0 N-CA-C 109.109 -0.7 . . . . 2.24 109.109 172.466 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 . . . . . 0 CA--C 1.523 -0.063 0 CA-C-O 121.241 0.544 . . . . 1.85 110.397 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.5 p -163.98 149.06 10.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.639 -0.71 . . . . 0.95 110.034 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.95 143.12 5.66 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 111.119 -0.792 . . . . 0.16 111.119 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.74 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.31 121.72 22.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 117.468 0.634 . . . . 0.43 111.047 -177.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.508 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -131.59 157.22 44.22 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 121.327 0.584 . . . . 0.13 111.697 -176.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 2.5 mp -95.08 114.58 31.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.477 -0.783 . . . . 0.29 109.291 175.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.608 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 74.8 t80 -122.58 111.32 16.65 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.191 -0.459 . . . . 0.56 110.031 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.509 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 40.3 mt-10 71.61 47.35 0.35 Allowed 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 124.072 0.857 . . . . 1.46 110.623 -176.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.509 ' HD2' ' C ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER 65.79 8.97 5.65 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.522 -1.217 . . . . 1.91 112.658 173.664 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.38 135.2 57.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.869 0.366 . . . . 0.47 110.436 174.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.522 ' HA ' HG13 ' A' ' 8' ' ' ILE . 23.7 t -78.25 124.99 28.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.289 0.566 . . . . 1.02 110.219 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.679 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -146.85 -156.7 7.04 Favored Glycine 0 N--CA 1.437 -1.26 0 CA-C-N 115.654 -0.703 . . . . 0.16 112.341 -178.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.74 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.1 mm -126.95 153.8 36.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.799 0.333 . . . . 0.19 110.582 -177.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.437 HD11 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -126.86 133.34 68.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 116.026 -0.534 . . . . 0.16 109.91 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.35 113.13 9.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.34 -0.391 . . . . 0.12 111.618 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.607 HD11 HG23 ' A' ' 100' ' ' ILE . 4.1 mp -84.43 121.76 37.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.002 -1.11 . . . . 0.18 108.002 171.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.437 HD22 ' HB3' ' A' ' 21' ' ' ASP . 3.5 t-20 -126.26 125.84 43.02 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.99 -0.374 . . . . 1.12 109.99 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.485 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 20.8 mt-10 -110.6 83.9 1.84 Allowed 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 116.928 -1.909 . . . . 0.74 107.616 163.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.437 ' HB3' HD22 ' A' ' 19' ' ' ASN . 13.7 t70 -120.87 -8.74 9.37 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.001 -1.851 . . . . 0.59 106.001 157.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.693 HG13 ' O ' ' A' ' 23' ' ' SER . 14.9 p -102.46 173.76 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 111.75 -2.477 . . . . 0.35 111.982 -158.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.693 ' O ' HG13 ' A' ' 22' ' ' VAL . 4.4 m -54.51 168.1 0.51 Allowed Pre-proline 0 C--O 1.223 -0.319 0 N-CA-C 106.853 -1.536 . . . . 1.31 106.853 165.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 10.2 Cg_endo -40.86 127.81 2.64 Favored 'Trans proline' 0 C--N 1.356 0.938 0 CA-C-N 122.016 1.756 . . . . 0.22 111.239 -152.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.692 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -33.9 136.23 0.12 Allowed 'General case' 0 CA--C 1.504 -0.793 0 O-C-N 125.361 1.663 . . . . 0.2 113.621 -156.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.519 ' HB2' HG11 ' A' ' 22' ' ' VAL . 74.3 mt-10 -124.8 140.29 53.07 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.387 -1.279 . . . . 1.26 111.191 -169.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.578 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.2 tt -101.58 142.41 32.99 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.419 -1.697 . . . . 0.15 106.419 172.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.41 ' N ' HD23 ' A' ' 27' ' ' LEU . 11.1 m -127.33 109.2 11.55 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.782 -0.767 . . . . 0.21 110.254 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.617 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.9 t90 -88.44 106.14 18.07 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.814 -0.81 . . . . 0.24 108.814 175.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -114.17 112.02 22.51 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.759 -1.11 . . . . 0.87 108.745 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.579 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 93.7 p -57.69 146.03 32.27 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.406 0.622 . . . . 0.75 110.85 -174.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.679 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 7.9 m -57.59 -24.51 56.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.707 -1.133 . . . . 0.39 111.236 -175.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -87.92 -27.42 22.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.892 -0.595 . . . . 2.33 111.129 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.78 21.96 27.17 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.715 -0.755 . . . . 0.55 113.443 176.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -110.2 -9.06 14.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.291 0.545 . . . . 1.13 110.833 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -139.92 119.07 12.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.913 -0.585 . . . . 2.03 109.96 -174.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 57.8 t -135.09 124.02 41.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.805 0.336 . . . . 0.55 110.712 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -130.14 122.17 27.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.309 -0.405 . . . . 0.69 110.589 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 24.5 m -102.43 134.93 44.95 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.664 0.268 . . . . 0.3 110.919 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.537 HG11 HD13 ' A' ' 62' ' ' LEU . 42.2 t -106.76 128.06 61.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 122.415 0.286 . . . . 0.66 111.52 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.496 ' O ' HG12 ' A' ' 45' ' ' ILE . 41.1 t -90.09 108.12 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-O 121.465 0.65 . . . . 0.18 109.595 173.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.573 HD11 HD22 ' A' ' 104' ' ' LEU . 1.7 mm? -53.76 -29.96 42.28 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.016 -0.993 . . . . 0.12 112.164 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.427 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 41.4 t -71.75 -35.54 70.15 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.965 -0.294 . . . . 1.06 110.672 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.418 ' OG1' ' HB ' ' A' ' 41' ' ' VAL . 66.8 p -77.1 -14.89 59.74 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 121.104 0.478 . . . . 0.2 110.12 176.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.578 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 41.4 mm -79.46 124.66 37.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.684 -0.689 . . . . 0.23 111.387 175.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.601 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 33.3 t70 -79.36 -48.16 14.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.969 -0.56 . . . . 0.7 110.737 176.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HB2' HG13 ' A' ' 63' ' ' ILE . 70.9 mmtt -135.31 149.26 49.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.728 -0.669 . . . . 1.95 110.543 -177.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.957 HD23 ' HG3' ' A' ' 105' ' ' GLN . 11.6 tp -112.92 145.24 41.1 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.086 -0.709 . . . . 0.14 109.086 164.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.481 ' H ' HD12 ' A' ' 48' ' ' LEU . 80.8 mm-40 -122.59 153.34 39.42 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.071 -0.968 . . . . 1.49 109.896 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.69 143.79 10.02 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.451 -0.795 . . . . 0.25 109.491 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 49.4 p -60.7 125.38 82.66 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-O 121.486 0.66 . . . . 0.37 111.065 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 60.6 Cg_endo -70.96 165.94 30.71 Favored 'Trans proline' 0 C--N 1.329 -0.465 0 C-N-CA 123.727 2.951 . . . . 0.64 111.285 175.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.9 -17.61 61.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.215 0.531 . . . . 1.02 110.617 176.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.7 m -77.2 -25.25 51.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.739 -0.664 . . . . 1.58 110.558 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.444 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 46.5 t -72.86 150.94 42.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.653 -0.703 . . . . 0.71 109.69 177.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -95.44 -2.85 48.02 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.586 0.708 . . . . 2.89 109.657 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HB2' HG21 ' A' ' 51' ' ' THR . 20.9 mmmt -107.05 -179.25 3.88 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.824 -1.08 . . . . 2.59 110.414 -175.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.479 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -136.97 110.22 7.83 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.278 -1.008 . . . . 1.78 108.278 169.52 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.621 ' HB3' ' CZ ' ' B' ' 261' ' ' PHE . 3.1 ttm -156.24 148.77 23.69 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.384 -0.527 . . . . 1.3 111.825 -173.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.524 HD23 HD11 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -117.7 157.22 26.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.437 -0.801 . . . . 0.14 110.479 173.974 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 62.8 ttp180 -151.58 114.18 4.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.708 0.29 . . . . 2.72 110.756 169.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.706 ' HG ' HD13 ' A' ' 48' ' ' LEU . 10.5 mt -92.3 112.58 24.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.1 0.476 . . . . 0.9 110.61 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.715 HG23 ' HG2' ' A' ' 86' ' ' ARG . 4.4 mm -87.22 113.85 25.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 123.55 0.74 . . . . 0.4 110.95 -175.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -79.41 141.0 23.41 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.122 -1.037 . . . . 0.48 111.579 176.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.601 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 7.2 mptt -54.46 134.28 45.95 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.964 0.382 . . . . 1.15 110.983 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--N 1.321 -0.665 0 N-CA-C 109.58 -0.526 . . . . 0.69 109.58 177.506 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.232 0 CA-C-O 121.442 0.639 . . . . 1.78 110.03 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.715 ' HG2' HG23 ' A' ' 63' ' ' ILE . 13.6 mtm180 -117.1 146.47 43.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.613 -0.721 . . . . 2.29 110.217 -172.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -111.13 111.98 23.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.58 -0.736 . . . . 0.5 109.414 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.541 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 50.4 ttm -106.64 129.51 54.54 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.049 0.452 . . . . 0.42 111.372 -176.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.437 ' CG ' HD11 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -120.03 122.68 41.65 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.719 -0.673 . . . . 1.33 109.338 178.028 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.556 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 20.3 m -88.74 128.23 35.62 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.022 -0.536 . . . . 0.94 110.45 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.594 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 27.8 m-85 -107.82 173.61 6.24 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.879 -0.6 . . . . 1.33 110.629 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -119.05 -0.05 11.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.704 -0.68 . . . . 1.53 110.107 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -141.17 128.47 21.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.926 -0.579 . . . . 0.83 109.96 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.478 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 2.5 tmt_? -69.61 -24.4 63.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.546 . . . . 2.16 110.371 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.43 HG22 HD21 ' A' ' 99' ' ' ASN . 91.2 m -69.4 -57.19 5.59 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.118 -0.327 . . . . 0.4 110.118 177.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 98.2 t -45.62 -56.38 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 115.955 -0.566 . . . . 0.29 111.384 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.476 ' HG2' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -65.02 -28.63 69.63 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 116.021 -0.536 . . . . 0.29 110.882 -177.566 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.42 -32.47 71.46 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.196 -0.668 . . . . 0.39 109.196 176.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.43 HD21 HG22 ' A' ' 95' ' ' THR . 90.7 m-20 -74.09 -49.25 24.8 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.721 -1.127 . . . . 1.55 109.501 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.607 HG23 HD11 ' A' ' 18' ' ' ILE . 34.1 mm -58.49 -53.07 51.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.945 -1.025 . . . . 0.13 110.427 175.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.705 ' HA ' HD21 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -55.3 -48.85 73.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.335 -0.848 . . . . 1.11 111.344 179.133 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.411 ' N ' ' HE2' ' A' ' 101' ' ' LYS . 12.8 ptt? -68.8 -24.99 64.47 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.63 -0.428 . . . . 1.17 110.191 -175.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 41.6 m -66.59 -49.78 65.23 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.427 0.632 . . . . 0.15 109.922 175.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.932 ' HB2' HD22 ' A' ' 48' ' ' LEU . 12.9 mt -69.94 -57.4 5.07 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.986 -1.006 . . . . 0.13 111.715 -174.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.957 ' HG3' HD23 ' A' ' 48' ' ' LEU . 46.2 mt-30 -51.51 -27.51 10.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.833 0.679 . . . . 1.45 112.833 -178.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -71.29 -30.13 65.89 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.056 0.931 . . . . 0.65 109.472 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.692 HG21 ' HB3' ' A' ' 25' ' ' ALA . 61.6 mt -75.88 -42.78 39.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 114.141 -1.39 . . . . 0.17 109.775 172.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.4 mt -67.39 -43.1 87.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.731 -0.668 . . . . 0.29 110.624 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.3 m -60.61 -29.1 69.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.366 0.603 . . . . 1.22 110.145 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.586 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 12.7 ttt180 -66.76 -30.27 70.44 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.061 -0.972 . . . . 3.79 109.588 175.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.486 ' HD2' ' O ' ' A' ' 107' ' ' ILE . 61.6 m-85 . . . . . 0 N--CA 1.447 -0.576 0 CA-C-N 115.78 -0.646 . . . . 0.6 111.664 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 261' ' ' PHE . . . . . 0.621 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 2.1 m-85 . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 109.854 -0.424 . . . . 0.95 109.854 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 11.8 p -143.37 144.64 23.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.649 -0.251 . . . . 1.37 110.639 175.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 C--O 1.235 0.315 0 N-CA-C 109.05 -0.722 . . . . 2.24 109.05 173.796 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 67.4 m80 . . . . . 0 C--O 1.224 -0.252 0 CA-C-O 120.844 0.354 . . . . 1.85 110.949 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.3 m -160.44 143.25 13.26 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.867 -0.42 . . . . 0.95 109.867 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.29 149.69 8.92 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.414 -1.074 . . . . 0.16 110.414 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.708 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -74.84 140.19 43.73 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 117.539 0.669 . . . . 0.43 111.19 -176.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.76 153.85 38.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.376 0.608 . . . . 0.13 111.723 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.561 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.0 mp -95.77 117.0 38.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.483 -0.78 . . . . 0.29 109.075 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.578 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 74.9 t80 -117.97 109.46 16.52 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.127 -0.323 . . . . 0.56 110.127 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 66.84 47.51 1.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.641 0.734 . . . . 1.46 110.758 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp 71.26 6.93 5.96 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.143 -1.389 . . . . 1.91 113.024 171.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -114.14 132.93 61.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.782 0.325 . . . . 0.47 110.414 171.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.561 ' HA ' HG13 ' A' ' 8' ' ' ILE . 41.2 t -74.64 134.51 42.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.311 0.577 . . . . 1.02 110.808 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.704 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -155.98 -158.16 8.67 Favored Glycine 0 N--CA 1.434 -1.486 0 CA-C-N 115.431 -0.804 . . . . 0.16 112.237 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.708 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 13.7 mm -124.57 153.56 31.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.053 0.454 . . . . 0.19 110.432 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.9 133.29 69.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.759 -0.655 . . . . 0.16 110.111 179.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.22 109.54 7.85 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.288 -0.414 . . . . 0.12 111.761 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.598 HD11 HG23 ' A' ' 100' ' ' ILE . 3.7 mp -85.51 121.05 36.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.567 -0.901 . . . . 0.18 108.567 172.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.431 HD22 ' HB3' ' A' ' 21' ' ' ASP . 1.7 t-20 -126.1 128.93 48.12 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 110.249 -0.278 . . . . 1.12 110.249 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.435 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 33.7 mt-10 -110.0 85.3 2.08 Favored 'General case' 0 N--CA 1.425 -1.715 0 C-N-CA 117.022 -1.871 . . . . 0.74 107.632 163.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.431 ' HB3' HD22 ' A' ' 19' ' ' ASN . 13.1 t70 -120.95 -10.58 9.06 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.287 -1.746 . . . . 0.59 106.287 156.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.688 HG11 ' HB2' ' A' ' 26' ' ' GLU . 14.3 p -102.49 174.76 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 111.66 -2.518 . . . . 0.35 112.192 -156.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.681 ' O ' HG13 ' A' ' 22' ' ' VAL . 1.1 t -54.52 167.63 0.56 Allowed Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 106.417 -1.697 . . . . 1.31 106.417 166.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.47 ' HD2' ' OG ' ' A' ' 23' ' ' SER . 13.0 Cg_endo -42.4 128.9 4.72 Favored 'Trans proline' 0 C--N 1.359 1.123 0 CA-C-N 122.266 1.845 . . . . 0.22 111.121 -152.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.623 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -32.43 135.71 0.08 Allowed 'General case' 0 CA--C 1.508 -0.652 0 O-C-N 125.242 1.589 . . . . 0.2 114.01 -155.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.688 ' HB2' HG11 ' A' ' 22' ' ' VAL . 29.2 mt-10 -121.7 136.95 54.93 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.579 -1.191 . . . . 1.26 111.213 -170.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.582 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.2 tt -101.29 143.3 31.52 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 106.222 -1.77 . . . . 0.15 106.222 170.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.449 ' N ' HD23 ' A' ' 27' ' ' LEU . 30.0 m -132.51 110.54 10.56 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.868 -0.733 . . . . 0.21 110.134 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.607 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.6 t90 -86.32 106.53 17.45 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.339 -0.846 . . . . 0.24 108.957 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -115.04 114.87 25.95 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.62 -1.173 . . . . 0.87 108.695 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.574 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 94.6 p -57.07 153.22 11.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.515 0.674 . . . . 0.75 111.574 -171.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.704 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 14.8 m -58.62 -28.49 65.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.557 -1.201 . . . . 0.39 110.87 -177.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -83.08 -28.6 29.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.085 -0.507 . . . . 2.33 110.555 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.22 17.98 32.72 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.112 -0.566 . . . . 0.55 113.072 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -103.5 -25.62 13.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.928 0.394 . . . . 1.13 111.511 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.1 tttm -117.28 122.07 42.92 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.927 -0.397 . . . . 2.03 109.927 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 84.1 t -132.07 123.01 50.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.849 0.357 . . . . 0.55 110.695 -177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -131.35 120.98 23.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.197 -0.456 . . . . 0.69 110.357 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.478 HG21 ' OE1' ' A' ' 26' ' ' GLU . 35.7 m -101.96 143.52 31.73 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 111.735 0.272 . . . . 0.3 111.735 -175.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 38.7 t -116.61 129.44 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 122.83 0.452 . . . . 0.66 111.333 176.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.552 ' O ' HG12 ' A' ' 45' ' ' ILE . 53.7 t -91.18 107.98 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 121.5 0.667 . . . . 0.18 109.43 172.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.654 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.4 mm? -53.19 -32.82 49.88 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.656 -1.156 . . . . 0.12 112.576 -178.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.466 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 52.7 m -75.92 -28.43 58.0 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.933 -0.307 . . . . 1.06 111.456 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.3 p -80.44 -10.89 59.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.187 0.517 . . . . 0.2 109.832 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 41' ' ' VAL . 36.3 mm -82.29 130.09 36.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.483 -0.78 . . . . 0.23 110.861 174.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.688 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 3.7 t70 -86.44 -41.54 14.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.689 -0.687 . . . . 0.7 111.456 176.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.525 ' HE3' ' OE1' ' B' ' 263' ' ' GLU . 11.1 tptt -140.47 138.5 34.7 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.795 -0.639 . . . . 1.95 110.005 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.092 HD23 ' HG3' ' A' ' 105' ' ' GLN . 13.9 tp -109.29 141.8 41.09 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.053 -0.721 . . . . 0.14 109.053 164.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.491 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 5.8 mt-30 -119.07 154.13 33.66 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.81 -1.086 . . . . 1.49 109.927 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.23 141.61 8.1 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.998 -0.546 . . . . 0.25 110.065 177.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 40.0 p -51.29 127.82 30.44 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-O 121.5 0.667 . . . . 0.37 111.418 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 45.0 Cg_endo -66.89 166.53 22.32 Favored 'Trans proline' 0 C--N 1.334 -0.214 0 C-N-CA 124.107 3.205 . . . . 0.64 112.105 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.407 ' N ' HH21 ' A' ' 94' ' ' ARG . . . -68.5 -11.27 59.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.087 0.47 . . . . 1.02 110.569 176.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.4 t -84.71 -24.64 28.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.999 -0.546 . . . . 1.58 109.753 173.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.574 ' OG ' ' HE3' ' A' ' 57' ' ' LYS . 21.2 t -71.59 146.13 48.59 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.067 -0.716 . . . . 0.71 109.067 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -95.42 -14.57 23.68 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.223 -1.028 . . . . 2.89 108.223 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.574 ' HE3' ' OG ' ' A' ' 55' ' ' SER . 0.0 OUTLIER -88.04 176.02 7.49 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 113.731 -1.577 . . . . 2.59 110.313 -177.213 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.532 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -138.32 109.46 6.83 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.454 -0.573 . . . . 1.78 109.454 173.931 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.57 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 3.2 mpp? -154.61 141.27 18.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.772 0.32 . . . . 1.3 111.448 -176.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.88 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 2.3 mp -109.16 161.83 14.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.722 -0.672 . . . . 0.14 110.719 170.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.491 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 2.8 ttt180 -154.03 114.36 3.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.239 -0.437 . . . . 2.72 110.925 172.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.797 ' HG ' HD13 ' A' ' 48' ' ' LEU . 11.7 mt -95.89 110.02 22.28 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 122.659 0.384 . . . . 0.9 110.88 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.616 HG23 ' HB3' ' A' ' 86' ' ' ARG . 4.3 mm -86.86 109.68 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.255 -0.43 . . . . 0.4 111.062 -174.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -74.97 143.23 30.71 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.136 -1.03 . . . . 0.48 110.956 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.688 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 6.2 mttm -64.13 134.65 55.29 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.545 0.688 . . . . 1.15 112.198 -175.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 C--N 1.316 -0.882 0 CA-C-N 114.738 -1.119 . . . . 0.69 108.551 174.036 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.284 0 CA-C-O 121.648 0.737 . . . . 1.78 110.192 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.616 ' HB3' HG23 ' A' ' 63' ' ' ILE . 26.2 ptt180 -125.12 143.71 50.79 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.535 -0.757 . . . . 2.29 111.439 -169.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -104.94 112.8 26.06 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.078 -0.964 . . . . 0.5 110.465 -173.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.465 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 48.3 ttm -107.56 125.31 51.14 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 110.417 -0.216 . . . . 0.42 110.417 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.604 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -117.06 139.33 50.83 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.808 -0.812 . . . . 1.33 108.808 176.046 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.526 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 31.1 t -97.48 128.16 44.02 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.193 -0.669 . . . . 0.94 109.193 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.88 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 6.2 m-85 -108.59 164.35 12.44 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.561 -0.745 . . . . 1.33 109.706 -176.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -109.29 -2.9 17.57 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.678 -0.409 . . . . 1.53 110.906 -172.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -146.69 127.77 14.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.375 0.607 . . . . 0.83 110.624 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.469 ' NH1' ' HB2' ' A' ' 98' ' ' ASP . 43.3 tpt85 -61.71 -27.28 68.6 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.852 -1.067 . . . . 2.16 111.325 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 92.3 m -74.64 -57.88 3.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.429 -0.35 . . . . 0.4 110.582 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.3 t -46.04 -54.06 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-N 116.17 -0.468 . . . . 0.29 111.289 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.558 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -66.08 -27.76 68.31 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.166 -0.47 . . . . 0.29 110.7 -177.566 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.469 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 32.9 t70 -68.93 -34.57 75.58 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 109.18 -0.674 . . . . 0.39 109.18 177.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.418 ' O ' ' HG2' ' A' ' 102' ' ' MET . 20.7 m120 -73.18 -49.26 29.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.34 -1.3 . . . . 1.55 109.53 -178.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.598 HG23 HD11 ' A' ' 18' ' ' ILE . 36.0 mm -55.84 -53.08 41.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.181 -0.918 . . . . 0.13 110.409 174.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.732 ' HA ' HD21 ' A' ' 48' ' ' LEU . 1.1 tmmm? -53.25 -52.52 58.71 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.781 -0.645 . . . . 1.11 110.937 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 99' ' ' ASN . 24.3 ptm -67.81 -24.45 65.3 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.95 -0.568 . . . . 1.17 109.768 -173.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 55.5 m -67.03 -50.52 61.78 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.54 0.686 . . . . 0.15 110.066 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.932 ' HB2' HD22 ' A' ' 48' ' ' LEU . 10.3 mt -70.45 -57.32 4.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.824 -1.08 . . . . 0.13 111.52 -174.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 1.092 ' HG3' HD23 ' A' ' 48' ' ' LEU . 63.3 mt-30 -53.85 -25.78 21.42 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.572 0.582 . . . . 1.45 112.572 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -66.42 -30.1 70.39 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.74 0.781 . . . . 0.65 109.374 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.623 HG21 ' HB3' ' A' ' 25' ' ' ALA . 31.7 mt -82.42 -44.28 19.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 114.117 -1.401 . . . . 0.17 110.312 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.4 mt -66.87 -51.38 55.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.574 -0.739 . . . . 0.29 110.804 -175.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.6 t -61.52 -22.38 65.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.544 0.688 . . . . 1.22 109.354 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.528 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 14.7 ttt180 -72.99 -38.96 66.46 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.746 -1.115 . . . . 3.79 110.184 177.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 . . . . . 0 N--CA 1.449 -0.525 0 CA-C-N 115.857 -0.61 . . . . 0.6 111.249 -176.481 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 261' ' ' PHE . . . . . 0.472 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 13.1 m-85 . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 109.419 -0.586 . . . . 0.95 109.419 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 7.8 p -140.93 143.99 27.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.818 0.342 . . . . 1.37 110.213 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 263' ' ' GLU . . . . . 0.525 ' OE1' ' HE3' ' A' ' 47' ' ' LYS . 44.4 tt0 . . . . . 0 C--N 1.323 -0.552 0 N-CA-C 109.065 -0.717 . . . . 2.24 109.065 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.427 ' HA ' HG21 ' A' ' 103' ' ' THR . 45.7 m80 . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 112.701 0.63 . . . . 1.85 112.701 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.413 ' C ' HD11 ' A' ' 100' ' ' ILE . 20.4 m -158.92 148.8 19.23 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.825 -0.435 . . . . 0.95 109.825 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.41 148.05 6.6 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.366 -1.094 . . . . 0.16 110.366 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.71 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -73.57 140.0 45.97 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 117.419 0.61 . . . . 0.43 111.524 -175.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.508 ' HB1' ' HB3' ' A' ' 89' ' ' PHE . . . -148.65 162.93 38.72 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 121.361 0.6 . . . . 0.13 111.638 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.555 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.1 mp -109.47 126.49 66.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.45 -0.796 . . . . 0.29 109.031 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -114.18 99.66 7.79 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 120.879 0.371 . . . . 0.56 110.249 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 56.69 59.2 3.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.286 0.565 . . . . 1.46 111.118 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 11' ' ' LYS . 21.1 mmtp 76.07 -8.73 1.57 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.858 -1.065 . . . . 1.91 113.68 170.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.1 p -96.6 130.38 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 119.892 -0.723 . . . . 0.47 109.987 169.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.555 ' HA ' HG13 ' A' ' 8' ' ' ILE . 18.6 t -85.3 133.55 34.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.024 -0.534 . . . . 1.02 110.804 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.726 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -155.5 -155.95 7.57 Favored Glycine 0 N--CA 1.438 -1.214 0 CA-C-N 115.749 -0.66 . . . . 0.16 112.598 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.71 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.7 mm -126.6 153.44 35.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 120.798 0.333 . . . . 0.19 110.614 -177.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.431 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -121.89 132.56 70.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.12 -0.491 . . . . 0.16 110.059 179.659 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.85 109.46 7.47 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.316 -0.402 . . . . 0.12 111.927 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.641 HD11 HG23 ' A' ' 100' ' ' ILE . 3.9 mp -85.95 115.66 27.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.897 -0.779 . . . . 0.18 108.897 173.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.417 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.6 t30 -118.38 126.34 51.88 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.982 -0.377 . . . . 1.12 109.982 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -110.89 83.35 1.74 Allowed 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 117.362 -1.735 . . . . 0.74 107.543 164.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.417 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 19.5 t70 -121.25 -10.5 8.94 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 106.638 -1.615 . . . . 0.59 106.638 156.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 23' ' ' SER . 14.8 p -101.43 174.66 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 112.099 -2.319 . . . . 0.35 112.031 -156.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.672 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -54.51 165.63 0.86 Allowed Pre-proline 0 C--O 1.225 -0.194 0 N-CA-C 106.04 -1.837 . . . . 1.31 106.04 166.489 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HD2' ' OG ' ' A' ' 23' ' ' SER . 10.1 Cg_endo -41.14 128.04 2.93 Favored 'Trans proline' 0 C--N 1.354 0.845 0 CA-C-N 121.899 1.714 . . . . 0.22 111.555 -150.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.67 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -32.15 135.21 0.08 Allowed 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 125.288 1.617 . . . . 0.2 113.719 -156.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.563 ' HB2' HG11 ' A' ' 22' ' ' VAL . 70.7 mt-10 -124.77 137.62 54.31 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 114.792 -1.094 . . . . 1.26 111.366 -168.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 1.3 tt -100.65 141.88 32.89 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 106.543 -1.651 . . . . 0.15 106.543 173.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.417 ' N ' HD23 ' A' ' 27' ' ' LEU . 6.8 m -130.1 108.77 10.32 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.848 -0.741 . . . . 0.21 110.413 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.64 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 82.8 t90 -88.0 113.68 23.88 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.478 0.656 . . . . 0.24 109.755 175.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -120.67 122.97 41.62 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.168 -0.924 . . . . 0.87 109.161 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.437 ' OG ' ' HG2' ' A' ' 36' ' ' LYS . 38.1 m -56.59 141.47 43.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.088 0.47 . . . . 0.75 110.482 -174.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.726 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 20.2 m -57.54 -35.9 70.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.092 -0.958 . . . . 0.39 110.443 -176.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -87.36 -8.04 57.07 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.502 -0.772 . . . . 2.33 111.153 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.89 21.02 54.48 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.82 -0.705 . . . . 0.55 112.39 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.404 ' H ' ' HB2' ' A' ' 31' ' ' SER . 24.2 t70 -69.85 -56.36 7.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.337 0.495 . . . . 1.13 112.337 -176.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.437 ' HG2' ' OG ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -143.88 161.71 37.99 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.806 0.336 . . . . 2.03 110.979 -176.164 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.2 138.06 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.337 -0.392 . . . . 0.55 110.678 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -135.67 115.77 13.31 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 122.551 0.34 . . . . 0.69 110.714 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.5 m -98.89 142.68 30.09 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.783 0.325 . . . . 0.3 111.461 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 22.0 t -116.62 128.8 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 122.827 0.451 . . . . 0.66 111.209 175.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 45' ' ' ILE . 43.2 t -90.56 109.25 20.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.078 0.466 . . . . 0.18 109.904 175.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.612 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.9 mm? -54.16 -26.43 27.83 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.372 -0.831 . . . . 0.12 112.762 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.3 m -75.27 -35.1 61.4 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.374 -0.53 . . . . 1.06 111.329 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.8 p -74.0 -14.48 61.03 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.402 -0.592 . . . . 0.2 109.402 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.606 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 48.9 mm -82.92 114.43 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.075 -0.966 . . . . 0.23 110.863 175.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.542 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 31.8 t70 -74.7 -39.46 61.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.109 -0.496 . . . . 0.7 111.266 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -147.24 158.13 43.84 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.227 -0.442 . . . . 1.95 110.199 -174.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.93 HD22 ' HB2' ' A' ' 104' ' ' LEU . 10.8 tp -124.53 146.01 49.23 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.303 0.573 . . . . 0.14 109.917 171.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.44 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 15.5 mm100 -123.16 155.98 35.96 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.793 -1.094 . . . . 1.49 109.653 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.18 138.23 6.5 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.55 -0.75 . . . . 0.25 109.649 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.409 HG23 ' HB2' ' A' ' 59' ' ' MET . 36.7 p -50.7 126.71 24.31 Favored Pre-proline 0 N--CA 1.466 0.339 0 CA-C-O 121.193 0.52 . . . . 0.37 110.396 176.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 43.0 Cg_endo -65.59 164.76 25.2 Favored 'Trans proline' 0 C--N 1.329 -0.494 0 C-N-CA 123.611 2.874 . . . . 0.64 112.017 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.06 66.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.279 0.561 . . . . 1.02 110.064 175.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.5 t -75.03 -24.6 58.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.287 -0.87 . . . . 1.58 110.575 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.414 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 46.8 t -68.42 148.37 50.75 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.59 -0.522 . . . . 0.71 109.59 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -89.21 -7.68 55.06 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.746 0.784 . . . . 2.89 109.389 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -107.89 -175.85 2.9 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.686 -1.143 . . . . 2.59 110.9 -172.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.493 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -141.7 110.39 6.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.257 -0.883 . . . . 1.78 109.171 175.039 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.508 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 2.4 mpp? -156.3 139.94 16.0 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.694 0.283 . . . . 1.3 111.456 -176.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.868 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 1.5 mp -110.66 155.42 22.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.121 -0.49 . . . . 0.14 110.928 171.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.691 ' NH2' ' HE3' ' A' ' 88' ' ' MET . 25.4 ttm-85 -145.5 113.76 6.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.083 0.468 . . . . 2.72 110.043 170.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.777 ' HG ' HD13 ' A' ' 48' ' ' LEU . 6.5 mp -91.9 111.69 23.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.075 -0.512 . . . . 0.9 110.522 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.546 ' HA ' ' CB ' ' A' ' 86' ' ' ARG . 3.0 mm -86.71 125.52 40.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.195 -0.457 . . . . 0.4 110.116 -173.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -89.31 156.07 25.66 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.164 -1.017 . . . . 0.48 111.474 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.542 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 0.7 OUTLIER -64.12 134.01 54.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.03 0.443 . . . . 1.15 110.025 176.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 C--N 1.317 -0.843 0 CA-C-N 115.615 -0.72 . . . . 0.69 109.165 174.679 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.507 -0.709 0 N-CA-C 108.835 -0.802 . . . . 1.78 108.835 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.61 ' HD2' ' HD3' ' A' ' 61' ' ' ARG . 28.7 ptt180 -143.64 140.9 30.34 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.663 -0.699 . . . . 2.29 111.303 -171.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -102.88 112.28 25.0 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.795 -1.093 . . . . 0.5 110.734 -170.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.691 ' HE3' ' NH2' ' A' ' 61' ' ' ARG . 38.6 ttm -104.04 137.54 41.86 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 121.067 -0.253 . . . . 0.42 110.806 -177.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.508 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 56.3 m-85 -124.1 139.18 54.18 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.514 -0.921 . . . . 1.33 108.514 169.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.54 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 14.7 m -95.1 124.18 39.0 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.313 -0.625 . . . . 0.94 109.313 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.868 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 7.7 m-85 -106.5 168.4 9.19 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 110.044 -0.354 . . . . 1.33 110.044 -174.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -114.37 -6.89 12.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.824 0.345 . . . . 1.53 111.325 -174.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -138.62 122.93 18.22 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.282 0.563 . . . . 0.83 110.954 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -54.6 -39.6 68.03 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 114.51 -1.223 . . . . 2.16 111.327 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 97.7 m -71.14 -57.25 4.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.564 -0.289 . . . . 0.4 110.599 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 100' ' ' ILE . 96.1 t -45.97 -55.6 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 116.126 -0.488 . . . . 0.29 111.299 175.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.657 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -65.41 -29.36 70.06 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.254 -0.43 . . . . 0.29 110.695 -177.127 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 30.2 t70 -71.42 -28.3 63.9 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.853 0.835 . . . . 0.39 109.318 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.535 ' O ' ' HG3' ' A' ' 102' ' ' MET . 20.3 m120 -77.64 -36.84 51.17 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.559 -1.2 . . . . 1.55 109.252 176.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.641 HG23 HD11 ' A' ' 18' ' ' ILE . 33.4 mm -64.42 -53.04 47.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 114.978 -1.01 . . . . 0.13 111.144 176.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.727 ' HA ' HD21 ' A' ' 48' ' ' LEU . 2.1 ptmt -59.29 -43.57 92.57 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 121.231 -0.188 . . . . 1.11 110.6 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.535 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.5 ppp? -68.08 -25.83 65.53 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.175 0.512 . . . . 1.17 109.719 -175.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 36.9 m -65.61 -51.95 55.77 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.463 -0.789 . . . . 0.15 109.815 173.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.93 ' HB2' HD22 ' A' ' 48' ' ' LEU . 12.2 mt -71.15 -56.92 5.09 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 115.183 -0.917 . . . . 0.13 111.141 -175.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.922 ' HG2' HD23 ' A' ' 48' ' ' LEU . 21.1 mm-40 -42.85 -35.0 1.05 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.808 0.67 . . . . 1.45 112.808 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -65.59 -48.29 72.82 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.845 -0.798 . . . . 0.65 108.845 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.67 HG21 ' HB3' ' A' ' 25' ' ' ALA . 68.2 mt -61.48 -43.12 96.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.39 -1.277 . . . . 0.17 110.6 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 105' ' ' GLN . 0.7 OUTLIER -62.37 -54.98 27.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.51 -0.768 . . . . 0.29 109.875 -177.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.8 m -54.4 -32.35 57.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.98 -0.554 . . . . 1.22 110.849 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.463 ' HD2' ' HA ' ' A' ' 107' ' ' ILE . 82.9 mtt180 -70.93 -27.99 64.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.593 -0.731 . . . . 3.79 110.662 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 N--CA 1.445 -0.709 0 CA-C-N 116.21 -0.45 . . . . 0.6 111.277 -178.076 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 261' ' ' PHE . . . . . 0.451 ' N ' ' CD1' ' B' ' 261' ' ' PHE . 3.9 m-30 . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 109.221 -0.659 . . . . 0.95 109.221 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 12.8 p -122.98 139.66 49.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.925 0.393 . . . . 1.37 110.322 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 109.156 -0.683 . . . . 2.24 109.156 174.691 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.1 m80 . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 121.647 0.737 . . . . 1.85 109.478 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.405 ' C ' HD11 ' A' ' 100' ' ' ILE . 90.1 p -162.99 154.45 17.55 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.815 -1.084 . . . . 0.95 108.626 -176.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.73 145.86 5.48 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.186 -0.765 . . . . 0.16 111.186 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.76 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.69 125.78 29.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.324 0.562 . . . . 0.43 111.36 -176.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.72 158.39 44.24 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 121.168 0.509 . . . . 0.13 111.36 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 2.0 mp -96.96 127.65 48.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.637 -0.711 . . . . 0.29 109.472 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.639 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 80.4 t80 -137.38 117.15 13.11 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.337 -0.616 . . . . 0.56 109.337 178.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 66.71 44.18 2.24 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.15 0.58 . . . . 1.46 110.419 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt 74.91 -8.95 1.44 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.777 -1.102 . . . . 1.91 112.718 171.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.48 131.92 47.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.903 0.382 . . . . 0.47 110.476 177.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.514 ' HA ' HG13 ' A' ' 8' ' ' ILE . 22.5 t -78.03 123.2 26.55 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.002 -0.544 . . . . 1.02 109.992 176.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.645 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -139.07 -154.73 6.46 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.543 -0.753 . . . . 0.16 112.06 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.76 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.7 mm -127.02 153.76 36.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 120.957 0.408 . . . . 0.19 110.779 -177.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.486 HG12 HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -128.56 132.81 67.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.856 -0.611 . . . . 0.16 110.113 -179.348 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.01 112.09 9.02 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 111.976 0.362 . . . . 0.12 111.976 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.621 HD11 HG23 ' A' ' 100' ' ' ILE . 3.7 mp -86.02 120.86 36.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.836 -0.802 . . . . 0.18 108.836 172.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.456 HD22 ' HB3' ' A' ' 21' ' ' ASP . 2.8 t-20 -126.22 125.39 42.32 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 110.234 -0.284 . . . . 1.12 110.234 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.467 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 22.2 mt-10 -108.47 84.51 1.95 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 117.069 -1.852 . . . . 0.74 107.468 163.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.456 ' HB3' HD22 ' A' ' 19' ' ' ASN . 17.9 t70 -121.54 -9.58 8.94 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 106.341 -1.726 . . . . 0.59 106.341 156.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.706 HG13 ' O ' ' A' ' 23' ' ' SER . 14.0 p -102.48 175.98 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 111.732 -2.486 . . . . 0.35 111.778 -157.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.706 ' O ' HG13 ' A' ' 22' ' ' VAL . 5.6 m -54.15 167.25 0.56 Allowed Pre-proline 0 C--O 1.225 -0.201 0 N-CA-C 106.997 -1.483 . . . . 1.31 106.997 166.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 10.7 Cg_endo -42.16 128.27 4.22 Favored 'Trans proline' 0 C--N 1.357 1.008 0 CA-C-N 122.018 1.756 . . . . 0.22 111.009 -154.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.743 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -31.58 134.61 0.08 Allowed 'General case' 0 CA--C 1.504 -0.805 0 O-C-N 125.19 1.557 . . . . 0.2 113.93 -155.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.594 ' HB2' HG11 ' A' ' 22' ' ' VAL . 33.6 mt-10 -121.3 134.93 55.16 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.646 -1.161 . . . . 1.26 111.031 -172.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.593 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.0 OUTLIER -100.34 141.26 33.43 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 106.052 -1.833 . . . . 0.15 106.052 173.39 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.465 ' N ' HD23 ' A' ' 27' ' ' LEU . 6.2 m -127.92 108.76 10.96 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.677 -0.809 . . . . 0.21 110.434 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.639 ' CE2' ' HB3' ' A' ' 9' ' ' PHE . 88.8 t90 -89.6 107.56 19.16 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.675 0.75 . . . . 0.24 109.271 175.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -113.83 120.53 41.06 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.888 -1.051 . . . . 0.87 109.088 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.593 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 88.9 p -61.78 144.97 53.93 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.197 -0.668 . . . . 0.75 109.197 -176.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.645 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 11.4 m -54.0 -23.25 12.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.013 -0.994 . . . . 0.39 111.99 -173.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -87.65 -10.59 50.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 111.982 0.364 . . . . 2.33 111.982 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.15 21.43 67.68 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.831 -0.7 . . . . 0.55 111.704 -176.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -93.49 -44.72 8.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.065 0.459 . . . . 1.13 111.334 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.407 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 29.3 mttt -110.34 146.12 36.32 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.895 -0.593 . . . . 2.03 110.794 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.0 t -144.12 115.7 2.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.874 -0.603 . . . . 0.55 109.69 174.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -125.46 111.22 14.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.926 -0.579 . . . . 0.69 110.066 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.406 HG21 ' OE1' ' A' ' 26' ' ' GLU . 14.4 m -98.74 143.17 29.39 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 120.824 -0.351 . . . . 0.3 111.326 -175.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 28.7 t -116.43 130.15 71.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 122.416 0.286 . . . . 0.66 111.536 176.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.534 ' O ' HG12 ' A' ' 45' ' ' ILE . 60.1 t -91.03 108.28 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-O 121.398 0.618 . . . . 0.18 109.875 173.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.6 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -53.19 -26.89 18.98 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.808 -1.087 . . . . 0.12 112.927 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.425 ' O ' ' HE3' ' A' ' 65' ' ' LYS . 59.4 m -80.68 -30.25 36.46 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.459 -0.496 . . . . 1.06 111.661 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.2 p -75.66 -16.23 60.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.099 -0.704 . . . . 0.2 109.099 172.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.691 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 46.6 mm -75.09 120.72 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.965 -1.016 . . . . 0.23 111.313 174.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.578 ' OD2' ' HG2' ' A' ' 47' ' ' LYS . 20.2 t70 -74.24 -50.22 19.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.851 -1.068 . . . . 0.7 110.99 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.578 ' HG2' ' OD2' ' A' ' 46' ' ' ASP . 48.2 mmtm -142.32 154.46 44.71 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 109.488 -0.56 . . . . 1.95 109.488 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.133 HD23 ' HG3' ' A' ' 105' ' ' GLN . 9.0 tp -112.59 145.05 41.03 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.391 -0.596 . . . . 0.14 109.391 167.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.548 ' H ' HD12 ' A' ' 48' ' ' LEU . 55.2 mt-30 -126.73 156.67 40.77 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.686 -1.143 . . . . 1.49 109.876 -177.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -161.76 151.11 16.12 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.427 -0.953 . . . . 0.25 108.427 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 22.3 p -50.25 121.22 13.3 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.588 0.709 . . . . 0.37 111.44 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 66.3 Cg_endo -71.95 167.82 25.64 Favored 'Trans proline' 0 C--N 1.331 -0.375 0 C-N-CA 124.205 3.27 . . . . 0.64 111.546 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.2 -27.94 37.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.26 0.552 . . . . 1.02 110.52 174.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 t -73.46 -22.78 60.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.838 -0.619 . . . . 1.58 110.889 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 24.6 t -86.6 136.28 33.11 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.9 -0.407 . . . . 0.71 109.9 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -88.99 -6.77 56.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.334 0.588 . . . . 2.89 111.093 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -99.75 -177.1 3.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.393 -0.821 . . . . 2.59 109.977 -176.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.581 ' SD ' ' HB2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -136.29 107.16 6.64 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.032 -0.729 . . . . 1.78 109.032 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.648 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 3.5 mpp? -156.86 146.62 20.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.977 0.418 . . . . 1.3 111.188 -175.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.864 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 1.9 mp -110.77 163.14 14.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.551 -0.75 . . . . 0.14 111.699 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.512 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 20.5 ttt180 -155.02 113.44 3.51 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.613 -0.721 . . . . 2.72 110.281 173.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.591 HD13 ' CE2' ' A' ' 89' ' ' PHE . 7.3 mp -94.81 113.27 25.0 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.139 0.495 . . . . 0.9 110.427 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.823 HG23 ' HG2' ' A' ' 86' ' ' ARG . 5.1 mm -84.58 124.09 39.59 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 C-N-CA 123.543 0.737 . . . . 0.4 109.105 -178.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.691 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -97.65 146.7 18.35 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 119.841 -1.171 . . . . 0.48 112.106 177.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.516 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -58.22 131.53 50.86 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.141 0.496 . . . . 1.15 111.452 -175.323 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 115.387 -0.824 . . . . 0.69 109.17 177.364 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 121.647 0.736 . . . . 1.78 110.995 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.823 ' HG2' HG23 ' A' ' 63' ' ' ILE . 25.5 mtm180 -110.33 157.0 19.97 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.495 -0.775 . . . . 2.29 111.032 -175.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -120.39 111.12 17.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.308 -0.86 . . . . 0.5 109.637 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.48 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 55.0 ttm -113.73 125.31 53.97 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.88 -0.145 . . . . 0.42 110.633 -174.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.591 ' CE2' HD13 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -118.75 148.43 42.81 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.339 -0.615 . . . . 1.33 109.339 174.088 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.648 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 32.2 m -97.79 126.54 43.2 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.659 -0.497 . . . . 0.94 109.659 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.864 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 8.8 m-85 -106.53 154.76 20.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.057 0.456 . . . . 1.33 111.349 -174.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -100.36 -6.65 25.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.984 -0.553 . . . . 1.53 110.955 -171.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -142.76 128.33 19.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.938 0.399 . . . . 0.83 110.581 -175.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.581 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 15.8 tpt180 -59.63 -34.69 73.11 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.109 -0.95 . . . . 2.16 110.847 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.6 m -74.03 -58.82 3.05 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.69 -0.687 . . . . 0.4 110.618 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 100' ' ' ILE . 94.6 t -45.19 -53.69 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-N 115.792 -0.64 . . . . 0.29 111.456 175.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.797 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -66.32 -29.81 70.09 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 120.515 -0.474 . . . . 0.29 110.563 -177.206 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.426 ' HA ' ' HD3' ' A' ' 101' ' ' LYS . 35.8 t70 -72.13 -24.26 61.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.62 0.724 . . . . 0.39 109.618 178.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.578 ' O ' ' HG3' ' A' ' 102' ' ' MET . 19.2 m120 -83.78 -42.93 15.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.845 -1.071 . . . . 1.55 109.742 177.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.621 HG23 HD11 ' A' ' 18' ' ' ILE . 33.7 mm -58.54 -51.85 66.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.482 -0.781 . . . . 0.13 110.837 176.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.812 ' HA ' HD21 ' A' ' 48' ' ' LEU . 2.6 ptmt -60.23 -39.25 86.01 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 120.851 0.358 . . . . 1.11 111.159 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.578 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.7 ppp? -76.52 -22.93 53.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.079 0.466 . . . . 1.17 109.761 -175.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 52.6 m -68.46 -53.2 25.03 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.649 -0.705 . . . . 0.15 109.679 174.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.934 ' HB2' HD22 ' A' ' 48' ' ' LEU . 13.1 mt -65.75 -56.59 11.21 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.151 -0.931 . . . . 0.13 110.932 -177.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 1.133 ' HG3' HD23 ' A' ' 48' ' ' LEU . 49.1 mt-30 -52.05 -26.38 10.77 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.808 0.67 . . . . 1.45 112.808 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -64.59 -43.8 92.66 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.923 -0.769 . . . . 0.65 108.923 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.743 HG21 ' HB3' ' A' ' 25' ' ' ALA . 33.4 mt -66.76 -43.89 89.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.293 -1.321 . . . . 0.17 110.876 176.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.2 mt -67.16 -47.84 80.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.05 -0.523 . . . . 0.29 110.445 -176.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.0 t -58.71 -27.34 64.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.366 0.603 . . . . 1.22 110.237 172.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 77.2 mtt180 -70.56 -31.79 68.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 3.79 110.25 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 . . . . . 0 N--CA 1.447 -0.617 0 CA-C-N 115.914 -0.584 . . . . 0.6 111.934 -178.862 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 261' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.909 -0.404 . . . . 0.95 109.909 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.97 166.32 26.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.36 -0.382 . . . . 1.37 110.72 -176.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 263' ' ' GLU . . . . . 0.534 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 8.0 pt-20 . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 116.282 -0.417 . . . . 2.24 110.089 173.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.554 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 37.9 m80 . . . . . 0 C--O 1.226 -0.164 0 N-CA-C 112.087 0.403 . . . . 1.85 112.087 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.474 ' C ' HD11 ' A' ' 100' ' ' ILE . 88.6 p -163.12 149.92 12.61 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.844 0.354 . . . . 0.95 110.715 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.72 147.45 6.35 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.496 -1.042 . . . . 0.16 110.496 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.747 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.55 136.75 40.55 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 117.653 0.726 . . . . 0.43 111.283 -175.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.31 160.11 40.81 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 121.278 0.561 . . . . 0.13 111.323 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.564 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.5 mp -105.58 126.39 60.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.603 -0.726 . . . . 0.29 109.163 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -116.82 101.8 8.85 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.711 -0.396 . . . . 0.56 110.279 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 60.69 53.0 4.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.19 0.519 . . . . 1.46 110.668 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt 78.99 -8.35 1.65 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.545 -1.207 . . . . 1.91 113.298 171.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -97.86 127.58 50.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.203 -0.599 . . . . 0.47 110.712 171.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.564 ' HA ' HG13 ' A' ' 8' ' ' ILE . 10.2 p -78.99 126.13 30.28 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.558 -0.746 . . . . 1.02 111.095 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.695 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -145.24 -155.42 6.46 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.465 -0.789 . . . . 0.16 112.098 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.747 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 6.4 mm -128.71 153.78 38.71 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.741 0 CA-C-O 120.768 0.318 . . . . 0.19 110.768 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.493 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -124.38 131.85 72.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.642 -0.503 . . . . 0.16 109.642 179.126 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.57 112.28 9.44 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.215 -0.448 . . . . 0.12 111.643 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.668 HD11 HG23 ' A' ' 100' ' ' ILE . 4.1 mp -84.8 120.75 35.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.265 -1.013 . . . . 0.18 108.265 171.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.415 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.4 t30 -123.64 124.88 43.75 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.967 -0.383 . . . . 1.12 109.967 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -108.53 83.11 1.72 Allowed 'General case' 0 N--CA 1.427 -1.62 0 C-N-CA 116.959 -1.896 . . . . 0.74 107.342 165.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.415 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 16.7 t70 -121.25 -12.35 8.66 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 106.625 -1.62 . . . . 0.59 106.625 158.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 23' ' ' SER . 14.9 p -101.75 177.9 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 111.812 -2.449 . . . . 0.35 111.852 -156.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.71 ' O ' HG13 ' A' ' 22' ' ' VAL . 4.4 m -53.61 168.4 0.4 Allowed Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 107.194 -1.41 . . . . 1.31 107.194 165.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 12.2 Cg_endo -42.6 128.21 4.75 Favored 'Trans proline' 0 C--N 1.357 1.016 0 CA-C-N 121.966 1.738 . . . . 0.22 110.94 -155.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.704 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -33.36 135.83 0.11 Allowed 'General case' 0 CA--C 1.507 -0.697 0 O-C-N 125.334 1.646 . . . . 0.2 113.892 -154.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.693 ' HB2' HG11 ' A' ' 22' ' ' VAL . 28.5 mt-10 -123.3 138.61 54.58 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 114.588 -1.187 . . . . 1.26 111.179 -170.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.57 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.4 tt -101.71 143.11 32.06 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 106.567 -1.642 . . . . 0.15 106.567 173.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.423 ' N ' HD23 ' A' ' 27' ' ' LEU . 16.5 m -130.99 109.78 10.77 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.846 -0.742 . . . . 0.21 110.67 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.638 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 87.8 t90 -85.92 106.03 16.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.687 0.756 . . . . 0.24 109.327 174.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -111.15 115.32 29.2 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.069 -0.969 . . . . 0.87 108.759 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.557 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 63.1 p -56.39 144.13 31.98 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.993 0.425 . . . . 0.75 110.064 -177.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.695 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 25.9 m -56.44 -25.04 49.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.175 -0.92 . . . . 0.39 110.751 -176.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -76.33 -27.96 56.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.899 -0.591 . . . . 2.33 111.299 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.83 8.01 60.93 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.702 -0.559 . . . . 0.55 111.702 -174.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -84.87 -72.68 0.46 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.056 0.455 . . . . 1.13 111.408 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -85.55 141.13 30.08 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.201 0.524 . . . . 2.03 111.48 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 93.9 t -137.69 125.86 31.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.741 -1.118 . . . . 0.55 109.441 177.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -130.34 111.29 12.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.53 -0.305 . . . . 0.69 110.273 -175.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -100.87 141.87 33.15 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 111.863 0.319 . . . . 0.3 111.863 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.59 HG11 HD13 ' A' ' 62' ' ' LEU . 43.1 t -116.11 129.69 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 122.623 0.369 . . . . 0.66 111.688 176.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.579 ' O ' HG12 ' A' ' 45' ' ' ILE . 60.4 t -91.11 108.42 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-O 121.268 0.556 . . . . 0.18 109.579 172.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.583 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.6 mm? -53.14 -29.52 31.71 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.877 -1.056 . . . . 0.12 112.546 -178.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.438 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 68.4 m -76.89 -33.79 57.78 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.608 -0.437 . . . . 1.06 111.581 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.7 p -74.07 -11.7 60.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.541 0.686 . . . . 0.2 109.371 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.579 HG12 ' O ' ' A' ' 41' ' ' VAL . 47.5 mm -82.62 133.03 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 114.77 -1.105 . . . . 0.23 111.002 173.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.653 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 35.8 t70 -85.91 -50.22 7.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.456 -0.793 . . . . 0.7 110.904 174.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.477 ' HB2' HG13 ' A' ' 63' ' ' ILE . 74.9 mmtt -136.77 156.14 48.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.245 -0.434 . . . . 1.95 110.1 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.09 HD23 ' HG3' ' A' ' 105' ' ' GLN . 11.6 tp -119.18 140.21 50.55 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.213 0.53 . . . . 0.14 109.871 167.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 11.8 mm100 -115.61 154.82 28.76 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.818 -1.083 . . . . 1.49 109.837 -178.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.85 141.65 8.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.588 -0.733 . . . . 0.25 109.278 177.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.492 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 33.5 p -51.94 123.52 25.95 Favored Pre-proline 0 N--CA 1.467 0.4 0 CA-C-O 121.484 0.659 . . . . 0.37 111.559 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.525 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 71.1 Cg_endo -70.76 167.29 26.16 Favored 'Trans proline' 0 CA--C 1.519 -0.275 0 C-N-CA 124.331 3.354 . . . . 0.64 112.126 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.425 ' HA ' HH12 ' A' ' 94' ' ' ARG . . . -55.63 -28.13 53.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.236 0.541 . . . . 1.02 110.575 174.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.8 m -68.73 -25.38 64.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.375 -0.83 . . . . 1.58 111.324 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.435 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 33.7 t -80.4 143.43 33.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.535 -0.757 . . . . 0.71 109.951 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -90.17 -7.66 53.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.484 0.659 . . . . 2.89 109.667 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 mmmt -98.89 178.33 4.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.225 -0.898 . . . . 2.59 110.403 -175.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.531 ' HB3' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -137.58 110.18 7.52 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.982 -1.008 . . . . 1.78 108.674 176.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.599 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 3.1 ttm -157.3 140.13 15.09 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.744 -0.382 . . . . 1.3 111.422 -173.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.863 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 1.9 mp -109.27 160.82 15.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.06 0.457 . . . . 0.14 111.016 172.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.644 ' HE ' ' HE2' ' A' ' 88' ' ' MET . 20.7 ttm180 -153.56 113.34 3.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.906 -0.588 . . . . 2.72 110.263 172.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.802 ' HG ' HD13 ' A' ' 48' ' ' LEU . 7.9 mt -93.61 113.79 25.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.055 0.455 . . . . 0.9 110.293 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.629 HG23 ' HG2' ' A' ' 86' ' ' ARG . 5.4 mm -86.63 109.28 18.78 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 CA-C-N 115.717 -0.674 . . . . 0.4 110.461 -173.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -76.43 138.48 22.55 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.731 -1.223 . . . . 0.48 111.384 176.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.653 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 1.7 mptp? -53.44 136.68 37.43 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.72 0.295 . . . . 1.15 110.941 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--N 1.32 -0.677 0 N-CA-C 109.923 -0.399 . . . . 0.69 109.923 175.267 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.385 0 CA-C-O 121.42 0.628 . . . . 1.78 109.87 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.629 ' HG2' HG23 ' A' ' 63' ' ' ILE . 18.5 mtm180 -110.78 160.42 16.75 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.64 -0.709 . . . . 2.29 110.227 -173.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -124.3 111.91 16.38 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.009 -0.542 . . . . 0.5 109.713 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.644 ' HE2' ' HE ' ' A' ' 61' ' ' ARG . 49.7 ttm -111.35 128.53 55.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.716 -0.22 . . . . 0.42 110.889 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.437 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 39.8 m-85 -117.24 143.63 45.68 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 108.832 -0.803 . . . . 1.33 108.832 173.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.545 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 19.1 m -96.88 125.59 41.43 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.469 -0.567 . . . . 0.94 109.469 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.863 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 4.5 m-85 -107.53 162.9 13.52 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.952 -0.388 . . . . 1.33 109.952 -177.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -115.91 -7.06 12.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.859 0.361 . . . . 1.53 110.911 -176.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -129.09 119.44 24.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.67 -0.493 . . . . 0.83 109.67 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.531 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 8.3 tpt180 -61.44 -29.08 69.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.844 -0.617 . . . . 2.16 111.227 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 50.0 m -74.17 -47.05 38.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.245 0.545 . . . . 0.4 110.52 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.821 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 66.3 t -60.27 -52.76 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 CA-C-N 115.646 -0.706 . . . . 0.29 111.633 177.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.541 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -60.41 -26.01 66.37 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.912 -0.715 . . . . 0.29 109.735 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 95' ' ' THR . 36.6 t70 -70.29 -41.74 72.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.261 0.553 . . . . 0.39 109.9 176.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.821 ' ND2' ' HA ' ' A' ' 96' ' ' VAL . 22.8 p30 -80.21 -29.19 38.54 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.073 -0.967 . . . . 1.55 110.879 -173.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.668 HG23 HD11 ' A' ' 18' ' ' ILE . 31.0 mm -67.41 -54.02 27.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.366 -0.834 . . . . 0.13 110.123 169.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.679 ' HA ' HD21 ' A' ' 48' ' ' LEU . 3.8 ttpt -54.79 -48.39 72.78 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.53 -0.759 . . . . 1.11 111.326 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -65.73 -26.09 67.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.9 0.381 . . . . 1.17 110.592 -176.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 22.1 m -68.06 -49.73 59.55 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.204 0.526 . . . . 0.15 110.354 177.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.957 ' HB2' HD22 ' A' ' 48' ' ' LEU . 9.7 mt -69.38 -57.25 5.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.391 -0.822 . . . . 0.13 111.156 -175.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 1.09 ' HG3' HD23 ' A' ' 48' ' ' LEU . 96.0 mt-30 -50.78 -28.35 9.11 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.223 0.453 . . . . 1.45 112.223 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -63.16 -49.81 72.87 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.842 -0.799 . . . . 0.65 108.842 176.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.704 HG21 ' HB3' ' A' ' 25' ' ' ALA . 60.1 mt -60.07 -44.75 95.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 113.906 -1.497 . . . . 0.17 110.518 176.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.2 mt -62.53 -55.52 23.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.675 -0.693 . . . . 0.29 110.412 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.6 m -59.01 -26.43 64.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.0 0.429 . . . . 1.22 110.966 175.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 56.9 mtt180 -69.22 -33.92 74.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.856 -0.611 . . . . 3.79 110.21 176.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 . . . . . 0 C--N 1.321 -0.662 0 CA-C-N 115.585 -0.734 . . . . 0.6 111.187 -179.585 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 261' ' ' PHE . . . . . 0.525 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 6.2 m-85 . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 109.434 -0.58 . . . . 0.95 109.434 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.72 150.3 19.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.624 -0.51 . . . . 1.37 109.624 173.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 263' ' ' GLU . . . . . 0.505 ' HB3' ' OE1' ' A' ' 49' ' ' GLN . 2.5 pp20? . . . . . 0 C--N 1.324 -0.526 0 N-CA-C 109.778 -0.453 . . . . 2.24 109.778 176.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 . . . . . 0 C--O 1.227 -0.121 0 CA-C-O 121.319 0.581 . . . . 1.85 110.005 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.4 ' C ' HD11 ' A' ' 100' ' ' ILE . 20.4 m -162.33 150.67 14.66 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.538 -0.755 . . . . 0.95 109.195 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.53 140.61 3.97 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.275 -0.73 . . . . 0.16 111.275 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.746 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -71.6 121.4 18.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 117.211 0.506 . . . . 0.43 111.173 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.548 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -130.83 158.78 39.23 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.256 0.551 . . . . 0.13 112.115 -177.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.504 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.5 mp -97.16 120.56 46.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.349 -0.841 . . . . 0.29 109.21 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.572 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 82.8 t80 -122.91 112.53 17.95 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.843 -0.428 . . . . 0.56 109.843 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 62.98 48.61 3.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.79 0.805 . . . . 1.46 110.127 -175.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt 72.61 -6.53 1.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.143 -1.389 . . . . 1.91 113.373 171.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.92 131.99 46.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.936 0.398 . . . . 0.47 110.236 173.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.504 ' HA ' HG13 ' A' ' 8' ' ' ILE . 23.3 t -78.89 130.55 35.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.059 -0.518 . . . . 1.02 110.522 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.67 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -149.4 -154.61 6.43 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 115.702 -0.681 . . . . 0.16 111.628 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.746 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 9.9 mm -124.44 153.42 31.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.948 0.374 . . . . 0.19 110.619 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.427 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -126.74 133.46 68.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.977 -0.556 . . . . 0.16 109.849 -179.824 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.89 111.44 8.63 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 116.281 -0.418 . . . . 0.12 111.751 175.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.633 HD11 HG23 ' A' ' 100' ' ' ILE . 4.0 mp -84.36 114.06 24.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.139 -1.06 . . . . 0.18 108.139 171.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.447 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.5 t30 -119.25 122.06 41.06 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.952 -0.388 . . . . 1.12 109.952 -179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.489 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 38.0 mt-10 -105.88 84.25 2.04 Favored 'General case' 0 N--CA 1.423 -1.785 0 C-N-CA 116.858 -1.937 . . . . 0.74 107.418 163.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.447 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 22.3 t70 -121.4 -11.22 8.78 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.622 -1.621 . . . . 0.59 106.622 156.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.7 HG11 ' HB2' ' A' ' 26' ' ' GLU . 14.2 p -102.58 174.8 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 112.001 -2.363 . . . . 0.35 111.653 -157.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.672 ' O ' HG13 ' A' ' 22' ' ' VAL . 17.3 p -54.27 166.3 0.71 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 117.052 -1.452 . . . . 1.31 107.117 166.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.639 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 10.3 Cg_endo -41.49 128.47 3.44 Favored 'Trans proline' 0 C--N 1.362 1.278 0 CA-C-N 122.233 1.833 . . . . 0.22 111.374 -151.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.628 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -29.92 133.81 0.05 Allowed 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 125.251 1.595 . . . . 0.2 114.004 -157.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.7 ' HB2' HG11 ' A' ' 22' ' ' VAL . 23.8 mt-10 -124.9 136.72 54.03 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 114.777 -1.101 . . . . 1.26 111.15 -172.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.589 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.0 OUTLIER -100.3 142.1 32.25 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.469 -1.678 . . . . 0.15 106.469 173.818 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.419 ' N ' HD23 ' A' ' 27' ' ' LEU . 9.7 m -126.94 109.22 11.71 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.796 -0.762 . . . . 0.21 110.241 -178.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.647 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 88.3 t90 -89.23 105.71 17.96 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.684 0.754 . . . . 0.24 109.086 175.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.426 ' HD3' ' O ' ' A' ' 31' ' ' SER . 3.6 tmt_? -113.54 115.0 27.28 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.723 -1.126 . . . . 0.87 108.523 -177.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.546 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 98.1 p -58.75 144.66 43.06 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.308 0.575 . . . . 0.75 110.444 -173.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.67 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 18.5 m -54.82 -25.16 26.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.765 -1.107 . . . . 0.39 111.816 -173.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -89.77 -13.95 35.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.97 -0.559 . . . . 2.33 111.723 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.69 22.05 60.64 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.319 -0.943 . . . . 0.55 111.108 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -84.52 -39.28 19.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.919 -0.64 . . . . 1.13 111.913 -174.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -146.74 161.57 40.34 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.207 0.527 . . . . 2.03 110.774 -177.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 85.3 t -144.08 131.0 16.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.1 -0.955 . . . . 0.55 110.124 -176.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -131.96 109.11 9.82 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.639 -0.709 . . . . 0.69 109.813 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.9 m -99.82 137.06 38.81 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.625 -0.262 . . . . 0.3 111.294 -175.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.528 HG11 HD13 ' A' ' 62' ' ' LEU . 40.7 t -110.01 128.43 66.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 122.653 0.381 . . . . 0.66 111.703 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 45' ' ' ILE . 53.2 t -90.53 108.19 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 109.319 -0.623 . . . . 0.18 109.319 172.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.601 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.0 mm? -54.95 -27.26 42.22 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.924 -1.035 . . . . 0.12 112.415 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.521 ' O ' ' HE2' ' A' ' 65' ' ' LYS . 43.1 t -75.75 -34.04 60.26 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.598 -0.441 . . . . 1.06 110.641 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.457 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 58.6 p -77.77 -10.37 59.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.472 0.653 . . . . 0.2 109.661 175.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.659 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 45.2 mm -79.85 123.84 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 114.995 -1.002 . . . . 0.23 111.256 173.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.581 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 5.8 t70 -73.85 -46.26 46.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.29 -0.868 . . . . 0.7 111.436 174.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.466 ' O ' HG12 ' A' ' 63' ' ' ILE . 43.6 tptt -151.52 159.48 44.12 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 120.763 0.316 . . . . 1.95 110.432 -177.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.017 HD23 ' HG3' ' A' ' 105' ' ' GLN . 11.8 tp -117.68 148.24 42.16 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.623 -0.51 . . . . 0.14 109.623 170.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 15.3 mm100 -126.55 156.47 40.78 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.23 -0.895 . . . . 1.49 109.573 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.605 ' HB3' ' HD3' ' A' ' 101' ' ' LYS . . . -163.04 144.06 9.61 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.228 -0.442 . . . . 0.25 109.925 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.515 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 40.8 p -52.41 126.72 38.7 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 121.36 0.6 . . . . 0.37 112.135 -176.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.52 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 59.6 Cg_endo -69.31 167.08 24.9 Favored 'Trans proline' 0 C--N 1.334 -0.225 0 C-N-CA 124.323 3.349 . . . . 0.64 112.305 177.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.01 -28.65 58.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.842 0.353 . . . . 1.02 111.272 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.3 t -72.43 -23.61 61.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 1.58 110.784 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.506 ' CB ' ' HB ' ' A' ' 51' ' ' THR . 31.6 t -71.74 133.46 45.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.923 -0.58 . . . . 0.71 110.081 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -80.35 -15.14 57.57 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.758 0.789 . . . . 2.89 109.309 177.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -106.49 172.62 6.72 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.054 -0.975 . . . . 2.59 109.787 -176.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.555 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.2 OUTLIER -131.34 109.83 10.64 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.526 -0.916 . . . . 1.78 108.526 -177.429 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.56 ' HG2' ' HA ' ' A' ' 90' ' ' SER . 72.9 mtm -154.73 155.5 34.66 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.79 0.329 . . . . 1.3 111.212 -172.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.593 HD23 HD11 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -120.82 160.13 24.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.553 -0.749 . . . . 0.14 110.956 176.252 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 48.8 ttp180 -152.43 113.61 4.24 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 120.882 0.372 . . . . 2.72 111.198 171.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.725 ' HG ' HD13 ' A' ' 48' ' ' LEU . 10.4 mt -94.46 110.53 22.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.358 -0.383 . . . . 0.9 110.945 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.662 HG23 ' HB3' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -87.61 125.7 41.24 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 CA-C-N 116.027 -0.533 . . . . 0.4 110.454 -176.837 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -99.01 151.94 19.57 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.029 -1.082 . . . . 0.48 111.096 174.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.581 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 1.0 OUTLIER -56.5 134.16 53.9 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.858 0.361 . . . . 1.15 111.263 -174.176 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.76 -0.655 . . . . 0.69 110.918 -179.844 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? . . . . . 0 CA--C 1.52 -0.184 0 CA-C-O 121.245 0.545 . . . . 1.78 110.956 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.662 ' HB3' HG23 ' A' ' 63' ' ' ILE . 12.9 ptt180 -129.56 145.0 51.51 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.629 0.728 . . . . 2.29 111.994 -173.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -107.39 116.63 32.27 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.633 -1.167 . . . . 0.5 110.517 -173.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.441 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 48.6 ttm -104.68 128.73 52.83 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.67 -0.412 . . . . 0.42 111.32 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.465 ' CE2' HD12 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -121.84 123.04 40.83 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.054 -0.721 . . . . 1.33 109.054 175.756 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.56 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 64.6 m -93.18 130.69 38.76 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.926 0.393 . . . . 0.94 110.264 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.593 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 40.2 m-85 -107.48 169.73 8.4 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.404 0.621 . . . . 1.33 110.896 176.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -112.15 -6.07 14.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.413 -0.812 . . . . 1.53 109.828 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.478 ' OD1' ' HB ' ' A' ' 95' ' ' THR . 28.6 t-20 -130.65 128.51 41.1 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.284 0.564 . . . . 0.83 111.282 -176.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.426 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 14.6 tpt180 -59.32 -37.06 76.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.76 -1.109 . . . . 2.16 111.641 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.478 ' HB ' ' OD1' ' A' ' 93' ' ' ASN . 91.7 m -72.26 -54.94 8.1 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.312 -0.403 . . . . 0.4 110.777 -176.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.8 t -44.95 -57.34 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 115.969 -0.559 . . . . 0.29 111.434 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.555 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -63.63 -29.92 71.09 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.578 -0.449 . . . . 0.29 111.218 -177.656 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.515 ' HA ' ' HE2' ' A' ' 101' ' ' LYS . 26.0 t70 -68.64 -33.06 73.35 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.465 0.65 . . . . 0.39 109.251 177.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.613 ' O ' ' HG3' ' A' ' 102' ' ' MET . 19.3 m120 -77.41 -50.74 12.07 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.634 -1.166 . . . . 1.55 110.055 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.633 HG23 HD11 ' A' ' 18' ' ' ILE . 32.4 mm -56.0 -48.44 78.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.235 -0.893 . . . . 0.13 110.14 178.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.758 ' HA ' HD21 ' A' ' 48' ' ' LEU . 13.3 ttpt -58.61 -50.96 71.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.368 -0.833 . . . . 1.11 111.133 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.613 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.3 ppp? -67.89 -23.06 65.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 1.17 110.335 -175.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.401 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 52.1 m -68.13 -51.57 44.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.89 -0.595 . . . . 0.15 110.507 174.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.976 ' HB2' HD22 ' A' ' 48' ' ' LEU . 13.1 mt -69.04 -56.79 6.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.184 -0.916 . . . . 0.13 111.7 -173.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 1.017 ' HG3' HD23 ' A' ' 48' ' ' LEU . 54.1 mt-30 -53.16 -29.19 30.12 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.049 0.388 . . . . 1.45 112.049 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -61.28 -28.16 68.99 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.84 0.828 . . . . 0.65 109.265 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 104' ' ' LEU . 25.2 mt -85.68 -45.28 17.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 113.803 -1.544 . . . . 0.17 110.791 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.7 mt -67.52 -53.81 28.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.417 -0.811 . . . . 0.29 111.46 -172.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.0 m -65.03 -14.96 61.73 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.567 0.699 . . . . 1.22 109.708 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.521 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 14.0 ttt180 -77.65 -42.95 32.94 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.863 -1.062 . . . . 3.79 109.752 174.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.759 -0.655 . . . . 0.6 111.156 -178.866 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 261' ' ' PHE . . . . . 0.52 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 12.0 m-85 . . . . . 0 N--CA 1.443 -0.802 0 N-CA-C 109.7 -0.481 . . . . 0.95 109.7 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.3 p -125.8 156.79 35.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.359 -0.978 . . . . 1.37 108.359 172.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 263' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' B' ' 263' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.312 -1.055 0 N-CA-C 109.322 -0.622 . . . . 2.24 109.322 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.9 p80 . . . . . 0 CA--C 1.53 0.201 0 CA-C-O 121.378 0.608 . . . . 1.85 111.335 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.7 p -161.89 149.53 14.56 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.757 -0.656 . . . . 0.95 109.607 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.23 142.75 4.41 Favored Glycine 0 C--O 1.224 -0.516 0 N-CA-C 111.388 -0.685 . . . . 0.16 111.388 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.774 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -73.53 121.25 20.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.175 0.487 . . . . 0.43 111.148 -177.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.602 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -128.27 161.01 30.36 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.289 0.566 . . . . 0.13 111.925 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.48 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.7 mp -102.74 113.62 39.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.274 -0.875 . . . . 0.29 109.291 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.505 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 84.1 t80 -112.96 101.91 9.93 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.989 -0.375 . . . . 0.56 109.989 -178.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 64.8 57.3 1.05 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.516 0.674 . . . . 1.46 110.721 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt 72.54 -8.2 1.26 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.332 -1.304 . . . . 1.91 113.369 170.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.432 HG21 ' HD3' ' A' ' 36' ' ' LYS . 0.5 OUTLIER -99.85 127.13 53.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.064 0.459 . . . . 0.47 110.37 173.054 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.48 ' HA ' HG13 ' A' ' 8' ' ' ILE . 14.1 p -78.71 126.55 30.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.817 -0.628 . . . . 1.02 110.552 177.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.658 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -147.3 -157.61 7.48 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.938 -0.649 . . . . 0.16 112.556 -177.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.774 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.0 mm -124.7 154.68 32.51 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.789 0 CA-C-O 120.756 0.312 . . . . 0.19 110.721 -177.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.558 HG12 HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -129.27 133.67 65.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.236 -0.438 . . . . 0.16 110.461 -179.616 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.28 112.62 9.25 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.03 -0.532 . . . . 0.12 111.468 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.587 HD11 HG23 ' A' ' 100' ' ' ILE . 4.8 mp -84.24 105.08 13.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.746 -0.835 . . . . 0.18 108.746 172.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -109.38 120.02 41.25 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 110.242 -0.281 . . . . 1.12 110.242 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.62 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 37.3 mt-10 -105.72 83.71 1.97 Allowed 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 117.13 -1.828 . . . . 0.74 107.403 165.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -122.04 -13.03 8.26 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 106.756 -1.572 . . . . 0.59 106.756 157.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.997 HG11 ' HB2' ' A' ' 26' ' ' GLU . 13.9 p -102.93 -179.79 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 111.823 -2.444 . . . . 0.35 111.58 -157.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.642 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 1.4 p -51.88 165.71 0.45 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 117.706 -1.14 . . . . 1.31 108.416 168.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.642 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 18.7 Cg_endo -45.42 124.38 6.43 Favored 'Trans proline' 0 C--N 1.358 1.071 0 CA-C-N 121.514 1.576 . . . . 0.22 111.803 -154.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.806 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -21.69 133.57 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.721 1.748 . . . . 0.2 115.721 -151.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.997 ' HB2' HG11 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -112.93 138.65 49.47 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 114.705 -1.134 . . . . 1.26 110.671 -179.264 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.813 ' HB3' HG12 ' A' ' 40' ' ' VAL . 2.2 tt -100.78 142.53 32.13 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.519 -1.66 . . . . 0.15 106.519 169.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.565 ' N ' HD23 ' A' ' 27' ' ' LEU . 10.5 m -127.47 107.98 10.42 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.973 -0.691 . . . . 0.21 110.122 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.614 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 89.6 t90 -91.34 105.4 17.75 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.664 -0.865 . . . . 0.24 108.664 174.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -114.37 117.17 30.29 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.118 -0.946 . . . . 0.87 109.053 -177.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.569 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 80.8 p -57.24 148.44 22.49 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.09 0.471 . . . . 0.75 110.822 -173.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.658 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 7.5 m -58.4 -27.34 64.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.364 -0.835 . . . . 0.39 110.266 -177.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.473 ' OD2' ' HB3' ' A' ' 35' ' ' ASP . 1.4 p-10 -81.37 -27.54 34.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.078 -0.964 . . . . 2.33 111.267 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.83 2.69 84.02 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.087 -0.578 . . . . 0.55 112.974 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.473 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 12.3 t70 -78.28 -26.1 46.95 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.735 0.272 . . . . 1.13 111.735 -177.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.432 ' HD3' HG21 ' A' ' 12' ' ' VAL . 16.7 ptmt -137.73 155.06 49.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.434 0.635 . . . . 2.03 110.363 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.3 p -149.64 140.69 16.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.226 -0.897 . . . . 0.55 110.392 -175.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -130.72 108.98 10.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.643 0.259 . . . . 0.69 110.369 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 27.0 m -97.83 129.3 44.82 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.323 -0.621 . . . . 0.3 109.323 175.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.813 HG12 ' HB3' ' A' ' 27' ' ' LEU . 9.6 p -119.29 139.98 44.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.76 -0.376 . . . . 0.66 111.501 -178.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.628 ' O ' HG12 ' A' ' 45' ' ' ILE . 60.7 t -89.74 109.54 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.288 0.566 . . . . 0.18 110.077 -177.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.707 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.9 mm? -53.44 -31.84 47.24 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.944 -1.025 . . . . 0.12 112.669 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 15.1 t -76.36 -33.76 58.92 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.581 -0.448 . . . . 1.06 111.012 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.548 ' OG1' ' HB ' ' A' ' 41' ' ' VAL . 72.8 p -74.44 -11.26 60.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.073 0.463 . . . . 0.2 109.908 172.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.628 HG12 ' O ' ' A' ' 41' ' ' VAL . 37.4 mm -83.94 121.31 36.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.885 -0.598 . . . . 0.23 110.391 172.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.716 ' HB2' ' CG ' ' A' ' 65' ' ' LYS . 14.6 t70 -85.81 -41.38 15.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.104 0.478 . . . . 0.7 111.46 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.6 ' HE2' ' OD2' ' A' ' 46' ' ' ASP . 53.4 mmtt -132.47 143.1 49.54 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.563 -0.532 . . . . 1.95 109.563 -177.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.853 HD22 ' HB2' ' A' ' 104' ' ' LEU . 8.1 tp -114.53 141.22 48.01 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.637 0.732 . . . . 0.14 109.223 165.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 78.2 mm-40 -122.53 151.52 41.28 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.433 -1.258 . . . . 1.49 109.695 -177.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.19 139.94 8.61 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.671 -0.695 . . . . 0.25 109.242 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.43 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 32.3 p -49.95 128.22 21.2 Favored Pre-proline 0 N--CA 1.468 0.472 0 CA-C-O 121.265 0.555 . . . . 0.37 111.705 -178.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.565 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 57.3 Cg_endo -69.26 166.94 25.26 Favored 'Trans proline' 0 C--N 1.334 -0.207 0 C-N-CA 124.293 3.329 . . . . 0.64 112.153 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.62 -28.49 68.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.255 0.55 . . . . 1.02 110.322 175.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.2 t -68.12 -24.8 65.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.532 -0.758 . . . . 1.58 110.333 176.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.438 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 46.6 t -74.06 136.03 43.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.744 -0.662 . . . . 0.71 110.413 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -87.14 0.4 55.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.474 0.654 . . . . 2.89 110.151 176.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.24 176.83 4.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.094 -0.957 . . . . 2.59 109.689 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.491 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -136.53 110.92 8.48 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.801 -1.185 . . . . 1.78 107.801 178.672 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.595 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 3.9 ttm -156.01 149.43 24.72 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 120.426 -0.509 . . . . 1.3 111.692 -172.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.44 HD22 HG22 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -120.06 151.2 39.37 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.367 -0.833 . . . . 0.14 110.416 174.365 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.566 ' HD3' ' HB2' ' A' ' 88' ' ' MET . 15.9 ttp180 -148.76 114.43 5.66 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 121.149 0.5 . . . . 2.72 110.62 171.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.833 HD13 ' CE2' ' A' ' 89' ' ' PHE . 8.9 mp -95.16 113.17 24.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.06 -0.518 . . . . 0.9 110.242 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.553 HG23 ' HB3' ' A' ' 86' ' ' ARG . 3.6 mm -87.75 107.54 17.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.881 -0.414 . . . . 0.4 109.881 -173.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -78.92 140.82 23.63 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.321 -0.942 . . . . 0.48 111.391 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.716 ' CG ' ' HB2' ' A' ' 46' ' ' ASP . 16.1 mttm -59.02 135.2 57.55 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.46 0.648 . . . . 1.15 112.142 -174.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 C--N 1.318 -0.778 0 CA-C-N 114.779 -1.101 . . . . 0.69 110.251 -179.202 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 123.334 1.54 . . . . 1.78 109.588 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.553 ' HB3' HG23 ' A' ' 63' ' ' ILE . 27.4 ptt180 -110.8 158.5 18.61 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.688 -1.596 . . . . 2.29 111.046 -172.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -127.03 112.32 15.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.142 -0.935 . . . . 0.5 110.152 -168.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.566 ' HB2' ' HD3' ' A' ' 61' ' ' ARG . 47.6 ttm -106.21 131.36 53.54 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 111.86 0.318 . . . . 0.42 111.86 -173.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.833 ' CE2' HD13 ' A' ' 62' ' ' LEU . 1.5 m-85 -119.04 123.57 44.81 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.071 -0.714 . . . . 1.33 109.071 172.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.545 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 23.4 m -87.44 126.76 35.08 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.101 -0.5 . . . . 0.94 110.021 178.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.602 ' CE1' ' HB2' ' A' ' 7' ' ' ALA . 33.1 m-85 -107.9 165.17 11.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.584 0.707 . . . . 1.33 111.047 176.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -109.9 -12.7 14.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.93 -1.032 . . . . 1.53 109.642 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.556 ' OD1' ' HB ' ' A' ' 95' ' ' THR . 28.5 t-20 -126.28 125.18 41.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.595 -0.73 . . . . 0.83 110.752 -174.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -58.48 -35.57 72.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.962 -1.017 . . . . 2.16 111.553 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.556 ' HB ' ' OD1' ' A' ' 93' ' ' ASN . 95.4 m -70.74 -55.32 8.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.625 0.25 . . . . 0.4 110.59 -176.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.7 t -45.76 -57.86 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 115.904 -0.589 . . . . 0.29 111.526 175.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.491 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -62.09 -29.86 70.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 120.616 -0.434 . . . . 0.29 111.288 -178.082 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.0 -32.15 70.18 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.412 0.625 . . . . 0.39 109.367 177.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.619 ' O ' ' HG3' ' A' ' 102' ' ' MET . 19.1 m120 -78.16 -48.77 15.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.817 -1.083 . . . . 1.55 110.116 -177.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.587 HG23 HD11 ' A' ' 18' ' ' ILE . 37.8 mm -57.24 -50.97 75.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.314 -0.857 . . . . 0.13 110.396 176.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.692 ' HA ' HD21 ' A' ' 48' ' ' LEU . 11.2 ttpt -56.39 -50.48 71.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.634 -0.712 . . . . 1.11 111.101 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.619 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.9 ppp? -66.44 -24.86 66.51 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.881 0.372 . . . . 1.17 110.841 -176.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 49.3 m -69.43 -49.73 52.38 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.48 0.657 . . . . 0.15 110.328 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.853 ' HB2' HD22 ' A' ' 48' ' ' LEU . 13.9 mt -67.74 -56.68 8.32 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.051 -0.977 . . . . 0.13 111.341 -175.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.761 ' HG3' HD23 ' A' ' 48' ' ' LEU . 43.1 mt-30 -50.02 -29.89 9.58 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.249 0.463 . . . . 1.45 112.249 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -60.91 -31.3 70.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.979 0.895 . . . . 0.65 109.414 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.806 HG21 ' HB3' ' A' ' 25' ' ' ALA . 21.3 mt -84.92 -46.51 17.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 113.594 -1.639 . . . . 0.17 110.503 178.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -64.68 -51.2 70.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.677 -0.692 . . . . 0.29 110.775 -174.436 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.3 m -57.4 -26.27 60.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.988 0.423 . . . . 1.22 110.673 174.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 12.1 mtt180 -69.2 -37.35 78.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.453 0.645 . . . . 3.79 110.006 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.449 ' HD2' ' O ' ' A' ' 107' ' ' ILE . 42.4 m-85 . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 114.982 -1.008 . . . . 0.6 111.734 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 261' ' ' PHE . . . . . 0.565 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 9.8 m-85 . . . . . 0 N--CA 1.444 -0.765 0 N-CA-C 109.747 -0.464 . . . . 0.95 109.747 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 10.6 p -135.59 140.17 45.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.272 -0.27 . . . . 1.37 110.272 175.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 . . . . . 0 C--N 1.324 -0.526 0 N-CA-C 108.639 -0.874 . . . . 2.24 108.639 174.067 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 . . . . . 0 C--O 1.228 -0.055 0 CA-C-O 121.23 0.538 . . . . 1.85 110.336 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.438 ' C ' HD11 ' A' ' 100' ' ' ILE . 77.4 p -162.72 149.53 13.02 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.496 -0.775 . . . . 0.95 109.655 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.26 147.0 7.74 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 110.839 -0.905 . . . . 0.16 110.839 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.741 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -79.26 117.43 20.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.644 0.722 . . . . 0.43 111.619 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.29 158.24 28.59 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.347 0.594 . . . . 0.13 111.587 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.492 HG13 ' HA ' ' A' ' 13' ' ' SER . 3.1 mp -99.01 129.22 49.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.409 -0.814 . . . . 0.29 109.263 177.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.578 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 89.1 t80 -139.28 111.96 7.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.913 -0.585 . . . . 0.56 109.917 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 69.49 45.21 0.84 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.727 0.775 . . . . 1.46 110.421 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? 70.01 3.14 4.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.276 -1.329 . . . . 1.91 112.732 172.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.1 131.68 59.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.784 0.326 . . . . 0.47 110.478 175.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.492 ' HA ' HG13 ' A' ' 8' ' ' ILE . 30.5 t -78.69 117.0 19.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.4 0.619 . . . . 1.02 110.042 177.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.718 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -130.97 -153.91 7.75 Favored Glycine 0 N--CA 1.434 -1.44 0 CA-C-N 115.288 -0.869 . . . . 0.16 111.3 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.741 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 7.8 mm -127.88 153.15 36.86 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 CA-C-O 120.919 0.39 . . . . 0.19 110.687 -177.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.442 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -125.41 131.94 71.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 115.824 -0.625 . . . . 0.16 109.332 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.94 113.97 10.58 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.758 -0.377 . . . . 0.12 111.555 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.603 HD11 HG23 ' A' ' 100' ' ' ILE . 4.4 mp -84.14 113.46 23.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.068 -1.086 . . . . 0.18 108.068 171.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -121.58 130.33 53.44 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.487 -0.324 . . . . 1.12 110.274 -177.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -110.48 84.55 1.95 Allowed 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 116.912 -1.915 . . . . 0.74 107.482 164.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -120.85 -10.32 9.14 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 106.122 -1.807 . . . . 0.59 106.122 157.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.749 HG11 ' HB2' ' A' ' 26' ' ' GLU . 14.0 p -102.08 179.15 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 111.743 -2.48 . . . . 0.35 111.395 -158.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.69 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -53.33 168.77 0.35 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 117.543 -1.217 . . . . 1.31 108.134 166.522 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.594 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 9.2 Cg_endo -41.68 127.2 3.41 Favored 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 121.796 1.664 . . . . 0.22 111.088 -157.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.54 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -30.72 131.51 0.09 Allowed 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 125.279 1.612 . . . . 0.2 113.557 -154.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.749 ' HB2' HG11 ' A' ' 22' ' ' VAL . 47.0 mt-10 -124.09 143.25 50.57 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.676 -1.147 . . . . 1.26 110.864 -169.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.576 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.1 tt -101.26 143.39 31.39 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 106.557 -1.645 . . . . 0.15 106.557 175.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.416 ' N ' HD23 ' A' ' 27' ' ' LEU . 14.1 m -129.46 109.65 11.23 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.846 -0.742 . . . . 0.21 110.705 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.647 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 85.1 t90 -86.71 106.59 17.75 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.52 0.676 . . . . 0.24 109.544 174.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -114.31 118.87 35.11 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.289 -0.869 . . . . 0.87 109.191 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.432 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 49.8 m -56.08 142.04 37.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.871 0.367 . . . . 0.75 110.756 -176.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.718 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 18.4 m -59.29 -28.19 66.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.452 -0.795 . . . . 0.39 110.166 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.09 -27.19 54.06 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.218 -0.901 . . . . 2.33 110.932 175.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.63 -3.98 50.1 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.122 -0.561 . . . . 0.55 112.681 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.4 ' OD2' ' HG3' ' A' ' 36' ' ' LYS . 32.3 t70 -69.98 -78.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.458 0.54 . . . . 1.13 112.458 -175.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.4 ' HG3' ' OD2' ' A' ' 35' ' ' ASP . 19.8 mtpp -83.99 142.66 30.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.291 0.567 . . . . 2.03 112.057 -175.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 61.1 t -138.29 117.23 14.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.788 -1.096 . . . . 0.55 109.618 177.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -124.37 110.01 14.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.31 -0.404 . . . . 0.69 110.434 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.7 m -97.72 138.83 34.52 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 121.188 -0.205 . . . . 0.3 111.386 -176.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.568 HG11 HD13 ' A' ' 62' ' ' LEU . 27.7 t -113.11 129.3 69.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 122.769 0.428 . . . . 0.66 111.625 177.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.592 ' O ' HG12 ' A' ' 45' ' ' ILE . 23.0 t -90.81 108.49 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 121.252 0.548 . . . . 0.18 109.942 174.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.604 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.6 mm? -56.1 -28.1 56.37 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.158 -0.928 . . . . 0.12 112.339 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 41.1 t -74.88 -31.67 61.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.75 0.309 . . . . 1.06 110.674 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.427 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 82.6 p -80.29 -9.78 59.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.635 0.731 . . . . 0.2 109.738 175.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.615 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 45.1 mm -85.21 123.75 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 114.872 -1.058 . . . . 0.23 111.143 174.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.655 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 4.9 t70 -74.84 -47.71 28.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.149 -0.932 . . . . 0.7 110.718 176.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.524 ' HD2' ' O ' ' A' ' 46' ' ' ASP . 0.5 OUTLIER -147.0 164.75 32.01 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.134 -0.485 . . . . 1.95 111.036 -176.451 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.087 HD23 ' HG3' ' A' ' 105' ' ' GLN . 13.0 tp -125.96 146.73 49.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.004 0.431 . . . . 0.14 109.944 172.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 16.7 mm100 -124.08 158.55 31.95 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.182 -0.917 . . . . 1.49 110.176 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HB1' ' CE ' ' A' ' 97' ' ' MET . . . -164.66 142.91 6.72 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.496 -0.774 . . . . 0.25 109.928 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.559 ' HB ' ' CB ' ' A' ' 55' ' ' SER . 41.5 p -55.53 129.73 69.99 Favored Pre-proline 0 N--CA 1.471 0.587 0 CA-C-O 121.235 0.54 . . . . 0.37 111.355 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.467 ' O ' ' HB3' ' A' ' 55' ' ' SER . 39.1 Cg_endo -64.59 165.9 19.21 Favored 'Trans proline' 0 N--CA 1.471 0.148 0 C-N-CA 124.017 3.144 . . . . 0.64 112.555 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.04 -27.26 65.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.97 0.414 . . . . 1.02 110.726 175.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.7 m -74.62 -24.22 58.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.922 -0.581 . . . . 1.58 111.16 177.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.559 ' CB ' ' HB ' ' A' ' 51' ' ' THR . 27.3 t -61.81 138.25 58.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.972 -0.558 . . . . 0.71 110.634 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.65 -18.16 42.07 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.793 -0.817 . . . . 2.89 108.793 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -103.74 174.1 6.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.718 -1.128 . . . . 2.59 109.577 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.511 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -134.24 111.76 10.52 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.151 -0.685 . . . . 1.78 109.151 177.423 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.513 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 69.3 mtm -153.77 142.11 20.6 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.932 0.396 . . . . 1.3 111.288 -175.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.535 HD23 HD11 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -110.79 157.26 19.99 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.472 -0.786 . . . . 0.14 110.422 175.556 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.489 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 38.0 ttp180 -149.75 114.6 5.35 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-O 121.26 0.552 . . . . 2.72 111.629 170.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.786 ' HG ' HD13 ' A' ' 48' ' ' LEU . 8.5 mt -91.97 112.62 24.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.875 -0.602 . . . . 0.9 110.706 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.574 HG23 ' HG2' ' A' ' 86' ' ' ARG . 3.8 mm -86.01 108.88 17.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 C-N-CA 123.72 0.808 . . . . 0.4 110.436 -173.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -78.99 155.94 41.34 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 119.969 -1.11 . . . . 0.48 111.64 176.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.655 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 0.2 OUTLIER -68.05 135.06 51.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.133 0.467 . . . . 1.15 110.726 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.323 -0.563 0 CA-C-O 120.998 0.428 . . . . 0.69 110.018 176.737 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.298 0 CA-C-O 121.864 0.84 . . . . 1.78 110.259 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.574 ' HG2' HG23 ' A' ' 63' ' ' ILE . 6.7 mtm180 -115.2 141.56 47.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.315 -0.857 . . . . 2.29 109.816 -175.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -107.69 111.83 24.23 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.852 -0.613 . . . . 0.5 109.781 -173.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.456 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 55.7 ttm -105.02 121.92 44.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.729 0.3 . . . . 0.42 111.037 -176.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.437 ' CG ' HD11 ' A' ' 16' ' ' ILE . 91.1 m-85 -119.46 124.41 46.42 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.724 -0.473 . . . . 1.33 109.724 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.485 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 42.0 m -90.16 133.28 34.99 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.978 0.418 . . . . 0.94 110.874 -176.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.629 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 24.2 m-85 -108.14 173.61 6.24 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.153 0.501 . . . . 1.33 111.303 176.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -114.13 1.06 14.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.549 -0.75 . . . . 1.53 110.178 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -145.77 126.83 14.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.7 -0.682 . . . . 0.83 109.979 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.511 ' HA ' ' HG2' ' A' ' 97' ' ' MET . 5.9 ttm180 -71.3 -20.79 62.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.785 -0.643 . . . . 2.16 110.982 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.7 m -72.73 -55.39 6.84 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.104 -0.332 . . . . 0.4 110.104 174.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.9 t -45.81 -56.0 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-N 116.233 -0.439 . . . . 0.29 111.289 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.528 ' CE ' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -64.52 -28.56 69.73 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.031 -0.531 . . . . 0.29 111.221 -177.533 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.54 -33.31 72.6 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.127 -0.694 . . . . 0.39 109.127 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.597 ' O ' ' HG3' ' A' ' 102' ' ' MET . 19.4 m120 -74.5 -46.3 40.24 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.622 -1.172 . . . . 1.55 109.657 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.629 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 30.0 mm -59.9 -51.4 73.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.917 -1.038 . . . . 0.13 110.522 175.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.829 ' HA ' HD21 ' A' ' 48' ' ' LEU . 3.0 ttpp -57.16 -47.79 80.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.515 -0.766 . . . . 1.11 110.85 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.597 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.7 ppp? -67.06 -26.09 66.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.581 -0.281 . . . . 1.17 110.398 -177.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 106' ' ' GLN . 61.0 m -66.64 -54.9 18.29 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.286 0.565 . . . . 0.15 110.143 175.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.93 ' HB2' HD22 ' A' ' 48' ' ' LEU . 10.6 mt -64.5 -56.22 15.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.264 -0.88 . . . . 0.13 110.925 -175.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 1.087 ' HG3' HD23 ' A' ' 48' ' ' LEU . 98.0 mt-30 -52.6 -24.19 7.86 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.889 0.7 . . . . 1.45 112.889 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 102' ' ' MET . 37.6 mt-30 -65.73 -40.97 92.69 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.899 0.857 . . . . 0.65 109.013 174.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.54 HG21 ' HB3' ' A' ' 25' ' ' ALA . 49.3 mt -72.5 -42.49 63.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 113.765 -1.561 . . . . 0.17 110.727 178.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.1 mt -63.95 -58.21 8.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.454 -0.794 . . . . 0.29 110.595 -176.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.0 t -54.64 -26.24 31.79 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.288 0.566 . . . . 1.22 110.802 173.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.435 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 8.3 ttt180 -69.59 -20.5 63.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.675 -0.693 . . . . 3.79 110.257 176.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.439 ' HD2' ' O ' ' A' ' 107' ' ' ILE . 18.0 m-85 . . . . . 0 N--CA 1.443 -0.796 0 CA-C-O 121.91 0.862 . . . . 0.6 108.694 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 261' ' ' PHE . . . . . 0.465 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 6.6 m-85 . . . . . 0 N--CA 1.447 -0.606 0 N-CA-C 110.045 -0.354 . . . . 0.95 110.045 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 10.2 p -143.96 140.81 25.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.75 -0.463 . . . . 1.37 109.75 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 . . . . . 0 C--N 1.317 -0.817 0 N-CA-C 108.836 -0.801 . . . . 2.24 108.836 175.585 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 52.7 p-80 . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 121.587 0.708 . . . . 1.85 110.675 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.4 p -162.7 134.89 5.42 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.205 -0.907 . . . . 0.95 109.241 173.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.5 148.22 10.47 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.664 -0.975 . . . . 0.16 110.664 -178.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.734 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.39 133.88 41.08 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 117.159 0.48 . . . . 0.43 111.44 -175.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.89 156.36 46.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.289 0.566 . . . . 0.13 111.386 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.544 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.2 mp -98.86 110.94 27.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.913 -0.773 . . . . 0.29 108.913 177.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.475 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 80.3 t80 -109.96 109.78 20.49 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.366 -0.379 . . . . 0.56 110.356 -177.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 63.61 46.53 4.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.883 0.849 . . . . 1.46 110.517 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt 77.18 -5.59 2.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.726 -1.579 . . . . 1.91 113.151 170.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.53 133.72 41.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.009 0.433 . . . . 0.47 110.427 173.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.544 ' HA ' HG13 ' A' ' 8' ' ' ILE . 22.6 t -78.16 126.63 31.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.91 -0.586 . . . . 1.02 110.532 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.674 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -150.05 -159.71 8.86 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.597 -0.729 . . . . 0.16 112.476 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.734 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 7.0 mm -126.31 153.43 34.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.821 0.343 . . . . 0.19 110.69 -178.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.49 133.69 68.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.977 -0.556 . . . . 0.16 109.762 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.0 108.03 7.18 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.013 0.435 . . . . 0.12 111.898 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.587 HD11 HG23 ' A' ' 100' ' ' ILE . 4.3 mp -85.73 110.74 20.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.833 -0.803 . . . . 0.18 108.833 172.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -114.19 127.65 56.0 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.651 -0.42 . . . . 1.12 110.268 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -109.8 83.65 1.79 Allowed 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 117.281 -1.768 . . . . 0.74 107.464 164.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -122.57 -11.25 8.29 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 106.466 -1.679 . . . . 0.59 106.466 156.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.939 HG11 ' HB3' ' A' ' 26' ' ' GLU . 14.5 p -101.44 173.58 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 111.964 -2.38 . . . . 0.35 112.072 -155.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.648 ' O ' HG13 ' A' ' 22' ' ' VAL . 7.6 m -54.42 165.81 0.81 Allowed Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 106.673 -1.603 . . . . 1.31 106.673 166.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 9.5 Cg_endo -40.36 127.52 2.24 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.655 1.57 . . . . 0.22 111.699 -147.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.666 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -31.01 131.48 0.1 Allowed 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 125.359 1.662 . . . . 0.2 112.649 -159.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.939 ' HB3' HG11 ' A' ' 22' ' ' VAL . 25.3 tt0 -130.14 133.73 46.83 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.51 -1.223 . . . . 1.26 111.658 -160.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.546 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.6 tt -101.62 147.39 26.47 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 107.006 -1.479 . . . . 0.15 107.006 177.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.516 ' N ' HD23 ' A' ' 27' ' ' LEU . 30.3 m -138.44 109.79 6.94 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.204 -0.599 . . . . 0.21 110.729 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.62 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 92.2 t90 -86.65 109.79 19.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.65 -0.705 . . . . 0.24 109.219 177.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.72 118.3 35.23 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.344 -0.844 . . . . 0.87 109.039 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.503 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 86.7 p -57.28 142.63 42.53 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 110.008 -0.367 . . . . 0.75 110.008 -177.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.674 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 38.3 m -46.67 -39.76 11.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.256 0.55 . . . . 0.39 110.91 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -72.32 -27.67 62.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.226 -0.897 . . . . 2.33 111.646 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.3 21.82 28.73 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.984 -0.627 . . . . 0.55 112.471 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -101.78 -30.76 11.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.158 0.504 . . . . 1.13 110.781 -173.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -126.22 130.06 50.2 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.663 -0.698 . . . . 2.03 110.154 -176.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 95.9 t -133.59 123.54 46.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.786 0.326 . . . . 0.55 110.223 -177.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -125.33 110.99 14.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.193 -0.458 . . . . 0.69 110.37 -177.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 40.2 m -92.6 145.05 24.73 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.805 0.336 . . . . 0.3 111.663 -177.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.574 HG11 HD13 ' A' ' 62' ' ' LEU . 32.0 t -122.02 124.72 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.254 -0.43 . . . . 0.66 110.913 174.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 45' ' ' ILE . 59.7 t -91.47 108.32 19.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.014 -0.736 . . . . 0.18 109.014 175.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.592 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.0 mm? -52.72 -27.63 18.46 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.409 -0.814 . . . . 0.12 112.79 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 45.4 t -75.38 -29.28 59.81 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.599 -0.44 . . . . 1.06 110.822 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.5 p -82.59 -4.64 57.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.46 0.647 . . . . 0.2 109.937 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.631 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 45.5 mm -89.39 126.01 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.134 -0.939 . . . . 0.23 111.448 175.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.577 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 21.7 t70 -77.5 -41.86 37.81 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.732 -0.667 . . . . 0.7 110.928 176.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -153.03 160.73 43.02 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 115.856 -0.611 . . . . 1.95 110.425 -175.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.999 HD23 ' HG2' ' A' ' 105' ' ' GLN . 12.9 tp -121.22 149.24 43.13 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.219 0.533 . . . . 0.14 109.566 171.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.57 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 67.6 mm-40 -125.39 156.34 38.95 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.229 -0.896 . . . . 1.49 109.5 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.03 145.24 11.89 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.809 -0.812 . . . . 0.25 108.809 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 36.6 p -54.61 124.96 51.82 Favored Pre-proline 0 C--O 1.234 0.286 0 CA-C-O 121.254 0.549 . . . . 0.37 111.419 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 62.0 Cg_endo -70.55 167.28 25.93 Favored 'Trans proline' 0 C--N 1.332 -0.34 0 C-N-CA 124.242 3.295 . . . . 0.64 112.061 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.57 -18.57 53.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.425 0.631 . . . . 1.02 110.215 172.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 63.5 m -83.79 -8.67 59.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.293 -0.867 . . . . 1.58 111.469 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.519 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 41.2 t -89.05 148.23 23.84 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.081 -0.508 . . . . 0.71 110.347 175.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -89.0 -11.2 44.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.798 -0.637 . . . . 2.89 110.985 177.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.9 mmmt -108.27 -177.05 3.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.763 -0.653 . . . . 2.59 110.324 -173.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.519 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -131.75 109.05 9.88 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.351 -0.981 . . . . 1.78 108.351 170.593 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.567 ' HG2' ' HA ' ' A' ' 90' ' ' SER . 68.7 mtm -155.39 146.04 22.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.044 0.384 . . . . 1.3 111.733 -175.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.878 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.7 OUTLIER -109.73 164.98 12.05 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.015 -0.539 . . . . 0.14 111.467 174.821 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 49.4 ttp180 -155.38 113.71 3.46 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.89 -0.595 . . . . 2.72 110.68 171.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.812 ' HG ' HD13 ' A' ' 48' ' ' LEU . 7.8 mt -93.37 114.52 26.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.094 0.473 . . . . 0.9 110.762 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.607 HG23 ' HG2' ' A' ' 86' ' ' ARG . 4.0 mm -86.74 106.1 15.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.718 -0.674 . . . . 0.4 110.517 -173.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.631 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -75.58 149.44 38.46 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 119.664 -1.255 . . . . 0.48 111.246 176.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.577 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 0.1 OUTLIER -60.4 134.91 57.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.258 0.529 . . . . 1.15 110.087 178.175 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 C--N 1.323 -0.585 0 CA-C-O 121.126 0.489 . . . . 0.69 110.62 176.442 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.447 -0.605 0 CA-C-O 122.483 1.135 . . . . 1.78 108.838 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.607 ' HG2' HG23 ' A' ' 63' ' ' ILE . 27.1 mtt85 -108.61 150.8 27.0 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.285 -1.325 . . . . 2.29 109.658 -176.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -109.15 110.41 21.63 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.865 -0.791 . . . . 0.5 108.865 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.484 ' HE2' ' HD3' ' A' ' 61' ' ' ARG . 52.8 ttm -111.44 120.89 43.67 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.698 -0.228 . . . . 0.42 110.669 -174.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.628 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -114.62 141.1 48.23 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.77 -0.826 . . . . 1.33 108.77 177.994 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.567 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 65.0 m -95.63 124.76 39.81 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.677 -0.49 . . . . 0.94 109.677 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.878 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 3.1 m-85 -107.41 167.29 10.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.302 -0.408 . . . . 1.33 109.994 -176.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -115.64 -2.3 12.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.95 0.405 . . . . 1.53 110.776 -173.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -145.2 129.29 17.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.18 0.514 . . . . 0.83 110.247 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 98' ' ' ASP . 6.7 tpt180 -65.1 -30.6 71.55 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.202 -0.908 . . . . 2.16 110.753 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.51 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 32.4 m -69.34 -47.59 63.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.21 0.529 . . . . 0.4 110.332 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.821 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 82.8 t -60.06 -53.18 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 CA-C-N 115.584 -0.735 . . . . 0.29 111.404 177.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.519 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -63.56 -24.45 67.81 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.906 -0.718 . . . . 0.29 109.582 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.51 ' HB3' ' O ' ' A' ' 95' ' ' THR . 33.0 t70 -69.92 -42.66 73.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.399 0.619 . . . . 0.39 109.522 175.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.821 ' ND2' ' HA ' ' A' ' 96' ' ' VAL . 21.5 p30 -80.56 -31.66 36.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.752 -1.113 . . . . 1.55 110.282 -173.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.587 HG23 HD11 ' A' ' 18' ' ' ILE . 27.3 mm -67.1 -52.46 43.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.483 -0.781 . . . . 0.13 110.219 171.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.767 ' HA ' HD21 ' A' ' 48' ' ' LEU . 4.2 ttpp -55.2 -51.18 67.39 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.986 -0.552 . . . . 1.11 110.641 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 5.1 ppp? -63.33 -27.64 69.46 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 120.668 0.271 . . . . 1.17 111.012 -175.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.9 m -65.31 -49.82 68.02 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.279 0.561 . . . . 0.15 109.933 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.919 ' HB2' HD22 ' A' ' 48' ' ' LEU . 9.2 mt -71.17 -57.6 4.35 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 115.193 -0.912 . . . . 0.13 111.19 -176.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.999 ' HG2' HD23 ' A' ' 48' ' ' LEU . 23.4 mm-40 -42.22 -35.49 0.97 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.174 0.805 . . . . 1.45 113.174 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -65.92 -44.85 83.97 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.728 0.775 . . . . 0.65 108.961 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.666 HG21 ' HB3' ' A' ' 25' ' ' ALA . 72.0 mt -65.68 -43.37 93.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 113.891 -1.504 . . . . 0.17 110.954 177.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.471 HG13 ' HA ' ' A' ' 105' ' ' GLN . 0.7 OUTLIER -61.6 -57.07 13.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.663 -0.699 . . . . 0.29 110.661 -176.191 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.8 m -54.49 -29.9 51.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.972 -0.558 . . . . 1.22 110.829 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 58.1 mtt180 -71.65 -29.62 64.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.712 -0.676 . . . . 3.79 110.832 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.47 ' OH ' ' HA ' ' A' ' 24' ' ' PRO . 14.5 m-85 . . . . . 0 C--N 1.321 -0.656 0 CA-C-N 115.859 -0.609 . . . . 0.6 111.435 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 261' ' ' PHE . . . . . 0.539 ' CE1' ' HB2' ' A' ' 59' ' ' MET . 3.3 m-85 . . . . . 0 N--CA 1.45 -0.468 0 CA-C-O 120.945 0.402 . . . . 0.95 110.429 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 4.7 p -133.66 163.65 36.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.962 -0.755 . . . . 1.37 108.962 175.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.313 -1.018 0 N-CA-C 109.476 -0.564 . . . . 2.24 109.476 173.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.601 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 39.4 m80 . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 120.626 0.25 . . . . 1.85 111.352 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 m -161.02 148.22 15.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.684 0.278 . . . . 0.95 110.511 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.81 147.6 7.18 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 110.409 -1.077 . . . . 0.16 110.409 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.718 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -81.06 119.97 24.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 117.935 0.868 . . . . 0.43 111.448 -175.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -127.9 160.35 32.1 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.541 0.686 . . . . 0.13 112.016 -176.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 2.6 mp -100.85 126.9 54.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.179 -0.918 . . . . 0.29 109.392 177.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.413 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 84.5 t80 -126.12 112.09 15.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.067 -0.515 . . . . 0.56 110.286 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 59.99 47.36 9.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.565 0.698 . . . . 1.46 110.903 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt 74.85 0.61 3.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.317 -1.31 . . . . 1.91 113.288 171.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -106.04 132.4 53.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.372 -0.531 . . . . 0.47 110.695 171.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.521 ' HA ' HG13 ' A' ' 8' ' ' ILE . 47.5 t -79.85 129.98 34.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.635 -0.711 . . . . 1.02 110.639 178.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.679 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -151.63 -153.26 6.15 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.797 -0.638 . . . . 0.16 112.036 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.718 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 7.5 mm -128.27 153.47 37.72 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 CA-C-O 120.948 0.404 . . . . 0.19 110.76 -177.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.469 HD11 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -122.61 134.6 65.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 115.911 -0.586 . . . . 0.16 109.628 179.672 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.58 109.26 7.04 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.52 -0.309 . . . . 0.12 111.7 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.674 HD11 HG23 ' A' ' 100' ' ' ILE . 3.7 mp -85.69 126.43 40.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.494 -0.928 . . . . 0.18 108.494 171.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.96 129.37 47.99 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.38 -0.528 . . . . 1.12 109.752 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -113.34 84.26 1.98 Allowed 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 117.353 -1.739 . . . . 0.74 107.694 164.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -122.25 -12.01 8.32 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 106.468 -1.678 . . . . 0.59 106.468 157.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 23' ' ' SER . 11.1 p -102.18 173.9 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 111.792 -2.458 . . . . 0.35 112.745 -154.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.732 ' O ' HG13 ' A' ' 22' ' ' VAL . 5.5 m -54.72 166.7 0.71 Allowed Pre-proline 0 C--O 1.221 -0.415 0 N-CA-C 106.689 -1.597 . . . . 1.31 106.689 165.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 11.0 Cg_endo -42.06 127.99 4.03 Favored 'Trans proline' 0 C--N 1.355 0.908 0 CA-C-N 122.036 1.763 . . . . 0.22 111.203 -151.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.784 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -33.47 137.61 0.08 Allowed 'General case' 0 CA--C 1.506 -0.715 0 O-C-N 125.379 1.674 . . . . 0.2 113.833 -155.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.568 ' HB2' HG11 ' A' ' 22' ' ' VAL . 30.6 mt-10 -121.35 131.05 53.97 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 114.933 -1.03 . . . . 1.26 111.055 -169.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.561 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.7 tt -101.02 140.4 35.37 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 106.215 -1.772 . . . . 0.15 106.215 171.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.436 ' N ' HD23 ' A' ' 27' ' ' LEU . 19.4 m -131.22 108.83 9.98 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.677 -0.809 . . . . 0.21 110.441 -178.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.616 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 89.6 t90 -85.56 107.78 17.65 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.383 -0.826 . . . . 0.24 109.323 176.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -113.46 114.77 27.03 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.788 -1.097 . . . . 0.87 108.414 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.591 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 37.3 p -56.48 143.96 33.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.963 0.411 . . . . 0.75 110.268 -177.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.679 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 19.8 m -53.0 -33.2 50.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.145 -0.934 . . . . 0.39 111.432 -177.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -80.68 -27.84 36.93 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.125 -0.489 . . . . 2.33 111.233 177.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.04 0.34 57.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.098 -0.572 . . . . 0.55 112.234 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -64.37 -48.18 76.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.104 0.478 . . . . 1.13 111.516 -177.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -117.59 148.72 41.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.803 -0.635 . . . . 2.03 111.706 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 89.6 t -145.22 125.41 6.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.486 -1.234 . . . . 0.55 109.808 178.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -133.08 115.51 15.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.479 -0.328 . . . . 0.69 110.717 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 24.2 m -98.44 139.63 33.9 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.928 -0.309 . . . . 0.3 111.403 -178.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 23.3 t -112.12 129.46 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 122.878 0.471 . . . . 0.66 111.127 176.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.546 ' O ' HG12 ' A' ' 45' ' ' ILE . 48.4 t -91.6 108.77 20.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 CA-C-O 121.293 0.568 . . . . 0.18 109.565 173.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.634 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.1 mm? -53.95 -25.72 22.05 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.127 -0.942 . . . . 0.12 113.03 -178.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 64.6 m -79.78 -31.42 40.85 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.521 -0.471 . . . . 1.06 111.689 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.8 p -76.88 -8.74 57.9 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.178 -0.675 . . . . 0.2 109.178 173.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.592 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 47.3 mm -86.45 121.56 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.044 -0.98 . . . . 0.23 111.552 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.672 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 23.0 t70 -80.08 -43.31 22.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.621 -0.718 . . . . 0.7 110.991 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -140.51 157.12 45.98 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.986 -0.376 . . . . 1.95 109.986 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.01 HD23 ' HG3' ' A' ' 105' ' ' GLN . 12.2 tp -118.74 144.73 46.07 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.271 -0.64 . . . . 0.14 109.271 166.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 74.8 mm-40 -122.88 151.91 41.27 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.066 -0.97 . . . . 1.49 109.317 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.05 146.3 10.72 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.51 -0.768 . . . . 0.25 109.132 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.496 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 54.6 p -60.58 126.12 84.13 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-O 121.548 0.69 . . . . 0.37 111.073 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.484 ' O ' ' HB3' ' A' ' 55' ' ' SER . 57.8 Cg_endo -67.46 166.49 23.55 Favored 'Trans proline' 0 C--N 1.333 -0.276 0 C-N-CA 123.984 3.123 . . . . 0.64 111.627 177.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.64 -21.88 66.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.928 0.394 . . . . 1.02 110.67 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 t -78.76 -19.74 51.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 1.58 110.545 177.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.484 ' HB3' ' O ' ' A' ' 52' ' ' PRO . 27.9 t -67.85 145.56 54.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.889 -0.596 . . . . 0.71 110.452 176.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -89.82 -13.82 35.75 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.4 0.619 . . . . 2.89 110.145 175.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -106.48 173.57 6.26 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.135 -0.939 . . . . 2.59 110.053 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.511 ' HB3' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -130.46 112.18 12.98 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.644 -0.707 . . . . 1.78 109.555 175.581 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.62 ' HB3' ' CZ ' ' B' ' 261' ' ' PHE . 2.5 mtm -156.03 148.28 23.49 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.838 0.351 . . . . 1.3 111.691 -176.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.33 154.96 30.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.519 -0.764 . . . . 0.14 110.428 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 21.3 ttm180 -151.11 113.88 4.7 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 120.931 0.396 . . . . 2.72 110.823 171.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.76 ' HG ' HD13 ' A' ' 48' ' ' LEU . 9.1 mt -92.56 112.6 24.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.112 0.482 . . . . 0.9 110.509 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.69 HG23 ' HG2' ' A' ' 86' ' ' ARG . 6.3 mm -87.05 111.75 22.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 C-N-CA 123.464 0.705 . . . . 0.4 110.513 -172.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.592 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -79.0 150.36 33.92 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 120.254 -0.974 . . . . 0.48 111.864 177.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.672 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 1.1 mptm? -63.74 132.19 50.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.012 0.406 . . . . 1.15 110.763 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 C--N 1.318 -0.799 0 N-CA-C 109.19 -0.67 . . . . 0.69 109.19 175.874 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.516 -0.351 0 CA-C-O 121.775 0.798 . . . . 1.78 109.761 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.69 ' HG2' HG23 ' A' ' 63' ' ' ILE . 37.7 mtm180 -116.71 140.32 49.55 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.48 -0.782 . . . . 2.29 110.285 -173.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -103.1 111.23 23.48 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.552 -0.749 . . . . 0.5 109.155 -177.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.523 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 43.4 ttm -102.78 132.41 48.96 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.716 0.293 . . . . 0.42 110.754 -176.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.469 ' CG ' HD11 ' A' ' 16' ' ' ILE . 95.4 m-85 -127.16 123.72 37.39 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.526 -0.546 . . . . 1.33 109.526 177.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.535 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 50.1 m -91.78 130.85 37.49 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.831 0.348 . . . . 0.94 110.556 -177.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.619 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 30.7 m-85 -108.16 173.65 6.23 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.034 -0.53 . . . . 1.33 110.156 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -117.43 -3.06 11.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.017 -0.538 . . . . 1.53 109.6 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.556 ' OD1' ' HB ' ' A' ' 95' ' ' THR . 28.6 t-20 -137.51 130.62 30.61 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.595 -0.73 . . . . 0.83 110.21 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.546 ' HA ' ' HG2' ' A' ' 97' ' ' MET . 2.2 tmt_? -74.29 -24.05 59.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.866 -0.606 . . . . 2.16 110.559 -174.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.556 ' HB ' ' OD1' ' A' ' 93' ' ' ASN . 51.6 m -71.95 -48.33 45.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.96 0.409 . . . . 0.4 110.326 177.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.826 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 96.8 t -55.9 -57.12 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-N 115.956 -0.565 . . . . 0.29 111.259 174.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.625 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -58.35 -30.9 67.11 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.526 -0.87 . . . . 0.29 109.529 -179.14 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.624 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 33.5 t70 -64.8 -43.75 92.15 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.623 0.725 . . . . 0.39 110.721 175.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.826 ' ND2' ' HA ' ' A' ' 96' ' ' VAL . 20.6 p30 -76.96 -25.52 52.92 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.071 -0.968 . . . . 1.55 109.899 -173.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.674 HG23 HD11 ' A' ' 18' ' ' ILE . 28.2 mm -72.39 -55.94 11.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.813 -1.085 . . . . 0.13 111.196 171.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.799 ' HA ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -59.07 -39.29 81.67 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 120.768 0.318 . . . . 1.11 111.259 -177.359 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.442 ' HB3' ' HE2' ' A' ' 101' ' ' LYS . 26.6 ptm -69.85 -27.27 64.7 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.28 -0.637 . . . . 1.17 109.28 -176.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 21.7 m -67.62 -53.37 28.56 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.65 -0.705 . . . . 0.15 110.018 174.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.921 ' HB2' HD22 ' A' ' 48' ' ' LEU . 10.4 mt -65.66 -56.44 12.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.193 -0.912 . . . . 0.13 111.221 -176.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 1.01 ' HG3' HD23 ' A' ' 48' ' ' LEU . 42.8 mt-30 -51.68 -30.12 20.69 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.48 0.548 . . . . 1.45 112.48 -178.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -68.6 -26.85 65.58 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.882 0.848 . . . . 0.65 109.571 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.784 HG21 ' HB3' ' A' ' 25' ' ' ALA . 47.8 mt -82.56 -41.72 17.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.052 -1.431 . . . . 0.17 110.071 176.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.3 mt -66.98 -49.88 69.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.551 -0.75 . . . . 0.29 110.752 -176.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.7 m -61.34 -22.72 65.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.506 0.669 . . . . 1.22 110.063 174.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 9.7 ttt180 -72.19 -32.15 66.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.106 -0.952 . . . . 3.79 109.862 176.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 . . . . . 0 N--CA 1.451 -0.401 0 CA-C-N 116.177 -0.465 . . . . 0.6 111.654 -177.288 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 261' ' ' PHE . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 2.8 m-30 . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.956 0.408 . . . . 0.95 110.239 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.36 140.6 22.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.927 -0.579 . . . . 1.37 110.205 174.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 C--N 1.328 -0.33 0 N-CA-C 108.809 -0.812 . . . . 2.24 108.809 171.348 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 . . . . . 0 N--CA 1.463 0.188 0 CA-C-O 121.587 0.708 . . . . 1.85 109.547 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.403 ' C ' HD11 ' A' ' 100' ' ' ILE . 68.1 p -163.27 148.84 11.56 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.929 -1.032 . . . . 0.95 108.883 -176.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.22 142.69 5.64 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.188 -0.765 . . . . 0.16 111.188 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.747 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -73.4 120.94 19.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 117.361 0.58 . . . . 0.43 111.237 -176.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.485 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -130.08 157.7 41.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.394 0.616 . . . . 0.13 111.852 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.529 ' HB ' ' HB3' ' A' ' 90' ' ' SER . 2.6 mp -95.93 124.47 48.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.125 -0.943 . . . . 0.29 109.07 176.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.489 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 88.8 t80 -128.69 103.44 7.08 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.164 -0.471 . . . . 0.56 109.919 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 67.24 58.41 0.55 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.792 -0.64 . . . . 1.46 110.872 -175.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp 70.13 -8.47 0.84 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.608 -1.178 . . . . 1.91 113.374 171.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -104.73 131.83 52.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.969 0.414 . . . . 0.47 111.061 177.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.492 ' HA ' HG13 ' A' ' 8' ' ' ILE . 28.7 p -79.9 125.95 30.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.707 -0.679 . . . . 1.02 110.721 176.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.649 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -144.82 -154.38 6.12 Favored Glycine 0 N--CA 1.436 -1.339 0 CA-C-N 115.711 -0.677 . . . . 0.16 111.637 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.747 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 9.2 mm -126.13 153.84 34.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 120.755 0.312 . . . . 0.19 110.68 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.28 133.72 68.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 116.102 -0.499 . . . . 0.16 109.95 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.63 113.98 10.18 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 111.899 0.333 . . . . 0.12 111.899 175.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.585 HD11 HG23 ' A' ' 100' ' ' ILE . 3.8 mp -85.38 124.39 40.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.359 -0.978 . . . . 0.18 108.359 171.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.437 HD22 ' HB3' ' A' ' 21' ' ' ASP . 4.1 t-20 -126.62 124.31 39.61 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.949 -0.389 . . . . 1.12 109.949 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.503 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 23.7 mt-10 -109.63 84.05 1.86 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 117.084 -1.847 . . . . 0.74 107.519 163.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.437 ' HB3' HD22 ' A' ' 19' ' ' ASN . 17.7 t70 -121.48 -9.86 8.93 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.476 -1.676 . . . . 0.59 106.476 156.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 23' ' ' SER . 14.7 p -101.98 173.1 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 112.045 -2.343 . . . . 0.35 111.63 -157.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.663 ' O ' HG13 ' A' ' 22' ' ' VAL . 14.5 m -54.98 166.66 0.75 Allowed Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 106.942 -1.503 . . . . 1.31 106.942 166.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 10.2 Cg_endo -40.67 127.42 2.45 Favored 'Trans proline' 0 C--N 1.357 0.997 0 CA-C-N 121.913 1.719 . . . . 0.22 111.34 -150.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.734 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -33.7 136.34 0.11 Allowed 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 125.379 1.674 . . . . 0.2 113.691 -156.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.54 ' HB2' HG11 ' A' ' 22' ' ' VAL . 80.7 mt-10 -123.5 138.87 54.48 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.422 -1.263 . . . . 1.26 111.099 -169.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.572 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.1 tt -101.41 144.44 30.21 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 106.257 -1.757 . . . . 0.15 106.257 171.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.456 ' N ' HD23 ' A' ' 27' ' ' LEU . 18.1 m -129.84 109.18 10.72 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.903 -0.719 . . . . 0.21 110.002 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.606 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 89.9 t90 -86.9 105.4 17.04 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.687 -0.857 . . . . 0.24 108.687 175.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -113.49 114.84 27.1 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.844 -1.071 . . . . 0.87 108.738 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.54 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 37.5 p -56.19 148.33 18.49 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.24 0.543 . . . . 0.75 111.282 -174.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.649 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 24.0 m -55.97 -30.09 61.21 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.953 -1.021 . . . . 0.39 111.371 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -80.2 -28.54 38.64 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.024 0.44 . . . . 2.33 110.756 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.19 6.61 53.43 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.956 -0.64 . . . . 0.55 112.631 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.38 -69.72 0.6 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.367 . . . . 1.13 111.363 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -82.55 137.6 34.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.472 0.653 . . . . 2.03 111.546 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 96.0 t -140.57 120.32 12.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.397 -1.274 . . . . 0.55 109.496 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -125.89 114.12 18.11 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.438 -0.347 . . . . 0.69 110.438 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.2 m -96.99 138.49 34.45 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 121.205 -0.198 . . . . 0.3 111.188 -177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 37.5 t -113.31 129.79 68.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 122.716 0.407 . . . . 0.66 111.722 178.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.553 ' O ' HG12 ' A' ' 45' ' ' ILE . 46.8 t -90.42 108.86 20.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 CA-C-O 121.286 0.565 . . . . 0.18 109.777 172.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.573 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -55.12 -27.04 42.34 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.312 -0.858 . . . . 0.12 112.633 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.448 ' O ' ' HE2' ' A' ' 65' ' ' LYS . 33.9 t -75.97 -35.11 59.76 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.722 -0.391 . . . . 1.06 110.799 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.2 p -76.99 -16.39 59.35 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.591 0.71 . . . . 0.2 109.249 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.733 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 42.2 mm -73.66 121.47 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 114.977 -1.01 . . . . 0.23 110.964 172.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.641 ' HA ' ' NZ ' ' A' ' 65' ' ' LYS . 23.0 t70 -78.61 -48.23 15.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.21 -0.45 . . . . 0.7 111.298 175.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -137.0 151.9 49.51 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 110.165 -0.309 . . . . 1.95 110.165 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.072 HD23 ' HG3' ' A' ' 105' ' ' GLN . 11.9 tp -116.07 144.9 43.5 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.118 -0.697 . . . . 0.14 109.118 166.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 53.8 mm-40 -120.22 159.51 24.8 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.399 -0.819 . . . . 1.49 109.396 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' HB3' ' HG3' ' A' ' 101' ' ' LYS . . . -161.69 152.43 17.83 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.48 -0.933 . . . . 0.25 108.48 174.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.452 ' CG2' ' HE2' ' A' ' 59' ' ' MET . 33.4 p -55.4 125.49 59.41 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.476 0.655 . . . . 0.37 111.432 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 43.0 Cg_endo -67.39 166.88 22.12 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 124.0 3.133 . . . . 0.64 111.581 176.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.01 -22.73 67.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.027 0.441 . . . . 1.02 110.303 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.3 p -74.48 -27.7 60.69 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.558 -0.746 . . . . 1.58 110.786 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.446 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 23.0 t -70.29 140.8 52.37 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.214 -0.903 . . . . 0.71 109.409 174.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -90.95 -13.63 33.09 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.788 -0.819 . . . . 2.89 108.788 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.562 ' N ' ' HD3' ' A' ' 57' ' ' LYS . 2.2 mppt? -99.21 -176.8 3.41 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.745 -1.116 . . . . 2.59 111.354 -175.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.449 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -139.87 109.22 6.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.483 . . . . 1.78 109.705 -177.082 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.524 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 2.6 mpp? -155.69 167.65 29.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.934 0.397 . . . . 1.3 111.721 -175.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.644 HD23 HD11 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -130.28 161.58 30.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.324 -0.853 . . . . 0.14 111.445 176.38 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.582 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 13.1 ttm180 -154.26 114.3 3.86 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.765 -0.198 . . . . 2.72 110.749 173.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.771 ' HG ' HD13 ' A' ' 48' ' ' LEU . 10.7 mt -96.65 110.3 22.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.863 0.364 . . . . 0.9 111.095 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.482 ' CD1' ' HD2' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -89.13 128.73 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.056 0.543 . . . . 0.4 110.086 -178.099 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.733 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -95.02 152.28 20.4 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.017 -1.087 . . . . 0.48 112.337 176.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.641 ' NZ ' ' HA ' ' A' ' 46' ' ' ASP . 1.2 mptp? -58.33 134.48 56.62 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.755 0.312 . . . . 1.15 110.627 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--N 1.319 -0.719 0 CA-C-O 121.184 0.516 . . . . 0.69 110.306 178.078 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.287 0.565 . . . . 1.78 110.385 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.81 160.17 26.57 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.794 -0.639 . . . . 2.29 111.017 -174.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -125.08 113.0 17.16 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.282 -0.872 . . . . 0.5 109.406 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 55.8 ttm -105.15 126.08 51.68 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.835 0.35 . . . . 0.42 111.447 -175.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.452 ' CE2' HD12 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -118.97 124.59 47.39 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.563 -0.532 . . . . 1.33 109.563 178.181 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.529 ' HB3' ' HB ' ' A' ' 8' ' ' ILE . 33.3 t -93.06 130.72 38.57 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.849 0.357 . . . . 0.94 110.226 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.603 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 27.2 m-85 -108.53 172.7 6.69 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.824 -0.625 . . . . 1.33 111.417 176.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -119.95 -4.72 10.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.364 -0.834 . . . . 1.53 110.465 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -134.63 129.27 34.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.95 0.405 . . . . 0.83 110.338 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 14.9 tpt180 -59.62 -32.94 70.89 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.398 -0.819 . . . . 2.16 111.188 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 87.3 m -70.42 -58.7 3.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.419 -0.355 . . . . 0.4 110.545 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.4 t -45.72 -56.04 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-N 115.695 -0.684 . . . . 0.29 111.85 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.525 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -64.7 -28.59 69.7 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.256 -0.429 . . . . 0.29 110.966 -176.408 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -73.32 -30.04 63.09 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.037 -0.727 . . . . 0.39 109.037 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.619 ' O ' ' HG3' ' A' ' 102' ' ' MET . 19.4 m120 -77.5 -48.05 18.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.666 -1.152 . . . . 1.55 109.842 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.603 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 36.4 mm -57.9 -49.16 82.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.248 -0.887 . . . . 0.13 110.153 176.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.797 ' HA ' HD21 ' A' ' 48' ' ' LEU . 2.3 tmmm? -57.0 -48.53 78.25 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.814 -0.63 . . . . 1.11 110.887 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.619 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 5.0 ppp? -70.08 -24.65 63.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.78 0.324 . . . . 1.17 110.506 -175.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 53.9 m -67.79 -50.79 55.02 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.491 0.662 . . . . 0.15 109.891 176.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.927 ' HB2' HD22 ' A' ' 48' ' ' LEU . 12.6 mt -69.85 -58.17 4.2 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.963 -1.017 . . . . 0.13 111.326 -175.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 1.072 ' HG3' HD23 ' A' ' 48' ' ' LEU . 49.4 mt-30 -53.45 -24.03 11.67 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.804 0.668 . . . . 1.45 112.804 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -65.69 -48.91 70.45 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.637 -0.875 . . . . 0.65 108.637 175.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.734 HG21 ' HB3' ' A' ' 25' ' ' ALA . 60.1 mt -58.53 -43.8 87.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.2 -1.364 . . . . 0.17 110.811 175.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.5 mt -65.03 -51.21 69.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.596 -0.729 . . . . 0.29 110.184 -177.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.7 m -55.18 -33.31 62.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.15 0.5 . . . . 1.22 110.605 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 91.2 mtt180 -67.19 -30.24 70.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.588 -0.733 . . . . 3.79 110.602 178.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 . . . . . 0 N--CA 1.448 -0.533 0 CA-C-N 116.124 -0.489 . . . . 0.6 111.357 -179.431 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 261' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 61' ' ' ARG . 7.1 m-30 . . . . . 0 CA--C 1.52 -0.203 0 CA-C-O 120.957 0.408 . . . . 0.95 110.856 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.08 160.6 29.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.301 -1.0 . . . . 1.37 108.301 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.658 0 C-N-CA 120.082 -0.647 . . . . 2.24 109.977 177.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.615 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 19.9 m170 . . . . . 0 C--O 1.225 -0.224 0 CA-C-O 120.618 0.247 . . . . 1.85 111.417 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.6 p -164.42 159.31 19.41 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.072 -0.344 . . . . 0.95 110.072 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.36 144.71 4.23 Favored Glycine 0 C--O 1.225 -0.456 0 N-CA-C 110.886 -0.886 . . . . 0.16 110.886 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.745 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -76.56 120.71 22.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.618 0.709 . . . . 0.43 111.124 -177.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.47 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -130.05 159.27 37.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.307 0.575 . . . . 0.13 111.725 -176.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.506 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.3 mp -97.28 118.14 43.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.216 -0.902 . . . . 0.29 109.115 175.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.598 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 82.8 t80 -123.35 110.03 14.65 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.379 -0.373 . . . . 0.56 109.997 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.588 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 41.1 mt-10 68.74 50.37 0.65 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.488 -0.778 . . . . 1.46 110.702 -175.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.588 ' HD2' ' C ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER 66.49 3.9 3.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.31 -1.314 . . . . 1.91 112.791 171.515 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.497 HG21 ' HD2' ' A' ' 36' ' ' LYS . 0.7 OUTLIER -110.81 133.76 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.797 0.332 . . . . 0.47 110.293 172.118 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.506 ' HA ' HG13 ' A' ' 8' ' ' ILE . 31.8 t -78.17 133.25 37.82 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.325 0.583 . . . . 1.02 110.57 178.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.646 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -154.33 -152.95 6.26 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.486 -0.779 . . . . 0.16 111.683 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.745 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.3 mm -126.66 154.02 36.03 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-O 120.795 0.331 . . . . 0.19 110.646 -178.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.473 HD11 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -127.02 135.15 64.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 116.011 -0.541 . . . . 0.16 109.833 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.81 113.28 9.47 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.015 0.436 . . . . 0.12 112.031 174.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.759 HD11 HG23 ' A' ' 100' ' ' ILE . 4.3 mp -84.56 113.18 22.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.74 -0.837 . . . . 0.18 108.74 171.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -118.16 123.98 46.86 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 110.135 -0.321 . . . . 1.12 110.135 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.468 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 22.3 mt-10 -107.69 83.35 1.79 Allowed 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 117.191 -1.804 . . . . 0.74 107.383 165.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -122.21 -11.78 8.37 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.782 -1.562 . . . . 0.59 106.782 157.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.671 HG13 ' O ' ' A' ' 23' ' ' SER . 14.8 p -101.68 179.86 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 111.887 -2.415 . . . . 0.35 111.737 -155.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.671 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -53.04 165.2 0.62 Allowed Pre-proline 0 C--O 1.224 -0.263 0 N-CA-C 107.699 -1.223 . . . . 1.31 107.699 166.746 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.569 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 15.4 Cg_endo -44.49 126.39 6.83 Favored 'Trans proline' 0 C--N 1.353 0.813 0 CA-C-N 121.366 1.523 . . . . 0.22 111.852 -154.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.749 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -23.69 134.27 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 O-C-N 125.127 1.517 . . . . 0.2 114.882 -153.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.665 ' HB2' HG11 ' A' ' 22' ' ' VAL . 37.9 mt-10 -126.26 137.36 53.51 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.697 -1.138 . . . . 1.26 111.034 -173.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.2 tt -99.99 145.27 28.07 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 106.47 -1.678 . . . . 0.15 106.47 175.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.504 ' N ' HD23 ' A' ' 27' ' ' LEU . 19.2 m -131.96 109.3 9.96 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.891 -0.724 . . . . 0.21 110.392 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.601 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.2 t90 -89.25 108.16 19.46 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.574 -0.739 . . . . 0.24 109.143 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -115.89 120.26 38.65 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.252 -0.885 . . . . 0.87 109.091 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.509 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 35.5 p -56.01 148.17 18.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.891 0.377 . . . . 0.75 110.892 -175.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.646 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 21.7 m -54.26 -32.96 57.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.431 -0.804 . . . . 0.39 110.949 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -77.54 -29.66 52.42 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.244 -0.434 . . . . 2.33 111.113 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.07 13.66 51.84 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.736 -0.745 . . . . 0.55 113.042 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -85.84 -69.04 0.69 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.159 0.504 . . . . 1.13 110.336 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.497 ' HD2' HG21 ' A' ' 12' ' ' VAL . 17.0 ptpt -87.49 145.09 26.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.624 0.726 . . . . 2.03 110.371 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 65.7 t -147.17 140.51 19.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.487 -1.233 . . . . 0.55 109.041 -176.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -141.21 122.67 15.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.571 0.224 . . . . 0.69 110.595 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.0 m -103.85 142.66 34.0 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 121.256 -0.177 . . . . 0.3 111.09 -177.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.533 HG11 HD13 ' A' ' 62' ' ' LEU . 45.8 t -119.42 130.02 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.187 0.44 . . . . 0.66 112.187 178.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.555 ' O ' HG12 ' A' ' 45' ' ' ILE . 49.9 t -91.13 108.88 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-O 121.499 0.666 . . . . 0.18 109.935 172.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.605 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.3 mm? -49.95 -35.46 24.23 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.512 -1.222 . . . . 0.12 112.463 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.523 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 69.4 m -74.9 -29.91 61.13 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.866 -0.333 . . . . 1.06 111.576 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.477 ' OG1' ' HB ' ' A' ' 41' ' ' VAL . 76.1 p -79.97 -8.58 59.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.499 0.666 . . . . 0.2 109.766 175.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.61 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 39.3 mm -82.38 132.58 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.061 -0.972 . . . . 0.23 111.219 174.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.66 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 12.0 t70 -82.82 -41.1 19.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.354 -0.839 . . . . 0.7 110.911 175.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.515 ' O ' HG12 ' A' ' 63' ' ' ILE . 45.9 mmtt -145.47 143.02 29.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.374 -0.83 . . . . 1.95 110.658 -173.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.149 HD23 ' HG3' ' A' ' 105' ' ' GLN . 13.6 tp -111.27 139.62 46.51 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.659 -0.817 . . . . 0.14 109.45 163.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.643 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 15.6 mm100 -118.27 155.77 30.01 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.425 -1.262 . . . . 1.49 110.001 -178.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.01 143.73 9.47 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.878 -1.056 . . . . 0.25 108.546 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 47.3 p -54.49 126.18 54.83 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.665 0.745 . . . . 0.37 111.106 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.542 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 65.8 Cg_endo -71.7 167.76 25.61 Favored 'Trans proline' 0 C--N 1.332 -0.29 0 C-N-CA 124.349 3.366 . . . . 0.64 112.045 176.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.17 -24.23 64.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.993 0.425 . . . . 1.02 110.659 174.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -69.17 -24.04 64.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.53 0.681 . . . . 1.58 110.162 174.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.596 ' OG ' ' HE2' ' A' ' 57' ' ' LYS . 28.8 t -84.43 139.34 32.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.471 -0.786 . . . . 0.71 109.256 176.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -92.95 -11.9 32.16 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.823 -0.806 . . . . 2.89 108.823 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.596 ' HE2' ' OG ' ' A' ' 55' ' ' SER . 2.3 mppt? -90.45 176.48 6.69 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.695 -1.139 . . . . 2.59 110.779 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.447 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -135.3 109.58 8.36 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.011 -0.737 . . . . 1.78 109.011 -178.613 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.547 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 63.4 mtm -155.96 150.11 25.51 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.87 0.367 . . . . 1.3 111.23 -173.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -121.42 156.48 32.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.396 -0.82 . . . . 0.14 110.421 174.345 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.587 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 33.8 ttt180 -153.67 113.22 3.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.989 0.424 . . . . 2.72 110.892 175.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.774 ' HG ' HD13 ' A' ' 48' ' ' LEU . 10.4 mt -93.73 111.66 23.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.105 0.479 . . . . 0.9 110.428 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.897 HG23 ' HG2' ' A' ' 86' ' ' ARG . 3.7 mm -86.17 106.47 15.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 123.534 0.734 . . . . 0.4 109.98 -174.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -81.2 139.43 20.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 119.897 -1.144 . . . . 0.48 112.1 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.66 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 5.9 mttt -53.3 135.77 38.14 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.227 0.537 . . . . 1.15 111.467 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--N 1.322 -0.622 0 CA-C-O 121.559 0.695 . . . . 0.69 111.048 -176.236 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 122.506 1.146 . . . . 1.78 111.038 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.897 ' HG2' HG23 ' A' ' 63' ' ' ILE . 17.8 mtt85 -102.97 144.26 31.48 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.473 -1.24 . . . . 2.29 109.813 -174.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -105.82 110.87 23.32 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.802 -0.814 . . . . 0.5 108.802 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.423 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 58.2 ttm -105.1 121.97 44.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.916 0.389 . . . . 0.42 110.924 -174.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.473 ' CG ' HD11 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -117.06 123.19 46.24 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.832 -0.803 . . . . 1.33 108.832 177.5 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.523 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 28.2 t -94.64 131.54 40.32 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.149 0.5 . . . . 0.94 110.188 -178.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.47 ' CE1' ' HB2' ' A' ' 7' ' ' ALA . 38.2 m-85 -108.59 165.54 11.46 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.527 -0.76 . . . . 1.33 110.504 175.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -114.62 -3.3 12.92 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.45 -0.796 . . . . 1.53 110.168 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -126.15 121.51 33.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.865 -0.607 . . . . 0.83 109.76 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -54.66 -36.55 64.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.816 -1.084 . . . . 2.16 111.483 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 93.7 m -73.23 -55.59 6.24 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.964 -0.562 . . . . 0.4 111.015 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 94.0 t -45.13 -57.24 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-N 116.111 -0.495 . . . . 0.29 111.364 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.756 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -60.9 -34.05 74.06 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.579 -0.448 . . . . 0.29 110.416 -176.582 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -71.57 -20.35 62.02 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.165 0.507 . . . . 0.39 110.427 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.629 ' O ' ' HG3' ' A' ' 102' ' ' MET . 19.6 m120 -86.93 -37.84 17.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.222 1.01 . . . . 1.55 109.094 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.759 HG23 HD11 ' A' ' 18' ' ' ILE . 1.6 mm -67.65 -50.7 58.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 113.934 -1.485 . . . . 0.13 111.675 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.756 ' HG2' ' O ' ' A' ' 97' ' ' MET . 2.6 ptmt -58.63 -39.56 80.86 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 120.689 0.28 . . . . 1.11 110.822 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.629 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.8 ppp? -73.65 -23.62 59.88 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.166 -0.679 . . . . 1.17 109.166 -176.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 21.2 m -68.02 -51.44 46.98 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.405 -0.816 . . . . 0.15 109.92 173.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.983 ' HB2' HD22 ' A' ' 48' ' ' LEU . 12.6 mt -72.72 -57.17 4.3 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.524 -0.762 . . . . 0.13 111.633 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 1.149 ' HG3' HD23 ' A' ' 48' ' ' LEU . 22.7 mt-30 -51.88 -26.56 10.37 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.64 0.607 . . . . 1.45 112.64 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -71.47 -42.8 67.69 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.229 -0.656 . . . . 0.65 109.229 177.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.749 HG21 ' HB3' ' A' ' 25' ' ' ALA . 69.8 mt -61.42 -44.43 98.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.545 -1.207 . . . . 0.17 110.145 174.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.559 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.2 mt -63.9 -47.8 89.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.635 -0.712 . . . . 0.29 109.906 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.4 t -58.77 -30.68 67.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.354 0.597 . . . . 1.22 109.973 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 12.6 ttt180 -67.36 -37.26 82.91 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.133 -0.939 . . . . 3.79 109.778 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 . . . . . 0 N--CA 1.445 -0.699 0 CA-C-N 115.827 -0.624 . . . . 0.6 111.479 -175.332 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 261' ' ' PHE . . . . . 0.643 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 8.2 m-30 . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 120.658 0.266 . . . . 0.95 110.893 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.71 156.98 12.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.421 -0.354 . . . . 1.37 110.233 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--N 1.327 -0.411 0 N-CA-C 109.279 -0.638 . . . . 2.24 109.279 173.995 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.6 m80 . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 121.117 0.484 . . . . 1.85 110.657 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 82.0 p -163.99 148.88 10.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.099 -0.501 . . . . 0.95 109.998 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.45 144.85 5.79 Favored Glycine 0 C--O 1.223 -0.579 0 N-CA-C 110.592 -1.003 . . . . 0.16 110.592 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.726 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -76.63 119.35 20.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.773 0.786 . . . . 0.43 111.448 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.432 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -124.82 158.22 33.93 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.484 0.659 . . . . 0.13 111.7 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.526 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.7 mp -100.48 123.99 53.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.04 -0.982 . . . . 0.29 109.028 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.43 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 85.7 t80 -121.9 101.71 7.73 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.29 -0.414 . . . . 0.56 110.061 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 65.99 56.98 0.82 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.575 0.702 . . . . 1.46 110.708 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt 73.13 -8.03 1.39 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.407 -1.27 . . . . 1.91 113.109 170.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -102.46 130.27 52.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.059 0.457 . . . . 0.47 110.712 174.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.526 ' HA ' HG13 ' A' ' 8' ' ' ILE . 27.0 t -79.86 130.84 35.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.685 -0.689 . . . . 1.02 110.404 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.647 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -148.95 -155.63 6.8 Favored Glycine 0 N--CA 1.435 -1.373 0 CA-C-N 115.588 -0.733 . . . . 0.16 111.906 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.726 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.3 mm -126.74 153.74 35.92 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 CA-C-O 120.801 0.334 . . . . 0.19 110.759 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.464 HD11 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -125.05 133.82 68.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.918 -0.583 . . . . 0.16 109.501 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.3 108.88 6.96 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.002 0.429 . . . . 0.12 111.992 175.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.622 HD11 HG23 ' A' ' 100' ' ' ILE . 3.6 mp -85.16 120.21 35.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.559 -0.904 . . . . 0.18 108.559 172.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -124.34 123.84 41.07 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.886 -0.413 . . . . 1.12 109.886 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -109.0 83.32 1.73 Allowed 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 117.187 -1.805 . . . . 0.74 107.632 165.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -122.48 -10.92 8.37 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 106.774 -1.565 . . . . 0.59 106.774 156.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 23' ' ' SER . 14.5 p -101.41 175.1 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 112.181 -2.282 . . . . 0.35 111.775 -155.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.683 ' O ' HG13 ' A' ' 22' ' ' VAL . 1.2 t -54.42 165.47 0.86 Allowed Pre-proline 0 C--O 1.225 -0.221 0 N-CA-C 105.972 -1.862 . . . . 1.31 105.972 167.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.558 ' HA ' ' OH ' ' A' ' 111' ' ' TYR . 9.8 Cg_endo -41.22 128.01 3.03 Favored 'Trans proline' 0 C--N 1.357 0.995 0 CA-C-N 122.204 1.823 . . . . 0.22 111.744 -151.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.716 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -29.81 133.81 0.05 Allowed 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 125.348 1.655 . . . . 0.2 113.756 -157.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.643 ' HB2' HG11 ' A' ' 22' ' ' VAL . 31.6 mt-10 -122.56 132.56 54.36 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.768 -1.105 . . . . 1.26 110.98 -171.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.2 tt -100.92 142.45 32.37 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.398 -1.704 . . . . 0.15 106.398 172.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.412 ' N ' HD23 ' A' ' 27' ' ' LEU . 24.5 m -129.8 110.04 11.42 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.636 -0.826 . . . . 0.21 110.505 -178.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.641 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 86.0 t90 -86.11 105.87 16.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.591 0.71 . . . . 0.24 109.27 174.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -113.26 114.14 26.29 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.91 -1.041 . . . . 0.87 108.741 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.584 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 93.1 p -57.61 147.53 26.99 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.422 0.63 . . . . 0.75 110.424 -174.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.647 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 18.9 m -51.98 -26.44 10.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.447 -1.251 . . . . 0.39 112.331 -174.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -88.07 -28.16 21.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.961 0.41 . . . . 2.33 111.234 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.91 17.33 28.16 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.996 -0.621 . . . . 0.55 112.361 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -90.01 -35.31 15.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.03 0.443 . . . . 1.13 111.15 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -118.61 141.71 48.33 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.162 0.506 . . . . 2.03 111.114 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 69.3 t -141.79 116.93 5.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.972 -1.013 . . . . 0.55 109.853 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -123.36 109.56 14.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.191 -0.459 . . . . 0.69 109.934 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 39.0 m -98.07 137.08 37.39 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.985 -0.286 . . . . 0.3 111.207 -176.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.524 HG11 HD13 ' A' ' 62' ' ' LEU . 40.0 t -110.8 129.69 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 122.705 0.402 . . . . 0.66 111.467 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.539 ' O ' HG12 ' A' ' 45' ' ' ILE . 55.3 t -91.21 108.04 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-O 121.282 0.563 . . . . 0.18 109.576 173.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.617 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.8 mm? -56.09 -28.32 57.24 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.07 -0.968 . . . . 0.12 112.533 -177.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 31.5 t -74.19 -31.3 62.6 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.297 -0.561 . . . . 1.06 110.504 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.6 p -79.94 -10.01 59.73 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.682 -0.488 . . . . 0.2 109.682 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.623 HG21 ' CD2' ' A' ' 62' ' ' LEU . 44.6 mm -84.44 116.53 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.61 -0.723 . . . . 0.23 111.535 176.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.63 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 2.5 t70 -74.96 -47.54 28.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.242 -0.89 . . . . 0.7 111.422 175.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.498 ' O ' HG12 ' A' ' 63' ' ' ILE . 15.5 tptt -136.02 136.66 40.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.047 -0.524 . . . . 1.95 109.916 -174.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.041 HD23 ' HG3' ' A' ' 105' ' ' GLN . 13.2 tp -106.74 142.65 36.04 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 119.661 -0.815 . . . . 0.14 109.081 164.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.572 HE21 ' HB2' ' B' ' 261' ' ' PHE . 4.1 mt-30 -122.96 152.69 40.62 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.687 -1.142 . . . . 1.49 109.675 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.497 ' H ' ' HB3' ' B' ' 261' ' ' PHE . . . -161.47 139.2 9.08 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.182 -0.673 . . . . 0.25 109.182 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 40.4 p -54.95 125.41 56.07 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-O 121.453 0.644 . . . . 0.37 111.715 -178.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 46.1 Cg_endo -67.34 166.74 22.48 Favored 'Trans proline' 0 C--N 1.334 -0.204 0 C-N-CA 124.064 3.176 . . . . 0.64 112.238 178.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.439 ' N ' HH21 ' A' ' 94' ' ' ARG . . . -60.43 -28.89 68.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.028 0.442 . . . . 1.02 110.419 175.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 t -71.75 -24.13 61.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.744 -0.662 . . . . 1.58 110.466 177.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.449 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 33.4 t -71.51 141.87 50.14 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.549 -0.537 . . . . 0.71 109.549 176.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -83.4 -17.64 41.54 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.302 0.572 . . . . 2.89 110.149 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -97.09 179.93 4.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.518 -0.764 . . . . 2.59 110.662 -173.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.467 ' N ' ' SD ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -133.75 110.32 9.73 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.177 -1.046 . . . . 1.78 108.177 171.311 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.522 ' HB3' ' HE1' ' B' ' 261' ' ' PHE . 29.8 ttm -157.11 137.61 13.03 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.592 -0.443 . . . . 1.3 111.247 -171.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.444 HD23 HD11 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -112.12 155.47 23.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.929 -0.578 . . . . 0.14 110.173 177.671 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 19.6 ttm180 -151.02 113.59 4.66 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.739 0.304 . . . . 2.72 110.794 173.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.785 ' HG ' HD13 ' A' ' 48' ' ' LEU . 10.7 mt -96.94 108.2 20.87 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.056 0.543 . . . . 0.9 111.331 -177.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.698 HG23 ' HB3' ' A' ' 86' ' ' ARG . 2.6 mm -88.88 131.46 36.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 C-N-CA 123.21 0.604 . . . . 0.4 110.872 -175.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -85.6 166.1 39.33 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.153 -1.022 . . . . 0.48 112.056 175.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.63 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 1.1 mptm? -75.07 131.24 40.42 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.622 -0.511 . . . . 1.15 109.622 173.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.2 p . . . . . 0 C--N 1.32 -0.675 0 CA-C-O 121.383 0.611 . . . . 0.69 111.416 -178.232 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.216 0 CA-C-O 121.998 0.904 . . . . 1.78 110.817 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.698 ' HB3' HG23 ' A' ' 63' ' ' ILE . 21.3 ptt180 -126.62 148.68 49.76 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.546 -0.752 . . . . 2.29 111.273 -174.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -117.63 113.07 21.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.227 -0.897 . . . . 0.5 110.523 -169.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.48 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 49.1 ttm -100.59 130.87 46.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.82 0.343 . . . . 0.42 111.537 -176.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.464 ' CG ' HD11 ' A' ' 16' ' ' ILE . 79.4 m-85 -126.28 122.66 36.12 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.433 -0.58 . . . . 1.33 109.433 174.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.426 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 35.5 m -92.46 132.93 36.38 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.302 -0.408 . . . . 0.94 110.161 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.647 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 25.5 m-85 -108.5 171.13 7.59 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.968 0.413 . . . . 1.33 110.846 177.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -112.0 -3.27 14.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.823 -0.626 . . . . 1.53 110.114 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -141.08 129.13 22.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.346 0.594 . . . . 0.83 110.799 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.439 HH21 ' N ' ' A' ' 53' ' ' ALA . 49.3 tpt85 -61.04 -27.98 68.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.806 -1.088 . . . . 2.16 111.405 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.3 m -75.8 -55.63 5.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.629 -0.259 . . . . 0.4 111.278 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.3 t -45.52 -56.8 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-O 120.852 0.358 . . . . 0.29 111.082 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.688 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -62.24 -32.09 72.74 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.779 -0.646 . . . . 0.29 110.602 -177.866 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.415 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 19.6 t70 -66.55 -34.13 77.22 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.77 0.795 . . . . 0.39 109.555 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.604 ' O ' ' HG3' ' A' ' 102' ' ' MET . 21.1 m120 -76.83 -41.32 44.69 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.421 -1.263 . . . . 1.55 109.878 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.647 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 23.4 mm -63.02 -53.43 46.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.948 -1.024 . . . . 0.13 111.15 176.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.785 ' HA ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -59.88 -38.14 81.36 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 120.726 0.298 . . . . 1.11 111.065 -177.742 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.604 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.4 ppp? -71.63 -25.74 62.28 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.365 -0.606 . . . . 1.17 109.365 -175.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 23.1 m -68.13 -52.15 38.11 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.488 -0.778 . . . . 0.15 110.258 174.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.946 ' HB2' HD22 ' A' ' 48' ' ' LEU . 8.2 mt -69.16 -57.44 5.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.523 -0.762 . . . . 0.13 111.33 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 1.041 ' HG3' HD23 ' A' ' 48' ' ' LEU . 95.2 mt-30 -52.7 -25.48 11.13 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.811 0.671 . . . . 1.45 112.811 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -73.41 -35.63 65.86 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.703 0.763 . . . . 0.65 109.403 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.716 HG21 ' HB3' ' A' ' 25' ' ' ALA . 69.5 mt -69.53 -41.7 80.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.539 -1.21 . . . . 0.17 110.249 175.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.2 mt -65.6 -50.86 69.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.805 -0.634 . . . . 0.29 110.544 -176.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.6 m -58.69 -28.86 66.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.212 0.53 . . . . 1.22 110.141 174.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.464 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 8.3 ttt180 -66.09 -39.51 90.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.405 -0.816 . . . . 3.79 109.509 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.558 ' OH ' ' HA ' ' A' ' 24' ' ' PRO . 21.3 m-85 . . . . . 0 N--CA 1.446 -0.625 0 CA-C-N 115.503 -0.772 . . . . 0.6 111.651 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 261' ' ' PHE . . . . . 0.572 ' HB2' HE21 ' A' ' 49' ' ' GLN . 35.1 m-85 . . . . . 0 N--CA 1.452 -0.371 0 CA-C-O 121.467 0.651 . . . . 0.95 112.287 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 11.9 p -144.23 147.64 19.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 114.729 -1.123 . . . . 1.37 108.907 171.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 263' ' ' GLU . . . . . 0.506 ' HA ' HE22 ' A' ' 105' ' ' GLN . 17.5 tt0 . . . . . 0 C--N 1.323 -0.547 0 N-CA-C 109.265 -0.643 . . . . 2.24 109.265 176.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo . . . . . 0 CA--C 1.527 0.128 0 N-CA-C 111.659 -0.169 . . . . 3.14 111.659 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.515 ' HA ' ' HB3' ' A' ' 99' ' ' ASN . 32.5 p -99.14 -59.5 1.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.069 0.461 . . . . 1.4 110.912 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -85.85 11.75 10.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.111 -0.495 . . . . 1.85 110.886 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 8.0 m -161.45 141.62 10.68 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.802 -0.444 . . . . 0.95 109.802 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.69 142.95 6.6 Favored Glycine 0 C--O 1.224 -0.491 0 N-CA-C 110.864 -0.894 . . . . 0.16 110.864 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.734 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -76.54 117.64 18.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.588 0.694 . . . . 0.43 111.847 -175.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.53 162.33 25.91 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.429 0.633 . . . . 0.13 111.92 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.591 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.8 mp -105.07 123.14 59.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.237 -0.892 . . . . 0.29 109.082 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -117.15 106.14 13.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.652 -0.249 . . . . 0.56 110.516 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 61.0 50.66 4.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.609 0.719 . . . . 1.46 110.366 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt 75.46 -8.67 1.54 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.151 -1.386 . . . . 1.91 113.382 170.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.45 HG21 ' HD2' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -93.18 131.62 39.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.393 -0.523 . . . . 0.47 110.172 172.441 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.591 ' HA ' HG13 ' A' ' 8' ' ' ILE . 40.9 t -79.75 130.39 35.3 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.586 -0.734 . . . . 1.02 110.854 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.652 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -155.87 -156.17 7.69 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.876 -0.678 . . . . 0.16 112.615 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.734 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.7 mm -126.81 153.85 36.17 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-O 120.834 0.349 . . . . 0.19 110.883 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.485 HD11 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -121.5 134.5 64.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.985 -0.552 . . . . 0.16 109.626 178.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.43 109.92 7.45 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.982 0.42 . . . . 0.12 111.924 174.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.668 HD11 HG23 ' A' ' 100' ' ' ILE . 4.0 mp -83.57 118.55 31.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 107.926 -1.139 . . . . 0.18 107.926 171.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.531 HD22 ' HB3' ' A' ' 21' ' ' ASP . 4.2 t-20 -121.41 122.73 40.44 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 110.0 -0.37 . . . . 1.12 110.0 -177.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -108.47 83.75 1.82 Allowed 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 117.146 -1.822 . . . . 0.74 107.215 163.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.531 ' HB3' HD22 ' A' ' 19' ' ' ASN . 11.9 t70 -121.99 -11.31 8.52 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.59 -1.633 . . . . 0.59 106.59 157.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.692 HG13 ' O ' ' A' ' 23' ' ' SER . 14.9 p -102.31 174.18 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 112.049 -2.342 . . . . 0.35 112.198 -154.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.692 ' O ' HG13 ' A' ' 22' ' ' VAL . 6.8 m -54.71 166.56 0.73 Allowed Pre-proline 0 C--O 1.224 -0.281 0 N-CA-C 106.586 -1.635 . . . . 1.31 106.586 164.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 11.9 Cg_endo -42.0 128.09 3.99 Favored 'Trans proline' 0 C--N 1.352 0.732 0 CA-C-N 121.862 1.701 . . . . 0.22 111.408 -149.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.668 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -32.23 133.29 0.11 Allowed 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 125.26 1.6 . . . . 0.2 113.446 -157.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.527 ' HB2' HG11 ' A' ' 22' ' ' VAL . 68.7 mt-10 -124.09 140.8 52.62 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.429 -1.26 . . . . 1.26 111.089 -168.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.557 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.7 tt -101.57 142.6 32.68 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 106.561 -1.644 . . . . 0.15 106.561 172.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.458 ' N ' HD23 ' A' ' 27' ' ' LEU . 10.6 m -130.55 108.47 9.95 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.919 -0.712 . . . . 0.21 110.164 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.607 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 88.5 t90 -87.0 112.03 21.43 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.558 0.694 . . . . 0.24 109.364 175.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.518 ' HD3' ' O ' ' A' ' 31' ' ' SER . 2.6 tmt_? -118.99 118.19 30.83 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.111 -0.949 . . . . 0.87 108.819 -177.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.518 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 35.8 p -56.0 144.28 29.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.292 0.568 . . . . 0.75 110.597 -176.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.652 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 21.4 m -53.85 -29.45 41.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.603 -1.18 . . . . 0.39 112.008 -175.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -83.56 -25.65 30.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.259 0.552 . . . . 2.33 111.065 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.3 16.67 39.61 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.886 -0.673 . . . . 0.55 112.337 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.36 -65.27 1.02 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.104 0.478 . . . . 1.13 110.99 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.45 ' HD2' HG21 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -106.43 155.06 19.95 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.508 -0.769 . . . . 2.03 110.777 -175.364 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 69.0 t -146.81 139.76 19.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.97 -1.014 . . . . 0.55 109.636 -175.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -139.34 111.23 7.29 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.234 -0.284 . . . . 0.69 110.234 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.3 m -98.31 138.75 35.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.58 0.229 . . . . 0.3 111.496 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.561 HG11 HD13 ' A' ' 62' ' ' LEU . 41.1 t -113.16 129.44 68.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 122.523 0.329 . . . . 0.66 111.521 176.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.559 ' O ' HG12 ' A' ' 45' ' ' ILE . 38.8 t -91.04 108.1 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 109.576 -0.528 . . . . 0.18 109.576 173.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.58 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.8 mm? -53.21 -28.89 29.27 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.091 -0.959 . . . . 0.12 112.597 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.406 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 68.4 m -74.88 -35.76 62.29 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.663 -0.415 . . . . 1.06 111.446 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.3 p -72.28 -14.17 61.7 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 121.376 0.608 . . . . 0.2 109.564 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.602 HG21 ' CD2' ' A' ' 62' ' ' LEU . 48.6 mm -82.32 120.93 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.335 -0.848 . . . . 0.23 111.395 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.628 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 15.7 t70 -78.46 -46.09 20.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.73 -0.668 . . . . 0.7 110.904 176.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.411 ' HB2' HG13 ' A' ' 63' ' ' ILE . 68.8 mmtt -136.88 150.52 48.3 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.129 -0.487 . . . . 1.95 109.975 -178.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.9 HD22 ' HB2' ' A' ' 104' ' ' LEU . 9.9 tp -113.45 144.23 43.16 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.29 -0.633 . . . . 0.14 109.29 165.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.488 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 82.0 mm-40 -120.87 154.57 35.66 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.978 -1.01 . . . . 1.49 109.518 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.484 ' HB1' ' CE ' ' A' ' 97' ' ' MET . . . -162.59 141.44 8.92 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.55 -0.75 . . . . 0.25 108.992 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.579 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 37.1 p -56.53 126.04 68.68 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-O 121.303 0.573 . . . . 0.37 112.055 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 72.9 Cg_endo -74.46 166.37 29.6 Favored 'Trans proline' 0 C--N 1.329 -0.457 0 C-N-CA 123.972 3.114 . . . . 0.64 111.314 172.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.6 -27.85 63.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.109 0.481 . . . . 1.02 110.415 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.4 m -69.07 -24.81 64.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.706 -0.679 . . . . 1.58 111.282 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.499 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 39.5 t -76.54 148.51 37.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.127 -0.488 . . . . 0.71 109.717 177.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -90.68 -2.18 57.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.42 0.629 . . . . 2.89 110.116 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -115.39 178.98 4.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.194 -0.912 . . . . 2.59 110.858 -174.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.579 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -132.35 107.76 8.74 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.017 -1.105 . . . . 1.78 108.017 168.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 75.1 mtm -154.54 152.0 29.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.982 0.42 . . . . 1.3 111.21 -176.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.471 HD11 ' O ' ' A' ' 97' ' ' MET . 0.8 OUTLIER -112.05 158.33 19.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.242 -0.89 . . . . 0.14 110.229 175.134 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 45.2 ttt180 -153.63 114.32 4.03 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 121.274 0.559 . . . . 2.72 111.009 170.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.713 ' HG ' HD13 ' A' ' 48' ' ' LEU . 9.0 mt -92.24 112.91 25.03 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.717 -0.674 . . . . 0.9 110.515 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.619 HG23 ' HG2' ' A' ' 86' ' ' ARG . 5.0 mm -86.7 116.64 29.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.512 0.725 . . . . 0.4 110.307 -174.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -85.33 144.97 21.01 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.159 -1.019 . . . . 0.48 111.487 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.628 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 8.2 mptt -58.73 134.98 57.3 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.057 0.456 . . . . 1.15 110.734 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 82' ' ' PRO . 7.7 p -74.43 150.87 7.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.509 -0.769 . . . . 0.69 110.289 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -80.19 91.98 5.64 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.377 -0.829 . . . . 2.56 110.95 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -85.56 -6.35 59.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.333 -0.849 . . . . 3.79 112.001 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.8 p -68.54 -38.72 81.07 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.089 -0.245 . . . . 3.05 111.563 -174.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.31 101.94 4.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.018 0.437 . . . . 5.48 110.451 174.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -54.89 138.61 42.67 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.364 -0.835 . . . . 4.42 110.847 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.557 ' HD2' ' HG3' ' A' ' 82' ' ' PRO . 1.7 ptm180 -85.43 170.18 12.94 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.589 -0.732 . . . . 4.27 109.735 -176.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -141.96 164.35 30.43 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.409 -0.589 . . . . 5.09 109.409 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -90.08 -165.3 1.32 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.187 -0.605 . . . . 4.98 110.01 -175.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -54.15 -31.53 52.77 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.729 0.64 . . . . 6.68 112.729 -173.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -102.11 8.27 40.8 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.625 0.726 . . . . 7.13 110.295 -173.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.09 34.21 42.56 Favored Glycine 0 C--N 1.315 -0.62 0 CA-C-N 114.612 -1.176 . . . . 5.53 111.645 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 79' ' ' GLU . 29.6 m120 -71.37 -92.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.721 -0.239 . . . . 5.62 110.7 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 13.6 pt-20 170.52 125.79 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.389 0.675 . . . . 5.0 110.518 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.508 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.0 t -127.94 148.83 32.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.205 -0.665 . . . . 3.33 109.205 175.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.4 p -110.19 96.85 27.81 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-O 121.51 0.671 . . . . 2.77 110.093 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.557 ' HG3' ' HD2' ' A' ' 72' ' ' ARG . 76.3 Cg_exo -50.31 141.73 31.1 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.656 2.904 . . . . 1.78 113.951 -177.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 0.9 OUTLIER -82.86 134.61 46.62 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 108.715 -0.846 . . . . 3.11 108.715 168.203 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 83' ' ' LYS . 18.1 Cg_exo -54.08 132.34 49.64 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.828 2.352 . . . . 0.67 112.46 -174.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -76.4 155.26 34.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.531 0.682 . . . . 1.78 109.264 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.619 ' HG2' HG23 ' A' ' 63' ' ' ILE . 18.7 mtt180 -140.13 153.73 46.78 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.551 -0.749 . . . . 2.29 110.33 -168.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -115.88 110.45 19.03 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.08 -0.711 . . . . 0.5 109.08 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.483 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 54.9 ttm -103.25 129.26 50.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.781 0.324 . . . . 0.42 110.827 -175.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.485 ' CG ' HD11 ' A' ' 16' ' ' ILE . 80.4 m-85 -123.46 122.54 38.51 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 109.245 -0.65 . . . . 1.33 109.245 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.493 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 22.7 m -91.18 128.95 37.21 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.04 -0.527 . . . . 0.94 110.838 -174.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.603 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 29.1 m-85 -108.16 174.79 5.72 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.95 -0.568 . . . . 1.33 110.816 176.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -119.57 0.22 10.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.706 -0.679 . . . . 1.53 109.821 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.511 ' OD1' ' HB ' ' A' ' 95' ' ' THR . 28.7 t-20 -143.38 131.43 21.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.324 -0.853 . . . . 0.83 110.647 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.491 ' HA ' ' HG2' ' A' ' 97' ' ' MET . 0.9 OUTLIER -74.97 -23.28 58.26 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.962 -0.563 . . . . 2.16 110.976 -174.128 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.511 ' HB ' ' OD1' ' A' ' 93' ' ' ASN . 92.8 m -70.99 -54.49 11.07 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.411 -0.516 . . . . 0.4 109.783 175.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.0 t -45.7 -57.36 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-N 116.134 -0.485 . . . . 0.29 111.103 173.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.491 ' HG2' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -64.12 -29.3 70.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.006 -0.543 . . . . 0.29 111.093 -178.134 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.29 -32.18 72.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.407 0.622 . . . . 0.39 109.554 175.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.515 ' HB3' ' HA ' ' A' ' 2' ' ' SER . 90.6 m-20 -75.03 -46.82 32.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.887 -1.051 . . . . 1.55 109.844 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.668 HG23 HD11 ' A' ' 18' ' ' ILE . 27.6 mm -61.28 -51.16 76.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.003 -0.999 . . . . 0.13 110.276 175.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.628 ' HA ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -55.74 -51.9 65.76 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.614 -0.721 . . . . 1.11 111.197 179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.487 ' N ' ' HE2' ' A' ' 101' ' ' LYS . 11.7 ptp -60.2 -32.15 70.82 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.081 0.467 . . . . 1.17 109.777 -176.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 54.1 m -63.36 -52.04 63.41 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.267 -0.879 . . . . 0.15 110.261 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.9 ' HB2' HD22 ' A' ' 48' ' ' LEU . 11.3 mt -66.95 -55.59 13.87 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.43 -0.805 . . . . 0.13 110.781 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.791 ' HG2' HD23 ' A' ' 48' ' ' LEU . 19.2 mm-40 -43.16 -37.54 2.11 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.653 0.596 . . . . 1.45 112.544 178.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -68.1 -35.51 78.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.823 0.82 . . . . 0.65 109.555 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.668 HG21 ' HB3' ' A' ' 25' ' ' ALA . 81.3 mt -72.51 -41.66 63.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.017 -1.447 . . . . 0.17 110.319 175.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.618 HG22 ' HD2' ' A' ' 112' ' ' LYS . 0.8 OUTLIER -65.3 -50.92 70.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.855 -0.611 . . . . 0.29 110.217 -177.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 38.6 t -58.53 -28.47 65.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.47 0.653 . . . . 1.22 109.941 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 11.0 ttt180 -68.73 -38.81 80.45 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.049 -0.978 . . . . 3.79 109.927 177.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.401 ' OH ' ' HA ' ' A' ' 24' ' ' PRO . 27.0 m-85 -88.37 -19.21 26.94 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.928 -0.578 . . . . 0.6 111.698 -175.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.618 ' HD2' HG22 ' A' ' 108' ' ' ILE . 12.4 mtpp -76.74 -23.88 53.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.23 0.538 . . . . 1.76 109.734 174.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.26 -25.76 64.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.434 -0.803 . . . . 1.56 109.8 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -116.68 27.16 9.35 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.293 -0.867 . . . . 1.09 110.707 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.4 t70 . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.488 -0.767 . . . . 2.16 110.274 -179.374 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.58 0 N-CA-C 112.001 -0.44 . . . . 25.39 112.001 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 101.18 170.44 28.34 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.941 -0.647 . . . . 24.6 111.75 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -137.13 162.45 25.31 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.748 -0.739 . . . . 23.97 111.918 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 110.47 17.25 9.43 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.763 -0.732 . . . . 23.13 112.226 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 246' ' ' TYR . . . . . 0.638 ' CE2' ' HA ' ' B' ' 249' ' ' GLU . 32.1 p90 -144.98 171.6 14.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.666 0.269 . . . . 24.92 110.663 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -74.6 143.22 44.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.294 -0.412 . . . . 21.4 110.396 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 8.5 p 44.85 42.31 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 124.375 1.047 . . . . 20.37 111.072 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 249' ' ' GLU . . . . . 0.638 ' HA ' ' CE2' ' B' ' 246' ' ' TYR . 10.9 pt-20 -59.78 163.87 4.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.97 -1.013 . . . . 17.68 111.23 175.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 64.6 mtt -125.06 34.49 4.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.555 0.693 . . . . 16.8 109.604 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.79 143.44 57.84 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.931 -1.032 . . . . 13.35 109.431 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 252' ' ' SER . . . . . 0.494 ' O ' ' HG3' ' B' ' 255' ' ' GLU . 52.0 p 67.11 -37.56 0.31 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.907 1.283 . . . . 10.66 111.963 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -65.12 -35.71 81.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 11.03 110.628 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.78 -47.75 84.43 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.823 -0.626 . . . . 10.94 111.48 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 255' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' B' ' 252' ' ' SER . 0.0 OUTLIER -71.16 -33.68 70.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.676 0.274 . . . . 9.82 111.373 -177.673 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 21.5 m -72.85 -36.02 67.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.212 0.529 . . . . 5.35 111.289 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -89.04 -0.93 57.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.449 0.643 . . . . 6.2 110.188 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -68.53 -27.02 65.74 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.547 -0.751 . . . . 6.14 111.682 -176.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.88 -55.5 16.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.039 0.447 . . . . 3.32 110.647 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 86.59 14.33 65.83 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.746 -0.661 . . . . 0.84 111.677 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 261' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 6.0 m-85 -116.7 179.05 4.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.056 0.455 . . . . 0.95 110.822 -174.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 12.9 p -135.09 145.22 32.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.669 -0.696 . . . . 1.37 109.165 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.01 142.25 27.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.021 0.439 . . . . 2.24 110.13 176.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.502 ' H ' ' NE2' ' A' ' 105' ' ' GLN . 61.5 t -105.29 103.86 16.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.292 0.568 . . . . 1.41 109.945 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 265' ' ' ASP . . . . . 0.464 ' OD1' ' HE2' ' A' ' 112' ' ' LYS . 23.7 t70 . . . . . 0 C--O 1.248 0.999 0 CA-C-N 115.349 -0.841 . . . . 3.04 109.892 -177.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo . . . . . 0 N--CA 1.481 0.788 0 N-CA-C 110.588 -0.582 . . . . 3.14 110.588 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.415 ' HA ' ' HB3' ' A' ' 99' ' ' ASN . 21.0 p -71.14 -20.82 62.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.195 0.521 . . . . 1.4 110.938 -178.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.612 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 36.0 m80 -85.57 18.07 2.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.739 -0.664 . . . . 1.85 111.858 -176.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.4 p -162.37 145.61 11.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.982 0.42 . . . . 0.95 110.906 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.48 145.71 6.72 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.71 -0.956 . . . . 0.16 110.71 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.736 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -71.68 142.88 49.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.21 0.505 . . . . 0.43 111.361 -176.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.474 ' HB1' ' HB3' ' A' ' 89' ' ' PHE . . . -152.62 155.09 36.66 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-O 121.209 0.528 . . . . 0.13 111.61 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.544 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.2 mp -92.34 131.18 40.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.606 -0.725 . . . . 0.29 109.4 176.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.566 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 89.3 t80 -139.74 112.87 8.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.28 -0.418 . . . . 0.56 110.134 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.495 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 51.3 mt-10 68.6 48.83 0.78 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.604 0.716 . . . . 1.46 110.371 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.495 ' HD2' ' C ' ' A' ' 10' ' ' GLU . 4.0 mptt 67.41 4.4 3.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.351 -1.295 . . . . 1.91 112.84 173.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.94 134.69 54.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.835 0.35 . . . . 0.47 110.623 175.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.544 ' HA ' HG13 ' A' ' 8' ' ' ILE . 31.8 t -75.02 128.53 35.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.028 -0.533 . . . . 1.02 109.819 176.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.691 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -148.1 -159.88 8.68 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.701 -0.762 . . . . 0.16 112.347 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.736 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.8 mm -126.33 152.66 34.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.066 0.46 . . . . 0.19 110.841 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.412 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -122.63 133.04 69.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.647 -0.706 . . . . 0.16 109.842 178.761 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.14 110.33 7.81 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.92 0.391 . . . . 0.12 111.958 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.685 HD11 HG23 ' A' ' 100' ' ' ILE . 3.6 mp -85.41 119.46 34.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.844 -0.799 . . . . 0.18 108.844 172.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.467 HD22 ' HB3' ' A' ' 21' ' ' ASP . 3.2 t-20 -120.77 123.42 42.62 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.992 -0.373 . . . . 1.12 109.992 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.439 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 15.9 mt-10 -108.85 83.08 1.7 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 117.332 -1.747 . . . . 0.74 107.452 164.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.467 ' HB3' HD22 ' A' ' 19' ' ' ASN . 23.0 t70 -122.04 -10.92 8.55 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 106.522 -1.658 . . . . 0.59 106.522 157.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 23' ' ' SER . 14.5 p -102.33 175.5 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 111.919 -2.4 . . . . 0.35 112.057 -155.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.686 ' O ' HG13 ' A' ' 22' ' ' VAL . 56.8 p -54.4 165.96 0.78 Allowed Pre-proline 0 C--O 1.225 -0.2 0 N-CA-C 106.714 -1.587 . . . . 1.31 106.714 166.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 12.0 Cg_endo -42.47 128.97 4.82 Favored 'Trans proline' 0 C--N 1.359 1.095 0 CA-C-N 122.326 1.866 . . . . 0.22 111.157 -152.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.788 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -31.46 136.11 0.06 Allowed 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 125.44 1.712 . . . . 0.2 114.193 -155.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.531 ' HB2' HG11 ' A' ' 22' ' ' VAL . 64.1 mt-10 -122.64 132.4 54.26 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 114.439 -1.255 . . . . 1.26 110.789 -171.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.566 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.3 tt -100.81 142.18 32.65 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 106.235 -1.765 . . . . 0.15 106.235 173.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.432 ' N ' HD23 ' A' ' 27' ' ' LEU . 25.9 m -130.67 109.34 10.56 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 119.537 -0.865 . . . . 0.21 110.551 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.611 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 88.8 t90 -85.83 108.85 18.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.624 0.726 . . . . 0.24 109.376 174.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -115.13 115.0 26.05 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.774 -1.103 . . . . 0.87 108.467 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.542 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 79.3 p -57.21 150.03 18.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.153 0.501 . . . . 0.75 110.751 -173.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.691 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 24.0 m -57.83 -29.05 64.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.176 -0.92 . . . . 0.39 110.435 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.495 ' OD2' ' HB3' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -80.65 -27.95 37.02 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.421 -0.809 . . . . 2.33 111.548 177.181 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.6 -5.07 56.78 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.818 -0.705 . . . . 0.55 113.161 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.495 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 2.4 t70 -67.28 -52.23 43.18 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.3 0.482 . . . . 1.13 112.3 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -103.0 143.48 32.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.621 0.724 . . . . 2.03 112.426 -174.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 76.9 t -141.86 116.44 5.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.175 -1.375 . . . . 0.55 109.802 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -123.75 109.74 14.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.949 -0.569 . . . . 0.69 109.904 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 32.8 m -97.35 137.84 35.72 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.944 -0.303 . . . . 0.3 111.177 -176.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 42.0 t -110.91 130.91 63.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 122.815 0.446 . . . . 0.66 111.655 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.509 ' O ' HG12 ' A' ' 45' ' ' ILE . 51.0 t -90.91 108.29 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 109.619 -0.512 . . . . 0.18 109.619 172.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.616 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -53.48 -27.96 28.07 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.994 -1.003 . . . . 0.12 112.844 -178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.0 m -75.47 -34.59 60.91 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.598 -0.441 . . . . 1.06 111.443 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.6 p -75.26 -11.95 60.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.273 0.558 . . . . 0.2 109.71 173.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.691 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 47.5 mm -81.75 117.02 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 115.143 -0.935 . . . . 0.23 111.282 173.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.537 ' OD2' ' HG2' ' A' ' 47' ' ' LYS . 21.2 t70 -73.93 -46.24 45.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.429 -0.805 . . . . 0.7 111.375 177.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.537 ' HG2' ' OD2' ' A' ' 46' ' ' ASP . 47.9 mmtm -140.75 157.3 45.62 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.473 -0.331 . . . . 1.95 110.354 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.077 HD23 ' HG3' ' A' ' 105' ' ' GLN . 13.2 tp -123.51 140.93 52.5 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.256 0.55 . . . . 0.14 109.941 167.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.558 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 16.3 mm100 -113.01 157.8 21.07 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.749 -1.114 . . . . 1.49 109.846 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.51 136.32 5.36 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.8 -0.636 . . . . 0.25 109.539 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 40.6 p -51.27 124.74 23.7 Favored Pre-proline 0 N--CA 1.467 0.404 0 CA-C-O 121.259 0.552 . . . . 0.37 111.243 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.555 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 48.3 Cg_endo -66.82 166.54 22.15 Favored 'Trans proline' 0 C--N 1.333 -0.287 0 C-N-CA 124.057 3.171 . . . . 0.64 111.983 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.417 ' N ' HH21 ' A' ' 94' ' ' ARG . . . -60.11 -25.0 65.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.902 0.382 . . . . 1.02 110.829 176.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.8 m -78.37 -24.39 46.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.847 -0.615 . . . . 1.58 111.521 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 29.7 t -67.54 149.29 50.33 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.216 -0.661 . . . . 0.71 109.216 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.48 -14.36 22.4 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.606 -0.887 . . . . 2.89 108.606 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.568 ' N ' ' HD3' ' A' ' 57' ' ' LYS . 2.7 mppt? -94.34 -177.89 4.41 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.821 -1.081 . . . . 2.59 110.996 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.511 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -136.49 110.67 8.37 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.388 -0.968 . . . . 1.78 108.388 172.314 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.682 ' HB3' ' CZ ' ' B' ' 261' ' ' PHE . 2.5 mtm -156.54 138.68 14.59 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.694 -0.402 . . . . 1.3 111.854 -173.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.841 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 2.3 mp -109.2 160.05 16.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.843 -0.617 . . . . 0.14 111.078 170.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.63 ' NH1' ' HB3' ' B' ' 259' ' ' ASP . 9.8 ttm180 -150.54 114.19 4.97 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.981 -0.554 . . . . 2.72 110.356 172.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.871 ' HG ' HD13 ' A' ' 48' ' ' LEU . 6.2 mp -94.19 110.44 22.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.075 0.464 . . . . 0.9 110.502 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.564 HG23 ' HG2' ' A' ' 86' ' ' ARG . 2.2 mm -87.95 124.6 41.21 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 C-N-CA 123.254 0.622 . . . . 0.4 109.701 -176.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.691 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -93.58 160.05 24.29 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 119.255 -1.45 . . . . 0.48 111.819 174.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 0.3 OUTLIER -69.29 132.86 47.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.72 0.295 . . . . 1.15 111.088 -178.599 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 82' ' ' PRO . 12.4 p -89.68 150.32 3.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.807 -0.812 . . . . 0.69 108.807 170.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -91.61 130.83 37.36 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.486 0.66 . . . . 2.56 112.147 -169.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -85.79 -17.27 36.25 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.082 -0.963 . . . . 3.79 110.465 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -55.88 -39.82 72.08 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.857 -0.611 . . . . 3.05 112.205 -173.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.2 52.79 2.05 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.276 0.56 . . . . 5.48 110.013 172.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -55.06 141.28 34.97 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.257 -0.883 . . . . 4.42 110.237 176.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.587 ' CG ' ' HB ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -88.34 170.32 11.07 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.357 -0.838 . . . . 4.27 111.336 -169.195 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -132.84 167.31 20.43 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.076 -0.713 . . . . 5.09 109.076 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 75' ' ' ASN . 21.1 t70 -79.6 -168.24 1.5 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.408 -0.517 . . . . 4.98 110.288 -174.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.444 ' H ' ' CG ' ' A' ' 74' ' ' ASP . 2.0 p-10 -69.46 -15.25 63.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.378 0.535 . . . . 6.68 110.22 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -99.49 -3.25 33.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.406 0.622 . . . . 7.13 109.868 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.89 35.14 16.59 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.275 -0.875 . . . . 5.53 112.145 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -78.22 -96.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.3 0.571 . . . . 5.62 111.488 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 12.3 pt-20 -177.21 120.59 0.12 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.169 -0.923 . . . . 5.0 109.781 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.587 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.2 t -128.59 148.59 33.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.873 -0.788 . . . . 3.33 108.873 172.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.35 104.47 44.76 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-O 121.472 0.653 . . . . 2.77 110.044 173.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.476 ' O ' HG21 ' A' ' 66' ' ' VAL . 43.2 Cg_exo -42.5 132.09 5.17 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.713 2.942 . . . . 1.78 112.459 174.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 60.5 mtpt -65.67 121.45 75.45 Favored Pre-proline 0 N--CA 1.445 -0.681 0 N-CA-C 109.985 -0.376 . . . . 3.11 109.985 177.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 83' ' ' LYS . 24.0 Cg_exo -59.47 148.48 86.77 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.007 2.472 . . . . 0.67 111.922 -177.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.419 ' H ' ' HG3' ' A' ' 85' ' ' GLN . 1.7 pp0? -75.77 115.59 15.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.931 0.872 . . . . 1.78 109.813 175.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.564 ' HG2' HG23 ' A' ' 63' ' ' ILE . 18.8 mtm180 -115.52 154.47 29.3 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.201 -0.909 . . . . 2.29 109.133 -175.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -117.51 109.43 16.73 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.164 -0.471 . . . . 0.5 110.003 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.544 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 51.1 ttm -108.99 122.38 47.12 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 110.061 -0.348 . . . . 0.42 110.061 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.499 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 57.8 m-85 -112.23 139.79 47.48 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.595 -0.891 . . . . 1.33 108.595 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.531 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 31.3 m -97.74 123.11 41.54 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.597 -0.519 . . . . 0.94 109.597 177.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.841 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 6.0 m-85 -106.09 165.06 11.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.986 -0.552 . . . . 1.33 109.819 -175.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -107.3 -6.46 17.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.882 0.372 . . . . 1.53 110.988 -171.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.401 ' HB3' HG23 ' A' ' 96' ' ' VAL . 48.9 t-20 -145.66 128.36 16.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.142 0.496 . . . . 0.83 110.663 -176.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.515 ' NH1' ' HB2' ' A' ' 98' ' ' ASP . 49.1 tpt85 -62.63 -26.24 68.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.06 -0.973 . . . . 2.16 111.131 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.2 m -73.46 -60.06 2.42 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.738 0.304 . . . . 0.4 110.382 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 100' ' ' ILE . 58.5 t -45.71 -55.57 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 CA-C-N 115.584 -0.734 . . . . 0.29 111.441 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.549 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -63.21 -30.63 71.74 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.227 -0.442 . . . . 0.29 110.786 -177.75 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.515 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 36.5 t70 -69.17 -31.3 69.84 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.619 0.723 . . . . 0.39 109.557 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.415 ' HB3' ' HA ' ' A' ' 2' ' ' SER . 19.9 m120 -72.93 -42.36 63.57 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.6 -1.182 . . . . 1.55 109.072 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.685 HG23 HD11 ' A' ' 18' ' ' ILE . 40.4 mm -62.64 -54.09 38.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.783 -1.099 . . . . 0.13 111.562 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.715 ' HA ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -60.87 -42.72 98.46 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 120.54 0.21 . . . . 1.11 111.481 -177.221 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.401 ' HB3' ' HE2' ' A' ' 101' ' ' LYS . 13.0 ptp -66.51 -29.56 69.68 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.66 -0.867 . . . . 1.17 108.66 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 32.7 m -66.0 -52.01 53.23 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.751 -1.113 . . . . 0.15 110.025 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.902 ' HB2' HD22 ' A' ' 48' ' ' LEU . 13.3 mt -69.31 -58.51 3.92 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.444 -0.798 . . . . 0.13 110.945 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 1.077 ' HG3' HD23 ' A' ' 48' ' ' LEU . 96.8 mt-30 -49.2 -28.21 4.32 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.757 0.651 . . . . 1.45 112.757 -178.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -67.14 -49.02 66.27 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.852 -0.796 . . . . 0.65 108.852 176.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.788 HG21 ' HB3' ' A' ' 25' ' ' ALA . 53.0 mt -59.65 -43.89 92.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.669 -1.15 . . . . 0.17 110.494 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.489 HG22 ' HE3' ' A' ' 112' ' ' LYS . 1.0 OUTLIER -61.18 -58.24 8.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.604 -0.726 . . . . 0.29 110.168 -176.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.571 ' HA ' ' HD2' ' A' ' 112' ' ' LYS . 13.9 m -55.37 -29.23 58.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.722 0.296 . . . . 1.22 111.467 173.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 92.5 mtt180 -68.93 -18.37 64.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.157 0.503 . . . . 3.79 110.481 176.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 23.6 m-85 -107.8 -4.9 17.63 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.687 -0.688 . . . . 0.6 109.916 178.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.571 ' HD2' ' HA ' ' A' ' 109' ' ' SER . 1.2 mpmm? -74.77 -36.29 62.55 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.408 -0.815 . . . . 1.76 109.525 172.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.84 -11.84 56.95 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.281 -1.327 . . . . 1.56 110.063 174.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.5 29.16 3.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.716 -0.675 . . . . 1.09 110.777 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 111' ' ' TYR . 17.0 t70 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.573 -0.727 . . . . 2.16 110.505 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.634 0 N-CA-C 111.826 -0.51 . . . . 25.39 111.826 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -162.51 123.46 1.2 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.692 -0.766 . . . . 24.6 111.906 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 129.36 -105.67 0.7 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.776 -0.726 . . . . 23.97 111.906 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -83.35 51.92 4.65 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.911 -0.661 . . . . 23.13 112.457 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -146.52 27.94 1.09 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.629 0.728 . . . . 24.92 109.525 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -99.13 86.22 3.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.993 -0.549 . . . . 21.4 109.982 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 39.0 t 55.35 65.0 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.514 -0.766 . . . . 20.37 110.328 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 249' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' B' ' 250' ' ' MET . 18.4 tt0 -113.85 167.77 10.36 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.735 -0.666 . . . . 17.68 109.612 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 250' ' ' MET . . . . . 0.508 ' HB2' ' O ' ' B' ' 249' ' ' GLU . 67.5 mtt 82.11 17.9 0.37 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 122.365 1.079 . . . . 16.8 108.206 -175.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -87.49 139.78 30.19 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.441 -1.709 . . . . 13.35 110.01 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 252' ' ' SER . . . . . 0.516 ' HB3' ' HB2' ' B' ' 255' ' ' GLU . 70.6 m -82.26 70.17 9.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.05 -0.523 . . . . 10.66 111.417 -175.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -80.27 -60.4 2.34 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.654 -0.703 . . . . 11.03 110.115 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 254' ' ' GLU . . . . . 0.584 ' CD ' ' H ' ' B' ' 254' ' ' GLU . 0.6 OUTLIER -79.39 -20.56 47.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.282 -0.872 . . . . 10.94 110.114 179.122 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 255' ' ' GLU . . . . . 0.555 ' HB3' HH21 ' A' ' 61' ' ' ARG . 30.7 mt-10 -71.37 -10.64 60.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.389 -0.823 . . . . 9.82 112.044 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 90.3 p 59.97 -164.57 0.22 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.012 0.925 . . . . 5.35 110.729 -175.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -73.45 -59.93 2.48 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.206 -0.198 . . . . 6.2 111.407 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -86.7 -70.94 0.58 Allowed 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 120.182 -0.607 . . . . 6.14 109.803 174.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.63 ' HB3' ' NH1' ' A' ' 61' ' ' ARG . 8.1 p-10 169.54 -39.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.542 -1.208 . . . . 3.32 109.528 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 88.43 4.38 77.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.072 -0.585 . . . . 0.84 112.95 174.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 261' ' ' PHE . . . . . 0.682 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 6.2 m-30 -100.18 179.68 4.4 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.839 0.352 . . . . 0.95 110.414 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.39 148.9 31.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.494 -0.558 . . . . 1.37 109.494 174.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 263' ' ' GLU . . . . . 0.552 ' HB3' ' OE1' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -110.92 128.58 55.86 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.332 0.587 . . . . 2.24 110.523 179.305 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.497 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 84.5 t -100.98 103.42 14.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.916 -0.584 . . . . 1.41 110.592 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.411 -0.804 . . . . 3.04 109.547 177.451 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 N--CA 1.479 0.666 0 N-CA-C 111.445 -0.252 . . . . 3.14 111.445 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 p -90.32 -17.02 28.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.154 0.502 . . . . 1.4 110.608 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.561 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 19.5 m80 -84.72 17.86 2.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.628 -0.714 . . . . 1.85 111.525 -174.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.6 p -163.54 142.44 8.08 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.733 0.301 . . . . 0.95 110.375 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.98 147.18 7.92 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.294 -1.122 . . . . 0.16 110.294 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.762 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -69.8 144.52 52.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 117.41 0.605 . . . . 0.43 111.603 -175.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' A' ' 89' ' ' PHE . . . -152.64 155.83 38.07 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 121.068 0.461 . . . . 0.13 111.38 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.563 HG13 ' HA ' ' A' ' 13' ' ' SER . 1.9 mp -94.73 133.84 34.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.793 -0.639 . . . . 0.29 109.297 177.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.451 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 74.3 t80 -139.69 121.0 14.93 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.285 -0.635 . . . . 0.56 109.285 176.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 65.03 41.76 4.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.466 0.651 . . . . 1.46 110.141 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 11' ' ' LYS . 41.4 mmtt 74.0 -6.43 1.83 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.519 -1.219 . . . . 1.91 112.922 171.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.97 135.34 36.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.914 0.388 . . . . 0.47 110.539 175.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.563 ' HA ' HG13 ' A' ' 8' ' ' ILE . 9.6 p -73.38 128.93 36.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.79 -0.641 . . . . 1.02 110.691 176.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.679 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -146.8 -159.5 8.31 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 115.645 -0.707 . . . . 0.16 112.192 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.762 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.4 mm -126.39 152.95 34.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 120.905 0.383 . . . . 0.19 111.007 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.04 134.34 66.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 116.079 -0.51 . . . . 0.16 109.891 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.83 110.78 8.22 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.933 0.397 . . . . 0.12 112.069 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.678 HD11 HG23 ' A' ' 100' ' ' ILE . 3.9 mp -85.13 112.8 22.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.785 -0.82 . . . . 0.18 108.785 171.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.48 HD22 ' HB3' ' A' ' 21' ' ' ASP . 2.9 t-20 -114.97 125.86 54.1 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.823 -0.351 . . . . 1.12 110.139 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.402 ' HG2' ' HB1' ' A' ' 25' ' ' ALA . 9.8 mt-10 -109.76 83.07 1.69 Allowed 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 117.255 -1.778 . . . . 0.74 107.37 163.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.48 ' HB3' HD22 ' A' ' 19' ' ' ASN . 16.9 t70 -122.26 -10.01 8.55 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 106.42 -1.696 . . . . 0.59 106.42 157.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.93 HG11 ' HB3' ' A' ' 26' ' ' GLU . 14.5 p -102.79 174.86 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 112.079 -2.328 . . . . 0.35 111.897 -156.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.687 ' O ' HG13 ' A' ' 22' ' ' VAL . 12.0 p -54.52 165.0 0.96 Allowed Pre-proline 0 N--CA 1.453 -0.322 0 N-CA-C 106.661 -1.607 . . . . 1.31 106.661 165.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.616 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 11.8 Cg_endo -41.73 129.01 3.86 Favored 'Trans proline' 0 C--N 1.353 0.792 0 CA-C-N 121.731 1.654 . . . . 0.22 111.809 -147.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.646 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -29.41 131.03 0.07 Allowed 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 125.406 1.691 . . . . 0.2 113.137 -159.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.93 ' HB3' HG11 ' A' ' 22' ' ' VAL . 36.7 tt0 -132.49 133.59 43.98 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.412 -1.267 . . . . 1.26 111.532 -160.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 1.6 tt -100.38 146.88 26.45 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 107.276 -1.379 . . . . 0.15 107.276 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.498 ' N ' HD23 ' A' ' 27' ' ' LEU . 22.6 m -137.57 109.31 7.07 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 120.134 -0.626 . . . . 0.21 110.552 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.589 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 88.3 t90 -85.58 112.38 20.91 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.688 -0.687 . . . . 0.24 109.29 175.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -117.93 118.3 31.61 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.442 -0.948 . . . . 0.87 108.442 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.568 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 71.6 p -57.21 152.18 14.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.667 0.27 . . . . 0.75 111.032 -174.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.679 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 23.7 m -55.53 -35.12 65.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.599 0.714 . . . . 0.39 109.889 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.18 -28.05 53.89 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.939 -1.028 . . . . 2.33 111.613 178.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.9 1.55 70.27 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.915 -0.66 . . . . 0.55 113.246 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -81.35 -25.05 36.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.856 0.328 . . . . 1.13 111.688 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -120.82 140.96 51.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.162 0.506 . . . . 2.03 111.719 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 73.7 t -142.45 126.11 15.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.298 -0.865 . . . . 0.55 110.496 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -128.04 112.22 14.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.913 0.387 . . . . 0.69 110.418 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 27' ' ' LEU . 30.2 m -96.17 146.81 24.37 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.503 -0.317 . . . . 0.3 111.476 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 36.9 t -126.28 127.67 70.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 122.476 0.31 . . . . 0.66 111.433 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.469 ' O ' HG12 ' A' ' 45' ' ' ILE . 58.4 t -90.39 107.95 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-O 121.392 0.615 . . . . 0.18 109.497 173.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.611 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.9 mm? -51.15 -29.76 14.66 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.901 -1.045 . . . . 0.12 112.79 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 60.5 m -73.48 -34.96 65.59 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.565 -0.454 . . . . 1.06 111.528 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.3 p -72.85 -18.1 61.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.362 0.601 . . . . 0.2 109.574 173.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.578 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 50.0 mm -79.72 117.58 25.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.256 -0.884 . . . . 0.23 111.024 175.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.592 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 28.7 t70 -75.81 -43.1 47.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.029 -0.532 . . . . 0.7 111.666 177.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.493 ' HG2' ' OD2' ' A' ' 46' ' ' ASP . 48.6 mmtm -141.05 153.93 45.73 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.865 -0.421 . . . . 1.95 109.865 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.036 HD23 ' HG3' ' A' ' 105' ' ' GLN . 9.7 tp -117.31 145.99 43.63 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.203 -0.666 . . . . 0.14 109.203 166.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.667 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 15.9 mm100 -124.12 157.17 35.25 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.661 -1.154 . . . . 1.49 109.974 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.61 146.22 11.42 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.471 -0.786 . . . . 0.25 109.64 177.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.42 ' HA ' ' HD2' ' A' ' 52' ' ' PRO . 20.1 p -43.83 125.83 4.12 Favored Pre-proline 0 N--CA 1.468 0.429 0 C-N-CA 123.583 0.753 . . . . 0.37 111.756 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.567 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 52.8 Cg_endo -66.82 165.65 25.14 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 C-N-CA 123.803 3.002 . . . . 0.64 111.649 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.21 -29.33 67.42 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.092 0.472 . . . . 1.02 110.313 175.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.9 t -70.43 -22.63 62.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.713 -0.676 . . . . 1.58 110.611 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.468 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 47.7 t -72.18 145.49 48.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.71 110.428 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -89.91 -7.98 52.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.354 0.597 . . . . 2.89 109.576 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -103.92 179.43 4.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.021 -0.991 . . . . 2.59 111.077 -173.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.584 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -137.29 109.88 7.5 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.375 -1.284 . . . . 1.78 108.064 178.021 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.773 ' HB3' ' CZ ' ' B' ' 261' ' ' PHE . 10.8 ttm -157.98 138.81 13.08 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.343 -0.543 . . . . 1.3 111.375 -169.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.817 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 3.2 mp -111.06 156.35 21.43 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.087 0.47 . . . . 0.14 112.028 174.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 59.9 ttp180 -150.28 113.2 4.81 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.776 -0.647 . . . . 2.72 110.593 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.787 ' HG ' HD13 ' A' ' 48' ' ' LEU . 6.4 mp -95.72 110.73 22.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.998 -0.546 . . . . 0.9 110.693 -176.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.565 HG23 ' HB3' ' A' ' 86' ' ' ARG . 1.2 mm -87.6 120.98 37.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.163 -0.472 . . . . 0.4 110.525 -173.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -83.17 156.24 33.74 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 119.89 -1.148 . . . . 0.48 111.747 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.592 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 9.7 mptt -68.48 137.08 54.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.96 0.38 . . . . 1.15 110.29 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 82' ' ' PRO . 9.4 p -104.84 163.18 4.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.207 -0.664 . . . . 0.69 109.207 173.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -111.36 109.01 18.8 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.755 -0.461 . . . . 2.56 109.755 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.61 -15.79 57.0 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.1 -0.24 . . . . 3.79 111.47 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.6 t -82.67 -39.39 22.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.828 0.346 . . . . 3.05 110.712 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -84.92 75.36 10.38 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.219 -0.446 . . . . 5.48 110.168 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -64.33 136.85 57.54 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.56 0.695 . . . . 4.42 111.062 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.739 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 9.0 ptm180 -84.98 176.22 8.57 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.501 -1.227 . . . . 4.27 109.523 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.547 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 12.2 mmtp -120.76 138.79 53.83 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.504 0.192 . . . . 5.09 110.543 -172.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.66 ' HB3' HD21 ' A' ' 78' ' ' ASN . 2.7 t70 -93.91 -157.33 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.788 -0.449 . . . . 4.98 109.788 -178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -59.49 -31.05 69.0 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.08 0.4 . . . . 6.68 112.08 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -94.75 0.68 55.17 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.797 0.808 . . . . 7.13 109.16 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.547 ' HA2' ' HB3' ' A' ' 73' ' ' LYS . . . 68.69 35.22 79.93 Favored Glycine 0 CA--C 1.503 -0.671 0 CA-C-N 114.273 -1.331 . . . . 5.53 110.711 -175.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.66 HD21 ' HB3' ' A' ' 74' ' ' ASP . 5.5 p30 -82.46 -86.0 0.11 Allowed 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.297 -0.451 . . . . 5.62 110.889 -175.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.739 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 11.4 pt-20 178.91 129.32 0.07 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.196 0.522 . . . . 5.0 110.954 174.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.444 ' HB ' ' HG2' ' A' ' 72' ' ' ARG . 2.1 t -126.5 147.95 31.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.938 -0.764 . . . . 3.33 108.938 171.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.3 p -106.61 96.7 14.73 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-O 121.728 0.775 . . . . 2.77 109.181 171.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.473 ' O ' HG21 ' A' ' 66' ' ' VAL . 19.1 Cg_endo -61.79 142.02 92.24 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.477 2.785 . . . . 1.78 113.557 -173.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.41 ' HG3' ' HD2' ' A' ' 84' ' ' PRO . 15.5 ttpp -71.54 136.33 83.59 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.605 -0.725 . . . . 3.11 109.104 171.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.436 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 30.4 Cg_exo -52.19 133.64 47.95 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 123.141 2.561 . . . . 0.67 112.7 -175.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.18 130.5 40.39 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.829 0.823 . . . . 1.78 109.791 177.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.565 ' HB3' HG23 ' A' ' 63' ' ' ILE . 22.3 ptt180 -127.73 141.65 51.54 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.251 -0.886 . . . . 2.29 110.444 -174.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -102.32 111.18 23.37 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.043 -0.98 . . . . 0.5 110.207 -170.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.495 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 53.6 ttm -108.27 120.12 41.45 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.598 -0.728 . . . . 0.42 110.483 -172.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.457 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 55.8 m-85 -111.5 140.48 46.07 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.394 -0.965 . . . . 1.33 108.394 175.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.623 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 49.5 m -97.47 125.08 41.93 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.523 -0.471 . . . . 0.94 110.221 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.817 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 5.6 m-85 -107.7 169.0 8.86 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.747 -0.661 . . . . 1.33 109.357 -176.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -126.27 -3.4 6.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.851 0.358 . . . . 1.53 110.68 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.453 ' OD1' HG23 ' A' ' 96' ' ' VAL . 28.6 t-20 -131.12 125.66 33.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.131 0.491 . . . . 0.83 110.616 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.443 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 12.7 tpt180 -62.29 -33.51 74.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.179 -0.918 . . . . 2.16 111.371 -177.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.42 ' HB ' ' OD1' ' A' ' 93' ' ' ASN . 87.2 m -73.24 -55.76 6.0 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.951 -0.3 . . . . 0.4 110.492 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.453 HG23 ' OD1' ' A' ' 93' ' ' ASN . 95.6 t -45.86 -56.39 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-N 115.824 -0.625 . . . . 0.29 111.539 175.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.584 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -65.94 -28.9 69.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.321 -0.399 . . . . 0.29 110.7 -177.397 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.95 -37.02 83.51 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.92 -0.77 . . . . 0.39 108.92 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.558 ' O ' ' HG3' ' A' ' 102' ' ' MET . 18.3 m120 -72.79 -48.53 37.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.205 -1.361 . . . . 1.55 109.581 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.678 HG23 HD11 ' A' ' 18' ' ' ILE . 41.0 mm -56.18 -53.05 43.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.985 -1.007 . . . . 0.13 110.075 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.785 ' HA ' HD21 ' A' ' 48' ' ' LEU . 6.6 ttpp -55.98 -50.15 71.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.778 -0.646 . . . . 1.11 111.329 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.558 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.1 ppp? -68.56 -24.48 64.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.328 -0.396 . . . . 1.17 110.339 -175.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.7 m -67.62 -51.79 46.02 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.462 0.649 . . . . 0.15 110.071 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.982 ' HB2' HD22 ' A' ' 48' ' ' LEU . 13.8 mt -69.14 -58.5 3.98 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.132 -0.94 . . . . 0.13 111.364 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 1.036 ' HG3' HD23 ' A' ' 48' ' ' LEU . 66.5 mt-30 -51.52 -26.46 8.5 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.758 0.651 . . . . 1.45 112.758 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -66.24 -49.5 67.0 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.411 -0.959 . . . . 0.65 108.411 175.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.646 HG21 ' HB3' ' A' ' 25' ' ' ALA . 67.7 mt -58.51 -43.57 87.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.303 -1.317 . . . . 0.17 110.487 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.727 HG22 ' HD2' ' A' ' 112' ' ' LYS . 1.1 mt -66.79 -49.24 76.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.996 -0.547 . . . . 0.29 110.654 -176.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 32.2 t -60.27 -26.14 66.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.388 0.613 . . . . 1.22 110.095 173.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 83.0 mtt180 -73.87 -30.63 62.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.494 -0.776 . . . . 3.79 110.624 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -94.98 -21.32 18.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.051 -0.522 . . . . 0.6 112.144 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.727 ' HD2' HG22 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -75.54 -21.68 57.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.447 0.641 . . . . 1.76 109.488 173.147 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -72.55 -19.12 61.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.957 -1.02 . . . . 1.56 110.175 173.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -134.55 36.06 3.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.571 -0.741 . . . . 1.09 110.92 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 30.8 t70 . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.608 -0.71 . . . . 2.16 110.537 -179.647 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.707 0 N-CA-C 112.197 -0.361 . . . . 25.39 112.197 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 243' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' B' ' 247' ' ' ASP . . . -176.26 60.04 0.1 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.821 -0.704 . . . . 24.6 111.956 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -79.96 151.8 34.08 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.891 -0.671 . . . . 23.97 112.455 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 124.89 -79.19 0.36 Allowed Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.271 -0.732 . . . . 23.13 111.271 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -99.47 21.46 12.13 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.695 -0.483 . . . . 24.92 109.695 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 247' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' B' ' 243' ' ' GLY . 9.5 p-10 -62.55 105.75 0.68 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.472 0.653 . . . . 21.4 110.578 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 4.9 t 52.58 52.56 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 114.879 -1.055 . . . . 20.37 110.328 -175.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -128.13 129.77 47.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.344 -0.844 . . . . 17.68 109.802 176.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 66.0 mtt -138.71 47.78 1.94 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.971 -0.751 . . . . 16.8 108.971 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.02 151.29 37.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.057 -0.974 . . . . 13.35 110.794 -174.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 56.5 m -143.57 123.47 13.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.734 -0.666 . . . . 10.66 109.595 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -61.47 -31.97 71.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.111 -0.949 . . . . 11.03 111.188 -175.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -68.18 -21.43 64.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.103 -0.498 . . . . 10.94 111.218 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -84.76 -12.53 53.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.632 -0.258 . . . . 9.82 111.352 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 46.5 t -62.96 141.54 58.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.948 0.404 . . . . 5.35 110.205 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -78.2 -21.47 50.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.246 0.546 . . . . 6.2 109.904 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -86.61 2.29 48.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.617 -0.72 . . . . 6.14 110.561 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -140.76 -152.91 0.43 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.222 -1.399 . . . . 3.32 107.222 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 90.75 44.26 4.58 Favored Glycine 0 C--N 1.307 -1.044 0 C-N-CA 121.037 -0.601 . . . . 0.84 113.071 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 261' ' ' PHE . . . . . 0.773 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 6.7 m-30 -66.29 171.81 4.47 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.042 0.449 . . . . 0.95 111.701 -177.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.1 p -138.18 148.2 25.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.916 -0.584 . . . . 1.37 110.264 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -80.01 121.35 25.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.931 -0.766 . . . . 2.24 108.931 175.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 57.7 t -107.33 102.82 14.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.968 0.413 . . . . 1.41 110.632 -176.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 35.0 t70 . . . . . 0 C--O 1.248 0.993 0 CA-C-N 115.984 -0.553 . . . . 3.04 109.717 -178.838 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 N--CA 1.475 0.389 0 N-CA-C 110.464 -0.629 . . . . 3.14 110.464 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.1 m 69.84 -11.76 0.52 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.982 0.734 . . . . 1.4 112.982 175.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.424 ' CE1' HG23 ' A' ' 103' ' ' THR . 12.4 m80 -85.61 13.03 7.53 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.421 0.526 . . . . 1.85 112.421 -169.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.9 p -162.8 140.07 7.88 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.318 0.58 . . . . 0.95 111.26 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.05 152.79 13.36 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.998 -1.241 . . . . 0.16 109.998 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.746 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -73.46 145.88 45.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 117.578 0.689 . . . . 0.43 111.5 -175.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.97 152.55 32.62 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.396 0.617 . . . . 0.13 111.525 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.507 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.7 mp -94.15 124.44 46.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.861 -0.792 . . . . 0.29 108.861 174.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.574 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 79.9 t80 -128.99 105.62 8.33 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 110.176 -0.305 . . . . 0.56 110.176 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 66.98 53.22 0.84 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.573 0.701 . . . . 1.46 110.664 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp 71.28 -8.16 1.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.175 -1.375 . . . . 1.91 113.252 171.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.435 HG11 ' HD3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -99.32 132.73 44.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.865 -0.42 . . . . 0.47 109.865 172.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.507 ' HA ' HG13 ' A' ' 8' ' ' ILE . 23.3 t -85.28 123.97 31.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.998 -0.546 . . . . 1.02 109.921 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.662 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -144.48 -155.08 6.32 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 120.906 -0.664 . . . . 0.16 112.276 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.746 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.3 mm -125.11 153.35 32.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 120.977 0.418 . . . . 0.19 110.448 -177.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.487 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -123.91 131.69 72.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.826 -0.625 . . . . 0.16 109.904 178.616 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.22 111.07 8.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.038 -0.528 . . . . 0.12 111.476 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.651 HD11 HG23 ' A' ' 100' ' ' ILE . 4.0 mp -84.22 118.98 32.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.053 -1.092 . . . . 0.18 108.053 172.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.433 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.8 t30 -121.94 123.23 41.19 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.909 -0.404 . . . . 1.12 109.909 -178.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.481 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 15.8 mt-10 -108.51 83.22 1.74 Allowed 'General case' 0 N--CA 1.426 -1.635 0 C-N-CA 117.113 -1.835 . . . . 0.74 107.541 164.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.433 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 13.3 t70 -121.49 -10.2 8.88 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 106.38 -1.711 . . . . 0.59 106.38 157.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 23' ' ' SER . 14.6 p -102.15 175.98 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 111.933 -2.394 . . . . 0.35 111.791 -157.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.705 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -54.51 167.29 0.6 Allowed Pre-proline 0 C--O 1.223 -0.291 0 N-CA-C 106.464 -1.68 . . . . 1.31 106.464 166.354 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.423 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 11.6 Cg_endo -42.05 128.29 4.09 Favored 'Trans proline' 0 C--N 1.357 1.002 0 CA-C-N 122.062 1.772 . . . . 0.22 111.309 -153.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.655 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -30.0 133.73 0.05 Allowed 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 125.384 1.678 . . . . 0.2 114.189 -157.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.636 ' HB2' HG11 ' A' ' 22' ' ' VAL . 28.2 mt-10 -124.27 140.34 53.05 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 114.791 -1.095 . . . . 1.26 111.302 -171.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.764 ' HB3' HG12 ' A' ' 40' ' ' VAL . 1.8 tt -100.1 142.9 30.95 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 106.579 -1.638 . . . . 0.15 106.579 174.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.546 ' N ' HD23 ' A' ' 27' ' ' LEU . 3.0 m -129.39 107.76 9.76 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.04 -0.664 . . . . 0.21 109.827 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.59 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.4 t90 -91.61 113.27 25.49 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.875 -0.787 . . . . 0.24 108.875 176.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -121.01 124.21 44.3 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.527 -0.76 . . . . 0.87 109.465 -176.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.432 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 29.8 m -56.01 141.18 40.86 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.801 -0.444 . . . . 0.75 109.801 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.662 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 22.8 m -55.29 -34.16 63.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.817 -0.629 . . . . 0.39 110.554 -178.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -87.09 -3.28 59.06 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.468 -0.787 . . . . 2.33 111.242 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.99 19.66 72.13 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.237 -0.506 . . . . 0.55 112.73 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -71.79 -74.58 0.15 Allowed 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 111.973 0.36 . . . . 1.13 111.973 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.435 ' HD3' HG11 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -116.59 153.39 32.33 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.946 0.403 . . . . 2.03 111.036 -177.722 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 59.7 t -132.36 130.16 59.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.216 -0.447 . . . . 0.55 110.641 -176.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -122.62 109.67 14.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.645 0.26 . . . . 0.69 110.676 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 7.0 m -94.99 138.64 32.44 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.613 -0.514 . . . . 0.3 109.613 175.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.764 HG12 ' HB3' ' A' ' 27' ' ' LEU . 8.9 p -128.54 139.12 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 120.569 -0.452 . . . . 0.66 111.774 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.572 ' O ' HG12 ' A' ' 45' ' ' ILE . 45.0 t -90.02 110.88 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-O 121.377 0.608 . . . . 0.18 110.389 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.651 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.4 mm? -54.1 -28.87 42.18 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.872 -1.058 . . . . 0.12 112.633 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.423 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 66.5 m -77.34 -34.28 55.26 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.67 -0.412 . . . . 1.06 111.28 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.492 ' OG1' ' HB ' ' A' ' 41' ' ' VAL . 65.9 p -75.26 -12.14 60.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.525 0.678 . . . . 0.2 109.465 173.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.633 HG21 HD22 ' A' ' 62' ' ' LEU . 40.9 mm -81.58 123.1 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 114.963 -1.017 . . . . 0.23 110.691 170.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.478 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 35.6 t70 -74.71 -48.85 23.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.751 -0.659 . . . . 0.7 110.982 176.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' HG13 ' A' ' 63' ' ' ILE . 49.2 mmtm -142.07 165.06 28.48 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.194 -0.457 . . . . 1.95 110.172 -177.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.054 HD23 ' HG3' ' A' ' 105' ' ' GLN . 10.5 tp -126.09 142.96 51.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.422 0.63 . . . . 0.14 109.386 170.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.421 ' CG ' HD11 ' A' ' 63' ' ' ILE . 30.9 mm-40 -117.3 157.46 26.05 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.919 -1.037 . . . . 1.49 109.144 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -161.63 155.38 21.72 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.812 -1.181 . . . . 0.25 107.812 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 20.6 p -57.87 119.91 37.78 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 121.453 0.644 . . . . 0.37 111.053 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.594 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 63.5 Cg_endo -72.52 169.11 22.59 Favored 'Trans proline' 0 C--N 1.33 -0.439 0 C-N-CA 124.73 3.62 . . . . 0.64 111.699 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.4 -26.35 52.95 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.003 0.43 . . . . 1.02 110.287 172.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.0 m -69.26 -25.7 64.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.047 -0.524 . . . . 1.58 110.705 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 22.7 t -87.87 142.91 27.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.942 -0.572 . . . . 0.71 109.603 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -94.74 -7.29 41.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.15 0.5 . . . . 2.89 110.57 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -102.75 -173.2 2.27 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.717 -0.674 . . . . 2.59 111.094 -172.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.51 ' HB3' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -130.35 112.43 13.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.818 -0.628 . . . . 1.78 110.046 175.516 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.559 ' CG ' ' HA ' ' A' ' 90' ' ' SER . 2.2 mtm -157.72 141.83 16.01 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 111.71 0.263 . . . . 1.3 111.71 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.923 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 2.8 mp -109.74 162.63 14.27 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.953 0.406 . . . . 0.14 111.151 171.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.574 ' HG3' ' OD1' ' B' ' 258' ' ' ASP . 0.0 OUTLIER -154.16 112.64 3.6 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.818 -0.628 . . . . 2.72 109.572 177.57 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.71 ' HG ' HD13 ' A' ' 48' ' ' LEU . 8.4 mt -95.7 117.28 30.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.3 0.571 . . . . 0.9 110.948 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.548 HG23 ' HG2' ' A' ' 86' ' ' ARG . 7.9 mm -87.67 102.95 13.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.412 -0.813 . . . . 0.4 110.704 -174.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -73.74 145.15 34.98 Favored Glycine 0 C--N 1.321 -0.268 0 C-N-CA 119.949 -1.12 . . . . 0.48 110.858 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.478 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 1.6 mptm? -54.5 135.28 46.02 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.382 0.611 . . . . 1.15 111.761 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.557 HG22 ' H ' ' A' ' 67' ' ' ASP . 10.7 p -69.26 171.67 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.885 -1.052 . . . . 0.69 110.156 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.557 ' H ' HG22 ' A' ' 66' ' ' VAL . 7.7 t70 -54.1 142.04 26.73 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.242 0.544 . . . . 2.56 110.809 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -59.02 -7.59 1.14 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 114.244 1.202 . . . . 3.79 114.244 -171.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.1 t -81.62 -12.94 58.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 118.02 0.373 . . . . 3.05 110.308 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 4.0 mptp? 41.82 -98.41 0.02 OUTLIER 'General case' 0 C--O 1.231 0.102 0 N-CA-C 113.729 1.011 . . . . 5.48 113.729 -175.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -72.93 130.38 40.25 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.593 0.711 . . . . 4.42 112.111 -172.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.491 ' HG2' ' HB ' ' A' ' 80' ' ' VAL . 8.0 ptm180 -107.25 172.74 6.66 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 106.31 -1.737 . . . . 4.27 106.31 169.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.547 ' CB ' ' HA2' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -134.05 162.71 31.34 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.61 -0.681 . . . . 5.09 109.963 176.654 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -87.56 -166.52 1.6 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.569 -0.9 . . . . 4.98 108.569 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -57.42 -28.22 63.09 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.552 0.575 . . . . 6.68 112.552 -173.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -101.56 -0.5 34.8 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.24 0.543 . . . . 7.13 110.746 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.547 ' HA2' ' CB ' ' A' ' 73' ' ' LYS . . . 81.55 28.83 41.85 Favored Glycine 0 C--N 1.321 -0.299 0 C-N-CA 120.419 -0.896 . . . . 5.53 111.2 -176.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 79' ' ' GLU . 24.0 m120 -61.33 -37.4 83.14 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.198 0.599 . . . . 5.62 112.601 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 46.4 mt-10 98.93 118.18 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 O-C-N 125.201 1.563 . . . . 5.0 111.263 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.491 ' HB ' ' HG2' ' A' ' 72' ' ' ARG . 2.0 t -123.58 147.88 27.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.053 -1.092 . . . . 3.33 108.053 172.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.8 p -112.93 103.37 55.64 Favored Pre-proline 0 C--N 1.312 -1.03 0 C-N-CA 119.895 -0.722 . . . . 2.77 111.043 177.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.01 139.47 20.3 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.565 2.843 . . . . 1.78 111.727 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.513 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 28.4 ttmt -80.39 124.78 82.17 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 121.986 0.898 . . . . 3.11 111.764 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 83' ' ' LYS . 21.1 Cg_exo -59.35 158.47 26.68 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 124.272 3.314 . . . . 0.67 112.962 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.17 119.12 24.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.296 0.569 . . . . 1.78 110.158 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.548 ' HG2' HG23 ' A' ' 63' ' ' ILE . 25.3 mtt180 -119.31 162.33 18.93 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.89 -0.595 . . . . 2.29 111.363 -169.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -124.78 115.24 20.37 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.887 -0.597 . . . . 0.5 110.242 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.514 ' CB ' ' HG2' ' A' ' 61' ' ' ARG . 59.6 ttm -107.07 129.22 54.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.811 -0.177 . . . . 0.42 111.111 -173.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.58 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -119.62 140.43 50.61 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.613 -0.884 . . . . 1.33 108.613 173.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.559 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 52.6 m -100.31 126.64 46.66 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.115 0.483 . . . . 0.94 109.768 177.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.923 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 18.8 m-85 -106.55 160.45 15.42 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.792 -0.64 . . . . 1.33 110.649 -173.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -101.99 -6.94 22.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.281 -0.418 . . . . 1.53 110.577 -171.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -148.32 131.27 16.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.358 0.599 . . . . 0.83 110.918 -175.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.51 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 9.2 tpt180 -60.88 -31.47 70.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.697 -1.138 . . . . 2.16 111.269 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 94.4 m -73.15 -57.88 3.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.806 0.336 . . . . 0.4 110.356 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 68.1 t -46.67 -52.67 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.994 -0.548 . . . . 0.29 111.716 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.476 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -66.71 -28.33 68.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.198 -0.455 . . . . 0.29 110.438 -178.203 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.93 -29.96 69.15 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.181 -0.674 . . . . 0.39 109.181 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.628 ' O ' ' HG3' ' A' ' 102' ' ' MET . 19.7 m120 -77.37 -50.03 13.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.988 -1.005 . . . . 1.55 110.083 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.651 HG23 HD11 ' A' ' 18' ' ' ILE . 40.5 mm -56.71 -50.76 73.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.314 -0.857 . . . . 0.13 110.304 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.711 ' HA ' HD21 ' A' ' 48' ' ' LEU . 7.2 ttpp -55.31 -50.78 68.71 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.735 -0.666 . . . . 1.11 111.046 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.628 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.3 ppp? -69.35 -20.95 63.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.118 -0.492 . . . . 1.17 110.646 -174.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.424 HG23 ' CE1' ' A' ' 3' ' ' HIS . 52.7 m -70.98 -56.74 5.55 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.337 0.589 . . . . 0.15 110.093 174.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.923 ' HB2' HD22 ' A' ' 48' ' ' LEU . 13.8 mt -61.2 -55.75 28.6 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.009 -0.996 . . . . 0.13 110.587 -176.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 1.054 ' HG3' HD23 ' A' ' 48' ' ' LEU . 75.3 mt-30 -53.61 -26.46 22.0 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.852 0.686 . . . . 1.45 112.852 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -65.93 -30.87 71.52 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 122.057 0.932 . . . . 0.65 108.933 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.655 HG21 ' HB3' ' A' ' 25' ' ' ALA . 30.1 mt -82.7 -43.81 18.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 113.678 -1.601 . . . . 0.17 110.232 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.703 HG22 ' HD2' ' A' ' 112' ' ' LYS . 1.1 mt -68.81 -47.12 77.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.546 -0.752 . . . . 0.29 111.174 -175.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 50.8 m -61.03 -27.61 68.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.581 0.705 . . . . 1.22 109.42 175.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.54 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 17.0 ttt180 -67.91 -34.18 76.13 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.598 -1.183 . . . . 3.79 109.732 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -95.15 -19.91 19.69 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.992 -0.549 . . . . 0.6 111.435 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.703 ' HD2' HG22 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -74.17 -31.44 62.69 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 110.141 -0.318 . . . . 1.76 110.141 174.426 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.39 -1.31 45.08 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.195 0.521 . . . . 1.56 110.463 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -114.53 1.58 14.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.668 -0.696 . . . . 1.09 110.544 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 30.2 t70 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.439 -0.791 . . . . 2.16 110.519 -177.537 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 N-CA-C 111.583 -0.607 . . . . 25.39 111.583 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -103.98 131.56 10.69 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.902 -0.666 . . . . 24.6 111.83 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -145.75 178.12 23.69 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.61 -0.805 . . . . 23.97 112.317 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 84.7 170.13 46.65 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.05 -0.595 . . . . 23.13 112.315 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -105.72 18.35 22.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.976 0.417 . . . . 24.92 110.832 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -115.18 145.14 42.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.323 -0.398 . . . . 21.4 110.354 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 10.3 p -83.95 -3.93 8.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 122.04 0.924 . . . . 20.37 109.155 175.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -90.72 121.66 32.8 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.879 -1.055 . . . . 17.68 109.394 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 28.0 ttt -169.06 55.06 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.403 -0.962 . . . . 16.8 108.403 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.78 117.38 7.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.136 -0.938 . . . . 13.35 110.658 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 24.8 p -146.92 -163.08 1.67 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.282 -0.872 . . . . 10.66 110.423 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -77.77 -12.36 59.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.513 -0.312 . . . . 11.03 110.904 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 254' ' ' GLU . . . . . 0.513 ' HA ' ' HB2' ' B' ' 257' ' ' ASP . 33.7 mm-40 -55.6 -26.88 46.24 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.023 -0.535 . . . . 10.94 112.012 -176.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -51.68 -38.3 54.41 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.968 0.413 . . . . 9.82 111.261 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 62.4 m -132.25 47.63 2.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.299 0.571 . . . . 5.35 110.242 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 257' ' ' ASP . . . . . 0.513 ' HB2' ' HA ' ' B' ' 254' ' ' GLU . 14.6 t70 -82.72 -54.93 4.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.724 -0.671 . . . . 6.2 111.268 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.574 ' OD1' ' HG3' ' A' ' 61' ' ' ARG . 14.3 t70 -69.35 -67.94 0.44 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.14 0.495 . . . . 6.14 111.123 -177.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -164.01 44.16 0.1 Allowed 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.949 -1.13 . . . . 3.32 107.949 174.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 100.33 -4.89 57.13 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 114.685 -1.143 . . . . 0.84 112.363 -176.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 261' ' ' PHE . . . . . 0.594 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 1.1 m-85 -111.07 158.84 18.38 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 110.055 -0.35 . . . . 0.95 110.055 -177.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 262' ' ' VAL . . . . . 0.49 ' CG1' ' HB3' ' A' ' 52' ' ' PRO . 13.0 p -144.5 165.72 12.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.882 -0.599 . . . . 1.37 109.452 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 263' ' ' GLU . . . . . 0.432 ' N ' HG22 ' B' ' 262' ' ' VAL . 14.1 tt0 -78.99 117.52 20.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.279 -1.008 . . . . 2.24 108.279 172.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.612 ' H ' HE22 ' A' ' 105' ' ' GLN . 40.6 t -116.34 103.8 15.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.469 -0.332 . . . . 1.41 110.356 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 21.6 t70 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.498 -0.763 . . . . 3.04 110.285 178.175 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.479 0.646 0 N-CA-C 110.734 -0.525 . . . . 3.14 110.734 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.419 ' C ' ' H ' ' A' ' 4' ' ' SER . 67.0 m -97.55 148.44 23.25 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.77 0.319 . . . . 1.4 110.285 174.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.509 ' HA ' HG21 ' A' ' 103' ' ' THR . 28.8 m80 63.65 -4.65 0.32 Allowed 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.45 -0.796 . . . . 1.85 112.45 -177.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 77.1 p -163.86 137.99 5.72 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.736 0.303 . . . . 0.95 110.249 177.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.19 151.38 10.57 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.431 -1.067 . . . . 0.16 110.431 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.717 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.94 138.16 40.81 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.336 0.568 . . . . 0.43 111.598 -175.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.21 157.1 43.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.13 110.844 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 2.3 mp -91.27 127.06 43.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.185 -0.672 . . . . 0.29 109.185 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.579 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 79.2 t80 -138.51 118.42 13.31 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.845 -0.428 . . . . 0.56 109.845 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 70.49 41.56 0.96 Allowed 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 123.851 0.719 . . . . 1.46 110.494 -176.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? 70.27 9.34 6.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.356 -1.293 . . . . 1.91 111.956 173.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.29 135.59 58.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.745 0.307 . . . . 0.47 110.524 176.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.5 ' HA ' HG13 ' A' ' 8' ' ' ILE . 48.5 t -76.95 120.57 22.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.089 0.471 . . . . 1.02 110.268 176.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.626 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -141.85 -154.44 6.17 Favored Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 115.766 -0.652 . . . . 0.16 112.004 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.717 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.3 mm -126.89 153.4 35.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 121.052 0.453 . . . . 0.19 110.676 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 4' ' ' SER . 0.1 OUTLIER -122.33 133.68 67.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 115.656 -0.702 . . . . 0.16 109.789 178.243 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.34 108.78 7.37 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.02 0.438 . . . . 0.12 111.607 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.661 HD11 HG23 ' A' ' 100' ' ' ILE . 4.0 mp -85.62 113.31 23.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.302 -0.999 . . . . 0.18 108.302 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.478 HD22 ' HB3' ' A' ' 21' ' ' ASP . 2.6 t-20 -116.58 122.66 45.29 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.649 -0.5 . . . . 1.12 109.649 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.441 ' HG2' ' HB1' ' A' ' 25' ' ' ALA . 8.6 mt-10 -108.17 82.86 1.69 Allowed 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 117.144 -1.823 . . . . 0.74 107.38 165.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.478 ' HB3' HD22 ' A' ' 19' ' ' ASN . 23.1 t70 -122.71 -8.6 8.45 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.6 -1.63 . . . . 0.59 106.6 157.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 23' ' ' SER . 14.6 p -101.59 174.2 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 112.182 -2.281 . . . . 0.35 111.707 -158.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.672 ' O ' HG13 ' A' ' 22' ' ' VAL . 11.3 p -54.7 165.67 0.89 Allowed Pre-proline 0 N--CA 1.455 -0.176 0 N-CA-C 107.094 -1.447 . . . . 1.31 107.094 166.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.617 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 11.0 Cg_endo -41.85 126.91 3.52 Favored 'Trans proline' 0 C--N 1.358 1.07 0 CA-C-N 122.037 1.763 . . . . 0.22 111.57 -147.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.684 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -30.29 132.41 0.07 Allowed 'General case' 0 CA--C 1.508 -0.637 0 O-C-N 125.391 1.682 . . . . 0.2 113.596 -158.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.607 ' HB2' HG11 ' A' ' 22' ' ' VAL . 36.4 mt-10 -127.47 140.42 52.16 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.697 -1.138 . . . . 1.26 111.525 -167.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.558 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.5 tt -101.36 144.62 29.95 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.101 -1.444 . . . . 0.15 107.101 175.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.462 ' N ' HD23 ' A' ' 27' ' ' LEU . 18.5 m -132.23 109.19 9.74 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.954 -0.698 . . . . 0.21 110.223 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.579 ' CE2' ' HB3' ' A' ' 9' ' ' PHE . 87.2 t90 -87.04 115.32 24.35 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.723 -0.843 . . . . 0.24 108.723 175.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -121.98 123.41 41.59 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.068 -0.969 . . . . 0.87 108.984 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.427 ' OG ' ' HB3' ' A' ' 36' ' ' LYS . 22.1 m -54.91 144.09 24.02 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.179 -0.304 . . . . 0.75 110.179 -177.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.626 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 19.4 m -55.23 -26.22 38.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.649 -0.705 . . . . 0.39 110.735 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -81.62 -27.5 34.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.887 -0.597 . . . . 2.33 111.196 175.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.99 22.28 18.19 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.708 -0.758 . . . . 0.55 112.849 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -97.51 -72.26 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.082 0.467 . . . . 1.13 110.775 -173.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.427 ' HB3' ' OG ' ' A' ' 31' ' ' SER . 18.7 ttmm -82.53 129.97 35.02 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.497 -0.774 . . . . 2.03 110.345 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 94.2 t -133.33 125.4 50.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.244 -0.435 . . . . 0.55 109.901 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -131.75 121.88 24.93 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.48 -0.327 . . . . 0.69 110.602 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 27' ' ' LEU . 31.4 m -104.38 142.07 35.23 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.683 0.278 . . . . 0.3 111.276 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 31.0 t -116.27 129.01 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 122.696 0.398 . . . . 0.66 111.167 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 45' ' ' ILE . 37.3 t -90.65 108.33 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.244 0.545 . . . . 0.18 109.663 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.598 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -55.26 -29.0 57.19 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.108 -0.951 . . . . 0.12 112.329 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 41.2 t -74.52 -30.44 61.79 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.425 -0.51 . . . . 1.06 110.738 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.6 p -80.07 -11.71 59.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.304 0.573 . . . . 0.2 109.532 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.623 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 39.1 mm -85.97 125.82 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.251 -0.886 . . . . 0.23 110.982 173.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.684 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 24.2 t70 -84.27 -38.95 19.82 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.14 -0.482 . . . . 0.7 111.217 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -143.89 153.59 42.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.927 -0.578 . . . . 1.95 110.053 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.025 HD22 ' HB2' ' A' ' 104' ' ' LEU . 10.7 tp -120.71 144.23 48.34 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.051 -0.722 . . . . 0.14 109.051 168.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.556 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 15.4 mm100 -118.63 157.59 27.1 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.016 -0.993 . . . . 1.49 109.639 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -161.58 141.39 10.35 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.134 -0.939 . . . . 0.25 108.652 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.521 ' HB ' ' CB ' ' A' ' 55' ' ' SER . 38.2 p -47.98 131.83 11.93 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 123.393 0.433 . . . . 0.37 110.877 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.433 ' O ' ' HB3' ' A' ' 55' ' ' SER . 46.7 Cg_endo -66.48 164.94 26.72 Favored 'Trans proline' 0 C--N 1.329 -0.465 0 C-N-CA 123.548 2.832 . . . . 0.64 111.536 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.56 -14.21 60.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.953 0.406 . . . . 1.02 111.027 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 56.5 m -84.59 -23.28 29.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.953 -0.567 . . . . 1.58 110.789 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.521 ' CB ' ' HB ' ' A' ' 51' ' ' THR . 29.3 t -62.33 137.3 58.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.716 -0.674 . . . . 0.71 110.587 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -83.28 -11.94 57.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.384 0.611 . . . . 2.89 110.076 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -109.07 171.58 7.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.237 -0.892 . . . . 2.59 109.485 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.603 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.2 OUTLIER -129.9 112.36 13.47 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.815 -1.18 . . . . 1.78 107.815 -178.297 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.617 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 2.4 mtm -155.75 140.96 17.52 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 119.936 -0.706 . . . . 1.3 112.237 -171.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.812 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 3.2 mp -109.43 161.08 15.65 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.684 -0.689 . . . . 0.14 110.897 170.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.556 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 7.9 ttm180 -154.57 113.85 3.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.67 -0.695 . . . . 2.72 110.273 174.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.746 ' HG ' HD13 ' A' ' 48' ' ' LEU . 10.0 mt -93.67 114.5 26.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.285 0.564 . . . . 0.9 111.249 -177.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.751 HG23 ' HG2' ' A' ' 86' ' ' ARG . 5.9 mm -87.55 108.95 18.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 123.813 0.845 . . . . 0.4 110.567 -173.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.623 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -80.45 141.4 22.89 Favored Glycine 0 C--O 1.227 -0.308 0 C-N-CA 120.286 -0.959 . . . . 0.48 112.048 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.684 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 0.5 OUTLIER -55.69 131.04 45.56 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 117.05 0.425 . . . . 1.15 110.269 179.239 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.4 p -79.43 152.23 4.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.899 -0.592 . . . . 0.69 109.718 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -82.19 101.51 10.51 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.799 -0.637 . . . . 2.56 110.698 -173.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -68.85 -31.84 71.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.742 -0.663 . . . . 3.79 110.888 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 m -70.3 -38.34 74.98 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 116.118 -0.492 . . . . 3.05 110.897 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -98.51 48.45 0.98 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.052 0.453 . . . . 5.48 110.145 177.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -66.4 126.42 28.75 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-O 121.48 0.657 . . . . 4.42 109.533 177.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.59 162.94 25.02 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 115.039 -0.982 . . . . 4.27 109.788 -173.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -133.29 159.78 39.22 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.846 -0.427 . . . . 5.09 109.846 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -86.67 -157.59 0.37 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.434 -0.348 . . . . 4.98 111.017 -173.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -75.29 -16.7 60.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.811 0.338 . . . . 6.68 111.15 -172.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 6.2 tp10 -95.0 2.17 55.3 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.064 -1.088 . . . . 7.13 108.064 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.99 27.66 71.81 Favored Glycine 0 CA--C 1.505 -0.558 0 CA-C-N 114.487 -1.233 . . . . 5.53 111.311 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.73 ' ND2' ' H ' ' A' ' 79' ' ' GLU . 6.4 p-10 -85.72 -86.67 0.14 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.384 -0.408 . . . . 5.62 111.587 -173.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.73 ' H ' ' ND2' ' A' ' 78' ' ' ASN . 9.8 pt-20 -165.74 135.72 3.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 118.596 0.635 . . . . 5.0 112.707 177.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 t -127.44 147.86 32.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.774 -1.195 . . . . 3.33 107.774 163.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 p -113.05 99.7 49.42 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-O 121.491 0.662 . . . . 2.77 110.377 175.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -52.98 136.03 59.84 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 123.163 2.575 . . . . 1.78 112.567 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -75.64 128.05 84.61 Favored Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 109.117 -0.697 . . . . 3.11 109.117 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.533 ' HG2' ' OE1' ' B' ' 249' ' ' GLU . 31.7 Cg_exo -49.63 139.56 30.63 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.731 2.954 . . . . 0.67 112.952 -173.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.434 ' CD ' ' H ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -71.81 118.73 15.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.842 0.83 . . . . 1.78 110.203 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.751 ' HG2' HG23 ' A' ' 63' ' ' ILE . 34.5 mtt180 -112.26 147.43 36.28 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.136 -0.938 . . . . 2.29 110.112 -174.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -108.57 112.66 25.13 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.596 -0.52 . . . . 0.5 109.596 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 44.7 ttm -107.06 130.71 54.63 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 121.206 -0.198 . . . . 0.42 111.449 -174.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.607 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -121.01 141.91 50.3 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.632 -0.877 . . . . 1.33 108.632 173.577 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.589 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 54.8 m -101.35 124.01 46.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.142 0.496 . . . . 0.94 110.43 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.812 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 5.7 m-85 -107.96 145.79 33.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.657 -0.702 . . . . 1.33 110.244 -175.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -100.17 -2.32 34.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.086 0.47 . . . . 1.53 110.639 -174.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -131.93 124.73 30.02 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.943 -0.572 . . . . 0.83 110.479 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.414 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 28.3 tpt180 -57.36 -35.32 69.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.237 -0.892 . . . . 2.16 111.015 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 91.6 m -71.78 -56.66 5.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.815 -0.63 . . . . 0.4 110.685 -176.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 85.0 t -45.8 -54.73 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 115.776 -0.647 . . . . 0.29 111.392 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.603 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -64.89 -29.22 70.16 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.678 -0.409 . . . . 0.29 110.955 -177.03 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.409 ' O ' ' HE3' ' A' ' 101' ' ' LYS . 29.5 t70 -71.04 -30.88 67.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.679 0.752 . . . . 0.39 109.22 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.614 ' O ' ' HG3' ' A' ' 102' ' ' MET . 19.5 m120 -78.26 -48.68 15.22 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.627 -1.17 . . . . 1.55 109.967 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.661 HG23 HD11 ' A' ' 18' ' ' ILE . 41.3 mm -58.51 -50.37 79.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.232 -0.894 . . . . 0.13 110.49 177.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.797 ' HA ' HD21 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -56.36 -48.7 76.28 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.161 -0.472 . . . . 1.11 111.023 178.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.614 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.1 ppp? -69.28 -23.36 63.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.146 0.498 . . . . 1.17 110.159 -175.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.509 HG21 ' HA ' ' A' ' 3' ' ' HIS . 54.9 m -67.64 -52.32 39.56 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.603 -0.726 . . . . 0.15 110.057 175.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.025 ' HB2' HD22 ' A' ' 48' ' ' LEU . 12.6 mt -70.87 -57.65 4.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.157 -0.929 . . . . 0.13 111.585 -173.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 1.008 ' HG3' HD23 ' A' ' 48' ' ' LEU . 9.5 mt-30 -50.78 -28.22 8.84 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.679 0.622 . . . . 1.45 112.679 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -65.02 -45.84 83.84 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.788 -0.819 . . . . 0.65 108.788 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.684 HG21 ' HB3' ' A' ' 25' ' ' ALA . 72.0 mt -63.21 -43.8 98.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.029 -1.441 . . . . 0.17 110.93 176.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.747 HG22 ' HD2' ' A' ' 112' ' ' LYS . 1.2 mt -62.4 -61.2 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.522 -0.763 . . . . 0.29 111.112 -174.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.7 m -52.99 -28.14 22.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.99 0.424 . . . . 1.22 111.261 173.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -71.98 -35.58 69.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.184 0.516 . . . . 3.79 110.665 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' A' ' 24' ' ' PRO . 12.8 m-85 -88.45 -18.85 27.41 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.752 -0.658 . . . . 0.6 112.208 -178.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.747 ' HD2' HG22 ' A' ' 108' ' ' ILE . 10.2 mtpp -86.44 -24.58 25.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.004 0.43 . . . . 1.76 110.535 177.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -76.77 -20.87 55.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.709 -0.678 . . . . 1.56 109.527 173.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -120.1 32.04 6.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.233 -0.894 . . . . 1.09 110.346 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.8 t70 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.539 -0.743 . . . . 2.16 110.049 179.258 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.886 0 N-CA-C 112.328 -0.309 . . . . 25.39 112.328 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -163.98 24.28 0.18 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.918 -0.658 . . . . 24.6 111.601 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -169.77 88.34 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 111.481 -0.648 . . . . 23.97 111.481 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -114.53 76.56 0.25 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.841 -0.904 . . . . 23.13 110.841 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 66.96 50.24 1.07 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.473 0.654 . . . . 24.92 109.392 -173.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -127.49 119.0 25.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.607 -0.724 . . . . 21.4 110.233 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 18.5 t 57.4 60.21 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.517 0.675 . . . . 20.37 109.942 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 249' ' ' GLU . . . . . 0.533 ' OE1' ' HG2' ' A' ' 84' ' ' PRO . 36.2 tt0 -63.47 114.78 4.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.454 -0.794 . . . . 17.68 111.245 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 88.6 mmm -130.28 37.5 3.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.386 -0.824 . . . . 16.8 108.961 175.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -79.46 141.44 36.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.149 -0.932 . . . . 13.35 110.725 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 43.8 m 54.32 60.8 3.35 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.851 0.719 . . . . 10.66 111.288 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.26 -13.66 59.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.558 -0.746 . . . . 11.03 110.956 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 254' ' ' GLU . . . . . 0.406 ' H ' ' HG3' ' B' ' 254' ' ' GLU . 0.0 OUTLIER -68.39 -29.59 68.32 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.832 0.349 . . . . 10.94 110.325 175.128 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -70.92 -57.61 4.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.091 0.472 . . . . 9.82 109.958 170.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 56.2 m -155.97 134.26 11.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.885 -0.598 . . . . 5.35 109.965 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -89.14 -64.45 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.108 -0.496 . . . . 6.2 110.489 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -85.02 -32.7 22.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.828 -0.623 . . . . 6.14 110.88 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 73.76 -15.89 0.54 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.276 -0.874 . . . . 3.32 112.346 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 98.35 -7.64 62.01 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.075 -0.583 . . . . 0.84 113.356 173.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 261' ' ' PHE . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 5.7 m-30 -128.55 162.94 26.07 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.439 -0.578 . . . . 0.95 109.439 -177.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 27.9 m -136.09 169.53 20.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.564 -0.532 . . . . 1.37 109.564 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.36 120.33 40.32 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.503 -0.479 . . . . 2.24 110.715 173.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.09 101.51 12.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.959 -0.756 . . . . 1.41 108.959 173.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.607 -0.711 . . . . 3.04 109.975 -176.595 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo . . . . . 0 N--CA 1.479 0.641 0 N-CA-C 110.769 -0.512 . . . . 3.14 110.769 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.8 t -174.32 -35.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.219 0.533 . . . . 1.4 110.194 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.585 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -82.87 23.73 0.8 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.532 -0.758 . . . . 1.85 111.392 -176.246 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.0 m -160.75 149.54 16.64 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.395 -0.594 . . . . 0.95 109.395 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.23 150.07 7.67 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.561 -1.016 . . . . 0.16 110.561 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.735 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -76.62 139.29 40.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 117.49 0.645 . . . . 0.43 111.416 -175.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.79 158.05 43.88 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.216 0.531 . . . . 0.13 111.119 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.567 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.1 mp -99.55 129.7 49.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.284 -0.636 . . . . 0.29 109.284 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.586 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 85.3 t80 -138.56 116.0 11.24 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.263 -0.426 . . . . 0.56 109.941 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 67.56 42.65 2.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.436 0.636 . . . . 1.46 110.739 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt 68.99 10.51 7.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.327 -1.306 . . . . 1.91 112.484 173.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -113.53 132.24 63.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.996 0.427 . . . . 0.47 110.311 173.213 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.567 ' HA ' HG13 ' A' ' 8' ' ' ILE . 32.6 t -77.75 117.68 19.37 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.833 -0.621 . . . . 1.02 109.952 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.661 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -137.23 -157.33 7.58 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.928 -0.653 . . . . 0.16 112.141 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.735 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 9.3 mm -127.04 153.42 36.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 120.827 0.346 . . . . 0.19 110.795 -176.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.466 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -123.95 132.8 70.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 115.883 -0.599 . . . . 0.16 109.675 179.022 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.93 109.54 7.47 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.109 0.411 . . . . 0.12 112.109 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.62 HD11 HG23 ' A' ' 100' ' ' ILE . 4.0 mp -85.38 103.43 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.001 -0.74 . . . . 0.18 109.001 171.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.435 HD22 ' CB ' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -110.44 129.6 55.74 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.724 -0.39 . . . . 1.12 110.202 -179.078 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -107.78 84.19 1.92 Allowed 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 116.811 -1.956 . . . . 0.74 107.345 164.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.435 ' CB ' HD22 ' A' ' 19' ' ' ASN . 17.2 t70 -121.77 -10.72 8.69 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 106.568 -1.641 . . . . 0.59 106.568 156.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.712 HG11 ' HB2' ' A' ' 26' ' ' GLU . 13.6 p -101.56 179.35 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 111.946 -2.388 . . . . 0.35 111.19 -157.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.643 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -52.44 167.2 0.38 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 117.974 -1.012 . . . . 1.31 108.338 168.019 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.582 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 15.8 Cg_endo -44.36 126.17 6.47 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.494 1.463 . . . . 0.22 111.525 -156.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.598 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -25.67 132.76 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.99 1.431 . . . . 0.2 114.725 -151.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.712 ' HB2' HG11 ' A' ' 22' ' ' VAL . 39.7 mt-10 -124.99 139.46 53.8 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.201 -0.909 . . . . 1.26 110.929 -172.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.577 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.1 tt -101.31 143.28 31.55 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 106.831 -1.544 . . . . 0.15 106.831 175.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.402 ' N ' HD23 ' A' ' 27' ' ' LEU . 6.6 m -130.17 108.99 10.46 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.688 -0.805 . . . . 0.21 110.519 -178.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.638 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 89.8 t90 -86.63 113.01 22.15 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.471 0.653 . . . . 0.24 109.417 174.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -120.47 120.78 36.88 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.173 -0.921 . . . . 0.87 109.157 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.46 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 20.1 m -55.9 141.35 39.55 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.771 -0.455 . . . . 0.75 109.771 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.661 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 28.8 m -54.15 -31.84 53.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.31 -0.859 . . . . 0.39 111.018 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -89.6 -9.21 50.6 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.236 -0.438 . . . . 2.33 111.599 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.01 18.8 57.29 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.979 -0.629 . . . . 0.55 112.553 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -72.46 -68.38 0.48 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.338 . . . . 1.13 111.527 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -110.0 152.29 26.09 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.217 0.532 . . . . 2.03 111.626 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 85.2 t -138.06 117.74 15.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.283 -0.871 . . . . 0.55 109.877 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -123.74 113.66 18.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.191 -0.459 . . . . 0.69 110.148 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.7 m -100.69 143.72 30.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.664 -0.243 . . . . 0.3 111.027 -175.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.592 HG11 HD13 ' A' ' 62' ' ' LEU . 43.1 t -117.69 128.24 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 111.797 0.295 . . . . 0.66 111.797 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 45' ' ' ILE . 33.3 t -90.63 107.93 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.279 0.561 . . . . 0.18 109.61 173.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.608 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.9 mm? -54.44 -29.83 50.78 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.806 -1.088 . . . . 0.12 112.565 -177.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.582 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 72.5 m -74.4 -34.77 63.38 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.514 -0.475 . . . . 1.06 111.46 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -74.62 -16.51 60.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.483 0.658 . . . . 0.2 109.468 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.589 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 43.3 mm -75.44 118.3 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 115.156 -0.929 . . . . 0.23 111.551 175.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.618 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 11.1 t70 -74.74 -49.59 20.5 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.423 -0.808 . . . . 0.7 111.237 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -134.09 150.92 51.19 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 116.765 -0.198 . . . . 1.95 110.58 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.92 HD22 ' HB2' ' A' ' 104' ' ' LEU . 12.3 tp -115.92 143.18 45.79 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.985 -0.746 . . . . 0.14 108.985 164.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.55 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 7.2 mt-30 -124.24 152.19 43.26 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.09 -0.959 . . . . 1.49 109.603 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.03 143.3 10.8 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.737 -0.838 . . . . 0.25 108.737 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 40.9 p -47.48 127.09 10.2 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-O 121.565 0.698 . . . . 0.37 111.025 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 61.4 Cg_endo -70.17 166.68 27.3 Favored 'Trans proline' 0 C--N 1.33 -0.402 0 C-N-CA 124.152 3.235 . . . . 0.64 112.015 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.85 -29.51 59.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.903 0.382 . . . . 1.02 110.896 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.4 m -69.62 -25.59 64.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.96 -0.563 . . . . 1.58 111.156 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.483 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 37.6 t -74.78 137.31 41.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.974 -0.557 . . . . 0.71 110.09 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -91.54 -0.07 57.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.669 0.747 . . . . 2.89 109.582 175.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.3 mmmt -107.98 176.55 5.1 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.946 -1.024 . . . . 2.59 109.985 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.555 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -137.15 109.48 7.34 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.108 -0.701 . . . . 1.78 109.108 -178.166 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.603 ' HG2' ' HA ' ' A' ' 90' ' ' SER . 68.0 mtm -157.09 140.71 15.89 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.478 0.18 . . . . 1.3 111.102 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.871 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 1.4 mp -110.15 160.05 16.82 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.23 -0.441 . . . . 0.14 111.074 174.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 21.8 ttt180 -153.31 114.88 4.23 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 121.208 0.528 . . . . 2.72 111.456 169.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.748 ' HG ' HD13 ' A' ' 48' ' ' LEU . 8.9 mt -92.86 110.19 21.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.864 -0.607 . . . . 0.9 110.813 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.579 HG23 ' HB3' ' A' ' 86' ' ' ARG . 3.9 mm -87.55 126.28 41.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 123.111 0.564 . . . . 0.4 110.456 -176.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -87.6 152.28 23.98 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.33 -0.938 . . . . 0.48 111.019 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.618 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 10.2 mptt -59.01 136.06 57.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.01 0.405 . . . . 1.15 110.394 178.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.4 ' HB ' ' HG3' ' A' ' 84' ' ' PRO . 9.3 p -72.23 157.66 6.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.774 -0.648 . . . . 0.69 109.743 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -59.18 140.1 56.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.902 -0.59 . . . . 2.56 110.706 -176.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -56.48 -17.1 7.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.64 -1.164 . . . . 3.79 113.196 -174.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.3 p -87.58 -11.83 47.5 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.892 -0.323 . . . . 3.05 111.374 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 45.73 -90.99 0.01 OUTLIER 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.082 0.953 . . . . 5.48 113.311 -174.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -61.49 139.62 58.2 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.813 0.816 . . . . 4.42 111.689 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.408 ' HG2' ' HD3' ' A' ' 82' ' ' PRO . 19.8 ptt85 -128.22 174.0 9.65 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.65 -1.159 . . . . 4.27 108.568 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.487 ' HD2' ' O ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -145.58 131.06 18.72 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.27 0.557 . . . . 5.09 110.138 177.35 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.574 ' HB3' ' OD1' ' A' ' 78' ' ' ASN . 5.2 t70 -76.21 174.53 10.01 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.326 -0.99 . . . . 4.98 108.326 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -54.74 -15.4 1.85 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.133 1.16 . . . . 6.68 114.133 -165.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -87.93 -18.77 28.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.681 0.753 . . . . 7.13 109.8 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.6 23.17 47.93 Favored Glycine 0 CA--C 1.506 -0.511 0 N-CA-C 108.972 -1.651 . . . . 5.53 108.972 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.574 ' OD1' ' HB3' ' A' ' 74' ' ' ASP . 5.3 p30 -70.8 -31.49 68.25 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 113.04 -1.58 . . . . 5.62 112.301 -173.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 53.0 mt-10 85.89 118.74 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.401 1.063 . . . . 5.0 111.483 173.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.92 147.63 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 108.041 -1.096 . . . . 3.33 108.041 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 52.0 t -117.6 96.55 49.59 Favored Pre-proline 0 C--N 1.3 -1.585 0 CA-C-O 121.588 0.709 . . . . 2.77 110.078 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.408 ' HD3' ' HG2' ' A' ' 72' ' ' ARG . 88.6 Cg_endo -77.82 128.91 9.58 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.52 2.813 . . . . 1.78 112.629 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -78.59 152.69 78.25 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.724 -0.671 . . . . 3.11 110.076 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.4 ' HG3' ' HB ' ' A' ' 66' ' ' VAL . 31.1 Cg_exo -51.55 140.72 44.35 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.028 2.486 . . . . 0.67 112.732 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -79.35 155.02 28.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.825 -0.805 . . . . 1.78 108.825 177.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.579 ' HB3' HG23 ' A' ' 63' ' ' ILE . 9.6 ptt180 -156.55 160.03 39.1 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.962 -0.563 . . . . 2.29 111.669 -166.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -120.29 111.44 17.78 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.594 -0.73 . . . . 0.5 110.058 -172.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 49.2 ttm -107.51 126.92 53.13 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.501 -0.124 . . . . 0.42 110.914 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.442 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 50.7 m-85 -116.19 143.72 45.13 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.647 -0.872 . . . . 1.33 108.647 174.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.603 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 14.9 m -99.11 123.7 43.6 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.974 0.416 . . . . 0.94 110.197 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.871 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 7.5 m-85 -108.52 157.17 18.71 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.064 -0.517 . . . . 1.33 110.246 -176.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -113.67 -6.34 13.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.904 0.383 . . . . 1.53 111.239 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -128.3 124.33 36.25 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.2 0.524 . . . . 0.83 110.145 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.436 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 29.8 tpt180 -57.24 -36.75 71.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.961 -1.018 . . . . 2.16 111.175 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 85.2 m -74.04 -55.42 6.14 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.7 -0.682 . . . . 0.4 110.83 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 100' ' ' ILE . 88.4 t -46.05 -55.21 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.29 111.352 175.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.555 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -66.88 -28.34 68.24 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.895 -0.322 . . . . 0.29 110.808 -177.431 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.15 -31.87 70.83 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.049 -0.723 . . . . 0.39 109.049 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.602 ' O ' ' HG3' ' A' ' 102' ' ' MET . 20.6 m120 -77.78 -46.31 22.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.559 -1.2 . . . . 1.55 109.726 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.62 HG23 HD11 ' A' ' 18' ' ' ILE . 35.4 mm -58.6 -51.54 70.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.104 -0.953 . . . . 0.13 110.393 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.64 ' HA ' HD21 ' A' ' 48' ' ' LEU . 4.1 ttpt -57.01 -51.39 69.46 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.886 -0.597 . . . . 1.11 110.429 178.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.602 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.3 ppp? -64.94 -25.18 67.77 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.903 0.383 . . . . 1.17 110.716 -175.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.412 HG21 ' HB ' ' A' ' 18' ' ' ILE . 35.7 m -66.02 -51.62 56.65 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.452 0.644 . . . . 0.15 110.128 175.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.92 ' HB2' HD22 ' A' ' 48' ' ' LEU . 8.7 mt -70.09 -55.95 8.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.88 -1.055 . . . . 0.13 110.927 -175.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.763 ' HG2' HD23 ' A' ' 48' ' ' LEU . 18.7 mm-40 -42.92 -36.15 1.43 Allowed 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.694 0.621 . . . . 1.45 112.664 177.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -65.42 -32.97 74.88 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.919 0.866 . . . . 0.65 109.663 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.598 HG21 ' HB3' ' A' ' 25' ' ' ALA . 42.0 mt -79.69 -41.79 22.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.066 -1.424 . . . . 0.17 110.123 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.607 HG22 ' HD2' ' A' ' 112' ' ' LYS . 0.6 OUTLIER -66.63 -51.34 57.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.248 -0.887 . . . . 0.29 110.87 -176.629 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.496 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 13.6 t -59.41 -29.03 67.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.411 0.624 . . . . 1.22 109.509 175.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 10.6 ttt180 -66.3 -34.19 77.44 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.043 -0.98 . . . . 3.79 109.949 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -94.74 -14.55 24.66 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 116.047 -0.524 . . . . 0.6 111.472 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.607 ' HD2' HG22 ' A' ' 108' ' ' ILE . 10.4 mtpp -80.9 -29.0 35.72 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.708 -0.479 . . . . 1.76 109.708 173.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.08 -17.74 59.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.629 0.728 . . . . 1.56 109.149 172.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -108.83 20.51 18.39 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.15 -0.932 . . . . 1.09 110.665 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.8 t70 . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.548 -0.739 . . . . 2.16 109.593 177.678 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' B' ' 246' ' ' TYR . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 111.454 -0.659 . . . . 25.39 111.454 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -68.0 -30.43 74.09 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.89 -0.671 . . . . 24.6 112.591 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -80.78 72.73 2.66 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.855 -0.688 . . . . 23.97 112.356 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 100.61 73.81 1.06 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.705 -0.759 . . . . 23.13 112.313 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 246' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' B' ' 242' ' ' GLY . 50.5 p90 -117.72 -16.51 10.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.032 0.444 . . . . 24.92 111.272 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -89.93 104.24 16.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.122 -0.49 . . . . 21.4 110.522 -172.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 9.4 p 43.04 39.56 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 122.463 1.125 . . . . 20.37 111.202 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -118.55 117.35 28.74 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.977 -1.01 . . . . 17.68 110.846 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 2.3 ppp? -143.95 23.17 1.73 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.764 -1.107 . . . . 16.8 109.259 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.73 141.23 49.32 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.181 -0.918 . . . . 13.35 111.259 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 252' ' ' SER . . . . . 0.4 ' HB3' ' HB2' ' B' ' 255' ' ' GLU . 20.3 m -71.83 100.89 2.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.416 -0.811 . . . . 10.66 111.031 -175.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -78.39 -38.36 41.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.032 -0.531 . . . . 11.03 111.023 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -76.99 -37.72 54.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 10.94 110.731 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 255' ' ' GLU . . . . . 0.4 ' HB2' ' HB3' ' B' ' 252' ' ' SER . 46.7 mt-10 -82.44 -15.25 53.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.333 -0.394 . . . . 9.82 110.884 177.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 39.7 t 68.46 104.62 0.05 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.274 -0.875 . . . . 5.35 111.093 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -89.91 -40.9 12.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.887 -0.597 . . . . 6.2 110.577 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -66.07 -65.14 0.72 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.904 -0.589 . . . . 6.14 111.862 -174.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -87.96 -41.8 12.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.237 0.542 . . . . 3.32 110.94 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 97.82 0.75 58.85 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.868 -0.893 . . . . 0.84 110.868 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 261' ' ' PHE . . . . . 0.55 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 1.5 m-85 -120.87 149.78 42.07 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.419 -0.586 . . . . 0.95 109.419 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.85 161.74 23.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.864 0.364 . . . . 1.37 111.824 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -90.15 124.48 34.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.818 -0.628 . . . . 2.24 109.478 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.401 ' H ' ' NE2' ' A' ' 105' ' ' GLN . 59.1 t -115.79 103.11 14.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.803 0.335 . . . . 1.41 110.715 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 C--O 1.246 0.902 0 N-CA-C 109.314 -0.624 . . . . 3.04 109.314 177.339 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo . . . . . 0 N--CA 1.48 0.718 0 N-CA-C 110.169 -0.743 . . . . 3.14 110.169 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 99.1 p 63.5 -41.72 0.22 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.299 1.439 . . . . 1.4 112.795 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.438 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 13.9 m80 -87.73 22.43 2.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.34 0.59 . . . . 1.85 110.077 -178.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.3 p -162.94 151.31 14.14 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.555 -0.748 . . . . 0.95 109.278 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.5 146.98 7.06 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.9 -0.88 . . . . 0.16 110.9 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.743 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -79.39 117.26 20.2 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 117.209 0.505 . . . . 0.43 111.296 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.503 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -125.23 155.95 39.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.349 0.595 . . . . 0.13 111.513 -177.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.501 HG13 ' HA ' ' A' ' 13' ' ' SER . 1.9 mp -96.42 119.59 44.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 108.611 -0.885 . . . . 0.29 108.611 176.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.441 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 93.2 t80 -119.47 102.82 8.93 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.518 -0.31 . . . . 0.56 110.263 -177.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 65.51 55.33 1.04 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.317 0.58 . . . . 1.46 110.939 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt 72.38 -4.81 1.94 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.641 -1.163 . . . . 1.91 113.304 171.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -103.99 130.24 54.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.939 0.399 . . . . 0.47 110.488 172.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.501 ' HA ' HG13 ' A' ' 8' ' ' ILE . 32.4 t -78.43 129.4 34.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.882 -0.599 . . . . 1.02 109.953 177.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.618 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -150.68 -159.84 9.02 Favored Glycine 0 N--CA 1.436 -1.321 0 C-N-CA 120.752 -0.737 . . . . 0.16 112.494 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.743 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 6.4 mm -125.97 153.24 33.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 120.768 0.318 . . . . 0.19 110.583 -177.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.89 135.12 63.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 116.114 -0.494 . . . . 0.16 109.861 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.19 110.57 7.44 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.207 0.447 . . . . 0.12 112.207 176.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.619 HD11 HG23 ' A' ' 100' ' ' ILE . 3.7 mp -86.08 121.44 37.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.667 -0.864 . . . . 0.18 108.667 171.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -126.7 134.28 50.72 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.699 -0.482 . . . . 1.12 109.699 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.512 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 18.0 mt-10 -114.99 83.15 1.86 Allowed 'General case' 0 N--CA 1.425 -1.723 0 C-N-CA 116.513 -2.075 . . . . 0.74 107.663 161.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -121.32 -9.79 9.02 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 106.168 -1.79 . . . . 0.59 106.168 159.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.893 HG11 ' HB3' ' A' ' 26' ' ' GLU . 13.2 p -103.52 173.82 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 111.583 -2.553 . . . . 0.35 111.821 -159.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.697 ' O ' HG13 ' A' ' 22' ' ' VAL . 16.3 m -55.08 166.28 0.85 Allowed Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 106.692 -1.596 . . . . 1.31 106.692 165.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 10.1 Cg_endo -40.55 128.06 2.44 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 121.601 1.608 . . . . 0.22 111.775 -147.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.711 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -28.2 132.78 0.04 OUTLIER 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 125.466 1.729 . . . . 0.2 113.217 -160.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.893 ' HB3' HG11 ' A' ' 22' ' ' VAL . 35.4 tt0 -130.58 132.04 45.32 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 115.229 -0.896 . . . . 1.26 111.244 -161.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.558 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.5 tt -100.83 144.94 29.18 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 106.94 -1.504 . . . . 0.15 106.94 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.505 ' N ' HD23 ' A' ' 27' ' ' LEU . 9.8 m -133.22 108.91 9.07 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.161 -0.616 . . . . 0.21 110.274 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.595 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.3 t90 -89.87 109.8 20.78 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.647 0.737 . . . . 0.24 109.056 176.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 30' ' ' ARG . 13.1 ttt-85 -113.35 121.35 44.09 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.132 -0.94 . . . . 0.87 109.236 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.48 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 88.9 p -57.33 148.02 24.13 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.078 -0.342 . . . . 0.75 110.078 -177.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.618 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 33.4 m -48.42 -38.13 18.85 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.084 0.468 . . . . 0.39 110.618 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -68.32 -28.03 66.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.628 -0.715 . . . . 2.33 111.642 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.74 21.55 46.68 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.034 -0.603 . . . . 0.55 112.068 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -104.91 -37.43 7.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.324 0.583 . . . . 1.13 110.816 -172.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -114.61 120.65 40.9 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.587 -0.733 . . . . 2.03 109.998 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.5 t -123.52 118.91 55.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.992 0.425 . . . . 0.55 110.348 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -119.41 109.96 16.38 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.98 -0.555 . . . . 0.69 110.237 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.9 m -95.69 143.32 27.05 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.471 -0.331 . . . . 0.3 111.448 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.586 HG11 HD13 ' A' ' 62' ' ' LEU . 30.1 t -120.83 124.37 72.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.295 -0.411 . . . . 0.66 111.16 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 45' ' ' ILE . 49.1 t -90.54 107.75 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 109.282 -0.636 . . . . 0.18 109.282 174.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.59 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.4 mm? -51.92 -29.09 18.66 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.957 -1.019 . . . . 0.12 112.67 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.455 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 43.1 t -71.8 -35.59 70.02 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.583 -0.447 . . . . 1.06 110.803 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.2 p -76.36 -13.82 60.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.081 0.467 . . . . 0.2 109.857 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.652 HG21 HD22 ' A' ' 62' ' ' LEU . 46.6 mm -79.84 121.17 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.579 -0.737 . . . . 0.23 111.391 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.638 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 34.0 t70 -81.78 -40.56 22.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.538 0.685 . . . . 0.7 110.881 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.597 ' HB2' ' CG1' ' A' ' 63' ' ' ILE . 46.0 mmtm -136.27 142.34 43.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.103 -0.953 . . . . 1.95 110.932 -172.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.027 HD23 ' HG3' ' A' ' 105' ' ' GLN . 12.7 tp -118.0 138.04 52.46 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.457 0.646 . . . . 0.14 109.302 164.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 14.0 mm100 -119.28 157.19 28.57 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.456 -1.247 . . . . 1.49 109.277 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -160.33 148.92 16.86 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.517 -1.29 . . . . 0.25 107.517 177.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 27.4 p -52.77 126.91 42.43 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 121.377 0.608 . . . . 0.37 111.083 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 50.1 Cg_endo -67.46 165.63 26.5 Favored 'Trans proline' 0 C--N 1.329 -0.461 0 C-N-CA 123.584 2.856 . . . . 0.64 111.068 176.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.34 -23.04 66.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.125 0.488 . . . . 1.02 110.353 176.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.3 m -73.74 -24.91 59.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.679 -0.691 . . . . 1.58 111.346 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.479 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 36.3 t -71.41 145.17 49.49 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.882 -0.414 . . . . 0.71 109.882 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -90.55 -6.05 55.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.272 0.558 . . . . 2.89 109.95 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -111.67 174.44 5.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.201 -0.909 . . . . 2.59 109.997 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.672 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 3.5 mmt -131.38 108.76 9.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.174 -0.676 . . . . 1.78 109.174 176.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.52 ' HG3' ' H ' ' A' ' 91' ' ' PHE . 3.9 mpp? -154.42 168.1 27.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.08 0.467 . . . . 1.3 111.666 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.555 HD23 HD11 ' A' ' 48' ' ' LEU . 1.1 mp -126.52 161.32 28.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.339 -0.846 . . . . 0.14 111.001 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 50.0 ttp180 -153.54 114.38 4.07 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.607 0.241 . . . . 2.72 110.986 169.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.652 HD22 HG21 ' A' ' 45' ' ' ILE . 12.6 mt -94.43 109.33 21.2 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.702 0.401 . . . . 0.9 110.942 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.726 HG23 ' HB3' ' A' ' 86' ' ' ARG . 1.0 OUTLIER -87.4 118.97 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 123.041 0.536 . . . . 0.4 110.081 -176.507 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -80.87 152.56 33.4 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.98 -1.105 . . . . 0.48 111.369 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.638 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 6.9 mptt -63.63 139.24 58.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.109 0.454 . . . . 1.15 110.306 176.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.8 p -91.74 156.88 2.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.007 -0.738 . . . . 0.69 109.007 172.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -81.41 90.53 6.19 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.29 0.567 . . . . 2.56 110.879 -175.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -84.73 -2.44 57.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.299 -0.864 . . . . 3.79 111.875 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.2 p -57.17 -40.04 76.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.781 0.324 . . . . 3.05 111.295 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.83 142.86 24.0 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 110.065 -0.346 . . . . 5.48 110.065 174.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -65.92 133.7 51.44 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.113 -0.494 . . . . 4.42 110.247 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.518 ' CG ' ' HB ' ' A' ' 80' ' ' VAL . 4.3 ptm180 -76.23 170.51 16.19 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.874 -0.788 . . . . 4.27 108.874 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.454 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -142.66 147.42 35.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.033 0.444 . . . . 5.09 111.563 -174.415 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -85.01 -157.57 0.31 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.405 -0.816 . . . . 4.98 110.915 -174.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -58.03 -30.43 66.11 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.392 0.516 . . . . 6.68 112.392 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -89.17 -14.14 36.76 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.675 0.75 . . . . 7.13 110.317 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.454 ' HA2' ' HB2' ' A' ' 73' ' ' LYS . . . 86.52 32.45 15.95 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 109.477 -1.449 . . . . 5.53 109.477 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -85.83 -89.08 0.11 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.881 -1.159 . . . . 5.62 111.085 -170.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 10.4 pt-20 -178.74 131.03 0.12 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.202 0.525 . . . . 5.0 110.681 173.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.518 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.4 t -126.88 148.21 31.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.414 -0.958 . . . . 3.33 108.414 172.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.4 p -108.39 98.22 26.52 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-O 121.848 0.832 . . . . 2.77 109.955 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.419 ' HD3' ' HG2' ' A' ' 72' ' ' ARG . 57.6 Cg_endo -71.19 140.47 37.46 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.877 2.385 . . . . 1.78 112.804 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.0 ttpp -79.85 137.52 54.09 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.659 -0.7 . . . . 3.11 110.261 175.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.407 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 21.1 Cg_exo -58.56 137.24 79.15 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.917 2.411 . . . . 0.67 111.729 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.02 114.19 12.06 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 122.352 1.072 . . . . 1.78 109.553 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.726 ' HB3' HG23 ' A' ' 63' ' ' ILE . 9.2 ptt180 -113.77 146.02 40.52 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.626 -1.17 . . . . 2.29 110.063 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -113.2 111.85 22.78 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.324 -0.853 . . . . 0.5 109.61 -170.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 53.9 ttm -104.43 126.03 51.15 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.237 -0.585 . . . . 0.42 111.395 -176.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.481 ' CE2' HD12 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -115.65 122.36 45.35 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 109.004 -0.739 . . . . 1.33 109.004 178.114 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.497 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 16.1 m -89.56 124.04 34.18 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.835 -0.621 . . . . 0.94 110.379 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.6 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 30.5 m-85 -107.29 174.15 6.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.042 -0.526 . . . . 1.33 109.753 174.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -122.56 -5.33 8.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.256 -0.429 . . . . 1.53 110.126 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -127.82 135.4 50.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.446 0.641 . . . . 0.83 111.135 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.527 ' N ' ' HG3' ' A' ' 58' ' ' MET . 28.0 tpt180 -65.84 -35.18 79.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.531 -1.213 . . . . 2.16 111.102 -174.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 94.7 m -76.27 -52.96 8.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.831 -0.622 . . . . 0.4 111.112 -175.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.3 t -45.29 -56.73 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 116.276 -0.42 . . . . 0.29 111.437 175.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.672 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -66.56 -29.25 69.27 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.194 -0.457 . . . . 0.29 110.718 -178.104 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -66.71 -33.47 75.71 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.121 -0.696 . . . . 0.39 109.121 176.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.584 ' O ' ' HG3' ' A' ' 102' ' ' MET . 18.0 m120 -75.23 -50.9 14.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.651 -1.159 . . . . 1.55 109.808 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.619 HG23 HD11 ' A' ' 18' ' ' ILE . 35.2 mm -56.59 -52.27 55.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.037 -0.983 . . . . 0.13 110.685 177.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.667 ' HA ' HD21 ' A' ' 48' ' ' LEU . 4.9 ttpt -55.82 -49.16 74.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.723 -0.672 . . . . 1.11 111.321 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.584 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.2 ppp? -68.88 -24.15 64.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.847 0.356 . . . . 1.17 110.444 -176.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 55.2 m -67.58 -51.81 46.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.436 0.636 . . . . 0.15 110.027 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.896 ' HB2' HD22 ' A' ' 48' ' ' LEU . 10.6 mt -68.02 -56.39 9.09 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.989 -1.005 . . . . 0.13 111.187 -175.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 1.027 ' HG3' HD23 ' A' ' 48' ' ' LEU . 70.9 mt-30 -46.44 -31.62 2.79 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.207 0.818 . . . . 1.45 113.207 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -68.78 -27.93 66.33 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.048 0.927 . . . . 0.65 109.692 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.711 HG21 ' HB3' ' A' ' 25' ' ' ALA . 64.8 mt -83.58 -43.68 18.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.008 -1.451 . . . . 0.17 110.148 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.929 HG22 ' HD2' ' A' ' 112' ' ' LYS . 0.8 OUTLIER -62.38 -53.56 45.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.975 -1.011 . . . . 0.29 110.28 -177.156 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.8 t -59.05 -28.07 66.1 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.682 -0.69 . . . . 1.22 110.001 176.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.446 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 11.3 ttt180 -69.47 -34.35 74.22 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.202 -0.908 . . . . 3.79 110.051 178.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -88.08 -28.98 20.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.527 -0.76 . . . . 0.6 111.319 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.929 ' HD2' HG22 ' A' ' 108' ' ' ILE . 3.5 mtpp -76.99 -14.13 59.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.429 0.633 . . . . 1.76 109.989 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -76.5 -22.09 54.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.197 -0.91 . . . . 1.56 109.624 172.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -104.16 -33.75 8.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.51 -0.768 . . . . 1.09 111.516 -177.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.1 t70 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.57 -0.728 . . . . 2.16 111.12 -177.602 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.573 0 N-CA-C 111.838 -0.505 . . . . 25.39 111.838 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 81.11 -163.86 45.62 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.748 -0.739 . . . . 24.6 112.354 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -129.08 -156.9 9.06 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.728 -0.549 . . . . 23.97 111.728 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.52 -7.37 81.48 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.729 -0.748 . . . . 23.13 112.665 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -78.55 -34.22 47.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.74 0.781 . . . . 24.92 109.609 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -125.01 152.92 43.59 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.786 -1.097 . . . . 21.4 108.868 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.3 76.38 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.312 0.577 . . . . 20.37 110.203 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -107.41 114.96 29.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.865 -0.607 . . . . 17.68 110.304 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 21.6 ptm -139.35 17.01 2.58 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.455 -0.572 . . . . 16.8 109.455 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.26 148.1 45.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.176 -0.92 . . . . 13.35 110.699 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 252' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' B' ' 256' ' ' SER . 22.3 t 77.5 -18.92 0.46 Allowed 'General case' 0 C--N 1.332 -0.19 0 O-C-N 123.886 0.741 . . . . 10.66 110.985 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -81.36 -54.72 5.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.17 0.51 . . . . 11.03 109.702 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.75 -46.43 17.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.403 -0.817 . . . . 10.94 111.896 -177.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -65.04 -21.69 66.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.927 0.394 . . . . 9.82 111.384 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 256' ' ' SER . . . . . 0.54 ' HB3' ' CG ' ' B' ' 259' ' ' ASP . 69.0 m -96.39 72.23 2.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.417 0.627 . . . . 5.35 109.672 173.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -72.7 -43.74 62.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.238 -0.892 . . . . 6.2 112.038 -174.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -72.0 -25.48 61.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.19 0.519 . . . . 6.14 110.298 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.54 ' CG ' ' HB3' ' B' ' 256' ' ' SER . 2.1 m-20 -67.24 -70.22 0.26 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.211 -0.904 . . . . 3.32 109.07 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 78.45 42.69 13.88 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.899 -1.143 . . . . 0.84 114.678 171.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 261' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 5.9 m-30 -121.36 150.9 40.78 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.323 -0.621 . . . . 0.95 109.323 176.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.3 p -134.99 152.83 33.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.162 -0.31 . . . . 1.37 110.162 -177.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -78.62 146.45 34.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.109 -0.7 . . . . 2.24 109.109 172.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 85.6 t -96.51 103.59 14.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.152 0.501 . . . . 1.41 110.259 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 34.4 t70 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.508 -0.758 . . . . 3.04 110.128 -177.118 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo . . . . . 0 N--CA 1.481 0.738 0 N-CA-C 110.584 -0.583 . . . . 3.14 110.584 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.6 p -102.04 -26.67 13.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.934 0.397 . . . . 1.4 111.328 -177.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -92.26 20.78 5.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.241 0.544 . . . . 1.85 110.397 -175.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.5 p -163.98 149.06 10.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.639 -0.71 . . . . 0.95 110.034 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.95 143.12 5.66 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 111.119 -0.792 . . . . 0.16 111.119 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.74 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.31 121.72 22.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 117.468 0.634 . . . . 0.43 111.047 -177.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.508 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -131.59 157.22 44.22 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 121.327 0.584 . . . . 0.13 111.697 -176.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 2.5 mp -95.08 114.58 31.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.477 -0.783 . . . . 0.29 109.291 175.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.608 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 74.8 t80 -122.58 111.32 16.65 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.191 -0.459 . . . . 0.56 110.031 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.509 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 40.3 mt-10 71.61 47.35 0.35 Allowed 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 124.072 0.857 . . . . 1.46 110.623 -176.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.509 ' HD2' ' C ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER 65.79 8.97 5.65 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.522 -1.217 . . . . 1.91 112.658 173.664 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.38 135.2 57.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.869 0.366 . . . . 0.47 110.436 174.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.522 ' HA ' HG13 ' A' ' 8' ' ' ILE . 23.7 t -78.25 124.99 28.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.289 0.566 . . . . 1.02 110.219 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.679 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -146.85 -156.7 7.04 Favored Glycine 0 N--CA 1.437 -1.26 0 CA-C-N 115.654 -0.703 . . . . 0.16 112.341 -178.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.74 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.1 mm -126.95 153.8 36.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.799 0.333 . . . . 0.19 110.582 -177.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.437 HD11 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -126.86 133.34 68.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 116.026 -0.534 . . . . 0.16 109.91 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.35 113.13 9.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.34 -0.391 . . . . 0.12 111.618 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.607 HD11 HG23 ' A' ' 100' ' ' ILE . 4.1 mp -84.43 121.76 37.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.002 -1.11 . . . . 0.18 108.002 171.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.437 HD22 ' HB3' ' A' ' 21' ' ' ASP . 3.5 t-20 -126.26 125.84 43.02 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.99 -0.374 . . . . 1.12 109.99 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.485 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 20.8 mt-10 -110.6 83.9 1.84 Allowed 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 116.928 -1.909 . . . . 0.74 107.616 163.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.437 ' HB3' HD22 ' A' ' 19' ' ' ASN . 13.7 t70 -120.87 -8.74 9.37 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.001 -1.851 . . . . 0.59 106.001 157.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.693 HG13 ' O ' ' A' ' 23' ' ' SER . 14.9 p -102.46 173.76 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 111.75 -2.477 . . . . 0.35 111.982 -158.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.693 ' O ' HG13 ' A' ' 22' ' ' VAL . 4.4 m -54.51 168.1 0.51 Allowed Pre-proline 0 C--O 1.223 -0.319 0 N-CA-C 106.853 -1.536 . . . . 1.31 106.853 165.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 10.2 Cg_endo -40.86 127.81 2.64 Favored 'Trans proline' 0 C--N 1.356 0.938 0 CA-C-N 122.016 1.756 . . . . 0.22 111.239 -152.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.692 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -33.9 136.23 0.12 Allowed 'General case' 0 CA--C 1.504 -0.793 0 O-C-N 125.361 1.663 . . . . 0.2 113.621 -156.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.519 ' HB2' HG11 ' A' ' 22' ' ' VAL . 74.3 mt-10 -124.8 140.29 53.07 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.387 -1.279 . . . . 1.26 111.191 -169.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.578 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.2 tt -101.58 142.41 32.99 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.419 -1.697 . . . . 0.15 106.419 172.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.41 ' N ' HD23 ' A' ' 27' ' ' LEU . 11.1 m -127.33 109.2 11.55 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.782 -0.767 . . . . 0.21 110.254 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.617 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.9 t90 -88.44 106.14 18.07 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.814 -0.81 . . . . 0.24 108.814 175.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -114.17 112.02 22.51 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.759 -1.11 . . . . 0.87 108.745 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.579 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 93.7 p -57.69 146.03 32.27 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.406 0.622 . . . . 0.75 110.85 -174.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.679 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 7.9 m -57.59 -24.51 56.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.707 -1.133 . . . . 0.39 111.236 -175.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -87.92 -27.42 22.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.892 -0.595 . . . . 2.33 111.129 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.78 21.96 27.17 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.715 -0.755 . . . . 0.55 113.443 176.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -110.2 -9.06 14.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.291 0.545 . . . . 1.13 110.833 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -139.92 119.07 12.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.913 -0.585 . . . . 2.03 109.96 -174.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 57.8 t -135.09 124.02 41.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.805 0.336 . . . . 0.55 110.712 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -130.14 122.17 27.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.309 -0.405 . . . . 0.69 110.589 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 24.5 m -102.43 134.93 44.95 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.664 0.268 . . . . 0.3 110.919 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.537 HG11 HD13 ' A' ' 62' ' ' LEU . 42.2 t -106.76 128.06 61.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 122.415 0.286 . . . . 0.66 111.52 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.496 ' O ' HG12 ' A' ' 45' ' ' ILE . 41.1 t -90.09 108.12 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-O 121.465 0.65 . . . . 0.18 109.595 173.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.573 HD11 HD22 ' A' ' 104' ' ' LEU . 1.7 mm? -53.76 -29.96 42.28 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.016 -0.993 . . . . 0.12 112.164 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.427 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 41.4 t -71.75 -35.54 70.15 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.965 -0.294 . . . . 1.06 110.672 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.418 ' OG1' ' HB ' ' A' ' 41' ' ' VAL . 66.8 p -77.1 -14.89 59.74 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 121.104 0.478 . . . . 0.2 110.12 176.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.578 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 41.4 mm -79.46 124.66 37.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.684 -0.689 . . . . 0.23 111.387 175.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.601 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 33.3 t70 -79.36 -48.16 14.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.969 -0.56 . . . . 0.7 110.737 176.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HB2' HG13 ' A' ' 63' ' ' ILE . 70.9 mmtt -135.31 149.26 49.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.728 -0.669 . . . . 1.95 110.543 -177.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.957 HD23 ' HG3' ' A' ' 105' ' ' GLN . 11.6 tp -112.92 145.24 41.1 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.086 -0.709 . . . . 0.14 109.086 164.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.481 ' H ' HD12 ' A' ' 48' ' ' LEU . 80.8 mm-40 -122.59 153.34 39.42 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.071 -0.968 . . . . 1.49 109.896 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.69 143.79 10.02 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.451 -0.795 . . . . 0.25 109.491 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 49.4 p -60.7 125.38 82.66 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-O 121.486 0.66 . . . . 0.37 111.065 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 60.6 Cg_endo -70.96 165.94 30.71 Favored 'Trans proline' 0 C--N 1.329 -0.465 0 C-N-CA 123.727 2.951 . . . . 0.64 111.285 175.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.9 -17.61 61.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.215 0.531 . . . . 1.02 110.617 176.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.7 m -77.2 -25.25 51.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.739 -0.664 . . . . 1.58 110.558 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.444 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 46.5 t -72.86 150.94 42.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.653 -0.703 . . . . 0.71 109.69 177.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -95.44 -2.85 48.02 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.586 0.708 . . . . 2.89 109.657 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HB2' HG21 ' A' ' 51' ' ' THR . 20.9 mmmt -107.05 -179.25 3.88 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.824 -1.08 . . . . 2.59 110.414 -175.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.479 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -136.97 110.22 7.83 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.278 -1.008 . . . . 1.78 108.278 169.52 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.621 ' HB3' ' CZ ' ' B' ' 261' ' ' PHE . 3.1 ttm -156.24 148.77 23.69 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.384 -0.527 . . . . 1.3 111.825 -173.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.524 HD23 HD11 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -117.7 157.22 26.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.437 -0.801 . . . . 0.14 110.479 173.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 62.8 ttp180 -151.58 114.18 4.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.708 0.29 . . . . 2.72 110.756 169.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.706 ' HG ' HD13 ' A' ' 48' ' ' LEU . 10.5 mt -92.3 112.58 24.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.1 0.476 . . . . 0.9 110.61 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.715 HG23 ' HG2' ' A' ' 86' ' ' ARG . 4.4 mm -87.22 113.85 25.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 123.55 0.74 . . . . 0.4 110.95 -175.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -79.41 141.0 23.41 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.122 -1.037 . . . . 0.48 111.579 176.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.601 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 7.2 mptt -54.46 134.28 45.95 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.964 0.382 . . . . 1.15 110.983 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.1 p -84.15 153.88 3.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.58 -0.526 . . . . 0.69 109.58 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -79.09 113.74 17.47 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.8 -0.636 . . . . 2.56 110.31 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -82.44 -25.2 33.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.733 -0.667 . . . . 3.79 111.732 -177.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.67 -37.88 73.7 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.869 -0.332 . . . . 3.05 110.679 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -90.75 48.37 1.52 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.793 0.33 . . . . 5.48 110.692 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -60.75 130.48 46.73 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.079 -0.51 . . . . 4.42 110.125 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.486 ' CB ' ' HB ' ' A' ' 80' ' ' VAL . 38.2 mtp180 -76.23 169.59 17.92 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 122.572 1.177 . . . . 4.27 113.174 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.483 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -146.59 153.04 39.89 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 112.97 -1.923 . . . . 5.09 108.38 177.391 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -87.46 -161.13 0.67 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.315 -0.554 . . . . 4.98 110.719 -170.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -62.6 -23.43 67.04 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.024 0.379 . . . . 6.68 112.024 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -95.71 -9.63 31.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.673 0.749 . . . . 7.13 109.341 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.483 ' HA2' ' HB2' ' A' ' 73' ' ' LYS . . . 89.09 32.34 10.81 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.971 -1.013 . . . . 5.53 110.758 -174.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -74.03 -91.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.671 0.272 . . . . 5.62 111.344 -176.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 14.5 pt-20 -176.78 130.6 0.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.526 . . . . 5.0 109.83 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.486 ' HB ' ' CB ' ' A' ' 72' ' ' ARG . 3.0 t -128.96 149.11 33.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.491 -0.929 . . . . 3.33 108.491 174.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 p -106.35 99.42 23.94 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-O 121.45 0.643 . . . . 2.77 110.63 174.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 80' ' ' VAL . 50.2 Cg_exo -53.38 140.19 63.59 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.199 2.599 . . . . 1.78 112.191 175.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -81.8 131.02 58.63 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-O 121.304 0.573 . . . . 3.11 110.519 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.441 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 23.6 Cg_exo -58.2 144.98 94.67 Favored 'Trans proline' 0 C--N 1.332 -0.323 0 C-N-CA 123.435 2.757 . . . . 0.67 112.381 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.47 122.05 22.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.442 0.639 . . . . 1.78 110.03 176.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.715 ' HG2' HG23 ' A' ' 63' ' ' ILE . 13.6 mtm180 -117.1 146.47 43.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.613 -0.721 . . . . 2.29 110.217 -172.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -111.13 111.98 23.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.58 -0.736 . . . . 0.5 109.414 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.541 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 50.4 ttm -106.64 129.51 54.54 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.049 0.452 . . . . 0.42 111.372 -176.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.437 ' CG ' HD11 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -120.03 122.68 41.65 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.719 -0.673 . . . . 1.33 109.338 178.028 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.556 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 20.3 m -88.74 128.23 35.62 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.022 -0.536 . . . . 0.94 110.45 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.594 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 27.8 m-85 -107.82 173.61 6.24 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.879 -0.6 . . . . 1.33 110.629 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -119.05 -0.05 11.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.704 -0.68 . . . . 1.53 110.107 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -141.17 128.47 21.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.926 -0.579 . . . . 0.83 109.96 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.478 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 2.5 tmt_? -69.61 -24.4 63.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.546 . . . . 2.16 110.371 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.43 HG22 HD21 ' A' ' 99' ' ' ASN . 91.2 m -69.4 -57.19 5.59 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.118 -0.327 . . . . 0.4 110.118 177.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 98.2 t -45.62 -56.38 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 115.955 -0.566 . . . . 0.29 111.384 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.476 ' HG2' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -65.02 -28.63 69.63 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 116.021 -0.536 . . . . 0.29 110.882 -177.566 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.42 -32.47 71.46 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.196 -0.668 . . . . 0.39 109.196 176.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.43 HD21 HG22 ' A' ' 95' ' ' THR . 90.7 m-20 -74.09 -49.25 24.8 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.721 -1.127 . . . . 1.55 109.501 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.607 HG23 HD11 ' A' ' 18' ' ' ILE . 34.1 mm -58.49 -53.07 51.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.945 -1.025 . . . . 0.13 110.427 175.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.705 ' HA ' HD21 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -55.3 -48.85 73.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.335 -0.848 . . . . 1.11 111.344 179.133 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.411 ' N ' ' HE2' ' A' ' 101' ' ' LYS . 12.8 ptt? -68.8 -24.99 64.47 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.63 -0.428 . . . . 1.17 110.191 -175.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 41.6 m -66.59 -49.78 65.23 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.427 0.632 . . . . 0.15 109.922 175.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.932 ' HB2' HD22 ' A' ' 48' ' ' LEU . 12.9 mt -69.94 -57.4 5.07 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.986 -1.006 . . . . 0.13 111.715 -174.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.957 ' HG3' HD23 ' A' ' 48' ' ' LEU . 38.1 mt-30 -51.51 -27.51 10.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.833 0.679 . . . . 1.45 112.833 -178.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -71.29 -30.13 65.89 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.056 0.931 . . . . 0.65 109.472 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.692 HG21 ' HB3' ' A' ' 25' ' ' ALA . 61.6 mt -75.88 -42.78 39.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 114.141 -1.39 . . . . 0.17 109.775 172.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.577 ' C ' ' HD2' ' A' ' 112' ' ' LYS . 1.4 mt -67.39 -43.1 87.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.731 -0.668 . . . . 0.29 110.624 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.575 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 45.3 m -60.61 -29.1 69.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.366 0.603 . . . . 1.22 110.145 174.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.586 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 12.7 ttt180 -66.76 -30.27 70.44 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.061 -0.972 . . . . 3.79 109.588 175.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.486 ' HD2' ' O ' ' A' ' 107' ' ' ILE . 61.6 m-85 -97.75 -18.89 18.55 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.78 -0.646 . . . . 0.6 111.664 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.577 ' HD2' ' C ' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -69.56 -35.41 75.37 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.848 -0.797 . . . . 1.76 108.848 170.68 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.84 -15.62 63.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.126 -0.943 . . . . 1.56 110.235 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -106.83 8.21 30.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.523 -0.762 . . . . 1.09 110.944 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.608 -0.71 . . . . 2.16 110.283 -179.471 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 111.827 -0.509 . . . . 25.39 111.827 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 89.25 113.56 1.35 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.706 -0.759 . . . . 24.6 111.887 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -114.92 23.92 11.27 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.562 -0.827 . . . . 23.97 112.29 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -132.9 94.22 0.28 Allowed Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.585 -0.817 . . . . 23.13 112.477 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -157.71 102.14 1.85 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.982 0.42 . . . . 24.92 110.455 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -101.04 136.19 41.28 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.506 -0.553 . . . . 21.4 109.506 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.61 71.33 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.428 0.632 . . . . 20.37 109.655 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -69.94 119.54 14.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.314 -0.857 . . . . 17.68 110.858 -177.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 23.6 ttt -142.66 42.93 1.6 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.129 -1.063 . . . . 16.8 108.129 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -62.51 139.32 58.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.897 -1.047 . . . . 13.35 110.422 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 252' ' ' SER . . . . . 0.487 ' HB3' ' OE2' ' B' ' 254' ' ' GLU . 68.8 m -68.81 109.34 3.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.979 -0.555 . . . . 10.66 110.661 -177.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.89 -34.74 78.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.095 -0.957 . . . . 11.03 111.376 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 254' ' ' GLU . . . . . 0.487 ' OE2' ' HB3' ' B' ' 252' ' ' SER . 1.4 pp20? -67.77 -20.88 65.27 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 112.475 0.546 . . . . 10.94 112.475 -176.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -64.62 -24.15 67.49 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.87 0.367 . . . . 9.82 110.711 177.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 39.8 m -86.17 83.0 7.84 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.357 -0.608 . . . . 5.35 109.357 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -62.08 -23.63 66.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.817 -0.629 . . . . 6.2 111.499 -176.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.14 -36.23 72.67 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.351 -0.386 . . . . 6.14 110.908 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.514 ' HB2' ' CD2' ' B' ' 261' ' ' PHE . 3.6 p-10 -152.28 -82.34 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.31 -0.404 . . . . 3.32 111.843 -177.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 260' ' ' GLY . . . . . 0.4 ' H ' ' CG ' ' B' ' 259' ' ' ASP . . . 100.51 20.85 13.91 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.746 -0.942 . . . . 0.84 110.746 -171.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 261' ' ' PHE . . . . . 0.621 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 2.1 m-85 -113.83 179.94 3.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.031 -0.584 . . . . 0.95 109.854 -175.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 11.8 p -143.37 144.64 23.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.649 -0.251 . . . . 1.37 110.639 175.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -79.81 122.33 26.49 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.05 -0.722 . . . . 2.24 109.05 173.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.578 ' HB ' HE22 ' A' ' 105' ' ' GLN . 15.0 t -103.29 102.68 13.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.853 0.359 . . . . 1.41 110.427 -177.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.572 -0.728 . . . . 3.04 110.054 179.239 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo . . . . . 0 N--CA 1.481 0.747 0 N-CA-C 110.648 -0.558 . . . . 3.14 110.648 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 t -147.56 -31.14 0.31 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.258 -0.428 . . . . 1.4 110.755 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 67.4 m80 -86.97 15.22 6.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.113 -0.494 . . . . 1.85 110.949 -178.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.3 m -160.44 143.25 13.26 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.867 -0.42 . . . . 0.95 109.867 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.29 149.69 8.92 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.414 -1.074 . . . . 0.16 110.414 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.708 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -74.84 140.19 43.73 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 117.539 0.669 . . . . 0.43 111.19 -176.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.76 153.85 38.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.376 0.608 . . . . 0.13 111.723 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.561 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.0 mp -95.77 117.0 38.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.483 -0.78 . . . . 0.29 109.075 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.578 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 74.9 t80 -117.97 109.46 16.52 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.127 -0.323 . . . . 0.56 110.127 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 66.84 47.51 1.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.641 0.734 . . . . 1.46 110.758 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp 71.26 6.93 5.96 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.143 -1.389 . . . . 1.91 113.024 171.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -114.14 132.93 61.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.782 0.325 . . . . 0.47 110.414 171.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.561 ' HA ' HG13 ' A' ' 8' ' ' ILE . 41.2 t -74.64 134.51 42.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.311 0.577 . . . . 1.02 110.808 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.704 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -155.98 -158.16 8.67 Favored Glycine 0 N--CA 1.434 -1.486 0 CA-C-N 115.431 -0.804 . . . . 0.16 112.237 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.708 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 13.7 mm -124.57 153.56 31.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.053 0.454 . . . . 0.19 110.432 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.9 133.29 69.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.759 -0.655 . . . . 0.16 110.111 179.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.22 109.54 7.85 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.288 -0.414 . . . . 0.12 111.761 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.598 HD11 HG23 ' A' ' 100' ' ' ILE . 3.7 mp -85.51 121.05 36.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.567 -0.901 . . . . 0.18 108.567 172.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.431 HD22 ' HB3' ' A' ' 21' ' ' ASP . 1.7 t-20 -126.1 128.93 48.12 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 110.249 -0.278 . . . . 1.12 110.249 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.435 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 33.7 mt-10 -110.0 85.3 2.08 Favored 'General case' 0 N--CA 1.425 -1.715 0 C-N-CA 117.022 -1.871 . . . . 0.74 107.632 163.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.431 ' HB3' HD22 ' A' ' 19' ' ' ASN . 13.1 t70 -120.95 -10.58 9.06 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.287 -1.746 . . . . 0.59 106.287 156.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.688 HG11 ' HB2' ' A' ' 26' ' ' GLU . 14.3 p -102.49 174.76 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 111.66 -2.518 . . . . 0.35 112.192 -156.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.681 ' O ' HG13 ' A' ' 22' ' ' VAL . 1.1 t -54.52 167.63 0.56 Allowed Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 106.417 -1.697 . . . . 1.31 106.417 166.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.47 ' HD2' ' OG ' ' A' ' 23' ' ' SER . 13.0 Cg_endo -42.4 128.9 4.72 Favored 'Trans proline' 0 C--N 1.359 1.123 0 CA-C-N 122.266 1.845 . . . . 0.22 111.121 -152.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.623 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -32.43 135.71 0.08 Allowed 'General case' 0 CA--C 1.508 -0.652 0 O-C-N 125.242 1.589 . . . . 0.2 114.01 -155.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.688 ' HB2' HG11 ' A' ' 22' ' ' VAL . 29.2 mt-10 -121.7 136.95 54.93 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.579 -1.191 . . . . 1.26 111.213 -170.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.582 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.2 tt -101.29 143.3 31.52 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 106.222 -1.77 . . . . 0.15 106.222 170.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.449 ' N ' HD23 ' A' ' 27' ' ' LEU . 30.0 m -132.51 110.54 10.56 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.868 -0.733 . . . . 0.21 110.134 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.607 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.6 t90 -86.32 106.53 17.45 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.339 -0.846 . . . . 0.24 108.957 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -115.04 114.87 25.95 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.62 -1.173 . . . . 0.87 108.695 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.574 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 94.6 p -57.07 153.22 11.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.515 0.674 . . . . 0.75 111.574 -171.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.704 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 14.8 m -58.62 -28.49 65.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.557 -1.201 . . . . 0.39 110.87 -177.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -83.08 -28.6 29.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.085 -0.507 . . . . 2.33 110.555 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.22 17.98 32.72 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.112 -0.566 . . . . 0.55 113.072 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -103.5 -25.62 13.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.928 0.394 . . . . 1.13 111.511 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.1 tttm -117.28 122.07 42.92 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.927 -0.397 . . . . 2.03 109.927 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 84.1 t -132.07 123.01 50.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.849 0.357 . . . . 0.55 110.695 -177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -131.35 120.98 23.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.197 -0.456 . . . . 0.69 110.357 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.478 HG21 ' OE1' ' A' ' 26' ' ' GLU . 35.7 m -101.96 143.52 31.73 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 111.735 0.272 . . . . 0.3 111.735 -175.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 38.7 t -116.61 129.44 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 122.83 0.452 . . . . 0.66 111.333 176.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.552 ' O ' HG12 ' A' ' 45' ' ' ILE . 53.7 t -91.18 107.98 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 121.5 0.667 . . . . 0.18 109.43 172.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.654 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.4 mm? -53.19 -32.82 49.88 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.656 -1.156 . . . . 0.12 112.576 -178.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.466 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 52.7 m -75.92 -28.43 58.0 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.933 -0.307 . . . . 1.06 111.456 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.3 p -80.44 -10.89 59.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.187 0.517 . . . . 0.2 109.832 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 41' ' ' VAL . 36.3 mm -82.29 130.09 36.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.483 -0.78 . . . . 0.23 110.861 174.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.688 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 3.7 t70 -86.44 -41.54 14.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.689 -0.687 . . . . 0.7 111.456 176.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.525 ' HE3' ' OE1' ' B' ' 263' ' ' GLU . 11.1 tptt -140.47 138.5 34.7 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.795 -0.639 . . . . 1.95 110.005 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.092 HD23 ' HG3' ' A' ' 105' ' ' GLN . 13.9 tp -109.29 141.8 41.09 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.053 -0.721 . . . . 0.14 109.053 164.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.491 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 5.8 mt-30 -119.07 154.13 33.66 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.81 -1.086 . . . . 1.49 109.927 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.23 141.61 8.1 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.998 -0.546 . . . . 0.25 110.065 177.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 40.0 p -51.29 127.82 30.44 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-O 121.5 0.667 . . . . 0.37 111.418 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 45.0 Cg_endo -66.89 166.53 22.32 Favored 'Trans proline' 0 C--N 1.334 -0.214 0 C-N-CA 124.107 3.205 . . . . 0.64 112.105 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.407 ' N ' HH21 ' A' ' 94' ' ' ARG . . . -68.5 -11.27 59.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.087 0.47 . . . . 1.02 110.569 176.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.4 t -84.71 -24.64 28.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.999 -0.546 . . . . 1.58 109.753 173.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.574 ' OG ' ' HE3' ' A' ' 57' ' ' LYS . 21.2 t -71.59 146.13 48.59 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.067 -0.716 . . . . 0.71 109.067 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -95.42 -14.57 23.68 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.223 -1.028 . . . . 2.89 108.223 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.574 ' HE3' ' OG ' ' A' ' 55' ' ' SER . 0.0 OUTLIER -88.04 176.02 7.49 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 113.731 -1.577 . . . . 2.59 110.313 -177.213 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.532 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -138.32 109.46 6.83 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.454 -0.573 . . . . 1.78 109.454 173.931 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.57 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 3.2 mpp? -154.61 141.27 18.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.772 0.32 . . . . 1.3 111.448 -176.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.88 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 2.3 mp -109.16 161.83 14.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.722 -0.672 . . . . 0.14 110.719 170.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.491 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 2.8 ttt180 -154.03 114.36 3.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.239 -0.437 . . . . 2.72 110.925 172.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.797 ' HG ' HD13 ' A' ' 48' ' ' LEU . 11.7 mt -95.89 110.02 22.28 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 122.659 0.384 . . . . 0.9 110.88 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.616 HG23 ' HB3' ' A' ' 86' ' ' ARG . 4.3 mm -86.86 109.68 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.255 -0.43 . . . . 0.4 111.062 -174.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -74.97 143.23 30.71 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.136 -1.03 . . . . 0.48 110.956 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.688 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 6.2 mttm -64.13 134.65 55.29 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.545 0.688 . . . . 1.15 112.198 -175.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 67' ' ' ASP . 11.7 p -83.59 168.58 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.738 -1.119 . . . . 0.69 108.551 174.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.44 ' H ' HG22 ' A' ' 66' ' ' VAL . 23.9 t70 -59.89 138.64 57.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.281 0.562 . . . . 2.56 110.68 -176.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 2.2 mp0 -54.18 -22.95 12.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.437 -1.256 . . . . 3.79 112.942 -173.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.8 p -75.31 -11.38 60.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.652 0.263 . . . . 3.05 111.275 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.442 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 13.8 mmmm 48.84 -95.97 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.107 0.963 . . . . 5.48 112.916 -177.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -69.66 125.15 25.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.804 0.812 . . . . 4.42 111.765 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 7.1 ptm85 -111.73 173.31 6.41 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.829 -1.078 . . . . 4.27 110.427 -173.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -118.66 137.93 52.96 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.14 -0.937 . . . . 5.09 108.684 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.684 ' HB3' HD21 ' A' ' 78' ' ' ASN . 2.0 t70 -97.63 -158.04 0.64 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.313 -0.625 . . . . 4.98 109.313 177.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -54.1 -31.33 51.73 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.72 0.637 . . . . 6.68 112.72 -177.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 36.7 tt0 -111.48 -1.69 15.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.294 0.569 . . . . 7.13 111.111 -175.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.07 24.7 73.1 Favored Glycine 0 CA--C 1.508 -0.38 0 N-CA-C 110.469 -1.052 . . . . 5.53 110.469 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.684 HD21 ' HB3' ' A' ' 74' ' ' ASP . 2.1 p30 -60.78 -26.21 67.09 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.229 -0.986 . . . . 5.62 111.363 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 52.9 mt-10 88.92 110.1 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.058 -1.428 . . . . 5.0 111.169 174.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.492 ' HB ' ' HG2' ' A' ' 72' ' ' ARG . 2.2 t -109.58 148.38 13.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.449 -0.796 . . . . 3.33 108.861 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.0 p -110.36 97.39 31.15 Favored Pre-proline 0 C--N 1.312 -1.038 0 CA-C-O 121.698 0.761 . . . . 2.77 110.432 175.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.526 ' HG3' ' HD2' ' A' ' 72' ' ' ARG . 31.1 Cg_exo -57.64 126.68 22.6 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.183 2.589 . . . . 1.78 112.073 178.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 1.8 ttpm? -85.37 130.13 52.77 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-O 121.266 0.555 . . . . 3.11 110.596 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 83' ' ' LYS . 22.5 Cg_exo -58.49 134.22 59.71 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.1 2.533 . . . . 0.67 111.798 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.69 117.96 17.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.648 0.737 . . . . 1.78 110.192 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.616 ' HB3' HG23 ' A' ' 63' ' ' ILE . 26.2 ptt180 -125.12 143.71 50.79 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.535 -0.757 . . . . 2.29 111.439 -169.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -104.94 112.8 26.06 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.078 -0.964 . . . . 0.5 110.465 -173.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.465 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 48.3 ttm -107.56 125.31 51.14 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 110.417 -0.216 . . . . 0.42 110.417 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.604 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -117.06 139.33 50.83 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.808 -0.812 . . . . 1.33 108.808 176.046 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.526 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 31.1 t -97.48 128.16 44.02 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.193 -0.669 . . . . 0.94 109.193 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.88 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 6.2 m-85 -108.59 164.35 12.44 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.561 -0.745 . . . . 1.33 109.706 -176.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -109.29 -2.9 17.57 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.678 -0.409 . . . . 1.53 110.906 -172.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -146.69 127.77 14.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.375 0.607 . . . . 0.83 110.624 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.469 ' NH1' ' HB2' ' A' ' 98' ' ' ASP . 43.3 tpt85 -61.71 -27.28 68.6 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.852 -1.067 . . . . 2.16 111.325 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 92.3 m -74.64 -57.88 3.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.429 -0.35 . . . . 0.4 110.582 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.3 t -46.04 -54.06 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-N 116.17 -0.468 . . . . 0.29 111.289 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.558 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -66.08 -27.76 68.31 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.166 -0.47 . . . . 0.29 110.7 -177.566 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.469 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 32.9 t70 -68.93 -34.57 75.58 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 109.18 -0.674 . . . . 0.39 109.18 177.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.418 ' O ' ' HG2' ' A' ' 102' ' ' MET . 20.7 m120 -73.18 -49.26 29.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.34 -1.3 . . . . 1.55 109.53 -178.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.598 HG23 HD11 ' A' ' 18' ' ' ILE . 36.0 mm -55.84 -53.08 41.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.181 -0.918 . . . . 0.13 110.409 174.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.732 ' HA ' HD21 ' A' ' 48' ' ' LEU . 1.1 tmmm? -53.25 -52.52 58.71 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.781 -0.645 . . . . 1.11 110.937 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 99' ' ' ASN . 24.3 ptm -67.81 -24.45 65.3 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.95 -0.568 . . . . 1.17 109.768 -173.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 55.5 m -67.03 -50.52 61.78 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.54 0.686 . . . . 0.15 110.066 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.932 ' HB2' HD22 ' A' ' 48' ' ' LEU . 10.3 mt -70.45 -57.32 4.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.824 -1.08 . . . . 0.13 111.52 -174.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 1.092 ' HG3' HD23 ' A' ' 48' ' ' LEU . 63.3 mt-30 -53.85 -25.78 21.42 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.572 0.582 . . . . 1.45 112.572 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -66.42 -30.1 70.39 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.74 0.781 . . . . 0.65 109.374 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.623 HG21 ' HB3' ' A' ' 25' ' ' ALA . 31.7 mt -82.42 -44.28 19.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 114.117 -1.401 . . . . 0.17 110.312 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.882 HG22 ' HD2' ' A' ' 112' ' ' LYS . 1.4 mt -66.87 -51.38 55.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.574 -0.739 . . . . 0.29 110.804 -175.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.6 t -61.52 -22.38 65.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.544 0.688 . . . . 1.22 109.354 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.528 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 14.7 ttt180 -72.99 -38.96 66.46 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.746 -1.115 . . . . 3.79 110.184 177.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -87.0 -27.95 22.93 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.857 -0.61 . . . . 0.6 111.249 -176.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.882 ' HD2' HG22 ' A' ' 108' ' ' ILE . 15.0 mtpp -75.62 -18.19 59.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.418 0.628 . . . . 1.76 109.484 176.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.95 -20.36 61.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.076 -0.966 . . . . 1.56 109.612 171.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.55 34.17 5.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.363 -0.835 . . . . 1.09 110.855 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.6 t70 . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.691 -0.671 . . . . 2.16 110.716 -178.101 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 N-CA-C 111.903 -0.479 . . . . 25.39 111.903 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -166.37 165.13 38.09 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.65 -0.786 . . . . 24.6 112.094 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 80.4 -77.15 1.99 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.155 -0.545 . . . . 23.97 112.546 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -169.33 -178.29 40.52 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.373 -0.691 . . . . 23.13 111.373 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 73.4 t80 66.85 114.45 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.346 0.593 . . . . 24.92 111.045 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -85.25 133.16 34.18 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.278 -0.638 . . . . 21.4 109.278 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 8.3 p -82.92 14.58 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.605 0.717 . . . . 20.37 110.647 -174.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -116.9 117.3 29.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.096 -0.502 . . . . 17.68 109.789 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 48.4 mtm -120.23 -26.66 5.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.588 0.709 . . . . 16.8 110.386 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -78.11 126.18 30.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.928 -1.033 . . . . 13.35 110.429 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 40.2 p -170.29 177.01 4.29 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.14 -0.482 . . . . 10.66 110.399 -175.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -73.91 -23.76 59.59 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.27 0.557 . . . . 11.03 109.84 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.9 -20.22 63.51 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.508 -0.769 . . . . 10.94 111.847 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -56.05 -28.56 57.98 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.293 0.37 . . . . 9.82 111.46 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 51.1 m 60.35 87.28 0.09 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.366 0.603 . . . . 5.35 112.186 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -63.77 -33.59 76.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.562 -0.745 . . . . 6.2 111.072 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.08 -66.25 0.57 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.874 -0.603 . . . . 6.14 110.111 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' B' ' 260' ' ' GLY . 4.4 p-10 -168.73 -84.79 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.493 -0.776 . . . . 3.32 110.87 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 260' ' ' GLY . . . . . 0.414 ' H ' ' CG ' ' B' ' 259' ' ' ASP . . . 70.05 22.83 77.33 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.455 -0.878 . . . . 0.84 111.812 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 261' ' ' PHE . . . . . 0.472 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 13.1 m-85 -123.21 179.93 4.52 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.419 -0.586 . . . . 0.95 109.419 -178.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 7.8 p -140.93 143.99 27.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.818 0.342 . . . . 1.37 110.213 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 263' ' ' GLU . . . . . 0.525 ' OE1' ' HE3' ' A' ' 47' ' ' LYS . 44.4 tt0 -89.94 121.36 31.97 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.065 -0.717 . . . . 2.24 109.065 174.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 46.8 t -101.02 103.28 14.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.878 0.371 . . . . 1.41 110.729 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 30.9 t70 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.405 -0.807 . . . . 3.04 110.089 179.714 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.477 0.509 0 N-CA-C 110.966 -0.436 . . . . 3.14 110.966 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.8 p 55.41 -173.33 0.05 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.585 0.754 . . . . 1.4 111.188 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.427 ' HA ' HG21 ' A' ' 103' ' ' THR . 45.7 m80 63.55 4.31 1.75 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.701 0.63 . . . . 1.85 112.701 175.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.413 ' C ' HD11 ' A' ' 100' ' ' ILE . 20.4 m -158.92 148.8 19.23 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.825 -0.435 . . . . 0.95 109.825 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.41 148.05 6.6 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.366 -1.094 . . . . 0.16 110.366 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.71 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -73.57 140.0 45.97 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 117.419 0.61 . . . . 0.43 111.524 -175.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.508 ' HB1' ' HB3' ' A' ' 89' ' ' PHE . . . -148.65 162.93 38.72 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 121.361 0.6 . . . . 0.13 111.638 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.555 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.1 mp -109.47 126.49 66.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.45 -0.796 . . . . 0.29 109.031 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -114.18 99.66 7.79 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 120.879 0.371 . . . . 0.56 110.249 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 56.69 59.2 3.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.286 0.565 . . . . 1.46 111.118 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 11' ' ' LYS . 21.1 mmtp 76.07 -8.73 1.57 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.858 -1.065 . . . . 1.91 113.68 170.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.1 p -96.6 130.38 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 119.892 -0.723 . . . . 0.47 109.987 169.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.555 ' HA ' HG13 ' A' ' 8' ' ' ILE . 18.6 t -85.3 133.55 34.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.024 -0.534 . . . . 1.02 110.804 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.726 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -155.5 -155.95 7.57 Favored Glycine 0 N--CA 1.438 -1.214 0 CA-C-N 115.749 -0.66 . . . . 0.16 112.598 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.71 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.7 mm -126.6 153.44 35.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 120.798 0.333 . . . . 0.19 110.614 -177.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.431 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -121.89 132.56 70.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.12 -0.491 . . . . 0.16 110.059 179.659 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.85 109.46 7.47 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.316 -0.402 . . . . 0.12 111.927 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.641 HD11 HG23 ' A' ' 100' ' ' ILE . 3.9 mp -85.95 115.66 27.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.897 -0.779 . . . . 0.18 108.897 173.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.417 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.6 t30 -118.38 126.34 51.88 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.982 -0.377 . . . . 1.12 109.982 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -110.89 83.35 1.74 Allowed 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 117.362 -1.735 . . . . 0.74 107.543 164.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.417 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 19.5 t70 -121.25 -10.5 8.94 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 106.638 -1.615 . . . . 0.59 106.638 156.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 23' ' ' SER . 14.8 p -101.43 174.66 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 112.099 -2.319 . . . . 0.35 112.031 -156.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.672 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -54.51 165.63 0.86 Allowed Pre-proline 0 C--O 1.225 -0.194 0 N-CA-C 106.04 -1.837 . . . . 1.31 106.04 166.489 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HD2' ' OG ' ' A' ' 23' ' ' SER . 10.1 Cg_endo -41.14 128.04 2.93 Favored 'Trans proline' 0 C--N 1.354 0.845 0 CA-C-N 121.899 1.714 . . . . 0.22 111.555 -150.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.67 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -32.15 135.21 0.08 Allowed 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 125.288 1.617 . . . . 0.2 113.719 -156.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.563 ' HB2' HG11 ' A' ' 22' ' ' VAL . 70.7 mt-10 -124.77 137.62 54.31 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 114.792 -1.094 . . . . 1.26 111.366 -168.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 1.3 tt -100.65 141.88 32.89 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 106.543 -1.651 . . . . 0.15 106.543 173.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.417 ' N ' HD23 ' A' ' 27' ' ' LEU . 6.8 m -130.1 108.77 10.32 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.848 -0.741 . . . . 0.21 110.413 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.64 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 82.8 t90 -88.0 113.68 23.88 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.478 0.656 . . . . 0.24 109.755 175.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -120.67 122.97 41.62 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.168 -0.924 . . . . 0.87 109.161 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.437 ' OG ' ' HG2' ' A' ' 36' ' ' LYS . 38.1 m -56.59 141.47 43.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.088 0.47 . . . . 0.75 110.482 -174.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.726 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 20.2 m -57.54 -35.9 70.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.092 -0.958 . . . . 0.39 110.443 -176.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -87.36 -8.04 57.07 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.502 -0.772 . . . . 2.33 111.153 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.89 21.02 54.48 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.82 -0.705 . . . . 0.55 112.39 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.404 ' H ' ' HB2' ' A' ' 31' ' ' SER . 24.2 t70 -69.85 -56.36 7.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.337 0.495 . . . . 1.13 112.337 -176.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.437 ' HG2' ' OG ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -143.88 161.71 37.99 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.806 0.336 . . . . 2.03 110.979 -176.164 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.2 138.06 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.337 -0.392 . . . . 0.55 110.678 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -135.67 115.77 13.31 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 122.551 0.34 . . . . 0.69 110.714 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.5 m -98.89 142.68 30.09 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.783 0.325 . . . . 0.3 111.461 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 22.0 t -116.62 128.8 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 122.827 0.451 . . . . 0.66 111.209 175.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 45' ' ' ILE . 43.2 t -90.56 109.25 20.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.078 0.466 . . . . 0.18 109.904 175.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.612 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.9 mm? -54.16 -26.43 27.83 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.372 -0.831 . . . . 0.12 112.762 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.3 m -75.27 -35.1 61.4 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.374 -0.53 . . . . 1.06 111.329 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.8 p -74.0 -14.48 61.03 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.402 -0.592 . . . . 0.2 109.402 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.606 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 48.9 mm -82.92 114.43 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.075 -0.966 . . . . 0.23 110.863 175.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.542 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 31.8 t70 -74.7 -39.46 61.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.109 -0.496 . . . . 0.7 111.266 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -147.24 158.13 43.84 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.227 -0.442 . . . . 1.95 110.199 -174.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.93 HD22 ' HB2' ' A' ' 104' ' ' LEU . 10.8 tp -124.53 146.01 49.23 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.303 0.573 . . . . 0.14 109.917 171.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.44 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 15.5 mm100 -123.16 155.98 35.96 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.793 -1.094 . . . . 1.49 109.653 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.18 138.23 6.5 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.55 -0.75 . . . . 0.25 109.649 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.409 HG23 ' HB2' ' A' ' 59' ' ' MET . 36.7 p -50.7 126.71 24.31 Favored Pre-proline 0 N--CA 1.466 0.339 0 CA-C-O 121.193 0.52 . . . . 0.37 110.396 176.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 43.0 Cg_endo -65.59 164.76 25.2 Favored 'Trans proline' 0 C--N 1.329 -0.494 0 C-N-CA 123.611 2.874 . . . . 0.64 112.017 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.06 66.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.279 0.561 . . . . 1.02 110.064 175.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.5 t -75.03 -24.6 58.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.287 -0.87 . . . . 1.58 110.575 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.414 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 46.8 t -68.42 148.37 50.75 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.59 -0.522 . . . . 0.71 109.59 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -89.21 -7.68 55.06 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.746 0.784 . . . . 2.89 109.389 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -107.89 -175.85 2.9 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.686 -1.143 . . . . 2.59 110.9 -172.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.493 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -141.7 110.39 6.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.257 -0.883 . . . . 1.78 109.171 175.039 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.508 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 2.4 mpp? -156.3 139.94 16.0 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.694 0.283 . . . . 1.3 111.456 -176.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.868 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 1.5 mp -110.66 155.42 22.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.121 -0.49 . . . . 0.14 110.928 171.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.691 ' NH2' ' HE3' ' A' ' 88' ' ' MET . 25.4 ttm-85 -145.5 113.76 6.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.083 0.468 . . . . 2.72 110.043 170.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.777 ' HG ' HD13 ' A' ' 48' ' ' LEU . 6.5 mp -91.9 111.69 23.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.075 -0.512 . . . . 0.9 110.522 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.546 ' HA ' ' CB ' ' A' ' 86' ' ' ARG . 3.0 mm -86.71 125.52 40.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.195 -0.457 . . . . 0.4 110.116 -173.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -89.31 156.07 25.66 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.164 -1.017 . . . . 0.48 111.474 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.542 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 0.7 OUTLIER -64.12 134.01 54.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.03 0.443 . . . . 1.15 110.025 176.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.2 p -80.28 158.08 4.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.615 -0.72 . . . . 0.69 109.165 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.588 ' CG ' ' HD3' ' A' ' 70' ' ' LYS . 11.3 t70 -105.2 134.61 48.02 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.224 -0.444 . . . . 2.56 109.833 -176.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -84.19 -30.14 26.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.87 -0.604 . . . . 3.79 111.509 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.9 p -82.66 -32.33 28.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.741 0.305 . . . . 3.05 111.161 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.588 ' HD3' ' CG ' ' A' ' 67' ' ' ASP . 12.5 mptt -78.14 47.04 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.752 0.278 . . . . 5.48 111.752 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -68.83 125.71 27.47 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.67 -0.493 . . . . 4.42 109.67 175.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.534 ' HG2' ' HD3' ' A' ' 82' ' ' PRO . 0.4 OUTLIER -89.11 173.83 8.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.624 -0.717 . . . . 4.27 111.319 -168.585 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.565 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 9.9 mmtp -121.46 154.09 37.04 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.398 -0.819 . . . . 5.09 109.959 -175.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.42 ' CG ' ' H ' ' A' ' 75' ' ' ASN . 10.8 t70 -103.41 -157.37 0.61 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.274 -0.639 . . . . 4.98 109.274 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.42 ' H ' ' CG ' ' A' ' 74' ' ' ASP . 24.5 t-20 -61.61 -31.87 71.96 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.383 0.512 . . . . 6.68 112.383 -172.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -92.39 -0.43 57.37 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.742 0.782 . . . . 7.13 109.161 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.565 ' HA2' ' HB3' ' A' ' 73' ' ' LYS . . . 70.96 26.33 74.14 Favored Glycine 0 CA--C 1.501 -0.784 0 CA-C-N 114.384 -1.28 . . . . 5.53 110.901 -176.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.473 ' CG ' ' H ' ' A' ' 79' ' ' GLU . 8.4 p30 -73.3 -78.59 0.09 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 119.367 -0.349 . . . . 5.62 110.373 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 10.7 pt-20 173.5 138.94 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.165 0.507 . . . . 5.0 111.083 171.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.509 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.3 t -128.55 149.46 33.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.465 -0.939 . . . . 3.33 108.465 169.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.441 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 7.3 p -100.97 99.98 11.82 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-O 121.946 0.879 . . . . 2.77 109.992 171.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.534 ' HD3' ' HG2' ' A' ' 72' ' ' ARG . 22.4 Cg_endo -62.99 135.33 50.8 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.916 2.411 . . . . 1.78 112.57 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.73 142.29 93.65 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.545 -0.752 . . . . 3.11 109.354 176.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.38 133.6 37.14 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.855 2.37 . . . . 0.67 113.017 -174.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.2 137.19 56.03 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.835 -0.802 . . . . 1.78 108.835 176.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.61 ' HD2' ' HD3' ' A' ' 61' ' ' ARG . 28.7 ptt180 -143.64 140.9 30.34 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.663 -0.699 . . . . 2.29 111.303 -171.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -102.88 112.28 25.0 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.795 -1.093 . . . . 0.5 110.734 -170.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.691 ' HE3' ' NH2' ' A' ' 61' ' ' ARG . 38.6 ttm -104.04 137.54 41.86 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 121.067 -0.253 . . . . 0.42 110.806 -177.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.508 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 56.3 m-85 -124.1 139.18 54.18 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.514 -0.921 . . . . 1.33 108.514 169.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.54 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 14.7 m -95.1 124.18 39.0 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.313 -0.625 . . . . 0.94 109.313 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.868 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 7.7 m-85 -106.5 168.4 9.19 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 110.044 -0.354 . . . . 1.33 110.044 -174.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -114.37 -6.89 12.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.824 0.345 . . . . 1.53 111.325 -174.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -138.62 122.93 18.22 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.282 0.563 . . . . 0.83 110.954 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -54.6 -39.6 68.03 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 114.51 -1.223 . . . . 2.16 111.327 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 97.7 m -71.14 -57.25 4.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.564 -0.289 . . . . 0.4 110.599 -177.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 100' ' ' ILE . 96.1 t -45.97 -55.6 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 116.126 -0.488 . . . . 0.29 111.299 175.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.657 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -65.41 -29.36 70.06 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.254 -0.43 . . . . 0.29 110.695 -177.127 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 30.2 t70 -71.42 -28.3 63.9 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.853 0.835 . . . . 0.39 109.318 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.535 ' O ' ' HG3' ' A' ' 102' ' ' MET . 20.3 m120 -77.64 -36.84 51.17 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.559 -1.2 . . . . 1.55 109.252 176.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.641 HG23 HD11 ' A' ' 18' ' ' ILE . 33.4 mm -64.42 -53.04 47.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 114.978 -1.01 . . . . 0.13 111.144 176.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.727 ' HA ' HD21 ' A' ' 48' ' ' LEU . 2.1 ptmt -59.29 -43.57 92.57 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 121.231 -0.188 . . . . 1.11 110.6 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.535 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.5 ppp? -68.08 -25.83 65.53 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.175 0.512 . . . . 1.17 109.719 -175.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 36.9 m -65.61 -51.95 55.77 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.463 -0.789 . . . . 0.15 109.815 173.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.93 ' HB2' HD22 ' A' ' 48' ' ' LEU . 12.2 mt -71.15 -56.92 5.09 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 115.183 -0.917 . . . . 0.13 111.141 -175.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.922 ' HG2' HD23 ' A' ' 48' ' ' LEU . 21.1 mm-40 -42.85 -35.0 1.05 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.808 0.67 . . . . 1.45 112.808 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -65.59 -48.29 72.82 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.845 -0.798 . . . . 0.65 108.845 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.67 HG21 ' HB3' ' A' ' 25' ' ' ALA . 68.2 mt -61.48 -43.12 96.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.39 -1.277 . . . . 0.17 110.6 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.522 HG22 ' HD2' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -62.37 -54.98 27.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.51 -0.768 . . . . 0.29 109.875 -177.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.406 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 15.8 m -54.4 -32.35 57.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.98 -0.554 . . . . 1.22 110.849 173.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.463 ' HD2' ' HA ' ' A' ' 107' ' ' ILE . 82.9 mtt180 -70.93 -27.99 64.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.593 -0.731 . . . . 3.79 110.662 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -95.75 -24.06 16.68 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.21 -0.45 . . . . 0.6 111.277 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.522 ' HD2' HG22 ' A' ' 108' ' ' ILE . 12.7 mtpp -71.87 -26.14 62.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.003 0.43 . . . . 1.76 110.081 175.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -72.06 -16.47 62.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.808 -0.633 . . . . 1.56 110.054 175.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.87 23.87 9.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.862 -0.608 . . . . 1.09 111.079 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.7 t70 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.358 -0.83 . . . . 2.16 110.09 179.831 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 112.221 -0.352 . . . . 25.39 112.221 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.13 -110.92 1.02 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.86 -0.686 . . . . 24.6 111.845 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 70.24 -111.5 3.83 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.973 -0.632 . . . . 23.97 112.292 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 111.57 -92.78 0.67 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.963 -0.636 . . . . 23.13 111.647 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -96.71 -11.17 25.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.096 0.474 . . . . 24.92 110.357 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -104.76 153.97 20.61 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.823 -0.626 . . . . 21.4 109.773 177.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 6.0 p 47.88 33.43 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.206 1.003 . . . . 20.37 112.071 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -80.36 162.8 24.32 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.547 -0.538 . . . . 17.68 109.547 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 25.8 mmt -139.23 45.0 1.98 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.376 0.608 . . . . 16.8 109.735 -171.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -63.71 137.2 57.98 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.095 -0.957 . . . . 13.35 110.68 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 252' ' ' SER . . . . . 0.448 ' HB2' ' HB2' ' B' ' 255' ' ' GLU . 81.0 p 53.04 42.33 32.22 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.567 -0.742 . . . . 10.66 111.356 -178.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 253' ' ' GLU . . . . . 0.537 ' HA ' ' HB2' ' B' ' 257' ' ' ASP . 33.2 tt0 -66.66 -53.8 30.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.246 -0.888 . . . . 11.03 110.978 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 254' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' B' ' 254' ' ' GLU . 0.2 OUTLIER -70.68 -24.31 62.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.885 -0.598 . . . . 10.94 110.208 -179.125 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 255' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' B' ' 252' ' ' SER . 17.3 mm-40 -69.24 -62.89 1.19 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 9.82 110.003 175.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 256' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' B' ' 255' ' ' GLU . 4.8 t 178.16 71.1 0.01 OUTLIER 'General case' 0 C--O 1.231 0.094 0 CA-C-O 121.042 0.449 . . . . 5.35 111.405 177.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 257' ' ' ASP . . . . . 0.537 ' HB2' ' HA ' ' B' ' 253' ' ' GLU . 11.0 t70 -78.34 -65.29 1.0 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.134 -0.691 . . . . 6.2 109.134 172.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -85.48 -41.04 15.71 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.86 -0.793 . . . . 6.14 108.86 169.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -168.18 -24.47 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.948 -1.024 . . . . 3.32 111.817 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.58 -1.78 45.89 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.549 -0.834 . . . . 0.84 112.457 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 261' ' ' PHE . . . . . 0.451 ' N ' ' CD1' ' B' ' 261' ' ' PHE . 3.9 m-30 -97.72 175.58 6.13 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.221 -0.659 . . . . 0.95 109.221 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 12.8 p -122.98 139.66 49.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.925 0.393 . . . . 1.37 110.322 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -76.08 121.73 23.22 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.156 -0.683 . . . . 2.24 109.156 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 11.8 t -99.38 102.49 13.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.952 0.406 . . . . 1.41 110.226 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 26.7 t70 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.532 -0.747 . . . . 3.04 110.333 -176.001 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 N--CA 1.478 0.596 0 N-CA-C 110.832 -0.488 . . . . 3.14 110.832 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.502 ' HA ' ' HB3' ' A' ' 99' ' ' ASN . 10.5 p -121.7 -49.77 2.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.937 0.399 . . . . 1.4 110.829 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -91.12 14.34 14.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.647 0.737 . . . . 1.85 109.478 176.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.405 ' C ' HD11 ' A' ' 100' ' ' ILE . 90.1 p -162.99 154.45 17.55 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.815 -1.084 . . . . 0.95 108.626 -176.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.73 145.86 5.48 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.186 -0.765 . . . . 0.16 111.186 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.76 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.69 125.78 29.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.324 0.562 . . . . 0.43 111.36 -176.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.72 158.39 44.24 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 121.168 0.509 . . . . 0.13 111.36 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 2.0 mp -96.96 127.65 48.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.637 -0.711 . . . . 0.29 109.472 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.639 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 80.4 t80 -137.38 117.15 13.11 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.337 -0.616 . . . . 0.56 109.337 178.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 66.71 44.18 2.24 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.15 0.58 . . . . 1.46 110.419 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt 74.91 -8.95 1.44 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.777 -1.102 . . . . 1.91 112.718 171.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.48 131.92 47.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.903 0.382 . . . . 0.47 110.476 177.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.514 ' HA ' HG13 ' A' ' 8' ' ' ILE . 22.5 t -78.03 123.2 26.55 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.002 -0.544 . . . . 1.02 109.992 176.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.645 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -139.07 -154.73 6.46 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.543 -0.753 . . . . 0.16 112.06 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.76 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.7 mm -127.02 153.76 36.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 120.957 0.408 . . . . 0.19 110.779 -177.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.486 HG12 HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -128.56 132.81 67.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.856 -0.611 . . . . 0.16 110.113 -179.348 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.01 112.09 9.02 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 111.976 0.362 . . . . 0.12 111.976 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.621 HD11 HG23 ' A' ' 100' ' ' ILE . 3.7 mp -86.02 120.86 36.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.836 -0.802 . . . . 0.18 108.836 172.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.456 HD22 ' HB3' ' A' ' 21' ' ' ASP . 2.8 t-20 -126.22 125.39 42.32 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 110.234 -0.284 . . . . 1.12 110.234 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.467 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 22.2 mt-10 -108.47 84.51 1.95 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 117.069 -1.852 . . . . 0.74 107.468 163.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.456 ' HB3' HD22 ' A' ' 19' ' ' ASN . 17.9 t70 -121.54 -9.58 8.94 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 106.341 -1.726 . . . . 0.59 106.341 156.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.706 HG13 ' O ' ' A' ' 23' ' ' SER . 14.0 p -102.48 175.98 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 111.732 -2.486 . . . . 0.35 111.778 -157.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.706 ' O ' HG13 ' A' ' 22' ' ' VAL . 5.6 m -54.15 167.25 0.56 Allowed Pre-proline 0 C--O 1.225 -0.201 0 N-CA-C 106.997 -1.483 . . . . 1.31 106.997 166.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 10.7 Cg_endo -42.16 128.27 4.22 Favored 'Trans proline' 0 C--N 1.357 1.008 0 CA-C-N 122.018 1.756 . . . . 0.22 111.009 -154.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.743 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -31.58 134.61 0.08 Allowed 'General case' 0 CA--C 1.504 -0.805 0 O-C-N 125.19 1.557 . . . . 0.2 113.93 -155.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.594 ' HB2' HG11 ' A' ' 22' ' ' VAL . 33.6 mt-10 -121.3 134.93 55.16 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.646 -1.161 . . . . 1.26 111.031 -172.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.593 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.0 OUTLIER -100.34 141.26 33.43 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 106.052 -1.833 . . . . 0.15 106.052 173.39 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.465 ' N ' HD23 ' A' ' 27' ' ' LEU . 6.2 m -127.92 108.76 10.96 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.677 -0.809 . . . . 0.21 110.434 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.639 ' CE2' ' HB3' ' A' ' 9' ' ' PHE . 88.8 t90 -89.6 107.56 19.16 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.675 0.75 . . . . 0.24 109.271 175.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -113.83 120.53 41.06 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.888 -1.051 . . . . 0.87 109.088 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.593 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 88.9 p -61.78 144.97 53.93 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.197 -0.668 . . . . 0.75 109.197 -176.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.645 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 11.4 m -54.0 -23.25 12.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.013 -0.994 . . . . 0.39 111.99 -173.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -87.65 -10.59 50.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 111.982 0.364 . . . . 2.33 111.982 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.15 21.43 67.68 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.831 -0.7 . . . . 0.55 111.704 -176.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -93.49 -44.72 8.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.065 0.459 . . . . 1.13 111.334 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.407 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 29.3 mttt -110.34 146.12 36.32 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.895 -0.593 . . . . 2.03 110.794 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.0 t -144.12 115.7 2.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.874 -0.603 . . . . 0.55 109.69 174.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -125.46 111.22 14.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.926 -0.579 . . . . 0.69 110.066 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.406 HG21 ' OE1' ' A' ' 26' ' ' GLU . 14.4 m -98.74 143.17 29.39 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 120.824 -0.351 . . . . 0.3 111.326 -175.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 28.7 t -116.43 130.15 71.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 122.416 0.286 . . . . 0.66 111.536 176.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.534 ' O ' HG12 ' A' ' 45' ' ' ILE . 60.1 t -91.03 108.28 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-O 121.398 0.618 . . . . 0.18 109.875 173.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.6 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -53.19 -26.89 18.98 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.808 -1.087 . . . . 0.12 112.927 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.425 ' O ' ' HE3' ' A' ' 65' ' ' LYS . 59.4 m -80.68 -30.25 36.46 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.459 -0.496 . . . . 1.06 111.661 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.2 p -75.66 -16.23 60.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.099 -0.704 . . . . 0.2 109.099 172.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.691 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 46.6 mm -75.09 120.72 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.965 -1.016 . . . . 0.23 111.313 174.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.578 ' OD2' ' HG2' ' A' ' 47' ' ' LYS . 20.2 t70 -74.24 -50.22 19.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.851 -1.068 . . . . 0.7 110.99 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.578 ' HG2' ' OD2' ' A' ' 46' ' ' ASP . 48.2 mmtm -142.32 154.46 44.71 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 109.488 -0.56 . . . . 1.95 109.488 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.133 HD23 ' HG3' ' A' ' 105' ' ' GLN . 9.0 tp -112.59 145.05 41.03 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.391 -0.596 . . . . 0.14 109.391 167.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.548 ' H ' HD12 ' A' ' 48' ' ' LEU . 55.2 mt-30 -126.73 156.67 40.77 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.686 -1.143 . . . . 1.49 109.876 -177.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -161.76 151.11 16.12 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.427 -0.953 . . . . 0.25 108.427 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 22.3 p -50.25 121.22 13.3 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.588 0.709 . . . . 0.37 111.44 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 66.3 Cg_endo -71.95 167.82 25.64 Favored 'Trans proline' 0 C--N 1.331 -0.375 0 C-N-CA 124.205 3.27 . . . . 0.64 111.546 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.2 -27.94 37.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.26 0.552 . . . . 1.02 110.52 174.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 t -73.46 -22.78 60.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.838 -0.619 . . . . 1.58 110.889 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 24.6 t -86.6 136.28 33.11 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.9 -0.407 . . . . 0.71 109.9 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -88.99 -6.77 56.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.334 0.588 . . . . 2.89 111.093 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -99.75 -177.1 3.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.393 -0.821 . . . . 2.59 109.977 -176.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.581 ' SD ' ' HB2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -136.29 107.16 6.64 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.032 -0.729 . . . . 1.78 109.032 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.648 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 3.5 mpp? -156.86 146.62 20.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.977 0.418 . . . . 1.3 111.188 -175.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.864 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 1.9 mp -110.77 163.14 14.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.551 -0.75 . . . . 0.14 111.699 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.512 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 20.5 ttt180 -155.02 113.44 3.51 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.613 -0.721 . . . . 2.72 110.281 173.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.591 HD13 ' CE2' ' A' ' 89' ' ' PHE . 7.3 mp -94.81 113.27 25.0 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.139 0.495 . . . . 0.9 110.427 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.823 HG23 ' HG2' ' A' ' 86' ' ' ARG . 5.1 mm -84.58 124.09 39.59 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 C-N-CA 123.543 0.737 . . . . 0.4 109.105 -178.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.691 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -97.65 146.7 18.35 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 119.841 -1.171 . . . . 0.48 112.106 177.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.516 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -58.22 131.53 50.86 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.141 0.496 . . . . 1.15 111.452 -175.323 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 67' ' ' ASP . 7.3 p -88.51 165.04 2.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.387 -0.824 . . . . 0.69 109.17 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.518 ' OD1' ' HD3' ' A' ' 70' ' ' LYS . 12.8 t70 -91.69 105.57 17.83 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.036 0.446 . . . . 2.56 111.253 -175.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -85.63 -2.46 58.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.614 -0.721 . . . . 3.79 110.665 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.7 t -73.03 -39.94 65.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.401 -0.363 . . . . 3.05 111.274 -173.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.518 ' HD3' ' OD1' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -134.63 103.81 5.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.285 0.564 . . . . 5.48 110.563 174.342 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.43 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 54.2 mtmt -66.2 146.68 54.35 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.568 -0.742 . . . . 4.42 110.56 178.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.675 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 6.1 ptm180 -85.11 174.97 9.29 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.417 -0.81 . . . . 4.27 109.135 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.497 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 11.1 mmtp -121.32 146.73 46.54 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.63 0.252 . . . . 5.09 110.983 -172.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 75' ' ' ASN . 13.6 t70 -94.98 -163.65 1.07 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.826 -0.805 . . . . 4.98 108.826 177.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.437 ' H ' ' CG ' ' A' ' 74' ' ' ASP . 39.4 m-80 -55.78 -31.97 63.07 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.503 0.927 . . . . 6.68 113.503 -171.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.411 ' HB3' HD22 ' A' ' 78' ' ' ASN . 7.8 tp10 -90.48 -15.66 30.39 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.672 0.749 . . . . 7.13 109.69 -176.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.497 ' HA2' ' HB3' ' A' ' 73' ' ' LYS . . . 94.74 25.72 14.62 Favored Glycine 0 CA--C 1.503 -0.712 0 N-CA-C 110.408 -1.077 . . . . 5.53 110.408 -174.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.411 HD22 ' HB3' ' A' ' 76' ' ' GLU . 4.0 p30 -75.47 -89.8 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.119 -0.541 . . . . 5.62 110.62 -177.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.675 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 8.7 pt-20 178.03 132.19 0.07 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.269 0.557 . . . . 5.0 111.606 177.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.461 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.7 t -127.86 148.88 32.44 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 N-CA-C 107.075 -1.454 . . . . 3.33 107.075 173.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.7 t -110.06 102.07 49.61 Favored Pre-proline 0 C--N 1.298 -1.657 0 CA-C-O 121.297 0.57 . . . . 2.77 109.927 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.4 ' HG3' ' HD2' ' A' ' 72' ' ' ARG . 80.7 Cg_exo -43.15 148.91 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 124.465 3.443 . . . . 1.78 113.6 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -77.19 128.58 80.44 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.273 -0.64 . . . . 3.11 109.273 174.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.586 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 42.6 Cg_exo -52.89 137.31 61.02 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.918 2.412 . . . . 0.67 112.299 -177.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.413 ' H ' ' HG3' ' A' ' 85' ' ' GLN . 3.1 pp0? -68.03 115.67 7.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.647 0.736 . . . . 1.78 110.995 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.823 ' HG2' HG23 ' A' ' 63' ' ' ILE . 25.5 mtm180 -110.33 157.0 19.97 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.495 -0.775 . . . . 2.29 111.032 -175.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -120.39 111.12 17.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.308 -0.86 . . . . 0.5 109.637 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.48 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 55.0 ttm -113.73 125.31 53.97 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.88 -0.145 . . . . 0.42 110.633 -174.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.591 ' CE2' HD13 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -118.75 148.43 42.81 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.339 -0.615 . . . . 1.33 109.339 174.088 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.648 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 32.2 m -97.79 126.54 43.2 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.659 -0.497 . . . . 0.94 109.659 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.864 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 8.8 m-85 -106.53 154.76 20.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.057 0.456 . . . . 1.33 111.349 -174.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -100.36 -6.65 25.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.984 -0.553 . . . . 1.53 110.955 -171.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -142.76 128.33 19.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.938 0.399 . . . . 0.83 110.581 -175.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.581 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 15.8 tpt180 -59.63 -34.69 73.11 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.109 -0.95 . . . . 2.16 110.847 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.6 m -74.03 -58.82 3.05 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.69 -0.687 . . . . 0.4 110.618 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 100' ' ' ILE . 94.6 t -45.19 -53.69 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-N 115.792 -0.64 . . . . 0.29 111.456 175.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.797 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -66.32 -29.81 70.09 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 120.515 -0.474 . . . . 0.29 110.563 -177.206 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.426 ' HA ' ' HD3' ' A' ' 101' ' ' LYS . 35.8 t70 -72.13 -24.26 61.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.62 0.724 . . . . 0.39 109.618 178.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.578 ' O ' ' HG3' ' A' ' 102' ' ' MET . 19.2 m120 -83.78 -42.93 15.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.845 -1.071 . . . . 1.55 109.742 177.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.621 HG23 HD11 ' A' ' 18' ' ' ILE . 33.7 mm -58.54 -51.85 66.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.482 -0.781 . . . . 0.13 110.837 176.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.812 ' HA ' HD21 ' A' ' 48' ' ' LEU . 2.6 ptmt -60.23 -39.25 86.01 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 120.851 0.358 . . . . 1.11 111.159 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.578 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.7 ppp? -76.52 -22.93 53.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.079 0.466 . . . . 1.17 109.761 -175.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 52.6 m -68.46 -53.2 25.03 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.649 -0.705 . . . . 0.15 109.679 174.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.934 ' HB2' HD22 ' A' ' 48' ' ' LEU . 13.1 mt -65.75 -56.59 11.21 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.151 -0.931 . . . . 0.13 110.932 -177.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 1.133 ' HG3' HD23 ' A' ' 48' ' ' LEU . 49.1 mt-30 -52.05 -26.38 10.77 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.808 0.67 . . . . 1.45 112.808 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -64.59 -43.8 92.66 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.923 -0.769 . . . . 0.65 108.923 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.743 HG21 ' HB3' ' A' ' 25' ' ' ALA . 33.4 mt -66.76 -43.89 89.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.293 -1.321 . . . . 0.17 110.876 176.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.667 HG22 ' HD2' ' A' ' 112' ' ' LYS . 1.2 mt -67.16 -47.84 80.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.05 -0.523 . . . . 0.29 110.445 -176.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.0 t -58.71 -27.34 64.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.366 0.603 . . . . 1.22 110.237 172.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 77.2 mtt180 -70.56 -31.79 68.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 3.79 110.25 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -93.94 -23.54 18.03 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.914 -0.584 . . . . 0.6 111.934 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.667 ' HD2' HG22 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -73.16 -23.55 60.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.137 0.494 . . . . 1.76 109.979 174.82 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.55 -22.39 65.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.588 -0.733 . . . . 1.56 109.755 172.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -114.0 23.11 13.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.565 -0.743 . . . . 1.09 110.711 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.3 t70 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.503 -0.76 . . . . 2.16 110.586 -178.006 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.906 0 N-CA-C 112.306 -0.318 . . . . 25.39 112.306 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 80.18 -121.96 5.61 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.071 -0.585 . . . . 24.6 112.119 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -85.0 57.85 4.99 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.028 -0.606 . . . . 23.97 111.846 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -110.46 148.38 17.56 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.948 -0.644 . . . . 23.13 111.864 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -81.05 -21.93 39.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.694 0.759 . . . . 24.92 109.628 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -133.63 148.37 51.54 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.088 -0.96 . . . . 21.4 109.33 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 9.3 p -93.31 5.72 6.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.732 0.777 . . . . 20.37 110.035 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -75.13 120.74 21.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.265 -0.88 . . . . 17.68 109.766 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 55.7 ttm -154.35 41.21 0.48 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.749 -0.834 . . . . 16.8 108.749 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -87.39 114.75 24.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.741 0.782 . . . . 13.35 110.844 -173.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 43.0 m -131.5 18.34 4.8 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.502 -1.226 . . . . 10.66 109.938 176.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -73.67 -36.73 65.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.428 -0.806 . . . . 11.03 109.833 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -72.46 -25.73 61.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.942 -0.572 . . . . 10.94 110.303 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -79.71 -51.81 8.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.647 -0.706 . . . . 9.82 110.45 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 256' ' ' SER . . . . . 0.414 ' OG ' ' HB2' ' B' ' 259' ' ' ASP . 64.7 p -170.48 101.74 0.26 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.028 -0.533 . . . . 5.35 110.824 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -76.74 -29.1 56.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.164 0.507 . . . . 6.2 110.417 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -73.5 -3.8 29.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.306 -0.861 . . . . 6.14 111.158 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.414 ' HB2' ' OG ' ' B' ' 256' ' ' SER . 9.0 m-20 -133.47 -145.71 0.25 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.658 -0.867 . . . . 3.32 108.658 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 73.86 36.12 53.18 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.153 -0.546 . . . . 0.84 113.182 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 261' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -72.35 138.01 46.99 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.909 -0.404 . . . . 0.95 109.909 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.97 166.32 26.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.36 -0.382 . . . . 1.37 110.72 -176.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 263' ' ' GLU . . . . . 0.534 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 8.0 pt-20 -93.31 142.37 27.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.282 -0.417 . . . . 2.24 110.089 173.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.444 HG12 HE22 ' A' ' 105' ' ' GLN . 7.5 p -89.58 106.01 16.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.778 0.799 . . . . 1.41 110.506 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.428 -0.796 . . . . 3.04 109.929 179.174 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 N--CA 1.481 0.744 0 N-CA-C 110.783 -0.506 . . . . 3.14 110.783 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.0 p 41.51 -93.69 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.528 1.131 . . . . 1.4 113.836 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.554 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 37.9 m80 -85.08 18.03 2.71 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.087 0.403 . . . . 1.85 112.087 -172.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.474 ' C ' HD11 ' A' ' 100' ' ' ILE . 88.6 p -163.12 149.92 12.61 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.844 0.354 . . . . 0.95 110.715 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.72 147.45 6.35 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.496 -1.042 . . . . 0.16 110.496 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.747 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.55 136.75 40.55 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 117.653 0.726 . . . . 0.43 111.283 -175.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.31 160.11 40.81 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 121.278 0.561 . . . . 0.13 111.323 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.564 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.5 mp -105.58 126.39 60.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.603 -0.726 . . . . 0.29 109.163 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -116.82 101.8 8.85 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.711 -0.396 . . . . 0.56 110.279 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 60.69 53.0 4.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.19 0.519 . . . . 1.46 110.668 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt 78.99 -8.35 1.65 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.545 -1.207 . . . . 1.91 113.298 171.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -97.86 127.58 50.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.203 -0.599 . . . . 0.47 110.712 171.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.564 ' HA ' HG13 ' A' ' 8' ' ' ILE . 10.2 p -78.99 126.13 30.28 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.558 -0.746 . . . . 1.02 111.095 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.695 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -145.24 -155.42 6.46 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.465 -0.789 . . . . 0.16 112.098 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.747 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 6.4 mm -128.71 153.78 38.71 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.741 0 CA-C-O 120.768 0.318 . . . . 0.19 110.768 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.493 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -124.38 131.85 72.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.642 -0.503 . . . . 0.16 109.642 179.126 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.57 112.28 9.44 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.215 -0.448 . . . . 0.12 111.643 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.668 HD11 HG23 ' A' ' 100' ' ' ILE . 4.1 mp -84.8 120.75 35.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.265 -1.013 . . . . 0.18 108.265 171.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.415 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.4 t30 -123.64 124.88 43.75 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.967 -0.383 . . . . 1.12 109.967 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -108.53 83.11 1.72 Allowed 'General case' 0 N--CA 1.427 -1.62 0 C-N-CA 116.959 -1.896 . . . . 0.74 107.342 165.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.415 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 16.7 t70 -121.25 -12.35 8.66 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 106.625 -1.62 . . . . 0.59 106.625 158.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 23' ' ' SER . 14.9 p -101.75 177.9 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 111.812 -2.449 . . . . 0.35 111.852 -156.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.71 ' O ' HG13 ' A' ' 22' ' ' VAL . 4.4 m -53.61 168.4 0.4 Allowed Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 107.194 -1.41 . . . . 1.31 107.194 165.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 12.2 Cg_endo -42.6 128.21 4.75 Favored 'Trans proline' 0 C--N 1.357 1.016 0 CA-C-N 121.966 1.738 . . . . 0.22 110.94 -155.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.704 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -33.36 135.83 0.11 Allowed 'General case' 0 CA--C 1.507 -0.697 0 O-C-N 125.334 1.646 . . . . 0.2 113.892 -154.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.693 ' HB2' HG11 ' A' ' 22' ' ' VAL . 28.5 mt-10 -123.3 138.61 54.58 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 114.588 -1.187 . . . . 1.26 111.179 -170.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.57 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.4 tt -101.71 143.11 32.06 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 106.567 -1.642 . . . . 0.15 106.567 173.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.423 ' N ' HD23 ' A' ' 27' ' ' LEU . 16.5 m -130.99 109.78 10.77 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.846 -0.742 . . . . 0.21 110.67 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.638 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 87.8 t90 -85.92 106.03 16.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.687 0.756 . . . . 0.24 109.327 174.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -111.15 115.32 29.2 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.069 -0.969 . . . . 0.87 108.759 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.557 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 63.1 p -56.39 144.13 31.98 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.993 0.425 . . . . 0.75 110.064 -177.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.695 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 25.9 m -56.44 -25.04 49.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.175 -0.92 . . . . 0.39 110.751 -176.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -76.33 -27.96 56.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.899 -0.591 . . . . 2.33 111.299 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.83 8.01 60.93 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.702 -0.559 . . . . 0.55 111.702 -174.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -84.87 -72.68 0.46 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.056 0.455 . . . . 1.13 111.408 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -85.55 141.13 30.08 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.201 0.524 . . . . 2.03 111.48 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 93.9 t -137.69 125.86 31.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.741 -1.118 . . . . 0.55 109.441 177.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -130.34 111.29 12.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.53 -0.305 . . . . 0.69 110.273 -175.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -100.87 141.87 33.15 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 111.863 0.319 . . . . 0.3 111.863 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.59 HG11 HD13 ' A' ' 62' ' ' LEU . 43.1 t -116.11 129.69 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 122.623 0.369 . . . . 0.66 111.688 176.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.579 ' O ' HG12 ' A' ' 45' ' ' ILE . 60.4 t -91.11 108.42 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-O 121.268 0.556 . . . . 0.18 109.579 172.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.583 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.6 mm? -53.14 -29.52 31.71 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.877 -1.056 . . . . 0.12 112.546 -178.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.438 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 68.4 m -76.89 -33.79 57.78 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.608 -0.437 . . . . 1.06 111.581 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.7 p -74.07 -11.7 60.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.541 0.686 . . . . 0.2 109.371 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.579 HG12 ' O ' ' A' ' 41' ' ' VAL . 47.5 mm -82.62 133.03 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 114.77 -1.105 . . . . 0.23 111.002 173.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.653 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 35.8 t70 -85.91 -50.22 7.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.456 -0.793 . . . . 0.7 110.904 174.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.477 ' HB2' HG13 ' A' ' 63' ' ' ILE . 74.9 mmtt -136.77 156.14 48.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.245 -0.434 . . . . 1.95 110.1 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.09 HD23 ' HG3' ' A' ' 105' ' ' GLN . 11.6 tp -119.18 140.21 50.55 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.213 0.53 . . . . 0.14 109.871 167.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 11.8 mm100 -115.61 154.82 28.76 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.818 -1.083 . . . . 1.49 109.837 -178.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.85 141.65 8.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.588 -0.733 . . . . 0.25 109.278 177.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.492 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 33.5 p -51.94 123.52 25.95 Favored Pre-proline 0 N--CA 1.467 0.4 0 CA-C-O 121.484 0.659 . . . . 0.37 111.559 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.525 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 71.1 Cg_endo -70.76 167.29 26.16 Favored 'Trans proline' 0 CA--C 1.519 -0.275 0 C-N-CA 124.331 3.354 . . . . 0.64 112.126 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.425 ' HA ' HH12 ' A' ' 94' ' ' ARG . . . -55.63 -28.13 53.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.236 0.541 . . . . 1.02 110.575 174.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.593 ' HG ' ' N ' ' B' ' 242' ' ' GLY . 13.8 m -68.73 -25.38 64.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.375 -0.83 . . . . 1.58 111.324 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.435 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 33.7 t -80.4 143.43 33.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.535 -0.757 . . . . 0.71 109.951 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -90.17 -7.66 53.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.484 0.659 . . . . 2.89 109.667 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 mmmt -98.89 178.33 4.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.225 -0.898 . . . . 2.59 110.403 -175.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.531 ' HB3' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -137.58 110.18 7.52 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.982 -1.008 . . . . 1.78 108.674 176.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.599 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 3.1 ttm -157.3 140.13 15.09 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.744 -0.382 . . . . 1.3 111.422 -173.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.863 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 1.9 mp -109.27 160.82 15.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.06 0.457 . . . . 0.14 111.016 172.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.644 ' HE ' ' HE2' ' A' ' 88' ' ' MET . 20.7 ttm180 -153.56 113.34 3.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.906 -0.588 . . . . 2.72 110.263 172.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.802 ' HG ' HD13 ' A' ' 48' ' ' LEU . 7.9 mt -93.61 113.79 25.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.055 0.455 . . . . 0.9 110.293 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.629 HG23 ' HG2' ' A' ' 86' ' ' ARG . 5.4 mm -86.63 109.28 18.78 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 CA-C-N 115.717 -0.674 . . . . 0.4 110.461 -173.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -76.43 138.48 22.55 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.731 -1.223 . . . . 0.48 111.384 176.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.653 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 1.7 mptp? -53.44 136.68 37.43 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.72 0.295 . . . . 1.15 110.941 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.558 HG21 ' O ' ' A' ' 82' ' ' PRO . 10.1 p -79.57 165.86 2.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.923 -0.399 . . . . 0.69 109.923 175.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.477 ' H ' HG22 ' A' ' 66' ' ' VAL . 8.5 m-20 -69.72 80.94 0.44 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.84 -0.618 . . . . 2.56 112.006 -174.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -80.29 -14.49 58.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.797 -0.638 . . . . 3.79 110.448 174.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.9 p -64.39 -38.48 91.17 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.673 -0.694 . . . . 3.05 110.646 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.55 98.69 2.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.901 -0.59 . . . . 5.48 110.676 176.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -62.92 143.0 58.08 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.25 0.548 . . . . 4.42 110.45 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.459 ' CG ' ' HB ' ' A' ' 80' ' ' VAL . 4.3 ptm180 -80.76 171.05 15.51 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.405 -0.816 . . . . 4.27 109.255 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -147.43 152.62 38.41 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.212 0.53 . . . . 5.09 110.468 179.036 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -92.23 -158.32 0.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.354 -0.839 . . . . 4.98 110.545 -172.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -63.81 -31.64 72.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.754 0.312 . . . . 6.68 111.375 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -90.1 -3.71 57.75 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.644 0.735 . . . . 7.13 109.523 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' A' ' 73' ' ' LYS . . . 68.66 25.88 74.78 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 114.654 -1.157 . . . . 5.53 110.782 -175.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.53 ' O ' ' HB2' ' A' ' 79' ' ' GLU . 2.5 p-10 -67.64 -33.3 74.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.267 -0.467 . . . . 5.62 111.719 -173.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.589 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 38.5 mt-10 100.25 126.56 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 125.367 1.667 . . . . 5.0 111.133 174.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.459 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.3 t -126.58 147.73 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 107.623 -1.251 . . . . 3.33 107.623 -176.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.6 t -112.25 100.72 50.41 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 109.528 -0.545 . . . . 2.77 109.528 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.558 ' O ' HG21 ' A' ' 66' ' ' VAL . 64.0 Cg_exo -48.53 159.42 0.82 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.86 3.04 . . . . 1.78 112.668 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 61.8 tttt -83.08 130.18 58.28 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-O 121.344 0.593 . . . . 3.11 110.242 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 83' ' ' LYS . 24.0 Cg_exo -55.44 140.52 82.71 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.547 2.832 . . . . 0.67 112.306 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.99 114.57 19.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.42 0.628 . . . . 1.78 109.87 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.629 ' HG2' HG23 ' A' ' 63' ' ' ILE . 18.5 mtm180 -110.78 160.42 16.75 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.64 -0.709 . . . . 2.29 110.227 -173.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -124.3 111.91 16.38 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.009 -0.542 . . . . 0.5 109.713 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.644 ' HE2' ' HE ' ' A' ' 61' ' ' ARG . 49.7 ttm -111.35 128.53 55.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.716 -0.22 . . . . 0.42 110.889 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.437 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 39.8 m-85 -117.24 143.63 45.68 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 108.832 -0.803 . . . . 1.33 108.832 173.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.545 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 19.1 m -96.88 125.59 41.43 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.469 -0.567 . . . . 0.94 109.469 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.863 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 4.5 m-85 -107.53 162.9 13.52 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.952 -0.388 . . . . 1.33 109.952 -177.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -115.91 -7.06 12.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.859 0.361 . . . . 1.53 110.911 -176.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -129.09 119.44 24.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.67 -0.493 . . . . 0.83 109.67 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.531 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 8.3 tpt180 -61.44 -29.08 69.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.844 -0.617 . . . . 2.16 111.227 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 50.0 m -74.17 -47.05 38.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.245 0.545 . . . . 0.4 110.52 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.821 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 66.3 t -60.27 -52.76 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 CA-C-N 115.646 -0.706 . . . . 0.29 111.633 177.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.541 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -60.41 -26.01 66.37 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.912 -0.715 . . . . 0.29 109.735 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 95' ' ' THR . 36.6 t70 -70.29 -41.74 72.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.261 0.553 . . . . 0.39 109.9 176.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.821 ' ND2' ' HA ' ' A' ' 96' ' ' VAL . 22.8 p30 -80.21 -29.19 38.54 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.073 -0.967 . . . . 1.55 110.879 -173.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.668 HG23 HD11 ' A' ' 18' ' ' ILE . 31.0 mm -67.41 -54.02 27.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.366 -0.834 . . . . 0.13 110.123 169.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.679 ' HA ' HD21 ' A' ' 48' ' ' LEU . 3.8 ttpt -54.79 -48.39 72.78 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.53 -0.759 . . . . 1.11 111.326 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -65.73 -26.09 67.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.9 0.381 . . . . 1.17 110.592 -176.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 22.1 m -68.06 -49.73 59.55 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.204 0.526 . . . . 0.15 110.354 177.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.957 ' HB2' HD22 ' A' ' 48' ' ' LEU . 9.7 mt -69.38 -57.25 5.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.391 -0.822 . . . . 0.13 111.156 -175.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 1.09 ' HG3' HD23 ' A' ' 48' ' ' LEU . 96.0 mt-30 -50.78 -28.35 9.11 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.223 0.453 . . . . 1.45 112.223 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -63.16 -49.81 72.87 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.842 -0.799 . . . . 0.65 108.842 176.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.704 HG21 ' HB3' ' A' ' 25' ' ' ALA . 60.1 mt -60.07 -44.75 95.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 113.906 -1.497 . . . . 0.17 110.518 176.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.652 HG22 ' HD2' ' A' ' 112' ' ' LYS . 1.2 mt -62.53 -55.52 23.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.675 -0.693 . . . . 0.29 110.412 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.494 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 59.6 m -59.01 -26.43 64.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.0 0.429 . . . . 1.22 110.966 175.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 56.9 mtt180 -69.22 -33.92 74.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.856 -0.611 . . . . 3.79 110.21 176.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -86.48 -28.22 23.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.585 -0.734 . . . . 0.6 111.187 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.652 ' HD2' HG22 ' A' ' 108' ' ' ILE . 16.0 mtpt -71.54 -27.8 63.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.074 0.464 . . . . 1.76 110.007 174.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.77 -19.93 65.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.491 0.663 . . . . 1.56 109.924 175.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -117.22 27.19 9.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.454 -0.793 . . . . 1.09 110.805 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 39.0 t70 . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.78 -0.629 . . . . 2.16 110.568 178.516 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.593 ' N ' ' HG ' ' A' ' 54' ' ' SER . . . . . . . . 0 N--CA 1.484 1.873 0 N-CA-C 112.251 -0.34 . . . . 25.39 112.251 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 137.92 -142.04 12.82 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.976 -0.631 . . . . 24.6 111.785 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 84.85 -62.3 4.57 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.843 -0.694 . . . . 23.97 112.444 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 70.15 -103.07 1.08 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.199 -0.525 . . . . 23.13 112.019 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -80.93 -17.65 49.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.337 0.589 . . . . 24.92 109.842 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -96.95 146.19 25.19 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.252 -0.886 . . . . 21.4 110.689 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 21.6 m -85.98 41.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.429 0.633 . . . . 20.37 110.792 178.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 249' ' ' GLU . . . . . 0.458 ' HG2' ' H ' ' B' ' 251' ' ' GLU . 32.4 tt0 -79.87 126.83 31.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.665 -0.698 . . . . 17.68 109.963 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 20.7 mmt -121.74 28.94 7.38 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.236 -0.653 . . . . 16.8 109.236 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 251' ' ' GLU . . . . . 0.458 ' H ' ' HG2' ' B' ' 249' ' ' GLU . 8.1 tp10 -71.1 96.35 1.33 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.002 -0.999 . . . . 13.35 110.896 -174.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 252' ' ' SER . . . . . 0.557 ' HG ' ' N ' ' B' ' 242' ' ' GLY . 49.4 m -165.93 -37.24 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.352 -1.295 . . . . 10.66 110.676 -175.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -52.35 -54.34 32.94 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.974 -0.557 . . . . 11.03 112.08 -174.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -67.69 -46.51 72.08 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.954 0.353 . . . . 10.94 111.954 -174.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -72.28 -31.83 66.09 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.258 0.466 . . . . 9.82 112.258 -174.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 49.0 m -100.91 20.5 15.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.734 0.302 . . . . 5.35 111.217 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -84.36 -22.56 30.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.604 -0.271 . . . . 6.2 111.013 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -57.43 -44.75 84.92 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 116.225 -0.443 . . . . 6.14 110.697 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.52 ' HA ' HH22 ' A' ' 61' ' ' ARG . 20.7 m-20 -100.58 -34.57 9.85 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.058 -0.519 . . . . 3.32 110.249 174.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 84.47 -7.31 73.27 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.095 -0.802 . . . . 0.84 111.095 -174.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 261' ' ' PHE . . . . . 0.525 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 6.2 m-85 -125.86 179.54 5.15 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.434 -0.58 . . . . 0.95 109.434 -176.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.72 150.3 19.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.624 -0.51 . . . . 1.37 109.624 173.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 263' ' ' GLU . . . . . 0.505 ' HB3' ' OE1' ' A' ' 49' ' ' GLN . 2.5 pp20? -103.82 134.16 47.59 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.778 -0.453 . . . . 2.24 109.778 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.55 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 60.2 t -100.06 108.93 23.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.009 -0.541 . . . . 1.41 110.018 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.435 -0.793 . . . . 3.04 110.144 -178.584 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo . . . . . 0 N--CA 1.479 0.649 0 N-CA-C 110.809 -0.496 . . . . 3.14 110.809 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.493 ' HA ' ' HB3' ' A' ' 99' ' ' ASN . 31.3 t -100.98 -70.26 0.75 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.212 -0.449 . . . . 1.4 110.695 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -92.97 20.28 6.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.319 0.581 . . . . 1.85 110.005 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.4 ' C ' HD11 ' A' ' 100' ' ' ILE . 20.4 m -162.33 150.67 14.66 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.538 -0.755 . . . . 0.95 109.195 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.53 140.61 3.97 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.275 -0.73 . . . . 0.16 111.275 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.746 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -71.6 121.4 18.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 117.211 0.506 . . . . 0.43 111.173 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.548 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -130.83 158.78 39.23 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.256 0.551 . . . . 0.13 112.115 -177.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.504 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.5 mp -97.16 120.56 46.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.349 -0.841 . . . . 0.29 109.21 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.572 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 82.8 t80 -122.91 112.53 17.95 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.843 -0.428 . . . . 0.56 109.843 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 62.98 48.61 3.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.79 0.805 . . . . 1.46 110.127 -175.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt 72.61 -6.53 1.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.143 -1.389 . . . . 1.91 113.373 171.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.92 131.99 46.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.936 0.398 . . . . 0.47 110.236 173.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.504 ' HA ' HG13 ' A' ' 8' ' ' ILE . 23.3 t -78.89 130.55 35.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.059 -0.518 . . . . 1.02 110.522 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.67 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -149.4 -154.61 6.43 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 115.702 -0.681 . . . . 0.16 111.628 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.746 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 9.9 mm -124.44 153.42 31.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.948 0.374 . . . . 0.19 110.619 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.427 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -126.74 133.46 68.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.977 -0.556 . . . . 0.16 109.849 -179.824 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.89 111.44 8.63 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 116.281 -0.418 . . . . 0.12 111.751 175.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.633 HD11 HG23 ' A' ' 100' ' ' ILE . 4.0 mp -84.36 114.06 24.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.139 -1.06 . . . . 0.18 108.139 171.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.447 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.5 t30 -119.25 122.06 41.06 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.952 -0.388 . . . . 1.12 109.952 -179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.489 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 38.0 mt-10 -105.88 84.25 2.04 Favored 'General case' 0 N--CA 1.423 -1.785 0 C-N-CA 116.858 -1.937 . . . . 0.74 107.418 163.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.447 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 22.3 t70 -121.4 -11.22 8.78 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.622 -1.621 . . . . 0.59 106.622 156.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.7 HG11 ' HB2' ' A' ' 26' ' ' GLU . 14.2 p -102.58 174.8 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 112.001 -2.363 . . . . 0.35 111.653 -157.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.672 ' O ' HG13 ' A' ' 22' ' ' VAL . 17.3 p -54.27 166.3 0.71 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 117.052 -1.452 . . . . 1.31 107.117 166.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.639 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 10.3 Cg_endo -41.49 128.47 3.44 Favored 'Trans proline' 0 C--N 1.362 1.278 0 CA-C-N 122.233 1.833 . . . . 0.22 111.374 -151.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.628 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -29.92 133.81 0.05 Allowed 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 125.251 1.595 . . . . 0.2 114.004 -157.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.7 ' HB2' HG11 ' A' ' 22' ' ' VAL . 23.8 mt-10 -124.9 136.72 54.03 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 114.777 -1.101 . . . . 1.26 111.15 -172.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.589 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.0 OUTLIER -100.3 142.1 32.25 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.469 -1.678 . . . . 0.15 106.469 173.818 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.419 ' N ' HD23 ' A' ' 27' ' ' LEU . 9.7 m -126.94 109.22 11.71 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.796 -0.762 . . . . 0.21 110.241 -178.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.647 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 88.3 t90 -89.23 105.71 17.96 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.684 0.754 . . . . 0.24 109.086 175.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.426 ' HD3' ' O ' ' A' ' 31' ' ' SER . 3.6 tmt_? -113.54 115.0 27.28 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.723 -1.126 . . . . 0.87 108.523 -177.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.546 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 98.1 p -58.75 144.66 43.06 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.308 0.575 . . . . 0.75 110.444 -173.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.67 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 18.5 m -54.82 -25.16 26.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.765 -1.107 . . . . 0.39 111.816 -173.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -89.77 -13.95 35.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.97 -0.559 . . . . 2.33 111.723 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.69 22.05 60.64 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.319 -0.943 . . . . 0.55 111.108 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -84.52 -39.28 19.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.919 -0.64 . . . . 1.13 111.913 -174.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -146.74 161.57 40.34 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.207 0.527 . . . . 2.03 110.774 -177.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 85.3 t -144.08 131.0 16.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.1 -0.955 . . . . 0.55 110.124 -176.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -131.96 109.11 9.82 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.639 -0.709 . . . . 0.69 109.813 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.9 m -99.82 137.06 38.81 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.625 -0.262 . . . . 0.3 111.294 -175.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.528 HG11 HD13 ' A' ' 62' ' ' LEU . 40.7 t -110.01 128.43 66.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 122.653 0.381 . . . . 0.66 111.703 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 45' ' ' ILE . 53.2 t -90.53 108.19 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 109.319 -0.623 . . . . 0.18 109.319 172.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.601 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.0 mm? -54.95 -27.26 42.22 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.924 -1.035 . . . . 0.12 112.415 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.521 ' O ' ' HE2' ' A' ' 65' ' ' LYS . 43.1 t -75.75 -34.04 60.26 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.598 -0.441 . . . . 1.06 110.641 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.457 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 58.6 p -77.77 -10.37 59.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.472 0.653 . . . . 0.2 109.661 175.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.659 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 45.2 mm -79.85 123.84 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 114.995 -1.002 . . . . 0.23 111.256 173.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.581 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 5.8 t70 -73.85 -46.26 46.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.29 -0.868 . . . . 0.7 111.436 174.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.466 ' O ' HG12 ' A' ' 63' ' ' ILE . 43.6 tptt -151.52 159.48 44.12 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 120.763 0.316 . . . . 1.95 110.432 -177.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.017 HD23 ' HG3' ' A' ' 105' ' ' GLN . 11.8 tp -117.68 148.24 42.16 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.623 -0.51 . . . . 0.14 109.623 170.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 15.3 mm100 -126.55 156.47 40.78 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.23 -0.895 . . . . 1.49 109.573 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.605 ' HB3' ' HD3' ' A' ' 101' ' ' LYS . . . -163.04 144.06 9.61 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.228 -0.442 . . . . 0.25 109.925 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.515 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 40.8 p -52.41 126.72 38.7 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 121.36 0.6 . . . . 0.37 112.135 -176.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.52 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 59.6 Cg_endo -69.31 167.08 24.9 Favored 'Trans proline' 0 C--N 1.334 -0.225 0 C-N-CA 124.323 3.349 . . . . 0.64 112.305 177.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.01 -28.65 58.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.842 0.353 . . . . 1.02 111.272 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.3 t -72.43 -23.61 61.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 1.58 110.784 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.506 ' CB ' ' HB ' ' A' ' 51' ' ' THR . 31.6 t -71.74 133.46 45.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.923 -0.58 . . . . 0.71 110.081 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -80.35 -15.14 57.57 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.758 0.789 . . . . 2.89 109.309 177.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -106.49 172.62 6.72 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.054 -0.975 . . . . 2.59 109.787 -176.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.555 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.2 OUTLIER -131.34 109.83 10.64 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.526 -0.916 . . . . 1.78 108.526 -177.429 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.56 ' HG2' ' HA ' ' A' ' 90' ' ' SER . 72.9 mtm -154.73 155.5 34.66 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.79 0.329 . . . . 1.3 111.212 -172.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.593 HD23 HD11 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -120.82 160.13 24.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.553 -0.749 . . . . 0.14 110.956 176.252 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 48.8 ttp180 -152.43 113.61 4.24 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 120.882 0.372 . . . . 2.72 111.198 171.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.725 ' HG ' HD13 ' A' ' 48' ' ' LEU . 10.4 mt -94.46 110.53 22.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.358 -0.383 . . . . 0.9 110.945 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.662 HG23 ' HB3' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -87.61 125.7 41.24 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 CA-C-N 116.027 -0.533 . . . . 0.4 110.454 -176.837 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -99.01 151.94 19.57 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.029 -1.082 . . . . 0.48 111.096 174.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.581 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 1.0 OUTLIER -56.5 134.16 53.9 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.858 0.361 . . . . 1.15 111.263 -174.176 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.502 HG22 ' H ' ' A' ' 67' ' ' ASP . 8.3 p -67.86 168.26 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.76 -0.655 . . . . 0.69 110.918 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.502 ' H ' HG22 ' A' ' 66' ' ' VAL . 25.7 t70 -59.01 140.55 55.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.611 0.719 . . . . 2.56 111.404 -176.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -54.43 -22.53 12.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.307 -1.315 . . . . 3.79 112.913 -176.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.8 t -74.58 -9.38 58.52 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 121.272 -0.171 . . . . 3.05 111.122 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.414 ' HB2' ' H ' ' A' ' 71' ' ' LYS . 65.8 mmtt 50.34 -89.7 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.116 0.966 . . . . 5.48 112.647 -178.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.414 ' H ' ' HB2' ' A' ' 70' ' ' LYS . 14.5 ptmm? -79.32 130.05 35.06 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.136 0.493 . . . . 4.42 110.36 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.551 ' CG ' ' HB ' ' A' ' 80' ' ' VAL . 4.1 ptm85 -122.36 170.73 9.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.086 -0.506 . . . . 4.27 110.331 -174.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.477 ' HB3' ' C ' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -121.06 165.08 15.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.843 0.354 . . . . 5.09 110.657 -177.593 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -97.61 -157.61 0.61 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.214 -0.448 . . . . 4.98 109.933 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -64.57 -25.52 68.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.002 0.43 . . . . 6.68 111.832 -172.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 34.2 tt0 -99.24 5.35 46.69 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 122.149 0.976 . . . . 7.13 109.016 -177.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.477 ' C ' ' HB3' ' A' ' 73' ' ' LYS . . . 70.93 29.41 69.17 Favored Glycine 0 CA--C 1.506 -0.517 0 CA-C-N 115.042 -0.981 . . . . 5.53 110.727 -178.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.744 ' ND2' ' H ' ' A' ' 79' ' ' GLU . 5.1 p-10 -84.47 -87.24 0.12 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.272 -0.464 . . . . 5.62 111.61 -177.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.744 ' H ' ' ND2' ' A' ' 78' ' ' ASN . 7.2 pt-20 -167.01 129.43 1.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.538 0.57 . . . . 5.0 112.538 178.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.551 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 3.3 t -128.32 148.65 32.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.321 -0.992 . . . . 3.33 108.321 165.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.7 p -111.58 97.47 36.85 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-O 121.711 0.767 . . . . 2.77 110.073 174.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.436 ' HD3' ' HG2' ' A' ' 72' ' ' ARG . 60.9 Cg_endo -72.85 136.59 25.51 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.067 2.512 . . . . 1.78 112.617 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.544 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 11.1 mptt -89.02 137.98 29.36 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.204 -0.665 . . . . 3.11 109.204 177.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.449 ' HB2' HG22 ' A' ' 63' ' ' ILE . 34.4 Cg_exo -56.0 133.85 60.54 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.421 2.081 . . . . 0.67 112.114 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -57.41 115.14 2.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.483 -0.78 . . . . 1.78 110.956 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.662 ' HB3' HG23 ' A' ' 63' ' ' ILE . 12.9 ptt180 -129.56 145.0 51.51 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.629 0.728 . . . . 2.29 111.994 -173.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -107.39 116.63 32.27 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.633 -1.167 . . . . 0.5 110.517 -173.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.441 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 48.6 ttm -104.68 128.73 52.83 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.67 -0.412 . . . . 0.42 111.32 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.465 ' CE2' HD12 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -121.84 123.04 40.83 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.054 -0.721 . . . . 1.33 109.054 175.756 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.56 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 64.6 m -93.18 130.69 38.76 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.926 0.393 . . . . 0.94 110.264 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.593 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 40.2 m-85 -107.48 169.73 8.4 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.404 0.621 . . . . 1.33 110.896 176.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -112.15 -6.07 14.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.413 -0.812 . . . . 1.53 109.828 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.478 ' OD1' ' HB ' ' A' ' 95' ' ' THR . 28.6 t-20 -130.65 128.51 41.1 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.284 0.564 . . . . 0.83 111.282 -176.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.426 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 14.6 tpt180 -59.32 -37.06 76.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.76 -1.109 . . . . 2.16 111.641 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.478 ' HB ' ' OD1' ' A' ' 93' ' ' ASN . 91.7 m -72.26 -54.94 8.1 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.312 -0.403 . . . . 0.4 110.777 -176.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.8 t -44.95 -57.34 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 115.969 -0.559 . . . . 0.29 111.434 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.555 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -63.63 -29.92 71.09 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.578 -0.449 . . . . 0.29 111.218 -177.656 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.515 ' HA ' ' HE2' ' A' ' 101' ' ' LYS . 26.0 t70 -68.64 -33.06 73.35 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.465 0.65 . . . . 0.39 109.251 177.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.613 ' O ' ' HG3' ' A' ' 102' ' ' MET . 19.3 m120 -77.41 -50.74 12.07 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.634 -1.166 . . . . 1.55 110.055 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.633 HG23 HD11 ' A' ' 18' ' ' ILE . 32.4 mm -56.0 -48.44 78.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.235 -0.893 . . . . 0.13 110.14 178.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.758 ' HA ' HD21 ' A' ' 48' ' ' LEU . 13.3 ttpt -58.61 -50.96 71.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.368 -0.833 . . . . 1.11 111.133 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.613 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.3 ppp? -67.89 -23.06 65.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 1.17 110.335 -175.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.401 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 52.1 m -68.13 -51.57 44.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.89 -0.595 . . . . 0.15 110.507 174.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.976 ' HB2' HD22 ' A' ' 48' ' ' LEU . 13.1 mt -69.04 -56.79 6.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.184 -0.916 . . . . 0.13 111.7 -173.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 1.017 ' HG3' HD23 ' A' ' 48' ' ' LEU . 54.1 mt-30 -53.16 -29.19 30.12 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.049 0.388 . . . . 1.45 112.049 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -61.28 -28.16 68.99 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.84 0.828 . . . . 0.65 109.265 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 104' ' ' LEU . 25.2 mt -85.68 -45.28 17.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 113.803 -1.544 . . . . 0.17 110.791 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.584 HG22 ' HD2' ' A' ' 112' ' ' LYS . 1.7 mt -67.52 -53.81 28.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.417 -0.811 . . . . 0.29 111.46 -172.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.48 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 7.0 m -65.03 -14.96 61.73 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.567 0.699 . . . . 1.22 109.708 176.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.521 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 14.0 ttt180 -77.65 -42.95 32.94 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.863 -1.062 . . . . 3.79 109.752 174.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -74.42 -34.13 63.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.759 -0.655 . . . . 0.6 111.156 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.584 ' HD2' HG22 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -74.5 -18.45 60.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.327 0.585 . . . . 1.76 110.105 177.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -79.51 -19.64 49.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.411 -0.813 . . . . 1.56 109.683 174.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -114.86 19.76 15.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.437 -0.802 . . . . 1.09 110.772 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.3 t70 . . . . . 0 C--O 1.245 0.853 0 CA-C-O 118.479 -0.772 . . . . 2.16 110.285 -178.836 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.712 0 N-CA-C 111.87 -0.492 . . . . 25.39 111.87 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -155.24 59.33 0.38 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.043 -0.599 . . . . 24.6 111.878 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 165.78 -137.22 4.56 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.944 -0.646 . . . . 23.97 111.832 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.55 -124.66 7.6 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.74 -0.743 . . . . 23.13 112.299 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 58.8 42.84 19.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.494 0.664 . . . . 24.92 110.789 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 247' ' ' ASP . . . . . 0.419 ' OD2' ' HB3' ' B' ' 249' ' ' GLU . 3.4 t70 -81.83 126.21 31.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.133 -0.94 . . . . 21.4 109.68 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 4.1 t -82.43 46.15 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.597 0.713 . . . . 20.37 110.986 -174.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 249' ' ' GLU . . . . . 0.419 ' HB3' ' OD2' ' B' ' 247' ' ' ASP . 45.3 tt0 -136.55 113.92 10.82 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.663 -0.699 . . . . 17.68 109.244 176.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 10.9 ptt? -172.8 30.16 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.444 0.64 . . . . 16.8 110.42 -175.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -86.45 91.86 8.66 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.47 -0.787 . . . . 13.35 110.068 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 50.7 p -118.74 22.78 11.82 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.707 0.765 . . . . 10.66 109.434 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -58.12 -55.79 30.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.613 -1.176 . . . . 11.03 109.955 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 254' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' B' ' 254' ' ' GLU . 1.5 mp0 -56.8 -22.46 36.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.349 -0.841 . . . . 10.94 111.635 -176.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -76.28 -64.11 1.18 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.626 -0.261 . . . . 9.82 110.985 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 52.0 m -160.88 -6.35 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.606 0.241 . . . . 5.35 111.238 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -87.56 -4.72 58.96 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.648 0.24 . . . . 6.2 111.648 -175.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -60.03 -54.98 39.62 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 120.966 0.412 . . . . 6.14 110.221 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' B' ' 260' ' ' GLY . 4.2 p-10 -118.1 -92.65 0.53 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.241 -0.436 . . . . 3.32 110.67 173.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 260' ' ' GLY . . . . . 0.41 ' H ' ' CG ' ' B' ' 259' ' ' ASP . . . 72.24 17.6 77.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.147 -1.025 . . . . 0.84 110.858 -174.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 261' ' ' PHE . . . . . 0.52 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 12.0 m-85 -118.3 169.88 9.36 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.227 -0.487 . . . . 0.95 109.7 -176.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.3 p -125.8 156.79 35.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.359 -0.978 . . . . 1.37 108.359 172.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 263' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' B' ' 263' ' ' GLU . 0.2 OUTLIER -111.04 121.61 45.78 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.322 -0.622 . . . . 2.24 109.322 176.67 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.428 ' N ' HE22 ' A' ' 105' ' ' GLN . 46.6 t -101.94 102.82 14.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.734 -0.666 . . . . 1.41 111.342 -172.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.382 -0.818 . . . . 3.04 110.012 178.498 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.476 0.456 0 N-CA-C 110.661 -0.554 . . . . 3.14 110.661 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.9 p -89.85 -37.76 14.23 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.316 -0.402 . . . . 1.4 111.329 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -90.84 31.2 1.09 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.378 0.608 . . . . 1.85 111.335 -175.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.7 p -161.89 149.53 14.56 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.757 -0.656 . . . . 0.95 109.607 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.23 142.75 4.41 Favored Glycine 0 C--O 1.224 -0.516 0 N-CA-C 111.388 -0.685 . . . . 0.16 111.388 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.774 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -73.53 121.25 20.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.175 0.487 . . . . 0.43 111.148 -177.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.602 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -128.27 161.01 30.36 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.289 0.566 . . . . 0.13 111.925 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.48 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.7 mp -102.74 113.62 39.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.274 -0.875 . . . . 0.29 109.291 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.505 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 84.1 t80 -112.96 101.91 9.93 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.989 -0.375 . . . . 0.56 109.989 -178.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 64.8 57.3 1.05 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.516 0.674 . . . . 1.46 110.721 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt 72.54 -8.2 1.26 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.332 -1.304 . . . . 1.91 113.369 170.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.432 HG21 ' HD3' ' A' ' 36' ' ' LYS . 0.5 OUTLIER -99.85 127.13 53.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.064 0.459 . . . . 0.47 110.37 173.054 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.48 ' HA ' HG13 ' A' ' 8' ' ' ILE . 14.1 p -78.71 126.55 30.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.817 -0.628 . . . . 1.02 110.552 177.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.658 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -147.3 -157.61 7.48 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.938 -0.649 . . . . 0.16 112.556 -177.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.774 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.0 mm -124.7 154.68 32.51 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.789 0 CA-C-O 120.756 0.312 . . . . 0.19 110.721 -177.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.558 HG12 HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -129.27 133.67 65.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.236 -0.438 . . . . 0.16 110.461 -179.616 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.28 112.62 9.25 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.03 -0.532 . . . . 0.12 111.468 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.587 HD11 HG23 ' A' ' 100' ' ' ILE . 4.8 mp -84.24 105.08 13.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.746 -0.835 . . . . 0.18 108.746 172.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -109.38 120.02 41.25 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 110.242 -0.281 . . . . 1.12 110.242 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.62 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 37.3 mt-10 -105.72 83.71 1.97 Allowed 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 117.13 -1.828 . . . . 0.74 107.403 165.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -122.04 -13.03 8.26 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 106.756 -1.572 . . . . 0.59 106.756 157.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.997 HG11 ' HB2' ' A' ' 26' ' ' GLU . 13.9 p -102.93 -179.79 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 111.823 -2.444 . . . . 0.35 111.58 -157.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.642 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 1.4 p -51.88 165.71 0.45 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 117.706 -1.14 . . . . 1.31 108.416 168.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.642 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 18.7 Cg_endo -45.42 124.38 6.43 Favored 'Trans proline' 0 C--N 1.358 1.071 0 CA-C-N 121.514 1.576 . . . . 0.22 111.803 -154.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.806 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -21.69 133.57 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.721 1.748 . . . . 0.2 115.721 -151.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.997 ' HB2' HG11 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -112.93 138.65 49.47 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 114.705 -1.134 . . . . 1.26 110.671 -179.264 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.813 ' HB3' HG12 ' A' ' 40' ' ' VAL . 2.2 tt -100.78 142.53 32.13 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.519 -1.66 . . . . 0.15 106.519 169.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.565 ' N ' HD23 ' A' ' 27' ' ' LEU . 10.5 m -127.47 107.98 10.42 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.973 -0.691 . . . . 0.21 110.122 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.614 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 89.6 t90 -91.34 105.4 17.75 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.664 -0.865 . . . . 0.24 108.664 174.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -114.37 117.17 30.29 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.118 -0.946 . . . . 0.87 109.053 -177.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.569 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 80.8 p -57.24 148.44 22.49 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.09 0.471 . . . . 0.75 110.822 -173.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.658 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 7.5 m -58.4 -27.34 64.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.364 -0.835 . . . . 0.39 110.266 -177.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.473 ' OD2' ' HB3' ' A' ' 35' ' ' ASP . 1.4 p-10 -81.37 -27.54 34.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.078 -0.964 . . . . 2.33 111.267 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.83 2.69 84.02 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.087 -0.578 . . . . 0.55 112.974 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.473 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 12.3 t70 -78.28 -26.1 46.95 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.735 0.272 . . . . 1.13 111.735 -177.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.432 ' HD3' HG21 ' A' ' 12' ' ' VAL . 16.7 ptmt -137.73 155.06 49.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.434 0.635 . . . . 2.03 110.363 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.3 p -149.64 140.69 16.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.226 -0.897 . . . . 0.55 110.392 -175.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -130.72 108.98 10.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.643 0.259 . . . . 0.69 110.369 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 27.0 m -97.83 129.3 44.82 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.323 -0.621 . . . . 0.3 109.323 175.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.813 HG12 ' HB3' ' A' ' 27' ' ' LEU . 9.6 p -119.29 139.98 44.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.76 -0.376 . . . . 0.66 111.501 -178.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.628 ' O ' HG12 ' A' ' 45' ' ' ILE . 60.7 t -89.74 109.54 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.288 0.566 . . . . 0.18 110.077 -177.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.707 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.9 mm? -53.44 -31.84 47.24 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.944 -1.025 . . . . 0.12 112.669 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 15.1 t -76.36 -33.76 58.92 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.581 -0.448 . . . . 1.06 111.012 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.548 ' OG1' ' HB ' ' A' ' 41' ' ' VAL . 72.8 p -74.44 -11.26 60.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.073 0.463 . . . . 0.2 109.908 172.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.628 HG12 ' O ' ' A' ' 41' ' ' VAL . 37.4 mm -83.94 121.31 36.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.885 -0.598 . . . . 0.23 110.391 172.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.716 ' HB2' ' CG ' ' A' ' 65' ' ' LYS . 14.6 t70 -85.81 -41.38 15.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.104 0.478 . . . . 0.7 111.46 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.6 ' HE2' ' OD2' ' A' ' 46' ' ' ASP . 53.4 mmtt -132.47 143.1 49.54 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.563 -0.532 . . . . 1.95 109.563 -177.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.853 HD22 ' HB2' ' A' ' 104' ' ' LEU . 8.1 tp -114.53 141.22 48.01 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.637 0.732 . . . . 0.14 109.223 165.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 78.2 mm-40 -122.53 151.52 41.28 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.433 -1.258 . . . . 1.49 109.695 -177.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.19 139.94 8.61 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.671 -0.695 . . . . 0.25 109.242 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.43 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 32.3 p -49.95 128.22 21.2 Favored Pre-proline 0 N--CA 1.468 0.472 0 CA-C-O 121.265 0.555 . . . . 0.37 111.705 -178.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.565 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 57.3 Cg_endo -69.26 166.94 25.26 Favored 'Trans proline' 0 C--N 1.334 -0.207 0 C-N-CA 124.293 3.329 . . . . 0.64 112.153 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.62 -28.49 68.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.255 0.55 . . . . 1.02 110.322 175.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.2 t -68.12 -24.8 65.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.532 -0.758 . . . . 1.58 110.333 176.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.438 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 46.6 t -74.06 136.03 43.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.744 -0.662 . . . . 0.71 110.413 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -87.14 0.4 55.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.474 0.654 . . . . 2.89 110.151 176.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.24 176.83 4.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.094 -0.957 . . . . 2.59 109.689 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.491 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -136.53 110.92 8.48 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.801 -1.185 . . . . 1.78 107.801 178.672 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.595 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 3.9 ttm -156.01 149.43 24.72 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 120.426 -0.509 . . . . 1.3 111.692 -172.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.44 HD22 HG22 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -120.06 151.2 39.37 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.367 -0.833 . . . . 0.14 110.416 174.365 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.566 ' HD3' ' HB2' ' A' ' 88' ' ' MET . 15.9 ttp180 -148.76 114.43 5.66 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 121.149 0.5 . . . . 2.72 110.62 171.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.833 HD13 ' CE2' ' A' ' 89' ' ' PHE . 8.9 mp -95.16 113.17 24.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.06 -0.518 . . . . 0.9 110.242 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.553 HG23 ' HB3' ' A' ' 86' ' ' ARG . 3.6 mm -87.75 107.54 17.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.881 -0.414 . . . . 0.4 109.881 -173.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -78.92 140.82 23.63 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.321 -0.942 . . . . 0.48 111.391 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.716 ' CG ' ' HB2' ' A' ' 46' ' ' ASP . 16.1 mttm -59.02 135.2 57.55 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.46 0.648 . . . . 1.15 112.142 -174.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.2 p -83.32 155.89 3.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 114.779 -1.101 . . . . 0.69 110.251 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -109.02 95.43 5.64 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.364 -0.835 . . . . 2.56 109.739 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -76.79 -4.62 44.45 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.782 -0.645 . . . . 3.79 111.105 -178.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.3 m -63.0 -32.94 74.41 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 120.808 0.337 . . . . 3.05 111.423 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.97 80.49 1.49 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.723 0.773 . . . . 5.48 111.42 174.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -58.67 136.38 57.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.37 -0.832 . . . . 4.42 110.057 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.577 ' CG ' ' HB ' ' A' ' 80' ' ' VAL . 9.0 ptt180 -95.33 169.23 10.22 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.499 -0.556 . . . . 4.27 109.499 -175.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.557 ' HB3' ' C ' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -123.97 168.52 12.7 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 110.124 -0.324 . . . . 5.09 110.124 -173.746 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -81.14 -165.46 0.93 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.416 -0.513 . . . . 4.98 109.66 -176.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -62.81 -20.28 64.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 118.063 0.392 . . . . 6.68 111.909 -175.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -98.83 -14.76 19.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.469 0.652 . . . . 7.13 110.288 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.557 ' C ' ' HB3' ' A' ' 73' ' ' LYS . . . 98.15 36.61 4.63 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.22 -0.9 . . . . 5.53 111.413 -171.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -83.31 -102.94 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.536 0.208 . . . . 5.62 110.91 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -155.36 119.48 4.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.361 -0.381 . . . . 5.0 111.035 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.577 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 4.7 t -128.11 149.01 32.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.347 -0.612 . . . . 3.33 109.347 168.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 81' ' ' VAL . 7.6 p -111.39 98.49 40.33 Favored Pre-proline 0 C--N 1.308 -1.239 0 CA-C-O 121.872 0.844 . . . . 2.77 109.338 171.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.496 ' HD3' ' HG2' ' A' ' 72' ' ' ARG . 23.7 Cg_endo -62.83 141.53 85.16 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.857 2.371 . . . . 1.78 112.581 -177.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -72.67 143.22 84.55 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 115.017 -0.992 . . . . 3.11 109.832 177.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -55.47 133.2 56.67 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.565 2.177 . . . . 0.67 111.518 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -71.66 113.38 8.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 123.334 1.54 . . . . 1.78 109.588 -174.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.553 ' HB3' HG23 ' A' ' 63' ' ' ILE . 27.4 ptt180 -110.8 158.5 18.61 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.688 -1.596 . . . . 2.29 111.046 -172.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -127.03 112.32 15.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.142 -0.935 . . . . 0.5 110.152 -168.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.566 ' HB2' ' HD3' ' A' ' 61' ' ' ARG . 47.6 ttm -106.21 131.36 53.54 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 111.86 0.318 . . . . 0.42 111.86 -173.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.833 ' CE2' HD13 ' A' ' 62' ' ' LEU . 1.5 m-85 -119.04 123.57 44.81 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.071 -0.714 . . . . 1.33 109.071 172.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.545 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 23.4 m -87.44 126.76 35.08 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.101 -0.5 . . . . 0.94 110.021 178.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.602 ' CE1' ' HB2' ' A' ' 7' ' ' ALA . 33.1 m-85 -107.9 165.17 11.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.584 0.707 . . . . 1.33 111.047 176.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -109.9 -12.7 14.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.93 -1.032 . . . . 1.53 109.642 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.556 ' OD1' ' HB ' ' A' ' 95' ' ' THR . 28.5 t-20 -126.28 125.18 41.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.595 -0.73 . . . . 0.83 110.752 -174.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -58.48 -35.57 72.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.962 -1.017 . . . . 2.16 111.553 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.556 ' HB ' ' OD1' ' A' ' 93' ' ' ASN . 95.4 m -70.74 -55.32 8.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.625 0.25 . . . . 0.4 110.59 -176.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.7 t -45.76 -57.86 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 115.904 -0.589 . . . . 0.29 111.526 175.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.491 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -62.09 -29.86 70.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 120.616 -0.434 . . . . 0.29 111.288 -178.082 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.0 -32.15 70.18 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.412 0.625 . . . . 0.39 109.367 177.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.619 ' O ' ' HG3' ' A' ' 102' ' ' MET . 19.1 m120 -78.16 -48.77 15.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.817 -1.083 . . . . 1.55 110.116 -177.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.587 HG23 HD11 ' A' ' 18' ' ' ILE . 37.8 mm -57.24 -50.97 75.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.314 -0.857 . . . . 0.13 110.396 176.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.692 ' HA ' HD21 ' A' ' 48' ' ' LEU . 11.2 ttpt -56.39 -50.48 71.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.634 -0.712 . . . . 1.11 111.101 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.619 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.9 ppp? -66.44 -24.86 66.51 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.881 0.372 . . . . 1.17 110.841 -176.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 49.3 m -69.43 -49.73 52.38 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.48 0.657 . . . . 0.15 110.328 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.853 ' HB2' HD22 ' A' ' 48' ' ' LEU . 13.9 mt -67.74 -56.68 8.32 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.051 -0.977 . . . . 0.13 111.341 -175.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.761 ' HG3' HD23 ' A' ' 48' ' ' LEU . 35.6 mt-30 -50.02 -29.89 9.58 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.249 0.463 . . . . 1.45 112.249 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -60.91 -31.3 70.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.979 0.895 . . . . 0.65 109.414 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.806 HG21 ' HB3' ' A' ' 25' ' ' ALA . 21.3 mt -84.92 -46.51 17.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 113.594 -1.639 . . . . 0.17 110.503 178.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.683 HG22 ' HD2' ' A' ' 112' ' ' LYS . 0.9 OUTLIER -64.68 -51.2 70.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.677 -0.692 . . . . 0.29 110.775 -174.436 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.3 m -57.4 -26.27 60.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.988 0.423 . . . . 1.22 110.673 174.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 12.1 mtt180 -69.2 -37.35 78.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.453 0.645 . . . . 3.79 110.006 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.449 ' HD2' ' O ' ' A' ' 107' ' ' ILE . 42.4 m-85 -88.79 -24.23 22.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.982 -1.008 . . . . 0.6 111.734 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.683 ' HD2' HG22 ' A' ' 108' ' ' ILE . 8.7 mtpp -75.7 -28.3 58.55 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.363 0.601 . . . . 1.76 109.53 172.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -72.1 -16.38 62.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.437 -0.801 . . . . 1.56 110.189 174.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -99.92 0.71 41.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.578 -0.737 . . . . 1.09 110.514 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.1 t70 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.691 -0.671 . . . . 2.16 109.888 -178.175 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 111.986 -0.446 . . . . 25.39 111.986 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -71.36 121.63 9.08 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.958 -0.639 . . . . 24.6 111.915 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 87.65 -96.87 2.22 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.78 -0.724 . . . . 23.97 111.693 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 81.26 5.97 89.66 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.88 -0.676 . . . . 23.13 112.396 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -92.1 39.39 1.02 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.438 0.637 . . . . 24.92 109.58 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -126.21 133.05 51.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.394 -0.821 . . . . 21.4 110.671 -173.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 13.3 p -90.58 -0.11 8.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.487 1.137 . . . . 20.37 107.947 169.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -136.0 114.68 11.95 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.023 -1.444 . . . . 17.68 109.155 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 25.3 mmt -108.8 -4.65 16.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.721 0.772 . . . . 16.8 109.709 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -70.29 134.96 48.48 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.331 -1.304 . . . . 13.35 110.623 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 7.8 p -124.61 -72.36 0.68 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.83 -0.623 . . . . 10.66 110.474 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -80.52 -14.0 58.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.154 0.502 . . . . 11.03 110.22 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -65.34 -21.77 66.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.459 -0.791 . . . . 10.94 110.746 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.3 -20.6 62.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.256 0.55 . . . . 9.82 110.139 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 69.2 m -88.44 122.88 32.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.545 -0.752 . . . . 5.35 110.194 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -84.01 -64.35 1.18 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.162 0.505 . . . . 6.2 110.033 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -85.45 -61.12 1.84 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.856 -0.611 . . . . 6.14 109.944 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -148.28 -38.64 0.18 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.543 -0.753 . . . . 3.32 110.534 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 80.5 -6.06 62.26 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.892 -0.671 . . . . 0.84 111.436 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 261' ' ' PHE . . . . . 0.565 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 9.8 m-85 -102.86 -179.33 3.93 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.958 -0.621 . . . . 0.95 109.747 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 10.6 p -135.59 140.17 45.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.272 -0.27 . . . . 1.37 110.272 175.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -86.69 121.67 29.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.639 -0.874 . . . . 2.24 108.639 174.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.543 ' HB ' HE22 ' A' ' 105' ' ' GLN . 52.8 t -103.08 100.53 10.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.792 0.33 . . . . 1.41 110.137 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 34.3 t70 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.236 -0.887 . . . . 3.04 110.473 -177.464 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo . . . . . 0 N--CA 1.48 0.681 0 N-CA-C 111.122 -0.376 . . . . 3.14 111.122 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.474 ' HA ' ' HB3' ' A' ' 99' ' ' ASN . 92.5 p 51.1 -83.48 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.609 1.164 . . . . 1.4 113.211 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -90.31 19.56 5.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.23 0.538 . . . . 1.85 110.336 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.438 ' C ' HD11 ' A' ' 100' ' ' ILE . 77.4 p -162.72 149.53 13.02 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.496 -0.775 . . . . 0.95 109.655 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.26 147.0 7.74 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 110.839 -0.905 . . . . 0.16 110.839 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.741 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -79.26 117.43 20.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.644 0.722 . . . . 0.43 111.619 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.29 158.24 28.59 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.347 0.594 . . . . 0.13 111.587 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.492 HG13 ' HA ' ' A' ' 13' ' ' SER . 3.1 mp -99.01 129.22 49.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.409 -0.814 . . . . 0.29 109.263 177.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.578 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 89.1 t80 -139.28 111.96 7.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.913 -0.585 . . . . 0.56 109.917 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 69.49 45.21 0.84 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.727 0.775 . . . . 1.46 110.421 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? 70.01 3.14 4.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.276 -1.329 . . . . 1.91 112.732 172.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.1 131.68 59.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.784 0.326 . . . . 0.47 110.478 175.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.492 ' HA ' HG13 ' A' ' 8' ' ' ILE . 30.5 t -78.69 117.0 19.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.4 0.619 . . . . 1.02 110.042 177.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.718 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -130.97 -153.91 7.75 Favored Glycine 0 N--CA 1.434 -1.44 0 CA-C-N 115.288 -0.869 . . . . 0.16 111.3 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.741 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 7.8 mm -127.88 153.15 36.86 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 CA-C-O 120.919 0.39 . . . . 0.19 110.687 -177.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.442 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -125.41 131.94 71.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 115.824 -0.625 . . . . 0.16 109.332 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.94 113.97 10.58 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.758 -0.377 . . . . 0.12 111.555 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.603 HD11 HG23 ' A' ' 100' ' ' ILE . 4.4 mp -84.14 113.46 23.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.068 -1.086 . . . . 0.18 108.068 171.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -121.58 130.33 53.44 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.487 -0.324 . . . . 1.12 110.274 -177.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -110.48 84.55 1.95 Allowed 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 116.912 -1.915 . . . . 0.74 107.482 164.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -120.85 -10.32 9.14 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 106.122 -1.807 . . . . 0.59 106.122 157.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.749 HG11 ' HB2' ' A' ' 26' ' ' GLU . 14.0 p -102.08 179.15 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 111.743 -2.48 . . . . 0.35 111.395 -158.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.69 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -53.33 168.77 0.35 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 117.543 -1.217 . . . . 1.31 108.134 166.522 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.594 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 9.2 Cg_endo -41.68 127.2 3.41 Favored 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 121.796 1.664 . . . . 0.22 111.088 -157.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.54 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -30.72 131.51 0.09 Allowed 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 125.279 1.612 . . . . 0.2 113.557 -154.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.749 ' HB2' HG11 ' A' ' 22' ' ' VAL . 47.0 mt-10 -124.09 143.25 50.57 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.676 -1.147 . . . . 1.26 110.864 -169.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.576 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.1 tt -101.26 143.39 31.39 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 106.557 -1.645 . . . . 0.15 106.557 175.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.416 ' N ' HD23 ' A' ' 27' ' ' LEU . 14.1 m -129.46 109.65 11.23 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.846 -0.742 . . . . 0.21 110.705 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.647 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 85.1 t90 -86.71 106.59 17.75 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.52 0.676 . . . . 0.24 109.544 174.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -114.31 118.87 35.11 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.289 -0.869 . . . . 0.87 109.191 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.432 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 49.8 m -56.08 142.04 37.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.871 0.367 . . . . 0.75 110.756 -176.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.718 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 18.4 m -59.29 -28.19 66.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.452 -0.795 . . . . 0.39 110.166 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.09 -27.19 54.06 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.218 -0.901 . . . . 2.33 110.932 175.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.63 -3.98 50.1 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.122 -0.561 . . . . 0.55 112.681 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.4 ' OD2' ' HG3' ' A' ' 36' ' ' LYS . 32.3 t70 -69.98 -78.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.458 0.54 . . . . 1.13 112.458 -175.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.4 ' HG3' ' OD2' ' A' ' 35' ' ' ASP . 19.8 mtpp -83.99 142.66 30.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.291 0.567 . . . . 2.03 112.057 -175.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 61.1 t -138.29 117.23 14.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.788 -1.096 . . . . 0.55 109.618 177.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -124.37 110.01 14.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.31 -0.404 . . . . 0.69 110.434 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.7 m -97.72 138.83 34.52 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 121.188 -0.205 . . . . 0.3 111.386 -176.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.568 HG11 HD13 ' A' ' 62' ' ' LEU . 27.7 t -113.11 129.3 69.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 122.769 0.428 . . . . 0.66 111.625 177.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.592 ' O ' HG12 ' A' ' 45' ' ' ILE . 23.0 t -90.81 108.49 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 121.252 0.548 . . . . 0.18 109.942 174.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.604 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.6 mm? -56.1 -28.1 56.37 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.158 -0.928 . . . . 0.12 112.339 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 41.1 t -74.88 -31.67 61.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.75 0.309 . . . . 1.06 110.674 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.427 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 82.6 p -80.29 -9.78 59.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.635 0.731 . . . . 0.2 109.738 175.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.615 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 45.1 mm -85.21 123.75 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 114.872 -1.058 . . . . 0.23 111.143 174.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.655 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 4.9 t70 -74.84 -47.71 28.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.149 -0.932 . . . . 0.7 110.718 176.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.524 ' HD2' ' O ' ' A' ' 46' ' ' ASP . 0.5 OUTLIER -147.0 164.75 32.01 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.134 -0.485 . . . . 1.95 111.036 -176.451 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.087 HD23 ' HG3' ' A' ' 105' ' ' GLN . 13.0 tp -125.96 146.73 49.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.004 0.431 . . . . 0.14 109.944 172.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 16.7 mm100 -124.08 158.55 31.95 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.182 -0.917 . . . . 1.49 110.176 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HB1' ' CE ' ' A' ' 97' ' ' MET . . . -164.66 142.91 6.72 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.496 -0.774 . . . . 0.25 109.928 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.559 ' HB ' ' CB ' ' A' ' 55' ' ' SER . 41.5 p -55.53 129.73 69.99 Favored Pre-proline 0 N--CA 1.471 0.587 0 CA-C-O 121.235 0.54 . . . . 0.37 111.355 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.467 ' O ' ' HB3' ' A' ' 55' ' ' SER . 39.1 Cg_endo -64.59 165.9 19.21 Favored 'Trans proline' 0 N--CA 1.471 0.148 0 C-N-CA 124.017 3.144 . . . . 0.64 112.555 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.04 -27.26 65.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.97 0.414 . . . . 1.02 110.726 175.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.434 ' HB3' ' HG2' ' B' ' 254' ' ' GLU . 50.7 m -74.62 -24.22 58.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.922 -0.581 . . . . 1.58 111.16 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.559 ' CB ' ' HB ' ' A' ' 51' ' ' THR . 27.3 t -61.81 138.25 58.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.972 -0.558 . . . . 0.71 110.634 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.65 -18.16 42.07 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.793 -0.817 . . . . 2.89 108.793 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -103.74 174.1 6.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.718 -1.128 . . . . 2.59 109.577 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.511 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -134.24 111.76 10.52 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.151 -0.685 . . . . 1.78 109.151 177.423 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.513 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 69.3 mtm -153.77 142.11 20.6 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.932 0.396 . . . . 1.3 111.288 -175.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.535 HD23 HD11 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -110.79 157.26 19.99 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.472 -0.786 . . . . 0.14 110.422 175.556 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.489 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 38.0 ttp180 -149.75 114.6 5.35 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-O 121.26 0.552 . . . . 2.72 111.629 170.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.786 ' HG ' HD13 ' A' ' 48' ' ' LEU . 8.5 mt -91.97 112.62 24.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.875 -0.602 . . . . 0.9 110.706 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.574 HG23 ' HG2' ' A' ' 86' ' ' ARG . 3.8 mm -86.01 108.88 17.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 C-N-CA 123.72 0.808 . . . . 0.4 110.436 -173.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -78.99 155.94 41.34 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 119.969 -1.11 . . . . 0.48 111.64 176.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.655 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 0.2 OUTLIER -68.05 135.06 51.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.133 0.467 . . . . 1.15 110.726 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.404 HG13 ' HG3' ' A' ' 68' ' ' GLU . 7.5 p -82.67 151.86 4.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.998 0.428 . . . . 0.69 110.018 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -80.91 81.08 7.26 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.456 -0.793 . . . . 2.56 111.198 -175.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.404 ' HG3' HG13 ' A' ' 66' ' ' VAL . 41.4 mt-10 -80.73 -2.73 48.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.77 -0.65 . . . . 3.79 111.808 -175.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.8 t -67.53 -36.67 81.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.624 0.249 . . . . 3.05 110.763 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 104.27 5.02 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.341 0.591 . . . . 5.48 111.408 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.644 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 21.2 ptmt -72.87 139.5 46.95 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.416 0.627 . . . . 4.42 110.377 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.5 mpt_? -68.53 173.65 4.85 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 114.67 1.359 . . . . 4.27 114.67 -173.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 28.2 mmtt -128.01 148.89 50.55 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 114.359 -1.291 . . . . 5.09 109.849 -174.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -103.28 -168.03 1.46 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.552 -0.907 . . . . 4.98 108.552 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -54.61 -30.83 55.83 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.501 0.556 . . . . 6.68 112.501 -174.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 32.0 tt0 -108.28 -3.33 18.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.141 0.495 . . . . 7.13 111.243 -176.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.52 19.05 46.39 Favored Glycine 0 C--N 1.318 -0.42 0 C-N-CA 120.205 -0.998 . . . . 5.53 111.678 -175.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.531 ' O ' ' HB2' ' A' ' 79' ' ' GLU . 13.4 m120 -52.39 -39.88 61.4 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.378 0.671 . . . . 5.62 111.616 177.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.652 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 46.7 mt-10 91.67 135.65 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 O-C-N 125.323 1.639 . . . . 5.0 110.667 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 t -124.06 148.58 28.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.005 -0.998 . . . . 3.33 109.116 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.9 p -109.78 96.22 23.31 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-O 121.994 0.902 . . . . 2.77 109.62 171.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.54 158.67 50.58 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.142 2.561 . . . . 1.78 112.671 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.435 ' HD3' ' N ' ' A' ' 83' ' ' LYS . 3.8 mppt? -90.6 145.59 32.58 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.496 -0.774 . . . . 3.11 110.494 -175.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.447 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 24.4 Cg_exo -57.44 144.12 92.56 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.732 2.288 . . . . 0.67 111.807 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.06 114.04 14.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.864 0.84 . . . . 1.78 110.259 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.574 ' HG2' HG23 ' A' ' 63' ' ' ILE . 6.7 mtm180 -115.2 141.56 47.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.315 -0.857 . . . . 2.29 109.816 -175.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -107.69 111.83 24.23 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.852 -0.613 . . . . 0.5 109.781 -173.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.456 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 55.7 ttm -105.02 121.92 44.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.729 0.3 . . . . 0.42 111.037 -176.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.437 ' CG ' HD11 ' A' ' 16' ' ' ILE . 91.1 m-85 -119.46 124.41 46.42 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.724 -0.473 . . . . 1.33 109.724 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.485 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 42.0 m -90.16 133.28 34.99 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.978 0.418 . . . . 0.94 110.874 -176.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.629 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 24.2 m-85 -108.14 173.61 6.24 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.153 0.501 . . . . 1.33 111.303 176.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -114.13 1.06 14.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.549 -0.75 . . . . 1.53 110.178 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -145.77 126.83 14.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.7 -0.682 . . . . 0.83 109.979 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.511 ' HA ' ' HG2' ' A' ' 97' ' ' MET . 5.9 ttm180 -71.3 -20.79 62.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.785 -0.643 . . . . 2.16 110.982 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.7 m -72.73 -55.39 6.84 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.104 -0.332 . . . . 0.4 110.104 174.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.9 t -45.81 -56.0 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-N 116.233 -0.439 . . . . 0.29 111.289 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.528 ' CE ' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -64.52 -28.56 69.73 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.031 -0.531 . . . . 0.29 111.221 -177.533 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.54 -33.31 72.6 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.127 -0.694 . . . . 0.39 109.127 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.597 ' O ' ' HG3' ' A' ' 102' ' ' MET . 19.4 m120 -74.5 -46.3 40.24 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.622 -1.172 . . . . 1.55 109.657 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.629 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 30.0 mm -59.9 -51.4 73.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.917 -1.038 . . . . 0.13 110.522 175.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.829 ' HA ' HD21 ' A' ' 48' ' ' LEU . 3.0 ttpp -57.16 -47.79 80.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.515 -0.766 . . . . 1.11 110.85 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.597 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.7 ppp? -67.06 -26.09 66.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.581 -0.281 . . . . 1.17 110.398 -177.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 106' ' ' GLN . 61.0 m -66.64 -54.9 18.29 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.286 0.565 . . . . 0.15 110.143 175.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.93 ' HB2' HD22 ' A' ' 48' ' ' LEU . 10.6 mt -64.5 -56.22 15.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.264 -0.88 . . . . 0.13 110.925 -175.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 1.087 ' HG3' HD23 ' A' ' 48' ' ' LEU . 98.0 mt-30 -52.6 -24.19 7.86 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.889 0.7 . . . . 1.45 112.889 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 102' ' ' MET . 37.6 mt-30 -65.73 -40.97 92.69 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.899 0.857 . . . . 0.65 109.013 174.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.54 HG21 ' HB3' ' A' ' 25' ' ' ALA . 49.3 mt -72.5 -42.49 63.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 113.765 -1.561 . . . . 0.17 110.727 178.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.876 HG22 ' HE3' ' A' ' 112' ' ' LYS . 1.1 mt -63.95 -58.21 8.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.454 -0.794 . . . . 0.29 110.595 -176.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.684 ' HA ' ' HD2' ' A' ' 112' ' ' LYS . 48.0 t -54.64 -26.24 31.79 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.288 0.566 . . . . 1.22 110.802 173.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.435 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 8.3 ttt180 -69.59 -20.5 63.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.675 -0.693 . . . . 3.79 110.257 176.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.439 ' HD2' ' O ' ' A' ' 107' ' ' ILE . 18.0 m-85 -102.65 -5.06 24.24 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.91 0.862 . . . . 0.6 108.694 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.876 ' HE3' HG22 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -88.14 -23.72 23.57 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.387 -1.279 . . . . 1.76 109.713 171.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -74.07 -17.68 60.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.228 -0.896 . . . . 1.56 109.705 171.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -118.7 28.14 8.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.308 -0.86 . . . . 1.09 110.397 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.406 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 24.8 t70 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.578 -0.725 . . . . 2.16 110.338 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.938 -0.465 . . . . 25.39 111.938 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -162.15 175.01 38.67 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 121.095 -0.574 . . . . 24.6 111.815 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 113.83 -85.54 0.39 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.877 -0.678 . . . . 23.97 112.027 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -84.29 -32.88 21.71 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.849 -0.691 . . . . 23.13 111.65 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -131.61 127.6 37.4 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.534 -0.543 . . . . 24.92 109.534 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -77.71 144.4 37.31 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.952 0.406 . . . . 21.4 110.303 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.97 -1.53 5.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.929 0.871 . . . . 20.37 109.523 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -117.0 145.44 43.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.869 -1.059 . . . . 17.68 110.186 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 26.0 mmt -120.3 21.35 11.74 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.842 0.829 . . . . 16.8 108.951 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -69.18 134.87 49.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.317 -1.31 . . . . 13.35 110.241 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 43.6 m -139.17 42.31 2.07 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.004 -0.543 . . . . 10.66 110.43 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -80.78 -29.37 36.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.024 0.44 . . . . 11.03 110.116 177.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 254' ' ' GLU . . . . . 0.434 ' HG2' ' HB3' ' A' ' 54' ' ' SER . 1.9 mp0 -56.83 -46.38 81.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.306 -0.861 . . . . 10.94 111.635 -176.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -60.73 -55.6 31.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.483 -0.326 . . . . 9.82 111.386 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 256' ' ' SER . . . . . 0.447 ' HB3' ' HA2' ' B' ' 260' ' ' GLY . 23.0 t 55.33 101.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.523 0.678 . . . . 5.35 112.342 176.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -66.67 -21.43 66.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.895 -0.593 . . . . 6.2 110.826 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.3 -40.18 93.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.894 -0.594 . . . . 6.14 111.781 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -161.14 -57.53 0.05 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.406 -0.361 . . . . 3.32 110.466 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 260' ' ' GLY . . . . . 0.447 ' HA2' ' HB3' ' B' ' 256' ' ' SER . . . 100.32 -6.5 57.87 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.303 -0.951 . . . . 0.84 113.592 171.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 261' ' ' PHE . . . . . 0.465 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 6.6 m-85 -108.02 174.21 5.98 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 110.045 -0.354 . . . . 0.95 110.045 -177.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 10.2 p -143.96 140.81 25.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.75 -0.463 . . . . 1.37 109.75 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -77.53 119.58 21.3 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.836 -0.801 . . . . 2.24 108.836 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 47.1 t -112.52 101.31 12.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.901 0.382 . . . . 1.41 110.204 -178.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.498 -0.763 . . . . 3.04 109.994 -178.954 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo . . . . . 0 N--CA 1.477 0.541 0 N-CA-C 109.741 -0.907 . . . . 3.14 109.741 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.7 p -125.64 -43.57 1.87 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.037 0.446 . . . . 1.4 110.963 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 52.7 p-80 -98.36 26.33 5.53 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.587 0.708 . . . . 1.85 110.675 -176.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.4 p -162.7 134.89 5.42 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.205 -0.907 . . . . 0.95 109.241 173.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.5 148.22 10.47 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.664 -0.975 . . . . 0.16 110.664 -178.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.734 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.39 133.88 41.08 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 117.159 0.48 . . . . 0.43 111.44 -175.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.89 156.36 46.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.289 0.566 . . . . 0.13 111.386 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.544 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.2 mp -98.86 110.94 27.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.913 -0.773 . . . . 0.29 108.913 177.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.475 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 80.3 t80 -109.96 109.78 20.49 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.366 -0.379 . . . . 0.56 110.356 -177.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 63.61 46.53 4.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.883 0.849 . . . . 1.46 110.517 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt 77.18 -5.59 2.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.726 -1.579 . . . . 1.91 113.151 170.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.53 133.72 41.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.009 0.433 . . . . 0.47 110.427 173.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.544 ' HA ' HG13 ' A' ' 8' ' ' ILE . 22.6 t -78.16 126.63 31.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.91 -0.586 . . . . 1.02 110.532 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.674 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -150.05 -159.71 8.86 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.597 -0.729 . . . . 0.16 112.476 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.734 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 7.0 mm -126.31 153.43 34.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.821 0.343 . . . . 0.19 110.69 -178.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.49 133.69 68.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.977 -0.556 . . . . 0.16 109.762 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.0 108.03 7.18 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.013 0.435 . . . . 0.12 111.898 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.587 HD11 HG23 ' A' ' 100' ' ' ILE . 4.3 mp -85.73 110.74 20.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.833 -0.803 . . . . 0.18 108.833 172.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -114.19 127.65 56.0 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.651 -0.42 . . . . 1.12 110.268 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -109.8 83.65 1.79 Allowed 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 117.281 -1.768 . . . . 0.74 107.464 164.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -122.57 -11.25 8.29 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 106.466 -1.679 . . . . 0.59 106.466 156.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.939 HG11 ' HB3' ' A' ' 26' ' ' GLU . 14.5 p -101.44 173.58 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 111.964 -2.38 . . . . 0.35 112.072 -155.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.648 ' O ' HG13 ' A' ' 22' ' ' VAL . 7.6 m -54.42 165.81 0.81 Allowed Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 106.673 -1.603 . . . . 1.31 106.673 166.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 9.5 Cg_endo -40.36 127.52 2.24 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.655 1.57 . . . . 0.22 111.699 -147.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.666 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -31.01 131.48 0.1 Allowed 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 125.359 1.662 . . . . 0.2 112.649 -159.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.939 ' HB3' HG11 ' A' ' 22' ' ' VAL . 25.3 tt0 -130.14 133.73 46.83 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.51 -1.223 . . . . 1.26 111.658 -160.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.546 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.6 tt -101.62 147.39 26.47 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 107.006 -1.479 . . . . 0.15 107.006 177.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.516 ' N ' HD23 ' A' ' 27' ' ' LEU . 30.3 m -138.44 109.79 6.94 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.204 -0.599 . . . . 0.21 110.729 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.62 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 92.2 t90 -86.65 109.79 19.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.65 -0.705 . . . . 0.24 109.219 177.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.72 118.3 35.23 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.344 -0.844 . . . . 0.87 109.039 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.503 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 86.7 p -57.28 142.63 42.53 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 110.008 -0.367 . . . . 0.75 110.008 -177.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.674 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 38.3 m -46.67 -39.76 11.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.256 0.55 . . . . 0.39 110.91 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -72.32 -27.67 62.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.226 -0.897 . . . . 2.33 111.646 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.3 21.82 28.73 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.984 -0.627 . . . . 0.55 112.471 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -101.78 -30.76 11.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.158 0.504 . . . . 1.13 110.781 -173.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -126.22 130.06 50.2 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.663 -0.698 . . . . 2.03 110.154 -176.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 95.9 t -133.59 123.54 46.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.786 0.326 . . . . 0.55 110.223 -177.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -125.33 110.99 14.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.193 -0.458 . . . . 0.69 110.37 -177.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 40.2 m -92.6 145.05 24.73 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.805 0.336 . . . . 0.3 111.663 -177.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.574 HG11 HD13 ' A' ' 62' ' ' LEU . 32.0 t -122.02 124.72 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.254 -0.43 . . . . 0.66 110.913 174.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 45' ' ' ILE . 59.7 t -91.47 108.32 19.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.014 -0.736 . . . . 0.18 109.014 175.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.592 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.0 mm? -52.72 -27.63 18.46 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.409 -0.814 . . . . 0.12 112.79 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 45.4 t -75.38 -29.28 59.81 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.599 -0.44 . . . . 1.06 110.822 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.5 p -82.59 -4.64 57.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.46 0.647 . . . . 0.2 109.937 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.631 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 45.5 mm -89.39 126.01 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.134 -0.939 . . . . 0.23 111.448 175.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.577 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 21.7 t70 -77.5 -41.86 37.81 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.732 -0.667 . . . . 0.7 110.928 176.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -153.03 160.73 43.02 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 115.856 -0.611 . . . . 1.95 110.425 -175.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.999 HD23 ' HG2' ' A' ' 105' ' ' GLN . 12.9 tp -121.22 149.24 43.13 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.219 0.533 . . . . 0.14 109.566 171.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.57 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 67.6 mm-40 -125.39 156.34 38.95 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.229 -0.896 . . . . 1.49 109.5 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.03 145.24 11.89 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.809 -0.812 . . . . 0.25 108.809 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 36.6 p -54.61 124.96 51.82 Favored Pre-proline 0 C--O 1.234 0.286 0 CA-C-O 121.254 0.549 . . . . 0.37 111.419 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 62.0 Cg_endo -70.55 167.28 25.93 Favored 'Trans proline' 0 C--N 1.332 -0.34 0 C-N-CA 124.242 3.295 . . . . 0.64 112.061 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.57 -18.57 53.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.425 0.631 . . . . 1.02 110.215 172.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' B' ' 252' ' ' SER . 63.5 m -83.79 -8.67 59.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.293 -0.867 . . . . 1.58 111.469 177.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.519 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 41.2 t -89.05 148.23 23.84 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.081 -0.508 . . . . 0.71 110.347 175.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -89.0 -11.2 44.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.798 -0.637 . . . . 2.89 110.985 177.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.9 mmmt -108.27 -177.05 3.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.763 -0.653 . . . . 2.59 110.324 -173.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.519 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -131.75 109.05 9.88 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.351 -0.981 . . . . 1.78 108.351 170.593 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.567 ' HG2' ' HA ' ' A' ' 90' ' ' SER . 68.7 mtm -155.39 146.04 22.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.044 0.384 . . . . 1.3 111.733 -175.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.878 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.7 OUTLIER -109.73 164.98 12.05 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.015 -0.539 . . . . 0.14 111.467 174.821 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 49.4 ttp180 -155.38 113.71 3.46 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.89 -0.595 . . . . 2.72 110.68 171.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.812 ' HG ' HD13 ' A' ' 48' ' ' LEU . 7.8 mt -93.37 114.52 26.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.094 0.473 . . . . 0.9 110.762 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.607 HG23 ' HG2' ' A' ' 86' ' ' ARG . 4.0 mm -86.74 106.1 15.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.718 -0.674 . . . . 0.4 110.517 -173.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.631 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -75.58 149.44 38.46 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 119.664 -1.255 . . . . 0.48 111.246 176.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.577 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 0.1 OUTLIER -60.4 134.91 57.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.258 0.529 . . . . 1.15 110.087 178.175 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.47 ' HB ' ' CA ' ' A' ' 84' ' ' PRO . 9.4 p -87.72 155.22 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.126 0.489 . . . . 0.69 110.62 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.459 ' OD2' ' HB3' ' A' ' 72' ' ' ARG . 2.3 p-10 -92.01 77.46 5.38 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.816 -0.629 . . . . 2.56 111.019 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -88.01 -44.27 11.11 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.674 -0.694 . . . . 3.79 111.185 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 p -64.57 -37.45 87.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.597 -0.729 . . . . 3.05 110.569 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.498 ' HD3' ' H ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -107.47 81.89 1.59 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.782 -0.822 . . . . 5.48 108.782 174.522 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -51.36 127.56 20.1 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.339 0.59 . . . . 4.42 111.349 -174.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -75.68 171.24 14.68 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.383 -0.969 . . . . 4.27 108.383 177.466 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.466 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -136.75 162.5 33.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 117.961 0.346 . . . . 5.09 110.608 -175.369 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -91.62 -165.94 1.46 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.63 -0.428 . . . . 4.98 109.947 -175.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -61.84 -22.69 65.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.963 0.347 . . . . 6.68 111.88 -174.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -99.89 2.18 43.52 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.593 0.711 . . . . 7.13 110.101 -178.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 73' ' ' LYS . . . 78.69 37.55 26.33 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 114.705 -1.134 . . . . 5.53 111.872 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -74.57 -99.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.126 0.488 . . . . 5.62 110.818 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 13.6 pt-20 177.01 119.32 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.084 -0.962 . . . . 5.0 109.708 177.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.462 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.9 t -121.52 148.55 24.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.196 -0.668 . . . . 3.33 109.196 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.8 p -112.27 96.11 33.76 Favored Pre-proline 0 C--N 1.311 -1.097 0 CA-C-O 122.119 0.961 . . . . 2.77 109.401 172.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.524 ' HG3' ' NE ' ' A' ' 72' ' ' ARG . 73.5 Cg_endo -73.77 164.72 34.03 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.368 2.712 . . . . 1.78 113.798 -174.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.96 140.94 29.24 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.064 -0.971 . . . . 3.11 108.459 169.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.47 ' CA ' ' HB ' ' A' ' 66' ' ' VAL . 36.5 Cg_exo -53.11 129.83 35.25 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.193 1.929 . . . . 0.67 112.134 -178.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.58 112.49 11.98 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 122.483 1.135 . . . . 1.78 108.838 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.607 ' HG2' HG23 ' A' ' 63' ' ' ILE . 27.1 mtt85 -108.61 150.8 27.0 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.285 -1.325 . . . . 2.29 109.658 -176.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -109.15 110.41 21.63 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.865 -0.791 . . . . 0.5 108.865 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.553 ' HE3' ' HD3' ' A' ' 61' ' ' ARG . 52.8 ttm -111.44 120.89 43.67 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.698 -0.228 . . . . 0.42 110.669 -174.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.628 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -114.62 141.1 48.23 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.77 -0.826 . . . . 1.33 108.77 177.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.567 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 65.0 m -95.63 124.76 39.81 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.677 -0.49 . . . . 0.94 109.677 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.878 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 3.1 m-85 -107.41 167.29 10.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.302 -0.408 . . . . 1.33 109.994 -176.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -115.64 -2.3 12.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.95 0.405 . . . . 1.53 110.776 -173.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -145.2 129.29 17.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.18 0.514 . . . . 0.83 110.247 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 98' ' ' ASP . 6.7 tpt180 -65.1 -30.6 71.55 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.202 -0.908 . . . . 2.16 110.753 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.51 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 32.4 m -69.34 -47.59 63.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.21 0.529 . . . . 0.4 110.332 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.821 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 82.8 t -60.06 -53.18 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 CA-C-N 115.584 -0.735 . . . . 0.29 111.404 177.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.519 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -63.56 -24.45 67.81 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.906 -0.718 . . . . 0.29 109.582 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.51 ' HB3' ' O ' ' A' ' 95' ' ' THR . 33.0 t70 -69.92 -42.66 73.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.399 0.619 . . . . 0.39 109.522 175.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.821 ' ND2' ' HA ' ' A' ' 96' ' ' VAL . 21.5 p30 -80.56 -31.66 36.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.752 -1.113 . . . . 1.55 110.282 -173.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.587 HG23 HD11 ' A' ' 18' ' ' ILE . 27.3 mm -67.1 -52.46 43.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.483 -0.781 . . . . 0.13 110.219 171.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.767 ' HA ' HD21 ' A' ' 48' ' ' LEU . 4.2 ttpp -55.2 -51.18 67.39 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.986 -0.552 . . . . 1.11 110.641 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 5.1 ppp? -63.33 -27.64 69.46 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 120.668 0.271 . . . . 1.17 111.012 -175.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.9 m -65.31 -49.82 68.02 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.279 0.561 . . . . 0.15 109.933 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.919 ' HB2' HD22 ' A' ' 48' ' ' LEU . 9.2 mt -71.17 -57.6 4.35 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 115.193 -0.912 . . . . 0.13 111.19 -176.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.999 ' HG2' HD23 ' A' ' 48' ' ' LEU . 23.4 mm-40 -42.22 -35.49 0.97 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.174 0.805 . . . . 1.45 113.174 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -65.92 -44.85 83.97 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.728 0.775 . . . . 0.65 108.961 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.666 HG21 ' HB3' ' A' ' 25' ' ' ALA . 72.0 mt -65.68 -43.37 93.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 113.891 -1.504 . . . . 0.17 110.954 177.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.618 HG22 ' HD2' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -61.6 -57.07 13.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.663 -0.699 . . . . 0.29 110.661 -176.191 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 11.8 m -54.49 -29.9 51.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.972 -0.558 . . . . 1.22 110.829 174.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 58.1 mtt180 -71.65 -29.62 64.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.712 -0.676 . . . . 3.79 110.832 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.47 ' OH ' ' HA ' ' A' ' 24' ' ' PRO . 14.5 m-85 -93.29 -23.04 18.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.859 -0.609 . . . . 0.6 111.435 -177.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.618 ' HD2' HG22 ' A' ' 108' ' ' ILE . 16.7 mtpp -79.01 -25.02 43.31 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.473 -0.566 . . . . 1.76 109.473 174.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.92 -18.18 64.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.149 -0.932 . . . . 1.56 109.883 171.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -115.72 22.19 13.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.318 -0.855 . . . . 1.09 110.327 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 111' ' ' TYR . 9.7 t70 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.537 -0.744 . . . . 2.16 109.858 -177.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.699 0 N-CA-C 111.854 -0.498 . . . . 25.39 111.854 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 149.62 -42.68 0.79 Allowed Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 111.465 -0.654 . . . . 24.6 111.465 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -127.12 -39.81 0.36 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.996 -0.621 . . . . 23.97 111.926 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -118.58 152.11 17.53 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.866 -0.683 . . . . 23.13 112.14 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -100.04 -13.39 19.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.927 0.394 . . . . 24.92 110.802 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -80.79 90.0 5.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.997 -0.547 . . . . 21.4 110.63 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 35.6 m 40.09 45.71 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 O-C-N 124.445 1.091 . . . . 20.37 113.03 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 249' ' ' GLU . . . . . 0.412 ' HA ' ' OE1' ' B' ' 251' ' ' GLU . 41.4 tt0 -93.14 114.1 26.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.057 0.456 . . . . 17.68 109.884 175.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 47.5 ttm -145.54 5.18 1.05 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.345 -0.843 . . . . 16.8 109.64 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 251' ' ' GLU . . . . . 0.412 ' OE1' ' HA ' ' B' ' 249' ' ' GLU . 3.7 pm0 -68.12 134.6 50.83 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.649 -0.705 . . . . 13.35 111.264 -176.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 252' ' ' SER . . . . . 0.528 ' HB3' ' O ' ' A' ' 54' ' ' SER . 24.6 m -75.39 -17.42 60.21 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.269 -0.878 . . . . 10.66 111.846 -173.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -58.13 -33.61 69.36 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.992 0.425 . . . . 11.03 111.191 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -76.1 -20.52 57.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.03 -0.532 . . . . 10.94 111.631 -175.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -76.75 -10.79 59.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.214 -0.448 . . . . 9.82 111.748 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 256' ' ' SER . . . . . 0.454 ' HA ' ' HA3' ' B' ' 260' ' ' GLY . 45.4 m -138.39 92.18 2.62 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.315 -0.402 . . . . 5.35 110.69 177.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -79.41 -70.91 0.48 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.566 -0.531 . . . . 6.2 109.566 -179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -90.49 -61.17 1.74 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.767 0.794 . . . . 6.14 109.36 171.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.57 ' CG ' ' H ' ' B' ' 260' ' ' GLY . 7.0 p-10 -113.47 -89.17 0.54 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.19 -1.368 . . . . 3.32 110.452 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 260' ' ' GLY . . . . . 0.57 ' H ' ' CG ' ' B' ' 259' ' ' ASP . . . 86.79 45.59 5.4 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.096 -0.573 . . . . 0.84 114.056 171.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 261' ' ' PHE . . . . . 0.539 ' CE1' ' HB2' ' A' ' 59' ' ' MET . 3.3 m-85 -95.55 169.85 9.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.945 0.402 . . . . 0.95 110.429 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 4.7 p -133.66 163.65 36.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.962 -0.755 . . . . 1.37 108.962 175.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.73 138.51 40.26 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.476 -0.564 . . . . 2.24 109.476 173.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.406 ' O ' HG13 ' B' ' 264' ' ' VAL . 6.5 p -69.12 103.87 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.756 0.789 . . . . 1.41 110.078 -177.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 29.5 t70 . . . . . 0 C--O 1.248 0.974 0 CA-C-N 115.38 -0.827 . . . . 3.04 110.39 -175.928 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 N--CA 1.477 0.536 0 N-CA-C 109.867 -0.859 . . . . 3.14 109.867 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.5 p -169.6 -50.72 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.361 0.6 . . . . 1.4 110.027 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.601 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 39.4 m80 -92.68 13.54 19.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.901 -0.59 . . . . 1.85 111.352 -175.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 m -161.02 148.22 15.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.684 0.278 . . . . 0.95 110.511 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.81 147.6 7.18 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 110.409 -1.077 . . . . 0.16 110.409 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.718 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -81.06 119.97 24.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 117.935 0.868 . . . . 0.43 111.448 -175.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -127.9 160.35 32.1 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.541 0.686 . . . . 0.13 112.016 -176.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 2.6 mp -100.85 126.9 54.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.179 -0.918 . . . . 0.29 109.392 177.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.413 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 84.5 t80 -126.12 112.09 15.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.067 -0.515 . . . . 0.56 110.286 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 59.99 47.36 9.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.565 0.698 . . . . 1.46 110.903 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt 74.85 0.61 3.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.317 -1.31 . . . . 1.91 113.288 171.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -106.04 132.4 53.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.372 -0.531 . . . . 0.47 110.695 171.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.521 ' HA ' HG13 ' A' ' 8' ' ' ILE . 47.5 t -79.85 129.98 34.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.635 -0.711 . . . . 1.02 110.639 178.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.679 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -151.63 -153.26 6.15 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.797 -0.638 . . . . 0.16 112.036 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.718 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 7.5 mm -128.27 153.47 37.72 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 CA-C-O 120.948 0.404 . . . . 0.19 110.76 -177.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.469 HD11 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -122.61 134.6 65.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 115.911 -0.586 . . . . 0.16 109.628 179.672 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.58 109.26 7.04 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.52 -0.309 . . . . 0.12 111.7 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.674 HD11 HG23 ' A' ' 100' ' ' ILE . 3.7 mp -85.69 126.43 40.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.494 -0.928 . . . . 0.18 108.494 171.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.96 129.37 47.99 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.38 -0.528 . . . . 1.12 109.752 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -113.34 84.26 1.98 Allowed 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 117.353 -1.739 . . . . 0.74 107.694 164.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -122.25 -12.01 8.32 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 106.468 -1.678 . . . . 0.59 106.468 157.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 23' ' ' SER . 11.1 p -102.18 173.9 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 111.792 -2.458 . . . . 0.35 112.745 -154.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.732 ' O ' HG13 ' A' ' 22' ' ' VAL . 5.5 m -54.72 166.7 0.71 Allowed Pre-proline 0 C--O 1.221 -0.415 0 N-CA-C 106.689 -1.597 . . . . 1.31 106.689 165.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 11.0 Cg_endo -42.06 127.99 4.03 Favored 'Trans proline' 0 C--N 1.355 0.908 0 CA-C-N 122.036 1.763 . . . . 0.22 111.203 -151.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.784 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -33.47 137.61 0.08 Allowed 'General case' 0 CA--C 1.506 -0.715 0 O-C-N 125.379 1.674 . . . . 0.2 113.833 -155.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.568 ' HB2' HG11 ' A' ' 22' ' ' VAL . 30.6 mt-10 -121.35 131.05 53.97 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 114.933 -1.03 . . . . 1.26 111.055 -169.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.561 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.7 tt -101.02 140.4 35.37 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 106.215 -1.772 . . . . 0.15 106.215 171.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.436 ' N ' HD23 ' A' ' 27' ' ' LEU . 19.4 m -131.22 108.83 9.98 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.677 -0.809 . . . . 0.21 110.441 -178.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.616 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 89.6 t90 -85.56 107.78 17.65 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.383 -0.826 . . . . 0.24 109.323 176.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -113.46 114.77 27.03 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.788 -1.097 . . . . 0.87 108.414 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.591 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 37.3 p -56.48 143.96 33.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.963 0.411 . . . . 0.75 110.268 -177.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.679 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 19.8 m -53.0 -33.2 50.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.145 -0.934 . . . . 0.39 111.432 -177.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -80.68 -27.84 36.93 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.125 -0.489 . . . . 2.33 111.233 177.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.04 0.34 57.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.098 -0.572 . . . . 0.55 112.234 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -64.37 -48.18 76.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.104 0.478 . . . . 1.13 111.516 -177.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -117.59 148.72 41.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.803 -0.635 . . . . 2.03 111.706 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 89.6 t -145.22 125.41 6.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.486 -1.234 . . . . 0.55 109.808 178.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -133.08 115.51 15.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.479 -0.328 . . . . 0.69 110.717 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 24.2 m -98.44 139.63 33.9 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.928 -0.309 . . . . 0.3 111.403 -178.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 23.3 t -112.12 129.46 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 122.878 0.471 . . . . 0.66 111.127 176.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.546 ' O ' HG12 ' A' ' 45' ' ' ILE . 48.4 t -91.6 108.77 20.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 CA-C-O 121.293 0.568 . . . . 0.18 109.565 173.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.634 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.1 mm? -53.95 -25.72 22.05 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.127 -0.942 . . . . 0.12 113.03 -178.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 64.6 m -79.78 -31.42 40.85 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.521 -0.471 . . . . 1.06 111.689 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.8 p -76.88 -8.74 57.9 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.178 -0.675 . . . . 0.2 109.178 173.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.592 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 47.3 mm -86.45 121.56 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.044 -0.98 . . . . 0.23 111.552 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.672 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 23.0 t70 -80.08 -43.31 22.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.621 -0.718 . . . . 0.7 110.991 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -140.51 157.12 45.98 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.986 -0.376 . . . . 1.95 109.986 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.01 HD23 ' HG3' ' A' ' 105' ' ' GLN . 12.2 tp -118.74 144.73 46.07 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.271 -0.64 . . . . 0.14 109.271 166.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 74.8 mm-40 -122.88 151.91 41.27 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.066 -0.97 . . . . 1.49 109.317 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.05 146.3 10.72 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.51 -0.768 . . . . 0.25 109.132 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.496 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 54.6 p -60.58 126.12 84.13 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-O 121.548 0.69 . . . . 0.37 111.073 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.484 ' O ' ' HB3' ' A' ' 55' ' ' SER . 57.8 Cg_endo -67.46 166.49 23.55 Favored 'Trans proline' 0 C--N 1.333 -0.276 0 C-N-CA 123.984 3.123 . . . . 0.64 111.627 177.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.64 -21.88 66.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.928 0.394 . . . . 1.02 110.67 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 t -78.76 -19.74 51.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 1.58 110.545 177.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.484 ' HB3' ' O ' ' A' ' 52' ' ' PRO . 27.9 t -67.85 145.56 54.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.889 -0.596 . . . . 0.71 110.452 176.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -89.82 -13.82 35.75 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.4 0.619 . . . . 2.89 110.145 175.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -106.48 173.57 6.26 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.135 -0.939 . . . . 2.59 110.053 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.511 ' HB3' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -130.46 112.18 12.98 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.644 -0.707 . . . . 1.78 109.555 175.581 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.62 ' HB3' ' CZ ' ' B' ' 261' ' ' PHE . 2.5 mtm -156.03 148.28 23.49 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.838 0.351 . . . . 1.3 111.691 -176.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.33 154.96 30.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.519 -0.764 . . . . 0.14 110.428 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 21.3 ttm180 -151.11 113.88 4.7 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 120.931 0.396 . . . . 2.72 110.823 171.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.76 ' HG ' HD13 ' A' ' 48' ' ' LEU . 9.1 mt -92.56 112.6 24.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.112 0.482 . . . . 0.9 110.509 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.69 HG23 ' HG2' ' A' ' 86' ' ' ARG . 6.3 mm -87.05 111.75 22.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 C-N-CA 123.464 0.705 . . . . 0.4 110.513 -172.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.592 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -79.0 150.36 33.92 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 120.254 -0.974 . . . . 0.48 111.864 177.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.672 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 1.1 mptm? -63.74 132.19 50.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.012 0.406 . . . . 1.15 110.763 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.0 p -90.2 157.84 2.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.19 -0.67 . . . . 0.69 109.19 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.427 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 5.6 p-10 -81.82 81.47 7.82 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.809 0.814 . . . . 2.56 110.816 -177.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -69.57 -18.81 63.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.774 -1.103 . . . . 3.79 111.08 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.8 p -61.08 -34.93 75.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.703 -0.681 . . . . 3.05 111.682 -178.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.464 ' N ' ' HD3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -133.12 123.21 25.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.006 0.431 . . . . 5.48 110.853 178.944 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -79.59 136.82 36.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.185 -0.461 . . . . 4.42 110.597 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 5.6 ptm180 -73.43 171.24 13.5 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.512 -0.921 . . . . 4.27 108.512 175.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.428 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -135.79 155.34 50.51 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.907 -0.405 . . . . 5.09 109.907 -177.877 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -88.37 -163.24 0.93 Allowed 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.385 -0.526 . . . . 4.98 110.387 -174.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -64.5 -22.43 66.96 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.176 0.435 . . . . 6.68 112.176 -174.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -96.61 -2.16 45.42 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.64 0.733 . . . . 7.13 109.998 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.428 ' HA2' ' HB2' ' A' ' 73' ' ' LYS . . . 78.8 43.72 11.16 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.614 -1.175 . . . . 5.53 111.183 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -81.25 -102.44 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 120.938 0.399 . . . . 5.62 110.444 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.556 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 10.9 pt-20 177.79 118.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.217 -0.902 . . . . 5.0 110.207 177.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.517 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.4 t -120.54 148.87 23.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.817 -0.809 . . . . 3.33 108.817 176.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.42 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 5.8 p -105.07 99.72 21.01 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-O 121.839 0.828 . . . . 2.77 109.627 171.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 81' ' ' VAL . 37.0 Cg_endo -67.01 133.96 32.75 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.94 2.427 . . . . 1.78 112.442 -178.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.469 ' HD2' ' CZ ' ' A' ' 86' ' ' ARG . 16.5 ttpt -62.72 134.97 95.58 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.656 -0.702 . . . . 3.11 110.056 174.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.469 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 52.3 Cg_exo -50.93 150.47 12.99 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.672 2.915 . . . . 0.67 113.06 -178.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.99 115.3 16.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.775 0.798 . . . . 1.78 109.761 176.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.69 ' HG2' HG23 ' A' ' 63' ' ' ILE . 37.7 mtm180 -116.71 140.32 49.55 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.48 -0.782 . . . . 2.29 110.285 -173.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -103.1 111.23 23.48 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.552 -0.749 . . . . 0.5 109.155 -177.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.523 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 43.4 ttm -102.78 132.41 48.96 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.716 0.293 . . . . 0.42 110.754 -176.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.469 ' CG ' HD11 ' A' ' 16' ' ' ILE . 95.4 m-85 -127.16 123.72 37.39 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.526 -0.546 . . . . 1.33 109.526 177.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.535 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 50.1 m -91.78 130.85 37.49 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.831 0.348 . . . . 0.94 110.556 -177.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.619 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 30.7 m-85 -108.16 173.65 6.23 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.034 -0.53 . . . . 1.33 110.156 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -117.43 -3.06 11.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.017 -0.538 . . . . 1.53 109.6 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.556 ' OD1' ' HB ' ' A' ' 95' ' ' THR . 28.6 t-20 -137.51 130.62 30.61 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.595 -0.73 . . . . 0.83 110.21 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.546 ' HA ' ' HG2' ' A' ' 97' ' ' MET . 2.2 tmt_? -74.29 -24.05 59.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.866 -0.606 . . . . 2.16 110.559 -174.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.556 ' HB ' ' OD1' ' A' ' 93' ' ' ASN . 51.6 m -71.95 -48.33 45.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.96 0.409 . . . . 0.4 110.326 177.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.826 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 96.8 t -55.9 -57.12 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-N 115.956 -0.565 . . . . 0.29 111.259 174.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.625 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -58.35 -30.9 67.11 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.526 -0.87 . . . . 0.29 109.529 -179.14 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.624 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 33.5 t70 -64.8 -43.75 92.15 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.623 0.725 . . . . 0.39 110.721 175.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.826 ' ND2' ' HA ' ' A' ' 96' ' ' VAL . 20.6 p30 -76.96 -25.52 52.92 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.071 -0.968 . . . . 1.55 109.899 -173.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.674 HG23 HD11 ' A' ' 18' ' ' ILE . 28.2 mm -72.39 -55.94 11.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.813 -1.085 . . . . 0.13 111.196 171.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.799 ' HA ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -59.07 -39.29 81.67 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 120.768 0.318 . . . . 1.11 111.259 -177.359 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.442 ' HB3' ' HE2' ' A' ' 101' ' ' LYS . 26.6 ptm -69.85 -27.27 64.7 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.28 -0.637 . . . . 1.17 109.28 -176.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 21.7 m -67.62 -53.37 28.56 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.65 -0.705 . . . . 0.15 110.018 174.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.921 ' HB2' HD22 ' A' ' 48' ' ' LEU . 10.4 mt -65.66 -56.44 12.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.193 -0.912 . . . . 0.13 111.221 -176.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 1.01 ' HG3' HD23 ' A' ' 48' ' ' LEU . 42.8 mt-30 -51.68 -30.12 20.69 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.48 0.548 . . . . 1.45 112.48 -178.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -68.6 -26.85 65.58 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.882 0.848 . . . . 0.65 109.571 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.784 HG21 ' HB3' ' A' ' 25' ' ' ALA . 47.8 mt -82.56 -41.72 17.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.052 -1.431 . . . . 0.17 110.071 176.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.704 HG22 ' HD2' ' A' ' 112' ' ' LYS . 1.3 mt -66.98 -49.88 69.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.551 -0.75 . . . . 0.29 110.752 -176.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 48.7 m -61.34 -22.72 65.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.506 0.669 . . . . 1.22 110.063 174.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 9.7 ttt180 -72.19 -32.15 66.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.106 -0.952 . . . . 3.79 109.862 176.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -95.61 -23.0 17.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.177 -0.465 . . . . 0.6 111.654 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.704 ' HD2' HG22 ' A' ' 108' ' ' ILE . 13.0 mtpp -76.43 -21.07 56.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.357 0.599 . . . . 1.76 109.444 174.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -71.16 -19.28 62.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.299 -0.864 . . . . 1.56 109.785 173.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -114.47 22.96 13.19 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.463 -0.79 . . . . 1.09 110.982 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.2 t70 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.492 -0.766 . . . . 2.16 110.028 178.678 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.612 0 N-CA-C 112.019 -0.433 . . . . 25.39 112.019 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 138.92 -74.5 0.39 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.759 -0.734 . . . . 24.6 112.279 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 99.56 -171.57 24.19 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.803 -0.713 . . . . 23.97 112.053 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -85.94 -24.36 41.76 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.744 -0.741 . . . . 23.13 112.451 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 63.55 18.45 11.08 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.899 0.479 . . . . 24.92 111.465 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -75.32 120.06 20.28 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.075 -0.343 . . . . 21.4 110.075 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 28.9 m 37.54 51.19 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 124.271 0.982 . . . . 20.37 111.319 -173.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -61.16 114.69 3.28 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.105 -0.952 . . . . 17.68 111.617 -173.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 94.5 mmm -145.98 21.46 1.42 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.584 -1.635 . . . . 16.8 106.584 177.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -70.28 151.07 45.71 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 113.118 -1.855 . . . . 13.35 110.899 -170.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 22.0 m -139.09 9.1 2.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.209 0.528 . . . . 10.66 110.693 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -74.45 -26.67 60.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.763 -0.653 . . . . 11.03 110.129 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -67.96 -38.37 82.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.662 -0.699 . . . . 10.94 110.07 176.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -72.9 -25.7 61.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.204 0.526 . . . . 9.82 110.388 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 256' ' ' SER . . . . . 0.404 ' HB3' ' NH1' ' A' ' 86' ' ' ARG . 37.7 m -91.79 10.79 27.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.689 -0.687 . . . . 5.35 111.198 -176.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -82.52 -59.47 2.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.034 -0.53 . . . . 6.2 111.223 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -86.44 -70.13 0.63 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.033 -0.53 . . . . 6.14 111.255 -174.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 54.73 28.3 9.98 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.196 0.522 . . . . 3.32 111.717 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 94.27 -6.38 71.87 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 120.995 -0.621 . . . . 0.84 112.656 177.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 261' ' ' PHE . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 2.8 m-30 -117.74 163.13 16.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.956 0.408 . . . . 0.95 110.239 -175.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.36 140.6 22.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.927 -0.579 . . . . 1.37 110.205 174.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -79.69 121.06 24.85 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.809 -0.812 . . . . 2.24 108.809 171.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.91 103.15 14.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.69 -0.686 . . . . 1.41 110.927 -171.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--O 1.247 0.946 0 CA-C-N 115.719 -0.673 . . . . 3.04 109.316 176.599 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo . . . . . 0 N--CA 1.48 0.733 0 N-CA-C 111.201 -0.346 . . . . 3.14 111.201 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.534 ' HA ' ' HB3' ' A' ' 99' ' ' ASN . 16.9 p -113.24 -65.76 1.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.116 -0.493 . . . . 1.4 110.655 178.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -94.33 18.31 11.31 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.587 0.708 . . . . 1.85 109.547 177.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.403 ' C ' HD11 ' A' ' 100' ' ' ILE . 68.1 p -163.27 148.84 11.56 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.929 -1.032 . . . . 0.95 108.883 -176.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.22 142.69 5.64 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.188 -0.765 . . . . 0.16 111.188 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.747 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -73.4 120.94 19.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 117.361 0.58 . . . . 0.43 111.237 -176.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.485 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -130.08 157.7 41.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.394 0.616 . . . . 0.13 111.852 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.529 ' HB ' ' HB3' ' A' ' 90' ' ' SER . 2.6 mp -95.93 124.47 48.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.125 -0.943 . . . . 0.29 109.07 176.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.489 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 88.8 t80 -128.69 103.44 7.08 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.164 -0.471 . . . . 0.56 109.919 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 67.24 58.41 0.55 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.792 -0.64 . . . . 1.46 110.872 -175.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp 70.13 -8.47 0.84 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.608 -1.178 . . . . 1.91 113.374 171.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -104.73 131.83 52.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.969 0.414 . . . . 0.47 111.061 177.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.492 ' HA ' HG13 ' A' ' 8' ' ' ILE . 28.7 p -79.9 125.95 30.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.707 -0.679 . . . . 1.02 110.721 176.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.649 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -144.82 -154.38 6.12 Favored Glycine 0 N--CA 1.436 -1.339 0 CA-C-N 115.711 -0.677 . . . . 0.16 111.637 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.747 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 9.2 mm -126.13 153.84 34.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 120.755 0.312 . . . . 0.19 110.68 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.28 133.72 68.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 116.102 -0.499 . . . . 0.16 109.95 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.63 113.98 10.18 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 111.899 0.333 . . . . 0.12 111.899 175.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.585 HD11 HG23 ' A' ' 100' ' ' ILE . 3.8 mp -85.38 124.39 40.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.359 -0.978 . . . . 0.18 108.359 171.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.437 HD22 ' HB3' ' A' ' 21' ' ' ASP . 4.1 t-20 -126.62 124.31 39.61 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.949 -0.389 . . . . 1.12 109.949 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.503 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 23.7 mt-10 -109.63 84.05 1.86 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 117.084 -1.847 . . . . 0.74 107.519 163.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.437 ' HB3' HD22 ' A' ' 19' ' ' ASN . 17.7 t70 -121.48 -9.86 8.93 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.476 -1.676 . . . . 0.59 106.476 156.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 23' ' ' SER . 14.7 p -101.98 173.1 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 112.045 -2.343 . . . . 0.35 111.63 -157.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.663 ' O ' HG13 ' A' ' 22' ' ' VAL . 14.5 m -54.98 166.66 0.75 Allowed Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 106.942 -1.503 . . . . 1.31 106.942 166.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 10.2 Cg_endo -40.67 127.42 2.45 Favored 'Trans proline' 0 C--N 1.357 0.997 0 CA-C-N 121.913 1.719 . . . . 0.22 111.34 -150.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.734 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -33.7 136.34 0.11 Allowed 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 125.379 1.674 . . . . 0.2 113.691 -156.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.54 ' HB2' HG11 ' A' ' 22' ' ' VAL . 80.7 mt-10 -123.5 138.87 54.48 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.422 -1.263 . . . . 1.26 111.099 -169.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.572 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.1 tt -101.41 144.44 30.21 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 106.257 -1.757 . . . . 0.15 106.257 171.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.456 ' N ' HD23 ' A' ' 27' ' ' LEU . 18.1 m -129.84 109.18 10.72 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.903 -0.719 . . . . 0.21 110.002 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.606 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 89.9 t90 -86.9 105.4 17.04 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.687 -0.857 . . . . 0.24 108.687 175.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -113.49 114.84 27.1 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.844 -1.071 . . . . 0.87 108.738 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.54 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 37.5 p -56.19 148.33 18.49 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.24 0.543 . . . . 0.75 111.282 -174.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.649 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 24.0 m -55.97 -30.09 61.21 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.953 -1.021 . . . . 0.39 111.371 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -80.2 -28.54 38.64 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.024 0.44 . . . . 2.33 110.756 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.19 6.61 53.43 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.956 -0.64 . . . . 0.55 112.631 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.38 -69.72 0.6 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.367 . . . . 1.13 111.363 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -82.55 137.6 34.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.472 0.653 . . . . 2.03 111.546 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 96.0 t -140.57 120.32 12.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.397 -1.274 . . . . 0.55 109.496 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -125.89 114.12 18.11 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.438 -0.347 . . . . 0.69 110.438 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.2 m -96.99 138.49 34.45 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 121.205 -0.198 . . . . 0.3 111.188 -177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 37.5 t -113.31 129.79 68.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 122.716 0.407 . . . . 0.66 111.722 178.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.553 ' O ' HG12 ' A' ' 45' ' ' ILE . 46.8 t -90.42 108.86 20.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 CA-C-O 121.286 0.565 . . . . 0.18 109.777 172.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.573 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -55.12 -27.04 42.34 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.312 -0.858 . . . . 0.12 112.633 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.448 ' O ' ' HE2' ' A' ' 65' ' ' LYS . 33.9 t -75.97 -35.11 59.76 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.722 -0.391 . . . . 1.06 110.799 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.2 p -76.99 -16.39 59.35 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.591 0.71 . . . . 0.2 109.249 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.733 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 42.2 mm -73.66 121.47 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 114.977 -1.01 . . . . 0.23 110.964 172.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.641 ' HA ' ' NZ ' ' A' ' 65' ' ' LYS . 23.0 t70 -78.61 -48.23 15.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.21 -0.45 . . . . 0.7 111.298 175.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -137.0 151.9 49.51 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 110.165 -0.309 . . . . 1.95 110.165 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.072 HD23 ' HG3' ' A' ' 105' ' ' GLN . 11.9 tp -116.07 144.9 43.5 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.118 -0.697 . . . . 0.14 109.118 166.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 53.8 mm-40 -120.22 159.51 24.8 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.399 -0.819 . . . . 1.49 109.396 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' HB3' ' HG3' ' A' ' 101' ' ' LYS . . . -161.69 152.43 17.83 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.48 -0.933 . . . . 0.25 108.48 174.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.452 ' CG2' ' HE2' ' A' ' 59' ' ' MET . 33.4 p -55.4 125.49 59.41 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.476 0.655 . . . . 0.37 111.432 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 43.0 Cg_endo -67.39 166.88 22.12 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 124.0 3.133 . . . . 0.64 111.581 176.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.01 -22.73 67.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.027 0.441 . . . . 1.02 110.303 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.3 p -74.48 -27.7 60.69 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.558 -0.746 . . . . 1.58 110.786 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.446 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 23.0 t -70.29 140.8 52.37 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.214 -0.903 . . . . 0.71 109.409 174.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -90.95 -13.63 33.09 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.788 -0.819 . . . . 2.89 108.788 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.562 ' N ' ' HD3' ' A' ' 57' ' ' LYS . 2.2 mppt? -99.21 -176.8 3.41 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.745 -1.116 . . . . 2.59 111.354 -175.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.449 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -139.87 109.22 6.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.483 . . . . 1.78 109.705 -177.082 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.661 ' HE1' ' O ' ' B' ' 254' ' ' GLU . 2.6 mpp? -155.69 167.65 29.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.934 0.397 . . . . 1.3 111.721 -175.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.644 HD23 HD11 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -130.28 161.58 30.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.324 -0.853 . . . . 0.14 111.445 176.38 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.661 ' NH2' ' HB3' ' B' ' 259' ' ' ASP . 13.1 ttm180 -154.26 114.3 3.86 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.765 -0.198 . . . . 2.72 110.749 173.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.771 ' HG ' HD13 ' A' ' 48' ' ' LEU . 10.7 mt -96.65 110.3 22.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.863 0.364 . . . . 0.9 111.095 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.482 ' CD1' ' HD2' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -89.13 128.73 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.056 0.543 . . . . 0.4 110.086 -178.099 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.733 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -95.02 152.28 20.4 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.017 -1.087 . . . . 0.48 112.337 176.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.641 ' NZ ' ' HA ' ' A' ' 46' ' ' ASP . 1.2 mptp? -58.33 134.48 56.62 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.755 0.312 . . . . 1.15 110.627 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.8 p -90.44 154.83 3.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.184 0.516 . . . . 0.69 110.306 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.495 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 4.1 p-10 -86.67 84.41 7.39 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.481 -0.781 . . . . 2.56 110.754 -177.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -66.24 -43.78 85.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.149 -0.932 . . . . 3.79 111.972 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.7 p -76.47 -35.11 58.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.507 -0.315 . . . . 3.05 111.584 -176.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 67' ' ' ASP . 3.2 mptp? -83.11 55.42 3.11 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.755 -0.461 . . . . 5.48 109.755 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -51.28 126.2 16.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.691 -0.686 . . . . 4.42 111.336 -174.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.582 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 0.5 OUTLIER -74.33 171.12 14.25 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.382 -0.97 . . . . 4.27 108.382 177.109 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.523 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -147.13 134.29 20.49 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.241 0.543 . . . . 5.09 111.069 -174.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 75' ' ' ASN . 17.9 t70 -78.33 -174.28 3.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.282 -0.872 . . . . 4.98 109.265 -178.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.403 ' H ' ' CG ' ' A' ' 74' ' ' ASP . 23.7 t-20 -52.14 -28.47 18.07 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.929 1.085 . . . . 6.68 113.929 -166.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -106.28 9.11 32.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.56 0.695 . . . . 7.13 110.67 -175.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.523 ' HA2' ' HB2' ' A' ' 73' ' ' LYS . . . 77.85 29.4 54.71 Favored Glycine 0 C--N 1.314 -0.65 0 CA-C-N 115.046 -0.979 . . . . 5.53 110.959 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 79' ' ' GLU . 14.0 m120 -53.63 -41.56 66.84 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.702 0.801 . . . . 5.62 111.92 -178.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.582 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 48.5 mt-10 84.13 106.04 0.05 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.444 -1.253 . . . . 5.0 110.717 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.29 148.57 19.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.84 -1.073 . . . . 3.33 109.474 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 81' ' ' VAL . 7.5 p -108.59 99.04 31.5 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-O 121.788 0.804 . . . . 2.77 109.519 172.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.447 ' HD3' ' HG2' ' A' ' 72' ' ' ARG . 44.1 Cg_endo -68.62 162.73 39.77 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 123.3 2.667 . . . . 1.78 113.201 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.433 ' HG3' ' HD2' ' A' ' 84' ' ' PRO . 20.3 ttmt -79.18 141.24 57.68 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.532 -0.758 . . . . 3.11 110.357 176.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.486 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 31.3 Cg_exo -52.83 141.11 56.26 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.185 2.59 . . . . 0.67 112.449 178.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -77.02 130.04 36.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.287 0.565 . . . . 1.78 110.385 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.81 160.17 26.57 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.794 -0.639 . . . . 2.29 111.017 -174.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -125.08 113.0 17.16 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.282 -0.872 . . . . 0.5 109.406 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 55.8 ttm -105.15 126.08 51.68 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.835 0.35 . . . . 0.42 111.447 -175.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.452 ' CE2' HD12 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -118.97 124.59 47.39 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.563 -0.532 . . . . 1.33 109.563 178.181 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.529 ' HB3' ' HB ' ' A' ' 8' ' ' ILE . 33.3 t -93.06 130.72 38.57 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.849 0.357 . . . . 0.94 110.226 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.603 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 27.2 m-85 -108.53 172.7 6.69 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.824 -0.625 . . . . 1.33 111.417 176.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -119.95 -4.72 10.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.364 -0.834 . . . . 1.53 110.465 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -134.63 129.27 34.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.95 0.405 . . . . 0.83 110.338 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 14.9 tpt180 -59.62 -32.94 70.89 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.398 -0.819 . . . . 2.16 111.188 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 87.3 m -70.42 -58.7 3.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.419 -0.355 . . . . 0.4 110.545 -177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.4 t -45.72 -56.04 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-N 115.695 -0.684 . . . . 0.29 111.85 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.525 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -64.7 -28.59 69.7 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.256 -0.429 . . . . 0.29 110.966 -176.408 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -73.32 -30.04 63.09 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.037 -0.727 . . . . 0.39 109.037 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.619 ' O ' ' HG3' ' A' ' 102' ' ' MET . 19.4 m120 -77.5 -48.05 18.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.666 -1.152 . . . . 1.55 109.842 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.603 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 36.4 mm -57.9 -49.16 82.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.248 -0.887 . . . . 0.13 110.153 176.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.797 ' HA ' HD21 ' A' ' 48' ' ' LEU . 2.3 tmmm? -57.0 -48.53 78.25 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.814 -0.63 . . . . 1.11 110.887 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.619 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 5.0 ppp? -70.08 -24.65 63.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.78 0.324 . . . . 1.17 110.506 -175.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 53.9 m -67.79 -50.79 55.02 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.491 0.662 . . . . 0.15 109.891 176.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.927 ' HB2' HD22 ' A' ' 48' ' ' LEU . 12.6 mt -69.85 -58.17 4.2 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.963 -1.017 . . . . 0.13 111.326 -175.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 1.072 ' HG3' HD23 ' A' ' 48' ' ' LEU . 11.0 mt-30 -53.45 -24.03 11.67 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.804 0.668 . . . . 1.45 112.804 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -65.69 -48.91 70.45 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.637 -0.875 . . . . 0.65 108.637 175.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.734 HG21 ' HB3' ' A' ' 25' ' ' ALA . 60.1 mt -58.53 -43.8 87.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.2 -1.364 . . . . 0.17 110.811 175.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.5 mt -65.03 -51.21 69.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.596 -0.729 . . . . 0.29 110.184 -177.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.442 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 16.7 m -55.18 -33.31 62.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.15 0.5 . . . . 1.22 110.605 172.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 91.2 mtt180 -67.19 -30.24 70.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.588 -0.733 . . . . 3.79 110.602 178.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -94.18 -13.45 26.66 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.124 -0.489 . . . . 0.6 111.357 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.446 ' HD2' HG22 ' A' ' 108' ' ' ILE . 9.1 mtpp -84.36 -22.92 30.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.097 0.475 . . . . 1.76 109.947 173.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -70.65 -22.42 62.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.588 0.709 . . . . 1.56 109.382 170.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -109.89 26.69 10.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.134 -0.939 . . . . 1.09 110.22 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.3 t70 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.516 -0.754 . . . . 2.16 110.382 -178.079 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 111.842 -0.503 . . . . 25.39 111.842 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -135.52 23.9 3.4 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.643 -0.789 . . . . 24.6 112.065 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -80.75 63.48 4.24 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.132 -0.556 . . . . 23.97 112.405 -178.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -144.17 57.26 0.54 Allowed Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.639 -0.584 . . . . 23.13 111.639 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -85.57 157.25 20.44 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.797 -0.446 . . . . 24.92 109.797 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -119.64 120.04 35.5 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.796 -0.446 . . . . 21.4 109.796 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 7.8 m -75.72 78.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.748 0.785 . . . . 20.37 110.463 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -59.74 121.67 12.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.231 -0.895 . . . . 17.68 110.764 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 19.8 ptp -134.95 28.91 3.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.789 -0.641 . . . . 16.8 109.903 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -74.57 140.93 44.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.361 -0.836 . . . . 13.35 110.286 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 252' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' B' ' 255' ' ' GLU . 67.7 m -83.93 52.01 2.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.892 -0.595 . . . . 10.66 111.26 -176.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -71.0 -43.04 68.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.22 0.533 . . . . 11.03 110.228 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 254' ' ' GLU . . . . . 0.661 ' O ' ' HE1' ' A' ' 59' ' ' MET . 0.0 OUTLIER -77.2 -35.83 55.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.636 -0.711 . . . . 10.94 110.056 -177.167 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 255' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' B' ' 252' ' ' SER . 46.6 mt-10 -60.72 -21.64 63.14 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.115 -0.493 . . . . 9.82 111.686 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 35.2 t 73.81 139.3 0.06 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.682 0.753 . . . . 5.35 111.779 175.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -89.29 -11.29 43.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.471 -0.786 . . . . 6.2 109.452 176.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' B' ' 259' ' ' ASP . 26.2 t70 -85.83 -1.56 57.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.122 -0.945 . . . . 6.14 109.874 175.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 259' ' ' ASP . . . . . 0.661 ' HB3' ' NH2' ' A' ' 61' ' ' ARG . 5.6 m-20 77.83 -41.92 0.35 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.021 -0.991 . . . . 3.32 109.907 -175.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 67.37 23.23 73.38 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 116.613 1.405 . . . . 0.84 116.613 158.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 261' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 61' ' ' ARG . 7.1 m-30 -124.73 160.13 29.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.879 1.339 . . . . 0.95 110.856 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.08 160.6 29.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.301 -1.0 . . . . 1.37 108.301 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.71 120.31 39.9 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.082 -0.647 . . . . 2.24 109.977 177.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 24.8 t -108.76 109.51 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.816 -0.629 . . . . 1.41 111.354 -172.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.574 -0.727 . . . . 3.04 109.283 174.614 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo . . . . . 0 C--O 1.232 0.209 0 N-CA-C 111.565 -0.206 . . . . 3.14 111.565 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.2 m 72.72 -35.12 0.32 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.684 0.794 . . . . 1.4 113.1 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.615 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 19.9 m170 -85.62 22.35 1.62 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.618 0.247 . . . . 1.85 111.417 -175.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.6 p -164.42 159.31 19.41 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.072 -0.344 . . . . 0.95 110.072 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.36 144.71 4.23 Favored Glycine 0 C--O 1.225 -0.456 0 N-CA-C 110.886 -0.886 . . . . 0.16 110.886 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.745 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -76.56 120.71 22.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.618 0.709 . . . . 0.43 111.124 -177.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.47 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -130.05 159.27 37.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.307 0.575 . . . . 0.13 111.725 -176.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.506 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.3 mp -97.28 118.14 43.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.216 -0.902 . . . . 0.29 109.115 175.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.598 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 82.8 t80 -123.35 110.03 14.65 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.379 -0.373 . . . . 0.56 109.997 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.588 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 41.1 mt-10 68.74 50.37 0.65 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.488 -0.778 . . . . 1.46 110.702 -175.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.588 ' HD2' ' C ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER 66.49 3.9 3.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.31 -1.314 . . . . 1.91 112.791 171.515 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.497 HG21 ' HD2' ' A' ' 36' ' ' LYS . 0.7 OUTLIER -110.81 133.76 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.797 0.332 . . . . 0.47 110.293 172.118 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.506 ' HA ' HG13 ' A' ' 8' ' ' ILE . 31.8 t -78.17 133.25 37.82 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.325 0.583 . . . . 1.02 110.57 178.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.646 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -154.33 -152.95 6.26 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.486 -0.779 . . . . 0.16 111.683 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.745 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.3 mm -126.66 154.02 36.03 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-O 120.795 0.331 . . . . 0.19 110.646 -178.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.473 HD11 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -127.02 135.15 64.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 116.011 -0.541 . . . . 0.16 109.833 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.81 113.28 9.47 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.015 0.436 . . . . 0.12 112.031 174.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.759 HD11 HG23 ' A' ' 100' ' ' ILE . 4.3 mp -84.56 113.18 22.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.74 -0.837 . . . . 0.18 108.74 171.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -118.16 123.98 46.86 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 110.135 -0.321 . . . . 1.12 110.135 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.468 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 22.3 mt-10 -107.69 83.35 1.79 Allowed 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 117.191 -1.804 . . . . 0.74 107.383 165.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -122.21 -11.78 8.37 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.782 -1.562 . . . . 0.59 106.782 157.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.671 HG13 ' O ' ' A' ' 23' ' ' SER . 14.8 p -101.68 179.86 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 111.887 -2.415 . . . . 0.35 111.737 -155.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.671 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -53.04 165.2 0.62 Allowed Pre-proline 0 C--O 1.224 -0.263 0 N-CA-C 107.699 -1.223 . . . . 1.31 107.699 166.746 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.569 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 15.4 Cg_endo -44.49 126.39 6.83 Favored 'Trans proline' 0 C--N 1.353 0.813 0 CA-C-N 121.366 1.523 . . . . 0.22 111.852 -154.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.749 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -23.69 134.27 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 O-C-N 125.127 1.517 . . . . 0.2 114.882 -153.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.665 ' HB2' HG11 ' A' ' 22' ' ' VAL . 37.9 mt-10 -126.26 137.36 53.51 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.697 -1.138 . . . . 1.26 111.034 -173.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.2 tt -99.99 145.27 28.07 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 106.47 -1.678 . . . . 0.15 106.47 175.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.504 ' N ' HD23 ' A' ' 27' ' ' LEU . 19.2 m -131.96 109.3 9.96 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.891 -0.724 . . . . 0.21 110.392 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.601 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.2 t90 -89.25 108.16 19.46 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.574 -0.739 . . . . 0.24 109.143 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -115.89 120.26 38.65 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.252 -0.885 . . . . 0.87 109.091 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.509 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 35.5 p -56.01 148.17 18.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.891 0.377 . . . . 0.75 110.892 -175.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.646 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 21.7 m -54.26 -32.96 57.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.431 -0.804 . . . . 0.39 110.949 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -77.54 -29.66 52.42 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.244 -0.434 . . . . 2.33 111.113 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.07 13.66 51.84 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.736 -0.745 . . . . 0.55 113.042 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -85.84 -69.04 0.69 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.159 0.504 . . . . 1.13 110.336 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.497 ' HD2' HG21 ' A' ' 12' ' ' VAL . 17.0 ptpt -87.49 145.09 26.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.624 0.726 . . . . 2.03 110.371 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 65.7 t -147.17 140.51 19.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.487 -1.233 . . . . 0.55 109.041 -176.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -141.21 122.67 15.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.571 0.224 . . . . 0.69 110.595 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.0 m -103.85 142.66 34.0 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 121.256 -0.177 . . . . 0.3 111.09 -177.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.533 HG11 HD13 ' A' ' 62' ' ' LEU . 45.8 t -119.42 130.02 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.187 0.44 . . . . 0.66 112.187 178.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.555 ' O ' HG12 ' A' ' 45' ' ' ILE . 49.9 t -91.13 108.88 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-O 121.499 0.666 . . . . 0.18 109.935 172.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.605 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.3 mm? -49.95 -35.46 24.23 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.512 -1.222 . . . . 0.12 112.463 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.523 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 69.4 m -74.9 -29.91 61.13 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.866 -0.333 . . . . 1.06 111.576 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.477 ' OG1' ' HB ' ' A' ' 41' ' ' VAL . 76.1 p -79.97 -8.58 59.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.499 0.666 . . . . 0.2 109.766 175.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.61 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 39.3 mm -82.38 132.58 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.061 -0.972 . . . . 0.23 111.219 174.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.66 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 12.0 t70 -82.82 -41.1 19.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.354 -0.839 . . . . 0.7 110.911 175.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.515 ' O ' HG12 ' A' ' 63' ' ' ILE . 45.9 mmtt -145.47 143.02 29.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.374 -0.83 . . . . 1.95 110.658 -173.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.149 HD23 ' HG3' ' A' ' 105' ' ' GLN . 13.6 tp -111.27 139.62 46.51 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.659 -0.817 . . . . 0.14 109.45 163.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.643 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 15.6 mm100 -118.27 155.77 30.01 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.425 -1.262 . . . . 1.49 110.001 -178.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.01 143.73 9.47 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.878 -1.056 . . . . 0.25 108.546 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 47.3 p -54.49 126.18 54.83 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.665 0.745 . . . . 0.37 111.106 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.542 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 65.8 Cg_endo -71.7 167.76 25.61 Favored 'Trans proline' 0 C--N 1.332 -0.29 0 C-N-CA 124.349 3.366 . . . . 0.64 112.045 176.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.17 -24.23 64.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.993 0.425 . . . . 1.02 110.659 174.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -69.17 -24.04 64.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.53 0.681 . . . . 1.58 110.162 174.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.596 ' OG ' ' HE2' ' A' ' 57' ' ' LYS . 28.8 t -84.43 139.34 32.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.471 -0.786 . . . . 0.71 109.256 176.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -92.95 -11.9 32.16 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.823 -0.806 . . . . 2.89 108.823 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.596 ' HE2' ' OG ' ' A' ' 55' ' ' SER . 2.3 mppt? -90.45 176.48 6.69 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.695 -1.139 . . . . 2.59 110.779 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.447 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -135.3 109.58 8.36 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.011 -0.737 . . . . 1.78 109.011 -178.613 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.547 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 63.4 mtm -155.96 150.11 25.51 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.87 0.367 . . . . 1.3 111.23 -173.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -121.42 156.48 32.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.396 -0.82 . . . . 0.14 110.421 174.345 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.587 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 33.8 ttt180 -153.67 113.22 3.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.989 0.424 . . . . 2.72 110.892 175.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.774 ' HG ' HD13 ' A' ' 48' ' ' LEU . 10.4 mt -93.73 111.66 23.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.105 0.479 . . . . 0.9 110.428 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.897 HG23 ' HG2' ' A' ' 86' ' ' ARG . 3.7 mm -86.17 106.47 15.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 123.534 0.734 . . . . 0.4 109.98 -174.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -81.2 139.43 20.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 119.897 -1.144 . . . . 0.48 112.1 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.66 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 5.9 mttt -53.3 135.77 38.14 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.227 0.537 . . . . 1.15 111.467 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.469 ' HB ' ' CA ' ' A' ' 84' ' ' PRO . 14.6 p -86.95 150.13 3.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.559 0.695 . . . . 0.69 111.048 -176.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -93.57 81.23 4.32 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.853 -1.067 . . . . 2.56 109.918 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.76 -32.4 27.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.515 -0.766 . . . . 3.79 111.286 -176.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.3 p -63.88 -33.23 75.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.504 0.669 . . . . 3.05 109.524 174.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -87.3 63.93 8.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.337 -0.847 . . . . 5.48 109.37 174.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -51.51 126.79 18.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.582 0.706 . . . . 4.42 111.758 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.502 ' HG2' ' HD3' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -92.5 171.31 9.11 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.162 -0.927 . . . . 4.27 109.489 -176.256 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.36 152.09 46.88 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.778 0.323 . . . . 5.09 110.389 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 75' ' ' ASN . 19.0 t70 -88.98 -163.7 1.03 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.767 -0.651 . . . . 4.98 109.473 -177.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.489 ' H ' ' CG ' ' A' ' 74' ' ' ASP . 73.4 m-20 -57.83 -28.17 63.84 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.912 0.708 . . . . 6.68 112.912 -169.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -82.42 -17.87 43.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.819 0.818 . . . . 7.13 109.549 -175.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.99 30.89 13.09 Favored Glycine 0 CA--C 1.503 -0.683 0 N-CA-C 109.089 -1.604 . . . . 5.53 109.089 -175.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -86.22 -86.94 0.14 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.357 -1.421 . . . . 5.62 111.904 -169.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 177.81 121.86 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.248 0.547 . . . . 5.0 111.666 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.485 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.6 t -128.54 147.69 33.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.439 -0.578 . . . . 3.33 109.439 170.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.9 p -114.51 95.79 41.23 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-O 122.086 0.946 . . . . 2.77 108.919 171.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.502 ' HD3' ' HG2' ' A' ' 72' ' ' ARG . 60.7 Cg_endo -72.37 160.59 46.56 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.193 2.595 . . . . 1.78 113.784 -172.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.439 ' HD3' ' N ' ' A' ' 83' ' ' LYS . 3.7 mppt? -84.62 146.11 46.1 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 114.935 -1.03 . . . . 3.11 108.799 175.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.469 ' CA ' ' HB ' ' A' ' 66' ' ' VAL . 38.3 Cg_exo -53.41 132.36 48.16 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.603 2.202 . . . . 0.67 112.206 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.433 ' H ' ' HG3' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -73.18 115.18 12.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.506 1.146 . . . . 1.78 111.038 -177.811 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.897 ' HG2' HG23 ' A' ' 63' ' ' ILE . 17.8 mtt85 -102.97 144.26 31.48 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.473 -1.24 . . . . 2.29 109.813 -174.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -105.82 110.87 23.32 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.802 -0.814 . . . . 0.5 108.802 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.423 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 58.2 ttm -105.1 121.97 44.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.916 0.389 . . . . 0.42 110.924 -174.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.473 ' CG ' HD11 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -117.06 123.19 46.24 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.832 -0.803 . . . . 1.33 108.832 177.5 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.523 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 28.2 t -94.64 131.54 40.32 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.149 0.5 . . . . 0.94 110.188 -178.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.47 ' CE1' ' HB2' ' A' ' 7' ' ' ALA . 38.2 m-85 -108.59 165.54 11.46 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.527 -0.76 . . . . 1.33 110.504 175.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -114.62 -3.3 12.92 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.45 -0.796 . . . . 1.53 110.168 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -126.15 121.51 33.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.865 -0.607 . . . . 0.83 109.76 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -54.66 -36.55 64.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.816 -1.084 . . . . 2.16 111.483 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 93.7 m -73.23 -55.59 6.24 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.964 -0.562 . . . . 0.4 111.015 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 94.0 t -45.13 -57.24 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-N 116.111 -0.495 . . . . 0.29 111.364 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.756 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -60.9 -34.05 74.06 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.579 -0.448 . . . . 0.29 110.416 -176.582 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -71.57 -20.35 62.02 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.165 0.507 . . . . 0.39 110.427 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.629 ' O ' ' HG3' ' A' ' 102' ' ' MET . 19.6 m120 -86.93 -37.84 17.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.222 1.01 . . . . 1.55 109.094 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.759 HG23 HD11 ' A' ' 18' ' ' ILE . 1.6 mm -67.65 -50.7 58.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 113.934 -1.485 . . . . 0.13 111.675 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.756 ' HG2' ' O ' ' A' ' 97' ' ' MET . 2.6 ptmt -58.63 -39.56 80.86 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 120.689 0.28 . . . . 1.11 110.822 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.629 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.8 ppp? -73.65 -23.62 59.88 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.166 -0.679 . . . . 1.17 109.166 -176.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 21.2 m -68.02 -51.44 46.98 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.405 -0.816 . . . . 0.15 109.92 173.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.983 ' HB2' HD22 ' A' ' 48' ' ' LEU . 12.6 mt -72.72 -57.17 4.3 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.524 -0.762 . . . . 0.13 111.633 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 1.149 ' HG3' HD23 ' A' ' 48' ' ' LEU . 22.7 mt-30 -51.88 -26.56 10.37 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.64 0.607 . . . . 1.45 112.64 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -71.47 -42.8 67.69 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.229 -0.656 . . . . 0.65 109.229 177.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.749 HG21 ' HB3' ' A' ' 25' ' ' ALA . 69.8 mt -61.42 -44.43 98.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.545 -1.207 . . . . 0.17 110.145 174.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.559 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.2 mt -63.9 -47.8 89.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.635 -0.712 . . . . 0.29 109.906 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.447 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 44.4 t -58.77 -30.68 67.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.354 0.597 . . . . 1.22 109.973 175.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 12.6 ttt180 -67.36 -37.26 82.91 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.133 -0.939 . . . . 3.79 109.778 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -88.5 -19.38 26.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.827 -0.624 . . . . 0.6 111.479 -175.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.539 ' HD2' HG22 ' A' ' 108' ' ' ILE . 8.5 mtpp -78.82 -23.73 44.9 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.416 0.627 . . . . 1.76 109.425 172.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -73.44 -14.42 61.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.237 -0.892 . . . . 1.56 110.093 175.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -131.97 30.63 4.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.732 -0.667 . . . . 1.09 111.073 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.782 -0.628 . . . . 2.16 110.825 -178.307 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.777 0 N-CA-C 112.376 -0.29 . . . . 25.39 112.376 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -123.67 -20.09 2.67 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.798 -0.715 . . . . 24.6 112.334 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -172.37 -143.01 3.96 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.054 -0.593 . . . . 23.97 111.639 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 84.12 -48.54 4.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.021 -0.609 . . . . 23.13 112.695 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -74.02 -17.24 61.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.018 0.437 . . . . 24.92 110.937 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -72.54 138.19 46.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.707 -0.679 . . . . 21.4 110.495 -177.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 15.5 t -82.48 56.42 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.843 0.83 . . . . 20.37 108.856 174.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -111.45 114.25 27.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.098 -0.956 . . . . 17.68 110.153 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -144.81 14.68 1.54 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.599 -0.273 . . . . 16.8 111.607 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.87 149.34 24.17 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.359 -0.608 . . . . 13.35 109.359 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 18.9 m -76.88 -12.43 59.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.025 -0.534 . . . . 10.66 110.775 -175.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -64.03 -32.76 74.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.237 -0.438 . . . . 11.03 111.237 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -75.04 -26.54 59.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.041 0.448 . . . . 10.94 110.584 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -82.15 -42.39 19.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.435 0.636 . . . . 9.82 109.554 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 256' ' ' SER . . . . . 0.435 ' HB3' ' HA3' ' B' ' 260' ' ' GLY . 70.2 m -150.55 122.22 8.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.25 -0.886 . . . . 5.35 109.174 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -53.93 -67.68 0.24 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.585 0.553 . . . . 6.2 112.28 -166.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -88.53 -47.87 8.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.348 0.594 . . . . 6.14 109.979 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -167.1 -38.42 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.515 -1.221 . . . . 3.32 108.971 -176.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 260' ' ' GLY . . . . . 0.435 ' HA3' ' HB3' ' B' ' 256' ' ' SER . . . 77.95 -7.77 41.21 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 115.366 -0.834 . . . . 0.84 114.549 168.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 261' ' ' PHE . . . . . 0.643 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 8.2 m-30 -103.62 177.93 4.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.84 0.32 . . . . 0.95 110.893 -176.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.71 156.98 12.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.421 -0.354 . . . . 1.37 110.233 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -106.0 128.65 53.97 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.279 -0.638 . . . . 2.24 109.279 173.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 38.6 t -105.44 109.4 27.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.067 0.46 . . . . 1.41 110.844 -175.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.491 -0.766 . . . . 3.04 109.621 177.223 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.478 0.608 0 N-CA-C 110.173 -0.741 . . . . 3.14 110.173 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.559 ' HA ' ' HB3' ' A' ' 99' ' ' ASN . 55.7 p -108.16 -43.08 4.47 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.944 0.402 . . . . 1.4 111.067 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -88.6 12.59 14.22 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.117 0.484 . . . . 1.85 110.657 -178.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 82.0 p -163.99 148.88 10.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.099 -0.501 . . . . 0.95 109.998 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.45 144.85 5.79 Favored Glycine 0 C--O 1.223 -0.579 0 N-CA-C 110.592 -1.003 . . . . 0.16 110.592 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.726 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -76.63 119.35 20.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.773 0.786 . . . . 0.43 111.448 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.432 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -124.82 158.22 33.93 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.484 0.659 . . . . 0.13 111.7 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.526 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.7 mp -100.48 123.99 53.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.04 -0.982 . . . . 0.29 109.028 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.43 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 85.7 t80 -121.9 101.71 7.73 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.29 -0.414 . . . . 0.56 110.061 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 65.99 56.98 0.82 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.575 0.702 . . . . 1.46 110.708 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt 73.13 -8.03 1.39 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.407 -1.27 . . . . 1.91 113.109 170.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -102.46 130.27 52.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.059 0.457 . . . . 0.47 110.712 174.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.526 ' HA ' HG13 ' A' ' 8' ' ' ILE . 27.0 t -79.86 130.84 35.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.685 -0.689 . . . . 1.02 110.404 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.647 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -148.95 -155.63 6.8 Favored Glycine 0 N--CA 1.435 -1.373 0 CA-C-N 115.588 -0.733 . . . . 0.16 111.906 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.726 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.3 mm -126.74 153.74 35.92 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 CA-C-O 120.801 0.334 . . . . 0.19 110.759 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.464 HD11 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -125.05 133.82 68.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.918 -0.583 . . . . 0.16 109.501 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.3 108.88 6.96 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.002 0.429 . . . . 0.12 111.992 175.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.622 HD11 HG23 ' A' ' 100' ' ' ILE . 3.6 mp -85.16 120.21 35.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.559 -0.904 . . . . 0.18 108.559 172.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -124.34 123.84 41.07 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.886 -0.413 . . . . 1.12 109.886 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -109.0 83.32 1.73 Allowed 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 117.187 -1.805 . . . . 0.74 107.632 165.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -122.48 -10.92 8.37 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 106.774 -1.565 . . . . 0.59 106.774 156.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 23' ' ' SER . 14.5 p -101.41 175.1 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 112.181 -2.282 . . . . 0.35 111.775 -155.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.683 ' O ' HG13 ' A' ' 22' ' ' VAL . 1.2 t -54.42 165.47 0.86 Allowed Pre-proline 0 C--O 1.225 -0.221 0 N-CA-C 105.972 -1.862 . . . . 1.31 105.972 167.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.558 ' HA ' ' OH ' ' A' ' 111' ' ' TYR . 9.8 Cg_endo -41.22 128.01 3.03 Favored 'Trans proline' 0 C--N 1.357 0.995 0 CA-C-N 122.204 1.823 . . . . 0.22 111.744 -151.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.716 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -29.81 133.81 0.05 Allowed 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 125.348 1.655 . . . . 0.2 113.756 -157.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.643 ' HB2' HG11 ' A' ' 22' ' ' VAL . 31.6 mt-10 -122.56 132.56 54.36 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.768 -1.105 . . . . 1.26 110.98 -171.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.2 tt -100.92 142.45 32.37 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.398 -1.704 . . . . 0.15 106.398 172.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.412 ' N ' HD23 ' A' ' 27' ' ' LEU . 24.5 m -129.8 110.04 11.42 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.636 -0.826 . . . . 0.21 110.505 -178.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.641 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 86.0 t90 -86.11 105.87 16.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.591 0.71 . . . . 0.24 109.27 174.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -113.26 114.14 26.29 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.91 -1.041 . . . . 0.87 108.741 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.584 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 93.1 p -57.61 147.53 26.99 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.422 0.63 . . . . 0.75 110.424 -174.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.647 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 18.9 m -51.98 -26.44 10.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.447 -1.251 . . . . 0.39 112.331 -174.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -88.07 -28.16 21.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.961 0.41 . . . . 2.33 111.234 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.91 17.33 28.16 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.996 -0.621 . . . . 0.55 112.361 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -90.01 -35.31 15.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.03 0.443 . . . . 1.13 111.15 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -118.61 141.71 48.33 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.162 0.506 . . . . 2.03 111.114 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 69.3 t -141.79 116.93 5.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.972 -1.013 . . . . 0.55 109.853 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -123.36 109.56 14.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.191 -0.459 . . . . 0.69 109.934 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 39.0 m -98.07 137.08 37.39 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.985 -0.286 . . . . 0.3 111.207 -176.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.524 HG11 HD13 ' A' ' 62' ' ' LEU . 40.0 t -110.8 129.69 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 122.705 0.402 . . . . 0.66 111.467 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.539 ' O ' HG12 ' A' ' 45' ' ' ILE . 55.3 t -91.21 108.04 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-O 121.282 0.563 . . . . 0.18 109.576 173.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.617 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.8 mm? -56.09 -28.32 57.24 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.07 -0.968 . . . . 0.12 112.533 -177.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 31.5 t -74.19 -31.3 62.6 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.297 -0.561 . . . . 1.06 110.504 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.6 p -79.94 -10.01 59.73 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.682 -0.488 . . . . 0.2 109.682 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.623 HG21 ' CD2' ' A' ' 62' ' ' LEU . 44.6 mm -84.44 116.53 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.61 -0.723 . . . . 0.23 111.535 176.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.63 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 2.5 t70 -74.96 -47.54 28.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.242 -0.89 . . . . 0.7 111.422 175.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.498 ' O ' HG12 ' A' ' 63' ' ' ILE . 15.5 tptt -136.02 136.66 40.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.047 -0.524 . . . . 1.95 109.916 -174.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.041 HD23 ' HG3' ' A' ' 105' ' ' GLN . 13.2 tp -106.74 142.65 36.04 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 119.661 -0.815 . . . . 0.14 109.081 164.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.791 HE21 HD11 ' A' ' 63' ' ' ILE . 25.1 mt-30 -122.96 152.69 40.62 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.687 -1.142 . . . . 1.49 109.675 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.497 ' H ' ' HB3' ' B' ' 261' ' ' PHE . . . -161.47 139.2 9.08 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.182 -0.673 . . . . 0.25 109.182 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 40.4 p -54.95 125.41 56.07 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-O 121.453 0.644 . . . . 0.37 111.715 -178.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 46.1 Cg_endo -67.34 166.74 22.48 Favored 'Trans proline' 0 C--N 1.334 -0.204 0 C-N-CA 124.064 3.176 . . . . 0.64 112.238 178.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.439 ' N ' HH21 ' A' ' 94' ' ' ARG . . . -60.43 -28.89 68.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.028 0.442 . . . . 1.02 110.419 175.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 t -71.75 -24.13 61.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.744 -0.662 . . . . 1.58 110.466 177.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.449 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 33.4 t -71.51 141.87 50.14 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.549 -0.537 . . . . 0.71 109.549 176.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -83.4 -17.64 41.54 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.302 0.572 . . . . 2.89 110.149 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -97.09 179.93 4.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.518 -0.764 . . . . 2.59 110.662 -173.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.467 ' N ' ' SD ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -133.75 110.32 9.73 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.177 -1.046 . . . . 1.78 108.177 171.311 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.522 ' HB3' ' HE1' ' B' ' 261' ' ' PHE . 29.8 ttm -157.11 137.61 13.03 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.592 -0.443 . . . . 1.3 111.247 -171.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.444 HD23 HD11 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -112.12 155.47 23.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.929 -0.578 . . . . 0.14 110.173 177.671 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 19.6 ttm180 -151.02 113.59 4.66 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.739 0.304 . . . . 2.72 110.794 173.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.785 ' HG ' HD13 ' A' ' 48' ' ' LEU . 10.7 mt -96.94 108.2 20.87 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.056 0.543 . . . . 0.9 111.331 -177.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.791 HD11 HE21 ' A' ' 49' ' ' GLN . 2.6 mm -88.88 131.46 36.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 C-N-CA 123.21 0.604 . . . . 0.4 110.872 -175.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -85.6 166.1 39.33 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.153 -1.022 . . . . 0.48 112.056 175.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.63 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 1.1 mptm? -75.07 131.24 40.42 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.622 -0.511 . . . . 1.15 109.622 173.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.535 ' HB ' ' HG3' ' A' ' 84' ' ' PRO . 5.2 p -74.73 152.75 6.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.383 0.611 . . . . 0.69 111.416 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.456 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 4.8 p-10 -89.82 82.58 6.22 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.128 -0.942 . . . . 2.56 111.457 -177.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 71' ' ' LYS . 0.1 OUTLIER -84.64 -24.44 29.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 3.79 111.059 -178.538 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.2 t -69.06 -20.26 64.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.117 0.484 . . . . 3.05 110.814 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.456 ' HE2' ' HB2' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -134.53 62.91 1.64 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.11 -0.496 . . . . 5.48 109.963 178.051 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 35.7 mtmm -56.72 146.32 26.15 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.784 0.802 . . . . 4.42 112.322 -176.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.461 ' HG2' ' HD3' ' A' ' 82' ' ' PRO . 8.1 ptm180 -82.39 172.91 12.54 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.532 -1.213 . . . . 4.27 108.773 175.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.438 ' HB3' ' C ' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -124.7 165.62 17.61 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.836 -0.431 . . . . 5.09 109.836 177.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.739 ' HB3' HD21 ' A' ' 78' ' ' ASN . 1.9 t70 -97.49 -157.17 0.57 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.484 -0.561 . . . . 4.98 109.484 178.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -57.95 -31.45 66.86 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.238 0.458 . . . . 6.68 112.238 -172.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -96.22 1.68 52.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.45 0.643 . . . . 7.13 109.843 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.438 ' C ' ' HB3' ' A' ' 73' ' ' LYS . . . 72.42 37.61 58.61 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 114.857 -1.065 . . . . 5.53 110.733 -176.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.739 HD21 ' HB3' ' A' ' 74' ' ' ASP . 5.8 p30 -83.88 -91.41 0.08 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.717 -0.241 . . . . 5.62 110.588 -177.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.418 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 10.7 pt-20 -175.47 124.57 0.23 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.251 0.548 . . . . 5.0 111.323 175.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.445 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.5 t -127.45 148.3 32.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.04 -0.726 . . . . 3.33 109.04 171.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.403 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 4.2 p -111.4 97.19 35.0 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-O 121.812 0.815 . . . . 2.77 109.648 172.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.461 ' HD3' ' HG2' ' A' ' 72' ' ' ARG . 18.0 Cg_endo -60.56 137.66 75.13 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.292 2.661 . . . . 1.78 112.399 -175.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -54.18 128.17 57.17 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 115.712 -0.677 . . . . 3.11 110.275 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.535 ' HG3' ' HB ' ' A' ' 66' ' ' VAL . 25.0 Cg_exo -49.5 135.41 33.1 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.385 2.724 . . . . 0.67 112.896 -173.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.04 117.48 6.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.998 0.904 . . . . 1.78 110.817 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.698 ' HB3' HG23 ' A' ' 63' ' ' ILE . 21.3 ptt180 -126.62 148.68 49.76 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.546 -0.752 . . . . 2.29 111.273 -174.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -117.63 113.07 21.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.227 -0.897 . . . . 0.5 110.523 -169.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.48 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 49.1 ttm -100.59 130.87 46.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.82 0.343 . . . . 0.42 111.537 -176.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.464 ' CG ' HD11 ' A' ' 16' ' ' ILE . 79.4 m-85 -126.28 122.66 36.12 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.433 -0.58 . . . . 1.33 109.433 174.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.426 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 35.5 m -92.46 132.93 36.38 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.302 -0.408 . . . . 0.94 110.161 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.647 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 25.5 m-85 -108.5 171.13 7.59 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.968 0.413 . . . . 1.33 110.846 177.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -112.0 -3.27 14.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.823 -0.626 . . . . 1.53 110.114 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -141.08 129.13 22.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.346 0.594 . . . . 0.83 110.799 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.439 HH21 ' N ' ' A' ' 53' ' ' ALA . 49.3 tpt85 -61.04 -27.98 68.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.806 -1.088 . . . . 2.16 111.405 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 99.3 m -75.8 -55.63 5.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.629 -0.259 . . . . 0.4 111.278 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.3 t -45.52 -56.8 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-O 120.852 0.358 . . . . 0.29 111.082 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.688 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -62.24 -32.09 72.74 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.779 -0.646 . . . . 0.29 110.602 -177.866 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.415 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 19.6 t70 -66.55 -34.13 77.22 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.77 0.795 . . . . 0.39 109.555 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.604 ' O ' ' HG3' ' A' ' 102' ' ' MET . 21.1 m120 -76.83 -41.32 44.69 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.421 -1.263 . . . . 1.55 109.878 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.647 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 23.4 mm -63.02 -53.43 46.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.948 -1.024 . . . . 0.13 111.15 176.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.785 ' HA ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -59.88 -38.14 81.36 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 120.726 0.298 . . . . 1.11 111.065 -177.742 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.604 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.4 ppp? -71.63 -25.74 62.28 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.365 -0.606 . . . . 1.17 109.365 -175.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 23.1 m -68.13 -52.15 38.11 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.488 -0.778 . . . . 0.15 110.258 174.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.946 ' HB2' HD22 ' A' ' 48' ' ' LEU . 8.2 mt -69.16 -57.44 5.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.523 -0.762 . . . . 0.13 111.33 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 1.041 ' HG3' HD23 ' A' ' 48' ' ' LEU . 95.2 mt-30 -52.7 -25.48 11.13 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.811 0.671 . . . . 1.45 112.811 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -73.41 -35.63 65.86 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.703 0.763 . . . . 0.65 109.403 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.716 HG21 ' HB3' ' A' ' 25' ' ' ALA . 69.5 mt -69.53 -41.7 80.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.539 -1.21 . . . . 0.17 110.249 175.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.548 HG22 ' HD2' ' A' ' 112' ' ' LYS . 1.2 mt -65.6 -50.86 69.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.805 -0.634 . . . . 0.29 110.544 -176.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.481 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 48.6 m -58.69 -28.86 66.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.212 0.53 . . . . 1.22 110.141 174.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.464 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 8.3 ttt180 -66.09 -39.51 90.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.405 -0.816 . . . . 3.79 109.509 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.558 ' OH ' ' HA ' ' A' ' 24' ' ' PRO . 21.3 m-85 -84.81 -23.19 29.22 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.503 -0.772 . . . . 0.6 111.651 -175.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.548 ' HD2' HG22 ' A' ' 108' ' ' ILE . 9.4 mtpp -77.19 -27.92 53.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.407 0.623 . . . . 1.76 109.756 175.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -70.18 -18.27 63.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.159 -0.928 . . . . 1.56 110.196 173.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -128.57 32.23 4.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.667 -0.697 . . . . 1.09 111.239 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 111' ' ' TYR . 20.4 t70 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.477 -0.773 . . . . 2.16 109.844 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 111.839 -0.505 . . . . 25.39 111.839 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -120.1 25.88 7.3 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.063 -0.589 . . . . 24.6 111.953 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -102.91 60.98 0.49 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.837 -0.697 . . . . 23.97 111.906 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.05 41.95 5.44 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.798 -0.715 . . . . 23.13 112.069 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -76.36 -32.13 58.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.238 0.542 . . . . 24.92 110.686 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -108.63 136.92 47.41 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.787 -0.642 . . . . 21.4 110.486 -178.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 33.5 m -90.3 9.32 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.915 -0.584 . . . . 20.37 109.996 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -99.53 116.91 32.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.462 -0.79 . . . . 17.68 110.652 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 22.6 ptp -150.61 16.7 0.8 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.971 -0.559 . . . . 16.8 110.246 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -78.05 139.92 39.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.025 -0.534 . . . . 13.35 111.244 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 14.1 m -72.05 -15.71 62.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.588 -0.733 . . . . 10.66 110.313 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -64.86 -37.11 86.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.732 -0.667 . . . . 11.03 110.847 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -67.2 -32.33 73.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 10.94 110.622 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 255' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' B' ' 256' ' ' SER . 49.2 mt-10 -84.38 -17.7 38.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.056 -0.52 . . . . 9.82 110.657 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 256' ' ' SER . . . . . 0.441 ' HB3' ' O ' ' B' ' 255' ' ' GLU . 41.9 t 73.07 105.76 0.07 Allowed 'General case' 0 C--N 1.332 -0.154 0 O-C-N 124.392 1.057 . . . . 5.35 109.487 -171.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -88.19 -35.09 17.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.844 -0.616 . . . . 6.2 111.338 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.85 -31.49 71.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 6.14 111.806 -175.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -151.54 -38.57 0.12 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.109 0.411 . . . . 3.32 112.109 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 100.57 17.54 23.58 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.241 -0.981 . . . . 0.84 112.902 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 261' ' ' PHE . . . . . 0.522 ' HE1' ' HB3' ' A' ' 59' ' ' MET . 35.1 m-85 -130.38 177.07 7.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.467 0.651 . . . . 0.95 112.287 -173.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 11.9 p -144.23 147.64 19.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 114.729 -1.123 . . . . 1.37 108.907 171.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 263' ' ' GLU . . . . . 0.506 ' HA ' HE22 ' A' ' 105' ' ' GLN . 17.5 tt0 -100.48 121.22 41.2 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.265 -0.643 . . . . 2.24 109.265 176.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 43.5 t -110.18 106.72 21.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.872 0.368 . . . . 1.41 110.921 -173.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.522 -0.751 . . . . 3.04 110.616 179.924 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.5 m80 . . . . . 0 C--O 1.224 -0.254 0 CA-C-O 120.816 0.341 . . . . 1.85 110.886 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 8.0 m -161.45 141.62 10.68 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.802 -0.444 . . . . 0.95 109.802 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.69 142.95 6.6 Favored Glycine 0 C--O 1.224 -0.491 0 N-CA-C 110.864 -0.894 . . . . 0.16 110.864 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.734 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -76.54 117.64 18.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.588 0.694 . . . . 0.43 111.847 -175.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.53 162.33 25.91 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.429 0.633 . . . . 0.13 111.92 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.591 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.8 mp -105.07 123.14 59.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.237 -0.892 . . . . 0.29 109.082 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -117.15 106.14 13.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.652 -0.249 . . . . 0.56 110.516 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 61.0 50.66 4.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.609 0.719 . . . . 1.46 110.366 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt 75.46 -8.67 1.54 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.151 -1.386 . . . . 1.91 113.382 170.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.45 HG21 ' HD2' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -93.18 131.62 39.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.393 -0.523 . . . . 0.47 110.172 172.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.591 ' HA ' HG13 ' A' ' 8' ' ' ILE . 40.9 t -79.75 130.39 35.3 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.586 -0.734 . . . . 1.02 110.854 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.652 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -155.87 -156.17 7.69 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.876 -0.678 . . . . 0.16 112.615 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.734 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.7 mm -126.81 153.85 36.17 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-O 120.834 0.349 . . . . 0.19 110.883 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.485 HD11 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -121.5 134.5 64.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.985 -0.552 . . . . 0.16 109.626 178.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.43 109.92 7.45 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.982 0.42 . . . . 0.12 111.924 174.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.668 HD11 HG23 ' A' ' 100' ' ' ILE . 4.0 mp -83.57 118.55 31.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 107.926 -1.139 . . . . 0.18 107.926 171.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.481 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 2.2 t30 -121.41 122.73 40.44 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 110.0 -0.37 . . . . 1.12 110.0 -177.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -108.47 83.75 1.82 Allowed 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 117.146 -1.822 . . . . 0.74 107.215 163.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.481 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 11.9 t70 -121.99 -11.31 8.52 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.59 -1.633 . . . . 0.59 106.59 157.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.692 HG13 ' O ' ' A' ' 23' ' ' SER . 14.9 p -102.31 174.18 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 112.049 -2.342 . . . . 0.35 112.198 -154.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.692 ' O ' HG13 ' A' ' 22' ' ' VAL . 6.8 m -54.71 166.56 0.73 Allowed Pre-proline 0 C--O 1.224 -0.281 0 N-CA-C 106.586 -1.635 . . . . 1.31 106.586 164.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 11.9 Cg_endo -42.0 128.09 3.99 Favored 'Trans proline' 0 C--N 1.352 0.732 0 CA-C-N 121.862 1.701 . . . . 0.22 111.408 -149.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.668 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -32.23 133.29 0.11 Allowed 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 125.26 1.6 . . . . 0.2 113.446 -157.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.527 ' HB2' HG11 ' A' ' 22' ' ' VAL . 68.7 mt-10 -124.09 140.8 52.62 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.429 -1.26 . . . . 1.26 111.089 -168.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.557 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.7 tt -101.57 142.6 32.68 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 106.561 -1.644 . . . . 0.15 106.561 172.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.458 ' N ' HD23 ' A' ' 27' ' ' LEU . 10.6 m -130.55 108.47 9.95 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.919 -0.712 . . . . 0.21 110.164 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.607 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 88.5 t90 -87.0 112.03 21.43 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.558 0.694 . . . . 0.24 109.364 175.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.518 ' HD3' ' O ' ' A' ' 31' ' ' SER . 2.6 tmt_? -118.99 118.19 30.83 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.111 -0.949 . . . . 0.87 108.819 -177.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.518 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 35.8 p -56.0 144.28 29.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.292 0.568 . . . . 0.75 110.597 -176.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.652 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 21.4 m -53.85 -29.45 41.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.603 -1.18 . . . . 0.39 112.008 -175.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -83.56 -25.65 30.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.259 0.552 . . . . 2.33 111.065 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.3 16.67 39.61 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.886 -0.673 . . . . 0.55 112.337 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.36 -65.27 1.02 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.104 0.478 . . . . 1.13 110.99 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.45 ' HD2' HG21 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -106.43 155.06 19.95 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.508 -0.769 . . . . 2.03 110.777 -175.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 69.0 t -146.81 139.76 19.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.97 -1.014 . . . . 0.55 109.636 -175.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -139.34 111.23 7.29 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.234 -0.284 . . . . 0.69 110.234 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.3 m -98.31 138.75 35.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.58 0.229 . . . . 0.3 111.496 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.561 HG11 HD13 ' A' ' 62' ' ' LEU . 41.1 t -113.16 129.44 68.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 122.523 0.329 . . . . 0.66 111.521 176.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.559 ' O ' HG12 ' A' ' 45' ' ' ILE . 38.8 t -91.04 108.1 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 109.576 -0.528 . . . . 0.18 109.576 173.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.58 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.8 mm? -53.21 -28.89 29.27 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.091 -0.959 . . . . 0.12 112.597 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.406 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 68.4 m -74.88 -35.76 62.29 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.663 -0.415 . . . . 1.06 111.446 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.3 p -72.28 -14.17 61.7 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 121.376 0.608 . . . . 0.2 109.564 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.602 HG21 ' CD2' ' A' ' 62' ' ' LEU . 48.6 mm -82.32 120.93 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.335 -0.848 . . . . 0.23 111.395 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.628 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 15.7 t70 -78.46 -46.09 20.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.73 -0.668 . . . . 0.7 110.904 176.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.411 ' HB2' HG13 ' A' ' 63' ' ' ILE . 68.8 mmtt -136.88 150.52 48.3 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.129 -0.487 . . . . 1.95 109.975 -178.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.9 HD22 ' HB2' ' A' ' 104' ' ' LEU . 9.9 tp -113.45 144.23 43.16 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.29 -0.633 . . . . 0.14 109.29 165.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.488 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 14.3 mm100 -120.87 154.57 35.66 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.978 -1.01 . . . . 1.49 109.518 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.484 ' HB1' ' CE ' ' A' ' 97' ' ' MET . . . -162.59 141.44 8.92 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.55 -0.75 . . . . 0.25 108.992 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.579 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 37.1 p -56.53 126.04 68.68 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-O 121.303 0.573 . . . . 0.37 112.055 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 72.9 Cg_endo -74.46 166.37 29.6 Favored 'Trans proline' 0 C--N 1.329 -0.457 0 C-N-CA 123.972 3.114 . . . . 0.64 111.314 172.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.6 -27.85 63.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.109 0.481 . . . . 1.02 110.415 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.4 m -69.07 -24.81 64.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.706 -0.679 . . . . 1.58 111.282 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.499 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 39.5 t -76.54 148.51 37.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.127 -0.488 . . . . 0.71 109.717 177.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -90.68 -2.18 57.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.42 0.629 . . . . 2.89 110.116 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -115.39 178.98 4.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.194 -0.912 . . . . 2.59 110.858 -174.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.579 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -132.35 107.76 8.74 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.017 -1.105 . . . . 1.78 108.017 168.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 75.1 mtm -154.54 152.0 29.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.982 0.42 . . . . 1.3 111.21 -176.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.471 HD11 ' O ' ' A' ' 97' ' ' MET . 0.8 OUTLIER -112.05 158.33 19.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.242 -0.89 . . . . 0.14 110.229 175.134 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 45.2 ttt180 -153.63 114.32 4.03 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 121.274 0.559 . . . . 2.72 111.009 170.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.713 ' HG ' HD13 ' A' ' 48' ' ' LEU . 9.0 mt -92.24 112.91 25.03 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.717 -0.674 . . . . 0.9 110.515 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.619 HG23 ' HG2' ' A' ' 86' ' ' ARG . 5.0 mm -86.7 116.64 29.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.512 0.725 . . . . 0.4 110.307 -174.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -85.33 144.97 21.01 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.159 -1.019 . . . . 0.48 111.487 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.628 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 8.2 mptt -58.73 134.98 57.3 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.057 0.456 . . . . 1.15 110.734 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--N 1.321 -0.662 0 CA-C-N 115.509 -0.769 . . . . 0.69 110.289 -179.326 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 . . . . . 0 N--CA 1.448 -0.527 0 CA-C-O 121.531 0.682 . . . . 1.78 109.264 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.619 ' HG2' HG23 ' A' ' 63' ' ' ILE . 18.7 mtt180 -140.13 153.73 46.78 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.551 -0.749 . . . . 2.29 110.33 -168.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -115.88 110.45 19.03 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.08 -0.711 . . . . 0.5 109.08 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.483 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 54.9 ttm -103.25 129.26 50.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.781 0.324 . . . . 0.42 110.827 -175.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.485 ' CG ' HD11 ' A' ' 16' ' ' ILE . 80.4 m-85 -123.46 122.54 38.51 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 109.245 -0.65 . . . . 1.33 109.245 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.493 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 22.7 m -91.18 128.95 37.21 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.04 -0.527 . . . . 0.94 110.838 -174.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.603 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 29.1 m-85 -108.16 174.79 5.72 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.95 -0.568 . . . . 1.33 110.816 176.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -119.57 0.22 10.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.706 -0.679 . . . . 1.53 109.821 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.511 ' OD1' ' HB ' ' A' ' 95' ' ' THR . 28.7 t-20 -143.38 131.43 21.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.324 -0.853 . . . . 0.83 110.647 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.491 ' HA ' ' HG2' ' A' ' 97' ' ' MET . 0.9 OUTLIER -74.97 -23.28 58.26 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.962 -0.563 . . . . 2.16 110.976 -174.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.511 ' HB ' ' OD1' ' A' ' 93' ' ' ASN . 92.8 m -70.99 -54.49 11.07 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.411 -0.516 . . . . 0.4 109.783 175.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.0 t -45.7 -57.36 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-N 116.134 -0.485 . . . . 0.29 111.103 173.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.491 ' HG2' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -64.12 -29.3 70.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.006 -0.543 . . . . 0.29 111.093 -178.134 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.29 -32.18 72.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.407 0.622 . . . . 0.39 109.554 175.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.495 HD21 HG22 ' A' ' 95' ' ' THR . 90.6 m-20 -75.03 -46.82 32.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.887 -1.051 . . . . 1.55 109.844 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.668 HG23 HD11 ' A' ' 18' ' ' ILE . 27.6 mm -61.28 -51.16 76.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.003 -0.999 . . . . 0.13 110.276 175.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.628 ' HA ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -55.74 -51.9 65.76 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.614 -0.721 . . . . 1.11 111.197 179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.487 ' N ' ' HE2' ' A' ' 101' ' ' LYS . 11.7 ptp -60.2 -32.15 70.82 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.081 0.467 . . . . 1.17 109.777 -176.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 54.1 m -63.36 -52.04 63.41 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.267 -0.879 . . . . 0.15 110.261 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.9 ' HB2' HD22 ' A' ' 48' ' ' LEU . 11.3 mt -66.95 -55.59 13.87 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.43 -0.805 . . . . 0.13 110.781 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.791 ' HG2' HD23 ' A' ' 48' ' ' LEU . 19.2 mm-40 -43.16 -37.54 2.11 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.653 0.596 . . . . 1.45 112.544 178.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -68.1 -35.51 78.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.823 0.82 . . . . 0.65 109.555 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.668 HG21 ' HB3' ' A' ' 25' ' ' ALA . 81.3 mt -72.51 -41.66 63.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.017 -1.447 . . . . 0.17 110.319 175.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.434 HG12 HD12 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -65.3 -50.92 70.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.855 -0.611 . . . . 0.29 110.217 -177.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.6 t -58.53 -28.47 65.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.47 0.653 . . . . 1.22 109.941 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 11.0 ttt180 -68.73 -38.81 80.45 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.049 -0.978 . . . . 3.79 109.927 177.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.401 ' OH ' ' HA ' ' A' ' 24' ' ' PRO . 27.0 m-85 . . . . . 0 N--CA 1.446 -0.65 0 CA-C-N 115.928 -0.578 . . . . 0.6 111.698 -175.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 261' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 6.0 m-85 . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 121.056 0.455 . . . . 0.95 110.822 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 12.9 p -135.09 145.22 32.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.669 -0.696 . . . . 1.37 109.165 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.607 0 CA-C-O 121.021 0.439 . . . . 2.24 110.13 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.612 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 36.0 m80 . . . . . 0 C--O 1.225 -0.191 0 N-CA-C 111.858 0.318 . . . . 1.85 111.858 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.4 p -162.37 145.61 11.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.982 0.42 . . . . 0.95 110.906 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.48 145.71 6.72 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.71 -0.956 . . . . 0.16 110.71 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.736 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -71.68 142.88 49.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.21 0.505 . . . . 0.43 111.361 -176.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.474 ' HB1' ' HB3' ' A' ' 89' ' ' PHE . . . -152.62 155.09 36.66 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-O 121.209 0.528 . . . . 0.13 111.61 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.544 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.2 mp -92.34 131.18 40.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.606 -0.725 . . . . 0.29 109.4 176.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.566 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 89.3 t80 -139.74 112.87 8.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.28 -0.418 . . . . 0.56 110.134 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.495 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 51.3 mt-10 68.6 48.83 0.78 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.604 0.716 . . . . 1.46 110.371 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.495 ' HD2' ' C ' ' A' ' 10' ' ' GLU . 4.0 mptt 67.41 4.4 3.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.351 -1.295 . . . . 1.91 112.84 173.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.94 134.69 54.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.835 0.35 . . . . 0.47 110.623 175.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.544 ' HA ' HG13 ' A' ' 8' ' ' ILE . 31.8 t -75.02 128.53 35.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.028 -0.533 . . . . 1.02 109.819 176.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.691 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -148.1 -159.88 8.68 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.701 -0.762 . . . . 0.16 112.347 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.736 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.8 mm -126.33 152.66 34.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.066 0.46 . . . . 0.19 110.841 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.412 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -122.63 133.04 69.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.647 -0.706 . . . . 0.16 109.842 178.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.14 110.33 7.81 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.92 0.391 . . . . 0.12 111.958 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.685 HD11 HG23 ' A' ' 100' ' ' ILE . 3.6 mp -85.41 119.46 34.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.844 -0.799 . . . . 0.18 108.844 172.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 2.0 t30 -120.77 123.42 42.62 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.992 -0.373 . . . . 1.12 109.992 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.439 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 15.9 mt-10 -108.85 83.08 1.7 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 117.332 -1.747 . . . . 0.74 107.452 164.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.423 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 23.0 t70 -122.04 -10.92 8.55 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 106.522 -1.658 . . . . 0.59 106.522 157.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 23' ' ' SER . 14.5 p -102.33 175.5 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 111.919 -2.4 . . . . 0.35 112.057 -155.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.686 ' O ' HG13 ' A' ' 22' ' ' VAL . 56.8 p -54.4 165.96 0.78 Allowed Pre-proline 0 C--O 1.225 -0.2 0 N-CA-C 106.714 -1.587 . . . . 1.31 106.714 166.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 12.0 Cg_endo -42.47 128.97 4.82 Favored 'Trans proline' 0 C--N 1.359 1.095 0 CA-C-N 122.326 1.866 . . . . 0.22 111.157 -152.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.788 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -31.46 136.11 0.06 Allowed 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 125.44 1.712 . . . . 0.2 114.193 -155.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.531 ' HB2' HG11 ' A' ' 22' ' ' VAL . 64.1 mt-10 -122.64 132.4 54.26 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 114.439 -1.255 . . . . 1.26 110.789 -171.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.566 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.3 tt -100.81 142.18 32.65 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 106.235 -1.765 . . . . 0.15 106.235 173.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.432 ' N ' HD23 ' A' ' 27' ' ' LEU . 25.9 m -130.67 109.34 10.56 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 119.537 -0.865 . . . . 0.21 110.551 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.611 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 88.8 t90 -85.83 108.85 18.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.624 0.726 . . . . 0.24 109.376 174.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -115.13 115.0 26.05 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.774 -1.103 . . . . 0.87 108.467 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.542 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 79.3 p -57.21 150.03 18.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.153 0.501 . . . . 0.75 110.751 -173.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.691 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 24.0 m -57.83 -29.05 64.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.176 -0.92 . . . . 0.39 110.435 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.495 ' OD2' ' HB3' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -80.65 -27.95 37.02 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.421 -0.809 . . . . 2.33 111.548 177.181 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.6 -5.07 56.78 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.818 -0.705 . . . . 0.55 113.161 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.495 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 2.4 t70 -67.28 -52.23 43.18 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.3 0.482 . . . . 1.13 112.3 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -103.0 143.48 32.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.621 0.724 . . . . 2.03 112.426 -174.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 76.9 t -141.86 116.44 5.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.175 -1.375 . . . . 0.55 109.802 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -123.75 109.74 14.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.949 -0.569 . . . . 0.69 109.904 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 32.8 m -97.35 137.84 35.72 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.944 -0.303 . . . . 0.3 111.177 -176.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 42.0 t -110.91 130.91 63.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 122.815 0.446 . . . . 0.66 111.655 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.509 ' O ' HG12 ' A' ' 45' ' ' ILE . 51.0 t -90.91 108.29 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 109.619 -0.512 . . . . 0.18 109.619 172.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.616 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -53.48 -27.96 28.07 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.994 -1.003 . . . . 0.12 112.844 -178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.0 m -75.47 -34.59 60.91 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.598 -0.441 . . . . 1.06 111.443 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.6 p -75.26 -11.95 60.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.273 0.558 . . . . 0.2 109.71 173.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.691 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 47.5 mm -81.75 117.02 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 115.143 -0.935 . . . . 0.23 111.282 173.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.537 ' OD2' ' HG2' ' A' ' 47' ' ' LYS . 21.2 t70 -73.93 -46.24 45.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.429 -0.805 . . . . 0.7 111.375 177.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.537 ' HG2' ' OD2' ' A' ' 46' ' ' ASP . 47.9 mmtm -140.75 157.3 45.62 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.473 -0.331 . . . . 1.95 110.354 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.077 HD23 ' HG3' ' A' ' 105' ' ' GLN . 13.2 tp -123.51 140.93 52.5 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.256 0.55 . . . . 0.14 109.941 167.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.558 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 16.3 mm100 -113.01 157.8 21.07 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.749 -1.114 . . . . 1.49 109.846 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.51 136.32 5.36 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.8 -0.636 . . . . 0.25 109.539 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 40.6 p -51.27 124.74 23.7 Favored Pre-proline 0 N--CA 1.467 0.404 0 CA-C-O 121.259 0.552 . . . . 0.37 111.243 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.555 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 48.3 Cg_endo -66.82 166.54 22.15 Favored 'Trans proline' 0 C--N 1.333 -0.287 0 C-N-CA 124.057 3.171 . . . . 0.64 111.983 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.417 ' N ' HH21 ' A' ' 94' ' ' ARG . . . -60.11 -25.0 65.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.902 0.382 . . . . 1.02 110.829 176.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.8 m -78.37 -24.39 46.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.847 -0.615 . . . . 1.58 111.521 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 29.7 t -67.54 149.29 50.33 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.216 -0.661 . . . . 0.71 109.216 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.48 -14.36 22.4 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.606 -0.887 . . . . 2.89 108.606 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.568 ' N ' ' HD3' ' A' ' 57' ' ' LYS . 2.7 mppt? -94.34 -177.89 4.41 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.821 -1.081 . . . . 2.59 110.996 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.511 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -136.49 110.67 8.37 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.388 -0.968 . . . . 1.78 108.388 172.314 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.682 ' HB3' ' CZ ' ' B' ' 261' ' ' PHE . 2.5 mtm -156.54 138.68 14.59 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.694 -0.402 . . . . 1.3 111.854 -173.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.841 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 2.3 mp -109.2 160.05 16.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.843 -0.617 . . . . 0.14 111.078 170.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.558 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 9.8 ttm180 -150.54 114.19 4.97 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.981 -0.554 . . . . 2.72 110.356 172.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.871 ' HG ' HD13 ' A' ' 48' ' ' LEU . 6.2 mp -94.19 110.44 22.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.075 0.464 . . . . 0.9 110.502 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.564 HG23 ' HG2' ' A' ' 86' ' ' ARG . 2.2 mm -87.95 124.6 41.21 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 C-N-CA 123.254 0.622 . . . . 0.4 109.701 -176.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.691 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -93.58 160.05 24.29 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 119.255 -1.45 . . . . 0.48 111.819 174.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 0.3 OUTLIER -69.29 132.86 47.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.72 0.295 . . . . 1.15 111.088 -178.599 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 C--N 1.316 -0.854 0 N-CA-C 108.807 -0.812 . . . . 0.69 108.807 170.674 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.367 0 CA-C-O 121.931 0.872 . . . . 1.78 109.813 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.564 ' HG2' HG23 ' A' ' 63' ' ' ILE . 18.8 mtm180 -115.52 154.47 29.3 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.201 -0.909 . . . . 2.29 109.133 -175.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -117.51 109.43 16.73 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.164 -0.471 . . . . 0.5 110.003 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.544 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 51.1 ttm -108.99 122.38 47.12 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 110.061 -0.348 . . . . 0.42 110.061 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.499 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 57.8 m-85 -112.23 139.79 47.48 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.595 -0.891 . . . . 1.33 108.595 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.531 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 31.3 m -97.74 123.11 41.54 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.597 -0.519 . . . . 0.94 109.597 177.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.841 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 6.0 m-85 -106.09 165.06 11.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.986 -0.552 . . . . 1.33 109.819 -175.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -107.3 -6.46 17.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.882 0.372 . . . . 1.53 110.988 -171.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.401 ' HB3' HG23 ' A' ' 96' ' ' VAL . 48.9 t-20 -145.66 128.36 16.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.142 0.496 . . . . 0.83 110.663 -176.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.515 ' NH1' ' HB2' ' A' ' 98' ' ' ASP . 49.1 tpt85 -62.63 -26.24 68.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.06 -0.973 . . . . 2.16 111.131 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.415 HG22 HD21 ' A' ' 99' ' ' ASN . 41.2 m -73.46 -60.06 2.42 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.738 0.304 . . . . 0.4 110.382 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 100' ' ' ILE . 58.5 t -45.71 -55.57 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 CA-C-N 115.584 -0.734 . . . . 0.29 111.441 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.549 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -63.21 -30.63 71.74 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.227 -0.442 . . . . 0.29 110.786 -177.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.515 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 36.5 t70 -69.17 -31.3 69.84 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.619 0.723 . . . . 0.39 109.557 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.415 HD21 HG22 ' A' ' 95' ' ' THR . 87.7 m-20 -72.93 -42.36 63.57 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.6 -1.182 . . . . 1.55 109.072 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.685 HG23 HD11 ' A' ' 18' ' ' ILE . 40.4 mm -62.64 -54.09 38.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.783 -1.099 . . . . 0.13 111.562 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.715 ' HA ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -60.87 -42.72 98.46 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 120.54 0.21 . . . . 1.11 111.481 -177.221 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.401 ' HB3' ' HE2' ' A' ' 101' ' ' LYS . 13.0 ptp -66.51 -29.56 69.68 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.66 -0.867 . . . . 1.17 108.66 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 32.7 m -66.0 -52.01 53.23 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.751 -1.113 . . . . 0.15 110.025 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.902 ' HB2' HD22 ' A' ' 48' ' ' LEU . 13.3 mt -69.31 -58.51 3.92 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.444 -0.798 . . . . 0.13 110.945 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 1.077 ' HG3' HD23 ' A' ' 48' ' ' LEU . 96.8 mt-30 -49.2 -28.21 4.32 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.757 0.651 . . . . 1.45 112.757 -178.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -67.14 -49.02 66.27 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.852 -0.796 . . . . 0.65 108.852 176.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.788 HG21 ' HB3' ' A' ' 25' ' ' ALA . 53.0 mt -59.65 -43.89 92.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.669 -1.15 . . . . 0.17 110.494 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.0 OUTLIER -61.18 -58.24 8.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.604 -0.726 . . . . 0.29 110.168 -176.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.9 m -55.37 -29.23 58.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.722 0.296 . . . . 1.22 111.467 173.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 92.5 mtt180 -68.93 -18.37 64.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.157 0.503 . . . . 3.79 110.481 176.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 . . . . . 0 N--CA 1.442 -0.869 0 CA-C-N 115.687 -0.688 . . . . 0.6 109.916 178.16 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 261' ' ' PHE . . . . . 0.682 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 6.2 m-30 . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 120.839 0.352 . . . . 0.95 110.414 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.39 148.9 31.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.494 -0.558 . . . . 1.37 109.494 174.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 263' ' ' GLU . . . . . 0.552 ' HB3' ' OE1' ' A' ' 49' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.617 0 CA-C-O 121.332 0.587 . . . . 2.24 110.523 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.561 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 19.5 m80 . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.722 0.296 . . . . 1.85 111.525 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.6 p -163.54 142.44 8.08 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.733 0.301 . . . . 0.95 110.375 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.98 147.18 7.92 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.294 -1.122 . . . . 0.16 110.294 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.762 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -69.8 144.52 52.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 117.41 0.605 . . . . 0.43 111.603 -175.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' A' ' 89' ' ' PHE . . . -152.64 155.83 38.07 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 121.068 0.461 . . . . 0.13 111.38 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.563 HG13 ' HA ' ' A' ' 13' ' ' SER . 1.9 mp -94.73 133.84 34.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.793 -0.639 . . . . 0.29 109.297 177.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.451 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 74.3 t80 -139.69 121.0 14.93 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.285 -0.635 . . . . 0.56 109.285 176.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 65.03 41.76 4.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.466 0.651 . . . . 1.46 110.141 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 11' ' ' LYS . 41.4 mmtt 74.0 -6.43 1.83 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.519 -1.219 . . . . 1.91 112.922 171.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.97 135.34 36.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.914 0.388 . . . . 0.47 110.539 175.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.563 ' HA ' HG13 ' A' ' 8' ' ' ILE . 9.6 p -73.38 128.93 36.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.79 -0.641 . . . . 1.02 110.691 176.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.679 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -146.8 -159.5 8.31 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 115.645 -0.707 . . . . 0.16 112.192 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.762 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.4 mm -126.39 152.95 34.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 120.905 0.383 . . . . 0.19 111.007 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.04 134.34 66.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 116.079 -0.51 . . . . 0.16 109.891 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.83 110.78 8.22 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.933 0.397 . . . . 0.12 112.069 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.678 HD11 HG23 ' A' ' 100' ' ' ILE . 3.9 mp -85.13 112.8 22.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.785 -0.82 . . . . 0.18 108.785 171.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.468 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.9 t30 -114.97 125.86 54.1 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.823 -0.351 . . . . 1.12 110.139 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.402 ' HG2' ' HB1' ' A' ' 25' ' ' ALA . 9.8 mt-10 -109.76 83.07 1.69 Allowed 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 117.255 -1.778 . . . . 0.74 107.37 163.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.468 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 16.9 t70 -122.26 -10.01 8.55 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 106.42 -1.696 . . . . 0.59 106.42 157.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.93 HG11 ' HB3' ' A' ' 26' ' ' GLU . 14.5 p -102.79 174.86 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 112.079 -2.328 . . . . 0.35 111.897 -156.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.687 ' O ' HG13 ' A' ' 22' ' ' VAL . 12.0 p -54.52 165.0 0.96 Allowed Pre-proline 0 N--CA 1.453 -0.322 0 N-CA-C 106.661 -1.607 . . . . 1.31 106.661 165.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.616 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 11.8 Cg_endo -41.73 129.01 3.86 Favored 'Trans proline' 0 C--N 1.353 0.792 0 CA-C-N 121.731 1.654 . . . . 0.22 111.809 -147.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.646 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -29.41 131.03 0.07 Allowed 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 125.406 1.691 . . . . 0.2 113.137 -159.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.93 ' HB3' HG11 ' A' ' 22' ' ' VAL . 36.7 tt0 -132.49 133.59 43.98 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.412 -1.267 . . . . 1.26 111.532 -160.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 1.6 tt -100.38 146.88 26.45 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 107.276 -1.379 . . . . 0.15 107.276 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.498 ' N ' HD23 ' A' ' 27' ' ' LEU . 22.6 m -137.57 109.31 7.07 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 120.134 -0.626 . . . . 0.21 110.552 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.589 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 88.3 t90 -85.58 112.38 20.91 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.688 -0.687 . . . . 0.24 109.29 175.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -117.93 118.3 31.61 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.442 -0.948 . . . . 0.87 108.442 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.568 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 71.6 p -57.21 152.18 14.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.667 0.27 . . . . 0.75 111.032 -174.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.679 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 23.7 m -55.53 -35.12 65.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.599 0.714 . . . . 0.39 109.889 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.18 -28.05 53.89 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.939 -1.028 . . . . 2.33 111.613 178.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.9 1.55 70.27 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.915 -0.66 . . . . 0.55 113.246 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -81.35 -25.05 36.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.856 0.328 . . . . 1.13 111.688 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -120.82 140.96 51.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.162 0.506 . . . . 2.03 111.719 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 73.7 t -142.45 126.11 15.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.298 -0.865 . . . . 0.55 110.496 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -128.04 112.22 14.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.913 0.387 . . . . 0.69 110.418 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 27' ' ' LEU . 30.2 m -96.17 146.81 24.37 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.503 -0.317 . . . . 0.3 111.476 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 36.9 t -126.28 127.67 70.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 122.476 0.31 . . . . 0.66 111.433 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.469 ' O ' HG12 ' A' ' 45' ' ' ILE . 58.4 t -90.39 107.95 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-O 121.392 0.615 . . . . 0.18 109.497 173.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.611 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.9 mm? -51.15 -29.76 14.66 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.901 -1.045 . . . . 0.12 112.79 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 60.5 m -73.48 -34.96 65.59 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.565 -0.454 . . . . 1.06 111.528 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.3 p -72.85 -18.1 61.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.362 0.601 . . . . 0.2 109.574 173.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.578 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 50.0 mm -79.72 117.58 25.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.256 -0.884 . . . . 0.23 111.024 175.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.592 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 28.7 t70 -75.81 -43.1 47.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.029 -0.532 . . . . 0.7 111.666 177.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.493 ' HG2' ' OD2' ' A' ' 46' ' ' ASP . 48.6 mmtm -141.05 153.93 45.73 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.865 -0.421 . . . . 1.95 109.865 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.036 HD23 ' HG3' ' A' ' 105' ' ' GLN . 9.7 tp -117.31 145.99 43.63 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.203 -0.666 . . . . 0.14 109.203 166.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.667 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 15.9 mm100 -124.12 157.17 35.25 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.661 -1.154 . . . . 1.49 109.974 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.61 146.22 11.42 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.471 -0.786 . . . . 0.25 109.64 177.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.42 ' HA ' ' HD2' ' A' ' 52' ' ' PRO . 20.1 p -43.83 125.83 4.12 Favored Pre-proline 0 N--CA 1.468 0.429 0 C-N-CA 123.583 0.753 . . . . 0.37 111.756 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.567 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 52.8 Cg_endo -66.82 165.65 25.14 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 C-N-CA 123.803 3.002 . . . . 0.64 111.649 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.21 -29.33 67.42 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.092 0.472 . . . . 1.02 110.313 175.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.9 t -70.43 -22.63 62.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.713 -0.676 . . . . 1.58 110.611 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.468 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 47.7 t -72.18 145.49 48.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.71 110.428 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -89.91 -7.98 52.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.354 0.597 . . . . 2.89 109.576 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -103.92 179.43 4.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.021 -0.991 . . . . 2.59 111.077 -173.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.584 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -137.29 109.88 7.5 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.375 -1.284 . . . . 1.78 108.064 178.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.773 ' HB3' ' CZ ' ' B' ' 261' ' ' PHE . 10.8 ttm -157.98 138.81 13.08 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.343 -0.543 . . . . 1.3 111.375 -169.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.817 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 3.2 mp -111.06 156.35 21.43 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.087 0.47 . . . . 0.14 112.028 174.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 59.9 ttp180 -150.28 113.2 4.81 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.776 -0.647 . . . . 2.72 110.593 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.787 ' HG ' HD13 ' A' ' 48' ' ' LEU . 6.4 mp -95.72 110.73 22.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.998 -0.546 . . . . 0.9 110.693 -176.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.565 HG23 ' HB3' ' A' ' 86' ' ' ARG . 1.2 mm -87.6 120.98 37.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.163 -0.472 . . . . 0.4 110.525 -173.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -83.17 156.24 33.74 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 119.89 -1.148 . . . . 0.48 111.747 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.592 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 9.7 mptt -68.48 137.08 54.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.96 0.38 . . . . 1.15 110.29 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 C--N 1.32 -0.68 0 N-CA-C 109.207 -0.664 . . . . 0.69 109.207 173.409 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? . . . . . 0 N--CA 1.445 -0.69 0 CA-C-O 121.829 0.823 . . . . 1.78 109.791 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.565 ' HB3' HG23 ' A' ' 63' ' ' ILE . 22.3 ptt180 -127.73 141.65 51.54 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.251 -0.886 . . . . 2.29 110.444 -174.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -102.32 111.18 23.37 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.043 -0.98 . . . . 0.5 110.207 -170.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.495 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 53.6 ttm -108.27 120.12 41.45 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.598 -0.728 . . . . 0.42 110.483 -172.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.457 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 55.8 m-85 -111.5 140.48 46.07 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.394 -0.965 . . . . 1.33 108.394 175.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.623 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 49.5 m -97.47 125.08 41.93 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.523 -0.471 . . . . 0.94 110.221 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.817 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 5.6 m-85 -107.7 169.0 8.86 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.747 -0.661 . . . . 1.33 109.357 -176.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -126.27 -3.4 6.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.851 0.358 . . . . 1.53 110.68 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.453 ' OD1' HG23 ' A' ' 96' ' ' VAL . 28.6 t-20 -131.12 125.66 33.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.131 0.491 . . . . 0.83 110.616 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.443 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 12.7 tpt180 -62.29 -33.51 74.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.179 -0.918 . . . . 2.16 111.371 -177.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.48 HG22 HD21 ' A' ' 99' ' ' ASN . 87.2 m -73.24 -55.76 6.0 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.951 -0.3 . . . . 0.4 110.492 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.453 HG23 ' OD1' ' A' ' 93' ' ' ASN . 95.6 t -45.86 -56.39 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-N 115.824 -0.625 . . . . 0.29 111.539 175.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.584 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -65.94 -28.9 69.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.321 -0.399 . . . . 0.29 110.7 -177.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.95 -37.02 83.51 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.92 -0.77 . . . . 0.39 108.92 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.558 ' O ' ' HG3' ' A' ' 102' ' ' MET . 90.4 m-20 -72.79 -48.53 37.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.205 -1.361 . . . . 1.55 109.581 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.678 HG23 HD11 ' A' ' 18' ' ' ILE . 41.0 mm -56.18 -53.05 43.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.985 -1.007 . . . . 0.13 110.075 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.785 ' HA ' HD21 ' A' ' 48' ' ' LEU . 6.6 ttpp -55.98 -50.15 71.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.778 -0.646 . . . . 1.11 111.329 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.558 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.1 ppp? -68.56 -24.48 64.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.328 -0.396 . . . . 1.17 110.339 -175.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.7 m -67.62 -51.79 46.02 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.462 0.649 . . . . 0.15 110.071 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.982 ' HB2' HD22 ' A' ' 48' ' ' LEU . 13.8 mt -69.14 -58.5 3.98 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.132 -0.94 . . . . 0.13 111.364 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 1.036 ' HG3' HD23 ' A' ' 48' ' ' LEU . 66.5 mt-30 -51.52 -26.46 8.5 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.758 0.651 . . . . 1.45 112.758 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -66.24 -49.5 67.0 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.411 -0.959 . . . . 0.65 108.411 175.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.646 HG21 ' HB3' ' A' ' 25' ' ' ALA . 67.7 mt -58.51 -43.57 87.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.303 -1.317 . . . . 0.17 110.487 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.1 mt -66.79 -49.24 76.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.996 -0.547 . . . . 0.29 110.654 -176.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.2 t -60.27 -26.14 66.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.388 0.613 . . . . 1.22 110.095 173.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 83.0 mtt180 -73.87 -30.63 62.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.494 -0.776 . . . . 3.79 110.624 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 . . . . . 0 N--CA 1.449 -0.478 0 CA-C-N 116.051 -0.522 . . . . 0.6 112.144 -179.364 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 261' ' ' PHE . . . . . 0.773 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 6.7 m-30 . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 121.042 0.449 . . . . 0.95 111.701 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.1 p -138.18 148.2 25.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.916 -0.584 . . . . 1.37 110.264 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 . . . . . 0 C--N 1.324 -0.501 0 N-CA-C 108.931 -0.766 . . . . 2.24 108.931 175.964 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.424 ' CE1' HG23 ' A' ' 103' ' ' THR . 12.4 m80 . . . . . 0 C--O 1.225 -0.224 0 N-CA-C 112.421 0.526 . . . . 1.85 112.421 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.9 p -162.8 140.07 7.88 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.318 0.58 . . . . 0.95 111.26 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.05 152.79 13.36 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.998 -1.241 . . . . 0.16 109.998 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.746 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -73.46 145.88 45.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 117.578 0.689 . . . . 0.43 111.5 -175.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.97 152.55 32.62 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.396 0.617 . . . . 0.13 111.525 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.507 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.7 mp -94.15 124.44 46.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.861 -0.792 . . . . 0.29 108.861 174.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.574 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 79.9 t80 -128.99 105.62 8.33 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 110.176 -0.305 . . . . 0.56 110.176 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 66.98 53.22 0.84 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.573 0.701 . . . . 1.46 110.664 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp 71.28 -8.16 1.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.175 -1.375 . . . . 1.91 113.252 171.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.435 HG11 ' HD3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -99.32 132.73 44.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.865 -0.42 . . . . 0.47 109.865 172.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.507 ' HA ' HG13 ' A' ' 8' ' ' ILE . 23.3 t -85.28 123.97 31.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.998 -0.546 . . . . 1.02 109.921 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.662 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -144.48 -155.08 6.32 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 120.906 -0.664 . . . . 0.16 112.276 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.746 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.3 mm -125.11 153.35 32.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 120.977 0.418 . . . . 0.19 110.448 -177.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.487 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -123.91 131.69 72.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.826 -0.625 . . . . 0.16 109.904 178.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.22 111.07 8.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.038 -0.528 . . . . 0.12 111.476 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.651 HD11 HG23 ' A' ' 100' ' ' ILE . 4.0 mp -84.22 118.98 32.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.053 -1.092 . . . . 0.18 108.053 172.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.433 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.8 t30 -121.94 123.23 41.19 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.909 -0.404 . . . . 1.12 109.909 -178.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.481 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 15.8 mt-10 -108.51 83.22 1.74 Allowed 'General case' 0 N--CA 1.426 -1.635 0 C-N-CA 117.113 -1.835 . . . . 0.74 107.541 164.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.433 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 13.3 t70 -121.49 -10.2 8.88 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 106.38 -1.711 . . . . 0.59 106.38 157.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 23' ' ' SER . 14.6 p -102.15 175.98 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 111.933 -2.394 . . . . 0.35 111.791 -157.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.705 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -54.51 167.29 0.6 Allowed Pre-proline 0 C--O 1.223 -0.291 0 N-CA-C 106.464 -1.68 . . . . 1.31 106.464 166.354 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.423 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 11.6 Cg_endo -42.05 128.29 4.09 Favored 'Trans proline' 0 C--N 1.357 1.002 0 CA-C-N 122.062 1.772 . . . . 0.22 111.309 -153.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.655 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -30.0 133.73 0.05 Allowed 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 125.384 1.678 . . . . 0.2 114.189 -157.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.636 ' HB2' HG11 ' A' ' 22' ' ' VAL . 28.2 mt-10 -124.27 140.34 53.05 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 114.791 -1.095 . . . . 1.26 111.302 -171.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.764 ' HB3' HG12 ' A' ' 40' ' ' VAL . 1.8 tt -100.1 142.9 30.95 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 106.579 -1.638 . . . . 0.15 106.579 174.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.546 ' N ' HD23 ' A' ' 27' ' ' LEU . 3.0 m -129.39 107.76 9.76 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.04 -0.664 . . . . 0.21 109.827 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.59 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.4 t90 -91.61 113.27 25.49 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.875 -0.787 . . . . 0.24 108.875 176.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -121.01 124.21 44.3 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.527 -0.76 . . . . 0.87 109.465 -176.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.432 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 29.8 m -56.01 141.18 40.86 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.801 -0.444 . . . . 0.75 109.801 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.662 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 22.8 m -55.29 -34.16 63.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.817 -0.629 . . . . 0.39 110.554 -178.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -87.09 -3.28 59.06 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.468 -0.787 . . . . 2.33 111.242 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.99 19.66 72.13 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.237 -0.506 . . . . 0.55 112.73 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -71.79 -74.58 0.15 Allowed 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 111.973 0.36 . . . . 1.13 111.973 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.435 ' HD3' HG11 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -116.59 153.39 32.33 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.946 0.403 . . . . 2.03 111.036 -177.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 59.7 t -132.36 130.16 59.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.216 -0.447 . . . . 0.55 110.641 -176.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -122.62 109.67 14.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.645 0.26 . . . . 0.69 110.676 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 7.0 m -94.99 138.64 32.44 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.613 -0.514 . . . . 0.3 109.613 175.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.764 HG12 ' HB3' ' A' ' 27' ' ' LEU . 8.9 p -128.54 139.12 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 120.569 -0.452 . . . . 0.66 111.774 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.572 ' O ' HG12 ' A' ' 45' ' ' ILE . 45.0 t -90.02 110.88 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-O 121.377 0.608 . . . . 0.18 110.389 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.651 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.4 mm? -54.1 -28.87 42.18 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.872 -1.058 . . . . 0.12 112.633 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.423 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 66.5 m -77.34 -34.28 55.26 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.67 -0.412 . . . . 1.06 111.28 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.492 ' OG1' ' HB ' ' A' ' 41' ' ' VAL . 65.9 p -75.26 -12.14 60.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.525 0.678 . . . . 0.2 109.465 173.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.633 HG21 HD22 ' A' ' 62' ' ' LEU . 40.9 mm -81.58 123.1 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 114.963 -1.017 . . . . 0.23 110.691 170.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.478 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 35.6 t70 -74.71 -48.85 23.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.751 -0.659 . . . . 0.7 110.982 176.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' HG13 ' A' ' 63' ' ' ILE . 49.2 mmtm -142.07 165.06 28.48 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.194 -0.457 . . . . 1.95 110.172 -177.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.054 HD23 ' HG3' ' A' ' 105' ' ' GLN . 10.5 tp -126.09 142.96 51.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.422 0.63 . . . . 0.14 109.386 170.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.421 ' CG ' HD11 ' A' ' 63' ' ' ILE . 12.4 mm100 -117.3 157.46 26.05 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.919 -1.037 . . . . 1.49 109.144 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -161.63 155.38 21.72 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.812 -1.181 . . . . 0.25 107.812 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 20.6 p -57.87 119.91 37.78 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 121.453 0.644 . . . . 0.37 111.053 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.594 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 63.5 Cg_endo -72.52 169.11 22.59 Favored 'Trans proline' 0 C--N 1.33 -0.439 0 C-N-CA 124.73 3.62 . . . . 0.64 111.699 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.4 -26.35 52.95 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.003 0.43 . . . . 1.02 110.287 172.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.0 m -69.26 -25.7 64.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.047 -0.524 . . . . 1.58 110.705 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 22.7 t -87.87 142.91 27.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.942 -0.572 . . . . 0.71 109.603 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -94.74 -7.29 41.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.15 0.5 . . . . 2.89 110.57 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -102.75 -173.2 2.27 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.717 -0.674 . . . . 2.59 111.094 -172.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.51 ' HB3' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -130.35 112.43 13.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.818 -0.628 . . . . 1.78 110.046 175.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.559 ' CG ' ' HA ' ' A' ' 90' ' ' SER . 2.2 mtm -157.72 141.83 16.01 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 111.71 0.263 . . . . 1.3 111.71 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.923 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 2.8 mp -109.74 162.63 14.27 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.953 0.406 . . . . 0.14 111.151 171.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.514 ' HG2' ' CB ' ' A' ' 88' ' ' MET . 0.0 OUTLIER -154.16 112.64 3.6 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.818 -0.628 . . . . 2.72 109.572 177.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.71 ' HG ' HD13 ' A' ' 48' ' ' LEU . 8.4 mt -95.7 117.28 30.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.3 0.571 . . . . 0.9 110.948 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.548 HG23 ' HG2' ' A' ' 86' ' ' ARG . 7.9 mm -87.67 102.95 13.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.412 -0.813 . . . . 0.4 110.704 -174.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -73.74 145.15 34.98 Favored Glycine 0 C--N 1.321 -0.268 0 C-N-CA 119.949 -1.12 . . . . 0.48 110.858 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.478 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 1.6 mptm? -54.5 135.28 46.02 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.382 0.611 . . . . 1.15 111.761 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 114.885 -1.052 . . . . 0.69 110.156 176.987 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.196 0 CA-C-O 121.296 0.569 . . . . 1.78 110.158 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.548 ' HG2' HG23 ' A' ' 63' ' ' ILE . 25.3 mtt180 -119.31 162.33 18.93 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.89 -0.595 . . . . 2.29 111.363 -169.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -124.78 115.24 20.37 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.887 -0.597 . . . . 0.5 110.242 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.514 ' CB ' ' HG2' ' A' ' 61' ' ' ARG . 59.6 ttm -107.07 129.22 54.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.811 -0.177 . . . . 0.42 111.111 -173.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.58 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -119.62 140.43 50.61 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.613 -0.884 . . . . 1.33 108.613 173.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.559 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 52.6 m -100.31 126.64 46.66 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.115 0.483 . . . . 0.94 109.768 177.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.923 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 18.8 m-85 -106.55 160.45 15.42 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.792 -0.64 . . . . 1.33 110.649 -173.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -101.99 -6.94 22.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.281 -0.418 . . . . 1.53 110.577 -171.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -148.32 131.27 16.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.358 0.599 . . . . 0.83 110.918 -175.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.51 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 9.2 tpt180 -60.88 -31.47 70.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.697 -1.138 . . . . 2.16 111.269 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 94.4 m -73.15 -57.88 3.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.806 0.336 . . . . 0.4 110.356 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 68.1 t -46.67 -52.67 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.994 -0.548 . . . . 0.29 111.716 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.476 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -66.71 -28.33 68.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.198 -0.455 . . . . 0.29 110.438 -178.203 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.93 -29.96 69.15 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.181 -0.674 . . . . 0.39 109.181 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.628 ' O ' ' HG3' ' A' ' 102' ' ' MET . 55.8 m-80 -77.37 -50.03 13.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.988 -1.005 . . . . 1.55 110.083 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.651 HG23 HD11 ' A' ' 18' ' ' ILE . 40.5 mm -56.71 -50.76 73.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.314 -0.857 . . . . 0.13 110.304 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.711 ' HA ' HD21 ' A' ' 48' ' ' LEU . 7.2 ttpp -55.31 -50.78 68.71 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.735 -0.666 . . . . 1.11 111.046 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.628 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.3 ppp? -69.35 -20.95 63.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.118 -0.492 . . . . 1.17 110.646 -174.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.424 HG23 ' CE1' ' A' ' 3' ' ' HIS . 52.7 m -70.98 -56.74 5.55 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.337 0.589 . . . . 0.15 110.093 174.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.923 ' HB2' HD22 ' A' ' 48' ' ' LEU . 13.8 mt -61.2 -55.75 28.6 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.009 -0.996 . . . . 0.13 110.587 -176.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 1.054 ' HG3' HD23 ' A' ' 48' ' ' LEU . 75.3 mt-30 -53.61 -26.46 22.0 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.852 0.686 . . . . 1.45 112.852 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -65.93 -30.87 71.52 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 122.057 0.932 . . . . 0.65 108.933 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.655 HG21 ' HB3' ' A' ' 25' ' ' ALA . 30.1 mt -82.7 -43.81 18.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 113.678 -1.601 . . . . 0.17 110.232 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.1 mt -68.81 -47.12 77.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.546 -0.752 . . . . 0.29 111.174 -175.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.8 m -61.03 -27.61 68.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.581 0.705 . . . . 1.22 109.42 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.54 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 17.0 ttt180 -67.91 -34.18 76.13 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.598 -1.183 . . . . 3.79 109.732 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 . . . . . 0 N--CA 1.446 -0.632 0 CA-C-N 115.992 -0.549 . . . . 0.6 111.435 -178.67 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 261' ' ' PHE . . . . . 0.594 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 1.1 m-85 . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 110.055 -0.35 . . . . 0.95 110.055 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . 0.49 ' CG1' ' HB3' ' A' ' 52' ' ' PRO . 13.0 p -144.5 165.72 12.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.882 -0.599 . . . . 1.37 109.452 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 263' ' ' GLU . . . . . 0.432 ' N ' HG22 ' B' ' 262' ' ' VAL . 14.1 tt0 . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 108.279 -1.008 . . . . 2.24 108.279 172.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.509 ' HA ' HG21 ' A' ' 103' ' ' THR . 28.8 m80 . . . . . 0 C--O 1.22 -0.498 0 N-CA-C 112.45 0.537 . . . . 1.85 112.45 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 77.1 p -163.86 137.99 5.72 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.736 0.303 . . . . 0.95 110.249 177.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.19 151.38 10.57 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.431 -1.067 . . . . 0.16 110.431 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.717 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.94 138.16 40.81 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.336 0.568 . . . . 0.43 111.598 -175.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.21 157.1 43.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.13 110.844 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 2.3 mp -91.27 127.06 43.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.185 -0.672 . . . . 0.29 109.185 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.579 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 79.2 t80 -138.51 118.42 13.31 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.845 -0.428 . . . . 0.56 109.845 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 70.49 41.56 0.96 Allowed 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 123.851 0.719 . . . . 1.46 110.494 -176.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? 70.27 9.34 6.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.356 -1.293 . . . . 1.91 111.956 173.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.29 135.59 58.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.745 0.307 . . . . 0.47 110.524 176.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.5 ' HA ' HG13 ' A' ' 8' ' ' ILE . 48.5 t -76.95 120.57 22.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.089 0.471 . . . . 1.02 110.268 176.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.626 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -141.85 -154.44 6.17 Favored Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 115.766 -0.652 . . . . 0.16 112.004 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.717 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.3 mm -126.89 153.4 35.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 121.052 0.453 . . . . 0.19 110.676 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 4' ' ' SER . 0.1 OUTLIER -122.33 133.68 67.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 115.656 -0.702 . . . . 0.16 109.789 178.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.34 108.78 7.37 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.02 0.438 . . . . 0.12 111.607 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.661 HD11 HG23 ' A' ' 100' ' ' ILE . 4.0 mp -85.62 113.31 23.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.302 -0.999 . . . . 0.18 108.302 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.7 t30 -116.58 122.66 45.29 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.649 -0.5 . . . . 1.12 109.649 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.441 ' HG2' ' HB1' ' A' ' 25' ' ' ALA . 8.6 mt-10 -108.17 82.86 1.69 Allowed 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 117.144 -1.823 . . . . 0.74 107.38 165.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.431 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 23.1 t70 -122.71 -8.6 8.45 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.6 -1.63 . . . . 0.59 106.6 157.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 23' ' ' SER . 14.6 p -101.59 174.2 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 112.182 -2.281 . . . . 0.35 111.707 -158.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.672 ' O ' HG13 ' A' ' 22' ' ' VAL . 11.3 p -54.7 165.67 0.89 Allowed Pre-proline 0 N--CA 1.455 -0.176 0 N-CA-C 107.094 -1.447 . . . . 1.31 107.094 166.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.617 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 11.0 Cg_endo -41.85 126.91 3.52 Favored 'Trans proline' 0 C--N 1.358 1.07 0 CA-C-N 122.037 1.763 . . . . 0.22 111.57 -147.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.684 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -30.29 132.41 0.07 Allowed 'General case' 0 CA--C 1.508 -0.637 0 O-C-N 125.391 1.682 . . . . 0.2 113.596 -158.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.607 ' HB2' HG11 ' A' ' 22' ' ' VAL . 36.4 mt-10 -127.47 140.42 52.16 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.697 -1.138 . . . . 1.26 111.525 -167.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.558 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.5 tt -101.36 144.62 29.95 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.101 -1.444 . . . . 0.15 107.101 175.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.462 ' N ' HD23 ' A' ' 27' ' ' LEU . 18.5 m -132.23 109.19 9.74 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.954 -0.698 . . . . 0.21 110.223 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.579 ' CE2' ' HB3' ' A' ' 9' ' ' PHE . 87.2 t90 -87.04 115.32 24.35 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.723 -0.843 . . . . 0.24 108.723 175.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -121.98 123.41 41.59 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.068 -0.969 . . . . 0.87 108.984 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.427 ' OG ' ' HB3' ' A' ' 36' ' ' LYS . 22.1 m -54.91 144.09 24.02 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.179 -0.304 . . . . 0.75 110.179 -177.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.626 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 19.4 m -55.23 -26.22 38.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.649 -0.705 . . . . 0.39 110.735 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -81.62 -27.5 34.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.887 -0.597 . . . . 2.33 111.196 175.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.99 22.28 18.19 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.708 -0.758 . . . . 0.55 112.849 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -97.51 -72.26 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.082 0.467 . . . . 1.13 110.775 -173.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.427 ' HB3' ' OG ' ' A' ' 31' ' ' SER . 18.7 ttmm -82.53 129.97 35.02 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.497 -0.774 . . . . 2.03 110.345 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 94.2 t -133.33 125.4 50.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.244 -0.435 . . . . 0.55 109.901 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -131.75 121.88 24.93 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.48 -0.327 . . . . 0.69 110.602 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 27' ' ' LEU . 31.4 m -104.38 142.07 35.23 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.683 0.278 . . . . 0.3 111.276 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 31.0 t -116.27 129.01 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 122.696 0.398 . . . . 0.66 111.167 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 45' ' ' ILE . 37.3 t -90.65 108.33 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.244 0.545 . . . . 0.18 109.663 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.598 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -55.26 -29.0 57.19 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.108 -0.951 . . . . 0.12 112.329 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 41.2 t -74.52 -30.44 61.79 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.425 -0.51 . . . . 1.06 110.738 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.6 p -80.07 -11.71 59.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.304 0.573 . . . . 0.2 109.532 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.623 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 39.1 mm -85.97 125.82 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.251 -0.886 . . . . 0.23 110.982 173.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.684 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 24.2 t70 -84.27 -38.95 19.82 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.14 -0.482 . . . . 0.7 111.217 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -143.89 153.59 42.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.927 -0.578 . . . . 1.95 110.053 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.025 HD22 ' HB2' ' A' ' 104' ' ' LEU . 10.7 tp -120.71 144.23 48.34 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.051 -0.722 . . . . 0.14 109.051 168.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.556 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 15.4 mm100 -118.63 157.59 27.1 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.016 -0.993 . . . . 1.49 109.639 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -161.58 141.39 10.35 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.134 -0.939 . . . . 0.25 108.652 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.521 ' HB ' ' CB ' ' A' ' 55' ' ' SER . 38.2 p -47.98 131.83 11.93 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 123.393 0.433 . . . . 0.37 110.877 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.433 ' O ' ' HB3' ' A' ' 55' ' ' SER . 46.7 Cg_endo -66.48 164.94 26.72 Favored 'Trans proline' 0 C--N 1.329 -0.465 0 C-N-CA 123.548 2.832 . . . . 0.64 111.536 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.56 -14.21 60.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.953 0.406 . . . . 1.02 111.027 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 56.5 m -84.59 -23.28 29.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.953 -0.567 . . . . 1.58 110.789 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.521 ' CB ' ' HB ' ' A' ' 51' ' ' THR . 29.3 t -62.33 137.3 58.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.716 -0.674 . . . . 0.71 110.587 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -83.28 -11.94 57.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.384 0.611 . . . . 2.89 110.076 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -109.07 171.58 7.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.237 -0.892 . . . . 2.59 109.485 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.603 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.2 OUTLIER -129.9 112.36 13.47 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.815 -1.18 . . . . 1.78 107.815 -178.297 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.617 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 2.4 mtm -155.75 140.96 17.52 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 119.936 -0.706 . . . . 1.3 112.237 -171.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.812 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 3.2 mp -109.43 161.08 15.65 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.684 -0.689 . . . . 0.14 110.897 170.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.556 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 7.9 ttm180 -154.57 113.85 3.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.67 -0.695 . . . . 2.72 110.273 174.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.746 ' HG ' HD13 ' A' ' 48' ' ' LEU . 10.0 mt -93.67 114.5 26.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.285 0.564 . . . . 0.9 111.249 -177.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.751 HG23 ' HG2' ' A' ' 86' ' ' ARG . 5.9 mm -87.55 108.95 18.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 123.813 0.845 . . . . 0.4 110.567 -173.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.623 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -80.45 141.4 22.89 Favored Glycine 0 C--O 1.227 -0.308 0 C-N-CA 120.286 -0.959 . . . . 0.48 112.048 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.684 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 0.5 OUTLIER -55.69 131.04 45.56 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 117.05 0.425 . . . . 1.15 110.269 179.239 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 C--N 1.319 -0.749 0 CA-C-N 115.899 -0.592 . . . . 0.69 109.718 178.577 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.355 0 CA-C-O 121.842 0.83 . . . . 1.78 110.203 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.751 ' HG2' HG23 ' A' ' 63' ' ' ILE . 34.5 mtt180 -112.26 147.43 36.28 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.136 -0.938 . . . . 2.29 110.112 -174.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -108.57 112.66 25.13 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.596 -0.52 . . . . 0.5 109.596 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 44.7 ttm -107.06 130.71 54.63 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 121.206 -0.198 . . . . 0.42 111.449 -174.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.607 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -121.01 141.91 50.3 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.632 -0.877 . . . . 1.33 108.632 173.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.589 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 54.8 m -101.35 124.01 46.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.142 0.496 . . . . 0.94 110.43 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.812 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 5.7 m-85 -107.96 145.79 33.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.657 -0.702 . . . . 1.33 110.244 -175.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -100.17 -2.32 34.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.086 0.47 . . . . 1.53 110.639 -174.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -131.93 124.73 30.02 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.943 -0.572 . . . . 0.83 110.479 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.414 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 28.3 tpt180 -57.36 -35.32 69.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.237 -0.892 . . . . 2.16 111.015 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.545 HG22 HD21 ' A' ' 99' ' ' ASN . 91.6 m -71.78 -56.66 5.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.815 -0.63 . . . . 0.4 110.685 -176.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 85.0 t -45.8 -54.73 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 115.776 -0.647 . . . . 0.29 111.392 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.603 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -64.89 -29.22 70.16 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.678 -0.409 . . . . 0.29 110.955 -177.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.409 ' O ' ' HE3' ' A' ' 101' ' ' LYS . 29.5 t70 -71.04 -30.88 67.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.679 0.752 . . . . 0.39 109.22 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.614 ' O ' ' HG3' ' A' ' 102' ' ' MET . 90.0 m-20 -78.26 -48.68 15.22 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.627 -1.17 . . . . 1.55 109.967 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.661 HG23 HD11 ' A' ' 18' ' ' ILE . 41.3 mm -58.51 -50.37 79.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.232 -0.894 . . . . 0.13 110.49 177.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.797 ' HA ' HD21 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -56.36 -48.7 76.28 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.161 -0.472 . . . . 1.11 111.023 178.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.614 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.1 ppp? -69.28 -23.36 63.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.146 0.498 . . . . 1.17 110.159 -175.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.509 HG21 ' HA ' ' A' ' 3' ' ' HIS . 54.9 m -67.64 -52.32 39.56 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.603 -0.726 . . . . 0.15 110.057 175.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.025 ' HB2' HD22 ' A' ' 48' ' ' LEU . 12.6 mt -70.87 -57.65 4.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.157 -0.929 . . . . 0.13 111.585 -173.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 1.008 ' HG3' HD23 ' A' ' 48' ' ' LEU . 45.2 mt-30 -50.78 -28.22 8.84 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.679 0.622 . . . . 1.45 112.679 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -65.02 -45.84 83.84 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.788 -0.819 . . . . 0.65 108.788 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.684 HG21 ' HB3' ' A' ' 25' ' ' ALA . 72.0 mt -63.21 -43.8 98.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.029 -1.441 . . . . 0.17 110.93 176.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.2 mt -62.4 -61.2 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.522 -0.763 . . . . 0.29 111.112 -174.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.7 m -52.99 -28.14 22.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.99 0.424 . . . . 1.22 111.261 173.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -71.98 -35.58 69.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.184 0.516 . . . . 3.79 110.665 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' A' ' 24' ' ' PRO . 12.8 m-85 . . . . . 0 C--N 1.323 -0.587 0 CA-C-N 115.752 -0.658 . . . . 0.6 112.208 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 261' ' ' PHE . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 5.7 m-30 . . . . . 0 N--CA 1.456 -0.173 0 N-CA-C 109.439 -0.578 . . . . 0.95 109.439 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 27.9 m -136.09 169.53 20.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.564 -0.532 . . . . 1.37 109.564 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 263' ' ' GLU . . . . . 0.509 ' HA ' HE22 ' A' ' 105' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.648 0 C-N-CA 120.503 -0.479 . . . . 2.24 110.715 173.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.585 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.161 0 CA-C-O 120.857 0.36 . . . . 1.85 111.392 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.0 m -160.75 149.54 16.64 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.395 -0.594 . . . . 0.95 109.395 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.23 150.07 7.67 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.561 -1.016 . . . . 0.16 110.561 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.735 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -76.62 139.29 40.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 117.49 0.645 . . . . 0.43 111.416 -175.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.79 158.05 43.88 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.216 0.531 . . . . 0.13 111.119 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.567 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.1 mp -99.55 129.7 49.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.284 -0.636 . . . . 0.29 109.284 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.586 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 85.3 t80 -138.56 116.0 11.24 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.263 -0.426 . . . . 0.56 109.941 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 67.56 42.65 2.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.436 0.636 . . . . 1.46 110.739 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt 68.99 10.51 7.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.327 -1.306 . . . . 1.91 112.484 173.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -113.53 132.24 63.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.996 0.427 . . . . 0.47 110.311 173.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.567 ' HA ' HG13 ' A' ' 8' ' ' ILE . 32.6 t -77.75 117.68 19.37 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.833 -0.621 . . . . 1.02 109.952 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.661 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -137.23 -157.33 7.58 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.928 -0.653 . . . . 0.16 112.141 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.735 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 9.3 mm -127.04 153.42 36.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 120.827 0.346 . . . . 0.19 110.795 -176.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.466 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -123.95 132.8 70.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 115.883 -0.599 . . . . 0.16 109.675 179.022 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.93 109.54 7.47 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.109 0.411 . . . . 0.12 112.109 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.62 HD11 HG23 ' A' ' 100' ' ' ILE . 4.0 mp -85.38 103.43 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.001 -0.74 . . . . 0.18 109.001 171.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.453 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -110.44 129.6 55.74 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.724 -0.39 . . . . 1.12 110.202 -179.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -107.78 84.19 1.92 Allowed 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 116.811 -1.956 . . . . 0.74 107.345 164.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.453 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 17.2 t70 -121.77 -10.72 8.69 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 106.568 -1.641 . . . . 0.59 106.568 156.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.712 HG11 ' HB2' ' A' ' 26' ' ' GLU . 13.6 p -101.56 179.35 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 111.946 -2.388 . . . . 0.35 111.19 -157.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.643 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -52.44 167.2 0.38 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 117.974 -1.012 . . . . 1.31 108.338 168.019 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.582 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 15.8 Cg_endo -44.36 126.17 6.47 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.494 1.463 . . . . 0.22 111.525 -156.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.598 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -25.67 132.76 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.99 1.431 . . . . 0.2 114.725 -151.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.712 ' HB2' HG11 ' A' ' 22' ' ' VAL . 39.7 mt-10 -124.99 139.46 53.8 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.201 -0.909 . . . . 1.26 110.929 -172.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.577 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.1 tt -101.31 143.28 31.55 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 106.831 -1.544 . . . . 0.15 106.831 175.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.402 ' N ' HD23 ' A' ' 27' ' ' LEU . 6.6 m -130.17 108.99 10.46 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.688 -0.805 . . . . 0.21 110.519 -178.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.638 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 89.8 t90 -86.63 113.01 22.15 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.471 0.653 . . . . 0.24 109.417 174.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -120.47 120.78 36.88 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.173 -0.921 . . . . 0.87 109.157 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.46 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 20.1 m -55.9 141.35 39.55 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.771 -0.455 . . . . 0.75 109.771 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.661 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 28.8 m -54.15 -31.84 53.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.31 -0.859 . . . . 0.39 111.018 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -89.6 -9.21 50.6 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.236 -0.438 . . . . 2.33 111.599 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.01 18.8 57.29 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.979 -0.629 . . . . 0.55 112.553 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -72.46 -68.38 0.48 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.338 . . . . 1.13 111.527 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -110.0 152.29 26.09 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.217 0.532 . . . . 2.03 111.626 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 85.2 t -138.06 117.74 15.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.283 -0.871 . . . . 0.55 109.877 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -123.74 113.66 18.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.191 -0.459 . . . . 0.69 110.148 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.7 m -100.69 143.72 30.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.664 -0.243 . . . . 0.3 111.027 -175.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.592 HG11 HD13 ' A' ' 62' ' ' LEU . 43.1 t -117.69 128.24 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 111.797 0.295 . . . . 0.66 111.797 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 45' ' ' ILE . 33.3 t -90.63 107.93 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.279 0.561 . . . . 0.18 109.61 173.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.608 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.9 mm? -54.44 -29.83 50.78 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.806 -1.088 . . . . 0.12 112.565 -177.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.582 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 72.5 m -74.4 -34.77 63.38 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.514 -0.475 . . . . 1.06 111.46 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -74.62 -16.51 60.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.483 0.658 . . . . 0.2 109.468 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.589 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 43.3 mm -75.44 118.3 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 115.156 -0.929 . . . . 0.23 111.551 175.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.618 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 11.1 t70 -74.74 -49.59 20.5 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.423 -0.808 . . . . 0.7 111.237 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -134.09 150.92 51.19 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 116.765 -0.198 . . . . 1.95 110.58 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.92 HD22 ' HB2' ' A' ' 104' ' ' LEU . 12.3 tp -115.92 143.18 45.79 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.985 -0.746 . . . . 0.14 108.985 164.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.55 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 7.2 mt-30 -124.24 152.19 43.26 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.09 -0.959 . . . . 1.49 109.603 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.03 143.3 10.8 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.737 -0.838 . . . . 0.25 108.737 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 40.9 p -47.48 127.09 10.2 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-O 121.565 0.698 . . . . 0.37 111.025 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 61.4 Cg_endo -70.17 166.68 27.3 Favored 'Trans proline' 0 C--N 1.33 -0.402 0 C-N-CA 124.152 3.235 . . . . 0.64 112.015 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.85 -29.51 59.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.903 0.382 . . . . 1.02 110.896 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.4 m -69.62 -25.59 64.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.96 -0.563 . . . . 1.58 111.156 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.483 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 37.6 t -74.78 137.31 41.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.974 -0.557 . . . . 0.71 110.09 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -91.54 -0.07 57.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.669 0.747 . . . . 2.89 109.582 175.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.3 mmmt -107.98 176.55 5.1 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.946 -1.024 . . . . 2.59 109.985 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.555 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -137.15 109.48 7.34 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.108 -0.701 . . . . 1.78 109.108 -178.166 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.603 ' HG2' ' HA ' ' A' ' 90' ' ' SER . 68.0 mtm -157.09 140.71 15.89 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.478 0.18 . . . . 1.3 111.102 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.871 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 1.4 mp -110.15 160.05 16.82 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.23 -0.441 . . . . 0.14 111.074 174.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 21.8 ttt180 -153.31 114.88 4.23 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 121.208 0.528 . . . . 2.72 111.456 169.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.748 ' HG ' HD13 ' A' ' 48' ' ' LEU . 8.9 mt -92.86 110.19 21.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.864 -0.607 . . . . 0.9 110.813 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.579 HG23 ' HB3' ' A' ' 86' ' ' ARG . 3.9 mm -87.55 126.28 41.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 123.111 0.564 . . . . 0.4 110.456 -176.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -87.6 152.28 23.98 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.33 -0.938 . . . . 0.48 111.019 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.618 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 10.2 mptt -59.01 136.06 57.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.01 0.405 . . . . 1.15 110.394 178.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 115.774 -0.648 . . . . 0.69 109.743 177.913 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 . . . . . 0 N--CA 1.449 -0.515 0 N-CA-C 108.825 -0.805 . . . . 1.78 108.825 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.579 ' HB3' HG23 ' A' ' 63' ' ' ILE . 9.6 ptt180 -156.55 160.03 39.1 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.962 -0.563 . . . . 2.29 111.669 -166.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -120.29 111.44 17.78 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.594 -0.73 . . . . 0.5 110.058 -172.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 49.2 ttm -107.51 126.92 53.13 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.501 -0.124 . . . . 0.42 110.914 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.442 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 50.7 m-85 -116.19 143.72 45.13 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.647 -0.872 . . . . 1.33 108.647 174.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.603 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 14.9 m -99.11 123.7 43.6 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.974 0.416 . . . . 0.94 110.197 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.871 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 7.5 m-85 -108.52 157.17 18.71 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.064 -0.517 . . . . 1.33 110.246 -176.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -113.67 -6.34 13.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.904 0.383 . . . . 1.53 111.239 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -128.3 124.33 36.25 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.2 0.524 . . . . 0.83 110.145 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.436 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 29.8 tpt180 -57.24 -36.75 71.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.961 -1.018 . . . . 2.16 111.175 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.442 HG22 HD21 ' A' ' 99' ' ' ASN . 85.2 m -74.04 -55.42 6.14 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.7 -0.682 . . . . 0.4 110.83 -176.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 100' ' ' ILE . 88.4 t -46.05 -55.21 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.29 111.352 175.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.555 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -66.88 -28.34 68.24 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.895 -0.322 . . . . 0.29 110.808 -177.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.15 -31.87 70.83 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.049 -0.723 . . . . 0.39 109.049 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.602 ' O ' ' HG3' ' A' ' 102' ' ' MET . 90.7 m-20 -77.78 -46.31 22.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.559 -1.2 . . . . 1.55 109.726 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.62 HG23 HD11 ' A' ' 18' ' ' ILE . 35.4 mm -58.6 -51.54 70.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.104 -0.953 . . . . 0.13 110.393 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.64 ' HA ' HD21 ' A' ' 48' ' ' LEU . 4.1 ttpt -57.01 -51.39 69.46 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.886 -0.597 . . . . 1.11 110.429 178.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.602 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.3 ppp? -64.94 -25.18 67.77 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.903 0.383 . . . . 1.17 110.716 -175.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.412 HG21 ' HB ' ' A' ' 18' ' ' ILE . 35.7 m -66.02 -51.62 56.65 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.452 0.644 . . . . 0.15 110.128 175.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.92 ' HB2' HD22 ' A' ' 48' ' ' LEU . 8.7 mt -70.09 -55.95 8.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.88 -1.055 . . . . 0.13 110.927 -175.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.763 ' HG2' HD23 ' A' ' 48' ' ' LEU . 18.7 mm-40 -42.92 -36.15 1.43 Allowed 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.694 0.621 . . . . 1.45 112.664 177.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -65.42 -32.97 74.88 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.919 0.866 . . . . 0.65 109.663 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.598 HG21 ' HB3' ' A' ' 25' ' ' ALA . 42.0 mt -79.69 -41.79 22.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.066 -1.424 . . . . 0.17 110.123 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.401 HG13 ' HA ' ' A' ' 105' ' ' GLN . 0.6 OUTLIER -66.63 -51.34 57.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.248 -0.887 . . . . 0.29 110.87 -176.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.6 t -59.41 -29.03 67.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.411 0.624 . . . . 1.22 109.509 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 10.6 ttt180 -66.3 -34.19 77.44 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.043 -0.98 . . . . 3.79 109.949 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 . . . . . 0 N--CA 1.446 -0.653 0 CA-C-N 116.047 -0.524 . . . . 0.6 111.472 -177.676 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 261' ' ' PHE . . . . . 0.55 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 1.5 m-85 . . . . . 0 N--CA 1.455 -0.194 0 N-CA-C 109.419 -0.586 . . . . 0.95 109.419 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.85 161.74 23.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.864 0.364 . . . . 1.37 111.824 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 115.818 -0.628 . . . . 2.24 109.478 175.785 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.438 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 13.9 m80 . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 121.34 0.59 . . . . 1.85 110.077 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.3 p -162.94 151.31 14.14 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.555 -0.748 . . . . 0.95 109.278 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.5 146.98 7.06 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.9 -0.88 . . . . 0.16 110.9 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.743 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -79.39 117.26 20.2 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 117.209 0.505 . . . . 0.43 111.296 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.503 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -125.23 155.95 39.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.349 0.595 . . . . 0.13 111.513 -177.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.501 HG13 ' HA ' ' A' ' 13' ' ' SER . 1.9 mp -96.42 119.59 44.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 108.611 -0.885 . . . . 0.29 108.611 176.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.441 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 93.2 t80 -119.47 102.82 8.93 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.518 -0.31 . . . . 0.56 110.263 -177.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 65.51 55.33 1.04 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.317 0.58 . . . . 1.46 110.939 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt 72.38 -4.81 1.94 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.641 -1.163 . . . . 1.91 113.304 171.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -103.99 130.24 54.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.939 0.399 . . . . 0.47 110.488 172.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.501 ' HA ' HG13 ' A' ' 8' ' ' ILE . 32.4 t -78.43 129.4 34.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.882 -0.599 . . . . 1.02 109.953 177.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.618 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -150.68 -159.84 9.02 Favored Glycine 0 N--CA 1.436 -1.321 0 C-N-CA 120.752 -0.737 . . . . 0.16 112.494 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.743 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 6.4 mm -125.97 153.24 33.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 120.768 0.318 . . . . 0.19 110.583 -177.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.89 135.12 63.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 116.114 -0.494 . . . . 0.16 109.861 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.19 110.57 7.44 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.207 0.447 . . . . 0.12 112.207 176.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.619 HD11 HG23 ' A' ' 100' ' ' ILE . 3.7 mp -86.08 121.44 37.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.667 -0.864 . . . . 0.18 108.667 171.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.742 HD21 ' HB ' ' A' ' 22' ' ' VAL . 0.7 OUTLIER -126.7 134.28 50.72 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.699 -0.482 . . . . 1.12 109.699 179.001 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.512 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 18.0 mt-10 -114.99 83.15 1.86 Allowed 'General case' 0 N--CA 1.425 -1.723 0 C-N-CA 116.513 -2.075 . . . . 0.74 107.663 161.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.447 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 34.1 t70 -121.32 -9.79 9.02 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 106.168 -1.79 . . . . 0.59 106.168 159.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.893 HG11 ' HB3' ' A' ' 26' ' ' GLU . 13.2 p -103.52 173.82 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 111.583 -2.553 . . . . 0.35 111.821 -159.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.697 ' O ' HG13 ' A' ' 22' ' ' VAL . 16.3 m -55.08 166.28 0.85 Allowed Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 106.692 -1.596 . . . . 1.31 106.692 165.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 10.1 Cg_endo -40.55 128.06 2.44 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 121.601 1.608 . . . . 0.22 111.775 -147.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.711 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -28.2 132.78 0.04 OUTLIER 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 125.466 1.729 . . . . 0.2 113.217 -160.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.893 ' HB3' HG11 ' A' ' 22' ' ' VAL . 35.4 tt0 -130.58 132.04 45.32 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 115.229 -0.896 . . . . 1.26 111.244 -161.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.558 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.5 tt -100.83 144.94 29.18 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 106.94 -1.504 . . . . 0.15 106.94 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.505 ' N ' HD23 ' A' ' 27' ' ' LEU . 9.8 m -133.22 108.91 9.07 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.161 -0.616 . . . . 0.21 110.274 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.595 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.3 t90 -89.87 109.8 20.78 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.647 0.737 . . . . 0.24 109.056 176.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 30' ' ' ARG . 13.1 ttt-85 -113.35 121.35 44.09 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.132 -0.94 . . . . 0.87 109.236 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.48 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 88.9 p -57.33 148.02 24.13 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.078 -0.342 . . . . 0.75 110.078 -177.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.618 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 33.4 m -48.42 -38.13 18.85 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.084 0.468 . . . . 0.39 110.618 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -68.32 -28.03 66.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.628 -0.715 . . . . 2.33 111.642 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.74 21.55 46.68 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.034 -0.603 . . . . 0.55 112.068 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -104.91 -37.43 7.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.324 0.583 . . . . 1.13 110.816 -172.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -114.61 120.65 40.9 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.587 -0.733 . . . . 2.03 109.998 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.5 t -123.52 118.91 55.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.992 0.425 . . . . 0.55 110.348 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -119.41 109.96 16.38 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.98 -0.555 . . . . 0.69 110.237 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.9 m -95.69 143.32 27.05 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.471 -0.331 . . . . 0.3 111.448 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.586 HG11 HD13 ' A' ' 62' ' ' LEU . 30.1 t -120.83 124.37 72.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.295 -0.411 . . . . 0.66 111.16 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 45' ' ' ILE . 49.1 t -90.54 107.75 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 109.282 -0.636 . . . . 0.18 109.282 174.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.59 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.4 mm? -51.92 -29.09 18.66 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.957 -1.019 . . . . 0.12 112.67 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.455 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 43.1 t -71.8 -35.59 70.02 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.583 -0.447 . . . . 1.06 110.803 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.2 p -76.36 -13.82 60.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.081 0.467 . . . . 0.2 109.857 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.652 HG21 HD22 ' A' ' 62' ' ' LEU . 46.6 mm -79.84 121.17 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.579 -0.737 . . . . 0.23 111.391 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.638 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 34.0 t70 -81.78 -40.56 22.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.538 0.685 . . . . 0.7 110.881 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.597 ' HB2' ' CG1' ' A' ' 63' ' ' ILE . 46.0 mmtm -136.27 142.34 43.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.103 -0.953 . . . . 1.95 110.932 -172.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.027 HD23 ' HG3' ' A' ' 105' ' ' GLN . 12.7 tp -118.0 138.04 52.46 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.457 0.646 . . . . 0.14 109.302 164.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 14.0 mm100 -119.28 157.19 28.57 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.456 -1.247 . . . . 1.49 109.277 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -160.33 148.92 16.86 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.517 -1.29 . . . . 0.25 107.517 177.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 27.4 p -52.77 126.91 42.43 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 121.377 0.608 . . . . 0.37 111.083 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 50.1 Cg_endo -67.46 165.63 26.5 Favored 'Trans proline' 0 C--N 1.329 -0.461 0 C-N-CA 123.584 2.856 . . . . 0.64 111.068 176.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.34 -23.04 66.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.125 0.488 . . . . 1.02 110.353 176.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.3 m -73.74 -24.91 59.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.679 -0.691 . . . . 1.58 111.346 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.479 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 36.3 t -71.41 145.17 49.49 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.882 -0.414 . . . . 0.71 109.882 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -90.55 -6.05 55.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.272 0.558 . . . . 2.89 109.95 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -111.67 174.44 5.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.201 -0.909 . . . . 2.59 109.997 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.672 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 3.5 mmt -131.38 108.76 9.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.174 -0.676 . . . . 1.78 109.174 176.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.52 ' HG3' ' H ' ' A' ' 91' ' ' PHE . 3.9 mpp? -154.42 168.1 27.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.08 0.467 . . . . 1.3 111.666 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.555 HD23 HD11 ' A' ' 48' ' ' LEU . 1.1 mp -126.52 161.32 28.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.339 -0.846 . . . . 0.14 111.001 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 50.0 ttp180 -153.54 114.38 4.07 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.607 0.241 . . . . 2.72 110.986 169.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.652 HD22 HG21 ' A' ' 45' ' ' ILE . 12.6 mt -94.43 109.33 21.2 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.702 0.401 . . . . 0.9 110.942 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.726 HG23 ' HB3' ' A' ' 86' ' ' ARG . 1.0 OUTLIER -87.4 118.97 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 123.041 0.536 . . . . 0.4 110.081 -176.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -80.87 152.56 33.4 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.98 -1.105 . . . . 0.48 111.369 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.638 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 6.9 mptt -63.63 139.24 58.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.109 0.454 . . . . 1.15 110.306 176.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 C--N 1.318 -0.766 0 N-CA-C 109.007 -0.738 . . . . 0.69 109.007 172.266 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 122.352 1.072 . . . . 1.78 109.553 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.726 ' HB3' HG23 ' A' ' 63' ' ' ILE . 9.2 ptt180 -113.77 146.02 40.52 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.626 -1.17 . . . . 2.29 110.063 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -113.2 111.85 22.78 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.324 -0.853 . . . . 0.5 109.61 -170.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 53.9 ttm -104.43 126.03 51.15 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.237 -0.585 . . . . 0.42 111.395 -176.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.481 ' CE2' HD12 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -115.65 122.36 45.35 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 109.004 -0.739 . . . . 1.33 109.004 178.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.497 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 16.1 m -89.56 124.04 34.18 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.835 -0.621 . . . . 0.94 110.379 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.6 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 30.5 m-85 -107.29 174.15 6.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.042 -0.526 . . . . 1.33 109.753 174.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -122.56 -5.33 8.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.256 -0.429 . . . . 1.53 110.126 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -127.82 135.4 50.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.446 0.641 . . . . 0.83 111.135 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.527 ' N ' ' HG3' ' A' ' 58' ' ' MET . 28.0 tpt180 -65.84 -35.18 79.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.531 -1.213 . . . . 2.16 111.102 -174.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.458 HG22 HD21 ' A' ' 99' ' ' ASN . 94.7 m -76.27 -52.96 8.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.831 -0.622 . . . . 0.4 111.112 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.3 t -45.29 -56.73 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 116.276 -0.42 . . . . 0.29 111.437 175.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.672 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -66.56 -29.25 69.27 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.194 -0.457 . . . . 0.29 110.718 -178.104 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -66.71 -33.47 75.71 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.121 -0.696 . . . . 0.39 109.121 176.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.584 ' O ' ' HG3' ' A' ' 102' ' ' MET . 86.9 m-20 -75.23 -50.9 14.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.651 -1.159 . . . . 1.55 109.808 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.619 HG23 HD11 ' A' ' 18' ' ' ILE . 35.2 mm -56.59 -52.27 55.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.037 -0.983 . . . . 0.13 110.685 177.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.667 ' HA ' HD21 ' A' ' 48' ' ' LEU . 4.9 ttpt -55.82 -49.16 74.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.723 -0.672 . . . . 1.11 111.321 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.584 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.2 ppp? -68.88 -24.15 64.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.847 0.356 . . . . 1.17 110.444 -176.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 55.2 m -67.58 -51.81 46.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.436 0.636 . . . . 0.15 110.027 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.896 ' HB2' HD22 ' A' ' 48' ' ' LEU . 10.6 mt -68.02 -56.39 9.09 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.989 -1.005 . . . . 0.13 111.187 -175.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 1.027 ' HG3' HD23 ' A' ' 48' ' ' LEU . 70.9 mt-30 -46.44 -31.62 2.79 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.207 0.818 . . . . 1.45 113.207 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -68.78 -27.93 66.33 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.048 0.927 . . . . 0.65 109.692 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.711 HG21 ' HB3' ' A' ' 25' ' ' ALA . 64.8 mt -83.58 -43.68 18.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.008 -1.451 . . . . 0.17 110.148 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.414 HG13 ' HA ' ' A' ' 105' ' ' GLN . 0.8 OUTLIER -62.38 -53.56 45.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.975 -1.011 . . . . 0.29 110.28 -177.156 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.8 t -59.05 -28.07 66.1 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.682 -0.69 . . . . 1.22 110.001 176.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.446 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 11.3 ttt180 -69.47 -34.35 74.22 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.202 -0.908 . . . . 3.79 110.051 178.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 . . . . . 0 N--CA 1.446 -0.647 0 CA-C-N 115.527 -0.76 . . . . 0.6 111.319 -178.432 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 261' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 5.9 m-30 . . . . . 0 C--O 1.235 0.313 0 N-CA-C 109.323 -0.621 . . . . 0.95 109.323 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.3 p -134.99 152.83 33.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.162 -0.31 . . . . 1.37 110.162 -177.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 C--N 1.327 -0.408 0 N-CA-C 109.109 -0.7 . . . . 2.24 109.109 172.466 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.2 m170 . . . . . 0 CA--C 1.523 -0.063 0 CA-C-O 121.241 0.544 . . . . 1.85 110.397 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.5 p -163.98 149.06 10.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.639 -0.71 . . . . 0.95 110.034 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.95 143.12 5.66 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 111.119 -0.792 . . . . 0.16 111.119 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.74 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.31 121.72 22.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 117.468 0.634 . . . . 0.43 111.047 -177.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.508 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -131.59 157.22 44.22 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 121.327 0.584 . . . . 0.13 111.697 -176.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 2.5 mp -95.08 114.58 31.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.477 -0.783 . . . . 0.29 109.291 175.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.608 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 74.8 t80 -122.58 111.32 16.65 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.191 -0.459 . . . . 0.56 110.031 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.509 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 40.3 mt-10 71.61 47.35 0.35 Allowed 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 124.072 0.857 . . . . 1.46 110.623 -176.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.509 ' HD2' ' C ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER 65.79 8.97 5.65 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.522 -1.217 . . . . 1.91 112.658 173.664 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.38 135.2 57.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.869 0.366 . . . . 0.47 110.436 174.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.522 ' HA ' HG13 ' A' ' 8' ' ' ILE . 23.7 t -78.25 124.99 28.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.289 0.566 . . . . 1.02 110.219 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.679 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -146.85 -156.7 7.04 Favored Glycine 0 N--CA 1.437 -1.26 0 CA-C-N 115.654 -0.703 . . . . 0.16 112.341 -178.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.74 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.1 mm -126.95 153.8 36.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.799 0.333 . . . . 0.19 110.582 -177.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.437 HD11 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -126.86 133.34 68.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 116.026 -0.534 . . . . 0.16 109.91 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.35 113.13 9.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.34 -0.391 . . . . 0.12 111.618 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.607 HD11 HG23 ' A' ' 100' ' ' ILE . 4.1 mp -84.43 121.76 37.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.002 -1.11 . . . . 0.18 108.002 171.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.459 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 2.1 t30 -126.26 125.84 43.02 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.99 -0.374 . . . . 1.12 109.99 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.485 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 20.8 mt-10 -110.6 83.9 1.84 Allowed 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 116.928 -1.909 . . . . 0.74 107.616 163.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.459 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 13.7 t70 -120.87 -8.74 9.37 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.001 -1.851 . . . . 0.59 106.001 157.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.693 HG13 ' O ' ' A' ' 23' ' ' SER . 14.9 p -102.46 173.76 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 111.75 -2.477 . . . . 0.35 111.982 -158.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.693 ' O ' HG13 ' A' ' 22' ' ' VAL . 4.4 m -54.51 168.1 0.51 Allowed Pre-proline 0 C--O 1.223 -0.319 0 N-CA-C 106.853 -1.536 . . . . 1.31 106.853 165.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 10.2 Cg_endo -40.86 127.81 2.64 Favored 'Trans proline' 0 C--N 1.356 0.938 0 CA-C-N 122.016 1.756 . . . . 0.22 111.239 -152.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.692 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -33.9 136.23 0.12 Allowed 'General case' 0 CA--C 1.504 -0.793 0 O-C-N 125.361 1.663 . . . . 0.2 113.621 -156.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.519 ' HB2' HG11 ' A' ' 22' ' ' VAL . 74.3 mt-10 -124.8 140.29 53.07 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.387 -1.279 . . . . 1.26 111.191 -169.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.578 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.2 tt -101.58 142.41 32.99 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.419 -1.697 . . . . 0.15 106.419 172.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.41 ' N ' HD23 ' A' ' 27' ' ' LEU . 11.1 m -127.33 109.2 11.55 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.782 -0.767 . . . . 0.21 110.254 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.617 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.9 t90 -88.44 106.14 18.07 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.814 -0.81 . . . . 0.24 108.814 175.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -114.17 112.02 22.51 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.759 -1.11 . . . . 0.87 108.745 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.579 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 93.7 p -57.69 146.03 32.27 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.406 0.622 . . . . 0.75 110.85 -174.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.679 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 7.9 m -57.59 -24.51 56.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.707 -1.133 . . . . 0.39 111.236 -175.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -87.92 -27.42 22.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.892 -0.595 . . . . 2.33 111.129 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.78 21.96 27.17 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.715 -0.755 . . . . 0.55 113.443 176.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -110.2 -9.06 14.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.291 0.545 . . . . 1.13 110.833 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -139.92 119.07 12.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.913 -0.585 . . . . 2.03 109.96 -174.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 57.8 t -135.09 124.02 41.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.805 0.336 . . . . 0.55 110.712 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -130.14 122.17 27.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.309 -0.405 . . . . 0.69 110.589 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 24.5 m -102.43 134.93 44.95 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.664 0.268 . . . . 0.3 110.919 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.537 HG11 HD13 ' A' ' 62' ' ' LEU . 42.2 t -106.76 128.06 61.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 122.415 0.286 . . . . 0.66 111.52 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.496 ' O ' HG12 ' A' ' 45' ' ' ILE . 41.1 t -90.09 108.12 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-O 121.465 0.65 . . . . 0.18 109.595 173.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.573 HD11 HD22 ' A' ' 104' ' ' LEU . 1.7 mm? -53.76 -29.96 42.28 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.016 -0.993 . . . . 0.12 112.164 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.427 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 41.4 t -71.75 -35.54 70.15 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.965 -0.294 . . . . 1.06 110.672 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.418 ' OG1' ' HB ' ' A' ' 41' ' ' VAL . 66.8 p -77.1 -14.89 59.74 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 121.104 0.478 . . . . 0.2 110.12 176.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.578 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 41.4 mm -79.46 124.66 37.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.684 -0.689 . . . . 0.23 111.387 175.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.601 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 33.3 t70 -79.36 -48.16 14.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.969 -0.56 . . . . 0.7 110.737 176.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HB2' HG13 ' A' ' 63' ' ' ILE . 70.9 mmtt -135.31 149.26 49.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.728 -0.669 . . . . 1.95 110.543 -177.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.957 HD23 ' HG3' ' A' ' 105' ' ' GLN . 11.6 tp -112.92 145.24 41.1 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.086 -0.709 . . . . 0.14 109.086 164.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.481 ' H ' HD12 ' A' ' 48' ' ' LEU . 13.9 mm100 -122.59 153.34 39.42 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.071 -0.968 . . . . 1.49 109.896 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.69 143.79 10.02 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.451 -0.795 . . . . 0.25 109.491 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 49.4 p -60.7 125.38 82.66 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-O 121.486 0.66 . . . . 0.37 111.065 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 60.6 Cg_endo -70.96 165.94 30.71 Favored 'Trans proline' 0 C--N 1.329 -0.465 0 C-N-CA 123.727 2.951 . . . . 0.64 111.285 175.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.9 -17.61 61.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.215 0.531 . . . . 1.02 110.617 176.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.7 m -77.2 -25.25 51.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.739 -0.664 . . . . 1.58 110.558 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.444 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 46.5 t -72.86 150.94 42.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.653 -0.703 . . . . 0.71 109.69 177.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -95.44 -2.85 48.02 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.586 0.708 . . . . 2.89 109.657 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HB2' HG21 ' A' ' 51' ' ' THR . 20.9 mmmt -107.05 -179.25 3.88 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.824 -1.08 . . . . 2.59 110.414 -175.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.479 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -136.97 110.22 7.83 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.278 -1.008 . . . . 1.78 108.278 169.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.621 ' HB3' ' CZ ' ' B' ' 261' ' ' PHE . 3.1 ttm -156.24 148.77 23.69 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.384 -0.527 . . . . 1.3 111.825 -173.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.524 HD23 HD11 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -117.7 157.22 26.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.437 -0.801 . . . . 0.14 110.479 173.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 62.8 ttp180 -151.58 114.18 4.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.708 0.29 . . . . 2.72 110.756 169.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.706 ' HG ' HD13 ' A' ' 48' ' ' LEU . 10.5 mt -92.3 112.58 24.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.1 0.476 . . . . 0.9 110.61 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.715 HG23 ' HG2' ' A' ' 86' ' ' ARG . 4.4 mm -87.22 113.85 25.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 123.55 0.74 . . . . 0.4 110.95 -175.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -79.41 141.0 23.41 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.122 -1.037 . . . . 0.48 111.579 176.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.601 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 7.2 mptt -54.46 134.28 45.95 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.964 0.382 . . . . 1.15 110.983 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--N 1.321 -0.665 0 N-CA-C 109.58 -0.526 . . . . 0.69 109.58 177.506 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.232 0 CA-C-O 121.442 0.639 . . . . 1.78 110.03 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.715 ' HG2' HG23 ' A' ' 63' ' ' ILE . 13.6 mtm180 -117.1 146.47 43.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.613 -0.721 . . . . 2.29 110.217 -172.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -111.13 111.98 23.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.58 -0.736 . . . . 0.5 109.414 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.541 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 50.4 ttm -106.64 129.51 54.54 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.049 0.452 . . . . 0.42 111.372 -176.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.437 ' CG ' HD11 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -120.03 122.68 41.65 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.719 -0.673 . . . . 1.33 109.338 178.028 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.556 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 20.3 m -88.74 128.23 35.62 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.022 -0.536 . . . . 0.94 110.45 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.594 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 27.8 m-85 -107.82 173.61 6.24 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.879 -0.6 . . . . 1.33 110.629 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -119.05 -0.05 11.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.704 -0.68 . . . . 1.53 110.107 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -141.17 128.47 21.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.926 -0.579 . . . . 0.83 109.96 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.478 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 2.5 tmt_? -69.61 -24.4 63.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.546 . . . . 2.16 110.371 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.43 HG22 HD21 ' A' ' 99' ' ' ASN . 91.2 m -69.4 -57.19 5.59 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.118 -0.327 . . . . 0.4 110.118 177.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 98.2 t -45.62 -56.38 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 115.955 -0.566 . . . . 0.29 111.384 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.476 ' HG2' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -65.02 -28.63 69.63 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 116.021 -0.536 . . . . 0.29 110.882 -177.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.42 -32.47 71.46 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.196 -0.668 . . . . 0.39 109.196 176.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.43 HD21 HG22 ' A' ' 95' ' ' THR . 90.7 m-20 -74.09 -49.25 24.8 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.721 -1.127 . . . . 1.55 109.501 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.607 HG23 HD11 ' A' ' 18' ' ' ILE . 34.1 mm -58.49 -53.07 51.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.945 -1.025 . . . . 0.13 110.427 175.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.705 ' HA ' HD21 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -55.3 -48.85 73.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.335 -0.848 . . . . 1.11 111.344 179.133 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.411 ' N ' ' HE2' ' A' ' 101' ' ' LYS . 12.8 ptt? -68.8 -24.99 64.47 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.63 -0.428 . . . . 1.17 110.191 -175.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 41.6 m -66.59 -49.78 65.23 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.427 0.632 . . . . 0.15 109.922 175.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.932 ' HB2' HD22 ' A' ' 48' ' ' LEU . 12.9 mt -69.94 -57.4 5.07 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.986 -1.006 . . . . 0.13 111.715 -174.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.957 ' HG3' HD23 ' A' ' 48' ' ' LEU . 38.1 mt-30 -51.51 -27.51 10.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.833 0.679 . . . . 1.45 112.833 -178.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -71.29 -30.13 65.89 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.056 0.931 . . . . 0.65 109.472 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.692 HG21 ' HB3' ' A' ' 25' ' ' ALA . 61.6 mt -75.88 -42.78 39.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 114.141 -1.39 . . . . 0.17 109.775 172.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.4 mt -67.39 -43.1 87.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.731 -0.668 . . . . 0.29 110.624 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.3 m -60.61 -29.1 69.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.366 0.603 . . . . 1.22 110.145 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.586 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 12.7 ttt180 -66.76 -30.27 70.44 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.061 -0.972 . . . . 3.79 109.588 175.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.486 ' HD2' ' O ' ' A' ' 107' ' ' ILE . 61.6 m-85 . . . . . 0 N--CA 1.447 -0.576 0 CA-C-N 115.78 -0.646 . . . . 0.6 111.664 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 261' ' ' PHE . . . . . 0.621 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 2.1 m-85 . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 109.854 -0.424 . . . . 0.95 109.854 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 11.8 p -143.37 144.64 23.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.649 -0.251 . . . . 1.37 110.639 175.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 C--O 1.235 0.315 0 N-CA-C 109.05 -0.722 . . . . 2.24 109.05 173.796 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 67.4 m80 . . . . . 0 C--O 1.224 -0.252 0 CA-C-O 120.844 0.354 . . . . 1.85 110.949 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.3 m -160.44 143.25 13.26 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.867 -0.42 . . . . 0.95 109.867 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.29 149.69 8.92 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.414 -1.074 . . . . 0.16 110.414 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.708 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -74.84 140.19 43.73 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 117.539 0.669 . . . . 0.43 111.19 -176.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.76 153.85 38.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.376 0.608 . . . . 0.13 111.723 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.561 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.0 mp -95.77 117.0 38.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.483 -0.78 . . . . 0.29 109.075 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.578 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 74.9 t80 -117.97 109.46 16.52 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.127 -0.323 . . . . 0.56 110.127 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 66.84 47.51 1.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.641 0.734 . . . . 1.46 110.758 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp 71.26 6.93 5.96 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.143 -1.389 . . . . 1.91 113.024 171.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -114.14 132.93 61.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.782 0.325 . . . . 0.47 110.414 171.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.561 ' HA ' HG13 ' A' ' 8' ' ' ILE . 41.2 t -74.64 134.51 42.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.311 0.577 . . . . 1.02 110.808 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.704 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -155.98 -158.16 8.67 Favored Glycine 0 N--CA 1.434 -1.486 0 CA-C-N 115.431 -0.804 . . . . 0.16 112.237 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.708 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 13.7 mm -124.57 153.56 31.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.053 0.454 . . . . 0.19 110.432 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.9 133.29 69.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.759 -0.655 . . . . 0.16 110.111 179.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.22 109.54 7.85 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.288 -0.414 . . . . 0.12 111.761 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.598 HD11 HG23 ' A' ' 100' ' ' ILE . 3.7 mp -85.51 121.05 36.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.567 -0.901 . . . . 0.18 108.567 172.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.483 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.3 t30 -126.1 128.93 48.12 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 110.249 -0.278 . . . . 1.12 110.249 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.435 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 33.7 mt-10 -110.0 85.3 2.08 Favored 'General case' 0 N--CA 1.425 -1.715 0 C-N-CA 117.022 -1.871 . . . . 0.74 107.632 163.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.483 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 13.1 t70 -120.95 -10.58 9.06 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.287 -1.746 . . . . 0.59 106.287 156.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.688 HG11 ' HB2' ' A' ' 26' ' ' GLU . 14.3 p -102.49 174.76 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 111.66 -2.518 . . . . 0.35 112.192 -156.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.681 ' O ' HG13 ' A' ' 22' ' ' VAL . 1.1 t -54.52 167.63 0.56 Allowed Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 106.417 -1.697 . . . . 1.31 106.417 166.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.47 ' HD2' ' OG ' ' A' ' 23' ' ' SER . 13.0 Cg_endo -42.4 128.9 4.72 Favored 'Trans proline' 0 C--N 1.359 1.123 0 CA-C-N 122.266 1.845 . . . . 0.22 111.121 -152.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.623 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -32.43 135.71 0.08 Allowed 'General case' 0 CA--C 1.508 -0.652 0 O-C-N 125.242 1.589 . . . . 0.2 114.01 -155.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.688 ' HB2' HG11 ' A' ' 22' ' ' VAL . 29.2 mt-10 -121.7 136.95 54.93 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.579 -1.191 . . . . 1.26 111.213 -170.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.582 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.2 tt -101.29 143.3 31.52 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 106.222 -1.77 . . . . 0.15 106.222 170.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.449 ' N ' HD23 ' A' ' 27' ' ' LEU . 30.0 m -132.51 110.54 10.56 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.868 -0.733 . . . . 0.21 110.134 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.607 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.6 t90 -86.32 106.53 17.45 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.339 -0.846 . . . . 0.24 108.957 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -115.04 114.87 25.95 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.62 -1.173 . . . . 0.87 108.695 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.574 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 94.6 p -57.07 153.22 11.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.515 0.674 . . . . 0.75 111.574 -171.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.704 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 14.8 m -58.62 -28.49 65.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.557 -1.201 . . . . 0.39 110.87 -177.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -83.08 -28.6 29.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.085 -0.507 . . . . 2.33 110.555 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.22 17.98 32.72 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.112 -0.566 . . . . 0.55 113.072 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -103.5 -25.62 13.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.928 0.394 . . . . 1.13 111.511 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.1 tttm -117.28 122.07 42.92 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.927 -0.397 . . . . 2.03 109.927 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 84.1 t -132.07 123.01 50.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.849 0.357 . . . . 0.55 110.695 -177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -131.35 120.98 23.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.197 -0.456 . . . . 0.69 110.357 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.478 HG21 ' OE1' ' A' ' 26' ' ' GLU . 35.7 m -101.96 143.52 31.73 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 111.735 0.272 . . . . 0.3 111.735 -175.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 38.7 t -116.61 129.44 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 122.83 0.452 . . . . 0.66 111.333 176.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.552 ' O ' HG12 ' A' ' 45' ' ' ILE . 53.7 t -91.18 107.98 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 121.5 0.667 . . . . 0.18 109.43 172.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.654 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.4 mm? -53.19 -32.82 49.88 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.656 -1.156 . . . . 0.12 112.576 -178.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.466 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 52.7 m -75.92 -28.43 58.0 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.933 -0.307 . . . . 1.06 111.456 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.3 p -80.44 -10.89 59.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.187 0.517 . . . . 0.2 109.832 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 41' ' ' VAL . 36.3 mm -82.29 130.09 36.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.483 -0.78 . . . . 0.23 110.861 174.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.688 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 3.7 t70 -86.44 -41.54 14.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.689 -0.687 . . . . 0.7 111.456 176.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.525 ' HE3' ' OE1' ' B' ' 263' ' ' GLU . 11.1 tptt -140.47 138.5 34.7 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.795 -0.639 . . . . 1.95 110.005 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.092 HD23 ' HG3' ' A' ' 105' ' ' GLN . 13.9 tp -109.29 141.8 41.09 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.053 -0.721 . . . . 0.14 109.053 164.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.491 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 5.8 mt-30 -119.07 154.13 33.66 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.81 -1.086 . . . . 1.49 109.927 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.23 141.61 8.1 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.998 -0.546 . . . . 0.25 110.065 177.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 40.0 p -51.29 127.82 30.44 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-O 121.5 0.667 . . . . 0.37 111.418 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 45.0 Cg_endo -66.89 166.53 22.32 Favored 'Trans proline' 0 C--N 1.334 -0.214 0 C-N-CA 124.107 3.205 . . . . 0.64 112.105 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.407 ' N ' HH21 ' A' ' 94' ' ' ARG . . . -68.5 -11.27 59.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.087 0.47 . . . . 1.02 110.569 176.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.4 t -84.71 -24.64 28.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.999 -0.546 . . . . 1.58 109.753 173.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.574 ' OG ' ' HE3' ' A' ' 57' ' ' LYS . 21.2 t -71.59 146.13 48.59 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.067 -0.716 . . . . 0.71 109.067 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -95.42 -14.57 23.68 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.223 -1.028 . . . . 2.89 108.223 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.574 ' HE3' ' OG ' ' A' ' 55' ' ' SER . 0.0 OUTLIER -88.04 176.02 7.49 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 113.731 -1.577 . . . . 2.59 110.313 -177.213 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.532 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -138.32 109.46 6.83 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.454 -0.573 . . . . 1.78 109.454 173.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.57 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 3.2 mpp? -154.61 141.27 18.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.772 0.32 . . . . 1.3 111.448 -176.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.88 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 2.3 mp -109.16 161.83 14.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.722 -0.672 . . . . 0.14 110.719 170.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.491 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 2.8 ttt180 -154.03 114.36 3.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.239 -0.437 . . . . 2.72 110.925 172.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.797 ' HG ' HD13 ' A' ' 48' ' ' LEU . 11.7 mt -95.89 110.02 22.28 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 122.659 0.384 . . . . 0.9 110.88 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.616 HG23 ' HB3' ' A' ' 86' ' ' ARG . 4.3 mm -86.86 109.68 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.255 -0.43 . . . . 0.4 111.062 -174.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -74.97 143.23 30.71 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.136 -1.03 . . . . 0.48 110.956 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.688 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 6.2 mttm -64.13 134.65 55.29 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.545 0.688 . . . . 1.15 112.198 -175.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 C--N 1.316 -0.882 0 CA-C-N 114.738 -1.119 . . . . 0.69 108.551 174.036 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.284 0 CA-C-O 121.648 0.737 . . . . 1.78 110.192 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.616 ' HB3' HG23 ' A' ' 63' ' ' ILE . 26.2 ptt180 -125.12 143.71 50.79 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.535 -0.757 . . . . 2.29 111.439 -169.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.421 ' CD2' HG22 ' A' ' 40' ' ' VAL . 97.2 m-70 -104.94 112.8 26.06 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.078 -0.964 . . . . 0.5 110.465 -173.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.465 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 48.3 ttm -107.56 125.31 51.14 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 110.417 -0.216 . . . . 0.42 110.417 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.604 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -117.06 139.33 50.83 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.808 -0.812 . . . . 1.33 108.808 176.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.526 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 31.1 t -97.48 128.16 44.02 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.193 -0.669 . . . . 0.94 109.193 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.88 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 6.2 m-85 -108.59 164.35 12.44 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.561 -0.745 . . . . 1.33 109.706 -176.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -109.29 -2.9 17.57 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.678 -0.409 . . . . 1.53 110.906 -172.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -146.69 127.77 14.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.375 0.607 . . . . 0.83 110.624 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.469 ' NH1' ' HB2' ' A' ' 98' ' ' ASP . 43.3 tpt85 -61.71 -27.28 68.6 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.852 -1.067 . . . . 2.16 111.325 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 92.3 m -74.64 -57.88 3.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.429 -0.35 . . . . 0.4 110.582 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.3 t -46.04 -54.06 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-N 116.17 -0.468 . . . . 0.29 111.289 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.558 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -66.08 -27.76 68.31 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.166 -0.47 . . . . 0.29 110.7 -177.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.469 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 32.9 t70 -68.93 -34.57 75.58 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 109.18 -0.674 . . . . 0.39 109.18 177.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.418 ' O ' ' HG2' ' A' ' 102' ' ' MET . 90.7 m-20 -73.18 -49.26 29.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.34 -1.3 . . . . 1.55 109.53 -178.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.598 HG23 HD11 ' A' ' 18' ' ' ILE . 36.0 mm -55.84 -53.08 41.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.181 -0.918 . . . . 0.13 110.409 174.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.732 ' HA ' HD21 ' A' ' 48' ' ' LEU . 1.1 tmmm? -53.25 -52.52 58.71 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.781 -0.645 . . . . 1.11 110.937 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 99' ' ' ASN . 24.3 ptm -67.81 -24.45 65.3 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.95 -0.568 . . . . 1.17 109.768 -173.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 55.5 m -67.03 -50.52 61.78 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.54 0.686 . . . . 0.15 110.066 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.932 ' HB2' HD22 ' A' ' 48' ' ' LEU . 10.3 mt -70.45 -57.32 4.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.824 -1.08 . . . . 0.13 111.52 -174.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 1.092 ' HG3' HD23 ' A' ' 48' ' ' LEU . 63.3 mt-30 -53.85 -25.78 21.42 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.572 0.582 . . . . 1.45 112.572 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -66.42 -30.1 70.39 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.74 0.781 . . . . 0.65 109.374 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.623 HG21 ' HB3' ' A' ' 25' ' ' ALA . 31.7 mt -82.42 -44.28 19.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 114.117 -1.401 . . . . 0.17 110.312 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.4 mt -66.87 -51.38 55.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.574 -0.739 . . . . 0.29 110.804 -175.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.6 t -61.52 -22.38 65.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.544 0.688 . . . . 1.22 109.354 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.528 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 14.7 ttt180 -72.99 -38.96 66.46 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.746 -1.115 . . . . 3.79 110.184 177.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 . . . . . 0 N--CA 1.449 -0.525 0 CA-C-N 115.857 -0.61 . . . . 0.6 111.249 -176.481 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 261' ' ' PHE . . . . . 0.472 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 13.1 m-85 . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 109.419 -0.586 . . . . 0.95 109.419 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 7.8 p -140.93 143.99 27.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.818 0.342 . . . . 1.37 110.213 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 263' ' ' GLU . . . . . 0.525 ' OE1' ' HE3' ' A' ' 47' ' ' LYS . 44.4 tt0 . . . . . 0 C--N 1.323 -0.552 0 N-CA-C 109.065 -0.717 . . . . 2.24 109.065 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.427 ' HA ' HG21 ' A' ' 103' ' ' THR . 45.7 m80 . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 112.701 0.63 . . . . 1.85 112.701 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.413 ' C ' HD11 ' A' ' 100' ' ' ILE . 20.4 m -158.92 148.8 19.23 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.825 -0.435 . . . . 0.95 109.825 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.41 148.05 6.6 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.366 -1.094 . . . . 0.16 110.366 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.71 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -73.57 140.0 45.97 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 117.419 0.61 . . . . 0.43 111.524 -175.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.508 ' HB1' ' HB3' ' A' ' 89' ' ' PHE . . . -148.65 162.93 38.72 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 121.361 0.6 . . . . 0.13 111.638 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.555 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.1 mp -109.47 126.49 66.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.45 -0.796 . . . . 0.29 109.031 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -114.18 99.66 7.79 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 120.879 0.371 . . . . 0.56 110.249 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 56.69 59.2 3.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.286 0.565 . . . . 1.46 111.118 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 11' ' ' LYS . 21.1 mmtp 76.07 -8.73 1.57 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.858 -1.065 . . . . 1.91 113.68 170.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.1 p -96.6 130.38 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 119.892 -0.723 . . . . 0.47 109.987 169.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.555 ' HA ' HG13 ' A' ' 8' ' ' ILE . 18.6 t -85.3 133.55 34.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.024 -0.534 . . . . 1.02 110.804 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.726 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -155.5 -155.95 7.57 Favored Glycine 0 N--CA 1.438 -1.214 0 CA-C-N 115.749 -0.66 . . . . 0.16 112.598 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.71 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.7 mm -126.6 153.44 35.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 120.798 0.333 . . . . 0.19 110.614 -177.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.431 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -121.89 132.56 70.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.12 -0.491 . . . . 0.16 110.059 179.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.85 109.46 7.47 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.316 -0.402 . . . . 0.12 111.927 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.641 HD11 HG23 ' A' ' 100' ' ' ILE . 3.9 mp -85.95 115.66 27.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.897 -0.779 . . . . 0.18 108.897 173.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.417 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.6 t30 -118.38 126.34 51.88 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.982 -0.377 . . . . 1.12 109.982 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -110.89 83.35 1.74 Allowed 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 117.362 -1.735 . . . . 0.74 107.543 164.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.417 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 19.5 t70 -121.25 -10.5 8.94 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 106.638 -1.615 . . . . 0.59 106.638 156.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 23' ' ' SER . 14.8 p -101.43 174.66 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 112.099 -2.319 . . . . 0.35 112.031 -156.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.672 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -54.51 165.63 0.86 Allowed Pre-proline 0 C--O 1.225 -0.194 0 N-CA-C 106.04 -1.837 . . . . 1.31 106.04 166.489 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HD2' ' OG ' ' A' ' 23' ' ' SER . 10.1 Cg_endo -41.14 128.04 2.93 Favored 'Trans proline' 0 C--N 1.354 0.845 0 CA-C-N 121.899 1.714 . . . . 0.22 111.555 -150.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.67 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -32.15 135.21 0.08 Allowed 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 125.288 1.617 . . . . 0.2 113.719 -156.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.563 ' HB2' HG11 ' A' ' 22' ' ' VAL . 70.7 mt-10 -124.77 137.62 54.31 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 114.792 -1.094 . . . . 1.26 111.366 -168.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 1.3 tt -100.65 141.88 32.89 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 106.543 -1.651 . . . . 0.15 106.543 173.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.417 ' N ' HD23 ' A' ' 27' ' ' LEU . 6.8 m -130.1 108.77 10.32 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.848 -0.741 . . . . 0.21 110.413 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.64 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 82.8 t90 -88.0 113.68 23.88 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.478 0.656 . . . . 0.24 109.755 175.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -120.67 122.97 41.62 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.168 -0.924 . . . . 0.87 109.161 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.437 ' OG ' ' HG2' ' A' ' 36' ' ' LYS . 38.1 m -56.59 141.47 43.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.088 0.47 . . . . 0.75 110.482 -174.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.726 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 20.2 m -57.54 -35.9 70.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.092 -0.958 . . . . 0.39 110.443 -176.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -87.36 -8.04 57.07 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.502 -0.772 . . . . 2.33 111.153 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.89 21.02 54.48 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.82 -0.705 . . . . 0.55 112.39 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.404 ' H ' ' HB2' ' A' ' 31' ' ' SER . 24.2 t70 -69.85 -56.36 7.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.337 0.495 . . . . 1.13 112.337 -176.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.437 ' HG2' ' OG ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -143.88 161.71 37.99 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.806 0.336 . . . . 2.03 110.979 -176.164 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.2 138.06 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.337 -0.392 . . . . 0.55 110.678 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -135.67 115.77 13.31 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 122.551 0.34 . . . . 0.69 110.714 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.5 m -98.89 142.68 30.09 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.783 0.325 . . . . 0.3 111.461 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 22.0 t -116.62 128.8 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 122.827 0.451 . . . . 0.66 111.209 175.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 45' ' ' ILE . 43.2 t -90.56 109.25 20.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.078 0.466 . . . . 0.18 109.904 175.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.612 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.9 mm? -54.16 -26.43 27.83 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.372 -0.831 . . . . 0.12 112.762 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.3 m -75.27 -35.1 61.4 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.374 -0.53 . . . . 1.06 111.329 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.8 p -74.0 -14.48 61.03 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.402 -0.592 . . . . 0.2 109.402 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.606 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 48.9 mm -82.92 114.43 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.075 -0.966 . . . . 0.23 110.863 175.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.542 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 31.8 t70 -74.7 -39.46 61.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.109 -0.496 . . . . 0.7 111.266 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -147.24 158.13 43.84 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.227 -0.442 . . . . 1.95 110.199 -174.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.93 HD22 ' HB2' ' A' ' 104' ' ' LEU . 10.8 tp -124.53 146.01 49.23 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.303 0.573 . . . . 0.14 109.917 171.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.44 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 15.5 mm100 -123.16 155.98 35.96 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.793 -1.094 . . . . 1.49 109.653 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.18 138.23 6.5 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.55 -0.75 . . . . 0.25 109.649 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.409 HG23 ' HB2' ' A' ' 59' ' ' MET . 36.7 p -50.7 126.71 24.31 Favored Pre-proline 0 N--CA 1.466 0.339 0 CA-C-O 121.193 0.52 . . . . 0.37 110.396 176.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 43.0 Cg_endo -65.59 164.76 25.2 Favored 'Trans proline' 0 C--N 1.329 -0.494 0 C-N-CA 123.611 2.874 . . . . 0.64 112.017 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.06 66.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.279 0.561 . . . . 1.02 110.064 175.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.5 t -75.03 -24.6 58.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.287 -0.87 . . . . 1.58 110.575 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.414 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 46.8 t -68.42 148.37 50.75 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.59 -0.522 . . . . 0.71 109.59 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -89.21 -7.68 55.06 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.746 0.784 . . . . 2.89 109.389 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -107.89 -175.85 2.9 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.686 -1.143 . . . . 2.59 110.9 -172.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.493 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -141.7 110.39 6.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.257 -0.883 . . . . 1.78 109.171 175.039 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.508 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 2.4 mpp? -156.3 139.94 16.0 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.694 0.283 . . . . 1.3 111.456 -176.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.868 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 1.5 mp -110.66 155.42 22.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.121 -0.49 . . . . 0.14 110.928 171.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.691 ' NH2' ' HE3' ' A' ' 88' ' ' MET . 25.4 ttm-85 -145.5 113.76 6.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.083 0.468 . . . . 2.72 110.043 170.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.777 ' HG ' HD13 ' A' ' 48' ' ' LEU . 6.5 mp -91.9 111.69 23.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.075 -0.512 . . . . 0.9 110.522 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.546 ' HA ' ' CB ' ' A' ' 86' ' ' ARG . 3.0 mm -86.71 125.52 40.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.195 -0.457 . . . . 0.4 110.116 -173.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -89.31 156.07 25.66 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.164 -1.017 . . . . 0.48 111.474 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.542 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 0.7 OUTLIER -64.12 134.01 54.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.03 0.443 . . . . 1.15 110.025 176.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 C--N 1.317 -0.843 0 CA-C-N 115.615 -0.72 . . . . 0.69 109.165 174.679 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? . . . . . 0 CA--C 1.507 -0.709 0 N-CA-C 108.835 -0.802 . . . . 1.78 108.835 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.61 ' HD2' ' HD3' ' A' ' 61' ' ' ARG . 28.7 ptt180 -143.64 140.9 30.34 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.663 -0.699 . . . . 2.29 111.303 -171.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -102.88 112.28 25.0 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.795 -1.093 . . . . 0.5 110.734 -170.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.691 ' HE3' ' NH2' ' A' ' 61' ' ' ARG . 38.6 ttm -104.04 137.54 41.86 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 121.067 -0.253 . . . . 0.42 110.806 -177.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.508 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 56.3 m-85 -124.1 139.18 54.18 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.514 -0.921 . . . . 1.33 108.514 169.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.54 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 14.7 m -95.1 124.18 39.0 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.313 -0.625 . . . . 0.94 109.313 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.868 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 7.7 m-85 -106.5 168.4 9.19 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 110.044 -0.354 . . . . 1.33 110.044 -174.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -114.37 -6.89 12.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.824 0.345 . . . . 1.53 111.325 -174.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -138.62 122.93 18.22 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.282 0.563 . . . . 0.83 110.954 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -54.6 -39.6 68.03 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 114.51 -1.223 . . . . 2.16 111.327 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.481 HG22 HD21 ' A' ' 99' ' ' ASN . 97.7 m -71.14 -57.25 4.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.564 -0.289 . . . . 0.4 110.599 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 100' ' ' ILE . 96.1 t -45.97 -55.6 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 116.126 -0.488 . . . . 0.29 111.299 175.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.657 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -65.41 -29.36 70.06 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.254 -0.43 . . . . 0.29 110.695 -177.127 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 30.2 t70 -71.42 -28.3 63.9 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.853 0.835 . . . . 0.39 109.318 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.535 ' O ' ' HG3' ' A' ' 102' ' ' MET . 87.8 m-20 -77.64 -36.84 51.17 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.559 -1.2 . . . . 1.55 109.252 176.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.641 HG23 HD11 ' A' ' 18' ' ' ILE . 33.4 mm -64.42 -53.04 47.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 114.978 -1.01 . . . . 0.13 111.144 176.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.727 ' HA ' HD21 ' A' ' 48' ' ' LEU . 2.1 ptmt -59.29 -43.57 92.57 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 121.231 -0.188 . . . . 1.11 110.6 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.535 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.5 ppp? -68.08 -25.83 65.53 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.175 0.512 . . . . 1.17 109.719 -175.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 36.9 m -65.61 -51.95 55.77 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.463 -0.789 . . . . 0.15 109.815 173.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.93 ' HB2' HD22 ' A' ' 48' ' ' LEU . 12.2 mt -71.15 -56.92 5.09 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 115.183 -0.917 . . . . 0.13 111.141 -175.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.922 ' HG2' HD23 ' A' ' 48' ' ' LEU . 21.1 mm-40 -42.85 -35.0 1.05 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.808 0.67 . . . . 1.45 112.808 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -65.59 -48.29 72.82 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.845 -0.798 . . . . 0.65 108.845 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.67 HG21 ' HB3' ' A' ' 25' ' ' ALA . 68.2 mt -61.48 -43.12 96.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.39 -1.277 . . . . 0.17 110.6 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 105' ' ' GLN . 0.7 OUTLIER -62.37 -54.98 27.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.51 -0.768 . . . . 0.29 109.875 -177.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.8 m -54.4 -32.35 57.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.98 -0.554 . . . . 1.22 110.849 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.463 ' HD2' ' HA ' ' A' ' 107' ' ' ILE . 82.9 mtt180 -70.93 -27.99 64.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.593 -0.731 . . . . 3.79 110.662 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 N--CA 1.445 -0.709 0 CA-C-N 116.21 -0.45 . . . . 0.6 111.277 -178.076 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 261' ' ' PHE . . . . . 0.451 ' N ' ' CD1' ' B' ' 261' ' ' PHE . 3.9 m-30 . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 109.221 -0.659 . . . . 0.95 109.221 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 12.8 p -122.98 139.66 49.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.925 0.393 . . . . 1.37 110.322 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 109.156 -0.683 . . . . 2.24 109.156 174.691 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.1 m80 . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 121.647 0.737 . . . . 1.85 109.478 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.405 ' C ' HD11 ' A' ' 100' ' ' ILE . 90.1 p -162.99 154.45 17.55 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.815 -1.084 . . . . 0.95 108.626 -176.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.73 145.86 5.48 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.186 -0.765 . . . . 0.16 111.186 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.76 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.69 125.78 29.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.324 0.562 . . . . 0.43 111.36 -176.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.72 158.39 44.24 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 121.168 0.509 . . . . 0.13 111.36 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 2.0 mp -96.96 127.65 48.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.637 -0.711 . . . . 0.29 109.472 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.639 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 80.4 t80 -137.38 117.15 13.11 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.337 -0.616 . . . . 0.56 109.337 178.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 66.71 44.18 2.24 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.15 0.58 . . . . 1.46 110.419 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt 74.91 -8.95 1.44 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.777 -1.102 . . . . 1.91 112.718 171.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.48 131.92 47.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.903 0.382 . . . . 0.47 110.476 177.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.514 ' HA ' HG13 ' A' ' 8' ' ' ILE . 22.5 t -78.03 123.2 26.55 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.002 -0.544 . . . . 1.02 109.992 176.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.645 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -139.07 -154.73 6.46 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.543 -0.753 . . . . 0.16 112.06 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.76 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.7 mm -127.02 153.76 36.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 120.957 0.408 . . . . 0.19 110.779 -177.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.486 HG12 HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -128.56 132.81 67.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.856 -0.611 . . . . 0.16 110.113 -179.348 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.01 112.09 9.02 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 111.976 0.362 . . . . 0.12 111.976 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.621 HD11 HG23 ' A' ' 100' ' ' ILE . 3.7 mp -86.02 120.86 36.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.836 -0.802 . . . . 0.18 108.836 172.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.464 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.9 t30 -126.22 125.39 42.32 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 110.234 -0.284 . . . . 1.12 110.234 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.467 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 22.2 mt-10 -108.47 84.51 1.95 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 117.069 -1.852 . . . . 0.74 107.468 163.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.464 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 17.9 t70 -121.54 -9.58 8.94 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 106.341 -1.726 . . . . 0.59 106.341 156.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.706 HG13 ' O ' ' A' ' 23' ' ' SER . 14.0 p -102.48 175.98 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 111.732 -2.486 . . . . 0.35 111.778 -157.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.706 ' O ' HG13 ' A' ' 22' ' ' VAL . 5.6 m -54.15 167.25 0.56 Allowed Pre-proline 0 C--O 1.225 -0.201 0 N-CA-C 106.997 -1.483 . . . . 1.31 106.997 166.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 10.7 Cg_endo -42.16 128.27 4.22 Favored 'Trans proline' 0 C--N 1.357 1.008 0 CA-C-N 122.018 1.756 . . . . 0.22 111.009 -154.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.743 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -31.58 134.61 0.08 Allowed 'General case' 0 CA--C 1.504 -0.805 0 O-C-N 125.19 1.557 . . . . 0.2 113.93 -155.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.594 ' HB2' HG11 ' A' ' 22' ' ' VAL . 33.6 mt-10 -121.3 134.93 55.16 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.646 -1.161 . . . . 1.26 111.031 -172.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.593 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.0 OUTLIER -100.34 141.26 33.43 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 106.052 -1.833 . . . . 0.15 106.052 173.39 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.465 ' N ' HD23 ' A' ' 27' ' ' LEU . 6.2 m -127.92 108.76 10.96 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.677 -0.809 . . . . 0.21 110.434 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.639 ' CE2' ' HB3' ' A' ' 9' ' ' PHE . 88.8 t90 -89.6 107.56 19.16 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.675 0.75 . . . . 0.24 109.271 175.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -113.83 120.53 41.06 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.888 -1.051 . . . . 0.87 109.088 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.593 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 88.9 p -61.78 144.97 53.93 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.197 -0.668 . . . . 0.75 109.197 -176.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.645 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 11.4 m -54.0 -23.25 12.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.013 -0.994 . . . . 0.39 111.99 -173.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -87.65 -10.59 50.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 111.982 0.364 . . . . 2.33 111.982 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.15 21.43 67.68 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.831 -0.7 . . . . 0.55 111.704 -176.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -93.49 -44.72 8.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.065 0.459 . . . . 1.13 111.334 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.407 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 29.3 mttt -110.34 146.12 36.32 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.895 -0.593 . . . . 2.03 110.794 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.0 t -144.12 115.7 2.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.874 -0.603 . . . . 0.55 109.69 174.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -125.46 111.22 14.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.926 -0.579 . . . . 0.69 110.066 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.406 HG21 ' OE1' ' A' ' 26' ' ' GLU . 14.4 m -98.74 143.17 29.39 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 120.824 -0.351 . . . . 0.3 111.326 -175.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 28.7 t -116.43 130.15 71.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 122.416 0.286 . . . . 0.66 111.536 176.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.534 ' O ' HG12 ' A' ' 45' ' ' ILE . 60.1 t -91.03 108.28 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-O 121.398 0.618 . . . . 0.18 109.875 173.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.6 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -53.19 -26.89 18.98 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.808 -1.087 . . . . 0.12 112.927 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.425 ' O ' ' HE3' ' A' ' 65' ' ' LYS . 59.4 m -80.68 -30.25 36.46 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.459 -0.496 . . . . 1.06 111.661 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.2 p -75.66 -16.23 60.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.099 -0.704 . . . . 0.2 109.099 172.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.691 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 46.6 mm -75.09 120.72 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.965 -1.016 . . . . 0.23 111.313 174.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.578 ' OD2' ' HG2' ' A' ' 47' ' ' LYS . 20.2 t70 -74.24 -50.22 19.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.851 -1.068 . . . . 0.7 110.99 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.578 ' HG2' ' OD2' ' A' ' 46' ' ' ASP . 48.2 mmtm -142.32 154.46 44.71 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 109.488 -0.56 . . . . 1.95 109.488 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.133 HD23 ' HG3' ' A' ' 105' ' ' GLN . 9.0 tp -112.59 145.05 41.03 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.391 -0.596 . . . . 0.14 109.391 167.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.548 ' H ' HD12 ' A' ' 48' ' ' LEU . 15.2 mt-30 -126.73 156.67 40.77 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.686 -1.143 . . . . 1.49 109.876 -177.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -161.76 151.11 16.12 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.427 -0.953 . . . . 0.25 108.427 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 22.3 p -50.25 121.22 13.3 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.588 0.709 . . . . 0.37 111.44 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 66.3 Cg_endo -71.95 167.82 25.64 Favored 'Trans proline' 0 C--N 1.331 -0.375 0 C-N-CA 124.205 3.27 . . . . 0.64 111.546 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.2 -27.94 37.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.26 0.552 . . . . 1.02 110.52 174.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 t -73.46 -22.78 60.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.838 -0.619 . . . . 1.58 110.889 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 24.6 t -86.6 136.28 33.11 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.9 -0.407 . . . . 0.71 109.9 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -88.99 -6.77 56.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.334 0.588 . . . . 2.89 111.093 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -99.75 -177.1 3.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.393 -0.821 . . . . 2.59 109.977 -176.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.581 ' SD ' ' HB2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -136.29 107.16 6.64 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.032 -0.729 . . . . 1.78 109.032 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.648 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 3.5 mpp? -156.86 146.62 20.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.977 0.418 . . . . 1.3 111.188 -175.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.864 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 1.9 mp -110.77 163.14 14.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.551 -0.75 . . . . 0.14 111.699 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.512 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 20.5 ttt180 -155.02 113.44 3.51 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.613 -0.721 . . . . 2.72 110.281 173.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.591 HD13 ' CE2' ' A' ' 89' ' ' PHE . 7.3 mp -94.81 113.27 25.0 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.139 0.495 . . . . 0.9 110.427 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.823 HG23 ' HG2' ' A' ' 86' ' ' ARG . 5.1 mm -84.58 124.09 39.59 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 C-N-CA 123.543 0.737 . . . . 0.4 109.105 -178.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.691 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -97.65 146.7 18.35 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 119.841 -1.171 . . . . 0.48 112.106 177.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.516 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -58.22 131.53 50.86 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.141 0.496 . . . . 1.15 111.452 -175.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 115.387 -0.824 . . . . 0.69 109.17 177.364 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.442 HE21 ' HB2' ' A' ' 85' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 121.647 0.736 . . . . 1.78 110.995 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.823 ' HG2' HG23 ' A' ' 63' ' ' ILE . 25.5 mtm180 -110.33 157.0 19.97 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.495 -0.775 . . . . 2.29 111.032 -175.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -120.39 111.12 17.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.308 -0.86 . . . . 0.5 109.637 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.48 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 55.0 ttm -113.73 125.31 53.97 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.88 -0.145 . . . . 0.42 110.633 -174.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.591 ' CE2' HD13 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -118.75 148.43 42.81 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.339 -0.615 . . . . 1.33 109.339 174.088 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.648 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 32.2 m -97.79 126.54 43.2 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.659 -0.497 . . . . 0.94 109.659 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.864 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 8.8 m-85 -106.53 154.76 20.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.057 0.456 . . . . 1.33 111.349 -174.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -100.36 -6.65 25.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.984 -0.553 . . . . 1.53 110.955 -171.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -142.76 128.33 19.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.938 0.399 . . . . 0.83 110.581 -175.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.581 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 15.8 tpt180 -59.63 -34.69 73.11 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.109 -0.95 . . . . 2.16 110.847 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.55 HG22 HD21 ' A' ' 99' ' ' ASN . 47.6 m -74.03 -58.82 3.05 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.69 -0.687 . . . . 0.4 110.618 -177.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 100' ' ' ILE . 94.6 t -45.19 -53.69 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-N 115.792 -0.64 . . . . 0.29 111.456 175.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.797 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -66.32 -29.81 70.09 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 120.515 -0.474 . . . . 0.29 110.563 -177.206 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.426 ' HA ' ' HD3' ' A' ' 101' ' ' LYS . 35.8 t70 -72.13 -24.26 61.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.62 0.724 . . . . 0.39 109.618 178.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.578 ' O ' ' HG3' ' A' ' 102' ' ' MET . 85.7 m-20 -83.78 -42.93 15.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.845 -1.071 . . . . 1.55 109.742 177.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.621 HG23 HD11 ' A' ' 18' ' ' ILE . 33.7 mm -58.54 -51.85 66.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.482 -0.781 . . . . 0.13 110.837 176.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.812 ' HA ' HD21 ' A' ' 48' ' ' LEU . 2.6 ptmt -60.23 -39.25 86.01 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 120.851 0.358 . . . . 1.11 111.159 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.578 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.7 ppp? -76.52 -22.93 53.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.079 0.466 . . . . 1.17 109.761 -175.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 52.6 m -68.46 -53.2 25.03 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.649 -0.705 . . . . 0.15 109.679 174.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.934 ' HB2' HD22 ' A' ' 48' ' ' LEU . 13.1 mt -65.75 -56.59 11.21 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.151 -0.931 . . . . 0.13 110.932 -177.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 1.133 ' HG3' HD23 ' A' ' 48' ' ' LEU . 49.1 mt-30 -52.05 -26.38 10.77 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.808 0.67 . . . . 1.45 112.808 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -64.59 -43.8 92.66 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.923 -0.769 . . . . 0.65 108.923 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.743 HG21 ' HB3' ' A' ' 25' ' ' ALA . 33.4 mt -66.76 -43.89 89.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.293 -1.321 . . . . 0.17 110.876 176.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.2 mt -67.16 -47.84 80.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.05 -0.523 . . . . 0.29 110.445 -176.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.0 t -58.71 -27.34 64.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.366 0.603 . . . . 1.22 110.237 172.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 77.2 mtt180 -70.56 -31.79 68.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 3.79 110.25 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 . . . . . 0 N--CA 1.447 -0.617 0 CA-C-N 115.914 -0.584 . . . . 0.6 111.934 -178.862 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 261' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.909 -0.404 . . . . 0.95 109.909 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.97 166.32 26.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.36 -0.382 . . . . 1.37 110.72 -176.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 263' ' ' GLU . . . . . 0.534 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 8.0 pt-20 . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 116.282 -0.417 . . . . 2.24 110.089 173.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.554 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 37.9 m80 . . . . . 0 C--O 1.226 -0.164 0 N-CA-C 112.087 0.403 . . . . 1.85 112.087 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.474 ' C ' HD11 ' A' ' 100' ' ' ILE . 88.6 p -163.12 149.92 12.61 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.844 0.354 . . . . 0.95 110.715 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.72 147.45 6.35 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.496 -1.042 . . . . 0.16 110.496 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.747 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.55 136.75 40.55 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 117.653 0.726 . . . . 0.43 111.283 -175.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.31 160.11 40.81 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 121.278 0.561 . . . . 0.13 111.323 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.564 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.5 mp -105.58 126.39 60.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.603 -0.726 . . . . 0.29 109.163 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -116.82 101.8 8.85 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.711 -0.396 . . . . 0.56 110.279 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 60.69 53.0 4.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.19 0.519 . . . . 1.46 110.668 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt 78.99 -8.35 1.65 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.545 -1.207 . . . . 1.91 113.298 171.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -97.86 127.58 50.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.203 -0.599 . . . . 0.47 110.712 171.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.564 ' HA ' HG13 ' A' ' 8' ' ' ILE . 10.2 p -78.99 126.13 30.28 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.558 -0.746 . . . . 1.02 111.095 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.695 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -145.24 -155.42 6.46 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.465 -0.789 . . . . 0.16 112.098 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.747 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 6.4 mm -128.71 153.78 38.71 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.741 0 CA-C-O 120.768 0.318 . . . . 0.19 110.768 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.493 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -124.38 131.85 72.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.642 -0.503 . . . . 0.16 109.642 179.126 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.57 112.28 9.44 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.215 -0.448 . . . . 0.12 111.643 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.668 HD11 HG23 ' A' ' 100' ' ' ILE . 4.1 mp -84.8 120.75 35.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.265 -1.013 . . . . 0.18 108.265 171.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.415 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.4 t30 -123.64 124.88 43.75 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.967 -0.383 . . . . 1.12 109.967 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -108.53 83.11 1.72 Allowed 'General case' 0 N--CA 1.427 -1.62 0 C-N-CA 116.959 -1.896 . . . . 0.74 107.342 165.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.415 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 16.7 t70 -121.25 -12.35 8.66 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 106.625 -1.62 . . . . 0.59 106.625 158.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 23' ' ' SER . 14.9 p -101.75 177.9 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 111.812 -2.449 . . . . 0.35 111.852 -156.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.71 ' O ' HG13 ' A' ' 22' ' ' VAL . 4.4 m -53.61 168.4 0.4 Allowed Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 107.194 -1.41 . . . . 1.31 107.194 165.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 12.2 Cg_endo -42.6 128.21 4.75 Favored 'Trans proline' 0 C--N 1.357 1.016 0 CA-C-N 121.966 1.738 . . . . 0.22 110.94 -155.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.704 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -33.36 135.83 0.11 Allowed 'General case' 0 CA--C 1.507 -0.697 0 O-C-N 125.334 1.646 . . . . 0.2 113.892 -154.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.693 ' HB2' HG11 ' A' ' 22' ' ' VAL . 28.5 mt-10 -123.3 138.61 54.58 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 114.588 -1.187 . . . . 1.26 111.179 -170.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.57 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.4 tt -101.71 143.11 32.06 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 106.567 -1.642 . . . . 0.15 106.567 173.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.423 ' N ' HD23 ' A' ' 27' ' ' LEU . 16.5 m -130.99 109.78 10.77 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.846 -0.742 . . . . 0.21 110.67 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.638 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 87.8 t90 -85.92 106.03 16.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.687 0.756 . . . . 0.24 109.327 174.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -111.15 115.32 29.2 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.069 -0.969 . . . . 0.87 108.759 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.557 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 63.1 p -56.39 144.13 31.98 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.993 0.425 . . . . 0.75 110.064 -177.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.695 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 25.9 m -56.44 -25.04 49.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.175 -0.92 . . . . 0.39 110.751 -176.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -76.33 -27.96 56.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.899 -0.591 . . . . 2.33 111.299 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.83 8.01 60.93 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.702 -0.559 . . . . 0.55 111.702 -174.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -84.87 -72.68 0.46 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.056 0.455 . . . . 1.13 111.408 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -85.55 141.13 30.08 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.201 0.524 . . . . 2.03 111.48 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 93.9 t -137.69 125.86 31.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.741 -1.118 . . . . 0.55 109.441 177.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -130.34 111.29 12.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.53 -0.305 . . . . 0.69 110.273 -175.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -100.87 141.87 33.15 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 111.863 0.319 . . . . 0.3 111.863 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.59 HG11 HD13 ' A' ' 62' ' ' LEU . 43.1 t -116.11 129.69 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 122.623 0.369 . . . . 0.66 111.688 176.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.579 ' O ' HG12 ' A' ' 45' ' ' ILE . 60.4 t -91.11 108.42 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-O 121.268 0.556 . . . . 0.18 109.579 172.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.583 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.6 mm? -53.14 -29.52 31.71 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.877 -1.056 . . . . 0.12 112.546 -178.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.438 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 68.4 m -76.89 -33.79 57.78 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.608 -0.437 . . . . 1.06 111.581 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.7 p -74.07 -11.7 60.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.541 0.686 . . . . 0.2 109.371 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.579 HG12 ' O ' ' A' ' 41' ' ' VAL . 47.5 mm -82.62 133.03 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 114.77 -1.105 . . . . 0.23 111.002 173.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.653 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 35.8 t70 -85.91 -50.22 7.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.456 -0.793 . . . . 0.7 110.904 174.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.477 ' HB2' HG13 ' A' ' 63' ' ' ILE . 74.9 mmtt -136.77 156.14 48.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.245 -0.434 . . . . 1.95 110.1 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.09 HD23 ' HG3' ' A' ' 105' ' ' GLN . 11.6 tp -119.18 140.21 50.55 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.213 0.53 . . . . 0.14 109.871 167.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 11.8 mm100 -115.61 154.82 28.76 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.818 -1.083 . . . . 1.49 109.837 -178.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.85 141.65 8.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.588 -0.733 . . . . 0.25 109.278 177.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.492 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 33.5 p -51.94 123.52 25.95 Favored Pre-proline 0 N--CA 1.467 0.4 0 CA-C-O 121.484 0.659 . . . . 0.37 111.559 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.525 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 71.1 Cg_endo -70.76 167.29 26.16 Favored 'Trans proline' 0 CA--C 1.519 -0.275 0 C-N-CA 124.331 3.354 . . . . 0.64 112.126 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.425 ' HA ' HH12 ' A' ' 94' ' ' ARG . . . -55.63 -28.13 53.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.236 0.541 . . . . 1.02 110.575 174.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.8 m -68.73 -25.38 64.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.375 -0.83 . . . . 1.58 111.324 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.435 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 33.7 t -80.4 143.43 33.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.535 -0.757 . . . . 0.71 109.951 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -90.17 -7.66 53.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.484 0.659 . . . . 2.89 109.667 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 mmmt -98.89 178.33 4.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.225 -0.898 . . . . 2.59 110.403 -175.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.531 ' HB3' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -137.58 110.18 7.52 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.982 -1.008 . . . . 1.78 108.674 176.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.599 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 3.1 ttm -157.3 140.13 15.09 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.744 -0.382 . . . . 1.3 111.422 -173.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.863 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 1.9 mp -109.27 160.82 15.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.06 0.457 . . . . 0.14 111.016 172.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.644 ' HE ' ' HE2' ' A' ' 88' ' ' MET . 20.7 ttm180 -153.56 113.34 3.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.906 -0.588 . . . . 2.72 110.263 172.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.802 ' HG ' HD13 ' A' ' 48' ' ' LEU . 7.9 mt -93.61 113.79 25.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.055 0.455 . . . . 0.9 110.293 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.629 HG23 ' HG2' ' A' ' 86' ' ' ARG . 5.4 mm -86.63 109.28 18.78 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 CA-C-N 115.717 -0.674 . . . . 0.4 110.461 -173.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -76.43 138.48 22.55 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.731 -1.223 . . . . 0.48 111.384 176.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.653 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 1.7 mptp? -53.44 136.68 37.43 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.72 0.295 . . . . 1.15 110.941 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--N 1.32 -0.677 0 N-CA-C 109.923 -0.399 . . . . 0.69 109.923 175.267 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.385 0 CA-C-O 121.42 0.628 . . . . 1.78 109.87 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.629 ' HG2' HG23 ' A' ' 63' ' ' ILE . 18.5 mtm180 -110.78 160.42 16.75 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.64 -0.709 . . . . 2.29 110.227 -173.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -124.3 111.91 16.38 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.009 -0.542 . . . . 0.5 109.713 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.644 ' HE2' ' HE ' ' A' ' 61' ' ' ARG . 49.7 ttm -111.35 128.53 55.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.716 -0.22 . . . . 0.42 110.889 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.437 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 39.8 m-85 -117.24 143.63 45.68 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 108.832 -0.803 . . . . 1.33 108.832 173.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.545 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 19.1 m -96.88 125.59 41.43 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.469 -0.567 . . . . 0.94 109.469 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.863 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 4.5 m-85 -107.53 162.9 13.52 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.952 -0.388 . . . . 1.33 109.952 -177.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -115.91 -7.06 12.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.859 0.361 . . . . 1.53 110.911 -176.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -129.09 119.44 24.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.67 -0.493 . . . . 0.83 109.67 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.531 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 8.3 tpt180 -61.44 -29.08 69.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.844 -0.617 . . . . 2.16 111.227 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 50.0 m -74.17 -47.05 38.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.245 0.545 . . . . 0.4 110.52 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.821 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 66.3 t -60.27 -52.76 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 CA-C-N 115.646 -0.706 . . . . 0.29 111.633 177.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.541 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -60.41 -26.01 66.37 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.912 -0.715 . . . . 0.29 109.735 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 95' ' ' THR . 36.6 t70 -70.29 -41.74 72.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.261 0.553 . . . . 0.39 109.9 176.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.821 ' ND2' ' HA ' ' A' ' 96' ' ' VAL . 22.8 p30 -80.21 -29.19 38.54 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.073 -0.967 . . . . 1.55 110.879 -173.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.668 HG23 HD11 ' A' ' 18' ' ' ILE . 31.0 mm -67.41 -54.02 27.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.366 -0.834 . . . . 0.13 110.123 169.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.679 ' HA ' HD21 ' A' ' 48' ' ' LEU . 3.8 ttpt -54.79 -48.39 72.78 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.53 -0.759 . . . . 1.11 111.326 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -65.73 -26.09 67.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.9 0.381 . . . . 1.17 110.592 -176.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 22.1 m -68.06 -49.73 59.55 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.204 0.526 . . . . 0.15 110.354 177.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.957 ' HB2' HD22 ' A' ' 48' ' ' LEU . 9.7 mt -69.38 -57.25 5.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.391 -0.822 . . . . 0.13 111.156 -175.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 1.09 ' HG3' HD23 ' A' ' 48' ' ' LEU . 96.0 mt-30 -50.78 -28.35 9.11 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.223 0.453 . . . . 1.45 112.223 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -63.16 -49.81 72.87 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.842 -0.799 . . . . 0.65 108.842 176.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.704 HG21 ' HB3' ' A' ' 25' ' ' ALA . 60.1 mt -60.07 -44.75 95.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 113.906 -1.497 . . . . 0.17 110.518 176.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.2 mt -62.53 -55.52 23.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.675 -0.693 . . . . 0.29 110.412 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.6 m -59.01 -26.43 64.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.0 0.429 . . . . 1.22 110.966 175.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 56.9 mtt180 -69.22 -33.92 74.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.856 -0.611 . . . . 3.79 110.21 176.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 . . . . . 0 C--N 1.321 -0.662 0 CA-C-N 115.585 -0.734 . . . . 0.6 111.187 -179.585 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 261' ' ' PHE . . . . . 0.525 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 6.2 m-85 . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 109.434 -0.58 . . . . 0.95 109.434 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.72 150.3 19.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.624 -0.51 . . . . 1.37 109.624 173.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 263' ' ' GLU . . . . . 0.505 ' HB3' ' OE1' ' A' ' 49' ' ' GLN . 2.5 pp20? . . . . . 0 C--N 1.324 -0.526 0 N-CA-C 109.778 -0.453 . . . . 2.24 109.778 176.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.406 ' CD2' HG23 ' A' ' 103' ' ' THR . 71.7 m80 . . . . . 0 C--O 1.227 -0.121 0 CA-C-O 121.319 0.581 . . . . 1.85 110.005 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.4 ' C ' HD11 ' A' ' 100' ' ' ILE . 20.4 m -162.33 150.67 14.66 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.538 -0.755 . . . . 0.95 109.195 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.53 140.61 3.97 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.275 -0.73 . . . . 0.16 111.275 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.746 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -71.6 121.4 18.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 117.211 0.506 . . . . 0.43 111.173 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.548 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -130.83 158.78 39.23 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.256 0.551 . . . . 0.13 112.115 -177.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.504 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.5 mp -97.16 120.56 46.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.349 -0.841 . . . . 0.29 109.21 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.572 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 82.8 t80 -122.91 112.53 17.95 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.843 -0.428 . . . . 0.56 109.843 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 62.98 48.61 3.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.79 0.805 . . . . 1.46 110.127 -175.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt 72.61 -6.53 1.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.143 -1.389 . . . . 1.91 113.373 171.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.92 131.99 46.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.936 0.398 . . . . 0.47 110.236 173.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.504 ' HA ' HG13 ' A' ' 8' ' ' ILE . 23.3 t -78.89 130.55 35.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.059 -0.518 . . . . 1.02 110.522 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.67 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -149.4 -154.61 6.43 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 115.702 -0.681 . . . . 0.16 111.628 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.746 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 9.9 mm -124.44 153.42 31.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.948 0.374 . . . . 0.19 110.619 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.427 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -126.74 133.46 68.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.977 -0.556 . . . . 0.16 109.849 -179.824 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.89 111.44 8.63 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 116.281 -0.418 . . . . 0.12 111.751 175.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.633 HD11 HG23 ' A' ' 100' ' ' ILE . 4.0 mp -84.36 114.06 24.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.139 -1.06 . . . . 0.18 108.139 171.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.447 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.5 t30 -119.25 122.06 41.06 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.952 -0.388 . . . . 1.12 109.952 -179.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.489 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 38.0 mt-10 -105.88 84.25 2.04 Favored 'General case' 0 N--CA 1.423 -1.785 0 C-N-CA 116.858 -1.937 . . . . 0.74 107.418 163.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.447 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 22.3 t70 -121.4 -11.22 8.78 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.622 -1.621 . . . . 0.59 106.622 156.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.7 HG11 ' HB2' ' A' ' 26' ' ' GLU . 14.2 p -102.58 174.8 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 112.001 -2.363 . . . . 0.35 111.653 -157.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.672 ' O ' HG13 ' A' ' 22' ' ' VAL . 17.3 p -54.27 166.3 0.71 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 117.052 -1.452 . . . . 1.31 107.117 166.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.639 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 10.3 Cg_endo -41.49 128.47 3.44 Favored 'Trans proline' 0 C--N 1.362 1.278 0 CA-C-N 122.233 1.833 . . . . 0.22 111.374 -151.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.628 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -29.92 133.81 0.05 Allowed 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 125.251 1.595 . . . . 0.2 114.004 -157.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.7 ' HB2' HG11 ' A' ' 22' ' ' VAL . 23.8 mt-10 -124.9 136.72 54.03 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 114.777 -1.101 . . . . 1.26 111.15 -172.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.589 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.0 OUTLIER -100.3 142.1 32.25 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.469 -1.678 . . . . 0.15 106.469 173.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.419 ' N ' HD23 ' A' ' 27' ' ' LEU . 9.7 m -126.94 109.22 11.71 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.796 -0.762 . . . . 0.21 110.241 -178.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.647 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 88.3 t90 -89.23 105.71 17.96 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.684 0.754 . . . . 0.24 109.086 175.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.426 ' HD3' ' O ' ' A' ' 31' ' ' SER . 3.6 tmt_? -113.54 115.0 27.28 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.723 -1.126 . . . . 0.87 108.523 -177.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.546 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 98.1 p -58.75 144.66 43.06 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.308 0.575 . . . . 0.75 110.444 -173.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.67 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 18.5 m -54.82 -25.16 26.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.765 -1.107 . . . . 0.39 111.816 -173.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -89.77 -13.95 35.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.97 -0.559 . . . . 2.33 111.723 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.69 22.05 60.64 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.319 -0.943 . . . . 0.55 111.108 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -84.52 -39.28 19.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.919 -0.64 . . . . 1.13 111.913 -174.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -146.74 161.57 40.34 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.207 0.527 . . . . 2.03 110.774 -177.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 85.3 t -144.08 131.0 16.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.1 -0.955 . . . . 0.55 110.124 -176.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -131.96 109.11 9.82 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.639 -0.709 . . . . 0.69 109.813 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.9 m -99.82 137.06 38.81 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.625 -0.262 . . . . 0.3 111.294 -175.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.528 HG11 HD13 ' A' ' 62' ' ' LEU . 40.7 t -110.01 128.43 66.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 122.653 0.381 . . . . 0.66 111.703 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 45' ' ' ILE . 53.2 t -90.53 108.19 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 109.319 -0.623 . . . . 0.18 109.319 172.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.601 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.0 mm? -54.95 -27.26 42.22 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.924 -1.035 . . . . 0.12 112.415 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.521 ' O ' ' HE2' ' A' ' 65' ' ' LYS . 43.1 t -75.75 -34.04 60.26 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.598 -0.441 . . . . 1.06 110.641 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.457 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 58.6 p -77.77 -10.37 59.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.472 0.653 . . . . 0.2 109.661 175.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.659 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 45.2 mm -79.85 123.84 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 114.995 -1.002 . . . . 0.23 111.256 173.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.581 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 5.8 t70 -73.85 -46.26 46.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.29 -0.868 . . . . 0.7 111.436 174.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.466 ' O ' HG12 ' A' ' 63' ' ' ILE . 43.6 tptt -151.52 159.48 44.12 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 120.763 0.316 . . . . 1.95 110.432 -177.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.017 HD23 ' HG3' ' A' ' 105' ' ' GLN . 11.8 tp -117.68 148.24 42.16 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.623 -0.51 . . . . 0.14 109.623 170.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 15.3 mm100 -126.55 156.47 40.78 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.23 -0.895 . . . . 1.49 109.573 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.605 ' HB3' ' HD3' ' A' ' 101' ' ' LYS . . . -163.04 144.06 9.61 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.228 -0.442 . . . . 0.25 109.925 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.515 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 40.8 p -52.41 126.72 38.7 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 121.36 0.6 . . . . 0.37 112.135 -176.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.52 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 59.6 Cg_endo -69.31 167.08 24.9 Favored 'Trans proline' 0 C--N 1.334 -0.225 0 C-N-CA 124.323 3.349 . . . . 0.64 112.305 177.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.01 -28.65 58.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.842 0.353 . . . . 1.02 111.272 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.3 t -72.43 -23.61 61.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 1.58 110.784 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.506 ' CB ' ' HB ' ' A' ' 51' ' ' THR . 31.6 t -71.74 133.46 45.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.923 -0.58 . . . . 0.71 110.081 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -80.35 -15.14 57.57 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.758 0.789 . . . . 2.89 109.309 177.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -106.49 172.62 6.72 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.054 -0.975 . . . . 2.59 109.787 -176.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.555 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.2 OUTLIER -131.34 109.83 10.64 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.526 -0.916 . . . . 1.78 108.526 -177.429 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.56 ' HG2' ' HA ' ' A' ' 90' ' ' SER . 72.9 mtm -154.73 155.5 34.66 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.79 0.329 . . . . 1.3 111.212 -172.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.593 HD23 HD11 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -120.82 160.13 24.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.553 -0.749 . . . . 0.14 110.956 176.252 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 48.8 ttp180 -152.43 113.61 4.24 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 120.882 0.372 . . . . 2.72 111.198 171.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.725 ' HG ' HD13 ' A' ' 48' ' ' LEU . 10.4 mt -94.46 110.53 22.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.358 -0.383 . . . . 0.9 110.945 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.662 HG23 ' HB3' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -87.61 125.7 41.24 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 CA-C-N 116.027 -0.533 . . . . 0.4 110.454 -176.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -99.01 151.94 19.57 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.029 -1.082 . . . . 0.48 111.096 174.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.581 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 1.0 OUTLIER -56.5 134.16 53.9 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.858 0.361 . . . . 1.15 111.263 -174.176 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.76 -0.655 . . . . 0.69 110.918 -179.844 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.184 0 CA-C-O 121.245 0.545 . . . . 1.78 110.956 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.662 ' HB3' HG23 ' A' ' 63' ' ' ILE . 12.9 ptt180 -129.56 145.0 51.51 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.629 0.728 . . . . 2.29 111.994 -173.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -107.39 116.63 32.27 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.633 -1.167 . . . . 0.5 110.517 -173.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.441 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 48.6 ttm -104.68 128.73 52.83 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.67 -0.412 . . . . 0.42 111.32 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.465 ' CE2' HD12 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -121.84 123.04 40.83 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.054 -0.721 . . . . 1.33 109.054 175.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.56 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 64.6 m -93.18 130.69 38.76 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.926 0.393 . . . . 0.94 110.264 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.593 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 40.2 m-85 -107.48 169.73 8.4 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.404 0.621 . . . . 1.33 110.896 176.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -112.15 -6.07 14.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.413 -0.812 . . . . 1.53 109.828 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.478 ' OD1' ' HB ' ' A' ' 95' ' ' THR . 28.6 t-20 -130.65 128.51 41.1 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.284 0.564 . . . . 0.83 111.282 -176.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.426 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 14.6 tpt180 -59.32 -37.06 76.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.76 -1.109 . . . . 2.16 111.641 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.535 HG22 HD21 ' A' ' 99' ' ' ASN . 91.7 m -72.26 -54.94 8.1 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.312 -0.403 . . . . 0.4 110.777 -176.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.8 t -44.95 -57.34 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 115.969 -0.559 . . . . 0.29 111.434 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.555 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -63.63 -29.92 71.09 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.578 -0.449 . . . . 0.29 111.218 -177.656 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.515 ' HA ' ' HE2' ' A' ' 101' ' ' LYS . 26.0 t70 -68.64 -33.06 73.35 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.465 0.65 . . . . 0.39 109.251 177.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.613 ' O ' ' HG3' ' A' ' 102' ' ' MET . 91.7 m-20 -77.41 -50.74 12.07 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.634 -1.166 . . . . 1.55 110.055 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.633 HG23 HD11 ' A' ' 18' ' ' ILE . 32.4 mm -56.0 -48.44 78.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.235 -0.893 . . . . 0.13 110.14 178.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.758 ' HA ' HD21 ' A' ' 48' ' ' LEU . 13.3 ttpt -58.61 -50.96 71.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.368 -0.833 . . . . 1.11 111.133 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.613 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.3 ppp? -67.89 -23.06 65.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 1.17 110.335 -175.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.406 HG23 ' CD2' ' A' ' 3' ' ' HIS . 52.1 m -68.13 -51.57 44.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.89 -0.595 . . . . 0.15 110.507 174.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.976 ' HB2' HD22 ' A' ' 48' ' ' LEU . 13.1 mt -69.04 -56.79 6.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.184 -0.916 . . . . 0.13 111.7 -173.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 1.017 ' HG3' HD23 ' A' ' 48' ' ' LEU . 42.2 mt-30 -53.16 -29.19 30.12 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.049 0.388 . . . . 1.45 112.049 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -61.28 -28.16 68.99 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.84 0.828 . . . . 0.65 109.265 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 104' ' ' LEU . 25.2 mt -85.68 -45.28 17.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 113.803 -1.544 . . . . 0.17 110.791 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.7 mt -67.52 -53.81 28.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.417 -0.811 . . . . 0.29 111.46 -172.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.0 m -65.03 -14.96 61.73 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.567 0.699 . . . . 1.22 109.708 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.521 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 14.0 ttt180 -77.65 -42.95 32.94 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.863 -1.062 . . . . 3.79 109.752 174.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.759 -0.655 . . . . 0.6 111.156 -178.866 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 261' ' ' PHE . . . . . 0.52 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 12.0 m-85 . . . . . 0 N--CA 1.443 -0.802 0 N-CA-C 109.7 -0.481 . . . . 0.95 109.7 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.3 p -125.8 156.79 35.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.359 -0.978 . . . . 1.37 108.359 172.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 263' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' B' ' 263' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.312 -1.055 0 N-CA-C 109.322 -0.622 . . . . 2.24 109.322 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 . . . . . 0 CA--C 1.53 0.201 0 CA-C-O 121.378 0.608 . . . . 1.85 111.335 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.7 p -161.89 149.53 14.56 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.757 -0.656 . . . . 0.95 109.607 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.23 142.75 4.41 Favored Glycine 0 C--O 1.224 -0.516 0 N-CA-C 111.388 -0.685 . . . . 0.16 111.388 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.774 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -73.53 121.25 20.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.175 0.487 . . . . 0.43 111.148 -177.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.602 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -128.27 161.01 30.36 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.289 0.566 . . . . 0.13 111.925 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.48 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.7 mp -102.74 113.62 39.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.274 -0.875 . . . . 0.29 109.291 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.505 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 84.1 t80 -112.96 101.91 9.93 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.989 -0.375 . . . . 0.56 109.989 -178.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 64.8 57.3 1.05 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.516 0.674 . . . . 1.46 110.721 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt 72.54 -8.2 1.26 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.332 -1.304 . . . . 1.91 113.369 170.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.432 HG21 ' HD3' ' A' ' 36' ' ' LYS . 0.5 OUTLIER -99.85 127.13 53.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.064 0.459 . . . . 0.47 110.37 173.054 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.48 ' HA ' HG13 ' A' ' 8' ' ' ILE . 14.1 p -78.71 126.55 30.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.817 -0.628 . . . . 1.02 110.552 177.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.658 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -147.3 -157.61 7.48 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.938 -0.649 . . . . 0.16 112.556 -177.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.774 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.0 mm -124.7 154.68 32.51 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.789 0 CA-C-O 120.756 0.312 . . . . 0.19 110.721 -177.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.558 HG12 HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -129.27 133.67 65.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.236 -0.438 . . . . 0.16 110.461 -179.616 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.28 112.62 9.25 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.03 -0.532 . . . . 0.12 111.468 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.587 HD11 HG23 ' A' ' 100' ' ' ILE . 4.8 mp -84.24 105.08 13.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.746 -0.835 . . . . 0.18 108.746 172.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -109.38 120.02 41.25 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 110.242 -0.281 . . . . 1.12 110.242 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.62 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 37.3 mt-10 -105.72 83.71 1.97 Allowed 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 117.13 -1.828 . . . . 0.74 107.403 165.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -122.04 -13.03 8.26 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 106.756 -1.572 . . . . 0.59 106.756 157.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.997 HG11 ' HB2' ' A' ' 26' ' ' GLU . 13.9 p -102.93 -179.79 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 111.823 -2.444 . . . . 0.35 111.58 -157.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.642 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 1.4 p -51.88 165.71 0.45 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 117.706 -1.14 . . . . 1.31 108.416 168.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.642 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 18.7 Cg_endo -45.42 124.38 6.43 Favored 'Trans proline' 0 C--N 1.358 1.071 0 CA-C-N 121.514 1.576 . . . . 0.22 111.803 -154.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.806 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -21.69 133.57 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.721 1.748 . . . . 0.2 115.721 -151.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.997 ' HB2' HG11 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -112.93 138.65 49.47 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 114.705 -1.134 . . . . 1.26 110.671 -179.264 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.813 ' HB3' HG12 ' A' ' 40' ' ' VAL . 2.2 tt -100.78 142.53 32.13 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.519 -1.66 . . . . 0.15 106.519 169.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.565 ' N ' HD23 ' A' ' 27' ' ' LEU . 10.5 m -127.47 107.98 10.42 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.973 -0.691 . . . . 0.21 110.122 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.614 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 89.6 t90 -91.34 105.4 17.75 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.664 -0.865 . . . . 0.24 108.664 174.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -114.37 117.17 30.29 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.118 -0.946 . . . . 0.87 109.053 -177.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.569 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 80.8 p -57.24 148.44 22.49 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.09 0.471 . . . . 0.75 110.822 -173.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.658 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 7.5 m -58.4 -27.34 64.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.364 -0.835 . . . . 0.39 110.266 -177.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.473 ' OD2' ' HB3' ' A' ' 35' ' ' ASP . 1.4 p-10 -81.37 -27.54 34.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.078 -0.964 . . . . 2.33 111.267 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.83 2.69 84.02 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.087 -0.578 . . . . 0.55 112.974 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.473 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 12.3 t70 -78.28 -26.1 46.95 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.735 0.272 . . . . 1.13 111.735 -177.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.432 ' HD3' HG21 ' A' ' 12' ' ' VAL . 16.7 ptmt -137.73 155.06 49.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.434 0.635 . . . . 2.03 110.363 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.3 p -149.64 140.69 16.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.226 -0.897 . . . . 0.55 110.392 -175.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -130.72 108.98 10.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.643 0.259 . . . . 0.69 110.369 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 27.0 m -97.83 129.3 44.82 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.323 -0.621 . . . . 0.3 109.323 175.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.813 HG12 ' HB3' ' A' ' 27' ' ' LEU . 9.6 p -119.29 139.98 44.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.76 -0.376 . . . . 0.66 111.501 -178.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.628 ' O ' HG12 ' A' ' 45' ' ' ILE . 60.7 t -89.74 109.54 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.288 0.566 . . . . 0.18 110.077 -177.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.707 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.9 mm? -53.44 -31.84 47.24 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.944 -1.025 . . . . 0.12 112.669 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 15.1 t -76.36 -33.76 58.92 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.581 -0.448 . . . . 1.06 111.012 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.548 ' OG1' ' HB ' ' A' ' 41' ' ' VAL . 72.8 p -74.44 -11.26 60.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.073 0.463 . . . . 0.2 109.908 172.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.628 HG12 ' O ' ' A' ' 41' ' ' VAL . 37.4 mm -83.94 121.31 36.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.885 -0.598 . . . . 0.23 110.391 172.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.716 ' HB2' ' CG ' ' A' ' 65' ' ' LYS . 14.6 t70 -85.81 -41.38 15.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.104 0.478 . . . . 0.7 111.46 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.6 ' HE2' ' OD2' ' A' ' 46' ' ' ASP . 53.4 mmtt -132.47 143.1 49.54 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.563 -0.532 . . . . 1.95 109.563 -177.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.853 HD22 ' HB2' ' A' ' 104' ' ' LEU . 8.1 tp -114.53 141.22 48.01 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.637 0.732 . . . . 0.14 109.223 165.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 13.8 mm100 -122.53 151.52 41.28 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.433 -1.258 . . . . 1.49 109.695 -177.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.19 139.94 8.61 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.671 -0.695 . . . . 0.25 109.242 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.43 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 32.3 p -49.95 128.22 21.2 Favored Pre-proline 0 N--CA 1.468 0.472 0 CA-C-O 121.265 0.555 . . . . 0.37 111.705 -178.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.565 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 57.3 Cg_endo -69.26 166.94 25.26 Favored 'Trans proline' 0 C--N 1.334 -0.207 0 C-N-CA 124.293 3.329 . . . . 0.64 112.153 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.62 -28.49 68.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.255 0.55 . . . . 1.02 110.322 175.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.2 t -68.12 -24.8 65.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.532 -0.758 . . . . 1.58 110.333 176.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.438 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 46.6 t -74.06 136.03 43.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.744 -0.662 . . . . 0.71 110.413 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -87.14 0.4 55.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.474 0.654 . . . . 2.89 110.151 176.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.24 176.83 4.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.094 -0.957 . . . . 2.59 109.689 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.491 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -136.53 110.92 8.48 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.801 -1.185 . . . . 1.78 107.801 178.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.595 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 3.9 ttm -156.01 149.43 24.72 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 120.426 -0.509 . . . . 1.3 111.692 -172.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.44 HD22 HG22 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -120.06 151.2 39.37 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.367 -0.833 . . . . 0.14 110.416 174.365 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.566 ' HD3' ' HB2' ' A' ' 88' ' ' MET . 15.9 ttp180 -148.76 114.43 5.66 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 121.149 0.5 . . . . 2.72 110.62 171.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.833 HD13 ' CE2' ' A' ' 89' ' ' PHE . 8.9 mp -95.16 113.17 24.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.06 -0.518 . . . . 0.9 110.242 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.553 HG23 ' HB3' ' A' ' 86' ' ' ARG . 3.6 mm -87.75 107.54 17.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.881 -0.414 . . . . 0.4 109.881 -173.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -78.92 140.82 23.63 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.321 -0.942 . . . . 0.48 111.391 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.716 ' CG ' ' HB2' ' A' ' 46' ' ' ASP . 16.1 mttm -59.02 135.2 57.55 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.46 0.648 . . . . 1.15 112.142 -174.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 C--N 1.318 -0.778 0 CA-C-N 114.779 -1.101 . . . . 0.69 110.251 -179.202 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 123.334 1.54 . . . . 1.78 109.588 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.553 ' HB3' HG23 ' A' ' 63' ' ' ILE . 27.4 ptt180 -110.8 158.5 18.61 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.688 -1.596 . . . . 2.29 111.046 -172.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -127.03 112.32 15.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.142 -0.935 . . . . 0.5 110.152 -168.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.566 ' HB2' ' HD3' ' A' ' 61' ' ' ARG . 47.6 ttm -106.21 131.36 53.54 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 111.86 0.318 . . . . 0.42 111.86 -173.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.833 ' CE2' HD13 ' A' ' 62' ' ' LEU . 1.5 m-85 -119.04 123.57 44.81 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.071 -0.714 . . . . 1.33 109.071 172.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.545 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 23.4 m -87.44 126.76 35.08 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.101 -0.5 . . . . 0.94 110.021 178.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.602 ' CE1' ' HB2' ' A' ' 7' ' ' ALA . 33.1 m-85 -107.9 165.17 11.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.584 0.707 . . . . 1.33 111.047 176.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -109.9 -12.7 14.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.93 -1.032 . . . . 1.53 109.642 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.556 ' OD1' ' HB ' ' A' ' 95' ' ' THR . 28.5 t-20 -126.28 125.18 41.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.595 -0.73 . . . . 0.83 110.752 -174.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -58.48 -35.57 72.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.962 -1.017 . . . . 2.16 111.553 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.556 ' HB ' ' OD1' ' A' ' 93' ' ' ASN . 95.4 m -70.74 -55.32 8.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.625 0.25 . . . . 0.4 110.59 -176.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.7 t -45.76 -57.86 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 115.904 -0.589 . . . . 0.29 111.526 175.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.491 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -62.09 -29.86 70.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 120.616 -0.434 . . . . 0.29 111.288 -178.082 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.0 -32.15 70.18 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.412 0.625 . . . . 0.39 109.367 177.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.619 ' O ' ' HG3' ' A' ' 102' ' ' MET . 92.0 m-20 -78.16 -48.77 15.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.817 -1.083 . . . . 1.55 110.116 -177.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.587 HG23 HD11 ' A' ' 18' ' ' ILE . 37.8 mm -57.24 -50.97 75.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.314 -0.857 . . . . 0.13 110.396 176.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.692 ' HA ' HD21 ' A' ' 48' ' ' LEU . 11.2 ttpt -56.39 -50.48 71.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.634 -0.712 . . . . 1.11 111.101 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.619 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.9 ppp? -66.44 -24.86 66.51 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.881 0.372 . . . . 1.17 110.841 -176.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 49.3 m -69.43 -49.73 52.38 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.48 0.657 . . . . 0.15 110.328 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.853 ' HB2' HD22 ' A' ' 48' ' ' LEU . 13.9 mt -67.74 -56.68 8.32 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.051 -0.977 . . . . 0.13 111.341 -175.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.761 ' HG3' HD23 ' A' ' 48' ' ' LEU . 35.6 mt-30 -50.02 -29.89 9.58 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.249 0.463 . . . . 1.45 112.249 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -60.91 -31.3 70.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.979 0.895 . . . . 0.65 109.414 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.806 HG21 ' HB3' ' A' ' 25' ' ' ALA . 21.3 mt -84.92 -46.51 17.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 113.594 -1.639 . . . . 0.17 110.503 178.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 104' ' ' LEU . 0.9 OUTLIER -64.68 -51.2 70.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.677 -0.692 . . . . 0.29 110.775 -174.436 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.3 m -57.4 -26.27 60.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.988 0.423 . . . . 1.22 110.673 174.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 12.1 mtt180 -69.2 -37.35 78.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.453 0.645 . . . . 3.79 110.006 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.449 ' HD2' ' O ' ' A' ' 107' ' ' ILE . 42.4 m-85 . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 114.982 -1.008 . . . . 0.6 111.734 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 261' ' ' PHE . . . . . 0.565 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 9.8 m-85 . . . . . 0 N--CA 1.444 -0.765 0 N-CA-C 109.747 -0.464 . . . . 0.95 109.747 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 10.6 p -135.59 140.17 45.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.272 -0.27 . . . . 1.37 110.272 175.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 . . . . . 0 C--N 1.324 -0.526 0 N-CA-C 108.639 -0.874 . . . . 2.24 108.639 174.067 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.0 m80 . . . . . 0 C--O 1.228 -0.055 0 CA-C-O 121.23 0.538 . . . . 1.85 110.336 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.438 ' C ' HD11 ' A' ' 100' ' ' ILE . 77.4 p -162.72 149.53 13.02 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.496 -0.775 . . . . 0.95 109.655 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.26 147.0 7.74 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 110.839 -0.905 . . . . 0.16 110.839 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.741 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -79.26 117.43 20.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.644 0.722 . . . . 0.43 111.619 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.29 158.24 28.59 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.347 0.594 . . . . 0.13 111.587 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.492 HG13 ' HA ' ' A' ' 13' ' ' SER . 3.1 mp -99.01 129.22 49.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.409 -0.814 . . . . 0.29 109.263 177.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.578 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 89.1 t80 -139.28 111.96 7.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.913 -0.585 . . . . 0.56 109.917 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 69.49 45.21 0.84 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.727 0.775 . . . . 1.46 110.421 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? 70.01 3.14 4.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.276 -1.329 . . . . 1.91 112.732 172.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.1 131.68 59.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.784 0.326 . . . . 0.47 110.478 175.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.492 ' HA ' HG13 ' A' ' 8' ' ' ILE . 30.5 t -78.69 117.0 19.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.4 0.619 . . . . 1.02 110.042 177.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.718 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -130.97 -153.91 7.75 Favored Glycine 0 N--CA 1.434 -1.44 0 CA-C-N 115.288 -0.869 . . . . 0.16 111.3 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.741 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 7.8 mm -127.88 153.15 36.86 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 CA-C-O 120.919 0.39 . . . . 0.19 110.687 -177.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.442 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -125.41 131.94 71.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 115.824 -0.625 . . . . 0.16 109.332 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.94 113.97 10.58 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.758 -0.377 . . . . 0.12 111.555 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.603 HD11 HG23 ' A' ' 100' ' ' ILE . 4.4 mp -84.14 113.46 23.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.068 -1.086 . . . . 0.18 108.068 171.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.466 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.1 t30 -121.58 130.33 53.44 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.487 -0.324 . . . . 1.12 110.274 -177.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -110.48 84.55 1.95 Allowed 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 116.912 -1.915 . . . . 0.74 107.482 164.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.466 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 13.2 t70 -120.85 -10.32 9.14 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 106.122 -1.807 . . . . 0.59 106.122 157.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.749 HG11 ' HB2' ' A' ' 26' ' ' GLU . 14.0 p -102.08 179.15 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 111.743 -2.48 . . . . 0.35 111.395 -158.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.69 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -53.33 168.77 0.35 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 117.543 -1.217 . . . . 1.31 108.134 166.522 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.594 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 9.2 Cg_endo -41.68 127.2 3.41 Favored 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 121.796 1.664 . . . . 0.22 111.088 -157.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.54 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -30.72 131.51 0.09 Allowed 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 125.279 1.612 . . . . 0.2 113.557 -154.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.749 ' HB2' HG11 ' A' ' 22' ' ' VAL . 47.0 mt-10 -124.09 143.25 50.57 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.676 -1.147 . . . . 1.26 110.864 -169.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.576 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.1 tt -101.26 143.39 31.39 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 106.557 -1.645 . . . . 0.15 106.557 175.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.416 ' N ' HD23 ' A' ' 27' ' ' LEU . 14.1 m -129.46 109.65 11.23 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.846 -0.742 . . . . 0.21 110.705 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.647 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 85.1 t90 -86.71 106.59 17.75 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.52 0.676 . . . . 0.24 109.544 174.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -114.31 118.87 35.11 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.289 -0.869 . . . . 0.87 109.191 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.432 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 49.8 m -56.08 142.04 37.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.871 0.367 . . . . 0.75 110.756 -176.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.718 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 18.4 m -59.29 -28.19 66.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.452 -0.795 . . . . 0.39 110.166 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.09 -27.19 54.06 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.218 -0.901 . . . . 2.33 110.932 175.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.63 -3.98 50.1 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.122 -0.561 . . . . 0.55 112.681 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.4 ' OD2' ' HG3' ' A' ' 36' ' ' LYS . 32.3 t70 -69.98 -78.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.458 0.54 . . . . 1.13 112.458 -175.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.4 ' HG3' ' OD2' ' A' ' 35' ' ' ASP . 19.8 mtpp -83.99 142.66 30.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.291 0.567 . . . . 2.03 112.057 -175.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 61.1 t -138.29 117.23 14.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.788 -1.096 . . . . 0.55 109.618 177.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -124.37 110.01 14.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.31 -0.404 . . . . 0.69 110.434 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.7 m -97.72 138.83 34.52 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 121.188 -0.205 . . . . 0.3 111.386 -176.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.568 HG11 HD13 ' A' ' 62' ' ' LEU . 27.7 t -113.11 129.3 69.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 122.769 0.428 . . . . 0.66 111.625 177.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.592 ' O ' HG12 ' A' ' 45' ' ' ILE . 23.0 t -90.81 108.49 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 121.252 0.548 . . . . 0.18 109.942 174.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.604 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.6 mm? -56.1 -28.1 56.37 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.158 -0.928 . . . . 0.12 112.339 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 41.1 t -74.88 -31.67 61.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.75 0.309 . . . . 1.06 110.674 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.427 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 82.6 p -80.29 -9.78 59.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.635 0.731 . . . . 0.2 109.738 175.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.615 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 45.1 mm -85.21 123.75 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 114.872 -1.058 . . . . 0.23 111.143 174.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.655 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 4.9 t70 -74.84 -47.71 28.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.149 -0.932 . . . . 0.7 110.718 176.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.524 ' HD2' ' O ' ' A' ' 46' ' ' ASP . 0.5 OUTLIER -147.0 164.75 32.01 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.134 -0.485 . . . . 1.95 111.036 -176.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.087 HD23 ' HG3' ' A' ' 105' ' ' GLN . 13.0 tp -125.96 146.73 49.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.004 0.431 . . . . 0.14 109.944 172.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 16.7 mm100 -124.08 158.55 31.95 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.182 -0.917 . . . . 1.49 110.176 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HB1' ' CE ' ' A' ' 97' ' ' MET . . . -164.66 142.91 6.72 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.496 -0.774 . . . . 0.25 109.928 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.559 ' HB ' ' CB ' ' A' ' 55' ' ' SER . 41.5 p -55.53 129.73 69.99 Favored Pre-proline 0 N--CA 1.471 0.587 0 CA-C-O 121.235 0.54 . . . . 0.37 111.355 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.467 ' O ' ' HB3' ' A' ' 55' ' ' SER . 39.1 Cg_endo -64.59 165.9 19.21 Favored 'Trans proline' 0 N--CA 1.471 0.148 0 C-N-CA 124.017 3.144 . . . . 0.64 112.555 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.04 -27.26 65.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.97 0.414 . . . . 1.02 110.726 175.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.7 m -74.62 -24.22 58.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.922 -0.581 . . . . 1.58 111.16 177.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.559 ' CB ' ' HB ' ' A' ' 51' ' ' THR . 27.3 t -61.81 138.25 58.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.972 -0.558 . . . . 0.71 110.634 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.65 -18.16 42.07 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.793 -0.817 . . . . 2.89 108.793 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -103.74 174.1 6.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.718 -1.128 . . . . 2.59 109.577 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.511 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -134.24 111.76 10.52 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.151 -0.685 . . . . 1.78 109.151 177.423 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.513 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 69.3 mtm -153.77 142.11 20.6 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.932 0.396 . . . . 1.3 111.288 -175.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.535 HD23 HD11 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -110.79 157.26 19.99 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.472 -0.786 . . . . 0.14 110.422 175.556 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.489 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 38.0 ttp180 -149.75 114.6 5.35 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-O 121.26 0.552 . . . . 2.72 111.629 170.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.786 ' HG ' HD13 ' A' ' 48' ' ' LEU . 8.5 mt -91.97 112.62 24.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.875 -0.602 . . . . 0.9 110.706 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.574 HG23 ' HG2' ' A' ' 86' ' ' ARG . 3.8 mm -86.01 108.88 17.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 C-N-CA 123.72 0.808 . . . . 0.4 110.436 -173.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -78.99 155.94 41.34 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 119.969 -1.11 . . . . 0.48 111.64 176.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.655 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 0.2 OUTLIER -68.05 135.06 51.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.133 0.467 . . . . 1.15 110.726 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.323 -0.563 0 CA-C-O 120.998 0.428 . . . . 0.69 110.018 176.737 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.298 0 CA-C-O 121.864 0.84 . . . . 1.78 110.259 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.574 ' HG2' HG23 ' A' ' 63' ' ' ILE . 6.7 mtm180 -115.2 141.56 47.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.315 -0.857 . . . . 2.29 109.816 -175.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -107.69 111.83 24.23 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.852 -0.613 . . . . 0.5 109.781 -173.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.456 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 55.7 ttm -105.02 121.92 44.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.729 0.3 . . . . 0.42 111.037 -176.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.437 ' CG ' HD11 ' A' ' 16' ' ' ILE . 91.1 m-85 -119.46 124.41 46.42 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.724 -0.473 . . . . 1.33 109.724 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.485 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 42.0 m -90.16 133.28 34.99 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.978 0.418 . . . . 0.94 110.874 -176.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.629 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 24.2 m-85 -108.14 173.61 6.24 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.153 0.501 . . . . 1.33 111.303 176.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -114.13 1.06 14.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.549 -0.75 . . . . 1.53 110.178 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -145.77 126.83 14.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.7 -0.682 . . . . 0.83 109.979 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.511 ' HA ' ' HG2' ' A' ' 97' ' ' MET . 5.9 ttm180 -71.3 -20.79 62.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.785 -0.643 . . . . 2.16 110.982 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.458 HG22 HD21 ' A' ' 99' ' ' ASN . 99.7 m -72.73 -55.39 6.84 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.104 -0.332 . . . . 0.4 110.104 174.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.9 t -45.81 -56.0 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-N 116.233 -0.439 . . . . 0.29 111.289 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.528 ' CE ' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -64.52 -28.56 69.73 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.031 -0.531 . . . . 0.29 111.221 -177.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.54 -33.31 72.6 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.127 -0.694 . . . . 0.39 109.127 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.597 ' O ' ' HG3' ' A' ' 102' ' ' MET . 89.8 m-20 -74.5 -46.3 40.24 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.622 -1.172 . . . . 1.55 109.657 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.629 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 30.0 mm -59.9 -51.4 73.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.917 -1.038 . . . . 0.13 110.522 175.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.829 ' HA ' HD21 ' A' ' 48' ' ' LEU . 3.0 ttpp -57.16 -47.79 80.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.515 -0.766 . . . . 1.11 110.85 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.597 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.7 ppp? -67.06 -26.09 66.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.581 -0.281 . . . . 1.17 110.398 -177.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 106' ' ' GLN . 61.0 m -66.64 -54.9 18.29 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.286 0.565 . . . . 0.15 110.143 175.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.93 ' HB2' HD22 ' A' ' 48' ' ' LEU . 10.6 mt -64.5 -56.22 15.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.264 -0.88 . . . . 0.13 110.925 -175.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 1.087 ' HG3' HD23 ' A' ' 48' ' ' LEU . 98.0 mt-30 -52.6 -24.19 7.86 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.889 0.7 . . . . 1.45 112.889 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 102' ' ' MET . 37.6 mt-30 -65.73 -40.97 92.69 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.899 0.857 . . . . 0.65 109.013 174.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.54 HG21 ' HB3' ' A' ' 25' ' ' ALA . 49.3 mt -72.5 -42.49 63.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 113.765 -1.561 . . . . 0.17 110.727 178.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.1 mt -63.95 -58.21 8.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.454 -0.794 . . . . 0.29 110.595 -176.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.0 t -54.64 -26.24 31.79 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.288 0.566 . . . . 1.22 110.802 173.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.435 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 8.3 ttt180 -69.59 -20.5 63.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.675 -0.693 . . . . 3.79 110.257 176.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.439 ' HD2' ' O ' ' A' ' 107' ' ' ILE . 18.0 m-85 . . . . . 0 N--CA 1.443 -0.796 0 CA-C-O 121.91 0.862 . . . . 0.6 108.694 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 261' ' ' PHE . . . . . 0.465 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 6.6 m-85 . . . . . 0 N--CA 1.447 -0.606 0 N-CA-C 110.045 -0.354 . . . . 0.95 110.045 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 10.2 p -143.96 140.81 25.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.75 -0.463 . . . . 1.37 109.75 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 . . . . . 0 C--N 1.317 -0.817 0 N-CA-C 108.836 -0.801 . . . . 2.24 108.836 175.585 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 52.7 p-80 . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 121.587 0.708 . . . . 1.85 110.675 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.4 p -162.7 134.89 5.42 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.205 -0.907 . . . . 0.95 109.241 173.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.5 148.22 10.47 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.664 -0.975 . . . . 0.16 110.664 -178.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.734 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.39 133.88 41.08 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 117.159 0.48 . . . . 0.43 111.44 -175.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.89 156.36 46.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.289 0.566 . . . . 0.13 111.386 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.544 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.2 mp -98.86 110.94 27.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.913 -0.773 . . . . 0.29 108.913 177.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.475 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 80.3 t80 -109.96 109.78 20.49 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.366 -0.379 . . . . 0.56 110.356 -177.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 63.61 46.53 4.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.883 0.849 . . . . 1.46 110.517 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt 77.18 -5.59 2.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.726 -1.579 . . . . 1.91 113.151 170.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.53 133.72 41.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.009 0.433 . . . . 0.47 110.427 173.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.544 ' HA ' HG13 ' A' ' 8' ' ' ILE . 22.6 t -78.16 126.63 31.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.91 -0.586 . . . . 1.02 110.532 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.674 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -150.05 -159.71 8.86 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.597 -0.729 . . . . 0.16 112.476 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.734 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 7.0 mm -126.31 153.43 34.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.821 0.343 . . . . 0.19 110.69 -178.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.49 133.69 68.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.977 -0.556 . . . . 0.16 109.762 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.0 108.03 7.18 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.013 0.435 . . . . 0.12 111.898 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.587 HD11 HG23 ' A' ' 100' ' ' ILE . 4.3 mp -85.73 110.74 20.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.833 -0.803 . . . . 0.18 108.833 172.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.445 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.6 t30 -114.19 127.65 56.0 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.651 -0.42 . . . . 1.12 110.268 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -109.8 83.65 1.79 Allowed 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 117.281 -1.768 . . . . 0.74 107.464 164.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.445 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 19.5 t70 -122.57 -11.25 8.29 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 106.466 -1.679 . . . . 0.59 106.466 156.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.939 HG11 ' HB3' ' A' ' 26' ' ' GLU . 14.5 p -101.44 173.58 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 111.964 -2.38 . . . . 0.35 112.072 -155.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.648 ' O ' HG13 ' A' ' 22' ' ' VAL . 7.6 m -54.42 165.81 0.81 Allowed Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 106.673 -1.603 . . . . 1.31 106.673 166.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 9.5 Cg_endo -40.36 127.52 2.24 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.655 1.57 . . . . 0.22 111.699 -147.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.666 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -31.01 131.48 0.1 Allowed 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 125.359 1.662 . . . . 0.2 112.649 -159.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.939 ' HB3' HG11 ' A' ' 22' ' ' VAL . 25.3 tt0 -130.14 133.73 46.83 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.51 -1.223 . . . . 1.26 111.658 -160.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.546 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.6 tt -101.62 147.39 26.47 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 107.006 -1.479 . . . . 0.15 107.006 177.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.516 ' N ' HD23 ' A' ' 27' ' ' LEU . 30.3 m -138.44 109.79 6.94 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.204 -0.599 . . . . 0.21 110.729 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.62 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 92.2 t90 -86.65 109.79 19.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.65 -0.705 . . . . 0.24 109.219 177.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.72 118.3 35.23 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.344 -0.844 . . . . 0.87 109.039 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.503 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 86.7 p -57.28 142.63 42.53 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 110.008 -0.367 . . . . 0.75 110.008 -177.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.674 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 38.3 m -46.67 -39.76 11.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.256 0.55 . . . . 0.39 110.91 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -72.32 -27.67 62.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.226 -0.897 . . . . 2.33 111.646 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.3 21.82 28.73 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.984 -0.627 . . . . 0.55 112.471 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -101.78 -30.76 11.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.158 0.504 . . . . 1.13 110.781 -173.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -126.22 130.06 50.2 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.663 -0.698 . . . . 2.03 110.154 -176.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 95.9 t -133.59 123.54 46.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.786 0.326 . . . . 0.55 110.223 -177.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -125.33 110.99 14.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.193 -0.458 . . . . 0.69 110.37 -177.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 40.2 m -92.6 145.05 24.73 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.805 0.336 . . . . 0.3 111.663 -177.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.574 HG11 HD13 ' A' ' 62' ' ' LEU . 32.0 t -122.02 124.72 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.254 -0.43 . . . . 0.66 110.913 174.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 45' ' ' ILE . 59.7 t -91.47 108.32 19.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.014 -0.736 . . . . 0.18 109.014 175.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.592 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.0 mm? -52.72 -27.63 18.46 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.409 -0.814 . . . . 0.12 112.79 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 45.4 t -75.38 -29.28 59.81 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.599 -0.44 . . . . 1.06 110.822 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.5 p -82.59 -4.64 57.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.46 0.647 . . . . 0.2 109.937 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.631 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 45.5 mm -89.39 126.01 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.134 -0.939 . . . . 0.23 111.448 175.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.577 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 21.7 t70 -77.5 -41.86 37.81 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.732 -0.667 . . . . 0.7 110.928 176.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -153.03 160.73 43.02 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 115.856 -0.611 . . . . 1.95 110.425 -175.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.999 HD23 ' HG2' ' A' ' 105' ' ' GLN . 12.9 tp -121.22 149.24 43.13 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.219 0.533 . . . . 0.14 109.566 171.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.57 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 10.6 mm100 -125.39 156.34 38.95 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.229 -0.896 . . . . 1.49 109.5 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.03 145.24 11.89 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.809 -0.812 . . . . 0.25 108.809 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 36.6 p -54.61 124.96 51.82 Favored Pre-proline 0 C--O 1.234 0.286 0 CA-C-O 121.254 0.549 . . . . 0.37 111.419 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 62.0 Cg_endo -70.55 167.28 25.93 Favored 'Trans proline' 0 C--N 1.332 -0.34 0 C-N-CA 124.242 3.295 . . . . 0.64 112.061 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.57 -18.57 53.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.425 0.631 . . . . 1.02 110.215 172.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 63.5 m -83.79 -8.67 59.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.293 -0.867 . . . . 1.58 111.469 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.519 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 41.2 t -89.05 148.23 23.84 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.081 -0.508 . . . . 0.71 110.347 175.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -89.0 -11.2 44.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.798 -0.637 . . . . 2.89 110.985 177.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.9 mmmt -108.27 -177.05 3.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.763 -0.653 . . . . 2.59 110.324 -173.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.519 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -131.75 109.05 9.88 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.351 -0.981 . . . . 1.78 108.351 170.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.567 ' HG2' ' HA ' ' A' ' 90' ' ' SER . 68.7 mtm -155.39 146.04 22.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.044 0.384 . . . . 1.3 111.733 -175.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.878 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.7 OUTLIER -109.73 164.98 12.05 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.015 -0.539 . . . . 0.14 111.467 174.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 49.4 ttp180 -155.38 113.71 3.46 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.89 -0.595 . . . . 2.72 110.68 171.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.812 ' HG ' HD13 ' A' ' 48' ' ' LEU . 7.8 mt -93.37 114.52 26.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.094 0.473 . . . . 0.9 110.762 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.607 HG23 ' HG2' ' A' ' 86' ' ' ARG . 4.0 mm -86.74 106.1 15.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.718 -0.674 . . . . 0.4 110.517 -173.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.631 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -75.58 149.44 38.46 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 119.664 -1.255 . . . . 0.48 111.246 176.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.577 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 0.1 OUTLIER -60.4 134.91 57.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.258 0.529 . . . . 1.15 110.087 178.175 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 C--N 1.323 -0.585 0 CA-C-O 121.126 0.489 . . . . 0.69 110.62 176.442 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.447 -0.605 0 CA-C-O 122.483 1.135 . . . . 1.78 108.838 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.607 ' HG2' HG23 ' A' ' 63' ' ' ILE . 27.1 mtt85 -108.61 150.8 27.0 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.285 -1.325 . . . . 2.29 109.658 -176.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -109.15 110.41 21.63 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.865 -0.791 . . . . 0.5 108.865 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.484 ' HE2' ' HD3' ' A' ' 61' ' ' ARG . 52.8 ttm -111.44 120.89 43.67 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.698 -0.228 . . . . 0.42 110.669 -174.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.628 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -114.62 141.1 48.23 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.77 -0.826 . . . . 1.33 108.77 177.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.567 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 65.0 m -95.63 124.76 39.81 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.677 -0.49 . . . . 0.94 109.677 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.878 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 3.1 m-85 -107.41 167.29 10.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.302 -0.408 . . . . 1.33 109.994 -176.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -115.64 -2.3 12.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.95 0.405 . . . . 1.53 110.776 -173.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -145.2 129.29 17.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.18 0.514 . . . . 0.83 110.247 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 98' ' ' ASP . 6.7 tpt180 -65.1 -30.6 71.55 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.202 -0.908 . . . . 2.16 110.753 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.51 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 32.4 m -69.34 -47.59 63.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.21 0.529 . . . . 0.4 110.332 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.821 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 82.8 t -60.06 -53.18 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 CA-C-N 115.584 -0.735 . . . . 0.29 111.404 177.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.519 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -63.56 -24.45 67.81 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.906 -0.718 . . . . 0.29 109.582 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.51 ' HB3' ' O ' ' A' ' 95' ' ' THR . 33.0 t70 -69.92 -42.66 73.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.399 0.619 . . . . 0.39 109.522 175.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.821 ' ND2' ' HA ' ' A' ' 96' ' ' VAL . 21.5 p30 -80.56 -31.66 36.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.752 -1.113 . . . . 1.55 110.282 -173.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.587 HG23 HD11 ' A' ' 18' ' ' ILE . 27.3 mm -67.1 -52.46 43.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.483 -0.781 . . . . 0.13 110.219 171.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.767 ' HA ' HD21 ' A' ' 48' ' ' LEU . 4.2 ttpp -55.2 -51.18 67.39 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.986 -0.552 . . . . 1.11 110.641 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 5.1 ppp? -63.33 -27.64 69.46 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 120.668 0.271 . . . . 1.17 111.012 -175.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.9 m -65.31 -49.82 68.02 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.279 0.561 . . . . 0.15 109.933 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.919 ' HB2' HD22 ' A' ' 48' ' ' LEU . 9.2 mt -71.17 -57.6 4.35 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 115.193 -0.912 . . . . 0.13 111.19 -176.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.999 ' HG2' HD23 ' A' ' 48' ' ' LEU . 23.4 mm-40 -42.22 -35.49 0.97 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.174 0.805 . . . . 1.45 113.174 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -65.92 -44.85 83.97 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.728 0.775 . . . . 0.65 108.961 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.666 HG21 ' HB3' ' A' ' 25' ' ' ALA . 72.0 mt -65.68 -43.37 93.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 113.891 -1.504 . . . . 0.17 110.954 177.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.471 HG13 ' HA ' ' A' ' 105' ' ' GLN . 0.7 OUTLIER -61.6 -57.07 13.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.663 -0.699 . . . . 0.29 110.661 -176.191 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.8 m -54.49 -29.9 51.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.972 -0.558 . . . . 1.22 110.829 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 58.1 mtt180 -71.65 -29.62 64.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.712 -0.676 . . . . 3.79 110.832 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.47 ' OH ' ' HA ' ' A' ' 24' ' ' PRO . 14.5 m-85 . . . . . 0 C--N 1.321 -0.656 0 CA-C-N 115.859 -0.609 . . . . 0.6 111.435 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 261' ' ' PHE . . . . . 0.539 ' CE1' ' HB2' ' A' ' 59' ' ' MET . 3.3 m-85 . . . . . 0 N--CA 1.45 -0.468 0 CA-C-O 120.945 0.402 . . . . 0.95 110.429 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 4.7 p -133.66 163.65 36.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.962 -0.755 . . . . 1.37 108.962 175.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.313 -1.018 0 N-CA-C 109.476 -0.564 . . . . 2.24 109.476 173.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.601 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 39.4 m80 . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 120.626 0.25 . . . . 1.85 111.352 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 m -161.02 148.22 15.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.684 0.278 . . . . 0.95 110.511 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.81 147.6 7.18 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 110.409 -1.077 . . . . 0.16 110.409 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.718 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -81.06 119.97 24.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 117.935 0.868 . . . . 0.43 111.448 -175.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -127.9 160.35 32.1 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.541 0.686 . . . . 0.13 112.016 -176.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 2.6 mp -100.85 126.9 54.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.179 -0.918 . . . . 0.29 109.392 177.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.413 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 84.5 t80 -126.12 112.09 15.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.067 -0.515 . . . . 0.56 110.286 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 59.99 47.36 9.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.565 0.698 . . . . 1.46 110.903 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt 74.85 0.61 3.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.317 -1.31 . . . . 1.91 113.288 171.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -106.04 132.4 53.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.372 -0.531 . . . . 0.47 110.695 171.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.521 ' HA ' HG13 ' A' ' 8' ' ' ILE . 47.5 t -79.85 129.98 34.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.635 -0.711 . . . . 1.02 110.639 178.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.679 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -151.63 -153.26 6.15 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.797 -0.638 . . . . 0.16 112.036 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.718 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 7.5 mm -128.27 153.47 37.72 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 CA-C-O 120.948 0.404 . . . . 0.19 110.76 -177.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.469 HD11 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -122.61 134.6 65.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 115.911 -0.586 . . . . 0.16 109.628 179.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.58 109.26 7.04 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.52 -0.309 . . . . 0.12 111.7 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.674 HD11 HG23 ' A' ' 100' ' ' ILE . 3.7 mp -85.69 126.43 40.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.494 -0.928 . . . . 0.18 108.494 171.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.767 HD21 ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -126.96 129.37 47.99 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.38 -0.528 . . . . 1.12 109.752 178.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -113.34 84.26 1.98 Allowed 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 117.353 -1.739 . . . . 0.74 107.694 164.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.43 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 20.5 t70 -122.25 -12.01 8.32 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 106.468 -1.678 . . . . 0.59 106.468 157.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.767 ' HB ' HD21 ' A' ' 19' ' ' ASN . 11.1 p -102.18 173.9 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 111.792 -2.458 . . . . 0.35 112.745 -154.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.732 ' O ' HG13 ' A' ' 22' ' ' VAL . 5.5 m -54.72 166.7 0.71 Allowed Pre-proline 0 C--O 1.221 -0.415 0 N-CA-C 106.689 -1.597 . . . . 1.31 106.689 165.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 11.0 Cg_endo -42.06 127.99 4.03 Favored 'Trans proline' 0 C--N 1.355 0.908 0 CA-C-N 122.036 1.763 . . . . 0.22 111.203 -151.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.784 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -33.47 137.61 0.08 Allowed 'General case' 0 CA--C 1.506 -0.715 0 O-C-N 125.379 1.674 . . . . 0.2 113.833 -155.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.568 ' HB2' HG11 ' A' ' 22' ' ' VAL . 30.6 mt-10 -121.35 131.05 53.97 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 114.933 -1.03 . . . . 1.26 111.055 -169.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.561 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.7 tt -101.02 140.4 35.37 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 106.215 -1.772 . . . . 0.15 106.215 171.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.436 ' N ' HD23 ' A' ' 27' ' ' LEU . 19.4 m -131.22 108.83 9.98 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.677 -0.809 . . . . 0.21 110.441 -178.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.616 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 89.6 t90 -85.56 107.78 17.65 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.383 -0.826 . . . . 0.24 109.323 176.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -113.46 114.77 27.03 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.788 -1.097 . . . . 0.87 108.414 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.591 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 37.3 p -56.48 143.96 33.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.963 0.411 . . . . 0.75 110.268 -177.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.679 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 19.8 m -53.0 -33.2 50.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.145 -0.934 . . . . 0.39 111.432 -177.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -80.68 -27.84 36.93 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.125 -0.489 . . . . 2.33 111.233 177.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.04 0.34 57.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.098 -0.572 . . . . 0.55 112.234 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -64.37 -48.18 76.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.104 0.478 . . . . 1.13 111.516 -177.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -117.59 148.72 41.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.803 -0.635 . . . . 2.03 111.706 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 89.6 t -145.22 125.41 6.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.486 -1.234 . . . . 0.55 109.808 178.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -133.08 115.51 15.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.479 -0.328 . . . . 0.69 110.717 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 24.2 m -98.44 139.63 33.9 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.928 -0.309 . . . . 0.3 111.403 -178.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 23.3 t -112.12 129.46 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 122.878 0.471 . . . . 0.66 111.127 176.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.546 ' O ' HG12 ' A' ' 45' ' ' ILE . 48.4 t -91.6 108.77 20.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 CA-C-O 121.293 0.568 . . . . 0.18 109.565 173.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.634 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.1 mm? -53.95 -25.72 22.05 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.127 -0.942 . . . . 0.12 113.03 -178.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 64.6 m -79.78 -31.42 40.85 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.521 -0.471 . . . . 1.06 111.689 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.8 p -76.88 -8.74 57.9 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.178 -0.675 . . . . 0.2 109.178 173.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.592 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 47.3 mm -86.45 121.56 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.044 -0.98 . . . . 0.23 111.552 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.672 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 23.0 t70 -80.08 -43.31 22.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.621 -0.718 . . . . 0.7 110.991 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -140.51 157.12 45.98 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.986 -0.376 . . . . 1.95 109.986 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.01 HD23 ' HG3' ' A' ' 105' ' ' GLN . 12.2 tp -118.74 144.73 46.07 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.271 -0.64 . . . . 0.14 109.271 166.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 12.3 mm100 -122.88 151.91 41.27 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.066 -0.97 . . . . 1.49 109.317 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.05 146.3 10.72 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.51 -0.768 . . . . 0.25 109.132 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.496 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 54.6 p -60.58 126.12 84.13 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-O 121.548 0.69 . . . . 0.37 111.073 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.484 ' O ' ' HB3' ' A' ' 55' ' ' SER . 57.8 Cg_endo -67.46 166.49 23.55 Favored 'Trans proline' 0 C--N 1.333 -0.276 0 C-N-CA 123.984 3.123 . . . . 0.64 111.627 177.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.64 -21.88 66.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.928 0.394 . . . . 1.02 110.67 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 t -78.76 -19.74 51.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 1.58 110.545 177.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.484 ' HB3' ' O ' ' A' ' 52' ' ' PRO . 27.9 t -67.85 145.56 54.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.889 -0.596 . . . . 0.71 110.452 176.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -89.82 -13.82 35.75 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.4 0.619 . . . . 2.89 110.145 175.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -106.48 173.57 6.26 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.135 -0.939 . . . . 2.59 110.053 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.511 ' HB3' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -130.46 112.18 12.98 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.644 -0.707 . . . . 1.78 109.555 175.581 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.62 ' HB3' ' CZ ' ' B' ' 261' ' ' PHE . 2.5 mtm -156.03 148.28 23.49 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.838 0.351 . . . . 1.3 111.691 -176.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.33 154.96 30.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.519 -0.764 . . . . 0.14 110.428 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 21.3 ttm180 -151.11 113.88 4.7 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 120.931 0.396 . . . . 2.72 110.823 171.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.76 ' HG ' HD13 ' A' ' 48' ' ' LEU . 9.1 mt -92.56 112.6 24.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.112 0.482 . . . . 0.9 110.509 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.69 HG23 ' HG2' ' A' ' 86' ' ' ARG . 6.3 mm -87.05 111.75 22.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 C-N-CA 123.464 0.705 . . . . 0.4 110.513 -172.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.592 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -79.0 150.36 33.92 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 120.254 -0.974 . . . . 0.48 111.864 177.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.672 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 1.1 mptm? -63.74 132.19 50.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.012 0.406 . . . . 1.15 110.763 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 C--N 1.318 -0.799 0 N-CA-C 109.19 -0.67 . . . . 0.69 109.19 175.874 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.351 0 CA-C-O 121.775 0.798 . . . . 1.78 109.761 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.69 ' HG2' HG23 ' A' ' 63' ' ' ILE . 37.7 mtm180 -116.71 140.32 49.55 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.48 -0.782 . . . . 2.29 110.285 -173.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -103.1 111.23 23.48 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.552 -0.749 . . . . 0.5 109.155 -177.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.523 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 43.4 ttm -102.78 132.41 48.96 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.716 0.293 . . . . 0.42 110.754 -176.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.469 ' CG ' HD11 ' A' ' 16' ' ' ILE . 95.4 m-85 -127.16 123.72 37.39 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.526 -0.546 . . . . 1.33 109.526 177.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.535 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 50.1 m -91.78 130.85 37.49 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.831 0.348 . . . . 0.94 110.556 -177.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.619 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 30.7 m-85 -108.16 173.65 6.23 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.034 -0.53 . . . . 1.33 110.156 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -117.43 -3.06 11.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.017 -0.538 . . . . 1.53 109.6 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.556 ' OD1' ' HB ' ' A' ' 95' ' ' THR . 28.6 t-20 -137.51 130.62 30.61 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.595 -0.73 . . . . 0.83 110.21 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.546 ' HA ' ' HG2' ' A' ' 97' ' ' MET . 2.2 tmt_? -74.29 -24.05 59.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.866 -0.606 . . . . 2.16 110.559 -174.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.556 ' HB ' ' OD1' ' A' ' 93' ' ' ASN . 51.6 m -71.95 -48.33 45.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.96 0.409 . . . . 0.4 110.326 177.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.826 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 96.8 t -55.9 -57.12 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-N 115.956 -0.565 . . . . 0.29 111.259 174.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.625 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -58.35 -30.9 67.11 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.526 -0.87 . . . . 0.29 109.529 -179.14 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.624 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 33.5 t70 -64.8 -43.75 92.15 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.623 0.725 . . . . 0.39 110.721 175.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.826 ' ND2' ' HA ' ' A' ' 96' ' ' VAL . 20.6 p30 -76.96 -25.52 52.92 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.071 -0.968 . . . . 1.55 109.899 -173.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.674 HG23 HD11 ' A' ' 18' ' ' ILE . 28.2 mm -72.39 -55.94 11.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.813 -1.085 . . . . 0.13 111.196 171.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.799 ' HA ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -59.07 -39.29 81.67 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 120.768 0.318 . . . . 1.11 111.259 -177.359 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.442 ' HB3' ' HE2' ' A' ' 101' ' ' LYS . 26.6 ptm -69.85 -27.27 64.7 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.28 -0.637 . . . . 1.17 109.28 -176.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 21.7 m -67.62 -53.37 28.56 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.65 -0.705 . . . . 0.15 110.018 174.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.921 ' HB2' HD22 ' A' ' 48' ' ' LEU . 10.4 mt -65.66 -56.44 12.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.193 -0.912 . . . . 0.13 111.221 -176.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 1.01 ' HG3' HD23 ' A' ' 48' ' ' LEU . 42.8 mt-30 -51.68 -30.12 20.69 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.48 0.548 . . . . 1.45 112.48 -178.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -68.6 -26.85 65.58 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.882 0.848 . . . . 0.65 109.571 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.784 HG21 ' HB3' ' A' ' 25' ' ' ALA . 47.8 mt -82.56 -41.72 17.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.052 -1.431 . . . . 0.17 110.071 176.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.3 mt -66.98 -49.88 69.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.551 -0.75 . . . . 0.29 110.752 -176.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.7 m -61.34 -22.72 65.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.506 0.669 . . . . 1.22 110.063 174.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 9.7 ttt180 -72.19 -32.15 66.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.106 -0.952 . . . . 3.79 109.862 176.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 . . . . . 0 N--CA 1.451 -0.401 0 CA-C-N 116.177 -0.465 . . . . 0.6 111.654 -177.288 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 261' ' ' PHE . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 2.8 m-30 . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.956 0.408 . . . . 0.95 110.239 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.36 140.6 22.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.927 -0.579 . . . . 1.37 110.205 174.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 C--N 1.328 -0.33 0 N-CA-C 108.809 -0.812 . . . . 2.24 108.809 171.348 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.3 m80 . . . . . 0 N--CA 1.463 0.188 0 CA-C-O 121.587 0.708 . . . . 1.85 109.547 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.403 ' C ' HD11 ' A' ' 100' ' ' ILE . 68.1 p -163.27 148.84 11.56 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.929 -1.032 . . . . 0.95 108.883 -176.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.22 142.69 5.64 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.188 -0.765 . . . . 0.16 111.188 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.747 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -73.4 120.94 19.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 117.361 0.58 . . . . 0.43 111.237 -176.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.485 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -130.08 157.7 41.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.394 0.616 . . . . 0.13 111.852 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.529 ' HB ' ' HB3' ' A' ' 90' ' ' SER . 2.6 mp -95.93 124.47 48.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.125 -0.943 . . . . 0.29 109.07 176.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.489 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 88.8 t80 -128.69 103.44 7.08 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.164 -0.471 . . . . 0.56 109.919 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 67.24 58.41 0.55 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.792 -0.64 . . . . 1.46 110.872 -175.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp 70.13 -8.47 0.84 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.608 -1.178 . . . . 1.91 113.374 171.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -104.73 131.83 52.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.969 0.414 . . . . 0.47 111.061 177.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.492 ' HA ' HG13 ' A' ' 8' ' ' ILE . 28.7 p -79.9 125.95 30.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.707 -0.679 . . . . 1.02 110.721 176.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.649 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -144.82 -154.38 6.12 Favored Glycine 0 N--CA 1.436 -1.339 0 CA-C-N 115.711 -0.677 . . . . 0.16 111.637 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.747 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 9.2 mm -126.13 153.84 34.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 120.755 0.312 . . . . 0.19 110.68 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.28 133.72 68.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 116.102 -0.499 . . . . 0.16 109.95 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.63 113.98 10.18 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 111.899 0.333 . . . . 0.12 111.899 175.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.585 HD11 HG23 ' A' ' 100' ' ' ILE . 3.8 mp -85.38 124.39 40.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.359 -0.978 . . . . 0.18 108.359 171.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.47 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 2.3 t30 -126.62 124.31 39.61 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.949 -0.389 . . . . 1.12 109.949 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.503 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 23.7 mt-10 -109.63 84.05 1.86 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 117.084 -1.847 . . . . 0.74 107.519 163.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.47 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 17.7 t70 -121.48 -9.86 8.93 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.476 -1.676 . . . . 0.59 106.476 156.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 23' ' ' SER . 14.7 p -101.98 173.1 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 112.045 -2.343 . . . . 0.35 111.63 -157.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.663 ' O ' HG13 ' A' ' 22' ' ' VAL . 14.5 m -54.98 166.66 0.75 Allowed Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 106.942 -1.503 . . . . 1.31 106.942 166.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 10.2 Cg_endo -40.67 127.42 2.45 Favored 'Trans proline' 0 C--N 1.357 0.997 0 CA-C-N 121.913 1.719 . . . . 0.22 111.34 -150.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.734 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -33.7 136.34 0.11 Allowed 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 125.379 1.674 . . . . 0.2 113.691 -156.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.54 ' HB2' HG11 ' A' ' 22' ' ' VAL . 80.7 mt-10 -123.5 138.87 54.48 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.422 -1.263 . . . . 1.26 111.099 -169.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.572 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.1 tt -101.41 144.44 30.21 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 106.257 -1.757 . . . . 0.15 106.257 171.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.456 ' N ' HD23 ' A' ' 27' ' ' LEU . 18.1 m -129.84 109.18 10.72 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.903 -0.719 . . . . 0.21 110.002 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.606 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 89.9 t90 -86.9 105.4 17.04 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.687 -0.857 . . . . 0.24 108.687 175.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -113.49 114.84 27.1 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.844 -1.071 . . . . 0.87 108.738 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.54 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 37.5 p -56.19 148.33 18.49 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.24 0.543 . . . . 0.75 111.282 -174.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.649 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 24.0 m -55.97 -30.09 61.21 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.953 -1.021 . . . . 0.39 111.371 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -80.2 -28.54 38.64 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.024 0.44 . . . . 2.33 110.756 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.19 6.61 53.43 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.956 -0.64 . . . . 0.55 112.631 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.38 -69.72 0.6 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.367 . . . . 1.13 111.363 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -82.55 137.6 34.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.472 0.653 . . . . 2.03 111.546 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 96.0 t -140.57 120.32 12.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.397 -1.274 . . . . 0.55 109.496 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -125.89 114.12 18.11 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.438 -0.347 . . . . 0.69 110.438 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.2 m -96.99 138.49 34.45 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 121.205 -0.198 . . . . 0.3 111.188 -177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 37.5 t -113.31 129.79 68.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 122.716 0.407 . . . . 0.66 111.722 178.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.553 ' O ' HG12 ' A' ' 45' ' ' ILE . 46.8 t -90.42 108.86 20.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 CA-C-O 121.286 0.565 . . . . 0.18 109.777 172.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.573 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -55.12 -27.04 42.34 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.312 -0.858 . . . . 0.12 112.633 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.448 ' O ' ' HE2' ' A' ' 65' ' ' LYS . 33.9 t -75.97 -35.11 59.76 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.722 -0.391 . . . . 1.06 110.799 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.2 p -76.99 -16.39 59.35 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.591 0.71 . . . . 0.2 109.249 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.733 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 42.2 mm -73.66 121.47 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 114.977 -1.01 . . . . 0.23 110.964 172.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.641 ' HA ' ' NZ ' ' A' ' 65' ' ' LYS . 23.0 t70 -78.61 -48.23 15.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.21 -0.45 . . . . 0.7 111.298 175.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -137.0 151.9 49.51 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 110.165 -0.309 . . . . 1.95 110.165 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.072 HD23 ' HG3' ' A' ' 105' ' ' GLN . 11.9 tp -116.07 144.9 43.5 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.118 -0.697 . . . . 0.14 109.118 166.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 8.1 mm100 -120.22 159.51 24.8 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.399 -0.819 . . . . 1.49 109.396 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' HB3' ' HG3' ' A' ' 101' ' ' LYS . . . -161.69 152.43 17.83 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.48 -0.933 . . . . 0.25 108.48 174.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.452 ' CG2' ' HE2' ' A' ' 59' ' ' MET . 33.4 p -55.4 125.49 59.41 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.476 0.655 . . . . 0.37 111.432 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 43.0 Cg_endo -67.39 166.88 22.12 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 124.0 3.133 . . . . 0.64 111.581 176.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.01 -22.73 67.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.027 0.441 . . . . 1.02 110.303 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.3 p -74.48 -27.7 60.69 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.558 -0.746 . . . . 1.58 110.786 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.446 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 23.0 t -70.29 140.8 52.37 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.214 -0.903 . . . . 0.71 109.409 174.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -90.95 -13.63 33.09 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.788 -0.819 . . . . 2.89 108.788 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.562 ' N ' ' HD3' ' A' ' 57' ' ' LYS . 2.2 mppt? -99.21 -176.8 3.41 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.745 -1.116 . . . . 2.59 111.354 -175.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.449 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -139.87 109.22 6.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.483 . . . . 1.78 109.705 -177.082 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.524 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 2.6 mpp? -155.69 167.65 29.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.934 0.397 . . . . 1.3 111.721 -175.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.644 HD23 HD11 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -130.28 161.58 30.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.324 -0.853 . . . . 0.14 111.445 176.38 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.582 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 13.1 ttm180 -154.26 114.3 3.86 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.765 -0.198 . . . . 2.72 110.749 173.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.771 ' HG ' HD13 ' A' ' 48' ' ' LEU . 10.7 mt -96.65 110.3 22.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.863 0.364 . . . . 0.9 111.095 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.482 ' CD1' ' HD2' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -89.13 128.73 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.056 0.543 . . . . 0.4 110.086 -178.099 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.733 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -95.02 152.28 20.4 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.017 -1.087 . . . . 0.48 112.337 176.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.641 ' NZ ' ' HA ' ' A' ' 46' ' ' ASP . 1.2 mptp? -58.33 134.48 56.62 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.755 0.312 . . . . 1.15 110.627 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--N 1.319 -0.719 0 CA-C-O 121.184 0.516 . . . . 0.69 110.306 178.078 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.446 HE21 ' HB2' ' A' ' 85' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.287 0.565 . . . . 1.78 110.385 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.81 160.17 26.57 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.794 -0.639 . . . . 2.29 111.017 -174.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -125.08 113.0 17.16 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.282 -0.872 . . . . 0.5 109.406 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 55.8 ttm -105.15 126.08 51.68 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.835 0.35 . . . . 0.42 111.447 -175.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.452 ' CE2' HD12 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -118.97 124.59 47.39 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.563 -0.532 . . . . 1.33 109.563 178.181 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.529 ' HB3' ' HB ' ' A' ' 8' ' ' ILE . 33.3 t -93.06 130.72 38.57 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.849 0.357 . . . . 0.94 110.226 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.603 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 27.2 m-85 -108.53 172.7 6.69 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.824 -0.625 . . . . 1.33 111.417 176.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -119.95 -4.72 10.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.364 -0.834 . . . . 1.53 110.465 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -134.63 129.27 34.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.95 0.405 . . . . 0.83 110.338 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 14.9 tpt180 -59.62 -32.94 70.89 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.398 -0.819 . . . . 2.16 111.188 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.529 HG22 HD21 ' A' ' 99' ' ' ASN . 87.3 m -70.42 -58.7 3.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.419 -0.355 . . . . 0.4 110.545 -177.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.4 t -45.72 -56.04 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-N 115.695 -0.684 . . . . 0.29 111.85 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.525 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -64.7 -28.59 69.7 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.256 -0.429 . . . . 0.29 110.966 -176.408 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -73.32 -30.04 63.09 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.037 -0.727 . . . . 0.39 109.037 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.619 ' O ' ' HG3' ' A' ' 102' ' ' MET . 91.6 m-20 -77.5 -48.05 18.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.666 -1.152 . . . . 1.55 109.842 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.603 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 36.4 mm -57.9 -49.16 82.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.248 -0.887 . . . . 0.13 110.153 176.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.797 ' HA ' HD21 ' A' ' 48' ' ' LEU . 2.3 tmmm? -57.0 -48.53 78.25 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.814 -0.63 . . . . 1.11 110.887 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.619 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 5.0 ppp? -70.08 -24.65 63.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.78 0.324 . . . . 1.17 110.506 -175.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 53.9 m -67.79 -50.79 55.02 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.491 0.662 . . . . 0.15 109.891 176.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.927 ' HB2' HD22 ' A' ' 48' ' ' LEU . 12.6 mt -69.85 -58.17 4.2 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.963 -1.017 . . . . 0.13 111.326 -175.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 1.072 ' HG3' HD23 ' A' ' 48' ' ' LEU . 49.4 mt-30 -53.45 -24.03 11.67 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.804 0.668 . . . . 1.45 112.804 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -65.69 -48.91 70.45 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.637 -0.875 . . . . 0.65 108.637 175.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.734 HG21 ' HB3' ' A' ' 25' ' ' ALA . 60.1 mt -58.53 -43.8 87.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.2 -1.364 . . . . 0.17 110.811 175.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.5 mt -65.03 -51.21 69.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.596 -0.729 . . . . 0.29 110.184 -177.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.7 m -55.18 -33.31 62.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.15 0.5 . . . . 1.22 110.605 172.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 91.2 mtt180 -67.19 -30.24 70.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.588 -0.733 . . . . 3.79 110.602 178.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 . . . . . 0 N--CA 1.448 -0.533 0 CA-C-N 116.124 -0.489 . . . . 0.6 111.357 -179.431 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 261' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 61' ' ' ARG . 7.1 m-30 . . . . . 0 CA--C 1.52 -0.203 0 CA-C-O 120.957 0.408 . . . . 0.95 110.856 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.08 160.6 29.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.301 -1.0 . . . . 1.37 108.301 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.658 0 C-N-CA 120.082 -0.647 . . . . 2.24 109.977 177.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.615 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 19.9 m170 . . . . . 0 C--O 1.225 -0.224 0 CA-C-O 120.618 0.247 . . . . 1.85 111.417 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.6 p -164.42 159.31 19.41 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.072 -0.344 . . . . 0.95 110.072 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.36 144.71 4.23 Favored Glycine 0 C--O 1.225 -0.456 0 N-CA-C 110.886 -0.886 . . . . 0.16 110.886 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.745 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -76.56 120.71 22.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.618 0.709 . . . . 0.43 111.124 -177.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.47 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -130.05 159.27 37.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.307 0.575 . . . . 0.13 111.725 -176.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.506 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.3 mp -97.28 118.14 43.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.216 -0.902 . . . . 0.29 109.115 175.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.598 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 82.8 t80 -123.35 110.03 14.65 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.379 -0.373 . . . . 0.56 109.997 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.588 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 41.1 mt-10 68.74 50.37 0.65 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.488 -0.778 . . . . 1.46 110.702 -175.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.588 ' HD2' ' C ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER 66.49 3.9 3.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.31 -1.314 . . . . 1.91 112.791 171.515 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.497 HG21 ' HD2' ' A' ' 36' ' ' LYS . 0.7 OUTLIER -110.81 133.76 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.797 0.332 . . . . 0.47 110.293 172.118 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.506 ' HA ' HG13 ' A' ' 8' ' ' ILE . 31.8 t -78.17 133.25 37.82 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.325 0.583 . . . . 1.02 110.57 178.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.646 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -154.33 -152.95 6.26 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.486 -0.779 . . . . 0.16 111.683 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.745 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.3 mm -126.66 154.02 36.03 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-O 120.795 0.331 . . . . 0.19 110.646 -178.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.473 HD11 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -127.02 135.15 64.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 116.011 -0.541 . . . . 0.16 109.833 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.81 113.28 9.47 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.015 0.436 . . . . 0.12 112.031 174.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.759 HD11 HG23 ' A' ' 100' ' ' ILE . 4.3 mp -84.56 113.18 22.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.74 -0.837 . . . . 0.18 108.74 171.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.452 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.8 t30 -118.16 123.98 46.86 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 110.135 -0.321 . . . . 1.12 110.135 -178.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.468 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 22.3 mt-10 -107.69 83.35 1.79 Allowed 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 117.191 -1.804 . . . . 0.74 107.383 165.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.452 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 18.1 t70 -122.21 -11.78 8.37 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.782 -1.562 . . . . 0.59 106.782 157.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.671 HG13 ' O ' ' A' ' 23' ' ' SER . 14.8 p -101.68 179.86 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 111.887 -2.415 . . . . 0.35 111.737 -155.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.671 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -53.04 165.2 0.62 Allowed Pre-proline 0 C--O 1.224 -0.263 0 N-CA-C 107.699 -1.223 . . . . 1.31 107.699 166.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.569 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 15.4 Cg_endo -44.49 126.39 6.83 Favored 'Trans proline' 0 C--N 1.353 0.813 0 CA-C-N 121.366 1.523 . . . . 0.22 111.852 -154.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.749 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -23.69 134.27 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 O-C-N 125.127 1.517 . . . . 0.2 114.882 -153.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.665 ' HB2' HG11 ' A' ' 22' ' ' VAL . 37.9 mt-10 -126.26 137.36 53.51 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.697 -1.138 . . . . 1.26 111.034 -173.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.2 tt -99.99 145.27 28.07 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 106.47 -1.678 . . . . 0.15 106.47 175.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.504 ' N ' HD23 ' A' ' 27' ' ' LEU . 19.2 m -131.96 109.3 9.96 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.891 -0.724 . . . . 0.21 110.392 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.601 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.2 t90 -89.25 108.16 19.46 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.574 -0.739 . . . . 0.24 109.143 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -115.89 120.26 38.65 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.252 -0.885 . . . . 0.87 109.091 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.509 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 35.5 p -56.01 148.17 18.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.891 0.377 . . . . 0.75 110.892 -175.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.646 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 21.7 m -54.26 -32.96 57.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.431 -0.804 . . . . 0.39 110.949 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -77.54 -29.66 52.42 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.244 -0.434 . . . . 2.33 111.113 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.07 13.66 51.84 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.736 -0.745 . . . . 0.55 113.042 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -85.84 -69.04 0.69 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.159 0.504 . . . . 1.13 110.336 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.497 ' HD2' HG21 ' A' ' 12' ' ' VAL . 17.0 ptpt -87.49 145.09 26.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.624 0.726 . . . . 2.03 110.371 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 65.7 t -147.17 140.51 19.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.487 -1.233 . . . . 0.55 109.041 -176.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -141.21 122.67 15.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.571 0.224 . . . . 0.69 110.595 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.0 m -103.85 142.66 34.0 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 121.256 -0.177 . . . . 0.3 111.09 -177.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.533 HG11 HD13 ' A' ' 62' ' ' LEU . 45.8 t -119.42 130.02 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.187 0.44 . . . . 0.66 112.187 178.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.555 ' O ' HG12 ' A' ' 45' ' ' ILE . 49.9 t -91.13 108.88 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-O 121.499 0.666 . . . . 0.18 109.935 172.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.605 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.3 mm? -49.95 -35.46 24.23 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.512 -1.222 . . . . 0.12 112.463 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.523 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 69.4 m -74.9 -29.91 61.13 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.866 -0.333 . . . . 1.06 111.576 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.477 ' OG1' ' HB ' ' A' ' 41' ' ' VAL . 76.1 p -79.97 -8.58 59.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.499 0.666 . . . . 0.2 109.766 175.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.61 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 39.3 mm -82.38 132.58 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.061 -0.972 . . . . 0.23 111.219 174.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.66 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 12.0 t70 -82.82 -41.1 19.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.354 -0.839 . . . . 0.7 110.911 175.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.515 ' O ' HG12 ' A' ' 63' ' ' ILE . 45.9 mmtt -145.47 143.02 29.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.374 -0.83 . . . . 1.95 110.658 -173.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.149 HD23 ' HG3' ' A' ' 105' ' ' GLN . 13.6 tp -111.27 139.62 46.51 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.659 -0.817 . . . . 0.14 109.45 163.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.643 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 15.6 mm100 -118.27 155.77 30.01 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.425 -1.262 . . . . 1.49 110.001 -178.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.01 143.73 9.47 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.878 -1.056 . . . . 0.25 108.546 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 47.3 p -54.49 126.18 54.83 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.665 0.745 . . . . 0.37 111.106 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.542 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 65.8 Cg_endo -71.7 167.76 25.61 Favored 'Trans proline' 0 C--N 1.332 -0.29 0 C-N-CA 124.349 3.366 . . . . 0.64 112.045 176.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.17 -24.23 64.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.993 0.425 . . . . 1.02 110.659 174.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -69.17 -24.04 64.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.53 0.681 . . . . 1.58 110.162 174.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.596 ' OG ' ' HE2' ' A' ' 57' ' ' LYS . 28.8 t -84.43 139.34 32.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.471 -0.786 . . . . 0.71 109.256 176.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -92.95 -11.9 32.16 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.823 -0.806 . . . . 2.89 108.823 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.596 ' HE2' ' OG ' ' A' ' 55' ' ' SER . 2.3 mppt? -90.45 176.48 6.69 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.695 -1.139 . . . . 2.59 110.779 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.447 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -135.3 109.58 8.36 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.011 -0.737 . . . . 1.78 109.011 -178.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.547 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 63.4 mtm -155.96 150.11 25.51 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.87 0.367 . . . . 1.3 111.23 -173.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -121.42 156.48 32.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.396 -0.82 . . . . 0.14 110.421 174.345 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.587 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 33.8 ttt180 -153.67 113.22 3.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.989 0.424 . . . . 2.72 110.892 175.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.774 ' HG ' HD13 ' A' ' 48' ' ' LEU . 10.4 mt -93.73 111.66 23.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.105 0.479 . . . . 0.9 110.428 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.897 HG23 ' HG2' ' A' ' 86' ' ' ARG . 3.7 mm -86.17 106.47 15.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 123.534 0.734 . . . . 0.4 109.98 -174.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -81.2 139.43 20.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 119.897 -1.144 . . . . 0.48 112.1 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.66 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 5.9 mttt -53.3 135.77 38.14 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.227 0.537 . . . . 1.15 111.467 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--N 1.322 -0.622 0 CA-C-O 121.559 0.695 . . . . 0.69 111.048 -176.236 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 122.506 1.146 . . . . 1.78 111.038 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.897 ' HG2' HG23 ' A' ' 63' ' ' ILE . 17.8 mtt85 -102.97 144.26 31.48 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.473 -1.24 . . . . 2.29 109.813 -174.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -105.82 110.87 23.32 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.802 -0.814 . . . . 0.5 108.802 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.423 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 58.2 ttm -105.1 121.97 44.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.916 0.389 . . . . 0.42 110.924 -174.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.473 ' CG ' HD11 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -117.06 123.19 46.24 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.832 -0.803 . . . . 1.33 108.832 177.5 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.523 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 28.2 t -94.64 131.54 40.32 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.149 0.5 . . . . 0.94 110.188 -178.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.47 ' CE1' ' HB2' ' A' ' 7' ' ' ALA . 38.2 m-85 -108.59 165.54 11.46 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.527 -0.76 . . . . 1.33 110.504 175.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -114.62 -3.3 12.92 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.45 -0.796 . . . . 1.53 110.168 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -126.15 121.51 33.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.865 -0.607 . . . . 0.83 109.76 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -54.66 -36.55 64.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.816 -1.084 . . . . 2.16 111.483 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.617 HG22 HD21 ' A' ' 99' ' ' ASN . 93.7 m -73.23 -55.59 6.24 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.964 -0.562 . . . . 0.4 111.015 -175.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 94.0 t -45.13 -57.24 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-N 116.111 -0.495 . . . . 0.29 111.364 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.756 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -60.9 -34.05 74.06 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.579 -0.448 . . . . 0.29 110.416 -176.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -71.57 -20.35 62.02 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.165 0.507 . . . . 0.39 110.427 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.629 ' O ' ' HG3' ' A' ' 102' ' ' MET . 92.1 m-20 -86.93 -37.84 17.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.222 1.01 . . . . 1.55 109.094 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.759 HG23 HD11 ' A' ' 18' ' ' ILE . 1.6 mm -67.65 -50.7 58.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 113.934 -1.485 . . . . 0.13 111.675 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.756 ' HG2' ' O ' ' A' ' 97' ' ' MET . 2.6 ptmt -58.63 -39.56 80.86 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 120.689 0.28 . . . . 1.11 110.822 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.629 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.8 ppp? -73.65 -23.62 59.88 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.166 -0.679 . . . . 1.17 109.166 -176.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 21.2 m -68.02 -51.44 46.98 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.405 -0.816 . . . . 0.15 109.92 173.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.983 ' HB2' HD22 ' A' ' 48' ' ' LEU . 12.6 mt -72.72 -57.17 4.3 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.524 -0.762 . . . . 0.13 111.633 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 1.149 ' HG3' HD23 ' A' ' 48' ' ' LEU . 95.1 mt-30 -51.88 -26.56 10.37 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.64 0.607 . . . . 1.45 112.64 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -71.47 -42.8 67.69 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.229 -0.656 . . . . 0.65 109.229 177.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.749 HG21 ' HB3' ' A' ' 25' ' ' ALA . 69.8 mt -61.42 -44.43 98.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.545 -1.207 . . . . 0.17 110.145 174.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.559 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.2 mt -63.9 -47.8 89.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.635 -0.712 . . . . 0.29 109.906 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.4 t -58.77 -30.68 67.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.354 0.597 . . . . 1.22 109.973 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 12.6 ttt180 -67.36 -37.26 82.91 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.133 -0.939 . . . . 3.79 109.778 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 . . . . . 0 N--CA 1.445 -0.699 0 CA-C-N 115.827 -0.624 . . . . 0.6 111.479 -175.332 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 261' ' ' PHE . . . . . 0.643 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 8.2 m-30 . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 120.658 0.266 . . . . 0.95 110.893 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.71 156.98 12.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.421 -0.354 . . . . 1.37 110.233 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 263' ' ' GLU . . . . . 0.462 ' HA ' ' NE2' ' A' ' 105' ' ' GLN . 40.1 tt0 . . . . . 0 C--N 1.327 -0.411 0 N-CA-C 109.279 -0.638 . . . . 2.24 109.279 173.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.6 m80 . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 121.117 0.484 . . . . 1.85 110.657 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 82.0 p -163.99 148.88 10.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.099 -0.501 . . . . 0.95 109.998 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.45 144.85 5.79 Favored Glycine 0 C--O 1.223 -0.579 0 N-CA-C 110.592 -1.003 . . . . 0.16 110.592 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.726 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -76.63 119.35 20.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.773 0.786 . . . . 0.43 111.448 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.432 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -124.82 158.22 33.93 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.484 0.659 . . . . 0.13 111.7 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.526 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.7 mp -100.48 123.99 53.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.04 -0.982 . . . . 0.29 109.028 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.43 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 85.7 t80 -121.9 101.71 7.73 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.29 -0.414 . . . . 0.56 110.061 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 65.99 56.98 0.82 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.575 0.702 . . . . 1.46 110.708 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt 73.13 -8.03 1.39 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.407 -1.27 . . . . 1.91 113.109 170.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -102.46 130.27 52.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.059 0.457 . . . . 0.47 110.712 174.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.526 ' HA ' HG13 ' A' ' 8' ' ' ILE . 27.0 t -79.86 130.84 35.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.685 -0.689 . . . . 1.02 110.404 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.647 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -148.95 -155.63 6.8 Favored Glycine 0 N--CA 1.435 -1.373 0 CA-C-N 115.588 -0.733 . . . . 0.16 111.906 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.726 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.3 mm -126.74 153.74 35.92 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 CA-C-O 120.801 0.334 . . . . 0.19 110.759 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.464 HD11 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -125.05 133.82 68.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.918 -0.583 . . . . 0.16 109.501 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.3 108.88 6.96 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.002 0.429 . . . . 0.12 111.992 175.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.622 HD11 HG23 ' A' ' 100' ' ' ILE . 3.6 mp -85.16 120.21 35.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.559 -0.904 . . . . 0.18 108.559 172.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.445 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 2.0 t30 -124.34 123.84 41.07 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.886 -0.413 . . . . 1.12 109.886 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -109.0 83.32 1.73 Allowed 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 117.187 -1.805 . . . . 0.74 107.632 165.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.445 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 11.9 t70 -122.48 -10.92 8.37 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 106.774 -1.565 . . . . 0.59 106.774 156.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 23' ' ' SER . 14.5 p -101.41 175.1 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 112.181 -2.282 . . . . 0.35 111.775 -155.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.683 ' O ' HG13 ' A' ' 22' ' ' VAL . 1.2 t -54.42 165.47 0.86 Allowed Pre-proline 0 C--O 1.225 -0.221 0 N-CA-C 105.972 -1.862 . . . . 1.31 105.972 167.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.558 ' HA ' ' OH ' ' A' ' 111' ' ' TYR . 9.8 Cg_endo -41.22 128.01 3.03 Favored 'Trans proline' 0 C--N 1.357 0.995 0 CA-C-N 122.204 1.823 . . . . 0.22 111.744 -151.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.716 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -29.81 133.81 0.05 Allowed 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 125.348 1.655 . . . . 0.2 113.756 -157.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.643 ' HB2' HG11 ' A' ' 22' ' ' VAL . 31.6 mt-10 -122.56 132.56 54.36 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.768 -1.105 . . . . 1.26 110.98 -171.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.2 tt -100.92 142.45 32.37 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.398 -1.704 . . . . 0.15 106.398 172.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.412 ' N ' HD23 ' A' ' 27' ' ' LEU . 24.5 m -129.8 110.04 11.42 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.636 -0.826 . . . . 0.21 110.505 -178.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.641 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 86.0 t90 -86.11 105.87 16.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.591 0.71 . . . . 0.24 109.27 174.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -113.26 114.14 26.29 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.91 -1.041 . . . . 0.87 108.741 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.584 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 93.1 p -57.61 147.53 26.99 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.422 0.63 . . . . 0.75 110.424 -174.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.647 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 18.9 m -51.98 -26.44 10.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.447 -1.251 . . . . 0.39 112.331 -174.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -88.07 -28.16 21.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.961 0.41 . . . . 2.33 111.234 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.91 17.33 28.16 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.996 -0.621 . . . . 0.55 112.361 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -90.01 -35.31 15.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.03 0.443 . . . . 1.13 111.15 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -118.61 141.71 48.33 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.162 0.506 . . . . 2.03 111.114 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 69.3 t -141.79 116.93 5.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.972 -1.013 . . . . 0.55 109.853 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -123.36 109.56 14.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.191 -0.459 . . . . 0.69 109.934 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 39.0 m -98.07 137.08 37.39 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.985 -0.286 . . . . 0.3 111.207 -176.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.524 HG11 HD13 ' A' ' 62' ' ' LEU . 40.0 t -110.8 129.69 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 122.705 0.402 . . . . 0.66 111.467 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.539 ' O ' HG12 ' A' ' 45' ' ' ILE . 55.3 t -91.21 108.04 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-O 121.282 0.563 . . . . 0.18 109.576 173.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.617 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.8 mm? -56.09 -28.32 57.24 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.07 -0.968 . . . . 0.12 112.533 -177.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 31.5 t -74.19 -31.3 62.6 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.297 -0.561 . . . . 1.06 110.504 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.6 p -79.94 -10.01 59.73 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.682 -0.488 . . . . 0.2 109.682 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.623 HG21 ' CD2' ' A' ' 62' ' ' LEU . 44.6 mm -84.44 116.53 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.61 -0.723 . . . . 0.23 111.535 176.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.63 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 2.5 t70 -74.96 -47.54 28.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.242 -0.89 . . . . 0.7 111.422 175.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.498 ' O ' HG12 ' A' ' 63' ' ' ILE . 15.5 tptt -136.02 136.66 40.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.047 -0.524 . . . . 1.95 109.916 -174.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.041 HD23 ' HG3' ' A' ' 105' ' ' GLN . 13.2 tp -106.74 142.65 36.04 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 119.661 -0.815 . . . . 0.14 109.081 164.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.572 HE21 ' HB2' ' B' ' 261' ' ' PHE . 4.1 mt-30 -122.96 152.69 40.62 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.687 -1.142 . . . . 1.49 109.675 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.497 ' H ' ' HB3' ' B' ' 261' ' ' PHE . . . -161.47 139.2 9.08 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.182 -0.673 . . . . 0.25 109.182 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 40.4 p -54.95 125.41 56.07 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-O 121.453 0.644 . . . . 0.37 111.715 -178.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 46.1 Cg_endo -67.34 166.74 22.48 Favored 'Trans proline' 0 C--N 1.334 -0.204 0 C-N-CA 124.064 3.176 . . . . 0.64 112.238 178.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.439 ' N ' HH21 ' A' ' 94' ' ' ARG . . . -60.43 -28.89 68.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.028 0.442 . . . . 1.02 110.419 175.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 t -71.75 -24.13 61.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.744 -0.662 . . . . 1.58 110.466 177.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.449 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 33.4 t -71.51 141.87 50.14 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.549 -0.537 . . . . 0.71 109.549 176.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -83.4 -17.64 41.54 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.302 0.572 . . . . 2.89 110.149 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -97.09 179.93 4.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.518 -0.764 . . . . 2.59 110.662 -173.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.467 ' N ' ' SD ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -133.75 110.32 9.73 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.177 -1.046 . . . . 1.78 108.177 171.311 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.522 ' HB3' ' HE1' ' B' ' 261' ' ' PHE . 29.8 ttm -157.11 137.61 13.03 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.592 -0.443 . . . . 1.3 111.247 -171.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.444 HD23 HD11 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -112.12 155.47 23.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.929 -0.578 . . . . 0.14 110.173 177.671 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 19.6 ttm180 -151.02 113.59 4.66 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.739 0.304 . . . . 2.72 110.794 173.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.785 ' HG ' HD13 ' A' ' 48' ' ' LEU . 10.7 mt -96.94 108.2 20.87 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.056 0.543 . . . . 0.9 111.331 -177.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.698 HG23 ' HB3' ' A' ' 86' ' ' ARG . 2.6 mm -88.88 131.46 36.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 C-N-CA 123.21 0.604 . . . . 0.4 110.872 -175.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -85.6 166.1 39.33 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.153 -1.022 . . . . 0.48 112.056 175.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.63 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 1.1 mptm? -75.07 131.24 40.42 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.622 -0.511 . . . . 1.15 109.622 173.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.2 p . . . . . 0 C--N 1.32 -0.675 0 CA-C-O 121.383 0.611 . . . . 0.69 111.416 -178.232 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.216 0 CA-C-O 121.998 0.904 . . . . 1.78 110.817 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.698 ' HB3' HG23 ' A' ' 63' ' ' ILE . 21.3 ptt180 -126.62 148.68 49.76 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.546 -0.752 . . . . 2.29 111.273 -174.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -117.63 113.07 21.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.227 -0.897 . . . . 0.5 110.523 -169.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.48 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 49.1 ttm -100.59 130.87 46.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.82 0.343 . . . . 0.42 111.537 -176.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.464 ' CG ' HD11 ' A' ' 16' ' ' ILE . 79.4 m-85 -126.28 122.66 36.12 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.433 -0.58 . . . . 1.33 109.433 174.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.426 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 35.5 m -92.46 132.93 36.38 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.302 -0.408 . . . . 0.94 110.161 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.647 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 25.5 m-85 -108.5 171.13 7.59 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.968 0.413 . . . . 1.33 110.846 177.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -112.0 -3.27 14.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.823 -0.626 . . . . 1.53 110.114 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -141.08 129.13 22.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.346 0.594 . . . . 0.83 110.799 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.439 HH21 ' N ' ' A' ' 53' ' ' ALA . 49.3 tpt85 -61.04 -27.98 68.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.806 -1.088 . . . . 2.16 111.405 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.481 HG22 HD21 ' A' ' 99' ' ' ASN . 99.3 m -75.8 -55.63 5.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.629 -0.259 . . . . 0.4 111.278 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.3 t -45.52 -56.8 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-O 120.852 0.358 . . . . 0.29 111.082 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.688 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -62.24 -32.09 72.74 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.779 -0.646 . . . . 0.29 110.602 -177.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.415 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 19.6 t70 -66.55 -34.13 77.22 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.77 0.795 . . . . 0.39 109.555 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.604 ' O ' ' HG3' ' A' ' 102' ' ' MET . 89.2 m-20 -76.83 -41.32 44.69 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.421 -1.263 . . . . 1.55 109.878 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.647 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 23.4 mm -63.02 -53.43 46.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.948 -1.024 . . . . 0.13 111.15 176.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.785 ' HA ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -59.88 -38.14 81.36 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 120.726 0.298 . . . . 1.11 111.065 -177.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.604 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.4 ppp? -71.63 -25.74 62.28 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.365 -0.606 . . . . 1.17 109.365 -175.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 23.1 m -68.13 -52.15 38.11 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.488 -0.778 . . . . 0.15 110.258 174.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.946 ' HB2' HD22 ' A' ' 48' ' ' LEU . 8.2 mt -69.16 -57.44 5.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.523 -0.762 . . . . 0.13 111.33 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 1.041 ' HG3' HD23 ' A' ' 48' ' ' LEU . 95.2 mt-30 -52.7 -25.48 11.13 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.811 0.671 . . . . 1.45 112.811 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -73.41 -35.63 65.86 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.703 0.763 . . . . 0.65 109.403 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.716 HG21 ' HB3' ' A' ' 25' ' ' ALA . 69.5 mt -69.53 -41.7 80.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.539 -1.21 . . . . 0.17 110.249 175.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.2 mt -65.6 -50.86 69.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.805 -0.634 . . . . 0.29 110.544 -176.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.6 m -58.69 -28.86 66.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.212 0.53 . . . . 1.22 110.141 174.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.464 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 8.3 ttt180 -66.09 -39.51 90.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.405 -0.816 . . . . 3.79 109.509 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.558 ' OH ' ' HA ' ' A' ' 24' ' ' PRO . 21.3 m-85 . . . . . 0 N--CA 1.446 -0.625 0 CA-C-N 115.503 -0.772 . . . . 0.6 111.651 -175.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 261' ' ' PHE . . . . . 0.572 ' HB2' HE21 ' A' ' 49' ' ' GLN . 35.1 m-85 . . . . . 0 N--CA 1.452 -0.371 0 CA-C-O 121.467 0.651 . . . . 0.95 112.287 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 11.9 p -144.23 147.64 19.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 114.729 -1.123 . . . . 1.37 108.907 171.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 263' ' ' GLU . . . . . 0.506 ' HA ' HE22 ' A' ' 105' ' ' GLN . 17.5 tt0 . . . . . 0 C--N 1.323 -0.547 0 N-CA-C 109.265 -0.643 . . . . 2.24 109.265 176.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo . . . . . 0 CA--C 1.527 0.128 0 N-CA-C 111.659 -0.169 . . . . 3.14 111.659 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.515 ' HA ' ' HB3' ' A' ' 99' ' ' ASN . 32.5 p -99.14 -59.5 1.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.069 0.461 . . . . 1.4 110.912 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -85.85 11.75 10.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.111 -0.495 . . . . 1.85 110.886 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 8.0 m -161.45 141.62 10.68 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.802 -0.444 . . . . 0.95 109.802 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -174.69 142.95 6.6 Favored Glycine 0 C--O 1.224 -0.491 0 N-CA-C 110.864 -0.894 . . . . 0.16 110.864 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.734 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -76.54 117.64 18.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.588 0.694 . . . . 0.43 111.847 -175.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.53 162.33 25.91 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.429 0.633 . . . . 0.13 111.92 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.591 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.8 mp -105.07 123.14 59.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.237 -0.892 . . . . 0.29 109.082 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -117.15 106.14 13.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.652 -0.249 . . . . 0.56 110.516 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 61.0 50.66 4.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.609 0.719 . . . . 1.46 110.366 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt 75.46 -8.67 1.54 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.151 -1.386 . . . . 1.91 113.382 170.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.45 HG21 ' HD2' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -93.18 131.62 39.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.393 -0.523 . . . . 0.47 110.172 172.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.591 ' HA ' HG13 ' A' ' 8' ' ' ILE . 40.9 t -79.75 130.39 35.3 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.586 -0.734 . . . . 1.02 110.854 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.652 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -155.87 -156.17 7.69 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.876 -0.678 . . . . 0.16 112.615 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.734 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.7 mm -126.81 153.85 36.17 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-O 120.834 0.349 . . . . 0.19 110.883 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.485 HD11 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -121.5 134.5 64.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-N 115.985 -0.552 . . . . 0.16 109.626 178.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.43 109.92 7.45 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.982 0.42 . . . . 0.12 111.924 174.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.668 HD11 HG23 ' A' ' 100' ' ' ILE . 4.0 mp -83.57 118.55 31.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 107.926 -1.139 . . . . 0.18 107.926 171.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.481 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 2.2 t30 -121.41 122.73 40.44 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 110.0 -0.37 . . . . 1.12 110.0 -177.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -108.47 83.75 1.82 Allowed 'General case' 0 N--CA 1.426 -1.646 0 C-N-CA 117.146 -1.822 . . . . 0.74 107.215 163.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.481 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 11.9 t70 -121.99 -11.31 8.52 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.59 -1.633 . . . . 0.59 106.59 157.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.692 HG13 ' O ' ' A' ' 23' ' ' SER . 14.9 p -102.31 174.18 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 112.049 -2.342 . . . . 0.35 112.198 -154.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.692 ' O ' HG13 ' A' ' 22' ' ' VAL . 6.8 m -54.71 166.56 0.73 Allowed Pre-proline 0 C--O 1.224 -0.281 0 N-CA-C 106.586 -1.635 . . . . 1.31 106.586 164.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 11.9 Cg_endo -42.0 128.09 3.99 Favored 'Trans proline' 0 C--N 1.352 0.732 0 CA-C-N 121.862 1.701 . . . . 0.22 111.408 -149.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.668 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -32.23 133.29 0.11 Allowed 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 125.26 1.6 . . . . 0.2 113.446 -157.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.527 ' HB2' HG11 ' A' ' 22' ' ' VAL . 68.7 mt-10 -124.09 140.8 52.62 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.429 -1.26 . . . . 1.26 111.089 -168.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.557 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.7 tt -101.57 142.6 32.68 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 106.561 -1.644 . . . . 0.15 106.561 172.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.458 ' N ' HD23 ' A' ' 27' ' ' LEU . 10.6 m -130.55 108.47 9.95 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.919 -0.712 . . . . 0.21 110.164 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.607 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 88.5 t90 -87.0 112.03 21.43 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.558 0.694 . . . . 0.24 109.364 175.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.518 ' HD3' ' O ' ' A' ' 31' ' ' SER . 2.6 tmt_? -118.99 118.19 30.83 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.111 -0.949 . . . . 0.87 108.819 -177.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.518 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 35.8 p -56.0 144.28 29.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.292 0.568 . . . . 0.75 110.597 -176.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.652 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 21.4 m -53.85 -29.45 41.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.603 -1.18 . . . . 0.39 112.008 -175.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -83.56 -25.65 30.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.259 0.552 . . . . 2.33 111.065 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.3 16.67 39.61 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.886 -0.673 . . . . 0.55 112.337 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.36 -65.27 1.02 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.104 0.478 . . . . 1.13 110.99 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.45 ' HD2' HG21 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -106.43 155.06 19.95 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.508 -0.769 . . . . 2.03 110.777 -175.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 69.0 t -146.81 139.76 19.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.97 -1.014 . . . . 0.55 109.636 -175.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -139.34 111.23 7.29 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.234 -0.284 . . . . 0.69 110.234 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.3 m -98.31 138.75 35.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.58 0.229 . . . . 0.3 111.496 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.561 HG11 HD13 ' A' ' 62' ' ' LEU . 41.1 t -113.16 129.44 68.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 122.523 0.329 . . . . 0.66 111.521 176.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.559 ' O ' HG12 ' A' ' 45' ' ' ILE . 38.8 t -91.04 108.1 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 109.576 -0.528 . . . . 0.18 109.576 173.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.58 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.8 mm? -53.21 -28.89 29.27 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.091 -0.959 . . . . 0.12 112.597 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.406 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 68.4 m -74.88 -35.76 62.29 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.663 -0.415 . . . . 1.06 111.446 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.3 p -72.28 -14.17 61.7 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 121.376 0.608 . . . . 0.2 109.564 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.602 HG21 ' CD2' ' A' ' 62' ' ' LEU . 48.6 mm -82.32 120.93 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.335 -0.848 . . . . 0.23 111.395 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.628 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 15.7 t70 -78.46 -46.09 20.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.73 -0.668 . . . . 0.7 110.904 176.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.411 ' HB2' HG13 ' A' ' 63' ' ' ILE . 68.8 mmtt -136.88 150.52 48.3 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.129 -0.487 . . . . 1.95 109.975 -178.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.9 HD22 ' HB2' ' A' ' 104' ' ' LEU . 9.9 tp -113.45 144.23 43.16 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.29 -0.633 . . . . 0.14 109.29 165.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.488 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 14.3 mm100 -120.87 154.57 35.66 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.978 -1.01 . . . . 1.49 109.518 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.484 ' HB1' ' CE ' ' A' ' 97' ' ' MET . . . -162.59 141.44 8.92 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.55 -0.75 . . . . 0.25 108.992 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.579 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 37.1 p -56.53 126.04 68.68 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-O 121.303 0.573 . . . . 0.37 112.055 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 72.9 Cg_endo -74.46 166.37 29.6 Favored 'Trans proline' 0 C--N 1.329 -0.457 0 C-N-CA 123.972 3.114 . . . . 0.64 111.314 172.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.6 -27.85 63.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.109 0.481 . . . . 1.02 110.415 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.4 m -69.07 -24.81 64.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.706 -0.679 . . . . 1.58 111.282 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.499 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 39.5 t -76.54 148.51 37.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.127 -0.488 . . . . 0.71 109.717 177.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -90.68 -2.18 57.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.42 0.629 . . . . 2.89 110.116 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -115.39 178.98 4.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.194 -0.912 . . . . 2.59 110.858 -174.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.579 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -132.35 107.76 8.74 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.017 -1.105 . . . . 1.78 108.017 168.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 75.1 mtm -154.54 152.0 29.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.982 0.42 . . . . 1.3 111.21 -176.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.471 HD11 ' O ' ' A' ' 97' ' ' MET . 0.8 OUTLIER -112.05 158.33 19.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.242 -0.89 . . . . 0.14 110.229 175.134 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 45.2 ttt180 -153.63 114.32 4.03 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-O 121.274 0.559 . . . . 2.72 111.009 170.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.713 ' HG ' HD13 ' A' ' 48' ' ' LEU . 9.0 mt -92.24 112.91 25.03 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.717 -0.674 . . . . 0.9 110.515 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.619 HG23 ' HG2' ' A' ' 86' ' ' ARG . 5.0 mm -86.7 116.64 29.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 123.512 0.725 . . . . 0.4 110.307 -174.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -85.33 144.97 21.01 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.159 -1.019 . . . . 0.48 111.487 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.628 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 8.2 mptt -58.73 134.98 57.3 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.057 0.456 . . . . 1.15 110.734 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 82' ' ' PRO . 7.7 p -74.43 150.87 7.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.509 -0.769 . . . . 0.69 110.289 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -80.19 91.98 5.64 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.377 -0.829 . . . . 2.56 110.95 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -85.56 -6.35 59.18 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.333 -0.849 . . . . 3.79 112.001 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.8 p -68.54 -38.72 81.07 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 121.089 -0.245 . . . . 3.05 111.563 -174.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.31 101.94 4.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.018 0.437 . . . . 5.48 110.451 174.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -54.89 138.61 42.67 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.364 -0.835 . . . . 4.42 110.847 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.557 ' HD2' ' HG3' ' A' ' 82' ' ' PRO . 1.7 ptm180 -85.43 170.18 12.94 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.589 -0.732 . . . . 4.27 109.735 -176.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -141.96 164.35 30.43 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.409 -0.589 . . . . 5.09 109.409 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -90.08 -165.3 1.32 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.187 -0.605 . . . . 4.98 110.01 -175.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -54.15 -31.53 52.77 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.729 0.64 . . . . 6.68 112.729 -173.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -102.11 8.27 40.8 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.625 0.726 . . . . 7.13 110.295 -173.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.09 34.21 42.56 Favored Glycine 0 C--N 1.315 -0.62 0 CA-C-N 114.612 -1.176 . . . . 5.53 111.645 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 79' ' ' GLU . 60.5 m-80 -71.37 -92.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.721 -0.239 . . . . 5.62 110.7 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 13.6 pt-20 170.52 125.79 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.389 0.675 . . . . 5.0 110.518 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.508 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.0 t -127.94 148.83 32.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.205 -0.665 . . . . 3.33 109.205 175.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.4 p -110.19 96.85 27.81 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-O 121.51 0.671 . . . . 2.77 110.093 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.557 ' HG3' ' HD2' ' A' ' 72' ' ' ARG . 76.3 Cg_exo -50.31 141.73 31.1 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.656 2.904 . . . . 1.78 113.951 -177.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 0.9 OUTLIER -82.86 134.61 46.62 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 108.715 -0.846 . . . . 3.11 108.715 168.203 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 83' ' ' LYS . 18.1 Cg_exo -54.08 132.34 49.64 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.828 2.352 . . . . 0.67 112.46 -174.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -76.4 155.26 34.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.531 0.682 . . . . 1.78 109.264 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.619 ' HG2' HG23 ' A' ' 63' ' ' ILE . 18.7 mtt180 -140.13 153.73 46.78 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.551 -0.749 . . . . 2.29 110.33 -168.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -115.88 110.45 19.03 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.08 -0.711 . . . . 0.5 109.08 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.483 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 54.9 ttm -103.25 129.26 50.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.781 0.324 . . . . 0.42 110.827 -175.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.485 ' CG ' HD11 ' A' ' 16' ' ' ILE . 80.4 m-85 -123.46 122.54 38.51 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 109.245 -0.65 . . . . 1.33 109.245 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.493 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 22.7 m -91.18 128.95 37.21 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.04 -0.527 . . . . 0.94 110.838 -174.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.603 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 29.1 m-85 -108.16 174.79 5.72 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.95 -0.568 . . . . 1.33 110.816 176.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -119.57 0.22 10.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.706 -0.679 . . . . 1.53 109.821 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.511 ' OD1' ' HB ' ' A' ' 95' ' ' THR . 28.7 t-20 -143.38 131.43 21.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.324 -0.853 . . . . 0.83 110.647 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.491 ' HA ' ' HG2' ' A' ' 97' ' ' MET . 0.9 OUTLIER -74.97 -23.28 58.26 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.962 -0.563 . . . . 2.16 110.976 -174.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.511 ' HB ' ' OD1' ' A' ' 93' ' ' ASN . 92.8 m -70.99 -54.49 11.07 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.411 -0.516 . . . . 0.4 109.783 175.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.0 t -45.7 -57.36 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-N 116.134 -0.485 . . . . 0.29 111.103 173.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.491 ' HG2' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -64.12 -29.3 70.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.006 -0.543 . . . . 0.29 111.093 -178.134 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.29 -32.18 72.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.407 0.622 . . . . 0.39 109.554 175.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.515 ' HB3' ' HA ' ' A' ' 2' ' ' SER . 90.6 m-20 -75.03 -46.82 32.35 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.887 -1.051 . . . . 1.55 109.844 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.668 HG23 HD11 ' A' ' 18' ' ' ILE . 27.6 mm -61.28 -51.16 76.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.003 -0.999 . . . . 0.13 110.276 175.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.628 ' HA ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -55.74 -51.9 65.76 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.614 -0.721 . . . . 1.11 111.197 179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.487 ' N ' ' HE2' ' A' ' 101' ' ' LYS . 11.7 ptp -60.2 -32.15 70.82 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.081 0.467 . . . . 1.17 109.777 -176.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 54.1 m -63.36 -52.04 63.41 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.267 -0.879 . . . . 0.15 110.261 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.9 ' HB2' HD22 ' A' ' 48' ' ' LEU . 11.3 mt -66.95 -55.59 13.87 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.43 -0.805 . . . . 0.13 110.781 -177.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.791 ' HG2' HD23 ' A' ' 48' ' ' LEU . 19.2 mm-40 -43.16 -37.54 2.11 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.653 0.596 . . . . 1.45 112.544 178.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -68.1 -35.51 78.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.823 0.82 . . . . 0.65 109.555 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.668 HG21 ' HB3' ' A' ' 25' ' ' ALA . 81.3 mt -72.51 -41.66 63.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 114.017 -1.447 . . . . 0.17 110.319 175.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.618 HG22 ' HD2' ' A' ' 112' ' ' LYS . 0.8 OUTLIER -65.3 -50.92 70.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.855 -0.611 . . . . 0.29 110.217 -177.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 38.6 t -58.53 -28.47 65.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.47 0.653 . . . . 1.22 109.941 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 11.0 ttt180 -68.73 -38.81 80.45 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.049 -0.978 . . . . 3.79 109.927 177.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.401 ' OH ' ' HA ' ' A' ' 24' ' ' PRO . 27.0 m-85 -88.37 -19.21 26.94 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.928 -0.578 . . . . 0.6 111.698 -175.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.618 ' HD2' HG22 ' A' ' 108' ' ' ILE . 12.4 mtpp -76.74 -23.88 53.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.23 0.538 . . . . 1.76 109.734 174.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.26 -25.76 64.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.434 -0.803 . . . . 1.56 109.8 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -116.68 27.16 9.35 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.293 -0.867 . . . . 1.09 110.707 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.4 t70 . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.488 -0.767 . . . . 2.16 110.274 -179.374 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.58 0 N-CA-C 112.001 -0.44 . . . . 25.39 112.001 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 101.18 170.44 28.34 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.941 -0.647 . . . . 24.6 111.75 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -137.13 162.45 25.31 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.748 -0.739 . . . . 23.97 111.918 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 110.47 17.25 9.43 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.763 -0.732 . . . . 23.13 112.226 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' TYR . . . . . 0.638 ' CE2' ' HA ' ' B' ' 249' ' ' GLU . 32.1 p90 -144.98 171.6 14.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.666 0.269 . . . . 24.92 110.663 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -74.6 143.22 44.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.294 -0.412 . . . . 21.4 110.396 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 8.5 p 44.85 42.31 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 124.375 1.047 . . . . 20.37 111.072 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . 0.638 ' HA ' ' CE2' ' B' ' 246' ' ' TYR . 10.9 pt-20 -59.78 163.87 4.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.97 -1.013 . . . . 17.68 111.23 175.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 64.6 mtt -125.06 34.49 4.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.555 0.693 . . . . 16.8 109.604 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.79 143.44 57.84 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.931 -1.032 . . . . 13.35 109.431 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . 0.494 ' O ' ' HG3' ' B' ' 255' ' ' GLU . 52.0 p 67.11 -37.56 0.31 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.907 1.283 . . . . 10.66 111.963 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -65.12 -35.71 81.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 11.03 110.628 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.78 -47.75 84.43 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.823 -0.626 . . . . 10.94 111.48 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' B' ' 252' ' ' SER . 0.0 OUTLIER -71.16 -33.68 70.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.676 0.274 . . . . 9.82 111.373 -177.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 21.5 m -72.85 -36.02 67.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.212 0.529 . . . . 5.35 111.289 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -89.04 -0.93 57.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.449 0.643 . . . . 6.2 110.188 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -68.53 -27.02 65.74 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.547 -0.751 . . . . 6.14 111.682 -176.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.88 -55.5 16.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.039 0.447 . . . . 3.32 110.647 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 86.59 14.33 65.83 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.746 -0.661 . . . . 0.84 111.677 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 261' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 6.0 m-85 -116.7 179.05 4.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.056 0.455 . . . . 0.95 110.822 -174.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 12.9 p -135.09 145.22 32.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.669 -0.696 . . . . 1.37 109.165 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.01 142.25 27.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.021 0.439 . . . . 2.24 110.13 176.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.502 ' H ' ' NE2' ' A' ' 105' ' ' GLN . 61.5 t -105.29 103.86 16.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.292 0.568 . . . . 1.41 109.945 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . 0.464 ' OD1' ' HE2' ' A' ' 112' ' ' LYS . 23.7 t70 . . . . . 0 C--O 1.248 0.999 0 CA-C-N 115.349 -0.841 . . . . 3.04 109.892 -177.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo . . . . . 0 N--CA 1.481 0.788 0 N-CA-C 110.588 -0.582 . . . . 3.14 110.588 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.415 ' HA ' ' HB3' ' A' ' 99' ' ' ASN . 21.0 p -71.14 -20.82 62.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.195 0.521 . . . . 1.4 110.938 -178.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.612 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 36.0 m80 -85.57 18.07 2.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.739 -0.664 . . . . 1.85 111.858 -176.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.4 p -162.37 145.61 11.52 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.982 0.42 . . . . 0.95 110.906 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.48 145.71 6.72 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.71 -0.956 . . . . 0.16 110.71 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.736 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -71.68 142.88 49.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.21 0.505 . . . . 0.43 111.361 -176.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.474 ' HB1' ' HB3' ' A' ' 89' ' ' PHE . . . -152.62 155.09 36.66 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-O 121.209 0.528 . . . . 0.13 111.61 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.544 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.2 mp -92.34 131.18 40.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.606 -0.725 . . . . 0.29 109.4 176.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.566 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 89.3 t80 -139.74 112.87 8.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.28 -0.418 . . . . 0.56 110.134 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.495 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 51.3 mt-10 68.6 48.83 0.78 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.604 0.716 . . . . 1.46 110.371 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.495 ' HD2' ' C ' ' A' ' 10' ' ' GLU . 4.0 mptt 67.41 4.4 3.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.351 -1.295 . . . . 1.91 112.84 173.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.94 134.69 54.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.835 0.35 . . . . 0.47 110.623 175.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.544 ' HA ' HG13 ' A' ' 8' ' ' ILE . 31.8 t -75.02 128.53 35.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.028 -0.533 . . . . 1.02 109.819 176.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.691 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -148.1 -159.88 8.68 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.701 -0.762 . . . . 0.16 112.347 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.736 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.8 mm -126.33 152.66 34.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.066 0.46 . . . . 0.19 110.841 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.412 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -122.63 133.04 69.99 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.647 -0.706 . . . . 0.16 109.842 178.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.14 110.33 7.81 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.92 0.391 . . . . 0.12 111.958 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.685 HD11 HG23 ' A' ' 100' ' ' ILE . 3.6 mp -85.41 119.46 34.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.844 -0.799 . . . . 0.18 108.844 172.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 2.0 t30 -120.77 123.42 42.62 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.992 -0.373 . . . . 1.12 109.992 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.439 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 15.9 mt-10 -108.85 83.08 1.7 Allowed 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 117.332 -1.747 . . . . 0.74 107.452 164.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.423 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 23.0 t70 -122.04 -10.92 8.55 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 106.522 -1.658 . . . . 0.59 106.522 157.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 23' ' ' SER . 14.5 p -102.33 175.5 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 111.919 -2.4 . . . . 0.35 112.057 -155.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.686 ' O ' HG13 ' A' ' 22' ' ' VAL . 56.8 p -54.4 165.96 0.78 Allowed Pre-proline 0 C--O 1.225 -0.2 0 N-CA-C 106.714 -1.587 . . . . 1.31 106.714 166.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 12.0 Cg_endo -42.47 128.97 4.82 Favored 'Trans proline' 0 C--N 1.359 1.095 0 CA-C-N 122.326 1.866 . . . . 0.22 111.157 -152.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.788 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -31.46 136.11 0.06 Allowed 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 125.44 1.712 . . . . 0.2 114.193 -155.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.531 ' HB2' HG11 ' A' ' 22' ' ' VAL . 64.1 mt-10 -122.64 132.4 54.26 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 114.439 -1.255 . . . . 1.26 110.789 -171.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.566 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.3 tt -100.81 142.18 32.65 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 106.235 -1.765 . . . . 0.15 106.235 173.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.432 ' N ' HD23 ' A' ' 27' ' ' LEU . 25.9 m -130.67 109.34 10.56 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 119.537 -0.865 . . . . 0.21 110.551 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.611 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 88.8 t90 -85.83 108.85 18.31 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.624 0.726 . . . . 0.24 109.376 174.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -115.13 115.0 26.05 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.774 -1.103 . . . . 0.87 108.467 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.542 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 79.3 p -57.21 150.03 18.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.153 0.501 . . . . 0.75 110.751 -173.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.691 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 24.0 m -57.83 -29.05 64.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.176 -0.92 . . . . 0.39 110.435 -176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.495 ' OD2' ' HB3' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -80.65 -27.95 37.02 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.421 -0.809 . . . . 2.33 111.548 177.181 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.6 -5.07 56.78 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.818 -0.705 . . . . 0.55 113.161 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.495 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 2.4 t70 -67.28 -52.23 43.18 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.3 0.482 . . . . 1.13 112.3 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -103.0 143.48 32.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.621 0.724 . . . . 2.03 112.426 -174.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 76.9 t -141.86 116.44 5.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.175 -1.375 . . . . 0.55 109.802 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -123.75 109.74 14.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.949 -0.569 . . . . 0.69 109.904 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 32.8 m -97.35 137.84 35.72 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.944 -0.303 . . . . 0.3 111.177 -176.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 42.0 t -110.91 130.91 63.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 122.815 0.446 . . . . 0.66 111.655 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.509 ' O ' HG12 ' A' ' 45' ' ' ILE . 51.0 t -90.91 108.29 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 109.619 -0.512 . . . . 0.18 109.619 172.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.616 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -53.48 -27.96 28.07 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.994 -1.003 . . . . 0.12 112.844 -178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.0 m -75.47 -34.59 60.91 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.598 -0.441 . . . . 1.06 111.443 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.6 p -75.26 -11.95 60.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.273 0.558 . . . . 0.2 109.71 173.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.691 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 47.5 mm -81.75 117.02 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 115.143 -0.935 . . . . 0.23 111.282 173.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.537 ' OD2' ' HG2' ' A' ' 47' ' ' LYS . 21.2 t70 -73.93 -46.24 45.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.429 -0.805 . . . . 0.7 111.375 177.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.537 ' HG2' ' OD2' ' A' ' 46' ' ' ASP . 47.9 mmtm -140.75 157.3 45.62 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.473 -0.331 . . . . 1.95 110.354 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.077 HD23 ' HG3' ' A' ' 105' ' ' GLN . 13.2 tp -123.51 140.93 52.5 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.256 0.55 . . . . 0.14 109.941 167.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.558 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 16.3 mm100 -113.01 157.8 21.07 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.749 -1.114 . . . . 1.49 109.846 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.51 136.32 5.36 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.8 -0.636 . . . . 0.25 109.539 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 40.6 p -51.27 124.74 23.7 Favored Pre-proline 0 N--CA 1.467 0.404 0 CA-C-O 121.259 0.552 . . . . 0.37 111.243 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.555 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 48.3 Cg_endo -66.82 166.54 22.15 Favored 'Trans proline' 0 C--N 1.333 -0.287 0 C-N-CA 124.057 3.171 . . . . 0.64 111.983 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.417 ' N ' HH21 ' A' ' 94' ' ' ARG . . . -60.11 -25.0 65.11 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.902 0.382 . . . . 1.02 110.829 176.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.8 m -78.37 -24.39 46.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.847 -0.615 . . . . 1.58 111.521 177.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 29.7 t -67.54 149.29 50.33 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.216 -0.661 . . . . 0.71 109.216 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.48 -14.36 22.4 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.606 -0.887 . . . . 2.89 108.606 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.568 ' N ' ' HD3' ' A' ' 57' ' ' LYS . 2.7 mppt? -94.34 -177.89 4.41 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.821 -1.081 . . . . 2.59 110.996 -177.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.511 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -136.49 110.67 8.37 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.388 -0.968 . . . . 1.78 108.388 172.314 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.682 ' HB3' ' CZ ' ' B' ' 261' ' ' PHE . 2.5 mtm -156.54 138.68 14.59 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.694 -0.402 . . . . 1.3 111.854 -173.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.841 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 2.3 mp -109.2 160.05 16.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.843 -0.617 . . . . 0.14 111.078 170.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.63 ' NH1' ' HB3' ' B' ' 259' ' ' ASP . 9.8 ttm180 -150.54 114.19 4.97 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.981 -0.554 . . . . 2.72 110.356 172.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.871 ' HG ' HD13 ' A' ' 48' ' ' LEU . 6.2 mp -94.19 110.44 22.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.075 0.464 . . . . 0.9 110.502 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.564 HG23 ' HG2' ' A' ' 86' ' ' ARG . 2.2 mm -87.95 124.6 41.21 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 C-N-CA 123.254 0.622 . . . . 0.4 109.701 -176.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.691 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -93.58 160.05 24.29 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 119.255 -1.45 . . . . 0.48 111.819 174.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 0.3 OUTLIER -69.29 132.86 47.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.72 0.295 . . . . 1.15 111.088 -178.599 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 82' ' ' PRO . 12.4 p -89.68 150.32 3.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.807 -0.812 . . . . 0.69 108.807 170.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -91.61 130.83 37.36 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.486 0.66 . . . . 2.56 112.147 -169.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -85.79 -17.27 36.25 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.082 -0.963 . . . . 3.79 110.465 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -55.88 -39.82 72.08 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.857 -0.611 . . . . 3.05 112.205 -173.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.2 52.79 2.05 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.276 0.56 . . . . 5.48 110.013 172.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -55.06 141.28 34.97 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.257 -0.883 . . . . 4.42 110.237 176.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.587 ' CG ' ' HB ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -88.34 170.32 11.07 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.357 -0.838 . . . . 4.27 111.336 -169.195 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -132.84 167.31 20.43 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.076 -0.713 . . . . 5.09 109.076 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.708 ' HB3' HD22 ' A' ' 78' ' ' ASN . 21.1 t70 -79.6 -168.24 1.5 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.408 -0.517 . . . . 4.98 110.288 -174.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.444 ' H ' ' CG ' ' A' ' 74' ' ' ASP . 2.0 p-10 -69.46 -15.25 63.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.378 0.535 . . . . 6.68 110.22 -178.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.519 ' HB2' ' ND2' ' A' ' 78' ' ' ASN . 32.1 mt-10 -99.49 -3.25 33.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.406 0.622 . . . . 7.13 109.868 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 83.89 35.14 16.59 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.275 -0.875 . . . . 5.53 112.145 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.708 HD22 ' HB3' ' A' ' 74' ' ' ASP . 64.0 m-80 -78.22 -96.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.3 0.571 . . . . 5.62 111.488 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 12.3 pt-20 -177.21 120.59 0.12 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.169 -0.923 . . . . 5.0 109.781 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.587 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.2 t -128.59 148.59 33.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.873 -0.788 . . . . 3.33 108.873 172.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.35 104.47 44.76 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-O 121.472 0.653 . . . . 2.77 110.044 173.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.476 ' O ' HG21 ' A' ' 66' ' ' VAL . 43.2 Cg_exo -42.5 132.09 5.17 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.713 2.942 . . . . 1.78 112.459 174.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 60.5 mtpt -65.67 121.45 75.45 Favored Pre-proline 0 N--CA 1.445 -0.681 0 N-CA-C 109.985 -0.376 . . . . 3.11 109.985 177.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 83' ' ' LYS . 24.0 Cg_exo -59.47 148.48 86.77 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.007 2.472 . . . . 0.67 111.922 -177.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.419 ' H ' ' HG3' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -75.77 115.59 15.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.931 0.872 . . . . 1.78 109.813 175.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.564 ' HG2' HG23 ' A' ' 63' ' ' ILE . 18.8 mtm180 -115.52 154.47 29.3 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.201 -0.909 . . . . 2.29 109.133 -175.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -117.51 109.43 16.73 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.164 -0.471 . . . . 0.5 110.003 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.544 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 51.1 ttm -108.99 122.38 47.12 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 110.061 -0.348 . . . . 0.42 110.061 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.499 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 57.8 m-85 -112.23 139.79 47.48 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.595 -0.891 . . . . 1.33 108.595 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.531 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 31.3 m -97.74 123.11 41.54 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.597 -0.519 . . . . 0.94 109.597 177.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.841 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 6.0 m-85 -106.09 165.06 11.5 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.986 -0.552 . . . . 1.33 109.819 -175.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -107.3 -6.46 17.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.882 0.372 . . . . 1.53 110.988 -171.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.401 ' HB3' HG23 ' A' ' 96' ' ' VAL . 48.9 t-20 -145.66 128.36 16.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.142 0.496 . . . . 0.83 110.663 -176.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.515 ' NH1' ' HB2' ' A' ' 98' ' ' ASP . 49.1 tpt85 -62.63 -26.24 68.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.06 -0.973 . . . . 2.16 111.131 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.415 HG22 HD21 ' A' ' 99' ' ' ASN . 41.2 m -73.46 -60.06 2.42 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 120.738 0.304 . . . . 0.4 110.382 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 100' ' ' ILE . 58.5 t -45.71 -55.57 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.543 0 CA-C-N 115.584 -0.734 . . . . 0.29 111.441 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.549 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -63.21 -30.63 71.74 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.227 -0.442 . . . . 0.29 110.786 -177.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.515 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 36.5 t70 -69.17 -31.3 69.84 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.619 0.723 . . . . 0.39 109.557 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.415 HD21 HG22 ' A' ' 95' ' ' THR . 87.7 m-20 -72.93 -42.36 63.57 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 114.6 -1.182 . . . . 1.55 109.072 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.685 HG23 HD11 ' A' ' 18' ' ' ILE . 40.4 mm -62.64 -54.09 38.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.783 -1.099 . . . . 0.13 111.562 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.715 ' HA ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -60.87 -42.72 98.46 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 120.54 0.21 . . . . 1.11 111.481 -177.221 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.401 ' HB3' ' HE2' ' A' ' 101' ' ' LYS . 13.0 ptp -66.51 -29.56 69.68 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.66 -0.867 . . . . 1.17 108.66 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 32.7 m -66.0 -52.01 53.23 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.751 -1.113 . . . . 0.15 110.025 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.902 ' HB2' HD22 ' A' ' 48' ' ' LEU . 13.3 mt -69.31 -58.51 3.92 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.444 -0.798 . . . . 0.13 110.945 -177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 1.077 ' HG3' HD23 ' A' ' 48' ' ' LEU . 96.8 mt-30 -49.2 -28.21 4.32 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.757 0.651 . . . . 1.45 112.757 -178.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -67.14 -49.02 66.27 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.852 -0.796 . . . . 0.65 108.852 176.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.788 HG21 ' HB3' ' A' ' 25' ' ' ALA . 53.0 mt -59.65 -43.89 92.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.669 -1.15 . . . . 0.17 110.494 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.489 HG22 ' HE3' ' A' ' 112' ' ' LYS . 1.0 OUTLIER -61.18 -58.24 8.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.604 -0.726 . . . . 0.29 110.168 -176.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.571 ' HA ' ' HD2' ' A' ' 112' ' ' LYS . 13.9 m -55.37 -29.23 58.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.722 0.296 . . . . 1.22 111.467 173.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 92.5 mtt180 -68.93 -18.37 64.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.157 0.503 . . . . 3.79 110.481 176.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 23.6 m-85 -107.8 -4.9 17.63 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.687 -0.688 . . . . 0.6 109.916 178.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.571 ' HD2' ' HA ' ' A' ' 109' ' ' SER . 1.2 mpmm? -74.77 -36.29 62.55 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.408 -0.815 . . . . 1.76 109.525 172.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.84 -11.84 56.95 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.281 -1.327 . . . . 1.56 110.063 174.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.5 29.16 3.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.716 -0.675 . . . . 1.09 110.777 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 111' ' ' TYR . 17.0 t70 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.573 -0.727 . . . . 2.16 110.505 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.634 0 N-CA-C 111.826 -0.51 . . . . 25.39 111.826 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -162.51 123.46 1.2 Allowed Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.692 -0.766 . . . . 24.6 111.906 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 129.36 -105.67 0.7 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.776 -0.726 . . . . 23.97 111.906 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -83.35 51.92 4.65 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.911 -0.661 . . . . 23.13 112.457 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -146.52 27.94 1.09 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.629 0.728 . . . . 24.92 109.525 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -99.13 86.22 3.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.993 -0.549 . . . . 21.4 109.982 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 39.0 t 55.35 65.0 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.514 -0.766 . . . . 20.37 110.328 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' B' ' 250' ' ' MET . 18.4 tt0 -113.85 167.77 10.36 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.735 -0.666 . . . . 17.68 109.612 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' MET . . . . . 0.508 ' HB2' ' O ' ' B' ' 249' ' ' GLU . 67.5 mtt 82.11 17.9 0.37 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 122.365 1.079 . . . . 16.8 108.206 -175.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -87.49 139.78 30.19 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.441 -1.709 . . . . 13.35 110.01 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . 0.516 ' HB3' ' HB2' ' B' ' 255' ' ' GLU . 70.6 m -82.26 70.17 9.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.05 -0.523 . . . . 10.66 111.417 -175.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -80.27 -60.4 2.34 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.654 -0.703 . . . . 11.03 110.115 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . 0.584 ' CD ' ' H ' ' B' ' 254' ' ' GLU . 0.6 OUTLIER -79.39 -20.56 47.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.282 -0.872 . . . . 10.94 110.114 179.122 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' GLU . . . . . 0.555 ' HB3' HH21 ' A' ' 61' ' ' ARG . 30.7 mt-10 -71.37 -10.64 60.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.389 -0.823 . . . . 9.82 112.044 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 90.3 p 59.97 -164.57 0.22 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.012 0.925 . . . . 5.35 110.729 -175.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -73.45 -59.93 2.48 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.206 -0.198 . . . . 6.2 111.407 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -86.7 -70.94 0.58 Allowed 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 120.182 -0.607 . . . . 6.14 109.803 174.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.63 ' HB3' ' NH1' ' A' ' 61' ' ' ARG . 8.1 p-10 169.54 -39.27 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.542 -1.208 . . . . 3.32 109.528 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 88.43 4.38 77.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.072 -0.585 . . . . 0.84 112.95 174.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 261' ' ' PHE . . . . . 0.682 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 6.2 m-30 -100.18 179.68 4.4 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.839 0.352 . . . . 0.95 110.414 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.39 148.9 31.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.494 -0.558 . . . . 1.37 109.494 174.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 263' ' ' GLU . . . . . 0.552 ' HB3' ' OE1' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -110.92 128.58 55.86 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.332 0.587 . . . . 2.24 110.523 179.305 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.497 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 84.5 t -100.98 103.42 14.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.916 -0.584 . . . . 1.41 110.592 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.411 -0.804 . . . . 3.04 109.547 177.451 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 N--CA 1.479 0.666 0 N-CA-C 111.445 -0.252 . . . . 3.14 111.445 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 p -90.32 -17.02 28.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.154 0.502 . . . . 1.4 110.608 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.561 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 19.5 m80 -84.72 17.86 2.6 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.628 -0.714 . . . . 1.85 111.525 -174.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.6 p -163.54 142.44 8.08 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.733 0.301 . . . . 0.95 110.375 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.98 147.18 7.92 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 110.294 -1.122 . . . . 0.16 110.294 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.762 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -69.8 144.52 52.61 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 117.41 0.605 . . . . 0.43 111.603 -175.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' A' ' 89' ' ' PHE . . . -152.64 155.83 38.07 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 121.068 0.461 . . . . 0.13 111.38 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.563 HG13 ' HA ' ' A' ' 13' ' ' SER . 1.9 mp -94.73 133.84 34.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.793 -0.639 . . . . 0.29 109.297 177.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.451 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 74.3 t80 -139.69 121.0 14.93 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.285 -0.635 . . . . 0.56 109.285 176.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 65.03 41.76 4.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.466 0.651 . . . . 1.46 110.141 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 11' ' ' LYS . 41.4 mmtt 74.0 -6.43 1.83 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 114.519 -1.219 . . . . 1.91 112.922 171.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.97 135.34 36.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.914 0.388 . . . . 0.47 110.539 175.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.563 ' HA ' HG13 ' A' ' 8' ' ' ILE . 9.6 p -73.38 128.93 36.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.79 -0.641 . . . . 1.02 110.691 176.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.679 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -146.8 -159.5 8.31 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-N 115.645 -0.707 . . . . 0.16 112.192 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.762 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.4 mm -126.39 152.95 34.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 120.905 0.383 . . . . 0.19 111.007 -177.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.04 134.34 66.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 116.079 -0.51 . . . . 0.16 109.891 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.83 110.78 8.22 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.933 0.397 . . . . 0.12 112.069 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.678 HD11 HG23 ' A' ' 100' ' ' ILE . 3.9 mp -85.13 112.8 22.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.785 -0.82 . . . . 0.18 108.785 171.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.468 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.9 t30 -114.97 125.86 54.1 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.823 -0.351 . . . . 1.12 110.139 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.402 ' HG2' ' HB1' ' A' ' 25' ' ' ALA . 9.8 mt-10 -109.76 83.07 1.69 Allowed 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 117.255 -1.778 . . . . 0.74 107.37 163.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.468 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 16.9 t70 -122.26 -10.01 8.55 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 106.42 -1.696 . . . . 0.59 106.42 157.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.93 HG11 ' HB3' ' A' ' 26' ' ' GLU . 14.5 p -102.79 174.86 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 112.079 -2.328 . . . . 0.35 111.897 -156.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.687 ' O ' HG13 ' A' ' 22' ' ' VAL . 12.0 p -54.52 165.0 0.96 Allowed Pre-proline 0 N--CA 1.453 -0.322 0 N-CA-C 106.661 -1.607 . . . . 1.31 106.661 165.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.616 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 11.8 Cg_endo -41.73 129.01 3.86 Favored 'Trans proline' 0 C--N 1.353 0.792 0 CA-C-N 121.731 1.654 . . . . 0.22 111.809 -147.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.646 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -29.41 131.03 0.07 Allowed 'General case' 0 CA--C 1.504 -0.796 0 O-C-N 125.406 1.691 . . . . 0.2 113.137 -159.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.93 ' HB3' HG11 ' A' ' 22' ' ' VAL . 36.7 tt0 -132.49 133.59 43.98 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 114.412 -1.267 . . . . 1.26 111.532 -160.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 1.6 tt -100.38 146.88 26.45 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 107.276 -1.379 . . . . 0.15 107.276 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.498 ' N ' HD23 ' A' ' 27' ' ' LEU . 22.6 m -137.57 109.31 7.07 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 120.134 -0.626 . . . . 0.21 110.552 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.589 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 88.3 t90 -85.58 112.38 20.91 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.688 -0.687 . . . . 0.24 109.29 175.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -117.93 118.3 31.61 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.442 -0.948 . . . . 0.87 108.442 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.568 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 71.6 p -57.21 152.18 14.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.667 0.27 . . . . 0.75 111.032 -174.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.679 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 23.7 m -55.53 -35.12 65.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.599 0.714 . . . . 0.39 109.889 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.18 -28.05 53.89 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.939 -1.028 . . . . 2.33 111.613 178.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.9 1.55 70.27 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.915 -0.66 . . . . 0.55 113.246 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -81.35 -25.05 36.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.856 0.328 . . . . 1.13 111.688 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -120.82 140.96 51.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.162 0.506 . . . . 2.03 111.719 -179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 73.7 t -142.45 126.11 15.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.298 -0.865 . . . . 0.55 110.496 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -128.04 112.22 14.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.913 0.387 . . . . 0.69 110.418 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 27' ' ' LEU . 30.2 m -96.17 146.81 24.37 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.503 -0.317 . . . . 0.3 111.476 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 36.9 t -126.28 127.67 70.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 122.476 0.31 . . . . 0.66 111.433 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.469 ' O ' HG12 ' A' ' 45' ' ' ILE . 58.4 t -90.39 107.95 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-O 121.392 0.615 . . . . 0.18 109.497 173.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.611 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.9 mm? -51.15 -29.76 14.66 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.901 -1.045 . . . . 0.12 112.79 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.473 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 60.5 m -73.48 -34.96 65.59 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.565 -0.454 . . . . 1.06 111.528 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.3 p -72.85 -18.1 61.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.362 0.601 . . . . 0.2 109.574 173.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.578 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 50.0 mm -79.72 117.58 25.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.256 -0.884 . . . . 0.23 111.024 175.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.592 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 28.7 t70 -75.81 -43.1 47.83 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.029 -0.532 . . . . 0.7 111.666 177.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.493 ' HG2' ' OD2' ' A' ' 46' ' ' ASP . 48.6 mmtm -141.05 153.93 45.73 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.865 -0.421 . . . . 1.95 109.865 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.036 HD23 ' HG3' ' A' ' 105' ' ' GLN . 9.7 tp -117.31 145.99 43.63 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.203 -0.666 . . . . 0.14 109.203 166.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.667 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 15.9 mm100 -124.12 157.17 35.25 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.661 -1.154 . . . . 1.49 109.974 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.61 146.22 11.42 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.471 -0.786 . . . . 0.25 109.64 177.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.42 ' HA ' ' HD2' ' A' ' 52' ' ' PRO . 20.1 p -43.83 125.83 4.12 Favored Pre-proline 0 N--CA 1.468 0.429 0 C-N-CA 123.583 0.753 . . . . 0.37 111.756 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.567 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 52.8 Cg_endo -66.82 165.65 25.14 Favored 'Trans proline' 0 C--N 1.331 -0.365 0 C-N-CA 123.803 3.002 . . . . 0.64 111.649 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.21 -29.33 67.42 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.092 0.472 . . . . 1.02 110.313 175.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.9 t -70.43 -22.63 62.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.713 -0.676 . . . . 1.58 110.611 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.468 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 47.7 t -72.18 145.49 48.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.71 110.428 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -89.91 -7.98 52.91 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.354 0.597 . . . . 2.89 109.576 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -103.92 179.43 4.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.021 -0.991 . . . . 2.59 111.077 -173.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.584 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -137.29 109.88 7.5 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.375 -1.284 . . . . 1.78 108.064 178.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.773 ' HB3' ' CZ ' ' B' ' 261' ' ' PHE . 10.8 ttm -157.98 138.81 13.08 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 120.343 -0.543 . . . . 1.3 111.375 -169.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.817 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 3.2 mp -111.06 156.35 21.43 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.087 0.47 . . . . 0.14 112.028 174.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 59.9 ttp180 -150.28 113.2 4.81 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.776 -0.647 . . . . 2.72 110.593 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.787 ' HG ' HD13 ' A' ' 48' ' ' LEU . 6.4 mp -95.72 110.73 22.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.998 -0.546 . . . . 0.9 110.693 -176.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.565 HG23 ' HB3' ' A' ' 86' ' ' ARG . 1.2 mm -87.6 120.98 37.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.163 -0.472 . . . . 0.4 110.525 -173.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -83.17 156.24 33.74 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 119.89 -1.148 . . . . 0.48 111.747 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.592 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 9.7 mptt -68.48 137.08 54.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.96 0.38 . . . . 1.15 110.29 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 82' ' ' PRO . 9.4 p -104.84 163.18 4.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.207 -0.664 . . . . 0.69 109.207 173.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -111.36 109.01 18.8 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.755 -0.461 . . . . 2.56 109.755 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.61 -15.79 57.0 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 121.1 -0.24 . . . . 3.79 111.47 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.6 t -82.67 -39.39 22.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.828 0.346 . . . . 3.05 110.712 -176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -84.92 75.36 10.38 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.219 -0.446 . . . . 5.48 110.168 176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -64.33 136.85 57.54 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.56 0.695 . . . . 4.42 111.062 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.739 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 9.0 ptm180 -84.98 176.22 8.57 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.501 -1.227 . . . . 4.27 109.523 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.547 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 12.2 mmtp -120.76 138.79 53.83 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.504 0.192 . . . . 5.09 110.543 -172.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.66 ' HB3' HD21 ' A' ' 78' ' ' ASN . 2.7 t70 -93.91 -157.33 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.788 -0.449 . . . . 4.98 109.788 -178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -59.49 -31.05 69.0 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.08 0.4 . . . . 6.68 112.08 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -94.75 0.68 55.17 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.797 0.808 . . . . 7.13 109.16 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.547 ' HA2' ' HB3' ' A' ' 73' ' ' LYS . . . 68.69 35.22 79.93 Favored Glycine 0 CA--C 1.503 -0.671 0 CA-C-N 114.273 -1.331 . . . . 5.53 110.711 -175.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.66 HD21 ' HB3' ' A' ' 74' ' ' ASP . 5.5 p30 -82.46 -86.0 0.11 Allowed 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.297 -0.451 . . . . 5.62 110.889 -175.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.739 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 11.4 pt-20 178.91 129.32 0.07 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.196 0.522 . . . . 5.0 110.954 174.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.444 ' HB ' ' HG2' ' A' ' 72' ' ' ARG . 2.1 t -126.5 147.95 31.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.938 -0.764 . . . . 3.33 108.938 171.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.3 p -106.61 96.7 14.73 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-O 121.728 0.775 . . . . 2.77 109.181 171.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.473 ' O ' HG21 ' A' ' 66' ' ' VAL . 19.1 Cg_endo -61.79 142.02 92.24 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.477 2.785 . . . . 1.78 113.557 -173.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.41 ' HG3' ' HD2' ' A' ' 84' ' ' PRO . 15.5 ttpp -71.54 136.33 83.59 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.605 -0.725 . . . . 3.11 109.104 171.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.436 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 30.4 Cg_exo -52.19 133.64 47.95 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 123.141 2.561 . . . . 0.67 112.7 -175.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -73.18 130.5 40.39 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.829 0.823 . . . . 1.78 109.791 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.565 ' HB3' HG23 ' A' ' 63' ' ' ILE . 22.3 ptt180 -127.73 141.65 51.54 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.251 -0.886 . . . . 2.29 110.444 -174.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -102.32 111.18 23.37 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.043 -0.98 . . . . 0.5 110.207 -170.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.495 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 53.6 ttm -108.27 120.12 41.45 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.598 -0.728 . . . . 0.42 110.483 -172.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.457 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 55.8 m-85 -111.5 140.48 46.07 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.394 -0.965 . . . . 1.33 108.394 175.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.623 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 49.5 m -97.47 125.08 41.93 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.523 -0.471 . . . . 0.94 110.221 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.817 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 5.6 m-85 -107.7 169.0 8.86 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.747 -0.661 . . . . 1.33 109.357 -176.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -126.27 -3.4 6.86 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.851 0.358 . . . . 1.53 110.68 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.453 ' OD1' HG23 ' A' ' 96' ' ' VAL . 28.6 t-20 -131.12 125.66 33.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.131 0.491 . . . . 0.83 110.616 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.443 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 12.7 tpt180 -62.29 -33.51 74.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.179 -0.918 . . . . 2.16 111.371 -177.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.48 HG22 HD21 ' A' ' 99' ' ' ASN . 87.2 m -73.24 -55.76 6.0 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.951 -0.3 . . . . 0.4 110.492 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.453 HG23 ' OD1' ' A' ' 93' ' ' ASN . 95.6 t -45.86 -56.39 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-N 115.824 -0.625 . . . . 0.29 111.539 175.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.584 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -65.94 -28.9 69.27 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.321 -0.399 . . . . 0.29 110.7 -177.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.95 -37.02 83.51 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 108.92 -0.77 . . . . 0.39 108.92 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.558 ' O ' ' HG3' ' A' ' 102' ' ' MET . 90.4 m-20 -72.79 -48.53 37.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.205 -1.361 . . . . 1.55 109.581 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.678 HG23 HD11 ' A' ' 18' ' ' ILE . 41.0 mm -56.18 -53.05 43.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.985 -1.007 . . . . 0.13 110.075 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.785 ' HA ' HD21 ' A' ' 48' ' ' LEU . 6.6 ttpp -55.98 -50.15 71.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.778 -0.646 . . . . 1.11 111.329 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.558 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.1 ppp? -68.56 -24.48 64.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.328 -0.396 . . . . 1.17 110.339 -175.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 34.7 m -67.62 -51.79 46.02 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.462 0.649 . . . . 0.15 110.071 175.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.982 ' HB2' HD22 ' A' ' 48' ' ' LEU . 13.8 mt -69.14 -58.5 3.98 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.132 -0.94 . . . . 0.13 111.364 -175.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 1.036 ' HG3' HD23 ' A' ' 48' ' ' LEU . 66.5 mt-30 -51.52 -26.46 8.5 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.758 0.651 . . . . 1.45 112.758 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -66.24 -49.5 67.0 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.411 -0.959 . . . . 0.65 108.411 175.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.646 HG21 ' HB3' ' A' ' 25' ' ' ALA . 67.7 mt -58.51 -43.57 87.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.303 -1.317 . . . . 0.17 110.487 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.727 HG22 ' HD2' ' A' ' 112' ' ' LYS . 1.1 mt -66.79 -49.24 76.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.996 -0.547 . . . . 0.29 110.654 -176.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 32.2 t -60.27 -26.14 66.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.388 0.613 . . . . 1.22 110.095 173.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 83.0 mtt180 -73.87 -30.63 62.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.494 -0.776 . . . . 3.79 110.624 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -94.98 -21.32 18.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.051 -0.522 . . . . 0.6 112.144 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.727 ' HD2' HG22 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -75.54 -21.68 57.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.447 0.641 . . . . 1.76 109.488 173.147 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -72.55 -19.12 61.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.957 -1.02 . . . . 1.56 110.175 173.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -134.55 36.06 3.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.571 -0.741 . . . . 1.09 110.92 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 30.8 t70 . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.608 -0.71 . . . . 2.16 110.537 -179.647 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.707 0 N-CA-C 112.197 -0.361 . . . . 25.39 112.197 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' B' ' 247' ' ' ASP . . . -176.26 60.04 0.1 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.821 -0.704 . . . . 24.6 111.956 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -79.96 151.8 34.08 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.891 -0.671 . . . . 23.97 112.455 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 124.89 -79.19 0.36 Allowed Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.271 -0.732 . . . . 23.13 111.271 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -99.47 21.46 12.13 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.695 -0.483 . . . . 24.92 109.695 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' B' ' 243' ' ' GLY . 9.5 p-10 -62.55 105.75 0.68 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.472 0.653 . . . . 21.4 110.578 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 4.9 t 52.58 52.56 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 114.879 -1.055 . . . . 20.37 110.328 -175.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -128.13 129.77 47.07 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.344 -0.844 . . . . 17.68 109.802 176.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 66.0 mtt -138.71 47.78 1.94 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.971 -0.751 . . . . 16.8 108.971 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.02 151.29 37.2 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.057 -0.974 . . . . 13.35 110.794 -174.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 56.5 m -143.57 123.47 13.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.734 -0.666 . . . . 10.66 109.595 178.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -61.47 -31.97 71.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.111 -0.949 . . . . 11.03 111.188 -175.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -68.18 -21.43 64.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.103 -0.498 . . . . 10.94 111.218 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -84.76 -12.53 53.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.632 -0.258 . . . . 9.82 111.352 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 46.5 t -62.96 141.54 58.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.948 0.404 . . . . 5.35 110.205 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -78.2 -21.47 50.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.246 0.546 . . . . 6.2 109.904 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -86.61 2.29 48.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.617 -0.72 . . . . 6.14 110.561 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -140.76 -152.91 0.43 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.222 -1.399 . . . . 3.32 107.222 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 90.75 44.26 4.58 Favored Glycine 0 C--N 1.307 -1.044 0 C-N-CA 121.037 -0.601 . . . . 0.84 113.071 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 261' ' ' PHE . . . . . 0.773 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 6.7 m-30 -66.29 171.81 4.47 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.042 0.449 . . . . 0.95 111.701 -177.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.1 p -138.18 148.2 25.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.916 -0.584 . . . . 1.37 110.264 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -80.01 121.35 25.38 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.931 -0.766 . . . . 2.24 108.931 175.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 57.7 t -107.33 102.82 14.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.968 0.413 . . . . 1.41 110.632 -176.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 35.0 t70 . . . . . 0 C--O 1.248 0.993 0 CA-C-N 115.984 -0.553 . . . . 3.04 109.717 -178.838 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 N--CA 1.475 0.389 0 N-CA-C 110.464 -0.629 . . . . 3.14 110.464 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.1 m 69.84 -11.76 0.52 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.982 0.734 . . . . 1.4 112.982 175.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.424 ' CE1' HG23 ' A' ' 103' ' ' THR . 12.4 m80 -85.61 13.03 7.53 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.421 0.526 . . . . 1.85 112.421 -169.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.9 p -162.8 140.07 7.88 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.318 0.58 . . . . 0.95 111.26 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.05 152.79 13.36 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.998 -1.241 . . . . 0.16 109.998 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.746 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -73.46 145.88 45.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 117.578 0.689 . . . . 0.43 111.5 -175.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.97 152.55 32.62 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.396 0.617 . . . . 0.13 111.525 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.507 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.7 mp -94.15 124.44 46.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.861 -0.792 . . . . 0.29 108.861 174.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.574 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 79.9 t80 -128.99 105.62 8.33 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 110.176 -0.305 . . . . 0.56 110.176 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 66.98 53.22 0.84 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.573 0.701 . . . . 1.46 110.664 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp 71.28 -8.16 1.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.175 -1.375 . . . . 1.91 113.252 171.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.435 HG11 ' HD3' ' A' ' 36' ' ' LYS . 0.3 OUTLIER -99.32 132.73 44.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.865 -0.42 . . . . 0.47 109.865 172.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.507 ' HA ' HG13 ' A' ' 8' ' ' ILE . 23.3 t -85.28 123.97 31.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.998 -0.546 . . . . 1.02 109.921 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.662 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -144.48 -155.08 6.32 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 120.906 -0.664 . . . . 0.16 112.276 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.746 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.3 mm -125.11 153.35 32.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 120.977 0.418 . . . . 0.19 110.448 -177.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.487 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -123.91 131.69 72.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.826 -0.625 . . . . 0.16 109.904 178.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.22 111.07 8.77 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.038 -0.528 . . . . 0.12 111.476 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.651 HD11 HG23 ' A' ' 100' ' ' ILE . 4.0 mp -84.22 118.98 32.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.053 -1.092 . . . . 0.18 108.053 172.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.433 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.8 t30 -121.94 123.23 41.19 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 109.909 -0.404 . . . . 1.12 109.909 -178.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.481 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 15.8 mt-10 -108.51 83.22 1.74 Allowed 'General case' 0 N--CA 1.426 -1.635 0 C-N-CA 117.113 -1.835 . . . . 0.74 107.541 164.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.433 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 13.3 t70 -121.49 -10.2 8.88 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 106.38 -1.711 . . . . 0.59 106.38 157.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 23' ' ' SER . 14.6 p -102.15 175.98 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 111.933 -2.394 . . . . 0.35 111.791 -157.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.705 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -54.51 167.29 0.6 Allowed Pre-proline 0 C--O 1.223 -0.291 0 N-CA-C 106.464 -1.68 . . . . 1.31 106.464 166.354 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.423 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 11.6 Cg_endo -42.05 128.29 4.09 Favored 'Trans proline' 0 C--N 1.357 1.002 0 CA-C-N 122.062 1.772 . . . . 0.22 111.309 -153.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.655 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -30.0 133.73 0.05 Allowed 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 125.384 1.678 . . . . 0.2 114.189 -157.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.636 ' HB2' HG11 ' A' ' 22' ' ' VAL . 28.2 mt-10 -124.27 140.34 53.05 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 114.791 -1.095 . . . . 1.26 111.302 -171.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.764 ' HB3' HG12 ' A' ' 40' ' ' VAL . 1.8 tt -100.1 142.9 30.95 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 106.579 -1.638 . . . . 0.15 106.579 174.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.546 ' N ' HD23 ' A' ' 27' ' ' LEU . 3.0 m -129.39 107.76 9.76 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.04 -0.664 . . . . 0.21 109.827 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.59 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.4 t90 -91.61 113.27 25.49 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.875 -0.787 . . . . 0.24 108.875 176.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -121.01 124.21 44.3 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.527 -0.76 . . . . 0.87 109.465 -176.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.432 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 29.8 m -56.01 141.18 40.86 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.801 -0.444 . . . . 0.75 109.801 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.662 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 22.8 m -55.29 -34.16 63.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.817 -0.629 . . . . 0.39 110.554 -178.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -87.09 -3.28 59.06 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.468 -0.787 . . . . 2.33 111.242 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.99 19.66 72.13 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.237 -0.506 . . . . 0.55 112.73 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -71.79 -74.58 0.15 Allowed 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 111.973 0.36 . . . . 1.13 111.973 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.435 ' HD3' HG11 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -116.59 153.39 32.33 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.946 0.403 . . . . 2.03 111.036 -177.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 59.7 t -132.36 130.16 59.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 116.216 -0.447 . . . . 0.55 110.641 -176.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -122.62 109.67 14.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.645 0.26 . . . . 0.69 110.676 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 7.0 m -94.99 138.64 32.44 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.613 -0.514 . . . . 0.3 109.613 175.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.764 HG12 ' HB3' ' A' ' 27' ' ' LEU . 8.9 p -128.54 139.12 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 120.569 -0.452 . . . . 0.66 111.774 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.572 ' O ' HG12 ' A' ' 45' ' ' ILE . 45.0 t -90.02 110.88 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-O 121.377 0.608 . . . . 0.18 110.389 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.651 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.4 mm? -54.1 -28.87 42.18 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.872 -1.058 . . . . 0.12 112.633 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.423 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 66.5 m -77.34 -34.28 55.26 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.67 -0.412 . . . . 1.06 111.28 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.492 ' OG1' ' HB ' ' A' ' 41' ' ' VAL . 65.9 p -75.26 -12.14 60.22 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.525 0.678 . . . . 0.2 109.465 173.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.633 HG21 HD22 ' A' ' 62' ' ' LEU . 40.9 mm -81.58 123.1 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 114.963 -1.017 . . . . 0.23 110.691 170.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.478 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 35.6 t70 -74.71 -48.85 23.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.751 -0.659 . . . . 0.7 110.982 176.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.434 ' HB2' HG13 ' A' ' 63' ' ' ILE . 49.2 mmtm -142.07 165.06 28.48 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.194 -0.457 . . . . 1.95 110.172 -177.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.054 HD23 ' HG3' ' A' ' 105' ' ' GLN . 10.5 tp -126.09 142.96 51.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.422 0.63 . . . . 0.14 109.386 170.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.421 ' CG ' HD11 ' A' ' 63' ' ' ILE . 12.4 mm100 -117.3 157.46 26.05 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.919 -1.037 . . . . 1.49 109.144 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -161.63 155.38 21.72 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.812 -1.181 . . . . 0.25 107.812 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 20.6 p -57.87 119.91 37.78 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 121.453 0.644 . . . . 0.37 111.053 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.594 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 63.5 Cg_endo -72.52 169.11 22.59 Favored 'Trans proline' 0 C--N 1.33 -0.439 0 C-N-CA 124.73 3.62 . . . . 0.64 111.699 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.4 -26.35 52.95 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.003 0.43 . . . . 1.02 110.287 172.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.0 m -69.26 -25.7 64.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.047 -0.524 . . . . 1.58 110.705 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 22.7 t -87.87 142.91 27.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.942 -0.572 . . . . 0.71 109.603 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -94.74 -7.29 41.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.15 0.5 . . . . 2.89 110.57 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -102.75 -173.2 2.27 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.717 -0.674 . . . . 2.59 111.094 -172.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.51 ' HB3' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -130.35 112.43 13.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.818 -0.628 . . . . 1.78 110.046 175.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.559 ' CG ' ' HA ' ' A' ' 90' ' ' SER . 2.2 mtm -157.72 141.83 16.01 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 111.71 0.263 . . . . 1.3 111.71 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.923 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 2.8 mp -109.74 162.63 14.27 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.953 0.406 . . . . 0.14 111.151 171.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.574 ' HG3' ' OD1' ' B' ' 258' ' ' ASP . 0.0 OUTLIER -154.16 112.64 3.6 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.818 -0.628 . . . . 2.72 109.572 177.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.71 ' HG ' HD13 ' A' ' 48' ' ' LEU . 8.4 mt -95.7 117.28 30.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.3 0.571 . . . . 0.9 110.948 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.548 HG23 ' HG2' ' A' ' 86' ' ' ARG . 7.9 mm -87.67 102.95 13.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.412 -0.813 . . . . 0.4 110.704 -174.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -73.74 145.15 34.98 Favored Glycine 0 C--N 1.321 -0.268 0 C-N-CA 119.949 -1.12 . . . . 0.48 110.858 175.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.478 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 1.6 mptm? -54.5 135.28 46.02 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.382 0.611 . . . . 1.15 111.761 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.557 HG22 ' H ' ' A' ' 67' ' ' ASP . 10.7 p -69.26 171.67 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.885 -1.052 . . . . 0.69 110.156 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.557 ' H ' HG22 ' A' ' 66' ' ' VAL . 7.7 t70 -54.1 142.04 26.73 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.242 0.544 . . . . 2.56 110.809 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -59.02 -7.59 1.14 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 114.244 1.202 . . . . 3.79 114.244 -171.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.1 t -81.62 -12.94 58.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 118.02 0.373 . . . . 3.05 110.308 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 4.0 mptp? 41.82 -98.41 0.02 OUTLIER 'General case' 0 C--O 1.231 0.102 0 N-CA-C 113.729 1.011 . . . . 5.48 113.729 -175.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -72.93 130.38 40.25 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 121.593 0.711 . . . . 4.42 112.111 -172.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.491 ' HG2' ' HB ' ' A' ' 80' ' ' VAL . 8.0 ptm180 -107.25 172.74 6.66 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 106.31 -1.737 . . . . 4.27 106.31 169.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.547 ' CB ' ' HA2' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -134.05 162.71 31.34 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.61 -0.681 . . . . 5.09 109.963 176.654 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.696 ' HB3' HD22 ' A' ' 78' ' ' ASN . 5.0 t70 -87.56 -166.52 1.6 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.569 -0.9 . . . . 4.98 108.569 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -57.42 -28.22 63.09 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.552 0.575 . . . . 6.68 112.552 -173.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -101.56 -0.5 34.8 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.24 0.543 . . . . 7.13 110.746 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.547 ' HA2' ' CB ' ' A' ' 73' ' ' LYS . . . 81.55 28.83 41.85 Favored Glycine 0 C--N 1.321 -0.299 0 C-N-CA 120.419 -0.896 . . . . 5.53 111.2 -176.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.696 HD22 ' HB3' ' A' ' 74' ' ' ASP . 52.6 m-80 -61.33 -37.4 83.14 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.198 0.599 . . . . 5.62 112.601 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 78' ' ' ASN . 46.4 mt-10 98.93 118.18 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 O-C-N 125.201 1.563 . . . . 5.0 111.263 178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.491 ' HB ' ' HG2' ' A' ' 72' ' ' ARG . 2.0 t -123.58 147.88 27.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.053 -1.092 . . . . 3.33 108.053 172.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.8 p -112.93 103.37 55.64 Favored Pre-proline 0 C--N 1.312 -1.03 0 C-N-CA 119.895 -0.722 . . . . 2.77 111.043 177.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.01 139.47 20.3 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.565 2.843 . . . . 1.78 111.727 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.513 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 28.4 ttmt -80.39 124.78 82.17 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 121.986 0.898 . . . . 3.11 111.764 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 83' ' ' LYS . 21.1 Cg_exo -59.35 158.47 26.68 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 124.272 3.314 . . . . 0.67 112.962 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.17 119.12 24.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.296 0.569 . . . . 1.78 110.158 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.548 ' HG2' HG23 ' A' ' 63' ' ' ILE . 25.3 mtt180 -119.31 162.33 18.93 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.89 -0.595 . . . . 2.29 111.363 -169.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -124.78 115.24 20.37 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.887 -0.597 . . . . 0.5 110.242 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.514 ' CB ' ' HG2' ' A' ' 61' ' ' ARG . 59.6 ttm -107.07 129.22 54.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.811 -0.177 . . . . 0.42 111.111 -173.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.58 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -119.62 140.43 50.61 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.613 -0.884 . . . . 1.33 108.613 173.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.559 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 52.6 m -100.31 126.64 46.66 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.115 0.483 . . . . 0.94 109.768 177.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.923 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 18.8 m-85 -106.55 160.45 15.42 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.792 -0.64 . . . . 1.33 110.649 -173.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -101.99 -6.94 22.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.281 -0.418 . . . . 1.53 110.577 -171.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -148.32 131.27 16.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.358 0.599 . . . . 0.83 110.918 -175.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.51 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 9.2 tpt180 -60.88 -31.47 70.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.697 -1.138 . . . . 2.16 111.269 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 94.4 m -73.15 -57.88 3.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.806 0.336 . . . . 0.4 110.356 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 68.1 t -46.67 -52.67 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.994 -0.548 . . . . 0.29 111.716 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.476 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -66.71 -28.33 68.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.198 -0.455 . . . . 0.29 110.438 -178.203 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.93 -29.96 69.15 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.181 -0.674 . . . . 0.39 109.181 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.628 ' O ' ' HG3' ' A' ' 102' ' ' MET . 55.8 m-80 -77.37 -50.03 13.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.988 -1.005 . . . . 1.55 110.083 178.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.651 HG23 HD11 ' A' ' 18' ' ' ILE . 40.5 mm -56.71 -50.76 73.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.314 -0.857 . . . . 0.13 110.304 178.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.711 ' HA ' HD21 ' A' ' 48' ' ' LEU . 7.2 ttpp -55.31 -50.78 68.71 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.735 -0.666 . . . . 1.11 111.046 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.628 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.3 ppp? -69.35 -20.95 63.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.118 -0.492 . . . . 1.17 110.646 -174.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.424 HG23 ' CE1' ' A' ' 3' ' ' HIS . 52.7 m -70.98 -56.74 5.55 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.337 0.589 . . . . 0.15 110.093 174.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.923 ' HB2' HD22 ' A' ' 48' ' ' LEU . 13.8 mt -61.2 -55.75 28.6 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.009 -0.996 . . . . 0.13 110.587 -176.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 1.054 ' HG3' HD23 ' A' ' 48' ' ' LEU . 75.3 mt-30 -53.61 -26.46 22.0 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.852 0.686 . . . . 1.45 112.852 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -65.93 -30.87 71.52 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 122.057 0.932 . . . . 0.65 108.933 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.655 HG21 ' HB3' ' A' ' 25' ' ' ALA . 30.1 mt -82.7 -43.81 18.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 113.678 -1.601 . . . . 0.17 110.232 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.703 HG22 ' HD2' ' A' ' 112' ' ' LYS . 1.1 mt -68.81 -47.12 77.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.546 -0.752 . . . . 0.29 111.174 -175.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 50.8 m -61.03 -27.61 68.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.581 0.705 . . . . 1.22 109.42 175.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.54 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 17.0 ttt180 -67.91 -34.18 76.13 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.598 -1.183 . . . . 3.79 109.732 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -95.15 -19.91 19.69 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.992 -0.549 . . . . 0.6 111.435 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.703 ' HD2' HG22 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -74.17 -31.44 62.69 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 110.141 -0.318 . . . . 1.76 110.141 174.426 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.39 -1.31 45.08 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.195 0.521 . . . . 1.56 110.463 175.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -114.53 1.58 14.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.668 -0.696 . . . . 1.09 110.544 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 30.2 t70 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.439 -0.791 . . . . 2.16 110.519 -177.537 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 N-CA-C 111.583 -0.607 . . . . 25.39 111.583 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -103.98 131.56 10.69 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.902 -0.666 . . . . 24.6 111.83 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -145.75 178.12 23.69 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.61 -0.805 . . . . 23.97 112.317 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 84.7 170.13 46.65 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.05 -0.595 . . . . 23.13 112.315 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -105.72 18.35 22.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.976 0.417 . . . . 24.92 110.832 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -115.18 145.14 42.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.323 -0.398 . . . . 21.4 110.354 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 10.3 p -83.95 -3.93 8.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 122.04 0.924 . . . . 20.37 109.155 175.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -90.72 121.66 32.8 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.879 -1.055 . . . . 17.68 109.394 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 28.0 ttt -169.06 55.06 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.403 -0.962 . . . . 16.8 108.403 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.78 117.38 7.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.136 -0.938 . . . . 13.35 110.658 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 24.8 p -146.92 -163.08 1.67 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.282 -0.872 . . . . 10.66 110.423 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -77.77 -12.36 59.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.513 -0.312 . . . . 11.03 110.904 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . 0.513 ' HA ' ' HB2' ' B' ' 257' ' ' ASP . 33.7 mm-40 -55.6 -26.88 46.24 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.023 -0.535 . . . . 10.94 112.012 -176.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -51.68 -38.3 54.41 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.968 0.413 . . . . 9.82 111.261 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 62.4 m -132.25 47.63 2.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.299 0.571 . . . . 5.35 110.242 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 257' ' ' ASP . . . . . 0.513 ' HB2' ' HA ' ' B' ' 254' ' ' GLU . 14.6 t70 -82.72 -54.93 4.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.724 -0.671 . . . . 6.2 111.268 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.574 ' OD1' ' HG3' ' A' ' 61' ' ' ARG . 14.3 t70 -69.35 -67.94 0.44 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.14 0.495 . . . . 6.14 111.123 -177.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -164.01 44.16 0.1 Allowed 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.949 -1.13 . . . . 3.32 107.949 174.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 100.33 -4.89 57.13 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 114.685 -1.143 . . . . 0.84 112.363 -176.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 261' ' ' PHE . . . . . 0.594 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 1.1 m-85 -111.07 158.84 18.38 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 110.055 -0.35 . . . . 0.95 110.055 -177.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . 0.49 ' CG1' ' HB3' ' A' ' 52' ' ' PRO . 13.0 p -144.5 165.72 12.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.882 -0.599 . . . . 1.37 109.452 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 263' ' ' GLU . . . . . 0.432 ' N ' HG22 ' B' ' 262' ' ' VAL . 14.1 tt0 -78.99 117.52 20.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.279 -1.008 . . . . 2.24 108.279 172.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.612 ' H ' HE22 ' A' ' 105' ' ' GLN . 40.6 t -116.34 103.8 15.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.469 -0.332 . . . . 1.41 110.356 -178.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 21.6 t70 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.498 -0.763 . . . . 3.04 110.285 178.175 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 N--CA 1.479 0.646 0 N-CA-C 110.734 -0.525 . . . . 3.14 110.734 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.419 ' C ' ' H ' ' A' ' 4' ' ' SER . 67.0 m -97.55 148.44 23.25 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.77 0.319 . . . . 1.4 110.285 174.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.509 ' HA ' HG21 ' A' ' 103' ' ' THR . 28.8 m80 63.65 -4.65 0.32 Allowed 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.45 -0.796 . . . . 1.85 112.45 -177.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 16' ' ' ILE . 77.1 p -163.86 137.99 5.72 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.736 0.303 . . . . 0.95 110.249 177.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.19 151.38 10.57 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.431 -1.067 . . . . 0.16 110.431 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.717 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.94 138.16 40.81 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.336 0.568 . . . . 0.43 111.598 -175.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.21 157.1 43.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.13 110.844 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 2.3 mp -91.27 127.06 43.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.185 -0.672 . . . . 0.29 109.185 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.579 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 79.2 t80 -138.51 118.42 13.31 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.845 -0.428 . . . . 0.56 109.845 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 70.49 41.56 0.96 Allowed 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 123.851 0.719 . . . . 1.46 110.494 -176.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? 70.27 9.34 6.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.356 -1.293 . . . . 1.91 111.956 173.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.29 135.59 58.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.745 0.307 . . . . 0.47 110.524 176.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.5 ' HA ' HG13 ' A' ' 8' ' ' ILE . 48.5 t -76.95 120.57 22.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.089 0.471 . . . . 1.02 110.268 176.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.626 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -141.85 -154.44 6.17 Favored Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 115.766 -0.652 . . . . 0.16 112.004 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.717 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.3 mm -126.89 153.4 35.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 121.052 0.453 . . . . 0.19 110.676 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 4' ' ' SER . 0.1 OUTLIER -122.33 133.68 67.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 115.656 -0.702 . . . . 0.16 109.789 178.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.34 108.78 7.37 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.02 0.438 . . . . 0.12 111.607 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.661 HD11 HG23 ' A' ' 100' ' ' ILE . 4.0 mp -85.62 113.31 23.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.302 -0.999 . . . . 0.18 108.302 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.7 t30 -116.58 122.66 45.29 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.649 -0.5 . . . . 1.12 109.649 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.441 ' HG2' ' HB1' ' A' ' 25' ' ' ALA . 8.6 mt-10 -108.17 82.86 1.69 Allowed 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 117.144 -1.823 . . . . 0.74 107.38 165.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.431 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 23.1 t70 -122.71 -8.6 8.45 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.6 -1.63 . . . . 0.59 106.6 157.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 23' ' ' SER . 14.6 p -101.59 174.2 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 112.182 -2.281 . . . . 0.35 111.707 -158.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.672 ' O ' HG13 ' A' ' 22' ' ' VAL . 11.3 p -54.7 165.67 0.89 Allowed Pre-proline 0 N--CA 1.455 -0.176 0 N-CA-C 107.094 -1.447 . . . . 1.31 107.094 166.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.617 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 11.0 Cg_endo -41.85 126.91 3.52 Favored 'Trans proline' 0 C--N 1.358 1.07 0 CA-C-N 122.037 1.763 . . . . 0.22 111.57 -147.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.684 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -30.29 132.41 0.07 Allowed 'General case' 0 CA--C 1.508 -0.637 0 O-C-N 125.391 1.682 . . . . 0.2 113.596 -158.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.607 ' HB2' HG11 ' A' ' 22' ' ' VAL . 36.4 mt-10 -127.47 140.42 52.16 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.697 -1.138 . . . . 1.26 111.525 -167.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.558 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.5 tt -101.36 144.62 29.95 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.101 -1.444 . . . . 0.15 107.101 175.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.462 ' N ' HD23 ' A' ' 27' ' ' LEU . 18.5 m -132.23 109.19 9.74 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.954 -0.698 . . . . 0.21 110.223 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.579 ' CE2' ' HB3' ' A' ' 9' ' ' PHE . 87.2 t90 -87.04 115.32 24.35 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.723 -0.843 . . . . 0.24 108.723 175.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -121.98 123.41 41.59 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.068 -0.969 . . . . 0.87 108.984 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.427 ' OG ' ' HB3' ' A' ' 36' ' ' LYS . 22.1 m -54.91 144.09 24.02 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.179 -0.304 . . . . 0.75 110.179 -177.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.626 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 19.4 m -55.23 -26.22 38.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.649 -0.705 . . . . 0.39 110.735 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -81.62 -27.5 34.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.887 -0.597 . . . . 2.33 111.196 175.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.99 22.28 18.19 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.708 -0.758 . . . . 0.55 112.849 -178.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -97.51 -72.26 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.082 0.467 . . . . 1.13 110.775 -173.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.427 ' HB3' ' OG ' ' A' ' 31' ' ' SER . 18.7 ttmm -82.53 129.97 35.02 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.497 -0.774 . . . . 2.03 110.345 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 94.2 t -133.33 125.4 50.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.244 -0.435 . . . . 0.55 109.901 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -131.75 121.88 24.93 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.48 -0.327 . . . . 0.69 110.602 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 27' ' ' LEU . 31.4 m -104.38 142.07 35.23 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.683 0.278 . . . . 0.3 111.276 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 31.0 t -116.27 129.01 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 122.696 0.398 . . . . 0.66 111.167 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 45' ' ' ILE . 37.3 t -90.65 108.33 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.244 0.545 . . . . 0.18 109.663 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.598 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -55.26 -29.0 57.19 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.108 -0.951 . . . . 0.12 112.329 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 41.2 t -74.52 -30.44 61.79 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.425 -0.51 . . . . 1.06 110.738 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.6 p -80.07 -11.71 59.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.304 0.573 . . . . 0.2 109.532 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.623 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 39.1 mm -85.97 125.82 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.251 -0.886 . . . . 0.23 110.982 173.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.684 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 24.2 t70 -84.27 -38.95 19.82 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.14 -0.482 . . . . 0.7 111.217 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -143.89 153.59 42.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.927 -0.578 . . . . 1.95 110.053 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.025 HD22 ' HB2' ' A' ' 104' ' ' LEU . 10.7 tp -120.71 144.23 48.34 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.051 -0.722 . . . . 0.14 109.051 168.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.556 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 15.4 mm100 -118.63 157.59 27.1 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.016 -0.993 . . . . 1.49 109.639 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -161.58 141.39 10.35 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.134 -0.939 . . . . 0.25 108.652 177.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.521 ' HB ' ' CB ' ' A' ' 55' ' ' SER . 38.2 p -47.98 131.83 11.93 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 123.393 0.433 . . . . 0.37 110.877 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.433 ' O ' ' HB3' ' A' ' 55' ' ' SER . 46.7 Cg_endo -66.48 164.94 26.72 Favored 'Trans proline' 0 C--N 1.329 -0.465 0 C-N-CA 123.548 2.832 . . . . 0.64 111.536 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.56 -14.21 60.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.953 0.406 . . . . 1.02 111.027 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 56.5 m -84.59 -23.28 29.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.953 -0.567 . . . . 1.58 110.789 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.521 ' CB ' ' HB ' ' A' ' 51' ' ' THR . 29.3 t -62.33 137.3 58.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.716 -0.674 . . . . 0.71 110.587 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -83.28 -11.94 57.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.384 0.611 . . . . 2.89 110.076 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -109.07 171.58 7.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.237 -0.892 . . . . 2.59 109.485 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.603 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.2 OUTLIER -129.9 112.36 13.47 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.815 -1.18 . . . . 1.78 107.815 -178.297 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.617 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 2.4 mtm -155.75 140.96 17.52 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 119.936 -0.706 . . . . 1.3 112.237 -171.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.812 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 3.2 mp -109.43 161.08 15.65 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.684 -0.689 . . . . 0.14 110.897 170.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.556 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 7.9 ttm180 -154.57 113.85 3.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.67 -0.695 . . . . 2.72 110.273 174.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.746 ' HG ' HD13 ' A' ' 48' ' ' LEU . 10.0 mt -93.67 114.5 26.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.285 0.564 . . . . 0.9 111.249 -177.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.751 HG23 ' HG2' ' A' ' 86' ' ' ARG . 5.9 mm -87.55 108.95 18.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 123.813 0.845 . . . . 0.4 110.567 -173.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.623 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -80.45 141.4 22.89 Favored Glycine 0 C--O 1.227 -0.308 0 C-N-CA 120.286 -0.959 . . . . 0.48 112.048 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.684 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 0.5 OUTLIER -55.69 131.04 45.56 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 117.05 0.425 . . . . 1.15 110.269 179.239 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.4 p -79.43 152.23 4.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.899 -0.592 . . . . 0.69 109.718 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -82.19 101.51 10.51 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.799 -0.637 . . . . 2.56 110.698 -173.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -68.85 -31.84 71.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.742 -0.663 . . . . 3.79 110.888 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 m -70.3 -38.34 74.98 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 116.118 -0.492 . . . . 3.05 110.897 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -98.51 48.45 0.98 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.052 0.453 . . . . 5.48 110.145 177.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -66.4 126.42 28.75 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-O 121.48 0.657 . . . . 4.42 109.533 177.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.59 162.94 25.02 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 115.039 -0.982 . . . . 4.27 109.788 -173.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -133.29 159.78 39.22 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.846 -0.427 . . . . 5.09 109.846 179.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.81 ' HB3' HD21 ' A' ' 78' ' ' ASN . 4.9 t70 -86.67 -157.59 0.37 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.434 -0.348 . . . . 4.98 111.017 -173.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -75.29 -16.7 60.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.811 0.338 . . . . 6.68 111.15 -172.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.588 ' HB3' HD22 ' A' ' 78' ' ' ASN . 6.2 tp10 -95.0 2.17 55.3 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.064 -1.088 . . . . 7.13 108.064 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.99 27.66 71.81 Favored Glycine 0 CA--C 1.505 -0.558 0 CA-C-N 114.487 -1.233 . . . . 5.53 111.311 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.81 HD21 ' HB3' ' A' ' 74' ' ' ASP . 3.6 p30 -85.72 -86.67 0.14 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.384 -0.408 . . . . 5.62 111.587 -173.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 9.8 pt-20 -165.74 135.72 3.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 118.596 0.635 . . . . 5.0 112.707 177.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 t -127.44 147.86 32.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.774 -1.195 . . . . 3.33 107.774 163.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 p -113.05 99.7 49.42 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-O 121.491 0.662 . . . . 2.77 110.377 175.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -52.98 136.03 59.84 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 123.163 2.575 . . . . 1.78 112.567 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -75.64 128.05 84.61 Favored Pre-proline 0 N--CA 1.447 -0.623 0 N-CA-C 109.117 -0.697 . . . . 3.11 109.117 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.533 ' HG2' ' OE1' ' B' ' 249' ' ' GLU . 31.7 Cg_exo -49.63 139.56 30.63 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.731 2.954 . . . . 0.67 112.952 -173.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.434 ' CD ' ' H ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -71.81 118.73 15.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.842 0.83 . . . . 1.78 110.203 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.751 ' HG2' HG23 ' A' ' 63' ' ' ILE . 34.5 mtt180 -112.26 147.43 36.28 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.136 -0.938 . . . . 2.29 110.112 -174.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -108.57 112.66 25.13 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.596 -0.52 . . . . 0.5 109.596 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 44.7 ttm -107.06 130.71 54.63 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 121.206 -0.198 . . . . 0.42 111.449 -174.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.607 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -121.01 141.91 50.3 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.632 -0.877 . . . . 1.33 108.632 173.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.589 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 54.8 m -101.35 124.01 46.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.142 0.496 . . . . 0.94 110.43 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.812 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 5.7 m-85 -107.96 145.79 33.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.657 -0.702 . . . . 1.33 110.244 -175.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -100.17 -2.32 34.32 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.086 0.47 . . . . 1.53 110.639 -174.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -131.93 124.73 30.02 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.943 -0.572 . . . . 0.83 110.479 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.414 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 28.3 tpt180 -57.36 -35.32 69.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.237 -0.892 . . . . 2.16 111.015 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.545 HG22 HD21 ' A' ' 99' ' ' ASN . 91.6 m -71.78 -56.66 5.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.815 -0.63 . . . . 0.4 110.685 -176.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 85.0 t -45.8 -54.73 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 115.776 -0.647 . . . . 0.29 111.392 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.603 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -64.89 -29.22 70.16 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.678 -0.409 . . . . 0.29 110.955 -177.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.409 ' O ' ' HE3' ' A' ' 101' ' ' LYS . 29.5 t70 -71.04 -30.88 67.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.679 0.752 . . . . 0.39 109.22 178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.614 ' O ' ' HG3' ' A' ' 102' ' ' MET . 90.0 m-20 -78.26 -48.68 15.22 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.627 -1.17 . . . . 1.55 109.967 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.661 HG23 HD11 ' A' ' 18' ' ' ILE . 41.3 mm -58.51 -50.37 79.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.232 -0.894 . . . . 0.13 110.49 177.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.797 ' HA ' HD21 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -56.36 -48.7 76.28 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.161 -0.472 . . . . 1.11 111.023 178.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.614 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.1 ppp? -69.28 -23.36 63.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.146 0.498 . . . . 1.17 110.159 -175.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.509 HG21 ' HA ' ' A' ' 3' ' ' HIS . 54.9 m -67.64 -52.32 39.56 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.603 -0.726 . . . . 0.15 110.057 175.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.025 ' HB2' HD22 ' A' ' 48' ' ' LEU . 12.6 mt -70.87 -57.65 4.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.157 -0.929 . . . . 0.13 111.585 -173.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 1.008 ' HG3' HD23 ' A' ' 48' ' ' LEU . 45.2 mt-30 -50.78 -28.22 8.84 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.679 0.622 . . . . 1.45 112.679 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -65.02 -45.84 83.84 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.788 -0.819 . . . . 0.65 108.788 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.684 HG21 ' HB3' ' A' ' 25' ' ' ALA . 72.0 mt -63.21 -43.8 98.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.029 -1.441 . . . . 0.17 110.93 176.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.747 HG22 ' HD2' ' A' ' 112' ' ' LYS . 1.2 mt -62.4 -61.2 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.522 -0.763 . . . . 0.29 111.112 -174.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.7 m -52.99 -28.14 22.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.99 0.424 . . . . 1.22 111.261 173.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -71.98 -35.58 69.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.184 0.516 . . . . 3.79 110.665 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' A' ' 24' ' ' PRO . 12.8 m-85 -88.45 -18.85 27.41 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.752 -0.658 . . . . 0.6 112.208 -178.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.747 ' HD2' HG22 ' A' ' 108' ' ' ILE . 10.2 mtpp -86.44 -24.58 25.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.004 0.43 . . . . 1.76 110.535 177.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -76.77 -20.87 55.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.709 -0.678 . . . . 1.56 109.527 173.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -120.1 32.04 6.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.233 -0.894 . . . . 1.09 110.346 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.8 t70 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.539 -0.743 . . . . 2.16 110.049 179.258 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.886 0 N-CA-C 112.328 -0.309 . . . . 25.39 112.328 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -163.98 24.28 0.18 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.918 -0.658 . . . . 24.6 111.601 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -169.77 88.34 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 111.481 -0.648 . . . . 23.97 111.481 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -114.53 76.56 0.25 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.841 -0.904 . . . . 23.13 110.841 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 66.96 50.24 1.07 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.473 0.654 . . . . 24.92 109.392 -173.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -127.49 119.0 25.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.607 -0.724 . . . . 21.4 110.233 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 18.5 t 57.4 60.21 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-O 121.517 0.675 . . . . 20.37 109.942 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . 0.533 ' OE1' ' HG2' ' A' ' 84' ' ' PRO . 36.2 tt0 -63.47 114.78 4.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.454 -0.794 . . . . 17.68 111.245 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 88.6 mmm -130.28 37.5 3.87 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.386 -0.824 . . . . 16.8 108.961 175.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -79.46 141.44 36.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.149 -0.932 . . . . 13.35 110.725 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 43.8 m 54.32 60.8 3.35 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.851 0.719 . . . . 10.66 111.288 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.26 -13.66 59.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.558 -0.746 . . . . 11.03 110.956 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . 0.406 ' H ' ' HG3' ' B' ' 254' ' ' GLU . 0.0 OUTLIER -68.39 -29.59 68.32 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.832 0.349 . . . . 10.94 110.325 175.128 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -70.92 -57.61 4.42 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.091 0.472 . . . . 9.82 109.958 170.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 56.2 m -155.97 134.26 11.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.885 -0.598 . . . . 5.35 109.965 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -89.14 -64.45 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.108 -0.496 . . . . 6.2 110.489 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -85.02 -32.7 22.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.828 -0.623 . . . . 6.14 110.88 -178.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 73.76 -15.89 0.54 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.276 -0.874 . . . . 3.32 112.346 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 98.35 -7.64 62.01 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 121.075 -0.583 . . . . 0.84 113.356 173.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 261' ' ' PHE . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 5.7 m-30 -128.55 162.94 26.07 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.439 -0.578 . . . . 0.95 109.439 -177.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 27.9 m -136.09 169.53 20.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.564 -0.532 . . . . 1.37 109.564 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 263' ' ' GLU . . . . . 0.509 ' HA ' HE22 ' A' ' 105' ' ' GLN . 0.0 OUTLIER -102.36 120.33 40.32 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.503 -0.479 . . . . 2.24 110.715 173.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.09 101.51 12.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.959 -0.756 . . . . 1.41 108.959 173.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.607 -0.711 . . . . 3.04 109.975 -176.595 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo . . . . . 0 N--CA 1.479 0.641 0 N-CA-C 110.769 -0.512 . . . . 3.14 110.769 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.8 t -174.32 -35.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.219 0.533 . . . . 1.4 110.194 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.585 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -82.87 23.73 0.8 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.532 -0.758 . . . . 1.85 111.392 -176.246 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.0 m -160.75 149.54 16.64 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.395 -0.594 . . . . 0.95 109.395 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.23 150.07 7.67 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.561 -1.016 . . . . 0.16 110.561 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.735 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -76.62 139.29 40.56 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 117.49 0.645 . . . . 0.43 111.416 -175.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.79 158.05 43.88 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.216 0.531 . . . . 0.13 111.119 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.567 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.1 mp -99.55 129.7 49.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.284 -0.636 . . . . 0.29 109.284 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.586 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 85.3 t80 -138.56 116.0 11.24 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.263 -0.426 . . . . 0.56 109.941 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 67.56 42.65 2.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.436 0.636 . . . . 1.46 110.739 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt 68.99 10.51 7.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.327 -1.306 . . . . 1.91 112.484 173.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -113.53 132.24 63.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.996 0.427 . . . . 0.47 110.311 173.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.567 ' HA ' HG13 ' A' ' 8' ' ' ILE . 32.6 t -77.75 117.68 19.37 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.833 -0.621 . . . . 1.02 109.952 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.661 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -137.23 -157.33 7.58 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 120.928 -0.653 . . . . 0.16 112.141 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.735 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 9.3 mm -127.04 153.42 36.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 120.827 0.346 . . . . 0.19 110.795 -176.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.466 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -123.95 132.8 70.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 115.883 -0.599 . . . . 0.16 109.675 179.022 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.93 109.54 7.47 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.109 0.411 . . . . 0.12 112.109 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.62 HD11 HG23 ' A' ' 100' ' ' ILE . 4.0 mp -85.38 103.43 12.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.001 -0.74 . . . . 0.18 109.001 171.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.453 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -110.44 129.6 55.74 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.724 -0.39 . . . . 1.12 110.202 -179.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -107.78 84.19 1.92 Allowed 'General case' 0 N--CA 1.427 -1.607 0 C-N-CA 116.811 -1.956 . . . . 0.74 107.345 164.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.453 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 17.2 t70 -121.77 -10.72 8.69 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 106.568 -1.641 . . . . 0.59 106.568 156.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.712 HG11 ' HB2' ' A' ' 26' ' ' GLU . 13.6 p -101.56 179.35 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 111.946 -2.388 . . . . 0.35 111.19 -157.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.643 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -52.44 167.2 0.38 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 117.974 -1.012 . . . . 1.31 108.338 168.019 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.582 ' HB2' ' OG ' ' A' ' 43' ' ' SER . 15.8 Cg_endo -44.36 126.17 6.47 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.494 1.463 . . . . 0.22 111.525 -156.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.598 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -25.67 132.76 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.99 1.431 . . . . 0.2 114.725 -151.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.712 ' HB2' HG11 ' A' ' 22' ' ' VAL . 39.7 mt-10 -124.99 139.46 53.8 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.201 -0.909 . . . . 1.26 110.929 -172.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.577 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.1 tt -101.31 143.28 31.55 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 106.831 -1.544 . . . . 0.15 106.831 175.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.402 ' N ' HD23 ' A' ' 27' ' ' LEU . 6.6 m -130.17 108.99 10.46 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.688 -0.805 . . . . 0.21 110.519 -178.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.638 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 89.8 t90 -86.63 113.01 22.15 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.471 0.653 . . . . 0.24 109.417 174.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -120.47 120.78 36.88 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.173 -0.921 . . . . 0.87 109.157 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.46 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 20.1 m -55.9 141.35 39.55 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.771 -0.455 . . . . 0.75 109.771 -177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.661 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 28.8 m -54.15 -31.84 53.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.31 -0.859 . . . . 0.39 111.018 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -89.6 -9.21 50.6 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 116.236 -0.438 . . . . 2.33 111.599 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.01 18.8 57.29 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.979 -0.629 . . . . 0.55 112.553 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -72.46 -68.38 0.48 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.338 . . . . 1.13 111.527 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -110.0 152.29 26.09 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.217 0.532 . . . . 2.03 111.626 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 85.2 t -138.06 117.74 15.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.283 -0.871 . . . . 0.55 109.877 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -123.74 113.66 18.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.191 -0.459 . . . . 0.69 110.148 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.7 m -100.69 143.72 30.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.664 -0.243 . . . . 0.3 111.027 -175.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.592 HG11 HD13 ' A' ' 62' ' ' LEU . 43.1 t -117.69 128.24 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 111.797 0.295 . . . . 0.66 111.797 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 45' ' ' ILE . 33.3 t -90.63 107.93 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.279 0.561 . . . . 0.18 109.61 173.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.608 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.9 mm? -54.44 -29.83 50.78 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.806 -1.088 . . . . 0.12 112.565 -177.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.582 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 72.5 m -74.4 -34.77 63.38 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.514 -0.475 . . . . 1.06 111.46 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -74.62 -16.51 60.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.483 0.658 . . . . 0.2 109.468 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.589 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 43.3 mm -75.44 118.3 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 115.156 -0.929 . . . . 0.23 111.551 175.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.618 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 11.1 t70 -74.74 -49.59 20.5 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.423 -0.808 . . . . 0.7 111.237 174.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -134.09 150.92 51.19 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 116.765 -0.198 . . . . 1.95 110.58 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.92 HD22 ' HB2' ' A' ' 104' ' ' LEU . 12.3 tp -115.92 143.18 45.79 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.985 -0.746 . . . . 0.14 108.985 164.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.55 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 7.2 mt-30 -124.24 152.19 43.26 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.09 -0.959 . . . . 1.49 109.603 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.03 143.3 10.8 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.737 -0.838 . . . . 0.25 108.737 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 40.9 p -47.48 127.09 10.2 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-O 121.565 0.698 . . . . 0.37 111.025 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 61.4 Cg_endo -70.17 166.68 27.3 Favored 'Trans proline' 0 C--N 1.33 -0.402 0 C-N-CA 124.152 3.235 . . . . 0.64 112.015 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.85 -29.51 59.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.903 0.382 . . . . 1.02 110.896 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.4 m -69.62 -25.59 64.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.96 -0.563 . . . . 1.58 111.156 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.483 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 37.6 t -74.78 137.31 41.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.974 -0.557 . . . . 0.71 110.09 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -91.54 -0.07 57.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.669 0.747 . . . . 2.89 109.582 175.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.3 mmmt -107.98 176.55 5.1 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.946 -1.024 . . . . 2.59 109.985 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.555 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -137.15 109.48 7.34 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.108 -0.701 . . . . 1.78 109.108 -178.166 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.603 ' HG2' ' HA ' ' A' ' 90' ' ' SER . 68.0 mtm -157.09 140.71 15.89 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.478 0.18 . . . . 1.3 111.102 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.871 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 1.4 mp -110.15 160.05 16.82 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.23 -0.441 . . . . 0.14 111.074 174.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 21.8 ttt180 -153.31 114.88 4.23 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 121.208 0.528 . . . . 2.72 111.456 169.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.748 ' HG ' HD13 ' A' ' 48' ' ' LEU . 8.9 mt -92.86 110.19 21.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.864 -0.607 . . . . 0.9 110.813 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.579 HG23 ' HB3' ' A' ' 86' ' ' ARG . 3.9 mm -87.55 126.28 41.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 123.111 0.564 . . . . 0.4 110.456 -176.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -87.6 152.28 23.98 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.33 -0.938 . . . . 0.48 111.019 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.618 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 10.2 mptt -59.01 136.06 57.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.01 0.405 . . . . 1.15 110.394 178.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.4 ' HB ' ' HG3' ' A' ' 84' ' ' PRO . 9.3 p -72.23 157.66 6.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.774 -0.648 . . . . 0.69 109.743 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -59.18 140.1 56.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.902 -0.59 . . . . 2.56 110.706 -176.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -56.48 -17.1 7.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.64 -1.164 . . . . 3.79 113.196 -174.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.3 p -87.58 -11.83 47.5 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.892 -0.323 . . . . 3.05 111.374 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 45.73 -90.99 0.01 OUTLIER 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.082 0.953 . . . . 5.48 113.311 -174.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -61.49 139.62 58.2 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.813 0.816 . . . . 4.42 111.689 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.408 ' HG2' ' HD3' ' A' ' 82' ' ' PRO . 19.8 ptt85 -128.22 174.0 9.65 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.65 -1.159 . . . . 4.27 108.568 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.487 ' HD2' ' O ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -145.58 131.06 18.72 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.27 0.557 . . . . 5.09 110.138 177.35 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.574 ' HB3' ' OD1' ' A' ' 78' ' ' ASN . 5.2 t70 -76.21 174.53 10.01 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.326 -0.99 . . . . 4.98 108.326 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -54.74 -15.4 1.85 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.133 1.16 . . . . 6.68 114.133 -165.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -87.93 -18.77 28.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.681 0.753 . . . . 7.13 109.8 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.6 23.17 47.93 Favored Glycine 0 CA--C 1.506 -0.511 0 N-CA-C 108.972 -1.651 . . . . 5.53 108.972 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.574 ' OD1' ' HB3' ' A' ' 74' ' ' ASP . 5.3 p30 -70.8 -31.49 68.25 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 113.04 -1.58 . . . . 5.62 112.301 -173.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 53.0 mt-10 85.89 118.74 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.401 1.063 . . . . 5.0 111.483 173.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.92 147.63 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 108.041 -1.096 . . . . 3.33 108.041 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 52.0 t -117.6 96.55 49.59 Favored Pre-proline 0 C--N 1.3 -1.585 0 CA-C-O 121.588 0.709 . . . . 2.77 110.078 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.408 ' HD3' ' HG2' ' A' ' 72' ' ' ARG . 88.6 Cg_endo -77.82 128.91 9.58 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.52 2.813 . . . . 1.78 112.629 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -78.59 152.69 78.25 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.724 -0.671 . . . . 3.11 110.076 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.4 ' HG3' ' HB ' ' A' ' 66' ' ' VAL . 31.1 Cg_exo -51.55 140.72 44.35 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.028 2.486 . . . . 0.67 112.732 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -79.35 155.02 28.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.825 -0.805 . . . . 1.78 108.825 177.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.579 ' HB3' HG23 ' A' ' 63' ' ' ILE . 9.6 ptt180 -156.55 160.03 39.1 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.962 -0.563 . . . . 2.29 111.669 -166.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -120.29 111.44 17.78 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.594 -0.73 . . . . 0.5 110.058 -172.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 49.2 ttm -107.51 126.92 53.13 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.501 -0.124 . . . . 0.42 110.914 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.442 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 50.7 m-85 -116.19 143.72 45.13 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.647 -0.872 . . . . 1.33 108.647 174.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.603 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 14.9 m -99.11 123.7 43.6 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.974 0.416 . . . . 0.94 110.197 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.871 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 7.5 m-85 -108.52 157.17 18.71 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.064 -0.517 . . . . 1.33 110.246 -176.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -113.67 -6.34 13.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.904 0.383 . . . . 1.53 111.239 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -128.3 124.33 36.25 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.2 0.524 . . . . 0.83 110.145 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.436 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 29.8 tpt180 -57.24 -36.75 71.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.961 -1.018 . . . . 2.16 111.175 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.442 HG22 HD21 ' A' ' 99' ' ' ASN . 85.2 m -74.04 -55.42 6.14 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.7 -0.682 . . . . 0.4 110.83 -176.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 100' ' ' ILE . 88.4 t -46.05 -55.21 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.29 111.352 175.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.555 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -66.88 -28.34 68.24 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.895 -0.322 . . . . 0.29 110.808 -177.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.15 -31.87 70.83 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.049 -0.723 . . . . 0.39 109.049 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.602 ' O ' ' HG3' ' A' ' 102' ' ' MET . 90.7 m-20 -77.78 -46.31 22.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.559 -1.2 . . . . 1.55 109.726 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.62 HG23 HD11 ' A' ' 18' ' ' ILE . 35.4 mm -58.6 -51.54 70.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.104 -0.953 . . . . 0.13 110.393 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.64 ' HA ' HD21 ' A' ' 48' ' ' LEU . 4.1 ttpt -57.01 -51.39 69.46 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.886 -0.597 . . . . 1.11 110.429 178.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.602 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.3 ppp? -64.94 -25.18 67.77 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.903 0.383 . . . . 1.17 110.716 -175.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.412 HG21 ' HB ' ' A' ' 18' ' ' ILE . 35.7 m -66.02 -51.62 56.65 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.452 0.644 . . . . 0.15 110.128 175.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.92 ' HB2' HD22 ' A' ' 48' ' ' LEU . 8.7 mt -70.09 -55.95 8.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.88 -1.055 . . . . 0.13 110.927 -175.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.763 ' HG2' HD23 ' A' ' 48' ' ' LEU . 18.7 mm-40 -42.92 -36.15 1.43 Allowed 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.694 0.621 . . . . 1.45 112.664 177.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -65.42 -32.97 74.88 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.919 0.866 . . . . 0.65 109.663 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.598 HG21 ' HB3' ' A' ' 25' ' ' ALA . 42.0 mt -79.69 -41.79 22.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.066 -1.424 . . . . 0.17 110.123 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.607 HG22 ' HD2' ' A' ' 112' ' ' LYS . 0.6 OUTLIER -66.63 -51.34 57.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.248 -0.887 . . . . 0.29 110.87 -176.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.496 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 13.6 t -59.41 -29.03 67.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.411 0.624 . . . . 1.22 109.509 175.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 10.6 ttt180 -66.3 -34.19 77.44 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.043 -0.98 . . . . 3.79 109.949 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -94.74 -14.55 24.66 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 116.047 -0.524 . . . . 0.6 111.472 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.607 ' HD2' HG22 ' A' ' 108' ' ' ILE . 10.4 mtpp -80.9 -29.0 35.72 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.708 -0.479 . . . . 1.76 109.708 173.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.08 -17.74 59.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.629 0.728 . . . . 1.56 109.149 172.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -108.83 20.51 18.39 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.15 -0.932 . . . . 1.09 110.665 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.8 t70 . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.548 -0.739 . . . . 2.16 109.593 177.678 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' B' ' 246' ' ' TYR . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 111.454 -0.659 . . . . 25.39 111.454 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -68.0 -30.43 74.09 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.89 -0.671 . . . . 24.6 112.591 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -80.78 72.73 2.66 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.855 -0.688 . . . . 23.97 112.356 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 100.61 73.81 1.06 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.705 -0.759 . . . . 23.13 112.313 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 246' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' B' ' 242' ' ' GLY . 50.5 p90 -117.72 -16.51 10.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.032 0.444 . . . . 24.92 111.272 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -89.93 104.24 16.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.122 -0.49 . . . . 21.4 110.522 -172.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 9.4 p 43.04 39.56 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 122.463 1.125 . . . . 20.37 111.202 -176.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -118.55 117.35 28.74 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.977 -1.01 . . . . 17.68 110.846 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 2.3 ppp? -143.95 23.17 1.73 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.764 -1.107 . . . . 16.8 109.259 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -57.73 141.23 49.32 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.181 -0.918 . . . . 13.35 111.259 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . 0.4 ' HB3' ' HB2' ' B' ' 255' ' ' GLU . 20.3 m -71.83 100.89 2.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.416 -0.811 . . . . 10.66 111.031 -175.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -78.39 -38.36 41.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.032 -0.531 . . . . 11.03 111.023 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -76.99 -37.72 54.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.821 0.343 . . . . 10.94 110.731 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 255' ' ' GLU . . . . . 0.4 ' HB2' ' HB3' ' B' ' 252' ' ' SER . 46.7 mt-10 -82.44 -15.25 53.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.333 -0.394 . . . . 9.82 110.884 177.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 39.7 t 68.46 104.62 0.05 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.274 -0.875 . . . . 5.35 111.093 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -89.91 -40.9 12.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.887 -0.597 . . . . 6.2 110.577 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -66.07 -65.14 0.72 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.904 -0.589 . . . . 6.14 111.862 -174.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -87.96 -41.8 12.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.237 0.542 . . . . 3.32 110.94 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 97.82 0.75 58.85 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.868 -0.893 . . . . 0.84 110.868 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 261' ' ' PHE . . . . . 0.55 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 1.5 m-85 -120.87 149.78 42.07 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.419 -0.586 . . . . 0.95 109.419 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.85 161.74 23.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.864 0.364 . . . . 1.37 111.824 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -90.15 124.48 34.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.818 -0.628 . . . . 2.24 109.478 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.401 ' H ' ' NE2' ' A' ' 105' ' ' GLN . 59.1 t -115.79 103.11 14.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.803 0.335 . . . . 1.41 110.715 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 C--O 1.246 0.902 0 N-CA-C 109.314 -0.624 . . . . 3.04 109.314 177.339 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo . . . . . 0 N--CA 1.48 0.718 0 N-CA-C 110.169 -0.743 . . . . 3.14 110.169 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 99.1 p 63.5 -41.72 0.22 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.299 1.439 . . . . 1.4 112.795 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.438 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 13.9 m80 -87.73 22.43 2.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.34 0.59 . . . . 1.85 110.077 -178.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.3 p -162.94 151.31 14.14 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.555 -0.748 . . . . 0.95 109.278 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.5 146.98 7.06 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.9 -0.88 . . . . 0.16 110.9 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.743 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -79.39 117.26 20.2 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 117.209 0.505 . . . . 0.43 111.296 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.503 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -125.23 155.95 39.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.349 0.595 . . . . 0.13 111.513 -177.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.501 HG13 ' HA ' ' A' ' 13' ' ' SER . 1.9 mp -96.42 119.59 44.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 108.611 -0.885 . . . . 0.29 108.611 176.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.441 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 93.2 t80 -119.47 102.82 8.93 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.518 -0.31 . . . . 0.56 110.263 -177.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 65.51 55.33 1.04 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.317 0.58 . . . . 1.46 110.939 -177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt 72.38 -4.81 1.94 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.641 -1.163 . . . . 1.91 113.304 171.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -103.99 130.24 54.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.939 0.399 . . . . 0.47 110.488 172.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.501 ' HA ' HG13 ' A' ' 8' ' ' ILE . 32.4 t -78.43 129.4 34.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.882 -0.599 . . . . 1.02 109.953 177.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.618 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -150.68 -159.84 9.02 Favored Glycine 0 N--CA 1.436 -1.321 0 C-N-CA 120.752 -0.737 . . . . 0.16 112.494 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.743 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 6.4 mm -125.97 153.24 33.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 120.768 0.318 . . . . 0.19 110.583 -177.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.89 135.12 63.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 116.114 -0.494 . . . . 0.16 109.861 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.19 110.57 7.44 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.207 0.447 . . . . 0.12 112.207 176.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.619 HD11 HG23 ' A' ' 100' ' ' ILE . 3.7 mp -86.08 121.44 37.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.667 -0.864 . . . . 0.18 108.667 171.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.742 HD21 ' HB ' ' A' ' 22' ' ' VAL . 0.7 OUTLIER -126.7 134.28 50.72 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.699 -0.482 . . . . 1.12 109.699 179.001 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.512 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 18.0 mt-10 -114.99 83.15 1.86 Allowed 'General case' 0 N--CA 1.425 -1.723 0 C-N-CA 116.513 -2.075 . . . . 0.74 107.663 161.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.447 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 34.1 t70 -121.32 -9.79 9.02 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 106.168 -1.79 . . . . 0.59 106.168 159.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.893 HG11 ' HB3' ' A' ' 26' ' ' GLU . 13.2 p -103.52 173.82 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 111.583 -2.553 . . . . 0.35 111.821 -159.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.697 ' O ' HG13 ' A' ' 22' ' ' VAL . 16.3 m -55.08 166.28 0.85 Allowed Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 106.692 -1.596 . . . . 1.31 106.692 165.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 10.1 Cg_endo -40.55 128.06 2.44 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 121.601 1.608 . . . . 0.22 111.775 -147.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.711 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -28.2 132.78 0.04 OUTLIER 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 125.466 1.729 . . . . 0.2 113.217 -160.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.893 ' HB3' HG11 ' A' ' 22' ' ' VAL . 35.4 tt0 -130.58 132.04 45.32 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 115.229 -0.896 . . . . 1.26 111.244 -161.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.558 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.5 tt -100.83 144.94 29.18 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 106.94 -1.504 . . . . 0.15 106.94 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.505 ' N ' HD23 ' A' ' 27' ' ' LEU . 9.8 m -133.22 108.91 9.07 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.161 -0.616 . . . . 0.21 110.274 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.595 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.3 t90 -89.87 109.8 20.78 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.647 0.737 . . . . 0.24 109.056 176.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 30' ' ' ARG . 13.1 ttt-85 -113.35 121.35 44.09 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.132 -0.94 . . . . 0.87 109.236 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.48 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 88.9 p -57.33 148.02 24.13 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.078 -0.342 . . . . 0.75 110.078 -177.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.618 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 33.4 m -48.42 -38.13 18.85 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.084 0.468 . . . . 0.39 110.618 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -68.32 -28.03 66.8 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.628 -0.715 . . . . 2.33 111.642 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.74 21.55 46.68 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.034 -0.603 . . . . 0.55 112.068 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -104.91 -37.43 7.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.324 0.583 . . . . 1.13 110.816 -172.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -114.61 120.65 40.9 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.587 -0.733 . . . . 2.03 109.998 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.5 t -123.52 118.91 55.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.992 0.425 . . . . 0.55 110.348 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -119.41 109.96 16.38 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.98 -0.555 . . . . 0.69 110.237 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.9 m -95.69 143.32 27.05 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.471 -0.331 . . . . 0.3 111.448 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.586 HG11 HD13 ' A' ' 62' ' ' LEU . 30.1 t -120.83 124.37 72.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.295 -0.411 . . . . 0.66 111.16 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 45' ' ' ILE . 49.1 t -90.54 107.75 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 109.282 -0.636 . . . . 0.18 109.282 174.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.59 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.4 mm? -51.92 -29.09 18.66 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.957 -1.019 . . . . 0.12 112.67 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.455 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 43.1 t -71.8 -35.59 70.02 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.583 -0.447 . . . . 1.06 110.803 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 81.2 p -76.36 -13.82 60.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.081 0.467 . . . . 0.2 109.857 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.652 HG21 HD22 ' A' ' 62' ' ' LEU . 46.6 mm -79.84 121.17 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.579 -0.737 . . . . 0.23 111.391 176.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.638 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 34.0 t70 -81.78 -40.56 22.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.538 0.685 . . . . 0.7 110.881 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.597 ' HB2' ' CG1' ' A' ' 63' ' ' ILE . 46.0 mmtm -136.27 142.34 43.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.103 -0.953 . . . . 1.95 110.932 -172.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.027 HD23 ' HG3' ' A' ' 105' ' ' GLN . 12.7 tp -118.0 138.04 52.46 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.457 0.646 . . . . 0.14 109.302 164.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 14.0 mm100 -119.28 157.19 28.57 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.456 -1.247 . . . . 1.49 109.277 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -160.33 148.92 16.86 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.517 -1.29 . . . . 0.25 107.517 177.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 27.4 p -52.77 126.91 42.43 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 121.377 0.608 . . . . 0.37 111.083 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 50.1 Cg_endo -67.46 165.63 26.5 Favored 'Trans proline' 0 C--N 1.329 -0.461 0 C-N-CA 123.584 2.856 . . . . 0.64 111.068 176.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.34 -23.04 66.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.125 0.488 . . . . 1.02 110.353 176.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.3 m -73.74 -24.91 59.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.679 -0.691 . . . . 1.58 111.346 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.479 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 36.3 t -71.41 145.17 49.49 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.882 -0.414 . . . . 0.71 109.882 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -90.55 -6.05 55.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.272 0.558 . . . . 2.89 109.95 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -111.67 174.44 5.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.201 -0.909 . . . . 2.59 109.997 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.672 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 3.5 mmt -131.38 108.76 9.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.174 -0.676 . . . . 1.78 109.174 176.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.52 ' HG3' ' H ' ' A' ' 91' ' ' PHE . 3.9 mpp? -154.42 168.1 27.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.08 0.467 . . . . 1.3 111.666 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.555 HD23 HD11 ' A' ' 48' ' ' LEU . 1.1 mp -126.52 161.32 28.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.339 -0.846 . . . . 0.14 111.001 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 50.0 ttp180 -153.54 114.38 4.07 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.607 0.241 . . . . 2.72 110.986 169.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.652 HD22 HG21 ' A' ' 45' ' ' ILE . 12.6 mt -94.43 109.33 21.2 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.702 0.401 . . . . 0.9 110.942 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.726 HG23 ' HB3' ' A' ' 86' ' ' ARG . 1.0 OUTLIER -87.4 118.97 34.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 123.041 0.536 . . . . 0.4 110.081 -176.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -80.87 152.56 33.4 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.98 -1.105 . . . . 0.48 111.369 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.638 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 6.9 mptt -63.63 139.24 58.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.109 0.454 . . . . 1.15 110.306 176.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.8 p -91.74 156.88 2.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.007 -0.738 . . . . 0.69 109.007 172.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -81.41 90.53 6.19 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.29 0.567 . . . . 2.56 110.879 -175.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -84.73 -2.44 57.61 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.299 -0.864 . . . . 3.79 111.875 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.2 p -57.17 -40.04 76.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.781 0.324 . . . . 3.05 111.295 -176.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.83 142.86 24.0 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 110.065 -0.346 . . . . 5.48 110.065 174.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -65.92 133.7 51.44 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.113 -0.494 . . . . 4.42 110.247 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.518 ' CG ' ' HB ' ' A' ' 80' ' ' VAL . 4.3 ptm180 -76.23 170.51 16.19 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.874 -0.788 . . . . 4.27 108.874 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.454 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -142.66 147.42 35.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.033 0.444 . . . . 5.09 111.563 -174.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -85.01 -157.57 0.31 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.405 -0.816 . . . . 4.98 110.915 -174.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -58.03 -30.43 66.11 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.392 0.516 . . . . 6.68 112.392 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -89.17 -14.14 36.76 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.675 0.75 . . . . 7.13 110.317 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.454 ' HA2' ' HB2' ' A' ' 73' ' ' LYS . . . 86.52 32.45 15.95 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 109.477 -1.449 . . . . 5.53 109.477 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -85.83 -89.08 0.11 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 113.881 -1.159 . . . . 5.62 111.085 -170.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 10.4 pt-20 -178.74 131.03 0.12 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.202 0.525 . . . . 5.0 110.681 173.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.518 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.4 t -126.88 148.21 31.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.414 -0.958 . . . . 3.33 108.414 172.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.4 p -108.39 98.22 26.52 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-O 121.848 0.832 . . . . 2.77 109.955 173.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.419 ' HD3' ' HG2' ' A' ' 72' ' ' ARG . 57.6 Cg_endo -71.19 140.47 37.46 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.877 2.385 . . . . 1.78 112.804 -177.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.0 ttpp -79.85 137.52 54.09 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.659 -0.7 . . . . 3.11 110.261 175.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.407 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 21.1 Cg_exo -58.56 137.24 79.15 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.917 2.411 . . . . 0.67 111.729 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.02 114.19 12.06 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 122.352 1.072 . . . . 1.78 109.553 177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.726 ' HB3' HG23 ' A' ' 63' ' ' ILE . 9.2 ptt180 -113.77 146.02 40.52 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.626 -1.17 . . . . 2.29 110.063 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -113.2 111.85 22.78 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.324 -0.853 . . . . 0.5 109.61 -170.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 53.9 ttm -104.43 126.03 51.15 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.237 -0.585 . . . . 0.42 111.395 -176.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.481 ' CE2' HD12 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -115.65 122.36 45.35 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 109.004 -0.739 . . . . 1.33 109.004 178.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.497 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 16.1 m -89.56 124.04 34.18 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.835 -0.621 . . . . 0.94 110.379 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.6 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 30.5 m-85 -107.29 174.15 6.01 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.042 -0.526 . . . . 1.33 109.753 174.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -122.56 -5.33 8.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.256 -0.429 . . . . 1.53 110.126 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -127.82 135.4 50.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.446 0.641 . . . . 0.83 111.135 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.527 ' N ' ' HG3' ' A' ' 58' ' ' MET . 28.0 tpt180 -65.84 -35.18 79.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.531 -1.213 . . . . 2.16 111.102 -174.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.458 HG22 HD21 ' A' ' 99' ' ' ASN . 94.7 m -76.27 -52.96 8.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.831 -0.622 . . . . 0.4 111.112 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.3 t -45.29 -56.73 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 116.276 -0.42 . . . . 0.29 111.437 175.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.672 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -66.56 -29.25 69.27 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.194 -0.457 . . . . 0.29 110.718 -178.104 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -66.71 -33.47 75.71 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.121 -0.696 . . . . 0.39 109.121 176.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.584 ' O ' ' HG3' ' A' ' 102' ' ' MET . 86.9 m-20 -75.23 -50.9 14.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.651 -1.159 . . . . 1.55 109.808 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.619 HG23 HD11 ' A' ' 18' ' ' ILE . 35.2 mm -56.59 -52.27 55.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.037 -0.983 . . . . 0.13 110.685 177.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.667 ' HA ' HD21 ' A' ' 48' ' ' LEU . 4.9 ttpt -55.82 -49.16 74.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.723 -0.672 . . . . 1.11 111.321 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.584 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.2 ppp? -68.88 -24.15 64.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.847 0.356 . . . . 1.17 110.444 -176.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 55.2 m -67.58 -51.81 46.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.436 0.636 . . . . 0.15 110.027 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.896 ' HB2' HD22 ' A' ' 48' ' ' LEU . 10.6 mt -68.02 -56.39 9.09 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.989 -1.005 . . . . 0.13 111.187 -175.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 1.027 ' HG3' HD23 ' A' ' 48' ' ' LEU . 70.9 mt-30 -46.44 -31.62 2.79 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.207 0.818 . . . . 1.45 113.207 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -68.78 -27.93 66.33 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.048 0.927 . . . . 0.65 109.692 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.711 HG21 ' HB3' ' A' ' 25' ' ' ALA . 64.8 mt -83.58 -43.68 18.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.008 -1.451 . . . . 0.17 110.148 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.929 HG22 ' HD2' ' A' ' 112' ' ' LYS . 0.8 OUTLIER -62.38 -53.56 45.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 114.975 -1.011 . . . . 0.29 110.28 -177.156 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.8 t -59.05 -28.07 66.1 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.682 -0.69 . . . . 1.22 110.001 176.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.446 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 11.3 ttt180 -69.47 -34.35 74.22 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.202 -0.908 . . . . 3.79 110.051 178.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -88.08 -28.98 20.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.527 -0.76 . . . . 0.6 111.319 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.929 ' HD2' HG22 ' A' ' 108' ' ' ILE . 3.5 mtpp -76.99 -14.13 59.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.429 0.633 . . . . 1.76 109.989 176.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -76.5 -22.09 54.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.197 -0.91 . . . . 1.56 109.624 172.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -104.16 -33.75 8.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.51 -0.768 . . . . 1.09 111.516 -177.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.1 t70 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.57 -0.728 . . . . 2.16 111.12 -177.602 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.573 0 N-CA-C 111.838 -0.505 . . . . 25.39 111.838 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 81.11 -163.86 45.62 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.748 -0.739 . . . . 24.6 112.354 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -129.08 -156.9 9.06 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.728 -0.549 . . . . 23.97 111.728 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.52 -7.37 81.48 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.729 -0.748 . . . . 23.13 112.665 176.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -78.55 -34.22 47.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.74 0.781 . . . . 24.92 109.609 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -125.01 152.92 43.59 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.786 -1.097 . . . . 21.4 108.868 176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.3 76.38 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.312 0.577 . . . . 20.37 110.203 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -107.41 114.96 29.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.865 -0.607 . . . . 17.68 110.304 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 21.6 ptm -139.35 17.01 2.58 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.455 -0.572 . . . . 16.8 109.455 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.26 148.1 45.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.176 -0.92 . . . . 13.35 110.699 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' B' ' 256' ' ' SER . 22.3 t 77.5 -18.92 0.46 Allowed 'General case' 0 C--N 1.332 -0.19 0 O-C-N 123.886 0.741 . . . . 10.66 110.985 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -81.36 -54.72 5.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.17 0.51 . . . . 11.03 109.702 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.75 -46.43 17.05 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.403 -0.817 . . . . 10.94 111.896 -177.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -65.04 -21.69 66.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.927 0.394 . . . . 9.82 111.384 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 256' ' ' SER . . . . . 0.54 ' HB3' ' CG ' ' B' ' 259' ' ' ASP . 69.0 m -96.39 72.23 2.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.417 0.627 . . . . 5.35 109.672 173.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -72.7 -43.74 62.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.238 -0.892 . . . . 6.2 112.038 -174.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -72.0 -25.48 61.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.19 0.519 . . . . 6.14 110.298 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.54 ' CG ' ' HB3' ' B' ' 256' ' ' SER . 2.1 m-20 -67.24 -70.22 0.26 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.211 -0.904 . . . . 3.32 109.07 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 78.45 42.69 13.88 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.899 -1.143 . . . . 0.84 114.678 171.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 261' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 5.9 m-30 -121.36 150.9 40.78 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.323 -0.621 . . . . 0.95 109.323 176.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.3 p -134.99 152.83 33.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.162 -0.31 . . . . 1.37 110.162 -177.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -78.62 146.45 34.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.109 -0.7 . . . . 2.24 109.109 172.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 85.6 t -96.51 103.59 14.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.152 0.501 . . . . 1.41 110.259 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 34.4 t70 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.508 -0.758 . . . . 3.04 110.128 -177.118 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo . . . . . 0 N--CA 1.481 0.738 0 N-CA-C 110.584 -0.583 . . . . 3.14 110.584 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.6 p -102.04 -26.67 13.31 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.934 0.397 . . . . 1.4 111.328 -177.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.2 m170 -92.26 20.78 5.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.241 0.544 . . . . 1.85 110.397 -175.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.5 p -163.98 149.06 10.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.639 -0.71 . . . . 0.95 110.034 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.95 143.12 5.66 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 111.119 -0.792 . . . . 0.16 111.119 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.74 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.31 121.72 22.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 117.468 0.634 . . . . 0.43 111.047 -177.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.508 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -131.59 157.22 44.22 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 121.327 0.584 . . . . 0.13 111.697 -176.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 2.5 mp -95.08 114.58 31.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.477 -0.783 . . . . 0.29 109.291 175.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.608 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 74.8 t80 -122.58 111.32 16.65 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.191 -0.459 . . . . 0.56 110.031 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.509 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 40.3 mt-10 71.61 47.35 0.35 Allowed 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 124.072 0.857 . . . . 1.46 110.623 -176.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.509 ' HD2' ' C ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER 65.79 8.97 5.65 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.522 -1.217 . . . . 1.91 112.658 173.664 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.38 135.2 57.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.869 0.366 . . . . 0.47 110.436 174.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.522 ' HA ' HG13 ' A' ' 8' ' ' ILE . 23.7 t -78.25 124.99 28.71 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.289 0.566 . . . . 1.02 110.219 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.679 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -146.85 -156.7 7.04 Favored Glycine 0 N--CA 1.437 -1.26 0 CA-C-N 115.654 -0.703 . . . . 0.16 112.341 -178.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.74 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.1 mm -126.95 153.8 36.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.799 0.333 . . . . 0.19 110.582 -177.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.437 HD11 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -126.86 133.34 68.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 116.026 -0.534 . . . . 0.16 109.91 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.35 113.13 9.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.34 -0.391 . . . . 0.12 111.618 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.607 HD11 HG23 ' A' ' 100' ' ' ILE . 4.1 mp -84.43 121.76 37.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.002 -1.11 . . . . 0.18 108.002 171.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.459 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 2.1 t30 -126.26 125.84 43.02 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.99 -0.374 . . . . 1.12 109.99 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.485 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 20.8 mt-10 -110.6 83.9 1.84 Allowed 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 116.928 -1.909 . . . . 0.74 107.616 163.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.459 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 13.7 t70 -120.87 -8.74 9.37 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.001 -1.851 . . . . 0.59 106.001 157.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.693 HG13 ' O ' ' A' ' 23' ' ' SER . 14.9 p -102.46 173.76 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 111.75 -2.477 . . . . 0.35 111.982 -158.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.693 ' O ' HG13 ' A' ' 22' ' ' VAL . 4.4 m -54.51 168.1 0.51 Allowed Pre-proline 0 C--O 1.223 -0.319 0 N-CA-C 106.853 -1.536 . . . . 1.31 106.853 165.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 10.2 Cg_endo -40.86 127.81 2.64 Favored 'Trans proline' 0 C--N 1.356 0.938 0 CA-C-N 122.016 1.756 . . . . 0.22 111.239 -152.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.692 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -33.9 136.23 0.12 Allowed 'General case' 0 CA--C 1.504 -0.793 0 O-C-N 125.361 1.663 . . . . 0.2 113.621 -156.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.519 ' HB2' HG11 ' A' ' 22' ' ' VAL . 74.3 mt-10 -124.8 140.29 53.07 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.387 -1.279 . . . . 1.26 111.191 -169.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.578 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.2 tt -101.58 142.41 32.99 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.419 -1.697 . . . . 0.15 106.419 172.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.41 ' N ' HD23 ' A' ' 27' ' ' LEU . 11.1 m -127.33 109.2 11.55 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.782 -0.767 . . . . 0.21 110.254 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.617 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.9 t90 -88.44 106.14 18.07 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.814 -0.81 . . . . 0.24 108.814 175.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -114.17 112.02 22.51 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.759 -1.11 . . . . 0.87 108.745 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.579 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 93.7 p -57.69 146.03 32.27 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.406 0.622 . . . . 0.75 110.85 -174.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.679 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 7.9 m -57.59 -24.51 56.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.707 -1.133 . . . . 0.39 111.236 -175.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -87.92 -27.42 22.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.892 -0.595 . . . . 2.33 111.129 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.78 21.96 27.17 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.715 -0.755 . . . . 0.55 113.443 176.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -110.2 -9.06 14.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.291 0.545 . . . . 1.13 110.833 -176.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -139.92 119.07 12.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.913 -0.585 . . . . 2.03 109.96 -174.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 57.8 t -135.09 124.02 41.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.805 0.336 . . . . 0.55 110.712 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -130.14 122.17 27.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.309 -0.405 . . . . 0.69 110.589 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 24.5 m -102.43 134.93 44.95 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.664 0.268 . . . . 0.3 110.919 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.537 HG11 HD13 ' A' ' 62' ' ' LEU . 42.2 t -106.76 128.06 61.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 122.415 0.286 . . . . 0.66 111.52 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.496 ' O ' HG12 ' A' ' 45' ' ' ILE . 41.1 t -90.09 108.12 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-O 121.465 0.65 . . . . 0.18 109.595 173.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.573 HD11 HD22 ' A' ' 104' ' ' LEU . 1.7 mm? -53.76 -29.96 42.28 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.016 -0.993 . . . . 0.12 112.164 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.427 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 41.4 t -71.75 -35.54 70.15 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.965 -0.294 . . . . 1.06 110.672 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.418 ' OG1' ' HB ' ' A' ' 41' ' ' VAL . 66.8 p -77.1 -14.89 59.74 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 121.104 0.478 . . . . 0.2 110.12 176.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.578 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 41.4 mm -79.46 124.66 37.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.684 -0.689 . . . . 0.23 111.387 175.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.601 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 33.3 t70 -79.36 -48.16 14.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.969 -0.56 . . . . 0.7 110.737 176.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HB2' HG13 ' A' ' 63' ' ' ILE . 70.9 mmtt -135.31 149.26 49.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.728 -0.669 . . . . 1.95 110.543 -177.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.957 HD23 ' HG3' ' A' ' 105' ' ' GLN . 11.6 tp -112.92 145.24 41.1 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.086 -0.709 . . . . 0.14 109.086 164.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.481 ' H ' HD12 ' A' ' 48' ' ' LEU . 13.9 mm100 -122.59 153.34 39.42 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.071 -0.968 . . . . 1.49 109.896 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.69 143.79 10.02 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.451 -0.795 . . . . 0.25 109.491 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 49.4 p -60.7 125.38 82.66 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-O 121.486 0.66 . . . . 0.37 111.065 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 60.6 Cg_endo -70.96 165.94 30.71 Favored 'Trans proline' 0 C--N 1.329 -0.465 0 C-N-CA 123.727 2.951 . . . . 0.64 111.285 175.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.9 -17.61 61.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.215 0.531 . . . . 1.02 110.617 176.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.7 m -77.2 -25.25 51.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.739 -0.664 . . . . 1.58 110.558 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.444 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 46.5 t -72.86 150.94 42.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.653 -0.703 . . . . 0.71 109.69 177.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -95.44 -2.85 48.02 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.586 0.708 . . . . 2.89 109.657 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HB2' HG21 ' A' ' 51' ' ' THR . 20.9 mmmt -107.05 -179.25 3.88 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.824 -1.08 . . . . 2.59 110.414 -175.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.479 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -136.97 110.22 7.83 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.278 -1.008 . . . . 1.78 108.278 169.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.621 ' HB3' ' CZ ' ' B' ' 261' ' ' PHE . 3.1 ttm -156.24 148.77 23.69 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.384 -0.527 . . . . 1.3 111.825 -173.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.524 HD23 HD11 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -117.7 157.22 26.87 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.437 -0.801 . . . . 0.14 110.479 173.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 62.8 ttp180 -151.58 114.18 4.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.708 0.29 . . . . 2.72 110.756 169.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.706 ' HG ' HD13 ' A' ' 48' ' ' LEU . 10.5 mt -92.3 112.58 24.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.1 0.476 . . . . 0.9 110.61 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.715 HG23 ' HG2' ' A' ' 86' ' ' ARG . 4.4 mm -87.22 113.85 25.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 123.55 0.74 . . . . 0.4 110.95 -175.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -79.41 141.0 23.41 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.122 -1.037 . . . . 0.48 111.579 176.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.601 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 7.2 mptt -54.46 134.28 45.95 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.964 0.382 . . . . 1.15 110.983 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.1 p -84.15 153.88 3.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.58 -0.526 . . . . 0.69 109.58 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -79.09 113.74 17.47 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.8 -0.636 . . . . 2.56 110.31 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -82.44 -25.2 33.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.733 -0.667 . . . . 3.79 111.732 -177.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.67 -37.88 73.7 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.869 -0.332 . . . . 3.05 110.679 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -90.75 48.37 1.52 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.793 0.33 . . . . 5.48 110.692 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -60.75 130.48 46.73 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 116.079 -0.51 . . . . 4.42 110.125 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.486 ' CB ' ' HB ' ' A' ' 80' ' ' VAL . 38.2 mtp180 -76.23 169.59 17.92 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 122.572 1.177 . . . . 4.27 113.174 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.483 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -146.59 153.04 39.89 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 112.97 -1.923 . . . . 5.09 108.38 177.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.551 ' HB3' HD22 ' A' ' 78' ' ' ASN . 4.3 t70 -87.46 -161.13 0.67 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.315 -0.554 . . . . 4.98 110.719 -170.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -62.6 -23.43 67.04 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.024 0.379 . . . . 6.68 112.024 -175.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.489 ' HB3' ' ND2' ' A' ' 78' ' ' ASN . 28.0 tt0 -95.71 -9.63 31.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.673 0.749 . . . . 7.13 109.341 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.483 ' HA2' ' HB2' ' A' ' 73' ' ' LYS . . . 89.09 32.34 10.81 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 114.971 -1.013 . . . . 5.53 110.758 -174.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.551 HD22 ' HB3' ' A' ' 74' ' ' ASP . 63.0 m-80 -74.03 -91.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.671 0.272 . . . . 5.62 111.344 -176.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 14.5 pt-20 -176.78 130.6 0.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.044 -0.526 . . . . 5.0 109.83 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.486 ' HB ' ' CB ' ' A' ' 72' ' ' ARG . 3.0 t -128.96 149.11 33.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.491 -0.929 . . . . 3.33 108.491 174.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.6 p -106.35 99.42 23.94 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-O 121.45 0.643 . . . . 2.77 110.63 174.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 80' ' ' VAL . 50.2 Cg_exo -53.38 140.19 63.59 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.199 2.599 . . . . 1.78 112.191 175.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -81.8 131.02 58.63 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-O 121.304 0.573 . . . . 3.11 110.519 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.441 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 23.6 Cg_exo -58.2 144.98 94.67 Favored 'Trans proline' 0 C--N 1.332 -0.323 0 C-N-CA 123.435 2.757 . . . . 0.67 112.381 179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.47 122.05 22.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.442 0.639 . . . . 1.78 110.03 176.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.715 ' HG2' HG23 ' A' ' 63' ' ' ILE . 13.6 mtm180 -117.1 146.47 43.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.613 -0.721 . . . . 2.29 110.217 -172.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -111.13 111.98 23.45 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.58 -0.736 . . . . 0.5 109.414 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.541 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 50.4 ttm -106.64 129.51 54.54 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.049 0.452 . . . . 0.42 111.372 -176.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.437 ' CG ' HD11 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -120.03 122.68 41.65 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.719 -0.673 . . . . 1.33 109.338 178.028 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.556 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 20.3 m -88.74 128.23 35.62 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.022 -0.536 . . . . 0.94 110.45 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.594 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 27.8 m-85 -107.82 173.61 6.24 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.879 -0.6 . . . . 1.33 110.629 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -119.05 -0.05 11.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.704 -0.68 . . . . 1.53 110.107 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -141.17 128.47 21.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.926 -0.579 . . . . 0.83 109.96 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.478 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 2.5 tmt_? -69.61 -24.4 63.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.546 . . . . 2.16 110.371 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.43 HG22 HD21 ' A' ' 99' ' ' ASN . 91.2 m -69.4 -57.19 5.59 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.118 -0.327 . . . . 0.4 110.118 177.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 98.2 t -45.62 -56.38 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 115.955 -0.566 . . . . 0.29 111.384 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.476 ' HG2' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -65.02 -28.63 69.63 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 116.021 -0.536 . . . . 0.29 110.882 -177.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.42 -32.47 71.46 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 109.196 -0.668 . . . . 0.39 109.196 176.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.43 HD21 HG22 ' A' ' 95' ' ' THR . 90.7 m-20 -74.09 -49.25 24.8 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.721 -1.127 . . . . 1.55 109.501 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.607 HG23 HD11 ' A' ' 18' ' ' ILE . 34.1 mm -58.49 -53.07 51.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.945 -1.025 . . . . 0.13 110.427 175.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.705 ' HA ' HD21 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -55.3 -48.85 73.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.335 -0.848 . . . . 1.11 111.344 179.133 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.411 ' N ' ' HE2' ' A' ' 101' ' ' LYS . 12.8 ptt? -68.8 -24.99 64.47 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.63 -0.428 . . . . 1.17 110.191 -175.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 41.6 m -66.59 -49.78 65.23 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.427 0.632 . . . . 0.15 109.922 175.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.932 ' HB2' HD22 ' A' ' 48' ' ' LEU . 12.9 mt -69.94 -57.4 5.07 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.986 -1.006 . . . . 0.13 111.715 -174.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.957 ' HG3' HD23 ' A' ' 48' ' ' LEU . 38.1 mt-30 -51.51 -27.51 10.89 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.833 0.679 . . . . 1.45 112.833 -178.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -71.29 -30.13 65.89 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.056 0.931 . . . . 0.65 109.472 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.692 HG21 ' HB3' ' A' ' 25' ' ' ALA . 61.6 mt -75.88 -42.78 39.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 114.141 -1.39 . . . . 0.17 109.775 172.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.577 ' C ' ' HD2' ' A' ' 112' ' ' LYS . 1.4 mt -67.39 -43.1 87.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.731 -0.668 . . . . 0.29 110.624 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.575 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 45.3 m -60.61 -29.1 69.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.366 0.603 . . . . 1.22 110.145 174.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.586 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 12.7 ttt180 -66.76 -30.27 70.44 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.061 -0.972 . . . . 3.79 109.588 175.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.486 ' HD2' ' O ' ' A' ' 107' ' ' ILE . 61.6 m-85 -97.75 -18.89 18.55 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.78 -0.646 . . . . 0.6 111.664 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.577 ' HD2' ' C ' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -69.56 -35.41 75.37 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 108.848 -0.797 . . . . 1.76 108.848 170.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.84 -15.62 63.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.126 -0.943 . . . . 1.56 110.235 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -106.83 8.21 30.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.523 -0.762 . . . . 1.09 110.944 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.608 -0.71 . . . . 2.16 110.283 -179.471 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 111.827 -0.509 . . . . 25.39 111.827 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 89.25 113.56 1.35 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.706 -0.759 . . . . 24.6 111.887 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -114.92 23.92 11.27 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.562 -0.827 . . . . 23.97 112.29 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -132.9 94.22 0.28 Allowed Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.585 -0.817 . . . . 23.13 112.477 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -157.71 102.14 1.85 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.982 0.42 . . . . 24.92 110.455 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -101.04 136.19 41.28 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.506 -0.553 . . . . 21.4 109.506 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 21.8 t -76.61 71.33 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.428 0.632 . . . . 20.37 109.655 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -69.94 119.54 14.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.314 -0.857 . . . . 17.68 110.858 -177.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 23.6 ttt -142.66 42.93 1.6 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.129 -1.063 . . . . 16.8 108.129 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -62.51 139.32 58.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.897 -1.047 . . . . 13.35 110.422 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . 0.487 ' HB3' ' OE2' ' B' ' 254' ' ' GLU . 68.8 m -68.81 109.34 3.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.979 -0.555 . . . . 10.66 110.661 -177.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.89 -34.74 78.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.095 -0.957 . . . . 11.03 111.376 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . 0.487 ' OE2' ' HB3' ' B' ' 252' ' ' SER . 1.4 pp20? -67.77 -20.88 65.27 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 112.475 0.546 . . . . 10.94 112.475 -176.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -64.62 -24.15 67.49 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.87 0.367 . . . . 9.82 110.711 177.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 39.8 m -86.17 83.0 7.84 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.357 -0.608 . . . . 5.35 109.357 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -62.08 -23.63 66.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.817 -0.629 . . . . 6.2 111.499 -176.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.14 -36.23 72.67 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.351 -0.386 . . . . 6.14 110.908 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.514 ' HB2' ' CD2' ' B' ' 261' ' ' PHE . 3.6 p-10 -152.28 -82.34 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.31 -0.404 . . . . 3.32 111.843 -177.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . 0.4 ' H ' ' CG ' ' B' ' 259' ' ' ASP . . . 100.51 20.85 13.91 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.746 -0.942 . . . . 0.84 110.746 -171.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 261' ' ' PHE . . . . . 0.621 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 2.1 m-85 -113.83 179.94 3.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.031 -0.584 . . . . 0.95 109.854 -175.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 11.8 p -143.37 144.64 23.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.649 -0.251 . . . . 1.37 110.639 175.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -79.81 122.33 26.49 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.05 -0.722 . . . . 2.24 109.05 173.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.578 ' HB ' HE22 ' A' ' 105' ' ' GLN . 15.0 t -103.29 102.68 13.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.853 0.359 . . . . 1.41 110.427 -177.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.572 -0.728 . . . . 3.04 110.054 179.239 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo . . . . . 0 N--CA 1.481 0.747 0 N-CA-C 110.648 -0.558 . . . . 3.14 110.648 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 t -147.56 -31.14 0.31 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.258 -0.428 . . . . 1.4 110.755 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.594 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 67.4 m80 -86.97 15.22 6.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.113 -0.494 . . . . 1.85 110.949 -178.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.3 m -160.44 143.25 13.26 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.867 -0.42 . . . . 0.95 109.867 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.29 149.69 8.92 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.414 -1.074 . . . . 0.16 110.414 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.708 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -74.84 140.19 43.73 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 117.539 0.669 . . . . 0.43 111.19 -176.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.76 153.85 38.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.376 0.608 . . . . 0.13 111.723 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.561 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.0 mp -95.77 117.0 38.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.483 -0.78 . . . . 0.29 109.075 176.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.578 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 74.9 t80 -117.97 109.46 16.52 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.127 -0.323 . . . . 0.56 110.127 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 66.84 47.51 1.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.641 0.734 . . . . 1.46 110.758 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp 71.26 6.93 5.96 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.143 -1.389 . . . . 1.91 113.024 171.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -114.14 132.93 61.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.782 0.325 . . . . 0.47 110.414 171.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.561 ' HA ' HG13 ' A' ' 8' ' ' ILE . 41.2 t -74.64 134.51 42.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.311 0.577 . . . . 1.02 110.808 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.704 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -155.98 -158.16 8.67 Favored Glycine 0 N--CA 1.434 -1.486 0 CA-C-N 115.431 -0.804 . . . . 0.16 112.237 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.708 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 13.7 mm -124.57 153.56 31.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.053 0.454 . . . . 0.19 110.432 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.9 133.29 69.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.759 -0.655 . . . . 0.16 110.111 179.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.22 109.54 7.85 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.288 -0.414 . . . . 0.12 111.761 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.598 HD11 HG23 ' A' ' 100' ' ' ILE . 3.7 mp -85.51 121.05 36.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.567 -0.901 . . . . 0.18 108.567 172.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.483 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.3 t30 -126.1 128.93 48.12 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 110.249 -0.278 . . . . 1.12 110.249 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.435 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 33.7 mt-10 -110.0 85.3 2.08 Favored 'General case' 0 N--CA 1.425 -1.715 0 C-N-CA 117.022 -1.871 . . . . 0.74 107.632 163.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.483 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 13.1 t70 -120.95 -10.58 9.06 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 106.287 -1.746 . . . . 0.59 106.287 156.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.688 HG11 ' HB2' ' A' ' 26' ' ' GLU . 14.3 p -102.49 174.76 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 111.66 -2.518 . . . . 0.35 112.192 -156.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.681 ' O ' HG13 ' A' ' 22' ' ' VAL . 1.1 t -54.52 167.63 0.56 Allowed Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 106.417 -1.697 . . . . 1.31 106.417 166.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.47 ' HD2' ' OG ' ' A' ' 23' ' ' SER . 13.0 Cg_endo -42.4 128.9 4.72 Favored 'Trans proline' 0 C--N 1.359 1.123 0 CA-C-N 122.266 1.845 . . . . 0.22 111.121 -152.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.623 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -32.43 135.71 0.08 Allowed 'General case' 0 CA--C 1.508 -0.652 0 O-C-N 125.242 1.589 . . . . 0.2 114.01 -155.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.688 ' HB2' HG11 ' A' ' 22' ' ' VAL . 29.2 mt-10 -121.7 136.95 54.93 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.579 -1.191 . . . . 1.26 111.213 -170.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.582 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.2 tt -101.29 143.3 31.52 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 106.222 -1.77 . . . . 0.15 106.222 170.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.449 ' N ' HD23 ' A' ' 27' ' ' LEU . 30.0 m -132.51 110.54 10.56 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.868 -0.733 . . . . 0.21 110.134 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.607 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.6 t90 -86.32 106.53 17.45 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.339 -0.846 . . . . 0.24 108.957 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -115.04 114.87 25.95 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.62 -1.173 . . . . 0.87 108.695 -178.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.574 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 94.6 p -57.07 153.22 11.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.515 0.674 . . . . 0.75 111.574 -171.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.704 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 14.8 m -58.62 -28.49 65.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.557 -1.201 . . . . 0.39 110.87 -177.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -83.08 -28.6 29.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.085 -0.507 . . . . 2.33 110.555 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.22 17.98 32.72 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.112 -0.566 . . . . 0.55 113.072 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -103.5 -25.62 13.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.928 0.394 . . . . 1.13 111.511 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.1 tttm -117.28 122.07 42.92 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.927 -0.397 . . . . 2.03 109.927 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 84.1 t -132.07 123.01 50.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.849 0.357 . . . . 0.55 110.695 -177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -131.35 120.98 23.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.197 -0.456 . . . . 0.69 110.357 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.478 HG21 ' OE1' ' A' ' 26' ' ' GLU . 35.7 m -101.96 143.52 31.73 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 111.735 0.272 . . . . 0.3 111.735 -175.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 38.7 t -116.61 129.44 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 122.83 0.452 . . . . 0.66 111.333 176.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.552 ' O ' HG12 ' A' ' 45' ' ' ILE . 53.7 t -91.18 107.98 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 121.5 0.667 . . . . 0.18 109.43 172.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.654 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.4 mm? -53.19 -32.82 49.88 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.656 -1.156 . . . . 0.12 112.576 -178.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.466 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 52.7 m -75.92 -28.43 58.0 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.933 -0.307 . . . . 1.06 111.456 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.3 p -80.44 -10.89 59.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.187 0.517 . . . . 0.2 109.832 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 41' ' ' VAL . 36.3 mm -82.29 130.09 36.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.483 -0.78 . . . . 0.23 110.861 174.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.688 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 3.7 t70 -86.44 -41.54 14.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.689 -0.687 . . . . 0.7 111.456 176.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.525 ' HE3' ' OE1' ' B' ' 263' ' ' GLU . 11.1 tptt -140.47 138.5 34.7 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.795 -0.639 . . . . 1.95 110.005 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.092 HD23 ' HG3' ' A' ' 105' ' ' GLN . 13.9 tp -109.29 141.8 41.09 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.053 -0.721 . . . . 0.14 109.053 164.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.491 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 5.8 mt-30 -119.07 154.13 33.66 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.81 -1.086 . . . . 1.49 109.927 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.23 141.61 8.1 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.998 -0.546 . . . . 0.25 110.065 177.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 40.0 p -51.29 127.82 30.44 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-O 121.5 0.667 . . . . 0.37 111.418 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 45.0 Cg_endo -66.89 166.53 22.32 Favored 'Trans proline' 0 C--N 1.334 -0.214 0 C-N-CA 124.107 3.205 . . . . 0.64 112.105 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.407 ' N ' HH21 ' A' ' 94' ' ' ARG . . . -68.5 -11.27 59.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.087 0.47 . . . . 1.02 110.569 176.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.4 t -84.71 -24.64 28.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.999 -0.546 . . . . 1.58 109.753 173.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.574 ' OG ' ' HE3' ' A' ' 57' ' ' LYS . 21.2 t -71.59 146.13 48.59 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.067 -0.716 . . . . 0.71 109.067 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -95.42 -14.57 23.68 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.223 -1.028 . . . . 2.89 108.223 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.574 ' HE3' ' OG ' ' A' ' 55' ' ' SER . 0.0 OUTLIER -88.04 176.02 7.49 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 113.731 -1.577 . . . . 2.59 110.313 -177.213 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.532 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -138.32 109.46 6.83 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.454 -0.573 . . . . 1.78 109.454 173.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.57 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 3.2 mpp? -154.61 141.27 18.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.772 0.32 . . . . 1.3 111.448 -176.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.88 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 2.3 mp -109.16 161.83 14.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.722 -0.672 . . . . 0.14 110.719 170.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.491 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 2.8 ttt180 -154.03 114.36 3.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.239 -0.437 . . . . 2.72 110.925 172.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.797 ' HG ' HD13 ' A' ' 48' ' ' LEU . 11.7 mt -95.89 110.02 22.28 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 122.659 0.384 . . . . 0.9 110.88 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.616 HG23 ' HB3' ' A' ' 86' ' ' ARG . 4.3 mm -86.86 109.68 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.255 -0.43 . . . . 0.4 111.062 -174.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -74.97 143.23 30.71 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.136 -1.03 . . . . 0.48 110.956 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.688 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 6.2 mttm -64.13 134.65 55.29 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.545 0.688 . . . . 1.15 112.198 -175.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 67' ' ' ASP . 11.7 p -83.59 168.58 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 114.738 -1.119 . . . . 0.69 108.551 174.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.44 ' H ' HG22 ' A' ' 66' ' ' VAL . 23.9 t70 -59.89 138.64 57.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.281 0.562 . . . . 2.56 110.68 -176.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 2.2 mp0 -54.18 -22.95 12.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.437 -1.256 . . . . 3.79 112.942 -173.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.8 p -75.31 -11.38 60.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.652 0.263 . . . . 3.05 111.275 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.442 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 13.8 mmmm 48.84 -95.97 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.107 0.963 . . . . 5.48 112.916 -177.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -69.66 125.15 25.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.804 0.812 . . . . 4.42 111.765 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 7.1 ptm85 -111.73 173.31 6.41 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.829 -1.078 . . . . 4.27 110.427 -173.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -118.66 137.93 52.96 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.14 -0.937 . . . . 5.09 108.684 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.684 ' HB3' HD21 ' A' ' 78' ' ' ASN . 2.0 t70 -97.63 -158.04 0.64 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.313 -0.625 . . . . 4.98 109.313 177.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -54.1 -31.33 51.73 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.72 0.637 . . . . 6.68 112.72 -177.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 36.7 tt0 -111.48 -1.69 15.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.294 0.569 . . . . 7.13 111.111 -175.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.07 24.7 73.1 Favored Glycine 0 CA--C 1.508 -0.38 0 N-CA-C 110.469 -1.052 . . . . 5.53 110.469 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.684 HD21 ' HB3' ' A' ' 74' ' ' ASP . 2.1 p30 -60.78 -26.21 67.09 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.229 -0.986 . . . . 5.62 111.363 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 52.9 mt-10 88.92 110.1 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.058 -1.428 . . . . 5.0 111.169 174.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.492 ' HB ' ' HG2' ' A' ' 72' ' ' ARG . 2.2 t -109.58 148.38 13.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.449 -0.796 . . . . 3.33 108.861 176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.0 p -110.36 97.39 31.15 Favored Pre-proline 0 C--N 1.312 -1.038 0 CA-C-O 121.698 0.761 . . . . 2.77 110.432 175.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.526 ' HG3' ' HD2' ' A' ' 72' ' ' ARG . 31.1 Cg_exo -57.64 126.68 22.6 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.183 2.589 . . . . 1.78 112.073 178.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 1.8 ttpm? -85.37 130.13 52.77 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-O 121.266 0.555 . . . . 3.11 110.596 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 83' ' ' LYS . 22.5 Cg_exo -58.49 134.22 59.71 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.1 2.533 . . . . 0.67 111.798 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.69 117.96 17.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.648 0.737 . . . . 1.78 110.192 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.616 ' HB3' HG23 ' A' ' 63' ' ' ILE . 26.2 ptt180 -125.12 143.71 50.79 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.535 -0.757 . . . . 2.29 111.439 -169.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.421 ' CD2' HG22 ' A' ' 40' ' ' VAL . 97.2 m-70 -104.94 112.8 26.06 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.078 -0.964 . . . . 0.5 110.465 -173.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.465 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 48.3 ttm -107.56 125.31 51.14 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 110.417 -0.216 . . . . 0.42 110.417 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.604 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -117.06 139.33 50.83 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.808 -0.812 . . . . 1.33 108.808 176.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.526 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 31.1 t -97.48 128.16 44.02 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.193 -0.669 . . . . 0.94 109.193 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.88 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 6.2 m-85 -108.59 164.35 12.44 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.561 -0.745 . . . . 1.33 109.706 -176.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -109.29 -2.9 17.57 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.678 -0.409 . . . . 1.53 110.906 -172.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -146.69 127.77 14.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.375 0.607 . . . . 0.83 110.624 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.469 ' NH1' ' HB2' ' A' ' 98' ' ' ASP . 43.3 tpt85 -61.71 -27.28 68.6 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.852 -1.067 . . . . 2.16 111.325 -178.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 92.3 m -74.64 -57.88 3.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.429 -0.35 . . . . 0.4 110.582 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.3 t -46.04 -54.06 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-N 116.17 -0.468 . . . . 0.29 111.289 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.558 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -66.08 -27.76 68.31 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.166 -0.47 . . . . 0.29 110.7 -177.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.469 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 32.9 t70 -68.93 -34.57 75.58 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 109.18 -0.674 . . . . 0.39 109.18 177.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.418 ' O ' ' HG2' ' A' ' 102' ' ' MET . 90.7 m-20 -73.18 -49.26 29.1 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.34 -1.3 . . . . 1.55 109.53 -178.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.598 HG23 HD11 ' A' ' 18' ' ' ILE . 36.0 mm -55.84 -53.08 41.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.181 -0.918 . . . . 0.13 110.409 174.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.732 ' HA ' HD21 ' A' ' 48' ' ' LEU . 1.1 tmmm? -53.25 -52.52 58.71 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.781 -0.645 . . . . 1.11 110.937 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 99' ' ' ASN . 24.3 ptm -67.81 -24.45 65.3 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.95 -0.568 . . . . 1.17 109.768 -173.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 55.5 m -67.03 -50.52 61.78 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.54 0.686 . . . . 0.15 110.066 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.932 ' HB2' HD22 ' A' ' 48' ' ' LEU . 10.3 mt -70.45 -57.32 4.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.824 -1.08 . . . . 0.13 111.52 -174.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 1.092 ' HG3' HD23 ' A' ' 48' ' ' LEU . 63.3 mt-30 -53.85 -25.78 21.42 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.572 0.582 . . . . 1.45 112.572 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -66.42 -30.1 70.39 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.74 0.781 . . . . 0.65 109.374 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.623 HG21 ' HB3' ' A' ' 25' ' ' ALA . 31.7 mt -82.42 -44.28 19.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 114.117 -1.401 . . . . 0.17 110.312 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.882 HG22 ' HD2' ' A' ' 112' ' ' LYS . 1.4 mt -66.87 -51.38 55.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.574 -0.739 . . . . 0.29 110.804 -175.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.6 t -61.52 -22.38 65.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.544 0.688 . . . . 1.22 109.354 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.528 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 14.7 ttt180 -72.99 -38.96 66.46 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.746 -1.115 . . . . 3.79 110.184 177.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -87.0 -27.95 22.93 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.857 -0.61 . . . . 0.6 111.249 -176.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.882 ' HD2' HG22 ' A' ' 108' ' ' ILE . 15.0 mtpp -75.62 -18.19 59.77 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.418 0.628 . . . . 1.76 109.484 176.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -71.95 -20.36 61.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.076 -0.966 . . . . 1.56 109.612 171.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.55 34.17 5.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.363 -0.835 . . . . 1.09 110.855 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.6 t70 . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.691 -0.671 . . . . 2.16 110.716 -178.101 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 N-CA-C 111.903 -0.479 . . . . 25.39 111.903 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -166.37 165.13 38.09 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.65 -0.786 . . . . 24.6 112.094 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 80.4 -77.15 1.99 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 121.155 -0.545 . . . . 23.97 112.546 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -169.33 -178.29 40.52 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.373 -0.691 . . . . 23.13 111.373 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 73.4 t80 66.85 114.45 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.346 0.593 . . . . 24.92 111.045 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -85.25 133.16 34.18 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.278 -0.638 . . . . 21.4 109.278 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 8.3 p -82.92 14.58 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.605 0.717 . . . . 20.37 110.647 -174.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -116.9 117.3 29.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.096 -0.502 . . . . 17.68 109.789 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 48.4 mtm -120.23 -26.66 5.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.588 0.709 . . . . 16.8 110.386 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -78.11 126.18 30.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.928 -1.033 . . . . 13.35 110.429 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 40.2 p -170.29 177.01 4.29 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.14 -0.482 . . . . 10.66 110.399 -175.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -73.91 -23.76 59.59 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.27 0.557 . . . . 11.03 109.84 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.9 -20.22 63.51 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.508 -0.769 . . . . 10.94 111.847 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -56.05 -28.56 57.98 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.293 0.37 . . . . 9.82 111.46 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 51.1 m 60.35 87.28 0.09 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.366 0.603 . . . . 5.35 112.186 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -63.77 -33.59 76.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.562 -0.745 . . . . 6.2 111.072 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.08 -66.25 0.57 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.874 -0.603 . . . . 6.14 110.111 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' B' ' 260' ' ' GLY . 4.4 p-10 -168.73 -84.79 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.493 -0.776 . . . . 3.32 110.87 177.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . 0.414 ' H ' ' CG ' ' B' ' 259' ' ' ASP . . . 70.05 22.83 77.33 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.455 -0.878 . . . . 0.84 111.812 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 261' ' ' PHE . . . . . 0.472 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 13.1 m-85 -123.21 179.93 4.52 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.419 -0.586 . . . . 0.95 109.419 -178.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 7.8 p -140.93 143.99 27.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.818 0.342 . . . . 1.37 110.213 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 263' ' ' GLU . . . . . 0.525 ' OE1' ' HE3' ' A' ' 47' ' ' LYS . 44.4 tt0 -89.94 121.36 31.97 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.065 -0.717 . . . . 2.24 109.065 174.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 46.8 t -101.02 103.28 14.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.878 0.371 . . . . 1.41 110.729 -175.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 30.9 t70 . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.405 -0.807 . . . . 3.04 110.089 179.714 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.477 0.509 0 N-CA-C 110.966 -0.436 . . . . 3.14 110.966 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.8 p 55.41 -173.33 0.05 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.585 0.754 . . . . 1.4 111.188 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.427 ' HA ' HG21 ' A' ' 103' ' ' THR . 45.7 m80 63.55 4.31 1.75 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.701 0.63 . . . . 1.85 112.701 175.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.413 ' C ' HD11 ' A' ' 100' ' ' ILE . 20.4 m -158.92 148.8 19.23 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.825 -0.435 . . . . 0.95 109.825 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.41 148.05 6.6 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 110.366 -1.094 . . . . 0.16 110.366 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.71 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -73.57 140.0 45.97 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 117.419 0.61 . . . . 0.43 111.524 -175.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.508 ' HB1' ' HB3' ' A' ' 89' ' ' PHE . . . -148.65 162.93 38.72 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 121.361 0.6 . . . . 0.13 111.638 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.555 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.1 mp -109.47 126.49 66.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.45 -0.796 . . . . 0.29 109.031 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -114.18 99.66 7.79 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 120.879 0.371 . . . . 0.56 110.249 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 56.69 59.2 3.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.286 0.565 . . . . 1.46 111.118 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 11' ' ' LYS . 21.1 mmtp 76.07 -8.73 1.57 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.858 -1.065 . . . . 1.91 113.68 170.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.1 p -96.6 130.38 45.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 119.892 -0.723 . . . . 0.47 109.987 169.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.555 ' HA ' HG13 ' A' ' 8' ' ' ILE . 18.6 t -85.3 133.55 34.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.024 -0.534 . . . . 1.02 110.804 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.726 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -155.5 -155.95 7.57 Favored Glycine 0 N--CA 1.438 -1.214 0 CA-C-N 115.749 -0.66 . . . . 0.16 112.598 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.71 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.7 mm -126.6 153.44 35.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 120.798 0.333 . . . . 0.19 110.614 -177.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.431 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -121.89 132.56 70.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 116.12 -0.491 . . . . 0.16 110.059 179.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.85 109.46 7.47 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.316 -0.402 . . . . 0.12 111.927 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.641 HD11 HG23 ' A' ' 100' ' ' ILE . 3.9 mp -85.95 115.66 27.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.897 -0.779 . . . . 0.18 108.897 173.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.417 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.6 t30 -118.38 126.34 51.88 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.982 -0.377 . . . . 1.12 109.982 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -110.89 83.35 1.74 Allowed 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 117.362 -1.735 . . . . 0.74 107.543 164.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.417 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 19.5 t70 -121.25 -10.5 8.94 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 106.638 -1.615 . . . . 0.59 106.638 156.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 23' ' ' SER . 14.8 p -101.43 174.66 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 112.099 -2.319 . . . . 0.35 112.031 -156.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.672 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.9 OUTLIER -54.51 165.63 0.86 Allowed Pre-proline 0 C--O 1.225 -0.194 0 N-CA-C 106.04 -1.837 . . . . 1.31 106.04 166.489 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HD2' ' OG ' ' A' ' 23' ' ' SER . 10.1 Cg_endo -41.14 128.04 2.93 Favored 'Trans proline' 0 C--N 1.354 0.845 0 CA-C-N 121.899 1.714 . . . . 0.22 111.555 -150.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.67 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -32.15 135.21 0.08 Allowed 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 125.288 1.617 . . . . 0.2 113.719 -156.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.563 ' HB2' HG11 ' A' ' 22' ' ' VAL . 70.7 mt-10 -124.77 137.62 54.31 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 114.792 -1.094 . . . . 1.26 111.366 -168.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 1.3 tt -100.65 141.88 32.89 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 106.543 -1.651 . . . . 0.15 106.543 173.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.417 ' N ' HD23 ' A' ' 27' ' ' LEU . 6.8 m -130.1 108.77 10.32 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.848 -0.741 . . . . 0.21 110.413 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.64 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 82.8 t90 -88.0 113.68 23.88 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.478 0.656 . . . . 0.24 109.755 175.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -120.67 122.97 41.62 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.168 -0.924 . . . . 0.87 109.161 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.437 ' OG ' ' HG2' ' A' ' 36' ' ' LYS . 38.1 m -56.59 141.47 43.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.088 0.47 . . . . 0.75 110.482 -174.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.726 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 20.2 m -57.54 -35.9 70.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.092 -0.958 . . . . 0.39 110.443 -176.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -87.36 -8.04 57.07 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.502 -0.772 . . . . 2.33 111.153 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.89 21.02 54.48 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.82 -0.705 . . . . 0.55 112.39 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.404 ' H ' ' HB2' ' A' ' 31' ' ' SER . 24.2 t70 -69.85 -56.36 7.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.337 0.495 . . . . 1.13 112.337 -176.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.437 ' HG2' ' OG ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -143.88 161.71 37.99 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.806 0.336 . . . . 2.03 110.979 -176.164 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.2 138.06 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.337 -0.392 . . . . 0.55 110.678 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -135.67 115.77 13.31 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 122.551 0.34 . . . . 0.69 110.714 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.5 m -98.89 142.68 30.09 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 120.783 0.325 . . . . 0.3 111.461 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 22.0 t -116.62 128.8 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 122.827 0.451 . . . . 0.66 111.209 175.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 45' ' ' ILE . 43.2 t -90.56 109.25 20.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.078 0.466 . . . . 0.18 109.904 175.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.612 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.9 mm? -54.16 -26.43 27.83 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.372 -0.831 . . . . 0.12 112.762 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.3 m -75.27 -35.1 61.4 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.374 -0.53 . . . . 1.06 111.329 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.8 p -74.0 -14.48 61.03 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.402 -0.592 . . . . 0.2 109.402 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.606 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 48.9 mm -82.92 114.43 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.075 -0.966 . . . . 0.23 110.863 175.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.542 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 31.8 t70 -74.7 -39.46 61.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.109 -0.496 . . . . 0.7 111.266 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -147.24 158.13 43.84 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.227 -0.442 . . . . 1.95 110.199 -174.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.93 HD22 ' HB2' ' A' ' 104' ' ' LEU . 10.8 tp -124.53 146.01 49.23 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.303 0.573 . . . . 0.14 109.917 171.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.44 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 15.5 mm100 -123.16 155.98 35.96 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.793 -1.094 . . . . 1.49 109.653 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.18 138.23 6.5 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.55 -0.75 . . . . 0.25 109.649 -178.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.409 HG23 ' HB2' ' A' ' 59' ' ' MET . 36.7 p -50.7 126.71 24.31 Favored Pre-proline 0 N--CA 1.466 0.339 0 CA-C-O 121.193 0.52 . . . . 0.37 110.396 176.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 43.0 Cg_endo -65.59 164.76 25.2 Favored 'Trans proline' 0 C--N 1.329 -0.494 0 C-N-CA 123.611 2.874 . . . . 0.64 112.017 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.36 -23.06 66.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.279 0.561 . . . . 1.02 110.064 175.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.5 t -75.03 -24.6 58.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.287 -0.87 . . . . 1.58 110.575 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.414 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 46.8 t -68.42 148.37 50.75 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.59 -0.522 . . . . 0.71 109.59 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -89.21 -7.68 55.06 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.746 0.784 . . . . 2.89 109.389 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -107.89 -175.85 2.9 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.686 -1.143 . . . . 2.59 110.9 -172.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.493 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -141.7 110.39 6.11 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.257 -0.883 . . . . 1.78 109.171 175.039 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.508 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 2.4 mpp? -156.3 139.94 16.0 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.694 0.283 . . . . 1.3 111.456 -176.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.868 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 1.5 mp -110.66 155.42 22.43 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.121 -0.49 . . . . 0.14 110.928 171.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.691 ' NH2' ' HE3' ' A' ' 88' ' ' MET . 25.4 ttm-85 -145.5 113.76 6.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.083 0.468 . . . . 2.72 110.043 170.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.777 ' HG ' HD13 ' A' ' 48' ' ' LEU . 6.5 mp -91.9 111.69 23.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.075 -0.512 . . . . 0.9 110.522 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.546 ' HA ' ' CB ' ' A' ' 86' ' ' ARG . 3.0 mm -86.71 125.52 40.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.195 -0.457 . . . . 0.4 110.116 -173.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -89.31 156.07 25.66 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.164 -1.017 . . . . 0.48 111.474 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.542 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 0.7 OUTLIER -64.12 134.01 54.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.03 0.443 . . . . 1.15 110.025 176.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.2 p -80.28 158.08 4.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.615 -0.72 . . . . 0.69 109.165 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.588 ' CG ' ' HD3' ' A' ' 70' ' ' LYS . 11.3 t70 -105.2 134.61 48.02 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.224 -0.444 . . . . 2.56 109.833 -176.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -84.19 -30.14 26.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.87 -0.604 . . . . 3.79 111.509 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.9 p -82.66 -32.33 28.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.741 0.305 . . . . 3.05 111.161 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.588 ' HD3' ' CG ' ' A' ' 67' ' ' ASP . 12.5 mptt -78.14 47.04 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.752 0.278 . . . . 5.48 111.752 177.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -68.83 125.71 27.47 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 109.67 -0.493 . . . . 4.42 109.67 175.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.534 ' HG2' ' HD3' ' A' ' 82' ' ' PRO . 0.4 OUTLIER -89.11 173.83 8.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.624 -0.717 . . . . 4.27 111.319 -168.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.565 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 9.9 mmtp -121.46 154.09 37.04 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.398 -0.819 . . . . 5.09 109.959 -175.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.42 ' CG ' ' H ' ' A' ' 75' ' ' ASN . 10.8 t70 -103.41 -157.37 0.61 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.274 -0.639 . . . . 4.98 109.274 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.42 ' H ' ' CG ' ' A' ' 74' ' ' ASP . 24.5 t-20 -61.61 -31.87 71.96 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.383 0.512 . . . . 6.68 112.383 -172.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -92.39 -0.43 57.37 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.742 0.782 . . . . 7.13 109.161 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.565 ' HA2' ' HB3' ' A' ' 73' ' ' LYS . . . 70.96 26.33 74.14 Favored Glycine 0 CA--C 1.501 -0.784 0 CA-C-N 114.384 -1.28 . . . . 5.53 110.901 -176.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.473 ' CG ' ' H ' ' A' ' 79' ' ' GLU . 8.4 p30 -73.3 -78.59 0.09 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 119.367 -0.349 . . . . 5.62 110.373 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 10.7 pt-20 173.5 138.94 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.165 0.507 . . . . 5.0 111.083 171.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.509 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.3 t -128.55 149.46 33.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 108.465 -0.939 . . . . 3.33 108.465 169.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.441 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 7.3 p -100.97 99.98 11.82 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-O 121.946 0.879 . . . . 2.77 109.992 171.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.534 ' HD3' ' HG2' ' A' ' 72' ' ' ARG . 22.4 Cg_endo -62.99 135.33 50.8 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.916 2.411 . . . . 1.78 112.57 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.73 142.29 93.65 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.545 -0.752 . . . . 3.11 109.354 176.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -50.38 133.6 37.14 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.855 2.37 . . . . 0.67 113.017 -174.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -67.2 137.19 56.03 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.835 -0.802 . . . . 1.78 108.835 176.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.61 ' HD2' ' HD3' ' A' ' 61' ' ' ARG . 28.7 ptt180 -143.64 140.9 30.34 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.663 -0.699 . . . . 2.29 111.303 -171.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -102.88 112.28 25.0 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.795 -1.093 . . . . 0.5 110.734 -170.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.691 ' HE3' ' NH2' ' A' ' 61' ' ' ARG . 38.6 ttm -104.04 137.54 41.86 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 121.067 -0.253 . . . . 0.42 110.806 -177.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.508 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 56.3 m-85 -124.1 139.18 54.18 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 108.514 -0.921 . . . . 1.33 108.514 169.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.54 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 14.7 m -95.1 124.18 39.0 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.313 -0.625 . . . . 0.94 109.313 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.868 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 7.7 m-85 -106.5 168.4 9.19 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 110.044 -0.354 . . . . 1.33 110.044 -174.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -114.37 -6.89 12.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.824 0.345 . . . . 1.53 111.325 -174.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -138.62 122.93 18.22 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.282 0.563 . . . . 0.83 110.954 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -54.6 -39.6 68.03 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 114.51 -1.223 . . . . 2.16 111.327 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.481 HG22 HD21 ' A' ' 99' ' ' ASN . 97.7 m -71.14 -57.25 4.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.564 -0.289 . . . . 0.4 110.599 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 100' ' ' ILE . 96.1 t -45.97 -55.6 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 116.126 -0.488 . . . . 0.29 111.299 175.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.657 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -65.41 -29.36 70.06 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.254 -0.43 . . . . 0.29 110.695 -177.127 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 30.2 t70 -71.42 -28.3 63.9 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.853 0.835 . . . . 0.39 109.318 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.535 ' O ' ' HG3' ' A' ' 102' ' ' MET . 87.8 m-20 -77.64 -36.84 51.17 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.559 -1.2 . . . . 1.55 109.252 176.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.641 HG23 HD11 ' A' ' 18' ' ' ILE . 33.4 mm -64.42 -53.04 47.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 114.978 -1.01 . . . . 0.13 111.144 176.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.727 ' HA ' HD21 ' A' ' 48' ' ' LEU . 2.1 ptmt -59.29 -43.57 92.57 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 121.231 -0.188 . . . . 1.11 110.6 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.535 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.5 ppp? -68.08 -25.83 65.53 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.175 0.512 . . . . 1.17 109.719 -175.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 36.9 m -65.61 -51.95 55.77 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.463 -0.789 . . . . 0.15 109.815 173.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.93 ' HB2' HD22 ' A' ' 48' ' ' LEU . 12.2 mt -71.15 -56.92 5.09 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 115.183 -0.917 . . . . 0.13 111.141 -175.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.922 ' HG2' HD23 ' A' ' 48' ' ' LEU . 21.1 mm-40 -42.85 -35.0 1.05 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.808 0.67 . . . . 1.45 112.808 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -65.59 -48.29 72.82 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.845 -0.798 . . . . 0.65 108.845 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.67 HG21 ' HB3' ' A' ' 25' ' ' ALA . 68.2 mt -61.48 -43.12 96.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.39 -1.277 . . . . 0.17 110.6 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.522 HG22 ' HD2' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -62.37 -54.98 27.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.51 -0.768 . . . . 0.29 109.875 -177.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.406 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 15.8 m -54.4 -32.35 57.01 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.98 -0.554 . . . . 1.22 110.849 173.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.463 ' HD2' ' HA ' ' A' ' 107' ' ' ILE . 82.9 mtt180 -70.93 -27.99 64.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.593 -0.731 . . . . 3.79 110.662 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -95.75 -24.06 16.68 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 116.21 -0.45 . . . . 0.6 111.277 -178.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.522 ' HD2' HG22 ' A' ' 108' ' ' ILE . 12.7 mtpp -71.87 -26.14 62.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.003 0.43 . . . . 1.76 110.081 175.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -72.06 -16.47 62.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.808 -0.633 . . . . 1.56 110.054 175.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -121.87 23.87 9.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.862 -0.608 . . . . 1.09 111.079 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.7 t70 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.358 -0.83 . . . . 2.16 110.09 179.831 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 112.221 -0.352 . . . . 25.39 112.221 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.13 -110.92 1.02 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.86 -0.686 . . . . 24.6 111.845 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 70.24 -111.5 3.83 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.973 -0.632 . . . . 23.97 112.292 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 111.57 -92.78 0.67 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.963 -0.636 . . . . 23.13 111.647 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -96.71 -11.17 25.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.096 0.474 . . . . 24.92 110.357 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -104.76 153.97 20.61 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.823 -0.626 . . . . 21.4 109.773 177.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 6.0 p 47.88 33.43 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.206 1.003 . . . . 20.37 112.071 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -80.36 162.8 24.32 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.547 -0.538 . . . . 17.68 109.547 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 25.8 mmt -139.23 45.0 1.98 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.376 0.608 . . . . 16.8 109.735 -171.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -63.71 137.2 57.98 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.095 -0.957 . . . . 13.35 110.68 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . 0.448 ' HB2' ' HB2' ' B' ' 255' ' ' GLU . 81.0 p 53.04 42.33 32.22 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.567 -0.742 . . . . 10.66 111.356 -178.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . 0.537 ' HA ' ' HB2' ' B' ' 257' ' ' ASP . 33.2 tt0 -66.66 -53.8 30.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.246 -0.888 . . . . 11.03 110.978 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' B' ' 254' ' ' GLU . 0.2 OUTLIER -70.68 -24.31 62.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.885 -0.598 . . . . 10.94 110.208 -179.125 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 255' ' ' GLU . . . . . 0.448 ' HB2' ' HB2' ' B' ' 252' ' ' SER . 17.3 mm-40 -69.24 -62.89 1.19 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 9.82 110.003 175.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 256' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' B' ' 255' ' ' GLU . 4.8 t 178.16 71.1 0.01 OUTLIER 'General case' 0 C--O 1.231 0.094 0 CA-C-O 121.042 0.449 . . . . 5.35 111.405 177.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 257' ' ' ASP . . . . . 0.537 ' HB2' ' HA ' ' B' ' 253' ' ' GLU . 11.0 t70 -78.34 -65.29 1.0 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.134 -0.691 . . . . 6.2 109.134 172.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -85.48 -41.04 15.71 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.86 -0.793 . . . . 6.14 108.86 169.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -168.18 -24.47 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.948 -1.024 . . . . 3.32 111.817 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.58 -1.78 45.89 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.549 -0.834 . . . . 0.84 112.457 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 261' ' ' PHE . . . . . 0.451 ' N ' ' CD1' ' B' ' 261' ' ' PHE . 3.9 m-30 -97.72 175.58 6.13 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.221 -0.659 . . . . 0.95 109.221 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 12.8 p -122.98 139.66 49.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 120.925 0.393 . . . . 1.37 110.322 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -76.08 121.73 23.22 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.156 -0.683 . . . . 2.24 109.156 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 11.8 t -99.38 102.49 13.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.952 0.406 . . . . 1.41 110.226 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 26.7 t70 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.532 -0.747 . . . . 3.04 110.333 -176.001 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 N--CA 1.478 0.596 0 N-CA-C 110.832 -0.488 . . . . 3.14 110.832 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.502 ' HA ' ' HB3' ' A' ' 99' ' ' ASN . 10.5 p -121.7 -49.77 2.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.937 0.399 . . . . 1.4 110.829 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -91.12 14.34 14.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.647 0.737 . . . . 1.85 109.478 176.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.405 ' C ' HD11 ' A' ' 100' ' ' ILE . 90.1 p -162.99 154.45 17.55 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.815 -1.084 . . . . 0.95 108.626 -176.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.73 145.86 5.48 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.186 -0.765 . . . . 0.16 111.186 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.76 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.69 125.78 29.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 117.324 0.562 . . . . 0.43 111.36 -176.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.72 158.39 44.24 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 121.168 0.509 . . . . 0.13 111.36 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 2.0 mp -96.96 127.65 48.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.637 -0.711 . . . . 0.29 109.472 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.639 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 80.4 t80 -137.38 117.15 13.11 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.337 -0.616 . . . . 0.56 109.337 178.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 66.71 44.18 2.24 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.15 0.58 . . . . 1.46 110.419 -175.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt 74.91 -8.95 1.44 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.777 -1.102 . . . . 1.91 112.718 171.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.48 131.92 47.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.903 0.382 . . . . 0.47 110.476 177.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.514 ' HA ' HG13 ' A' ' 8' ' ' ILE . 22.5 t -78.03 123.2 26.55 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.002 -0.544 . . . . 1.02 109.992 176.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.645 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -139.07 -154.73 6.46 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.543 -0.753 . . . . 0.16 112.06 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.76 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 8.7 mm -127.02 153.76 36.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 120.957 0.408 . . . . 0.19 110.779 -177.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.486 HG12 HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -128.56 132.81 67.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.856 -0.611 . . . . 0.16 110.113 -179.348 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.01 112.09 9.02 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 111.976 0.362 . . . . 0.12 111.976 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.621 HD11 HG23 ' A' ' 100' ' ' ILE . 3.7 mp -86.02 120.86 36.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.836 -0.802 . . . . 0.18 108.836 172.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.464 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.9 t30 -126.22 125.39 42.32 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 110.234 -0.284 . . . . 1.12 110.234 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.467 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 22.2 mt-10 -108.47 84.51 1.95 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 117.069 -1.852 . . . . 0.74 107.468 163.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.464 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 17.9 t70 -121.54 -9.58 8.94 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 106.341 -1.726 . . . . 0.59 106.341 156.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.706 HG13 ' O ' ' A' ' 23' ' ' SER . 14.0 p -102.48 175.98 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 111.732 -2.486 . . . . 0.35 111.778 -157.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.706 ' O ' HG13 ' A' ' 22' ' ' VAL . 5.6 m -54.15 167.25 0.56 Allowed Pre-proline 0 C--O 1.225 -0.201 0 N-CA-C 106.997 -1.483 . . . . 1.31 106.997 166.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 10.7 Cg_endo -42.16 128.27 4.22 Favored 'Trans proline' 0 C--N 1.357 1.008 0 CA-C-N 122.018 1.756 . . . . 0.22 111.009 -154.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.743 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -31.58 134.61 0.08 Allowed 'General case' 0 CA--C 1.504 -0.805 0 O-C-N 125.19 1.557 . . . . 0.2 113.93 -155.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.594 ' HB2' HG11 ' A' ' 22' ' ' VAL . 33.6 mt-10 -121.3 134.93 55.16 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 114.646 -1.161 . . . . 1.26 111.031 -172.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.593 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.0 OUTLIER -100.34 141.26 33.43 Favored 'General case' 0 CA--C 1.497 -1.06 0 N-CA-C 106.052 -1.833 . . . . 0.15 106.052 173.39 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.465 ' N ' HD23 ' A' ' 27' ' ' LEU . 6.2 m -127.92 108.76 10.96 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.677 -0.809 . . . . 0.21 110.434 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.639 ' CE2' ' HB3' ' A' ' 9' ' ' PHE . 88.8 t90 -89.6 107.56 19.16 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.675 0.75 . . . . 0.24 109.271 175.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -113.83 120.53 41.06 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.888 -1.051 . . . . 0.87 109.088 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.593 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 88.9 p -61.78 144.97 53.93 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.197 -0.668 . . . . 0.75 109.197 -176.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.645 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 11.4 m -54.0 -23.25 12.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.013 -0.994 . . . . 0.39 111.99 -173.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -87.65 -10.59 50.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 111.982 0.364 . . . . 2.33 111.982 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.15 21.43 67.68 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.831 -0.7 . . . . 0.55 111.704 -176.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -93.49 -44.72 8.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.065 0.459 . . . . 1.13 111.334 -175.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.407 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 29.3 mttt -110.34 146.12 36.32 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.895 -0.593 . . . . 2.03 110.794 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.0 t -144.12 115.7 2.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.874 -0.603 . . . . 0.55 109.69 174.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -125.46 111.22 14.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.926 -0.579 . . . . 0.69 110.066 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.406 HG21 ' OE1' ' A' ' 26' ' ' GLU . 14.4 m -98.74 143.17 29.39 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 120.824 -0.351 . . . . 0.3 111.326 -175.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 28.7 t -116.43 130.15 71.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 122.416 0.286 . . . . 0.66 111.536 176.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.534 ' O ' HG12 ' A' ' 45' ' ' ILE . 60.1 t -91.03 108.28 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-O 121.398 0.618 . . . . 0.18 109.875 173.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.6 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -53.19 -26.89 18.98 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.808 -1.087 . . . . 0.12 112.927 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.425 ' O ' ' HE3' ' A' ' 65' ' ' LYS . 59.4 m -80.68 -30.25 36.46 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.459 -0.496 . . . . 1.06 111.661 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.2 p -75.66 -16.23 60.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.099 -0.704 . . . . 0.2 109.099 172.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.691 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 46.6 mm -75.09 120.72 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.965 -1.016 . . . . 0.23 111.313 174.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.578 ' OD2' ' HG2' ' A' ' 47' ' ' LYS . 20.2 t70 -74.24 -50.22 19.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.851 -1.068 . . . . 0.7 110.99 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.578 ' HG2' ' OD2' ' A' ' 46' ' ' ASP . 48.2 mmtm -142.32 154.46 44.71 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 109.488 -0.56 . . . . 1.95 109.488 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.133 HD23 ' HG3' ' A' ' 105' ' ' GLN . 9.0 tp -112.59 145.05 41.03 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.391 -0.596 . . . . 0.14 109.391 167.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.548 ' H ' HD12 ' A' ' 48' ' ' LEU . 15.2 mt-30 -126.73 156.67 40.77 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.686 -1.143 . . . . 1.49 109.876 -177.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -161.76 151.11 16.12 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.427 -0.953 . . . . 0.25 108.427 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 22.3 p -50.25 121.22 13.3 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.588 0.709 . . . . 0.37 111.44 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 66.3 Cg_endo -71.95 167.82 25.64 Favored 'Trans proline' 0 C--N 1.331 -0.375 0 C-N-CA 124.205 3.27 . . . . 0.64 111.546 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.2 -27.94 37.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.26 0.552 . . . . 1.02 110.52 174.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 t -73.46 -22.78 60.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.838 -0.619 . . . . 1.58 110.889 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 24.6 t -86.6 136.28 33.11 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.9 -0.407 . . . . 0.71 109.9 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -88.99 -6.77 56.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.334 0.588 . . . . 2.89 111.093 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -99.75 -177.1 3.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.393 -0.821 . . . . 2.59 109.977 -176.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.581 ' SD ' ' HB2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -136.29 107.16 6.64 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.032 -0.729 . . . . 1.78 109.032 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.648 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 3.5 mpp? -156.86 146.62 20.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.977 0.418 . . . . 1.3 111.188 -175.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.864 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 1.9 mp -110.77 163.14 14.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.551 -0.75 . . . . 0.14 111.699 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.512 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 20.5 ttt180 -155.02 113.44 3.51 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.613 -0.721 . . . . 2.72 110.281 173.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.591 HD13 ' CE2' ' A' ' 89' ' ' PHE . 7.3 mp -94.81 113.27 25.0 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.139 0.495 . . . . 0.9 110.427 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.823 HG23 ' HG2' ' A' ' 86' ' ' ARG . 5.1 mm -84.58 124.09 39.59 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 C-N-CA 123.543 0.737 . . . . 0.4 109.105 -178.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.691 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -97.65 146.7 18.35 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 119.841 -1.171 . . . . 0.48 112.106 177.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.516 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -58.22 131.53 50.86 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.141 0.496 . . . . 1.15 111.452 -175.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 67' ' ' ASP . 7.3 p -88.51 165.04 2.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.387 -0.824 . . . . 0.69 109.17 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.518 ' OD1' ' HD3' ' A' ' 70' ' ' LYS . 12.8 t70 -91.69 105.57 17.83 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.036 0.446 . . . . 2.56 111.253 -175.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -85.63 -2.46 58.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.614 -0.721 . . . . 3.79 110.665 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.7 t -73.03 -39.94 65.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.401 -0.363 . . . . 3.05 111.274 -173.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.518 ' HD3' ' OD1' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -134.63 103.81 5.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.285 0.564 . . . . 5.48 110.563 174.342 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.43 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 54.2 mtmt -66.2 146.68 54.35 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.568 -0.742 . . . . 4.42 110.56 178.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.675 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 6.1 ptm180 -85.11 174.97 9.29 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.417 -0.81 . . . . 4.27 109.135 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.497 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 11.1 mmtp -121.32 146.73 46.54 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.63 0.252 . . . . 5.09 110.983 -172.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 75' ' ' ASN . 13.6 t70 -94.98 -163.65 1.07 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.826 -0.805 . . . . 4.98 108.826 177.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.437 ' H ' ' CG ' ' A' ' 74' ' ' ASP . 39.4 m-80 -55.78 -31.97 63.07 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.503 0.927 . . . . 6.68 113.503 -171.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.411 ' HB3' HD22 ' A' ' 78' ' ' ASN . 7.8 tp10 -90.48 -15.66 30.39 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.672 0.749 . . . . 7.13 109.69 -176.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.497 ' HA2' ' HB3' ' A' ' 73' ' ' LYS . . . 94.74 25.72 14.62 Favored Glycine 0 CA--C 1.503 -0.712 0 N-CA-C 110.408 -1.077 . . . . 5.53 110.408 -174.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.411 HD22 ' HB3' ' A' ' 76' ' ' GLU . 4.0 p30 -75.47 -89.8 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.119 -0.541 . . . . 5.62 110.62 -177.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.675 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 8.7 pt-20 178.03 132.19 0.07 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.269 0.557 . . . . 5.0 111.606 177.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.461 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.7 t -127.86 148.88 32.44 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 N-CA-C 107.075 -1.454 . . . . 3.33 107.075 173.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.7 t -110.06 102.07 49.61 Favored Pre-proline 0 C--N 1.298 -1.657 0 CA-C-O 121.297 0.57 . . . . 2.77 109.927 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.4 ' HG3' ' HD2' ' A' ' 72' ' ' ARG . 80.7 Cg_exo -43.15 148.91 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 124.465 3.443 . . . . 1.78 113.6 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -77.19 128.58 80.44 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.273 -0.64 . . . . 3.11 109.273 174.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.586 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 42.6 Cg_exo -52.89 137.31 61.02 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.918 2.412 . . . . 0.67 112.299 -177.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.442 HE21 ' HB2' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -68.03 115.67 7.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.647 0.736 . . . . 1.78 110.995 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.823 ' HG2' HG23 ' A' ' 63' ' ' ILE . 25.5 mtm180 -110.33 157.0 19.97 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.495 -0.775 . . . . 2.29 111.032 -175.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -120.39 111.12 17.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.308 -0.86 . . . . 0.5 109.637 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.48 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 55.0 ttm -113.73 125.31 53.97 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.88 -0.145 . . . . 0.42 110.633 -174.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.591 ' CE2' HD13 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -118.75 148.43 42.81 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.339 -0.615 . . . . 1.33 109.339 174.088 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.648 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 32.2 m -97.79 126.54 43.2 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.659 -0.497 . . . . 0.94 109.659 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.864 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 8.8 m-85 -106.53 154.76 20.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.057 0.456 . . . . 1.33 111.349 -174.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -100.36 -6.65 25.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.984 -0.553 . . . . 1.53 110.955 -171.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -142.76 128.33 19.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.938 0.399 . . . . 0.83 110.581 -175.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.581 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 15.8 tpt180 -59.63 -34.69 73.11 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.109 -0.95 . . . . 2.16 110.847 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.55 HG22 HD21 ' A' ' 99' ' ' ASN . 47.6 m -74.03 -58.82 3.05 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.69 -0.687 . . . . 0.4 110.618 -177.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 100' ' ' ILE . 94.6 t -45.19 -53.69 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-N 115.792 -0.64 . . . . 0.29 111.456 175.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.797 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -66.32 -29.81 70.09 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 120.515 -0.474 . . . . 0.29 110.563 -177.206 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.426 ' HA ' ' HD3' ' A' ' 101' ' ' LYS . 35.8 t70 -72.13 -24.26 61.44 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.62 0.724 . . . . 0.39 109.618 178.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.578 ' O ' ' HG3' ' A' ' 102' ' ' MET . 85.7 m-20 -83.78 -42.93 15.97 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.845 -1.071 . . . . 1.55 109.742 177.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.621 HG23 HD11 ' A' ' 18' ' ' ILE . 33.7 mm -58.54 -51.85 66.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.482 -0.781 . . . . 0.13 110.837 176.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.812 ' HA ' HD21 ' A' ' 48' ' ' LEU . 2.6 ptmt -60.23 -39.25 86.01 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 120.851 0.358 . . . . 1.11 111.159 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.578 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.7 ppp? -76.52 -22.93 53.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.079 0.466 . . . . 1.17 109.761 -175.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 52.6 m -68.46 -53.2 25.03 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.649 -0.705 . . . . 0.15 109.679 174.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.934 ' HB2' HD22 ' A' ' 48' ' ' LEU . 13.1 mt -65.75 -56.59 11.21 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.151 -0.931 . . . . 0.13 110.932 -177.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 1.133 ' HG3' HD23 ' A' ' 48' ' ' LEU . 49.1 mt-30 -52.05 -26.38 10.77 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.808 0.67 . . . . 1.45 112.808 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -64.59 -43.8 92.66 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.923 -0.769 . . . . 0.65 108.923 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.743 HG21 ' HB3' ' A' ' 25' ' ' ALA . 33.4 mt -66.76 -43.89 89.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 114.293 -1.321 . . . . 0.17 110.876 176.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.667 HG22 ' HD2' ' A' ' 112' ' ' LYS . 1.2 mt -67.16 -47.84 80.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.05 -0.523 . . . . 0.29 110.445 -176.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.0 t -58.71 -27.34 64.79 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.366 0.603 . . . . 1.22 110.237 172.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 77.2 mtt180 -70.56 -31.79 68.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.631 -0.713 . . . . 3.79 110.25 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -93.94 -23.54 18.03 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.914 -0.584 . . . . 0.6 111.934 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.667 ' HD2' HG22 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -73.16 -23.55 60.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.137 0.494 . . . . 1.76 109.979 174.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.55 -22.39 65.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.588 -0.733 . . . . 1.56 109.755 172.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -114.0 23.11 13.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.565 -0.743 . . . . 1.09 110.711 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.3 t70 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.503 -0.76 . . . . 2.16 110.586 -178.006 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.906 0 N-CA-C 112.306 -0.318 . . . . 25.39 112.306 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 80.18 -121.96 5.61 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.071 -0.585 . . . . 24.6 112.119 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -85.0 57.85 4.99 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.028 -0.606 . . . . 23.97 111.846 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -110.46 148.38 17.56 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.948 -0.644 . . . . 23.13 111.864 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -81.05 -21.93 39.68 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.694 0.759 . . . . 24.92 109.628 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -133.63 148.37 51.54 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.088 -0.96 . . . . 21.4 109.33 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 9.3 p -93.31 5.72 6.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.732 0.777 . . . . 20.37 110.035 -176.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -75.13 120.74 21.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.265 -0.88 . . . . 17.68 109.766 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 55.7 ttm -154.35 41.21 0.48 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.749 -0.834 . . . . 16.8 108.749 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -87.39 114.75 24.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.741 0.782 . . . . 13.35 110.844 -173.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 43.0 m -131.5 18.34 4.8 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.502 -1.226 . . . . 10.66 109.938 176.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -73.67 -36.73 65.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.428 -0.806 . . . . 11.03 109.833 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -72.46 -25.73 61.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.942 -0.572 . . . . 10.94 110.303 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -79.71 -51.81 8.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.647 -0.706 . . . . 9.82 110.45 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 256' ' ' SER . . . . . 0.414 ' OG ' ' HB2' ' B' ' 259' ' ' ASP . 64.7 p -170.48 101.74 0.26 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.028 -0.533 . . . . 5.35 110.824 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -76.74 -29.1 56.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.164 0.507 . . . . 6.2 110.417 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -73.5 -3.8 29.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.306 -0.861 . . . . 6.14 111.158 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.414 ' HB2' ' OG ' ' B' ' 256' ' ' SER . 9.0 m-20 -133.47 -145.71 0.25 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.658 -0.867 . . . . 3.32 108.658 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 73.86 36.12 53.18 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 121.153 -0.546 . . . . 0.84 113.182 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 261' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -72.35 138.01 46.99 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.909 -0.404 . . . . 0.95 109.909 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.97 166.32 26.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.36 -0.382 . . . . 1.37 110.72 -176.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 263' ' ' GLU . . . . . 0.534 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 8.0 pt-20 -93.31 142.37 27.39 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.282 -0.417 . . . . 2.24 110.089 173.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.444 HG12 HE22 ' A' ' 105' ' ' GLN . 7.5 p -89.58 106.01 16.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.778 0.799 . . . . 1.41 110.506 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.428 -0.796 . . . . 3.04 109.929 179.174 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 N--CA 1.481 0.744 0 N-CA-C 110.783 -0.506 . . . . 3.14 110.783 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.0 p 41.51 -93.69 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.528 1.131 . . . . 1.4 113.836 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.554 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 37.9 m80 -85.08 18.03 2.71 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.087 0.403 . . . . 1.85 112.087 -172.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.474 ' C ' HD11 ' A' ' 100' ' ' ILE . 88.6 p -163.12 149.92 12.61 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.844 0.354 . . . . 0.95 110.715 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.72 147.45 6.35 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.496 -1.042 . . . . 0.16 110.496 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.747 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.55 136.75 40.55 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 117.653 0.726 . . . . 0.43 111.283 -175.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.31 160.11 40.81 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 121.278 0.561 . . . . 0.13 111.323 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.564 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.5 mp -105.58 126.39 60.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.603 -0.726 . . . . 0.29 109.163 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -116.82 101.8 8.85 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.711 -0.396 . . . . 0.56 110.279 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 60.69 53.0 4.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.19 0.519 . . . . 1.46 110.668 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt 78.99 -8.35 1.65 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.545 -1.207 . . . . 1.91 113.298 171.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -97.86 127.58 50.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.203 -0.599 . . . . 0.47 110.712 171.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.564 ' HA ' HG13 ' A' ' 8' ' ' ILE . 10.2 p -78.99 126.13 30.28 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.558 -0.746 . . . . 1.02 111.095 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.695 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -145.24 -155.42 6.46 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.465 -0.789 . . . . 0.16 112.098 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.747 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 6.4 mm -128.71 153.78 38.71 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.741 0 CA-C-O 120.768 0.318 . . . . 0.19 110.768 -178.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.493 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -124.38 131.85 72.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.642 -0.503 . . . . 0.16 109.642 179.126 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.57 112.28 9.44 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.215 -0.448 . . . . 0.12 111.643 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.668 HD11 HG23 ' A' ' 100' ' ' ILE . 4.1 mp -84.8 120.75 35.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.265 -1.013 . . . . 0.18 108.265 171.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.415 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.4 t30 -123.64 124.88 43.75 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.967 -0.383 . . . . 1.12 109.967 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -108.53 83.11 1.72 Allowed 'General case' 0 N--CA 1.427 -1.62 0 C-N-CA 116.959 -1.896 . . . . 0.74 107.342 165.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.415 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 16.7 t70 -121.25 -12.35 8.66 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 106.625 -1.62 . . . . 0.59 106.625 158.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 23' ' ' SER . 14.9 p -101.75 177.9 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 111.812 -2.449 . . . . 0.35 111.852 -156.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.71 ' O ' HG13 ' A' ' 22' ' ' VAL . 4.4 m -53.61 168.4 0.4 Allowed Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 107.194 -1.41 . . . . 1.31 107.194 165.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 12.2 Cg_endo -42.6 128.21 4.75 Favored 'Trans proline' 0 C--N 1.357 1.016 0 CA-C-N 121.966 1.738 . . . . 0.22 110.94 -155.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.704 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -33.36 135.83 0.11 Allowed 'General case' 0 CA--C 1.507 -0.697 0 O-C-N 125.334 1.646 . . . . 0.2 113.892 -154.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.693 ' HB2' HG11 ' A' ' 22' ' ' VAL . 28.5 mt-10 -123.3 138.61 54.58 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 114.588 -1.187 . . . . 1.26 111.179 -170.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.57 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.4 tt -101.71 143.11 32.06 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 106.567 -1.642 . . . . 0.15 106.567 173.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.423 ' N ' HD23 ' A' ' 27' ' ' LEU . 16.5 m -130.99 109.78 10.77 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.846 -0.742 . . . . 0.21 110.67 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.638 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 87.8 t90 -85.92 106.03 16.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.687 0.756 . . . . 0.24 109.327 174.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -111.15 115.32 29.2 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.069 -0.969 . . . . 0.87 108.759 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.557 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 63.1 p -56.39 144.13 31.98 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.993 0.425 . . . . 0.75 110.064 -177.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.695 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 25.9 m -56.44 -25.04 49.22 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.175 -0.92 . . . . 0.39 110.751 -176.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -76.33 -27.96 56.71 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.899 -0.591 . . . . 2.33 111.299 178.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.83 8.01 60.93 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 111.702 -0.559 . . . . 0.55 111.702 -174.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -84.87 -72.68 0.46 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.056 0.455 . . . . 1.13 111.408 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -85.55 141.13 30.08 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.201 0.524 . . . . 2.03 111.48 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 93.9 t -137.69 125.86 31.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.741 -1.118 . . . . 0.55 109.441 177.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -130.34 111.29 12.21 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.53 -0.305 . . . . 0.69 110.273 -175.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -100.87 141.87 33.15 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 111.863 0.319 . . . . 0.3 111.863 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.59 HG11 HD13 ' A' ' 62' ' ' LEU . 43.1 t -116.11 129.69 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 122.623 0.369 . . . . 0.66 111.688 176.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.579 ' O ' HG12 ' A' ' 45' ' ' ILE . 60.4 t -91.11 108.42 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-O 121.268 0.556 . . . . 0.18 109.579 172.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.583 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.6 mm? -53.14 -29.52 31.71 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.877 -1.056 . . . . 0.12 112.546 -178.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.438 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 68.4 m -76.89 -33.79 57.78 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.608 -0.437 . . . . 1.06 111.581 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.7 p -74.07 -11.7 60.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.541 0.686 . . . . 0.2 109.371 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.579 HG12 ' O ' ' A' ' 41' ' ' VAL . 47.5 mm -82.62 133.03 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 114.77 -1.105 . . . . 0.23 111.002 173.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.653 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 35.8 t70 -85.91 -50.22 7.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.456 -0.793 . . . . 0.7 110.904 174.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.477 ' HB2' HG13 ' A' ' 63' ' ' ILE . 74.9 mmtt -136.77 156.14 48.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.245 -0.434 . . . . 1.95 110.1 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.09 HD23 ' HG3' ' A' ' 105' ' ' GLN . 11.6 tp -119.18 140.21 50.55 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.213 0.53 . . . . 0.14 109.871 167.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 11.8 mm100 -115.61 154.82 28.76 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.818 -1.083 . . . . 1.49 109.837 -178.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.85 141.65 8.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.588 -0.733 . . . . 0.25 109.278 177.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.492 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 33.5 p -51.94 123.52 25.95 Favored Pre-proline 0 N--CA 1.467 0.4 0 CA-C-O 121.484 0.659 . . . . 0.37 111.559 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.525 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 71.1 Cg_endo -70.76 167.29 26.16 Favored 'Trans proline' 0 CA--C 1.519 -0.275 0 C-N-CA 124.331 3.354 . . . . 0.64 112.126 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.425 ' HA ' HH12 ' A' ' 94' ' ' ARG . . . -55.63 -28.13 53.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.236 0.541 . . . . 1.02 110.575 174.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.593 ' HG ' ' N ' ' B' ' 242' ' ' GLY . 13.8 m -68.73 -25.38 64.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.375 -0.83 . . . . 1.58 111.324 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.435 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 33.7 t -80.4 143.43 33.48 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.535 -0.757 . . . . 0.71 109.951 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -90.17 -7.66 53.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.484 0.659 . . . . 2.89 109.667 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 mmmt -98.89 178.33 4.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.225 -0.898 . . . . 2.59 110.403 -175.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.531 ' HB3' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -137.58 110.18 7.52 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.982 -1.008 . . . . 1.78 108.674 176.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.599 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 3.1 ttm -157.3 140.13 15.09 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.744 -0.382 . . . . 1.3 111.422 -173.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.863 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 1.9 mp -109.27 160.82 15.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.06 0.457 . . . . 0.14 111.016 172.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.644 ' HE ' ' HE2' ' A' ' 88' ' ' MET . 20.7 ttm180 -153.56 113.34 3.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.906 -0.588 . . . . 2.72 110.263 172.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.802 ' HG ' HD13 ' A' ' 48' ' ' LEU . 7.9 mt -93.61 113.79 25.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.055 0.455 . . . . 0.9 110.293 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.629 HG23 ' HG2' ' A' ' 86' ' ' ARG . 5.4 mm -86.63 109.28 18.78 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 CA-C-N 115.717 -0.674 . . . . 0.4 110.461 -173.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -76.43 138.48 22.55 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.731 -1.223 . . . . 0.48 111.384 176.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.653 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 1.7 mptp? -53.44 136.68 37.43 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.72 0.295 . . . . 1.15 110.941 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.558 HG21 ' O ' ' A' ' 82' ' ' PRO . 10.1 p -79.57 165.86 2.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.923 -0.399 . . . . 0.69 109.923 175.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.477 ' H ' HG22 ' A' ' 66' ' ' VAL . 8.5 m-20 -69.72 80.94 0.44 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.84 -0.618 . . . . 2.56 112.006 -174.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -80.29 -14.49 58.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.797 -0.638 . . . . 3.79 110.448 174.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.9 p -64.39 -38.48 91.17 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.673 -0.694 . . . . 3.05 110.646 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.55 98.69 2.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.901 -0.59 . . . . 5.48 110.676 176.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -62.92 143.0 58.08 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.25 0.548 . . . . 4.42 110.45 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.459 ' CG ' ' HB ' ' A' ' 80' ' ' VAL . 4.3 ptm180 -80.76 171.05 15.51 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.405 -0.816 . . . . 4.27 109.255 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -147.43 152.62 38.41 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.212 0.53 . . . . 5.09 110.468 179.036 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.593 ' HB3' HD21 ' A' ' 78' ' ' ASN . 2.6 t70 -92.23 -158.32 0.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.354 -0.839 . . . . 4.98 110.545 -172.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -63.81 -31.64 72.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.754 0.312 . . . . 6.68 111.375 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -90.1 -3.71 57.75 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.644 0.735 . . . . 7.13 109.523 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' A' ' 73' ' ' LYS . . . 68.66 25.88 74.78 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 114.654 -1.157 . . . . 5.53 110.782 -175.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.593 HD21 ' HB3' ' A' ' 74' ' ' ASP . 8.7 p30 -67.64 -33.3 74.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.267 -0.467 . . . . 5.62 111.719 -173.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.589 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 38.5 mt-10 100.25 126.56 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 O-C-N 125.367 1.667 . . . . 5.0 111.133 174.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.459 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.3 t -126.58 147.73 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 107.623 -1.251 . . . . 3.33 107.623 -176.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.6 t -112.25 100.72 50.41 Favored Pre-proline 0 C--N 1.296 -1.734 0 N-CA-C 109.528 -0.545 . . . . 2.77 109.528 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.558 ' O ' HG21 ' A' ' 66' ' ' VAL . 64.0 Cg_exo -48.53 159.42 0.82 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.86 3.04 . . . . 1.78 112.668 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 61.8 tttt -83.08 130.18 58.28 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-O 121.344 0.593 . . . . 3.11 110.242 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 83' ' ' LYS . 24.0 Cg_exo -55.44 140.52 82.71 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.547 2.832 . . . . 0.67 112.306 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.99 114.57 19.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.42 0.628 . . . . 1.78 109.87 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.629 ' HG2' HG23 ' A' ' 63' ' ' ILE . 18.5 mtm180 -110.78 160.42 16.75 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.64 -0.709 . . . . 2.29 110.227 -173.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -124.3 111.91 16.38 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.009 -0.542 . . . . 0.5 109.713 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.644 ' HE2' ' HE ' ' A' ' 61' ' ' ARG . 49.7 ttm -111.35 128.53 55.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.716 -0.22 . . . . 0.42 110.889 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.437 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 39.8 m-85 -117.24 143.63 45.68 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 108.832 -0.803 . . . . 1.33 108.832 173.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.545 ' HA ' ' CG ' ' A' ' 59' ' ' MET . 19.1 m -96.88 125.59 41.43 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.469 -0.567 . . . . 0.94 109.469 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.863 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 4.5 m-85 -107.53 162.9 13.52 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.952 -0.388 . . . . 1.33 109.952 -177.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -115.91 -7.06 12.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.859 0.361 . . . . 1.53 110.911 -176.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -129.09 119.44 24.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.67 -0.493 . . . . 0.83 109.67 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.531 ' HA ' ' HB3' ' A' ' 58' ' ' MET . 8.3 tpt180 -61.44 -29.08 69.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.844 -0.617 . . . . 2.16 111.227 -178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.471 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 50.0 m -74.17 -47.05 38.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.245 0.545 . . . . 0.4 110.52 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.821 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 66.3 t -60.27 -52.76 57.56 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 CA-C-N 115.646 -0.706 . . . . 0.29 111.633 177.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.541 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -60.41 -26.01 66.37 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.912 -0.715 . . . . 0.29 109.735 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 95' ' ' THR . 36.6 t70 -70.29 -41.74 72.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.261 0.553 . . . . 0.39 109.9 176.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.821 ' ND2' ' HA ' ' A' ' 96' ' ' VAL . 22.8 p30 -80.21 -29.19 38.54 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.073 -0.967 . . . . 1.55 110.879 -173.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.668 HG23 HD11 ' A' ' 18' ' ' ILE . 31.0 mm -67.41 -54.02 27.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.366 -0.834 . . . . 0.13 110.123 169.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.679 ' HA ' HD21 ' A' ' 48' ' ' LEU . 3.8 ttpt -54.79 -48.39 72.78 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.53 -0.759 . . . . 1.11 111.326 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -65.73 -26.09 67.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.9 0.381 . . . . 1.17 110.592 -176.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 22.1 m -68.06 -49.73 59.55 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.204 0.526 . . . . 0.15 110.354 177.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.957 ' HB2' HD22 ' A' ' 48' ' ' LEU . 9.7 mt -69.38 -57.25 5.52 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.391 -0.822 . . . . 0.13 111.156 -175.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 1.09 ' HG3' HD23 ' A' ' 48' ' ' LEU . 96.0 mt-30 -50.78 -28.35 9.11 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.223 0.453 . . . . 1.45 112.223 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -63.16 -49.81 72.87 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.842 -0.799 . . . . 0.65 108.842 176.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.704 HG21 ' HB3' ' A' ' 25' ' ' ALA . 60.1 mt -60.07 -44.75 95.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 113.906 -1.497 . . . . 0.17 110.518 176.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.652 HG22 ' HD2' ' A' ' 112' ' ' LYS . 1.2 mt -62.53 -55.52 23.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.675 -0.693 . . . . 0.29 110.412 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.494 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 59.6 m -59.01 -26.43 64.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.0 0.429 . . . . 1.22 110.966 175.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 56.9 mtt180 -69.22 -33.92 74.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.856 -0.611 . . . . 3.79 110.21 176.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -86.48 -28.22 23.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.585 -0.734 . . . . 0.6 111.187 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.652 ' HD2' HG22 ' A' ' 108' ' ' ILE . 16.0 mtpt -71.54 -27.8 63.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.074 0.464 . . . . 1.76 110.007 174.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.77 -19.93 65.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.491 0.663 . . . . 1.56 109.924 175.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -117.22 27.19 9.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.454 -0.793 . . . . 1.09 110.805 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 39.0 t70 . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.78 -0.629 . . . . 2.16 110.568 178.516 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.593 ' N ' ' HG ' ' A' ' 54' ' ' SER . . . . . . . . 0 N--CA 1.484 1.873 0 N-CA-C 112.251 -0.34 . . . . 25.39 112.251 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 137.92 -142.04 12.82 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.976 -0.631 . . . . 24.6 111.785 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 84.85 -62.3 4.57 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.843 -0.694 . . . . 23.97 112.444 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 70.15 -103.07 1.08 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.199 -0.525 . . . . 23.13 112.019 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -80.93 -17.65 49.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.337 0.589 . . . . 24.92 109.842 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -96.95 146.19 25.19 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.252 -0.886 . . . . 21.4 110.689 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 21.6 m -85.98 41.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.429 0.633 . . . . 20.37 110.792 178.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . 0.458 ' HG2' ' H ' ' B' ' 251' ' ' GLU . 32.4 tt0 -79.87 126.83 31.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.665 -0.698 . . . . 17.68 109.963 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 20.7 mmt -121.74 28.94 7.38 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.236 -0.653 . . . . 16.8 109.236 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . 0.458 ' H ' ' HG2' ' B' ' 249' ' ' GLU . 8.1 tp10 -71.1 96.35 1.33 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.002 -0.999 . . . . 13.35 110.896 -174.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . 0.557 ' HG ' ' N ' ' B' ' 242' ' ' GLY . 49.4 m -165.93 -37.24 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.352 -1.295 . . . . 10.66 110.676 -175.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -52.35 -54.34 32.94 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 115.974 -0.557 . . . . 11.03 112.08 -174.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -67.69 -46.51 72.08 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.954 0.353 . . . . 10.94 111.954 -174.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -72.28 -31.83 66.09 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.258 0.466 . . . . 9.82 112.258 -174.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 49.0 m -100.91 20.5 15.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.734 0.302 . . . . 5.35 111.217 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -84.36 -22.56 30.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.604 -0.271 . . . . 6.2 111.013 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -57.43 -44.75 84.92 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 116.225 -0.443 . . . . 6.14 110.697 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.52 ' HA ' HH22 ' A' ' 61' ' ' ARG . 20.7 m-20 -100.58 -34.57 9.85 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.058 -0.519 . . . . 3.32 110.249 174.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 84.47 -7.31 73.27 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.095 -0.802 . . . . 0.84 111.095 -174.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 261' ' ' PHE . . . . . 0.525 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 6.2 m-85 -125.86 179.54 5.15 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.434 -0.58 . . . . 0.95 109.434 -176.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.72 150.3 19.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.624 -0.51 . . . . 1.37 109.624 173.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 263' ' ' GLU . . . . . 0.505 ' HB3' ' OE1' ' A' ' 49' ' ' GLN . 2.5 pp20? -103.82 134.16 47.59 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.778 -0.453 . . . . 2.24 109.778 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.55 ' HB ' ' OE1' ' A' ' 105' ' ' GLN . 60.2 t -100.06 108.93 23.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.009 -0.541 . . . . 1.41 110.018 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.435 -0.793 . . . . 3.04 110.144 -178.584 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo . . . . . 0 N--CA 1.479 0.649 0 N-CA-C 110.809 -0.496 . . . . 3.14 110.809 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.493 ' HA ' ' HB3' ' A' ' 99' ' ' ASN . 31.3 t -100.98 -70.26 0.75 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.212 -0.449 . . . . 1.4 110.695 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.406 ' CD2' HG23 ' A' ' 103' ' ' THR . 71.7 m80 -92.97 20.28 6.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.319 0.581 . . . . 1.85 110.005 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.4 ' C ' HD11 ' A' ' 100' ' ' ILE . 20.4 m -162.33 150.67 14.66 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.538 -0.755 . . . . 0.95 109.195 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.53 140.61 3.97 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.275 -0.73 . . . . 0.16 111.275 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.746 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -71.6 121.4 18.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 117.211 0.506 . . . . 0.43 111.173 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.548 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -130.83 158.78 39.23 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.256 0.551 . . . . 0.13 112.115 -177.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.504 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.5 mp -97.16 120.56 46.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.349 -0.841 . . . . 0.29 109.21 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.572 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 82.8 t80 -122.91 112.53 17.95 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.843 -0.428 . . . . 0.56 109.843 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 62.98 48.61 3.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.79 0.805 . . . . 1.46 110.127 -175.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt 72.61 -6.53 1.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.143 -1.389 . . . . 1.91 113.373 171.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.92 131.99 46.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.936 0.398 . . . . 0.47 110.236 173.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.504 ' HA ' HG13 ' A' ' 8' ' ' ILE . 23.3 t -78.89 130.55 35.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.059 -0.518 . . . . 1.02 110.522 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.67 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -149.4 -154.61 6.43 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 115.702 -0.681 . . . . 0.16 111.628 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.746 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 9.9 mm -124.44 153.42 31.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.948 0.374 . . . . 0.19 110.619 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.427 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -126.74 133.46 68.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 115.977 -0.556 . . . . 0.16 109.849 -179.824 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.89 111.44 8.63 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 116.281 -0.418 . . . . 0.12 111.751 175.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.633 HD11 HG23 ' A' ' 100' ' ' ILE . 4.0 mp -84.36 114.06 24.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.139 -1.06 . . . . 0.18 108.139 171.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.447 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.5 t30 -119.25 122.06 41.06 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.952 -0.388 . . . . 1.12 109.952 -179.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.489 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 38.0 mt-10 -105.88 84.25 2.04 Favored 'General case' 0 N--CA 1.423 -1.785 0 C-N-CA 116.858 -1.937 . . . . 0.74 107.418 163.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.447 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 22.3 t70 -121.4 -11.22 8.78 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 106.622 -1.621 . . . . 0.59 106.622 156.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.7 HG11 ' HB2' ' A' ' 26' ' ' GLU . 14.2 p -102.58 174.8 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 112.001 -2.363 . . . . 0.35 111.653 -157.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.672 ' O ' HG13 ' A' ' 22' ' ' VAL . 17.3 p -54.27 166.3 0.71 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 117.052 -1.452 . . . . 1.31 107.117 166.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.639 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 10.3 Cg_endo -41.49 128.47 3.44 Favored 'Trans proline' 0 C--N 1.362 1.278 0 CA-C-N 122.233 1.833 . . . . 0.22 111.374 -151.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.628 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -29.92 133.81 0.05 Allowed 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 125.251 1.595 . . . . 0.2 114.004 -157.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.7 ' HB2' HG11 ' A' ' 22' ' ' VAL . 23.8 mt-10 -124.9 136.72 54.03 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 114.777 -1.101 . . . . 1.26 111.15 -172.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.589 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.0 OUTLIER -100.3 142.1 32.25 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.469 -1.678 . . . . 0.15 106.469 173.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.419 ' N ' HD23 ' A' ' 27' ' ' LEU . 9.7 m -126.94 109.22 11.71 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 119.796 -0.762 . . . . 0.21 110.241 -178.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.647 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 88.3 t90 -89.23 105.71 17.96 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.684 0.754 . . . . 0.24 109.086 175.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.426 ' HD3' ' O ' ' A' ' 31' ' ' SER . 3.6 tmt_? -113.54 115.0 27.28 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.723 -1.126 . . . . 0.87 108.523 -177.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.546 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 98.1 p -58.75 144.66 43.06 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.308 0.575 . . . . 0.75 110.444 -173.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.67 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 18.5 m -54.82 -25.16 26.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.765 -1.107 . . . . 0.39 111.816 -173.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -89.77 -13.95 35.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.97 -0.559 . . . . 2.33 111.723 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.69 22.05 60.64 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.319 -0.943 . . . . 0.55 111.108 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -84.52 -39.28 19.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.919 -0.64 . . . . 1.13 111.913 -174.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -146.74 161.57 40.34 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.207 0.527 . . . . 2.03 110.774 -177.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 85.3 t -144.08 131.0 16.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.1 -0.955 . . . . 0.55 110.124 -176.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -131.96 109.11 9.82 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.639 -0.709 . . . . 0.69 109.813 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.9 m -99.82 137.06 38.81 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.625 -0.262 . . . . 0.3 111.294 -175.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.528 HG11 HD13 ' A' ' 62' ' ' LEU . 40.7 t -110.01 128.43 66.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 122.653 0.381 . . . . 0.66 111.703 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 45' ' ' ILE . 53.2 t -90.53 108.19 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 109.319 -0.623 . . . . 0.18 109.319 172.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.601 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.0 mm? -54.95 -27.26 42.22 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.924 -1.035 . . . . 0.12 112.415 -178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.521 ' O ' ' HE2' ' A' ' 65' ' ' LYS . 43.1 t -75.75 -34.04 60.26 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.598 -0.441 . . . . 1.06 110.641 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.457 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 58.6 p -77.77 -10.37 59.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.472 0.653 . . . . 0.2 109.661 175.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.659 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 45.2 mm -79.85 123.84 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-N 114.995 -1.002 . . . . 0.23 111.256 173.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.581 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 5.8 t70 -73.85 -46.26 46.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.29 -0.868 . . . . 0.7 111.436 174.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.466 ' O ' HG12 ' A' ' 63' ' ' ILE . 43.6 tptt -151.52 159.48 44.12 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 120.763 0.316 . . . . 1.95 110.432 -177.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.017 HD23 ' HG3' ' A' ' 105' ' ' GLN . 11.8 tp -117.68 148.24 42.16 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.623 -0.51 . . . . 0.14 109.623 170.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 15.3 mm100 -126.55 156.47 40.78 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.23 -0.895 . . . . 1.49 109.573 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.605 ' HB3' ' HD3' ' A' ' 101' ' ' LYS . . . -163.04 144.06 9.61 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.228 -0.442 . . . . 0.25 109.925 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.515 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 40.8 p -52.41 126.72 38.7 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 121.36 0.6 . . . . 0.37 112.135 -176.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.52 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 59.6 Cg_endo -69.31 167.08 24.9 Favored 'Trans proline' 0 C--N 1.334 -0.225 0 C-N-CA 124.323 3.349 . . . . 0.64 112.305 177.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.01 -28.65 58.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.842 0.353 . . . . 1.02 111.272 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.3 t -72.43 -23.61 61.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 1.58 110.784 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.506 ' CB ' ' HB ' ' A' ' 51' ' ' THR . 31.6 t -71.74 133.46 45.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.923 -0.58 . . . . 0.71 110.081 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -80.35 -15.14 57.57 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.758 0.789 . . . . 2.89 109.309 177.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.5 mmmt -106.49 172.62 6.72 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.054 -0.975 . . . . 2.59 109.787 -176.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.555 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.2 OUTLIER -131.34 109.83 10.64 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.526 -0.916 . . . . 1.78 108.526 -177.429 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.56 ' HG2' ' HA ' ' A' ' 90' ' ' SER . 72.9 mtm -154.73 155.5 34.66 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.79 0.329 . . . . 1.3 111.212 -172.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.593 HD23 HD11 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -120.82 160.13 24.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.553 -0.749 . . . . 0.14 110.956 176.252 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 48.8 ttp180 -152.43 113.61 4.24 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 120.882 0.372 . . . . 2.72 111.198 171.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.725 ' HG ' HD13 ' A' ' 48' ' ' LEU . 10.4 mt -94.46 110.53 22.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.358 -0.383 . . . . 0.9 110.945 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.662 HG23 ' HB3' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -87.61 125.7 41.24 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.777 0 CA-C-N 116.027 -0.533 . . . . 0.4 110.454 -176.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -99.01 151.94 19.57 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.029 -1.082 . . . . 0.48 111.096 174.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.581 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 1.0 OUTLIER -56.5 134.16 53.9 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.858 0.361 . . . . 1.15 111.263 -174.176 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.502 HG22 ' H ' ' A' ' 67' ' ' ASP . 8.3 p -67.86 168.26 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.76 -0.655 . . . . 0.69 110.918 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.502 ' H ' HG22 ' A' ' 66' ' ' VAL . 25.7 t70 -59.01 140.55 55.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.611 0.719 . . . . 2.56 111.404 -176.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -54.43 -22.53 12.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.307 -1.315 . . . . 3.79 112.913 -176.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.8 t -74.58 -9.38 58.52 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 121.272 -0.171 . . . . 3.05 111.122 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.414 ' HB2' ' H ' ' A' ' 71' ' ' LYS . 65.8 mmtt 50.34 -89.7 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.116 0.966 . . . . 5.48 112.647 -178.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.414 ' H ' ' HB2' ' A' ' 70' ' ' LYS . 14.5 ptmm? -79.32 130.05 35.06 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.136 0.493 . . . . 4.42 110.36 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.551 ' CG ' ' HB ' ' A' ' 80' ' ' VAL . 4.1 ptm85 -122.36 170.73 9.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.086 -0.506 . . . . 4.27 110.331 -174.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.477 ' HB3' ' C ' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -121.06 165.08 15.81 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.843 0.354 . . . . 5.09 110.657 -177.593 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.775 ' HB3' HD21 ' A' ' 78' ' ' ASN . 6.4 t70 -97.61 -157.61 0.61 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.214 -0.448 . . . . 4.98 109.933 -177.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -64.57 -25.52 68.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.002 0.43 . . . . 6.68 111.832 -172.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.566 ' HB3' HD22 ' A' ' 78' ' ' ASN . 34.2 tt0 -99.24 5.35 46.69 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 122.149 0.976 . . . . 7.13 109.016 -177.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.477 ' C ' ' HB3' ' A' ' 73' ' ' LYS . . . 70.93 29.41 69.17 Favored Glycine 0 CA--C 1.506 -0.517 0 CA-C-N 115.042 -0.981 . . . . 5.53 110.727 -178.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.775 HD21 ' HB3' ' A' ' 74' ' ' ASP . 3.1 p30 -84.47 -87.24 0.12 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.272 -0.464 . . . . 5.62 111.61 -177.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 7.2 pt-20 -167.01 129.43 1.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.538 0.57 . . . . 5.0 112.538 178.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.551 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 3.3 t -128.32 148.65 32.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.321 -0.992 . . . . 3.33 108.321 165.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.7 p -111.58 97.47 36.85 Favored Pre-proline 0 C--N 1.312 -1.058 0 CA-C-O 121.711 0.767 . . . . 2.77 110.073 174.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.436 ' HD3' ' HG2' ' A' ' 72' ' ' ARG . 60.9 Cg_endo -72.85 136.59 25.51 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.067 2.512 . . . . 1.78 112.617 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.544 ' N ' ' HD2' ' A' ' 83' ' ' LYS . 11.1 mptt -89.02 137.98 29.36 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 109.204 -0.665 . . . . 3.11 109.204 177.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.449 ' HB2' HG22 ' A' ' 63' ' ' ILE . 34.4 Cg_exo -56.0 133.85 60.54 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.421 2.081 . . . . 0.67 112.114 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.41 115.14 2.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.483 -0.78 . . . . 1.78 110.956 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.662 ' HB3' HG23 ' A' ' 63' ' ' ILE . 12.9 ptt180 -129.56 145.0 51.51 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.629 0.728 . . . . 2.29 111.994 -173.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -107.39 116.63 32.27 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.633 -1.167 . . . . 0.5 110.517 -173.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.441 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 48.6 ttm -104.68 128.73 52.83 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.67 -0.412 . . . . 0.42 111.32 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.465 ' CE2' HD12 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -121.84 123.04 40.83 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.054 -0.721 . . . . 1.33 109.054 175.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.56 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 64.6 m -93.18 130.69 38.76 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.926 0.393 . . . . 0.94 110.264 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.593 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 40.2 m-85 -107.48 169.73 8.4 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.404 0.621 . . . . 1.33 110.896 176.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -112.15 -6.07 14.17 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.413 -0.812 . . . . 1.53 109.828 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.478 ' OD1' ' HB ' ' A' ' 95' ' ' THR . 28.6 t-20 -130.65 128.51 41.1 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.284 0.564 . . . . 0.83 111.282 -176.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.426 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 14.6 tpt180 -59.32 -37.06 76.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.76 -1.109 . . . . 2.16 111.641 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.535 HG22 HD21 ' A' ' 99' ' ' ASN . 91.7 m -72.26 -54.94 8.1 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.312 -0.403 . . . . 0.4 110.777 -176.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.8 t -44.95 -57.34 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 115.969 -0.559 . . . . 0.29 111.434 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.555 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -63.63 -29.92 71.09 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.578 -0.449 . . . . 0.29 111.218 -177.656 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.515 ' HA ' ' HE2' ' A' ' 101' ' ' LYS . 26.0 t70 -68.64 -33.06 73.35 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.465 0.65 . . . . 0.39 109.251 177.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.613 ' O ' ' HG3' ' A' ' 102' ' ' MET . 91.7 m-20 -77.41 -50.74 12.07 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.634 -1.166 . . . . 1.55 110.055 -178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.633 HG23 HD11 ' A' ' 18' ' ' ILE . 32.4 mm -56.0 -48.44 78.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.235 -0.893 . . . . 0.13 110.14 178.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.758 ' HA ' HD21 ' A' ' 48' ' ' LEU . 13.3 ttpt -58.61 -50.96 71.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.368 -0.833 . . . . 1.11 111.133 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.613 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.3 ppp? -67.89 -23.06 65.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 1.17 110.335 -175.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.406 HG23 ' CD2' ' A' ' 3' ' ' HIS . 52.1 m -68.13 -51.57 44.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.89 -0.595 . . . . 0.15 110.507 174.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.976 ' HB2' HD22 ' A' ' 48' ' ' LEU . 13.1 mt -69.04 -56.79 6.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.184 -0.916 . . . . 0.13 111.7 -173.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 1.017 ' HG3' HD23 ' A' ' 48' ' ' LEU . 42.2 mt-30 -53.16 -29.19 30.12 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.049 0.388 . . . . 1.45 112.049 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -61.28 -28.16 68.99 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.84 0.828 . . . . 0.65 109.265 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.653 HD12 ' HA ' ' A' ' 104' ' ' LEU . 25.2 mt -85.68 -45.28 17.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 113.803 -1.544 . . . . 0.17 110.791 178.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.584 HG22 ' HD2' ' A' ' 112' ' ' LYS . 1.7 mt -67.52 -53.81 28.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.417 -0.811 . . . . 0.29 111.46 -172.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.48 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 7.0 m -65.03 -14.96 61.73 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.567 0.699 . . . . 1.22 109.708 176.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.521 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 14.0 ttt180 -77.65 -42.95 32.94 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.863 -1.062 . . . . 3.79 109.752 174.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -74.42 -34.13 63.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.759 -0.655 . . . . 0.6 111.156 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.584 ' HD2' HG22 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -74.5 -18.45 60.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.327 0.585 . . . . 1.76 110.105 177.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -79.51 -19.64 49.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.411 -0.813 . . . . 1.56 109.683 174.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -114.86 19.76 15.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.437 -0.802 . . . . 1.09 110.772 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.3 t70 . . . . . 0 C--O 1.245 0.853 0 CA-C-O 118.479 -0.772 . . . . 2.16 110.285 -178.836 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.712 0 N-CA-C 111.87 -0.492 . . . . 25.39 111.87 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -155.24 59.33 0.38 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.043 -0.599 . . . . 24.6 111.878 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 165.78 -137.22 4.56 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.944 -0.646 . . . . 23.97 111.832 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.55 -124.66 7.6 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.74 -0.743 . . . . 23.13 112.299 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 58.8 42.84 19.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.494 0.664 . . . . 24.92 110.789 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 247' ' ' ASP . . . . . 0.419 ' OD2' ' HB3' ' B' ' 249' ' ' GLU . 3.4 t70 -81.83 126.21 31.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.133 -0.94 . . . . 21.4 109.68 178.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 4.1 t -82.43 46.15 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.597 0.713 . . . . 20.37 110.986 -174.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . 0.419 ' HB3' ' OD2' ' B' ' 247' ' ' ASP . 45.3 tt0 -136.55 113.92 10.82 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.663 -0.699 . . . . 17.68 109.244 176.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 10.9 ptt? -172.8 30.16 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.444 0.64 . . . . 16.8 110.42 -175.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -86.45 91.86 8.66 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.47 -0.787 . . . . 13.35 110.068 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 50.7 p -118.74 22.78 11.82 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.707 0.765 . . . . 10.66 109.434 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -58.12 -55.79 30.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.613 -1.176 . . . . 11.03 109.955 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' B' ' 254' ' ' GLU . 1.5 mp0 -56.8 -22.46 36.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.349 -0.841 . . . . 10.94 111.635 -176.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -76.28 -64.11 1.18 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.626 -0.261 . . . . 9.82 110.985 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 52.0 m -160.88 -6.35 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.606 0.241 . . . . 5.35 111.238 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -87.56 -4.72 58.96 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.648 0.24 . . . . 6.2 111.648 -175.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -60.03 -54.98 39.62 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 120.966 0.412 . . . . 6.14 110.221 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' B' ' 260' ' ' GLY . 4.2 p-10 -118.1 -92.65 0.53 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.241 -0.436 . . . . 3.32 110.67 173.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . 0.41 ' H ' ' CG ' ' B' ' 259' ' ' ASP . . . 72.24 17.6 77.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.147 -1.025 . . . . 0.84 110.858 -174.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 261' ' ' PHE . . . . . 0.52 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 12.0 m-85 -118.3 169.88 9.36 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.227 -0.487 . . . . 0.95 109.7 -176.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.3 p -125.8 156.79 35.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.359 -0.978 . . . . 1.37 108.359 172.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 263' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' B' ' 263' ' ' GLU . 0.2 OUTLIER -111.04 121.61 45.78 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.322 -0.622 . . . . 2.24 109.322 176.67 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.52 ' H ' HE22 ' A' ' 105' ' ' GLN . 46.6 t -101.94 102.82 14.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.734 -0.666 . . . . 1.41 111.342 -172.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.382 -0.818 . . . . 3.04 110.012 178.498 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo . . . . . 0 N--CA 1.476 0.456 0 N-CA-C 110.661 -0.554 . . . . 3.14 110.661 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.9 p -89.85 -37.76 14.23 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.316 -0.402 . . . . 1.4 111.329 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -90.84 31.2 1.09 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.378 0.608 . . . . 1.85 111.335 -175.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.7 p -161.89 149.53 14.56 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.757 -0.656 . . . . 0.95 109.607 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.23 142.75 4.41 Favored Glycine 0 C--O 1.224 -0.516 0 N-CA-C 111.388 -0.685 . . . . 0.16 111.388 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.774 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -73.53 121.25 20.31 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 117.175 0.487 . . . . 0.43 111.148 -177.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.602 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -128.27 161.01 30.36 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.289 0.566 . . . . 0.13 111.925 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.48 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.7 mp -102.74 113.62 39.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.274 -0.875 . . . . 0.29 109.291 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.505 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 84.1 t80 -112.96 101.91 9.93 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.989 -0.375 . . . . 0.56 109.989 -178.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 64.8 57.3 1.05 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.516 0.674 . . . . 1.46 110.721 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt 72.54 -8.2 1.26 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.332 -1.304 . . . . 1.91 113.369 170.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.432 HG21 ' HD3' ' A' ' 36' ' ' LYS . 0.5 OUTLIER -99.85 127.13 53.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.064 0.459 . . . . 0.47 110.37 173.054 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.48 ' HA ' HG13 ' A' ' 8' ' ' ILE . 14.1 p -78.71 126.55 30.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.817 -0.628 . . . . 1.02 110.552 177.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.658 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -147.3 -157.61 7.48 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.938 -0.649 . . . . 0.16 112.556 -177.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.774 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.0 mm -124.7 154.68 32.51 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.789 0 CA-C-O 120.756 0.312 . . . . 0.19 110.721 -177.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.558 HG12 HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -129.27 133.67 65.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-N 116.236 -0.438 . . . . 0.16 110.461 -179.616 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.28 112.62 9.25 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.03 -0.532 . . . . 0.12 111.468 174.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.587 HD11 HG23 ' A' ' 100' ' ' ILE . 4.8 mp -84.24 105.08 13.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 108.746 -0.835 . . . . 0.18 108.746 172.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -109.38 120.02 41.25 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 110.242 -0.281 . . . . 1.12 110.242 -176.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.62 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 37.3 mt-10 -105.72 83.71 1.97 Allowed 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 117.13 -1.828 . . . . 0.74 107.403 165.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -122.04 -13.03 8.26 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 106.756 -1.572 . . . . 0.59 106.756 157.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.997 HG11 ' HB2' ' A' ' 26' ' ' GLU . 13.9 p -102.93 -179.79 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 111.823 -2.444 . . . . 0.35 111.58 -157.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.642 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 1.4 p -51.88 165.71 0.45 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 117.706 -1.14 . . . . 1.31 108.416 168.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.642 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 18.7 Cg_endo -45.42 124.38 6.43 Favored 'Trans proline' 0 C--N 1.358 1.071 0 CA-C-N 121.514 1.576 . . . . 0.22 111.803 -154.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.806 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -21.69 133.57 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.721 1.748 . . . . 0.2 115.721 -151.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.997 ' HB2' HG11 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -112.93 138.65 49.47 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 114.705 -1.134 . . . . 1.26 110.671 -179.264 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.813 ' HB3' HG12 ' A' ' 40' ' ' VAL . 2.2 tt -100.78 142.53 32.13 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.519 -1.66 . . . . 0.15 106.519 169.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.565 ' N ' HD23 ' A' ' 27' ' ' LEU . 10.5 m -127.47 107.98 10.42 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.973 -0.691 . . . . 0.21 110.122 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.614 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 89.6 t90 -91.34 105.4 17.75 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.664 -0.865 . . . . 0.24 108.664 174.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -114.37 117.17 30.29 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.118 -0.946 . . . . 0.87 109.053 -177.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.569 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 80.8 p -57.24 148.44 22.49 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.09 0.471 . . . . 0.75 110.822 -173.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.658 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 7.5 m -58.4 -27.34 64.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.364 -0.835 . . . . 0.39 110.266 -177.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.473 ' OD2' ' HB3' ' A' ' 35' ' ' ASP . 1.4 p-10 -81.37 -27.54 34.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.078 -0.964 . . . . 2.33 111.267 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.83 2.69 84.02 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.087 -0.578 . . . . 0.55 112.974 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.473 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 12.3 t70 -78.28 -26.1 46.95 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.735 0.272 . . . . 1.13 111.735 -177.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.432 ' HD3' HG21 ' A' ' 12' ' ' VAL . 16.7 ptmt -137.73 155.06 49.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.434 0.635 . . . . 2.03 110.363 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.3 p -149.64 140.69 16.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.226 -0.897 . . . . 0.55 110.392 -175.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -130.72 108.98 10.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.643 0.259 . . . . 0.69 110.369 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 27.0 m -97.83 129.3 44.82 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.323 -0.621 . . . . 0.3 109.323 175.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.813 HG12 ' HB3' ' A' ' 27' ' ' LEU . 9.6 p -119.29 139.98 44.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.76 -0.376 . . . . 0.66 111.501 -178.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.628 ' O ' HG12 ' A' ' 45' ' ' ILE . 60.7 t -89.74 109.54 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.288 0.566 . . . . 0.18 110.077 -177.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.707 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.9 mm? -53.44 -31.84 47.24 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.944 -1.025 . . . . 0.12 112.669 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 15.1 t -76.36 -33.76 58.92 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.581 -0.448 . . . . 1.06 111.012 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.548 ' OG1' ' HB ' ' A' ' 41' ' ' VAL . 72.8 p -74.44 -11.26 60.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.073 0.463 . . . . 0.2 109.908 172.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.628 HG12 ' O ' ' A' ' 41' ' ' VAL . 37.4 mm -83.94 121.31 36.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.885 -0.598 . . . . 0.23 110.391 172.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.716 ' HB2' ' CG ' ' A' ' 65' ' ' LYS . 14.6 t70 -85.81 -41.38 15.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.104 0.478 . . . . 0.7 111.46 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.6 ' HE2' ' OD2' ' A' ' 46' ' ' ASP . 53.4 mmtt -132.47 143.1 49.54 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.563 -0.532 . . . . 1.95 109.563 -177.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.853 HD22 ' HB2' ' A' ' 104' ' ' LEU . 8.1 tp -114.53 141.22 48.01 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.637 0.732 . . . . 0.14 109.223 165.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 13.8 mm100 -122.53 151.52 41.28 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.433 -1.258 . . . . 1.49 109.695 -177.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.19 139.94 8.61 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.671 -0.695 . . . . 0.25 109.242 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.43 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 32.3 p -49.95 128.22 21.2 Favored Pre-proline 0 N--CA 1.468 0.472 0 CA-C-O 121.265 0.555 . . . . 0.37 111.705 -178.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.565 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 57.3 Cg_endo -69.26 166.94 25.26 Favored 'Trans proline' 0 C--N 1.334 -0.207 0 C-N-CA 124.293 3.329 . . . . 0.64 112.153 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.62 -28.49 68.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.255 0.55 . . . . 1.02 110.322 175.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.2 t -68.12 -24.8 65.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.532 -0.758 . . . . 1.58 110.333 176.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.438 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 46.6 t -74.06 136.03 43.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.744 -0.662 . . . . 0.71 110.413 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -87.14 0.4 55.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.474 0.654 . . . . 2.89 110.151 176.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.24 176.83 4.87 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.094 -0.957 . . . . 2.59 109.689 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.491 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -136.53 110.92 8.48 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.801 -1.185 . . . . 1.78 107.801 178.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.595 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 3.9 ttm -156.01 149.43 24.72 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 120.426 -0.509 . . . . 1.3 111.692 -172.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.44 HD22 HG22 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -120.06 151.2 39.37 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.367 -0.833 . . . . 0.14 110.416 174.365 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.566 ' HD3' ' HB2' ' A' ' 88' ' ' MET . 15.9 ttp180 -148.76 114.43 5.66 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 121.149 0.5 . . . . 2.72 110.62 171.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.833 HD13 ' CE2' ' A' ' 89' ' ' PHE . 8.9 mp -95.16 113.17 24.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.06 -0.518 . . . . 0.9 110.242 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.553 HG23 ' HB3' ' A' ' 86' ' ' ARG . 3.6 mm -87.75 107.54 17.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.881 -0.414 . . . . 0.4 109.881 -173.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -78.92 140.82 23.63 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.321 -0.942 . . . . 0.48 111.391 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.716 ' CG ' ' HB2' ' A' ' 46' ' ' ASP . 16.1 mttm -59.02 135.2 57.55 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.46 0.648 . . . . 1.15 112.142 -174.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.2 p -83.32 155.89 3.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 114.779 -1.101 . . . . 0.69 110.251 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -109.02 95.43 5.64 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.364 -0.835 . . . . 2.56 109.739 178.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -76.79 -4.62 44.45 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.782 -0.645 . . . . 3.79 111.105 -178.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.3 m -63.0 -32.94 74.41 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 120.808 0.337 . . . . 3.05 111.423 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.97 80.49 1.49 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.723 0.773 . . . . 5.48 111.42 174.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -58.67 136.38 57.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.37 -0.832 . . . . 4.42 110.057 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.577 ' CG ' ' HB ' ' A' ' 80' ' ' VAL . 9.0 ptt180 -95.33 169.23 10.22 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.499 -0.556 . . . . 4.27 109.499 -175.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.557 ' HB3' ' C ' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -123.97 168.52 12.7 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 110.124 -0.324 . . . . 5.09 110.124 -173.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.658 ' HB3' HD22 ' A' ' 78' ' ' ASN . 4.5 t70 -81.14 -165.46 0.93 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.416 -0.513 . . . . 4.98 109.66 -176.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -62.81 -20.28 64.89 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 118.063 0.392 . . . . 6.68 111.909 -175.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.419 ' HB3' ' ND2' ' A' ' 78' ' ' ASN . 24.1 tt0 -98.83 -14.76 19.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.469 0.652 . . . . 7.13 110.288 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.557 ' C ' ' HB3' ' A' ' 73' ' ' LYS . . . 98.15 36.61 4.63 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.22 -0.9 . . . . 5.53 111.413 -171.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.658 HD22 ' HB3' ' A' ' 74' ' ' ASP . 57.5 m-80 -83.31 -102.94 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.536 0.208 . . . . 5.62 110.91 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -155.36 119.48 4.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.361 -0.381 . . . . 5.0 111.035 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.577 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 4.7 t -128.11 149.01 32.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.347 -0.612 . . . . 3.33 109.347 168.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 81' ' ' VAL . 7.6 p -111.39 98.49 40.33 Favored Pre-proline 0 C--N 1.308 -1.239 0 CA-C-O 121.872 0.844 . . . . 2.77 109.338 171.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.496 ' HD3' ' HG2' ' A' ' 72' ' ' ARG . 23.7 Cg_endo -62.83 141.53 85.16 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.857 2.371 . . . . 1.78 112.581 -177.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -72.67 143.22 84.55 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 115.017 -0.992 . . . . 3.11 109.832 177.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -55.47 133.2 56.67 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.565 2.177 . . . . 0.67 111.518 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -71.66 113.38 8.64 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 123.334 1.54 . . . . 1.78 109.588 -174.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.553 ' HB3' HG23 ' A' ' 63' ' ' ILE . 27.4 ptt180 -110.8 158.5 18.61 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.688 -1.596 . . . . 2.29 111.046 -172.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -127.03 112.32 15.09 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.142 -0.935 . . . . 0.5 110.152 -168.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.566 ' HB2' ' HD3' ' A' ' 61' ' ' ARG . 47.6 ttm -106.21 131.36 53.54 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 111.86 0.318 . . . . 0.42 111.86 -173.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.833 ' CE2' HD13 ' A' ' 62' ' ' LEU . 1.5 m-85 -119.04 123.57 44.81 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.071 -0.714 . . . . 1.33 109.071 172.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.545 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 23.4 m -87.44 126.76 35.08 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.101 -0.5 . . . . 0.94 110.021 178.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.602 ' CE1' ' HB2' ' A' ' 7' ' ' ALA . 33.1 m-85 -107.9 165.17 11.65 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.584 0.707 . . . . 1.33 111.047 176.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -109.9 -12.7 14.54 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.93 -1.032 . . . . 1.53 109.642 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.556 ' OD1' ' HB ' ' A' ' 95' ' ' THR . 28.5 t-20 -126.28 125.18 41.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.595 -0.73 . . . . 0.83 110.752 -174.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -58.48 -35.57 72.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.962 -1.017 . . . . 2.16 111.553 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.556 ' HB ' ' OD1' ' A' ' 93' ' ' ASN . 95.4 m -70.74 -55.32 8.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.625 0.25 . . . . 0.4 110.59 -176.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.7 t -45.76 -57.86 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-N 115.904 -0.589 . . . . 0.29 111.526 175.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.491 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -62.09 -29.86 70.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 120.616 -0.434 . . . . 0.29 111.288 -178.082 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.0 -32.15 70.18 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.412 0.625 . . . . 0.39 109.367 177.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.619 ' O ' ' HG3' ' A' ' 102' ' ' MET . 92.0 m-20 -78.16 -48.77 15.19 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.817 -1.083 . . . . 1.55 110.116 -177.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.587 HG23 HD11 ' A' ' 18' ' ' ILE . 37.8 mm -57.24 -50.97 75.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.314 -0.857 . . . . 0.13 110.396 176.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.692 ' HA ' HD21 ' A' ' 48' ' ' LEU . 11.2 ttpt -56.39 -50.48 71.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.634 -0.712 . . . . 1.11 111.101 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.619 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.9 ppp? -66.44 -24.86 66.51 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.881 0.372 . . . . 1.17 110.841 -176.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 49.3 m -69.43 -49.73 52.38 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.48 0.657 . . . . 0.15 110.328 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.853 ' HB2' HD22 ' A' ' 48' ' ' LEU . 13.9 mt -67.74 -56.68 8.32 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.051 -0.977 . . . . 0.13 111.341 -175.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.761 ' HG3' HD23 ' A' ' 48' ' ' LEU . 35.6 mt-30 -50.02 -29.89 9.58 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.249 0.463 . . . . 1.45 112.249 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -60.91 -31.3 70.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.979 0.895 . . . . 0.65 109.414 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.806 HG21 ' HB3' ' A' ' 25' ' ' ALA . 21.3 mt -84.92 -46.51 17.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 113.594 -1.639 . . . . 0.17 110.503 178.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.683 HG22 ' HD2' ' A' ' 112' ' ' LYS . 0.9 OUTLIER -64.68 -51.2 70.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.677 -0.692 . . . . 0.29 110.775 -174.436 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.3 m -57.4 -26.27 60.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.988 0.423 . . . . 1.22 110.673 174.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 12.1 mtt180 -69.2 -37.35 78.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.453 0.645 . . . . 3.79 110.006 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.449 ' HD2' ' O ' ' A' ' 107' ' ' ILE . 42.4 m-85 -88.79 -24.23 22.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.982 -1.008 . . . . 0.6 111.734 -177.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.683 ' HD2' HG22 ' A' ' 108' ' ' ILE . 8.7 mtpp -75.7 -28.3 58.55 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.363 0.601 . . . . 1.76 109.53 172.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -72.1 -16.38 62.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.437 -0.801 . . . . 1.56 110.189 174.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -99.92 0.71 41.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.578 -0.737 . . . . 1.09 110.514 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.1 t70 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.691 -0.671 . . . . 2.16 109.888 -178.175 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 111.986 -0.446 . . . . 25.39 111.986 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -71.36 121.63 9.08 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.958 -0.639 . . . . 24.6 111.915 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 87.65 -96.87 2.22 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.78 -0.724 . . . . 23.97 111.693 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 81.26 5.97 89.66 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.88 -0.676 . . . . 23.13 112.396 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -92.1 39.39 1.02 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.438 0.637 . . . . 24.92 109.58 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -126.21 133.05 51.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.394 -0.821 . . . . 21.4 110.671 -173.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 13.3 p -90.58 -0.11 8.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.487 1.137 . . . . 20.37 107.947 169.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -136.0 114.68 11.95 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.023 -1.444 . . . . 17.68 109.155 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 25.3 mmt -108.8 -4.65 16.74 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.721 0.772 . . . . 16.8 109.709 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -70.29 134.96 48.48 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.331 -1.304 . . . . 13.35 110.623 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 7.8 p -124.61 -72.36 0.68 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.83 -0.623 . . . . 10.66 110.474 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -80.52 -14.0 58.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.154 0.502 . . . . 11.03 110.22 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -65.34 -21.77 66.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.459 -0.791 . . . . 10.94 110.746 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.3 -20.6 62.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.256 0.55 . . . . 9.82 110.139 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 69.2 m -88.44 122.88 32.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.545 -0.752 . . . . 5.35 110.194 176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -84.01 -64.35 1.18 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.162 0.505 . . . . 6.2 110.033 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -85.45 -61.12 1.84 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.856 -0.611 . . . . 6.14 109.944 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -148.28 -38.64 0.18 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.543 -0.753 . . . . 3.32 110.534 175.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 80.5 -6.06 62.26 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.892 -0.671 . . . . 0.84 111.436 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 261' ' ' PHE . . . . . 0.565 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 9.8 m-85 -102.86 -179.33 3.93 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.958 -0.621 . . . . 0.95 109.747 -177.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 10.6 p -135.59 140.17 45.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.272 -0.27 . . . . 1.37 110.272 175.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -86.69 121.67 29.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.639 -0.874 . . . . 2.24 108.639 174.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.543 ' HB ' HE22 ' A' ' 105' ' ' GLN . 52.8 t -103.08 100.53 10.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.792 0.33 . . . . 1.41 110.137 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 34.3 t70 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.236 -0.887 . . . . 3.04 110.473 -177.464 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo . . . . . 0 N--CA 1.48 0.681 0 N-CA-C 111.122 -0.376 . . . . 3.14 111.122 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.474 ' HA ' ' HB3' ' A' ' 99' ' ' ASN . 92.5 p 51.1 -83.48 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.609 1.164 . . . . 1.4 113.211 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -90.31 19.56 5.06 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.23 0.538 . . . . 1.85 110.336 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.438 ' C ' HD11 ' A' ' 100' ' ' ILE . 77.4 p -162.72 149.53 13.02 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.496 -0.775 . . . . 0.95 109.655 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.26 147.0 7.74 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 110.839 -0.905 . . . . 0.16 110.839 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.741 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -79.26 117.43 20.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.644 0.722 . . . . 0.43 111.619 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.29 158.24 28.59 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.347 0.594 . . . . 0.13 111.587 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.492 HG13 ' HA ' ' A' ' 13' ' ' SER . 3.1 mp -99.01 129.22 49.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.409 -0.814 . . . . 0.29 109.263 177.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.578 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 89.1 t80 -139.28 111.96 7.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.913 -0.585 . . . . 0.56 109.917 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 69.49 45.21 0.84 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.727 0.775 . . . . 1.46 110.421 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? 70.01 3.14 4.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.276 -1.329 . . . . 1.91 112.732 172.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.1 131.68 59.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.784 0.326 . . . . 0.47 110.478 175.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.492 ' HA ' HG13 ' A' ' 8' ' ' ILE . 30.5 t -78.69 117.0 19.42 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.4 0.619 . . . . 1.02 110.042 177.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.718 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -130.97 -153.91 7.75 Favored Glycine 0 N--CA 1.434 -1.44 0 CA-C-N 115.288 -0.869 . . . . 0.16 111.3 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.741 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 7.8 mm -127.88 153.15 36.86 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 CA-C-O 120.919 0.39 . . . . 0.19 110.687 -177.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.442 HG12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -125.41 131.94 71.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-N 115.824 -0.625 . . . . 0.16 109.332 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.94 113.97 10.58 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.758 -0.377 . . . . 0.12 111.555 176.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.603 HD11 HG23 ' A' ' 100' ' ' ILE . 4.4 mp -84.14 113.46 23.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.068 -1.086 . . . . 0.18 108.068 171.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.466 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.1 t30 -121.58 130.33 53.44 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.487 -0.324 . . . . 1.12 110.274 -177.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -110.48 84.55 1.95 Allowed 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 116.912 -1.915 . . . . 0.74 107.482 164.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.466 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 13.2 t70 -120.85 -10.32 9.14 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 106.122 -1.807 . . . . 0.59 106.122 157.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.749 HG11 ' HB2' ' A' ' 26' ' ' GLU . 14.0 p -102.08 179.15 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 111.743 -2.48 . . . . 0.35 111.395 -158.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.69 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -53.33 168.77 0.35 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 117.543 -1.217 . . . . 1.31 108.134 166.522 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.594 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 9.2 Cg_endo -41.68 127.2 3.41 Favored 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 121.796 1.664 . . . . 0.22 111.088 -157.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.54 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -30.72 131.51 0.09 Allowed 'General case' 0 CA--C 1.507 -0.679 0 O-C-N 125.279 1.612 . . . . 0.2 113.557 -154.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.749 ' HB2' HG11 ' A' ' 22' ' ' VAL . 47.0 mt-10 -124.09 143.25 50.57 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.676 -1.147 . . . . 1.26 110.864 -169.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.576 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.1 tt -101.26 143.39 31.39 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 106.557 -1.645 . . . . 0.15 106.557 175.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.416 ' N ' HD23 ' A' ' 27' ' ' LEU . 14.1 m -129.46 109.65 11.23 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.846 -0.742 . . . . 0.21 110.705 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.647 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 85.1 t90 -86.71 106.59 17.75 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.52 0.676 . . . . 0.24 109.544 174.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -114.31 118.87 35.11 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.289 -0.869 . . . . 0.87 109.191 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.432 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 49.8 m -56.08 142.04 37.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.871 0.367 . . . . 0.75 110.756 -176.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.718 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 18.4 m -59.29 -28.19 66.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.452 -0.795 . . . . 0.39 110.166 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.09 -27.19 54.06 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.218 -0.901 . . . . 2.33 110.932 175.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.63 -3.98 50.1 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.122 -0.561 . . . . 0.55 112.681 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.4 ' OD2' ' HG3' ' A' ' 36' ' ' LYS . 32.3 t70 -69.98 -78.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.458 0.54 . . . . 1.13 112.458 -175.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.4 ' HG3' ' OD2' ' A' ' 35' ' ' ASP . 19.8 mtpp -83.99 142.66 30.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.291 0.567 . . . . 2.03 112.057 -175.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 61.1 t -138.29 117.23 14.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.788 -1.096 . . . . 0.55 109.618 177.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -124.37 110.01 14.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.31 -0.404 . . . . 0.69 110.434 -176.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.7 m -97.72 138.83 34.52 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 121.188 -0.205 . . . . 0.3 111.386 -176.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.568 HG11 HD13 ' A' ' 62' ' ' LEU . 27.7 t -113.11 129.3 69.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 122.769 0.428 . . . . 0.66 111.625 177.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.592 ' O ' HG12 ' A' ' 45' ' ' ILE . 23.0 t -90.81 108.49 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 121.252 0.548 . . . . 0.18 109.942 174.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.604 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.6 mm? -56.1 -28.1 56.37 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.158 -0.928 . . . . 0.12 112.339 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 41.1 t -74.88 -31.67 61.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.75 0.309 . . . . 1.06 110.674 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.427 ' O ' ' HD3' ' A' ' 65' ' ' LYS . 82.6 p -80.29 -9.78 59.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.635 0.731 . . . . 0.2 109.738 175.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.615 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 45.1 mm -85.21 123.75 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 114.872 -1.058 . . . . 0.23 111.143 174.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.655 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 4.9 t70 -74.84 -47.71 28.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.149 -0.932 . . . . 0.7 110.718 176.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.524 ' HD2' ' O ' ' A' ' 46' ' ' ASP . 0.5 OUTLIER -147.0 164.75 32.01 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.134 -0.485 . . . . 1.95 111.036 -176.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.087 HD23 ' HG3' ' A' ' 105' ' ' GLN . 13.0 tp -125.96 146.73 49.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.004 0.431 . . . . 0.14 109.944 172.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 16.7 mm100 -124.08 158.55 31.95 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.182 -0.917 . . . . 1.49 110.176 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HB1' ' CE ' ' A' ' 97' ' ' MET . . . -164.66 142.91 6.72 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.496 -0.774 . . . . 0.25 109.928 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.559 ' HB ' ' CB ' ' A' ' 55' ' ' SER . 41.5 p -55.53 129.73 69.99 Favored Pre-proline 0 N--CA 1.471 0.587 0 CA-C-O 121.235 0.54 . . . . 0.37 111.355 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.467 ' O ' ' HB3' ' A' ' 55' ' ' SER . 39.1 Cg_endo -64.59 165.9 19.21 Favored 'Trans proline' 0 N--CA 1.471 0.148 0 C-N-CA 124.017 3.144 . . . . 0.64 112.555 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.04 -27.26 65.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.97 0.414 . . . . 1.02 110.726 175.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.434 ' HB3' ' HG2' ' B' ' 254' ' ' GLU . 50.7 m -74.62 -24.22 58.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.922 -0.581 . . . . 1.58 111.16 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.559 ' CB ' ' HB ' ' A' ' 51' ' ' THR . 27.3 t -61.81 138.25 58.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.972 -0.558 . . . . 0.71 110.634 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.65 -18.16 42.07 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.793 -0.817 . . . . 2.89 108.793 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -103.74 174.1 6.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.718 -1.128 . . . . 2.59 109.577 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.511 ' HA ' ' OG1' ' A' ' 51' ' ' THR . 0.0 OUTLIER -134.24 111.76 10.52 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.151 -0.685 . . . . 1.78 109.151 177.423 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.513 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 69.3 mtm -153.77 142.11 20.6 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.932 0.396 . . . . 1.3 111.288 -175.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.535 HD23 HD11 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -110.79 157.26 19.99 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.472 -0.786 . . . . 0.14 110.422 175.556 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.489 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 38.0 ttp180 -149.75 114.6 5.35 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-O 121.26 0.552 . . . . 2.72 111.629 170.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.786 ' HG ' HD13 ' A' ' 48' ' ' LEU . 8.5 mt -91.97 112.62 24.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.875 -0.602 . . . . 0.9 110.706 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.574 HG23 ' HG2' ' A' ' 86' ' ' ARG . 3.8 mm -86.01 108.88 17.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 C-N-CA 123.72 0.808 . . . . 0.4 110.436 -173.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -78.99 155.94 41.34 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 119.969 -1.11 . . . . 0.48 111.64 176.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.655 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 0.2 OUTLIER -68.05 135.06 51.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.133 0.467 . . . . 1.15 110.726 179.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.404 HG13 ' HG3' ' A' ' 68' ' ' GLU . 7.5 p -82.67 151.86 4.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.998 0.428 . . . . 0.69 110.018 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -80.91 81.08 7.26 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.456 -0.793 . . . . 2.56 111.198 -175.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.404 ' HG3' HG13 ' A' ' 66' ' ' VAL . 41.4 mt-10 -80.73 -2.73 48.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.77 -0.65 . . . . 3.79 111.808 -175.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.8 t -67.53 -36.67 81.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.624 0.249 . . . . 3.05 110.763 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 104.27 5.02 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.341 0.591 . . . . 5.48 111.408 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.644 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 21.2 ptmt -72.87 139.5 46.95 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.416 0.627 . . . . 4.42 110.377 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.5 mpt_? -68.53 173.65 4.85 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 114.67 1.359 . . . . 4.27 114.67 -173.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 28.2 mmtt -128.01 148.89 50.55 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 114.359 -1.291 . . . . 5.09 109.849 -174.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.716 ' HB3' HD22 ' A' ' 78' ' ' ASN . 4.7 t70 -103.28 -168.03 1.46 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.552 -0.907 . . . . 4.98 108.552 177.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -54.61 -30.83 55.83 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.501 0.556 . . . . 6.68 112.501 -174.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 76' ' ' GLU . 32.0 tt0 -108.28 -3.33 18.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.141 0.495 . . . . 7.13 111.243 -176.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 90.52 19.05 46.39 Favored Glycine 0 C--N 1.318 -0.42 0 C-N-CA 120.205 -0.998 . . . . 5.53 111.678 -175.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.716 HD22 ' HB3' ' A' ' 74' ' ' ASP . 22.8 m-80 -52.39 -39.88 61.4 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.378 0.671 . . . . 5.62 111.616 177.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.652 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 46.7 mt-10 91.67 135.65 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 O-C-N 125.323 1.639 . . . . 5.0 110.667 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 t -124.06 148.58 28.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.005 -0.998 . . . . 3.33 109.116 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.9 p -109.78 96.22 23.31 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-O 121.994 0.902 . . . . 2.77 109.62 171.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.54 158.67 50.58 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.142 2.561 . . . . 1.78 112.671 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.435 ' HD3' ' N ' ' A' ' 83' ' ' LYS . 3.8 mppt? -90.6 145.59 32.58 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.496 -0.774 . . . . 3.11 110.494 -175.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.447 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 24.4 Cg_exo -57.44 144.12 92.56 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.732 2.288 . . . . 0.67 111.807 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.06 114.04 14.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.864 0.84 . . . . 1.78 110.259 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.574 ' HG2' HG23 ' A' ' 63' ' ' ILE . 6.7 mtm180 -115.2 141.56 47.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.315 -0.857 . . . . 2.29 109.816 -175.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -107.69 111.83 24.23 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.852 -0.613 . . . . 0.5 109.781 -173.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.456 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 55.7 ttm -105.02 121.92 44.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.729 0.3 . . . . 0.42 111.037 -176.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.437 ' CG ' HD11 ' A' ' 16' ' ' ILE . 91.1 m-85 -119.46 124.41 46.42 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.724 -0.473 . . . . 1.33 109.724 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.485 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 42.0 m -90.16 133.28 34.99 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.978 0.418 . . . . 0.94 110.874 -176.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.629 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 24.2 m-85 -108.14 173.61 6.24 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.153 0.501 . . . . 1.33 111.303 176.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -114.13 1.06 14.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.549 -0.75 . . . . 1.53 110.178 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -145.77 126.83 14.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.7 -0.682 . . . . 0.83 109.979 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.511 ' HA ' ' HG2' ' A' ' 97' ' ' MET . 5.9 ttm180 -71.3 -20.79 62.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.785 -0.643 . . . . 2.16 110.982 -176.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.458 HG22 HD21 ' A' ' 99' ' ' ASN . 99.7 m -72.73 -55.39 6.84 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.104 -0.332 . . . . 0.4 110.104 174.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.9 t -45.81 -56.0 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-N 116.233 -0.439 . . . . 0.29 111.289 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.528 ' CE ' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -64.52 -28.56 69.73 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.031 -0.531 . . . . 0.29 111.221 -177.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.54 -33.31 72.6 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.127 -0.694 . . . . 0.39 109.127 176.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.597 ' O ' ' HG3' ' A' ' 102' ' ' MET . 89.8 m-20 -74.5 -46.3 40.24 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.622 -1.172 . . . . 1.55 109.657 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.629 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 30.0 mm -59.9 -51.4 73.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.917 -1.038 . . . . 0.13 110.522 175.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.829 ' HA ' HD21 ' A' ' 48' ' ' LEU . 3.0 ttpp -57.16 -47.79 80.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.515 -0.766 . . . . 1.11 110.85 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.597 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.7 ppp? -67.06 -26.09 66.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.581 -0.281 . . . . 1.17 110.398 -177.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 106' ' ' GLN . 61.0 m -66.64 -54.9 18.29 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.286 0.565 . . . . 0.15 110.143 175.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.93 ' HB2' HD22 ' A' ' 48' ' ' LEU . 10.6 mt -64.5 -56.22 15.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.264 -0.88 . . . . 0.13 110.925 -175.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 1.087 ' HG3' HD23 ' A' ' 48' ' ' LEU . 98.0 mt-30 -52.6 -24.19 7.86 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.889 0.7 . . . . 1.45 112.889 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 102' ' ' MET . 37.6 mt-30 -65.73 -40.97 92.69 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.899 0.857 . . . . 0.65 109.013 174.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.54 HG21 ' HB3' ' A' ' 25' ' ' ALA . 49.3 mt -72.5 -42.49 63.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 113.765 -1.561 . . . . 0.17 110.727 178.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.876 HG22 ' HE3' ' A' ' 112' ' ' LYS . 1.1 mt -63.95 -58.21 8.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.454 -0.794 . . . . 0.29 110.595 -176.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.684 ' HA ' ' HD2' ' A' ' 112' ' ' LYS . 48.0 t -54.64 -26.24 31.79 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.288 0.566 . . . . 1.22 110.802 173.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.435 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 8.3 ttt180 -69.59 -20.5 63.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.675 -0.693 . . . . 3.79 110.257 176.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.439 ' HD2' ' O ' ' A' ' 107' ' ' ILE . 18.0 m-85 -102.65 -5.06 24.24 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.91 0.862 . . . . 0.6 108.694 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.876 ' HE3' HG22 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -88.14 -23.72 23.57 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.387 -1.279 . . . . 1.76 109.713 171.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -74.07 -17.68 60.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.228 -0.896 . . . . 1.56 109.705 171.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -118.7 28.14 8.49 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.308 -0.86 . . . . 1.09 110.397 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.406 ' HB2' ' HA ' ' A' ' 112' ' ' LYS . 24.8 t70 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.578 -0.725 . . . . 2.16 110.338 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.938 -0.465 . . . . 25.39 111.938 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -162.15 175.01 38.67 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 121.095 -0.574 . . . . 24.6 111.815 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 113.83 -85.54 0.39 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.877 -0.678 . . . . 23.97 112.027 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -84.29 -32.88 21.71 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.849 -0.691 . . . . 23.13 111.65 178.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -131.61 127.6 37.4 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.534 -0.543 . . . . 24.92 109.534 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -77.71 144.4 37.31 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.952 0.406 . . . . 21.4 110.303 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.97 -1.53 5.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.929 0.871 . . . . 20.37 109.523 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -117.0 145.44 43.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.869 -1.059 . . . . 17.68 110.186 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 26.0 mmt -120.3 21.35 11.74 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.842 0.829 . . . . 16.8 108.951 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -69.18 134.87 49.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.317 -1.31 . . . . 13.35 110.241 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 43.6 m -139.17 42.31 2.07 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.004 -0.543 . . . . 10.66 110.43 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -80.78 -29.37 36.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.024 0.44 . . . . 11.03 110.116 177.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . 0.434 ' HG2' ' HB3' ' A' ' 54' ' ' SER . 1.9 mp0 -56.83 -46.38 81.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.306 -0.861 . . . . 10.94 111.635 -176.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -60.73 -55.6 31.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.483 -0.326 . . . . 9.82 111.386 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 256' ' ' SER . . . . . 0.447 ' HB3' ' HA2' ' B' ' 260' ' ' GLY . 23.0 t 55.33 101.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.523 0.678 . . . . 5.35 112.342 176.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -66.67 -21.43 66.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.895 -0.593 . . . . 6.2 110.826 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.3 -40.18 93.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.894 -0.594 . . . . 6.14 111.781 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -161.14 -57.53 0.05 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.406 -0.361 . . . . 3.32 110.466 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . 0.447 ' HA2' ' HB3' ' B' ' 256' ' ' SER . . . 100.32 -6.5 57.87 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.303 -0.951 . . . . 0.84 113.592 171.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 261' ' ' PHE . . . . . 0.465 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 6.6 m-85 -108.02 174.21 5.98 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 110.045 -0.354 . . . . 0.95 110.045 -177.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 10.2 p -143.96 140.81 25.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.75 -0.463 . . . . 1.37 109.75 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -77.53 119.58 21.3 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.836 -0.801 . . . . 2.24 108.836 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 47.1 t -112.52 101.31 12.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.901 0.382 . . . . 1.41 110.204 -178.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.498 -0.763 . . . . 3.04 109.994 -178.954 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo . . . . . 0 N--CA 1.477 0.541 0 N-CA-C 109.741 -0.907 . . . . 3.14 109.741 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.7 p -125.64 -43.57 1.87 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.037 0.446 . . . . 1.4 110.963 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 52.7 p-80 -98.36 26.33 5.53 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.587 0.708 . . . . 1.85 110.675 -176.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.4 p -162.7 134.89 5.42 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.205 -0.907 . . . . 0.95 109.241 173.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.5 148.22 10.47 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.664 -0.975 . . . . 0.16 110.664 -178.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.734 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -75.39 133.88 41.08 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 117.159 0.48 . . . . 0.43 111.44 -175.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.89 156.36 46.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.289 0.566 . . . . 0.13 111.386 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.544 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.2 mp -98.86 110.94 27.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.913 -0.773 . . . . 0.29 108.913 177.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.475 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 80.3 t80 -109.96 109.78 20.49 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.366 -0.379 . . . . 0.56 110.356 -177.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 63.61 46.53 4.13 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.883 0.849 . . . . 1.46 110.517 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt 77.18 -5.59 2.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 113.726 -1.579 . . . . 1.91 113.151 170.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -99.53 133.72 41.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.009 0.433 . . . . 0.47 110.427 173.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.544 ' HA ' HG13 ' A' ' 8' ' ' ILE . 22.6 t -78.16 126.63 31.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.91 -0.586 . . . . 1.02 110.532 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.674 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -150.05 -159.71 8.86 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.597 -0.729 . . . . 0.16 112.476 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.734 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 7.0 mm -126.31 153.43 34.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 120.821 0.343 . . . . 0.19 110.69 -178.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.49 133.69 68.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.977 -0.556 . . . . 0.16 109.762 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -136.0 108.03 7.18 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.013 0.435 . . . . 0.12 111.898 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.587 HD11 HG23 ' A' ' 100' ' ' ILE . 4.3 mp -85.73 110.74 20.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 108.833 -0.803 . . . . 0.18 108.833 172.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.445 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.6 t30 -114.19 127.65 56.0 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.651 -0.42 . . . . 1.12 110.268 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -109.8 83.65 1.79 Allowed 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 117.281 -1.768 . . . . 0.74 107.464 164.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.445 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 19.5 t70 -122.57 -11.25 8.29 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 106.466 -1.679 . . . . 0.59 106.466 156.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.939 HG11 ' HB3' ' A' ' 26' ' ' GLU . 14.5 p -101.44 173.58 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 111.964 -2.38 . . . . 0.35 112.072 -155.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.648 ' O ' HG13 ' A' ' 22' ' ' VAL . 7.6 m -54.42 165.81 0.81 Allowed Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 106.673 -1.603 . . . . 1.31 106.673 166.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 9.5 Cg_endo -40.36 127.52 2.24 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.655 1.57 . . . . 0.22 111.699 -147.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.666 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -31.01 131.48 0.1 Allowed 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 125.359 1.662 . . . . 0.2 112.649 -159.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.939 ' HB3' HG11 ' A' ' 22' ' ' VAL . 25.3 tt0 -130.14 133.73 46.83 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 114.51 -1.223 . . . . 1.26 111.658 -160.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.546 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.6 tt -101.62 147.39 26.47 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 107.006 -1.479 . . . . 0.15 107.006 177.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.516 ' N ' HD23 ' A' ' 27' ' ' LEU . 30.3 m -138.44 109.79 6.94 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.204 -0.599 . . . . 0.21 110.729 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.62 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 92.2 t90 -86.65 109.79 19.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.65 -0.705 . . . . 0.24 109.219 177.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.72 118.3 35.23 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.344 -0.844 . . . . 0.87 109.039 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.503 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 86.7 p -57.28 142.63 42.53 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 110.008 -0.367 . . . . 0.75 110.008 -177.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.674 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 38.3 m -46.67 -39.76 11.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.256 0.55 . . . . 0.39 110.91 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -72.32 -27.67 62.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.226 -0.897 . . . . 2.33 111.646 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.3 21.82 28.73 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.984 -0.627 . . . . 0.55 112.471 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -101.78 -30.76 11.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.158 0.504 . . . . 1.13 110.781 -173.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -126.22 130.06 50.2 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.663 -0.698 . . . . 2.03 110.154 -176.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 95.9 t -133.59 123.54 46.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.786 0.326 . . . . 0.55 110.223 -177.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -125.33 110.99 14.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.193 -0.458 . . . . 0.69 110.37 -177.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 28' ' ' THR . 40.2 m -92.6 145.05 24.73 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.805 0.336 . . . . 0.3 111.663 -177.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.574 HG11 HD13 ' A' ' 62' ' ' LEU . 32.0 t -122.02 124.72 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.254 -0.43 . . . . 0.66 110.913 174.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 45' ' ' ILE . 59.7 t -91.47 108.32 19.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.014 -0.736 . . . . 0.18 109.014 175.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.592 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.0 mm? -52.72 -27.63 18.46 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.409 -0.814 . . . . 0.12 112.79 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 45.4 t -75.38 -29.28 59.81 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.599 -0.44 . . . . 1.06 110.822 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.5 p -82.59 -4.64 57.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.46 0.647 . . . . 0.2 109.937 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.631 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 45.5 mm -89.39 126.01 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.134 -0.939 . . . . 0.23 111.448 175.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.577 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 21.7 t70 -77.5 -41.86 37.81 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.732 -0.667 . . . . 0.7 110.928 176.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -153.03 160.73 43.02 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 115.856 -0.611 . . . . 1.95 110.425 -175.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.999 HD23 ' HG2' ' A' ' 105' ' ' GLN . 12.9 tp -121.22 149.24 43.13 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.219 0.533 . . . . 0.14 109.566 171.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.57 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 10.6 mm100 -125.39 156.34 38.95 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.229 -0.896 . . . . 1.49 109.5 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -162.03 145.24 11.89 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.809 -0.812 . . . . 0.25 108.809 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 36.6 p -54.61 124.96 51.82 Favored Pre-proline 0 C--O 1.234 0.286 0 CA-C-O 121.254 0.549 . . . . 0.37 111.419 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 62.0 Cg_endo -70.55 167.28 25.93 Favored 'Trans proline' 0 C--N 1.332 -0.34 0 C-N-CA 124.242 3.295 . . . . 0.64 112.061 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.57 -18.57 53.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.425 0.631 . . . . 1.02 110.215 172.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' B' ' 252' ' ' SER . 63.5 m -83.79 -8.67 59.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.293 -0.867 . . . . 1.58 111.469 177.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.519 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 41.2 t -89.05 148.23 23.84 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.081 -0.508 . . . . 0.71 110.347 175.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -89.0 -11.2 44.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.798 -0.637 . . . . 2.89 110.985 177.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.9 mmmt -108.27 -177.05 3.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.763 -0.653 . . . . 2.59 110.324 -173.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.519 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -131.75 109.05 9.88 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.351 -0.981 . . . . 1.78 108.351 170.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.567 ' HG2' ' HA ' ' A' ' 90' ' ' SER . 68.7 mtm -155.39 146.04 22.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.044 0.384 . . . . 1.3 111.733 -175.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.878 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.7 OUTLIER -109.73 164.98 12.05 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.015 -0.539 . . . . 0.14 111.467 174.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 49.4 ttp180 -155.38 113.71 3.46 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.89 -0.595 . . . . 2.72 110.68 171.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.812 ' HG ' HD13 ' A' ' 48' ' ' LEU . 7.8 mt -93.37 114.52 26.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.094 0.473 . . . . 0.9 110.762 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.607 HG23 ' HG2' ' A' ' 86' ' ' ARG . 4.0 mm -86.74 106.1 15.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.718 -0.674 . . . . 0.4 110.517 -173.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.631 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -75.58 149.44 38.46 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 119.664 -1.255 . . . . 0.48 111.246 176.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.577 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 0.1 OUTLIER -60.4 134.91 57.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.258 0.529 . . . . 1.15 110.087 178.175 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.47 ' HB ' ' CA ' ' A' ' 84' ' ' PRO . 9.4 p -87.72 155.22 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.126 0.489 . . . . 0.69 110.62 176.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.459 ' OD2' ' HB3' ' A' ' 72' ' ' ARG . 2.3 p-10 -92.01 77.46 5.38 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.816 -0.629 . . . . 2.56 111.019 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -88.01 -44.27 11.11 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.674 -0.694 . . . . 3.79 111.185 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 p -64.57 -37.45 87.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.597 -0.729 . . . . 3.05 110.569 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.498 ' HD3' ' H ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -107.47 81.89 1.59 Allowed 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.782 -0.822 . . . . 5.48 108.782 174.522 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -51.36 127.56 20.1 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.339 0.59 . . . . 4.42 111.349 -174.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -75.68 171.24 14.68 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.383 -0.969 . . . . 4.27 108.383 177.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.466 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -136.75 162.5 33.01 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 117.961 0.346 . . . . 5.09 110.608 -175.369 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -91.62 -165.94 1.46 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.63 -0.428 . . . . 4.98 109.947 -175.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -61.84 -22.69 65.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.963 0.347 . . . . 6.68 111.88 -174.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -99.89 2.18 43.52 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.593 0.711 . . . . 7.13 110.101 -178.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 73' ' ' LYS . . . 78.69 37.55 26.33 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 114.705 -1.134 . . . . 5.53 111.872 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -74.57 -99.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.126 0.488 . . . . 5.62 110.818 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 13.6 pt-20 177.01 119.32 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.084 -0.962 . . . . 5.0 109.708 177.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.462 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.9 t -121.52 148.55 24.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.196 -0.668 . . . . 3.33 109.196 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.8 p -112.27 96.11 33.76 Favored Pre-proline 0 C--N 1.311 -1.097 0 CA-C-O 122.119 0.961 . . . . 2.77 109.401 172.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.524 ' HG3' ' NE ' ' A' ' 72' ' ' ARG . 73.5 Cg_endo -73.77 164.72 34.03 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.368 2.712 . . . . 1.78 113.798 -174.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.96 140.94 29.24 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.064 -0.971 . . . . 3.11 108.459 169.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.47 ' CA ' ' HB ' ' A' ' 66' ' ' VAL . 36.5 Cg_exo -53.11 129.83 35.25 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.193 1.929 . . . . 0.67 112.134 -178.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.58 112.49 11.98 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 122.483 1.135 . . . . 1.78 108.838 179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.607 ' HG2' HG23 ' A' ' 63' ' ' ILE . 27.1 mtt85 -108.61 150.8 27.0 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.285 -1.325 . . . . 2.29 109.658 -176.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -109.15 110.41 21.63 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.865 -0.791 . . . . 0.5 108.865 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.553 ' HE3' ' HD3' ' A' ' 61' ' ' ARG . 52.8 ttm -111.44 120.89 43.67 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.698 -0.228 . . . . 0.42 110.669 -174.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.628 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -114.62 141.1 48.23 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 108.77 -0.826 . . . . 1.33 108.77 177.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.567 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 65.0 m -95.63 124.76 39.81 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.677 -0.49 . . . . 0.94 109.677 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.878 ' CE1' ' HB2' ' A' ' 60' ' ' LEU . 3.1 m-85 -107.41 167.29 10.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.302 -0.408 . . . . 1.33 109.994 -176.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -115.64 -2.3 12.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.95 0.405 . . . . 1.53 110.776 -173.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -145.2 129.29 17.56 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.18 0.514 . . . . 0.83 110.247 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 98' ' ' ASP . 6.7 tpt180 -65.1 -30.6 71.55 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.202 -0.908 . . . . 2.16 110.753 -177.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.51 ' O ' ' HB3' ' A' ' 98' ' ' ASP . 32.4 m -69.34 -47.59 63.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.21 0.529 . . . . 0.4 110.332 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.821 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 82.8 t -60.06 -53.18 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 CA-C-N 115.584 -0.735 . . . . 0.29 111.404 177.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.519 ' HG2' ' HB3' ' A' ' 58' ' ' MET . 0.0 OUTLIER -63.56 -24.45 67.81 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.906 -0.718 . . . . 0.29 109.582 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.51 ' HB3' ' O ' ' A' ' 95' ' ' THR . 33.0 t70 -69.92 -42.66 73.04 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.399 0.619 . . . . 0.39 109.522 175.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.821 ' ND2' ' HA ' ' A' ' 96' ' ' VAL . 21.5 p30 -80.56 -31.66 36.85 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.752 -1.113 . . . . 1.55 110.282 -173.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.587 HG23 HD11 ' A' ' 18' ' ' ILE . 27.3 mm -67.1 -52.46 43.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.483 -0.781 . . . . 0.13 110.219 171.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.767 ' HA ' HD21 ' A' ' 48' ' ' LEU . 4.2 ttpp -55.2 -51.18 67.39 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.986 -0.552 . . . . 1.11 110.641 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 5.1 ppp? -63.33 -27.64 69.46 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 120.668 0.271 . . . . 1.17 111.012 -175.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.9 m -65.31 -49.82 68.02 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.279 0.561 . . . . 0.15 109.933 175.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.919 ' HB2' HD22 ' A' ' 48' ' ' LEU . 9.2 mt -71.17 -57.6 4.35 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 115.193 -0.912 . . . . 0.13 111.19 -176.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.999 ' HG2' HD23 ' A' ' 48' ' ' LEU . 23.4 mm-40 -42.22 -35.49 0.97 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.174 0.805 . . . . 1.45 113.174 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -65.92 -44.85 83.97 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.728 0.775 . . . . 0.65 108.961 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.666 HG21 ' HB3' ' A' ' 25' ' ' ALA . 72.0 mt -65.68 -43.37 93.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 113.891 -1.504 . . . . 0.17 110.954 177.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.618 HG22 ' HD2' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -61.6 -57.07 13.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.663 -0.699 . . . . 0.29 110.661 -176.191 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 11.8 m -54.49 -29.9 51.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.972 -0.558 . . . . 1.22 110.829 174.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 58.1 mtt180 -71.65 -29.62 64.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.712 -0.676 . . . . 3.79 110.832 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.47 ' OH ' ' HA ' ' A' ' 24' ' ' PRO . 14.5 m-85 -93.29 -23.04 18.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.859 -0.609 . . . . 0.6 111.435 -177.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.618 ' HD2' HG22 ' A' ' 108' ' ' ILE . 16.7 mtpp -79.01 -25.02 43.31 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.473 -0.566 . . . . 1.76 109.473 174.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.92 -18.18 64.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.149 -0.932 . . . . 1.56 109.883 171.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -115.72 22.19 13.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.318 -0.855 . . . . 1.09 110.327 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 111' ' ' TYR . 9.7 t70 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.537 -0.744 . . . . 2.16 109.858 -177.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.699 0 N-CA-C 111.854 -0.498 . . . . 25.39 111.854 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 149.62 -42.68 0.79 Allowed Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 111.465 -0.654 . . . . 24.6 111.465 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -127.12 -39.81 0.36 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.996 -0.621 . . . . 23.97 111.926 177.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -118.58 152.11 17.53 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.866 -0.683 . . . . 23.13 112.14 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -100.04 -13.39 19.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.927 0.394 . . . . 24.92 110.802 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -80.79 90.0 5.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.997 -0.547 . . . . 21.4 110.63 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 35.6 m 40.09 45.71 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 O-C-N 124.445 1.091 . . . . 20.37 113.03 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . 0.412 ' HA ' ' OE1' ' B' ' 251' ' ' GLU . 41.4 tt0 -93.14 114.1 26.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.057 0.456 . . . . 17.68 109.884 175.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 47.5 ttm -145.54 5.18 1.05 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.345 -0.843 . . . . 16.8 109.64 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . 0.412 ' OE1' ' HA ' ' B' ' 249' ' ' GLU . 3.7 pm0 -68.12 134.6 50.83 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.649 -0.705 . . . . 13.35 111.264 -176.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . 0.528 ' HB3' ' O ' ' A' ' 54' ' ' SER . 24.6 m -75.39 -17.42 60.21 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.269 -0.878 . . . . 10.66 111.846 -173.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -58.13 -33.61 69.36 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.992 0.425 . . . . 11.03 111.191 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -76.1 -20.52 57.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.03 -0.532 . . . . 10.94 111.631 -175.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -76.75 -10.79 59.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.214 -0.448 . . . . 9.82 111.748 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 256' ' ' SER . . . . . 0.454 ' HA ' ' HA3' ' B' ' 260' ' ' GLY . 45.4 m -138.39 92.18 2.62 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.315 -0.402 . . . . 5.35 110.69 177.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -79.41 -70.91 0.48 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.566 -0.531 . . . . 6.2 109.566 -179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -90.49 -61.17 1.74 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.767 0.794 . . . . 6.14 109.36 171.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.57 ' CG ' ' H ' ' B' ' 260' ' ' GLY . 7.0 p-10 -113.47 -89.17 0.54 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.19 -1.368 . . . . 3.32 110.452 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . 0.57 ' H ' ' CG ' ' B' ' 259' ' ' ASP . . . 86.79 45.59 5.4 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.096 -0.573 . . . . 0.84 114.056 171.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 261' ' ' PHE . . . . . 0.539 ' CE1' ' HB2' ' A' ' 59' ' ' MET . 3.3 m-85 -95.55 169.85 9.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.945 0.402 . . . . 0.95 110.429 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 4.7 p -133.66 163.65 36.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.962 -0.755 . . . . 1.37 108.962 175.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.73 138.51 40.26 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.476 -0.564 . . . . 2.24 109.476 173.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.406 ' O ' HG13 ' B' ' 264' ' ' VAL . 6.5 p -69.12 103.87 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.756 0.789 . . . . 1.41 110.078 -177.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 29.5 t70 . . . . . 0 C--O 1.248 0.974 0 CA-C-N 115.38 -0.827 . . . . 3.04 110.39 -175.928 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 N--CA 1.477 0.536 0 N-CA-C 109.867 -0.859 . . . . 3.14 109.867 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.5 p -169.6 -50.72 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.361 0.6 . . . . 1.4 110.027 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.601 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 39.4 m80 -92.68 13.54 19.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.901 -0.59 . . . . 1.85 111.352 -175.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.8 m -161.02 148.22 15.28 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.684 0.278 . . . . 0.95 110.511 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.81 147.6 7.18 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 110.409 -1.077 . . . . 0.16 110.409 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.718 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -81.06 119.97 24.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 117.935 0.868 . . . . 0.43 111.448 -175.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -127.9 160.35 32.1 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.541 0.686 . . . . 0.13 112.016 -176.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 90' ' ' SER . 2.6 mp -100.85 126.9 54.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.179 -0.918 . . . . 0.29 109.392 177.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.413 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 84.5 t80 -126.12 112.09 15.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.067 -0.515 . . . . 0.56 110.286 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 59.99 47.36 9.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.565 0.698 . . . . 1.46 110.903 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt 74.85 0.61 3.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.317 -1.31 . . . . 1.91 113.288 171.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -106.04 132.4 53.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.372 -0.531 . . . . 0.47 110.695 171.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.521 ' HA ' HG13 ' A' ' 8' ' ' ILE . 47.5 t -79.85 129.98 34.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.635 -0.711 . . . . 1.02 110.639 178.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.679 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -151.63 -153.26 6.15 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.797 -0.638 . . . . 0.16 112.036 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.718 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 7.5 mm -128.27 153.47 37.72 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.7 0 CA-C-O 120.948 0.404 . . . . 0.19 110.76 -177.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.469 HD11 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -122.61 134.6 65.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 115.911 -0.586 . . . . 0.16 109.628 179.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.58 109.26 7.04 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.52 -0.309 . . . . 0.12 111.7 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.674 HD11 HG23 ' A' ' 100' ' ' ILE . 3.7 mp -85.69 126.43 40.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.494 -0.928 . . . . 0.18 108.494 171.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.767 HD21 ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -126.96 129.37 47.99 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.38 -0.528 . . . . 1.12 109.752 178.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -113.34 84.26 1.98 Allowed 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 117.353 -1.739 . . . . 0.74 107.694 164.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.43 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 20.5 t70 -122.25 -12.01 8.32 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 106.468 -1.678 . . . . 0.59 106.468 157.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.767 ' HB ' HD21 ' A' ' 19' ' ' ASN . 11.1 p -102.18 173.9 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 111.792 -2.458 . . . . 0.35 112.745 -154.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.732 ' O ' HG13 ' A' ' 22' ' ' VAL . 5.5 m -54.72 166.7 0.71 Allowed Pre-proline 0 C--O 1.221 -0.415 0 N-CA-C 106.689 -1.597 . . . . 1.31 106.689 165.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 11.0 Cg_endo -42.06 127.99 4.03 Favored 'Trans proline' 0 C--N 1.355 0.908 0 CA-C-N 122.036 1.763 . . . . 0.22 111.203 -151.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.784 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -33.47 137.61 0.08 Allowed 'General case' 0 CA--C 1.506 -0.715 0 O-C-N 125.379 1.674 . . . . 0.2 113.833 -155.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.568 ' HB2' HG11 ' A' ' 22' ' ' VAL . 30.6 mt-10 -121.35 131.05 53.97 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 114.933 -1.03 . . . . 1.26 111.055 -169.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.561 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.7 tt -101.02 140.4 35.37 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 106.215 -1.772 . . . . 0.15 106.215 171.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.436 ' N ' HD23 ' A' ' 27' ' ' LEU . 19.4 m -131.22 108.83 9.98 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.677 -0.809 . . . . 0.21 110.441 -178.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.616 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 89.6 t90 -85.56 107.78 17.65 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.383 -0.826 . . . . 0.24 109.323 176.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -113.46 114.77 27.03 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.788 -1.097 . . . . 0.87 108.414 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.591 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 37.3 p -56.48 143.96 33.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.963 0.411 . . . . 0.75 110.268 -177.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.679 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 19.8 m -53.0 -33.2 50.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.145 -0.934 . . . . 0.39 111.432 -177.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -80.68 -27.84 36.93 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.125 -0.489 . . . . 2.33 111.233 177.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.04 0.34 57.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.098 -0.572 . . . . 0.55 112.234 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -64.37 -48.18 76.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.104 0.478 . . . . 1.13 111.516 -177.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.5 mttp -117.59 148.72 41.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.803 -0.635 . . . . 2.03 111.706 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 89.6 t -145.22 125.41 6.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.486 -1.234 . . . . 0.55 109.808 178.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -133.08 115.51 15.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.479 -0.328 . . . . 0.69 110.717 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 24.2 m -98.44 139.63 33.9 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.928 -0.309 . . . . 0.3 111.403 -178.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 23.3 t -112.12 129.46 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 122.878 0.471 . . . . 0.66 111.127 176.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.546 ' O ' HG12 ' A' ' 45' ' ' ILE . 48.4 t -91.6 108.77 20.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 CA-C-O 121.293 0.568 . . . . 0.18 109.565 173.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.634 HD11 ' CD2' ' A' ' 104' ' ' LEU . 2.1 mm? -53.95 -25.72 22.05 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.127 -0.942 . . . . 0.12 113.03 -178.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 64.6 m -79.78 -31.42 40.85 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.521 -0.471 . . . . 1.06 111.689 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.8 p -76.88 -8.74 57.9 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.178 -0.675 . . . . 0.2 109.178 173.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.592 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 47.3 mm -86.45 121.56 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 115.044 -0.98 . . . . 0.23 111.552 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.672 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 23.0 t70 -80.08 -43.31 22.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.621 -0.718 . . . . 0.7 110.991 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -140.51 157.12 45.98 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 109.986 -0.376 . . . . 1.95 109.986 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.01 HD23 ' HG3' ' A' ' 105' ' ' GLN . 12.2 tp -118.74 144.73 46.07 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.271 -0.64 . . . . 0.14 109.271 166.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 12.3 mm100 -122.88 151.91 41.27 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.066 -0.97 . . . . 1.49 109.317 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.05 146.3 10.72 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.51 -0.768 . . . . 0.25 109.132 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.496 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 54.6 p -60.58 126.12 84.13 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-O 121.548 0.69 . . . . 0.37 111.073 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.484 ' O ' ' HB3' ' A' ' 55' ' ' SER . 57.8 Cg_endo -67.46 166.49 23.55 Favored 'Trans proline' 0 C--N 1.333 -0.276 0 C-N-CA 123.984 3.123 . . . . 0.64 111.627 177.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.64 -21.88 66.02 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.928 0.394 . . . . 1.02 110.67 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 t -78.76 -19.74 51.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 1.58 110.545 177.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.484 ' HB3' ' O ' ' A' ' 52' ' ' PRO . 27.9 t -67.85 145.56 54.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.889 -0.596 . . . . 0.71 110.452 176.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -89.82 -13.82 35.75 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.4 0.619 . . . . 2.89 110.145 175.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -106.48 173.57 6.26 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.135 -0.939 . . . . 2.59 110.053 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.511 ' HB3' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -130.46 112.18 12.98 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.644 -0.707 . . . . 1.78 109.555 175.581 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.62 ' HB3' ' CZ ' ' B' ' 261' ' ' PHE . 2.5 mtm -156.03 148.28 23.49 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.838 0.351 . . . . 1.3 111.691 -176.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.33 154.96 30.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.519 -0.764 . . . . 0.14 110.428 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 21.3 ttm180 -151.11 113.88 4.7 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 120.931 0.396 . . . . 2.72 110.823 171.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.76 ' HG ' HD13 ' A' ' 48' ' ' LEU . 9.1 mt -92.56 112.6 24.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.112 0.482 . . . . 0.9 110.509 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.69 HG23 ' HG2' ' A' ' 86' ' ' ARG . 6.3 mm -87.05 111.75 22.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 C-N-CA 123.464 0.705 . . . . 0.4 110.513 -172.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.592 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -79.0 150.36 33.92 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 120.254 -0.974 . . . . 0.48 111.864 177.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.672 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 1.1 mptm? -63.74 132.19 50.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.012 0.406 . . . . 1.15 110.763 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.0 p -90.2 157.84 2.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.19 -0.67 . . . . 0.69 109.19 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.427 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 5.6 p-10 -81.82 81.47 7.82 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.809 0.814 . . . . 2.56 110.816 -177.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -69.57 -18.81 63.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.774 -1.103 . . . . 3.79 111.08 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.8 p -61.08 -34.93 75.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.703 -0.681 . . . . 3.05 111.682 -178.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.464 ' N ' ' HD3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -133.12 123.21 25.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.006 0.431 . . . . 5.48 110.853 178.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -79.59 136.82 36.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.185 -0.461 . . . . 4.42 110.597 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 5.6 ptm180 -73.43 171.24 13.5 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.512 -0.921 . . . . 4.27 108.512 175.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.428 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -135.79 155.34 50.51 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.907 -0.405 . . . . 5.09 109.907 -177.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -88.37 -163.24 0.93 Allowed 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.385 -0.526 . . . . 4.98 110.387 -174.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -64.5 -22.43 66.96 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.176 0.435 . . . . 6.68 112.176 -174.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.434 ' HB2' ' ND2' ' A' ' 78' ' ' ASN . 61.5 mm-40 -96.61 -2.16 45.42 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.64 0.733 . . . . 7.13 109.998 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.428 ' HA2' ' HB2' ' A' ' 73' ' ' LYS . . . 78.8 43.72 11.16 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.614 -1.175 . . . . 5.53 111.183 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.434 ' ND2' ' HB2' ' A' ' 76' ' ' GLU . 66.7 m-80 -81.25 -102.44 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 120.938 0.399 . . . . 5.62 110.444 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.556 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 10.9 pt-20 177.79 118.12 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.217 -0.902 . . . . 5.0 110.207 177.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.517 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.4 t -120.54 148.87 23.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.817 -0.809 . . . . 3.33 108.817 176.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.42 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 5.8 p -105.07 99.72 21.01 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-O 121.839 0.828 . . . . 2.77 109.627 171.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 81' ' ' VAL . 37.0 Cg_endo -67.01 133.96 32.75 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.94 2.427 . . . . 1.78 112.442 -178.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.469 ' HD2' ' CZ ' ' A' ' 86' ' ' ARG . 16.5 ttpt -62.72 134.97 95.58 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.656 -0.702 . . . . 3.11 110.056 174.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.469 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 52.3 Cg_exo -50.93 150.47 12.99 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.672 2.915 . . . . 0.67 113.06 -178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.99 115.3 16.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.775 0.798 . . . . 1.78 109.761 176.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.69 ' HG2' HG23 ' A' ' 63' ' ' ILE . 37.7 mtm180 -116.71 140.32 49.55 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.48 -0.782 . . . . 2.29 110.285 -173.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -103.1 111.23 23.48 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.552 -0.749 . . . . 0.5 109.155 -177.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.523 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 43.4 ttm -102.78 132.41 48.96 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.716 0.293 . . . . 0.42 110.754 -176.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.469 ' CG ' HD11 ' A' ' 16' ' ' ILE . 95.4 m-85 -127.16 123.72 37.39 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.526 -0.546 . . . . 1.33 109.526 177.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.535 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 50.1 m -91.78 130.85 37.49 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.831 0.348 . . . . 0.94 110.556 -177.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.619 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 30.7 m-85 -108.16 173.65 6.23 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.034 -0.53 . . . . 1.33 110.156 176.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -117.43 -3.06 11.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.017 -0.538 . . . . 1.53 109.6 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.556 ' OD1' ' HB ' ' A' ' 95' ' ' THR . 28.6 t-20 -137.51 130.62 30.61 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.595 -0.73 . . . . 0.83 110.21 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.546 ' HA ' ' HG2' ' A' ' 97' ' ' MET . 2.2 tmt_? -74.29 -24.05 59.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.866 -0.606 . . . . 2.16 110.559 -174.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.556 ' HB ' ' OD1' ' A' ' 93' ' ' ASN . 51.6 m -71.95 -48.33 45.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.96 0.409 . . . . 0.4 110.326 177.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.826 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 96.8 t -55.9 -57.12 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-N 115.956 -0.565 . . . . 0.29 111.259 174.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.625 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -58.35 -30.9 67.11 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.526 -0.87 . . . . 0.29 109.529 -179.14 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.624 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 33.5 t70 -64.8 -43.75 92.15 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.623 0.725 . . . . 0.39 110.721 175.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.826 ' ND2' ' HA ' ' A' ' 96' ' ' VAL . 20.6 p30 -76.96 -25.52 52.92 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.071 -0.968 . . . . 1.55 109.899 -173.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.674 HG23 HD11 ' A' ' 18' ' ' ILE . 28.2 mm -72.39 -55.94 11.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 114.813 -1.085 . . . . 0.13 111.196 171.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.799 ' HA ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -59.07 -39.29 81.67 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 120.768 0.318 . . . . 1.11 111.259 -177.359 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.442 ' HB3' ' HE2' ' A' ' 101' ' ' LYS . 26.6 ptm -69.85 -27.27 64.7 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.28 -0.637 . . . . 1.17 109.28 -176.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 21.7 m -67.62 -53.37 28.56 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.65 -0.705 . . . . 0.15 110.018 174.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.921 ' HB2' HD22 ' A' ' 48' ' ' LEU . 10.4 mt -65.66 -56.44 12.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.193 -0.912 . . . . 0.13 111.221 -176.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 1.01 ' HG3' HD23 ' A' ' 48' ' ' LEU . 42.8 mt-30 -51.68 -30.12 20.69 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.48 0.548 . . . . 1.45 112.48 -178.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -68.6 -26.85 65.58 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.882 0.848 . . . . 0.65 109.571 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.784 HG21 ' HB3' ' A' ' 25' ' ' ALA . 47.8 mt -82.56 -41.72 17.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.052 -1.431 . . . . 0.17 110.071 176.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.704 HG22 ' HD2' ' A' ' 112' ' ' LYS . 1.3 mt -66.98 -49.88 69.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.551 -0.75 . . . . 0.29 110.752 -176.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 48.7 m -61.34 -22.72 65.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.506 0.669 . . . . 1.22 110.063 174.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 9.7 ttt180 -72.19 -32.15 66.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.106 -0.952 . . . . 3.79 109.862 176.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -95.61 -23.0 17.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.177 -0.465 . . . . 0.6 111.654 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.704 ' HD2' HG22 ' A' ' 108' ' ' ILE . 13.0 mtpp -76.43 -21.07 56.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.357 0.599 . . . . 1.76 109.444 174.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -71.16 -19.28 62.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.299 -0.864 . . . . 1.56 109.785 173.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -114.47 22.96 13.19 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.463 -0.79 . . . . 1.09 110.982 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.2 t70 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.492 -0.766 . . . . 2.16 110.028 178.678 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.612 0 N-CA-C 112.019 -0.433 . . . . 25.39 112.019 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . 138.92 -74.5 0.39 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.759 -0.734 . . . . 24.6 112.279 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 99.56 -171.57 24.19 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.803 -0.713 . . . . 23.97 112.053 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -85.94 -24.36 41.76 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.744 -0.741 . . . . 23.13 112.451 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 63.55 18.45 11.08 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.899 0.479 . . . . 24.92 111.465 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -75.32 120.06 20.28 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.075 -0.343 . . . . 21.4 110.075 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 28.9 m 37.54 51.19 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 124.271 0.982 . . . . 20.37 111.319 -173.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -61.16 114.69 3.28 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.105 -0.952 . . . . 17.68 111.617 -173.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 94.5 mmm -145.98 21.46 1.42 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.584 -1.635 . . . . 16.8 106.584 177.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -70.28 151.07 45.71 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 113.118 -1.855 . . . . 13.35 110.899 -170.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 22.0 m -139.09 9.1 2.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.209 0.528 . . . . 10.66 110.693 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -74.45 -26.67 60.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.763 -0.653 . . . . 11.03 110.129 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -67.96 -38.37 82.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.662 -0.699 . . . . 10.94 110.07 176.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -72.9 -25.7 61.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.204 0.526 . . . . 9.82 110.388 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 256' ' ' SER . . . . . 0.404 ' HB3' ' NH1' ' A' ' 86' ' ' ARG . 37.7 m -91.79 10.79 27.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.689 -0.687 . . . . 5.35 111.198 -176.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -82.52 -59.47 2.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.034 -0.53 . . . . 6.2 111.223 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -86.44 -70.13 0.63 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.033 -0.53 . . . . 6.14 111.255 -174.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 54.73 28.3 9.98 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.196 0.522 . . . . 3.32 111.717 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 94.27 -6.38 71.87 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 120.995 -0.621 . . . . 0.84 112.656 177.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 261' ' ' PHE . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 59' ' ' MET . 2.8 m-30 -117.74 163.13 16.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.956 0.408 . . . . 0.95 110.239 -175.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 14.6 p -145.36 140.6 22.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.927 -0.579 . . . . 1.37 110.205 174.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -79.69 121.06 24.85 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.809 -0.812 . . . . 2.24 108.809 171.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.91 103.15 14.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.69 -0.686 . . . . 1.41 110.927 -171.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--O 1.247 0.946 0 CA-C-N 115.719 -0.673 . . . . 3.04 109.316 176.599 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo . . . . . 0 N--CA 1.48 0.733 0 N-CA-C 111.201 -0.346 . . . . 3.14 111.201 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.534 ' HA ' ' HB3' ' A' ' 99' ' ' ASN . 16.9 p -113.24 -65.76 1.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.116 -0.493 . . . . 1.4 110.655 178.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -94.33 18.31 11.31 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.587 0.708 . . . . 1.85 109.547 177.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.403 ' C ' HD11 ' A' ' 100' ' ' ILE . 68.1 p -163.27 148.84 11.56 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.929 -1.032 . . . . 0.95 108.883 -176.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.22 142.69 5.64 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.188 -0.765 . . . . 0.16 111.188 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.747 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -73.4 120.94 19.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 117.361 0.58 . . . . 0.43 111.237 -176.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.485 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -130.08 157.7 41.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.394 0.616 . . . . 0.13 111.852 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.529 ' HB ' ' HB3' ' A' ' 90' ' ' SER . 2.6 mp -95.93 124.47 48.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.125 -0.943 . . . . 0.29 109.07 176.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.489 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 88.8 t80 -128.69 103.44 7.08 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.164 -0.471 . . . . 0.56 109.919 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 67.24 58.41 0.55 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.792 -0.64 . . . . 1.46 110.872 -175.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp 70.13 -8.47 0.84 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.608 -1.178 . . . . 1.91 113.374 171.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -104.73 131.83 52.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.969 0.414 . . . . 0.47 111.061 177.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.492 ' HA ' HG13 ' A' ' 8' ' ' ILE . 28.7 p -79.9 125.95 30.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.707 -0.679 . . . . 1.02 110.721 176.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.649 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -144.82 -154.38 6.12 Favored Glycine 0 N--CA 1.436 -1.339 0 CA-C-N 115.711 -0.677 . . . . 0.16 111.637 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.747 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 9.2 mm -126.13 153.84 34.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 120.755 0.312 . . . . 0.19 110.68 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.28 133.72 68.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 116.102 -0.499 . . . . 0.16 109.95 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.63 113.98 10.18 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 111.899 0.333 . . . . 0.12 111.899 175.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.585 HD11 HG23 ' A' ' 100' ' ' ILE . 3.8 mp -85.38 124.39 40.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.359 -0.978 . . . . 0.18 108.359 171.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.47 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 2.3 t30 -126.62 124.31 39.61 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.949 -0.389 . . . . 1.12 109.949 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.503 ' HG2' ' CB ' ' A' ' 25' ' ' ALA . 23.7 mt-10 -109.63 84.05 1.86 Allowed 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 117.084 -1.847 . . . . 0.74 107.519 163.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.47 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 17.7 t70 -121.48 -9.86 8.93 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.476 -1.676 . . . . 0.59 106.476 156.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 23' ' ' SER . 14.7 p -101.98 173.1 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 112.045 -2.343 . . . . 0.35 111.63 -157.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.663 ' O ' HG13 ' A' ' 22' ' ' VAL . 14.5 m -54.98 166.66 0.75 Allowed Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 106.942 -1.503 . . . . 1.31 106.942 166.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 10.2 Cg_endo -40.67 127.42 2.45 Favored 'Trans proline' 0 C--N 1.357 0.997 0 CA-C-N 121.913 1.719 . . . . 0.22 111.34 -150.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.734 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -33.7 136.34 0.11 Allowed 'General case' 0 CA--C 1.503 -0.863 0 O-C-N 125.379 1.674 . . . . 0.2 113.691 -156.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.54 ' HB2' HG11 ' A' ' 22' ' ' VAL . 80.7 mt-10 -123.5 138.87 54.48 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.422 -1.263 . . . . 1.26 111.099 -169.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.572 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.1 tt -101.41 144.44 30.21 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 106.257 -1.757 . . . . 0.15 106.257 171.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.456 ' N ' HD23 ' A' ' 27' ' ' LEU . 18.1 m -129.84 109.18 10.72 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.903 -0.719 . . . . 0.21 110.002 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.606 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 89.9 t90 -86.9 105.4 17.04 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.687 -0.857 . . . . 0.24 108.687 175.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -113.49 114.84 27.1 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.844 -1.071 . . . . 0.87 108.738 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.54 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 37.5 p -56.19 148.33 18.49 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.24 0.543 . . . . 0.75 111.282 -174.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.649 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 24.0 m -55.97 -30.09 61.21 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.953 -1.021 . . . . 0.39 111.371 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -80.2 -28.54 38.64 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.024 0.44 . . . . 2.33 110.756 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.19 6.61 53.43 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.956 -0.64 . . . . 0.55 112.631 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.38 -69.72 0.6 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.367 . . . . 1.13 111.363 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -82.55 137.6 34.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.472 0.653 . . . . 2.03 111.546 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 96.0 t -140.57 120.32 12.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.397 -1.274 . . . . 0.55 109.496 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -125.89 114.12 18.11 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.438 -0.347 . . . . 0.69 110.438 -178.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.2 m -96.99 138.49 34.45 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 121.205 -0.198 . . . . 0.3 111.188 -177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 37.5 t -113.31 129.79 68.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 122.716 0.407 . . . . 0.66 111.722 178.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.553 ' O ' HG12 ' A' ' 45' ' ' ILE . 46.8 t -90.42 108.86 20.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.2 0 CA-C-O 121.286 0.565 . . . . 0.18 109.777 172.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.573 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.7 mm? -55.12 -27.04 42.34 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.312 -0.858 . . . . 0.12 112.633 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.448 ' O ' ' HE2' ' A' ' 65' ' ' LYS . 33.9 t -75.97 -35.11 59.76 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.722 -0.391 . . . . 1.06 110.799 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 80.2 p -76.99 -16.39 59.35 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.591 0.71 . . . . 0.2 109.249 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.733 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 42.2 mm -73.66 121.47 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 114.977 -1.01 . . . . 0.23 110.964 172.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.641 ' HA ' ' NZ ' ' A' ' 65' ' ' LYS . 23.0 t70 -78.61 -48.23 15.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.21 -0.45 . . . . 0.7 111.298 175.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -137.0 151.9 49.51 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 110.165 -0.309 . . . . 1.95 110.165 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.072 HD23 ' HG3' ' A' ' 105' ' ' GLN . 11.9 tp -116.07 144.9 43.5 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.118 -0.697 . . . . 0.14 109.118 166.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 8.1 mm100 -120.22 159.51 24.8 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.399 -0.819 . . . . 1.49 109.396 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' HB3' ' HG3' ' A' ' 101' ' ' LYS . . . -161.69 152.43 17.83 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.48 -0.933 . . . . 0.25 108.48 174.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.452 ' CG2' ' HE2' ' A' ' 59' ' ' MET . 33.4 p -55.4 125.49 59.41 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.476 0.655 . . . . 0.37 111.432 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 55' ' ' SER . 43.0 Cg_endo -67.39 166.88 22.12 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 124.0 3.133 . . . . 0.64 111.581 176.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.01 -22.73 67.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.027 0.441 . . . . 1.02 110.303 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.3 p -74.48 -27.7 60.69 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.558 -0.746 . . . . 1.58 110.786 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.446 ' HB3' ' HB ' ' A' ' 51' ' ' THR . 23.0 t -70.29 140.8 52.37 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.214 -0.903 . . . . 0.71 109.409 174.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -90.95 -13.63 33.09 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.788 -0.819 . . . . 2.89 108.788 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.562 ' N ' ' HD3' ' A' ' 57' ' ' LYS . 2.2 mppt? -99.21 -176.8 3.41 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.745 -1.116 . . . . 2.59 111.354 -175.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.449 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -139.87 109.22 6.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.483 . . . . 1.78 109.705 -177.082 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.661 ' HE1' ' O ' ' B' ' 254' ' ' GLU . 2.6 mpp? -155.69 167.65 29.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.934 0.397 . . . . 1.3 111.721 -175.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.644 HD23 HD11 ' A' ' 48' ' ' LEU . 0.8 OUTLIER -130.28 161.58 30.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.324 -0.853 . . . . 0.14 111.445 176.38 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.661 ' NH2' ' HB3' ' B' ' 259' ' ' ASP . 13.1 ttm180 -154.26 114.3 3.86 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.765 -0.198 . . . . 2.72 110.749 173.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.771 ' HG ' HD13 ' A' ' 48' ' ' LEU . 10.7 mt -96.65 110.3 22.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.863 0.364 . . . . 0.9 111.095 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.482 ' CD1' ' HD2' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -89.13 128.73 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.056 0.543 . . . . 0.4 110.086 -178.099 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.733 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -95.02 152.28 20.4 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.017 -1.087 . . . . 0.48 112.337 176.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.641 ' NZ ' ' HA ' ' A' ' 46' ' ' ASP . 1.2 mptp? -58.33 134.48 56.62 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.755 0.312 . . . . 1.15 110.627 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.8 p -90.44 154.83 3.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.184 0.516 . . . . 0.69 110.306 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.495 ' HB2' ' HB2' ' A' ' 70' ' ' LYS . 4.1 p-10 -86.67 84.41 7.39 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.481 -0.781 . . . . 2.56 110.754 -177.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -66.24 -43.78 85.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.149 -0.932 . . . . 3.79 111.972 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.7 p -76.47 -35.11 58.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.507 -0.315 . . . . 3.05 111.584 -176.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 67' ' ' ASP . 3.2 mptp? -83.11 55.42 3.11 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.755 -0.461 . . . . 5.48 109.755 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -51.28 126.2 16.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.691 -0.686 . . . . 4.42 111.336 -174.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.582 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 0.5 OUTLIER -74.33 171.12 14.25 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.382 -0.97 . . . . 4.27 108.382 177.109 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.523 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -147.13 134.29 20.49 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.241 0.543 . . . . 5.09 111.069 -174.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.417 ' HB3' ' ND2' ' A' ' 78' ' ' ASN . 17.9 t70 -78.33 -174.28 3.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.282 -0.872 . . . . 4.98 109.265 -178.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.403 ' H ' ' CG ' ' A' ' 74' ' ' ASP . 23.7 t-20 -52.14 -28.47 18.07 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.929 1.085 . . . . 6.68 113.929 -166.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -106.28 9.11 32.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.56 0.695 . . . . 7.13 110.67 -175.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.523 ' HA2' ' HB2' ' A' ' 73' ' ' LYS . . . 77.85 29.4 54.71 Favored Glycine 0 C--N 1.314 -0.65 0 CA-C-N 115.046 -0.979 . . . . 5.53 110.959 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 79' ' ' GLU . 23.5 m-80 -53.63 -41.56 66.84 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.702 0.801 . . . . 5.62 111.92 -178.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.582 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 48.5 mt-10 84.13 106.04 0.05 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 114.444 -1.253 . . . . 5.0 110.717 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.2 t -117.29 148.57 19.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.84 -1.073 . . . . 3.33 109.474 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 81' ' ' VAL . 7.5 p -108.59 99.04 31.5 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-O 121.788 0.804 . . . . 2.77 109.519 172.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.447 ' HD3' ' HG2' ' A' ' 72' ' ' ARG . 44.1 Cg_endo -68.62 162.73 39.77 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 123.3 2.667 . . . . 1.78 113.201 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.433 ' HG3' ' HD2' ' A' ' 84' ' ' PRO . 20.3 ttmt -79.18 141.24 57.68 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.532 -0.758 . . . . 3.11 110.357 176.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.486 ' HB3' ' O ' ' A' ' 64' ' ' GLY . 31.3 Cg_exo -52.83 141.11 56.26 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.185 2.59 . . . . 0.67 112.449 178.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.446 HE21 ' HB2' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -77.02 130.04 36.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.287 0.565 . . . . 1.78 110.385 178.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.81 160.17 26.57 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.794 -0.639 . . . . 2.29 111.017 -174.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -125.08 113.0 17.16 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.282 -0.872 . . . . 0.5 109.406 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 55.8 ttm -105.15 126.08 51.68 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.835 0.35 . . . . 0.42 111.447 -175.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.452 ' CE2' HD12 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -118.97 124.59 47.39 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.563 -0.532 . . . . 1.33 109.563 178.181 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.529 ' HB3' ' HB ' ' A' ' 8' ' ' ILE . 33.3 t -93.06 130.72 38.57 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.849 0.357 . . . . 0.94 110.226 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.603 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 27.2 m-85 -108.53 172.7 6.69 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.824 -0.625 . . . . 1.33 111.417 176.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -119.95 -4.72 10.11 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.364 -0.834 . . . . 1.53 110.465 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -134.63 129.27 34.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.95 0.405 . . . . 0.83 110.338 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 14.9 tpt180 -59.62 -32.94 70.89 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.398 -0.819 . . . . 2.16 111.188 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.529 HG22 HD21 ' A' ' 99' ' ' ASN . 87.3 m -70.42 -58.7 3.44 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.419 -0.355 . . . . 0.4 110.545 -177.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.4 t -45.72 -56.04 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 CA-C-N 115.695 -0.684 . . . . 0.29 111.85 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.525 ' O ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -64.7 -28.59 69.7 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 116.256 -0.429 . . . . 0.29 110.966 -176.408 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -73.32 -30.04 63.09 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.037 -0.727 . . . . 0.39 109.037 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.619 ' O ' ' HG3' ' A' ' 102' ' ' MET . 91.6 m-20 -77.5 -48.05 18.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.666 -1.152 . . . . 1.55 109.842 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.603 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 36.4 mm -57.9 -49.16 82.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.248 -0.887 . . . . 0.13 110.153 176.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.797 ' HA ' HD21 ' A' ' 48' ' ' LEU . 2.3 tmmm? -57.0 -48.53 78.25 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.814 -0.63 . . . . 1.11 110.887 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.619 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 5.0 ppp? -70.08 -24.65 63.26 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.78 0.324 . . . . 1.17 110.506 -175.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 53.9 m -67.79 -50.79 55.02 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.491 0.662 . . . . 0.15 109.891 176.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.927 ' HB2' HD22 ' A' ' 48' ' ' LEU . 12.6 mt -69.85 -58.17 4.2 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.963 -1.017 . . . . 0.13 111.326 -175.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 1.072 ' HG3' HD23 ' A' ' 48' ' ' LEU . 49.4 mt-30 -53.45 -24.03 11.67 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.804 0.668 . . . . 1.45 112.804 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -65.69 -48.91 70.45 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.637 -0.875 . . . . 0.65 108.637 175.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.734 HG21 ' HB3' ' A' ' 25' ' ' ALA . 60.1 mt -58.53 -43.8 87.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.2 -1.364 . . . . 0.17 110.811 175.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.5 mt -65.03 -51.21 69.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.596 -0.729 . . . . 0.29 110.184 -177.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.442 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 16.7 m -55.18 -33.31 62.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.15 0.5 . . . . 1.22 110.605 172.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' A' ' 107' ' ' ILE . 91.2 mtt180 -67.19 -30.24 70.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.588 -0.733 . . . . 3.79 110.602 178.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -94.18 -13.45 26.66 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.124 -0.489 . . . . 0.6 111.357 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.446 ' HD2' HG22 ' A' ' 108' ' ' ILE . 9.1 mtpp -84.36 -22.92 30.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.097 0.475 . . . . 1.76 109.947 173.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -70.65 -22.42 62.5 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.588 0.709 . . . . 1.56 109.382 170.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -109.89 26.69 10.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.134 -0.939 . . . . 1.09 110.22 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.3 t70 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.516 -0.754 . . . . 2.16 110.382 -178.079 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 111.842 -0.503 . . . . 25.39 111.842 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -135.52 23.9 3.4 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.643 -0.789 . . . . 24.6 112.065 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -80.75 63.48 4.24 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.132 -0.556 . . . . 23.97 112.405 -178.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . -144.17 57.26 0.54 Allowed Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.639 -0.584 . . . . 23.13 111.639 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -85.57 157.25 20.44 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.797 -0.446 . . . . 24.92 109.797 -178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -119.64 120.04 35.5 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.796 -0.446 . . . . 21.4 109.796 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 7.8 m -75.72 78.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.748 0.785 . . . . 20.37 110.463 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -59.74 121.67 12.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.231 -0.895 . . . . 17.68 110.764 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 19.8 ptp -134.95 28.91 3.48 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.789 -0.641 . . . . 16.8 109.903 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -74.57 140.93 44.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.361 -0.836 . . . . 13.35 110.286 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' B' ' 255' ' ' GLU . 67.7 m -83.93 52.01 2.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.892 -0.595 . . . . 10.66 111.26 -176.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -71.0 -43.04 68.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.22 0.533 . . . . 11.03 110.228 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . 0.661 ' O ' ' HE1' ' A' ' 59' ' ' MET . 0.0 OUTLIER -77.2 -35.83 55.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.636 -0.711 . . . . 10.94 110.056 -177.167 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 255' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' B' ' 252' ' ' SER . 46.6 mt-10 -60.72 -21.64 63.14 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.115 -0.493 . . . . 9.82 111.686 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 256' ' ' SER . . . . . . . . . . . . . 35.2 t 73.81 139.3 0.06 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.682 0.753 . . . . 5.35 111.779 175.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -89.29 -11.29 43.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.471 -0.786 . . . . 6.2 109.452 176.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' B' ' 259' ' ' ASP . 26.2 t70 -85.83 -1.56 57.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.122 -0.945 . . . . 6.14 109.874 175.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.661 ' HB3' ' NH2' ' A' ' 61' ' ' ARG . 5.6 m-20 77.83 -41.92 0.35 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.021 -0.991 . . . . 3.32 109.907 -175.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 67.37 23.23 73.38 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 116.613 1.405 . . . . 0.84 116.613 158.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 261' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 61' ' ' ARG . 7.1 m-30 -124.73 160.13 29.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.879 1.339 . . . . 0.95 110.856 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.08 160.6 29.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.301 -1.0 . . . . 1.37 108.301 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 263' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.71 120.31 39.9 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.082 -0.647 . . . . 2.24 109.977 177.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 24.8 t -108.76 109.51 28.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.816 -0.629 . . . . 1.41 111.354 -172.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.574 -0.727 . . . . 3.04 109.283 174.614 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo . . . . . 0 C--O 1.232 0.209 0 N-CA-C 111.565 -0.206 . . . . 3.14 111.565 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.2 m 72.72 -35.12 0.32 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.684 0.794 . . . . 1.4 113.1 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.615 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 19.9 m170 -85.62 22.35 1.62 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.618 0.247 . . . . 1.85 111.417 -175.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 88.6 p -164.42 159.31 19.41 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.072 -0.344 . . . . 0.95 110.072 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.36 144.71 4.23 Favored Glycine 0 C--O 1.225 -0.456 0 N-CA-C 110.886 -0.886 . . . . 0.16 110.886 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.745 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -76.56 120.71 22.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.618 0.709 . . . . 0.43 111.124 -177.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.47 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -130.05 159.27 37.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.307 0.575 . . . . 0.13 111.725 -176.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.506 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.3 mp -97.28 118.14 43.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.216 -0.902 . . . . 0.29 109.115 175.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.598 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 82.8 t80 -123.35 110.03 14.65 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.379 -0.373 . . . . 0.56 109.997 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.588 ' C ' ' HD2' ' A' ' 11' ' ' LYS . 41.1 mt-10 68.74 50.37 0.65 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.488 -0.778 . . . . 1.46 110.702 -175.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.588 ' HD2' ' C ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER 66.49 3.9 3.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.31 -1.314 . . . . 1.91 112.791 171.515 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.497 HG21 ' HD2' ' A' ' 36' ' ' LYS . 0.7 OUTLIER -110.81 133.76 55.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.797 0.332 . . . . 0.47 110.293 172.118 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.506 ' HA ' HG13 ' A' ' 8' ' ' ILE . 31.8 t -78.17 133.25 37.82 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.325 0.583 . . . . 1.02 110.57 178.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.646 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -154.33 -152.95 6.26 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.486 -0.779 . . . . 0.16 111.683 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.745 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.3 mm -126.66 154.02 36.03 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-O 120.795 0.331 . . . . 0.19 110.646 -178.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.473 HD11 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -127.02 135.15 64.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 116.011 -0.541 . . . . 0.16 109.833 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.81 113.28 9.47 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.015 0.436 . . . . 0.12 112.031 174.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.759 HD11 HG23 ' A' ' 100' ' ' ILE . 4.3 mp -84.56 113.18 22.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.74 -0.837 . . . . 0.18 108.74 171.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.452 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 1.8 t30 -118.16 123.98 46.86 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 110.135 -0.321 . . . . 1.12 110.135 -178.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.468 ' HG2' ' HB2' ' A' ' 25' ' ' ALA . 22.3 mt-10 -107.69 83.35 1.79 Allowed 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 117.191 -1.804 . . . . 0.74 107.383 165.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.452 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 18.1 t70 -122.21 -11.78 8.37 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.782 -1.562 . . . . 0.59 106.782 157.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.671 HG13 ' O ' ' A' ' 23' ' ' SER . 14.8 p -101.68 179.86 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 111.887 -2.415 . . . . 0.35 111.737 -155.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.671 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -53.04 165.2 0.62 Allowed Pre-proline 0 C--O 1.224 -0.263 0 N-CA-C 107.699 -1.223 . . . . 1.31 107.699 166.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.569 ' HD2' ' HB2' ' A' ' 23' ' ' SER . 15.4 Cg_endo -44.49 126.39 6.83 Favored 'Trans proline' 0 C--N 1.353 0.813 0 CA-C-N 121.366 1.523 . . . . 0.22 111.852 -154.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.749 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -23.69 134.27 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 O-C-N 125.127 1.517 . . . . 0.2 114.882 -153.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.665 ' HB2' HG11 ' A' ' 22' ' ' VAL . 37.9 mt-10 -126.26 137.36 53.51 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.697 -1.138 . . . . 1.26 111.034 -173.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.2 tt -99.99 145.27 28.07 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 106.47 -1.678 . . . . 0.15 106.47 175.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.504 ' N ' HD23 ' A' ' 27' ' ' LEU . 19.2 m -131.96 109.3 9.96 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.891 -0.724 . . . . 0.21 110.392 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.601 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 90.2 t90 -89.25 108.16 19.46 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.574 -0.739 . . . . 0.24 109.143 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -115.89 120.26 38.65 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.252 -0.885 . . . . 0.87 109.091 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.509 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 35.5 p -56.01 148.17 18.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.891 0.377 . . . . 0.75 110.892 -175.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.646 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 21.7 m -54.26 -32.96 57.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.431 -0.804 . . . . 0.39 110.949 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -77.54 -29.66 52.42 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.244 -0.434 . . . . 2.33 111.113 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.07 13.66 51.84 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.736 -0.745 . . . . 0.55 113.042 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -85.84 -69.04 0.69 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.159 0.504 . . . . 1.13 110.336 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.497 ' HD2' HG21 ' A' ' 12' ' ' VAL . 17.0 ptpt -87.49 145.09 26.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.624 0.726 . . . . 2.03 110.371 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 65.7 t -147.17 140.51 19.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.487 -1.233 . . . . 0.55 109.041 -176.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 6.4 t60 -141.21 122.67 15.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.571 0.224 . . . . 0.69 110.595 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.0 m -103.85 142.66 34.0 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 121.256 -0.177 . . . . 0.3 111.09 -177.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.533 HG11 HD13 ' A' ' 62' ' ' LEU . 45.8 t -119.42 130.02 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.187 0.44 . . . . 0.66 112.187 178.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.555 ' O ' HG12 ' A' ' 45' ' ' ILE . 49.9 t -91.13 108.88 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 CA-C-O 121.499 0.666 . . . . 0.18 109.935 172.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.605 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.3 mm? -49.95 -35.46 24.23 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.512 -1.222 . . . . 0.12 112.463 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.523 ' OG ' ' HB2' ' A' ' 24' ' ' PRO . 69.4 m -74.9 -29.91 61.13 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.866 -0.333 . . . . 1.06 111.576 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.477 ' OG1' ' HB ' ' A' ' 41' ' ' VAL . 76.1 p -79.97 -8.58 59.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.499 0.666 . . . . 0.2 109.766 175.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.61 ' HA ' ' HA2' ' A' ' 64' ' ' GLY . 39.3 mm -82.38 132.58 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.061 -0.972 . . . . 0.23 111.219 174.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.66 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 12.0 t70 -82.82 -41.1 19.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.354 -0.839 . . . . 0.7 110.911 175.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.515 ' O ' HG12 ' A' ' 63' ' ' ILE . 45.9 mmtt -145.47 143.02 29.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.374 -0.83 . . . . 1.95 110.658 -173.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.149 HD23 ' HG3' ' A' ' 105' ' ' GLN . 13.6 tp -111.27 139.62 46.51 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.659 -0.817 . . . . 0.14 109.45 163.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.643 ' HB3' ' HB2' ' B' ' 261' ' ' PHE . 15.6 mm100 -118.27 155.77 30.01 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.425 -1.262 . . . . 1.49 110.001 -178.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 59' ' ' MET . . . -163.01 143.73 9.47 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.878 -1.056 . . . . 0.25 108.546 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 47.3 p -54.49 126.18 54.83 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 121.665 0.745 . . . . 0.37 111.106 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.542 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 65.8 Cg_endo -71.7 167.76 25.61 Favored 'Trans proline' 0 C--N 1.332 -0.29 0 C-N-CA 124.349 3.366 . . . . 0.64 112.045 176.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.17 -24.23 64.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.993 0.425 . . . . 1.02 110.659 174.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -69.17 -24.04 64.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.53 0.681 . . . . 1.58 110.162 174.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.596 ' OG ' ' HE2' ' A' ' 57' ' ' LYS . 28.8 t -84.43 139.34 32.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.471 -0.786 . . . . 0.71 109.256 176.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -92.95 -11.9 32.16 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.823 -0.806 . . . . 2.89 108.823 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.596 ' HE2' ' OG ' ' A' ' 55' ' ' SER . 2.3 mppt? -90.45 176.48 6.69 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.695 -1.139 . . . . 2.59 110.779 -177.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.447 ' HB3' ' HG2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -135.3 109.58 8.36 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.011 -0.737 . . . . 1.78 109.011 -178.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.547 ' O ' ' HA ' ' A' ' 50' ' ' ALA . 63.4 mtm -155.96 150.11 25.51 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.87 0.367 . . . . 1.3 111.23 -173.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -121.42 156.48 32.6 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.396 -0.82 . . . . 0.14 110.421 174.345 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.587 ' HB3' ' HB2' ' A' ' 49' ' ' GLN . 33.8 ttt180 -153.67 113.22 3.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.989 0.424 . . . . 2.72 110.892 175.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.774 ' HG ' HD13 ' A' ' 48' ' ' LEU . 10.4 mt -93.73 111.66 23.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.105 0.479 . . . . 0.9 110.428 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.897 HG23 ' HG2' ' A' ' 86' ' ' ARG . 3.7 mm -86.17 106.47 15.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 123.534 0.734 . . . . 0.4 109.98 -174.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -81.2 139.43 20.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 119.897 -1.144 . . . . 0.48 112.1 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.66 ' HG3' ' HB2' ' A' ' 46' ' ' ASP . 5.9 mttt -53.3 135.77 38.14 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.227 0.537 . . . . 1.15 111.467 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.469 ' HB ' ' CA ' ' A' ' 84' ' ' PRO . 14.6 p -86.95 150.13 3.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.559 0.695 . . . . 0.69 111.048 -176.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -93.57 81.23 4.32 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.853 -1.067 . . . . 2.56 109.918 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.76 -32.4 27.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.515 -0.766 . . . . 3.79 111.286 -176.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.3 p -63.88 -33.23 75.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.504 0.669 . . . . 3.05 109.524 174.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -87.3 63.93 8.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.337 -0.847 . . . . 5.48 109.37 174.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -51.51 126.79 18.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.582 0.706 . . . . 4.42 111.758 -176.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.502 ' HG2' ' HD3' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -92.5 171.31 9.11 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.162 -0.927 . . . . 4.27 109.489 -176.256 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.36 152.09 46.88 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.778 0.323 . . . . 5.09 110.389 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 75' ' ' ASN . 19.0 t70 -88.98 -163.7 1.03 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.767 -0.651 . . . . 4.98 109.473 -177.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.489 ' H ' ' CG ' ' A' ' 74' ' ' ASP . 73.4 m-20 -57.83 -28.17 63.84 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.912 0.708 . . . . 6.68 112.912 -169.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -82.42 -17.87 43.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.819 0.818 . . . . 7.13 109.549 -175.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.99 30.89 13.09 Favored Glycine 0 CA--C 1.503 -0.683 0 N-CA-C 109.089 -1.604 . . . . 5.53 109.089 -175.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -86.22 -86.94 0.14 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.357 -1.421 . . . . 5.62 111.904 -169.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 177.81 121.86 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.248 0.547 . . . . 5.0 111.666 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.485 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.6 t -128.54 147.69 33.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.439 -0.578 . . . . 3.33 109.439 170.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.9 p -114.51 95.79 41.23 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-O 122.086 0.946 . . . . 2.77 108.919 171.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.502 ' HD3' ' HG2' ' A' ' 72' ' ' ARG . 60.7 Cg_endo -72.37 160.59 46.56 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.193 2.595 . . . . 1.78 113.784 -172.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.439 ' HD3' ' N ' ' A' ' 83' ' ' LYS . 3.7 mppt? -84.62 146.11 46.1 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 114.935 -1.03 . . . . 3.11 108.799 175.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.469 ' CA ' ' HB ' ' A' ' 66' ' ' VAL . 38.3 Cg_exo -53.41 132.36 48.16 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.603 2.202 . . . . 0.67 112.206 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.433 ' H ' ' HG3' ' A' ' 85' ' ' GLN . 0.7 OUTLIER -73.18 115.18 12.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.506 1.146 . . . . 1.78 111.038 -177.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.897 ' HG2' HG23 ' A' ' 63' ' ' ILE . 17.8 mtt85 -102.97 144.26 31.48 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.473 -1.24 . . . . 2.29 109.813 -174.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -105.82 110.87 23.32 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.802 -0.814 . . . . 0.5 108.802 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.423 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 58.2 ttm -105.1 121.97 44.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.916 0.389 . . . . 0.42 110.924 -174.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.473 ' CG ' HD11 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -117.06 123.19 46.24 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.832 -0.803 . . . . 1.33 108.832 177.5 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.523 ' HA ' ' HG2' ' A' ' 59' ' ' MET . 28.2 t -94.64 131.54 40.32 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.149 0.5 . . . . 0.94 110.188 -178.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.47 ' CE1' ' HB2' ' A' ' 7' ' ' ALA . 38.2 m-85 -108.59 165.54 11.46 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.527 -0.76 . . . . 1.33 110.504 175.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -114.62 -3.3 12.92 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.45 -0.796 . . . . 1.53 110.168 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -126.15 121.51 33.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.865 -0.607 . . . . 0.83 109.76 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 -54.66 -36.55 64.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.816 -1.084 . . . . 2.16 111.483 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.617 HG22 HD21 ' A' ' 99' ' ' ASN . 93.7 m -73.23 -55.59 6.24 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.964 -0.562 . . . . 0.4 111.015 -175.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 94.0 t -45.13 -57.24 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-N 116.111 -0.495 . . . . 0.29 111.364 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.756 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -60.9 -34.05 74.06 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.579 -0.448 . . . . 0.29 110.416 -176.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -71.57 -20.35 62.02 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.165 0.507 . . . . 0.39 110.427 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.629 ' O ' ' HG3' ' A' ' 102' ' ' MET . 92.1 m-20 -86.93 -37.84 17.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.222 1.01 . . . . 1.55 109.094 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.759 HG23 HD11 ' A' ' 18' ' ' ILE . 1.6 mm -67.65 -50.7 58.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 113.934 -1.485 . . . . 0.13 111.675 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.756 ' HG2' ' O ' ' A' ' 97' ' ' MET . 2.6 ptmt -58.63 -39.56 80.86 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-O 120.689 0.28 . . . . 1.11 110.822 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.629 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.8 ppp? -73.65 -23.62 59.88 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.166 -0.679 . . . . 1.17 109.166 -176.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 21.2 m -68.02 -51.44 46.98 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.405 -0.816 . . . . 0.15 109.92 173.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.983 ' HB2' HD22 ' A' ' 48' ' ' LEU . 12.6 mt -72.72 -57.17 4.3 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.524 -0.762 . . . . 0.13 111.633 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 1.149 ' HG3' HD23 ' A' ' 48' ' ' LEU . 95.1 mt-30 -51.88 -26.56 10.37 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.64 0.607 . . . . 1.45 112.64 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -71.47 -42.8 67.69 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.229 -0.656 . . . . 0.65 109.229 177.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.749 HG21 ' HB3' ' A' ' 25' ' ' ALA . 69.8 mt -61.42 -44.43 98.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.545 -1.207 . . . . 0.17 110.145 174.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.559 HG13 ' O ' ' A' ' 104' ' ' LEU . 1.2 mt -63.9 -47.8 89.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.635 -0.712 . . . . 0.29 109.906 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.447 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 44.4 t -58.77 -30.68 67.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.354 0.597 . . . . 1.22 109.973 175.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 12.6 ttt180 -67.36 -37.26 82.91 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.133 -0.939 . . . . 3.79 109.778 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -88.5 -19.38 26.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.827 -0.624 . . . . 0.6 111.479 -175.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.539 ' HD2' HG22 ' A' ' 108' ' ' ILE . 8.5 mtpp -78.82 -23.73 44.9 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.416 0.627 . . . . 1.76 109.425 172.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -73.44 -14.42 61.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.237 -0.892 . . . . 1.56 110.093 175.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -131.97 30.63 4.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.732 -0.667 . . . . 1.09 111.073 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.782 -0.628 . . . . 2.16 110.825 -178.307 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.777 0 N-CA-C 112.376 -0.29 . . . . 25.39 112.376 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -123.67 -20.09 2.67 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.798 -0.715 . . . . 24.6 112.334 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -172.37 -143.01 3.96 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.054 -0.593 . . . . 23.97 111.639 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 84.12 -48.54 4.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.021 -0.609 . . . . 23.13 112.695 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -74.02 -17.24 61.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.018 0.437 . . . . 24.92 110.937 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -72.54 138.19 46.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.707 -0.679 . . . . 21.4 110.495 -177.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 15.5 t -82.48 56.42 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.843 0.83 . . . . 20.37 108.856 174.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -111.45 114.25 27.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.098 -0.956 . . . . 17.68 110.153 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -144.81 14.68 1.54 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.599 -0.273 . . . . 16.8 111.607 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.87 149.34 24.17 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.359 -0.608 . . . . 13.35 109.359 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 18.9 m -76.88 -12.43 59.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.025 -0.534 . . . . 10.66 110.775 -175.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -64.03 -32.76 74.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.237 -0.438 . . . . 11.03 111.237 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -75.04 -26.54 59.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.041 0.448 . . . . 10.94 110.584 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 255' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -82.15 -42.39 19.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.435 0.636 . . . . 9.82 109.554 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 256' ' ' SER . . . . . 0.435 ' HB3' ' HA3' ' B' ' 260' ' ' GLY . 70.2 m -150.55 122.22 8.04 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.25 -0.886 . . . . 5.35 109.174 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -53.93 -67.68 0.24 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.585 0.553 . . . . 6.2 112.28 -166.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -88.53 -47.87 8.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.348 0.594 . . . . 6.14 109.979 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -167.1 -38.42 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.515 -1.221 . . . . 3.32 108.971 -176.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . 0.435 ' HA3' ' HB3' ' B' ' 256' ' ' SER . . . 77.95 -7.77 41.21 Favored Glycine 0 C--N 1.333 0.392 0 CA-C-N 115.366 -0.834 . . . . 0.84 114.549 168.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 261' ' ' PHE . . . . . 0.643 ' HB2' ' HB3' ' A' ' 49' ' ' GLN . 8.2 m-30 -103.62 177.93 4.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.84 0.32 . . . . 0.95 110.893 -176.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.71 156.98 12.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.421 -0.354 . . . . 1.37 110.233 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 263' ' ' GLU . . . . . 0.462 ' HA ' ' NE2' ' A' ' 105' ' ' GLN . 40.1 tt0 -106.0 128.65 53.97 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.279 -0.638 . . . . 2.24 109.279 173.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 38.6 t -105.44 109.4 27.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.067 0.46 . . . . 1.41 110.844 -175.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.491 -0.766 . . . . 3.04 109.621 177.223 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.478 0.608 0 N-CA-C 110.173 -0.741 . . . . 3.14 110.173 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.559 ' HA ' ' HB3' ' A' ' 99' ' ' ASN . 55.7 p -108.16 -43.08 4.47 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.944 0.402 . . . . 1.4 111.067 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -88.6 12.59 14.22 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.117 0.484 . . . . 1.85 110.657 -178.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 82.0 p -163.99 148.88 10.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.099 -0.501 . . . . 0.95 109.998 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.45 144.85 5.79 Favored Glycine 0 C--O 1.223 -0.579 0 N-CA-C 110.592 -1.003 . . . . 0.16 110.592 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.726 ' HA ' ' HA ' ' A' ' 15' ' ' ILE . . . -76.63 119.35 20.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.773 0.786 . . . . 0.43 111.448 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.432 ' HB2' ' CE1' ' A' ' 91' ' ' PHE . . . -124.82 158.22 33.93 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.484 0.659 . . . . 0.13 111.7 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.526 HG13 ' HA ' ' A' ' 13' ' ' SER . 2.7 mp -100.48 123.99 53.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.04 -0.982 . . . . 0.29 109.028 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.43 ' HB3' ' CE2' ' A' ' 29' ' ' TRP . 85.7 t80 -121.9 101.71 7.73 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.29 -0.414 . . . . 0.56 110.061 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 65.99 56.98 0.82 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.575 0.702 . . . . 1.46 110.708 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt 73.13 -8.03 1.39 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.407 -1.27 . . . . 1.91 113.109 170.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -102.46 130.27 52.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.059 0.457 . . . . 0.47 110.712 174.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.526 ' HA ' HG13 ' A' ' 8' ' ' ILE . 27.0 t -79.86 130.84 35.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.685 -0.689 . . . . 1.02 110.404 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.647 ' HA2' ' H ' ' A' ' 32' ' ' THR . . . -148.95 -155.63 6.8 Favored Glycine 0 N--CA 1.435 -1.373 0 CA-C-N 115.588 -0.733 . . . . 0.16 111.906 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.726 ' HA ' ' HA ' ' A' ' 6' ' ' ALA . 10.3 mm -126.74 153.74 35.92 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.765 0 CA-C-O 120.801 0.334 . . . . 0.19 110.759 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.464 HD11 ' CG ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -125.05 133.82 68.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 115.918 -0.583 . . . . 0.16 109.501 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.3 108.88 6.96 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.002 0.429 . . . . 0.12 111.992 175.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.622 HD11 HG23 ' A' ' 100' ' ' ILE . 3.6 mp -85.16 120.21 35.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.559 -0.904 . . . . 0.18 108.559 172.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.445 ' ND2' ' H ' ' A' ' 21' ' ' ASP . 2.0 t30 -124.34 123.84 41.07 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.886 -0.413 . . . . 1.12 109.886 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -109.0 83.32 1.73 Allowed 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 117.187 -1.805 . . . . 0.74 107.632 165.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.445 ' H ' ' ND2' ' A' ' 19' ' ' ASN . 11.9 t70 -122.48 -10.92 8.37 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 106.774 -1.565 . . . . 0.59 106.774 156.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 23' ' ' SER . 14.5 p -101.41 175.1 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 112.181 -2.282 . . . . 0.35 111.775 -155.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.683 ' O ' HG13 ' A' ' 22' ' ' VAL . 1.2 t -54.42 165.47 0.86 Allowed Pre-proline 0 C--O 1.225 -0.221 0 N-CA-C 105.972 -1.862 . . . . 1.31 105.972 167.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.558 ' HA ' ' OH ' ' A' ' 111' ' ' TYR . 9.8 Cg_endo -41.22 128.01 3.03 Favored 'Trans proline' 0 C--N 1.357 0.995 0 CA-C-N 122.204 1.823 . . . . 0.22 111.744 -151.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.716 ' HB3' HG21 ' A' ' 107' ' ' ILE . . . -29.81 133.81 0.05 Allowed 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 125.348 1.655 . . . . 0.2 113.756 -157.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.643 ' HB2' HG11 ' A' ' 22' ' ' VAL . 31.6 mt-10 -122.56 132.56 54.36 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.768 -1.105 . . . . 1.26 110.98 -171.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.565 HD23 ' C ' ' A' ' 27' ' ' LEU . 1.2 tt -100.92 142.45 32.37 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.398 -1.704 . . . . 0.15 106.398 172.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.412 ' N ' HD23 ' A' ' 27' ' ' LEU . 24.5 m -129.8 110.04 11.42 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.636 -0.826 . . . . 0.21 110.505 -178.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.641 ' HA ' ' O ' ' A' ' 15' ' ' ILE . 86.0 t90 -86.11 105.87 16.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.591 0.71 . . . . 0.24 109.27 174.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -113.26 114.14 26.29 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.91 -1.041 . . . . 0.87 108.741 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.584 ' HA ' ' HA3' ' A' ' 14' ' ' GLY . 93.1 p -57.61 147.53 26.99 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.422 0.63 . . . . 0.75 110.424 -174.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.647 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 18.9 m -51.98 -26.44 10.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.447 -1.251 . . . . 0.39 112.331 -174.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -88.07 -28.16 21.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.961 0.41 . . . . 2.33 111.234 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.91 17.33 28.16 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.996 -0.621 . . . . 0.55 112.361 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -90.01 -35.31 15.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.03 0.443 . . . . 1.13 111.15 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -118.61 141.71 48.33 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.162 0.506 . . . . 2.03 111.114 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 29' ' ' TRP . 69.3 t -141.79 116.93 5.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.972 -1.013 . . . . 0.55 109.853 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -123.36 109.56 14.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.191 -0.459 . . . . 0.69 109.934 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 39.0 m -98.07 137.08 37.39 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.985 -0.286 . . . . 0.3 111.207 -176.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.524 HG11 HD13 ' A' ' 62' ' ' LEU . 40.0 t -110.8 129.69 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 122.705 0.402 . . . . 0.66 111.467 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.539 ' O ' HG12 ' A' ' 45' ' ' ILE . 55.3 t -91.21 108.04 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-O 121.282 0.563 . . . . 0.18 109.576 173.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.617 HD11 ' CD2' ' A' ' 104' ' ' LEU . 1.8 mm? -56.09 -28.32 57.24 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.07 -0.968 . . . . 0.12 112.533 -177.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' ' 24' ' ' PRO . 31.5 t -74.19 -31.3 62.6 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.297 -0.561 . . . . 1.06 110.504 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.6 p -79.94 -10.01 59.73 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.682 -0.488 . . . . 0.2 109.682 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.623 HG21 ' CD2' ' A' ' 62' ' ' LEU . 44.6 mm -84.44 116.53 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.61 -0.723 . . . . 0.23 111.535 176.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.63 ' N ' ' HD2' ' A' ' 65' ' ' LYS . 2.5 t70 -74.96 -47.54 28.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.242 -0.89 . . . . 0.7 111.422 175.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.498 ' O ' HG12 ' A' ' 63' ' ' ILE . 15.5 tptt -136.02 136.66 40.46 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.047 -0.524 . . . . 1.95 109.916 -174.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.041 HD23 ' HG3' ' A' ' 105' ' ' GLN . 13.2 tp -106.74 142.65 36.04 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 119.661 -0.815 . . . . 0.14 109.081 164.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.572 HE21 ' HB2' ' B' ' 261' ' ' PHE . 4.1 mt-30 -122.96 152.69 40.62 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.687 -1.142 . . . . 1.49 109.675 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.497 ' H ' ' HB3' ' B' ' 261' ' ' PHE . . . -161.47 139.2 9.08 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.182 -0.673 . . . . 0.25 109.182 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 58' ' ' MET . 40.4 p -54.95 125.41 56.07 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-O 121.453 0.644 . . . . 0.37 111.715 -178.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' B' ' 261' ' ' PHE . 46.1 Cg_endo -67.34 166.74 22.48 Favored 'Trans proline' 0 C--N 1.334 -0.204 0 C-N-CA 124.064 3.176 . . . . 0.64 112.238 178.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.439 ' N ' HH21 ' A' ' 94' ' ' ARG . . . -60.43 -28.89 68.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.028 0.442 . . . . 1.02 110.419 175.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 t -71.75 -24.13 61.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.744 -0.662 . . . . 1.58 110.466 177.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.449 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 33.4 t -71.51 141.87 50.14 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.549 -0.537 . . . . 0.71 109.549 176.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -83.4 -17.64 41.54 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.302 0.572 . . . . 2.89 110.149 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -97.09 179.93 4.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.518 -0.764 . . . . 2.59 110.662 -173.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.467 ' N ' ' SD ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -133.75 110.32 9.73 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.177 -1.046 . . . . 1.78 108.177 171.311 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.522 ' HB3' ' HE1' ' B' ' 261' ' ' PHE . 29.8 ttm -157.11 137.61 13.03 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.592 -0.443 . . . . 1.3 111.247 -171.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.444 HD23 HD11 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -112.12 155.47 23.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.929 -0.578 . . . . 0.14 110.173 177.671 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 88' ' ' MET . 19.6 ttm180 -151.02 113.59 4.66 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.739 0.304 . . . . 2.72 110.794 173.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.785 ' HG ' HD13 ' A' ' 48' ' ' LEU . 10.7 mt -96.94 108.2 20.87 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.056 0.543 . . . . 0.9 111.331 -177.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.698 HG23 ' HB3' ' A' ' 86' ' ' ARG . 2.6 mm -88.88 131.46 36.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 C-N-CA 123.21 0.604 . . . . 0.4 110.872 -175.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 45' ' ' ILE . . . -85.6 166.1 39.33 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.153 -1.022 . . . . 0.48 112.056 175.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.63 ' HD2' ' N ' ' A' ' 46' ' ' ASP . 1.1 mptm? -75.07 131.24 40.42 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.622 -0.511 . . . . 1.15 109.622 173.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.535 ' HB ' ' HG3' ' A' ' 84' ' ' PRO . 5.2 p -74.73 152.75 6.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.383 0.611 . . . . 0.69 111.416 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.456 ' HB2' ' HE2' ' A' ' 70' ' ' LYS . 4.8 p-10 -89.82 82.58 6.22 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.128 -0.942 . . . . 2.56 111.457 -177.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 71' ' ' LYS . 0.1 OUTLIER -84.64 -24.44 29.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 3.79 111.059 -178.538 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.2 t -69.06 -20.26 64.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.117 0.484 . . . . 3.05 110.814 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.456 ' HE2' ' HB2' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -134.53 62.91 1.64 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.11 -0.496 . . . . 5.48 109.963 178.051 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 68' ' ' GLU . 35.7 mtmm -56.72 146.32 26.15 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.784 0.802 . . . . 4.42 112.322 -176.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.461 ' HG2' ' HD3' ' A' ' 82' ' ' PRO . 8.1 ptm180 -82.39 172.91 12.54 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.532 -1.213 . . . . 4.27 108.773 175.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.438 ' HB3' ' C ' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -124.7 165.62 17.61 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.836 -0.431 . . . . 5.09 109.836 177.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.739 ' HB3' HD21 ' A' ' 78' ' ' ASN . 1.9 t70 -97.49 -157.17 0.57 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.484 -0.561 . . . . 4.98 109.484 178.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -57.95 -31.45 66.86 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.238 0.458 . . . . 6.68 112.238 -172.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -96.22 1.68 52.36 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.45 0.643 . . . . 7.13 109.843 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.438 ' C ' ' HB3' ' A' ' 73' ' ' LYS . . . 72.42 37.61 58.61 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 114.857 -1.065 . . . . 5.53 110.733 -176.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.739 HD21 ' HB3' ' A' ' 74' ' ' ASP . 5.8 p30 -83.88 -91.41 0.08 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.717 -0.241 . . . . 5.62 110.588 -177.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.418 ' H ' ' CG ' ' A' ' 78' ' ' ASN . 10.7 pt-20 -175.47 124.57 0.23 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.251 0.548 . . . . 5.0 111.323 175.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.445 ' HB ' ' CG ' ' A' ' 72' ' ' ARG . 2.5 t -127.45 148.3 32.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.04 -0.726 . . . . 3.33 109.04 171.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.403 ' HA ' ' HD2' ' A' ' 82' ' ' PRO . 4.2 p -111.4 97.19 35.0 Favored Pre-proline 0 C--N 1.31 -1.118 0 CA-C-O 121.812 0.815 . . . . 2.77 109.648 172.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.461 ' HD3' ' HG2' ' A' ' 72' ' ' ARG . 18.0 Cg_endo -60.56 137.66 75.13 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.292 2.661 . . . . 1.78 112.399 -175.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -54.18 128.17 57.17 Favored Pre-proline 0 C--O 1.236 0.348 0 CA-C-N 115.712 -0.677 . . . . 3.11 110.275 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.535 ' HG3' ' HB ' ' A' ' 66' ' ' VAL . 25.0 Cg_exo -49.5 135.41 33.1 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.385 2.724 . . . . 0.67 112.896 -173.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.04 117.48 6.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.998 0.904 . . . . 1.78 110.817 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.698 ' HB3' HG23 ' A' ' 63' ' ' ILE . 21.3 ptt180 -126.62 148.68 49.76 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.546 -0.752 . . . . 2.29 111.273 -174.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -117.63 113.07 21.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.227 -0.897 . . . . 0.5 110.523 -169.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.48 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 49.1 ttm -100.59 130.87 46.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.82 0.343 . . . . 0.42 111.537 -176.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.464 ' CG ' HD11 ' A' ' 16' ' ' ILE . 79.4 m-85 -126.28 122.66 36.12 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.433 -0.58 . . . . 1.33 109.433 174.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.426 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 35.5 m -92.46 132.93 36.38 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.302 -0.408 . . . . 0.94 110.161 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.647 ' CZ ' HG13 ' A' ' 100' ' ' ILE . 25.5 m-85 -108.5 171.13 7.59 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.968 0.413 . . . . 1.33 110.846 177.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -112.0 -3.27 14.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.823 -0.626 . . . . 1.53 110.114 -177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -141.08 129.13 22.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.346 0.594 . . . . 0.83 110.799 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.439 HH21 ' N ' ' A' ' 53' ' ' ALA . 49.3 tpt85 -61.04 -27.98 68.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.806 -1.088 . . . . 2.16 111.405 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.481 HG22 HD21 ' A' ' 99' ' ' ASN . 99.3 m -75.8 -55.63 5.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.629 -0.259 . . . . 0.4 111.278 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.3 t -45.52 -56.8 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-O 120.852 0.358 . . . . 0.29 111.082 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.688 ' O ' ' HG2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -62.24 -32.09 72.74 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.779 -0.646 . . . . 0.29 110.602 -177.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.415 ' HB2' ' NH1' ' A' ' 94' ' ' ARG . 19.6 t70 -66.55 -34.13 77.22 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.77 0.795 . . . . 0.39 109.555 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.604 ' O ' ' HG3' ' A' ' 102' ' ' MET . 89.2 m-20 -76.83 -41.32 44.69 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.421 -1.263 . . . . 1.55 109.878 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.647 HG13 ' CZ ' ' A' ' 91' ' ' PHE . 23.4 mm -63.02 -53.43 46.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.948 -1.024 . . . . 0.13 111.15 176.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.785 ' HA ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -59.88 -38.14 81.36 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 120.726 0.298 . . . . 1.11 111.065 -177.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.604 ' HG3' ' O ' ' A' ' 99' ' ' ASN . 4.4 ppp? -71.63 -25.74 62.28 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.365 -0.606 . . . . 1.17 109.365 -175.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 100' ' ' ILE . 23.1 m -68.13 -52.15 38.11 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.488 -0.778 . . . . 0.15 110.258 174.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.946 ' HB2' HD22 ' A' ' 48' ' ' LEU . 8.2 mt -69.16 -57.44 5.38 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.523 -0.762 . . . . 0.13 111.33 -175.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 1.041 ' HG3' HD23 ' A' ' 48' ' ' LEU . 95.2 mt-30 -52.7 -25.48 11.13 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.811 0.671 . . . . 1.45 112.811 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -73.41 -35.63 65.86 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.703 0.763 . . . . 0.65 109.403 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.716 HG21 ' HB3' ' A' ' 25' ' ' ALA . 69.5 mt -69.53 -41.7 80.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.539 -1.21 . . . . 0.17 110.249 175.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.548 HG22 ' HD2' ' A' ' 112' ' ' LYS . 1.2 mt -65.6 -50.86 69.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.805 -0.634 . . . . 0.29 110.544 -176.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.481 ' HA ' ' HD3' ' A' ' 112' ' ' LYS . 48.6 m -58.69 -28.86 66.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.212 0.53 . . . . 1.22 110.141 174.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.464 ' HB3' ' O ' ' A' ' 107' ' ' ILE . 8.3 ttt180 -66.09 -39.51 90.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.405 -0.816 . . . . 3.79 109.509 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.558 ' OH ' ' HA ' ' A' ' 24' ' ' PRO . 21.3 m-85 -84.81 -23.19 29.22 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.503 -0.772 . . . . 0.6 111.651 -175.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.548 ' HD2' HG22 ' A' ' 108' ' ' ILE . 9.4 mtpp -77.19 -27.92 53.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.407 0.623 . . . . 1.76 109.756 175.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -70.18 -18.27 63.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.159 -0.928 . . . . 1.56 110.196 173.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -128.57 32.23 4.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.667 -0.697 . . . . 1.09 111.239 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 111' ' ' TYR . 20.4 t70 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.477 -0.773 . . . . 2.16 109.844 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 111.839 -0.505 . . . . 25.39 111.839 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 243' ' ' GLY . . . . . . . . . . . . . . . -120.1 25.88 7.3 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.063 -0.589 . . . . 24.6 111.953 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -102.91 60.98 0.49 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.837 -0.697 . . . . 23.97 111.906 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.05 41.95 5.44 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.798 -0.715 . . . . 23.13 112.069 -178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 246' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -76.36 -32.13 58.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.238 0.542 . . . . 24.92 110.686 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 247' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -108.63 136.92 47.41 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.787 -0.642 . . . . 21.4 110.486 -178.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . . . . . . . . . 33.5 m -90.3 9.32 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.915 -0.584 . . . . 20.37 109.996 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 249' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -99.53 116.91 32.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.462 -0.79 . . . . 17.68 110.652 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 250' ' ' MET . . . . . . . . . . . . . 22.6 ptp -150.61 16.7 0.8 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.971 -0.559 . . . . 16.8 110.246 176.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -78.05 139.92 39.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.025 -0.534 . . . . 13.35 111.244 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 14.1 m -72.05 -15.71 62.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.588 -0.733 . . . . 10.66 110.313 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 253' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -64.86 -37.11 86.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.732 -0.667 . . . . 11.03 110.847 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 254' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -67.2 -32.33 73.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 10.94 110.622 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 255' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' B' ' 256' ' ' SER . 49.2 mt-10 -84.38 -17.7 38.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.056 -0.52 . . . . 9.82 110.657 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 256' ' ' SER . . . . . 0.441 ' HB3' ' O ' ' B' ' 255' ' ' GLU . 41.9 t 73.07 105.76 0.07 Allowed 'General case' 0 C--N 1.332 -0.154 0 O-C-N 124.392 1.057 . . . . 5.35 109.487 -171.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 257' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -88.19 -35.09 17.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.844 -0.616 . . . . 6.2 111.338 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.85 -31.49 71.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 6.14 111.806 -175.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 259' ' ' ASP . . . . . 0.416 ' CG ' HE22 ' A' ' 49' ' ' GLN . 1.4 p30 -151.54 -38.57 0.12 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.109 0.411 . . . . 3.32 112.109 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 100.57 17.54 23.58 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.241 -0.981 . . . . 0.84 112.902 176.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 261' ' ' PHE . . . . . 0.572 ' HB2' HE21 ' A' ' 49' ' ' GLN . 35.1 m-85 -130.38 177.07 7.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.467 0.651 . . . . 0.95 112.287 -173.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 262' ' ' VAL . . . . . . . . . . . . . 11.9 p -144.23 147.64 19.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 114.729 -1.123 . . . . 1.37 108.907 171.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 263' ' ' GLU . . . . . 0.506 ' HA ' HE22 ' A' ' 105' ' ' GLN . 17.5 tt0 -100.48 121.22 41.2 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.265 -0.643 . . . . 2.24 109.265 176.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 43.5 t -110.18 106.72 21.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.872 0.368 . . . . 1.41 110.921 -173.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 265' ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.522 -0.751 . . . . 3.04 110.616 179.924 . . . . . . . . 0 0 . 1 stop_ save_